archetype #,Feature Name,P value (Mann-Whitney),Median Difference,Mean Difference,Significant after Benjamini-Hochberg correction?,Is first bin maximal?
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,5.508e-06,1.7184,1.5009,1,1
1,GO BLEB ASSEMBLY,2.7578e-07,1.6202,1.4129,1,1
1,GO MEMBRANE RAFT ASSEMBLY,2.5774e-06,1.4257,1.574,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,1.349e-05,1.3467,1.1412,1,1
1,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,3.17e-07,1.2317,1.0873,1,1
1,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,8.4155e-08,1.1934,1.1896,1,1
1,GO NEGATIVE REGULATION OF HIPPO SIGNALING,2.4515e-08,1.1682,1.1164,1,1
1,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,2.9957e-08,1.1619,1.1056,1,1
1,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,7.013e-05,1.1571,1.0862,1,1
1,GO NEUTROPHIL HOMEOSTASIS,2.1831e-07,1.0953,1.0242,1,1
1,GO RESPONSE TO INTERFERON ALPHA,3.3202e-07,1.076,1.1515,1,1
1,GO T HELPER 2 CELL DIFFERENTIATION,1.725e-07,1.0692,1.0512,1,1
1,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,1.2971e-07,1.054,1.0019,1,1
1,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,4.6623e-06,1.0476,0.9885,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,9.389e-05,1.0416,0.80787,1,1
1,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,1.9873e-07,1.0286,1.0401,1,1
1,GO HYALURONAN CATABOLIC PROCESS,6.93e-08,1.0272,1.0615,1,1
1,GO REGULATION OF PLASMINOGEN ACTIVATION,4.4878e-05,1.0145,0.89651,1,1
1,GO GLYCOPROTEIN CATABOLIC PROCESS,2.3975e-07,0.99651,0.87839,1,1
1,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,6.2786e-05,0.99375,0.8563,1,1
1,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,1.4039e-05,0.9908,0.87926,1,1
1,GO T HELPER 1 CELL DIFFERENTIATION,2.2879e-07,0.98973,0.84912,1,1
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,4.2876e-06,0.98827,0.87997,1,1
1,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,3.6414e-07,0.9695,0.95482,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,5.0683e-06,0.94575,0.95524,1,1
1,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,3.8423e-08,0.93272,0.93407,1,1
1,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,3.17e-07,0.93268,0.99762,1,1
1,GO BONE TRABECULA FORMATION,1.4039e-05,0.92917,0.88071,1,1
1,GO NEGATIVE REGULATION OF CELL KILLING,2.9301e-06,0.92892,0.84687,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,6.4994e-06,0.92141,0.86984,1,1
1,GO REGULATION OF METANEPHROS DEVELOPMENT,2.8496e-08,0.92007,0.9877,1,1
1,GO TROPHOBLAST CELL MIGRATION,1.0311e-06,0.91684,0.86337,1,1
1,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.00011241,0.91524,0.72381,1,1
1,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,2.0784e-06,0.90936,0.89304,1,1
1,GO INFLAMMATORY RESPONSE TO WOUNDING,3.9926e-07,0.90577,0.97577,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,8.628e-07,0.90321,0.81079,1,1
1,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,4.6623e-06,0.89158,1.0644,1,1
1,GO HEMIDESMOSOME ASSEMBLY,1.3441e-06,0.88821,1.2473,1,1
1,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,7.2756e-08,0.88753,0.92083,1,1
1,GO ENDODERMAL CELL DIFFERENTIATION,3.479e-08,0.87035,0.95484,1,1
1,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,3.6414e-07,0.86993,0.83986,1,1
1,GO GLOMERULAR MESANGIUM DEVELOPMENT,1.2366e-07,0.8622,0.84804,1,1
1,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,7.2111e-07,0.86061,0.73218,1,1
1,GO COLLAGEN BIOSYNTHETIC PROCESS,4.2424e-08,0.85508,0.86684,1,1
1,GO MEMBRANE RAFT ORGANIZATION,2.4692e-06,0.85217,0.93814,1,1
1,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,2.0033e-05,0.83667,0.7734,1,1
1,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,5.6999e-08,0.83422,0.84731,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,2.1702e-06,0.83326,0.72633,1,1
1,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,4.5813e-07,0.83235,0.72335,1,1
1,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,2.2879e-07,0.83091,0.83929,1,1
1,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,2.6322e-07,0.82762,0.77824,1,1
1,GO CD40 SIGNALING PATHWAY,3.8131e-07,0.82693,0.76047,1,1
1,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,1.1237e-07,0.82175,0.79057,1,1
1,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,6.6003e-08,0.81999,0.79183,1,1
1,GO RESPONSE TO INTERFERON BETA,2.3654e-06,0.81918,0.96086,1,1
1,GO HIPPO SIGNALING,1.0311e-06,0.81736,0.66293,1,1
1,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,6.5896e-07,0.81364,0.88591,1,1
1,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,1.5201e-05,0.80448,0.81594,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,3.4772e-07,0.80446,0.68239,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,5.0194e-07,0.80137,0.70362,1,1
1,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,3.9926e-07,0.79819,0.77418,1,1
1,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,2.5308e-05,0.79748,0.71523,1,1
1,GO ZYMOGEN INHIBITION,3.3202e-07,0.79652,0.81438,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,7.5427e-07,0.79611,0.70191,1,1
1,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,1.725e-07,0.79161,0.77508,1,1
1,GO PLASMINOGEN ACTIVATION,5.2139e-05,0.79105,0.63467,1,1
1,GO METANEPHRIC GLOMERULUS DEVELOPMENT,3.1904e-06,0.7774,0.68572,1,1
1,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,1.0207e-07,0.77482,0.71761,1,1
1,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,8.6584e-06,0.77167,0.65882,1,1
1,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,9.7275e-08,0.76737,0.76016,1,1
1,GO CHRONIC INFLAMMATORY RESPONSE,1.8958e-07,0.76567,0.76789,1,1
1,GO ENDODERM FORMATION,4.6826e-08,0.76452,0.83948,1,1
1,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,2.7578e-07,0.75871,0.87318,1,1
1,GO REGULATION OF GLOMERULUS DEVELOPMENT,3.7791e-06,0.7582,0.71576,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,1.104e-05,0.75427,0.68002,1,1
1,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,1.7118e-05,0.75255,0.63701,1,1
1,GO CHAPERONE MEDIATED AUTOPHAGY,0.00079435,0.74994,0.54448,1,1
1,GO CYTIDINE TO URIDINE EDITING,0.00014935,0.74461,0.67938,1,1
1,GO METANEPHRIC EPITHELIUM DEVELOPMENT,1.2971e-07,0.74323,0.70837,1,1
1,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,6.0198e-07,0.74315,0.72966,1,1
1,GO INFLAMMATORY CELL APOPTOTIC PROCESS,1.1267e-06,0.73634,0.69929,1,1
1,GO EPIBOLY,8.8325e-08,0.73565,0.80908,1,1
1,GO LATERAL MESODERM DEVELOPMENT,4.8612e-06,0.73191,0.6384,1,1
1,GO GAP JUNCTION ASSEMBLY,1.0311e-06,0.73129,0.67255,1,1
1,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,5.986e-08,0.72952,0.70342,1,1
1,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,9.2696e-08,0.72741,0.6954,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,3.6228e-06,0.72536,0.74745,1,1
1,GO CELLULAR RESPONSE TO X RAY,1.9263e-05,0.72155,0.59077,1,1
1,GO BRANCH ELONGATION OF AN EPITHELIUM,0.00038934,0.72057,0.54763,1,1
1,GO RESPONSE TO MURAMYL DIPEPTIDE,5.1671e-08,0.71959,0.70783,1,1
1,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,7.0571e-06,0.71559,0.71371,1,1
1,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,5.2139e-05,0.71338,0.67383,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,9.4334e-07,0.71211,0.68399,1,1
1,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,6.6003e-08,0.71003,0.73512,1,1
1,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,2.4346e-05,0.70774,0.63065,1,1
1,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,2.0784e-06,0.70343,0.74778,1,1
1,GO LEUKOCYTE AGGREGATION,0.00011241,0.69722,0.60339,1,1
1,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,6.93e-08,0.69716,0.69103,1,1
1,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,1.6729e-06,0.69356,0.62259,1,1
1,GO BONE TRABECULA MORPHOGENESIS,0.00017186,0.69309,0.56826,1,1
1,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,6.0198e-07,0.69195,0.63481,1,1
1,GO NOTOCHORD DEVELOPMENT,2.5122e-07,0.68927,0.78584,1,1
1,GO T CELL MEDIATED CYTOTOXICITY,1.4039e-05,0.68836,0.6141,1,1
1,GO DENDRITIC CELL APOPTOTIC PROCESS,2.7343e-05,0.68761,0.55695,1,1
1,GO MULTI ORGANISM CELLULAR PROCESS,3.8131e-07,0.68664,0.84649,1,1
1,GO SALIVARY GLAND DEVELOPMENT,3.17e-07,0.68638,0.67602,1,1
1,GO RAP PROTEIN SIGNAL TRANSDUCTION,5.986e-08,0.68278,0.66825,1,1
1,GO VASCULOGENESIS,2.8496e-08,0.68204,0.65965,1,1
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,9.4334e-07,0.67953,0.73999,1,1
1,GO FIBRINOLYSIS,1.0779e-06,0.67892,0.81607,1,1
1,GO T HELPER 1 TYPE IMMUNE RESPONSE,4.5813e-07,0.67742,0.59491,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,3.3287e-06,0.67604,0.57416,1,1
1,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,2.3975e-07,0.67448,0.73294,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL BUD,4.1617e-05,0.67352,0.63404,1,1
1,GO BIOLOGICAL PHASE,0.00020448,0.67212,0.61919,1,1
1,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,9.8628e-07,0.67077,0.80045,1,1
1,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,3.4728e-06,0.66881,0.80018,1,1
1,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,5.2837e-06,0.66835,0.62614,1,1
1,GO CYSTEINE METABOLIC PROCESS,0.00021909,0.664,0.50011,1,1
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,3.4728e-06,0.66109,0.51158,1,1
1,GO NEGATIVE REGULATION OF VIRAL PROCESS,9.4334e-07,0.6609,0.61441,1,1
1,GO RESPONSE TO INTERLEUKIN 18,0.0073363,0.66078,0.60706,1,1
1,GO T CELL EXTRAVASATION,7.0571e-06,0.66048,0.67233,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,1.3441e-06,0.65821,0.59943,1,1
1,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,5.9841e-06,0.65686,0.55414,1,1
1,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,1.3441e-06,0.65443,0.66436,1,1
1,GO REGULATION OF PINOCYTOSIS,4.8379e-05,0.65266,0.63654,1,1
1,GO SKIN MORPHOGENESIS,8.3127e-06,0.65191,0.80368,1,1
1,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,3.1888e-05,0.65072,0.62192,1,1
1,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,5.2837e-06,0.64875,0.6295,1,1
1,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,1.1267e-06,0.6482,0.70463,1,1
1,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.00065623,0.64802,0.50733,1,1
1,GO OLIGOSACCHARIDE CATABOLIC PROCESS,9.3916e-06,0.64565,0.56948,1,1
1,GO APOPTOTIC CELL CLEARANCE,8.8325e-08,0.64512,0.73573,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,4.2876e-06,0.64479,0.57037,1,1
1,GO MUCUS SECRETION,0.0011199,0.64318,0.51538,1,1
1,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,5.2139e-05,0.64162,0.56673,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,2.5774e-06,0.64007,0.62719,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,7.889e-07,0.6392,0.60534,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,2.5308e-05,0.63898,0.55847,1,1
1,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,2.8077e-06,0.63626,0.74231,1,1
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,1.4963e-07,0.62926,0.67969,1,1
1,GO NEGATIVE REGULATION OF CELL AGING,3.8423e-08,0.62907,0.62618,1,1
1,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,3.7791e-06,0.62864,0.55245,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,9.0221e-07,0.62737,0.74372,1,1
1,GO ENDODERM DEVELOPMENT,6.2859e-08,0.62469,0.69376,1,1
1,GO CELLULAR RESPONSE TO IRON ION,1.8084e-07,0.62306,0.63603,1,1
1,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,3.8131e-07,0.62179,0.63472,1,1
1,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,4.0375e-08,0.62011,0.63901,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,1.1776e-06,0.61767,0.65141,1,1
1,GO DNA DEAMINATION,5.7413e-06,0.61555,0.62226,1,1
1,GO REGULATION OF MACROPHAGE DIFFERENTIATION,6.7728e-06,0.61406,0.59624,1,1
1,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,2.3654e-06,0.61151,0.545,1,1
1,GO REGULATION OF ISOTYPE SWITCHING,6.2786e-05,0.60729,0.43524,1,1
1,GO CHEMOKINE BIOSYNTHETIC PROCESS,2.4692e-06,0.60628,0.71537,1,1
1,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,1.6455e-05,0.60417,0.56309,1,1
1,GO BASEMENT MEMBRANE ORGANIZATION,2.1702e-06,0.60305,0.66544,1,1
1,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,1.1267e-06,0.60224,0.66415,1,1
1,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,5.0194e-07,0.60223,0.62889,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,1.725e-07,0.60211,0.65678,1,1
1,GO COLLAGEN METABOLIC PROCESS,1.9873e-07,0.60033,0.61925,1,1
1,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,6.7728e-06,0.60027,0.59159,1,1
1,GO POSITIVE REGULATION OF VASOCONSTRICTION,2.2879e-07,0.59871,0.51871,1,1
1,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.0037331,0.59725,0.37797,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,1.6729e-06,0.59693,0.67702,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,4.1617e-05,0.59676,0.56317,1,1
1,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,1.4044e-06,0.59621,0.50964,1,1
1,GO LIVER REGENERATION,2.2167e-08,0.59611,0.62435,1,1
1,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.00027832,0.59606,0.41536,1,1
1,GO REGULATION OF VIRAL GENOME REPLICATION,1.0311e-06,0.59451,0.54487,1,1
1,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,5.508e-06,0.59393,0.69408,1,1
1,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0038387,0.59369,0.68239,1,1
1,GO REGULATION OF FIBRINOLYSIS,2.0033e-05,0.59308,0.60813,1,1
1,GO NUCLEOSIDE CATABOLIC PROCESS,2.3418e-05,0.59277,0.51755,1,1
1,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.00011241,0.59186,0.49079,1,1
1,GO REGULATION OF COLLAGEN METABOLIC PROCESS,6.2985e-07,0.59159,0.66751,1,1
1,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.0073363,0.59057,0.48591,1,1
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,5.0683e-06,0.58951,0.60123,1,1
1,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,3.4728e-06,0.58625,0.51544,1,1
1,GO RESPONSE TO X RAY,2.8496e-08,0.58533,0.6381,1,1
1,GO RESPONSE TO NITROSATIVE STRESS,7.2754e-05,0.58363,0.46339,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,2.9301e-06,0.58286,0.52773,1,1
1,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,1.4963e-07,0.58243,0.59464,1,1
1,GO SKELETAL MUSCLE TISSUE REGENERATION,1.906e-06,0.58178,0.49143,1,1
1,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00022676,0.58103,0.49147,1,1
1,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,1.0604e-05,0.58028,0.54071,1,1
1,GO MODULATION BY HOST OF VIRAL PROCESS,1.8084e-07,0.57919,0.61678,1,1
1,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,1.2971e-07,0.57918,0.63349,1,1
1,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,1.4039e-05,0.57865,0.5865,1,1
1,GO CELL SUBSTRATE JUNCTION ORGANIZATION,4.7955e-07,0.57823,0.54135,1,1
1,GO RESPONSE TO TYPE I INTERFERON,2.3418e-05,0.57683,0.64307,1,1
1,GO RIBONUCLEOSIDE CATABOLIC PROCESS,2.6902e-06,0.57606,0.64345,1,1
1,GO AORTIC VALVE DEVELOPMENT,1.4674e-06,0.57598,0.57178,1,1
1,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,3.7791e-06,0.57578,0.67583,1,1
1,GO AMYLOID BETA CLEARANCE,5.2533e-07,0.57467,0.502,1,1
1,GO NEGATIVE REGULATION OF COAGULATION,1.104e-05,0.57423,0.60146,1,1
1,GO GLYCOLIPID CATABOLIC PROCESS,2.1663e-05,0.57321,0.53206,1,1
1,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,7.0571e-06,0.57217,0.59984,1,1
1,GO ENTRY INTO HOST,2.2879e-07,0.57198,0.59714,1,1
1,GO HEME METABOLIC PROCESS,2.0784e-06,0.57183,0.51518,1,1
1,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,1.6015e-06,0.57079,0.49733,1,1
1,GO REGULATION OF AMYLOID BETA CLEARANCE,0.00016023,0.57034,0.45126,1,1
1,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,3.9418e-06,0.56938,0.5261,1,1
1,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,1.0604e-05,0.56519,0.46787,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,3.0576e-06,0.56309,0.74151,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,2.7343e-05,0.56139,0.45568,1,1
1,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,3.4772e-07,0.56103,0.59418,1,1
1,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,1.104e-05,0.5601,0.53101,1,1
1,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,2.0033e-05,0.55988,0.47954,1,1
1,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,1.2308e-06,0.55959,0.51596,1,1
1,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,7.889e-07,0.55853,0.56302,1,1
1,GO TOLERANCE INDUCTION,0.00011241,0.55805,0.50511,1,1
1,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.019739,0.55727,0.38238,1,1
1,GO CELLULAR RESPONSE TO DSRNA,1.0207e-07,0.557,0.58626,1,1
1,GO PIGMENT GRANULE MATURATION,0.00014935,0.55681,0.4344,1,1
1,GO IMMUNE RESPONSE TO TUMOR CELL,5.0683e-06,0.5539,0.53795,1,1
1,GO REGULATION OF GLOMERULAR FILTRATION,0.00013917,0.5528,0.60879,1,1
1,GO POSITIVE REGULATION OF STEROL TRANSPORT,5.2533e-07,0.55218,0.50396,1,1
1,GO TYPE 2 IMMUNE RESPONSE,5.508e-06,0.5506,0.56334,1,1
1,GO CYTOLYSIS,3.6228e-06,0.54962,0.48231,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,6.0198e-07,0.5484,0.59362,1,1
1,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,1.4963e-07,0.54697,0.53793,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.0007696,0.54679,0.43161,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.0025083,0.5456,0.39081,1,1
1,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.0001165,0.54443,0.48453,1,1
1,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,3.7791e-06,0.54439,0.47906,1,1
1,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,4.4712e-06,0.54234,0.58473,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.00065623,0.54189,0.43228,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,1.4044e-06,0.54152,0.51795,1,1
1,GO INTERLEUKIN 1 PRODUCTION,4.1112e-06,0.53987,0.49721,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,1.4609e-05,0.53898,0.40458,1,1
1,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,9.3916e-06,0.53874,0.49543,1,1
1,GO COLLAGEN CATABOLIC PROCESS,5.4977e-07,0.53677,0.59561,1,1
1,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,1.2454e-05,0.53459,0.55137,1,1
1,GO MESODERMAL CELL DIFFERENTIATION,4.1802e-07,0.53434,0.49367,1,1
1,GO ZYMOGEN ACTIVATION,1.1964e-05,0.53383,0.54373,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,3.8131e-07,0.5333,0.58501,1,1
1,GO CELLULAR RESPONSE TO SALT STRESS,7.889e-07,0.53276,0.58372,1,1
1,GO EXOCRINE SYSTEM DEVELOPMENT,7.3528e-06,0.53275,0.49209,1,1
1,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,1.0207e-07,0.53268,0.56439,1,1
1,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.00013433,0.53213,0.48009,1,1
1,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,9.0179e-06,0.53206,0.65343,1,1
1,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,5.8301e-05,0.5317,0.42431,1,1
1,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.0046564,0.53123,0.35871,1,1
1,GO VAGINA DEVELOPMENT,1.5331e-06,0.53062,0.60296,1,1
1,GO REGULATION OF VIRAL LIFE CYCLE,6.2985e-07,0.53034,0.52662,1,1
1,GO SUBSTRATE DEPENDENT CELL MIGRATION,7.2111e-07,0.52885,0.50215,1,1
1,GO RESPONSE TO INTERFERON GAMMA,2.0784e-06,0.52776,0.528,1,1
1,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,3.5759e-05,0.52653,0.46011,1,1
1,GO EXTRACELLULAR MATRIX DISASSEMBLY,1.5691e-07,0.52641,0.60119,1,1
1,GO XENOBIOTIC CATABOLIC PROCESS,0.00090094,0.52614,0.55853,1,1
1,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,1.4268e-07,0.52534,0.48066,1,1
1,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,1.2454e-05,0.52479,0.53952,1,1
1,GO FORMATION OF PRIMARY GERM LAYER,6.2859e-08,0.52372,0.53622,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,3.31e-08,0.52304,0.51984,1,1
1,GO REGULATION OF T CELL APOPTOTIC PROCESS,1.6729e-06,0.52287,0.45135,1,1
1,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,5.0194e-07,0.52137,0.50984,1,1
1,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,6.5149e-05,0.52076,0.45961,1,1
1,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.00041602,0.51955,0.4455,1,1
1,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0019282,0.51884,0.38198,1,1
1,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,5.4977e-07,0.51825,0.46919,1,1
1,GO VIRAL GENOME REPLICATION,6.8936e-07,0.51779,0.47932,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,3.3202e-07,0.51749,0.47658,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,3.3287e-06,0.51692,0.53205,1,1
1,GO CELLULAR RESPONSE TO INTERFERON BETA,4.0073e-05,0.51528,0.50871,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,1.349e-05,0.51489,0.44234,1,1
1,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,2.1663e-05,0.51455,0.53631,1,1
1,GO THYMOCYTE APOPTOTIC PROCESS,1.4674e-06,0.51362,0.47492,1,1
1,GO INTEGRIN MEDIATED SIGNALING PATHWAY,1.725e-07,0.51143,0.54693,1,1
1,GO REGULATION OF MEMBRANE INVAGINATION,3.4421e-05,0.51102,0.50668,1,1
1,GO PULMONARY VALVE DEVELOPMENT,8.1192e-05,0.51006,0.51078,1,1
1,GO COLLAGEN FIBRIL ORGANIZATION,4.5813e-07,0.50975,0.75055,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,6.7596e-05,0.50867,0.44217,1,1
1,GO REGULATION OF T HELPER CELL DIFFERENTIATION,2.8077e-06,0.50831,0.45265,1,1
1,GO SEMI LUNAR VALVE DEVELOPMENT,3.0576e-06,0.5083,0.53335,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,5.6999e-08,0.50793,0.52023,1,1
1,GO T CELL MEDIATED IMMUNITY,1.6729e-06,0.50765,0.49809,1,1
1,GO ENAMEL MINERALIZATION,6.7596e-05,0.5076,0.50329,1,1
1,GO OSTEOBLAST DEVELOPMENT,6.7596e-05,0.50516,0.46095,1,1
1,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.0001165,0.50438,0.478,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,3.8583e-05,0.50344,0.39677,1,1
1,GO RESPONSE TO HYPEROXIA,1.0184e-05,0.50157,0.52224,1,1
1,GO 3 UTR MEDIATED MRNA DESTABILIZATION,1.2308e-06,0.50143,0.48073,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,2.9301e-06,0.50099,0.58244,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MATURATION,9.0221e-07,0.5007,0.6274,1,1
1,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,7.8282e-05,0.4997,0.50542,1,1
1,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,4.7955e-07,0.49959,0.51994,1,1
1,GO MAMMARY GLAND MORPHOGENESIS,2.2658e-06,0.49926,0.49037,1,1
1,GO PEPTIDE CROSS LINKING,5.4121e-05,0.49844,0.5217,1,1
1,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,2.9532e-05,0.4983,0.52124,1,1
1,GO AMINOGLYCAN CATABOLIC PROCESS,1.5331e-06,0.49778,0.54084,1,1
1,GO POSITIVE REGULATION OF ERAD PATHWAY,9.3916e-06,0.4976,0.43014,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,2.6322e-07,0.49739,0.56731,1,1
1,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.00041602,0.49693,0.47921,1,1
1,GO LYMPHANGIOGENESIS,2.5122e-07,0.49659,0.52339,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.00030804,0.49644,0.42953,1,1
1,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.001191,0.49603,0.42872,1,1
1,GO STORE OPERATED CALCIUM ENTRY,6.4994e-06,0.49539,0.4176,1,1
1,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.001662,0.49509,0.40113,1,1
1,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.0010528,0.49409,0.40842,1,1
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,1.8251e-06,0.49401,0.46549,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,7.013e-05,0.49286,0.36739,1,1
1,GO GLAND MORPHOGENESIS,2.6902e-06,0.49221,0.47366,1,1
1,GO DETECTION OF BIOTIC STIMULUS,2.1702e-06,0.49201,0.50412,1,1
1,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.00084609,0.49094,0.46949,1,1
1,GO FOREGUT MORPHOGENESIS,7.0571e-06,0.49031,0.50204,1,1
1,GO FIBROBLAST ACTIVATION,0.00012512,0.48989,0.42295,1,1
1,GO ENDOTHELIAL CELL MORPHOGENESIS,0.0029794,0.48779,0.41499,1,1
1,GO GROWTH PLATE CARTILAGE DEVELOPMENT,9.8628e-07,0.48769,0.52434,1,1
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.011326,0.48596,0.40804,1,1
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.00072223,0.48586,0.37189,1,1
1,GO PINOCYTOSIS,2.7578e-07,0.48579,0.61965,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,5.4272e-08,0.48568,0.50204,1,1
1,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,2.5308e-05,0.48508,0.39866,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.00074557,0.48507,0.52123,1,1
1,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,5.2533e-07,0.48502,0.46893,1,1
1,GO PROTEIN OXIDATION,0.00031859,0.48447,0.47647,1,1
1,GO MYELOID CELL APOPTOTIC PROCESS,6.4994e-06,0.48286,0.47391,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,1.1493e-05,0.4825,0.39885,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,1.2962e-05,0.48197,0.52592,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,7.6603e-06,0.48118,0.48768,1,1
1,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,1.5201e-05,0.48084,0.4311,1,1
1,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00055855,0.48059,0.37338,1,1
1,GO PROGESTERONE METABOLIC PROCESS,0.007729,0.48008,0.26905,1,1
1,GO RESPONSE TO ANGIOTENSIN,9.4334e-07,0.47974,0.46273,1,1
1,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,5.7413e-06,0.47935,0.48012,1,1
1,GO MAMMARY GLAND DUCT MORPHOGENESIS,2.1702e-06,0.47868,0.48843,1,1
1,GO VIRAL RNA GENOME REPLICATION,5.6999e-08,0.47778,0.47308,1,1
1,GO REGULATION OF TRANSPOSITION,1.5816e-05,0.47764,0.5152,1,1
1,GO REGULATION OF T CELL MEDIATED IMMUNITY,3.1904e-06,0.47736,0.43811,1,1
1,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,3.3132e-05,0.47718,0.45458,1,1
1,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,3.9926e-07,0.4766,0.40141,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00013433,0.47632,0.39817,1,1
1,GO NIK NF KAPPAB SIGNALING,1.1788e-07,0.4751,0.44192,1,1
1,GO CYTOKINE METABOLIC PROCESS,1.7474e-06,0.47403,0.41172,1,1
1,GO BLOOD VESSEL REMODELING,4.8379e-05,0.47379,0.42356,1,1
1,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,5.2533e-07,0.47301,0.51739,1,1
1,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,4.4878e-05,0.47298,0.41503,1,1
1,GO HYALURONAN METABOLIC PROCESS,2.5122e-07,0.47297,0.50941,1,1
1,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,4.1802e-07,0.47221,0.49903,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,2.2524e-05,0.47181,0.44653,1,1
1,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,1.0184e-05,0.47136,0.49741,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,4.1112e-06,0.4713,0.48348,1,1
1,GO REGULATION OF T CELL CYTOKINE PRODUCTION,3.3287e-06,0.47005,0.50663,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.00079435,0.46966,0.45714,1,1
1,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,2.9301e-06,0.46884,0.53929,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,2.1663e-05,0.46861,0.41337,1,1
1,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,1.1964e-05,0.46829,0.43867,1,1
1,GO MOVEMENT IN HOST ENVIRONMENT,3.8131e-07,0.46814,0.51002,1,1
1,GO REGULATION OF MYOBLAST FUSION,4.6597e-05,0.46731,0.53485,1,1
1,GO DEFENSE RESPONSE TO VIRUS,5.2837e-06,0.46678,0.43157,1,1
1,GO REGULATION OF HORMONE METABOLIC PROCESS,2.2524e-05,0.46674,0.45194,1,1
1,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,4.3763e-07,0.46666,0.51311,1,1
1,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,1.6729e-06,0.4665,0.42559,1,1
1,GO KERATAN SULFATE CATABOLIC PROCESS,1.6455e-05,0.46564,0.59884,1,1
1,GO DERMATAN SULFATE METABOLIC PROCESS,0.0019282,0.46498,0.59317,1,1
1,GO HYPEROSMOTIC SALINITY RESPONSE,9.0551e-05,0.46484,0.39138,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,8.628e-07,0.46434,0.47518,1,1
1,GO LYMPH VESSEL MORPHOGENESIS,1.0779e-06,0.46341,0.46979,1,1
1,GO POSITIVE REGULATION OF VASCULOGENESIS,0.0018173,0.46336,0.38856,1,1
1,GO RESPONSE TO INTERLEUKIN 12,3.0264e-07,0.4632,0.44406,1,1
1,GO BONE GROWTH,1.1267e-06,0.4616,0.5596,1,1
1,GO POSITIVE REGULATION OF PROTEIN IMPORT,3.7791e-06,0.46152,0.41941,1,1
1,GO MEMBRANE PROTEIN PROTEOLYSIS,6.0198e-07,0.46152,0.47516,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,4.6826e-08,0.46133,0.4494,1,1
1,GO MACROPHAGE PROLIFERATION,0.00057693,0.46034,0.46996,1,1
1,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.00018427,0.46009,0.42487,1,1
1,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.0060989,0.45999,0.32449,1,1
1,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,9.3916e-06,0.45962,0.41041,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,5.2837e-06,0.45935,0.44055,1,1
1,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,7.013e-05,0.45863,0.39536,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.00034072,0.45763,0.41108,1,1
1,GO INTERLEUKIN 1 BETA PRODUCTION,5.0683e-06,0.45696,0.45277,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,3.7791e-06,0.45695,0.41965,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,9.8628e-07,0.4567,0.40206,1,1
1,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,4.8612e-06,0.45662,0.41288,1,1
1,GO REPLICATIVE SENESCENCE,0.00036427,0.4566,0.45109,1,1
1,GO NEGATIVE REGULATION OF BIOMINERALIZATION,1.5201e-05,0.45603,0.53236,1,1
1,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0013457,0.45586,0.43816,1,1
1,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,7.0571e-06,0.45585,0.45832,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,7.5427e-07,0.45481,0.41386,1,1
1,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,5.508e-06,0.45459,0.41183,1,1
1,GO ANIMAL ORGAN REGENERATION,9.7275e-08,0.45455,0.51689,1,1
1,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,1.4268e-07,0.45439,0.40297,1,1
1,GO PROTEASOME ASSEMBLY,0.00017186,0.45437,0.31453,1,1
1,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,3.3132e-05,0.45359,0.69859,1,1
1,GO SMAD PROTEIN COMPLEX ASSEMBLY,7.6603e-06,0.45257,0.49676,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS,1.3605e-07,0.4525,0.51194,1,1
1,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,6.5896e-07,0.45234,0.48177,1,1
1,GO REGULATION OF RECEPTOR BINDING,0.0018173,0.45175,0.36868,1,1
1,GO TRABECULA FORMATION,0.00011241,0.4515,0.48904,1,1
1,GO MRNA TRANSCRIPTION,2.7343e-05,0.45148,0.37433,1,1
1,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.014486,0.45146,0.28393,1,1
1,GO MUSCLE CELL FATE COMMITMENT,3.1888e-05,0.45136,0.45821,1,1
1,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,2.7343e-05,0.45131,0.35745,1,1
1,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.00052342,0.45123,0.32221,1,1
1,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,1.0311e-06,0.45052,0.41222,1,1
1,GO RESPONSE TO SALT STRESS,3.0264e-07,0.45042,0.41909,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.001191,0.45035,0.36474,1,1
1,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,1.3441e-06,0.45007,0.39798,1,1
1,GO EXTRACELLULAR STRUCTURE ORGANIZATION,3.17e-07,0.44967,0.52049,1,1
1,GO MODULATION BY HOST OF SYMBIONT PROCESS,7.5427e-07,0.44963,0.42391,1,1
1,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,3.0264e-07,0.44781,0.42852,1,1
1,GO TONGUE MORPHOGENESIS,0.01282,0.44763,0.31539,1,1
1,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,3.3132e-05,0.44759,0.40291,1,1
1,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,3.9926e-07,0.44684,0.4321,1,1
1,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.00018427,0.44657,0.4854,1,1
1,GO HAIR FOLLICLE MATURATION,0.00087311,0.44653,0.36396,1,1
1,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,2.1663e-05,0.44636,0.36603,1,1
1,GO MATURATION OF LSU RRNA,0.00013917,0.4463,0.38091,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00027832,0.44597,0.36682,1,1
1,GO RESPONSE TO PROGESTERONE,0.0060989,0.44549,0.29835,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,5.4977e-07,0.44516,0.43554,1,1
1,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,2.6902e-06,0.44463,0.51177,1,1
1,GO ETHANOL OXIDATION,0.013798,0.44459,0.38118,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION,6.8936e-07,0.44452,0.39721,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,3.0576e-06,0.44436,0.4461,1,1
1,GO CELLULAR COPPER ION HOMEOSTASIS,2.7343e-05,0.44397,0.53568,1,1
1,GO REGULATION OF KIDNEY DEVELOPMENT,4.1112e-06,0.44386,0.39086,1,1
1,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,5.8301e-05,0.44368,0.32778,1,1
1,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.00013433,0.44332,0.39958,1,1
1,GO CELLULAR RESPONSE TO OSMOTIC STRESS,6.5896e-07,0.4425,0.41131,1,1
1,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,5.9841e-06,0.44232,0.47999,1,1
1,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.00081984,0.44133,0.33266,1,1
1,GO EMBRYO IMPLANTATION,3.0264e-07,0.44132,0.53216,1,1
1,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.00065623,0.44109,0.40692,1,1
1,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,1.7474e-06,0.44108,0.54439,1,1
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,7.6603e-06,0.43997,0.47511,1,1
1,GO ENDOTHELIAL CELL CHEMOTAXIS,2.1663e-05,0.43992,0.49914,1,1
1,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.00090094,0.43989,0.46246,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,9.8628e-07,0.43934,0.45692,1,1
1,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,1.349e-05,0.43912,0.41624,1,1
1,GO REGULATION OF HIPPO SIGNALING,5.4121e-05,0.43903,0.40661,1,1
1,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.023205,0.43896,0.27247,1,1
1,GO POSITIVE REGULATION OF HEART GROWTH,4.6597e-05,0.4387,0.35116,1,1
1,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.00074557,0.43804,0.54122,1,1
1,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,9.0551e-05,0.43779,0.6396,1,1
1,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.0017641,0.43741,0.31401,1,1
1,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.00057693,0.4374,0.51477,1,1
1,GO VIRAL TRANSLATION,5.2837e-06,0.4367,0.41455,1,1
1,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,3.4421e-05,0.43643,0.41067,1,1
1,GO RESPONSE TO FLUID SHEAR STRESS,3.9418e-06,0.43604,0.45408,1,1
1,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00067758,0.43512,0.32015,1,1
1,GO DISTAL TUBULE DEVELOPMENT,0.012203,0.43499,0.34738,1,1
1,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,8.3127e-06,0.43469,0.41498,1,1
1,GO INTERLEUKIN 2 PRODUCTION,5.4977e-07,0.43407,0.45457,1,1
1,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,5.508e-06,0.43402,0.48004,1,1
1,GO CELL ADHESION MEDIATED BY INTEGRIN,2.2524e-05,0.434,0.4691,1,1
1,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,6.2786e-05,0.4337,0.39049,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,6.7596e-05,0.43294,0.35645,1,1
1,GO REGULATION OF PROTEIN POLYUBIQUITINATION,2.3418e-05,0.43243,0.31654,1,1
1,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,7.2754e-05,0.43216,0.3845,1,1
1,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.00057693,0.43181,0.35482,1,1
1,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,4.4878e-05,0.43171,0.37885,1,1
1,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0050528,0.43133,0.26081,1,1
1,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00084609,0.43072,0.46835,1,1
1,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.9263e-05,0.43051,0.47308,1,1
1,GO FOCAL ADHESION ASSEMBLY,3.3287e-06,0.4299,0.43249,1,1
1,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.0039469,0.42942,0.28778,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,2.1702e-06,0.42879,0.41876,1,1
1,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,1.5331e-06,0.42869,0.59202,1,1
1,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,9.0551e-05,0.42777,0.38098,1,1
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.0034322,0.42732,0.3936,1,1
1,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.0011549,0.42653,0.3326,1,1
1,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,6.2367e-06,0.42639,0.38131,1,1
1,GO FIBROBLAST MIGRATION,4.1802e-07,0.42632,0.44796,1,1
1,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.00059588,0.4263,0.49259,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,1.4963e-07,0.42609,0.45895,1,1
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,4.6623e-06,0.42585,0.46272,1,1
1,GO REGULATION OF SYMBIOTIC PROCESS,6.2985e-07,0.4255,0.41943,1,1
1,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,1.2862e-06,0.4253,0.43484,1,1
1,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,5.7413e-06,0.42502,0.39932,1,1
1,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,1.2971e-07,0.42501,0.39221,1,1
1,GO POSITIVE REGULATION OF ORGAN GROWTH,4.4712e-06,0.42487,0.37314,1,1
1,GO I KAPPAB PHOSPHORYLATION,5.0683e-06,0.42378,0.34683,1,1
1,GO RECEPTOR CATABOLIC PROCESS,4.8612e-06,0.42329,0.42185,1,1
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,5.753e-07,0.42324,0.39979,1,1
1,GO REGULATION OF FIBROBLAST MIGRATION,1.1776e-06,0.42312,0.46262,1,1
1,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,3.8583e-05,0.42129,0.34644,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.00047456,0.42118,0.48173,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,1.2962e-05,0.4211,0.40813,1,1
1,GO REGULATION OF TRANSLATIONAL TERMINATION,4.4878e-05,0.42104,0.36792,1,1
1,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,4.1617e-05,0.42058,0.38039,1,1
1,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,1.2308e-06,0.41965,0.3758,1,1
1,GO CYTOPLASMIC TRANSLATION,0.00063551,0.41955,0.30059,1,1
1,GO VIRAL LIFE CYCLE,1.6452e-07,0.41928,0.43742,1,1
1,GO IRON ION TRANSMEMBRANE TRANSPORT,6.2985e-07,0.41881,0.36738,1,1
1,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,2.2658e-06,0.4188,0.40225,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.00034072,0.41814,0.35916,1,1
1,GO TOOTH MINERALIZATION,0.00031859,0.41799,0.35106,1,1
1,GO IMMATURE T CELL PROLIFERATION,6.4994e-06,0.41788,0.47812,1,1
1,GO HISTONE SERINE PHOSPHORYLATION,3.7791e-06,0.41779,0.44856,1,1
1,GO PEPTIDYL PROLINE MODIFICATION,3.9418e-06,0.41743,0.36297,1,1
1,GO MULTI ORGANISM LOCALIZATION,6.6003e-08,0.41721,0.41753,1,1
1,GO PARAXIAL MESODERM DEVELOPMENT,8.7323e-05,0.41665,0.42495,1,1
1,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,1.2454e-05,0.41629,0.42609,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.00016595,0.41575,0.34953,1,1
1,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.00029782,0.41551,0.33804,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.001986,0.41542,0.33184,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.00013433,0.41503,0.39286,1,1
1,GO LENS FIBER CELL DIFFERENTIATION,2.0833e-05,0.41442,0.39404,1,1
1,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,2.7343e-05,0.41398,0.4873,1,1
1,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,4.4712e-06,0.41343,0.40083,1,1
1,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,2.0829e-07,0.4132,0.41919,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,1.349e-05,0.4132,0.35796,1,1
1,GO REGULATION OF STEM CELL DIFFERENTIATION,9.2696e-08,0.41314,0.40922,1,1
1,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.00074557,0.41258,0.35594,1,1
1,GO L ASCORBIC ACID METABOLIC PROCESS,0.0057817,0.41251,0.32307,1,1
1,GO POSITIVE REGULATION OF HAIR CYCLE,0.0023671,0.4121,0.41985,1,1
1,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,4.4712e-06,0.41181,0.41574,1,1
1,GO LENS FIBER CELL DEVELOPMENT,7.8282e-05,0.41124,0.46027,1,1
1,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,1.5201e-05,0.41118,0.49195,1,1
1,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00095906,0.41106,0.31698,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0014299,0.41106,0.31566,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,8.2505e-07,0.41099,0.41056,1,1
1,GO PLATELET AGGREGATION,6.8936e-07,0.41073,0.39543,1,1
1,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.00012074,0.41069,0.39557,1,1
1,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00025131,0.41067,0.40932,1,1
1,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.0013872,0.4106,0.37924,1,1
1,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,1.7474e-06,0.41033,0.41669,1,1
1,GO COPPER ION HOMEOSTASIS,5.7413e-06,0.40959,0.49461,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00055855,0.40881,0.32476,1,1
1,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.00031859,0.40821,0.38782,1,1
1,GO REGULATION OF MRNA BINDING,2.9532e-05,0.40814,0.35834,1,1
1,GO NEGATIVE REGULATION OF WOUND HEALING,7.3528e-06,0.40805,0.43756,1,1
1,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,2.1663e-05,0.40762,0.31474,1,1
1,GO REGULATION OF SECONDARY METABOLIC PROCESS,6.7728e-06,0.40742,0.46673,1,1
1,GO INTERACTION WITH SYMBIONT,6.4994e-06,0.40735,0.35046,1,1
1,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,1.5201e-05,0.40725,0.60288,1,1
1,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.0039469,0.40721,0.31257,1,1
1,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,3.8583e-05,0.40714,0.40231,1,1
1,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.0045306,0.4063,0.42698,1,1
1,GO RIBOSOME ASSEMBLY,0.00095906,0.40605,0.30983,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,1.8251e-06,0.40562,0.42348,1,1
1,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.0038387,0.40561,0.29002,1,1
1,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,5.2837e-06,0.4053,0.48023,1,1
1,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,6.8936e-07,0.40499,0.37879,1,1
1,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.0064317,0.40495,0.45903,1,1
1,GO CARDIOBLAST DIFFERENTIATION,0.00013917,0.40493,0.41342,1,1
1,GO POSITIVE REGULATION OF CELL SIZE,0.03245,0.40476,0.24325,1,1
1,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.019283,0.40455,0.25412,1,1
1,GO REGULATION OF AUTOPHAGOSOME MATURATION,2.2524e-05,0.40431,0.35948,1,1
1,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.00013917,0.40385,0.41031,1,1
1,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,9.3916e-06,0.40363,0.36413,1,1
1,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.00038934,0.40356,0.3555,1,1
1,GO INTERLEUKIN 8 PRODUCTION,4.6623e-06,0.40344,0.40128,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,4.6597e-05,0.40231,0.48349,1,1
1,GO CELL SUBSTRATE ADHESION,3.3202e-07,0.40222,0.43433,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,4.8379e-05,0.40197,0.42985,1,1
1,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.00038934,0.40041,0.48014,1,1
1,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.00087311,0.40024,0.30491,1,1
1,GO REGULATION OF STEROL TRANSPORT,3.3287e-06,0.40018,0.3528,1,1
1,GO PROGRAMMED NECROTIC CELL DEATH,9.7801e-06,0.3998,0.47496,1,1
1,GO INTERFERON BETA PRODUCTION,2.4346e-05,0.39934,0.33089,1,1
1,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,5.0226e-05,0.39932,0.40259,1,1
1,GO REGULATION OF NIK NF KAPPAB SIGNALING,4.7955e-07,0.39927,0.38815,1,1
1,GO SERTOLI CELL DEVELOPMENT,0.00026003,0.399,0.37255,1,1
1,GO GENITALIA MORPHOGENESIS,0.0014299,0.39898,0.34403,1,1
1,GO CERAMIDE CATABOLIC PROCESS,0.00014418,0.39898,0.36353,1,1
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,7.8282e-05,0.39853,0.40436,1,1
1,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.00057693,0.3984,0.32299,1,1
1,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,5.2533e-07,0.39777,0.42665,1,1
1,GO SPROUTING ANGIOGENESIS,1.0311e-06,0.39741,0.39064,1,1
1,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,3.1904e-06,0.39685,0.35255,1,1
1,GO NEURAL CREST CELL MIGRATION,0.0025083,0.39675,0.27672,1,1
1,GO PRIMARY MIRNA PROCESSING,3.7145e-05,0.39624,0.39607,1,1
1,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,3.4728e-06,0.39609,0.39301,1,1
1,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.018398,0.39607,0.35906,1,1
1,GO TYPE I INTERFERON PRODUCTION,7.0571e-06,0.39558,0.34487,1,1
1,GO GALACTOSE METABOLIC PROCESS,0.00049035,0.39556,0.32527,1,1
1,GO REGULATION OF PROTEIN DEUBIQUITINATION,1.7474e-06,0.39547,0.498,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,5.7413e-06,0.39516,0.44722,1,1
1,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.00023468,0.39484,0.5331,1,1
1,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.0019282,0.39441,0.33315,1,1
1,GO PULMONARY VALVE MORPHOGENESIS,0.0036303,0.39434,0.48562,1,1
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,8.3127e-06,0.39367,0.44573,1,1
1,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.00049035,0.39326,0.33356,1,1
1,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.015574,0.39287,0.2673,1,1
1,GO CHONDROCYTE DEVELOPMENT,2.6307e-05,0.3927,0.42333,1,1
1,GO POSITIVE REGULATION OF MITOPHAGY,8.7323e-05,0.39213,0.36006,1,1
1,GO MYOBLAST DIFFERENTIATION,1.2308e-06,0.39197,0.37714,1,1
1,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.015574,0.39159,0.23633,1,1
1,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.00027832,0.39137,0.33663,1,1
1,GO OSTEOCLAST DEVELOPMENT,1.4674e-06,0.39084,0.4321,1,1
1,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,7.0571e-06,0.39081,0.37292,1,1
1,GO REGULATION OF RIBOSOME BIOGENESIS,2.0033e-05,0.39063,0.44451,1,1
1,GO CARNITINE METABOLIC PROCESS,9.389e-05,0.39055,0.37277,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,7.3528e-06,0.39052,0.42323,1,1
1,GO CARDIAC MUSCLE CELL PROLIFERATION,1.2962e-05,0.39002,0.36923,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.013798,0.39,0.35536,1,1
1,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.00022676,0.38999,0.41384,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,2.1702e-06,0.38909,0.37049,1,1
1,GO URETER DEVELOPMENT,0.00041602,0.38905,0.36045,1,1
1,GO INTERACTION WITH HOST,4.3763e-07,0.38851,0.43804,1,1
1,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,1.3441e-06,0.38821,0.42304,1,1
1,GO ERBB2 SIGNALING PATHWAY,3.4728e-06,0.38782,0.35095,1,1
1,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.0028957,0.38744,0.36176,1,1
1,GO T CELL APOPTOTIC PROCESS,9.8628e-07,0.38743,0.37698,1,1
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00040247,0.38656,0.30366,1,1
1,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,6.2859e-08,0.38616,0.39678,1,1
1,GO AMINO ACID BETAINE METABOLIC PROCESS,0.0007696,0.3861,0.3116,1,1
1,GO RESPONSE TO ESTROGEN,2.8891e-07,0.38605,0.40701,1,1
1,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.0033e-05,0.38539,0.34552,1,1
1,GO REGULATION OF GASTRULATION,4.5813e-07,0.38483,0.39684,1,1
1,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00040247,0.38479,0.40096,1,1
1,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,3.6228e-06,0.3847,0.35572,1,1
1,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.00012074,0.38339,0.31385,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0026572,0.38332,0.32862,1,1
1,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.0021062,0.38304,0.28445,1,1
1,GO PHAGOCYTOSIS RECOGNITION,0.00016595,0.38198,0.52221,1,1
1,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,7.9801e-06,0.38186,0.34631,1,1
1,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00027832,0.3813,0.37827,1,1
1,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.0016129,0.38098,0.44887,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,1.1493e-05,0.38043,0.33234,1,1
1,GO TELOMERASE RNA LOCALIZATION,0.00030804,0.37929,0.31592,1,1
1,GO SMOOTH MUSCLE CELL MIGRATION,0.011326,0.37908,0.24689,1,1
1,GO MEMBRANE INVAGINATION,1.1267e-06,0.37863,0.37241,1,1
1,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,1.1267e-06,0.3785,0.47687,1,1
1,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00087311,0.37847,0.40253,1,1
1,GO NEGATIVE REGULATION OF CELL SIZE,6.7728e-06,0.37795,0.3289,1,1
1,GO REGULATION OF NECROTIC CELL DEATH,9.7801e-06,0.37792,0.48888,1,1
1,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,8.3127e-06,0.3776,0.31717,1,1
1,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,2.9301e-06,0.37758,0.44774,1,1
1,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,8.628e-07,0.37732,0.38043,1,1
1,GO MUSCLE FILAMENT SLIDING,2.1702e-06,0.37727,0.38353,1,1
1,GO REGULATION OF PHAGOCYTOSIS,3.0264e-07,0.37716,0.40933,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,1.1776e-06,0.37663,0.41177,1,1
1,GO PROTEIN TARGETING TO LYSOSOME,0.00017186,0.37643,0.33811,1,1
1,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.0001547,0.37627,0.3262,1,1
1,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,1.6729e-06,0.37625,0.35319,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,8.1192e-05,0.37601,0.28929,1,1
1,GO REGULATION OF HEART MORPHOGENESIS,0.00026903,0.37583,0.35501,1,1
1,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,4.7955e-07,0.37582,0.52909,1,1
1,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.00026003,0.37515,0.31233,1,1
1,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.009256,0.37506,0.29688,1,1
1,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.00057693,0.37462,0.34686,1,1
1,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.00049035,0.37432,0.47491,1,1
1,GO T CELL CYTOKINE PRODUCTION,3.0576e-06,0.37391,0.43388,1,1
1,GO REGULATION OF LIPASE ACTIVITY,7.6603e-06,0.37269,0.29335,1,1
1,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,8.7323e-05,0.37205,0.29455,1,1
1,GO REGULATION OF CELL SUBSTRATE ADHESION,1.6015e-06,0.37192,0.40919,1,1
1,GO REGULATION OF PROTEIN IMPORT,8.6584e-06,0.37155,0.3762,1,1
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,1.104e-05,0.37147,0.34969,1,1
1,GO ENDOTHELIAL CELL DEVELOPMENT,0.00011241,0.37114,0.2928,1,1
1,GO MITRAL VALVE DEVELOPMENT,0.0039469,0.37088,0.43334,1,1
1,GO MEMBRANE DISASSEMBLY,0.00017186,0.37042,0.30777,1,1
1,GO INTERLEUKIN 17 PRODUCTION,4.6623e-06,0.37025,0.45312,1,1
1,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0022332,0.36963,0.44343,1,1
1,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,2.1663e-05,0.36911,0.30242,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,5.2139e-05,0.36901,0.29275,1,1
1,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0013457,0.3688,0.25294,1,1
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0020453,0.36879,0.28683,1,1
1,GO CHEMOKINE PRODUCTION,0.00084609,0.36857,0.28433,1,1
1,GO RIG I SIGNALING PATHWAY,8.4205e-05,0.36825,0.35611,1,1
1,GO DENDRITIC CELL DIFFERENTIATION,0.0017641,0.3679,0.3187,1,1
1,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.00095906,0.36769,0.27998,1,1
1,GO CHONDROCYTE DIFFERENTIATION,2.3654e-06,0.36766,0.34635,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,9.389e-05,0.36731,0.30709,1,1
1,GO KERATINOCYTE MIGRATION,2.6307e-05,0.3672,0.36761,1,1
1,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.00034072,0.3671,0.36236,1,1
1,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.001872,0.36695,0.29009,1,1
1,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00095906,0.36639,0.28986,1,1
1,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,7.9801e-06,0.36626,0.3458,1,1
1,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.00036427,0.36623,0.29937,1,1
1,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,4.0073e-05,0.36599,0.32294,1,1
1,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,9.0551e-05,0.3658,0.2936,1,1
1,GO GLIAL CELL ACTIVATION,0.00036427,0.36566,0.33333,1,1
1,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.0083534,0.36563,0.38078,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0032441,0.36536,0.30037,1,1
1,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.00042998,0.36517,0.28183,1,1
1,GO NEGATIVE REGULATION OF LIPID STORAGE,0.0012662,0.36504,0.33149,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,8.1192e-05,0.36502,0.44186,1,1
1,GO MODULATION OF PROCESS OF OTHER ORGANISM,3.0689e-05,0.36479,0.31308,1,1
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.00044439,0.36451,0.30988,1,1
1,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.012203,0.36361,0.32982,1,1
1,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,1.6729e-06,0.36359,0.36797,1,1
1,GO TRANSLATIONAL INITIATION,0.00030804,0.36348,0.29944,1,1
1,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,2.9301e-06,0.36298,0.40298,1,1
1,GO MESODERM MORPHOGENESIS,2.0829e-07,0.36274,0.38813,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,6.2786e-05,0.36267,0.30401,1,1
1,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,5.9841e-06,0.36256,0.33475,1,1
1,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.00045924,0.36245,0.36964,1,1
1,GO LYMPH VESSEL DEVELOPMENT,9.0551e-05,0.3623,0.41288,1,1
1,GO PROSTANOID BIOSYNTHETIC PROCESS,0.00021909,0.36224,0.3815,1,1
1,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00050664,0.36221,0.305,1,1
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.0015653,0.36207,0.27075,1,1
1,GO PROSTANOID METABOLIC PROCESS,4.3218e-05,0.36201,0.38651,1,1
1,GO EPITHELIAL CELL APOPTOTIC PROCESS,3.7145e-05,0.36163,0.34897,1,1
1,GO MYELOID DENDRITIC CELL ACTIVATION,0.013798,0.36073,0.34667,1,1
1,GO MUSCLE CELL MIGRATION,0.0032441,0.36066,0.26953,1,1
1,GO VASCULATURE DEVELOPMENT,1.0311e-06,0.36033,0.33505,1,1
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,3.8131e-07,0.36015,0.34958,1,1
1,GO RESPONSE TO CORTICOSTEROID,8.4205e-05,0.36013,0.2709,1,1
1,GO GASTRULATION,1.4268e-07,0.35998,0.39661,1,1
1,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00019079,0.35981,0.31965,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,3.1888e-05,0.3595,0.33992,1,1
1,GO RETINAL METABOLIC PROCESS,0.010245,0.35945,0.31067,1,1
1,GO RESPONSE TO VIRUS,3.0576e-06,0.3591,0.37023,1,1
1,GO MATURATION OF 5 8S RRNA,0.00067758,0.35875,0.26412,1,1
1,GO NEGATIVE REGULATION OF GENE SILENCING,0.0001165,0.35868,0.29248,1,1
1,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,2.0033e-05,0.35847,0.2988,1,1
1,GO FOREBRAIN MORPHOGENESIS,0.036164,0.35829,0.18538,1,1
1,GO UBIQUITIN DEPENDENT ERAD PATHWAY,2.1663e-05,0.35821,0.28555,1,1
1,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.010506,0.35819,0.24596,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,1.2962e-05,0.35757,0.39017,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.00065623,0.35754,0.31708,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,7.9801e-06,0.35743,0.37553,1,1
1,GO HYPOTONIC RESPONSE,0.00022676,0.35712,0.32167,1,1
1,GO WOUND HEALING,3.3287e-06,0.35685,0.34761,1,1
1,GO SERTOLI CELL DIFFERENTIATION,0.00040247,0.35657,0.31584,1,1
1,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,7.547e-05,0.35638,0.40028,1,1
1,GO POSITIVE REGULATION OF T CELL PROLIFERATION,1.7118e-05,0.35633,0.33618,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.00030804,0.35629,0.30948,1,1
1,GO CELL CELL JUNCTION MAINTENANCE,0.0047853,0.3562,0.29745,1,1
1,GO SMOOTH MUSCLE CELL PROLIFERATION,2.3654e-06,0.35555,0.38151,1,1
1,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,1.6452e-07,0.35527,0.39832,1,1
1,GO REGULATION OF SPROUTING ANGIOGENESIS,3.7791e-06,0.35527,0.37698,1,1
1,GO REGULATION OF PROTEIN MATURATION,1.0311e-06,0.35515,0.37907,1,1
1,GO SKELETAL MUSCLE CELL PROLIFERATION,0.00074557,0.35474,0.33669,1,1
1,GO MATERNAL PLACENTA DEVELOPMENT,1.0604e-05,0.35434,0.39998,1,1
1,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,3.8583e-05,0.35427,0.33478,1,1
1,GO ENDOTHELIAL CELL MIGRATION,2.8077e-06,0.35421,0.36021,1,1
1,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,1.7118e-05,0.35415,0.34044,1,1
1,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.00013433,0.35402,0.2949,1,1
1,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,8.6584e-06,0.35398,0.35815,1,1
1,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,9.0179e-06,0.35377,0.37693,1,1
1,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,4.4712e-06,0.35336,0.37131,1,1
1,GO POSITIVE REGULATION OF TRANSLATION,9.2696e-08,0.35322,0.37305,1,1
1,GO STRIATED MUSCLE CELL PROLIFERATION,5.7413e-06,0.35291,0.33919,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,2.5774e-06,0.35283,0.34003,1,1
1,GO CHONDROCYTE PROLIFERATION,0.00067758,0.35273,0.47315,1,1
1,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,3.9418e-06,0.35213,0.41541,1,1
1,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0013872,0.35078,0.24248,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,3.7145e-05,0.35072,0.33176,1,1
1,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.00010845,0.35045,0.33658,1,1
1,GO B CELL MEDIATED IMMUNITY,9.0179e-06,0.35039,0.32256,1,1
1,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,1.9904e-06,0.35015,0.34875,1,1
1,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.033166,0.34999,0.29114,1,1
1,GO LEUKOCYTE MEDIATED CYTOTOXICITY,4.3218e-05,0.34992,0.28461,1,1
1,GO ERAD PATHWAY,1.5816e-05,0.34991,0.2649,1,1
1,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,2.8418e-05,0.34969,0.27193,1,1
1,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.00037661,0.34967,0.3816,1,1
1,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.00034072,0.34936,0.41664,1,1
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,7.2754e-05,0.34888,0.4205,1,1
1,GO SULFUR COMPOUND CATABOLIC PROCESS,2.9532e-05,0.34883,0.37954,1,1
1,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,5.2139e-05,0.34844,0.38134,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,6.4994e-06,0.34652,0.35534,1,1
1,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.00055855,0.34579,0.314,1,1
1,GO ENDOCHONDRAL BONE MORPHOGENESIS,2.4692e-06,0.34515,0.38039,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0049174,0.34434,0.24962,1,1
1,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0006154,0.34418,0.3643,1,1
1,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.0024367,0.34378,0.32105,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.001191,0.34376,0.31282,1,1
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,1.5201e-05,0.34369,0.30267,1,1
1,GO TISSUE MIGRATION,5.9841e-06,0.34364,0.33071,1,1
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0067808,0.3431,0.28886,1,1
1,GO VIRAL GENE EXPRESSION,5.0226e-05,0.34305,0.33472,1,1
1,GO BLOOD VESSEL MORPHOGENESIS,7.5427e-07,0.34289,0.33847,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,2.8077e-06,0.34281,0.38271,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00013917,0.34245,0.25611,1,1
1,GO INNER CELL MASS CELL PROLIFERATION,0.00031859,0.34226,0.36283,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.00012074,0.34205,0.45551,1,1
1,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,2.0033e-05,0.34183,0.34739,1,1
1,GO NEGATIVE REGULATION OF LIPID TRANSPORT,2.6307e-05,0.34159,0.31082,1,1
1,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.00010092,0.34126,0.33201,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,5.0226e-05,0.3411,0.37569,1,1
1,GO REGULATION OF HISTONE PHOSPHORYLATION,4.4878e-05,0.34108,0.35422,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,2.8077e-06,0.34067,0.34491,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,6.5896e-07,0.34036,0.43025,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00037661,0.34028,0.42126,1,1
1,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.0021689,0.33988,0.36928,1,1
1,GO NEGATIVE REGULATION OF CHEMOTAXIS,4.6597e-05,0.33981,0.31344,1,1
1,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,5.2139e-05,0.3398,0.3566,1,1
1,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.00044439,0.3396,0.34908,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,2.0033e-05,0.33957,0.40821,1,1
1,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,6.4994e-06,0.33933,0.33087,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.00026903,0.33911,0.3873,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.00087311,0.33898,0.3122,1,1
1,GO REGULATION OF TOLERANCE INDUCTION,0.0022992,0.33887,0.32333,1,1
1,GO CELLULAR RESPONSE TO RETINOIC ACID,0.00030804,0.33869,0.31819,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.0006154,0.33851,0.45396,1,1
1,GO NATURAL KILLER CELL ACTIVATION,1.0311e-06,0.33817,0.34937,1,1
1,GO DECIDUALIZATION,0.0012662,0.33798,0.41675,1,1
1,GO L GLUTAMATE IMPORT,0.0039469,0.33789,0.28867,1,1
1,GO CARTILAGE DEVELOPMENT,4.2876e-06,0.33751,0.31029,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,5.508e-06,0.33746,0.29246,1,1
1,GO KERATAN SULFATE METABOLIC PROCESS,3.1904e-06,0.33729,0.39959,1,1
1,GO PROTEIN HYDROXYLATION,0.007729,0.33717,0.36629,1,1
1,GO REGULATION OF PROTEIN FOLDING,0.00028792,0.33692,0.26,1,1
1,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00038934,0.33691,0.31374,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00023468,0.33684,0.33748,1,1
1,GO CORTICAL CYTOSKELETON ORGANIZATION,1.8958e-07,0.33631,0.3641,1,1
1,GO INTERFERON ALPHA PRODUCTION,0.00047456,0.33612,0.27297,1,1
1,GO PROSTATIC BUD FORMATION,0.0006154,0.33585,0.48138,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,2.7343e-05,0.33554,0.36556,1,1
1,GO ADAPTIVE IMMUNE RESPONSE,7.0571e-06,0.3351,0.31242,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,8.4205e-05,0.3345,0.24353,1,1
1,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,7.3528e-06,0.33443,0.4164,1,1
1,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.00013433,0.33435,0.32518,1,1
1,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.023205,0.3342,0.1934,1,1
1,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,3.0689e-05,0.33416,0.28992,1,1
1,GO RESPONSE TO HYDROGEN PEROXIDE,3.4421e-05,0.3341,0.27906,1,1
1,GO REGULATION OF CALCIUM ION IMPORT,0.00067758,0.33395,0.21679,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,5.2837e-06,0.33393,0.3391,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,1.349e-05,0.33372,0.46564,1,1
1,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,5.2837e-06,0.33369,0.33207,1,1
1,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,5.2533e-07,0.33348,0.4048,1,1
1,GO REGULATION OF PODOSOME ASSEMBLY,0.00016023,0.33311,0.43196,1,1
1,GO CELL MATRIX ADHESION,3.3287e-06,0.33299,0.36709,1,1
1,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,7.013e-05,0.33296,0.35892,1,1
1,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,9.389e-05,0.33279,0.37146,1,1
1,GO ENDOCARDIAL CUSHION FORMATION,0.0083534,0.3324,0.25428,1,1
1,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,3.8131e-07,0.33206,0.34353,1,1
1,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.00032948,0.33181,0.33723,1,1
1,GO REGULATION OF VASCULATURE DEVELOPMENT,1.906e-06,0.33124,0.32594,1,1
1,GO GLOMERULUS DEVELOPMENT,2.7343e-05,0.33113,0.41455,1,1
1,GO LYMPHOCYTE MEDIATED IMMUNITY,5.0683e-06,0.33076,0.32029,1,1
1,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00084609,0.33076,0.24147,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.00084609,0.33051,0.29838,1,1
1,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.00010845,0.33042,0.262,1,1
1,GO RESPONSE TO WOUNDING,2.3654e-06,0.33042,0.30397,1,1
1,GO MONONUCLEAR CELL MIGRATION,0.00021167,0.33034,0.3116,1,1
1,GO RESPONSE TO MANGANESE ION,1.5201e-05,0.3302,0.31716,1,1
1,GO PROTEIN TARGETING TO VACUOLE,7.8282e-05,0.33016,0.26638,1,1
1,GO TISSUE REGENERATION,1.7806e-05,0.32996,0.3383,1,1
1,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,2.3654e-06,0.32971,0.31148,1,1
1,GO KETONE BIOSYNTHETIC PROCESS,8.1192e-05,0.32953,0.29167,1,1
1,GO POSITIVE REGULATION OF LIPID STORAGE,3.4728e-06,0.3294,0.40405,1,1
1,GO NADPH REGENERATION,0.00036427,0.32921,0.30185,1,1
1,GO REGULATION OF BMP SIGNALING PATHWAY,3.3132e-05,0.32891,0.30439,1,1
1,GO ACTIVATION OF MAPKK ACTIVITY,6.2367e-06,0.32887,0.33631,1,1
1,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0028957,0.32879,0.31063,1,1
1,GO AMYLOID FIBRIL FORMATION,0.022165,0.32847,0.26309,1,1
1,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0017123,0.32836,0.36234,1,1
1,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.00079435,0.32824,0.25527,1,1
1,GO REGENERATION,1.2971e-07,0.32782,0.33217,1,1
1,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0017641,0.32774,0.22786,1,1
1,GO MACROPHAGE MIGRATION,1.1267e-06,0.3277,0.38329,1,1
1,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.0025817,0.32766,0.33896,1,1
1,GO REGULATION OF HEART GROWTH,6.7728e-06,0.32763,0.29731,1,1
1,GO MACROPHAGE DIFFERENTIATION,8.6584e-06,0.32739,0.37734,1,1
1,GO MUSCLE CELL PROLIFERATION,6.2985e-07,0.32726,0.3483,1,1
1,GO PIGMENT ACCUMULATION,0.00028792,0.32724,0.30868,1,1
1,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.00025131,0.32704,0.2921,1,1
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00018427,0.327,0.32984,1,1
1,GO LEUKOCYTE APOPTOTIC PROCESS,1.4044e-06,0.32652,0.35994,1,1
1,GO PEPTIDE CATABOLIC PROCESS,7.547e-05,0.32645,0.26176,1,1
1,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,9.0551e-05,0.3263,0.29501,1,1
1,GO RESPONSE TO PEPTIDOGLYCAN,0.00035231,0.3263,0.36867,1,1
1,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.00019079,0.32555,0.36693,1,1
1,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00038934,0.32549,0.35457,1,1
1,GO REGULATION OF EPITHELIAL CELL MIGRATION,6.4994e-06,0.32525,0.32283,1,1
1,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.00019079,0.32491,0.29078,1,1
1,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,7.3528e-06,0.32487,0.29303,1,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0025817,0.32434,0.26089,1,1
1,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,8.2505e-07,0.32407,0.29046,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,9.0221e-07,0.324,0.3143,1,1
1,GO MATURATION OF SSU RRNA,0.0006154,0.32345,0.29832,1,1
1,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.00010845,0.3227,0.28532,1,1
1,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.00022676,0.32251,0.30849,1,1
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.017549,0.32249,0.19299,1,1
1,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,2.6307e-05,0.32243,0.40398,1,1
1,GO SPINDLE MIDZONE ASSEMBLY,0.00035231,0.32241,0.29484,1,1
1,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00016595,0.32237,0.31355,1,1
1,GO RESPONSE TO INTERLEUKIN 1,1.0311e-06,0.32236,0.36946,1,1
1,GO REGULATION OF IMMUNE EFFECTOR PROCESS,4.2876e-06,0.32235,0.30915,1,1
1,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,4.6623e-06,0.32205,0.35115,1,1
1,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,5.9841e-06,0.322,0.35441,1,1
1,GO RESPONSE TO DEXAMETHASONE,0.0014299,0.32189,0.27618,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,1.5331e-06,0.32185,0.33129,1,1
1,GO TETRAPYRROLE METABOLIC PROCESS,0.00013433,0.32172,0.22954,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.0025817,0.32141,0.23581,1,1
1,GO NECROTIC CELL DEATH,4.0073e-05,0.32109,0.40332,1,1
1,GO CYTOKINETIC PROCESS,2.6902e-06,0.32024,0.32384,1,1
1,GO REGULATION OF MULTI ORGANISM PROCESS,8.1192e-05,0.31984,0.27394,1,1
1,GO KERATINOCYTE PROLIFERATION,0.0039469,0.31971,0.36279,1,1
1,GO SYNCYTIUM FORMATION,1.0184e-05,0.31957,0.3487,1,1
1,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.00016595,0.31928,0.26441,1,1
1,GO ASTROCYTE ACTIVATION,9.0551e-05,0.31904,0.35246,1,1
1,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,4.3763e-07,0.31874,0.3538,1,1
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,1.9904e-06,0.31858,0.35186,1,1
1,GO HISTONE PHOSPHORYLATION,3.9926e-07,0.31819,0.31884,1,1
1,GO RESPONSE TO PARATHYROID HORMONE,0.00025131,0.31814,0.34164,1,1
1,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,2.5308e-05,0.31805,0.39551,1,1
1,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00036427,0.31799,0.32963,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,7.5427e-07,0.31778,0.3424,1,1
1,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,1.4609e-05,0.31755,0.3962,1,1
1,GO VIRAL RELEASE FROM HOST CELL,7.2754e-05,0.31754,0.2805,1,1
1,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.00090094,0.31733,0.27638,1,1
1,GO REGULATION OF NEURON PROJECTION REGENERATION,0.0015653,0.3172,0.23568,1,1
1,GO SNRNA PROCESSING,0.001986,0.31672,0.5482,1,1
1,GO REGULATION OF CELL KILLING,0.00095906,0.3167,0.23408,1,1
1,GO RECEPTOR BIOSYNTHETIC PROCESS,3.5759e-05,0.31668,0.30788,1,1
1,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,7.889e-07,0.31659,0.35953,1,1
1,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,4.8379e-05,0.31656,0.34451,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0001165,0.31639,0.2824,1,1
1,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.00044439,0.31617,0.30669,1,1
1,GO REGULATION OF ORGAN GROWTH,2.0829e-07,0.31608,0.34289,1,1
1,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.0079323,0.31575,0.30824,1,1
1,GO RENAL FILTRATION,0.0050528,0.31496,0.37967,1,1
1,GO IRON ION HOMEOSTASIS,4.6623e-06,0.3149,0.27564,1,1
1,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,7.2756e-08,0.3146,0.32672,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,3.0689e-05,0.31442,0.26702,1,1
1,GO INNATE IMMUNE RESPONSE,8.6584e-06,0.31441,0.28882,1,1
1,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.0062634,0.31427,0.45453,1,1
1,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.0097392,0.31416,0.23587,1,1
1,GO INTERLEUKIN 5 PRODUCTION,0.012508,0.31412,0.27244,1,1
1,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0001547,0.31363,0.28863,1,1
1,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.00095906,0.31356,0.40301,1,1
1,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,7.8282e-05,0.31341,0.30256,1,1
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00019753,0.31318,0.30409,1,1
1,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.00031859,0.31284,0.29268,1,1
1,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.00018427,0.31264,0.35992,1,1
1,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0010206,0.31251,0.23892,1,1
1,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.00052342,0.31232,0.29881,1,1
1,GO LIPOPROTEIN LOCALIZATION,0.0001547,0.31231,0.39588,1,1
1,GO REGULATION OF VIRAL TRANSCRIPTION,2.0033e-05,0.31221,0.26598,1,1
1,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,4.0073e-05,0.31209,0.35194,1,1
1,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.00010845,0.31172,0.28948,1,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.001191,0.31156,0.20843,1,1
1,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,3.3132e-05,0.31143,0.38887,1,1
1,GO VESICLE CARGO LOADING,0.00012512,0.31075,0.28125,1,1
1,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.033894,0.31059,0.3728,1,1
1,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,6.0504e-05,0.31036,0.30161,1,1
1,GO OSTEOBLAST DIFFERENTIATION,1.6015e-06,0.31013,0.32627,1,1
1,GO ALPHA BETA T CELL ACTIVATION,0.00011241,0.31,0.24847,1,1
1,GO C21 STEROID HORMONE METABOLIC PROCESS,0.00024286,0.30971,0.34122,1,1
1,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,5.0226e-05,0.30967,0.28641,1,1
1,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,7.6603e-06,0.30918,0.30546,1,1
1,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,1.104e-05,0.30911,0.28582,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,7.9801e-06,0.30905,0.41325,1,1
1,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,6.5149e-05,0.30894,0.41687,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.00026903,0.30892,0.2929,1,1
1,GO REGULATION OF CELL MATRIX ADHESION,1.7806e-05,0.30885,0.37349,1,1
1,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,1.7474e-06,0.30865,0.35557,1,1
1,GO MACROPHAGE CHEMOTAXIS,1.9263e-05,0.30858,0.35615,1,1
1,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,2.7578e-07,0.30854,0.33426,1,1
1,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.00065623,0.30823,0.2854,1,1
1,GO RESPONSE TO PROTOZOAN,0.00017186,0.30772,0.31899,1,1
1,GO NUCLEAR ENVELOPE REASSEMBLY,2.9301e-06,0.30765,0.28173,1,1
1,GO OLIGOPEPTIDE TRANSPORT,0.00065623,0.30728,0.41601,1,1
1,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00072223,0.30639,0.2643,1,1
1,GO NEURAL TUBE PATTERNING,0.00092958,0.30636,0.25352,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0017123,0.3054,0.32425,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,8.7323e-05,0.30525,0.25046,1,1
1,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,7.3528e-06,0.30464,0.2858,1,1
1,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.00025131,0.30439,0.2987,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.00018427,0.304,0.22811,1,1
1,GO MESENCHYME MORPHOGENESIS,0.0011549,0.30372,0.33791,1,1
1,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,1.3441e-06,0.30344,0.23737,1,1
1,GO AMINO SUGAR BIOSYNTHETIC PROCESS,3.5759e-05,0.30279,0.30688,1,1
1,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.0014738,0.30263,0.29383,1,1
1,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,2.1702e-06,0.30251,0.44319,1,1
1,GO NEURAL CREST CELL DIFFERENTIATION,0.0054795,0.30223,0.22642,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,1.7118e-05,0.3022,0.27805,1,1
1,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,9.389e-05,0.30201,0.29465,1,1
1,GO PIGMENT METABOLIC PROCESS,1.6455e-05,0.30198,0.26703,1,1
1,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.00049035,0.30195,0.28375,1,1
1,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.00016595,0.30194,0.31737,1,1
1,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.0087944,0.30191,0.35138,1,1
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,1.6015e-06,0.30179,0.28198,1,1
1,GO I KAPPAB KINASE NF KAPPAB SIGNALING,2.1702e-06,0.30171,0.37943,1,1
1,GO POLYAMINE METABOLIC PROCESS,0.00025131,0.30164,0.27413,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00012964,0.3015,0.28746,1,1
1,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.015953,0.30136,0.41823,1,1
1,GO RRNA PSEUDOURIDINE SYNTHESIS,0.020205,0.30131,0.22145,1,1
1,GO SELECTIVE AUTOPHAGY,1.6729e-06,0.30121,0.29974,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,4.3218e-05,0.30117,0.29474,1,1
1,GO PLASMA MEMBRANE TUBULATION,6.4994e-06,0.30096,0.34669,1,1
1,GO RESPONSE TO TUMOR NECROSIS FACTOR,7.9801e-06,0.30055,0.32719,1,1
1,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,1.349e-05,0.30038,0.27366,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,1.906e-06,0.30032,0.33949,1,1
1,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.0010859,0.30023,0.26164,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.0075304,0.29989,0.22155,1,1
1,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.03245,0.2998,0.27523,1,1
1,GO POSITIVE REGULATION OF CELL ADHESION,1.1493e-05,0.29941,0.31055,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00010845,0.29918,0.28576,1,1
1,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,2.0033e-05,0.29899,0.23336,1,1
1,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.0017123,0.29871,0.30857,1,1
1,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,5.7413e-06,0.29853,0.26885,1,1
1,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,7.8282e-05,0.29845,0.38103,1,1
1,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0021689,0.29829,0.23479,1,1
1,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.024288,0.29828,0.31289,1,1
1,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.0013457,0.29826,0.25989,1,1
1,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.00011241,0.29798,0.20307,1,1
1,GO REGULATION OF CHOLESTEROL EFFLUX,2.7343e-05,0.29795,0.31879,1,1
1,GO AMINO SUGAR METABOLIC PROCESS,7.0571e-06,0.29783,0.29025,1,1
1,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.0023671,0.29761,0.30454,1,1
1,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,6.5149e-05,0.29726,0.28649,1,1
1,GO PODOSOME ASSEMBLY,7.2754e-05,0.2969,0.37578,1,1
1,GO CYTOKINE MEDIATED SIGNALING PATHWAY,5.7413e-06,0.2969,0.36236,1,1
1,GO PROSTATE GLAND DEVELOPMENT,0.00010462,0.2967,0.45796,1,1
1,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.00057693,0.29649,0.29969,1,1
1,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.00019753,0.29605,0.30434,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,1.2308e-06,0.296,0.28361,1,1
1,GO TRABECULA MORPHOGENESIS,0.00013917,0.29589,0.31048,1,1
1,GO AMEBOIDAL TYPE CELL MIGRATION,1.7474e-06,0.29555,0.30055,1,1
1,GO CORONARY VASCULATURE DEVELOPMENT,1.5816e-05,0.29552,0.35078,1,1
1,GO TRANSPOSITION,0.001662,0.29552,0.28455,1,1
1,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,3.5759e-05,0.29543,0.27013,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.014841,0.29542,0.23032,1,1
1,GO RESPONSE TO CYTOKINE,4.2876e-06,0.29539,0.31178,1,1
1,GO RESPONSE TO RETINOIC ACID,2.5308e-05,0.29505,0.2842,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.00047456,0.29502,0.2337,1,1
1,GO REGULATION OF MRNA CATABOLIC PROCESS,1.8251e-06,0.29489,0.25889,1,1
1,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.0014299,0.29486,0.27412,1,1
1,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,2.1702e-06,0.2947,0.31701,1,1
1,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00017796,0.29444,0.35979,1,1
1,GO TRNA CATABOLIC PROCESS,0.050569,0.29439,0.24047,1,1
1,GO TONGUE DEVELOPMENT,0.00055855,0.29437,0.37263,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.00098941,0.29414,0.25104,1,1
1,GO CYTOKINE PRODUCTION,9.0179e-06,0.2941,0.27399,1,1
1,GO REGULATION OF CELL AGING,1.9873e-07,0.29407,0.33221,1,1
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.001191,0.29401,0.22511,1,1
1,GO SPERM EGG RECOGNITION,1.349e-05,0.29394,0.25495,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,4.0073e-05,0.29373,0.24818,1,1
1,GO POSITIVE CHEMOTAXIS,0.0012662,0.29362,0.25041,1,1
1,GO PEPTIDYL PROLINE HYDROXYLATION,0.047551,0.29351,0.34456,1,1
1,GO SNRNA METABOLIC PROCESS,0.00059588,0.29348,0.43984,1,1
1,GO TRACHEA MORPHOGENESIS,0.00026003,0.29325,0.2967,1,1
1,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,3.3132e-05,0.29324,0.31984,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00024286,0.29295,0.33106,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.0037331,0.29266,0.25563,1,1
1,GO RESPONSE TO DSRNA,3.4728e-06,0.29261,0.35998,1,1
1,GO COAGULATION,3.7791e-06,0.29223,0.3057,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.00040247,0.29219,0.24676,1,1
1,GO RIBONUCLEOSIDE METABOLIC PROCESS,7.9801e-06,0.29206,0.29555,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.0041716,0.29199,0.22628,1,1
1,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.00022676,0.29186,0.29323,1,1
1,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,6.5149e-05,0.29172,0.25076,1,1
1,GO GONADOTROPIN SECRETION,0.019739,0.29148,0.23541,1,1
1,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0047853,0.29144,0.36004,1,1
1,GO LEFT RIGHT AXIS SPECIFICATION,0.027188,0.29121,0.30367,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,2.8077e-06,0.29105,0.31887,1,1
1,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.018836,0.29093,0.24037,1,1
1,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,1.9904e-06,0.2906,0.23951,1,1
1,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,1.2862e-06,0.29037,0.30295,1,1
1,GO REGULATION OF KERATINOCYTE MIGRATION,0.00035231,0.29032,0.27157,1,1
1,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.00023468,0.29,0.25329,1,1
1,GO NCRNA PROCESSING,0.00012964,0.28872,0.24901,1,1
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00021167,0.2886,0.26168,1,1
1,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.00025131,0.28853,0.26949,1,1
1,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,8.4205e-05,0.28779,0.31816,1,1
1,GO MYOBLAST FUSION,6.5149e-05,0.28771,0.35071,1,1
1,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,2.4346e-05,0.28766,0.27792,1,1
1,GO T CELL CHEMOTAXIS,6.5149e-05,0.28754,0.24611,1,1
1,GO REGULATION OF RNA BINDING,1.104e-05,0.28722,0.28958,1,1
1,GO RESPONSE TO BACTERIUM,1.8521e-05,0.2872,0.26653,1,1
1,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,3.0576e-06,0.28709,0.26919,1,1
1,GO SYMBIOTIC PROCESS,1.5691e-07,0.28705,0.28733,1,1
1,GO LIPID IMPORT INTO CELL,0.0067808,0.28695,0.23656,1,1
1,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,3.0264e-07,0.28687,0.27271,1,1
1,GO REGULATION OF WOUND HEALING,0.00012964,0.28669,0.3103,1,1
1,GO STEROL TRANSPORT,0.0001547,0.28642,0.22613,1,1
1,GO ACUTE INFLAMMATORY RESPONSE,7.547e-05,0.28628,0.3471,1,1
1,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,8.7323e-05,0.28627,0.28864,1,1
1,GO ARTERY DEVELOPMENT,0.00042998,0.28608,0.30981,1,1
1,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.023741,0.28599,0.18652,1,1
1,GO REGULATION OF CELLULAR EXTRAVASATION,0.0016129,0.28595,0.27698,1,1
1,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.012203,0.28592,0.23012,1,1
1,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00014935,0.28584,0.25273,1,1
1,GO NEGATIVE REGULATION OF OSSIFICATION,3.1888e-05,0.28583,0.2813,1,1
1,GO CELL CELL RECOGNITION,1.2308e-06,0.28569,0.28905,1,1
1,GO ASTROCYTE DEVELOPMENT,2.2524e-05,0.28566,0.34615,1,1
1,GO BONE MORPHOGENESIS,4.0073e-05,0.2853,0.30585,1,1
1,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.014841,0.2853,0.19944,1,1
1,GO CELLULAR RESPONSE TO VIRUS,0.00027832,0.28499,0.27219,1,1
1,GO PLACENTA DEVELOPMENT,9.7346e-05,0.28417,0.24456,1,1
1,GO AMINOGLYCAN METABOLIC PROCESS,2.5308e-05,0.28405,0.29741,1,1
1,GO REGULATION OF PEPTIDASE ACTIVITY,0.00067758,0.28405,0.20614,1,1
1,GO T CELL RECEPTOR SIGNALING PATHWAY,2.6902e-06,0.28401,0.26802,1,1
1,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.2962e-05,0.28384,0.34917,1,1
1,GO DEFENSE RESPONSE TO OTHER ORGANISM,8.3127e-06,0.2838,0.27605,1,1
1,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,1.4039e-05,0.28378,0.25396,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0059384,0.28353,0.20022,1,1
1,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,3.9418e-06,0.28344,0.23832,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00044439,0.28341,0.24429,1,1
1,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.00020448,0.28297,0.3166,1,1
1,GO REGULATION OF LEUKOCYTE MIGRATION,1.7118e-05,0.28291,0.28086,1,1
1,GO ALPHA BETA T CELL DIFFERENTIATION,0.00045924,0.28272,0.22747,1,1
1,GO CARDIAC SEPTUM MORPHOGENESIS,0.0013872,0.28271,0.27102,1,1
1,GO CELLULAR RESPONSE TO CHEMICAL STRESS,2.0784e-06,0.28244,0.26693,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,6.7728e-06,0.28234,0.29194,1,1
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.00020448,0.28227,0.40919,1,1
1,GO REGULATION OF MACROPHAGE MIGRATION,1.6455e-05,0.28227,0.29371,1,1
1,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,7.2754e-05,0.28222,0.23035,1,1
1,GO RNA 5 END PROCESSING,0.001191,0.28201,0.24118,1,1
1,GO REGULATION OF EXOSOMAL SECRETION,0.0073363,0.2819,0.20986,1,1
1,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.0045306,0.2815,0.4372,1,1
1,GO HISTONE H4 DEACETYLATION,0.0029794,0.28093,0.27769,1,1
1,GO CELLULAR HYPEROSMOTIC RESPONSE,0.00067758,0.28063,0.33651,1,1
1,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,6.2786e-05,0.28061,0.367,1,1
1,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.042857,0.28057,0.1818,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,9.7346e-05,0.28031,0.21748,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00059588,0.28015,0.24508,1,1
1,GO REGULATION OF GENE SILENCING,1.906e-06,0.28012,0.25829,1,1
1,GO RESPONSE TO IONIZING RADIATION,1.5331e-06,0.2792,0.29396,1,1
1,GO CHOLESTEROL EFFLUX,4.6597e-05,0.27905,0.27208,1,1
1,GO TISSUE REMODELING,0.00020448,0.27882,0.26781,1,1
1,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.019739,0.27863,0.22413,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,3.7145e-05,0.27862,0.31563,1,1
1,GO NUCLEOSIDE SALVAGE,0.0019282,0.27852,0.40917,1,1
1,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,6.7596e-05,0.27852,0.45626,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,3.0576e-06,0.27834,0.30938,1,1
1,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,1.0184e-05,0.27826,0.22138,1,1
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION,7.547e-05,0.27737,0.2725,1,1
1,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.0028141,0.27715,0.1955,1,1
1,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.018836,0.27707,0.22399,1,1
1,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.024288,0.27702,0.20516,1,1
1,GO MYOBLAST PROLIFERATION,0.05161,0.27701,0.15435,1,1
1,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,2.4346e-05,0.27695,0.28518,1,1
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.023741,0.27687,0.22191,1,1
1,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.00081984,0.2768,0.20867,1,1
1,GO MESENCHYME DEVELOPMENT,1.7118e-05,0.27658,0.25865,1,1
1,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.013139,0.27636,0.20499,1,1
1,GO RESPONSE TO OXYGEN RADICAL,7.547e-05,0.27635,0.21509,1,1
1,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.01282,0.27612,0.24158,1,1
1,GO IMMUNOGLOBULIN PRODUCTION,1.8521e-05,0.27595,0.2436,1,1
1,GO ERK1 AND ERK2 CASCADE,4.1112e-06,0.27594,0.2625,1,1
1,GO RRNA METABOLIC PROCESS,0.00054072,0.27593,0.24076,1,1
1,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.00084609,0.27574,0.28123,1,1
1,GO TRNA 5 LEADER REMOVAL,0.00036427,0.27553,0.29987,1,1
1,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,2.7343e-05,0.27534,0.27607,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00019079,0.27517,0.25607,1,1
1,GO MYELOID LEUKOCYTE DIFFERENTIATION,9.7801e-06,0.27511,0.23816,1,1
1,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,6.2786e-05,0.27492,0.2892,1,1
1,GO CELLULAR RESPONSE TO LIPID,4.1617e-05,0.27488,0.21772,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.01282,0.27483,0.46088,1,1
1,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,8.6584e-06,0.27461,0.26384,1,1
1,GO T CELL MIGRATION,0.00014935,0.27459,0.27706,1,1
1,GO CELL REDOX HOMEOSTASIS,4.8379e-05,0.27437,0.27323,1,1
1,GO ALPHA BETA T CELL PROLIFERATION,0.024288,0.27378,0.22604,1,1
1,GO ACUTE PHASE RESPONSE,0.0034322,0.27373,0.27708,1,1
1,GO POST TRANSLATIONAL PROTEIN MODIFICATION,2.6902e-06,0.2732,0.24281,1,1
1,GO FACE DEVELOPMENT,3.7145e-05,0.27319,0.29234,1,1
1,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,4.3218e-05,0.27309,0.33784,1,1
1,GO CORONARY VASCULATURE MORPHOGENESIS,0.023205,0.27304,0.32487,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,1.1267e-06,0.27301,0.25721,1,1
1,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.00059588,0.27266,0.3078,1,1
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,2.4346e-05,0.27192,0.26024,1,1
1,GO REGULATION OF INNATE IMMUNE RESPONSE,0.00013433,0.27188,0.21454,1,1
1,GO MESODERM DEVELOPMENT,4.1112e-06,0.27184,0.2408,1,1
1,GO DNA LIGATION,0.00011241,0.27181,0.30211,1,1
1,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.0013054,0.27174,0.27647,1,1
1,GO RESPONSE TO OSMOTIC STRESS,0.00017186,0.27149,0.22086,1,1
1,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.0001165,0.27146,0.21707,1,1
1,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.0032441,0.27135,0.26312,1,1
1,GO INTRACELLULAR MRNA LOCALIZATION,3.4421e-05,0.27126,0.36892,1,1
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0083534,0.27115,0.23253,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION,6.8936e-07,0.27113,0.27984,1,1
1,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.0604e-05,0.27041,0.3078,1,1
1,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00028792,0.27038,0.27467,1,1
1,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.027803,0.27019,0.21006,1,1
1,GO LYMPHOCYTE APOPTOTIC PROCESS,0.00012964,0.27019,0.23496,1,1
1,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.0012662,0.27018,0.30552,1,1
1,GO DETECTION OF OTHER ORGANISM,0.0012662,0.27011,0.32779,1,1
1,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0011549,0.27009,0.28314,1,1
1,GO TUBE MORPHOGENESIS,1.349e-05,0.26996,0.24183,1,1
1,GO METANEPHRIC NEPHRON DEVELOPMENT,0.00018427,0.26994,0.28228,1,1
1,GO ASTROCYTE DIFFERENTIATION,0.00074557,0.26975,0.21137,1,1
1,GO RIBOSOME BIOGENESIS,0.00041602,0.26974,0.2562,1,1
1,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.00013917,0.26973,0.29802,1,1
1,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.0032441,0.26933,0.35257,1,1
1,GO IRON SULFUR CLUSTER ASSEMBLY,0.001228,0.26924,0.25561,1,1
1,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.0013054,0.26909,0.30565,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.00027832,0.26873,0.29176,1,1
1,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0034322,0.26864,0.25376,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0011199,0.26858,0.23295,1,1
1,GO PHAGOCYTOSIS,6.8936e-07,0.26827,0.33898,1,1
1,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.0833e-05,0.26815,0.26917,1,1
1,GO NCRNA 3 END PROCESSING,0.018398,0.26797,0.34733,1,1
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0032441,0.26796,0.28997,1,1
1,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,7.6603e-06,0.26748,0.26385,1,1
1,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,3.4772e-07,0.26747,0.27359,1,1
1,GO REGULATION OF LIGASE ACTIVITY,0.0031536,0.26747,0.24447,1,1
1,GO SEQUESTERING OF METAL ION,0.001191,0.26745,0.24946,1,1
1,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.007729,0.2673,0.19503,1,1
1,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,1.3441e-06,0.26716,0.27067,1,1
1,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.00038934,0.2671,0.2179,1,1
1,GO RESPONSE TO REDOX STATE,0.012203,0.2669,0.22639,1,1
1,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.016339,0.26674,0.2591,1,1
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00079435,0.26622,0.22936,1,1
1,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,2.4346e-05,0.2662,0.28044,1,1
1,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0071468,0.26593,0.33779,1,1
1,GO MIDGUT DEVELOPMENT,0.043763,0.26564,0.20965,1,1
1,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,4.4878e-05,0.26542,0.22717,1,1
1,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.0016129,0.2653,0.35709,1,1
1,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.0026572,0.26523,0.30048,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY,3.17e-07,0.26522,0.27484,1,1
1,GO RNA CATABOLIC PROCESS,2.0784e-06,0.26513,0.25257,1,1
1,GO NCRNA METABOLIC PROCESS,0.00026903,0.26492,0.21954,1,1
1,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00067758,0.26473,0.28537,1,1
1,GO REGULATION OF PROTEOLYSIS,1.4609e-05,0.26473,0.20941,1,1
1,GO RESPONSE TO OXYGEN LEVELS,0.00027832,0.2647,0.20119,1,1
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0042883,0.26457,0.23402,1,1
1,GO CELL AGING,4.8612e-06,0.26455,0.22253,1,1
1,GO MACROPHAGE CYTOKINE PRODUCTION,0.00098941,0.26451,0.43728,1,1
1,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0027346,0.2644,0.22926,1,1
1,GO VIRION ASSEMBLY,6.0504e-05,0.26433,0.21113,1,1
1,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.0066042,0.26425,0.20845,1,1
1,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,2.1702e-06,0.2642,0.26294,1,1
1,GO TOXIN TRANSPORT,0.0029794,0.26416,0.17846,1,1
1,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.00050664,0.26416,0.28707,1,1
1,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.027188,0.26392,0.18094,1,1
1,GO CARDIAC SEPTUM DEVELOPMENT,9.389e-05,0.26377,0.26546,1,1
1,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.015203,0.26359,0.20967,1,1
1,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.00040247,0.26345,0.24733,1,1
1,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00055855,0.26343,0.23979,1,1
1,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,9.7801e-06,0.26321,0.38129,1,1
1,GO POLYAMINE BIOSYNTHETIC PROCESS,0.0057817,0.26317,0.26312,1,1
1,GO PROTEIN KINASE B SIGNALING,4.4712e-06,0.26305,0.23763,1,1
1,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.001228,0.26304,0.18421,1,1
1,GO CELLULAR KETONE METABOLIC PROCESS,2.0833e-05,0.26289,0.21133,1,1
1,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,8.6584e-06,0.26241,0.24509,1,1
1,GO RHO PROTEIN SIGNAL TRANSDUCTION,3.3132e-05,0.2621,0.25039,1,1
1,GO HEART VALVE DEVELOPMENT,0.00016023,0.26197,0.31117,1,1
1,GO NUCLEAR ENVELOPE ORGANIZATION,0.00011241,0.26154,0.23751,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,6.7728e-06,0.26154,0.28503,1,1
1,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.00026003,0.26143,0.24139,1,1
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.0018173,0.26131,0.34176,1,1
1,GO REGULATION OF STEM CELL PROLIFERATION,0.018398,0.26096,0.14652,1,1
1,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.00041602,0.2609,0.23322,1,1
1,GO AUTOPHAGOSOME MATURATION,8.4205e-05,0.26078,0.25791,1,1
1,GO FATTY ACID BETA OXIDATION,0.00028792,0.26068,0.24757,1,1
1,GO CELLULAR RESPONSE TO OXYGEN LEVELS,9.7801e-06,0.26068,0.22634,1,1
1,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,2.2658e-06,0.26056,0.33255,1,1
1,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0051916,0.26052,0.2117,1,1
1,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.0015653,0.26043,0.25278,1,1
1,GO ATP BIOSYNTHETIC PROCESS,0.0042883,0.2604,0.21414,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,5.8301e-05,0.25998,0.23987,1,1
1,GO GLYCOSYL COMPOUND METABOLIC PROCESS,7.547e-05,0.25962,0.20759,1,1
1,GO RESPONSE TO TESTOSTERONE,2.1663e-05,0.25954,0.28266,1,1
1,GO REGULATION OF RESPONSE TO TUMOR CELL,0.0059384,0.25944,0.22938,1,1
1,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.0021062,0.25933,0.24494,1,1
1,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.00028792,0.2593,0.27413,1,1
1,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.00045924,0.25927,0.23846,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,6.4994e-06,0.25923,0.3464,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,4.8612e-06,0.25921,0.26233,1,1
1,GO ETHANOL METABOLIC PROCESS,0.0059384,0.25921,0.279,1,1
1,GO MESENCHYMAL CELL DIFFERENTIATION,0.0001165,0.25908,0.23883,1,1
1,GO RNA DESTABILIZATION,3.0689e-05,0.25884,0.2522,1,1
1,GO T CELL PROLIFERATION,0.00032948,0.25878,0.21627,1,1
1,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.00027832,0.25858,0.24164,1,1
1,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,2.0033e-05,0.25824,0.22355,1,1
1,GO IMMUNE EFFECTOR PROCESS,7.0571e-06,0.25819,0.28504,1,1
1,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,6.0504e-05,0.25806,0.26873,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,2.3654e-06,0.25792,0.31376,1,1
1,GO RESPONSE TO VITAMIN A,0.014138,0.25784,0.19917,1,1
1,GO PROTEIN FOLDING,8.4205e-05,0.25772,0.2204,1,1
1,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,2.9301e-06,0.2576,0.28521,1,1
1,GO EMBRYONIC EYE MORPHOGENESIS,0.0031536,0.25748,0.25602,1,1
1,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,2.7343e-05,0.25738,0.31123,1,1
1,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.0001547,0.25732,0.2487,1,1
1,GO NUCLEAR PORE ORGANIZATION,0.00049035,0.25727,0.25089,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,1.5816e-05,0.25722,0.2565,1,1
1,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,7.2754e-05,0.25674,0.33627,1,1
1,GO TRNA 5 END PROCESSING,0.00029782,0.25637,0.27623,1,1
1,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.00074557,0.25617,0.31142,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.00017796,0.25562,0.22705,1,1
1,GO STRESS FIBER ASSEMBLY,0.0007696,0.25553,0.23735,1,1
1,GO SULFUR AMINO ACID METABOLIC PROCESS,0.00095906,0.25546,0.1819,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.01282,0.25533,0.18868,1,1
1,GO RESPONSE TO OXIDATIVE STRESS,1.2308e-06,0.25531,0.24738,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.00010092,0.25529,0.27071,1,1
1,GO HEPATOCYTE DIFFERENTIATION,0.036948,0.25513,0.28711,1,1
1,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.2962e-05,0.2547,0.29806,1,1
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.00029782,0.25459,0.19909,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,1.104e-05,0.2544,0.25618,1,1
1,GO PIGMENT BIOSYNTHETIC PROCESS,3.0689e-05,0.25431,0.2312,1,1
1,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.02068,0.25355,0.19067,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,5.508e-06,0.25329,0.27255,1,1
1,GO RESPONSE TO BIOTIC STIMULUS,7.9801e-06,0.25303,0.254,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,6.0198e-07,0.25298,0.24698,1,1
1,GO LEUKOCYTE CELL CELL ADHESION,7.013e-05,0.25279,0.24207,1,1
1,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,6.2786e-05,0.25276,0.28574,1,1
1,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.01282,0.25264,0.27943,1,1
1,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.00026003,0.25262,0.20319,1,1
1,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.014841,0.25259,0.22491,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,3.0689e-05,0.25242,0.21137,1,1
1,GO REGULATION OF RESPONSE TO WOUNDING,0.00010092,0.25227,0.26807,1,1
1,GO LYMPHOCYTE MIGRATION,9.0551e-05,0.25196,0.22897,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00063551,0.25158,0.26698,1,1
1,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,2.4692e-06,0.25132,0.2362,1,1
1,GO INFLAMMATORY RESPONSE,6.7596e-05,0.25125,0.24954,1,1
1,GO REGULATION OF VASOCONSTRICTION,0.00018427,0.25096,0.25556,1,1
1,GO FIBROBLAST APOPTOTIC PROCESS,0.017137,0.25051,0.23408,1,1
1,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.00047456,0.25035,0.24009,1,1
1,GO OSTEOCLAST DIFFERENTIATION,1.9904e-06,0.25017,0.24218,1,1
1,GO GOLGI TO VACUOLE TRANSPORT,0.0028957,0.25013,0.21101,1,1
1,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.0019282,0.24999,0.30159,1,1
1,GO CELLULAR RESPONSE TO IONIZING RADIATION,5.8301e-05,0.2499,0.29269,1,1
1,GO POSITIVE REGULATION OF IMMUNE RESPONSE,2.0833e-05,0.24952,0.21807,1,1
1,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.0029794,0.24942,0.21488,1,1
1,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,1.5816e-05,0.24918,0.29605,1,1
1,GO REGULATION OF MIRNA METABOLIC PROCESS,0.0028957,0.24892,0.2482,1,1
1,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.010245,0.24891,0.28982,1,1
1,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.0024367,0.24844,0.32417,1,1
1,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00017186,0.24818,0.21648,1,1
1,GO RRNA TRANSCRIPTION,0.0019282,0.24808,0.19882,1,1
1,GO NUCLEUS LOCALIZATION,0.0073363,0.24791,0.16321,1,1
1,GO PEPTIDE BIOSYNTHETIC PROCESS,2.8418e-05,0.24744,0.21394,1,1
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,9.389e-05,0.24708,0.23038,1,1
1,GO SEQUESTERING OF TRIGLYCERIDE,0.0028957,0.24704,0.33249,1,1
1,GO GTP METABOLIC PROCESS,0.00052342,0.24681,0.28293,1,1
1,GO T CELL ACTIVATION,3.7145e-05,0.24678,0.2242,1,1
1,GO CONNECTIVE TISSUE DEVELOPMENT,1.6455e-05,0.24651,0.25956,1,1
1,GO AMELOGENESIS,0.009256,0.24648,0.24992,1,1
1,GO PEPTIDYL TYROSINE MODIFICATION,4.8612e-06,0.24637,0.24519,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00016023,0.24627,0.20578,1,1
1,GO SMOOTHENED SIGNALING PATHWAY,0.00057693,0.24626,0.17812,1,1
1,GO CARDIOLIPIN METABOLIC PROCESS,0.036948,0.24609,0.12711,1,1
1,GO LYMPHOCYTE CHEMOTAXIS,7.6603e-06,0.24599,0.29026,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,8.4205e-05,0.24585,0.22292,1,1
1,GO P38MAPK CASCADE,2.4346e-05,0.24581,0.33779,1,1
1,GO NEGATIVE REGULATION OF DNA REPLICATION,0.023205,0.24469,0.17117,1,1
1,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00013433,0.24461,0.22382,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0042883,0.24436,0.3828,1,1
1,GO POSITIVE REGULATION OF LIPID LOCALIZATION,1.1493e-05,0.24432,0.24978,1,1
1,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,7.3528e-06,0.24408,0.21467,1,1
1,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.00042998,0.24347,0.22118,1,1
1,GO HOMOTYPIC CELL CELL ADHESION,0.00013433,0.24342,0.29105,1,1
1,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.046579,0.24318,0.16755,1,1
1,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.0013872,0.24315,0.21731,1,1
1,GO AORTA DEVELOPMENT,0.0033369,0.24311,0.29162,1,1
1,GO NATURAL KILLER CELL PROLIFERATION,0.0042883,0.24301,0.34396,1,1
1,GO RESPONSE TO STEROID HORMONE,0.00021167,0.24275,0.20022,1,1
1,GO CANONICAL WNT SIGNALING PATHWAY,3.1888e-05,0.24259,0.21215,1,1
1,GO REGULATION OF IMMUNE RESPONSE,1.0184e-05,0.24247,0.2257,1,1
1,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,3.6228e-06,0.24234,0.24713,1,1
1,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0006154,0.24227,0.22492,1,1
1,GO MITOTIC CYTOKINETIC PROCESS,0.00014935,0.24204,0.26179,1,1
1,GO RRNA MODIFICATION,0.012203,0.24195,0.1653,1,1
1,GO LEUKOCYTE MEDIATED IMMUNITY,1.349e-05,0.24185,0.28526,1,1
1,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00055855,0.24174,0.19226,1,1
1,GO REGULATION OF MITOPHAGY,0.019739,0.24166,0.19067,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.0069616,0.24149,0.15923,1,1
1,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00054072,0.24144,0.1851,1,1
1,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,1.4039e-05,0.24117,0.2362,1,1
1,GO NADP METABOLIC PROCESS,0.037747,0.24105,0.16528,1,1
1,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,2.4346e-05,0.24064,0.21189,1,1
1,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.00049035,0.24034,0.27216,1,1
1,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,1.4044e-06,0.24034,0.22714,1,1
1,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.00022676,0.24023,0.2237,1,1
1,GO PEPTIDE METABOLIC PROCESS,8.6584e-06,0.24018,0.20283,1,1
1,GO OSSIFICATION,5.0226e-05,0.24013,0.23337,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00057693,0.24008,0.22153,1,1
1,GO AUTOPHAGY OF NUCLEUS,0.0015653,0.24005,0.22822,1,1
1,GO PLATELET ACTIVATION,6.7596e-05,0.23998,0.24849,1,1
1,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0025817,0.23997,0.23458,1,1
1,GO SCHWANN CELL DIFFERENTIATION,0.00012074,0.23988,0.21572,1,1
1,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,3.4421e-05,0.23948,0.36188,1,1
1,GO REGULATION OF CELL ADHESION,0.00045924,0.23935,0.20896,1,1
1,GO DEFENSE RESPONSE,2.8418e-05,0.2391,0.23251,1,1
1,GO MITOTIC CELL CYCLE ARREST,0.0099891,0.23909,0.19715,1,1
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0034322,0.23905,0.18963,1,1
1,GO NUCLEOBASE METABOLIC PROCESS,0.0028141,0.23891,0.20424,1,1
1,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.014138,0.23889,0.25244,1,1
1,GO MEMBRANE BIOGENESIS,0.011047,0.23859,0.21032,1,1
1,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0021062,0.23848,0.35418,1,1
1,GO PROTEIN LOCALIZATION TO VACUOLE,0.0007696,0.23846,0.19006,1,1
1,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,2.2524e-05,0.23845,0.3011,1,1
1,GO EPITHELIAL CELL PROLIFERATION,0.00026903,0.23821,0.21377,1,1
1,GO CELLULAR DEFENSE RESPONSE,0.0017641,0.23782,0.28637,1,1
1,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.00032948,0.2378,0.18826,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0017123,0.23778,0.25366,1,1
1,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.00025131,0.23778,0.33391,1,1
1,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.0019282,0.23758,0.20325,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.0062634,0.23754,0.2021,1,1
1,GO ANIMAL ORGAN FORMATION,0.00095906,0.23742,0.21853,1,1
1,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,1.2454e-05,0.23739,0.21833,1,1
1,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.00041602,0.23711,0.2014,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,1.8521e-05,0.23703,0.27174,1,1
1,GO MYOBLAST MIGRATION,0.011047,0.23699,0.38271,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00063551,0.23651,0.23134,1,1
1,GO HEAD MORPHOGENESIS,0.00072223,0.23645,0.26753,1,1
1,GO ACTIN CYTOSKELETON REORGANIZATION,0.00072223,0.23614,0.22916,1,1
1,GO MYOTUBE DIFFERENTIATION,0.0066042,0.23595,0.16044,1,1
1,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.00054072,0.23585,0.25146,1,1
1,GO ORGAN GROWTH,5.0226e-05,0.23549,0.24024,1,1
1,GO DNA DEALKYLATION,0.0011199,0.23537,0.224,1,1
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.0020453,0.23516,0.21539,1,1
1,GO HYPEROSMOTIC RESPONSE,0.00092958,0.23488,0.24565,1,1
1,GO HISTONE H2B UBIQUITINATION,0.007729,0.23483,0.1696,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.00013433,0.23444,0.20871,1,1
1,GO CELLULAR IRON ION HOMEOSTASIS,5.8301e-05,0.23317,0.20343,1,1
1,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,9.8628e-07,0.2331,0.27221,1,1
1,GO REGULATION OF MYOTUBE DIFFERENTIATION,8.1192e-05,0.23293,0.26472,1,1
1,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.00036427,0.23282,0.23798,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0007696,0.23266,0.27671,1,1
1,GO NEGATIVE REGULATION OF DNA REPAIR,1.1964e-05,0.23235,0.24826,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,7.547e-05,0.23229,0.24429,1,1
1,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.014486,0.23228,0.2219,1,1
1,GO LEUKOCYTE PROLIFERATION,0.0011549,0.23221,0.18435,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,9.3916e-06,0.23214,0.21486,1,1
1,GO PROTEIN LOCALIZATION TO LYSOSOME,0.0059384,0.23172,0.17069,1,1
1,GO MYELOID CELL HOMEOSTASIS,2.9301e-06,0.23169,0.23265,1,1
1,GO CELLULAR EXTRAVASATION,9.7346e-05,0.23119,0.22768,1,1
1,GO CELLULAR OXIDANT DETOXIFICATION,0.0019282,0.23117,0.18135,1,1
1,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.00034072,0.23093,0.26455,1,1
1,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.00012512,0.23091,0.19516,1,1
1,GO POSITIVE REGULATION OF CELL ACTIVATION,3.1888e-05,0.23062,0.23412,1,1
1,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.00029782,0.23044,0.20567,1,1
1,GO TRNA METHYLATION,0.0012662,0.23037,0.18249,1,1
1,GO REGULATION OF PROTON TRANSPORT,0.0024367,0.23037,0.21071,1,1
1,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.0013054,0.23001,0.23649,1,1
1,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,1.6729e-06,0.22991,0.2337,1,1
1,GO REGULATION OF HEMOPOIESIS,4.1112e-06,0.22985,0.22174,1,1
1,GO STEROL IMPORT,0.00029782,0.22965,0.4251,1,1
1,GO RNA 3 END PROCESSING,0.00069957,0.22924,0.17783,1,1
1,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,2.3654e-06,0.22913,0.20771,1,1
1,GO DE NOVO PROTEIN FOLDING,0.0085714,0.22912,0.15997,1,1
1,GO REGULATION OF NUCLEASE ACTIVITY,0.0019282,0.22889,0.2447,1,1
1,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,7.2754e-05,0.22864,0.25798,1,1
1,GO ESTABLISHMENT OF SPINDLE ORIENTATION,1.4044e-06,0.22854,0.23009,1,1
1,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.0013457,0.22842,0.19926,1,1
1,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.001986,0.22801,0.19141,1,1
1,GO NEGATIVE REGULATION OF CELL ADHESION,0.0030654,0.22757,0.19869,1,1
1,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0030654,0.22732,0.19223,1,1
1,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.00019753,0.22728,0.23402,1,1
1,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,3.7145e-05,0.22703,0.26137,1,1
1,GO RESPONSE TO REACTIVE OXYGEN SPECIES,2.1663e-05,0.22691,0.22672,1,1
1,GO AGING,2.1663e-05,0.22677,0.19722,1,1
1,GO POSITIVE REGULATION OF CELL KILLING,0.014138,0.22677,0.16809,1,1
1,GO MITOPHAGY,0.0010206,0.22669,0.22377,1,1
1,GO BINDING OF SPERM TO ZONA PELLUCIDA,2.1663e-05,0.22657,0.24154,1,1
1,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00041602,0.22647,0.22662,1,1
1,GO REGULATION OF LYMPHOCYTE ACTIVATION,2.4346e-05,0.22606,0.22339,1,1
1,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.00012964,0.226,0.24294,1,1
1,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.00014418,0.22585,0.21157,1,1
1,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.00014418,0.22555,0.35716,1,1
1,GO NUCLEOSIDE METABOLIC PROCESS,2.9532e-05,0.2255,0.23577,1,1
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,7.5427e-07,0.2252,0.20175,1,1
1,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.00035231,0.22519,0.27492,1,1
1,GO REGULATION OF BODY FLUID LEVELS,8.7323e-05,0.22516,0.20614,1,1
1,GO KINETOCHORE ASSEMBLY,0.033894,0.22504,0.17756,1,1
1,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.0021689,0.22479,0.29095,1,1
1,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,6.7596e-05,0.22465,0.18459,1,1
1,GO SKELETAL SYSTEM MORPHOGENESIS,0.0014299,0.22433,0.17241,1,1
1,GO POSITIVE REGULATION OF LIPASE ACTIVITY,2.3418e-05,0.22415,0.21293,1,1
1,GO EXTRACELLULAR VESICLE BIOGENESIS,0.0026572,0.22404,0.19728,1,1
1,GO RESPONSE TO GONADOTROPIN,0.0032441,0.2238,0.28977,1,1
1,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.00042998,0.22367,0.22375,1,1
1,GO PERICARDIUM DEVELOPMENT,0.0013054,0.2236,0.2806,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,1.9263e-05,0.22333,0.28046,1,1
1,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.0069616,0.2233,0.20609,1,1
1,GO CELL KILLING,0.0023671,0.22321,0.16413,1,1
1,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0056288,0.22304,0.22693,1,1
1,GO REGULATION OF INFLAMMATORY RESPONSE,0.00090094,0.22304,0.19288,1,1
1,GO PLATELET MORPHOGENESIS,0.00041602,0.22279,0.22896,1,1
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0017123,0.22265,0.21737,1,1
1,GO MITOCHONDRIAL PROTEIN PROCESSING,0.0007696,0.22254,0.23043,1,1
1,GO LEUKOCYTE HOMEOSTASIS,9.389e-05,0.22209,0.20622,1,1
1,GO CIRCULATORY SYSTEM DEVELOPMENT,4.1112e-06,0.22209,0.24222,1,1
1,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00019753,0.22208,0.32803,1,1
1,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.011326,0.22193,0.1673,1,1
1,GO HINDLIMB MORPHOGENESIS,0.02068,0.22184,0.22142,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0025083,0.22171,0.2781,1,1
1,GO PROTEIN LOCALIZATION TO CELL SURFACE,2.4692e-06,0.22127,0.21364,1,1
1,GO RESPONSE TO MISFOLDED PROTEIN,0.0045306,0.22116,0.19011,1,1
1,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.00012074,0.22115,0.22921,1,1
1,GO ACTIVATION OF IMMUNE RESPONSE,2.6307e-05,0.22078,0.19256,1,1
1,GO REGULATION OF URINE VOLUME,9.389e-05,0.22054,0.25475,1,1
1,GO MITOCHONDRIAL DNA REPLICATION,0.001662,0.22028,0.17466,1,1
1,GO REPLACEMENT OSSIFICATION,0.0014299,0.22015,0.32086,1,1
1,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,4.6597e-05,0.21995,0.21261,1,1
1,GO OVULATION,0.031059,0.21987,0.22934,1,1
1,GO BODY FLUID SECRETION,0.00036427,0.21983,0.20859,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00031859,0.21961,0.23222,1,1
1,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.00038934,0.21958,0.20983,1,1
1,GO REGULATION OF IMMUNE SYSTEM PROCESS,1.4609e-05,0.21957,0.2041,1,1
1,GO NCRNA EXPORT FROM NUCLEUS,0.001986,0.21939,0.19961,1,1
1,GO TISSUE MORPHOGENESIS,3.0689e-05,0.21928,0.197,1,1
1,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.0050528,0.21909,0.19272,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,1.5816e-05,0.21904,0.2348,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,1.5201e-05,0.21884,0.22275,1,1
1,GO HEMOGLOBIN METABOLIC PROCESS,0.011904,0.2188,0.17683,1,1
1,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.00024286,0.21859,0.20796,1,1
1,GO REGULATION OF VASCULOGENESIS,0.024288,0.2178,0.27745,1,1
1,GO INTERFERON GAMMA PRODUCTION,5.2139e-05,0.21747,0.26436,1,1
1,GO REGULATION OF CENTRIOLE REPLICATION,0.004408,0.21699,0.16796,1,1
1,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.0017123,0.2169,0.18389,1,1
1,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.0014299,0.21687,0.21787,1,1
1,GO POSITIVE REGULATION OF NEURON MIGRATION,0.042857,0.21642,0.16515,1,1
1,GO MORPHOGENESIS OF AN EPITHELIUM,2.8418e-05,0.21603,0.20201,1,1
1,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00026903,0.216,0.19705,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,1.0604e-05,0.216,0.18088,1,1
1,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.001228,0.21583,0.18594,1,1
1,GO TRANSEPITHELIAL TRANSPORT,0.0010528,0.21566,0.22342,1,1
1,GO HYALURONAN BIOSYNTHETIC PROCESS,0.0097392,0.21555,0.24567,1,1
1,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.0062634,0.21546,0.20174,1,1
1,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.00098941,0.21528,0.23103,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS,7.0571e-06,0.21526,0.19502,1,1
1,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,1.4674e-06,0.21471,0.20647,1,1
1,GO REGULATION OF CELL ACTIVATION,5.4121e-05,0.21463,0.20738,1,1
1,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.00027832,0.21444,0.22214,1,1
1,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.0038387,0.2141,0.15056,1,1
1,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0011199,0.21397,0.24272,1,1
1,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.00092958,0.21394,0.23137,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0032441,0.21379,0.21339,1,1
1,GO PEPTIDYL ASPARAGINE MODIFICATION,0.0033369,0.21359,0.13852,1,1
1,GO BONE DEVELOPMENT,3.5759e-05,0.21353,0.24032,1,1
1,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.022165,0.21345,0.2021,1,1
1,GO SPINDLE LOCALIZATION,3.3287e-06,0.21337,0.2116,1,1
1,GO TRANSITION METAL ION HOMEOSTASIS,0.00012512,0.21324,0.20425,1,1
1,GO NEURAL TUBE DEVELOPMENT,0.00084609,0.21322,0.20908,1,1
1,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.0017641,0.21315,0.19176,1,1
1,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.042857,0.21291,0.12547,1,1
1,GO TRNA MODIFICATION,0.0036303,0.21222,0.14837,1,1
1,GO GLUTATHIONE METABOLIC PROCESS,0.0021062,0.21206,0.21644,1,1
1,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.052669,0.2118,0.10649,1,1
1,GO AMINE CATABOLIC PROCESS,0.0010528,0.21166,0.31193,1,1
1,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.0079323,0.21153,0.26754,1,1
1,GO RNA MODIFICATION,0.00069957,0.21144,0.16051,1,1
1,GO CELL ACTIVATION,1.4039e-05,0.21138,0.23614,1,1
1,GO REGULATION OF DEFENSE RESPONSE,8.4205e-05,0.21122,0.20466,1,1
1,GO POSITIVE REGULATION OF VIRAL PROCESS,2.2658e-06,0.21113,0.24401,1,1
1,GO RESPONSE TO LIPID,0.00032948,0.21105,0.17802,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.0015189,0.21091,0.18545,1,1
1,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,2.4346e-05,0.21087,0.23069,1,1
1,GO MITOTIC CYTOKINESIS,0.00014418,0.21071,0.22298,1,1
1,GO LYMPHOCYTE ACTIVATION,2.8418e-05,0.21024,0.20422,1,1
1,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,1.7806e-05,0.21022,0.21866,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,2.6307e-05,0.20992,0.18093,1,1
1,GO PROTEIN TARGETING TO MEMBRANE,0.0083534,0.20978,0.17206,1,1
1,GO REGULATION OF MRNA 3 END PROCESSING,0.00025131,0.20959,0.19766,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.00013917,0.20958,0.19798,1,1
1,GO RRNA METHYLATION,0.018398,0.20936,0.13963,1,1
1,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.0040578,0.20936,0.18476,1,1
1,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.0067808,0.20905,0.18836,1,1
1,GO REGULATION OF T CELL ACTIVATION,0.00017796,0.20885,0.19896,1,1
1,GO TRNA PROCESSING,0.0025083,0.20879,0.14846,1,1
1,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.019739,0.20847,0.24045,1,1
1,GO FATTY ACID CATABOLIC PROCESS,0.0024367,0.20847,0.16859,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,6.7728e-06,0.20827,0.2102,1,1
1,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.001228,0.20827,0.19278,1,1
1,GO MYELOID CELL DIFFERENTIATION,4.2876e-06,0.20806,0.19327,1,1
1,GO POST GOLGI VESICLE MEDIATED TRANSPORT,4.4712e-06,0.20749,0.23372,1,1
1,GO CAMP METABOLIC PROCESS,0.02843,0.20744,0.21666,1,1
1,GO POSITIVE REGULATION OF MACROAUTOPHAGY,1.104e-05,0.20742,0.25151,1,1
1,GO SUPEROXIDE METABOLIC PROCESS,0.0020453,0.20702,0.17657,1,1
1,GO MYELOID LEUKOCYTE ACTIVATION,5.0226e-05,0.20697,0.27355,1,1
1,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00038934,0.20654,0.18097,1,1
1,GO EMBRYONIC HEART TUBE DEVELOPMENT,1.7118e-05,0.20651,0.22746,1,1
1,GO LEUKOCYTE MIGRATION,0.0016129,0.20628,0.19458,1,1
1,GO PROTEIN ADP RIBOSYLATION,0.012508,0.20567,0.16538,1,1
1,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.00353,0.20564,0.17078,1,1
1,GO POSITIVE REGULATION OF PROTEIN BINDING,0.00013917,0.20545,0.19083,1,1
1,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.00042998,0.2054,0.22312,1,1
1,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0037331,0.2054,0.22591,1,1
1,GO ENDODERMAL CELL FATE COMMITMENT,0.0028957,0.20534,0.22461,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,8.3127e-06,0.20499,0.2006,1,1
1,GO RUFFLE ORGANIZATION,0.001986,0.20481,0.1557,1,1
1,GO HORMONE BIOSYNTHETIC PROCESS,0.0013054,0.20481,0.20942,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00041602,0.2047,0.1791,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0011549,0.20466,0.19094,1,1
1,GO REGULATION OF LIPID LOCALIZATION,0.00034072,0.20436,0.16897,1,1
1,GO RESPONSE TO KETONE,0.0038387,0.20427,0.15619,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,1.8251e-06,0.20376,0.23503,1,1
1,GO CELLULAR RESPONSE TO ATP,0.0007696,0.20366,0.19658,1,1
1,GO MIDBODY ABSCISSION,0.0094949,0.2034,0.20782,1,1
1,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.001986,0.2032,0.28738,1,1
1,GO EMBRYONIC HEART TUBE MORPHOGENESIS,1.9263e-05,0.20319,0.21673,1,1
1,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,6.5149e-05,0.20293,0.15689,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.00037661,0.20272,0.17302,1,1
1,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,6.2786e-05,0.20259,0.25004,1,1
1,GO REGULATION OF LIPID STORAGE,0.00069957,0.2024,0.23966,1,1
1,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.0060989,0.20239,0.23577,1,1
1,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.009256,0.20209,0.19572,1,1
1,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0007696,0.20208,0.18926,1,1
1,GO REGULATION OF WNT SIGNALING PATHWAY,0.00026903,0.20205,0.17786,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.0017641,0.20204,0.18437,1,1
1,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.00013917,0.20189,0.1684,1,1
1,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,4.6623e-06,0.20184,0.19624,1,1
1,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.001228,0.20164,0.16341,1,1
1,GO SECRETION BY TISSUE,0.029068,0.20161,0.14299,1,1
1,GO HEART GROWTH,0.00057693,0.20136,0.1967,1,1
1,GO TRNA METABOLIC PROCESS,0.0030654,0.20095,0.14574,1,1
1,GO DNA TEMPLATED TRANSCRIPTION INITIATION,1.0311e-06,0.20085,0.1923,1,1
1,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.010245,0.2008,0.22092,1,1
1,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,1.906e-06,0.20027,0.18125,1,1
1,GO POSITIVE REGULATION OF TISSUE REMODELING,0.0022992,0.20026,0.22245,1,1
1,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.011326,0.20021,0.16208,1,1
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00032948,0.20009,0.19356,1,1
1,GO BODY MORPHOGENESIS,0.0033369,0.19999,0.18658,1,1
1,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,9.7346e-05,0.19988,0.17125,1,1
1,GO PROTEIN PROCESSING,0.00023468,0.19977,0.20209,1,1
1,GO VESICLE BUDDING FROM MEMBRANE,0.00069957,0.19966,0.20027,1,1
1,GO EMBRYONIC DIGIT MORPHOGENESIS,0.035393,0.19912,0.1502,1,1
1,GO CARNITINE SHUTTLE,0.042857,0.19902,0.15634,1,1
1,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00065623,0.19887,0.16878,1,1
1,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,5.2533e-07,0.19884,0.16616,1,1
1,GO NUCLEAR EXPORT,8.3127e-06,0.19868,0.20204,1,1
1,GO TUBE DEVELOPMENT,0.00010462,0.19846,0.19742,1,1
1,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.02268,0.19825,0.20528,1,1
1,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.013139,0.19799,0.13373,1,1
1,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.0026572,0.19748,0.20278,1,1
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.013798,0.1974,0.15479,1,1
1,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,6.2786e-05,0.19708,0.18961,1,1
1,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.033894,0.19694,0.091015,1,1
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.010245,0.19672,0.19274,1,1
1,GO NEURAL TUBE FORMATION,0.001986,0.19646,0.20077,1,1
1,GO HEART TRABECULA MORPHOGENESIS,0.0053338,0.19631,0.20348,1,1
1,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,9.7801e-06,0.19627,0.22044,1,1
1,GO PROTEOGLYCAN METABOLIC PROCESS,0.0026572,0.19597,0.22768,1,1
1,GO PROTEIN K63 LINKED UBIQUITINATION,3.1888e-05,0.1959,0.17572,1,1
1,GO VESICLE TARGETING,0.00049035,0.19585,0.19756,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.011326,0.1958,0.20103,1,1
1,GO STEM CELL DIFFERENTIATION,2.2524e-05,0.19562,0.20305,1,1
1,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.031748,0.19555,0.15749,1,1
1,GO AMIDE BIOSYNTHETIC PROCESS,0.00014418,0.19521,0.16457,1,1
1,GO NEGATIVE REGULATION OF CELL DEATH,6.7728e-06,0.19489,0.18352,1,1
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,4.4878e-05,0.19428,0.2027,1,1
1,GO TRANSLATIONAL ELONGATION,0.007729,0.19408,0.16328,1,1
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.010773,0.19402,0.12874,1,1
1,GO REGULATION OF MYELOID CELL DIFFERENTIATION,1.5816e-05,0.19354,0.19428,1,1
1,GO ALDITOL METABOLIC PROCESS,0.0013872,0.19338,0.20366,1,1
1,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.027803,0.19335,0.16387,1,1
1,GO TRANSLATIONAL TERMINATION,0.0029794,0.19295,0.19824,1,1
1,GO FC RECEPTOR SIGNALING PATHWAY,0.00019753,0.19255,0.17619,1,1
1,GO RESPONSE TO GAMMA RADIATION,6.7596e-05,0.19175,0.23926,1,1
1,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.00034072,0.19172,0.29373,1,1
1,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.044685,0.19165,0.16492,1,1
1,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,2.0033e-05,0.19162,0.19654,1,1
1,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,9.0551e-05,0.1916,0.23249,1,1
1,GO RESPONSE TO UV,2.9532e-05,0.19128,0.19393,1,1
1,GO REGULATION OF TRANSLATIONAL ELONGATION,0.017137,0.19034,0.14352,1,1
1,GO PROTEIN TARGETING,0.00034072,0.19024,0.16372,1,1
1,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,9.389e-05,0.19012,0.16057,1,1
1,GO SULFUR COMPOUND METABOLIC PROCESS,6.7596e-05,0.19004,0.18236,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00025131,0.19004,0.19606,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.00035231,0.19003,0.16092,1,1
1,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.00074557,0.19001,0.18505,1,1
1,GO POSITIVE REGULATION OF MAPK CASCADE,4.4878e-05,0.18989,0.1941,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.001228,0.18987,0.16965,1,1
1,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.00010092,0.18966,0.19574,1,1
1,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.00067758,0.18957,0.16348,1,1
1,GO NEGATIVE REGULATION OF MAPK CASCADE,0.0006154,0.18945,0.14596,1,1
1,GO CARDIAC CHAMBER MORPHOGENESIS,0.013139,0.1894,0.17167,1,1
1,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.004408,0.18937,0.14175,1,1
1,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,6.0504e-05,0.18895,0.20022,1,1
1,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.00024286,0.1889,0.20944,1,1
1,GO PEPTIDYL ARGININE MODIFICATION,0.00067758,0.18864,0.15066,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION,0.0029794,0.18839,0.13876,1,1
1,GO IMMUNE SYSTEM DEVELOPMENT,1.1964e-05,0.18834,0.16972,1,1
1,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0025083,0.18806,0.18791,1,1
1,GO REGULATION OF VACUOLE ORGANIZATION,0.00041602,0.18757,0.19532,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.00098941,0.18753,0.1846,1,1
1,GO APOPTOTIC SIGNALING PATHWAY,0.00019079,0.18744,0.17768,1,1
1,GO MACROMOLECULE CATABOLIC PROCESS,3.6414e-07,0.18718,0.1792,1,1
1,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,2.0033e-05,0.18716,0.15696,1,1
1,GO RESPONSE TO GROWTH FACTOR,8.7323e-05,0.18714,0.178,1,1
1,GO HISTONE DEACETYLATION,0.00052342,0.18712,0.1312,1,1
1,GO ORGANELLE INHERITANCE,0.0013054,0.18635,0.17319,1,1
1,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.031748,0.18628,0.1327,1,1
1,GO CELLULAR RESPONSE TO UV,0.00025131,0.18588,0.18047,1,1
1,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,3.1904e-06,0.18517,0.1544,1,1
1,GO PROTEIN HOMOTETRAMERIZATION,6.5149e-05,0.18497,0.18282,1,1
1,GO POSITIVE REGULATION OF CELL AGING,0.0054795,0.18468,0.26426,1,1
1,GO BIOLOGICAL ADHESION,0.0054795,0.18456,0.13772,1,1
1,GO REGULATION OF CELL CYCLE PHASE TRANSITION,5.2139e-05,0.18445,0.15923,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.00054072,0.18442,0.16693,1,1
1,GO PROTEIN LOCALIZATION TO ENDOSOME,0.023205,0.18388,0.16966,1,1
1,GO RNA METHYLATION,0.0024367,0.18327,0.15141,1,1
1,GO REGULATION OF AMYLOID BETA FORMATION,0.026586,0.18289,0.16963,1,1
1,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.0073363,0.18289,0.15852,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,7.2754e-05,0.18279,0.17373,1,1
1,GO SKELETAL SYSTEM DEVELOPMENT,0.00092958,0.18265,0.1753,1,1
1,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.024846,0.18262,0.13464,1,1
1,GO CELLULAR RESPONSE TO HEAT,0.001986,0.18255,0.16681,1,1
1,GO POSITIVE REGULATION OF CATABOLIC PROCESS,3.6228e-06,0.18255,0.184,1,1
1,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.0039469,0.18224,0.12844,1,1
1,GO HISTONE MRNA METABOLIC PROCESS,0.011326,0.18222,0.1246,1,1
1,GO CELLULAR AMIDE METABOLIC PROCESS,4.0073e-05,0.18161,0.1616,1,1
1,GO RESPONSE TO INTERLEUKIN 4,0.001986,0.18153,0.16156,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.00021167,0.18152,0.16634,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0013872,0.18143,0.14652,1,1
1,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.029719,0.1806,0.21274,1,1
1,GO REGULATION OF LYSOSOMAL LUMEN PH,0.007729,0.18033,0.20721,1,1
1,GO RESPONSE TO INTERLEUKIN 6,0.046579,0.18024,0.11719,1,1
1,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.00055855,0.18021,0.17218,1,1
1,GO CARDIAC CHAMBER DEVELOPMENT,0.0049174,0.18001,0.16127,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.031059,0.17981,0.12261,1,1
1,GO REGULATION OF CELLULAR CATABOLIC PROCESS,4.3763e-07,0.17974,0.17823,1,1
1,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00027832,0.17948,0.15484,1,1
1,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.036164,0.17914,0.1784,1,1
1,GO POSITIVE REGULATION OF DNA REPLICATION,0.0081404,0.17905,0.11172,1,1
1,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.0040578,0.17899,0.15288,1,1
1,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.00041602,0.1787,0.16371,1,1
1,GO MODULATION BY VIRUS OF HOST PROCESS,0.00069957,0.17842,0.17965,1,1
1,GO RESPONSE TO IRON ION,0.02068,0.17827,0.14099,1,1
1,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.00017796,0.17811,0.1754,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEUS,0.00020448,0.17808,0.15762,1,1
1,GO XENOBIOTIC TRANSPORT,0.0022332,0.17807,0.23296,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,9.0179e-06,0.17749,0.1777,1,1
1,GO EPITHELIAL CELL DEVELOPMENT,0.0046564,0.17726,0.15774,1,1
1,GO MITOTIC SPINDLE ORGANIZATION,0.00030804,0.17717,0.17856,1,1
1,GO MEIOTIC SPINDLE ORGANIZATION,0.0017641,0.17712,0.18556,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00090094,0.17681,0.20695,1,1
1,GO SULFUR COMPOUND TRANSPORT,0.00024286,0.17648,0.16499,1,1
1,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00016023,0.17599,0.16591,1,1
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.0067808,0.17584,0.13437,1,1
1,GO TRNA TRANSPORT,0.0097392,0.17573,0.14978,1,1
1,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.00023468,0.17564,0.19278,1,1
1,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,3.4728e-06,0.17557,0.16743,1,1
1,GO AUTOPHAGOSOME ORGANIZATION,0.00013917,0.17476,0.2001,1,1
1,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.0047853,0.17469,0.16813,1,1
1,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.0036303,0.17454,0.14473,1,1
1,GO MULTIVESICULAR BODY ORGANIZATION,0.0053338,0.17437,0.13567,1,1
1,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.00087311,0.17435,0.16124,1,1
1,GO GOLGI VESICLE TRANSPORT,2.3418e-05,0.17426,0.16258,1,1
1,GO REGULATION OF DNA RECOMBINATION,0.0011549,0.17419,0.1829,1,1
1,GO INTRA S DNA DAMAGE CHECKPOINT,0.0028957,0.17392,0.14811,1,1
1,GO SCHWANN CELL DEVELOPMENT,0.0021062,0.17384,0.1709,1,1
1,GO CENTRIOLE ASSEMBLY,0.007729,0.17344,0.12327,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.0040578,0.17324,0.12996,1,1
1,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.0019282,0.17314,0.29718,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00049035,0.17309,0.17282,1,1
1,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,2.6902e-06,0.17273,0.16172,1,1
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.013139,0.17266,0.17177,1,1
1,GO REGULATION OF MAPK CASCADE,8.4205e-05,0.17259,0.16851,1,1
1,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0013872,0.17233,0.18664,1,1
1,GO DEFENSE RESPONSE TO BACTERIUM,0.0018173,0.17231,0.16897,1,1
1,GO RESPONSE TO CHEMOKINE,0.016339,0.17226,0.18439,1,1
1,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.021165,0.1722,0.13754,1,1
1,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.0075304,0.17211,0.17531,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS,1.906e-06,0.17186,0.16152,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.0021062,0.17184,0.15173,1,1
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00069957,0.17181,0.17894,1,1
1,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.04854,0.1717,0.19297,1,1
1,GO LYSOSOMAL TRANSPORT,0.00057693,0.17139,0.16816,1,1
1,GO TRANSLESION SYNTHESIS,0.00034072,0.17119,0.17023,1,1
1,GO POSITIVE REGULATION OF CELL DIVISION,0.030383,0.17116,0.13323,1,1
1,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.0033369,0.17095,0.16982,1,1
1,GO REGULATION OF RESPONSE TO STRESS,2.6307e-05,0.17084,0.16534,1,1
1,GO COENZYME A METABOLIC PROCESS,0.013139,0.17074,0.15407,1,1
1,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,4.8379e-05,0.17043,0.18236,1,1
1,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.02268,0.17033,0.13997,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.0017641,0.17018,0.14282,1,1
1,GO REGULATION OF NUCLEAR DIVISION,2.7343e-05,0.17003,0.14911,1,1
1,GO BLASTOCYST GROWTH,0.0025083,0.16955,0.24007,1,1
1,GO REGULATION OF CATABOLIC PROCESS,7.889e-07,0.1695,0.1623,1,1
1,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0001547,0.16919,0.13964,1,1
1,GO REGULATION OF CELL SHAPE,0.0030654,0.16902,0.18732,1,1
1,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.041093,0.16883,0.10593,1,1
1,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.001228,0.16866,0.24956,1,1
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.0053338,0.16863,0.19901,1,1
1,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.0038387,0.16858,0.19841,1,1
1,GO MUSCLE ORGAN MORPHOGENESIS,0.047551,0.16848,0.13367,1,1
1,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0075304,0.16841,0.12716,1,1
1,GO VACUOLAR TRANSPORT,0.0012662,0.1682,0.14035,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0039469,0.16818,0.14856,1,1
1,GO IMPORT INTO NUCLEUS,0.00028792,0.16798,0.13799,1,1
1,GO COPII COATED VESICLE CARGO LOADING,0.0016129,0.16756,0.18402,1,1
1,GO CELLULAR COMPONENT DISASSEMBLY,3.7791e-06,0.16748,0.15617,1,1
1,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.00353,0.16744,0.17834,1,1
1,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.026586,0.16734,0.1768,1,1
1,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0011199,0.16726,0.13087,1,1
1,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.00026003,0.16683,0.18679,1,1
1,GO RESPONSE TO BMP,0.021165,0.16642,0.13928,1,1
1,GO PROTEIN DENEDDYLATION,0.0094949,0.16628,0.16,1,1
1,GO AMYLOID BETA METABOLIC PROCESS,0.016339,0.16626,0.15872,1,1
1,GO REGULATION OF B CELL ACTIVATION,0.011326,0.16617,0.12793,1,1
1,GO LAMELLIPODIUM ORGANIZATION,0.00052342,0.1659,0.21976,1,1
1,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.041093,0.16577,0.13426,1,1
1,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0019282,0.16567,0.1888,1,1
1,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,6.5149e-05,0.16563,0.14963,1,1
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.0021689,0.16556,0.13085,1,1
1,GO CELL CYCLE G2 M PHASE TRANSITION,9.7346e-05,0.16554,0.13758,1,1
1,GO NEGATIVE REGULATION OF JNK CASCADE,0.0083534,0.16545,0.13942,1,1
1,GO TRNA WOBBLE URIDINE MODIFICATION,0.011612,0.16518,0.17322,1,1
1,GO PROTEIN KINASE A SIGNALING,0.00020448,0.16514,0.20909,1,1
1,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.00034072,0.16511,0.20207,1,1
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.004408,0.16504,0.17076,1,1
1,GO POSITIVE REGULATION OF CELL DEATH,0.00055855,0.16459,0.14039,1,1
1,GO LAMELLIPODIUM ASSEMBLY,0.00067758,0.16451,0.21238,1,1
1,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,4.2876e-06,0.16447,0.16909,1,1
1,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.00018427,0.16445,0.18211,1,1
1,GO REGULATION OF MYELINATION,0.011612,0.16445,0.14145,1,1
1,GO POSITIVE REGULATION OF T CELL MIGRATION,0.011326,0.16437,0.17336,1,1
1,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0026572,0.16378,0.12129,1,1
1,GO RESPONSE TO PH,0.025994,0.16335,0.17198,1,1
1,GO RESPONSE TO ANTIBIOTIC,0.0016129,0.16316,0.19236,1,1
1,GO RNA DECAPPING,0.00041602,0.16313,0.19151,1,1
1,GO POSITIVE REGULATION OF BINDING,0.00016595,0.16287,0.15988,1,1
1,GO CELLULAR PROTEIN CATABOLIC PROCESS,6.4994e-06,0.16278,0.14523,1,1
1,GO HEART MORPHOGENESIS,0.0034322,0.16235,0.16245,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.02843,0.16233,0.11369,1,1
1,GO REGULATION OF SPINDLE ORGANIZATION,0.00081984,0.16213,0.15755,1,1
1,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.00041602,0.16211,0.20325,1,1
1,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.00074557,0.16209,0.15972,1,1
1,GO VACUOLE ORGANIZATION,0.00030804,0.16206,0.14107,1,1
1,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0025083,0.16198,0.148,1,1
1,GO RRNA 3 END PROCESSING,0.0036303,0.16195,0.1766,1,1
1,GO REGULATION OF FATTY ACID BETA OXIDATION,0.007729,0.16176,0.16112,1,1
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,8.1192e-05,0.16169,0.18276,1,1
1,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.0047853,0.16141,0.18005,1,1
1,GO RECEPTOR RECYCLING,0.016339,0.16122,0.11988,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.030383,0.16117,0.13923,1,1
1,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0020453,0.16108,0.12252,1,1
1,GO PROTEIN POLYUBIQUITINATION,2.2524e-05,0.161,0.1564,1,1
1,GO THYROID HORMONE METABOLIC PROCESS,0.02268,0.161,0.14363,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.017549,0.16073,0.14857,1,1
1,GO REGULATION OF GLIAL CELL MIGRATION,0.0027346,0.16042,0.19923,1,1
1,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.0051916,0.16023,0.098224,1,1
1,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.013139,0.16022,0.13386,1,1
1,GO MAMMARY GLAND DEVELOPMENT,0.0060989,0.16021,0.16434,1,1
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0014738,0.16001,0.20788,1,1
1,GO HOMEOSTASIS OF NUMBER OF CELLS,4.1617e-05,0.15981,0.16332,1,1
1,GO PLASMA MEMBRANE ORGANIZATION,0.009256,0.15957,0.14197,1,1
1,GO PROTEOLYSIS,1.7806e-05,0.15947,0.14516,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.0081404,0.15933,0.19789,1,1
1,GO ERYTHROCYTE HOMEOSTASIS,4.8379e-05,0.15925,0.19057,1,1
1,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.013465,0.15898,0.17564,1,1
1,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.0087944,0.15839,0.16827,1,1
1,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.0031536,0.15826,0.13885,1,1
1,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.00036427,0.15794,0.20364,1,1
1,GO POSTREPLICATION REPAIR,0.00026903,0.15789,0.14927,1,1
1,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.010245,0.15752,0.15917,1,1
1,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.00353,0.15736,0.14973,1,1
1,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.012508,0.15712,0.23929,1,1
1,GO CELL CELL SIGNALING BY WNT,0.0010528,0.15697,0.14163,1,1
1,GO PROTEIN IMPORT,0.0001165,0.15671,0.15442,1,1
1,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.0054795,0.15665,0.19456,1,1
1,GO MAINTENANCE OF LOCATION,9.0551e-05,0.156,0.16337,1,1
1,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.0006154,0.1558,0.15242,1,1
1,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.049546,0.15579,0.16194,1,1
1,GO LYMPHOCYTE COSTIMULATION,0.0069616,0.15512,0.14122,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.00098941,0.15497,0.15627,1,1
1,GO PROTEIN CATABOLIC PROCESS,3.1904e-06,0.15492,0.14536,1,1
1,GO RESPONSE TO HEAT,0.00034072,0.15478,0.17555,1,1
1,GO MUSCLE STRUCTURE DEVELOPMENT,0.00028792,0.15417,0.16766,1,1
1,GO UV DAMAGE EXCISION REPAIR,0.00041602,0.15401,0.18536,1,1
1,GO CENTRIOLE CENTRIOLE COHESION,0.0039469,0.15345,0.19305,1,1
1,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,3.5759e-05,0.15332,0.18274,1,1
1,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,1.2962e-05,0.15305,0.18414,1,1
1,GO OUTFLOW TRACT MORPHOGENESIS,0.001872,0.15302,0.28042,1,1
1,GO CELL MOTILITY,0.0040578,0.15291,0.12094,1,1
1,GO MUSCLE ORGAN DEVELOPMENT,0.00059588,0.1528,0.14423,1,1
1,GO AMYLOID BETA FORMATION,0.024846,0.15269,0.15724,1,1
1,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.0064317,0.15266,0.10873,1,1
1,GO TELOMERE ORGANIZATION,0.0011549,0.15251,0.12291,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO STRESS,3.5759e-05,0.1523,0.13415,1,1
1,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,7.3528e-06,0.15189,0.15562,1,1
1,GO REGULATION OF CELL DEATH,7.547e-05,0.15169,0.14259,1,1
1,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.030383,0.15166,0.10566,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.001228,0.15159,0.11503,1,1
1,GO B CELL ACTIVATION,0.001228,0.15151,0.14117,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.00031859,0.15137,0.13575,1,1
1,GO REGULATION OF BINDING,0.00018427,0.15112,0.14291,1,1
1,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.00019753,0.15091,0.1491,1,1
1,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,2.0833e-05,0.15067,0.16434,1,1
1,GO PIGMENT GRANULE ORGANIZATION,0.010773,0.15056,0.1985,1,1
1,GO LACTATION,0.0083534,0.15046,0.1752,1,1
1,GO REGULATION OF ERAD PATHWAY,0.00057693,0.1504,0.14562,1,1
1,GO RESPONSE TO LEPTIN,0.02166,0.15038,0.18643,1,1
1,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0012662,0.15034,0.16853,1,1
1,GO GOLGI VESICLE BUDDING,0.0026572,0.14979,0.1623,1,1
1,GO RESPONSE TO VITAMIN,0.036948,0.14949,0.16878,1,1
1,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.050569,0.14938,0.10615,1,1
1,GO HEART DEVELOPMENT,0.00026003,0.14936,0.16167,1,1
1,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.0099891,0.14936,0.12219,1,1
1,GO REGULATION OF RECEPTOR RECYCLING,0.0019282,0.14929,0.20351,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.0042883,0.14927,0.12862,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.00052342,0.14921,0.13892,1,1
1,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.00057693,0.14897,0.13662,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,2.7343e-05,0.14888,0.15111,1,1
1,GO ESTABLISHMENT OF TISSUE POLARITY,0.00014935,0.14842,0.19145,1,1
1,GO REGULATION OF CHROMOSOME SEPARATION,0.00081984,0.14805,0.18477,1,1
1,GO REGULATION OF PROTEIN BINDING,0.00024286,0.14769,0.15781,1,1
1,GO DNA BIOSYNTHETIC PROCESS,1.4674e-06,0.14764,0.16582,1,1
1,GO ESTABLISHMENT OF CELL POLARITY,0.0023671,0.1476,0.11515,1,1
1,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.00017186,0.14706,0.12228,1,1
1,GO TUBE FORMATION,0.0071468,0.147,0.15003,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0053338,0.14694,0.14833,1,1
1,GO POSITIVE REGULATION OF DNA BINDING,0.020205,0.14691,0.12296,1,1
1,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.0040578,0.14631,0.18715,1,1
1,GO REGULATION OF MAP KINASE ACTIVITY,0.00055855,0.14608,0.13845,1,1
1,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.02843,0.14584,0.09765,1,1
1,GO CHROMOSOME LOCALIZATION,0.022165,0.14565,0.11807,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE,0.00012074,0.14545,0.12204,1,1
1,GO MITOTIC RECOMBINATION,0.018836,0.14529,0.16391,1,1
1,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.0069616,0.1451,0.17432,1,1
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.011047,0.14478,0.21527,1,1
1,GO RECEPTOR METABOLIC PROCESS,0.0013457,0.14472,0.13601,1,1
1,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0045306,0.14472,0.16678,1,1
1,GO NUCLEAR TRANSPORT,5.4121e-05,0.14458,0.14747,1,1
1,GO REGULATION OF CELL DIVISION,0.0075304,0.14453,0.10529,1,1
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.00010092,0.14448,0.14527,1,1
1,GO CELLULAR RESPONSE TO RADIATION,0.00026003,0.14447,0.14938,1,1
1,GO REGULATION OF DNA BINDING,0.018836,0.14437,0.089188,1,1
1,GO RNA LOCALIZATION,0.00035231,0.14429,0.17298,1,1
1,GO CELL CYCLE PHASE TRANSITION,0.00021167,0.14391,0.12443,1,1
1,GO VACUOLAR ACIDIFICATION,0.0060989,0.14387,0.15795,1,1
1,GO REGULATION OF SENSORY PERCEPTION,0.010773,0.14368,0.15257,1,1
1,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.011612,0.14339,0.14595,1,1
1,GO REGULATION OF PHOSPHORYLATION,0.00023468,0.14318,0.12769,1,1
1,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.031059,0.14317,0.14727,1,1
1,GO POSITIVE REGULATION OF URINE VOLUME,0.012508,0.14311,0.23337,1,1
1,GO RNA PROCESSING,0.00030804,0.14295,0.14859,1,1
1,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.0039469,0.14253,0.10982,1,1
1,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.00035231,0.14245,0.18739,1,1
1,GO COPII COATED VESICLE BUDDING,0.0051916,0.14234,0.16085,1,1
1,GO EPITHELIAL TUBE FORMATION,0.023741,0.14213,0.13709,1,1
1,GO RNA CAPPING,0.001662,0.14165,0.14068,1,1
1,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.013798,0.14134,0.11431,1,1
1,GO PROTEIN NEDDYLATION,0.0046564,0.14116,0.16595,1,1
1,GO REGULATION OF CARTILAGE DEVELOPMENT,0.027803,0.14074,0.16823,1,1
1,GO SMALL MOLECULE CATABOLIC PROCESS,0.00090094,0.1406,0.12916,1,1
1,GO REGULATION OF MITOTIC CELL CYCLE,6.2786e-05,0.14057,0.13341,1,1
1,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.00011241,0.14043,0.13928,1,1
1,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.0014738,0.13975,0.12927,1,1
1,GO CYTOKINESIS,0.00084609,0.13949,0.12969,1,1
1,GO ESTABLISHMENT OF RNA LOCALIZATION,0.00029782,0.13896,0.16921,1,1
1,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.0085714,0.13892,0.14136,1,1
1,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,2.6307e-05,0.13892,0.15048,1,1
1,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.00018427,0.13874,0.16295,1,1
1,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.0064317,0.13807,0.12252,1,1
1,GO ENDOSOME ORGANIZATION,0.00047456,0.13765,0.15976,1,1
1,GO SPINDLE ORGANIZATION,0.00059588,0.13731,0.13477,1,1
1,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0075304,0.13726,0.12022,1,1
1,GO APOPTOTIC PROCESS,7.547e-05,0.13719,0.13407,1,1
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00012964,0.13711,0.14077,1,1
1,GO REGULATION OF ENDOCYTOSIS,0.0059384,0.13709,0.11533,1,1
1,GO CELLULAR HORMONE METABOLIC PROCESS,0.0032441,0.13703,0.17041,1,1
1,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.0066042,0.13702,0.18703,1,1
1,GO IN UTERO EMBRYONIC DEVELOPMENT,0.00041602,0.13666,0.12392,1,1
1,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.00023468,0.13645,0.16829,1,1
1,GO NUCLEUS ORGANIZATION,0.0031536,0.13624,0.11874,1,1
1,GO GENE SILENCING,9.389e-05,0.13576,0.13397,1,1
1,GO MITOTIC METAPHASE PLATE CONGRESSION,0.01282,0.13522,0.1106,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.00021167,0.13508,0.13112,1,1
1,GO FAT CELL DIFFERENTIATION,0.0034322,0.13495,0.1279,1,1
1,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.0039469,0.13485,0.10686,1,1
1,GO PROTEIN MONOUBIQUITINATION,0.0085714,0.13419,0.092766,1,1
1,GO MAINTENANCE OF LOCATION IN CELL,0.00021909,0.13395,0.15154,1,1
1,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.0071468,0.13392,0.19536,1,1
1,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.015953,0.13331,0.19639,1,1
1,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.00031859,0.13267,0.14978,1,1
1,GO OXALATE TRANSPORT,0.044685,0.13224,0.096043,1,1
1,GO VIRAL BUDDING,0.0046564,0.13218,0.13868,1,1
1,GO REGULATION OF CENTROSOME DUPLICATION,0.004408,0.13215,0.14936,1,1
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.0013872,0.13127,0.13589,1,1
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00055855,0.13116,0.13708,1,1
1,GO ANIMAL ORGAN MORPHOGENESIS,0.0051916,0.13114,0.11846,1,1
1,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00067758,0.13107,0.17764,1,1
1,GO CHROMOSOME CONDENSATION,0.0027346,0.13093,0.13786,1,1
1,GO CELL CYCLE G1 S PHASE TRANSITION,0.00353,0.1305,0.12038,1,1
1,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.0016129,0.12993,0.13255,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.0097392,0.1297,0.096545,1,1
1,GO CELL DIVISION,0.00027832,0.12918,0.12456,1,1
1,GO G2 DNA DAMAGE CHECKPOINT,0.013139,0.1291,0.11961,1,1
1,GO EMBRYONIC MORPHOGENESIS,0.0010206,0.12904,0.13878,1,1
1,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.00036427,0.12876,0.13773,1,1
1,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,4.0073e-05,0.1286,0.14635,1,1
1,GO REGULATION OF MRNA METABOLIC PROCESS,0.00014935,0.12824,0.13755,1,1
1,GO MRNA METABOLIC PROCESS,7.547e-05,0.12795,0.14857,1,1
1,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0024367,0.12782,0.11782,1,1
1,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.0014299,0.12768,0.19351,1,1
1,GO RESPONSE TO ABIOTIC STIMULUS,0.0017641,0.12762,0.11201,1,1
1,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.023741,0.12753,0.10933,1,1
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.00063551,0.12744,0.12114,1,1
1,GO REGULATION OF DNA REPAIR,0.0075304,0.1273,0.097303,1,1
1,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.00024286,0.12654,0.11295,1,1
1,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00038934,0.12649,0.14089,1,1
1,GO REGULATION OF HYDROLASE ACTIVITY,0.0019282,0.12643,0.11157,1,1
1,GO NON RECOMBINATIONAL REPAIR,0.0019282,0.12626,0.13215,1,1
1,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.00059588,0.12616,0.10988,1,1
1,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00081984,0.12615,0.11659,1,1
1,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.03939,0.1261,0.16067,1,1
1,GO PROTEIN LOCALIZATION TO ORGANELLE,7.0571e-06,0.12604,0.12122,1,1
1,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00050664,0.12601,0.12139,1,1
1,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00017186,0.12559,0.21519,1,1
1,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.004408,0.12541,0.11332,1,1
1,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.011326,0.12507,0.097991,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.00069957,0.12468,0.12999,1,1
1,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.004408,0.12466,0.1094,1,1
1,GO MEMBRANE ORGANIZATION,0.0027346,0.12443,0.10151,1,1
1,GO MITOTIC CELL CYCLE,0.00016023,0.1243,0.12277,1,1
1,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,3.3132e-05,0.12394,0.12685,1,1
1,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.00353,0.12356,0.1176,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00049035,0.12336,0.12878,1,1
1,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.02068,0.12309,0.15501,1,1
1,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.016339,0.12303,0.098804,1,1
1,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.00065623,0.12286,0.14005,1,1
1,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.0030654,0.12269,0.1348,1,1
1,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.009256,0.12254,0.089169,1,1
1,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.00023468,0.12208,0.10341,1,1
1,GO ACTIN FILAMENT ORGANIZATION,0.033166,0.12171,0.099949,1,1
1,GO NEGATIVE REGULATION OF SIGNALING,4.8379e-05,0.12119,0.13265,1,1
1,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.00045924,0.12117,0.1705,1,1
1,GO CELLULAR SENESCENCE,0.0027346,0.12096,0.12477,1,1
1,GO RESPIRATORY SYSTEM DEVELOPMENT,0.007729,0.12057,0.16699,1,1
1,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.02843,0.12043,0.088165,1,1
1,GO ENDOCYTOSIS,0.00095906,0.11991,0.13217,1,1
1,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.0018173,0.11989,0.1627,1,1
1,GO REGULATION OF CELL CYCLE PROCESS,0.00012964,0.11974,0.11378,1,1
1,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.00353,0.1197,0.11694,1,1
1,GO FLUID TRANSPORT,0.0046564,0.11895,0.15022,1,1
1,GO REGULATION OF DNA REPLICATION,0.0013054,0.11843,0.11621,1,1
1,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.027803,0.11822,0.096605,1,1
1,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,5.6174e-05,0.11802,0.13885,1,1
1,GO CHROMOSOME SEPARATION,0.0071468,0.11668,0.13798,1,1
1,GO REGULATION OF ACTIN FILAMENT LENGTH,0.018836,0.11649,0.090456,1,1
1,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.0013872,0.1163,0.11478,1,1
1,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.00017796,0.11605,0.13622,1,1
1,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.001986,0.11582,0.12664,1,1
1,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0047853,0.11574,0.12475,1,1
1,GO REGULATION OF TELOMERE MAINTENANCE,0.018836,0.11523,0.094847,1,1
1,GO AUTOPHAGY OF MITOCHONDRION,0.0011199,0.11502,0.13863,1,1
1,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.00084609,0.11494,0.1192,1,1
1,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.0024367,0.11489,0.12106,1,1
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.010506,0.11482,0.11863,1,1
1,GO REGULATION OF REPRODUCTIVE PROCESS,0.015574,0.11446,0.080023,1,1
1,GO REGULATION OF AUTOPHAGY,5.8301e-05,0.11411,0.13587,1,1
1,GO REGULATION OF INTRACELLULAR TRANSPORT,0.0013457,0.11376,0.11618,1,1
1,GO ORGANELLE FISSION,0.0014738,0.11369,0.098494,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.0053338,0.11364,0.086034,1,1
1,GO TRANSCRIPTION BY RNA POLYMERASE I,0.031059,0.11323,0.12129,1,1
1,GO MITOTIC NUCLEAR DIVISION,0.00072223,0.11293,0.11902,1,1
1,GO REGULATION OF TRANSFERASE ACTIVITY,0.0001547,0.11267,0.11329,1,1
1,GO NUCLEOTIDE EXCISION REPAIR,0.00050664,0.11239,0.12939,1,1
1,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.023205,0.11234,0.081032,1,1
1,GO APOPTOTIC DNA FRAGMENTATION,0.0026572,0.11233,0.10475,1,1
1,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.00038934,0.11221,0.11171,1,1
1,GO MACROAUTOPHAGY,5.6174e-05,0.11204,0.13267,1,1
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.0047853,0.11169,0.09179,1,1
1,GO FEMALE GAMETE GENERATION,0.0025083,0.11153,0.099842,1,1
1,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.0024367,0.11144,0.11354,1,1
1,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.02166,0.1111,0.10296,1,1
1,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.00067758,0.11092,0.12495,1,1
1,GO METAPHASE PLATE CONGRESSION,0.015203,0.11086,0.11512,1,1
1,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.011047,0.11076,0.12479,1,1
1,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.017969,0.10967,0.090435,1,1
1,GO MRNA TRANSPORT,0.00072223,0.10949,0.1556,1,1
1,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,1.8521e-05,0.10925,0.12536,1,1
1,GO ORGANELLE DISASSEMBLY,0.00074557,0.10897,0.11714,1,1
1,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.0006154,0.10845,0.10094,1,1
1,GO CYTOSKELETON ORGANIZATION,0.02843,0.10832,0.073862,1,1
1,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.00054072,0.1082,0.1135,1,1
1,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,2.2524e-05,0.10751,0.11314,1,1
1,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.01282,0.10742,0.098388,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.0067808,0.10647,0.1066,1,1
1,GO SULFATE TRANSPORT,0.0031536,0.10612,0.11352,1,1
1,GO CARDIOCYTE DIFFERENTIATION,0.0036303,0.10576,0.1797,1,1
1,GO HORMONE MEDIATED SIGNALING PATHWAY,0.030383,0.10568,0.073984,1,1
1,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.0062634,0.10564,0.16601,1,1
1,GO MITOTIC CELL CYCLE CHECKPOINT,0.0006154,0.10542,0.1258,1,1
1,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.001662,0.10406,0.12773,1,1
1,GO PEPTIDYL THREONINE MODIFICATION,0.0083534,0.10385,0.097964,1,1
1,GO NON CANONICAL WNT SIGNALING PATHWAY,0.0083534,0.1038,0.12848,1,1
1,GO CELL CYCLE PROCESS,0.00030804,0.10353,0.10072,1,1
1,GO MRNA CLEAVAGE,0.010245,0.10301,0.095414,1,1
1,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.027188,0.10203,0.075965,1,1
1,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.016339,0.10138,0.086063,1,1
1,GO NEGATIVE REGULATION OF BINDING,0.0051916,0.10135,0.11124,1,1
1,GO DNA INTEGRITY CHECKPOINT,0.030383,0.10104,0.086549,1,1
1,GO REGULATION OF CELL CYCLE,0.00042998,0.10084,0.088985,1,1
1,GO EMBRYONIC ORGAN DEVELOPMENT,0.029719,0.10063,0.087048,1,1
1,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00014418,0.099937,0.13449,1,1
1,GO PROTEIN TETRAMERIZATION,0.0083534,0.099286,0.10184,1,1
1,GO REGULATION OF DNA CATABOLIC PROCESS,0.004408,0.098904,0.19827,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0028957,0.098743,0.095974,1,1
1,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.042857,0.098423,0.11141,1,1
1,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.013139,0.098032,0.095114,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0062634,0.096813,0.18237,1,1
1,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.036948,0.09675,0.091883,1,1
1,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.0006154,0.095805,0.076897,1,1
1,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.0027346,0.095001,0.088013,1,1
1,GO MACROMOLECULE DEACYLATION,0.018398,0.094987,0.074363,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0064317,0.094858,0.12223,1,1
1,GO PEPTIDYL AMINO ACID MODIFICATION,0.00045924,0.094263,0.087248,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.0018173,0.093935,0.10508,1,1
1,GO MRNA 3 END PROCESSING,0.022165,0.093093,0.098174,1,1
1,GO TRANSCRIPTION BY RNA POLYMERASE III,0.011612,0.092858,0.080535,1,1
1,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.0030654,0.092091,0.12969,1,1
1,GO MULTI ORGANISM PROCESS,0.0047853,0.092018,0.068931,1,1
1,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.018398,0.091715,0.088866,1,1
1,GO REGULATION OF CHROMOSOME SEGREGATION,0.016734,0.09145,0.11259,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0066042,0.091401,0.14546,1,1
1,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0017641,0.090791,0.11587,1,1
1,GO CELL CYCLE,0.00050664,0.09073,0.08412,1,1
1,GO NEGATIVE REGULATION OF GROWTH,0.025994,0.090637,0.079313,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.05161,0.090494,0.08378,1,1
1,GO REGULATION OF ATPASE ACTIVITY,0.017969,0.090262,0.08705,1,1
1,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.0051916,0.089693,0.093786,1,1
1,GO IRON ION TRANSPORT,0.0081404,0.08938,0.094071,1,1
1,GO REGULATION OF CYTOKINESIS,0.037747,0.089267,0.074076,1,1
1,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.01282,0.088978,0.08993,1,1
1,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.029719,0.088833,0.068501,1,1
1,GO REGULATION OF CENTROSOME CYCLE,0.0085714,0.08844,0.11339,1,1
1,GO RESPONSE TO ACID CHEMICAL,0.046579,0.088233,0.11721,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.00035231,0.087704,0.092213,1,1
1,GO MUSCLE CELL DIFFERENTIATION,0.03245,0.087516,0.10749,1,1
1,GO ACTIN FILAMENT BASED PROCESS,0.014138,0.087492,0.10299,1,1
1,GO SPINDLE ASSEMBLY,0.0049174,0.086935,0.097064,1,1
1,GO DNA METABOLIC PROCESS,0.00034072,0.086822,0.094615,1,1
1,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.0033369,0.086683,0.12624,1,1
1,GO INTRACELLULAR PROTEIN TRANSPORT,0.00031859,0.085656,0.088966,1,1
1,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.0037331,0.085483,0.098986,1,1
1,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.019739,0.085254,0.077934,1,1
1,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.00044439,0.084405,0.10058,1,1
1,GO POSITIVE REGULATION OF SIGNALING,0.011326,0.084129,0.076112,1,1
1,GO REGULATION OF DNA METABOLIC PROCESS,0.00034072,0.083888,0.10582,1,1
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0046564,0.083293,0.065301,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00025131,0.083088,0.093344,1,1
1,GO DNA GEOMETRIC CHANGE,0.025414,0.08162,0.11952,1,1
1,GO RESPONSE TO RADIATION,0.007729,0.081098,0.069949,1,1
1,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.037747,0.079624,0.056011,1,1
1,GO CELL CYCLE CHECKPOINT,0.0047853,0.079292,0.088715,1,1
1,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.042857,0.079178,0.075305,1,1
1,GO JNK CASCADE,0.03939,0.075757,0.066911,1,1
1,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.0028957,0.075382,0.13985,1,1
1,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.041093,0.074211,0.082131,1,1
1,GO MITOTIC SISTER CHROMATID SEGREGATION,0.038561,0.073357,0.086039,1,1
1,GO DNA CATABOLIC PROCESS,0.012203,0.073105,0.069313,1,1
1,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.04854,0.072454,0.080875,1,1
1,GO CHROMOSOME SEGREGATION,0.022165,0.071793,0.087507,1,1
1,GO RESPONSE TO ENDOGENOUS STIMULUS,0.0066042,0.071599,0.094573,1,1
1,GO T CELL LINEAGE COMMITMENT,0.043763,0.071521,0.10918,1,1
1,GO PROTEIN LOCALIZATION TO MEMBRANE,0.0099891,0.071049,0.066936,1,1
1,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.023741,0.070728,0.11404,1,1
1,GO EMBRYO DEVELOPMENT,0.015953,0.070658,0.088129,1,1
1,GO NUCLEAR CHROMOSOME SEGREGATION,0.030383,0.07063,0.078195,1,1
1,GO REGULATION OF ORGANELLE ORGANIZATION,0.011326,0.068697,0.055381,1,1
1,GO SNRNA TRANSCRIPTION,0.0067808,0.065664,0.093449,1,1
1,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.050569,0.065535,0.070285,1,1
1,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.035393,0.065358,0.059211,1,1
1,GO GLAND DEVELOPMENT,0.037747,0.064331,0.096809,1,1
1,GO DNA REPAIR,0.0071468,0.06391,0.07903,1,1
1,GO DOUBLE STRAND BREAK REPAIR,0.01282,0.063461,0.09106,1,1
1,GO INTRACELLULAR TRANSPORT,0.0038387,0.063372,0.067539,1,1
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.03245,0.061943,0.046634,1,1
1,GO MITOCHONDRION ORGANIZATION,0.010245,0.061687,0.066657,1,1
1,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.014486,0.06149,0.052455,1,1
1,GO REPRODUCTION,0.029719,0.06079,0.055817,1,1
1,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.019739,0.060453,0.060427,1,1
1,GO REGULATION OF MACROAUTOPHAGY,0.0046564,0.058212,0.1191,1,1
1,GO CELLULAR MACROMOLECULE LOCALIZATION,0.0017641,0.055678,0.069428,1,1
1,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.050569,0.055151,0.053682,1,1
1,GO DNA REPLICATION,0.047551,0.049182,0.062098,1,1
1,GO DNA RECOMBINATION,0.049546,0.043564,0.081338,1,1
1,GO ORGANELLE ASSEMBLY,0.013798,0.040663,0.062271,1,1
1,GO ELASTIC FIBER ASSEMBLY,4.8379e-05,0.58863,0.77004,1,0
1,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.00013433,0.47855,0.55458,1,0
1,GO ENTRY OF BACTERIUM INTO HOST CELL,0.00087311,0.46949,0.47329,1,0
1,GO GERMINAL CENTER FORMATION,0.00052342,0.42882,0.40147,1,0
1,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.00095906,0.40023,0.40711,1,0
1,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.0018173,0.39749,0.33233,1,0
1,GO INTERLEUKIN 13 PRODUCTION,0.00032948,0.39432,0.46301,1,0
1,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.0007696,0.38781,0.32837,1,0
1,GO PLATELET DEGRANULATION,9.3916e-06,0.37956,0.43397,1,0
1,GO MONONUCLEAR CELL DIFFERENTIATION,0.00013917,0.37812,0.34601,1,0
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0028141,0.37579,0.34321,1,0
1,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.001872,0.37538,0.35648,1,0
1,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.019739,0.37202,0.36261,1,0
1,GO FIBROBLAST PROLIFERATION,2.0833e-05,0.37164,0.35526,1,0
1,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.00054072,0.37077,0.38401,1,0
1,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00021909,0.37076,0.46051,1,0
1,GO REGULATION OF COAGULATION,2.5308e-05,0.3648,0.41743,1,0
1,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0012662,0.3636,0.36672,1,0
1,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.0097392,0.35747,0.29219,1,0
1,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.00081984,0.34498,0.2687,1,0
1,GO TRACHEA DEVELOPMENT,0.00087311,0.34132,0.30734,1,0
1,GO ASYMMETRIC CELL DIVISION,0.00034072,0.32482,0.28407,1,0
1,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.001191,0.32245,0.28884,1,0
1,GO ETHER BIOSYNTHETIC PROCESS,0.0050528,0.31628,0.34057,1,0
1,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.0049174,0.3156,0.50054,1,0
1,GO PROTEIN DEGLYCOSYLATION,0.00021167,0.31509,0.30841,1,0
1,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00010845,0.314,0.27587,1,0
1,GO EOSINOPHIL MIGRATION,0.0039469,0.31021,0.35672,1,0
1,GO PSEUDOURIDINE SYNTHESIS,0.014486,0.30845,0.19956,1,0
1,GO REGULATION OF MONONUCLEAR CELL MIGRATION,5.2139e-05,0.30716,0.33814,1,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00045924,0.30154,0.36232,1,0
1,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0018173,0.29765,0.37465,1,0
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0019282,0.29469,0.34333,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,3.5759e-05,0.29377,0.25879,1,0
1,GO MEMBRANE LIPID CATABOLIC PROCESS,0.0029794,0.29308,0.19773,1,0
1,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.0042883,0.28967,0.28732,1,0
1,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.022165,0.28042,0.24626,1,0
1,GO EPOXYGENASE P450 PATHWAY,0.010773,0.27946,0.22839,1,0
1,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.0029794,0.27928,0.34203,1,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,5.6174e-05,0.27514,0.27334,1,0
1,GO RESPONSE TO THYROID HORMONE,0.00022676,0.27496,0.31539,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.0099891,0.27338,0.28357,1,0
1,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,8.4205e-05,0.2694,0.26503,1,0
1,GO ACTIN FILAMENT SEVERING,0.02166,0.26758,0.23447,1,0
1,GO RESPONSE TO TUMOR CELL,0.011612,0.2672,0.21902,1,0
1,GO FOAM CELL DIFFERENTIATION,0.0013872,0.26715,0.24968,1,0
1,GO EOSINOPHIL CHEMOTAXIS,0.031748,0.26561,0.33384,1,0
1,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.00013917,0.2653,0.34483,1,0
1,GO POSITIVE REGULATION OF COAGULATION,0.0047853,0.26264,0.27563,1,0
1,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.00069957,0.26187,0.22488,1,0
1,GO MONOCYTE CHEMOTAXIS,0.00050664,0.2614,0.32362,1,0
1,GO METANEPHROS DEVELOPMENT,3.3132e-05,0.25939,0.26281,1,0
1,GO PENTOSE METABOLIC PROCESS,0.0067808,0.25889,0.19578,1,0
1,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.00014418,0.2536,0.2135,1,0
1,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0026572,0.25359,0.22083,1,0
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.04854,0.25306,0.1463,1,0
1,GO LIPID OXIDATION,0.0015189,0.2504,0.19167,1,0
1,GO AMINO SUGAR CATABOLIC PROCESS,0.00049035,0.24798,0.22422,1,0
1,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.0022332,0.24784,0.25064,1,0
1,GO LIVER MORPHOGENESIS,0.042857,0.2462,0.17809,1,0
1,GO REGULATION OF ANOIKIS,0.023741,0.24272,0.23697,1,0
1,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.00027832,0.24223,0.23301,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0013054,0.24196,0.18179,1,0
1,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.016734,0.24008,0.33692,1,0
1,GO AXIS ELONGATION,0.0060989,0.23616,0.28763,1,0
1,GO NEGATIVE REGULATION OF CELL ACTIVATION,8.1192e-05,0.2357,0.24914,1,0
1,GO LIPID STORAGE,0.00032948,0.23358,0.23996,1,0
1,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.052669,0.23326,0.19571,1,0
1,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,1.1964e-05,0.23268,0.35232,1,0
1,GO GLYCINE METABOLIC PROCESS,0.05161,0.23202,0.17426,1,0
1,GO INTERLEUKIN 4 PRODUCTION,0.0021689,0.23194,0.19406,1,0
1,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.0017641,0.2312,0.19034,1,0
1,GO CELL JUNCTION DISASSEMBLY,0.0034322,0.23111,0.23586,1,0
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0029794,0.23004,0.30007,1,0
1,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.0030654,0.22944,0.18803,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.019739,0.22837,0.23931,1,0
1,GO POSITIVE REGULATION OF HEMOPOIESIS,8.4205e-05,0.22711,0.22781,1,0
1,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.00079435,0.22678,0.25143,1,0
1,GO SUPEROXIDE ANION GENERATION,0.0028141,0.22601,0.26864,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,9.389e-05,0.22457,0.26724,1,0
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0069616,0.22344,0.20549,1,0
1,GO GRANULOCYTE MIGRATION,0.00016023,0.22343,0.27789,1,0
1,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00026903,0.22294,0.23449,1,0
1,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.001191,0.22185,0.21192,1,0
1,GO REGULATION OF MUSCLE HYPERTROPHY,0.020205,0.22062,0.15277,1,0
1,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.031059,0.21936,0.15708,1,0
1,GO PORE COMPLEX ASSEMBLY,0.0050528,0.21566,0.17833,1,0
1,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.00084609,0.21325,0.17644,1,0
1,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.009256,0.21202,0.2458,1,0
1,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00016023,0.21143,0.19185,1,0
1,GO FATTY ACID HOMEOSTASIS,0.04854,0.21042,0.15725,1,0
1,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0081404,0.21035,0.25722,1,0
1,GO RESPONSE TO ISCHEMIA,0.00079435,0.20766,0.19136,1,0
1,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.007729,0.20665,0.14549,1,0
1,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.00017796,0.20658,0.20582,1,0
1,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.0022992,0.20503,0.20466,1,0
1,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.027803,0.20173,0.2066,1,0
1,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.0032441,0.20054,0.20109,1,0
1,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.00090094,0.19931,0.23381,1,0
1,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.04854,0.19793,0.15776,1,0
1,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.00063551,0.19779,0.20405,1,0
1,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,7.2754e-05,0.19742,0.20919,1,0
1,GO REGULATION OF PLATELET ACTIVATION,0.036164,0.19693,0.1654,1,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.0027346,0.19579,0.22081,1,0
1,GO TRNA WOBBLE BASE MODIFICATION,0.0087944,0.19538,0.1661,1,0
1,GO IMMUNOGLOBULIN SECRETION,0.0045306,0.19485,0.26715,1,0
1,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.043763,0.19424,0.13872,1,0
1,GO ANTIBACTERIAL HUMORAL RESPONSE,0.018836,0.19309,0.13349,1,0
1,GO GRANULOCYTE CHEMOTAXIS,0.0027346,0.19272,0.24457,1,0
1,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.050569,0.18975,0.15282,1,0
1,GO REGULATION OF CELL CELL ADHESION,0.0015653,0.18834,0.16286,1,0
1,GO GLYCEROL ETHER METABOLIC PROCESS,0.0069616,0.18825,0.21009,1,0
1,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,1.5201e-05,0.18675,0.23211,1,0
1,GO RETINOL METABOLIC PROCESS,0.0046564,0.18663,0.19112,1,0
1,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.013139,0.18647,0.22754,1,0
1,GO PROTEIN DEMANNOSYLATION,0.017549,0.18607,0.17096,1,0
1,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.012508,0.18485,0.14158,1,0
1,GO REGULATION OF BONE DEVELOPMENT,0.0011199,0.18423,0.25301,1,0
1,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.033894,0.18372,0.19789,1,0
1,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00045924,0.18284,0.15845,1,0
1,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0057817,0.18278,0.13569,1,0
1,GO REGULATION OF T CELL DIFFERENTIATION,0.004408,0.18259,0.15375,1,0
1,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.017549,0.1822,0.27747,1,0
1,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.035393,0.18029,0.17197,1,0
1,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,6.7596e-05,0.18004,0.22469,1,0
1,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.033894,0.17995,0.23596,1,0
1,GO ISOPRENOID METABOLIC PROCESS,0.025994,0.1794,0.1342,1,0
1,GO NEPHRON TUBULE FORMATION,0.044685,0.17874,0.21533,1,0
1,GO BILE ACID AND BILE SALT TRANSPORT,0.052669,0.17554,0.11629,1,0
1,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.0099891,0.17462,0.17046,1,0
1,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0015653,0.17438,0.22316,1,0
1,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.019283,0.17437,0.1448,1,0
1,GO T CELL DIFFERENTIATION,0.0019282,0.17422,0.14327,1,0
1,GO MITOCHONDRIAL TRANSLATION,0.0075304,0.17296,0.15636,1,0
1,GO RESPONSE TO INTERLEUKIN 15,0.0032441,0.17135,0.28078,1,0
1,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00029782,0.1709,0.20945,1,0
1,GO MYELOID LEUKOCYTE MIGRATION,0.010773,0.17045,0.19114,1,0
1,GO LEUKOCYTE DIFFERENTIATION,0.00014418,0.17039,0.17214,1,0
1,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.023205,0.17037,0.37242,1,0
1,GO RESPONSE TO MINERALOCORTICOID,0.0056288,0.1699,0.2433,1,0
1,GO REGULATION OF MACROPHAGE ACTIVATION,0.011047,0.16907,0.17037,1,0
1,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.014486,0.16862,0.23073,1,0
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.02843,0.16833,0.16576,1,0
1,GO DENDRITIC CELL CHEMOTAXIS,0.036164,0.16812,0.20338,1,0
1,GO GLUCOCORTICOID METABOLIC PROCESS,0.036948,0.16789,0.16982,1,0
1,GO DRUG METABOLIC PROCESS,0.037747,0.16779,0.10207,1,0
1,GO REGULATION OF OSSIFICATION,0.00025131,0.16574,0.23308,1,0
1,GO REGULATION OF ERBB SIGNALING PATHWAY,9.0551e-05,0.16495,0.29061,1,0
1,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.00041602,0.16465,0.17424,1,0
1,GO PROTEIN MATURATION,0.00021167,0.16448,0.14976,1,0
1,GO REGULATION OF MUSCLE ADAPTATION,0.044685,0.16286,0.099072,1,0
1,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.00098941,0.16223,0.20482,1,0
1,GO ERBB SIGNALING PATHWAY,0.00014935,0.16211,0.23362,1,0
1,GO BONE REMODELING,0.0019282,0.16144,0.19205,1,0
1,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.00036427,0.16102,0.18465,1,0
1,GO MUSCLE ADAPTATION,0.013465,0.1606,0.11489,1,0
1,GO RESPONSE TO XENOBIOTIC STIMULUS,0.030383,0.16001,0.12336,1,0
1,GO ETHER METABOLIC PROCESS,0.049546,0.1593,0.15714,1,0
1,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.035393,0.15882,0.14408,1,0
1,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.020205,0.15843,0.1462,1,0
1,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.019739,0.15799,0.21007,1,0
1,GO REGULATION OF LYMPHOCYTE MIGRATION,0.00057693,0.15742,0.2235,1,0
1,GO INOSITOL LIPID MEDIATED SIGNALING,0.00011241,0.15708,0.19563,1,0
1,GO INTEGRIN ACTIVATION,0.016339,0.15641,0.16743,1,0
1,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.0011549,0.156,0.15295,1,0
1,GO MITOCHONDRIAL GENE EXPRESSION,0.011612,0.15594,0.14298,1,0
1,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.00044439,0.15577,0.14245,1,0
1,GO PROTEIN N LINKED GLYCOSYLATION,0.0039469,0.15557,0.13341,1,0
1,GO ORGANIC ACID CATABOLIC PROCESS,0.0034322,0.15422,0.1491,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.025414,0.15399,0.16173,1,0
1,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.015953,0.15383,0.18499,1,0
1,GO RESPONSE TO DRUG,0.0094949,0.15335,0.11519,1,0
1,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00019753,0.15321,0.19715,1,0
1,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.007729,0.15302,0.15348,1,0
1,GO FATTY ACID METABOLIC PROCESS,0.0022332,0.15297,0.1245,1,0
1,GO LYMPHOCYTE DIFFERENTIATION,0.00045924,0.15239,0.15061,1,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.035393,0.15186,0.17889,1,0
1,GO CELL CHEMOTAXIS,0.0022992,0.15136,0.1954,1,0
1,GO RESPONSE TO NUTRIENT,0.023741,0.15094,0.13752,1,0
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00019753,0.15048,0.23452,1,0
1,GO CELLULAR LIPID CATABOLIC PROCESS,0.0047853,0.14958,0.12363,1,0
1,GO REGULATION OF LIPID TRANSPORT,0.0011199,0.14923,0.14402,1,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0069616,0.14901,0.13005,1,0
1,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0067808,0.1481,0.16238,1,0
1,GO NEUTROPHIL MIGRATION,0.0034322,0.14773,0.23039,1,0
1,GO DIOL BIOSYNTHETIC PROCESS,0.033894,0.14711,0.11073,1,0
1,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.0079323,0.14699,0.11904,1,0
1,GO AEROBIC RESPIRATION,0.038561,0.14559,0.094552,1,0
1,GO ORGANIC ACID METABOLIC PROCESS,0.00052342,0.1454,0.12297,1,0
1,GO REGULATION OF CHEMOTAXIS,0.0027346,0.14433,0.14168,1,0
1,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.00045924,0.14322,0.11889,1,0
1,GO CELL PROLIFERATION IN HINDBRAIN,0.02166,0.14055,0.1838,1,0
1,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00011241,0.14054,0.1881,1,0
1,GO ERYTHROCYTE MATURATION,0.013139,0.13963,0.2323,1,0
1,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.010245,0.13955,0.15817,1,0
1,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.025414,0.13824,0.12081,1,0
1,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0025817,0.13779,0.21276,1,0
1,GO REGULATION OF LIPID METABOLIC PROCESS,0.0025817,0.13545,0.10837,1,0
1,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.047551,0.13373,0.15281,1,0
1,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.024846,0.13354,0.094981,1,0
1,GO MATURE B CELL DIFFERENTIATION,0.019739,0.13056,0.19201,1,0
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0099891,0.12908,0.12939,1,0
1,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.013465,0.12847,0.14565,1,0
1,GO ENDOCRINE PROCESS,0.013139,0.12835,0.13944,1,0
1,GO REGULATION OF CELL POPULATION PROLIFERATION,0.0050528,0.12793,0.10855,1,0
1,GO GOLGI TO ENDOSOME TRANSPORT,0.0094949,0.12728,0.16319,1,0
1,GO LIPID CATABOLIC PROCESS,0.004408,0.12669,0.095345,1,0
1,GO EXOCYTOSIS,0.001872,0.12645,0.13272,1,0
1,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00038934,0.12622,0.33618,1,0
1,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0069616,0.12591,0.11571,1,0
1,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.035393,0.12563,0.097927,1,0
1,GO CELLULAR RESPIRATION,0.02268,0.12505,0.10078,1,0
1,GO LIPID HOMEOSTASIS,0.019283,0.12411,0.072072,1,0
1,GO LIPID MODIFICATION,0.010506,0.12396,0.097748,1,0
1,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0069616,0.12097,0.13225,1,0
1,GO BLASTOCYST FORMATION,0.015953,0.12014,0.12905,1,0
1,GO RESPONSE TO ESTRADIOL,0.019283,0.12009,0.12109,1,0
1,GO TRANSITION METAL ION TRANSPORT,0.0021689,0.11946,0.086016,1,0
1,GO HUMORAL IMMUNE RESPONSE,0.011326,0.1193,0.11957,1,0
1,GO OXIDATION REDUCTION PROCESS,0.0094949,0.11854,0.090852,1,0
1,GO REGULATION OF PROTEIN STABILITY,0.0007696,0.11752,0.11114,1,0
1,GO PROTEIN TARGETING TO MITOCHONDRION,0.050569,0.11711,0.081355,1,0
1,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.049546,0.11647,0.11536,1,0
1,GO GOLGI ORGANIZATION,0.0046564,0.11613,0.11633,1,0
1,GO RESPONSE TO HORMONE,0.001228,0.11492,0.12158,1,0
1,GO UROGENITAL SYSTEM DEVELOPMENT,0.0085714,0.11468,0.17988,1,0
1,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.018398,0.11411,0.28258,1,0
1,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.00012512,0.11368,0.12567,1,0
1,GO REGULATION OF ATP METABOLIC PROCESS,0.021165,0.11367,0.093388,1,0
1,GO AMINE METABOLIC PROCESS,0.025414,0.11325,0.091552,1,0
1,GO PEPTIDYL METHIONINE MODIFICATION,0.02166,0.113,0.12155,1,0
1,GO RNA SURVEILLANCE,0.0030654,0.11283,0.16482,1,0
1,GO RESPONSE TO PEPTIDE,0.001872,0.1123,0.10325,1,0
1,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0036303,0.11225,0.088971,1,0
1,GO CELLULAR PIGMENTATION,0.04854,0.10983,0.08577,1,0
1,GO LIPID LOCALIZATION,0.03245,0.10962,0.067193,1,0
1,GO LEUKOCYTE CHEMOTAXIS,0.049546,0.10957,0.14125,1,0
1,GO INTRACELLULAR LIPID TRANSPORT,0.050569,0.10921,0.13309,1,0
1,GO ESTROGEN METABOLIC PROCESS,0.027188,0.10866,0.15418,1,0
1,GO REGULATION OF LIPID CATABOLIC PROCESS,0.02166,0.10866,0.11088,1,0
1,GO POSITIVE REGULATION OF CHEMOTAXIS,0.041093,0.10752,0.12974,1,0
1,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.0030654,0.10678,0.10589,1,0
1,GO CARBOHYDRATE CATABOLIC PROCESS,0.013798,0.1066,0.092276,1,0
1,GO REGULATION OF LIPID KINASE ACTIVITY,0.0060989,0.10616,0.12615,1,0
1,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.011612,0.10573,0.19856,1,0
1,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.033894,0.10536,0.21569,1,0
1,GO CELLULAR RESPONSE TO PEPTIDE,0.0021689,0.10516,0.093556,1,0
1,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.024288,0.10367,0.14078,1,0
1,GO RNA POLYADENYLATION,0.0053338,0.10277,0.12901,1,0
1,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0060989,0.10265,0.094539,1,0
1,GO ALCOHOL METABOLIC PROCESS,0.03245,0.10242,0.069999,1,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.043763,0.10234,0.091844,1,0
1,GO PEROXISOME ORGANIZATION,0.0028141,0.10105,0.16727,1,0
1,GO CELLULAR RESPONSE TO DRUG,0.035393,0.099759,0.10347,1,0
1,GO CELLULAR LIPID METABOLIC PROCESS,0.029068,0.098918,0.058927,1,0
1,GO ALPHA AMINO ACID METABOLIC PROCESS,0.035393,0.098655,0.073372,1,0
1,GO RESPONSE TO PEPTIDE HORMONE,0.0059384,0.098274,0.084721,1,0
1,GO PEROXISOMAL TRANSPORT,0.0038387,0.098213,0.17439,1,0
1,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.044685,0.097952,0.10779,1,0
1,GO HORMONE METABOLIC PROCESS,0.0046564,0.097909,0.12187,1,0
1,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.0069616,0.09764,0.17296,1,0
1,GO NEPHRON DEVELOPMENT,0.010773,0.097375,0.18502,1,0
1,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.025414,0.096574,0.12723,1,0
1,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.0010528,0.09651,0.10507,1,0
1,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.0083534,0.096042,0.09663,1,0
1,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.027803,0.095801,0.088413,1,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.014486,0.095704,0.13597,1,0
1,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.015574,0.094728,0.066686,1,0
1,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.03245,0.092574,0.15188,1,0
1,GO GLYCOPROTEIN METABOLIC PROCESS,0.011326,0.092243,0.08285,1,0
1,GO PROTEIN AUTOPHOSPHORYLATION,0.037747,0.092106,0.080387,1,0
1,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.017969,0.090966,0.068593,1,0
1,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0028141,0.090629,0.10261,1,0
1,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.0018173,0.090496,0.10563,1,0
1,GO BONE RESORPTION,0.038561,0.08991,0.10845,1,0
1,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.015953,0.089295,0.094337,1,0
1,GO EPITHELIUM DEVELOPMENT,0.014138,0.088153,0.10909,1,0
1,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.043763,0.088046,0.051168,1,0
1,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.03939,0.087804,0.10545,1,0
1,GO VESICLE ORGANIZATION,0.019739,0.087253,0.087883,1,0
1,GO ACTIVATION OF MAPK ACTIVITY,0.017549,0.087098,0.083251,1,0
1,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.023741,0.0869,0.067298,1,0
1,GO LIPID METABOLIC PROCESS,0.017137,0.08625,0.06188,1,0
1,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.024846,0.085725,0.05016,1,0
1,GO NEGATIVE REGULATION OF TRANSPORT,0.0099891,0.085441,0.087363,1,0
1,GO FATTY ACID TRANSPORT,0.047551,0.085055,0.075323,1,0
1,GO MALE SEX DIFFERENTIATION,0.036948,0.0849,0.11101,1,0
1,GO RNA EXPORT FROM NUCLEUS,0.025414,0.082505,0.099336,1,0
1,GO MIRNA METABOLIC PROCESS,0.02268,0.081499,0.10802,1,0
1,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.05161,0.08001,0.071971,1,0
1,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.031059,0.07915,0.055924,1,0
1,GO CARBOHYDRATE METABOLIC PROCESS,0.0087944,0.078528,0.068798,1,0
1,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.038561,0.078243,0.048605,1,0
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.033894,0.075629,0.1194,1,0
1,GO REGULATION OF SPINDLE CHECKPOINT,0.040234,0.075502,0.14497,1,0
1,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.001986,0.07455,0.091324,1,0
1,GO BIOMINERALIZATION,0.035393,0.072403,0.15546,1,0
1,GO REGULATION OF TUBE SIZE,0.016339,0.072113,0.12947,1,0
1,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.015574,0.07194,0.088852,1,0
1,GO NCRNA TRANSCRIPTION,0.043763,0.071543,0.080709,1,0
1,GO ATP METABOLIC PROCESS,0.034637,0.071083,0.073221,1,0
1,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.026586,0.069578,0.055286,1,0
1,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.04854,0.06396,0.072132,1,0
1,GO ANTIMICROBIAL HUMORAL RESPONSE,0.043763,0.061034,0.11223,1,0
1,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.020205,0.059805,0.067687,1,0
1,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.049546,0.043743,0.09423,1,0
1,GO LIPOSACCHARIDE METABOLIC PROCESS,0.050569,-0.027947,-0.10582,1,0
1,GO PEPTIDYL LYSINE ACETYLATION,0.029068,-0.041878,-0.066827,1,0
1,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.0059384,-0.047688,-0.10895,1,0
1,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.02068,-0.059122,-0.087931,1,0
1,GO STEROL BIOSYNTHETIC PROCESS,0.03939,-0.060481,-0.17024,1,0
1,GO ORGANIC ACID TRANSPORT,0.0087944,-0.064267,-0.093501,1,0
1,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.037747,-0.06894,-0.10858,1,0
1,GO REGULATION OF RECEPTOR INTERNALIZATION,0.015953,-0.071158,-0.11757,1,0
1,GO CERAMIDE BIOSYNTHETIC PROCESS,0.042857,-0.075721,-0.0912,1,0
1,GO PROTEIN ACETYLATION,0.0054795,-0.080392,-0.078937,1,0
1,GO REGULATION OF PROTEIN ACETYLATION,0.024288,-0.080509,-0.088908,1,0
1,GO ANATOMICAL STRUCTURE MATURATION,0.05161,-0.080524,-0.074824,1,0
1,GO TRANSMEMBRANE TRANSPORT,0.009256,-0.082732,-0.075373,1,0
1,GO PH REDUCTION,0.049546,-0.082842,-0.086453,1,0
1,GO REGULATION OF ANION TRANSPORT,0.018398,-0.083661,-0.11354,1,0
1,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.04854,-0.084312,-0.10203,1,0
1,GO SENSORY PERCEPTION OF SMELL,0.017969,-0.084331,-0.084143,1,0
1,GO CARBOHYDRATE HOMEOSTASIS,0.012203,-0.094651,-0.10376,1,0
1,GO ADULT FEEDING BEHAVIOR,0.027803,-0.096581,-0.17934,1,0
1,GO SECOND MESSENGER MEDIATED SIGNALING,0.0023671,-0.097125,-0.11229,1,0
1,GO REGULATION OF HORMONE LEVELS,0.0094949,-0.097622,-0.11342,1,0
1,GO PEPTIDE SECRETION,0.0020453,-0.099981,-0.10971,1,0
1,GO MATING,0.017969,-0.10132,-0.09974,1,0
1,GO REGULATION OF MEIOTIC CELL CYCLE,0.024846,-0.10172,-0.10244,1,0
1,GO FEAR RESPONSE,0.0045306,-0.1021,-0.1576,1,0
1,GO POSITIVE REGULATION OF SECRETION,0.0031536,-0.10334,-0.10807,1,0
1,GO DETECTION OF STIMULUS,0.00036427,-0.10348,-0.11094,1,0
1,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.043763,-0.10368,-0.13579,1,0
1,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.025994,-0.10376,-0.089233,1,0
1,GO POSITIVE REGULATION OF ANION TRANSPORT,0.0069616,-0.10466,-0.14834,1,0
1,GO CALCIUM ION IMPORT,0.024846,-0.10647,-0.10922,1,0
1,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.036948,-0.10949,-0.13165,1,0
1,GO METAL ION TRANSPORT,0.0015653,-0.10961,-0.10757,1,0
1,GO LEUKOCYTE TETHERING OR ROLLING,0.012203,-0.11019,-0.12376,1,0
1,GO REGULATION OF ACTIN NUCLEATION,0.013465,-0.11063,-0.16551,1,0
1,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.0069616,-0.11132,-0.11835,1,0
1,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.0010528,-0.11262,-0.15319,1,0
1,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.04854,-0.11467,-0.10516,1,0
1,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.014486,-0.11586,-0.079328,1,0
1,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.05161,-0.11621,-0.10936,1,0
1,GO OLIGODENDROCYTE DEVELOPMENT,0.007729,-0.11769,-0.20309,1,0
1,GO PROTON TRANSMEMBRANE TRANSPORT,0.0050528,-0.11797,-0.10212,1,0
1,GO CELL MATURATION,0.0023671,-0.11967,-0.11494,1,0
1,GO REGULATION OF PEPTIDE SECRETION,0.0064317,-0.11992,-0.10079,1,0
1,GO POSITIVE REGULATION OF RNA SPLICING,0.0062634,-0.12019,-0.1157,1,0
1,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.0034322,-0.12199,-0.11257,1,0
1,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.03245,-0.12249,-0.10999,1,0
1,GO SENSORY PERCEPTION OF BITTER TASTE,0.036948,-0.12298,-0.092248,1,0
1,GO MECHANORECEPTOR DIFFERENTIATION,0.038561,-0.12302,-0.15491,1,0
1,GO REGULATION OF SISTER CHROMATID COHESION,0.05161,-0.12361,-0.10406,1,0
1,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.031748,-0.12387,-0.13456,1,0
1,GO ION TRANSPORT,0.00054072,-0.12438,-0.11063,1,0
1,GO POSITIVE REGULATION OF HORMONE SECRETION,0.00072223,-0.12508,-0.17338,1,0
1,GO CELLULAR GLUCOSE HOMEOSTASIS,0.015574,-0.12666,-0.091402,1,0
1,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.035393,-0.12823,-0.15535,1,0
1,GO HYPOTHALAMUS DEVELOPMENT,0.046579,-0.12992,-0.1508,1,0
1,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.00014418,-0.13024,-0.14711,1,0
1,GO SYNAPTIC TRANSMISSION GABAERGIC,0.029719,-0.13363,-0.12353,1,0
1,GO GLUTAMATE METABOLIC PROCESS,0.034637,-0.13405,-0.11249,1,0
1,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.024846,-0.13559,-0.11414,1,0
1,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.0020453,-0.13645,-0.17227,1,0
1,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.011612,-0.13696,-0.18867,1,0
1,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.046579,-0.13846,-0.22976,1,0
1,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.021165,-0.13911,-0.1298,1,0
1,GO NEGATIVE REGULATION OF RNA SPLICING,0.00353,-0.14034,-0.1408,1,0
1,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.0069616,-0.14107,-0.18212,1,0
1,GO LIPID DROPLET ORGANIZATION,0.0079323,-0.14519,-0.16957,1,0
1,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.00038934,-0.14547,-0.13882,1,0
1,GO ION TRANSMEMBRANE TRANSPORT,0.00031859,-0.14569,-0.12992,1,0
1,GO NEURON PROJECTION ORGANIZATION,0.0079323,-0.14649,-0.17679,1,0
1,GO SENSORY PERCEPTION OF TASTE,0.0064317,-0.14698,-0.17156,1,0
1,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.0064317,-0.14739,-0.20232,1,0
1,GO EXCITATORY SYNAPSE ASSEMBLY,0.04854,-0.14863,-0.2205,1,0
1,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.011047,-0.14885,-0.19079,1,0
1,GO REGULATION OF SECRETION,3.8583e-05,-0.15007,-0.1487,1,0
1,GO HISTONE H3 K9 METHYLATION,0.015574,-0.15012,-0.13603,1,0
1,GO POSITIVE REGULATION OF MRNA PROCESSING,0.00041602,-0.15052,-0.16827,1,0
1,GO NEUTRAL LIPID CATABOLIC PROCESS,0.014486,-0.15065,-0.15341,1,0
1,GO SENSORY PERCEPTION,0.00013433,-0.15191,-0.13562,1,0
1,GO DETERMINATION OF ADULT LIFESPAN,0.043763,-0.1522,-0.14245,1,0
1,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.030383,-0.15336,-0.1759,1,0
1,GO CATION TRANSPORT,9.0551e-05,-0.15391,-0.14131,1,0
1,GO REGULATION OF APPETITE,0.00074557,-0.15555,-0.16978,1,0
1,GO SODIUM ION TRANSPORT,0.00049035,-0.15864,-0.16222,1,0
1,GO TELENCEPHALON DEVELOPMENT,0.0011199,-0.15892,-0.1689,1,0
1,GO REGULATION OF RESPIRATORY BURST,0.035393,-0.15911,-0.20044,1,0
1,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.02268,-0.15917,-0.11534,1,0
1,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,8.7323e-05,-0.16089,-0.17279,1,0
1,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0025083,-0.16108,-0.23962,1,0
1,GO REGULATION OF ION TRANSPORT,6.0504e-05,-0.16317,-0.16375,1,0
1,GO MITOTIC SISTER CHROMATID COHESION,0.034637,-0.16341,-0.13181,1,0
1,GO CATION TRANSMEMBRANE TRANSPORT,0.00018427,-0.16409,-0.14442,1,0
1,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.031748,-0.16453,-0.20804,1,0
1,GO CHLORIDE TRANSPORT,0.0011549,-0.16599,-0.13288,1,0
1,GO HISTONE H4 ACETYLATION,0.00067758,-0.1661,-0.15104,1,0
1,GO REGULATION OF ICOSANOID SECRETION,0.04854,-0.16616,-0.13097,1,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.00047456,-0.1667,-0.13817,1,0
1,GO EATING BEHAVIOR,0.0022332,-0.16882,-0.15667,1,0
1,GO HISTONE H4 K16 ACETYLATION,0.00065623,-0.16885,-0.23492,1,0
1,GO REGULATION OF BLOOD CIRCULATION,0.0016129,-0.16908,-0.14614,1,0
1,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.00017186,-0.17063,-0.14593,1,0
1,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.046579,-0.17071,-0.16264,1,0
1,GO DIGESTIVE SYSTEM PROCESS,0.026586,-0.17127,-0.13286,1,0
1,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.0036303,-0.17235,-0.16981,1,0
1,GO ACID SECRETION,0.00074557,-0.17314,-0.1879,1,0
1,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.0023671,-0.17339,-0.19218,1,0
1,GO HISTONE H3 K4 METHYLATION,0.031748,-0.1741,-0.17834,1,0
1,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.00040247,-0.17502,-0.14985,1,0
1,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.05161,-0.17589,-0.20588,1,0
1,GO REGULATION OF HISTONE H4 ACETYLATION,0.024846,-0.17706,-0.16326,1,0
1,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.036948,-0.17747,-0.16659,1,0
1,GO REGULATION OF SODIUM ION TRANSPORT,0.011047,-0.17817,-0.15319,1,0
1,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.00019079,-0.17845,-0.18921,1,0
1,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.0039469,-0.17873,-0.13998,1,0
1,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.033894,-0.17936,-0.17475,1,0
1,GO MEMBRANE FISSION,0.0040578,-0.17975,-0.24154,1,0
1,GO PHAGOSOME ACIDIFICATION,0.0090226,-0.18138,-0.16383,1,0
1,GO NEUTRAL AMINO ACID TRANSPORT,0.02068,-0.18152,-0.15486,1,0
1,GO OXIDATIVE DEMETHYLATION,0.0017641,-0.18339,-0.15016,1,0
1,GO POLYOL TRANSPORT,0.042857,-0.18473,-0.15507,1,0
1,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.011326,-0.1902,-0.13267,1,0
1,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.00072223,-0.19061,-0.22595,1,0
1,GO DIGESTION,0.0060989,-0.19258,-0.16309,1,0
1,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.029068,-0.19258,-0.24526,1,0
1,GO RESPONSE TO INTERLEUKIN 2,0.0040578,-0.19289,-0.23364,1,0
1,GO RESPONSE TO ALKALOID,7.3528e-06,-0.19348,-0.2091,1,0
1,GO REGULATION OF HORMONE SECRETION,1.1493e-05,-0.19387,-0.22636,1,0
1,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.0075304,-0.19403,-0.20219,1,0
1,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.007729,-0.19481,-0.24589,1,0
1,GO STRIATUM DEVELOPMENT,0.001191,-0.19617,-0.26527,1,0
1,GO HISTONE H3 K9 DEMETHYLATION,0.013798,-0.19631,-0.19255,1,0
1,GO RESPONSE TO AMPHETAMINE,0.00069957,-0.20037,-0.26445,1,0
1,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.0014738,-0.20226,-0.21083,1,0
1,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00018427,-0.2027,-0.19856,1,0
1,GO HAIR CELL DIFFERENTIATION,0.023741,-0.20357,-0.21429,1,0
1,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.012203,-0.20367,-0.17888,1,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.0013457,-0.20596,-0.22565,1,0
1,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.00037661,-0.20835,-0.18521,1,0
1,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0026572,-0.20964,-0.18082,1,0
1,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.044685,-0.20977,-0.21806,1,0
1,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,6.5149e-05,-0.2101,-0.18966,1,0
1,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.0022992,-0.21069,-0.22783,1,0
1,GO LIPID TRANSLOCATION,0.0064317,-0.2115,-0.18774,1,0
1,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.004408,-0.21182,-0.20445,1,0
1,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.00095906,-0.21249,-0.22699,1,0
1,GO HORMONE TRANSPORT,3.1904e-06,-0.21296,-0.24434,1,0
1,GO SODIUM ION HOMEOSTASIS,0.0011549,-0.21594,-0.25205,1,0
1,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.019283,-0.2167,-0.19266,1,0
1,GO BILE ACID BIOSYNTHETIC PROCESS,0.0053338,-0.2194,-0.19581,1,0
1,GO REGULATION OF ORGANIC ACID TRANSPORT,7.3528e-06,-0.22292,-0.25914,1,0
1,GO ACROSOME REACTION,0.0085714,-0.22302,-0.16377,1,0
1,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00044439,-0.22523,-0.16763,1,0
1,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,2.9532e-05,-0.22632,-0.22727,1,0
1,GO REPRODUCTIVE BEHAVIOR,0.00020448,-0.22816,-0.24181,1,0
1,GO PROTEIN HETEROOLIGOMERIZATION,0.00023468,-0.22905,-0.22193,1,0
1,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.033166,-0.23141,-0.17884,1,0
1,GO BILE ACID METABOLIC PROCESS,0.015953,-0.2389,-0.17155,1,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.0064317,-0.23963,-0.22665,1,0
1,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.014138,-0.24218,-0.19846,1,0
1,GO GASTRULATION WITH MOUTH FORMING SECOND,0.029068,-0.24295,-0.19056,1,0
1,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.0020453,-0.24481,-0.22115,1,0
1,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.017137,-0.24501,-0.22002,1,0
1,GO HIPPOCAMPUS DEVELOPMENT,0.00045924,-0.24531,-0.26896,1,0
1,GO TUBULIN DEACETYLATION,0.010506,-0.24588,-0.25841,1,0
1,GO PANCREAS DEVELOPMENT,0.004408,-0.25112,-0.19693,1,0
1,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0062634,-0.25348,-0.24668,1,0
1,GO FEEDING BEHAVIOR,1.725e-07,-0.25467,-0.27886,1,0
1,GO FOREBRAIN REGIONALIZATION,0.00095906,-0.25496,-0.31716,1,0
1,GO REGULATION OF ACTION POTENTIAL,0.0073363,-0.25755,-0.19174,1,0
1,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,5.4121e-05,-0.25913,-0.25887,1,0
1,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.0075304,-0.25972,-0.22979,1,0
1,GO AMINO ACID TRANSPORT,1.2454e-05,-0.26044,-0.23429,1,0
1,GO CELLULAR RESPONSE TO CALCIUM ION,0.00021909,-0.26075,-0.23465,1,0
1,GO REGULATION OF NERVOUS SYSTEM PROCESS,1.7118e-05,-0.26132,-0.28991,1,0
1,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,2.5774e-06,-0.26497,-0.23131,1,0
1,GO CAMP BIOSYNTHETIC PROCESS,0.0038387,-0.26581,-0.26899,1,0
1,GO AMINE BIOSYNTHETIC PROCESS,0.0073363,-0.26678,-0.20337,1,0
1,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.011612,-0.26854,-0.2151,1,0
1,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.00017186,-0.26984,-0.24979,1,0
1,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.014138,-0.27258,-0.33075,1,0
1,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.0036303,-0.27272,-0.20814,1,0
1,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.00014935,-0.2733,-0.36208,1,0
1,GO GLYCINE TRANSPORT,0.013465,-0.27644,-0.29237,1,0
1,GO RDNA HETEROCHROMATIN ASSEMBLY,2.2524e-05,-0.27798,-0.2674,1,0
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.033166,-0.27859,-0.27392,1,0
1,GO CORTICOSTEROID HORMONE SECRETION,0.0022332,-0.2795,-0.30326,1,0
1,GO SIGNAL RELEASE,2.8891e-07,-0.28052,-0.26865,1,0
1,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.0017641,-0.28276,-0.25139,1,0
1,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.0025817,-0.28303,-0.23771,1,0
1,GO ENDOCRINE PANCREAS DEVELOPMENT,0.013798,-0.28526,-0.18513,1,0
1,GO PEPTIDE HORMONE SECRETION,6.8936e-07,-0.28632,-0.3008,1,0
1,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.0017123,-0.28765,-0.29757,1,0
1,GO REGULATION OF PEPTIDE HORMONE SECRETION,1.2308e-06,-0.28974,-0.287,1,0
1,GO REGULATION OF INSULIN SECRETION,9.0179e-06,-0.28997,-0.27193,1,0
1,GO GLYCOLIPID BIOSYNTHETIC PROCESS,9.0221e-07,-0.2901,-0.27297,1,0
1,GO HISTONE H4 K5 ACETYLATION,9.7346e-05,-0.29457,-0.27925,1,0
1,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.001662,-0.29809,-0.24515,1,0
1,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.04854,-0.29832,-0.20213,1,0
1,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,4.0073e-05,-0.29887,-0.29831,1,0
1,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.037747,-0.29933,-0.23857,1,0
1,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,5.9841e-06,-0.29984,-0.29135,1,0
1,GO CELLULAR RESPONSE TO LITHIUM ION,0.0022332,-0.30529,-0.30704,1,0
1,GO INSEMINATION,0.03245,-0.30648,-0.1839,1,0
1,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.0059384,-0.30791,-0.29913,1,0
1,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.011612,-0.30827,-0.26001,1,0
1,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.011904,-0.30929,-0.26756,1,0
1,GO INSULIN SECRETION,2.9301e-06,-0.3103,-0.29351,1,0
1,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,7.9801e-06,-0.31077,-0.29618,1,0
1,GO RESPONSE TO MAGNESIUM ION,0.00353,-0.31211,-0.29406,1,0
1,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0037331,-0.31297,-0.30454,1,0
1,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,6.7728e-06,-0.31473,-0.33195,1,0
1,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.00055855,-0.3166,-0.28252,1,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.015203,-0.317,-0.22344,1,0
1,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,7.6603e-06,-0.31707,-0.32246,1,0
1,GO POSITIVE REGULATION OF EXOCYTOSIS,2.1831e-07,-0.31759,-0.32494,1,0
1,GO ADRENAL GLAND DEVELOPMENT,0.00016595,-0.32048,-0.34704,1,0
1,GO MITOCHONDRION DISTRIBUTION,0.00065623,-0.32165,-0.30577,1,0
1,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.02068,-0.32343,-0.24445,1,0
1,GO ASSOCIATIVE LEARNING,3.4421e-05,-0.32529,-0.26414,1,0
1,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.0033369,-0.32553,-0.26675,1,0
1,GO NEGATIVE REGULATION OF HISTONE METHYLATION,4.1617e-05,-0.32726,-0.27332,1,0
1,GO DENDRITIC TRANSPORT,0.0032441,-0.3289,-0.29694,1,0
1,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,6.7728e-06,-0.32932,-0.34972,1,0
1,GO CEREBELLAR CORTEX DEVELOPMENT,1.7474e-06,-0.33419,-0.38169,1,0
1,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.0057817,-0.33924,-0.22468,1,0
1,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.00079435,-0.3396,-0.34178,1,0
1,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.0071468,-0.33985,-0.32526,1,0
1,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.00047456,-0.3403,-0.29467,1,0
1,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.04854,-0.34382,-0.18396,1,0
1,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.0010206,-0.34488,-0.28774,1,0
1,GO NEGATIVE REGULATION OF BEHAVIOR,0.0085714,-0.3472,-0.24987,1,0
1,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0083534,-0.34736,-0.29459,1,0
1,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.00017186,-0.3474,-0.33738,1,0
1,GO LEARNING,6.2367e-06,-0.34827,-0.311,1,0
1,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.011047,-0.34974,-0.41562,1,0
1,GO EPITHELIAL STRUCTURE MAINTENANCE,1.6455e-05,-0.35324,-0.34623,1,0
1,GO PHASIC SMOOTH MUSCLE CONTRACTION,7.547e-05,-0.3536,-0.39104,1,0
1,GO N GLYCAN PROCESSING,0.00032948,-0.35547,-0.3392,1,0
1,GO REGULATION OF EXOCYTOSIS,6.5896e-07,-0.35666,-0.32215,1,0
1,GO MEMBRANE DEPOLARIZATION,4.0073e-05,-0.3596,-0.30365,1,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.00072223,-0.36004,-0.28171,1,0
1,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.011326,-0.36236,-0.25576,1,0
1,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,7.9801e-06,-0.36275,-0.44363,1,0
1,GO LIPID DROPLET FORMATION,0.0036303,-0.36562,-0.36143,1,0
1,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.0051916,-0.36716,-0.23543,1,0
1,GO RESPONSE TO DIETARY EXCESS,0.00016595,-0.37244,-0.39033,1,0
1,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.00019079,-0.37346,-0.37308,1,0
1,GO AROMATIC AMINO ACID TRANSPORT,0.00040247,-0.37346,-0.35746,1,0
1,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.00067758,-0.37943,-0.33077,1,0
1,GO NOREPINEPHRINE TRANSPORT,0.00019079,-0.38079,-0.3106,1,0
1,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.016734,-0.38083,-0.28053,1,0
1,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,1.3441e-06,-0.38235,-0.37983,1,0
1,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.010506,-0.38945,-0.32376,1,0
1,GO POSTSYNAPSE ASSEMBLY,0.0020453,-0.3896,-0.40637,1,0
1,GO OPTIC NERVE DEVELOPMENT,0.00065623,-0.39006,-0.37108,1,0
1,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0017123,-0.39232,-0.28504,1,0
1,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.0066042,-0.39576,-0.29404,1,0
1,GO CELL DIFFERENTIATION IN HINDBRAIN,2.0033e-05,-0.39669,-0.35414,1,0
1,GO MRNA SPLICE SITE SELECTION,1.5201e-05,-0.39984,-0.36815,1,0
1,GO SECRETORY GRANULE LOCALIZATION,0.00024286,-0.41139,-0.59317,1,0
1,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,6.7728e-06,-0.41244,-0.44056,1,0
1,GO LUNG EPITHELIUM DEVELOPMENT,0.020205,-0.41545,-0.24202,1,0
1,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,1.5331e-06,-0.42301,-0.40686,1,0
1,GO REGULATION OF CGMP MEDIATED SIGNALING,0.0014299,-0.42584,-0.37092,1,0
1,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,2.6307e-05,-0.4263,-0.41521,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.0097392,-0.42712,-0.3063,1,0
1,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,2.1663e-05,-0.43205,-0.50871,1,0
1,GO RESPONSE TO L GLUTAMATE,0.00090094,-0.43447,-0.45488,1,0
1,GO NEUROTRANSMITTER METABOLIC PROCESS,2.3654e-06,-0.44394,-0.4386,1,0
1,GO SUCKLING BEHAVIOR,0.00032948,-0.44493,-0.4125,1,0
1,GO REGULATION OF REGULATED SECRETORY PATHWAY,1.2862e-06,-0.44555,-0.41116,1,0
1,GO EXOCYTIC PROCESS,1.6452e-07,-0.45225,-0.44155,1,0
1,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,5.0683e-06,-0.45367,-0.40434,1,0
1,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,2.1663e-05,-0.45869,-0.45635,1,0
1,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,5.4272e-08,-0.46269,-0.54371,1,0
1,GO PYRAMIDAL NEURON DIFFERENTIATION,0.019283,-0.4665,-0.44787,1,0
1,GO AMMONIUM ION METABOLIC PROCESS,3.5759e-05,-0.46707,-0.42901,1,0
1,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.044685,-0.48016,-0.30397,1,0
1,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,9.3916e-06,-0.48194,-0.64797,1,0
1,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,3.0264e-07,-0.48934,-0.49617,1,0
1,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0038387,-0.49498,-0.50842,1,0
1,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,6.2985e-07,-0.49949,-0.50382,1,0
1,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.00072223,-0.50684,-0.45366,1,0
1,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.041093,-0.50881,-0.2771,1,0
1,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.00054072,-0.51333,-0.42654,1,0
1,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.041093,-0.51574,-0.25513,1,0
1,GO CGMP METABOLIC PROCESS,1.4674e-06,-0.51939,-0.54224,1,0
1,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.00014418,-0.54045,-0.4434,1,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,1.4963e-07,-0.54818,-0.52911,1,0
1,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.00030804,-0.55403,-0.38951,1,0
1,GO REGULATION OF NEURON MATURATION,0.00084609,-0.55486,-0.48021,1,0
1,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.00017186,-0.55907,-0.46098,1,0
1,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.0017123,-0.56332,-0.44996,1,0
1,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,8.1192e-05,-0.57347,-0.4111,1,0
1,GO LUNG CELL DIFFERENTIATION,0.0045306,-0.57447,-0.4186,1,0
1,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,7.2111e-07,-0.59011,-0.53436,1,0
1,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00019079,-0.592,-0.4968,1,0
1,GO SIALYLATION,1.0311e-06,-0.6012,-0.57693,1,0
1,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,8.6584e-06,-0.60295,-0.57,1,0
1,GO BRANCHING MORPHOGENESIS OF A NERVE,0.00052342,-0.60694,-0.59471,1,0
1,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,4.1617e-05,-0.60857,-0.48991,1,0
1,GO REGULATION OF SYNAPSE MATURATION,8.4205e-05,-0.62295,-0.58908,1,0
1,GO DOPAMINE METABOLIC PROCESS,1.4963e-07,-0.63318,-0.60186,1,0
1,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.00036427,-0.63525,-0.44047,1,0
1,GO DENTATE GYRUS DEVELOPMENT,0.00050664,-0.63696,-0.53389,1,0
1,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.0013054,-0.64208,-0.48285,1,0
1,GO NEUROEPITHELIAL CELL DIFFERENTIATION,3.7791e-06,-0.66067,-0.52279,1,0
1,GO INHIBITORY SYNAPSE ASSEMBLY,2.7578e-07,-0.67351,-0.77451,1,0
1,GO RESPONSE TO LITHIUM ION,7.3528e-06,-0.68229,-0.58147,1,0
1,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,4.8612e-06,-0.69069,-0.7266,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.00010092,-0.69926,-0.58851,1,0
1,GO RESPONSE TO HISTAMINE,3.6414e-07,-0.71108,-0.73935,1,0
1,GO THALAMUS DEVELOPMENT,1.9263e-05,-0.72111,-0.58447,1,0
1,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,3.7145e-05,-0.72507,-0.66917,1,0
1,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,5.508e-06,-0.74799,-0.62655,1,0
1,GO CALCIUM ION REGULATED EXOCYTOSIS,8.628e-07,-0.76166,-0.68228,1,0
1,GO SYNAPTIC VESICLE DOCKING,7.5427e-07,-0.76187,-0.75504,1,0
1,GO INNERVATION,3.3287e-06,-0.76895,-0.63911,1,0
1,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,1.0779e-06,-0.77378,-0.77697,1,0
1,GO SEROTONIN METABOLIC PROCESS,2.8077e-06,-0.80773,-0.6816,1,0
1,GO SYNAPSE MATURATION,7.3528e-06,-0.81147,-0.75657,1,0
1,GO PROTEIN LOCALIZATION TO AXON,5.2533e-07,-0.81572,-0.96159,1,0
1,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,1.2962e-05,-0.81891,-0.81364,1,0
1,GO EPITHELIAL CELL FATE COMMITMENT,0.00052342,-0.8366,-0.67764,1,0
1,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,1.6729e-06,-0.85528,-0.83469,1,0
1,GO SYNAPTIC VESICLE MATURATION,6.7728e-06,-0.85695,-0.82752,1,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,2.2879e-07,-0.88784,-0.77983,1,0
1,GO SYNAPTIC VESICLE PRIMING,5.4977e-07,-0.89151,-0.83599,1,0
1,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,5.4272e-08,-0.97087,-0.91106,1,0
1,GO REGULATION OF DENDRITE EXTENSION,9.7275e-08,-0.97206,-0.88928,1,0
1,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,8.0176e-08,-0.97572,-0.91941,1,0
1,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,7.889e-07,-1.0372,-0.99694,1,0
1,GO VESICLE FUSION TO PLASMA MEMBRANE,1.6729e-06,-1.0401,-0.89494,1,0
1,GO NOSE DEVELOPMENT,3.9418e-06,-1.1182,-0.84574,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,3.9926e-07,-1.1642,-1.0797,1,0
1,GO FOREBRAIN NEURON FATE COMMITMENT,6.7728e-06,-1.2119,-1.0874,1,0
1,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,1.4674e-06,-1.6108,-1.5999,1,0
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.12908,0.51852,0.24513,0,1
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.054842,0.35151,0.21391,0,1
1,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.059411,0.35149,0.1571,0,1
1,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.56075,0.33949,0.27661,0,1
1,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.26471,0.31559,0.14399,0,1
1,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.17374,0.30882,0.18071,0,1
1,GO MICROVILLUS ASSEMBLY,0.092194,0.28076,0.15827,0,1
1,GO L SERINE METABOLIC PROCESS,0.12473,0.2806,0.1349,0,1
1,GO NUCLEAR MIGRATION,0.082489,0.26748,0.11709,0,1
1,GO VITAMIN D METABOLIC PROCESS,0.072231,0.2603,0.19797,0,1
1,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.082489,0.25355,0.14922,0,1
1,GO REGULATION OF MESODERM DEVELOPMENT,0.084046,0.24949,0.20547,0,1
1,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.059411,0.24785,0.20259,0,1
1,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.25001,0.24278,0.13751,0,1
1,GO POSITIVE REGULATION OF VESICLE FUSION,0.25729,0.24167,0.1989,0,1
1,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.060602,0.2406,0.25313,0,1
1,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.12473,0.23509,0.23721,0,1
1,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.079444,0.23384,0.14037,0,1
1,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.061812,0.2296,0.27888,0,1
1,GO LYSINE METABOLIC PROCESS,0.092194,0.22542,0.18973,0,1
1,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.26098,0.22048,0.072053,0,1
1,GO ATRIAL SEPTUM MORPHOGENESIS,0.082489,0.21815,0.20869,0,1
1,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.080955,0.21464,0.12231,0,1
1,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.068167,0.21355,0.22664,0,1
1,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.12473,0.20439,0.18288,0,1
1,GO NEGATIVE T CELL SELECTION,0.075049,0.19886,0.16188,0,1
1,GO VIRAL LATENCY,0.22905,0.1978,0.073748,0,1
1,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.077957,0.19072,0.11122,0,1
1,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.27227,0.18415,0.14868,0,1
1,GO DNA DEMETHYLATION,0.05824,0.1819,0.13333,0,1
1,GO PRO B CELL DIFFERENTIATION,0.47588,0.17409,0.10216,0,1
1,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.54321,0.17246,0.04649,0,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.085627,0.17176,0.09057,0,1
1,GO ENDOTHELIUM DEVELOPMENT,0.079444,0.17126,0.088565,0,1
1,GO REGULATION OF CELLULAR RESPIRATION,0.076492,0.17109,0.11733,0,1
1,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.070855,0.16762,0.14872,0,1
1,GO FOLIC ACID METABOLIC PROCESS,0.15517,0.16684,0.078583,0,1
1,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.39858,0.16512,0.092566,0,1
1,GO PEPTIDYL ARGININE N METHYLATION,0.13355,0.16317,0.10367,0,1
1,GO ARTERY MORPHOGENESIS,0.066855,0.16224,0.22778,0,1
1,GO PROTEIN REFOLDING,0.14526,0.16111,0.11844,0,1
1,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.33812,0.15908,0.083874,0,1
1,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.073629,0.15882,0.14051,0,1
1,GO HEART TRABECULA FORMATION,0.12689,0.15692,0.22296,0,1
1,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.14048,0.15329,0.05491,0,1
1,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.12049,0.15129,0.078812,0,1
1,GO MAINTENANCE OF CELL NUMBER,0.072231,0.14971,0.12327,0,1
1,GO PEPTIDYL ARGININE METHYLATION,0.097379,0.14385,0.095438,0,1
1,GO REGULATION OF NEUROBLAST PROLIFERATION,0.25363,0.14383,0.10617,0,1
1,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.1028,0.14174,0.064351,0,1
1,GO REGULATION OF HAIR CYCLE,0.072231,0.14064,0.21238,0,1
1,GO INOSITOL METABOLIC PROCESS,0.22568,0.13978,0.067235,0,1
1,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.065563,0.13724,0.1307,0,1
1,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.12473,0.13667,0.11104,0,1
1,GO RESPONSE TO VITAMIN D,0.63978,0.13635,0.03293,0,1
1,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.17374,0.13571,0.1059,0,1
1,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.27227,0.13462,0.066419,0,1
1,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.23589,0.1345,0.054147,0,1
1,GO REGULATION OF T CELL CHEMOTAXIS,0.053746,0.13316,0.12767,0,1
1,GO HISTONE H3 DEACETYLATION,0.057089,0.13305,0.1063,0,1
1,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.13355,0.13274,0.08458,0,1
1,GO RESPONSE TO NITRIC OXIDE,0.22568,0.13258,0.071,0,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.068167,0.13238,0.13933,0,1
1,GO TAXIS,0.092194,0.13153,0.053951,0,1
1,GO ACTIVATED T CELL PROLIFERATION,0.059411,0.12918,0.11014,0,1
1,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.14285,0.12875,0.10467,0,1
1,GO ATP TRANSPORT,0.14769,0.12863,0.065538,0,1
1,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.19095,0.12852,0.11784,0,1
1,GO SPHINGOMYELIN METABOLIC PROCESS,0.16032,0.12799,0.076922,0,1
1,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.053746,0.1273,0.10162,0,1
1,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.24288,0.12724,0.058523,0,1
1,GO INTERLEUKIN 6 PRODUCTION,0.11841,0.12623,0.10503,0,1
1,GO RETROGRADE AXONAL TRANSPORT,0.64605,0.12599,-0.012119,0,1
1,GO MITOTIC DNA REPLICATION CHECKPOINT,0.12689,0.12569,0.092677,0,1
1,GO RESPONSE TO PROSTAGLANDIN E,0.079444,0.12529,0.098866,0,1
1,GO INTRACELLULAR STEROL TRANSPORT,0.19393,0.12487,0.11193,0,1
1,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.054842,0.12405,0.12152,0,1
1,GO MAINTENANCE OF ORGANELLE LOCATION,0.15773,0.12339,0.076271,0,1
1,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.14769,0.12288,0.084158,0,1
1,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.46512,0.12093,0.039931,0,1
1,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.077957,0.12069,0.096579,0,1
1,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.16294,0.11949,0.091074,0,1
1,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.14285,0.11858,0.088009,0,1
1,GO REGULATION OF GASTRIC ACID SECRETION,0.17934,0.11669,0.097427,0,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.12689,0.11596,0.092086,0,1
1,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.40349,0.11376,0.013626,0,1
1,GO RNA INTERFERENCE,0.46512,0.11313,0.047271,0,1
1,GO REGULATION OF RENAL SYSTEM PROCESS,0.1313,0.11111,0.12452,0,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.099158,0.11088,0.13304,0,1
1,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.22568,0.11029,0.059516,0,1
1,GO DEFINITIVE HEMOPOIESIS,0.19695,0.10935,0.089966,0,1
1,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.05824,0.1093,0.091277,0,1
1,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.15015,0.10926,0.1051,0,1
1,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.10465,0.10468,0.082747,0,1
1,GO HISTONE ARGININE METHYLATION,0.36064,0.10344,0.046564,0,1
1,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.22905,0.1028,0.093844,0,1
1,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.39371,0.10173,0.043001,0,1
1,GO LYTIC VACUOLE ORGANIZATION,0.2839,0.10115,0.035867,0,1
1,GO CENTROSOME DUPLICATION,0.0695,0.1011,0.087891,0,1
1,GO INTERMEDIATE FILAMENT BASED PROCESS,0.24288,0.1006,0.12002,0,1
1,GO APPENDAGE DEVELOPMENT,0.18219,0.098468,0.098413,0,1
1,GO PEPTIDYL LYSINE TRIMETHYLATION,0.099158,0.096116,0.064858,0,1
1,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.079444,0.095923,0.070428,0,1
1,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.15264,0.095914,0.09496,0,1
1,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.12259,0.094172,0.091139,0,1
1,GO NEGATIVE REGULATION OF DNA BINDING,0.15517,0.094099,0.06176,0,1
1,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.22905,0.093846,0.053214,0,1
1,GO REGULATION OF T CELL MIGRATION,0.24643,0.092845,0.077609,0,1
1,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.12473,0.092311,0.1262,0,1
1,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.11235,0.092034,0.085522,0,1
1,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.2839,0.091651,0.05208,0,1
1,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.20621,0.090074,0.11618,0,1
1,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.059411,0.088705,0.099605,0,1
1,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.066855,0.088269,0.073587,0,1
1,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.22905,0.086625,0.074532,0,1
1,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.088862,0.085245,0.088425,0,1
1,GO MIDBRAIN DEVELOPMENT,0.10845,0.083122,0.091928,0,1
1,GO MEIOTIC CHROMOSOME SEGREGATION,0.080955,0.081904,0.10736,0,1
1,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.16294,0.081311,0.12269,0,1
1,GO REGULATION OF INTEGRIN ACTIVATION,0.67776,0.080078,0.0098386,0,1
1,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.093897,0.07984,0.10494,0,1
1,GO LACTATE METABOLIC PROCESS,0.15015,0.079638,0.089705,0,1
1,GO PROTEIN LOCALIZATION TO CILIUM,0.36991,0.079112,0.067296,0,1
1,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.40349,0.078721,0.074405,0,1
1,GO P BODY ASSEMBLY,0.61497,0.078396,0.027278,0,1
1,GO HISTONE EXCHANGE,0.26471,0.075341,0.06564,0,1
1,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.16828,0.073737,0.076579,0,1
1,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.099158,0.073716,0.050607,0,1
1,GO PROTEIN K48 LINKED UBIQUITINATION,0.23937,0.072909,0.059752,0,1
1,GO REGULATION OF GTPASE ACTIVITY,0.092194,0.07231,0.059265,0,1
1,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.072231,0.072131,0.047035,0,1
1,GO FERTILIZATION,0.097379,0.070817,0.052542,0,1
1,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.21579,0.069838,0.073305,0,1
1,GO CELL PROJECTION ASSEMBLY,0.1028,0.067938,0.059116,0,1
1,GO APPENDAGE MORPHOGENESIS,0.36064,0.067816,0.070141,0,1
1,GO BASE EXCISION REPAIR AP SITE FORMATION,0.87144,0.067532,0.0014144,0,1
1,GO URONIC ACID METABOLIC PROCESS,0.31232,0.066944,0.029162,0,1
1,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.47588,0.066591,0.033126,0,1
1,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.40843,0.066099,0.027172,0,1
1,GO RESPONSE TO LEAD ION,0.13355,0.064649,0.098267,0,1
1,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.087232,0.061187,0.072739,0,1
1,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.19393,0.055701,0.052308,0,1
1,GO DNA CONFORMATION CHANGE,0.16032,0.053859,0.054513,0,1
1,GO MICROTUBULE ANCHORING,0.48131,0.053065,0.03419,0,1
1,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.061812,0.048267,0.096421,0,1
1,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.080955,0.04814,0.055307,0,1
1,GO POSITIVE REGULATION OF CELL CYCLE,0.12259,0.047104,0.040346,0,1
1,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.69061,0.046457,0.012421,0,1
1,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.86455,0.045621,0.0010332,0,1
1,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.82348,0.044402,0.0028601,0,1
1,GO REGULATION OF DEPHOSPHORYLATION,0.76281,0.041337,-0.0024251,0,1
1,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.29184,0.040858,0.02584,0,1
1,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.14285,0.040112,0.039657,0,1
1,GO RECOMBINATIONAL REPAIR,0.65234,0.040048,0.041696,0,1
1,GO DNA MODIFICATION,0.05824,0.039047,0.067755,0,1
1,GO ERROR FREE TRANSLESION SYNTHESIS,0.21905,0.037345,0.042178,0,1
1,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.17099,0.032885,0.035098,0,1
1,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.00027832,0.52319,0.59709,0,0
1,GO EXTRACELLULAR MATRIX ASSEMBLY,0.00028792,0.50101,0.4917,0,0
1,GO PROTEIN ACTIVATION CASCADE,1.1493e-05,0.44166,0.37722,0,0
1,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.00067758,0.43658,0.58281,0,0
1,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,8.1192e-05,0.43236,0.58916,0,0
1,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.00010462,0.42,0.42627,0,0
1,GO VASCULAR TRANSPORT,0.0062634,0.41798,0.49423,0,0
1,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.014138,0.41556,0.47269,0,0
1,GO HOMOCYSTEINE METABOLIC PROCESS,0.0030654,0.40023,0.29137,0,0
1,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.0045306,0.38003,0.34412,0,0
1,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.00010092,0.36765,0.45558,0,0
1,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0032441,0.3507,0.3001,0,0
1,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.0020453,0.35017,0.31618,0,0
1,GO BASEMENT MEMBRANE ASSEMBLY,0.00013433,0.34985,0.53882,0,0
1,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.0073363,0.34493,0.35824,0,0
1,GO ARGININE METABOLIC PROCESS,0.00057693,0.34214,0.35295,0,0
1,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.00031859,0.33694,0.56942,0,0
1,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,6.5149e-05,0.33688,0.34884,0,0
1,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.0083534,0.33431,0.4336,0,0
1,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.014841,0.3196,0.41723,0,0
1,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,0.053746,0.3074,0.19363,0,0
1,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.12908,0.30385,0.32568,0,0
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.11434,0.30312,0.18385,0,0
1,GO HEPARIN METABOLIC PROCESS,0.0029794,0.29926,0.37078,0,0
1,GO CYCLOOXYGENASE PATHWAY,0.11434,0.29727,0.25942,0,0
1,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.0007696,0.29653,0.38364,0,0
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.0015189,0.29058,0.26699,0,0
1,GO LUNG MORPHOGENESIS,0.00042998,0.29041,0.32643,0,0
1,GO RESPONSE TO UV B,0.036164,0.29036,0.2277,0,0
1,GO COPPER ION TRANSPORT,0.00012512,0.28722,0.2998,0,0
1,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0021689,0.28499,0.32445,0,0
1,GO MACROPHAGE APOPTOTIC PROCESS,0.0007696,0.28445,0.37107,0,0
1,GO BEHAVIORAL RESPONSE TO PAIN,0.0045306,0.28287,0.26955,0,0
1,GO MINERALOCORTICOID METABOLIC PROCESS,0.04854,0.2817,0.27476,0,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.019283,0.28044,0.23299,0,0
1,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.019283,0.27642,0.21389,0,0
1,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.027803,0.27274,0.24614,0,0
1,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.0069616,0.27212,0.28256,0,0
1,GO COMPLEMENT ACTIVATION,7.0571e-06,0.27136,0.29459,0,0
1,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,2.3418e-05,0.27127,0.31394,0,0
1,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.11039,0.26736,0.14461,0,0
1,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.020205,0.26693,0.24718,0,0
1,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.0057817,0.26597,0.26183,0,0
1,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.5816e-05,0.2657,0.27122,0,0
1,GO CELLULAR RESPONSE TO ETHANOL,0.0028957,0.26448,0.28119,0,0
1,GO KIDNEY MESENCHYME DEVELOPMENT,0.011047,0.26088,0.20969,0,0
1,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.0062634,0.25973,0.21081,0,0
1,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.00010462,0.25949,0.43593,0,0
1,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.2,0.24979,0.17087,0,0
1,GO PROSTATE GLAND MORPHOGENESIS,0.031748,0.2483,0.36871,0,0
1,GO BARBED END ACTIN FILAMENT CAPPING,0.10465,0.24563,0.14462,0,0
1,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00028792,0.244,0.27341,0,0
1,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.023205,0.24242,0.15661,0,0
1,GO OXYGEN TRANSPORT,0.53742,0.24068,0.096853,0,0
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.00025131,0.2387,0.33778,0,0
1,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.042857,0.23632,0.18957,0,0
1,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.0010859,0.23208,0.25865,0,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.3746,0.23138,0.11854,0,0
1,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.018836,0.23134,0.15806,0,0
1,GO CERAMIDE TRANSPORT,0.0075304,0.22783,0.2135,0,0
1,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.00010462,0.22718,0.2525,0,0
1,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.073629,0.22203,0.10621,0,0
1,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.00057693,0.21539,0.26003,0,0
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.0071468,0.21454,0.28688,0,0
1,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.22905,0.21439,0.12838,0,0
1,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.02268,0.21399,0.24884,0,0
1,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.059411,0.21298,0.31199,0,0
1,GO REGULATION OF BONE MINERALIZATION,0.0040578,0.21161,0.24851,0,0
1,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.041093,0.21101,0.25528,0,0
1,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.0024367,0.20979,0.21822,0,0
1,GO TETRAHYDROFOLATE INTERCONVERSION,0.0085714,0.20848,0.21244,0,0
1,GO LAMELLIPODIUM MORPHOGENESIS,0.42855,0.20847,0.10891,0,0
1,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.0071468,0.20731,0.2454,0,0
1,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0073363,0.20604,0.1813,0,0
1,GO GLIAL CELL APOPTOTIC PROCESS,0.0090226,0.20574,0.2971,0,0
1,GO REGULATION OF BIOMINERALIZATION,0.00072223,0.2034,0.26383,0,0
1,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.084046,0.20239,0.12298,0,0
1,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.43367,0.20211,0.10337,0,0
1,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.065563,0.2003,0.30757,0,0
1,GO NEUROINFLAMMATORY RESPONSE,0.025414,0.19991,0.2154,0,0
1,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.2,0.19851,0.090143,0,0
1,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.34702,0.19806,0.096662,0,0
1,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.11235,0.1976,0.14538,0,0
1,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.043763,0.19646,0.21767,0,0
1,GO RESPONSE TO CADMIUM ION,0.21579,0.19549,0.10191,0,0
1,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.2839,0.19544,0.18022,0,0
1,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.00030804,0.19408,0.21396,0,0
1,GO UV PROTECTION,0.12689,0.1928,0.15033,0,0
1,GO REGULATION OF FATTY ACID OXIDATION,0.10096,0.19166,0.1053,0,0
1,GO COLLECTING DUCT DEVELOPMENT,0.061812,0.19065,0.14402,0,0
1,GO ENDOTHELIAL CELL PROLIFERATION,0.00032948,0.19008,0.2029,0,0
1,GO HEART VALVE FORMATION,0.20309,0.18984,0.18179,0,0
1,GO GLIAL CELL MIGRATION,0.017549,0.18746,0.1878,0,0
1,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.12259,0.1866,0.16404,0,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0013054,0.18588,0.22103,0,0
1,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.22568,0.18505,0.2483,0,0
1,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.15015,0.18478,0.13062,0,0
1,GO DENDRITIC CELL MIGRATION,0.32077,0.18442,0.11193,0,0
1,GO REGULATION OF TRANSLATIONAL FIDELITY,0.10845,0.18382,0.088074,0,0
1,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.009256,0.18381,0.19625,0,0
1,GO PROTEIN AUTOPROCESSING,0.10654,0.18314,0.10146,0,0
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.04854,0.182,0.15516,0,0
1,GO ANION HOMEOSTASIS,0.0079323,0.18146,0.15085,0,0
1,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.12908,0.18128,0.15958,0,0
1,GO MITOCHONDRIAL TRANSCRIPTION,0.075049,0.18126,0.1238,0,0
1,GO DORSAL VENTRAL AXIS SPECIFICATION,0.085627,0.18125,0.3202,0,0
1,GO CHYLOMICRON ASSEMBLY,0.038561,0.18109,0.1737,0,0
1,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.00052342,0.18029,0.19057,0,0
1,GO GAS TRANSPORT,0.188,0.17923,0.17438,0,0
1,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.065563,0.17916,0.18698,0,0
1,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.38888,0.17727,0.097565,0,0
1,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.30402,0.17648,0.090326,0,0
1,GO MESENCHYMAL CELL PROLIFERATION,0.1028,0.17636,0.1756,0,0
1,GO T CELL DIFFERENTIATION IN THYMUS,0.00014418,0.17575,0.185,0,0
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.038561,0.17561,0.17266,0,0
1,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.076492,0.17539,0.17678,0,0
1,GO VITAMIN BIOSYNTHETIC PROCESS,0.17099,0.17398,0.12401,0,0
1,GO NEGATIVE REGULATION OF ANOIKIS,0.084046,0.17334,0.21648,0,0
1,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.33812,0.1728,0.10504,0,0
1,GO KINETOCHORE ORGANIZATION,0.077957,0.17277,0.12498,0,0
1,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.17374,0.17196,0.087857,0,0
1,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.16559,0.17144,0.1063,0,0
1,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.05824,0.17059,0.17433,0,0
1,GO RESPONSE TO UV C,0.0075304,0.17038,0.20641,0,0
1,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.21579,0.16839,0.095981,0,0
1,GO INACTIVATION OF MAPK ACTIVITY,0.043763,0.16747,0.22211,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.16559,0.16744,0.13781,0,0
1,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.29184,0.16732,0.2317,0,0
1,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.13583,0.16694,0.14788,0,0
1,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.016339,0.16632,0.13615,0,0
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.068167,0.16573,0.19582,0,0
1,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.36064,0.16403,0.060289,0,0
1,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.027188,0.16357,0.21513,0,0
1,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.033166,0.16347,0.1506,0,0
1,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.082489,0.16259,0.13798,0,0
1,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.2,0.1622,0.073408,0,0
1,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.0010206,0.16216,0.15184,0,0
1,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.014841,0.16093,0.17832,0,0
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00059588,0.15904,0.20454,0,0
1,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.063042,0.15894,0.24674,0,0
1,GO REGULATION OF GTP BINDING,0.13355,0.15858,0.1503,0,0
1,GO AMINO ACID ACTIVATION,0.040234,0.15854,0.13588,0,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.50337,0.15844,0.063769,0,0
1,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.58456,0.15828,0.045592,0,0
1,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.12908,0.15799,0.11677,0,0
1,GO TRICARBOXYLIC ACID CYCLE,0.20621,0.15798,0.052561,0,0
1,GO NEUROBLAST DIVISION,0.23589,0.15779,0.12247,0,0
1,GO DETOXIFICATION,0.012508,0.15753,0.13844,0,0
1,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.29586,0.15701,0.21639,0,0
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.064293,0.15612,0.14099,0,0
1,GO DENDRITIC SPINE MAINTENANCE,0.040234,0.15602,0.18668,0,0
1,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.0085714,0.15544,0.14571,0,0
1,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.041967,0.15493,0.1302,0,0
1,GO RENAL VESICLE DEVELOPMENT,0.25363,0.15457,0.10873,0,0
1,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.033894,0.15425,0.1424,0,0
1,GO PROTEIN STABILIZATION,6.5149e-05,0.15372,0.15513,0,0
1,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.059411,0.15303,0.099453,0,0
1,GO ACTIN FILAMENT NETWORK FORMATION,0.73628,0.1528,-0.014942,0,0
1,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.0042883,0.15267,0.1551,0,0
1,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.27999,0.15187,0.11263,0,0
1,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.15015,0.15179,0.12175,0,0
1,GO STEM CELL DIVISION,0.082489,0.15108,0.17158,0,0
1,GO CENTROSOME SEPARATION,0.057089,0.15102,0.11608,0,0
1,GO CELLULAR RESPONSE TO CADMIUM ION,0.22905,0.151,0.13864,0,0
1,GO MUSCLE HYPERTROPHY,0.2839,0.15062,0.061737,0,0
1,GO INTERMEMBRANE LIPID TRANSFER,0.0027346,0.15047,0.15595,0,0
1,GO LATERAL VENTRICLE DEVELOPMENT,0.10845,0.15036,0.16085,0,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.038561,0.15027,0.19261,0,0
1,GO INTERMEDIATE FILAMENT ORGANIZATION,0.20309,0.15019,0.17505,0,0
1,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.05824,0.1479,0.10101,0,0
1,GO NUCLEOTIDE SALVAGE,0.24643,0.14775,0.19971,0,0
1,GO MALE GENITALIA DEVELOPMENT,0.29184,0.14772,0.05004,0,0
1,GO REGULATION OF GONAD DEVELOPMENT,0.54903,0.14709,0.005719,0,0
1,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.11235,0.14665,0.21195,0,0
1,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.064293,0.14643,0.13486,0,0
1,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.16032,0.14512,0.13476,0,0
1,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.095625,0.14507,0.14272,0,0
1,GO EXTRACELLULAR TRANSPORT,0.085627,0.14495,0.12282,0,0
1,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.59664,0.1448,0.080716,0,0
1,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.11636,0.1435,0.12336,0,0
1,GO CORPUS CALLOSUM DEVELOPMENT,0.088862,0.14349,0.13821,0,0
1,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.070855,0.14319,0.064786,0,0
1,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.8303,0.14273,-0.0048016,0,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.16294,0.14268,0.1258,0,0
1,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.20937,0.14245,0.081289,0,0
1,GO NCRNA CATABOLIC PROCESS,0.073629,0.14238,0.1243,0,0
1,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.59059,0.14211,0.078013,0,0
1,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.084046,0.14169,0.097343,0,0
1,GO STEROL HOMEOSTASIS,0.055956,0.1415,0.082803,0,0
1,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0097392,0.14105,0.21879,0,0
1,GO EMBRYONIC PLACENTA DEVELOPMENT,0.32077,0.14048,0.081656,0,0
1,GO NEGATIVE REGULATION OF AUTOPHAGY,0.011047,0.13972,0.13337,0,0
1,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.066855,0.13892,0.06831,0,0
1,GO REGULATION OF WATER LOSS VIA SKIN,0.32938,0.13885,0.10118,0,0
1,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.11235,0.13876,0.11992,0,0
1,GO POSITIVE REGULATION OF WOUND HEALING,0.060602,0.13831,0.19938,0,0
1,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.20309,0.13725,0.064349,0,0
1,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.14526,0.1372,0.12376,0,0
1,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.20937,0.13695,0.083566,0,0
1,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.2839,0.13688,0.089277,0,0
1,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.71006,0.13668,0.016722,0,0
1,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.077957,0.13591,0.1681,0,0
1,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.24288,0.13591,0.042726,0,0
1,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.1313,0.1358,0.093226,0,0
1,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.18508,0.13559,0.1339,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.12049,0.13524,0.14247,0,0
1,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.077957,0.13467,0.1131,0,0
1,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.19095,0.13463,0.091416,0,0
1,GO GENITALIA DEVELOPMENT,0.0094949,0.1344,0.11426,0,0
1,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.017137,0.13436,0.27215,0,0
1,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.092194,0.13395,0.15587,0,0
1,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.082489,0.1327,0.12174,0,0
1,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.092194,0.13225,0.11941,0,0
1,GO MANGANESE ION TRANSPORT,0.099158,0.132,0.12715,0,0
1,GO ACTIVATION OF JNKK ACTIVITY,0.1028,0.13189,0.10211,0,0
1,GO PARAXIAL MESODERM MORPHOGENESIS,0.11434,0.13162,0.22761,0,0
1,GO MACROPHAGE ACTIVATION,0.059411,0.13154,0.13661,0,0
1,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.18508,0.13128,0.096384,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0024367,0.12995,0.13906,0,0
1,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.19095,0.12965,0.10678,0,0
1,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.32077,0.12957,0.14604,0,0
1,GO LIPID DIGESTION,0.33373,0.12938,0.037878,0,0
1,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0020453,0.12889,0.14908,0,0
1,GO RESPONSE TO INTERLEUKIN 7,0.072231,0.12855,0.16179,0,0
1,GO PROXIMAL DISTAL PATTERN FORMATION,0.49227,0.12835,0.051051,0,0
1,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.26847,0.12801,0.079064,0,0
1,GO ANOIKIS,0.16294,0.12786,0.11931,0,0
1,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0064317,0.12767,0.15354,0,0
1,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.35153,0.12726,0.048122,0,0
1,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.059411,0.12725,0.13289,0,0
1,GO CELL PROLIFERATION IN FOREBRAIN,0.41341,0.12702,0.040158,0,0
1,GO SKIN DEVELOPMENT,0.059411,0.12676,0.17111,0,0
1,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.0087944,0.12666,0.19571,0,0
1,GO TERPENOID METABOLIC PROCESS,0.0695,0.12653,0.12853,0,0
1,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.21256,0.12632,0.12175,0,0
1,GO REGULATION OF TISSUE REMODELING,0.061812,0.12632,0.081792,0,0
1,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.54321,0.12575,0.0454,0,0
1,GO GLYCOSIDE METABOLIC PROCESS,0.43883,0.12568,0.071585,0,0
1,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.064293,0.12548,0.19331,0,0
1,GO REVERSE CHOLESTEROL TRANSPORT,0.26098,0.12519,0.07704,0,0
1,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.10465,0.12518,0.094179,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.066855,0.12468,0.12184,0,0
1,GO ENGULFMENT OF APOPTOTIC CELL,0.12473,0.12443,0.089701,0,0
1,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.082489,0.12402,0.21579,0,0
1,GO PIRNA METABOLIC PROCESS,0.38408,0.12242,0.134,0,0
1,GO PHOSPHOLIPID CATABOLIC PROCESS,0.064293,0.12176,0.11156,0,0
1,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.16828,0.12166,0.058738,0,0
1,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.024846,0.12151,0.10387,0,0
1,GO PROTEIN KINASE C SIGNALING,0.32077,0.12144,0.043941,0,0
1,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.030383,0.12141,0.15674,0,0
1,GO CELLULAR RESPONSE TO KETONE,0.073629,0.12124,0.09965,0,0
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.16032,0.12098,0.19075,0,0
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.0053338,0.12085,0.18101,0,0
1,GO REGULATION OF HISTONE DEACETYLATION,0.061812,0.12055,0.10692,0,0
1,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.16032,0.12055,0.058756,0,0
1,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.031748,0.12038,0.076634,0,0
1,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.023205,0.12036,0.099644,0,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.44924,0.11917,0.12615,0,0
1,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.61497,0.11864,0.033535,0,0
1,GO AORTA MORPHOGENESIS,0.4978,0.11834,0.15967,0,0
1,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.24288,0.11794,0.073892,0,0
1,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.20309,0.11784,0.076869,0,0
1,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.52025,0.11668,-0.14507,0,0
1,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.075049,0.11632,0.091392,0,0
1,GO NEURON PROJECTION REGENERATION,0.10654,0.11578,0.08534,0,0
1,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.0062634,0.11558,0.094557,0,0
1,GO POSITIVE REGULATION OF BONE RESORPTION,0.14526,0.11529,0.11285,0,0
1,GO SPHINGOID METABOLIC PROCESS,0.10654,0.11507,0.066982,0,0
1,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.14526,0.11487,0.16268,0,0
1,GO CELLULAR RESPONSE TO CHOLESTEROL,0.21256,0.11426,0.13055,0,0
1,GO UBIQUINONE METABOLIC PROCESS,0.2,0.1142,0.059234,0,0
1,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.65234,0.11386,0.004905,0,0
1,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.036948,0.11354,0.10852,0,0
1,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.077957,0.11315,0.10764,0,0
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.0021062,0.11193,0.098696,0,0
1,GO POSITIVE REGULATION OF OSSIFICATION,0.011904,0.11186,0.19251,0,0
1,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.061812,0.11154,0.14307,0,0
1,GO TRIGLYCERIDE METABOLIC PROCESS,0.088862,0.11149,0.055876,0,0
1,GO CELL CELL ADHESION,0.11039,0.11135,0.068589,0,0
1,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.19393,0.11109,0.050922,0,0
1,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.22905,0.11101,0.077659,0,0
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.049546,0.11071,0.11691,0,0
1,GO MUSCLE FIBER DEVELOPMENT,0.13355,0.11048,0.068602,0,0
1,GO FATTY ACID BIOSYNTHETIC PROCESS,0.055956,0.11018,0.065263,0,0
1,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.13355,0.11002,0.060761,0,0
1,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.1028,0.10981,0.11148,0,0
1,GO RESPONSE TO HYDROPEROXIDE,0.4978,0.10974,0.1154,0,0
1,GO PHOSPHOLIPID EFFLUX,0.28785,0.10956,0.1816,0,0
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.36991,0.10889,0.072655,0,0
1,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.27611,0.1087,0.081154,0,0
1,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.22235,0.1083,0.1671,0,0
1,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.061812,0.1082,0.12039,0,0
1,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.40349,0.10812,0.053651,0,0
1,GO L PHENYLALANINE METABOLIC PROCESS,0.40349,0.10809,0.032357,0,0
1,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.32938,0.10794,0.051129,0,0
1,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.079444,0.10777,0.094039,0,0
1,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.30815,0.10767,0.026157,0,0
1,GO REGULATION OF MAST CELL ACTIVATION,0.19695,0.10746,0.10101,0,0
1,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.05824,0.1074,0.13026,0,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.057089,0.10739,0.13876,0,0
1,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.084046,0.1071,0.082793,0,0
1,GO ICOSANOID BIOSYNTHETIC PROCESS,0.29992,0.10708,0.067262,0,0
1,GO MONOSACCHARIDE CATABOLIC PROCESS,0.25363,0.10705,0.049309,0,0
1,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.21579,0.10704,0.12923,0,0
1,GO KERATINOCYTE DIFFERENTIATION,0.12473,0.10696,0.15493,0,0
1,GO PURINE CONTAINING COMPOUND SALVAGE,0.56666,0.10694,0.029354,0,0
1,GO LIPOPROTEIN CATABOLIC PROCESS,0.39371,0.10676,0.058583,0,0
1,GO RESPONSE TO STEROL,0.093897,0.10639,0.11093,0,0
1,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.044685,0.10621,0.14105,0,0
1,GO ACETYL COA METABOLIC PROCESS,0.21579,0.10604,0.04543,0,0
1,GO ER NUCLEUS SIGNALING PATHWAY,0.39371,0.10603,0.037236,0,0
1,GO OVULATION CYCLE PROCESS,0.20937,0.10602,0.075277,0,0
1,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.12908,0.10589,0.10825,0,0
1,GO PYRUVATE METABOLIC PROCESS,0.25729,0.10582,0.050143,0,0
1,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0695,0.10564,0.056087,0,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.080955,0.10553,0.10153,0,0
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.15264,0.10534,0.09093,0,0
1,GO ODONTOGENESIS,0.0034322,0.10518,0.23103,0,0
1,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.1313,0.10505,0.087972,0,0
1,GO LEFT RIGHT PATTERN FORMATION,0.0695,0.10503,0.18779,0,0
1,GO NAD METABOLIC PROCESS,0.26847,0.1047,0.096295,0,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.10096,0.10463,0.072577,0,0
1,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.41842,0.10419,0.06888,0,0
1,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.12259,0.10415,0.11286,0,0
1,GO GLIAL CELL DEVELOPMENT,0.11039,0.10411,0.062324,0,0
1,GO OVULATION CYCLE,0.018398,0.10379,0.14746,0,0
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.26098,0.10379,0.14209,0,0
1,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.82348,0.10298,-0.012544,0,0
1,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.0695,0.10237,0.15498,0,0
1,GO MUSCLE CELL APOPTOTIC PROCESS,0.054842,0.10225,0.095761,0,0
1,GO B CELL DIFFERENTIATION,0.053746,0.1017,0.099358,0,0
1,GO REGULATION OF TELOMERASE ACTIVITY,0.054842,0.10153,0.093355,0,0
1,GO THIOESTER METABOLIC PROCESS,0.10845,0.10143,0.071512,0,0
1,GO MITOCHONDRIAL DEPOLARIZATION,0.14048,0.10073,0.12697,0,0
1,GO STEROID ESTERIFICATION,0.12473,0.10046,0.14593,0,0
1,GO EPITHELIAL TUBE MORPHOGENESIS,0.0079323,0.099608,0.13682,0,0
1,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.26098,0.099449,0.087533,0,0
1,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.39858,0.098648,0.043697,0,0
1,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.11636,0.098508,0.090675,0,0
1,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.023741,0.098393,0.13198,0,0
1,GO POSITIVE REGULATION OF MYELINATION,0.14769,0.097841,0.11907,0,0
1,GO COCHLEA MORPHOGENESIS,0.78289,0.097431,-0.027526,0,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.55487,0.097396,0.052923,0,0
1,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.57857,0.096932,0.090184,0,0
1,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.097379,0.096653,0.075055,0,0
1,GO CRISTAE FORMATION,0.11235,0.096536,0.138,0,0
1,GO ATRIAL SEPTUM DEVELOPMENT,0.50896,0.096458,0.060268,0,0
1,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.47049,0.095471,0.077401,0,0
1,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.090515,0.095356,0.078223,0,0
1,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.27227,0.095288,0.12371,0,0
1,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.15264,0.095138,0.060614,0,0
1,GO NUCLEOTIDE PHOSPHORYLATION,0.15773,0.094913,0.056289,0,0
1,GO POLYSACCHARIDE CATABOLIC PROCESS,0.11636,0.094865,0.090946,0,0
1,GO ADHERENS JUNCTION ASSEMBLY,0.23589,0.094765,0.089585,0,0
1,GO ACTIVATION OF GTPASE ACTIVITY,0.095625,0.094598,0.081825,0,0
1,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.27999,0.094108,0.057916,0,0
1,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.059411,0.093588,0.098996,0,0
1,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.33373,0.093484,0.046891,0,0
1,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.10096,0.093473,0.052545,0,0
1,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.18508,0.092629,0.12756,0,0
1,GO TRIPARTITE REGIONAL SUBDIVISION,0.58456,0.092194,0.032941,0,0
1,GO CENTROMERE COMPLEX ASSEMBLY,0.19695,0.092133,0.089332,0,0
1,GO INTESTINAL LIPID ABSORPTION,0.18508,0.092128,0.092879,0,0
1,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.56075,0.092087,0.064426,0,0
1,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.15517,0.091727,0.046691,0,0
1,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.05161,0.0916,0.094081,0,0
1,GO NEUTRAL LIPID METABOLIC PROCESS,0.27227,0.091529,0.026913,0,0
1,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.012203,0.091334,0.078173,0,0
1,GO REGULATION OF B CELL DIFFERENTIATION,0.85768,0.091295,0.028119,0,0
1,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.13583,0.09109,0.14025,0,0
1,GO CELLULAR RESPONSE TO PH,0.27999,0.09083,0.071733,0,0
1,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.20621,0.090581,0.17346,0,0
1,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.42855,0.090556,0.08744,0,0
1,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.58456,0.090535,0.14367,0,0
1,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.072231,0.090336,0.13863,0,0
1,GO CELLULAR RESPONSE TO AMYLOID BETA,0.22568,0.090187,0.11877,0,0
1,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.12689,0.090139,0.06477,0,0
1,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.22235,0.090136,0.063425,0,0
1,GO NATURAL KILLER CELL DIFFERENTIATION,0.072231,0.090014,0.12287,0,0
1,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.073629,0.089551,0.098062,0,0
1,GO RESPONSE TO ALCOHOL,0.37932,0.089243,0.036981,0,0
1,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.037747,0.089193,0.13759,0,0
1,GO B CELL PROLIFERATION,0.50896,0.088547,0.017531,0,0
1,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.34702,0.088502,0.11922,0,0
1,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.34256,0.088477,0.032058,0,0
1,GO MYELIN MAINTENANCE,0.50896,0.088396,0.064599,0,0
1,GO RNA STABILIZATION,0.075049,0.088289,0.092828,0,0
1,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.11434,0.088189,0.067591,0,0
1,GO OOCYTE MATURATION,0.29184,0.088046,0.043066,0,0
1,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.12259,0.087945,0.068664,0,0
1,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.40843,0.087698,0.025322,0,0
1,GO CELL CYCLE ARREST,0.0062634,0.087257,0.078992,0,0
1,GO MUSCLE ATROPHY,0.25001,0.086402,0.13436,0,0
1,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.057089,0.086336,0.11282,0,0
1,GO PROTEIN SUMOYLATION,0.084046,0.086251,0.073148,0,0
1,GO B CELL APOPTOTIC PROCESS,0.64605,0.086093,0.010272,0,0
1,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.26098,0.085987,0.071986,0,0
1,GO INTERLEUKIN 12 PRODUCTION,0.12908,0.085532,0.10112,0,0
1,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.49227,0.084856,0.015339,0,0
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.15015,0.084807,0.042067,0,0
1,GO REGULATION OF RUFFLE ASSEMBLY,0.17653,0.084514,0.067097,0,0
1,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.016734,0.084413,0.11562,0,0
1,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.099158,0.084331,0.099312,0,0
1,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.27999,0.084186,0.10917,0,0
1,GO STEROL METABOLIC PROCESS,0.26847,0.084099,0.026502,0,0
1,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.95466,0.083729,-0.03184,0,0
1,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.27227,0.083694,0.068511,0,0
1,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.11235,0.083544,0.13632,0,0
1,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.059411,0.083497,0.1342,0,0
1,GO PROTEIN AUTO ADP RIBOSYLATION,0.58456,0.083468,0.048272,0,0
1,GO POLYOL BIOSYNTHETIC PROCESS,0.0695,0.083423,0.068998,0,0
1,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.12049,0.083418,0.098505,0,0
1,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.4598,0.083294,0.065245,0,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.17099,0.082895,0.069441,0,0
1,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.41842,0.082734,0.058726,0,0
1,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.090515,0.082518,0.065792,0,0
1,GO GOLGI RIBBON FORMATION,0.17653,0.082104,0.11963,0,0
1,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.50337,0.082011,0.052454,0,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.15773,0.081955,0.073743,0,0
1,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.40843,0.081901,0.036524,0,0
1,GO OSTEOBLAST PROLIFERATION,0.12473,0.081862,0.1824,0,0
1,GO LYMPHOCYTE HOMEOSTASIS,0.30815,0.081529,0.031207,0,0
1,GO KETONE CATABOLIC PROCESS,0.29992,0.08124,0.12773,0,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.18508,0.081199,0.094618,0,0
1,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.59059,0.08096,0.037763,0,0
1,GO RESPONSE TO WATER,0.5726,0.080941,0.073112,0,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.27999,0.080817,0.071492,0,0
1,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.042857,0.080795,0.074153,0,0
1,GO NEGATIVE REGULATION OF SECRETION,0.061812,0.080785,0.076314,0,0
1,GO CALCINEURIN MEDIATED SIGNALING,0.11235,0.080698,0.079166,0,0
1,GO RESPONSE TO ATP,0.031748,0.080477,0.098945,0,0
1,GO STEROID METABOLIC PROCESS,0.14048,0.080366,0.03721,0,0
1,GO OXIDATIVE PHOSPHORYLATION,0.13583,0.080171,0.079355,0,0
1,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.89215,0.079714,-0.088275,0,0
1,GO CYTOCHROME COMPLEX ASSEMBLY,0.055956,0.079586,0.12463,0,0
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.69061,0.079166,-0.0098249,0,0
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.15264,0.07911,0.10185,0,0
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.23245,0.078466,0.083159,0,0
1,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.088862,0.078375,0.11806,0,0
1,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.27999,0.07802,0.12559,0,0
1,GO MULTIVESICULAR BODY SORTING PATHWAY,0.11235,0.077925,0.0657,0,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.17374,0.077882,0.099682,0,0
1,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.57857,0.077695,0.011906,0,0
1,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.99651,0.077571,-0.038959,0,0
1,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.42347,0.077536,0.054533,0,0
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.36064,0.077396,0.062642,0,0
1,GO MONOSACCHARIDE METABOLIC PROCESS,0.055956,0.07722,0.05398,0,0
1,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.024846,0.077082,0.072086,0,0
1,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.29184,0.076827,0.035678,0,0
1,GO REGULATION OF STEROID METABOLIC PROCESS,0.26098,0.07679,0.032564,0,0
1,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.16294,0.076717,0.08166,0,0
1,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.49227,0.076624,0.026517,0,0
1,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.90599,0.076619,-0.011208,0,0
1,GO ESCRT COMPLEX DISASSEMBLY,0.36064,0.076511,0.060225,0,0
1,GO VITAMIN D BIOSYNTHETIC PROCESS,0.92682,0.076434,0.078873,0,0
1,GO TUMOR NECROSIS FACTOR SECRETION,0.29586,0.076232,0.10858,0,0
1,GO SULFATION,0.19695,0.076201,0.1424,0,0
1,GO ELECTRON TRANSPORT CHAIN,0.037747,0.076105,0.083723,0,0
1,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.40843,0.076024,0.18506,0,0
1,GO NEURAL CREST FORMATION,1,0.075967,0.028289,0,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.059411,0.075747,0.07447,0,0
1,GO RESPONSE TO MUSCLE INACTIVITY,0.14769,0.075588,0.13244,0,0
1,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.19695,0.0755,0.064946,0,0
1,GO STEM CELL PROLIFERATION,0.59059,0.075386,0.0052359,0,0
1,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.12908,0.075222,0.070092,0,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.052669,0.075149,0.1892,0,0
1,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.16559,0.075131,0.10029,0,0
1,GO PHOSPHOLIPID HOMEOSTASIS,0.21579,0.074686,0.12967,0,0
1,GO BLASTODERM SEGMENTATION,0.29184,0.074614,0.14358,0,0
1,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.059411,0.074607,0.061885,0,0
1,GO PEPTIDYL SERINE MODIFICATION,0.029719,0.074445,0.065094,0,0
1,GO PROTEIN K11 LINKED UBIQUITINATION,0.11434,0.074344,0.08595,0,0
1,GO GROWTH,0.034637,0.074265,0.065317,0,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.26847,0.0741,0.078338,0,0
1,GO EMBRYONIC HEMOPOIESIS,0.96163,0.073653,-0.0067416,0,0
1,GO RRNA CATABOLIC PROCESS,0.50337,0.073622,0.041535,0,0
1,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.39371,0.073401,0.061003,0,0
1,GO ADHESION OF SYMBIONT TO HOST,0.1028,0.073317,0.21212,0,0
1,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.040234,0.073237,0.078011,0,0
1,GO LOCOMOTOR RHYTHM,0.38888,0.07317,0.079327,0,0
1,GO RESPIRATORY BURST,0.46512,0.072495,0.030644,0,0
1,GO NOTCH RECEPTOR PROCESSING,0.23937,0.072483,0.1361,0,0
1,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.18219,0.072351,0.083828,0,0
1,GO HEXOSE CATABOLIC PROCESS,0.3746,0.07222,0.03216,0,0
1,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.22235,0.072214,0.14374,0,0
1,GO SARCOMERE ORGANIZATION,0.59664,0.072142,0.063372,0,0
1,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.34256,0.071956,0.096622,0,0
1,GO PEPTIDYL HISTIDINE MODIFICATION,0.17934,0.071894,0.092514,0,0
1,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.20309,0.071716,0.087305,0,0
1,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.26471,0.071313,0.082468,0,0
1,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.36526,0.071277,0.15541,0,0
1,GO NEUTROPHIL CHEMOTAXIS,0.077957,0.070917,0.17854,0,0
1,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.053746,0.07084,0.089334,0,0
1,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.21905,0.070765,0.11208,0,0
1,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.097379,0.07074,0.080416,0,0
1,GO CYTOKINE SECRETION,0.32506,0.070564,0.061338,0,0
1,GO MALE MEIOTIC NUCLEAR DIVISION,0.71658,0.070555,0.081421,0,0
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.066855,0.070462,0.11424,0,0
1,GO MYELOID CELL DEVELOPMENT,0.19393,0.069954,0.069643,0,0
1,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.1028,0.069828,0.048078,0,0
1,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.91987,0.069811,-0.013908,0,0
1,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.96163,0.069775,-0.030423,0,0
1,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.10845,0.06976,0.052742,0,0
1,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.24643,0.069678,0.14793,0,0
1,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.021165,0.069561,0.2359,0,0
1,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.30402,0.06956,0.13761,0,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.15517,0.069523,0.071865,0,0
1,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.72969,0.069501,-0.002996,0,0
1,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.00098941,0.069134,0.095136,0,0
1,GO VENTRICULAR SEPTUM DEVELOPMENT,0.053746,0.069099,0.14885,0,0
1,GO NEGATIVE CHEMOTAXIS,0.13583,0.068751,0.12632,0,0
1,GO SEQUESTERING OF CALCIUM ION,0.20309,0.068582,0.061577,0,0
1,GO RUFFLE ASSEMBLY,0.10465,0.068166,0.085894,0,0
1,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.19095,0.068097,0.052897,0,0
1,GO RESPONSE TO PROSTAGLANDIN,0.13583,0.067957,0.15714,0,0
1,GO REGULATION OF FAT CELL DIFFERENTIATION,0.023205,0.067846,0.12261,0,0
1,GO MRNA EXPORT FROM NUCLEUS,0.073629,0.067562,0.073399,0,0
1,GO POSITIVE REGULATION OF CYTOKINESIS,0.52025,0.067391,0.048109,0,0
1,GO POSITIVE REGULATION OF AXON EXTENSION,0.18508,0.067372,0.067585,0,0
1,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.24643,0.067345,0.095796,0,0
1,GO HISTONE H3 K27 METHYLATION,0.33812,0.067274,0.047425,0,0
1,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.24643,0.067239,0.073509,0,0
1,GO REGULATION OF HISTONE UBIQUITINATION,0.055956,0.06676,0.10977,0,0
1,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.4598,0.06673,0.042404,0,0
1,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.31653,0.066711,0.053545,0,0
1,GO RESPONSE TO TOXIC SUBSTANCE,0.42347,0.066572,0.029481,0,0
1,GO EMBRYONIC ORGAN MORPHOGENESIS,0.11841,0.066535,0.067795,0,0
1,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.37932,0.066365,0.011623,0,0
1,GO REGULATION OF CELL FATE SPECIFICATION,0.30815,0.066205,0.13406,0,0
1,GO NADH METABOLIC PROCESS,0.27227,0.066191,0.082794,0,0
1,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.31232,0.066086,0.067142,0,0
1,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.89907,0.065854,-0.018393,0,0
1,GO PLASMA MEMBRANE FUSION,0.17374,0.065842,0.13824,0,0
1,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.11636,0.065657,0.092568,0,0
1,GO RECEPTOR INTERNALIZATION,0.12473,0.065623,0.069289,0,0
1,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.17099,0.065479,0.051917,0,0
1,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.4978,0.065436,0.024584,0,0
1,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.35153,0.065368,0.056139,0,0
1,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.20937,0.065009,0.042182,0,0
1,GO SMOOTH MUSCLE CONTRACTION,0.34702,0.065002,0.052403,0,0
1,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.77618,0.064615,0.011473,0,0
1,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.34702,0.064383,0.069567,0,0
1,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.41341,0.064298,0.03406,0,0
1,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.35153,0.064231,0.047297,0,0
1,GO THYROID GLAND DEVELOPMENT,0.47049,0.063999,0.072594,0,0
1,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.24643,0.063819,0.046435,0,0
1,GO GLYCEROLIPID METABOLIC PROCESS,0.076492,0.063351,0.041462,0,0
1,GO POSITIVE REGULATION OF NEURON DEATH,0.32077,0.063324,0.041733,0,0
1,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.38888,0.063322,0.10874,0,0
1,GO REGULATION OF HELICASE ACTIVITY,0.38888,0.063124,0.076538,0,0
1,GO TISSUE HOMEOSTASIS,0.10465,0.062816,0.056265,0,0
1,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.76948,0.062545,-0.019612,0,0
1,GO RESPIRATORY SYSTEM PROCESS,0.69061,0.062509,0.020597,0,0
1,GO APICAL JUNCTION ASSEMBLY,0.20937,0.062473,0.10785,0,0
1,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.19695,0.06236,0.071765,0,0
1,GO MODIFIED AMINO ACID TRANSPORT,0.053746,0.062293,0.11765,0,0
1,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.77618,0.062245,0.0023675,0,0
1,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.043763,0.061481,0.31576,0,0
1,GO RESPONSE TO CORTICOSTERONE,0.11235,0.061384,0.20629,0,0
1,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.60272,0.061298,0.042358,0,0
1,GO BONE CELL DEVELOPMENT,0.47049,0.061201,0.047885,0,0
1,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.13355,0.061138,0.054122,0,0
1,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.43367,0.061072,0.037175,0,0
1,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.054842,0.060966,0.07818,0,0
1,GO RESPONSE TO AMYLOID BETA,0.34256,0.060803,0.11296,0,0
1,GO NEGATIVE REGULATION OF CELL GROWTH,0.066855,0.06072,0.066375,0,0
1,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.4545,0.060584,0.1036,0,0
1,GO POSITIVE REGULATION OF DNA REPAIR,0.15264,0.060476,0.05628,0,0
1,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.28785,0.060002,0.10827,0,0
1,GO MEMBRANE FUSION,0.26098,0.059833,0.035347,0,0
1,GO PANCREATIC JUICE SECRETION,0.72969,0.05948,0.039147,0,0
1,GO REGULATION OF NEUTROPHIL MIGRATION,0.15773,0.059461,0.07885,0,0
1,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.20937,0.059378,0.030983,0,0
1,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.32506,0.05929,0.10919,0,0
1,GO COENZYME A BIOSYNTHETIC PROCESS,0.33812,0.058957,0.042571,0,0
1,GO REGULATION OF TELOMERE CAPPING,0.71006,0.058786,0.0088064,0,0
1,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.34702,0.058765,0.069687,0,0
1,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.60883,0.058736,0.099786,0,0
1,GO REGULATION OF EXIT FROM MITOSIS,0.16559,0.058616,0.068188,0,0
1,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.082489,0.05853,0.11853,0,0
1,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.11039,0.058469,0.048998,0,0
1,GO INCLUSION BODY ASSEMBLY,0.66501,0.058464,-0.097322,0,0
1,GO PROTEIN AUTOUBIQUITINATION,0.34702,0.058319,0.029106,0,0
1,GO ACETYL COA BIOSYNTHETIC PROCESS,0.30815,0.058283,0.053853,0,0
1,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.0014738,0.05801,0.087935,0,0
1,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.40843,0.057866,0.079099,0,0
1,GO REGULATION OF PROTEIN TARGETING,0.32077,0.057624,0.037778,0,0
1,GO EPIDERMIS DEVELOPMENT,0.25001,0.057582,0.11978,0,0
1,GO ENSHEATHMENT OF NEURONS,0.20937,0.057383,0.049684,0,0
1,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.71006,0.057363,0.019302,0,0
1,GO MICROVILLUS ORGANIZATION,0.41341,0.057264,-0.10114,0,0
1,GO MISMATCH REPAIR,0.32077,0.057231,0.04407,0,0
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.088862,0.056938,0.043536,0,0
1,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.50896,0.056114,0.14186,0,0
1,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.25363,0.056009,0.061231,0,0
1,GO MUSCLE SYSTEM PROCESS,0.22568,0.055954,0.048029,0,0
1,GO DNA REPLICATION INITIATION,0.36526,0.055904,0.031784,0,0
1,GO POLYOL METABOLIC PROCESS,0.0695,0.05581,0.053129,0,0
1,GO EXECUTION PHASE OF APOPTOSIS,0.0695,0.055558,0.05809,0,0
1,GO RESPONSE TO TEMPERATURE STIMULUS,0.076492,0.055361,0.071751,0,0
1,GO AMMONIUM TRANSPORT,0.059411,0.055347,0.1655,0,0
1,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.53167,0.055172,0.057071,0,0
1,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.98953,0.055141,-0.021058,0,0
1,GO SPECIFICATION OF SYMMETRY,0.068167,0.055086,0.067615,0,0
1,GO POSITIVE REGULATION OF JNK CASCADE,0.17099,0.055038,0.047551,0,0
1,GO ACTIVATION OF JUN KINASE ACTIVITY,0.27999,0.054821,0.048965,0,0
1,GO MEIOTIC CELL CYCLE PROCESS,0.12049,0.054783,0.066177,0,0
1,GO CHLORIDE ION HOMEOSTASIS,0.4978,0.054489,0.039101,0,0
1,GO LONG CHAIN FATTY ACID TRANSPORT,0.1313,0.054374,0.058209,0,0
1,GO MITOTIC CHROMOSOME CONDENSATION,0.91987,0.054236,0.010746,0,0
1,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.44924,0.054103,0.098152,0,0
1,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.15015,0.053713,0.057612,0,0
1,GO REGULATION OF CELL SIZE,0.29184,0.053632,0.030636,0,0
1,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.31653,0.053629,0.040508,0,0
1,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.39371,0.05351,0.034448,0,0
1,GO ERYTHROCYTE DEVELOPMENT,0.090515,0.053448,0.10682,0,0
1,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.10465,0.053363,0.12038,0,0
1,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.50896,0.053159,0.072749,0,0
1,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.11841,0.053025,0.11395,0,0
1,GO MUSCLE TISSUE DEVELOPMENT,0.16559,0.052983,0.079773,0,0
1,GO MITOTIC SPINDLE ASSEMBLY,0.15517,0.052901,0.079285,0,0
1,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.03245,0.052866,0.074848,0,0
1,GO T HELPER CELL LINEAGE COMMITMENT,0.088862,0.052815,0.12157,0,0
1,GO GOLGI LOCALIZATION,0.9686,0.052534,0.0023713,0,0
1,GO HOMEOSTATIC PROCESS,0.18219,0.052336,0.025792,0,0
1,GO RESPONSE TO MECHANICAL STIMULUS,0.22568,0.052079,0.079703,0,0
1,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.91987,0.051821,0.013205,0,0
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.32506,0.051594,0.082465,0,0
1,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.42855,0.051288,0.027564,0,0
1,GO RESPONSE TO INORGANIC SUBSTANCE,0.16828,0.051219,0.059665,0,0
1,GO NEPHRIC DUCT MORPHOGENESIS,0.80312,0.051212,-0.011,0,0
1,GO DNA REPLICATION CHECKPOINT,0.56666,0.051173,0.027467,0,0
1,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.39858,0.051093,0.072101,0,0
1,GO REGULATION OF PROTEIN DEACETYLATION,0.74288,0.05094,0.0062787,0,0
1,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.88523,0.05051,-0.0018625,0,0
1,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.084046,0.050509,0.059315,0,0
1,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.023741,0.050345,0.072492,0,0
1,GO RESPONSE TO INSULIN,0.2,0.05024,0.02772,0,0
1,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.19393,0.050224,0.051613,0,0
1,GO AMP METABOLIC PROCESS,0.36064,0.049977,0.14997,0,0
1,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.29184,0.049963,0.095788,0,0
1,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.61497,0.049928,0.017027,0,0
1,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.17374,0.049915,0.082341,0,0
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.64605,0.049882,0.040752,0,0
1,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.38888,0.049654,0.019071,0,0
1,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.65234,0.049636,0.024977,0,0
1,GO PROTEIN COMPLEX OLIGOMERIZATION,0.27999,0.049466,0.038317,0,0
1,GO SKIN EPIDERMIS DEVELOPMENT,0.23589,0.049224,0.15923,0,0
1,GO RESPONSE TO ACTIVITY,0.27227,0.048946,0.034714,0,0
1,GO ICOSANOID METABOLIC PROCESS,0.22568,0.048926,0.074619,0,0
1,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.59664,0.048905,0.029001,0,0
1,GO REGULATION OF B CELL PROLIFERATION,0.74288,0.04885,-0.0062404,0,0
1,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.33373,0.048783,0.071047,0,0
1,GO RESPONSE TO STEROL DEPLETION,0.89215,0.048757,-0.052064,0,0
1,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.43883,0.048339,0.044287,0,0
1,GO PHOSPHOLIPID METABOLIC PROCESS,0.11235,0.047968,0.035459,0,0
1,GO CHROMATIN REMODELING AT CENTROMERE,0.47588,0.047909,0.026854,0,0
1,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.80312,0.047893,-0.0084869,0,0
1,GO NEPHRON EPITHELIUM DEVELOPMENT,0.25729,0.047863,0.10735,0,0
1,GO REGULATION OF CELLULAR COMPONENT SIZE,0.15773,0.047789,0.038643,0,0
1,GO PURINE NUCLEOTIDE TRANSPORT,0.54903,0.047686,0.021903,0,0
1,GO PROTEIN DESTABILIZATION,0.70355,0.047535,0.012495,0,0
1,GO VITAMIN METABOLIC PROCESS,0.11636,0.047375,0.069031,0,0
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.26098,0.047302,0.045157,0,0
1,GO MRNA PROCESSING,0.33812,0.047,0.037377,0,0
1,GO RESPONSE TO COPPER ION,0.75615,0.04697,0.041769,0,0
1,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.48678,0.046833,-0.1748,0,0
1,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.52594,0.046496,0.011217,0,0
1,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.079444,0.046495,0.051482,0,0
1,GO SECRETION,0.061812,0.045892,0.059321,0,0
1,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.20309,0.045881,0.13829,0,0
1,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.26098,0.045873,0.06584,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.60272,0.045846,0.022964,0,0
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.38888,0.045747,0.059836,0,0
1,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.55487,0.045615,0.033241,0,0
1,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.19095,0.045524,0.070334,0,0
1,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.55487,0.045376,0.062571,0,0
1,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.83713,0.045368,0.031561,0,0
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.14769,0.04529,0.035578,0,0
1,GO TRANSFERRIN TRANSPORT,0.50337,0.045175,0.016969,0,0
1,GO REGULATION OF GROWTH,0.061812,0.045143,0.053457,0,0
1,GO ENDOSOME TO LYSOSOME TRANSPORT,0.31653,0.044665,0.048255,0,0
1,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.44402,0.04459,0.018215,0,0
1,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.87833,0.044565,-0.031435,0,0
1,GO MITOCHONDRIAL GENOME MAINTENANCE,0.61497,0.04452,-0.0030979,0,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.4598,0.044428,0.086841,0,0
1,GO RESPONSE TO ZINC ION,0.46512,0.044298,0.044683,0,0
1,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.43883,0.044005,0.042218,0,0
1,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.21256,0.043801,0.046242,0,0
1,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.50896,0.043794,-0.075073,0,0
1,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.17653,0.043689,0.12639,0,0
1,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.49227,0.043536,0.037242,0,0
1,GO RESPONSE TO AXON INJURY,0.74288,0.043292,0.00079299,0,0
1,GO EPITHELIAL CELL DIFFERENTIATION,0.22568,0.043292,0.082639,0,0
1,GO NEGATIVE REGULATION OF BONE REMODELING,0.5726,0.04322,0.076528,0,0
1,GO BRONCHUS DEVELOPMENT,0.70355,0.043216,0.034853,0,0
1,GO MONOCARBOXYLIC ACID TRANSPORT,0.31232,0.043172,0.02214,0,0
1,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.32938,0.043059,0.036895,0,0
1,GO CELLULAR ION HOMEOSTASIS,0.30815,0.042912,0.02975,0,0
1,GO ONE CARBON METABOLIC PROCESS,0.38888,0.042884,0.043942,0,0
1,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.43883,0.042792,0.027837,0,0
1,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.34256,0.042276,0.027431,0,0
1,GO METHIONINE METABOLIC PROCESS,0.72313,0.042082,-0.02501,0,0
1,GO RESPONSE TO NITROGEN COMPOUND,0.070855,0.042053,0.055653,0,0
1,GO PROTEIN O LINKED GLYCOSYLATION,0.89907,0.041933,-0.031235,0,0
1,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.36526,0.041797,0.10808,0,0
1,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.91293,0.041691,-0.010636,0,0
1,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.15264,0.041673,0.079665,0,0
1,GO MITOCHONDRIAL TRANSPORT,0.16559,0.041663,0.038214,0,0
1,GO BASE EXCISION REPAIR,0.12259,0.041643,0.08145,0,0
1,GO DNA METHYLATION OR DEMETHYLATION,0.29586,0.041616,0.047673,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION,0.14769,0.041521,0.037564,0,0
1,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.50896,0.04134,0.017015,0,0
1,GO NAD BIOSYNTHETIC PROCESS,0.72313,0.041251,0.050228,0,0
1,GO REGULATION OF EXCRETION,0.78289,0.04108,-0.028927,0,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.60883,0.041054,0.019537,0,0
1,GO PHOTOPERIODISM,0.43367,0.041053,0.01525,0,0
1,GO PROTEIN POLYMERIZATION,0.188,0.040933,0.03949,0,0
1,GO CARDIAC VENTRICLE DEVELOPMENT,0.20937,0.040889,0.075361,0,0
1,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.49227,0.040126,0.046742,0,0
1,GO REGULATION OF GLUCONEOGENESIS,0.39371,0.039916,0.015964,0,0
1,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.20621,0.039851,0.17571,0,0
1,GO RNA SPLICING,0.26471,0.039613,0.037995,0,0
1,GO MEGAKARYOCYTE DIFFERENTIATION,0.39858,0.039608,0.047583,0,0
1,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.82348,0.039598,-0.00096838,0,0
1,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.47049,0.039579,-0.067806,0,0
1,GO CELL VOLUME HOMEOSTASIS,0.22568,0.039497,0.049795,0,0
1,GO REGULATION OF BLOOD PRESSURE,0.63978,0.039394,0.030408,0,0
1,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.3746,0.039386,0.068261,0,0
1,GO ENDOSOMAL TRANSPORT,0.052669,0.03914,0.063962,0,0
1,GO FEMALE GENITALIA DEVELOPMENT,0.32506,0.039129,0.085216,0,0
1,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.13814,0.039004,0.082723,0,0
1,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.20937,0.038841,0.043309,0,0
1,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.17653,0.038709,0.041179,0,0
1,GO DISACCHARIDE METABOLIC PROCESS,0.31232,0.038616,0.083256,0,0
1,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.47049,0.038523,0.035708,0,0
1,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.29992,0.038392,0.07147,0,0
1,GO METAL ION HOMEOSTASIS,0.38408,0.038153,0.025152,0,0
1,GO REGULATION OF ORGANELLE ASSEMBLY,0.087232,0.038113,0.052625,0,0
1,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.04854,0.038077,0.067733,0,0
1,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.94073,0.037951,-0.026134,0,0
1,GO MICROTUBULE NUCLEATION,0.39858,0.037931,0.051218,0,0
1,GO PROSTAGLANDIN SECRETION,0.18219,0.03793,0.10034,0,0
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.84397,0.037783,0.024227,0,0
1,GO REGULATION OF ODONTOGENESIS,0.54321,0.037754,0.06549,0,0
1,GO REGULATION OF SPINDLE ASSEMBLY,0.26471,0.037741,0.073144,0,0
1,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.11636,0.037457,0.057609,0,0
1,GO CERAMIDE METABOLIC PROCESS,0.27999,0.037319,0.010001,0,0
1,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.32506,0.037173,0.08957,0,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.10465,0.036927,0.10387,0,0
1,GO ORGAN INDUCTION,0.11434,0.036747,0.11749,0,0
1,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.76281,0.036639,0.02524,0,0
1,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.87833,0.036608,0.020318,0,0
1,GO AUTOPHAGIC CELL DEATH,0.32938,0.036252,0.099409,0,0
1,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.41341,0.03624,0.080074,0,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.69707,0.036134,0.02321,0,0
1,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.56666,0.036023,0.032833,0,0
1,GO HISTONE H3 ACETYLATION,0.50896,0.035782,0.021002,0,0
1,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.84397,0.035777,-0.00012577,0,0
1,GO GLUCOSE CATABOLIC PROCESS,0.55487,0.035388,0.043845,0,0
1,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.98255,0.035241,-0.0073004,0,0
1,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.34256,0.035019,0.028879,0,0
1,GO SISTER CHROMATID SEGREGATION,0.1313,0.034871,0.061101,0,0
1,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.24643,0.034781,0.081761,0,0
1,GO ONE CARBON COMPOUND TRANSPORT,0.61497,0.034774,0.066331,0,0
1,GO POSITIVE REGULATION OF GROWTH,0.21905,0.034583,0.041774,0,0
1,GO CELL GROWTH,0.44402,0.034571,0.031026,0,0
1,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.90599,0.034492,0.00026877,0,0
1,GO BONE MATURATION,0.42347,0.034455,0.02131,0,0
1,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.49227,0.034361,0.036619,0,0
1,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.74288,0.034221,-0.040134,0,0
1,GO DIOL METABOLIC PROCESS,0.59059,0.034214,0.019992,0,0
1,GO REGULATION OF MICROVILLUS ORGANIZATION,0.58456,0.033958,-0.14167,0,0
1,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.48678,0.033836,0.050777,0,0
1,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.30402,0.033684,0.035728,0,0
1,GO POSITIVE REGULATION OF GLIOGENESIS,0.32506,0.033621,0.050875,0,0
1,GO NEGATIVE REGULATION OF AXON EXTENSION,0.59664,0.033577,0.032641,0,0
1,GO MOLTING CYCLE,0.19095,0.033546,0.15975,0,0
1,GO REGULATION OF GOLGI ORGANIZATION,0.34702,0.033316,0.050694,0,0
1,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.15773,0.033088,0.1234,0,0
1,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.87833,0.033073,-0.034241,0,0
1,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.4545,0.032916,0.011631,0,0
1,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.80312,0.032646,0.021824,0,0
1,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.98255,0.032618,-0.020067,0,0
1,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.63354,0.032568,0.031444,0,0
1,GO ENDOCRINE HORMONE SECRETION,0.67776,0.032526,0.026552,0,0
1,GO MUSCLE CELL DEVELOPMENT,0.26471,0.032445,0.076511,0,0
1,GO REGULATION OF PLATELET AGGREGATION,0.65866,0.032442,-0.058374,0,0
1,GO REGULATION OF JUN KINASE ACTIVITY,0.43367,0.03221,0.042794,0,0
1,GO CELLULAR RESPONSE TO FATTY ACID,0.46512,0.032148,0.069096,0,0
1,GO SEX DIFFERENTIATION,0.50337,0.031838,0.024929,0,0
1,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.47588,0.03173,0.1302,0,0
1,GO CHOLESTEROL STORAGE,0.41341,0.03159,0.091564,0,0
1,GO PROSTAGLANDIN TRANSPORT,0.92682,0.031303,-0.012343,0,0
1,GO MULTICELLULAR ORGANISM REPRODUCTION,0.18508,0.031221,0.029594,0,0
1,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.60883,0.031218,0.016391,0,0
1,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.71006,0.030893,-0.03293,0,0
1,GO POLYSACCHARIDE METABOLIC PROCESS,0.75615,0.030886,-0.0095813,0,0
1,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.89215,0.030814,-0.0079321,0,0
1,GO CARDIAC VENTRICLE MORPHOGENESIS,0.71658,0.030342,0.0065204,0,0
1,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.87144,0.030149,-0.019464,0,0
1,GO HISTONE UBIQUITINATION,0.4978,0.030082,0.033109,0,0
1,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.50337,0.02983,0.034233,0,0
1,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.34256,0.029807,0.064561,0,0
1,GO TRANSCYTOSIS,0.32506,0.02937,0.088208,0,0
1,GO HISTONE H3 K4 TRIMETHYLATION,0.78289,0.029327,0.024813,0,0
1,GO SINGLE FERTILIZATION,0.50337,0.029053,0.019695,0,0
1,GO APICAL PROTEIN LOCALIZATION,0.58456,0.028983,-0.080796,0,0
1,GO DNA METHYLATION,0.61497,0.028977,0.008546,0,0
1,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.91987,0.028968,0.0041603,0,0
1,GO PROTEIN HETEROTETRAMERIZATION,0.78962,0.02888,-0.0041332,0,0
1,GO ION HOMEOSTASIS,0.49227,0.028603,0.019283,0,0
1,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.65866,0.028417,0.016145,0,0
1,GO DEVELOPMENTAL GROWTH,0.52025,0.028303,0.021607,0,0
1,GO REGULATION OF PHOSPHATASE ACTIVITY,0.93377,0.028272,-0.012745,0,0
1,GO MEIOTIC CELL CYCLE,0.43367,0.02819,0.038378,0,0
1,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.93377,0.028112,-0.016819,0,0
1,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.94769,0.028088,0.026925,0,0
1,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.47588,0.028081,0.049772,0,0
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.25001,0.027988,0.07679,0,0
1,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.76281,0.027909,0.065501,0,0
1,GO ESTROUS CYCLE,0.47588,0.027641,0.075043,0,0
1,GO CYTOPLASM ORGANIZATION,0.56075,0.027598,0.067253,0,0
1,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.63354,0.027413,0.028754,0,0
1,GO REGULATION OF SULFUR METABOLIC PROCESS,0.93377,0.027338,-0.012599,0,0
1,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.35607,0.027211,0.050839,0,0
1,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.59664,0.02713,0.01653,0,0
1,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.58456,0.026947,0.0049196,0,0
1,GO IRON COORDINATION ENTITY TRANSPORT,0.94769,0.026854,-0.035023,0,0
1,GO RESPONSE TO CAMP,0.21579,0.026708,0.10681,0,0
1,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.15517,0.026704,0.097668,0,0
1,GO CELLULAR RESPONSE TO ALCOHOL,0.4545,0.026671,0.052279,0,0
1,GO IMP METABOLIC PROCESS,0.69707,0.026646,0.032645,0,0
1,GO PIGMENT CELL DIFFERENTIATION,0.63978,0.026561,0.050833,0,0
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.36064,0.026299,0.084226,0,0
1,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.63978,0.026086,0.0053337,0,0
1,GO RETINA HOMEOSTASIS,0.99651,0.026073,-0.017771,0,0
1,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.25729,0.02593,0.10826,0,0
1,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.53742,0.025521,0.033297,0,0
1,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.57857,0.025494,0.039035,0,0
1,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.14285,0.025185,0.16831,0,0
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.76281,0.025082,0.0015494,0,0
1,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.63978,0.024966,0.022139,0,0
1,GO CELLULAR GLUCAN METABOLIC PROCESS,0.69707,0.024771,0.014365,0,0
1,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.36991,0.024764,0.078473,0,0
1,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.2839,0.024566,0.081989,0,0
1,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.40349,0.024349,0.024048,0,0
1,GO REGULATION OF PROTEIN POLYMERIZATION,0.91293,0.02427,-0.0003888,0,0
1,GO TEMPERATURE HOMEOSTASIS,0.48678,0.024265,0.022404,0,0
1,GO DIACYLGLYCEROL METABOLIC PROCESS,0.69707,0.023952,-0.05767,0,0
1,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.84397,0.023943,0.0016805,0,0
1,GO ACTIN NUCLEATION,0.74288,0.023871,-0.022561,0,0
1,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.39858,0.023812,0.037834,0,0
1,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.36526,0.023783,0.12993,0,0
1,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.32938,0.02357,0.024242,0,0
1,GO VITAMIN CATABOLIC PROCESS,0.62113,0.023215,-0.02581,0,0
1,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.37932,0.023156,0.075095,0,0
1,GO RESPONSE TO ACIDIC PH,0.58456,0.023099,0.028593,0,0
1,GO REGULATION OF HISTONE MODIFICATION,0.89215,0.022779,0.0079184,0,0
1,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.28785,0.022717,0.046453,0,0
1,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.89907,0.022694,0.0068375,0,0
1,GO LIPID BIOSYNTHETIC PROCESS,0.42855,0.022432,-0.00023338,0,0
1,GO RETINAL CONE CELL DIFFERENTIATION,0.82348,0.02218,-0.060428,0,0
1,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.40843,0.02217,0.02622,0,0
1,GO REGULATION OF CHROMOSOME ORGANIZATION,0.4545,0.022111,0.02542,0,0
1,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.60883,0.021587,-0.084415,0,0
1,GO FATTY ACID DERIVATIVE TRANSPORT,0.5726,0.021281,-0.044458,0,0
1,GO MITOCHONDRIAL FISSION,0.71658,0.021278,0.01637,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.38888,0.021136,0.02693,0,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.72969,0.020979,0.023566,0,0
1,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.47049,0.02088,0.019038,0,0
1,GO MICROTUBULE SEVERING,0.52025,0.020716,-0.043739,0,0
1,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.77618,0.019888,0.012835,0,0
1,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.84397,0.01988,0.0099295,0,0
1,GO PROTEIN HOMOOLIGOMERIZATION,0.62732,0.019845,0.017303,0,0
1,GO FUCOSE METABOLIC PROCESS,0.94073,0.019839,-0.019509,0,0
1,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.68418,0.019774,0.033062,0,0
1,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.60272,0.019596,0.0056256,0,0
1,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.5726,0.01945,0.022578,0,0
1,GO REGULATION OF CELL DIFFERENTIATION,0.2839,0.01914,0.033711,0,0
1,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.76948,0.019111,-0.0338,0,0
1,GO MIDDLE EAR MORPHOGENESIS,0.7495,0.019082,0.072199,0,0
1,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.76281,0.019051,0.016872,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.9686,0.01895,0.0096451,0,0
1,GO HISTONE MONOUBIQUITINATION,0.59664,0.018931,0.017441,0,0
1,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.39371,0.018444,0.031074,0,0
1,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.34256,0.018414,0.031906,0,0
1,GO HISTONE H2A UBIQUITINATION,0.76948,0.018368,0.013883,0,0
1,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.55487,0.017976,0.0090037,0,0
1,GO MEIOTIC CHROMOSOME SEPARATION,0.71658,0.017964,0.074141,0,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.33373,0.01762,0.066089,0,0
1,GO VENTRICULAR SYSTEM DEVELOPMENT,0.9686,0.017549,0.021191,0,0
1,GO CELLULAR HOMEOSTASIS,0.25001,0.017506,0.031624,0,0
1,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.76281,0.017327,-0.10028,0,0
1,GO NEGATIVE REGULATION OF CELL DIVISION,0.65866,0.016864,0.021683,0,0
1,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.65866,0.016751,0.0037759,0,0
1,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.7495,0.016669,0.054768,0,0
1,GO VITAMIN TRANSPORT,0.94073,0.016634,-0.0079963,0,0
1,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.62113,0.016629,0.032867,0,0
1,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.96163,0.016278,-0.022685,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.76281,0.016271,0.034256,0,0
1,GO ANIMAL ORGAN MATURATION,0.56666,0.016183,0.041139,0,0
1,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.5726,0.016082,0.026524,0,0
1,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.8303,0.015978,-0.028264,0,0
1,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.89907,0.015719,0.013804,0,0
1,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.20937,0.01566,0.28102,0,0
1,GO MOTILE CILIUM ASSEMBLY,0.83713,0.015654,0.0062361,0,0
1,GO RESPONSE TO ORGANOPHOSPHORUS,0.061812,0.015565,0.11507,0,0
1,GO NUCLEOTIDE TRANSPORT,0.5726,0.015554,0.0070389,0,0
1,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.30402,0.015403,0.091687,0,0
1,GO LIPID PHOSPHORYLATION,0.83713,0.014905,0.0015557,0,0
1,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.27999,0.014805,0.032455,0,0
1,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.64605,0.014732,0.041415,0,0
1,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.77618,0.014569,0.022713,0,0
1,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.44402,0.014363,0.080834,0,0
1,GO REGULATION OF CELLULAR LOCALIZATION,0.5726,0.01424,0.015378,0,0
1,GO TOR SIGNALING,0.98953,0.013798,0.0093264,0,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.51459,0.013723,0.025666,0,0
1,GO GLYCOSYLATION,0.89215,0.013578,-0.040138,0,0
1,GO POSITIVE REGULATION OF CELL GROWTH,0.62732,0.013063,0.021687,0,0
1,GO POSITIVE REGULATION OF TRANSPORT,0.38408,0.012855,0.024335,0,0
1,GO CHROMOSOME ORGANIZATION,0.52025,0.012811,0.025771,0,0
1,GO ENDOCYTIC RECYCLING,0.188,0.012798,0.053393,0,0
1,GO REGULATION OF CALCIUM ION TRANSPORT,0.4598,0.012479,0.025475,0,0
1,GO MUSCLE CONTRACTION,0.42855,0.012253,0.037029,0,0
1,GO ANDROGEN METABOLIC PROCESS,0.72313,0.012216,-0.0076308,0,0
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.67776,0.012116,0.04845,0,0
1,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.44402,0.01199,0.042299,0,0
1,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.71658,0.011855,0.041619,0,0
1,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.96163,0.011725,-0.02538,0,0
1,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.59664,0.011621,0.010325,0,0
1,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.60883,0.011417,0.029859,0,0
1,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.84397,0.011416,0.0049488,0,0
1,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.93377,0.011349,-0.0019056,0,0
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.32938,0.01128,0.22417,0,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.63354,0.011256,0.037605,0,0
1,GO DIVALENT METAL ION EXPORT,0.77618,0.011072,0.016629,0,0
1,GO REGULATION OF CHLORIDE TRANSPORT,0.98255,0.010898,0.0054547,0,0
1,GO ACYLGLYCEROL HOMEOSTASIS,0.85082,0.010853,-0.032166,0,0
1,GO REGULATION OF MUSCLE CONTRACTION,0.60272,0.010834,0.020848,0,0
1,GO INTERSTRAND CROSS LINK REPAIR,0.54903,0.010795,0.015601,0,0
1,GO STRIATED MUSCLE ADAPTATION,0.78289,0.010629,0.0023499,0,0
1,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.90599,0.010615,0.021742,0,0
1,GO GLUCOSE IMPORT,0.74288,0.010433,-0.025585,0,0
1,GO ETHANOL CATABOLIC PROCESS,0.70355,0.010425,0.12088,0,0
1,GO RESPONSE TO LIGHT STIMULUS,0.86455,0.01034,-0.0022365,0,0
1,GO ENERGY RESERVE METABOLIC PROCESS,0.8303,0.010201,0.0023268,0,0
1,GO REGULATION OF MITOCHONDRIAL FISSION,0.84397,0.010089,0.015697,0,0
1,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.81668,0.009984,-0.012724,0,0
1,GO REGULATION OF PROTEIN SUMOYLATION,0.37932,0.0099176,0.082953,0,0
1,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.99651,0.0097933,0.045432,0,0
1,GO DNA DEPENDENT DNA REPLICATION,0.58456,0.0097865,0.021628,0,0
1,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.40843,0.0095535,-0.065946,0,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.91987,0.0093522,-0.01669,0,0
1,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.43883,0.0091093,0.10628,0,0
1,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.94073,0.0089795,-0.0075017,0,0
1,GO RETINOIC ACID METABOLIC PROCESS,0.65234,0.0089665,0.0598,0,0
1,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.4545,0.008734,0.078381,0,0
1,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.84397,0.0086856,-0.010073,0,0
1,GO HISTONE H3 K9 TRIMETHYLATION,1,0.0085235,-0.0044787,0,0
1,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.40843,0.0084504,0.062125,0,0
1,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.72969,0.0082964,0.021157,0,0
1,GO HISTONE H3 K9 ACETYLATION,0.62113,0.0082186,0.046187,0,0
1,GO MYELIN ASSEMBLY,0.63354,0.0081881,0.04435,0,0
1,GO ORGANELLE MEMBRANE FUSION,0.93377,0.0080999,-0.0099218,0,0
1,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.72969,0.0080861,0.014392,0,0
1,GO REGULATION OF CHROMATIN ORGANIZATION,0.65234,0.0079758,-0.006342,0,0
1,GO CELL CELL JUNCTION ASSEMBLY,0.34702,0.0077344,0.045651,0,0
1,GO ARACHIDONIC ACID SECRETION,0.55487,0.0076162,-0.086074,0,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.82348,0.0075917,0.027768,0,0
1,GO SINGLE STRAND BREAK REPAIR,0.91987,0.0074265,0.016605,0,0
1,GO ADAPTIVE THERMOGENESIS,0.67776,0.0071635,0.018896,0,0
1,GO PHOSPHOLIPID TRANSPORT,0.88523,0.0071449,-0.0080248,0,0
1,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.43367,0.0070358,0.0539,0,0
1,GO REGULATION OF VASCULAR PERMEABILITY,0.82348,0.0069352,-0.012349,0,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.58456,0.0067392,-0.03233,0,0
1,GO STEROID BIOSYNTHETIC PROCESS,0.74288,0.0063959,-0.045494,0,0
1,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.63978,0.0061886,0.025628,0,0
1,GO PEPTIDYL LYSINE MODIFICATION,0.53167,0.0061204,-0.02464,0,0
1,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.99651,0.0058693,-0.021761,0,0
1,GO HETEROTYPIC CELL CELL ADHESION,0.55487,0.00576,0.038261,0,0
1,GO STRESS GRANULE ASSEMBLY,0.53167,0.0056795,-0.033215,0,0
1,GO VASODILATION,0.64605,0.0056344,-0.075409,0,0
1,GO CELL RECOGNITION,0.65234,0.0055472,-0.024348,0,0
1,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.89907,0.0054449,-0.0036565,0,0
1,GO MEIOSIS I CELL CYCLE PROCESS,0.59664,0.0052723,0.040939,0,0
1,GO B CELL HOMEOSTASIS,0.84397,0.0051746,-0.0036586,0,0
1,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.82348,0.0049806,-0.039934,0,0
1,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.57857,0.0048643,-0.028484,0,0
1,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.92682,0.0047889,0.03043,0,0
1,GO NODAL SIGNALING PATHWAY,0.89215,0.0046767,0.0033979,0,0
1,GO RESPONSE TO GROWTH HORMONE,0.44924,0.004669,0.067619,0,0
1,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.59664,0.0045312,0.057971,0,0
1,GO LYMPH NODE DEVELOPMENT,0.74288,0.0045066,0.082447,0,0
1,GO CHROMATIN DISASSEMBLY,0.67776,0.0044687,0.0031935,0,0
1,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.60272,0.0044527,0.041943,0,0
1,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.93377,0.0041688,-0.0087053,0,0
1,GO MRNA METHYLATION,0.91987,0.004158,0.0020584,0,0
1,GO NON MOTILE CILIUM ASSEMBLY,0.87144,0.003638,-0.0053702,0,0
1,GO CONVERGENT EXTENSION,0.90599,0.0034441,0.0040514,0,0
1,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.90599,0.0033734,-0.027105,0,0
1,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.89907,0.0032863,-0.0039892,0,0
1,GO CELLULAR RESPONSE TO VITAMIN D,0.77618,0.0031101,-0.025484,0,0
1,GO PHOSPHATE ION TRANSPORT,0.69061,0.0030329,-0.014254,0,0
1,GO CELLULAR RESPONSE TO VITAMIN,0.9686,0.0030296,0.04658,0,0
1,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.89907,0.0027275,-0.0025344,0,0
1,GO MACROMOLECULE DEPALMITOYLATION,0.83713,0.0027099,0.019677,0,0
1,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.54321,0.0025383,-0.033242,0,0
1,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.4545,0.0018691,0.062166,0,0
1,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.39371,0.0016786,-0.062047,0,0
1,GO MAGNESIUM ION HOMEOSTASIS,0.64605,0.0014784,0.057116,0,0
1,GO GLIOGENESIS,0.53742,0.0013621,0.020945,0,0
1,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.96163,0.0011646,-0.0053437,0,0
1,GO PATTERN SPECIFICATION PROCESS,0.50896,0.0011501,-0.054655,0,0
1,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.82348,0.0010432,0.0091545,0,0
1,GO DEPHOSPHORYLATION,0.52025,0.00079431,-0.02428,0,0
1,GO EYE MORPHOGENESIS,0.98255,0.00071635,0.003655,0,0
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.85082,0.00070773,-0.016179,0,0
1,GO 3 UTR MEDIATED MRNA STABILIZATION,0.72969,0.00023964,0.071511,0,0
1,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.75615,-0.00011307,-0.015906,0,0
1,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.7495,-0.00021799,0.021686,0,0
1,GO REGULATION OF CELLULAR PH,0.87833,-0.00030724,-0.003566,0,0
1,GO SEXUAL REPRODUCTION,0.63978,-0.00087517,0.010789,0,0
1,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.97557,-0.001125,0.035164,0,0
1,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.29992,-0.0014047,0.061072,0,0
1,GO CHEMICAL HOMEOSTASIS,0.67137,-0.001426,-0.018272,0,0
1,GO CARBOHYDRATE TRANSPORT,0.96163,-0.0015082,-0.016243,0,0
1,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.50896,-0.0016425,0.06792,0,0
1,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.78289,-0.0018598,0.005255,0,0
1,GO REGULATION OF ENDOCRINE PROCESS,0.59664,-0.0021235,0.027583,0,0
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.65866,-0.0021606,0.04615,0,0
1,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.91987,-0.0022372,0.04389,0,0
1,GO REPLICATION FORK PROCESSING,0.70355,-0.0022801,0.06041,0,0
1,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.85082,-0.0022908,0.0089568,0,0
1,GO TELOMERIC LOOP DISASSEMBLY,0.75615,-0.0023184,-0.034862,0,0
1,GO CAMERA TYPE EYE DEVELOPMENT,0.57857,-0.0023462,0.03447,0,0
1,GO DEVELOPMENTAL PIGMENTATION,0.57857,-0.0024347,-0.031225,0,0
1,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.89215,-0.0025827,-0.021355,0,0
1,GO METHYLATION,0.79636,-0.0031648,-0.0057988,0,0
1,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.95466,-0.0032073,0.13672,0,0
1,GO EPITHELIAL CELL CELL ADHESION,0.59059,-0.004139,0.13676,0,0
1,GO RESPONSE TO GLUCAGON,0.91987,-0.0042423,-0.0088162,0,0
1,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.86455,-0.0044906,0.003008,0,0
1,GO REGULATION OF ANIMAL ORGAN FORMATION,0.64605,-0.0046899,0.04535,0,0
1,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.95466,-0.0052017,-0.0098625,0,0
1,GO TONIC SMOOTH MUSCLE CONTRACTION,0.74288,-0.0052914,0.1295,0,0
1,GO MESODERMAL CELL FATE COMMITMENT,0.85768,-0.005424,-0.056891,0,0
1,GO REGIONALIZATION,0.47049,-0.0054885,-0.067665,0,0
1,GO HEPATOCYTE APOPTOTIC PROCESS,0.97557,-0.0057069,0.031281,0,0
1,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.55487,-0.0058327,0.041121,0,0
1,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.92682,-0.0058562,0.0062935,0,0
1,GO RENAL SODIUM EXCRETION,0.46512,-0.0063661,-0.050905,0,0
1,GO LIPOPROTEIN METABOLIC PROCESS,0.54903,-0.0063736,-0.043212,0,0
1,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.90599,-0.0064268,-0.0242,0,0
1,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.91293,-0.0065413,0.032825,0,0
1,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.98255,-0.0065943,-0.052238,0,0
1,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.57857,-0.0067809,0.038693,0,0
1,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.99651,-0.0070428,0.0018205,0,0
1,GO GLIAL CELL DIFFERENTIATION,0.97557,-0.0073423,-0.0078941,0,0
1,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.98953,-0.0074861,-0.024791,0,0
1,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.88523,-0.0074902,-0.024426,0,0
1,GO REGULATION OF RNA SPLICING,0.76281,-0.0076035,-0.023809,0,0
1,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.72969,-0.0078124,-0.012708,0,0
1,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.63978,-0.0080142,-0.025327,0,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.89215,-0.008195,-0.0056454,0,0
1,GO CARDIAC CELL FATE COMMITMENT,0.76281,-0.0082448,-0.046035,0,0
1,GO PROTEIN LOCALIZATION TO CHROMATIN,0.69061,-0.0082558,0.052692,0,0
1,GO ACTIN FILAMENT BASED MOVEMENT,0.94769,-0.0083239,0.0082647,0,0
1,GO ALCOHOL BIOSYNTHETIC PROCESS,0.72313,-0.0084116,-0.019641,0,0
1,GO REGULATION OF MITOCHONDRIAL FUSION,0.81668,-0.0084773,-0.0078706,0,0
1,GO PRENYLATION,0.67137,-0.0085747,-0.048637,0,0
1,GO O GLYCAN PROCESSING,0.69061,-0.0093573,-0.069511,0,0
1,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.89907,-0.0094784,0.0072892,0,0
1,GO NEPHRIC DUCT DEVELOPMENT,0.84397,-0.0095472,-0.0089428,0,0
1,GO SENSORY ORGAN MORPHOGENESIS,0.87144,-0.0095609,-0.013954,0,0
1,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.68418,-0.010135,-0.049237,0,0
1,GO REGULATION OF AXON GUIDANCE,0.92682,-0.010275,-0.014684,0,0
1,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.91987,-0.010309,-0.028055,0,0
1,GO MICROTUBULE BASED PROCESS,0.75615,-0.010395,-0.016341,0,0
1,GO PROSTATE GLAND GROWTH,0.50896,-0.010952,0.24843,0,0
1,GO MEMBRANE HYPERPOLARIZATION,0.83713,-0.010959,-0.015993,0,0
1,GO COVALENT CHROMATIN MODIFICATION,0.47588,-0.011003,-0.017496,0,0
1,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.59059,-0.011143,-0.064029,0,0
1,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.91987,-0.011174,-0.021003,0,0
1,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.63354,-0.011315,-0.04682,0,0
1,GO REGULATION OF ENDOCYTIC RECYCLING,0.51459,-0.011467,-0.070032,0,0
1,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.79636,-0.011534,-0.02868,0,0
1,GO RESPONSE TO FATTY ACID,0.72969,-0.011587,0.048265,0,0
1,GO NEUROBLAST PROLIFERATION,0.36991,-0.011722,-0.10266,0,0
1,GO REGULATION OF PEPTIDE TRANSPORT,0.56075,-0.011867,-0.022267,0,0
1,GO REGULATION OF MRNA PROCESSING,0.73628,-0.012012,-0.022427,0,0
1,GO NEGATIVE REGULATION OF TOR SIGNALING,0.32506,-0.012103,-0.055447,0,0
1,GO REGULATION OF MRNA POLYADENYLATION,0.91293,-0.012534,0.019702,0,0
1,GO HISTAMINE TRANSPORT,0.68418,-0.012581,-0.074401,0,0
1,GO CELLULAR RESPONSE TO MANGANESE ION,0.84397,-0.012645,-0.0004154,0,0
1,GO RENAL TUBULE DEVELOPMENT,0.36991,-0.012776,0.10139,0,0
1,GO CARDIAC ATRIUM MORPHOGENESIS,0.49227,-0.012883,0.077914,0,0
1,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.87144,-0.012954,-0.045928,0,0
1,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.43367,-0.013291,-0.057393,0,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.63978,-0.013465,-0.014661,0,0
1,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.85768,-0.013892,-0.012216,0,0
1,GO BICARBONATE TRANSPORT,0.67137,-0.014092,0.025118,0,0
1,GO REGULATION OF MEMBRANE REPOLARIZATION,0.47588,-0.014259,-0.055656,0,0
1,GO REGULATION OF STEM CELL DIVISION,0.92682,-0.014293,-0.015098,0,0
1,GO NEPHRON MORPHOGENESIS,0.48678,-0.014495,0.050943,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.61497,-0.014502,-0.0072148,0,0
1,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.95466,-0.014518,0.0028885,0,0
1,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.81668,-0.014805,0.020721,0,0
1,GO MYOTUBE CELL DEVELOPMENT,0.70355,-0.01482,-0.065178,0,0
1,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.4978,-0.015192,-0.040708,0,0
1,GO REGULATION OF FATTY ACID TRANSPORT,0.99651,-0.015509,0.0041156,0,0
1,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.95466,-0.015588,0.0079907,0,0
1,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.86455,-0.015699,0.014548,0,0
1,GO REGULATION OF LYASE ACTIVITY,0.98255,-0.015778,0.0028833,0,0
1,GO GMP METABOLIC PROCESS,0.75615,-0.015894,-0.030818,0,0
1,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.60883,-0.016173,0.078967,0,0
1,GO REGULATION OF CELL CYCLE CHECKPOINT,0.56666,-0.016311,-0.019036,0,0
1,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.74288,-0.016389,0.059037,0,0
1,GO CELLULAR RESPONSE TO STEROL,0.29184,-0.016397,-0.078495,0,0
1,GO SENSORY SYSTEM DEVELOPMENT,0.67137,-0.016411,0.013638,0,0
1,GO ADULT HEART DEVELOPMENT,0.54321,-0.016447,-0.072369,0,0
1,GO REGULATION OF MICROTUBULE BASED PROCESS,0.49227,-0.016683,-0.031669,0,0
1,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.94769,-0.016949,-0.018,0,0
1,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.65866,-0.016974,-0.031964,0,0
1,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.95466,-0.016975,0.00021596,0,0
1,GO CARBOHYDRATE PHOSPHORYLATION,0.80312,-0.017624,0.019326,0,0
1,GO SUBSTANTIA NIGRA DEVELOPMENT,0.37932,-0.017814,-0.052736,0,0
1,GO QUINONE METABOLIC PROCESS,0.82348,-0.017886,0.023044,0,0
1,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.79636,-0.017891,-0.013177,0,0
1,GO RENAL ABSORPTION,0.78289,-0.018212,0.036035,0,0
1,GO PROTEIN DEPHOSPHORYLATION,0.8303,-0.018215,-0.00855,0,0
1,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.41341,-0.018372,-0.10196,0,0
1,GO ASTRAL MICROTUBULE ORGANIZATION,0.22568,-0.018479,-0.099624,0,0
1,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.57857,-0.018488,-0.084231,0,0
1,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.59059,-0.018789,0.045465,0,0
1,GO PLASMA MEMBRANE REPAIR,0.78962,-0.018946,-0.061884,0,0
1,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.62732,-0.018984,0.026359,0,0
1,GO KIDNEY EPITHELIUM DEVELOPMENT,0.33812,-0.019194,0.10804,0,0
1,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.24643,-0.019365,-0.11675,0,0
1,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.94073,-0.019552,0.052041,0,0
1,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.87833,-0.019647,0.022563,0,0
1,GO OOGENESIS,0.43883,-0.019655,-0.030234,0,0
1,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.65866,-0.019665,-0.032589,0,0
1,GO PROTEIN TRIMERIZATION,0.93377,-0.019825,-0.0016031,0,0
1,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.67137,-0.020034,0.027043,0,0
1,GO DIVALENT INORGANIC CATION TRANSPORT,0.58456,-0.02013,-0.019657,0,0
1,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.66501,-0.020166,-0.021392,0,0
1,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.7495,-0.0203,-0.0063504,0,0
1,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.66501,-0.020925,-0.010471,0,0
1,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,1,-0.02117,0.025216,0,0
1,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.4545,-0.021758,-0.069229,0,0
1,GO ORGANELLE FUSION,0.65234,-0.022544,-0.017753,0,0
1,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.67776,-0.022634,0.3071,0,0
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.56075,-0.022692,-0.055144,0,0
1,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.52025,-0.022777,-0.070196,0,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.41842,-0.023069,-0.044282,0,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.97557,-0.023111,0.01941,0,0
1,GO HISTONE DEUBIQUITINATION,0.95466,-0.023466,0.011609,0,0
1,GO CARDIAC CHAMBER FORMATION,0.76281,-0.023488,-0.094013,0,0
1,GO ACTIN MEDIATED CELL CONTRACTION,0.60883,-0.023837,0.036382,0,0
1,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.92682,-0.024104,0.0080342,0,0
1,GO EXIT FROM MITOSIS,0.88523,-0.024208,0.011768,0,0
1,GO GAMETE GENERATION,0.78289,-0.024278,0.009377,0,0
1,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.70355,-0.024606,-0.029024,0,0
1,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.20937,-0.025207,-0.14394,0,0
1,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.99651,-0.025231,-0.0069984,0,0
1,GO ARACHIDONIC ACID METABOLIC PROCESS,0.85082,-0.025283,0.0077484,0,0
1,GO DRUG CATABOLIC PROCESS,0.87833,-0.025323,-0.012522,0,0
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.77618,-0.025347,0.010156,0,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.71006,-0.025424,-0.030374,0,0
1,GO PIGMENTATION,0.63354,-0.025498,-0.0058805,0,0
1,GO LYSOSOME LOCALIZATION,0.55487,-0.025524,-0.021404,0,0
1,GO AXON EXTENSION,0.68418,-0.025526,-0.021544,0,0
1,GO ALDEHYDE CATABOLIC PROCESS,0.70355,-0.025554,-0.0022573,0,0
1,GO TELENCEPHALON REGIONALIZATION,0.72969,-0.025713,-0.052982,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.69061,-0.025724,-0.024544,0,0
1,GO RHYTHMIC PROCESS,0.16294,-0.025781,-0.044873,0,0
1,GO REGULATION OF BONE REMODELING,0.99651,-0.025975,-0.0087756,0,0
1,GO REGULATION OF METAL ION TRANSPORT,0.52025,-0.026049,-0.01591,0,0
1,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.80312,-0.02615,0.023319,0,0
1,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.40843,-0.026303,-0.051459,0,0
1,GO SKELETAL MUSCLE CONTRACTION,0.65866,-0.026448,-0.035801,0,0
1,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.43883,-0.026531,-0.032614,0,0
1,GO NUCLEOSOME ORGANIZATION,0.44924,-0.02654,-0.031128,0,0
1,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.66501,-0.026693,-0.06661,0,0
1,GO HOMOLOGOUS RECOMBINATION,0.90599,-0.027129,0.038293,0,0
1,GO METHIONINE BIOSYNTHETIC PROCESS,0.25729,-0.027276,-0.10682,0,0
1,GO C4 DICARBOXYLATE TRANSPORT,0.94073,-0.02777,0.021581,0,0
1,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.61497,-0.028245,0.24614,0,0
1,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.52025,-0.028324,-0.028462,0,0
1,GO BONE MINERALIZATION,0.37932,-0.028439,0.10769,0,0
1,GO CELLULAR RESPONSE TO COPPER ION,0.86455,-0.028642,-0.088786,0,0
1,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.47049,-0.028654,-0.043835,0,0
1,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.70355,-0.028757,-0.011202,0,0
1,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.56075,-0.02884,-0.023161,0,0
1,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.85768,-0.028846,0.010146,0,0
1,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.43883,-0.028854,-0.065218,0,0
1,GO REGULATION OF CELL MORPHOGENESIS,0.48131,-0.028957,-0.039598,0,0
1,GO PROTEIN NITROSYLATION,0.64605,-0.02903,-0.049964,0,0
1,GO GLUCOSE METABOLIC PROCESS,0.63354,-0.029312,-0.025877,0,0
1,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.60272,-0.0297,-0.002955,0,0
1,GO ROOF OF MOUTH DEVELOPMENT,0.79636,-0.029849,-0.026918,0,0
1,GO MALE GAMETE GENERATION,0.63354,-0.02985,-0.006035,0,0
1,GO KERATINOCYTE DEVELOPMENT,0.95466,-0.029892,-0.013544,0,0
1,GO TELOMERE CAPPING,0.67776,-0.030002,-0.011354,0,0
1,GO MULTICELLULAR ORGANISM GROWTH,0.16559,-0.030069,-0.045562,0,0
1,GO HISTAMINE SECRETION,0.92682,-0.030177,-0.0090466,0,0
1,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.20621,-0.030278,-0.07234,0,0
1,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.48678,-0.030441,0.05168,0,0
1,GO CYTOSOLIC TRANSPORT,0.98255,-0.030586,0.016359,0,0
1,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.76281,-0.030614,0.044155,0,0
1,GO THYMIC T CELL SELECTION,0.63978,-0.030702,0.00038608,0,0
1,GO SECONDARY METABOLIC PROCESS,0.79636,-0.030768,0.021181,0,0
1,GO POST ANAL TAIL MORPHOGENESIS,0.33373,-0.030836,-0.088401,0,0
1,GO GRANULOCYTE DIFFERENTIATION,0.4978,-0.030863,-0.047892,0,0
1,GO REGULATION OF PH,0.96163,-0.030914,-0.0073616,0,0
1,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.18508,-0.031327,-0.06567,0,0
1,GO ZINC ION TRANSPORT,0.87144,-0.031351,0.018469,0,0
1,GO STEROID CATABOLIC PROCESS,0.89907,-0.031524,0.0050125,0,0
1,GO AMINO ACID IMPORT,0.78289,-0.031533,-0.0082187,0,0
1,GO EPIDERMAL CELL DIFFERENTIATION,0.69707,-0.031724,0.073651,0,0
1,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.22905,-0.031744,-0.1207,0,0
1,GO PROTEIN INSERTION INTO MEMBRANE,0.61497,-0.031857,-0.027223,0,0
1,GO THIOESTER BIOSYNTHETIC PROCESS,0.58456,-0.031894,-0.043483,0,0
1,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.49227,-0.031895,-0.025412,0,0
1,GO ORGANELLE LOCALIZATION,0.26471,-0.032192,-0.02458,0,0
1,GO CHEMOSENSORY BEHAVIOR,0.38888,-0.032526,-0.11211,0,0
1,GO GLIAL CELL PROLIFERATION,0.50896,-0.032607,0.061622,0,0
1,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.88523,-0.032671,-0.032288,0,0
1,GO REGULATION OF TOR SIGNALING,0.29184,-0.032812,-0.028322,0,0
1,GO ANION TRANSPORT,0.076492,-0.032926,-0.05701,0,0
1,GO DNA DOUBLE STRAND BREAK PROCESSING,0.63354,-0.033141,-0.016463,0,0
1,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.59664,-0.03321,0.028548,0,0
1,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.12049,-0.033326,-0.074044,0,0
1,GO SIGNAL PEPTIDE PROCESSING,0.77618,-0.033521,0.02527,0,0
1,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.60272,-0.033614,-0.017232,0,0
1,GO REGULATION OF PROSTAGLANDIN SECRETION,0.44402,-0.034003,0.067492,0,0
1,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.48131,-0.034277,-0.065277,0,0
1,GO ORGANIC ANION TRANSPORT,0.093897,-0.034407,-0.062165,0,0
1,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.26098,-0.034513,-0.10888,0,0
1,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.22235,-0.034648,-0.11763,0,0
1,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.11434,-0.034656,-0.067729,0,0
1,GO SEGMENTATION,0.57857,-0.034833,-0.015533,0,0
1,GO METANEPHROS MORPHOGENESIS,0.71658,-0.035022,-0.049004,0,0
1,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.59059,-0.035028,-0.013874,0,0
1,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.23589,-0.035255,-0.027221,0,0
1,GO HISTONE H2A ACETYLATION,0.78289,-0.035451,-0.014591,0,0
1,GO RESPONSE TO METAL ION,0.5726,-0.035558,-0.021347,0,0
1,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.95466,-0.036047,0.043593,0,0
1,GO PIGMENT GRANULE LOCALIZATION,0.33812,-0.036086,-0.061743,0,0
1,GO RESPONSE TO ETHANOL,0.19393,-0.036173,-0.056965,0,0
1,GO HETEROCHROMATIN ORGANIZATION,0.84397,-0.036289,-0.006972,0,0
1,GO MICROTUBULE ANCHORING AT CENTROSOME,0.78962,-0.036354,-0.001991,0,0
1,GO INORGANIC ANION TRANSPORT,0.2,-0.03659,-0.041546,0,0
1,GO ESTROGEN BIOSYNTHETIC PROCESS,0.87833,-0.036699,-0.0083822,0,0
1,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.23937,-0.036863,-0.066113,0,0
1,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.84397,-0.037016,-0.0077861,0,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.87833,-0.037109,0.0068697,0,0
1,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.46512,-0.037109,-0.045823,0,0
1,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.26847,-0.037118,-0.085896,0,0
1,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.41341,-0.037136,-0.041492,0,0
1,GO PEROXISOMAL MEMBRANE TRANSPORT,0.19095,-0.037234,-0.07669,0,0
1,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.67776,-0.03803,-0.0060217,0,0
1,GO REGULATION OF DEVELOPMENTAL GROWTH,0.31653,-0.038404,-0.040836,0,0
1,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.36526,-0.038418,-0.05321,0,0
1,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.93377,-0.038638,0.023488,0,0
1,GO TYPE B PANCREATIC CELL PROLIFERATION,0.99651,-0.038751,0.012508,0,0
1,GO HEART INDUCTION,0.88523,-0.038887,0.031607,0,0
1,GO MITOCHONDRION MORPHOGENESIS,0.41341,-0.039001,-0.020165,0,0
1,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.15264,-0.03907,-0.070523,0,0
1,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.22568,-0.039092,-0.058555,0,0
1,GO HISTONE H3 K14 ACETYLATION,0.62113,-0.039276,-0.038959,0,0
1,GO IMMUNOLOGICAL MEMORY PROCESS,0.82348,-0.039474,-0.012883,0,0
1,GO CELL JUNCTION ASSEMBLY,0.99651,-0.039572,0.0021018,0,0
1,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.34702,-0.039617,-0.0959,0,0
1,GO NEURON DEATH,0.30815,-0.039695,-0.02595,0,0
1,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.87833,-0.039735,-0.01909,0,0
1,GO CELLULAR RESPONSE TO ZINC ION,0.29586,-0.039825,-0.19246,0,0
1,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.54321,-0.040006,-0.031256,0,0
1,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.33373,-0.040496,-0.092313,0,0
1,GO RESPONSE TO SALT,0.99651,-0.041014,-0.036106,0,0
1,GO MITOCHONDRIAL FUSION,0.86455,-0.041036,-0.0068175,0,0
1,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.67137,-0.041295,-0.024589,0,0
1,GO LINOLEIC ACID METABOLIC PROCESS,0.35607,-0.041848,-0.13957,0,0
1,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.46512,-0.04211,-0.050468,0,0
1,GO CELLULAR RESPONSE TO CAMP,0.18219,-0.042146,-0.047554,0,0
1,GO MANNOSYLATION,0.26471,-0.042241,-0.062593,0,0
1,GO EMBRYONIC BODY MORPHOGENESIS,0.7495,-0.042381,-0.031334,0,0
1,GO DETOXIFICATION OF INORGANIC COMPOUND,0.69707,-0.042398,-0.15314,0,0
1,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.075049,-0.042527,-0.093473,0,0
1,GO NEGATIVE REGULATION OF AXONOGENESIS,0.26098,-0.042552,-0.091563,0,0
1,GO RESPONSE TO STARVATION,0.5726,-0.042619,-0.029083,0,0
1,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.53167,-0.042799,-0.11636,0,0
1,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.25363,-0.042871,-0.068107,0,0
1,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.42347,-0.042884,-0.054714,0,0
1,GO FEMALE SEX DIFFERENTIATION,0.42347,-0.042917,-0.033147,0,0
1,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.60272,-0.043139,-0.016971,0,0
1,GO CARDIAC CELL DEVELOPMENT,0.9686,-0.043184,0.023284,0,0
1,GO PRE MIRNA PROCESSING,0.79636,-0.043613,-0.021258,0,0
1,GO SPERMATID NUCLEUS DIFFERENTIATION,0.67776,-0.043655,0.025308,0,0
1,GO ANATOMICAL STRUCTURE REGRESSION,0.47588,-0.043771,-0.13076,0,0
1,GO WHITE FAT CELL DIFFERENTIATION,0.80312,-0.043987,-0.0096192,0,0
1,GO MITOCHONDRIAL RNA PROCESSING,0.77618,-0.044036,0.029159,0,0
1,GO INTERLEUKIN 10 PRODUCTION,0.72313,-0.044076,0.0075215,0,0
1,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.36991,-0.044364,-0.059724,0,0
1,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.56666,-0.044581,-0.039195,0,0
1,GO CELLULAR RESPONSE TO STARVATION,0.40349,-0.044629,-0.035836,0,0
1,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.89215,-0.044831,-0.00048238,0,0
1,GO OOCYTE DIFFERENTIATION,0.13355,-0.044948,-0.063194,0,0
1,GO CELLULAR RESPONSE TO ALKALOID,0.13355,-0.045065,-0.087169,0,0
1,GO T CELL SELECTION,0.68418,-0.045103,-0.0010551,0,0
1,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.39371,-0.045175,-0.063707,0,0
1,GO MESONEPHROS DEVELOPMENT,0.64605,-0.04523,0.061302,0,0
1,GO SENSORY ORGAN DEVELOPMENT,0.63354,-0.045422,-0.033519,0,0
1,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.25729,-0.045484,-0.083423,0,0
1,GO DNA PACKAGING,0.74288,-0.045514,-0.012471,0,0
1,GO REGULATION OF CELL FATE COMMITMENT,0.67776,-0.045606,0.10073,0,0
1,GO RESPONSE TO CALCIUM ION,0.30402,-0.045817,-0.056448,0,0
1,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.052669,-0.045836,-0.086155,0,0
1,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.85768,-0.045914,-0.018788,0,0
1,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.36991,-0.045983,-0.1205,0,0
1,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.47049,-0.046037,-0.03718,0,0
1,GO MALE MEIOSIS I,0.63354,-0.046327,-0.040681,0,0
1,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.93377,-0.046427,-0.012154,0,0
1,GO MYOFIBRIL ASSEMBLY,0.85768,-0.046525,0.052316,0,0
1,GO GLUTAMINE METABOLIC PROCESS,0.5726,-0.046627,-0.073276,0,0
1,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.064293,-0.046685,-0.11895,0,0
1,GO RESPONSE TO CARBOHYDRATE,0.34256,-0.046738,-0.026252,0,0
1,GO BLASTOCYST DEVELOPMENT,0.31232,-0.046791,-0.028685,0,0
1,GO CHROMATIN ORGANIZATION,0.22235,-0.047137,-0.030117,0,0
1,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.32938,-0.047197,-0.11284,0,0
1,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.77618,-0.047361,-0.01244,0,0
1,GO REGULATION OF OOGENESIS,0.33373,-0.047537,-0.032238,0,0
1,GO PEPTIDYL LYSINE DIMETHYLATION,0.84397,-0.047763,-0.014445,0,0
1,GO RESPONSE TO MUSCLE ACTIVITY,0.9686,-0.047852,0.0026056,0,0
1,GO WATER TRANSPORT,0.23245,-0.048059,-0.05741,0,0
1,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.20937,-0.048074,-0.078475,0,0
1,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.36991,-0.048077,-0.075542,0,0
1,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.48678,-0.04836,-0.046017,0,0
1,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.99651,-0.048826,0.032422,0,0
1,GO CRANIAL NERVE MORPHOGENESIS,0.40349,-0.048828,-0.050904,0,0
1,GO CELL MORPHOGENESIS,0.26098,-0.048829,-0.049025,0,0
1,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.4978,-0.048919,-0.038896,0,0
1,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.95466,-0.049118,0.016239,0,0
1,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.3746,-0.049378,-0.026879,0,0
1,GO REGULATION OF NEURON MIGRATION,0.4545,-0.049932,-0.074052,0,0
1,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.97557,-0.050187,0.023097,0,0
1,GO OLIGODENDROCYTE DIFFERENTIATION,0.31653,-0.050317,-0.093442,0,0
1,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.38888,-0.050464,-0.074294,0,0
1,GO TERPENOID BIOSYNTHETIC PROCESS,0.36064,-0.050688,-0.10021,0,0
1,GO CELL CYCLE DNA REPLICATION,0.43883,-0.051257,-0.050372,0,0
1,GO MRNA MODIFICATION,0.89215,-0.051616,-0.0070753,0,0
1,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.98255,-0.05169,0.03287,0,0
1,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.31232,-0.051929,-0.11365,0,0
1,GO DIGESTIVE SYSTEM DEVELOPMENT,0.73628,-0.051947,-0.013182,0,0
1,GO SNORNA 3 END PROCESSING,0.62113,-0.052057,-0.075546,0,0
1,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.41341,-0.052086,-0.02896,0,0
1,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.23589,-0.052189,-0.08093,0,0
1,GO ECTODERM DEVELOPMENT,0.71006,-0.052218,0.032758,0,0
1,GO REGULATION OF FEEDING BEHAVIOR,0.35607,-0.052237,-0.076508,0,0
1,GO PROTEIN O LINKED MANNOSYLATION,0.49227,-0.05228,-0.047775,0,0
1,GO RENAL SYSTEM PROCESS,0.65234,-0.052337,-0.01586,0,0
1,GO LOCALIZATION WITHIN MEMBRANE,0.38888,-0.052592,-0.047696,0,0
1,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.67137,-0.052843,0.16046,0,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.56666,-0.05301,-0.036764,0,0
1,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.85768,-0.053055,0.02078,0,0
1,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.87144,-0.053097,-0.032326,0,0
1,GO DEMETHYLATION,0.47588,-0.05315,-0.01224,0,0
1,GO ACTIN FILAMENT DEPOLYMERIZATION,0.56075,-0.053226,-0.017216,0,0
1,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.42855,-0.053341,-0.016298,0,0
1,GO SPHINGOLIPID METABOLIC PROCESS,0.092194,-0.053575,-0.071692,0,0
1,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.3746,-0.054076,-0.040548,0,0
1,GO T CELL HOMEOSTASIS,0.188,-0.054375,-0.060509,0,0
1,GO CILIUM ORGANIZATION,0.5726,-0.054493,-0.0061974,0,0
1,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.10845,-0.054634,-0.13614,0,0
1,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.40843,-0.055028,-0.11447,0,0
1,GO REGULATION OF GLUCOSE IMPORT,0.12259,-0.05517,-0.086181,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.18219,-0.055394,-0.082817,0,0
1,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.22905,-0.055473,-0.033826,0,0
1,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.59664,-0.055537,-0.052149,0,0
1,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,0.51459,-0.05556,-0.10117,0,0
1,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.2839,-0.055949,-0.059885,0,0
1,GO MEMBRANE LIPID METABOLIC PROCESS,0.054842,-0.056239,-0.085263,0,0
1,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.21579,-0.056354,-0.049169,0,0
1,GO FRUCTOSE METABOLIC PROCESS,0.42855,-0.056419,-0.13658,0,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.53167,-0.05658,-0.065048,0,0
1,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.76281,-0.056677,-0.0062467,0,0
1,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.94769,-0.056677,0.014478,0,0
1,GO MEMBRANE DOCKING,0.36526,-0.056914,-0.027294,0,0
1,GO HISTONE H3 K36 METHYLATION,0.34702,-0.056918,-0.073993,0,0
1,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.85768,-0.056922,-0.00079132,0,0
1,GO MAST CELL ACTIVATION,0.14526,-0.056964,-0.11099,0,0
1,GO RESPONSE TO MONOSACCHARIDE,0.19393,-0.057341,-0.037818,0,0
1,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.26847,-0.057404,-0.034606,0,0
1,GO MICROTUBULE BASED TRANSPORT,0.37932,-0.057694,-0.026045,0,0
1,GO POSITIVE REGULATION OF INSULIN SECRETION,0.1028,-0.058347,-0.11047,0,0
1,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.2839,-0.058476,-0.063539,0,0
1,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.11235,-0.05852,-0.063547,0,0
1,GO POST EMBRYONIC DEVELOPMENT,0.63978,-0.05871,-0.017844,0,0
1,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.50337,-0.058892,-0.013005,0,0
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.22568,-0.059299,-0.063659,0,0
1,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.11841,-0.059451,-0.090493,0,0
1,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.69061,-0.059626,-0.039756,0,0
1,GO SPLEEN DEVELOPMENT,0.91293,-0.059628,0.031937,0,0
1,GO RESPONSE TO INACTIVITY,0.50896,-0.059873,-0.059132,0,0
1,GO REGULATION OF CYCLASE ACTIVITY,0.28785,-0.059929,-0.050347,0,0
1,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.097379,-0.060109,-0.071579,0,0
1,GO SYNAPTIC VESICLE BUDDING,0.89215,-0.060469,0.0074477,0,0
1,GO DNA STRAND ELONGATION,0.24643,-0.060593,-0.07672,0,0
1,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.61497,-0.060598,0.096039,0,0
1,GO OUTER DYNEIN ARM ASSEMBLY,0.67137,-0.060646,0.0091042,0,0
1,GO ATP DEPENDENT CHROMATIN REMODELING,0.18508,-0.060823,-0.066832,0,0
1,GO B CELL RECEPTOR SIGNALING PATHWAY,0.087232,-0.060884,-0.13838,0,0
1,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.084046,-0.060893,-0.091568,0,0
1,GO REGULATION OF TRANSPORT,0.060602,-0.060984,-0.051879,0,0
1,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.53167,-0.061041,-0.13111,0,0
1,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.94073,-0.061478,0.014425,0,0
1,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.73628,-0.062545,-0.038302,0,0
1,GO REGULATION OF FERTILIZATION,0.28785,-0.062559,-0.07597,0,0
1,GO CELL PROJECTION ORGANIZATION,0.020205,-0.062765,-0.082673,0,0
1,GO REGULATION OF CELL CYCLE ARREST,0.16559,-0.062923,-0.04678,0,0
1,GO REGULATION OF RECEPTOR CLUSTERING,0.40843,-0.063364,-0.061225,0,0
1,GO RADIAL GLIAL CELL DIFFERENTIATION,0.73628,-0.063669,-0.020257,0,0
1,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.16828,-0.063896,-0.038787,0,0
1,GO ACTIN CROSSLINK FORMATION,0.47588,-0.064066,-0.11573,0,0
1,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.42347,-0.064241,-0.071305,0,0
1,GO MITOTIC DNA REPLICATION,0.56666,-0.064269,-0.036738,0,0
1,GO ERROR PRONE TRANSLESION SYNTHESIS,0.65866,-0.064434,-0.04006,0,0
1,GO CIRCULATORY SYSTEM PROCESS,0.21256,-0.064554,-0.044804,0,0
1,GO CARTILAGE MORPHOGENESIS,0.4545,-0.065409,-0.1057,0,0
1,GO CELLULAR COMPONENT MAINTENANCE,0.19695,-0.065431,-0.081163,0,0
1,GO FUCOSYLATION,0.19095,-0.065618,-0.087788,0,0
1,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.52025,-0.065788,-0.038204,0,0
1,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.54903,-0.065858,-0.049635,0,0
1,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.31653,-0.065882,-0.043718,0,0
1,GO ADIPOSE TISSUE DEVELOPMENT,0.060602,-0.06604,-0.13951,0,0
1,GO PHAGOSOME MATURATION,0.7495,-0.066357,-0.020845,0,0
1,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.31653,-0.066734,-0.10935,0,0
1,GO SPERM MOTILITY,0.075049,-0.066903,-0.071708,0,0
1,GO ALCOHOL CATABOLIC PROCESS,0.24288,-0.067066,-0.019835,0,0
1,GO CELL FATE COMMITMENT,0.11434,-0.067066,-0.10671,0,0
1,GO RESPONSE TO COLD,0.26471,-0.067173,-0.098212,0,0
1,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.59059,-0.067203,-0.01011,0,0
1,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.21905,-0.067302,-0.17176,0,0
1,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.41341,-0.06743,-0.12618,0,0
1,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.11841,-0.067892,-0.094833,0,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.58456,-0.067966,-0.0043257,0,0
1,GO REGULATION OF DNA METHYLATION,0.64605,-0.068081,-0.031009,0,0
1,GO AXO DENDRITIC PROTEIN TRANSPORT,0.1313,-0.068178,-0.1363,0,0
1,GO GANGLIOSIDE METABOLIC PROCESS,0.095625,-0.06819,-0.10346,0,0
1,GO BROWN FAT CELL DIFFERENTIATION,0.68418,-0.068242,-0.027854,0,0
1,GO REGULATORY T CELL DIFFERENTIATION,0.42347,-0.068519,-0.072761,0,0
1,GO EMBRYONIC PATTERN SPECIFICATION,0.20309,-0.068889,-0.12184,0,0
1,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.12473,-0.068985,-0.055022,0,0
1,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.19695,-0.069402,-0.13609,0,0
1,GO POSITIVE T CELL SELECTION,0.53167,-0.069519,0.013697,0,0
1,GO VESICLE LOCALIZATION,0.053746,-0.069603,-0.055507,0,0
1,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.4598,-0.06969,-0.069581,0,0
1,GO CELL CELL JUNCTION ORGANIZATION,0.93377,-0.069791,0.0011679,0,0
1,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.5726,-0.069828,-0.011097,0,0
1,GO DRINKING BEHAVIOR,0.16828,-0.069884,-0.12103,0,0
1,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.35607,-0.069898,-0.071259,0,0
1,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.54321,-0.069959,-0.042011,0,0
1,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.15773,-0.070071,-0.079179,0,0
1,GO REGULATION OF CELL DEVELOPMENT,0.035393,-0.070154,-0.09552,0,0
1,GO PENILE ERECTION,0.24643,-0.070211,-0.10188,0,0
1,GO MICROTUBULE BASED MOVEMENT,0.18219,-0.070907,-0.048884,0,0
1,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.25001,-0.070974,-0.11373,0,0
1,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.075049,-0.07109,-0.064285,0,0
1,GO CALCIUM MEDIATED SIGNALING,0.11039,-0.071283,-0.051299,0,0
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.15773,-0.071711,-0.059282,0,0
1,GO ALANINE TRANSPORT,0.25001,-0.071805,-0.10624,0,0
1,GO NUCLEOSOME ASSEMBLY,0.28785,-0.071962,-0.059296,0,0
1,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.031748,-0.07219,-0.085327,0,0
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.88523,-0.072491,-0.030668,0,0
1,GO CGMP MEDIATED SIGNALING,0.31232,-0.072635,-0.065649,0,0
1,GO ANION TRANSMEMBRANE TRANSPORT,0.11841,-0.073135,-0.059037,0,0
1,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.50896,-0.07351,-0.059997,0,0
1,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.65234,-0.073783,-0.026381,0,0
1,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.93377,-0.073956,0.044422,0,0
1,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.027803,-0.074115,-0.15209,0,0
1,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.14526,-0.07419,-0.11887,0,0
1,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.064293,-0.074292,-0.18096,0,0
1,GO DIET INDUCED THERMOGENESIS,0.087232,-0.074351,-0.13579,0,0
1,GO EAR MORPHOGENESIS,0.24288,-0.074781,-0.069607,0,0
1,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.92682,-0.074906,0.020708,0,0
1,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.77618,-0.074911,-0.052598,0,0
1,GO CELLULAR ANION HOMEOSTASIS,0.39371,-0.074958,-0.048337,0,0
1,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.40843,-0.074991,-0.035463,0,0
1,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.085627,-0.075189,-0.084045,0,0
1,GO SISTER CHROMATID COHESION,0.27611,-0.075287,-0.054448,0,0
1,GO CARDIAC MYOFIBRIL ASSEMBLY,0.24643,-0.075334,-0.14732,0,0
1,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.12259,-0.075751,-0.090905,0,0
1,GO DIGESTIVE TRACT MORPHOGENESIS,0.94073,-0.075979,0.0089758,0,0
1,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.54321,-0.076182,-0.0041338,0,0
1,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.86455,-0.076207,0.013675,0,0
1,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.95466,-0.076521,0.0050173,0,0
1,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.31653,-0.076737,-0.1218,0,0
1,GO PARTURITION,0.4978,-0.076936,-0.079011,0,0
1,GO NOTCH SIGNALING PATHWAY,0.22568,-0.076954,-0.057144,0,0
1,GO LIPID EXPORT FROM CELL,0.53167,-0.07733,-0.042378,0,0
1,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.073629,-0.077348,-0.096988,0,0
1,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.50896,-0.077796,-0.056095,0,0
1,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.21256,-0.077827,-0.058551,0,0
1,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.67137,-0.07788,0.047322,0,0
1,GO MOTOR NEURON AXON GUIDANCE,0.11434,-0.077897,-0.087203,0,0
1,GO REGULATION OF GLIAL CELL PROLIFERATION,0.42855,-0.078055,-0.041499,0,0
1,GO GPI ANCHOR METABOLIC PROCESS,0.093897,-0.078471,-0.086879,0,0
1,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.44402,-0.078721,-0.054009,0,0
1,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.043763,-0.07904,-0.073797,0,0
1,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.25001,-0.079109,-0.071078,0,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.90599,-0.079618,0.000551,0,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.23245,-0.079805,-0.08028,0,0
1,GO REGULATION OF EXTENT OF CELL GROWTH,0.16294,-0.079828,-0.064302,0,0
1,GO ER OVERLOAD RESPONSE,0.67137,-0.080222,-0.028515,0,0
1,GO FORELIMB MORPHOGENESIS,0.49227,-0.080419,-0.045987,0,0
1,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.073629,-0.080688,-0.116,0,0
1,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.064293,-0.08087,-0.08894,0,0
1,GO POLYOL CATABOLIC PROCESS,0.12049,-0.080871,-0.09924,0,0
1,GO CARDIAC VENTRICLE FORMATION,0.29184,-0.081009,-0.24801,0,0
1,GO GERM CELL DEVELOPMENT,0.0695,-0.08184,-0.053831,0,0
1,GO POSITIVE REGULATION OF TOR SIGNALING,0.0695,-0.081929,-0.070588,0,0
1,GO AXO DENDRITIC TRANSPORT,0.045624,-0.082022,-0.14424,0,0
1,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.085627,-0.082039,-0.15409,0,0
1,GO COBALAMIN METABOLIC PROCESS,0.090515,-0.082387,-0.12491,0,0
1,GO NEGATIVE REGULATION OF NEURON DEATH,0.053746,-0.082757,-0.059988,0,0
1,GO CIRCADIAN RHYTHM,0.0047853,-0.082936,-0.098521,0,0
1,GO NEGATIVE REGULATION OF ION TRANSPORT,0.077957,-0.082987,-0.062283,0,0
1,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.57857,-0.083126,-0.014038,0,0
1,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.32506,-0.083158,-0.022612,0,0
1,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.60272,-0.083484,-0.013622,0,0
1,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.41842,-0.083493,-0.096451,0,0
1,GO L AMINO ACID TRANSPORT,0.32938,-0.083583,-0.059744,0,0
1,GO RESPONSE TO MUSCLE STRETCH,0.97557,-0.083613,0.046217,0,0
1,GO BRAIN MORPHOGENESIS,0.18219,-0.083676,-0.097521,0,0
1,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.099158,-0.084012,-0.09118,0,0
1,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.085627,-0.084054,-0.061473,0,0
1,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.11434,-0.084179,-0.12371,0,0
1,GO MITOCHONDRIAL TRNA PROCESSING,0.84397,-0.084349,-0.0016556,0,0
1,GO HEAD DEVELOPMENT,0.0083534,-0.084411,-0.12989,0,0
1,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.10465,-0.084763,-0.068571,0,0
1,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.42347,-0.084859,-0.12822,0,0
1,GO TRANSPORT ALONG MICROTUBULE,0.2839,-0.08529,-0.055468,0,0
1,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.063042,-0.085488,-0.12529,0,0
1,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.54321,-0.086054,-0.010864,0,0
1,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.21579,-0.086511,-0.077806,0,0
1,GO REGULATION OF TRANSPORTER ACTIVITY,0.15015,-0.086591,-0.061589,0,0
1,GO REGULATION OF CILIUM BEAT FREQUENCY,0.60272,-0.086837,-0.037323,0,0
1,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.05824,-0.086851,-0.097175,0,0
1,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.034637,-0.087069,-0.11088,0,0
1,GO MAST CELL MEDIATED IMMUNITY,0.15015,-0.087325,-0.098143,0,0
1,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.087232,-0.088025,-0.11698,0,0
1,GO SPERM CAPACITATION,0.34702,-0.088133,-0.051565,0,0
1,GO CELLULAR RESPONSE TO NUTRIENT,0.47588,-0.088535,-0.028238,0,0
1,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.22905,-0.088551,-0.10809,0,0
1,GO MAGNESIUM ION TRANSPORT,0.1313,-0.089072,-0.093262,0,0
1,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.29992,-0.089143,-0.1146,0,0
1,GO PROTEIN CONTAINING COMPLEX REMODELING,0.076492,-0.089979,-0.13409,0,0
1,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.25363,-0.090493,-0.067733,0,0
1,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.30402,-0.090726,-0.083068,0,0
1,GO ADAPTATION OF SIGNALING PATHWAY,0.22905,-0.090784,-0.097865,0,0
1,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.34702,-0.091562,-0.11221,0,0
1,GO HISTONE H3 K9 MODIFICATION,0.10096,-0.091879,-0.093614,0,0
1,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.14526,-0.091923,-0.049224,0,0
1,GO GASTRIC ACID SECRETION,0.54903,-0.092486,-0.040357,0,0
1,GO ZINC ION HOMEOSTASIS,0.72313,-0.092717,-0.037893,0,0
1,GO SOMITOGENESIS,0.057089,-0.092774,-0.073282,0,0
1,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.60272,-0.09281,-0.040035,0,0
1,GO HORMONE CATABOLIC PROCESS,0.67137,-0.0929,-0.038001,0,0
1,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.15015,-0.092996,-0.081435,0,0
1,GO REGULATION OF DEACETYLASE ACTIVITY,0.56666,-0.093163,-0.027293,0,0
1,GO REGULATION OF TORC1 SIGNALING,0.0090226,-0.093432,-0.12047,0,0
1,GO KIDNEY MORPHOGENESIS,0.74288,-0.093772,-0.0082075,0,0
1,GO EXPLORATION BEHAVIOR,0.11841,-0.094317,-0.17247,0,0
1,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.47588,-0.094537,-0.05572,0,0
1,GO TELENCEPHALON GLIAL CELL MIGRATION,0.10654,-0.094679,-0.17905,0,0
1,GO GLYCEROLIPID CATABOLIC PROCESS,0.27611,-0.095186,-0.040529,0,0
1,GO PROTEIN DEMETHYLATION,0.093897,-0.095266,-0.12679,0,0
1,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.16559,-0.095364,-0.12831,0,0
1,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.48131,-0.095541,-0.040945,0,0
1,GO ANTEROGRADE AXONAL TRANSPORT,0.037747,-0.095739,-0.16778,0,0
1,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.34256,-0.095894,-0.034908,0,0
1,GO SNORNA METABOLIC PROCESS,0.56075,-0.095969,-0.069839,0,0
1,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.14526,-0.096039,-0.08869,0,0
1,GO STEROID HORMONE SECRETION,0.19695,-0.096382,-0.11448,0,0
1,GO CHROMATIN REMODELING,0.17099,-0.096453,-0.064189,0,0
1,GO NEURON APOPTOTIC PROCESS,0.015574,-0.096625,-0.084106,0,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00079435,-0.096685,-0.10359,0,0
1,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.61497,-0.096731,-0.033416,0,0
1,GO NEUROTROPHIN SIGNALING PATHWAY,0.077957,-0.097157,-0.096046,0,0
1,GO LONG TERM MEMORY,0.27999,-0.097207,-0.072886,0,0
1,GO CELL JUNCTION ORGANIZATION,0.10465,-0.097272,-0.069188,0,0
1,GO POSITIVE REGULATION OF FERTILIZATION,0.53742,-0.097427,-0.077707,0,0
1,GO EXCRETION,0.24643,-0.097436,-0.048022,0,0
1,GO CILIUM MOVEMENT,0.14526,-0.098263,-0.056062,0,0
1,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.29184,-0.098307,-0.09125,0,0
1,GO REGULATION OF CILIUM ASSEMBLY,0.092194,-0.098489,-0.084443,0,0
1,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.019283,-0.098603,-0.1774,0,0
1,GO DORSAL VENTRAL PATTERN FORMATION,0.05824,-0.098635,-0.13216,0,0
1,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.14769,-0.098735,-0.099106,0,0
1,GO PSEUDOPODIUM ORGANIZATION,0.78962,-0.098764,-0.020183,0,0
1,GO HEART FORMATION,0.14285,-0.098894,-0.11892,0,0
1,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.047551,-0.099401,-0.1105,0,0
1,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.25729,-0.099608,-0.079278,0,0
1,GO SOMITE DEVELOPMENT,0.017549,-0.099749,-0.10764,0,0
1,GO RECEPTOR CLUSTERING,0.027188,-0.099931,-0.156,0,0
1,GO MULTICELLULAR ORGANISM AGING,0.05161,-0.10013,-0.10526,0,0
1,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.060602,-0.10023,-0.096107,0,0
1,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.075049,-0.1003,-0.076967,0,0
1,GO CHROMATIN SILENCING,0.12908,-0.10055,-0.047009,0,0
1,GO DOSAGE COMPENSATION,0.34702,-0.10058,-0.030011,0,0
1,GO PROTEIN ACYLATION,0.00029782,-0.10067,-0.10478,0,0
1,GO IMPORT ACROSS PLASMA MEMBRANE,0.075049,-0.10116,-0.08186,0,0
1,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.39371,-0.10136,-0.052058,0,0
1,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.053746,-0.10152,-0.12367,0,0
1,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.17374,-0.102,-0.056798,0,0
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.05161,-0.10246,-0.05738,0,0
1,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.63354,-0.10264,-0.019657,0,0
1,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.024288,-0.10286,-0.087629,0,0
1,GO CAMERA TYPE EYE MORPHOGENESIS,0.33373,-0.10394,-0.082836,0,0
1,GO RETINAL ROD CELL DIFFERENTIATION,0.58456,-0.10401,-0.069719,0,0
1,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.27611,-0.10403,-0.045418,0,0
1,GO CORNIFICATION,0.62113,-0.10419,0.00094599,0,0
1,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.29586,-0.10438,-0.11018,0,0
1,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.079444,-0.1049,-0.080905,0,0
1,GO REGULATION OF PROTEIN GLYCOSYLATION,0.27999,-0.10508,-0.085596,0,0
1,GO RESPONSE TO FUNGUS,0.097379,-0.10566,-0.1107,0,0
1,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.064293,-0.10619,-0.047763,0,0
1,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.53742,-0.10671,-0.022048,0,0
1,GO UTERUS DEVELOPMENT,0.10845,-0.1068,-0.15821,0,0
1,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.86455,-0.10692,-0.055028,0,0
1,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.0097392,-0.10745,-0.10653,0,0
1,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.77618,-0.10764,0.00074886,0,0
1,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.068167,-0.10765,-0.10956,0,0
1,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.0046564,-0.10791,-0.13828,0,0
1,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.093897,-0.10799,-0.10184,0,0
1,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.17653,-0.10847,-0.1052,0,0
1,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.3746,-0.10848,-0.052941,0,0
1,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.15015,-0.10849,-0.082656,0,0
1,GO ACTIVATION OF MAPKKK ACTIVITY,0.33812,-0.10913,-0.072534,0,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.3746,-0.10914,-0.058926,0,0
1,GO G0 TO G1 TRANSITION,0.188,-0.10986,-0.05441,0,0
1,GO AXIS SPECIFICATION,0.14769,-0.11015,-0.099656,0,0
1,GO TORC1 SIGNALING,0.068167,-0.11076,-0.065832,0,0
1,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.29184,-0.11094,-0.083418,0,0
1,GO FATTY ACYL COA METABOLIC PROCESS,0.25363,-0.11099,-0.08684,0,0
1,GO LUNG ALVEOLUS DEVELOPMENT,0.31232,-0.11141,-0.07751,0,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.092194,-0.11162,-0.17582,0,0
1,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.41842,-0.11223,-0.077615,0,0
1,GO DEFENSE RESPONSE TO FUNGUS,0.009256,-0.1126,-0.1516,0,0
1,GO POSITIVE REGULATION OF ION TRANSPORT,0.009256,-0.11281,-0.095471,0,0
1,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.17374,-0.11318,-0.10155,0,0
1,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.9686,-0.11327,0.057145,0,0
1,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.0022332,-0.11336,-0.13681,0,0
1,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.15773,-0.11404,-0.091281,0,0
1,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.05824,-0.11439,-0.11855,0,0
1,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.4598,-0.11458,-0.088247,0,0
1,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.23937,-0.11516,-0.13505,0,0
1,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.0015653,-0.11519,-0.11821,0,0
1,GO MEMBRANE REPOLARIZATION,0.099158,-0.11565,-0.11818,0,0
1,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.4545,-0.11638,-0.012864,0,0
1,GO VASCULAR WOUND HEALING,0.34702,-0.11661,-0.12321,0,0
1,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.21905,-0.1171,-0.086263,0,0
1,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.025414,-0.11724,-0.13605,0,0
1,GO SPERMATID DIFFERENTIATION,0.092194,-0.11763,-0.068729,0,0
1,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.32506,-0.1177,-0.071907,0,0
1,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.047551,-0.11773,-0.14924,0,0
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.30815,-0.11776,-0.074917,0,0
1,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.097379,-0.11795,-0.2315,0,0
1,GO NEURAL PRECURSOR CELL PROLIFERATION,0.0053338,-0.11797,-0.18493,0,0
1,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.60272,-0.11812,-0.13195,0,0
1,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.007729,-0.11827,-0.12848,0,0
1,GO LABYRINTHINE LAYER DEVELOPMENT,0.89907,-0.11947,0.006438,0,0
1,GO RHYTHMIC BEHAVIOR,0.055956,-0.11962,-0.1332,0,0
1,GO DENDRITE SELF AVOIDANCE,0.49227,-0.11965,-0.03216,0,0
1,GO LEUKOTRIENE METABOLIC PROCESS,0.32506,-0.11968,-0.079103,0,0
1,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.10096,-0.12019,-0.10696,0,0
1,GO CELL CELL SIGNALING,0.0017641,-0.1202,-0.10296,0,0
1,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.11841,-0.1203,-0.063914,0,0
1,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.17374,-0.1206,-0.084955,0,0
1,GO REGULATION OF RESPONSE TO FOOD,0.01282,-0.12087,-0.15683,0,0
1,GO CARDIAC ATRIUM DEVELOPMENT,0.75615,-0.12089,-0.0030187,0,0
1,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.019283,-0.12139,-0.14514,0,0
1,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.043763,-0.12188,-0.11089,0,0
1,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.010506,-0.12195,-0.11076,0,0
1,GO MATING BEHAVIOR,0.080955,-0.1228,-0.11263,0,0
1,GO NEURON PROJECTION GUIDANCE,0.035393,-0.12295,-0.14813,0,0
1,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0010859,-0.1232,-0.16207,0,0
1,GO WATER HOMEOSTASIS,0.12908,-0.12331,-0.080501,0,0
1,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.0060989,-0.12337,-0.1169,0,0
1,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.11039,-0.12375,-0.10717,0,0
1,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.97557,-0.1238,0.084564,0,0
1,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.092194,-0.12382,-0.081806,0,0
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.28785,-0.12386,-0.11337,0,0
1,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.16828,-0.12406,-0.09491,0,0
1,GO FACIAL NERVE MORPHOGENESIS,0.42855,-0.12434,-0.031516,0,0
1,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.24288,-0.12467,-0.10663,0,0
1,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.016339,-0.1248,-0.13663,0,0
1,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.061812,-0.12493,-0.15178,0,0
1,GO DEVELOPMENTAL INDUCTION,0.13355,-0.12513,-0.10491,0,0
1,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.027188,-0.12513,-0.15857,0,0
1,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.0023671,-0.12518,-0.25852,0,0
1,GO BASIC AMINO ACID TRANSPORT,0.082489,-0.126,-0.17404,0,0
1,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.11841,-0.12609,-0.11589,0,0
1,GO KERATINIZATION,0.43883,-0.12627,-0.032139,0,0
1,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.00095906,-0.12676,-0.14993,0,0
1,GO VESICLE CYTOSKELETAL TRAFFICKING,0.0083534,-0.12783,-0.15779,0,0
1,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0024367,-0.12791,-0.13514,0,0
1,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.39858,-0.12849,-0.082637,0,0
1,GO HISTONE METHYLATION,0.019739,-0.1288,-0.10999,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.22905,-0.1307,-0.075353,0,0
1,GO LAYER FORMATION IN CEREBRAL CORTEX,0.1313,-0.13073,-0.17718,0,0
1,GO REGULATION OF CILIUM MOVEMENT,0.0057817,-0.13077,-0.1351,0,0
1,GO REGULATION OF CHROMATIN ASSEMBLY,0.11636,-0.13082,-0.10862,0,0
1,GO REGULATION OF GLIOGENESIS,0.072231,-0.13097,-0.088005,0,0
1,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.0060989,-0.13101,-0.15757,0,0
1,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.12473,-0.13115,-0.089993,0,0
1,GO COLLATERAL SPROUTING,0.084046,-0.13119,-0.11517,0,0
1,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.050569,-0.1318,-0.21118,0,0
1,GO RESPONSE TO ETHER,0.188,-0.13189,-0.1226,0,0
1,GO REGULATION OF CARDIAC CONDUCTION,0.022165,-0.1326,-0.11899,0,0
1,GO PHOTOTRANSDUCTION,0.00028792,-0.1327,-0.16521,0,0
1,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.082489,-0.13289,-0.098471,0,0
1,GO PEPTIDYL LYSINE METHYLATION,0.073629,-0.133,-0.10455,0,0
1,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.073629,-0.13308,-0.10218,0,0
1,GO DEVELOPMENTAL CELL GROWTH,0.0040578,-0.13315,-0.14394,0,0
1,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.012508,-0.13375,-0.12392,0,0
1,GO RENAL WATER HOMEOSTASIS,0.10654,-0.13451,-0.081744,0,0
1,GO REGULATION OF POSITIVE CHEMOTAXIS,0.35607,-0.13472,-0.070363,0,0
1,GO INNER EAR MORPHOGENESIS,0.10845,-0.13515,-0.11884,0,0
1,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.19095,-0.13522,-0.10032,0,0
1,GO RESPONSE TO ELECTRICAL STIMULUS,0.22568,-0.1362,-0.088704,0,0
1,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.17374,-0.13622,-0.10955,0,0
1,GO NEUROGENESIS,0.0016129,-0.13646,-0.14252,0,0
1,GO FEVER GENERATION,0.31653,-0.13648,0.00010399,0,0
1,GO REGULATION OF CATION CHANNEL ACTIVITY,0.080955,-0.13672,-0.097187,0,0
1,GO RESPONSE TO AMINE,0.034637,-0.13686,-0.14695,0,0
1,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.034637,-0.13723,-0.23342,0,0
1,GO THYMUS DEVELOPMENT,0.20621,-0.13733,-0.076035,0,0
1,GO AXONAL TRANSPORT,0.013139,-0.13755,-0.18656,0,0
1,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.0028141,-0.13761,-0.15567,0,0
1,GO PROTEIN MANNOSYLATION,0.10096,-0.13797,-0.084578,0,0
1,GO SECRETORY GRANULE ORGANIZATION,0.016339,-0.13803,-0.13001,0,0
1,GO NEGATIVE REGULATION OF GLIOGENESIS,0.015203,-0.13828,-0.19495,0,0
1,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.072231,-0.13849,-0.096277,0,0
1,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.1313,-0.13852,-0.15787,0,0
1,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.059411,-0.13861,-0.10324,0,0
1,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.11235,-0.14026,-0.11405,0,0
1,GO MICROTUBULE POLYMERIZATION,0.0042883,-0.14064,-0.15246,0,0
1,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.33812,-0.14086,-0.056322,0,0
1,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.98953,-0.1414,0.10248,0,0
1,GO HINDBRAIN MORPHOGENESIS,0.0030654,-0.14161,-0.16425,0,0
1,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.052669,-0.14279,-0.087929,0,0
1,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.11434,-0.14388,-0.088602,0,0
1,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.014138,-0.14407,-0.14845,0,0
1,GO REGULATION OF SYSTEM PROCESS,0.00074557,-0.14496,-0.13207,0,0
1,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.27999,-0.1456,-0.086783,0,0
1,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.15264,-0.14628,-0.075314,0,0
1,GO V D J RECOMBINATION,0.29586,-0.14638,-0.059817,0,0
1,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.10654,-0.1472,-0.084693,0,0
1,GO FOREBRAIN CELL MIGRATION,0.013465,-0.14783,-0.18879,0,0
1,GO CELL PART MORPHOGENESIS,0.00047456,-0.14804,-0.18723,0,0
1,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.53167,-0.14804,-0.04572,0,0
1,GO PHOTORECEPTOR CELL MAINTENANCE,0.00045924,-0.14856,-0.21584,0,0
1,GO REGULATION OF COLLATERAL SPROUTING,0.088862,-0.14858,-0.14791,0,0
1,GO CELL FATE DETERMINATION,0.038561,-0.14878,-0.1918,0,0
1,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.13583,-0.14883,-0.099871,0,0
1,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.50337,-0.14897,-0.027834,0,0
1,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.37932,-0.14905,-0.095574,0,0
1,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.041967,-0.15031,-0.091093,0,0
1,GO POSITIVE REGULATION OF AXONOGENESIS,0.097379,-0.1507,-0.078266,0,0
1,GO POSITIVE THYMIC T CELL SELECTION,0.15517,-0.15072,-0.075985,0,0
1,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.00065623,-0.15123,-0.19428,0,0
1,GO SNARE COMPLEX ASSEMBLY,0.32938,-0.15149,-0.053491,0,0
1,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.093897,-0.15151,-0.078321,0,0
1,GO COMMISSURAL NEURON AXON GUIDANCE,0.47049,-0.15169,-0.072147,0,0
1,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.011326,-0.15193,-0.12955,0,0
1,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.061812,-0.15229,-0.14806,0,0
1,GO REGULATION OF HISTONE METHYLATION,0.03245,-0.15287,-0.1077,0,0
1,GO GAMMA DELTA T CELL ACTIVATION,0.48678,-0.15301,-0.075657,0,0
1,GO EPIDERMIS MORPHOGENESIS,0.91293,-0.15394,0.18905,0,0
1,GO SEQUESTERING OF ACTIN MONOMERS,0.19695,-0.15495,-0.10817,0,0
1,GO CELLULAR COMPONENT MORPHOGENESIS,0.00074557,-0.15502,-0.16599,0,0
1,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.35607,-0.15523,-0.059814,0,0
1,GO EMBRYONIC BRAIN DEVELOPMENT,0.073629,-0.1554,-0.16844,0,0
1,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.188,-0.15605,-0.097157,0,0
1,GO HISTONE H2A MONOUBIQUITINATION,0.15773,-0.15633,-0.090659,0,0
1,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.013465,-0.15648,-0.12251,0,0
1,GO FOREBRAIN DEVELOPMENT,0.0006154,-0.15704,-0.17901,0,0
1,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.010773,-0.15722,-0.38062,0,0
1,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.0014299,-0.15779,-0.19366,0,0
1,GO RESPONSE TO EPINEPHRINE,0.21256,-0.15785,-0.14168,0,0
1,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.19095,-0.15819,-0.13245,0,0
1,GO LABYRINTHINE LAYER MORPHOGENESIS,0.84397,-0.15821,0.0021654,0,0
1,GO RESPONSE TO IMMOBILIZATION STRESS,0.072231,-0.1585,-0.15652,0,0
1,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.12259,-0.15881,-0.060081,0,0
1,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.077957,-0.15991,-0.11827,0,0
1,GO REGULATION OF ACROSOME REACTION,0.17934,-0.16064,-0.1295,0,0
1,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.00095906,-0.16073,-0.14234,0,0
1,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.17099,-0.16119,-0.12554,0,0
1,GO PHAGOLYSOSOME ASSEMBLY,0.12259,-0.16153,-0.14126,0,0
1,GO PROTEIN METHYLATION,0.010506,-0.16261,-0.11807,0,0
1,GO INTRACILIARY TRANSPORT,0.25001,-0.16272,-0.076328,0,0
1,GO COPULATION,0.097379,-0.16357,-0.12473,0,0
1,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0059384,-0.16393,-0.20144,0,0
1,GO MELANOCYTE DIFFERENTIATION,0.15015,-0.16397,-0.10899,0,0
1,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.10845,-0.16399,-0.11622,0,0
1,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.014138,-0.16486,-0.184,0,0
1,GO PROTEIN DEPOLYMERIZATION,0.0011199,-0.16551,-0.19734,0,0
1,GO CEREBRAL CORTEX CELL MIGRATION,0.050569,-0.16673,-0.19637,0,0
1,GO NEURON REMODELING,0.89907,-0.16691,0.014911,0,0
1,GO OVARIAN FOLLICLE DEVELOPMENT,0.11636,-0.16733,-0.080671,0,0
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.59664,-0.16757,-0.001958,0,0
1,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.045624,-0.16881,-0.20774,0,0
1,GO COCHLEA DEVELOPMENT,0.0067808,-0.16888,-0.22891,0,0
1,GO NUCLEAR BODY ORGANIZATION,0.018398,-0.16935,-0.21607,0,0
1,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.30402,-0.16954,-0.078514,0,0
1,GO AXON DEVELOPMENT,0.0038387,-0.16958,-0.17539,0,0
1,GO RESPONSE TO POTASSIUM ION,0.027803,-0.16962,-0.26194,0,0
1,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.030383,-0.16962,-0.17567,0,0
1,GO POSITIVE REGULATION OF BEHAVIOR,0.0094949,-0.16998,-0.22641,0,0
1,GO INTESTINAL ABSORPTION,0.065563,-0.16999,-0.15259,0,0
1,GO GDP METABOLIC PROCESS,0.079444,-0.17052,-0.20981,0,0
1,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.0066042,-0.17077,-0.17809,0,0
1,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.31232,-0.1708,-0.081252,0,0
1,GO REGULATION OF CIRCADIAN RHYTHM,0.00012964,-0.17096,-0.17151,0,0
1,GO DETECTION OF LIGHT STIMULUS,1.5201e-05,-0.17101,-0.20078,0,0
1,GO HEART PROCESS,0.001191,-0.1712,-0.15392,0,0
1,GO REGULATION OF AXONOGENESIS,0.001228,-0.17133,-0.18332,0,0
1,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.036948,-0.17156,-0.19582,0,0
1,GO DORSAL AORTA DEVELOPMENT,0.20309,-0.17178,-0.10494,0,0
1,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.188,-0.17218,-0.059347,0,0
1,GO RESPONSE TO AMINO ACID STARVATION,0.0059384,-0.17306,-0.13847,0,0
1,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.029068,-0.17309,-0.13377,0,0
1,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.00054072,-0.17341,-0.18144,0,0
1,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.031748,-0.17379,-0.15387,0,0
1,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0010206,-0.17465,-0.19203,0,0
1,GO CELL AGGREGATION,0.40843,-0.17482,-0.043873,0,0
1,GO POSITIVE REGULATION OF HEART RATE,0.39858,-0.17488,-0.045296,0,0
1,GO REGULATION OF NEURON DIFFERENTIATION,0.00044439,-0.17532,-0.1898,0,0
1,GO MAINTENANCE OF CELL POLARITY,0.0079323,-0.17608,-0.16461,0,0
1,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.010773,-0.17704,-0.17538,0,0
1,GO VESICLE DOCKING,0.00049035,-0.17778,-0.18084,0,0
1,GO REGULATION OF BEHAVIOR,0.00353,-0.17809,-0.16839,0,0
1,GO STRIATED MUSCLE CONTRACTION,0.0056288,-0.17838,-0.14052,0,0
1,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.095625,-0.18034,-0.19001,0,0
1,GO OLFACTORY LOBE DEVELOPMENT,0.041967,-0.1806,-0.22047,0,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.0021062,-0.1811,-0.20849,0,0
1,GO TRIGLYCERIDE CATABOLIC PROCESS,0.041093,-0.18123,-0.14111,0,0
1,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.0016129,-0.18186,-0.18645,0,0
1,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.0019282,-0.18192,-0.19686,0,0
1,GO CARDIAC MUSCLE CONTRACTION,0.02068,-0.1822,-0.11995,0,0
1,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.0062634,-0.18222,-0.31811,0,0
1,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.26471,-0.18258,-0.14325,0,0
1,GO POSITIVE REGULATION OF HEART CONTRACTION,0.05824,-0.18308,-0.13084,0,0
1,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.15264,-0.18348,-0.15089,0,0
1,GO EAR DEVELOPMENT,0.030383,-0.18412,-0.14805,0,0
1,GO POSITIVE REGULATION OF CELL MATURATION,0.36064,-0.18436,-0.096441,0,0
1,GO INTRACILIARY RETROGRADE TRANSPORT,0.38408,-0.18438,-0.079484,0,0
1,GO RESPONSE TO FORSKOLIN,0.16828,-0.18464,-0.14449,0,0
1,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.14048,-0.18474,-0.012324,0,0
1,GO DEVELOPMENTAL MATURATION,0.00010462,-0.18481,-0.18294,0,0
1,GO SPERM AXONEME ASSEMBLY,0.10845,-0.18489,-0.12393,0,0
1,GO TOXIN METABOLIC PROCESS,0.11636,-0.18491,-0.16252,0,0
1,GO CARDIOBLAST PROLIFERATION,0.053746,-0.18513,-0.31187,0,0
1,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.05824,-0.18524,-0.18217,0,0
1,GO SLEEP,0.0017641,-0.18585,-0.17507,0,0
1,GO DENDRITIC SPINE DEVELOPMENT,0.010506,-0.18603,-0.16059,0,0
1,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.088862,-0.18694,-0.20786,0,0
1,GO LEYDIG CELL DIFFERENTIATION,0.42347,-0.18696,-0.10243,0,0
1,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.00098941,-0.18738,-0.18588,0,0
1,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.00035231,-0.18738,-0.24052,0,0
1,GO IMPORT INTO CELL,0.0040578,-0.1881,-0.13749,0,0
1,GO LONG TERM SYNAPTIC POTENTIATION,0.0079323,-0.18847,-0.1644,0,0
1,GO REGULATION OF CHROMATIN BINDING,0.011612,-0.18873,-0.17581,0,0
1,GO CELL DIFFERENTIATION IN SPINAL CORD,0.013798,-0.18957,-0.2129,0,0
1,GO NEURON DEVELOPMENT,0.00018427,-0.18983,-0.18698,0,0
1,GO RESPONSE TO CAFFEINE,0.17099,-0.19011,-0.1043,0,0
1,GO EXPORT ACROSS PLASMA MEMBRANE,0.017137,-0.19204,-0.17331,0,0
1,GO NERVOUS SYSTEM PROCESS,1.5331e-06,-0.19211,-0.19309,0,0
1,GO SECONDARY PALATE DEVELOPMENT,0.018836,-0.19282,-0.16932,0,0
1,GO NEURON DIFFERENTIATION,0.00011241,-0.19386,-0.18914,0,0
1,GO RESPONSE TO PAIN,0.01282,-0.1954,-0.19157,0,0
1,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.00014935,-0.19555,-0.17234,0,0
1,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.0020453,-0.19675,-0.23024,0,0
1,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.16828,-0.19696,-0.12968,0,0
1,GO NEUROMUSCULAR PROCESS,0.00020448,-0.19696,-0.2066,0,0
1,GO POSTSYNAPSE ORGANIZATION,0.00042998,-0.19794,-0.22709,0,0
1,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.0081404,-0.19798,-0.23041,0,0
1,GO DETECTION OF VISIBLE LIGHT,7.2754e-05,-0.1987,-0.1889,0,0
1,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.014138,-0.1988,-0.17317,0,0
1,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.0017641,-0.19916,-0.17046,0,0
1,GO SPINAL CORD DEVELOPMENT,0.001191,-0.20009,-0.23352,0,0
1,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.52025,-0.20159,-0.035516,0,0
1,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.00063551,-0.20407,-0.25677,0,0
1,GO PALLIUM DEVELOPMENT,0.0021062,-0.20428,-0.18776,0,0
1,GO PEPTIDYL CYSTEINE MODIFICATION,5.0226e-05,-0.20447,-0.19802,0,0
1,GO INNER DYNEIN ARM ASSEMBLY,0.087232,-0.20514,-0.18282,0,0
1,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.024846,-0.2052,-0.22233,0,0
1,GO ORGANIC CATION TRANSPORT,0.00014935,-0.20551,-0.23982,0,0
1,GO MESODERMAL CELL FATE SPECIFICATION,0.14526,-0.20692,-0.21669,0,0
1,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,5.6174e-05,-0.20694,-0.22937,0,0
1,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.17653,-0.20716,-0.11403,0,0
1,GO NEURON PROJECTION EXTENSION,0.0023671,-0.20769,-0.17501,0,0
1,GO PROTEIN POLYGLUTAMYLATION,0.00044439,-0.20791,-0.25942,0,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.029068,-0.20849,-0.19217,0,0
1,GO PRESYNAPSE ORGANIZATION,0.001662,-0.21027,-0.25418,0,0
1,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.001986,-0.21268,-0.21331,0,0
1,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0051916,-0.2138,-0.21394,0,0
1,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.00021909,-0.21394,-0.22377,0,0
1,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.20937,-0.21464,-0.14712,0,0
1,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0083534,-0.21519,-0.19565,0,0
1,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.00072223,-0.21569,-0.24947,0,0
1,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.0023671,-0.21623,-0.20947,0,0
1,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,9.7346e-05,-0.21633,-0.26886,0,0
1,GO RESPONSE TO FOOD,6.2786e-05,-0.21685,-0.19497,0,0
1,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0036303,-0.21693,-0.24892,0,0
1,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,3.1888e-05,-0.21705,-0.20959,0,0
1,GO REGULATION OF POTASSIUM ION TRANSPORT,7.8282e-05,-0.21787,-0.20128,0,0
1,GO CEREBRAL CORTEX DEVELOPMENT,0.012203,-0.21945,-0.16643,0,0
1,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.0075304,-0.21965,-0.21892,0,0
1,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.0015189,-0.21973,-0.19647,0,0
1,GO ENDOCRINE SYSTEM DEVELOPMENT,0.0015189,-0.21988,-0.20264,0,0
1,GO CARDIAC MUSCLE CELL CONTRACTION,0.068167,-0.22149,-0.12375,0,0
1,GO REGULATION OF CELL MATURATION,0.0050528,-0.22172,-0.19846,0,0
1,GO VISUAL BEHAVIOR,0.00012512,-0.22191,-0.20002,0,0
1,GO COGNITION,3.1888e-05,-0.22251,-0.20829,0,0
1,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,5.2139e-05,-0.22292,-0.22963,0,0
1,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.015574,-0.22301,-0.25446,0,0
1,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.28785,-0.22322,-0.079165,0,0
1,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.00018427,-0.22328,-0.31649,0,0
1,GO ADHERENS JUNCTION ORGANIZATION,0.0056288,-0.22367,-0.2223,0,0
1,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0057817,-0.22455,-0.24758,0,0
1,GO FILOPODIUM ASSEMBLY,0.009256,-0.22496,-0.18834,0,0
1,GO CLATHRIN COAT ASSEMBLY,0.015953,-0.22503,-0.22439,0,0
1,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.17374,-0.22581,-0.12605,0,0
1,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.0071468,-0.22632,-0.14732,0,0
1,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.00353,-0.22656,-0.14359,0,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0016129,-0.22733,-0.19763,0,0
1,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.00010462,-0.22735,-0.26896,0,0
1,GO KETONE BODY METABOLIC PROCESS,0.0087944,-0.22803,-0.28357,0,0
1,GO MICROTUBULE BUNDLE FORMATION,0.010506,-0.22815,-0.13835,0,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.10654,-0.22934,-0.15261,0,0
1,GO REGULATION OF SYNAPSE ASSEMBLY,0.00092958,-0.22945,-0.24997,0,0
1,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.0032441,-0.2298,-0.16121,0,0
1,GO REGULATION OF MICROTUBULE BINDING,0.00014935,-0.2308,-0.25999,0,0
1,GO RESPONSE TO CATECHOLAMINE,5.0226e-05,-0.23128,-0.21257,0,0
1,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.013798,-0.23156,-0.21051,0,0
1,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.064293,-0.23175,-0.16791,0,0
1,GO REGULATION OF MEMBRANE PERMEABILITY,0.0027346,-0.23206,-0.15759,0,0
1,GO MEMORY,5.8301e-05,-0.23357,-0.2095,0,0
1,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.038561,-0.23387,-0.30096,0,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.0022992,-0.23414,-0.2392,0,0
1,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.041093,-0.23467,-0.15478,0,0
1,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.37932,-0.23486,-0.079674,0,0
1,GO MONOVALENT INORGANIC CATION TRANSPORT,1.1267e-06,-0.23566,-0.22598,0,0
1,GO EMBRYONIC AXIS SPECIFICATION,0.0019282,-0.23587,-0.25157,0,0
1,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.0094949,-0.23607,-0.28894,0,0
1,GO CRANIAL NERVE DEVELOPMENT,0.0019282,-0.23756,-0.24088,0,0
1,GO BEHAVIOR,1.6015e-06,-0.23774,-0.23389,0,0
1,GO LONG TERM SYNAPTIC DEPRESSION,0.00014935,-0.23833,-0.31024,0,0
1,GO RESPONSE TO HYDROXYUREA,0.0090226,-0.23848,-0.19989,0,0
1,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.22235,-0.2394,-0.090355,0,0
1,GO SEX DETERMINATION,0.018836,-0.24037,-0.18506,0,0
1,GO RESPONSE TO NERVE GROWTH FACTOR,0.0028957,-0.24172,-0.18131,0,0
1,GO LIMBIC SYSTEM DEVELOPMENT,0.00087311,-0.2435,-0.24177,0,0
1,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00059588,-0.24438,-0.1798,0,0
1,GO SHORT TERM MEMORY,0.0059384,-0.24447,-0.32036,0,0
1,GO EPITHELIAL CELL MORPHOGENESIS,0.40349,-0.24534,-0.075859,0,0
1,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.0011199,-0.24542,-0.2267,0,0
1,GO REGULATION OF FLAGELLATED SPERM MOTILITY,4.3218e-05,-0.24648,-0.21257,0,0
1,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,1.5816e-05,-0.24696,-0.22421,0,0
1,GO HEAT GENERATION,0.15264,-0.24747,-0.13513,0,0
1,GO REGULATION OF CAMP MEDIATED SIGNALING,0.00098941,-0.24832,-0.20563,0,0
1,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,6.7728e-06,-0.24972,-0.2284,0,0
1,GO REGULATION OF DENDRITE MORPHOGENESIS,0.00059588,-0.25075,-0.24868,0,0
1,GO CARDIAC CONDUCTION,0.00021909,-0.25079,-0.2507,0,0
1,GO HEART FIELD SPECIFICATION,0.14048,-0.25182,-0.17666,0,0
1,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.0067808,-0.25402,-0.31646,0,0
1,GO DETECTION OF ABIOTIC STIMULUS,2.8891e-07,-0.25422,-0.27673,0,0
1,GO MICROTUBULE DEPOLYMERIZATION,3.4421e-05,-0.25483,-0.34172,0,0
1,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.001662,-0.25512,-0.25083,0,0
1,GO RESPONSE TO DOPAMINE,3.6228e-06,-0.25522,-0.24172,0,0
1,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,3.3132e-05,-0.25555,-0.30201,0,0
1,GO CEREBELLAR CORTEX MORPHOGENESIS,0.00023468,-0.25661,-0.28742,0,0
1,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.034637,-0.25673,-0.17575,0,0
1,GO REGULATION OF HEART RATE,0.00055855,-0.25768,-0.2275,0,0
1,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00026903,-0.25787,-0.26308,0,0
1,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.097379,-0.25809,-0.21569,0,0
1,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.095625,-0.25824,-0.18291,0,0
1,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.0020453,-0.25824,-0.20997,0,0
1,GO CHROMATIN SILENCING AT TELOMERE,2.8418e-05,-0.25832,-0.24474,0,0
1,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.00087311,-0.25932,-0.29029,0,0
1,GO GENETIC IMPRINTING,0.0054795,-0.26005,-0.17627,0,0
1,GO VENTRAL SPINAL CORD DEVELOPMENT,0.0026572,-0.26008,-0.26695,0,0
1,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.00054072,-0.26042,-0.3051,0,0
1,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.063042,-0.26044,-0.14921,0,0
1,GO REGULATION OF FILOPODIUM ASSEMBLY,0.017969,-0.26077,-0.20764,0,0
1,GO CELL FATE SPECIFICATION,0.0015653,-0.26287,-0.30223,0,0
1,GO ENERGY HOMEOSTASIS,0.0047853,-0.26479,-0.2379,0,0
1,GO KILLING OF CELLS OF OTHER ORGANISM,0.00010845,-0.26735,-0.22491,0,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0075304,-0.26772,-0.22545,0,0
1,GO AXONEME ASSEMBLY,0.036948,-0.26925,-0.16311,0,0
1,GO RESPONSE TO LIGHT INTENSITY,0.00010845,-0.27176,-0.33082,0,0
1,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.0015189,-0.27176,-0.26704,0,0
1,GO IMMATURE B CELL DIFFERENTIATION,0.027803,-0.27203,-0.16637,0,0
1,GO ACTIN FILAMENT BASED TRANSPORT,0.04854,-0.27299,-0.18057,0,0
1,GO PHOTORECEPTOR CELL DIFFERENTIATION,3.7145e-05,-0.27462,-0.32275,0,0
1,GO TRIGEMINAL NERVE DEVELOPMENT,0.030383,-0.27639,-0.3531,0,0
1,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.064293,-0.27689,-0.27196,0,0
1,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.011326,-0.27864,-0.27617,0,0
1,GO FOREBRAIN GENERATION OF NEURONS,0.00031859,-0.27989,-0.32567,0,0
1,GO PHOTORECEPTOR CELL DEVELOPMENT,1.1493e-05,-0.28118,-0.31402,0,0
1,GO DETECTION OF MECHANICAL STIMULUS,2.8418e-05,-0.28245,-0.29648,0,0
1,GO DENDRITIC SPINE MORPHOGENESIS,0.0019282,-0.28261,-0.27632,0,0
1,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,6.7596e-05,-0.28276,-0.26487,0,0
1,GO LIPOXYGENASE PATHWAY,0.033166,-0.28313,-0.25181,0,0
1,GO SENSORY PERCEPTION OF PAIN,3.0576e-06,-0.2845,-0.25554,0,0
1,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.00014418,-0.28486,-0.35368,0,0
1,GO RELAXATION OF MUSCLE,0.017549,-0.28495,-0.19984,0,0
1,GO ACROSOME ASSEMBLY,0.0006154,-0.28782,-0.23972,0,0
1,GO CELL JUNCTION MAINTENANCE,0.0085714,-0.28811,-0.24497,0,0
1,GO CALCIUM ION IMPORT INTO CYTOSOL,0.0031536,-0.28811,-0.24646,0,0
1,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.0013872,-0.28945,-0.31933,0,0
1,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.0028957,-0.29031,-0.26799,0,0
1,GO SYNAPSE ORGANIZATION,4.8379e-05,-0.29118,-0.2744,0,0
1,GO NEURON PROJECTION ARBORIZATION,0.0085714,-0.29145,-0.20999,0,0
1,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0015653,-0.2928,-0.3179,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.12259,-0.29589,-0.19524,0,0
1,GO HINDBRAIN DEVELOPMENT,7.6603e-06,-0.29671,-0.2796,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.053746,-0.29712,-0.20814,0,0
1,GO DENDRITE MORPHOGENESIS,6.0504e-05,-0.29767,-0.28516,0,0
1,GO RESPONSE TO NICOTINE,0.0015189,-0.2979,-0.24438,0,0
1,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.00037661,-0.29836,-0.33325,0,0
1,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.035393,-0.29844,-0.44101,0,0
1,GO CELL MIGRATION IN HINDBRAIN,0.00019079,-0.29885,-0.38279,0,0
1,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0029794,-0.29998,-0.2612,0,0
1,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.0001547,-0.30046,-0.33547,0,0
1,GO NERVE DEVELOPMENT,9.389e-05,-0.30094,-0.29098,0,0
1,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,9.7801e-06,-0.30096,-0.36836,0,0
1,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.00034072,-0.303,-0.29475,0,0
1,GO POTASSIUM ION HOMEOSTASIS,0.001986,-0.30379,-0.22797,0,0
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,1.7806e-05,-0.30427,-0.2833,0,0
1,GO REGULATION OF DENDRITE DEVELOPMENT,0.00013917,-0.30615,-0.25575,0,0
1,GO DENDRITE DEVELOPMENT,3.5759e-05,-0.30649,-0.26934,0,0
1,GO SKELETAL MUSCLE ADAPTATION,0.013465,-0.30721,-0.2044,0,0
1,GO SOMATIC STEM CELL DIVISION,0.43367,-0.308,-0.091122,0,0
1,GO PROTEIN PALMITOYLATION,2.1702e-06,-0.3094,-0.31599,0,0
1,GO AXONAL TRANSPORT OF MITOCHONDRION,0.001191,-0.31046,-0.36209,0,0
1,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,1.4039e-05,-0.31234,-0.36619,0,0
1,GO MULTICELLULAR ORGANISMAL SIGNALING,4.4712e-06,-0.31241,-0.32267,0,0
1,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.00013433,-0.31322,-0.25645,0,0
1,GO NOREPINEPHRINE SECRETION,0.00017796,-0.31395,-0.29508,0,0
1,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.001872,-0.31486,-0.23635,0,0
1,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.0057817,-0.3161,-0.29429,0,0
1,GO ACIDIC AMINO ACID TRANSPORT,1.5816e-05,-0.31615,-0.28972,0,0
1,GO NEURON CELLULAR HOMEOSTASIS,0.00079435,-0.31843,-0.31942,0,0
1,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.0013054,-0.31857,-0.31559,0,0
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.0011199,-0.3187,-0.28771,0,0
1,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.0001547,-0.31903,-0.309,0,0
1,GO POSITIVE REGULATION OF CILIUM MOVEMENT,1.8521e-05,-0.31955,-0.29098,0,0
1,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,1.104e-05,-0.32062,-0.29527,0,0
1,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,3.4728e-06,-0.3212,-0.32465,0,0
1,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.0011199,-0.32124,-0.33889,0,0
1,GO FOREBRAIN NEURON DEVELOPMENT,0.012203,-0.32282,-0.29404,0,0
1,GO ACTION POTENTIAL,1.4039e-05,-0.32453,-0.31952,0,0
1,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0001165,-0.32646,-0.2938,0,0
1,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.0013872,-0.32699,-0.30974,0,0
1,GO FAT CELL PROLIFERATION,0.00092958,-0.32759,-0.33829,0,0
1,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.0087944,-0.32948,-0.22734,0,0
1,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.033166,-0.32951,-0.19051,0,0
1,GO SYNAPTIC VESICLE RECYCLING,3.7791e-06,-0.32967,-0.35435,0,0
1,GO SYNAPTIC VESICLE TRANSPORT,1.6455e-05,-0.33029,-0.33875,0,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0022332,-0.33055,-0.27774,0,0
1,GO DICARBOXYLIC ACID TRANSPORT,1.349e-05,-0.33069,-0.24707,0,0
1,GO OTIC VESICLE MORPHOGENESIS,0.15015,-0.33144,-0.27934,0,0
1,GO PROTEIN LOCALIZATION TO SYNAPSE,1.8521e-05,-0.33144,-0.37618,0,0
1,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,2.4346e-05,-0.33257,-0.32319,0,0
1,GO REGULATION OF SYNAPTIC PLASTICITY,6.4994e-06,-0.33472,-0.33533,0,0
1,GO PITUITARY GLAND DEVELOPMENT,8.1192e-05,-0.33561,-0.39731,0,0
1,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,1.4039e-05,-0.33621,-0.31332,0,0
1,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.0021062,-0.33752,-0.22641,0,0
1,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,4.8379e-05,-0.34081,-0.36783,0,0
1,GO REGULATION OF MEMBRANE POTENTIAL,3.6414e-07,-0.34233,-0.33906,0,0
1,GO RECEPTOR LOCALIZATION TO SYNAPSE,2.5308e-05,-0.34264,-0.39705,0,0
1,GO MITOCHONDRION LOCALIZATION,0.00059588,-0.34275,-0.26695,0,0
1,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.04854,-0.34298,-0.24134,0,0
1,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.001228,-0.34622,-0.33225,0,0
1,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,5.9841e-06,-0.34713,-0.39179,0,0
1,GO CELLULAR SODIUM ION HOMEOSTASIS,0.0013872,-0.34781,-0.33078,0,0
1,GO NEURON MIGRATION,5.8301e-05,-0.34908,-0.34179,0,0
1,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.04854,-0.34925,-0.27695,0,0
1,GO SEGMENT SPECIFICATION,0.00024286,-0.35193,-0.44501,0,0
1,GO INDOLALKYLAMINE METABOLIC PROCESS,0.0029794,-0.35248,-0.27713,0,0
1,GO SECONDARY HEART FIELD SPECIFICATION,0.017137,-0.35613,-0.33759,0,0
1,GO METENCEPHALON DEVELOPMENT,6.5896e-07,-0.35615,-0.37689,0,0
1,GO NEURAL RETINA DEVELOPMENT,1.7806e-05,-0.35859,-0.40908,0,0
1,GO RESPONSE TO LEUCINE,0.0081404,-0.35924,-0.34088,0,0
1,GO LOCOMOTORY BEHAVIOR,1.0207e-07,-0.36024,-0.39737,0,0
1,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0041716,-0.36031,-0.31871,0,0
1,GO ECTODERMAL PLACODE DEVELOPMENT,0.060602,-0.36125,-0.2284,0,0
1,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.00022676,-0.36544,-0.32334,0,0
1,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,7.0571e-06,-0.36563,-0.40406,0,0
1,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,1.2454e-05,-0.36704,-0.38679,0,0
1,GO SYNAPTIC SIGNALING,6.8936e-07,-0.3675,-0.33074,0,0
1,GO POTASSIUM ION TRANSPORT,2.2879e-07,-0.36758,-0.34299,0,0
1,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,3.4728e-06,-0.36907,-0.35359,0,0
1,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.00087311,-0.3732,-0.51219,0,0
1,GO REGULATION OF TRANS SYNAPTIC SIGNALING,1.8251e-06,-0.37423,-0.34575,0,0
1,GO RESPONSE TO INSECTICIDE,0.00042998,-0.37667,-0.34672,0,0
1,GO MALE SEX DETERMINATION,0.021165,-0.37695,-0.26779,0,0
1,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00050664,-0.3772,-0.33152,0,0
1,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.00012074,-0.37799,-0.38659,0,0
1,GO WALKING BEHAVIOR,2.0033e-05,-0.37866,-0.36476,0,0
1,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,1.5201e-05,-0.3841,-0.44977,0,0
1,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.00063551,-0.38474,-0.3302,0,0
1,GO RESPONSE TO ACETYLCHOLINE,0.00032948,-0.38529,-0.33204,0,0
1,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.00026903,-0.38823,-0.34683,0,0
1,GO CIRCADIAN SLEEP WAKE CYCLE,1.5201e-05,-0.38882,-0.37773,0,0
1,GO REGULATION OF TUBULIN DEACETYLATION,0.00067758,-0.39162,-0.44077,0,0
1,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,2.6902e-06,-0.39727,-0.44757,0,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.00034072,-0.39817,-0.34173,0,0
1,GO GLIAL CELL FATE COMMITMENT,0.0015653,-0.39988,-0.50952,0,0
1,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,3.1904e-06,-0.40043,-0.38782,0,0
1,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00042998,-0.40157,-0.44765,0,0
1,GO RESPONSE TO COCAINE,1.5691e-07,-0.40183,-0.44614,0,0
1,GO NEUROTRANSMITTER REUPTAKE,4.1112e-06,-0.40183,-0.40261,0,0
1,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0006154,-0.4049,-0.38452,0,0
1,GO NEURON RECOGNITION,1.4039e-05,-0.40569,-0.44644,0,0
1,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,4.1112e-06,-0.40674,-0.36857,0,0
1,GO NEUROPEPTIDE SIGNALING PATHWAY,1.4268e-07,-0.40682,-0.38878,0,0
1,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.00023468,-0.4085,-0.54173,0,0
1,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.79636,-0.41216,0.061913,0,0
1,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.00025131,-0.4137,-0.34935,0,0
1,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.00067758,-0.41501,-0.36714,0,0
1,GO RELAXATION OF CARDIAC MUSCLE,0.0049174,-0.41594,-0.36698,0,0
1,GO RETROGRADE TRANS SYNAPTIC SIGNALING,7.8282e-05,-0.41906,-0.55562,0,0
1,GO PRESYNAPTIC ENDOCYTOSIS,3.0576e-06,-0.41998,-0.39135,0,0
1,GO REGULATION OF HEAT GENERATION,0.015953,-0.4238,-0.31765,0,0
1,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.017137,-0.42502,-0.36486,0,0
1,GO REGULATION OF AMINO ACID TRANSPORT,2.5122e-07,-0.42545,-0.44145,0,0
1,GO ADULT LOCOMOTORY BEHAVIOR,4.9191e-08,-0.4272,-0.45676,0,0
1,GO SYNAPTIC VESICLE LOCALIZATION,4.1112e-06,-0.42777,-0.45465,0,0
1,GO SYNAPSE ASSEMBLY,1.6015e-06,-0.42938,-0.42414,0,0
1,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,6.8936e-07,-0.43133,-0.44275,0,0
1,GO PARENTAL BEHAVIOR,0.00020448,-0.43186,-0.39798,0,0
1,GO TRANSMISSION OF NERVE IMPULSE,5.2533e-07,-0.43317,-0.4643,0,0
1,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.050569,-0.43332,-0.25224,0,0
1,GO SEROTONIN TRANSPORT,2.1831e-07,-0.43436,-0.58001,0,0
1,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.00021167,-0.43542,-0.35079,0,0
1,GO ADULT BEHAVIOR,3.6563e-08,-0.43592,-0.50759,0,0
1,GO DIENCEPHALON DEVELOPMENT,1.0604e-05,-0.43668,-0.36463,0,0
1,GO OTIC VESICLE DEVELOPMENT,0.057089,-0.43677,-0.24226,0,0
1,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,9.389e-05,-0.43724,-0.42603,0,0
1,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,8.7323e-05,-0.44488,-0.38641,0,0
1,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.00011241,-0.44581,-0.50964,0,0
1,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,2.0833e-05,-0.45042,-0.52153,0,0
1,GO NEURON MATURATION,5.2837e-06,-0.45356,-0.43091,0,0
1,GO ENDOCARDIUM DEVELOPMENT,0.0695,-0.45783,-0.23081,0,0
1,GO LIMB BUD FORMATION,0.22235,-0.46012,-0.16276,0,0
1,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,1.0207e-07,-0.46281,-0.44451,0,0
1,GO FOREBRAIN NEURON DIFFERENTIATION,5.4121e-05,-0.46289,-0.43763,0,0
1,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.0027346,-0.46606,-0.37116,0,0
1,GO MEGAKARYOCYTE DEVELOPMENT,0.00057693,-0.46746,-0.38436,0,0
1,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,5.6174e-05,-0.46947,-0.46808,0,0
1,GO NEUROTRANSMITTER UPTAKE,6.4994e-06,-0.47043,-0.38323,0,0
1,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.00036427,-0.477,-0.40535,0,0
1,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.00019079,-0.47711,-0.39609,0,0
1,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,1.6729e-06,-0.47716,-0.4941,0,0
1,GO REGULATION OF CELL PROJECTION SIZE,1.8251e-06,-0.47781,-0.50862,0,0
1,GO SUBPALLIUM DEVELOPMENT,5.2139e-05,-0.47814,-0.43461,0,0
1,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.00065623,-0.48095,-0.32073,0,0
1,GO AXONAL FASCICULATION,0.001191,-0.48472,-0.46814,0,0
1,GO INHIBITORY POSTSYNAPTIC POTENTIAL,1.104e-05,-0.48527,-0.54599,0,0
1,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,4.4878e-05,-0.48581,-0.41638,0,0
1,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,8.6584e-06,-0.49535,-0.45978,0,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,4.2876e-06,-0.50169,-0.42875,0,0
1,GO CATECHOLAMINE UPTAKE,1.1493e-05,-0.50302,-0.4399,0,0
1,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.2,-0.50354,-0.20063,0,0
1,GO CEREBELLAR CORTEX FORMATION,3.9926e-07,-0.5063,-0.52608,0,0
1,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,6.2859e-08,-0.50635,-0.49741,0,0
1,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,2.8077e-06,-0.50796,-0.54827,0,0
1,GO NEURON FATE COMMITMENT,2.6902e-06,-0.50975,-0.64711,0,0
1,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,1.6455e-05,-0.5109,-0.36296,0,0
1,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.0085714,-0.51113,-0.46464,0,0
1,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,9.8628e-07,-0.51629,-0.4672,0,0
1,GO EPITHELIAL CELL MATURATION,2.3418e-05,-0.51645,-0.49395,0,0
1,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.00067758,-0.51969,-0.42581,0,0
1,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,1.2862e-06,-0.52704,-0.56323,0,0
1,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,1.6729e-06,-0.52774,-0.53412,0,0
1,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,9.3916e-06,-0.53045,-0.48635,0,0
1,GO NEURAL NUCLEUS DEVELOPMENT,1.3441e-06,-0.53337,-0.46478,0,0
1,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,7.5427e-07,-0.53377,-0.57045,0,0
1,GO STABILIZATION OF MEMBRANE POTENTIAL,1.5201e-05,-0.53483,-0.5575,0,0
1,GO GROOMING BEHAVIOR,2.9301e-06,-0.53668,-0.47006,0,0
1,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.00055855,-0.53871,-0.48615,0,0
1,GO REGULATION OF VESICLE FUSION,9.0551e-05,-0.54171,-0.45695,0,0
1,GO POSITIVE REGULATION OF HEAT GENERATION,0.017969,-0.54359,-0.33639,0,0
1,GO GLUTAMATE SECRETION,2.2658e-06,-0.5485,-0.47971,0,0
1,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,3.3202e-07,-0.55192,-0.54546,0,0
1,GO ADENOHYPOPHYSIS DEVELOPMENT,6.0504e-05,-0.55287,-0.61416,0,0
1,GO REGULATION OF NEUROTRANSMITTER LEVELS,2.5122e-07,-0.55375,-0.53635,0,0
1,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,1.104e-05,-0.55515,-0.48655,0,0
1,GO REFLEX,0.00010462,-0.56442,-0.51893,0,0
1,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,4.8612e-06,-0.56795,-0.56727,0,0
1,GO DETECTION OF TEMPERATURE STIMULUS,6.2985e-07,-0.56965,-0.60051,0,0
1,GO RAB PROTEIN SIGNAL TRANSDUCTION,2.7578e-07,-0.57427,-0.54838,0,0
1,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,3.1904e-06,-0.57546,-0.56974,0,0
1,GO MAST CELL MIGRATION,0.00055855,-0.58071,-0.46882,0,0
1,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,1.0207e-07,-0.58284,-0.62252,0,0
1,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,5.9841e-06,-0.58404,-0.59955,0,0
1,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,2.0033e-05,-0.58472,-0.57017,0,0
1,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,1.104e-05,-0.58525,-0.62544,0,0
1,GO NOREPINEPHRINE METABOLIC PROCESS,1.7806e-05,-0.58637,-0.58837,0,0
1,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,3.6414e-07,-0.58639,-0.58879,0,0
1,GO DETECTION OF CALCIUM ION,1.2454e-05,-0.58999,-0.55061,0,0
1,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,1.4963e-07,-0.59617,-0.56439,0,0
1,GO SYNAPTIC MEMBRANE ADHESION,0.0001165,-0.59644,-0.50978,0,0
1,GO SPINAL CORD PATTERNING,2.4346e-05,-0.59801,-0.55025,0,0
1,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,3.7791e-06,-0.60931,-0.53938,0,0
1,GO BEHAVIORAL RESPONSE TO COCAINE,2.2658e-06,-0.61227,-0.68688,0,0
1,GO GROWTH HORMONE SECRETION,3.8131e-07,-0.61447,-0.57924,0,0
1,GO NEUROTRANSMITTER TRANSPORT,2.3975e-07,-0.61572,-0.58543,0,0
1,GO MAINTENANCE OF SYNAPSE STRUCTURE,1.4609e-05,-0.61995,-0.61915,0,0
1,GO REGULATION OF GLUTAMATE SECRETION,6.8936e-07,-0.62414,-0.58199,0,0
1,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,5.0194e-07,-0.62708,-0.64379,0,0
1,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,1.2366e-07,-0.6331,-0.65215,0,0
1,GO NEURONAL ACTION POTENTIAL,2.0829e-07,-0.63542,-0.66671,0,0
1,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,6.0198e-07,-0.65651,-0.62372,0,0
1,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,1.6729e-06,-0.6579,-0.69032,0,0
1,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.20309,-0.66317,-0.3269,0,0
1,GO STARTLE RESPONSE,9.8628e-07,-0.66452,-0.55928,0,0
1,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,3.8131e-07,-0.66615,-0.61138,0,0
1,GO RETINAL GANGLION CELL AXON GUIDANCE,4.8379e-05,-0.66821,-0.71054,0,0
1,GO NEUROTRANSMITTER SECRETION,3.9926e-07,-0.67206,-0.63694,0,0
1,GO CATECHOLAMINE METABOLIC PROCESS,1.725e-07,-0.68065,-0.58594,0,0
1,GO REGULATION OF SYNAPTIC VESICLE CYCLE,2.8891e-07,-0.69269,-0.67158,0,0
1,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,1.8084e-07,-0.7019,-0.68691,0,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,1.725e-07,-0.70374,-0.61103,0,0
1,GO DORSAL SPINAL CORD DEVELOPMENT,4.1802e-07,-0.70621,-0.67119,0,0
1,GO SYNAPTIC VESICLE EXOCYTOSIS,6.5896e-07,-0.71008,-0.67468,0,0
1,GO POSITIVE REGULATION OF AMINE TRANSPORT,6.93e-08,-0.72267,-0.68145,0,0
1,GO DENSE CORE GRANULE TRANSPORT,4.2876e-06,-0.7241,-0.94087,0,0
1,GO SPONTANEOUS SYNAPTIC TRANSMISSION,5.508e-06,-0.72507,-0.66077,0,0
1,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.0021689,-0.73268,-0.49192,0,0
1,GO GAMMA DELTA T CELL DIFFERENTIATION,0.0073363,-0.73735,-0.5769,0,0
1,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,2.8891e-07,-0.73801,-0.69229,0,0
1,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,9.7275e-08,-0.74019,-0.77244,0,0
1,GO NEURON CELL CELL ADHESION,8.2505e-07,-0.74952,-0.92074,0,0
1,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,1.5816e-05,-0.76701,-0.6741,0,0
1,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,9.7275e-08,-0.76739,-0.76479,0,0
1,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,3.9926e-07,-0.76874,-0.74413,0,0
1,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,4.4712e-06,-0.77358,-0.70814,0,0
1,GO AMINE TRANSPORT,8.0176e-08,-0.77655,-0.67146,0,0
1,GO MONOAMINE TRANSPORT,8.4155e-08,-0.78163,-0.70645,0,0
1,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.0067808,-0.78379,-0.52936,0,0
1,GO RESPONSE TO AUDITORY STIMULUS,3.6228e-06,-0.78722,-0.64707,0,0
1,GO SEROTONIN SECRETION,1.8251e-06,-0.79114,-0.63194,0,0
1,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,1.6729e-06,-0.80254,-0.75186,0,0
1,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,4.2876e-06,-0.8321,-0.76004,0,0
1,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,4.4712e-06,-0.8381,-0.71324,0,0
1,GO NEURON FATE SPECIFICATION,1.8251e-06,-0.86658,-0.90746,0,0
1,GO VOCALIZATION BEHAVIOR,1.1776e-06,-0.86899,-0.85993,0,0
1,GO DENDRITE EXTENSION,7.2756e-08,-0.88462,-0.80029,0,0
1,GO REGULATION OF GROWTH HORMONE SECRETION,7.2756e-08,-0.89905,-0.86263,0,0
1,GO RETINA LAYER FORMATION,6.4994e-06,-0.91788,-0.68728,0,0
1,GO PREPULSE INHIBITION,3.0264e-07,-0.92547,-0.83144,0,0
1,GO NEURONAL ION CHANNEL CLUSTERING,8.3127e-06,-0.93,-0.79369,0,0
1,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,2.9532e-05,-0.94595,-0.80486,0,0
1,GO DOPAMINE TRANSPORT,9.2696e-08,-0.97561,-0.84422,0,0
1,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,1.1776e-06,-0.98507,-0.8102,0,0
1,GO SYNAPTIC VESICLE CLUSTERING,1.4674e-06,-0.99067,-0.89963,0,0
1,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,5.986e-08,-1.0108,-1.0535,0,0
1,GO CATECHOLAMINE SECRETION,1.071e-07,-1.0262,-0.86284,0,0
1,GO DOPAMINE BIOSYNTHETIC PROCESS,3.6228e-06,-1.0488,-0.84844,0,0
1,GO NEGATIVE REGULATION OF AMINE TRANSPORT,7.2111e-07,-1.0573,-0.86353,0,0
1,GO GANGLION DEVELOPMENT,1.5691e-07,-1.0795,-0.95242,0,0
1,GO GABAERGIC NEURON DIFFERENTIATION,2.2658e-06,-1.0796,-0.95271,0,0
1,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,1.8958e-07,-1.0969,-1.0478,0,0
1,GO MECHANOSENSORY BEHAVIOR,4.7955e-07,-1.1346,-1.0423,0,0
1,GO REGULATION OF DOPAMINE SECRETION,1.1788e-07,-1.1705,-1.0443,0,0
1,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,2.7578e-07,-1.4043,-1.2392,0,0
1,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,4.3763e-07,-1.5934,-1.4408,0,0
2,GO ETHER BIOSYNTHETIC PROCESS,2.3975e-07,1.2188,0.98077,1,1
2,GO ETHANOL OXIDATION,6.8936e-07,1.0574,0.91957,1,1
2,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.00025131,0.96721,0.71972,1,1
2,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,3.6414e-07,0.82551,0.76751,1,1
2,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.00049035,0.82084,0.6559,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,3.7791e-06,0.80051,0.61412,1,1
2,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,1.4963e-07,0.77703,0.7163,1,1
2,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.00012074,0.75668,0.61402,1,1
2,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.0001547,0.7414,0.61311,1,1
2,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00067758,0.73434,0.48717,1,1
2,GO RESPONSE TO INTERLEUKIN 18,8.4205e-05,0.71907,0.69033,1,1
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,9.7801e-06,0.70935,0.70201,1,1
2,GO T HELPER 2 CELL DIFFERENTIATION,0.00021909,0.69788,0.51912,1,1
2,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,4.2876e-06,0.68144,0.51662,1,1
2,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,3.8131e-07,0.68021,0.52836,1,1
2,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,3.3202e-07,0.67989,0.64115,1,1
2,GO T HELPER 1 CELL DIFFERENTIATION,2.0833e-05,0.67581,0.59002,1,1
2,GO BIOLOGICAL PHASE,5.8301e-05,0.67252,0.64455,1,1
2,GO MUCUS SECRETION,0.00041602,0.66447,0.62258,1,1
2,GO T CELL MEDIATED CYTOTOXICITY,0.00014418,0.66081,0.48671,1,1
2,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00012512,0.65356,0.55602,1,1
2,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.0032441,0.64671,0.46843,1,1
2,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.00079435,0.63924,0.56895,1,1
2,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.0067808,0.63783,0.41816,1,1
2,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.00026903,0.62238,0.47929,1,1
2,GO PROSTANOID BIOSYNTHETIC PROCESS,7.9801e-06,0.61743,0.54446,1,1
2,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00079435,0.6163,0.43915,1,1
2,GO MYOBLAST MIGRATION,0.012203,0.61214,0.48969,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,1.9904e-06,0.61141,0.58141,1,1
2,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.0006154,0.60615,0.39289,1,1
2,GO CELLULAR RESPONSE TO ANTIBIOTIC,2.8077e-06,0.59842,0.53565,1,1
2,GO INFLAMMATORY RESPONSE TO WOUNDING,7.013e-05,0.59822,0.57271,1,1
2,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,3.4421e-05,0.59241,0.56255,1,1
2,GO BARBED END ACTIN FILAMENT CAPPING,0.001662,0.5892,0.41026,1,1
2,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0014738,0.58398,0.48389,1,1
2,GO PROSTATE GLAND GROWTH,2.6902e-06,0.58277,0.66094,1,1
2,GO PROSTANOID METABOLIC PROCESS,1.2454e-05,0.57692,0.50387,1,1
2,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.0036303,0.57617,0.5243,1,1
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00072223,0.5746,0.41042,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,4.8612e-06,0.5727,0.41492,1,1
2,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,8.3127e-06,0.57002,0.51339,1,1
2,GO BRANCH ELONGATION OF AN EPITHELIUM,0.00054072,0.56861,0.49296,1,1
2,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,5.0226e-05,0.56849,0.50487,1,1
2,GO HAIR FOLLICLE MATURATION,5.0226e-05,0.56535,0.46299,1,1
2,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,7.547e-05,0.56443,0.52748,1,1
2,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,6.0504e-05,0.5639,0.50941,1,1
2,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.00029782,0.55977,0.55728,1,1
2,GO ETHER METABOLIC PROCESS,2.2658e-06,0.55969,0.52151,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.00057693,0.54504,0.45648,1,1
2,GO LYSINE METABOLIC PROCESS,0.00027832,0.54427,0.50937,1,1
2,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,1.5331e-06,0.53953,0.52941,1,1
2,GO OTIC VESICLE DEVELOPMENT,0.00035231,0.53863,0.44538,1,1
2,GO GLYCEROL ETHER METABOLIC PROCESS,5.2533e-07,0.5381,0.50383,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,1.1493e-05,0.53748,0.58244,1,1
2,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.00035231,0.53501,0.54111,1,1
2,GO PSEUDOPODIUM ORGANIZATION,0.0085714,0.53404,0.37151,1,1
2,GO RETINAL METABOLIC PROCESS,0.011612,0.52399,0.33519,1,1
2,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,1.5201e-05,0.52013,0.45297,1,1
2,GO PROTEIN DNA COMPLEX DISASSEMBLY,8.1192e-05,0.50824,0.40378,1,1
2,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.00040247,0.50678,0.4586,1,1
2,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.0023671,0.50474,0.3476,1,1
2,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.00045924,0.50334,0.43411,1,1
2,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,1.0184e-05,0.50221,0.42961,1,1
2,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00012964,0.50121,0.46953,1,1
2,GO CARDIOLIPIN METABOLIC PROCESS,2.8418e-05,0.50099,0.40463,1,1
2,GO REGULATION OF GASTRIC ACID SECRETION,0.00013433,0.49905,0.45815,1,1
2,GO HEPATOCYTE DIFFERENTIATION,0.0034322,0.49763,0.40906,1,1
2,GO CYCLOOXYGENASE PATHWAY,0.0073363,0.49416,0.4227,1,1
2,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.00037661,0.49345,0.43814,1,1
2,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0010206,0.48643,0.35473,1,1
2,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.00034072,0.48059,0.47727,1,1
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,2.4692e-06,0.47901,0.43059,1,1
2,GO ACTIN FILAMENT SEVERING,0.03939,0.47803,0.31778,1,1
2,GO IMMUNE RESPONSE TO TUMOR CELL,0.00011241,0.47764,0.43602,1,1
2,GO OXYGEN TRANSPORT,0.0097392,0.47714,0.44234,1,1
2,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,6.7728e-06,0.47699,0.47013,1,1
2,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,5.2139e-05,0.4752,0.43857,1,1
2,GO ETHANOL METABOLIC PROCESS,3.9418e-06,0.47423,0.53454,1,1
2,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.0094949,0.47382,0.31455,1,1
2,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,1.7806e-05,0.47187,0.42891,1,1
2,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.043763,0.47024,0.31162,1,1
2,GO MUSCLE ATROPHY,0.0056288,0.46832,0.35363,1,1
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00074557,0.46758,0.36777,1,1
2,GO T HELPER 1 TYPE IMMUNE RESPONSE,2.8077e-06,0.46665,0.46345,1,1
2,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.017969,0.46374,0.33599,1,1
2,GO REGULATION OF HIPPO SIGNALING,0.052669,0.46175,0.2215,1,1
2,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0039469,0.46115,0.3362,1,1
2,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.00010092,0.45356,0.32321,1,1
2,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,5.0683e-06,0.45162,0.44542,1,1
2,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.0025083,0.45013,0.35679,1,1
2,GO POSITIVE REGULATION OF PROTEIN IMPORT,5.2139e-05,0.44985,0.38143,1,1
2,GO NEPHRON TUBULE FORMATION,0.0051916,0.44818,0.29165,1,1
2,GO SKELETAL MUSCLE TISSUE REGENERATION,1.8521e-05,0.44531,0.36481,1,1
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,5.2139e-05,0.44416,0.39268,1,1
2,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,3.4421e-05,0.44402,0.44861,1,1
2,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.00038934,0.4434,0.31054,1,1
2,GO OTIC VESICLE MORPHOGENESIS,0.00065623,0.43886,0.40518,1,1
2,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.0012662,0.43534,0.28381,1,1
2,GO PSEUDOURIDINE SYNTHESIS,0.00065623,0.43487,0.32608,1,1
2,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.0037331,0.43454,0.36136,1,1
2,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.021165,0.4339,0.38552,1,1
2,GO DENDRITIC CELL MIGRATION,0.00023468,0.43328,0.35887,1,1
2,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.0013054,0.43308,0.34556,1,1
2,GO ENTRY OF BACTERIUM INTO HOST CELL,0.0014738,0.43185,0.41882,1,1
2,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00054072,0.43045,0.34009,1,1
2,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.0099891,0.41912,0.31179,1,1
2,GO LABYRINTHINE LAYER MORPHOGENESIS,0.03245,0.41769,0.28844,1,1
2,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.00081984,0.41675,0.40011,1,1
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,8.7323e-05,0.41199,0.35263,1,1
2,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,7.6603e-06,0.41126,0.34496,1,1
2,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.00095906,0.40983,0.34481,1,1
2,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.00067758,0.40915,0.3631,1,1
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.013798,0.40864,0.36164,1,1
2,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.0013872,0.40716,0.36921,1,1
2,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.036948,0.40538,0.21569,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.00059588,0.40313,0.31314,1,1
2,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.0021689,0.40206,0.36819,1,1
2,GO PIGMENT GRANULE MATURATION,0.0064317,0.40113,0.28935,1,1
2,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,5.8301e-05,0.39563,0.37481,1,1
2,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0007696,0.39535,0.36431,1,1
2,GO MONONUCLEAR CELL DIFFERENTIATION,1.4609e-05,0.39275,0.36363,1,1
2,GO NEURAL CREST FORMATION,0.001986,0.39274,0.31258,1,1
2,GO PORE COMPLEX ASSEMBLY,1.5331e-06,0.39017,0.3861,1,1
2,GO NEUTROPHIL HOMEOSTASIS,0.0056288,0.38851,0.34701,1,1
2,GO CELLULAR RESPONSE TO SALT STRESS,0.0021062,0.38673,0.39568,1,1
2,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.00024286,0.38641,0.33182,1,1
2,GO CELLULAR HYPEROSMOTIC RESPONSE,0.0071468,0.3838,0.34373,1,1
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,3.6228e-06,0.38376,0.3767,1,1
2,GO GAS TRANSPORT,0.0027346,0.38344,0.3948,1,1
2,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00047456,0.38307,0.29409,1,1
2,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.00034072,0.38284,0.29717,1,1
2,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.0085714,0.38202,0.30739,1,1
2,GO RRNA PSEUDOURIDINE SYNTHESIS,0.010506,0.38191,0.27894,1,1
2,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.01282,0.38181,0.34354,1,1
2,GO MITOCHONDRIAL TRANSCRIPTION,0.00013917,0.37995,0.34824,1,1
2,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,5.2139e-05,0.3795,0.44891,1,1
2,GO FATTY ACID HOMEOSTASIS,0.0060989,0.37871,0.24295,1,1
2,GO TRIPARTITE REGIONAL SUBDIVISION,0.0059384,0.37771,0.34512,1,1
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0022992,0.3771,0.31748,1,1
2,GO LIMB BUD FORMATION,0.004408,0.37637,0.45708,1,1
2,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,3.6228e-06,0.37556,0.3522,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,7.9801e-06,0.37499,0.34095,1,1
2,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.00081984,0.37398,0.26276,1,1
2,GO LEFT RIGHT AXIS SPECIFICATION,0.00020448,0.3725,0.44521,1,1
2,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,1.6015e-06,0.37228,0.38208,1,1
2,GO MYELOID CELL APOPTOTIC PROCESS,0.001986,0.37038,0.27804,1,1
2,GO VESICLE CARGO LOADING,7.6603e-06,0.36955,0.32422,1,1
2,GO LAMELLIPODIUM MORPHOGENESIS,0.00079435,0.36948,0.30425,1,1
2,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.00017186,0.36863,0.3066,1,1
2,GO REGULATION OF RESPONSE TO TUMOR CELL,8.1192e-05,0.36734,0.34248,1,1
2,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.00095906,0.36619,0.34868,1,1
2,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,3.4421e-05,0.36571,0.30276,1,1
2,GO ACETYL COA METABOLIC PROCESS,0.00050664,0.36557,0.26279,1,1
2,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.042857,0.36536,0.1533,1,1
2,GO POSITIVE REGULATION OF CELL MATURATION,0.015574,0.36517,0.32126,1,1
2,GO REGULATION OF MICROVILLUS ORGANIZATION,0.0015189,0.36464,0.39153,1,1
2,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0025083,0.3632,0.3316,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0007696,0.36136,0.28495,1,1
2,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.00013433,0.36053,0.30139,1,1
2,GO REGULATION OF RIBOSOME BIOGENESIS,2.5308e-05,0.35899,0.36324,1,1
2,GO ERYTHROCYTE MATURATION,0.0032441,0.35683,0.33047,1,1
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00055855,0.3557,0.30435,1,1
2,GO ICOSANOID BIOSYNTHETIC PROCESS,5.4121e-05,0.35549,0.35851,1,1
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0011199,0.35417,0.25943,1,1
2,GO I KAPPAB PHOSPHORYLATION,0.0040578,0.35337,0.21368,1,1
2,GO SENSORY PERCEPTION OF BITTER TASTE,4.4878e-05,0.35275,0.36296,1,1
2,GO INTERLEUKIN 13 PRODUCTION,0.00079435,0.35091,0.3868,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0013872,0.35069,0.28011,1,1
2,GO TYPE 2 IMMUNE RESPONSE,0.00037661,0.34998,0.27938,1,1
2,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,3.7791e-06,0.3499,0.32381,1,1
2,GO HEMOGLOBIN METABOLIC PROCESS,6.5149e-05,0.34977,0.29849,1,1
2,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,4.8379e-05,0.34956,0.49294,1,1
2,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.0011199,0.34881,0.38049,1,1
2,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.0001165,0.34839,0.33558,1,1
2,GO TETRAPYRROLE METABOLIC PROCESS,8.7323e-05,0.34835,0.24901,1,1
2,GO PROTEIN DEMANNOSYLATION,0.0015653,0.34824,0.25943,1,1
2,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.00017796,0.34744,0.30255,1,1
2,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.016734,0.34708,0.26331,1,1
2,GO GLYCINE METABOLIC PROCESS,0.0010859,0.34597,0.28162,1,1
2,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.017969,0.34567,0.21733,1,1
2,GO PRE MIRNA PROCESSING,0.0024367,0.34144,0.21951,1,1
2,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.015953,0.34087,0.33089,1,1
2,GO REGULATION OF PROTEIN IMPORT,0.0001165,0.33992,0.29113,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0022992,0.33906,0.28396,1,1
2,GO REGULATION OF DNA METHYLATION,0.00049035,0.3388,0.242,1,1
2,GO NEUROBLAST DIVISION,0.00072223,0.33846,0.37127,1,1
2,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.00057693,0.33599,0.28252,1,1
2,GO MATURE B CELL DIFFERENTIATION,0.0024367,0.33597,0.23208,1,1
2,GO HYPEROSMOTIC SALINITY RESPONSE,0.038561,0.3359,0.18055,1,1
2,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.0019282,0.33542,0.26919,1,1
2,GO NOTOCHORD DEVELOPMENT,0.00017186,0.3353,0.50849,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.021165,0.33524,0.21581,1,1
2,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.027803,0.3351,0.19838,1,1
2,GO RESPONSE TO STEROL DEPLETION,0.00011241,0.33447,0.3165,1,1
2,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.0033369,0.3344,0.33026,1,1
2,GO RNA DECAPPING,1.1493e-05,0.33388,0.25129,1,1
2,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.00035231,0.3336,0.25115,1,1
2,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,1.6455e-05,0.33295,0.37286,1,1
2,GO REGULATION OF PODOSOME ASSEMBLY,0.001662,0.33102,0.3149,1,1
2,GO ERBB2 SIGNALING PATHWAY,0.00074557,0.33092,0.25496,1,1
2,GO TONGUE MORPHOGENESIS,0.019283,0.33071,0.29047,1,1
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.001228,0.33066,0.33854,1,1
2,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,2.5308e-05,0.33032,0.35008,1,1
2,GO RETINOL METABOLIC PROCESS,8.1192e-05,0.33001,0.34236,1,1
2,GO FIBROBLAST ACTIVATION,0.00032948,0.32998,0.33966,1,1
2,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.0018173,0.32972,0.32863,1,1
2,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.001662,0.32941,0.2276,1,1
2,GO POSITIVE REGULATION OF CELL KILLING,0.0087944,0.32827,0.20394,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00084609,0.32825,0.27999,1,1
2,GO MICROVILLUS ASSEMBLY,0.010506,0.32748,0.307,1,1
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0062634,0.3265,0.22607,1,1
2,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.0067808,0.32616,0.21725,1,1
2,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.017969,0.32523,0.24907,1,1
2,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,9.7801e-06,0.32178,0.32829,1,1
2,GO FIBROBLAST APOPTOTIC PROCESS,0.0011199,0.32154,0.29743,1,1
2,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0010528,0.32145,0.2392,1,1
2,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.0036303,0.32106,0.27455,1,1
2,GO FOREGUT MORPHOGENESIS,0.001228,0.32032,0.36484,1,1
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0073363,0.3201,0.28901,1,1
2,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00013917,0.31908,0.42465,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.00022676,0.31757,0.28225,1,1
2,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,2.4692e-06,0.31751,0.26071,1,1
2,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,4.3218e-05,0.31731,0.30741,1,1
2,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.024288,0.31666,0.21477,1,1
2,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.0012662,0.31647,0.25098,1,1
2,GO REGULATION OF TELOMERASE ACTIVITY,6.2985e-07,0.31647,0.29308,1,1
2,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0013054,0.31594,0.27754,1,1
2,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00011241,0.31574,0.2736,1,1
2,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.0034322,0.31543,0.26202,1,1
2,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.00021909,0.31514,0.27835,1,1
2,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.012203,0.31502,0.22058,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,2.6902e-06,0.31497,0.33393,1,1
2,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.0081404,0.31474,0.29061,1,1
2,GO REGULATION OF MAST CELL ACTIVATION,0.00050664,0.3143,0.2573,1,1
2,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.02268,0.31397,0.26268,1,1
2,GO MIDDLE EAR MORPHOGENESIS,0.011326,0.31389,0.23893,1,1
2,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.00027832,0.31301,0.28947,1,1
2,GO CARNITINE SHUTTLE,4.4878e-05,0.31298,0.32458,1,1
2,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.0069616,0.31284,0.29225,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.0022992,0.31212,0.25508,1,1
2,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.001228,0.31164,0.26226,1,1
2,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,3.6228e-06,0.3115,0.30406,1,1
2,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,1.0604e-05,0.31107,0.26557,1,1
2,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0040578,0.31092,0.30449,1,1
2,GO REGULATION OF LIPASE ACTIVITY,1.6455e-05,0.3096,0.24778,1,1
2,GO AMP METABOLIC PROCESS,0.0083534,0.30824,0.24605,1,1
2,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.015953,0.30823,0.22793,1,1
2,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0013872,0.30794,0.20978,1,1
2,GO REGULATION OF TRANSLATIONAL TERMINATION,0.0025817,0.30789,0.24625,1,1
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00017186,0.3076,0.27318,1,1
2,GO OVULATION,7.547e-05,0.30732,0.34627,1,1
2,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.00055855,0.30703,0.26567,1,1
2,GO LEUKOTRIENE METABOLIC PROCESS,0.0028957,0.30673,0.22582,1,1
2,GO DNA LIGATION,0.0013872,0.30662,0.22916,1,1
2,GO MONOCYTE CHEMOTAXIS,0.00059588,0.30575,0.26266,1,1
2,GO MONONUCLEAR CELL MIGRATION,5.4121e-05,0.3057,0.27806,1,1
2,GO INTERLEUKIN 2 PRODUCTION,5.8301e-05,0.30565,0.2589,1,1
2,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00072223,0.30557,0.27088,1,1
2,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.014138,0.305,0.3023,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.0010528,0.30438,0.22548,1,1
2,GO CHONDROCYTE PROLIFERATION,0.0016129,0.30433,0.37661,1,1
2,GO NEGATIVE REGULATION OF CELL DIVISION,0.0087944,0.30363,0.18653,1,1
2,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.0090226,0.30346,0.27204,1,1
2,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0010859,0.30308,0.29313,1,1
2,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0010528,0.30198,0.25207,1,1
2,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.00016595,0.29938,0.32981,1,1
2,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.00072223,0.29931,0.23673,1,1
2,GO CELLULAR OXIDANT DETOXIFICATION,0.00010092,0.29871,0.25627,1,1
2,GO RESPONSE TO GONADOTROPIN,0.0030654,0.29827,0.2272,1,1
2,GO INTERLEUKIN 8 PRODUCTION,0.00040247,0.29755,0.24907,1,1
2,GO RESPONSE TO TUMOR CELL,0.001228,0.29688,0.2561,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.00012512,0.29589,0.29569,1,1
2,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.0001165,0.29584,0.32224,1,1
2,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.0028141,0.29582,0.18248,1,1
2,GO NUCLEAR PORE ORGANIZATION,5.9841e-06,0.29577,0.36087,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0010859,0.29556,0.20829,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.0021689,0.29527,0.28158,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.00010092,0.29466,0.24138,1,1
2,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.0012662,0.29446,0.24354,1,1
2,GO REGULATION OF VIRAL TRANSCRIPTION,7.2111e-07,0.29425,0.2659,1,1
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0046564,0.2937,0.26234,1,1
2,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.0010206,0.29304,0.23921,1,1
2,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.0097392,0.29273,0.26839,1,1
2,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,7.013e-05,0.29107,0.24873,1,1
2,GO HISTONE H4 DEACETYLATION,4.4878e-05,0.29103,0.3279,1,1
2,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0001547,0.29001,0.29361,1,1
2,GO PODOSOME ASSEMBLY,0.0022332,0.28995,0.25805,1,1
2,GO REGULATION OF GTP BINDING,0.050569,0.28956,0.18015,1,1
2,GO GRANULOCYTE DIFFERENTIATION,0.0034322,0.28871,0.23378,1,1
2,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.0038387,0.28853,0.27612,1,1
2,GO REGULATION OF MIRNA METABOLIC PROCESS,0.0010859,0.28853,0.22523,1,1
2,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.00022676,0.28845,0.29004,1,1
2,GO MRNA MODIFICATION,0.001191,0.28832,0.21786,1,1
2,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.00017796,0.28826,0.26875,1,1
2,GO GASTRIC ACID SECRETION,0.0024367,0.28823,0.22976,1,1
2,GO RIG I SIGNALING PATHWAY,9.389e-05,0.2881,0.25117,1,1
2,GO REGULATION OF TOLERANCE INDUCTION,0.044685,0.28763,0.17223,1,1
2,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.023741,0.28738,0.34516,1,1
2,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.00027832,0.28729,0.27398,1,1
2,GO PEPTIDE CROSS LINKING,0.0021689,0.28685,0.26412,1,1
2,GO FRUCTOSE METABOLIC PROCESS,0.020205,0.28525,0.3749,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.0060989,0.28503,0.23448,1,1
2,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00018427,0.28472,0.21719,1,1
2,GO TELOMERASE RNA LOCALIZATION,0.001872,0.28431,0.27043,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,3.1888e-05,0.28428,0.28014,1,1
2,GO RESPONSE TO INTERLEUKIN 12,0.00012074,0.28381,0.26318,1,1
2,GO BLASTODERM SEGMENTATION,0.027803,0.28377,0.28331,1,1
2,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0054795,0.28375,0.24407,1,1
2,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.037747,0.28284,0.2367,1,1
2,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0001547,0.28128,0.25224,1,1
2,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.00016023,0.28011,0.24105,1,1
2,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.00050664,0.27965,0.2655,1,1
2,GO EPITHELIAL CELL CELL ADHESION,0.001228,0.27896,0.4369,1,1
2,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00031859,0.27855,0.2719,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00054072,0.27659,0.25955,1,1
2,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,2.0033e-05,0.27471,0.25233,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEOLUS,4.3218e-05,0.27462,0.37623,1,1
2,GO PROSTATE GLAND DEVELOPMENT,0.0059384,0.27414,0.33267,1,1
2,GO REGULATION OF CELL KILLING,0.0036303,0.27402,0.19491,1,1
2,GO ARACHIDONIC ACID SECRETION,0.00029782,0.27323,0.27101,1,1
2,GO HIPPO SIGNALING,0.0017123,0.27315,0.33362,1,1
2,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.029719,0.27292,0.33387,1,1
2,GO CHROMATIN DISASSEMBLY,0.0033369,0.27261,0.19177,1,1
2,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.0038387,0.27242,0.24319,1,1
2,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0015189,0.27208,0.20134,1,1
2,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00072223,0.27153,0.26824,1,1
2,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.04854,0.2695,0.16692,1,1
2,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.0013457,0.26947,0.21333,1,1
2,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.0032441,0.26892,0.23371,1,1
2,GO MIRNA METABOLIC PROCESS,2.7343e-05,0.26846,0.21557,1,1
2,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,7.013e-05,0.2683,0.23074,1,1
2,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,8.1192e-05,0.26805,0.24199,1,1
2,GO L PHENYLALANINE METABOLIC PROCESS,0.0017641,0.26734,0.28463,1,1
2,GO GTP METABOLIC PROCESS,0.0021689,0.26711,0.27004,1,1
2,GO REGULATION OF MACROPHAGE ACTIVATION,0.00047456,0.26689,0.19917,1,1
2,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.018398,0.26687,0.20717,1,1
2,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00031859,0.26667,0.23997,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.00049035,0.2655,0.24123,1,1
2,GO GLUCOCORTICOID METABOLIC PROCESS,0.009256,0.26545,0.19744,1,1
2,GO VITAMIN BIOSYNTHETIC PROCESS,0.046579,0.26516,0.14257,1,1
2,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0017123,0.26478,0.19242,1,1
2,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.0064317,0.26433,0.24907,1,1
2,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0019282,0.26382,0.2562,1,1
2,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.0019282,0.26309,0.20352,1,1
2,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.026586,0.263,0.21919,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION,0.0020453,0.26282,0.18821,1,1
2,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0057817,0.26253,0.26756,1,1
2,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.017549,0.26251,0.14963,1,1
2,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.0083534,0.26208,0.22252,1,1
2,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.004408,0.26155,0.19522,1,1
2,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.0040578,0.26074,0.30895,1,1
2,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.00092958,0.26067,0.25007,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0013054,0.26006,0.18805,1,1
2,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.017969,0.25969,0.15241,1,1
2,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.00017186,0.25959,0.22385,1,1
2,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.00035231,0.25894,0.24524,1,1
2,GO T CELL CHEMOTAXIS,0.00018427,0.25766,0.2468,1,1
2,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0024367,0.25744,0.20189,1,1
2,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.029719,0.25735,0.17793,1,1
2,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.04854,0.25722,0.18507,1,1
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0011549,0.25712,0.20929,1,1
2,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.00069957,0.2569,0.2449,1,1
2,GO MATURATION OF SSU RRNA,0.00084609,0.25673,0.29059,1,1
2,GO AMINE CATABOLIC PROCESS,0.0036303,0.25667,0.29734,1,1
2,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.04854,0.25663,0.21703,1,1
2,GO LINOLEIC ACID METABOLIC PROCESS,0.00081984,0.25639,0.41676,1,1
2,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.0014738,0.25496,0.20245,1,1
2,GO MODULATION BY HOST OF SYMBIONT PROCESS,1.7118e-05,0.2542,0.27672,1,1
2,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.0021689,0.2539,0.28436,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0034322,0.25361,0.27097,1,1
2,GO HYPEROSMOTIC RESPONSE,0.0015653,0.25339,0.25632,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.0013457,0.25295,0.22878,1,1
2,GO FATTY ACID BIOSYNTHETIC PROCESS,4.8379e-05,0.25284,0.22507,1,1
2,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.0062634,0.25197,0.248,1,1
2,GO HISTONE H3 K9 ACETYLATION,7.2754e-05,0.25194,0.23856,1,1
2,GO NUCLEAR MIGRATION,0.015203,0.25191,0.17003,1,1
2,GO LAMELLIPODIUM ORGANIZATION,0.00014418,0.25118,0.24104,1,1
2,GO TRNA METHYLATION,0.00032948,0.25004,0.22206,1,1
2,GO TONIC SMOOTH MUSCLE CONTRACTION,0.017549,0.24908,0.15923,1,1
2,GO MITOCHONDRIAL TRANSLATION,0.00063551,0.24882,0.23474,1,1
2,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0049174,0.2486,0.2264,1,1
2,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.00065623,0.24712,0.21993,1,1
2,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.050569,0.247,0.2102,1,1
2,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.0034322,0.2458,0.24629,1,1
2,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.0027346,0.24537,0.16134,1,1
2,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.0006154,0.24507,0.18006,1,1
2,GO BILE ACID AND BILE SALT TRANSPORT,0.038561,0.24479,0.19904,1,1
2,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.001191,0.2446,0.23915,1,1
2,GO POSITIVE REGULATION OF TRANSLATION,4.1617e-05,0.24431,0.21518,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.05161,0.24393,0.10771,1,1
2,GO PIGMENT ACCUMULATION,0.0018173,0.24311,0.23967,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.014138,0.24257,0.14992,1,1
2,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.0037331,0.24227,0.3657,1,1
2,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.0020453,0.2422,0.17979,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.046579,0.24218,0.16041,1,1
2,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0033369,0.24189,0.25778,1,1
2,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.001986,0.24169,0.24642,1,1
2,GO SECRETION BY TISSUE,0.00084609,0.24153,0.26552,1,1
2,GO RESPONSE TO X RAY,0.00021167,0.24149,0.32623,1,1
2,GO ARACHIDONIC ACID METABOLIC PROCESS,0.0013054,0.24067,0.22835,1,1
2,GO RESPIRATORY BURST,0.0071468,0.24015,0.208,1,1
2,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00030804,0.2401,0.23034,1,1
2,GO LIPID OXIDATION,0.0021062,0.23939,0.17205,1,1
2,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.00041602,0.23939,0.21465,1,1
2,GO BONE GROWTH,0.029068,0.23881,0.1969,1,1
2,GO RESPONSE TO OXYGEN RADICAL,0.0037331,0.23853,0.16552,1,1
2,GO RNA DESTABILIZATION,0.0024367,0.2384,0.17203,1,1
2,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.024846,0.2383,0.23175,1,1
2,GO MITOCHONDRIAL DNA REPLICATION,0.00065623,0.23789,0.20556,1,1
2,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.0025817,0.23788,0.2218,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0031536,0.23774,0.16335,1,1
2,GO REGULATION OF STEM CELL DIFFERENTIATION,0.00092958,0.23742,0.22919,1,1
2,GO LAMELLIPODIUM ASSEMBLY,0.00072223,0.23741,0.19308,1,1
2,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.0033369,0.23721,0.1863,1,1
2,GO POSITIVE REGULATION OF COAGULATION,0.0037331,0.23681,0.25739,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0013457,0.23666,0.23242,1,1
2,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00031859,0.23639,0.23097,1,1
2,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.0069616,0.23437,0.19769,1,1
2,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.0042883,0.23412,0.21176,1,1
2,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.0069616,0.23371,0.21872,1,1
2,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.014841,0.23354,0.15149,1,1
2,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.0057817,0.23337,0.23912,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0033369,0.23332,0.25122,1,1
2,GO PLATELET MORPHOGENESIS,0.00035231,0.23317,0.22927,1,1
2,GO ERYTHROCYTE DEVELOPMENT,0.0045306,0.23289,0.16763,1,1
2,GO APOPTOTIC CELL CLEARANCE,0.0016129,0.23281,0.16276,1,1
2,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0014738,0.23278,0.1853,1,1
2,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.017969,0.232,0.23813,1,1
2,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.00087311,0.23158,0.14143,1,1
2,GO PEPTIDYL METHIONINE MODIFICATION,0.0021062,0.23137,0.2324,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.001986,0.23108,0.20533,1,1
2,GO BLASTOCYST FORMATION,0.00018427,0.23087,0.21374,1,1
2,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.0006154,0.23059,0.22253,1,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.010245,0.23008,0.16171,1,1
2,GO HISTONE MRNA METABOLIC PROCESS,4.4878e-05,0.22963,0.18907,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.0022332,0.22962,0.29499,1,1
2,GO MALE GENITALIA DEVELOPMENT,0.0021062,0.22959,0.2365,1,1
2,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00012074,0.22931,0.24113,1,1
2,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.0073363,0.22907,0.20161,1,1
2,GO GOLGI LOCALIZATION,0.013798,0.22894,0.17862,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.00014418,0.22856,0.19017,1,1
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.0010528,0.22811,0.15312,1,1
2,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.029068,0.22789,0.2342,1,1
2,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,6.7728e-06,0.2271,0.20914,1,1
2,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.00028792,0.22699,0.22064,1,1
2,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.00054072,0.22693,0.18568,1,1
2,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.036164,0.22639,0.15966,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.0051916,0.22589,0.25335,1,1
2,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0028957,0.22506,0.15516,1,1
2,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.0059384,0.22408,0.14845,1,1
2,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.0025817,0.22397,0.23425,1,1
2,GO B CELL RECEPTOR SIGNALING PATHWAY,0.00353,0.22311,0.19444,1,1
2,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.001986,0.22295,0.22217,1,1
2,GO NUCLEUS LOCALIZATION,0.0022992,0.22255,0.17072,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,3.1888e-05,0.22099,0.21191,1,1
2,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.0021062,0.22023,0.22781,1,1
2,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.026586,0.21991,0.22807,1,1
2,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.0073363,0.21941,0.17182,1,1
2,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.0014299,0.21924,0.20608,1,1
2,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0013872,0.21916,0.1558,1,1
2,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0001165,0.21882,0.18182,1,1
2,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,6.2786e-05,0.21847,0.19701,1,1
2,GO T CELL RECEPTOR SIGNALING PATHWAY,7.547e-05,0.21796,0.18325,1,1
2,GO REGULATION OF STEROID METABOLIC PROCESS,0.00057693,0.2177,0.19629,1,1
2,GO STEM CELL DIVISION,0.0024367,0.21697,0.2289,1,1
2,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.017137,0.21665,0.1399,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.00054072,0.21655,0.15534,1,1
2,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0013457,0.21629,0.18669,1,1
2,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.0042883,0.21627,0.18511,1,1
2,GO T CELL APOPTOTIC PROCESS,0.00042998,0.21578,0.23293,1,1
2,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.00047456,0.21534,0.22068,1,1
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0054795,0.21529,0.23026,1,1
2,GO MAINTENANCE OF CELL NUMBER,0.00028792,0.21523,0.20008,1,1
2,GO REGULATION OF GENE SILENCING,5.0683e-06,0.21484,0.20369,1,1
2,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.0020453,0.2146,0.23118,1,1
2,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.017969,0.21442,0.17791,1,1
2,GO RESPONSE TO INTERLEUKIN 15,0.0013457,0.21402,0.19559,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0014299,0.21348,0.16489,1,1
2,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.00035231,0.2133,0.22123,1,1
2,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.015953,0.21288,0.16625,1,1
2,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0087944,0.2128,0.19349,1,1
2,GO B CELL HOMEOSTASIS,0.05161,0.21235,0.1073,1,1
2,GO LEUKOCYTE APOPTOTIC PROCESS,0.0017641,0.21185,0.19463,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.00038934,0.21182,0.21758,1,1
2,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.0062634,0.21164,0.15797,1,1
2,GO B CELL APOPTOTIC PROCESS,0.012203,0.21164,0.14712,1,1
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.00059588,0.21126,0.22841,1,1
2,GO MULTI ORGANISM LOCALIZATION,0.00011241,0.21104,0.18282,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.0028957,0.21095,0.16386,1,1
2,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00035231,0.21028,0.20847,1,1
2,GO RRNA TRANSCRIPTION,0.00045924,0.21026,0.2361,1,1
2,GO RESPONSE TO INTERLEUKIN 7,0.0025817,0.2102,0.1538,1,1
2,GO LEUKOCYTE PROLIFERATION,0.00081984,0.20964,0.16127,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,5.0226e-05,0.2095,0.19498,1,1
2,GO FATTY ACID DERIVATIVE TRANSPORT,0.00024286,0.20924,0.16592,1,1
2,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.00012074,0.20924,0.19773,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.011047,0.20914,0.15851,1,1
2,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.010506,0.20862,0.17098,1,1
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0059384,0.20828,0.15751,1,1
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0075304,0.20759,0.20384,1,1
2,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.00013433,0.20735,0.26378,1,1
2,GO RNA POLYADENYLATION,0.00090094,0.20729,0.15255,1,1
2,GO CYTOPLASM ORGANIZATION,0.014138,0.20701,0.22853,1,1
2,GO RNA STABILIZATION,0.0010859,0.20696,0.15655,1,1
2,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.017549,0.20675,0.17263,1,1
2,GO POSITIVE REGULATION OF WOUND HEALING,0.045624,0.20643,0.17967,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0040578,0.20642,0.15938,1,1
2,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.00041602,0.20632,0.23578,1,1
2,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.043763,0.20628,0.15932,1,1
2,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0050528,0.20625,0.15868,1,1
2,GO EPITHELIAL STRUCTURE MAINTENANCE,0.025994,0.20513,0.18979,1,1
2,GO ASYMMETRIC CELL DIVISION,0.017549,0.20512,0.17735,1,1
2,GO REGULATION OF SPROUTING ANGIOGENESIS,0.00098941,0.20481,0.21861,1,1
2,GO RECEPTOR BIOSYNTHETIC PROCESS,0.0013872,0.20411,0.18274,1,1
2,GO NCRNA EXPORT FROM NUCLEUS,9.7801e-06,0.20398,0.25326,1,1
2,GO CORNIFICATION,0.0054795,0.20373,0.26068,1,1
2,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.00063551,0.20371,0.1765,1,1
2,GO LATERAL VENTRICLE DEVELOPMENT,0.00079435,0.2034,0.26889,1,1
2,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.0030654,0.20338,0.21657,1,1
2,GO HISTONE DEUBIQUITINATION,7.547e-05,0.2029,0.18267,1,1
2,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.00353,0.20256,0.21796,1,1
2,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00021167,0.20213,0.2128,1,1
2,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0010859,0.20199,0.18167,1,1
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0099891,0.20159,0.14887,1,1
2,GO COPII COATED VESICLE CARGO LOADING,0.0038387,0.20083,0.15725,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.031748,0.20068,0.16199,1,1
2,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.02166,0.20016,0.1438,1,1
2,GO PROTEIN ADP RIBOSYLATION,0.0038387,0.2001,0.20733,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,9.0551e-05,0.20004,0.17681,1,1
2,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.00029782,0.19988,0.18905,1,1
2,GO INTERACTION WITH SYMBIONT,0.00013917,0.19985,0.21832,1,1
2,GO TRACHEA DEVELOPMENT,0.036164,0.19939,0.18053,1,1
2,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0039469,0.19936,0.23072,1,1
2,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.010506,0.19913,0.15499,1,1
2,GO POST GOLGI VESICLE MEDIATED TRANSPORT,9.0551e-05,0.19886,0.19566,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00013917,0.19847,0.1919,1,1
2,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.0085714,0.19833,0.20911,1,1
2,GO RNA METHYLATION,0.00092958,0.19798,0.16294,1,1
2,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.0094949,0.19781,0.19501,1,1
2,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.00017186,0.1976,0.2146,1,1
2,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.0028957,0.19753,0.16624,1,1
2,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0014299,0.19602,0.1642,1,1
2,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.0049174,0.196,0.18078,1,1
2,GO POLYOL BIOSYNTHETIC PROCESS,0.0075304,0.19591,0.12552,1,1
2,GO REGULATION OF BONE DEVELOPMENT,0.0047853,0.1957,0.14912,1,1
2,GO LEFT RIGHT PATTERN FORMATION,0.0085714,0.19557,0.23464,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0031536,0.19524,0.19626,1,1
2,GO REGULATION OF T CELL CHEMOTAXIS,0.016339,0.19508,0.18222,1,1
2,GO PEPTIDYL ARGININE MODIFICATION,5.2139e-05,0.19463,0.21572,1,1
2,GO PRIMARY MIRNA PROCESSING,0.0011549,0.19456,0.20914,1,1
2,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.019283,0.19425,0.13959,1,1
2,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0013054,0.19389,0.16848,1,1
2,GO INTERLEUKIN 10 PRODUCTION,0.016734,0.19333,0.15527,1,1
2,GO GENITALIA MORPHOGENESIS,0.033894,0.19304,0.18236,1,1
2,GO DENDRITIC CELL CHEMOTAXIS,0.0054795,0.19231,0.21851,1,1
2,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0029794,0.19218,0.16155,1,1
2,GO AXIS ELONGATION,0.0057817,0.19211,0.29493,1,1
2,GO DIGESTIVE SYSTEM PROCESS,0.0019282,0.19199,0.16639,1,1
2,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.030383,0.19172,0.21302,1,1
2,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00021909,0.19153,0.23874,1,1
2,GO NEGATIVE T CELL SELECTION,0.0097392,0.19146,0.10581,1,1
2,GO TRNA TRANSPORT,1.2962e-05,0.19136,0.24443,1,1
2,GO ACTIN CYTOSKELETON REORGANIZATION,0.0022992,0.19126,0.18958,1,1
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00017186,0.19105,0.1935,1,1
2,GO POSITIVE REGULATION OF CELL ACTIVATION,0.0015653,0.191,0.15022,1,1
2,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.02166,0.19062,0.1709,1,1
2,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,1.1964e-05,0.19023,0.1697,1,1
2,GO TRNA METABOLIC PROCESS,0.00024286,0.19017,0.18626,1,1
2,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.0064317,0.19007,0.16536,1,1
2,GO NEPHRON EPITHELIUM DEVELOPMENT,0.036948,0.18975,0.13877,1,1
2,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.004408,0.18971,0.13579,1,1
2,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.013798,0.18928,0.1723,1,1
2,GO ISOPRENOID METABOLIC PROCESS,0.0046564,0.18915,0.16219,1,1
2,GO T CELL PROLIFERATION,0.0013054,0.1891,0.16658,1,1
2,GO GLUTAMINE METABOLIC PROCESS,0.00026903,0.18909,0.24946,1,1
2,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,1.8251e-06,0.18902,0.20438,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.00057693,0.18899,0.15748,1,1
2,GO THYMUS DEVELOPMENT,0.0037331,0.18875,0.16836,1,1
2,GO TOXIN TRANSPORT,0.0057817,0.1885,0.1456,1,1
2,GO CELLULAR RESPONSE TO CHOLESTEROL,0.0051916,0.18804,0.21643,1,1
2,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.052669,0.18756,0.18764,1,1
2,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.001662,0.18718,0.18496,1,1
2,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,1.104e-05,0.18701,0.20664,1,1
2,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0071468,0.18672,0.17147,1,1
2,GO RNA INTERFERENCE,0.0079323,0.18581,0.17857,1,1
2,GO LYMPHOCYTE APOPTOTIC PROCESS,0.0012662,0.18571,0.18463,1,1
2,GO PIGMENT GRANULE ORGANIZATION,8.7323e-05,0.18527,0.22708,1,1
2,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0069616,0.18433,0.11737,1,1
2,GO RESPONSE TO ANTIBIOTIC,0.0006154,0.18295,0.19425,1,1
2,GO TERPENOID METABOLIC PROCESS,0.014138,0.18173,0.16093,1,1
2,GO REGULATION OF KIDNEY DEVELOPMENT,0.035393,0.18155,0.17467,1,1
2,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.03245,0.18005,0.25633,1,1
2,GO REGULATION OF RNA EXPORT FROM NUCLEUS,7.547e-05,0.17989,0.2359,1,1
2,GO MYELOID DENDRITIC CELL ACTIVATION,0.011047,0.17951,0.15129,1,1
2,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.023741,0.17946,0.15152,1,1
2,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.016734,0.17875,0.21327,1,1
2,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.001228,0.17842,0.16056,1,1
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.030383,0.17838,0.13751,1,1
2,GO FATTY ACID TRANSPORT,0.00047456,0.17825,0.15179,1,1
2,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.052669,0.17825,0.12082,1,1
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0024367,0.17744,0.16598,1,1
2,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.023205,0.17733,0.16175,1,1
2,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.041093,0.17726,0.15127,1,1
2,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.00095906,0.17713,0.16939,1,1
2,GO LIPID MODIFICATION,0.0021689,0.17696,0.12455,1,1
2,GO NATURAL KILLER CELL PROLIFERATION,0.024288,0.17676,0.2034,1,1
2,GO REGULATION OF MRNA CATABOLIC PROCESS,0.00017796,0.17655,0.1617,1,1
2,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,1.0604e-05,0.17621,0.15951,1,1
2,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.00044439,0.17616,0.15531,1,1
2,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.00081984,0.17614,0.17901,1,1
2,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0039469,0.17582,0.12905,1,1
2,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.00026003,0.17577,0.17065,1,1
2,GO TRANSLATIONAL ELONGATION,0.0083534,0.17542,0.1696,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.00023468,0.17535,0.20304,1,1
2,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0057817,0.17464,0.21213,1,1
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.019739,0.17461,0.12015,1,1
2,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.0094949,0.17437,0.15959,1,1
2,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.0042883,0.17424,0.14521,1,1
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.0011549,0.17327,0.20141,1,1
2,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0042883,0.17306,0.17563,1,1
2,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0021689,0.17303,0.13629,1,1
2,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.017549,0.17208,0.16465,1,1
2,GO LONG CHAIN FATTY ACID TRANSPORT,0.00050664,0.17196,0.17433,1,1
2,GO HISTONE H3 K4 TRIMETHYLATION,0.0015653,0.1718,0.17091,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.049546,0.17176,0.11927,1,1
2,GO INTERFERON GAMMA PRODUCTION,0.001662,0.17143,0.14687,1,1
2,GO MYOBLAST DIFFERENTIATION,0.009256,0.17078,0.18835,1,1
2,GO HISTONE H2B UBIQUITINATION,0.007729,0.17077,0.14854,1,1
2,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.015574,0.17074,0.15454,1,1
2,GO CELLULAR RESPONSE TO ALCOHOL,0.00042998,0.1698,0.17626,1,1
2,GO STEROL METABOLIC PROCESS,0.011612,0.16977,0.11677,1,1
2,GO METANEPHROS DEVELOPMENT,0.043763,0.16974,0.14965,1,1
2,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.0025083,0.16922,0.21776,1,1
2,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.01282,0.16889,0.11203,1,1
2,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.0046564,0.16874,0.16218,1,1
2,GO FATTY ACID METABOLIC PROCESS,0.00038934,0.1686,0.16018,1,1
2,GO MACROPHAGE CHEMOTAXIS,0.014841,0.16833,0.16284,1,1
2,GO NEGATIVE REGULATION OF DNA REPAIR,0.0027346,0.16813,0.18006,1,1
2,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.00074557,0.16787,0.13555,1,1
2,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.03939,0.16748,0.16595,1,1
2,GO CELL CELL JUNCTION ORGANIZATION,0.041967,0.16729,0.11507,1,1
2,GO MRNA METHYLATION,0.043763,0.16696,0.13958,1,1
2,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.025414,0.16674,0.14619,1,1
2,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.0053338,0.16558,0.16805,1,1
2,GO KERATINOCYTE PROLIFERATION,0.049546,0.16557,0.26095,1,1
2,GO HISTONE H3 K14 ACETYLATION,0.0001165,0.16544,0.16381,1,1
2,GO SCHWANN CELL DIFFERENTIATION,0.018836,0.16524,0.13202,1,1
2,GO NEUTRAL LIPID METABOLIC PROCESS,0.0022332,0.16519,0.13686,1,1
2,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0085714,0.16502,0.17276,1,1
2,GO LIPID HOMEOSTASIS,0.0066042,0.16454,0.13305,1,1
2,GO GRANULOCYTE CHEMOTAXIS,0.030383,0.16397,0.099348,1,1
2,GO FC RECEPTOR SIGNALING PATHWAY,0.0024367,0.1636,0.14178,1,1
2,GO PHOTOPERIODISM,0.037747,0.163,0.10871,1,1
2,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.044685,0.16235,0.15542,1,1
2,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0036303,0.16221,0.11467,1,1
2,GO REGULATION OF LIPID METABOLIC PROCESS,0.00092958,0.16212,0.13204,1,1
2,GO MRNA TRANSCRIPTION,0.0054795,0.1621,0.15992,1,1
2,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.0011199,0.16207,0.18441,1,1
2,GO CELLULAR LIPID METABOLIC PROCESS,0.00045924,0.16152,0.1328,1,1
2,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.017969,0.1614,0.10898,1,1
2,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.014138,0.16136,0.10153,1,1
2,GO REGULATION OF INFLAMMATORY RESPONSE,0.010506,0.16111,0.10097,1,1
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.05161,0.16072,0.13974,1,1
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.0051916,0.16065,0.11368,1,1
2,GO STEROL BIOSYNTHETIC PROCESS,0.013139,0.16041,0.17544,1,1
2,GO ERBB SIGNALING PATHWAY,0.0025083,0.16019,0.13469,1,1
2,GO T CELL DIFFERENTIATION,0.0038387,0.15926,0.13341,1,1
2,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.046579,0.15901,0.17462,1,1
2,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.035393,0.15896,0.12123,1,1
2,GO REGULATION OF CELL CELL ADHESION,0.014138,0.1585,0.12078,1,1
2,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.0017641,0.15845,0.25468,1,1
2,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.022165,0.15811,0.16841,1,1
2,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.0020453,0.15803,0.2254,1,1
2,GO POSITIVE REGULATION OF T CELL MIGRATION,0.0099891,0.15693,0.16133,1,1
2,GO REGULATION OF CELL ACTIVATION,0.0036303,0.15647,0.1229,1,1
2,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.0071468,0.15591,0.12945,1,1
2,GO P BODY ASSEMBLY,0.0021062,0.15574,0.13824,1,1
2,GO ALCOHOL METABOLIC PROCESS,0.00016023,0.15532,0.16415,1,1
2,GO REGULATION OF DEFENSE RESPONSE,0.0037331,0.1552,0.11424,1,1
2,GO REGULATION OF LIPID KINASE ACTIVITY,0.018836,0.15387,0.12064,1,1
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.0007696,0.15353,0.18701,1,1
2,GO REGULATION OF HAIR CYCLE,0.015203,0.15329,0.21629,1,1
2,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.00016023,0.15322,0.17951,1,1
2,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.0012662,0.15321,0.26055,1,1
2,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00055855,0.15295,0.14861,1,1
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00019753,0.15285,0.13176,1,1
2,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.038561,0.15277,0.2914,1,1
2,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00054072,0.15264,0.1465,1,1
2,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.0023671,0.15244,0.16936,1,1
2,GO DIGESTION,0.010245,0.15226,0.12736,1,1
2,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,8.1192e-05,0.15147,0.14497,1,1
2,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,1.2454e-05,0.15134,0.17892,1,1
2,GO DIACYLGLYCEROL METABOLIC PROCESS,0.0099891,0.15133,0.228,1,1
2,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.00025131,0.15068,0.1261,1,1
2,GO T CELL ACTIVATION,0.0071468,0.15054,0.12592,1,1
2,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00026903,0.15027,0.16241,1,1
2,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.0029794,0.15024,0.15125,1,1
2,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00029782,0.15017,0.14509,1,1
2,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.0011549,0.14967,0.1426,1,1
2,GO CORTICAL CYTOSKELETON ORGANIZATION,0.0028957,0.14932,0.15495,1,1
2,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.029719,0.14929,0.20822,1,1
2,GO ALCOHOL BIOSYNTHETIC PROCESS,0.0025083,0.1487,0.13906,1,1
2,GO CELLULAR RESPONSE TO RETINOIC ACID,0.016734,0.14825,0.22555,1,1
2,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.0069616,0.14791,0.18175,1,1
2,GO REGULATION OF TELOMERE MAINTENANCE,0.00055855,0.14791,0.14492,1,1
2,GO B CELL DIFFERENTIATION,0.0083534,0.14779,0.11728,1,1
2,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.015203,0.14779,0.12728,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00065623,0.14779,0.13653,1,1
2,GO GOLGI VESICLE BUDDING,0.001191,0.1476,0.12614,1,1
2,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.009256,0.14702,0.13791,1,1
2,GO REGULATION OF T CELL ACTIVATION,0.0067808,0.14699,0.12821,1,1
2,GO LEUKOCYTE CELL CELL ADHESION,0.00353,0.1469,0.14386,1,1
2,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.0071468,0.14637,0.11556,1,1
2,GO LYMPHOCYTE DIFFERENTIATION,0.0022992,0.14556,0.12527,1,1
2,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0013872,0.14542,0.16642,1,1
2,GO LIPOPROTEIN LOCALIZATION,0.041967,0.14542,0.10338,1,1
2,GO IMPORT INTO NUCLEUS,0.02166,0.14532,0.11211,1,1
2,GO ACTIN FILAMENT ORGANIZATION,0.013465,0.1451,0.10265,1,1
2,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.0039469,0.1451,0.16692,1,1
2,GO GMP METABOLIC PROCESS,0.029068,0.14505,0.14564,1,1
2,GO REGULATION OF ACTIN FILAMENT LENGTH,0.0097392,0.14404,0.10802,1,1
2,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.0027346,0.14395,0.22552,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.0073363,0.1434,0.12064,1,1
2,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.013139,0.14308,0.11518,1,1
2,GO SERTOLI CELL DIFFERENTIATION,0.023741,0.14298,0.20433,1,1
2,GO GOLGI RIBBON FORMATION,0.018398,0.14271,0.13842,1,1
2,GO REGULATION OF PROTEIN SUMOYLATION,0.050569,0.14237,0.11908,1,1
2,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.01282,0.14237,0.09459,1,1
2,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.00065623,0.14228,0.12581,1,1
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.016339,0.14159,0.09467,1,1
2,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00045924,0.14128,0.12944,1,1
2,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.012508,0.14123,0.11833,1,1
2,GO DNA DOUBLE STRAND BREAK PROCESSING,0.021165,0.14081,0.13514,1,1
2,GO POSITIVE REGULATION OF VIRAL PROCESS,0.00034072,0.14024,0.1391,1,1
2,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.010245,0.14011,0.14857,1,1
2,GO INOSITOL LIPID MEDIATED SIGNALING,0.0017641,0.13993,0.1523,1,1
2,GO TRNA WOBBLE BASE MODIFICATION,0.015574,0.13976,0.11239,1,1
2,GO POLYOL METABOLIC PROCESS,0.00022676,0.13931,0.16091,1,1
2,GO TISSUE HOMEOSTASIS,0.010506,0.13892,0.095562,1,1
2,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,7.8282e-05,0.13869,0.13004,1,1
2,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.0024367,0.13867,0.13598,1,1
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,5.8301e-05,0.13846,0.13368,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.0090226,0.13832,0.11569,1,1
2,GO MALE SEX DIFFERENTIATION,0.050569,0.13817,0.12307,1,1
2,GO RESPONSE TO IRON ION,0.050569,0.13805,0.14981,1,1
2,GO GLYCEROLIPID METABOLIC PROCESS,3.1888e-05,0.13781,0.14227,1,1
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.0034322,0.13759,0.1665,1,1
2,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.00028792,0.13758,0.17884,1,1
2,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.018398,0.13753,0.087825,1,1
2,GO ACTIN FILAMENT BASED MOVEMENT,0.013465,0.13733,0.1162,1,1
2,GO COPII COATED VESICLE BUDDING,0.0010859,0.13715,0.12497,1,1
2,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.014486,0.13686,0.14357,1,1
2,GO RESPONSE TO ACTIVITY,0.02843,0.13685,0.096477,1,1
2,GO LIPID BIOSYNTHETIC PROCESS,0.00025131,0.13617,0.13029,1,1
2,GO BASE EXCISION REPAIR,0.0038387,0.13528,0.12574,1,1
2,GO NUCLEAR EXPORT,9.7346e-05,0.13523,0.16091,1,1
2,GO FEVER GENERATION,0.050569,0.13509,0.1561,1,1
2,GO ALPHA BETA T CELL ACTIVATION,0.001986,0.13488,0.16073,1,1
2,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.01282,0.13487,0.12132,1,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.027188,0.13476,0.15834,1,1
2,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.00029782,0.13335,0.15018,1,1
2,GO TELOMERE ORGANIZATION,0.00038934,0.13287,0.13776,1,1
2,GO LIPID METABOLIC PROCESS,0.0011199,0.13283,0.11064,1,1
2,GO PROTEIN AUTOPHOSPHORYLATION,0.0025817,0.13282,0.11717,1,1
2,GO EMBRYONIC DIGIT MORPHOGENESIS,0.050569,0.13238,0.13667,1,1
2,GO DNA GEOMETRIC CHANGE,0.00014418,0.13213,0.15335,1,1
2,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.00049035,0.13205,0.12337,1,1
2,GO TRNA WOBBLE URIDINE MODIFICATION,0.04854,0.13121,0.097599,1,1
2,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,7.2754e-05,0.13118,0.13638,1,1
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00052342,0.13042,0.15987,1,1
2,GO MRNA CLEAVAGE,2.2524e-05,0.12849,0.1658,1,1
2,GO HOMEOSTASIS OF NUMBER OF CELLS,0.011612,0.12821,0.09855,1,1
2,GO MRNA 3 END PROCESSING,0.00045924,0.12808,0.14323,1,1
2,GO REGULATION OF CELL ADHESION,0.035393,0.12796,0.10496,1,1
2,GO HISTONE PHOSPHORYLATION,0.0090226,0.12784,0.10778,1,1
2,GO OXIDATIVE DEMETHYLATION,0.020205,0.12765,0.092979,1,1
2,GO GOLGI VESICLE TRANSPORT,0.0015189,0.12696,0.098636,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION,0.0022332,0.12681,0.13721,1,1
2,GO NUCLEOTIDE PHOSPHORYLATION,0.042857,0.1268,0.083463,1,1
2,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.046579,0.12674,0.081802,1,1
2,GO STEROL IMPORT,0.01282,0.12604,0.17471,1,1
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,9.7346e-05,0.12488,0.11788,1,1
2,GO HISTONE H3 DEACETYLATION,0.019283,0.12442,0.11692,1,1
2,GO RESPONSE TO IONIZING RADIATION,0.0015189,0.12418,0.16255,1,1
2,GO RNA PROCESSING,0.00016595,0.12406,0.15172,1,1
2,GO GENE SILENCING,1.4609e-05,0.12385,0.13436,1,1
2,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.041967,0.12359,0.091026,1,1
2,GO SPROUTING ANGIOGENESIS,0.014138,0.12281,0.14236,1,1
2,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.015574,0.1223,0.1206,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0026572,0.12217,0.14542,1,1
2,GO MRNA METABOLIC PROCESS,0.00017796,0.12179,0.13519,1,1
2,GO PROTEIN SUMOYLATION,0.00012074,0.12162,0.12794,1,1
2,GO STRESS GRANULE ASSEMBLY,0.012203,0.12125,0.11656,1,1
2,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.016339,0.1207,0.11852,1,1
2,GO CELL CYCLE G1 S PHASE TRANSITION,0.0069616,0.1204,0.10391,1,1
2,GO RESPONSE TO MUSCLE ACTIVITY,0.024288,0.12038,0.18032,1,1
2,GO PHOSPHOLIPID METABOLIC PROCESS,0.00021909,0.12029,0.1183,1,1
2,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.0053338,0.12013,0.14305,1,1
2,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.0099891,0.11889,0.15156,1,1
2,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0028957,0.11847,0.10615,1,1
2,GO PROTEIN NEDDYLATION,0.029719,0.1179,0.10556,1,1
2,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00022676,0.11771,0.13518,1,1
2,GO FOCAL ADHESION ASSEMBLY,0.044685,0.11749,0.15245,1,1
2,GO ACTIN NUCLEATION,0.018836,0.11733,0.11748,1,1
2,GO REGULATION OF ORGAN GROWTH,0.044685,0.11715,0.1211,1,1
2,GO NON RECOMBINATIONAL REPAIR,0.0094949,0.11703,0.1006,1,1
2,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.0037331,0.11662,0.091428,1,1
2,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00084609,0.11653,0.15272,1,1
2,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.0033369,0.11639,0.10396,1,1
2,GO DNA BIOSYNTHETIC PROCESS,0.00035231,0.11606,0.10502,1,1
2,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.017137,0.11562,0.16704,1,1
2,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00042998,0.11559,0.13664,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEUS,0.0022992,0.11526,0.12147,1,1
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.02268,0.11509,0.16863,1,1
2,GO ACTIVATION OF GTPASE ACTIVITY,0.02268,0.11326,0.098049,1,1
2,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.015203,0.11295,0.095117,1,1
2,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.046579,0.11292,0.15119,1,1
2,GO LEUKOCYTE DIFFERENTIATION,0.0099891,0.11272,0.098411,1,1
2,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00047456,0.11254,0.13846,1,1
2,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.033166,0.11249,0.11698,1,1
2,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.013139,0.11244,0.092192,1,1
2,GO REGULATION OF MRNA 3 END PROCESSING,0.015203,0.11232,0.11,1,1
2,GO PEPTIDYL LYSINE DIMETHYLATION,0.027803,0.11186,0.085733,1,1
2,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.033894,0.11167,0.081114,1,1
2,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.0018173,0.11141,0.12801,1,1
2,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.02843,0.11116,0.10349,1,1
2,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.011047,0.11097,0.083466,1,1
2,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.031748,0.11092,0.13206,1,1
2,GO REGULATION OF T CELL DIFFERENTIATION,0.013798,0.1109,0.1266,1,1
2,GO RNA EXPORT FROM NUCLEUS,0.0001165,0.11068,0.16892,1,1
2,GO ERYTHROCYTE HOMEOSTASIS,0.012508,0.11064,0.11214,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.010506,0.11016,0.10935,1,1
2,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.0067808,0.11001,0.12022,1,1
2,GO ESTABLISHMENT OF RNA LOCALIZATION,0.00020448,0.10956,0.14177,1,1
2,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.020205,0.10936,0.088882,1,1
2,GO REGULATION OF MRNA METABOLIC PROCESS,0.00084609,0.10883,0.11147,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.0087944,0.10781,0.10084,1,1
2,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.013139,0.1067,0.087767,1,1
2,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.031748,0.10467,0.10111,1,1
2,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.036164,0.10462,0.10478,1,1
2,GO CELLULAR RESPONSE TO DRUG,0.012203,0.10453,0.11572,1,1
2,GO MRNA TRANSPORT,0.00098941,0.10385,0.13743,1,1
2,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00024286,0.1037,0.11292,1,1
2,GO SENSORY PERCEPTION OF TASTE,0.0079323,0.10355,0.24638,1,1
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.004408,0.10246,0.096349,1,1
2,GO PEPTIDYL TYROSINE MODIFICATION,0.011326,0.10223,0.12461,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,6.2786e-05,0.10215,0.13018,1,1
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.0014738,0.10198,0.11941,1,1
2,GO MRNA PROCESSING,0.00098941,0.10175,0.10927,1,1
2,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.0022332,0.10162,0.13468,1,1
2,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.036164,0.10158,0.11777,1,1
2,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.02068,0.1014,0.0759,1,1
2,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.02843,0.10107,0.10756,1,1
2,GO RNA LOCALIZATION,0.00018427,0.098195,0.15138,1,1
2,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.0046564,0.098112,0.12286,1,1
2,GO MEGAKARYOCYTE DIFFERENTIATION,0.0025817,0.097503,0.12772,1,1
2,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.014138,0.096221,0.11691,1,1
2,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.05161,0.094905,0.10417,1,1
2,GO DNA METHYLATION,0.009256,0.09471,0.090647,1,1
2,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.007729,0.094352,0.098635,1,1
2,GO STEM CELL DIFFERENTIATION,0.010506,0.094058,0.12132,1,1
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.0059384,0.093334,0.12289,1,1
2,GO ACTIN FILAMENT BASED PROCESS,0.05161,0.091497,0.07557,1,1
2,GO DNA CONFORMATION CHANGE,0.0094949,0.090581,0.083715,1,1
2,GO REGULATION OF INTRACELLULAR TRANSPORT,0.033166,0.09009,0.05905,1,1
2,GO RESPONSE TO UV,0.0054795,0.089115,0.12713,1,1
2,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.029068,0.088773,0.086824,1,1
2,GO RNA SPLICING,0.0020453,0.088566,0.107,1,1
2,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.0001165,0.088133,0.11976,1,1
2,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.00074557,0.0881,0.11853,1,1
2,GO GLUCOSE METABOLIC PROCESS,0.025414,0.087595,0.056385,1,1
2,GO NUCLEOTIDE EXCISION REPAIR,0.007729,0.087517,0.074423,1,1
2,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.024288,0.087296,0.15212,1,1
2,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.017549,0.08723,0.086512,1,1
2,GO CHROMATIN REMODELING,0.0028141,0.08717,0.097614,1,1
2,GO REGULATION OF HISTONE UBIQUITINATION,0.024288,0.086722,0.099406,1,1
2,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.0027346,0.085276,0.13248,1,1
2,GO CELL CYCLE PHASE TRANSITION,0.013465,0.084988,0.07816,1,1
2,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.011904,0.083078,0.08958,1,1
2,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.05161,0.081166,0.12635,1,1
2,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.031059,0.080511,0.077587,1,1
2,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.00092958,0.080457,0.097065,1,1
2,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.015203,0.080293,0.083498,1,1
2,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.018398,0.080161,0.17197,1,1
2,GO HISTONE H3 ACETYLATION,0.0027346,0.079136,0.091673,1,1
2,GO MAINTENANCE OF ORGANELLE LOCATION,0.033166,0.078754,0.15685,1,1
2,GO CELLULAR RESPONSE TO UV,0.0069616,0.078364,0.11375,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.024288,0.077301,0.066165,1,1
2,GO DOUBLE STRAND BREAK REPAIR,0.0094949,0.077022,0.090903,1,1
2,GO EPITHELIAL TUBE FORMATION,0.052669,0.076783,0.11943,1,1
2,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.024288,0.07674,0.09339,1,1
2,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.02166,0.073512,0.070546,1,1
2,GO MACROAUTOPHAGY,0.017137,0.0718,0.058488,1,1
2,GO RESPONSE TO RADIATION,0.026586,0.070833,0.063464,1,1
2,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.015203,0.068177,0.080644,1,1
2,GO REGULATION OF DNA METABOLIC PROCESS,0.0051916,0.068134,0.076837,1,1
2,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.025994,0.067604,0.060824,1,1
2,GO REGULATION OF GTPASE ACTIVITY,0.046579,0.066185,0.065842,1,1
2,GO DNA INTEGRITY CHECKPOINT,0.023741,0.065549,0.083447,1,1
2,GO DNA METABOLIC PROCESS,0.004408,0.0637,0.06765,1,1
2,GO CELLULAR RESPONSE TO RADIATION,0.052669,0.062614,0.086433,1,1
2,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.017137,0.062306,0.080172,1,1
2,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.043763,0.062204,0.059861,1,1
2,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.011326,0.06093,0.084026,1,1
2,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.042857,0.060125,0.1171,1,1
2,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.01282,0.059742,0.066338,1,1
2,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.025414,0.059455,0.10878,1,1
2,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.044685,0.059404,0.068066,1,1
2,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.02268,0.058892,0.11355,1,1
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0056288,0.058792,0.05732,1,1
2,GO DNA REPAIR,0.010506,0.056856,0.066843,1,1
2,GO TUBE FORMATION,0.052669,0.051947,0.11581,1,1
2,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.04854,0.051571,0.065494,1,1
2,GO REGULATION OF CHROMOSOME ORGANIZATION,0.014486,0.048574,0.065694,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.0038387,1.138,0.85188,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.00353,0.96422,0.68716,1,0
2,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0028957,0.8366,0.52159,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.00024286,0.79234,0.65233,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00353,0.70604,0.44328,1,0
2,GO NEGATIVE REGULATION OF CELL KILLING,0.0025083,0.63952,0.43062,1,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,8.1192e-05,0.62672,0.54969,1,0
2,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0050528,0.59403,0.40774,1,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,4.8379e-05,0.56446,0.5591,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.00041602,0.55842,0.38525,1,0
2,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0014299,0.53424,0.37862,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.0014299,0.49496,0.35548,1,0
2,GO RESPONSE TO INTERFERON BETA,0.014841,0.46842,0.33406,1,0
2,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.00079435,0.44175,0.41148,1,0
2,GO HEME METABOLIC PROCESS,0.0001165,0.43026,0.36397,1,0
2,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.0019282,0.41489,0.4172,1,0
2,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.00024286,0.40309,0.35282,1,0
2,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00084609,0.39496,0.37627,1,0
2,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.00010462,0.39259,0.33245,1,0
2,GO TOLERANCE INDUCTION,0.0081404,0.39066,0.29059,1,0
2,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.00012512,0.39002,0.30019,1,0
2,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.0036303,0.38886,0.24956,1,0
2,GO CYSTEINE METABOLIC PROCESS,0.00052342,0.38428,0.45613,1,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.00019753,0.37234,0.31057,1,0
2,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00059588,0.37187,0.25297,1,0
2,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.011612,0.36735,0.27613,1,0
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0099891,0.36188,0.30721,1,0
2,GO PENTOSE METABOLIC PROCESS,9.389e-05,0.36036,0.36299,1,0
2,GO XENOBIOTIC CATABOLIC PROCESS,0.018836,0.35986,0.33488,1,0
2,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.044685,0.35396,0.22261,1,0
2,GO GLYCOPROTEIN CATABOLIC PROCESS,0.015203,0.35094,0.22572,1,0
2,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.0006154,0.35048,0.29794,1,0
2,GO COLLAGEN BIOSYNTHETIC PROCESS,0.020205,0.34859,0.23365,1,0
2,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00042998,0.34749,0.40917,1,0
2,GO T CELL MEDIATED IMMUNITY,0.00047456,0.34696,0.27333,1,0
2,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.020205,0.34249,0.23351,1,0
2,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.0028957,0.34167,0.22797,1,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0099891,0.33904,0.22043,1,0
2,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.017969,0.33702,0.30073,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0083534,0.33389,0.21814,1,0
2,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.00353,0.33197,0.20721,1,0
2,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.00031859,0.32938,0.3004,1,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.00063551,0.32312,0.24574,1,0
2,GO REGULATION OF HORMONE METABOLIC PROCESS,0.0057817,0.32299,0.26181,1,0
2,GO L ASCORBIC ACID METABOLIC PROCESS,0.0066042,0.3199,0.31447,1,0
2,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0059384,0.31716,0.23558,1,0
2,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.0053338,0.31633,0.24956,1,0
2,GO RESPONSE TO NITROSATIVE STRESS,0.014486,0.31618,0.27754,1,0
2,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00013917,0.31551,0.29973,1,0
2,GO PHAGOCYTOSIS RECOGNITION,0.0075304,0.31489,0.24774,1,0
2,GO RESPONSE TO ANGIOTENSIN,0.00017186,0.3137,0.29961,1,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0073363,0.31211,0.22347,1,0
2,GO GERMINAL CENTER FORMATION,0.047551,0.31157,0.1849,1,0
2,GO HISTONE SERINE PHOSPHORYLATION,0.00087311,0.31004,0.25051,1,0
2,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.00050664,0.30986,0.21472,1,0
2,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.0014738,0.30768,0.32743,1,0
2,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.0097392,0.30686,0.26815,1,0
2,GO THYMOCYTE APOPTOTIC PROCESS,0.0087944,0.30646,0.24362,1,0
2,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.0020453,0.2993,0.2478,1,0
2,GO PROTEIN DEGLYCOSYLATION,0.0020453,0.2992,0.25235,1,0
2,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.035393,0.29898,0.22937,1,0
2,GO PHOSPHOLIPID CATABOLIC PROCESS,2.3418e-05,0.29884,0.2868,1,0
2,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.0064317,0.29801,0.21124,1,0
2,GO URETER DEVELOPMENT,0.017137,0.29587,0.27349,1,0
2,GO ENTRY INTO HOST,0.0021689,0.29495,0.21752,1,0
2,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00022676,0.29315,0.29834,1,0
2,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.0038387,0.29291,0.19189,1,0
2,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.00032948,0.29162,0.30054,1,0
2,GO MATURATION OF LSU RRNA,0.0025083,0.29137,0.3167,1,0
2,GO ZYMOGEN INHIBITION,0.010245,0.29042,0.24546,1,0
2,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0032441,0.29041,0.22435,1,0
2,GO VIRAL TRANSLATION,0.00029782,0.2879,0.3207,1,0
2,GO NADPH REGENERATION,0.0017641,0.28635,0.26696,1,0
2,GO IRON ION TRANSMEMBRANE TRANSPORT,0.00032948,0.28463,0.2552,1,0
2,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.02268,0.28104,0.37924,1,0
2,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.00065623,0.28103,0.19887,1,0
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0037331,0.28095,0.2198,1,0
2,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00023468,0.27964,0.36523,1,0
2,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0037331,0.2768,0.36624,1,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0017641,0.27646,0.20075,1,0
2,GO ACETYL COA BIOSYNTHETIC PROCESS,0.02166,0.27533,0.19504,1,0
2,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.027803,0.27488,0.28056,1,0
2,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.0013457,0.27447,0.17784,1,0
2,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.001872,0.27392,0.26244,1,0
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0036303,0.27045,0.252,1,0
2,GO RESPONSE TO INTERFERON GAMMA,0.0081404,0.26871,0.20036,1,0
2,GO VIRAL GENE EXPRESSION,0.0013872,0.26609,0.24196,1,0
2,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0087944,0.2652,0.21549,1,0
2,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.001191,0.26443,0.29381,1,0
2,GO RESPONSE TO CADMIUM ION,0.04854,0.26217,0.18851,1,0
2,GO MOVEMENT IN HOST ENVIRONMENT,0.001986,0.26104,0.19359,1,0
2,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00041602,0.26031,0.22615,1,0
2,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.019739,0.26004,0.24362,1,0
2,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.0067808,0.25804,0.21197,1,0
2,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0016129,0.25764,0.2328,1,0
2,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.007729,0.2573,0.15246,1,0
2,GO CELL REDOX HOMEOSTASIS,0.00019079,0.25586,0.23492,1,0
2,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.021165,0.25578,0.2371,1,0
2,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.0047853,0.25545,0.30462,1,0
2,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.00069957,0.255,0.2861,1,0
2,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0046564,0.25488,0.20254,1,0
2,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.0028957,0.25469,0.27699,1,0
2,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.010773,0.25458,0.16782,1,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.0067808,0.25369,0.22767,1,0
2,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0040578,0.25298,0.25278,1,0
2,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.0041716,0.25283,0.28006,1,0
2,GO AMINO SUGAR METABOLIC PROCESS,0.0013054,0.25253,0.19678,1,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0047853,0.25176,0.16018,1,0
2,GO OSTEOBLAST DEVELOPMENT,0.0007696,0.25012,0.29923,1,0
2,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.001986,0.25005,0.2615,1,0
2,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.0010206,0.24986,0.17177,1,0
2,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.044685,0.24969,0.14031,1,0
2,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.016734,0.24912,0.22943,1,0
2,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.00026003,0.24904,0.27761,1,0
2,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.0049174,0.24796,0.25013,1,0
2,GO L SERINE METABOLIC PROCESS,0.010245,0.24727,0.27613,1,0
2,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00038934,0.24674,0.24009,1,0
2,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.00029782,0.24587,0.23021,1,0
2,GO GLUTATHIONE METABOLIC PROCESS,3.7145e-05,0.24489,0.30063,1,0
2,GO NADP METABOLIC PROCESS,0.0040578,0.24197,0.21318,1,0
2,GO ALDITOL METABOLIC PROCESS,0.00042998,0.24196,0.29156,1,0
2,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.00049035,0.24142,0.25504,1,0
2,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.02166,0.24111,0.23275,1,0
2,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00084609,0.24081,0.28566,1,0
2,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.0010859,0.24071,0.20213,1,0
2,GO ADAPTIVE IMMUNE RESPONSE,0.00079435,0.24069,0.18663,1,0
2,GO RESPONSE TO PROTOZOAN,0.029719,0.24025,0.1423,1,0
2,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.019739,0.23977,0.25071,1,0
2,GO RESPONSE TO SALT STRESS,0.015203,0.23956,0.21946,1,0
2,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.014841,0.23949,0.29946,1,0
2,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.025994,0.23823,0.18665,1,0
2,GO PROTEASOME ASSEMBLY,0.0045306,0.23755,0.17653,1,0
2,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.0036303,0.23737,0.20855,1,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,7.547e-05,0.23686,0.22712,1,0
2,GO PIGMENT METABOLIC PROCESS,0.00079435,0.23664,0.21849,1,0
2,GO MITOCHONDRIAL GENE EXPRESSION,0.00069957,0.23604,0.23027,1,0
2,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.033894,0.23465,0.19223,1,0
2,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.010245,0.23464,0.22901,1,0
2,GO REGULATION OF TRANSLATIONAL FIDELITY,0.0083534,0.23382,0.19717,1,0
2,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.0056288,0.23319,0.23287,1,0
2,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.010773,0.23317,0.23857,1,0
2,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.023205,0.23139,0.1733,1,0
2,GO NIK NF KAPPAB SIGNALING,0.00069957,0.23138,0.18493,1,0
2,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.00084609,0.23136,0.20754,1,0
2,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.023741,0.2311,0.23819,1,0
2,GO RESPONSE TO MANGANESE ION,0.0032441,0.23076,0.21233,1,0
2,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.0027346,0.23076,0.21381,1,0
2,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0030654,0.22886,0.28273,1,0
2,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0029794,0.22867,0.16082,1,0
2,GO REGULATION OF VIRAL GENOME REPLICATION,0.050569,0.22646,0.16166,1,0
2,GO RESPONSE TO INTERLEUKIN 1,0.00047456,0.22602,0.17607,1,0
2,GO LIVER REGENERATION,0.009256,0.22487,0.17921,1,0
2,GO MATURATION OF 5 8S RRNA,0.0013872,0.22463,0.26926,1,0
2,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0028141,0.22434,0.18227,1,0
2,GO FATTY ACID BETA OXIDATION,0.0097392,0.22386,0.13625,1,0
2,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0022992,0.22377,0.25427,1,0
2,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.031059,0.22358,0.213,1,0
2,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0024367,0.22328,0.16015,1,0
2,GO TRANSLATIONAL TERMINATION,0.001662,0.22313,0.21854,1,0
2,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.047551,0.22297,0.12548,1,0
2,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.001228,0.22269,0.1664,1,0
2,GO INTESTINAL ABSORPTION,0.0087944,0.22167,0.19457,1,0
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.022165,0.22068,0.17369,1,0
2,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.001986,0.21951,0.22876,1,0
2,GO RIBOSOME BIOGENESIS,0.00027832,0.21919,0.25342,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00034072,0.21914,0.23942,1,0
2,GO ICOSANOID METABOLIC PROCESS,0.001986,0.21868,0.18629,1,0
2,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.010245,0.21766,0.12813,1,0
2,GO AMINO SUGAR CATABOLIC PROCESS,0.02843,0.21616,0.17568,1,0
2,GO IRON ION HOMEOSTASIS,0.00353,0.21575,0.16266,1,0
2,GO KERATAN SULFATE METABOLIC PROCESS,0.042857,0.21563,0.1387,1,0
2,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.016339,0.21488,0.18081,1,0
2,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.0045306,0.21476,0.17825,1,0
2,GO AMYLOID BETA CLEARANCE,0.0053338,0.21354,0.19606,1,0
2,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0013054,0.21353,0.17504,1,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.010245,0.21234,0.19501,1,0
2,GO INTERACTION WITH HOST,0.0015653,0.21138,0.17433,1,0
2,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.031059,0.21126,0.19432,1,0
2,GO LYMPHOCYTE MEDIATED IMMUNITY,0.0031536,0.21046,0.1433,1,0
2,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.036948,0.21016,0.12121,1,0
2,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.035393,0.21012,0.17625,1,0
2,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00059588,0.21,0.20423,1,0
2,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0013457,0.2097,0.23096,1,0
2,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.001986,0.20965,0.18519,1,0
2,GO MODULATION BY HOST OF VIRAL PROCESS,0.00353,0.20899,0.1704,1,0
2,GO REGULATION OF NECROTIC CELL DEATH,0.010773,0.20837,0.21633,1,0
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.031059,0.20813,0.13046,1,0
2,GO REGULATION OF B CELL PROLIFERATION,0.0034322,0.20778,0.16856,1,0
2,GO TYPE I INTERFERON PRODUCTION,0.0064317,0.20764,0.17278,1,0
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.0025817,0.20756,0.17138,1,0
2,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0079323,0.20737,0.13116,1,0
2,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.029068,0.20715,0.23126,1,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.047551,0.20663,0.1471,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0010206,0.20549,0.16386,1,0
2,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00011241,0.20513,0.18637,1,0
2,GO RRNA MODIFICATION,0.0064317,0.20453,0.20358,1,0
2,GO NCRNA PROCESSING,0.00041602,0.20423,0.2166,1,0
2,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.031748,0.20364,0.16144,1,0
2,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.0099891,0.20327,0.15712,1,0
2,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.050569,0.2029,0.10848,1,0
2,GO CYTOPLASMIC TRANSLATION,0.027803,0.20244,0.1905,1,0
2,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.0021062,0.20239,0.17034,1,0
2,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.0006154,0.2018,0.18869,1,0
2,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.0024367,0.20161,0.18814,1,0
2,GO CELL CELL JUNCTION MAINTENANCE,0.0075304,0.20095,0.25875,1,0
2,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.031748,0.20084,0.13299,1,0
2,GO RESPONSE TO ESTROGEN,0.0087944,0.20081,0.17641,1,0
2,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0051916,0.20066,0.225,1,0
2,GO CELLULAR IRON ION HOMEOSTASIS,0.0028957,0.20054,0.14857,1,0
2,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0023671,0.20051,0.12722,1,0
2,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.015203,0.20034,0.11934,1,0
2,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.025994,0.20005,0.18769,1,0
2,GO CELL ADHESION MEDIATED BY INTEGRIN,0.03939,0.19964,0.14,1,0
2,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.0015189,0.19911,0.25399,1,0
2,GO RIBOSOME ASSEMBLY,0.0046564,0.199,0.23715,1,0
2,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.030383,0.19871,0.14288,1,0
2,GO C21 STEROID HORMONE METABOLIC PROCESS,0.02268,0.19854,0.17481,1,0
2,GO MICROVILLUS ORGANIZATION,0.018398,0.19815,0.28573,1,0
2,GO B CELL MEDIATED IMMUNITY,0.0059384,0.19809,0.14249,1,0
2,GO CELLULAR KETONE METABOLIC PROCESS,0.0030654,0.1979,0.13998,1,0
2,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.0019282,0.19743,0.15948,1,0
2,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.015574,0.19701,0.14489,1,0
2,GO PEPTIDYL PROLINE MODIFICATION,0.0021062,0.19675,0.16849,1,0
2,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.0064317,0.19616,0.20011,1,0
2,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.024288,0.19573,0.21444,1,0
2,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.049546,0.19565,0.13607,1,0
2,GO RRNA METABOLIC PROCESS,0.00055855,0.1949,0.22801,1,0
2,GO AEROBIC RESPIRATION,0.00067758,0.19461,0.20015,1,0
2,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.041967,0.19459,0.11585,1,0
2,GO POLYAMINE BIOSYNTHETIC PROCESS,0.011047,0.19441,0.16738,1,0
2,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.017137,0.19358,0.19846,1,0
2,GO ORGANIC ACID CATABOLIC PROCESS,0.00081984,0.19263,0.15868,1,0
2,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0053338,0.1925,0.15136,1,0
2,GO SERTOLI CELL DEVELOPMENT,0.024846,0.19142,0.24298,1,0
2,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.0013872,0.19076,0.15061,1,0
2,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.0020453,0.19051,0.18013,1,0
2,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.018836,0.19027,0.12598,1,0
2,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.023741,0.18962,0.18593,1,0
2,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0071468,0.18946,0.13467,1,0
2,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.0087944,0.1893,0.17194,1,0
2,GO NCRNA METABOLIC PROCESS,0.00055855,0.18855,0.19249,1,0
2,GO EPOXYGENASE P450 PATHWAY,0.05161,0.18786,0.17388,1,0
2,GO MONOSACCHARIDE CATABOLIC PROCESS,0.0022332,0.18785,0.18755,1,0
2,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.041093,0.18769,0.11979,1,0
2,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.045624,0.18763,0.15208,1,0
2,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.0030654,0.18731,0.17513,1,0
2,GO TRANSLATIONAL INITIATION,0.030383,0.18694,0.17979,1,0
2,GO NEGATIVE REGULATION OF GENE SILENCING,0.001662,0.18686,0.20618,1,0
2,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.0025817,0.18598,0.19064,1,0
2,GO FATTY ACID CATABOLIC PROCESS,0.016734,0.18597,0.12578,1,0
2,GO ENAMEL MINERALIZATION,0.05161,0.18393,0.28276,1,0
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.0069616,0.18345,0.13427,1,0
2,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.052669,0.18337,0.15964,1,0
2,GO PINOCYTOSIS,0.014841,0.18316,0.12439,1,0
2,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.0022332,0.18237,0.14422,1,0
2,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.00012964,0.18213,0.16658,1,0
2,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.025994,0.1818,0.11009,1,0
2,GO NECROTIC CELL DEATH,0.020205,0.18127,0.16414,1,0
2,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0045306,0.18087,0.15133,1,0
2,GO INTERLEUKIN 1 PRODUCTION,0.0069616,0.18054,0.22126,1,0
2,GO RNA 5 END PROCESSING,0.00353,0.18042,0.19983,1,0
2,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.046579,0.18021,0.16375,1,0
2,GO RESPONSE TO OSMOTIC STRESS,0.0015653,0.18012,0.16492,1,0
2,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.0090226,0.17921,0.19403,1,0
2,GO RNA MODIFICATION,0.00044439,0.17762,0.15747,1,0
2,GO SYMBIOTIC PROCESS,0.00024286,0.17731,0.1543,1,0
2,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0034322,0.17693,0.1522,1,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0053338,0.17656,0.13126,1,0
2,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.0013872,0.17632,0.31742,1,0
2,GO STEROL HOMEOSTASIS,0.011047,0.17565,0.15574,1,0
2,GO RESPONSE TO HYDROGEN PEROXIDE,0.0028957,0.17527,0.15919,1,0
2,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.020205,0.17464,0.13701,1,0
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.0090226,0.17438,0.13526,1,0
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.047551,0.1743,0.13988,1,0
2,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.014486,0.17283,0.1539,1,0
2,GO ANIMAL ORGAN REGENERATION,0.027188,0.17246,0.12398,1,0
2,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.0037331,0.17227,0.19047,1,0
2,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.026586,0.17219,0.12706,1,0
2,GO LEUKOCYTE MEDIATED IMMUNITY,0.0059384,0.17209,0.13113,1,0
2,GO RESPONSE TO CORTICOSTEROID,0.052669,0.17206,0.11945,1,0
2,GO TRNA MODIFICATION,0.0010528,0.17206,0.17241,1,0
2,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.029719,0.17203,0.12588,1,0
2,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.025414,0.17191,0.10941,1,0
2,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.03939,0.17135,0.20164,1,0
2,GO CHRONIC INFLAMMATORY RESPONSE,0.040234,0.17131,0.1715,1,0
2,GO TRNA PROCESSING,0.00049035,0.17067,0.17675,1,0
2,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.052669,0.17062,0.11496,1,0
2,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.00054072,0.17004,0.17289,1,0
2,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.0094949,0.16996,0.16746,1,0
2,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.0006154,0.16995,0.19681,1,0
2,GO APICAL JUNCTION ASSEMBLY,0.023205,0.16919,0.17737,1,0
2,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.025414,0.16808,0.2129,1,0
2,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.01282,0.16756,0.17904,1,0
2,GO B CELL PROLIFERATION,0.0047853,0.16701,0.14361,1,0
2,GO PIGMENT BIOSYNTHETIC PROCESS,0.001228,0.16684,0.19329,1,0
2,GO REGULATION OF SYMBIOTIC PROCESS,0.011904,0.1666,0.17072,1,0
2,GO THIOESTER BIOSYNTHETIC PROCESS,0.050569,0.16568,0.15236,1,0
2,GO VIRAL LIFE CYCLE,0.0036303,0.16567,0.15337,1,0
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0057817,0.16474,0.13628,1,0
2,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.03939,0.16403,0.11607,1,0
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.014486,0.16376,0.14946,1,0
2,GO REGULATION OF PHAGOCYTOSIS,0.012203,0.1637,0.1256,1,0
2,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0014738,0.16358,0.14047,1,0
2,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.0042883,0.16351,0.16534,1,0
2,GO PEPTIDE METABOLIC PROCESS,0.0010528,0.16319,0.1454,1,0
2,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.011904,0.16298,0.11383,1,0
2,GO CYTOKINE PRODUCTION,0.0064317,0.16274,0.1265,1,0
2,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.021165,0.1624,0.14384,1,0
2,GO RNA CATABOLIC PROCESS,0.00065623,0.16236,0.15626,1,0
2,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.035393,0.16185,0.15526,1,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.05161,0.16181,0.16158,1,0
2,GO CYTOKINE METABOLIC PROCESS,0.0047853,0.16174,0.13514,1,0
2,GO INTERLEUKIN 17 PRODUCTION,0.0083534,0.16154,0.13889,1,0
2,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0029794,0.16138,0.13888,1,0
2,GO POSITIVE CHEMOTAXIS,0.02068,0.16138,0.13575,1,0
2,GO T CELL CYTOKINE PRODUCTION,0.0028141,0.16123,0.16319,1,0
2,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.023741,0.16092,0.10399,1,0
2,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.0064317,0.16078,0.11643,1,0
2,GO CD40 SIGNALING PATHWAY,0.023205,0.1606,0.1248,1,0
2,GO RESPONSE TO BACTERIUM,0.013798,0.16045,0.1005,1,0
2,GO POSITIVE REGULATION OF CELL ADHESION,0.018398,0.16042,0.12306,1,0
2,GO INNATE IMMUNE RESPONSE,0.0066042,0.16021,0.13071,1,0
2,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.023205,0.16015,0.15877,1,0
2,GO REGULATION OF IMMUNE RESPONSE,0.0028141,0.15981,0.12407,1,0
2,GO PEPTIDE BIOSYNTHETIC PROCESS,0.00050664,0.15975,0.16706,1,0
2,GO MYELOID LEUKOCYTE ACTIVATION,0.0039469,0.15965,0.13605,1,0
2,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.001662,0.15962,0.17465,1,0
2,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.014841,0.1596,0.14453,1,0
2,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.011326,0.15945,0.14807,1,0
2,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.0029794,0.15939,0.13956,1,0
2,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.040234,0.15938,0.10529,1,0
2,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.010773,0.1578,0.10157,1,0
2,GO PROTEIN KINASE B SIGNALING,0.024846,0.15722,0.099977,1,0
2,GO CHEMOKINE PRODUCTION,0.0060989,0.15687,0.19117,1,0
2,GO POLYAMINE METABOLIC PROCESS,0.018836,0.15685,0.13907,1,0
2,GO TRANSITION METAL ION HOMEOSTASIS,0.0032441,0.15641,0.15467,1,0
2,GO VIRAL RNA GENOME REPLICATION,0.037747,0.15628,0.13703,1,0
2,GO ALPHA AMINO ACID METABOLIC PROCESS,0.00026003,0.15589,0.16989,1,0
2,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.00092958,0.15548,0.15424,1,0
2,GO CELLULAR LIPID CATABOLIC PROCESS,0.0099891,0.15546,0.11883,1,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.02843,0.1554,0.11709,1,0
2,GO NUCLEOBASE METABOLIC PROCESS,0.0010206,0.15521,0.19759,1,0
2,GO SMALL MOLECULE CATABOLIC PROCESS,0.0020453,0.1547,0.12485,1,0
2,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.0038387,0.15392,0.11986,1,0
2,GO LYMPHOCYTE CHEMOTAXIS,0.027188,0.15363,0.12555,1,0
2,GO VESICLE TARGETING,0.0027346,0.15303,0.13314,1,0
2,GO REGULATION OF VIRAL LIFE CYCLE,0.047551,0.15299,0.15692,1,0
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.038561,0.15271,0.13388,1,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.014138,0.1527,0.15803,1,0
2,GO PHAGOCYTOSIS,0.0053338,0.15245,0.14532,1,0
2,GO CELLULAR RESPONSE TO VIRUS,0.01282,0.15211,0.13598,1,0
2,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.013139,0.15199,0.095955,1,0
2,GO RESPONSE TO CYTOKINE,0.010245,0.15167,0.11094,1,0
2,GO PLATELET ACTIVATION,0.050569,0.15154,0.089358,1,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0059384,0.15083,0.17458,1,0
2,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.037747,0.15073,0.2,1,0
2,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.0019282,0.15066,0.16843,1,0
2,GO INTERFERON BETA PRODUCTION,0.027803,0.15021,0.14766,1,0
2,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.023741,0.14998,0.10987,1,0
2,GO TRANSCRIPTION BY RNA POLYMERASE I,0.00095906,0.14965,0.18134,1,0
2,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.0094949,0.14907,0.11794,1,0
2,GO TRNA 5 LEADER REMOVAL,0.0037331,0.14896,0.18576,1,0
2,GO PROGRAMMED NECROTIC CELL DEATH,0.024846,0.14852,0.15197,1,0
2,GO SULFUR COMPOUND METABOLIC PROCESS,0.0017641,0.14824,0.14279,1,0
2,GO PROTEIN IMPORT,0.0019282,0.14747,0.13069,1,0
2,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.019283,0.14734,0.19193,1,0
2,GO TRANSEPITHELIAL TRANSPORT,0.0099891,0.14711,0.16459,1,0
2,GO REGULATION OF ACTION POTENTIAL,0.035393,0.14703,0.12533,1,0
2,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.030383,0.147,0.13639,1,0
2,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,4.0073e-05,0.14657,0.1437,1,0
2,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.041967,0.14637,0.30564,1,0
2,GO RECEPTOR CATABOLIC PROCESS,0.023205,0.14637,0.15217,1,0
2,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.031059,0.14634,0.1214,1,0
2,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0064317,0.14602,0.12032,1,0
2,GO ACTIVATION OF IMMUNE RESPONSE,0.0014299,0.14556,0.13322,1,0
2,GO POSITIVE REGULATION OF HEMOPOIESIS,0.023741,0.14512,0.11237,1,0
2,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.029068,0.14507,0.1199,1,0
2,GO CELL KILLING,0.010245,0.14501,0.12763,1,0
2,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0062634,0.14475,0.14604,1,0
2,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.016734,0.1447,0.19623,1,0
2,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.041967,0.14461,0.16146,1,0
2,GO CELLULAR AMIDE METABOLIC PROCESS,0.00045924,0.14451,0.14198,1,0
2,GO RESPONSE TO BIOTIC STIMULUS,0.011904,0.14415,0.10279,1,0
2,GO SMOOTH MUSCLE CELL PROLIFERATION,0.038561,0.14392,0.11589,1,0
2,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.0053338,0.1438,0.17457,1,0
2,GO RESPONSE TO OXIDATIVE STRESS,0.010506,0.14334,0.10937,1,0
2,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.004408,0.1428,0.16105,1,0
2,GO ALPHA BETA T CELL DIFFERENTIATION,0.0060989,0.14273,0.16905,1,0
2,GO ANTIBACTERIAL HUMORAL RESPONSE,0.034637,0.14212,0.12967,1,0
2,GO SIGNAL PEPTIDE PROCESSING,0.024846,0.14192,0.18904,1,0
2,GO OXIDATION REDUCTION PROCESS,0.0017641,0.14183,0.12411,1,0
2,GO HEXOSE CATABOLIC PROCESS,0.0079323,0.1415,0.17319,1,0
2,GO IMMUNE EFFECTOR PROCESS,0.0066042,0.14144,0.12496,1,0
2,GO STRESS FIBER ASSEMBLY,0.04854,0.1413,0.1257,1,0
2,GO SULFUR AMINO ACID METABOLIC PROCESS,0.013465,0.14105,0.18162,1,0
2,GO RESPONSE TO GAMMA RADIATION,0.001228,0.14088,0.18212,1,0
2,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.033166,0.14087,0.19502,1,0
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.050569,0.14071,0.10297,1,0
2,GO MITOCHONDRIAL PROTEIN PROCESSING,0.02843,0.14062,0.16459,1,0
2,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0031536,0.14025,0.183,1,0
2,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0062634,0.14016,0.12479,1,0
2,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.011047,0.14009,0.1295,1,0
2,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0021062,0.14006,0.1955,1,0
2,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.00045924,0.14001,0.18454,1,0
2,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.014138,0.13922,0.1544,1,0
2,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.0060989,0.13914,0.11523,1,0
2,GO TRNA 5 END PROCESSING,0.011326,0.13873,0.15724,1,0
2,GO INTERFERON ALPHA PRODUCTION,0.027188,0.1384,0.18867,1,0
2,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0075304,0.13836,0.10637,1,0
2,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.02268,0.13821,0.12472,1,0
2,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.0017123,0.13778,0.12931,1,0
2,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.020205,0.13768,0.1028,1,0
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,7.8282e-05,0.1376,0.15382,1,0
2,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0027346,0.13732,0.13605,1,0
2,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.016734,0.1369,0.14322,1,0
2,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0036303,0.13685,0.11346,1,0
2,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.023205,0.13679,0.11631,1,0
2,GO REGULATION OF HEMOPOIESIS,0.007729,0.13664,0.11952,1,0
2,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.0059384,0.13645,0.15131,1,0
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.020205,0.13609,0.13976,1,0
2,GO REGULATION OF B CELL ACTIVATION,0.015953,0.13589,0.10866,1,0
2,GO AMIDE BIOSYNTHETIC PROCESS,0.00049035,0.13545,0.15649,1,0
2,GO ERK1 AND ERK2 CASCADE,0.019739,0.13512,0.11902,1,0
2,GO MACROPHAGE MIGRATION,0.025994,0.1348,0.13815,1,0
2,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.0001547,0.13381,0.17833,1,0
2,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.019283,0.13353,0.10579,1,0
2,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.010245,0.13342,0.11188,1,0
2,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.013798,0.13291,0.12961,1,0
2,GO LYMPHOCYTE ACTIVATION,0.010773,0.13245,0.10337,1,0
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.0060989,0.13199,0.16888,1,0
2,GO CELL ACTIVATION,0.013465,0.13196,0.098859,1,0
2,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.010245,0.13166,0.14685,1,0
2,GO CELLULAR HORMONE METABOLIC PROCESS,0.034637,0.13135,0.13753,1,0
2,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.041967,0.13121,0.16611,1,0
2,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.017137,0.13073,0.1163,1,0
2,GO MAMMARY GLAND MORPHOGENESIS,0.015203,0.13047,0.25445,1,0
2,GO ORGANIC ACID METABOLIC PROCESS,0.0010859,0.13044,0.11862,1,0
2,GO CELL CELL RECOGNITION,0.016734,0.13043,0.10222,1,0
2,GO REGULATION OF INNATE IMMUNE RESPONSE,0.0054795,0.12974,0.12503,1,0
2,GO DEFENSE RESPONSE,0.021165,0.12953,0.082723,1,0
2,GO RESPONSE TO TOXIC SUBSTANCE,0.0036303,0.12951,0.12591,1,0
2,GO STEROID BIOSYNTHETIC PROCESS,0.0053338,0.12924,0.12441,1,0
2,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.047551,0.12911,0.13171,1,0
2,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.0090226,0.12856,0.12848,1,0
2,GO BODY FLUID SECRETION,0.00090094,0.12831,0.15203,1,0
2,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.018398,0.12784,0.17315,1,0
2,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.037747,0.1276,0.11031,1,0
2,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.0085714,0.12758,0.1446,1,0
2,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.0090226,0.12752,0.13045,1,0
2,GO RESPONSE TO KETONE,0.050569,0.12686,0.092858,1,0
2,GO CARBOHYDRATE CATABOLIC PROCESS,0.001872,0.12617,0.12099,1,0
2,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.012508,0.12586,0.16701,1,0
2,GO MYELOID CELL HOMEOSTASIS,0.0075304,0.12576,0.1236,1,0
2,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.019283,0.12555,0.088981,1,0
2,GO LIPID CATABOLIC PROCESS,0.011904,0.1254,0.099419,1,0
2,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.019739,0.12444,0.084239,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.026586,0.12342,0.11507,1,0
2,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.018836,0.12338,0.18031,1,0
2,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.047551,0.12157,0.097572,1,0
2,GO INTERLEUKIN 4 PRODUCTION,0.050569,0.12115,0.1093,1,0
2,GO REGULATION OF LIPID CATABOLIC PROCESS,0.038561,0.1209,0.10299,1,0
2,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.044685,0.12059,0.087742,1,0
2,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.014486,0.1204,0.15337,1,0
2,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.013465,0.1201,0.10696,1,0
2,GO REGULATION OF ERBB SIGNALING PATHWAY,0.033894,0.1196,0.069089,1,0
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.029068,0.11945,0.11822,1,0
2,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0017123,0.11902,0.14885,1,0
2,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.004408,0.11894,0.17245,1,0
2,GO OXIDATIVE PHOSPHORYLATION,0.041967,0.11893,0.11637,1,0
2,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.027803,0.11866,0.083935,1,0
2,GO REGULATION OF MYELINATION,0.038561,0.11862,0.10344,1,0
2,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.033166,0.11851,0.10815,1,0
2,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.014486,0.11797,0.090136,1,0
2,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.02068,0.11795,0.1316,1,0
2,GO RESPONSE TO STEROID HORMONE,0.047551,0.11788,0.095905,1,0
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.0026572,0.11731,0.11132,1,0
2,GO KERATINOCYTE DIFFERENTIATION,0.011047,0.11693,0.21399,1,0
2,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.025994,0.11658,0.10127,1,0
2,GO MONOSACCHARIDE METABOLIC PROCESS,0.0032441,0.11633,0.097154,1,0
2,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0033369,0.1161,0.10579,1,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.037747,0.11605,0.10562,1,0
2,GO RESPONSE TO ALCOHOL,0.030383,0.11596,0.089355,1,0
2,GO PEROXISOMAL TRANSPORT,0.0062634,0.11531,0.13382,1,0
2,GO PYRUVATE METABOLIC PROCESS,0.047551,0.11417,0.086022,1,0
2,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0083534,0.11383,0.10364,1,0
2,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.033894,0.11371,0.11804,1,0
2,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.033166,0.11368,0.091151,1,0
2,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.0046564,0.11353,0.16041,1,0
2,GO EPIDERMIS DEVELOPMENT,0.021165,0.11342,0.16004,1,0
2,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.041967,0.11319,0.066742,1,0
2,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.017969,0.11311,0.078825,1,0
2,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0049174,0.11225,0.094239,1,0
2,GO NUCLEOSIDE METABOLIC PROCESS,0.0053338,0.11221,0.11821,1,0
2,GO NUCLEAR TRANSPORT,0.0018173,0.11205,0.11881,1,0
2,GO NEGATIVE REGULATION OF CELL ADHESION,0.03939,0.11133,0.11888,1,0
2,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0026572,0.11053,0.13885,1,0
2,GO CELLULAR RESPIRATION,0.0090226,0.11016,0.14416,1,0
2,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.052669,0.11011,0.095652,1,0
2,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.001986,0.10989,0.11985,1,0
2,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.05161,0.10988,0.07732,1,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.035393,0.10958,0.078272,1,0
2,GO HUMORAL IMMUNE RESPONSE,0.021165,0.10956,0.070156,1,0
2,GO PEROXISOME ORGANIZATION,0.0079323,0.10944,0.11875,1,0
2,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0045306,0.10927,0.12488,1,0
2,GO REGULATION OF LEUKOCYTE MIGRATION,0.031059,0.10864,0.088391,1,0
2,GO TRIGLYCERIDE METABOLIC PROCESS,0.025414,0.10792,0.091682,1,0
2,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.0029794,0.10774,0.082699,1,0
2,GO REGULATION OF ATP METABOLIC PROCESS,0.016339,0.10697,0.087305,1,0
2,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.042857,0.10645,0.11624,1,0
2,GO POSITIVE REGULATION OF AUTOPHAGY,0.035393,0.10585,0.09222,1,0
2,GO VIRAL RELEASE FROM HOST CELL,0.017969,0.10491,0.12078,1,0
2,GO KERATINIZATION,0.043763,0.10427,0.17057,1,0
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.046579,0.1041,0.10784,1,0
2,GO NEGATIVE REGULATION OF CELL DEATH,0.017137,0.10317,0.081932,1,0
2,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.012508,0.10205,0.18478,1,0
2,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.0039469,0.10171,0.10602,1,0
2,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.014486,0.10103,0.090429,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.041967,0.10013,0.12686,1,0
2,GO REGULATION OF RESPONSE TO STRESS,0.016734,0.099552,0.073165,1,0
2,GO RNA 3 END PROCESSING,0.0057817,0.099327,0.11797,1,0
2,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.00057693,0.099124,0.098164,1,0
2,GO CELLULAR RESPONSE TO LIPID,0.017549,0.098976,0.096403,1,0
2,GO VESICLE BUDDING FROM MEMBRANE,0.023741,0.098839,0.081716,1,0
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.036164,0.098715,0.07261,1,0
2,GO IMMUNE SYSTEM DEVELOPMENT,0.018398,0.097919,0.08746,1,0
2,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.033894,0.097259,0.11515,1,0
2,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.045624,0.097182,0.075032,1,0
2,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.007729,0.09698,0.14849,1,0
2,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.018398,0.096798,0.066552,1,0
2,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.017969,0.096777,0.11998,1,0
2,GO NEGATIVE REGULATION OF SECRETION,0.025414,0.096758,0.084518,1,0
2,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.04854,0.096747,0.14137,1,0
2,GO REGULATION OF CATABOLIC PROCESS,0.0045306,0.096121,0.075563,1,0
2,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.03245,0.09567,0.095013,1,0
2,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.0099891,0.09543,0.095039,1,0
2,GO POSITIVE REGULATION OF PROTEOLYSIS,0.019283,0.094969,0.095211,1,0
2,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.03245,0.094176,0.085156,1,0
2,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.013139,0.092965,0.11187,1,0
2,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.0037331,0.092719,0.099204,1,0
2,GO RESPONSE TO HEAT,0.023205,0.092209,0.096968,1,0
2,GO SNRNA PROCESSING,0.015953,0.091876,0.089899,1,0
2,GO SKIN DEVELOPMENT,0.037747,0.091574,0.15729,1,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.011904,0.091509,0.11392,1,0
2,GO REGULATION OF CELL SHAPE,0.040234,0.091423,0.1247,1,0
2,GO EPIDERMAL CELL DIFFERENTIATION,0.016734,0.090882,0.17315,1,0
2,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.031748,0.090444,0.1863,1,0
2,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.029068,0.089912,0.078888,1,0
2,GO CELL AGING,0.029719,0.089427,0.077403,1,0
2,GO RNA CAPPING,0.011326,0.089316,0.09395,1,0
2,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.0017123,0.089078,0.099938,1,0
2,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.018836,0.088762,0.10341,1,0
2,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.0081404,0.088757,0.10054,1,0
2,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.045624,0.088661,0.13228,1,0
2,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.0020453,0.087903,0.080348,1,0
2,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.013465,0.087811,0.079473,1,0
2,GO CELLULAR RESPONSE TO HEAT,0.027803,0.087546,0.10435,1,0
2,GO PROTEIN POLYUBIQUITINATION,0.021165,0.087472,0.072275,1,0
2,GO CARBOHYDRATE METABOLIC PROCESS,0.0064317,0.08741,0.077006,1,0
2,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.001986,0.087387,0.081898,1,0
2,GO B CELL ACTIVATION,0.0071468,0.087369,0.096825,1,0
2,GO PLACENTA DEVELOPMENT,0.047551,0.08683,0.11298,1,0
2,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.023741,0.086541,0.12529,1,0
2,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.037747,0.086203,0.081786,1,0
2,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.022165,0.085765,0.10052,1,0
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.0062634,0.085721,0.14359,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.011047,0.085512,0.11567,1,0
2,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.04854,0.084751,0.10662,1,0
2,GO MACROMOLECULE CATABOLIC PROCESS,0.0051916,0.084422,0.074039,1,0
2,GO STEROID METABOLIC PROCESS,0.0094949,0.08392,0.10543,1,0
2,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.043763,0.083876,0.064938,1,0
2,GO ENDOCRINE PROCESS,0.036948,0.083704,0.099355,1,0
2,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.050569,0.083464,0.052446,1,0
2,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.001872,0.082814,0.090291,1,0
2,GO RRNA METHYLATION,0.031059,0.081485,0.15902,1,0
2,GO ERAD PATHWAY,0.012508,0.081021,0.10279,1,0
2,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.033894,0.080907,0.14041,1,0
2,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.014841,0.080462,0.056878,1,0
2,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.040234,0.080415,0.094849,1,0
2,GO NCRNA TRANSCRIPTION,0.01282,0.080268,0.092715,1,0
2,GO APOPTOTIC SIGNALING PATHWAY,0.044685,0.080223,0.064321,1,0
2,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.019739,0.080129,0.14325,1,0
2,GO SELECTIVE AUTOPHAGY,0.017137,0.079739,0.094735,1,0
2,GO PROTEIN CATABOLIC PROCESS,0.036948,0.077488,0.050192,1,0
2,GO TISSUE MIGRATION,0.034637,0.07691,0.12267,1,0
2,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.047551,0.076601,0.11128,1,0
2,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.04854,0.075743,0.09271,1,0
2,GO MYELOID CELL DIFFERENTIATION,0.031748,0.075335,0.085187,1,0
2,GO CELLULAR COMPONENT DISASSEMBLY,0.047551,0.075331,0.056464,1,0
2,GO SNRNA METABOLIC PROCESS,0.0053338,0.07527,0.09641,1,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.020205,0.075099,0.085013,1,0
2,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.034637,0.074611,0.10856,1,0
2,GO MONOCARBOXYLIC ACID TRANSPORT,0.015953,0.074118,0.083679,1,0
2,GO ALCOHOL CATABOLIC PROCESS,0.026586,0.073346,0.13253,1,0
2,GO HISTONE DEACETYLATION,0.0099891,0.073149,0.086896,1,0
2,GO MITOCHONDRIAL TRANSPORT,0.011047,0.072808,0.090779,1,0
2,GO REGULATION OF CHROMOSOME SEPARATION,0.042857,0.071806,0.089381,1,0
2,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.029068,0.071761,0.097148,1,0
2,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.0064317,0.071385,0.10616,1,0
2,GO REGULATION OF GLUCONEOGENESIS,0.05161,0.071089,0.068492,1,0
2,GO REGULATION OF PROTEIN STABILITY,0.017969,0.06935,0.068076,1,0
2,GO REGULATION OF VASCULATURE DEVELOPMENT,0.043763,0.068468,0.10681,1,0
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.04854,0.066692,0.060075,1,0
2,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.02268,0.063877,0.05164,1,0
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.037747,0.063522,0.070517,1,0
2,GO DNA MODIFICATION,0.015203,0.06315,0.059423,1,0
2,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0085714,0.063147,0.064397,1,0
2,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.034637,0.061746,0.08234,1,0
2,GO CHROMOSOME CONDENSATION,0.047551,0.061065,0.077465,1,0
2,GO INTRA S DNA DAMAGE CHECKPOINT,0.042857,0.060539,0.090977,1,0
2,GO TRANSCRIPTION BY RNA POLYMERASE III,0.044685,0.059932,0.075487,1,0
2,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.052669,0.059572,0.058881,1,0
2,GO IN UTERO EMBRYONIC DEVELOPMENT,0.021165,0.058186,0.084135,1,0
2,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.042857,0.057639,0.060944,1,0
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.025414,0.054148,0.046814,1,0
2,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.017137,0.053453,0.051302,1,0
2,GO METHYLATION,0.0064317,0.04502,0.071068,1,0
2,GO SNRNA TRANSCRIPTION,0.014841,0.038684,0.074131,1,0
2,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.046579,0.034587,0.061009,1,0
2,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.041093,0.032896,0.044536,1,0
2,GO NEURON DEATH,0.042857,-0.048111,-0.063209,1,0
2,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.049546,-0.061049,-0.088915,1,0
2,GO PEPTIDE SECRETION,0.033166,-0.062393,-0.088797,1,0
2,GO FEAR RESPONSE,0.042857,-0.062561,-0.12621,1,0
2,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.031748,-0.063511,-0.059013,1,0
2,GO METAL ION TRANSPORT,0.015953,-0.080093,-0.088956,1,0
2,GO SENSORY PERCEPTION OF SMELL,0.044685,-0.080246,-0.075703,1,0
2,GO ANATOMICAL STRUCTURE MATURATION,0.031748,-0.084532,-0.081316,1,0
2,GO POSITIVE REGULATION OF SECRETION,0.0071468,-0.085082,-0.10242,1,0
2,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.03939,-0.085362,-0.08028,1,0
2,GO ION TRANSMEMBRANE TRANSPORT,0.02166,-0.088061,-0.085515,1,0
2,GO REGULATION OF SECRETION,0.02068,-0.088713,-0.0923,1,0
2,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.014486,-0.090757,-0.11501,1,0
2,GO CATION TRANSPORT,0.015203,-0.092023,-0.089465,1,0
2,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.037747,-0.098227,-0.13525,1,0
2,GO RESPONSE TO MECHANICAL STIMULUS,0.046579,-0.099978,-0.10098,1,0
2,GO REGULATION OF BLOOD CIRCULATION,0.02268,-0.10223,-0.10572,1,0
2,GO REGULATION OF MEIOTIC CELL CYCLE,0.0023671,-0.104,-0.14276,1,0
2,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.03245,-0.10569,-0.1523,1,0
2,GO CHLORIDE TRANSPORT,0.031748,-0.1081,-0.098541,1,0
2,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.0075304,-0.10842,-0.10558,1,0
2,GO POSITIVE REGULATION OF HORMONE SECRETION,0.0094949,-0.11008,-0.11269,1,0
2,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.025994,-0.1107,-0.1761,1,0
2,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.050569,-0.11076,-0.12312,1,0
2,GO ADIPOSE TISSUE DEVELOPMENT,0.041967,-0.11254,-0.12601,1,0
2,GO CATION TRANSMEMBRANE TRANSPORT,0.0090226,-0.11309,-0.1,1,0
2,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.036948,-0.11428,-0.093852,1,0
2,GO RESPONSE TO ALKALOID,0.0028957,-0.11633,-0.15109,1,0
2,GO FEEDING BEHAVIOR,0.033894,-0.11713,-0.098931,1,0
2,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.013465,-0.11736,-0.10042,1,0
2,GO CELL MATURATION,0.0067808,-0.11822,-0.11562,1,0
2,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.027188,-0.11822,-0.095743,1,0
2,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0040578,-0.11977,-0.13897,1,0
2,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.024288,-0.12008,-0.17897,1,0
2,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.024288,-0.12062,-0.13558,1,0
2,GO REGULATION OF ION TRANSPORT,0.0087944,-0.12549,-0.10957,1,0
2,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.04854,-0.12554,-0.14773,1,0
2,GO PHAGOSOME MATURATION,0.02068,-0.12601,-0.13216,1,0
2,GO REGULATION OF HORMONE SECRETION,0.0028141,-0.12856,-0.13032,1,0
2,GO PIRNA METABOLIC PROCESS,0.044685,-0.13253,-0.18969,1,0
2,GO REGULATION OF APPETITE,0.034637,-0.14129,-0.10958,1,0
2,GO SODIUM ION TRANSPORT,0.0032441,-0.14244,-0.13786,1,0
2,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.033894,-0.14309,-0.15081,1,0
2,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.0032441,-0.14309,-0.14919,1,0
2,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.0051916,-0.14452,-0.15605,1,0
2,GO HORMONE TRANSPORT,0.0033369,-0.14561,-0.1338,1,0
2,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.011612,-0.14724,-0.14223,1,0
2,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.035393,-0.1493,-0.14091,1,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.00010462,-0.15014,-0.1726,1,0
2,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.030383,-0.15016,-0.13885,1,0
2,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.00065623,-0.15063,-0.17227,1,0
2,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.0060989,-0.15074,-0.14546,1,0
2,GO REPRODUCTIVE BEHAVIOR,0.0023671,-0.1508,-0.20795,1,0
2,GO LYMPH NODE DEVELOPMENT,0.0027346,-0.15363,-0.2055,1,0
2,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.0030654,-0.15462,-0.15878,1,0
2,GO REGULATION OF DNA BINDING,0.017137,-0.15475,-0.11958,1,0
2,GO RESPONSE TO CALCIUM ION,0.0053338,-0.15485,-0.148,1,0
2,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.0083534,-0.15529,-0.097714,1,0
2,GO REGULATION OF INSULIN SECRETION,0.0066042,-0.15835,-0.13039,1,0
2,GO REGULATION OF ORGANIC ACID TRANSPORT,0.0026572,-0.15857,-0.16968,1,0
2,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.012203,-0.16064,-0.20274,1,0
2,GO PROTEIN HETEROOLIGOMERIZATION,0.0017123,-0.16124,-0.1522,1,0
2,GO NATURAL KILLER CELL DIFFERENTIATION,0.0015189,-0.16153,-0.19814,1,0
2,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.036164,-0.16169,-0.18281,1,0
2,GO PROTEIN LOCALIZATION TO LYSOSOME,0.041093,-0.16269,-0.12979,1,0
2,GO SUCKLING BEHAVIOR,0.014841,-0.16275,-0.23342,1,0
2,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.016734,-0.16358,-0.1648,1,0
2,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.017969,-0.16588,-0.22832,1,0
2,GO POSITIVE REGULATION OF ANION TRANSPORT,0.0023671,-0.16698,-0.17207,1,0
2,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.0053338,-0.168,-0.14838,1,0
2,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.0064317,-0.17263,-0.20861,1,0
2,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.04854,-0.17581,-0.176,1,0
2,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.02068,-0.17582,-0.20035,1,0
2,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.0075304,-0.17893,-0.26668,1,0
2,GO ANDROGEN METABOLIC PROCESS,0.040234,-0.17912,-0.071323,1,0
2,GO REGULATION OF CGMP MEDIATED SIGNALING,0.049546,-0.17935,-0.24481,1,0
2,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.0006154,-0.17982,-0.16591,1,0
2,GO INSULIN SECRETION,0.0066042,-0.17994,-0.14029,1,0
2,GO CAMP METABOLIC PROCESS,0.038561,-0.1818,-0.17325,1,0
2,GO RDNA HETEROCHROMATIN ASSEMBLY,0.0033369,-0.18623,-0.14935,1,0
2,GO PROTEIN KINASE C SIGNALING,0.0064317,-0.18628,-0.21498,1,0
2,GO AMINO ACID TRANSPORT,0.00098941,-0.1863,-0.19181,1,0
2,GO POSITIVE REGULATION OF EXOCYTOSIS,0.0007696,-0.18694,-0.19989,1,0
2,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.02843,-0.18747,-0.22547,1,0
2,GO REGULATION OF ENDOCYTIC RECYCLING,0.010506,-0.19095,-0.22819,1,0
2,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.0090226,-0.1915,-0.15378,1,0
2,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.0011199,-0.19204,-0.17957,1,0
2,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.00037661,-0.19293,-0.1986,1,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.0010859,-0.19314,-0.20653,1,0
2,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.00050664,-0.19737,-0.20649,1,0
2,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.0016129,-0.19819,-0.19221,1,0
2,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.0010206,-0.19835,-0.18128,1,0
2,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.0014738,-0.19929,-0.22693,1,0
2,GO STRIATUM DEVELOPMENT,0.0069616,-0.20081,-0.23813,1,0
2,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.0059384,-0.20111,-0.1339,1,0
2,GO PEPTIDE HORMONE SECRETION,0.00045924,-0.20159,-0.17852,1,0
2,GO REGULATION OF FERTILIZATION,0.0015653,-0.2019,-0.1974,1,0
2,GO RESPONSE TO FUNGUS,0.0037331,-0.20389,-0.14599,1,0
2,GO SIGNAL RELEASE,0.00012074,-0.20499,-0.16978,1,0
2,GO CAMP BIOSYNTHETIC PROCESS,0.0029794,-0.20549,-0.28145,1,0
2,GO DENDRITIC TRANSPORT,0.025414,-0.21053,-0.20565,1,0
2,GO CELLULAR RESPONSE TO CALCIUM ION,0.00079435,-0.21056,-0.22187,1,0
2,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.018836,-0.21069,-0.22139,1,0
2,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.024288,-0.2111,-0.18921,1,0
2,GO CALCIUM ION IMPORT,0.00021909,-0.21137,-0.20977,1,0
2,GO TELENCEPHALON DEVELOPMENT,0.00023468,-0.21206,-0.1721,1,0
2,GO RESPONSE TO PH,0.023205,-0.21215,-0.14171,1,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.045624,-0.21626,-0.23385,1,0
2,GO DIVALENT METAL ION EXPORT,0.017137,-0.21757,-0.20318,1,0
2,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.010245,-0.2195,-0.17283,1,0
2,GO FACIAL NERVE MORPHOGENESIS,0.03939,-0.22369,-0.29967,1,0
2,GO BRANCHING MORPHOGENESIS OF A NERVE,0.049546,-0.22808,-0.20625,1,0
2,GO REGULATION OF EXOCYTOSIS,0.0071468,-0.2305,-0.18465,1,0
2,GO CGMP METABOLIC PROCESS,0.045624,-0.23291,-0.20903,1,0
2,GO INSEMINATION,0.052669,-0.23544,-0.19735,1,0
2,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.012203,-0.23558,-0.26128,1,0
2,GO ASSOCIATIVE LEARNING,0.0014738,-0.23927,-0.20993,1,0
2,GO VITAMIN CATABOLIC PROCESS,0.025994,-0.24011,-0.23319,1,0
2,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00016023,-0.24873,-0.22131,1,0
2,GO ACROSOME REACTION,0.00034072,-0.25085,-0.22925,1,0
2,GO LEARNING,0.00065623,-0.25137,-0.23618,1,0
2,GO SIALYLATION,0.02843,-0.25261,-0.2102,1,0
2,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.001662,-0.25748,-0.3272,1,0
2,GO THALAMUS DEVELOPMENT,0.012203,-0.25771,-0.23578,1,0
2,GO AMMONIUM ION METABOLIC PROCESS,0.0057817,-0.26182,-0.27576,1,0
2,GO CEREBELLAR CORTEX DEVELOPMENT,2.4346e-05,-0.26317,-0.26987,1,0
2,GO MEMBRANE FISSION,0.0028957,-0.26481,-0.25935,1,0
2,GO REGULATION OF NERVOUS SYSTEM PROCESS,5.2139e-05,-0.26617,-0.24721,1,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.031748,-0.26628,-0.22889,1,0
2,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.0094949,-0.2669,-0.30182,1,0
2,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,2.0784e-06,-0.26834,-0.26998,1,0
2,GO NEUROTRANSMITTER METABOLIC PROCESS,0.0024367,-0.26922,-0.23852,1,0
2,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.044685,-0.27008,-0.20895,1,0
2,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.011047,-0.27069,-0.34342,1,0
2,GO AMINE BIOSYNTHETIC PROCESS,0.0062634,-0.27163,-0.19677,1,0
2,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.00022676,-0.27186,-0.31015,1,0
2,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.009256,-0.27352,-0.30867,1,0
2,GO PYRAMIDAL NEURON DIFFERENTIATION,0.011612,-0.27433,-0.29277,1,0
2,GO INTRACILIARY TRANSPORT,0.0013054,-0.27466,-0.23595,1,0
2,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.049546,-0.27534,-0.18113,1,0
2,GO EXCITATORY SYNAPSE ASSEMBLY,0.001986,-0.27644,-0.33458,1,0
2,GO MEMBRANE DEPOLARIZATION,7.547e-05,-0.27841,-0.30182,1,0
2,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.0010859,-0.28015,-0.23914,1,0
2,GO REGULATION OF ACROSOME REACTION,0.0039469,-0.28107,-0.27225,1,0
2,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0056288,-0.28343,-0.23293,1,0
2,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,1.6455e-05,-0.28349,-0.32418,1,0
2,GO ALANINE TRANSPORT,0.014486,-0.28426,-0.19128,1,0
2,GO MEMBRANE BIOGENESIS,0.0067808,-0.28516,-0.21802,1,0
2,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,2.8418e-05,-0.28626,-0.32466,1,0
2,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.0013457,-0.28732,-0.23763,1,0
2,GO HORMONE CATABOLIC PROCESS,0.026586,-0.29056,-0.18762,1,0
2,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.011047,-0.29623,-0.26894,1,0
2,GO OPTIC NERVE DEVELOPMENT,0.00353,-0.29833,-0.31267,1,0
2,GO SECRETORY GRANULE LOCALIZATION,0.0057817,-0.30858,-0.3296,1,0
2,GO TOXIN METABOLIC PROCESS,0.041093,-0.3095,-0.2175,1,0
2,GO NOREPINEPHRINE TRANSPORT,0.001191,-0.3096,-0.25154,1,0
2,GO TUBULIN DEACETYLATION,0.0056288,-0.31111,-0.23405,1,0
2,GO LUNG ALVEOLUS DEVELOPMENT,0.023205,-0.31189,-0.23159,1,0
2,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,8.1192e-05,-0.31378,-0.29285,1,0
2,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,6.5149e-05,-0.32139,-0.28044,1,0
2,GO POSITIVE REGULATION OF FERTILIZATION,0.0033369,-0.32549,-0.25505,1,0
2,GO EXOCYTIC PROCESS,6.5149e-05,-0.32779,-0.27868,1,0
2,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.00034072,-0.33215,-0.35432,1,0
2,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.00014418,-0.33256,-0.33006,1,0
2,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.0011199,-0.34695,-0.2692,1,0
2,GO DORSAL AORTA DEVELOPMENT,2.0033e-05,-0.35222,-0.38177,1,0
2,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,6.0504e-05,-0.3543,-0.40923,1,0
2,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.00057693,-0.35917,-0.27599,1,0
2,GO RESPONSE TO DIETARY EXCESS,0.00041602,-0.36072,-0.38641,1,0
2,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.00021909,-0.3711,-0.3776,1,0
2,GO CELL DIFFERENTIATION IN HINDBRAIN,2.9532e-05,-0.37203,-0.3619,1,0
2,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.0045306,-0.39075,-0.34257,1,0
2,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.0029794,-0.39131,-0.33692,1,0
2,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.00016595,-0.39718,-0.35308,1,0
2,GO ADRENAL GLAND DEVELOPMENT,4.4878e-05,-0.39755,-0.41232,1,0
2,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,3.4421e-05,-0.41294,-0.37964,1,0
2,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,9.389e-05,-0.41611,-0.32533,1,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,1.9263e-05,-0.41802,-0.38864,1,0
2,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.0069616,-0.41804,-0.33531,1,0
2,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,1.104e-05,-0.41953,-0.42704,1,0
2,GO INHIBITORY SYNAPSE ASSEMBLY,0.0021062,-0.43651,-0.33772,1,0
2,GO DORSAL VENTRAL AXIS SPECIFICATION,0.024846,-0.46498,-0.296,1,0
2,GO RESPONSE TO HISTAMINE,0.00042998,-0.46764,-0.52218,1,0
2,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.00059588,-0.4731,-0.62579,1,0
2,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.0057817,-0.4742,-0.38282,1,0
2,GO RESPONSE TO LITHIUM ION,0.0013872,-0.48226,-0.3472,1,0
2,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,1.1776e-06,-0.48566,-0.43682,1,0
2,GO TELENCEPHALON REGIONALIZATION,0.00090094,-0.48665,-0.43538,1,0
2,GO DOPAMINE METABOLIC PROCESS,4.8612e-06,-0.493,-0.45643,1,0
2,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.0020453,-0.49519,-0.44063,1,0
2,GO PROTEIN LOCALIZATION TO AXON,0.0042883,-0.49988,-0.51522,1,0
2,GO FOREBRAIN REGIONALIZATION,1.8521e-05,-0.50683,-0.44827,1,0
2,GO REGULATION OF NEURON PROJECTION ARBORIZATION,9.0179e-06,-0.51127,-0.4967,1,0
2,GO SEROTONIN METABOLIC PROCESS,0.00012964,-0.51618,-0.48398,1,0
2,GO POSTSYNAPSE ASSEMBLY,4.0073e-05,-0.53093,-0.54051,1,0
2,GO REGULATION OF SYNAPSE MATURATION,0.00032948,-0.53915,-0.44638,1,0
2,GO PLASMA MEMBRANE REPAIR,5.6174e-05,-0.5512,-0.59354,1,0
2,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00045924,-0.55607,-0.41556,1,0
2,GO CALCIUM ION REGULATED EXOCYTOSIS,7.9801e-06,-0.56854,-0.56987,1,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,6.2786e-05,-0.57945,-0.49844,1,0
2,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.00019753,-0.59447,-0.57583,1,0
2,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,1.2454e-05,-0.62242,-0.60131,1,0
2,GO REGULATION OF DENDRITE EXTENSION,1.4044e-06,-0.63491,-0.67112,1,0
2,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.00019753,-0.68225,-0.59851,1,0
2,GO NOSE DEVELOPMENT,0.00037661,-0.68387,-0.53349,1,0
2,GO SYNAPTIC VESICLE DOCKING,0.00081984,-0.68503,-0.54517,1,0
2,GO SYNAPTIC VESICLE PRIMING,6.7596e-05,-0.68553,-0.56218,1,0
2,GO SYNAPSE MATURATION,2.9532e-05,-0.68558,-0.63869,1,0
2,GO INNERVATION,1.2862e-06,-0.69684,-0.70258,1,0
2,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,6.7728e-06,-0.70171,-0.64283,1,0
2,GO SYNAPTIC VESICLE MATURATION,8.3127e-06,-0.70729,-0.76326,1,0
2,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,4.7955e-07,-0.73288,-0.7439,1,0
2,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,6.7596e-05,-0.76375,-0.65106,1,0
2,GO VESICLE FUSION TO PLASMA MEMBRANE,0.00038934,-0.82534,-0.63904,1,0
2,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,4.3763e-07,-0.89906,-0.86905,1,0
2,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,7.8282e-05,-0.92275,-0.71216,1,0
2,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,2.4346e-05,-0.98847,-0.92485,1,0
2,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.00353,-1.1089,-0.88928,1,0
2,GO FOREBRAIN NEURON FATE COMMITMENT,8.2505e-07,-1.3246,-1.3117,1,0
2,GO ECTODERMAL PLACODE DEVELOPMENT,0.080955,0.38487,0.22266,0,1
2,GO BLEB ASSEMBLY,0.093897,0.35148,0.21631,0,1
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.29184,0.33582,0.14403,0,1
2,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.2839,0.3324,0.09428,0,1
2,GO RESPONSE TO HYDROPEROXIDE,0.065563,0.32846,0.2261,0,1
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.057089,0.32157,0.14601,0,1
2,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.088862,0.2992,0.19098,0,1
2,GO POSITIVE REGULATION OF VESICLE FUSION,0.22235,0.2954,0.1369,0,1
2,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.087232,0.29077,0.33096,0,1
2,GO EPIBOLY,0.053746,0.28775,0.16702,0,1
2,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.13583,0.28361,0.17335,0,1
2,GO LIPID DROPLET FORMATION,0.24643,0.27697,0.1663,0,1
2,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.13814,0.27522,0.11734,0,1
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.15015,0.27108,0.12299,0,1
2,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.054842,0.27104,0.13684,0,1
2,GO LATERAL MESODERM DEVELOPMENT,0.58456,0.26822,0.079068,0,1
2,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.057089,0.26803,0.14163,0,1
2,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.12689,0.26768,0.17934,0,1
2,GO MUSCLE CELL FATE COMMITMENT,0.095625,0.26686,0.2174,0,1
2,GO REPLICATIVE SENESCENCE,0.16294,0.26561,0.1168,0,1
2,GO LEYDIG CELL DIFFERENTIATION,0.93377,0.25142,-0.059376,0,1
2,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.073629,0.24623,0.18956,0,1
2,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.064293,0.24328,0.25429,0,1
2,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.092194,0.24267,0.13945,0,1
2,GO SKELETAL MUSCLE CELL PROLIFERATION,0.092194,0.2398,0.19845,0,1
2,GO VITAMIN D BIOSYNTHETIC PROCESS,0.32077,0.23439,0.087182,0,1
2,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.16828,0.2329,0.082452,0,1
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.068167,0.22679,0.19783,0,1
2,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.13583,0.22586,0.14651,0,1
2,GO REGULATION OF GASTRULATION,0.085627,0.22362,0.11002,0,1
2,GO LENS FIBER CELL DEVELOPMENT,0.11636,0.22162,0.15686,0,1
2,GO LIPID IMPORT INTO CELL,0.061812,0.2143,0.14245,0,1
2,GO MAGNESIUM ION HOMEOSTASIS,0.064293,0.21305,0.24165,0,1
2,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.055956,0.21293,0.157,0,1
2,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.054842,0.20936,0.16877,0,1
2,GO REGULATION OF NEURON MATURATION,0.12259,0.20895,0.17081,0,1
2,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.10096,0.20819,0.13771,0,1
2,GO ENDODERMAL CELL FATE COMMITMENT,0.25363,0.20678,0.074198,0,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.061812,0.20547,0.1102,0,1
2,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.073629,0.2029,0.16161,0,1
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.29184,0.20147,0.08261,0,1
2,GO RESPONSE TO LIGHT INTENSITY,0.20621,0.19564,0.11576,0,1
2,GO SEQUESTERING OF METAL ION,0.063042,0.1939,0.17141,0,1
2,GO PARAXIAL MESODERM DEVELOPMENT,0.60883,0.19032,0.082736,0,1
2,GO GRANULOCYTE MIGRATION,0.057089,0.18658,0.089707,0,1
2,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.066855,0.18597,0.12651,0,1
2,GO PIGMENT CELL DIFFERENTIATION,0.080955,0.18587,0.089522,0,1
2,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.50896,0.18519,0.083008,0,1
2,GO HETEROTYPIC CELL CELL ADHESION,0.084046,0.18345,0.12892,0,1
2,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.22235,0.18056,0.087653,0,1
2,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.059411,0.17867,0.14436,0,1
2,GO RENAL TUBULE DEVELOPMENT,0.072231,0.17611,0.13289,0,1
2,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.26847,0.17367,0.080919,0,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.060602,0.1715,0.16258,0,1
2,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.15264,0.17048,0.13938,0,1
2,GO DETOXIFICATION OF INORGANIC COMPOUND,0.21579,0.17028,0.45232,0,1
2,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.055956,0.17002,0.3346,0,1
2,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.070855,0.16931,0.14962,0,1
2,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.11434,0.16861,0.098807,0,1
2,GO PRO B CELL DIFFERENTIATION,0.13814,0.16811,0.17448,0,1
2,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.37932,0.16802,0.058955,0,1
2,GO LIPOXYGENASE PATHWAY,0.16559,0.16772,0.15902,0,1
2,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.19695,0.16755,0.05786,0,1
2,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.068167,0.16637,0.09031,0,1
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.2,0.16435,0.069143,0,1
2,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.053746,0.16377,0.10305,0,1
2,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.059411,0.16298,0.10188,0,1
2,GO CELL CELL JUNCTION ASSEMBLY,0.066855,0.16285,0.099333,0,1
2,GO DEVELOPMENTAL PIGMENTATION,0.11235,0.16095,0.072407,0,1
2,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.11434,0.15829,0.13917,0,1
2,GO CELLULAR COPPER ION HOMEOSTASIS,0.12473,0.15818,0.063564,0,1
2,GO DIOL BIOSYNTHETIC PROCESS,0.188,0.15724,0.065485,0,1
2,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.065563,0.15653,0.15437,0,1
2,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.10845,0.15396,0.089352,0,1
2,GO TRACHEA MORPHOGENESIS,0.16828,0.15286,0.084797,0,1
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.33373,0.15205,0.1027,0,1
2,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.50896,0.15115,0.040151,0,1
2,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.53167,0.15089,0.039508,0,1
2,GO VIRAL LATENCY,0.30815,0.15043,0.075981,0,1
2,GO REGULATION OF URINE VOLUME,0.057089,0.14863,0.14911,0,1
2,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.26098,0.14801,0.072995,0,1
2,GO COBALAMIN METABOLIC PROCESS,0.11636,0.14752,0.086772,0,1
2,GO REGULATION OF B CELL DIFFERENTIATION,0.12908,0.1472,0.13816,0,1
2,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.061812,0.14632,0.18406,0,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.22568,0.14624,0.10786,0,1
2,GO REGULATION OF EXIT FROM MITOSIS,0.11434,0.14549,0.08678,0,1
2,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.064293,0.1431,0.1027,0,1
2,GO GONADOTROPIN SECRETION,0.33373,0.1416,0.07184,0,1
2,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.22905,0.14099,0.10207,0,1
2,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.10654,0.1376,0.098199,0,1
2,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.20309,0.13741,0.078497,0,1
2,GO RESPONSE TO UV C,0.075049,0.13699,0.1781,0,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0695,0.13642,0.10682,0,1
2,GO MODULATION BY VIRUS OF HOST PROCESS,0.063042,0.1361,0.11484,0,1
2,GO ACTIVATION OF JNKK ACTIVITY,0.1028,0.13577,0.11402,0,1
2,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.057089,0.13573,0.10493,0,1
2,GO DIOL METABOLIC PROCESS,0.17934,0.13564,0.089759,0,1
2,GO HISTONE MONOUBIQUITINATION,0.15264,0.13517,0.079626,0,1
2,GO LYMPHOCYTE COSTIMULATION,0.10845,0.13515,0.076141,0,1
2,GO PANCREATIC JUICE SECRETION,0.19095,0.13455,0.11508,0,1
2,GO RESPONSE TO UV B,0.43883,0.13376,0.09136,0,1
2,GO PROTEIN LOCALIZATION TO CHROMATIN,0.11434,0.13364,0.080248,0,1
2,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.24288,0.13346,0.086675,0,1
2,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.1028,0.13318,0.12515,0,1
2,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.059411,0.13209,0.09131,0,1
2,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.26098,0.13206,0.12818,0,1
2,GO INTERMEMBRANE LIPID TRANSFER,0.060602,0.13151,0.08933,0,1
2,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.090515,0.13029,0.098373,0,1
2,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.36064,0.12918,0.05576,0,1
2,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.063042,0.12901,0.11476,0,1
2,GO POSITIVE REGULATION OF URINE VOLUME,0.25363,0.12877,0.15628,0,1
2,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.055956,0.12774,0.11468,0,1
2,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.13583,0.12666,0.11127,0,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.12473,0.12631,0.082532,0,1
2,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.16828,0.12622,0.053136,0,1
2,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.13583,0.12586,0.1188,0,1
2,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.22568,0.12586,0.078873,0,1
2,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.064293,0.12579,0.11107,0,1
2,GO GLYCEROLIPID CATABOLIC PROCESS,0.063042,0.12517,0.10421,0,1
2,GO TELOMERIC LOOP DISASSEMBLY,0.057089,0.12506,0.12334,0,1
2,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.095625,0.12422,0.087534,0,1
2,GO REGULATION OF SPINDLE ORGANIZATION,0.17934,0.1229,0.065533,0,1
2,GO RUFFLE ORGANIZATION,0.092194,0.12238,0.072639,0,1
2,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.25001,0.12218,0.084396,0,1
2,GO LYMPHANGIOGENESIS,0.14526,0.12207,0.10848,0,1
2,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.61497,0.12177,0.031894,0,1
2,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.18219,0.12165,0.078352,0,1
2,GO CHOLESTEROL STORAGE,0.10654,0.12112,0.1439,0,1
2,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.30402,0.11961,0.15989,0,1
2,GO NEPHRON DEVELOPMENT,0.088862,0.1177,0.11667,0,1
2,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.26847,0.11758,0.04733,0,1
2,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.30815,0.11751,0.067843,0,1
2,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.093897,0.11597,0.16274,0,1
2,GO HISTONE UBIQUITINATION,0.088862,0.11564,0.066123,0,1
2,GO EXIT FROM MITOSIS,0.088862,0.11516,0.064135,0,1
2,GO REGULATION OF CELL MATURATION,0.088862,0.11449,0.12117,0,1
2,GO BILE ACID METABOLIC PROCESS,0.057089,0.11361,0.15449,0,1
2,GO AMYLOID BETA METABOLIC PROCESS,0.22905,0.11272,0.052374,0,1
2,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.26847,0.11175,0.089364,0,1
2,GO REGULATION OF CHROMATIN ASSEMBLY,0.054842,0.11128,0.087777,0,1
2,GO POSITIVE REGULATION OF HEART GROWTH,0.077957,0.11106,0.11157,0,1
2,GO RESPONSE TO LEPTIN,0.2839,0.11018,0.063978,0,1
2,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.52594,0.10933,0.029219,0,1
2,GO SPHINGOID METABOLIC PROCESS,0.12689,0.10921,0.11144,0,1
2,GO SPLEEN DEVELOPMENT,0.079444,0.10899,0.11865,0,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.060602,0.10815,0.12756,0,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.059411,0.10776,0.12099,0,1
2,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.11636,0.10775,0.076252,0,1
2,GO BODY MORPHOGENESIS,0.94073,0.10764,-0.017362,0,1
2,GO ACTIN FILAMENT DEPOLYMERIZATION,0.0695,0.10759,0.099446,0,1
2,GO LYMPH VESSEL DEVELOPMENT,0.23937,0.10715,0.15126,0,1
2,GO RESPONSE TO INACTIVITY,0.30815,0.10681,0.068087,0,1
2,GO REGULATION OF CELL SUBSTRATE ADHESION,0.13355,0.10663,0.089021,0,1
2,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.088862,0.10546,0.076086,0,1
2,GO HAIR CELL DIFFERENTIATION,0.22568,0.10399,0.075128,0,1
2,GO CELLULAR RESPONSE TO X RAY,0.11235,0.10298,0.17594,0,1
2,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.13583,0.099757,0.070787,0,1
2,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.15264,0.099755,0.09644,0,1
2,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.34256,0.099506,0.078523,0,1
2,GO MESODERMAL CELL DIFFERENTIATION,0.10465,0.099192,0.14364,0,1
2,GO PROTEIN MONOUBIQUITINATION,0.077957,0.098914,0.06319,0,1
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.072231,0.098218,0.070119,0,1
2,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.063042,0.097247,0.075757,0,1
2,GO BONE MORPHOGENESIS,0.068167,0.09644,0.12503,0,1
2,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.087232,0.096435,0.062645,0,1
2,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.34256,0.096344,0.096742,0,1
2,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.16032,0.096189,0.063134,0,1
2,GO REGULATION OF DNA REPAIR,0.079444,0.095058,0.057662,0,1
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.060602,0.094182,0.08205,0,1
2,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.082489,0.09414,0.063575,0,1
2,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.20937,0.092703,0.11412,0,1
2,GO DNA REPLICATION INITIATION,0.23589,0.092476,0.071566,0,1
2,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.1313,0.091865,0.058301,0,1
2,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.14526,0.090379,0.049426,0,1
2,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.072231,0.090359,0.10641,0,1
2,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.23937,0.090124,0.069741,0,1
2,GO KIDNEY EPITHELIUM DEVELOPMENT,0.1313,0.089421,0.12692,0,1
2,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.22905,0.086725,0.068068,0,1
2,GO NEURAL TUBE DEVELOPMENT,0.29184,0.086613,0.092549,0,1
2,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.21905,0.084164,0.054765,0,1
2,GO EPITHELIAL CELL DIFFERENTIATION,0.2,0.084018,0.082088,0,1
2,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.082489,0.083856,0.081404,0,1
2,GO ACTIVATION OF MAPKK ACTIVITY,0.48131,0.083842,0.035298,0,1
2,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.05824,0.082925,0.065111,0,1
2,GO GENITALIA DEVELOPMENT,0.12049,0.080401,0.070371,0,1
2,GO CERAMIDE BIOSYNTHETIC PROCESS,0.18508,0.080097,0.052439,0,1
2,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.079444,0.078719,0.064374,0,1
2,GO PEPTIDYL LYSINE TRIMETHYLATION,0.12689,0.078591,0.068206,0,1
2,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.13583,0.078207,0.030329,0,1
2,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.072231,0.075185,0.061397,0,1
2,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.33812,0.073247,0.051448,0,1
2,GO DNA STRAND ELONGATION,0.30815,0.072537,0.046847,0,1
2,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.27611,0.071197,0.044131,0,1
2,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.22905,0.071195,0.061893,0,1
2,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.67137,0.070719,0.017186,0,1
2,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.17374,0.070333,0.08018,0,1
2,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.4545,0.070059,0.01594,0,1
2,GO IMMUNOLOGICAL MEMORY PROCESS,0.20937,0.069902,0.11581,0,1
2,GO REGULATION OF FEEDING BEHAVIOR,0.080955,0.069672,0.13257,0,1
2,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.52594,0.06857,0.017132,0,1
2,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.47588,0.068109,0.015972,0,1
2,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.19695,0.06755,0.032662,0,1
2,GO DNA DEPENDENT DNA REPLICATION,0.070855,0.06747,0.078884,0,1
2,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.42347,0.066892,0.044659,0,1
2,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.73628,0.066832,-0.0098556,0,1
2,GO LIPID PHOSPHORYLATION,0.10096,0.066729,0.055988,0,1
2,GO POLYOL CATABOLIC PROCESS,0.20621,0.065999,0.04707,0,1
2,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.53167,0.065404,0.030318,0,1
2,GO NEURAL TUBE FORMATION,0.11039,0.063658,0.11713,0,1
2,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.20621,0.063312,0.089835,0,1
2,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.17374,0.06218,0.10736,0,1
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.055956,0.059895,0.080027,0,1
2,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.47049,0.059545,0.024318,0,1
2,GO NEGATIVE REGULATION OF CELL CYCLE,0.12689,0.059295,0.050526,0,1
2,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.097379,0.059264,0.050593,0,1
2,GO MEMBRANE LIPID METABOLIC PROCESS,0.23937,0.058502,0.0282,0,1
2,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.072231,0.057372,0.042179,0,1
2,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.27999,0.057258,0.020029,0,1
2,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.087232,0.05687,0.044303,0,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.13355,0.056524,0.037642,0,1
2,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.076492,0.054714,0.073762,0,1
2,GO PEPTIDYL AMINO ACID MODIFICATION,0.073629,0.054566,0.046402,0,1
2,GO SPHINGOLIPID METABOLIC PROCESS,0.36991,0.05315,0.013936,0,1
2,GO RESPONSE TO LIGHT STIMULUS,0.097379,0.052565,0.04853,0,1
2,GO REGULATION OF RNA SPLICING,0.11434,0.049129,0.064477,0,1
2,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.84397,0.048118,0.0097135,0,1
2,GO CELL CYCLE G2 M PHASE TRANSITION,0.073629,0.047949,0.063547,0,1
2,GO RECOMBINATIONAL REPAIR,0.32506,0.047318,0.060457,0,1
2,GO REGULATION OF ATPASE ACTIVITY,0.13355,0.046244,0.054773,0,1
2,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.60272,0.045751,0.0099525,0,1
2,GO REGULATION OF TRANSFERASE ACTIVITY,0.24643,0.045723,0.033676,0,1
2,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.060602,0.045243,0.070766,0,1
2,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.22568,0.044901,0.030597,0,1
2,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.14048,0.044477,0.043083,0,1
2,GO PROTEIN HETEROTETRAMERIZATION,0.58456,0.043855,0.027109,0,1
2,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.20937,0.043799,0.048456,0,1
2,GO REGULATION OF CHROMATIN ORGANIZATION,0.19095,0.043626,0.042786,0,1
2,GO MYOFIBRIL ASSEMBLY,0.27611,0.043396,0.044495,0,1
2,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.10845,0.04019,0.081764,0,1
2,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.16294,0.039028,0.031862,0,1
2,GO REGULATION OF ORGANELLE ORGANIZATION,0.35607,0.035477,0.020796,0,1
2,GO COVALENT CHROMATIN MODIFICATION,0.13355,0.033243,0.039948,0,1
2,GO PEPTIDYL LYSINE MODIFICATION,0.077957,0.028043,0.041344,0,1
2,GO CELL CYCLE PROCESS,0.088862,0.027517,0.046,0,1
2,GO CHROMATIN ORGANIZATION,0.23589,0.023718,0.03341,0,1
2,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.0037331,0.58809,0.38473,0,0
2,GO RESPONSE TO INTERFERON ALPHA,0.063042,0.54113,0.22231,0,0
2,GO HOMOCYSTEINE METABOLIC PROCESS,0.0042883,0.42078,0.35767,0,0
2,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.012508,0.39302,0.25517,0,0
2,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.16294,0.39154,0.28594,0,0
2,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.0057817,0.3878,0.26355,0,0
2,GO REGULATION OF PLASMINOGEN ACTIVATION,0.082489,0.37762,0.26315,0,0
2,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.00029782,0.34843,0.37059,0,0
2,GO REGULATION OF GLOMERULAR FILTRATION,0.099158,0.31969,0.23045,0,0
2,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.56666,0.31933,0.038372,0,0
2,GO RETINAL ROD CELL DIFFERENTIATION,0.050569,0.31374,0.16713,0,0
2,GO RENAL VESICLE DEVELOPMENT,0.0069616,0.30486,0.24256,0,0
2,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.019283,0.30472,0.30503,0,0
2,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.033894,0.29084,0.31826,0,0
2,GO IMP METABOLIC PROCESS,0.060602,0.28529,0.25349,0,0
2,GO DETOXIFICATION,0.00023468,0.28367,0.25648,0,0
2,GO REGULATION OF METANEPHROS DEVELOPMENT,0.077957,0.27839,0.26011,0,0
2,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.093897,0.2779,0.20106,0,0
2,GO RESPONSE TO TYPE I INTERFERON,0.082489,0.27709,0.15385,0,0
2,GO MEMBRANE RAFT ASSEMBLY,0.44402,0.27411,0.019861,0,0
2,GO TETRAHYDROFOLATE INTERCONVERSION,0.00052342,0.2726,0.39055,0,0
2,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.19095,0.26562,0.11913,0,0
2,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.063042,0.26146,0.21245,0,0
2,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.011047,0.2531,0.31198,0,0
2,GO NUCLEOTIDE SALVAGE,0.27227,0.25074,0.12218,0,0
2,GO CELLULAR RESPONSE TO ETHANOL,0.0024367,0.25058,0.24338,0,0
2,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.03245,0.24865,0.26531,0,0
2,GO ZYMOGEN ACTIVATION,0.088862,0.246,0.19494,0,0
2,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.011612,0.24511,0.23128,0,0
2,GO AMINO ACID ACTIVATION,0.00012512,0.2448,0.28844,0,0
2,GO HYALURONAN CATABOLIC PROCESS,0.32938,0.24062,0.099074,0,0
2,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.26471,0.23828,0.060823,0,0
2,GO CELLULAR AMINO ACID CATABOLIC PROCESS,8.4205e-05,0.2378,0.21736,0,0
2,GO ENDODERMAL CELL DIFFERENTIATION,0.38408,0.23773,0.10749,0,0
2,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.00032948,0.23636,0.18846,0,0
2,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.13355,0.23608,0.15843,0,0
2,GO CELLULAR RESPONSE TO CADMIUM ION,0.22905,0.23287,0.17104,0,0
2,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.4978,0.23175,0.033712,0,0
2,GO HEART VALVE FORMATION,0.18219,0.22788,0.16582,0,0
2,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.05161,0.22623,0.21643,0,0
2,GO CYTOCHROME COMPLEX ASSEMBLY,0.0051916,0.22504,0.19169,0,0
2,GO ARGININE METABOLIC PROCESS,0.042857,0.22346,0.19524,0,0
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.001191,0.22342,0.23147,0,0
2,GO GAP JUNCTION ASSEMBLY,0.31232,0.2231,0.085722,0,0
2,GO ALPHA AMINO ACID CATABOLIC PROCESS,6.7596e-05,0.22022,0.21071,0,0
2,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.057089,0.21735,0.17258,0,0
2,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.25729,0.21603,0.12694,0,0
2,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.0024367,0.21452,0.16188,0,0
2,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.11841,0.21248,0.19384,0,0
2,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.10465,0.21225,0.13291,0,0
2,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.00017186,0.21095,0.22245,0,0
2,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.0695,0.21084,0.10684,0,0
2,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.0073363,0.20983,0.34947,0,0
2,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.20621,0.2098,0.14021,0,0
2,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0695,0.20974,0.13068,0,0
2,GO TROPHOBLAST CELL MIGRATION,0.068167,0.20951,0.1586,0,0
2,GO DETECTION OF OTHER ORGANISM,0.12908,0.20762,0.083082,0,0
2,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.10465,0.20713,0.18127,0,0
2,GO THIOESTER METABOLIC PROCESS,0.0017123,0.20708,0.19953,0,0
2,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.12049,0.20656,0.15656,0,0
2,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.055956,0.20611,0.19914,0,0
2,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.037747,0.2052,0.14902,0,0
2,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.080955,0.20477,0.14161,0,0
2,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.073629,0.20446,0.19594,0,0
2,GO COPPER ION TRANSPORT,0.009256,0.2032,0.1839,0,0
2,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.18219,0.20133,0.14194,0,0
2,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.41842,0.20094,0.067461,0,0
2,GO REGULATION OF CELLULAR RESPIRATION,0.025414,0.19993,0.16782,0,0
2,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.077957,0.19846,0.17008,0,0
2,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.17099,0.19838,0.077583,0,0
2,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.0695,0.19812,0.13539,0,0
2,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.12689,0.19668,0.11638,0,0
2,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.19095,0.19591,0.096522,0,0
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.20937,0.19587,0.11256,0,0
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.12049,0.19584,0.11147,0,0
2,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.27999,0.19559,0.17439,0,0
2,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.10845,0.19376,0.14501,0,0
2,GO CHYLOMICRON ASSEMBLY,0.010245,0.19239,0.13701,0,0
2,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.19393,0.19236,0.041747,0,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.070855,0.19227,0.17953,0,0
2,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,0.054842,0.19195,0.23784,0,0
2,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.23245,0.19122,0.070318,0,0
2,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.087232,0.19109,0.11793,0,0
2,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.39371,0.19101,0.049554,0,0
2,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.11434,0.19048,0.095229,0,0
2,GO CYTIDINE TO URIDINE EDITING,0.099158,0.18903,0.26021,0,0
2,GO VASCULOGENESIS,0.055956,0.18889,0.14778,0,0
2,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.1313,0.18883,0.28085,0,0
2,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.088862,0.18848,0.1969,0,0
2,GO ELASTIC FIBER ASSEMBLY,0.077957,0.1882,0.22282,0,0
2,GO PROTEIN ACTIVATION CASCADE,0.072231,0.18518,0.19348,0,0
2,GO MINERALOCORTICOID METABOLIC PROCESS,0.29184,0.18435,0.078925,0,0
2,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.16559,0.18416,0.10967,0,0
2,GO REGULATION OF FATTY ACID OXIDATION,0.064293,0.18338,0.12435,0,0
2,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.63978,0.18262,0.0021483,0,0
2,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.12473,0.18182,0.11063,0,0
2,GO HISTAMINE TRANSPORT,0.16032,0.1811,0.11397,0,0
2,GO CELL AGGREGATION,0.018398,0.1811,0.17618,0,0
2,GO TRICARBOXYLIC ACID CYCLE,0.0022332,0.18054,0.22706,0,0
2,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.084046,0.18006,0.10998,0,0
2,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.079444,0.17995,0.14984,0,0
2,GO PEPTIDYL PROLINE HYDROXYLATION,0.20937,0.17896,0.11266,0,0
2,GO GLYCOLIPID CATABOLIC PROCESS,0.31232,0.17875,0.052113,0,0
2,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.073629,0.17874,0.13278,0,0
2,GO VIRAL GENOME REPLICATION,0.065563,0.17838,0.13495,0,0
2,GO EMBRYO IMPLANTATION,0.068167,0.17722,0.12447,0,0
2,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0029794,0.17721,0.16503,0,0
2,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.073629,0.17551,0.11475,0,0
2,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.05824,0.17372,0.095999,0,0
2,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.10465,0.17281,0.22753,0,0
2,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.059411,0.17272,0.11077,0,0
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0014738,0.17259,0.17271,0,0
2,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.087232,0.17181,0.11405,0,0
2,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.8303,0.17173,-0.021904,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.10845,0.17084,0.16805,0,0
2,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.088862,0.17039,0.15067,0,0
2,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.046579,0.17014,0.12077,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.11636,0.1694,0.15093,0,0
2,GO POSITIVE REGULATION OF HAIR CYCLE,0.16032,0.16865,0.19145,0,0
2,GO ENDODERM DEVELOPMENT,0.26847,0.16863,0.10656,0,0
2,GO EMBRYONIC HEMOPOIESIS,0.13583,0.16853,0.10269,0,0
2,GO PROTEIN AUTOPROCESSING,0.15015,0.16767,0.11861,0,0
2,GO EPITHELIAL CELL FATE COMMITMENT,0.53167,0.16765,0.038435,0,0
2,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.44402,0.16763,0.035114,0,0
2,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.1313,0.16705,0.12838,0,0
2,GO FOREBRAIN MORPHOGENESIS,0.17374,0.16695,0.11023,0,0
2,GO DENDRITIC CELL DIFFERENTIATION,0.32938,0.16689,0.043929,0,0
2,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.20621,0.16687,0.1257,0,0
2,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.092194,0.16684,0.13711,0,0
2,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.13814,0.16669,0.10982,0,0
2,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.11235,0.16663,0.09743,0,0
2,GO RESPONSE TO DEXAMETHASONE,0.060602,0.16635,0.14814,0,0
2,GO CERAMIDE TRANSPORT,0.17374,0.16584,0.13205,0,0
2,GO NEGATIVE REGULATION OF CELL AGING,0.23245,0.16551,0.11312,0,0
2,GO PENILE ERECTION,0.22568,0.16534,0.065227,0,0
2,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.068167,0.16503,0.077257,0,0
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.014138,0.16502,0.47093,0,0
2,GO SKIN MORPHOGENESIS,0.42347,0.16451,0.072708,0,0
2,GO NAD BIOSYNTHETIC PROCESS,0.37932,0.16397,0.084627,0,0
2,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.055956,0.16396,0.17549,0,0
2,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.61497,0.16366,0.018161,0,0
2,GO BRONCHUS DEVELOPMENT,0.23245,0.16304,0.12625,0,0
2,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.073629,0.16297,0.091833,0,0
2,GO CYTOLYSIS,0.17099,0.16233,0.12004,0,0
2,GO HYPOTONIC RESPONSE,0.11039,0.162,0.1295,0,0
2,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.023205,0.16192,0.14178,0,0
2,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.12689,0.16184,0.15446,0,0
2,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.21905,0.16119,0.14073,0,0
2,GO INTERMEDIATE FILAMENT ORGANIZATION,0.0050528,0.16108,0.23242,0,0
2,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.22235,0.1605,0.14003,0,0
2,GO NAD METABOLIC PROCESS,0.11235,0.16039,0.12541,0,0
2,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.31232,0.16014,0.08255,0,0
2,GO DEFENSE RESPONSE TO VIRUS,0.053746,0.15992,0.12457,0,0
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.48131,0.15964,0.012996,0,0
2,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.15264,0.15934,0.10203,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.29992,0.15824,0.081431,0,0
2,GO COPPER ION HOMEOSTASIS,0.14526,0.15823,0.058481,0,0
2,GO MALE SEX DETERMINATION,0.088862,0.15768,0.14581,0,0
2,GO NUCLEOSIDE CATABOLIC PROCESS,0.54903,0.15754,0.01227,0,0
2,GO EMBRYONIC BRAIN DEVELOPMENT,0.063042,0.15644,0.1737,0,0
2,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.092194,0.1561,0.11948,0,0
2,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.31232,0.15558,0.20794,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.11235,0.15541,0.12413,0,0
2,GO GOLGI TO VACUOLE TRANSPORT,0.27611,0.15487,0.073976,0,0
2,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.26471,0.15469,0.071473,0,0
2,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.0087944,0.15451,0.1445,0,0
2,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.099158,0.1544,0.14888,0,0
2,GO REGULATION OF PLATELET ACTIVATION,0.16559,0.15364,0.10391,0,0
2,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.21905,0.15361,0.068908,0,0
2,GO ELECTRON TRANSPORT CHAIN,0.0075304,0.15341,0.1267,0,0
2,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.0064317,0.15296,0.14558,0,0
2,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.079444,0.15288,0.14247,0,0
2,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.11636,0.15262,0.11212,0,0
2,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.58456,0.15238,0.010018,0,0
2,GO MACROPHAGE APOPTOTIC PROCESS,0.084046,0.15148,0.12569,0,0
2,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.093897,0.15144,0.12422,0,0
2,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.14769,0.15085,0.11782,0,0
2,GO RESPONSE TO VIRUS,0.059411,0.15,0.099898,0,0
2,GO MEMBRANE RAFT ORGANIZATION,0.4598,0.14994,0.047045,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.19695,0.1499,0.13802,0,0
2,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.27611,0.14969,0.089586,0,0
2,GO COCHLEA MORPHOGENESIS,0.023741,0.14914,0.15472,0,0
2,GO POSITIVE REGULATION OF NEURON MIGRATION,0.1028,0.14911,0.12537,0,0
2,GO KIDNEY MESENCHYME DEVELOPMENT,0.068167,0.14909,0.15697,0,0
2,GO HISTAMINE SECRETION,0.092194,0.14889,0.15752,0,0
2,GO INTRACELLULAR MRNA LOCALIZATION,0.27999,0.14869,0.12168,0,0
2,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.014138,0.14815,0.12236,0,0
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.079444,0.14797,0.08087,0,0
2,GO RESPONSE TO THYROID HORMONE,0.064293,0.14797,0.16201,0,0
2,GO ANION HOMEOSTASIS,0.049546,0.14786,0.13483,0,0
2,GO MULTI ORGANISM CELLULAR PROCESS,0.19095,0.14704,0.093555,0,0
2,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.099158,0.14695,0.075805,0,0
2,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.56075,0.14566,0.033947,0,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.080955,0.14554,0.1267,0,0
2,GO LIPOPROTEIN CATABOLIC PROCESS,0.057089,0.14532,0.14845,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.40349,0.14509,0.055244,0,0
2,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.26847,0.14406,0.053756,0,0
2,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.12259,0.14405,0.095081,0,0
2,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.3746,0.14401,0.058861,0,0
2,GO CELLULAR RESPONSE TO DSRNA,0.093897,0.14396,0.089456,0,0
2,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.077957,0.1439,0.13831,0,0
2,GO POSITIVE REGULATION OF CELL AGING,0.0695,0.14388,0.12377,0,0
2,GO POSITIVE REGULATION OF HEAT GENERATION,0.30402,0.14372,0.078414,0,0
2,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.10845,0.14315,0.095776,0,0
2,GO RESPONSE TO COPPER ION,0.25363,0.14301,0.13107,0,0
2,GO INNER EAR MORPHOGENESIS,0.055956,0.1429,0.11297,0,0
2,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.060602,0.14229,0.1496,0,0
2,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.13814,0.14202,0.14797,0,0
2,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.079444,0.14194,0.12858,0,0
2,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.14769,0.14187,0.068057,0,0
2,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.085627,0.14173,0.11721,0,0
2,GO MACROPHAGE PROLIFERATION,0.32077,0.14173,0.087752,0,0
2,GO PROTEIN TARGETING TO MITOCHONDRION,0.070855,0.14156,0.093252,0,0
2,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.21256,0.14155,0.17677,0,0
2,GO SOMATIC STEM CELL DIVISION,0.33373,0.14148,0.1415,0,0
2,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.065563,0.1414,0.1243,0,0
2,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.10654,0.14132,0.095675,0,0
2,GO SUPEROXIDE METABOLIC PROCESS,0.072231,0.14087,0.10585,0,0
2,GO REGULATION OF ANOIKIS,0.15773,0.14065,0.1159,0,0
2,GO AMINO ACID BETAINE METABOLIC PROCESS,0.25001,0.14053,0.050568,0,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.13583,0.14016,0.089871,0,0
2,GO V D J RECOMBINATION,0.10654,0.13993,0.14102,0,0
2,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.090515,0.13993,0.090351,0,0
2,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.080955,0.13988,0.14825,0,0
2,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.10096,0.13961,0.092271,0,0
2,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.25001,0.1396,0.075345,0,0
2,GO NEGATIVE REGULATION OF AUTOPHAGY,0.009256,0.13947,0.11403,0,0
2,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.72969,0.13933,-0.008866,0,0
2,GO CORONARY VASCULATURE MORPHOGENESIS,0.34702,0.13923,0.077272,0,0
2,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.05824,0.13917,0.10256,0,0
2,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.099158,0.13848,0.10269,0,0
2,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.092194,0.13818,0.10126,0,0
2,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.064293,0.13815,0.089921,0,0
2,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.060602,0.13814,0.093329,0,0
2,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.11841,0.13786,0.1347,0,0
2,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.36991,0.13785,0.10663,0,0
2,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.17653,0.13774,0.13468,0,0
2,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.27227,0.13761,0.036422,0,0
2,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.13814,0.13738,0.12182,0,0
2,GO HEMIDESMOSOME ASSEMBLY,0.070855,0.13729,0.32097,0,0
2,GO INTERLEUKIN 1 BETA PRODUCTION,0.079444,0.13675,0.1534,0,0
2,GO REGULATION OF STEROL TRANSPORT,0.11841,0.1366,0.10535,0,0
2,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.14769,0.13653,0.031313,0,0
2,GO LEUKOCYTE HOMEOSTASIS,0.1313,0.13639,0.063869,0,0
2,GO RETINAL CONE CELL DIFFERENTIATION,0.31653,0.1363,0.12241,0,0
2,GO REGULATION OF AMYLOID BETA CLEARANCE,0.28785,0.13615,0.070826,0,0
2,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.092194,0.13604,0.16583,0,0
2,GO PROGESTERONE METABOLIC PROCESS,0.28785,0.13587,0.14681,0,0
2,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.11235,0.13587,0.10433,0,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.12908,0.1355,0.061498,0,0
2,GO PLASMA MEMBRANE FUSION,0.27999,0.13487,0.063169,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.079444,0.13486,0.09668,0,0
2,GO MEMBRANE HYPERPOLARIZATION,0.61497,0.13482,0.0336,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.055956,0.13462,0.096665,0,0
2,GO RESPONSE TO TESTOSTERONE,0.16559,0.13454,0.095674,0,0
2,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.25001,0.13426,0.085579,0,0
2,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.084046,0.13404,0.10988,0,0
2,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.23589,0.13391,0.11047,0,0
2,GO MUSCLE CELL MIGRATION,0.070855,0.13384,0.13158,0,0
2,GO PROXIMAL DISTAL PATTERN FORMATION,0.53742,0.13374,0.075356,0,0
2,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.13355,0.13276,0.065381,0,0
2,GO MYOBLAST FUSION,0.24288,0.13208,0.052877,0,0
2,GO NEGATIVE REGULATION OF WOUND HEALING,0.40843,0.13206,0.039793,0,0
2,GO ACTIN CROSSLINK FORMATION,0.27999,0.13198,0.049633,0,0
2,GO GASTRULATION,0.24288,0.1316,0.091063,0,0
2,GO MITOCHONDRIAL RNA PROCESSING,0.050569,0.13139,0.13625,0,0
2,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.53742,0.13123,0.083537,0,0
2,GO COAGULATION,0.12049,0.13102,0.067262,0,0
2,GO STORE OPERATED CALCIUM ENTRY,0.12049,0.13099,0.12141,0,0
2,GO GDP METABOLIC PROCESS,0.33812,0.13079,0.078605,0,0
2,GO PROTEIN HYDROXYLATION,0.18508,0.13071,0.074944,0,0
2,GO FIBROBLAST PROLIFERATION,0.21256,0.13067,0.090643,0,0
2,GO REGULATION OF COAGULATION,0.54903,0.1304,0.040398,0,0
2,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.14526,0.13037,0.063631,0,0
2,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.11434,0.13015,0.10944,0,0
2,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.62732,0.13006,0.0037658,0,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.085627,0.12976,0.18558,0,0
2,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.11841,0.12957,0.1228,0,0
2,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.38888,0.12944,0.067557,0,0
2,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.21579,0.12935,0.052737,0,0
2,GO IMMATURE T CELL PROLIFERATION,0.12259,0.12925,0.14068,0,0
2,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.1313,0.12919,0.079426,0,0
2,GO MEMBRANE PROTEIN PROTEOLYSIS,0.1028,0.12868,0.080478,0,0
2,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.29586,0.12856,0.075636,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.16828,0.12843,0.08257,0,0
2,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.23245,0.12822,0.08049,0,0
2,GO LEUKOCYTE AGGREGATION,0.27227,0.12819,0.11164,0,0
2,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.15015,0.12816,0.088549,0,0
2,GO INFLAMMATORY RESPONSE,0.085627,0.12814,0.061529,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.085627,0.12767,0.10489,0,0
2,GO FILOPODIUM ASSEMBLY,0.51459,0.12761,0.023456,0,0
2,GO RESPONSE TO IMMOBILIZATION STRESS,0.4545,0.12746,0.023906,0,0
2,GO RRNA 3 END PROCESSING,0.088862,0.12745,0.11038,0,0
2,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.33373,0.12736,0.05348,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.10654,0.1268,0.1099,0,0
2,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.066855,0.12677,0.11821,0,0
2,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.20621,0.12664,0.21301,0,0
2,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.188,0.12639,0.090517,0,0
2,GO NEGATIVE REGULATION OF CELL SIZE,0.079444,0.12625,0.10138,0,0
2,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.090515,0.12583,0.13983,0,0
2,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.12473,0.12577,0.11613,0,0
2,GO POSITIVE REGULATION OF CELL SIZE,0.16828,0.12538,0.13284,0,0
2,GO REGULATION OF PROTEOLYSIS,0.0695,0.12535,0.07339,0,0
2,GO HEPATOCYTE APOPTOTIC PROCESS,0.060602,0.12528,0.3753,0,0
2,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.12049,0.12507,0.069283,0,0
2,GO MYELIN ASSEMBLY,0.38408,0.12493,0.079493,0,0
2,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.17099,0.12488,0.061163,0,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.64605,0.12462,0.021644,0,0
2,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.54321,0.12457,0.052761,0,0
2,GO METANEPHRIC NEPHRON DEVELOPMENT,0.084046,0.1245,0.15396,0,0
2,GO REGULATION OF HISTONE PHOSPHORYLATION,0.2839,0.12441,0.10232,0,0
2,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.11841,0.12402,0.11408,0,0
2,GO COLLECTING DUCT DEVELOPMENT,0.21256,0.12287,0.1068,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.40843,0.12287,0.041964,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.48131,0.12276,0.087928,0,0
2,GO RESPONSE TO VITAMIN A,0.092194,0.12268,0.15362,0,0
2,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.066855,0.12262,0.091816,0,0
2,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.42855,0.12241,0.14488,0,0
2,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.12689,0.1224,0.082685,0,0
2,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.39858,0.12175,0.063185,0,0
2,GO EPITHELIAL CELL MORPHOGENESIS,0.15773,0.12124,0.16123,0,0
2,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.029068,0.12124,0.11861,0,0
2,GO MAST CELL ACTIVATION,0.14285,0.12117,0.10219,0,0
2,GO ADHESION OF SYMBIONT TO HOST,0.2,0.12095,0.1175,0,0
2,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.21579,0.12041,0.040357,0,0
2,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.057089,0.12041,0.12085,0,0
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.22568,0.1204,0.097014,0,0
2,GO RESPONSE TO FATTY ACID,0.079444,0.12023,0.10232,0,0
2,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.033894,0.12019,0.15197,0,0
2,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.33812,0.11995,0.033225,0,0
2,GO REGULATION OF RUFFLE ASSEMBLY,0.073629,0.1199,0.099555,0,0
2,GO NEGATIVE REGULATION OF LIPID STORAGE,0.14769,0.11968,0.06432,0,0
2,GO RENAL ABSORPTION,0.20621,0.11918,0.15836,0,0
2,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.60272,0.11917,0.028142,0,0
2,GO KERATINOCYTE MIGRATION,0.080955,0.11906,0.11853,0,0
2,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.097379,0.11906,0.12386,0,0
2,GO CARNITINE METABOLIC PROCESS,0.29992,0.11888,0.049815,0,0
2,GO CELLULAR RESPONSE TO ZINC ION,0.4545,0.11878,0.21283,0,0
2,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.23937,0.11867,0.17945,0,0
2,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.072231,0.11849,0.10903,0,0
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.14048,0.11846,0.096823,0,0
2,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.55487,0.11824,0.0074321,0,0
2,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.21579,0.11808,0.056079,0,0
2,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.22905,0.11799,0.12028,0,0
2,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.079444,0.11779,0.10406,0,0
2,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.4598,0.11721,0.019327,0,0
2,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.26471,0.11709,0.052568,0,0
2,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.14526,0.1168,0.15146,0,0
2,GO NEPHRIC DUCT MORPHOGENESIS,0.12473,0.11669,0.31063,0,0
2,GO UV PROTECTION,0.13355,0.11661,0.11273,0,0
2,GO BEHAVIORAL RESPONSE TO PAIN,0.25363,0.11655,0.1283,0,0
2,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.30402,0.11647,0.081891,0,0
2,GO PLASMINOGEN ACTIVATION,0.16828,0.11645,0.12835,0,0
2,GO REGULATION OF LIPID TRANSPORT,0.060602,0.1164,0.08925,0,0
2,GO TONGUE DEVELOPMENT,0.19095,0.11632,0.11962,0,0
2,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.188,0.11623,0.11115,0,0
2,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.099158,0.1162,0.30427,0,0
2,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.21579,0.11505,0.095892,0,0
2,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.13583,0.11501,0.063598,0,0
2,GO PLATELET AGGREGATION,0.092194,0.1149,0.11076,0,0
2,GO MYELOID LEUKOCYTE MIGRATION,0.073629,0.1149,0.073663,0,0
2,GO NEPHRON MORPHOGENESIS,0.16294,0.11469,0.07751,0,0
2,GO REGULATION OF WOUND HEALING,0.25001,0.11457,0.074979,0,0
2,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.9686,0.11446,-0.0006603,0,0
2,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.62113,0.11428,-0.0079114,0,0
2,GO WOUND HEALING,0.12259,0.1142,0.081568,0,0
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.30815,0.11409,0.047113,0,0
2,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.20621,0.11406,0.073129,0,0
2,GO LIPID LOCALIZATION,0.05824,0.11397,0.069322,0,0
2,GO ENDODERM FORMATION,0.44924,0.11395,0.07845,0,0
2,GO EAR MORPHOGENESIS,0.017969,0.11382,0.13164,0,0
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.32506,0.11341,0.043418,0,0
2,GO AUTOPHAGY OF NUCLEUS,0.17374,0.11324,0.069741,0,0
2,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.12689,0.11318,0.13556,0,0
2,GO REGULATION OF HISTONE H4 ACETYLATION,0.22568,0.11314,0.10885,0,0
2,GO FATTY ACYL COA METABOLIC PROCESS,0.025994,0.11296,0.17457,0,0
2,GO PROTEIN PROCESSING,0.32938,0.11263,0.048001,0,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.11434,0.11249,0.084839,0,0
2,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.40843,0.11248,0.097408,0,0
2,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.27227,0.11221,0.088019,0,0
2,GO ACUTE INFLAMMATORY RESPONSE,0.19695,0.11214,0.057077,0,0
2,GO REGULATION OF FIBRINOLYSIS,0.15264,0.11211,0.099759,0,0
2,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.47588,0.11205,0.030682,0,0
2,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.057089,0.11197,0.08541,0,0
2,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.053746,0.11196,0.11981,0,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.059411,0.11195,0.15856,0,0
2,GO REGULATION OF ACTIN NUCLEATION,0.12689,0.11137,0.13614,0,0
2,GO OLIGOPEPTIDE TRANSPORT,0.17653,0.11127,0.1901,0,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.076492,0.11116,0.10593,0,0
2,GO ZINC ION HOMEOSTASIS,0.13814,0.11109,0.20186,0,0
2,GO BASE EXCISION REPAIR AP SITE FORMATION,0.42347,0.11091,0.082201,0,0
2,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.43367,0.11053,0.026849,0,0
2,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.54321,0.11039,0.055093,0,0
2,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.075049,0.11039,0.088663,0,0
2,GO RESPONSE TO HYPEROXIA,0.61497,0.11014,0.017471,0,0
2,GO REGULATION OF LIPID LOCALIZATION,0.054842,0.10998,0.084576,0,0
2,GO CELL CHEMOTAXIS,0.066855,0.10986,0.087616,0,0
2,GO VITAMIN D METABOLIC PROCESS,0.61497,0.10984,0.016772,0,0
2,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.38408,0.10959,0.077868,0,0
2,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.23245,0.1094,0.062074,0,0
2,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0024367,0.1094,0.11329,0,0
2,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.40349,0.10928,0.079367,0,0
2,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.29586,0.10926,0.13615,0,0
2,GO REGULATION OF MYOBLAST FUSION,0.25363,0.10909,0.062985,0,0
2,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.25001,0.10878,0.099767,0,0
2,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.67776,0.10842,0.033637,0,0
2,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.89907,0.10817,-0.027581,0,0
2,GO KETONE BODY METABOLIC PROCESS,0.21579,0.10801,0.099652,0,0
2,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.43367,0.1079,0.04157,0,0
2,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.30402,0.10781,0.1409,0,0
2,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.75615,0.10733,0.017307,0,0
2,GO NEGATIVE REGULATION OF JNK CASCADE,0.14526,0.10711,0.082571,0,0
2,GO PROSTATE GLAND MORPHOGENESIS,0.40843,0.10707,0.1772,0,0
2,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.76281,0.10697,0.020478,0,0
2,GO CELLULAR RESPONSE TO KETONE,0.11235,0.10677,0.082631,0,0
2,GO POSITIVE REGULATION OF LIPID STORAGE,0.088862,0.10676,0.10972,0,0
2,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.15773,0.10673,0.08894,0,0
2,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.18508,0.10652,0.038049,0,0
2,GO GALACTOSE METABOLIC PROCESS,0.52594,0.10649,0.029711,0,0
2,GO PEPTIDYL ARGININE METHYLATION,0.1313,0.10648,0.095011,0,0
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.26098,0.10637,0.14889,0,0
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.099158,0.10627,0.10818,0,0
2,GO RESPONSE TO LIPID,0.0695,0.1062,0.072828,0,0
2,GO NEURAL CREST CELL MIGRATION,0.32506,0.10617,0.0677,0,0
2,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.059411,0.10605,0.094489,0,0
2,GO RESPONSE TO SALT,0.025414,0.10581,0.16652,0,0
2,GO REGULATION OF BODY FLUID LEVELS,0.10654,0.10573,0.061124,0,0
2,GO RESPONSE TO XENOBIOTIC STIMULUS,0.059411,0.1055,0.1336,0,0
2,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.075049,0.10544,0.17634,0,0
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.21256,0.1053,0.033189,0,0
2,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.22235,0.10485,0.083723,0,0
2,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.15264,0.10456,0.18017,0,0
2,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.054842,0.10455,0.10282,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.092194,0.10451,0.096344,0,0
2,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.18508,0.10447,0.1401,0,0
2,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.38408,0.10443,0.089899,0,0
2,GO REGULATION OF CALCIUM ION IMPORT,0.47049,0.10405,0.025789,0,0
2,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.34702,0.10402,0.090579,0,0
2,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.087232,0.1039,0.12863,0,0
2,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.023741,0.1036,0.13061,0,0
2,GO RESPONSE TO OXYGEN LEVELS,0.061812,0.10352,0.06748,0,0
2,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.41341,0.10341,0.029649,0,0
2,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.14769,0.10338,0.17649,0,0
2,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.18219,0.10315,0.090404,0,0
2,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.14769,0.10305,0.055041,0,0
2,GO MUSCLE FILAMENT SLIDING,0.38408,0.10294,0.057297,0,0
2,GO CELLULAR DEFENSE RESPONSE,0.21579,0.10288,0.023808,0,0
2,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.20937,0.10286,0.061079,0,0
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.22905,0.10279,0.086979,0,0
2,GO CYTOKINETIC PROCESS,0.11636,0.10261,0.10373,0,0
2,GO POSITIVE REGULATION OF TISSUE REMODELING,0.67137,0.1026,0.027999,0,0
2,GO RESPONSE TO RETINOIC ACID,0.17099,0.10255,0.1089,0,0
2,GO ACUTE PHASE RESPONSE,0.10654,0.10216,0.082293,0,0
2,GO T CELL MIGRATION,0.37932,0.10216,0.052318,0,0
2,GO LEUKOCYTE CHEMOTAXIS,0.054842,0.10188,0.079892,0,0
2,GO FIBRINOLYSIS,0.93377,0.10186,-0.018493,0,0
2,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.23937,0.10173,0.13546,0,0
2,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.26471,0.1017,0.086367,0,0
2,GO MEMBRANE INVAGINATION,0.12259,0.10167,0.076923,0,0
2,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.41842,0.10154,0.044147,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.27999,0.10138,0.082795,0,0
2,GO RESPONSE TO DSRNA,0.082489,0.10092,0.076593,0,0
2,GO PEPTIDYL HISTIDINE MODIFICATION,0.20937,0.10088,0.10962,0,0
2,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.22568,0.10084,0.042231,0,0
2,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.59664,0.10081,0.052241,0,0
2,GO ALPHA BETA T CELL PROLIFERATION,0.11841,0.10057,0.080837,0,0
2,GO REGENERATION,0.11434,0.1002,0.081626,0,0
2,GO ACTIN MEDIATED CELL CONTRACTION,0.018398,0.10015,0.12694,0,0
2,GO HYALURONAN METABOLIC PROCESS,0.4545,0.10003,-0.070845,0,0
2,GO INTERLEUKIN 12 PRODUCTION,0.099158,0.099976,0.099231,0,0
2,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.23589,0.09988,0.076684,0,0
2,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.10845,0.099611,0.15451,0,0
2,GO RESPONSE TO NUTRIENT,0.42347,0.099491,0.040713,0,0
2,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.066855,0.099294,0.056174,0,0
2,GO LIVER MORPHOGENESIS,0.20937,0.099285,0.069364,0,0
2,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.049546,0.099204,0.075117,0,0
2,GO MUSCLE ADAPTATION,0.53167,0.09915,0.036455,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.56666,0.099032,0.030653,0,0
2,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.087232,0.098624,0.15229,0,0
2,GO INTERMEDIATE FILAMENT BASED PROCESS,0.23245,0.097973,0.092468,0,0
2,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.37932,0.097927,0.063185,0,0
2,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.32506,0.097921,0.10248,0,0
2,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.42855,0.097736,0.0099991,0,0
2,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.94073,0.097726,-0.026272,0,0
2,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.29992,0.097471,0.041019,0,0
2,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.1028,0.097279,0.11535,0,0
2,GO ACTIN FILAMENT BASED TRANSPORT,0.26471,0.097242,0.090795,0,0
2,GO MRNA EXPORT FROM NUCLEUS,0.00037661,0.097151,0.15034,0,0
2,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.15517,0.096737,0.071417,0,0
2,GO PURINE CONTAINING COMPOUND SALVAGE,0.065563,0.096697,0.16723,0,0
2,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.12473,0.096681,0.084971,0,0
2,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.71006,0.096537,0.024914,0,0
2,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.072231,0.096436,0.084495,0,0
2,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.51459,0.096297,0.072128,0,0
2,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.060602,0.096202,0.15998,0,0
2,GO LIPID STORAGE,0.11039,0.096141,0.07665,0,0
2,GO TISSUE REGENERATION,0.063042,0.095834,0.11722,0,0
2,GO PHOSPHOLIPID HOMEOSTASIS,0.22568,0.095769,0.10472,0,0
2,GO REGULATION OF SENSORY PERCEPTION,0.13583,0.095613,0.10298,0,0
2,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.56075,0.095587,0.015111,0,0
2,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.24288,0.095559,0.056253,0,0
2,GO POSITIVE REGULATION OF MYELINATION,0.15015,0.095451,0.086097,0,0
2,GO METHIONINE METABOLIC PROCESS,0.58456,0.095339,0.0018157,0,0
2,GO MANGANESE ION TRANSPORT,0.30815,0.094835,0.063081,0,0
2,GO REGULATION OF STEM CELL DIVISION,0.39371,0.094815,0.097405,0,0
2,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.063042,0.094804,0.063511,0,0
2,GO PROTEOLYSIS,0.064293,0.09465,0.054824,0,0
2,GO MITOCHONDRIAL TRNA PROCESSING,0.13814,0.094647,0.10892,0,0
2,GO CELLULAR RESPONSE TO FATTY ACID,0.61497,0.094526,0.032514,0,0
2,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.68418,0.094423,0.019796,0,0
2,GO DRUG CATABOLIC PROCESS,0.33373,0.094332,0.050661,0,0
2,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.20621,0.094244,0.10102,0,0
2,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.090515,0.094207,0.066378,0,0
2,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.11434,0.094117,0.11679,0,0
2,GO COENZYME A METABOLIC PROCESS,0.13583,0.094107,0.087217,0,0
2,GO RENAL FILTRATION,0.63354,0.094037,0.00096906,0,0
2,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.1313,0.094024,0.096368,0,0
2,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.42855,0.093847,0.090528,0,0
2,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.16294,0.093667,0.073057,0,0
2,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.03939,0.093606,0.13947,0,0
2,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.97557,0.093433,-0.054127,0,0
2,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.00026903,0.093346,0.10056,0,0
2,GO RESPONSE TO DRUG,0.11636,0.093337,0.064976,0,0
2,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.5726,0.093292,0.012496,0,0
2,GO REGULATION OF RENAL SYSTEM PROCESS,0.31653,0.093155,0.062193,0,0
2,GO OSTEOBLAST PROLIFERATION,0.188,0.093068,0.10656,0,0
2,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.061812,0.092713,0.099242,0,0
2,GO GLUCOSE CATABOLIC PROCESS,0.16294,0.092678,0.11635,0,0
2,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.21905,0.092669,0.094173,0,0
2,GO REGULATION OF HELICASE ACTIVITY,0.21256,0.09258,0.092422,0,0
2,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.1028,0.092521,0.15063,0,0
2,GO MESONEPHROS DEVELOPMENT,0.29586,0.092384,0.075402,0,0
2,GO MUSCLE CELL PROLIFERATION,0.17653,0.092315,0.080449,0,0
2,GO NEGATIVE REGULATION OF DNA REPLICATION,0.59059,0.092213,0.08617,0,0
2,GO ER NUCLEUS SIGNALING PATHWAY,0.18508,0.092175,0.084447,0,0
2,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.036948,0.092147,0.084753,0,0
2,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.20937,0.092023,0.057879,0,0
2,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.22235,0.091694,0.080191,0,0
2,GO NEUTROPHIL MIGRATION,0.17099,0.091633,0.032042,0,0
2,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.15517,0.091431,0.12159,0,0
2,GO LABYRINTHINE LAYER DEVELOPMENT,0.24643,0.091392,0.096258,0,0
2,GO BLOOD VESSEL MORPHOGENESIS,0.32938,0.091315,0.066117,0,0
2,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.05824,0.091289,0.27887,0,0
2,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.14048,0.091261,0.11753,0,0
2,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.12689,0.091074,0.047437,0,0
2,GO CELLULAR RESPONSE TO INTERFERON BETA,0.39371,0.091067,0.087993,0,0
2,GO PROTEIN NITROSYLATION,0.43367,0.091042,0.079073,0,0
2,GO REGULATION OF BONE MINERALIZATION,0.42347,0.090986,0.045114,0,0
2,GO MOLTING CYCLE,0.11636,0.090904,0.12444,0,0
2,GO RESPONSE TO PROGESTERONE,0.25729,0.090795,0.10099,0,0
2,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.47049,0.090757,0.051336,0,0
2,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.41842,0.090617,0.070806,0,0
2,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.26847,0.090611,0.08548,0,0
2,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.22568,0.090496,0.046941,0,0
2,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.072231,0.090322,0.11147,0,0
2,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.20309,0.090209,0.06768,0,0
2,GO GLOMERULUS DEVELOPMENT,0.11235,0.090139,0.1677,0,0
2,GO CELLULAR RESPONSE TO COPPER ION,0.25001,0.090106,0.21318,0,0
2,GO REGULATION OF NUCLEASE ACTIVITY,0.13583,0.089697,0.09415,0,0
2,GO ASTROCYTE DEVELOPMENT,0.41842,0.089405,0.056937,0,0
2,GO PROTEIN MATURATION,0.13814,0.089251,0.054372,0,0
2,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.063042,0.089166,0.06544,0,0
2,GO ORGANELLE INHERITANCE,0.057089,0.089061,0.063955,0,0
2,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.036948,0.088925,0.086146,0,0
2,GO PEPTIDYL ARGININE N METHYLATION,0.19695,0.08886,0.11773,0,0
2,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.37932,0.088799,0.072739,0,0
2,GO MACROPHAGE ACTIVATION,0.075049,0.088741,0.058071,0,0
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.31232,0.088665,0.091196,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.35607,0.088611,0.064784,0,0
2,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.12049,0.088419,0.087538,0,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.9686,0.088383,-0.024385,0,0
2,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.16828,0.088368,0.055699,0,0
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.084046,0.088338,0.08885,0,0
2,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.98255,0.088299,-0.014168,0,0
2,GO RESPONSE TO PEPTIDOGLYCAN,0.075049,0.088034,0.0786,0,0
2,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.25729,0.087746,0.04585,0,0
2,GO CELL CELL ADHESION,0.20937,0.08758,0.048905,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.11636,0.087563,0.069361,0,0
2,GO AORTA MORPHOGENESIS,0.64605,0.087484,0.03621,0,0
2,GO DENDRITIC CELL APOPTOTIC PROCESS,0.27227,0.087448,0.10435,0,0
2,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.59059,0.08732,-0.01058,0,0
2,GO REGULATION OF MACROPHAGE MIGRATION,0.080955,0.087273,0.1248,0,0
2,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.064293,0.087165,0.065531,0,0
2,GO PERICARDIUM DEVELOPMENT,0.18508,0.087023,0.12926,0,0
2,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.14048,0.08695,0.091156,0,0
2,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.12049,0.0869,0.042364,0,0
2,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.17099,0.086829,0.052305,0,0
2,GO RESPONSE TO ETHANOL,0.16828,0.086561,0.066735,0,0
2,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.38408,0.086494,0.034244,0,0
2,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.23937,0.086227,0.046253,0,0
2,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.81668,0.086178,0.0042539,0,0
2,GO ANOIKIS,0.26847,0.0861,0.072002,0,0
2,GO REGULATION OF GLIAL CELL PROLIFERATION,0.37932,0.086034,0.060725,0,0
2,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.64605,0.085809,0.036181,0,0
2,GO SYNCYTIUM FORMATION,0.21579,0.085778,0.057868,0,0
2,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.13814,0.085723,0.11213,0,0
2,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.29586,0.085383,0.032481,0,0
2,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.43883,0.085063,0.058101,0,0
2,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.12689,0.084897,0.06924,0,0
2,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.95466,0.084825,-0.0078341,0,0
2,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.18508,0.084715,0.078109,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.44402,0.084673,0.040067,0,0
2,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.35153,0.084302,0.046332,0,0
2,GO REGULATION OF LIPID STORAGE,0.16828,0.084122,0.058116,0,0
2,GO REGULATION OF CHOLESTEROL EFFLUX,0.21256,0.084095,0.069034,0,0
2,GO CELLULAR RESPONSE TO IRON ION,0.16559,0.084042,0.16198,0,0
2,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.20621,0.084034,0.1635,0,0
2,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.12473,0.083965,0.12297,0,0
2,GO EMBRYONIC PLACENTA DEVELOPMENT,0.15264,0.083882,0.096195,0,0
2,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.35607,0.083764,0.052465,0,0
2,GO KETONE BIOSYNTHETIC PROCESS,0.30402,0.083734,0.031997,0,0
2,GO MEMBRANE LIPID CATABOLIC PROCESS,0.52594,0.083659,0.031965,0,0
2,GO POSTREPLICATION REPAIR,0.14526,0.083645,0.044703,0,0
2,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.0695,0.083536,0.12491,0,0
2,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.11841,0.083459,0.09335,0,0
2,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.89215,0.083423,0.01096,0,0
2,GO DETECTION OF BIOTIC STIMULUS,0.17653,0.083265,0.087848,0,0
2,GO PIGMENTATION,0.24288,0.083208,0.048605,0,0
2,GO MYOBLAST PROLIFERATION,0.43883,0.083189,0.042293,0,0
2,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.80989,0.082922,-0.050793,0,0
2,GO CRISTAE FORMATION,0.063042,0.082908,0.13426,0,0
2,GO REGULATION OF LYSOSOMAL LUMEN PH,0.0695,0.082895,0.13943,0,0
2,GO POSITIVE REGULATION OF ERAD PATHWAY,0.16294,0.082884,0.067025,0,0
2,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.27999,0.082817,0.063307,0,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.12473,0.082697,0.089399,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.44924,0.082646,0.070745,0,0
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.12049,0.08263,0.059723,0,0
2,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.18508,0.082554,0.074205,0,0
2,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.11039,0.082511,0.093174,0,0
2,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.32938,0.082092,0.04531,0,0
2,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.052669,0.08195,0.073113,0,0
2,GO ACTIN FILAMENT NETWORK FORMATION,0.5726,0.081927,0.047205,0,0
2,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.27611,0.081828,0.098635,0,0
2,GO IMMATURE B CELL DIFFERENTIATION,0.39858,0.081808,0.086525,0,0
2,GO 3 UTR MEDIATED MRNA STABILIZATION,0.31232,0.081742,0.043632,0,0
2,GO MYOTUBE DIFFERENTIATION,0.36526,0.08157,0.037138,0,0
2,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.26847,0.081418,0.11727,0,0
2,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.0695,0.081236,0.065082,0,0
2,GO CELLULAR RESPONSE TO STEROL,0.072231,0.081171,0.12902,0,0
2,GO HISTONE H2A UBIQUITINATION,0.4598,0.081142,0.040003,0,0
2,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.11841,0.081074,0.063127,0,0
2,GO AMINOGLYCAN CATABOLIC PROCESS,0.50337,0.08066,0.044958,0,0
2,GO TRANSLESION SYNTHESIS,0.23245,0.080556,0.03765,0,0
2,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.11235,0.080543,0.065889,0,0
2,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.90599,0.080215,-0.011087,0,0
2,GO REGULATION OF CELL DEATH,0.066855,0.080025,0.064078,0,0
2,GO PEPTIDYL ASPARAGINE MODIFICATION,0.32077,0.07987,0.044413,0,0
2,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.72969,0.079749,0.067673,0,0
2,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.054842,0.079717,0.066517,0,0
2,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.060602,0.07959,0.070055,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.095625,0.079399,0.1268,0,0
2,GO HOMOTYPIC CELL CELL ADHESION,0.082489,0.079372,0.14946,0,0
2,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.12689,0.079212,0.065304,0,0
2,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.87144,0.079179,-0.002172,0,0
2,GO REGULATION OF RESPONSE TO WOUNDING,0.25363,0.079126,0.071764,0,0
2,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.099158,0.079117,0.09513,0,0
2,GO CARDIAC MUSCLE CELL CONTRACTION,0.012508,0.078993,0.14714,0,0
2,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.31653,0.07899,0.048058,0,0
2,GO SMOOTH MUSCLE CELL MIGRATION,0.29184,0.078989,0.059958,0,0
2,GO MESODERMAL CELL FATE COMMITMENT,0.60883,0.078934,0.060271,0,0
2,GO REGULATION OF TRANSLATIONAL ELONGATION,0.099158,0.078786,0.11244,0,0
2,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.19095,0.078723,0.12738,0,0
2,GO DEFENSE RESPONSE TO BACTERIUM,0.054842,0.078703,0.072775,0,0
2,GO MAST CELL MEDIATED IMMUNITY,0.28785,0.078598,0.08807,0,0
2,GO RETROGRADE AXONAL TRANSPORT,0.20621,0.078274,0.094806,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.10096,0.077965,0.086054,0,0
2,GO STEROID ESTERIFICATION,0.16032,0.077939,0.087396,0,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.016734,0.077577,0.087139,0,0
2,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.05824,0.077561,0.070672,0,0
2,GO VASCULATURE DEVELOPMENT,0.21579,0.07744,0.072908,0,0
2,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.44924,0.077381,0.023105,0,0
2,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.33373,0.077273,0.038413,0,0
2,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.99651,0.077114,-0.049793,0,0
2,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.12473,0.07689,0.040457,0,0
2,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.58456,0.076884,0.057007,0,0
2,GO RESPONSE TO HORMONE,0.16294,0.076735,0.044275,0,0
2,GO SEQUESTERING OF CALCIUM ION,0.31232,0.076715,0.050178,0,0
2,GO RENAL SYSTEM PROCESS,0.25001,0.076609,0.048952,0,0
2,GO REGULATION OF BLOOD PRESSURE,0.24288,0.076378,0.034462,0,0
2,GO POSITIVE REGULATION OF PROTEIN BINDING,0.32938,0.076357,0.041056,0,0
2,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.23589,0.076336,0.092755,0,0
2,GO REGULATION OF PEPTIDASE ACTIVITY,0.097379,0.076232,0.080975,0,0
2,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.095625,0.07619,0.049325,0,0
2,GO RESPONSE TO ESTRADIOL,0.33812,0.076073,0.039108,0,0
2,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.11235,0.076035,0.043356,0,0
2,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.10096,0.075956,0.085506,0,0
2,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.20309,0.075847,0.075634,0,0
2,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.39858,0.075778,0.10638,0,0
2,GO BILE ACID BIOSYNTHETIC PROCESS,0.080955,0.075706,0.11539,0,0
2,GO XENOBIOTIC TRANSPORT,0.53167,0.075706,0.072644,0,0
2,GO TISSUE REMODELING,0.78962,0.075662,0.0031628,0,0
2,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.17934,0.075632,0.061281,0,0
2,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.41341,0.075529,0.0081552,0,0
2,GO LEUKOCYTE MIGRATION,0.13355,0.075468,0.058185,0,0
2,GO CELLULAR PIGMENTATION,0.085627,0.075329,0.091981,0,0
2,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.4545,0.075327,0.041534,0,0
2,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.53167,0.075269,-0.11028,0,0
2,GO HISTONE ARGININE METHYLATION,0.22905,0.075256,0.063656,0,0
2,GO ORGAN GROWTH,0.097379,0.075231,0.11457,0,0
2,GO PROTEIN K63 LINKED UBIQUITINATION,0.11841,0.075183,0.055451,0,0
2,GO GLYCOPROTEIN METABOLIC PROCESS,0.26471,0.07503,0.024294,0,0
2,GO NEGATIVE REGULATION OF COAGULATION,0.99651,0.074887,-0.031894,0,0
2,GO KIDNEY MORPHOGENESIS,0.14769,0.074182,0.074984,0,0
2,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.037747,0.074162,0.089584,0,0
2,GO TRNA CATABOLIC PROCESS,0.50337,0.073786,0.077552,0,0
2,GO NEGATIVE REGULATION OF MAPK CASCADE,0.11434,0.073768,0.063863,0,0
2,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.018836,0.073754,0.10395,0,0
2,GO REGULATION OF TELOMERE CAPPING,0.037747,0.073641,0.090477,0,0
2,GO T CELL DIFFERENTIATION IN THYMUS,0.21905,0.073635,0.052971,0,0
2,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.29586,0.073398,0.052743,0,0
2,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.11636,0.073265,0.057768,0,0
2,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.48131,0.073198,0.083978,0,0
2,GO RECEPTOR METABOLIC PROCESS,0.23937,0.073142,0.047939,0,0
2,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.88523,0.073125,-0.044063,0,0
2,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.19095,0.073008,0.056941,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.055956,0.072966,0.12744,0,0
2,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.29184,0.07291,0.036466,0,0
2,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.12259,0.072879,0.064063,0,0
2,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.53742,0.072807,0.0020666,0,0
2,GO ADHERENS JUNCTION ORGANIZATION,0.37932,0.072784,0.034731,0,0
2,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.14285,0.072782,0.096903,0,0
2,GO MACROPHAGE DIFFERENTIATION,0.29992,0.072697,0.038802,0,0
2,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.21256,0.072562,0.041164,0,0
2,GO REGULATION OF WATER LOSS VIA SKIN,0.36991,0.072556,0.10527,0,0
2,GO RESPONSE TO INSULIN,0.070855,0.072547,0.042346,0,0
2,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.46512,0.072331,0.058579,0,0
2,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.18219,0.07219,0.051368,0,0
2,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.03245,0.072105,0.1759,0,0
2,GO ENDOSOME ORGANIZATION,0.14285,0.072082,0.067592,0,0
2,GO REGULATION OF CELL POPULATION PROLIFERATION,0.11235,0.072074,0.058623,0,0
2,GO RUFFLE ASSEMBLY,0.19695,0.072029,0.057157,0,0
2,GO PROTEIN N LINKED GLYCOSYLATION,0.21579,0.071987,0.04243,0,0
2,GO REGULATION OF PROTEIN MATURATION,0.10465,0.071932,0.11124,0,0
2,GO MITOTIC SPINDLE ASSEMBLY,0.35153,0.07191,0.043249,0,0
2,GO URONIC ACID METABOLIC PROCESS,0.18508,0.071851,0.09253,0,0
2,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.30815,0.071737,0.12124,0,0
2,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.78962,0.071665,0.0070213,0,0
2,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.12259,0.071568,0.095413,0,0
2,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.092194,0.071566,0.073684,0,0
2,GO REGULATION OF CELL AGING,0.33373,0.071439,0.039404,0,0
2,GO IMMUNOGLOBULIN PRODUCTION,0.079444,0.071435,0.063845,0,0
2,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.15517,0.071369,0.10321,0,0
2,GO PHOSPHOLIPID TRANSPORT,0.39371,0.071167,0.02047,0,0
2,GO RESPONSE TO PROSTAGLANDIN,0.29184,0.071089,0.07567,0,0
2,GO AUTOPHAGOSOME MATURATION,0.188,0.070855,0.059502,0,0
2,GO GLIAL CELL ACTIVATION,0.22235,0.070847,0.054778,0,0
2,GO ACTIVATION OF MAPKKK ACTIVITY,0.48678,0.070742,0.056992,0,0
2,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.36526,0.070674,0.072818,0,0
2,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.25363,0.070657,0.061644,0,0
2,GO SCHWANN CELL DEVELOPMENT,0.27999,0.070647,0.053058,0,0
2,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.32938,0.070572,0.045885,0,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.87144,0.07057,0.0030165,0,0
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.061812,0.070512,0.13806,0,0
2,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.17934,0.070509,0.049555,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.24288,0.0705,0.087909,0,0
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.30815,0.070287,0.037393,0,0
2,GO COENZYME A BIOSYNTHETIC PROCESS,0.29992,0.07025,0.073023,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.5726,0.070004,0.026147,0,0
2,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.34702,0.069837,0.026482,0,0
2,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.12908,0.069697,0.088339,0,0
2,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.063042,0.069657,0.20039,0,0
2,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.38888,0.069472,0.055228,0,0
2,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.87144,0.069295,-0.00035789,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.95466,0.06929,-0.030714,0,0
2,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.27227,0.069046,0.060352,0,0
2,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.12689,0.068975,0.084159,0,0
2,GO REGULATION OF HYDROLASE ACTIVITY,0.055956,0.068934,0.062965,0,0
2,GO REGULATION OF CELL PROJECTION SIZE,0.2,0.068798,0.18985,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.98953,0.068728,-0.025439,0,0
2,GO MESODERM DEVELOPMENT,0.23937,0.068722,0.069906,0,0
2,GO BICARBONATE TRANSPORT,0.32077,0.068715,0.066466,0,0
2,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.27611,0.06863,0.066392,0,0
2,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.27999,0.068606,0.10096,0,0
2,GO FORMATION OF PRIMARY GERM LAYER,0.69061,0.068507,0.041163,0,0
2,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.15773,0.068483,0.063138,0,0
2,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.10654,0.068472,0.073738,0,0
2,GO CORONARY VASCULATURE DEVELOPMENT,0.44924,0.068389,0.074364,0,0
2,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.7495,0.068361,0.04339,0,0
2,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.26098,0.068196,0.029662,0,0
2,GO PEPTIDE CATABOLIC PROCESS,0.26847,0.067985,0.063865,0,0
2,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.62113,0.06794,0.014666,0,0
2,GO REGULATION OF ERAD PATHWAY,0.055956,0.067916,0.075182,0,0
2,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.072231,0.067854,0.094771,0,0
2,GO REGULATION OF ISOTYPE SWITCHING,0.42855,0.067826,0.053204,0,0
2,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.14285,0.067801,0.059931,0,0
2,GO RESPONSE TO INTERLEUKIN 4,0.057089,0.067719,0.083894,0,0
2,GO AMMONIUM TRANSPORT,0.47049,0.067664,0.050254,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.26098,0.067498,0.072428,0,0
2,GO TRANSCYTOSIS,0.17653,0.067317,0.071398,0,0
2,GO SUPEROXIDE ANION GENERATION,0.25001,0.067255,0.09332,0,0
2,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.16559,0.067186,0.22309,0,0
2,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.98953,0.067092,-0.016826,0,0
2,GO POSITIVE REGULATION OF VASCULOGENESIS,0.4598,0.067088,0.043355,0,0
2,GO NADH METABOLIC PROCESS,0.34702,0.067056,0.068801,0,0
2,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.7495,0.067043,0.058175,0,0
2,GO UROGENITAL SYSTEM DEVELOPMENT,0.14285,0.066977,0.097502,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.53742,0.066972,0.02261,0,0
2,GO RNA SURVEILLANCE,0.12473,0.066628,0.097117,0,0
2,GO RESPONSE TO WOUNDING,0.29184,0.066617,0.052858,0,0
2,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.69707,0.066378,-0.010361,0,0
2,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.11039,0.066311,0.04756,0,0
2,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.19695,0.066124,0.059684,0,0
2,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.32938,0.066063,0.058131,0,0
2,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.33373,0.065958,0.051236,0,0
2,GO EXOCYTOSIS,0.22905,0.065642,0.033676,0,0
2,GO CELLULAR EXTRAVASATION,0.14769,0.065606,0.062092,0,0
2,GO REGULATION OF MITOCHONDRIAL FUSION,0.10845,0.065279,0.10475,0,0
2,GO DETERMINATION OF ADULT LIFESPAN,0.11039,0.065114,0.12516,0,0
2,GO LIPOSACCHARIDE METABOLIC PROCESS,0.25363,0.065055,0.027797,0,0
2,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.78289,0.065043,-0.015947,0,0
2,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.079444,0.065017,0.069519,0,0
2,GO HORMONE METABOLIC PROCESS,0.1313,0.064958,0.084313,0,0
2,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.89215,0.064939,-0.035654,0,0
2,GO NEGATIVE REGULATION OF AXON EXTENSION,0.76948,0.064931,-0.018214,0,0
2,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.19095,0.064915,0.14503,0,0
2,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.17099,0.064642,0.095309,0,0
2,GO NCRNA CATABOLIC PROCESS,0.066855,0.06463,0.10967,0,0
2,GO MITOTIC CYTOKINETIC PROCESS,0.42347,0.064588,0.058606,0,0
2,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.070855,0.064521,0.077683,0,0
2,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.16294,0.064399,0.041157,0,0
2,GO ER OVERLOAD RESPONSE,0.51459,0.06436,0.058558,0,0
2,GO REGULATION OF SPINDLE ASSEMBLY,0.11636,0.064357,0.1064,0,0
2,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.13583,0.063934,0.065174,0,0
2,GO REGULATION OF RECEPTOR RECYCLING,0.55487,0.063907,0.040183,0,0
2,GO DENTATE GYRUS DEVELOPMENT,0.53167,0.063833,0.049612,0,0
2,GO POSITIVE REGULATION OF CELL DEATH,0.188,0.063792,0.052637,0,0
2,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.48131,0.063774,0.017469,0,0
2,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.18508,0.063767,0.085786,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.23245,0.063755,0.059672,0,0
2,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.4978,0.063578,-0.099994,0,0
2,GO COLLAGEN CATABOLIC PROCESS,0.43883,0.063562,0.02257,0,0
2,GO RESPONSE TO MURAMYL DIPEPTIDE,0.25363,0.063539,0.10307,0,0
2,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.12049,0.063486,0.15647,0,0
2,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.88523,0.063472,-0.014339,0,0
2,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.65234,0.063441,0.010904,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.59664,0.063388,0.027366,0,0
2,GO GLYCOSYLATION,0.35607,0.063382,0.0022593,0,0
2,GO IRON SULFUR CLUSTER ASSEMBLY,0.095625,0.063363,0.095752,0,0
2,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.76948,0.063301,0.057677,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.15264,0.063284,0.042523,0,0
2,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.38888,0.06321,0.013181,0,0
2,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.05824,0.063191,0.11528,0,0
2,GO NUCLEAR ENVELOPE REASSEMBLY,0.16032,0.063126,0.069114,0,0
2,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.32938,0.063053,0.056422,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.47049,0.062748,0.078003,0,0
2,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.18219,0.062608,0.099802,0,0
2,GO VIRION ASSEMBLY,0.30402,0.062566,0.03971,0,0
2,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.1028,0.062462,0.053973,0,0
2,GO CELL MATRIX ADHESION,0.30815,0.062385,0.068191,0,0
2,GO RESPONSE TO MISFOLDED PROTEIN,0.23937,0.062231,0.079162,0,0
2,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.18219,0.062219,0.065854,0,0
2,GO NEGATIVE REGULATION OF TRANSPORT,0.17653,0.062154,0.037275,0,0
2,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.12689,0.062107,0.11944,0,0
2,GO EOSINOPHIL MIGRATION,0.53167,0.062024,0.030003,0,0
2,GO APOPTOTIC PROCESS,0.11235,0.062024,0.045331,0,0
2,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.33373,0.061993,0.09053,0,0
2,GO POLYSACCHARIDE CATABOLIC PROCESS,0.25001,0.061992,0.059602,0,0
2,GO HOMEOSTATIC PROCESS,0.14285,0.06184,0.026156,0,0
2,GO AUTOPHAGOSOME ORGANIZATION,0.15015,0.061766,0.057686,0,0
2,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.63978,0.061722,0.030241,0,0
2,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.1313,0.061657,0.083221,0,0
2,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.1313,0.061642,0.060189,0,0
2,GO LYMPHOCYTE HOMEOSTASIS,0.59664,0.061632,0.0073668,0,0
2,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.12259,0.061523,0.19262,0,0
2,GO MAINTENANCE OF LOCATION,0.20309,0.06152,0.041113,0,0
2,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.035393,0.061512,0.08402,0,0
2,GO MUSCLE HYPERTROPHY,0.52025,0.061505,0.048203,0,0
2,GO DE NOVO PROTEIN FOLDING,0.70355,0.061453,0.014449,0,0
2,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.26098,0.061358,0.051267,0,0
2,GO PROTEIN DESTABILIZATION,0.13583,0.061293,0.066914,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.095625,0.061175,0.11034,0,0
2,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.17374,0.061073,0.11841,0,0
2,GO PROTEIN STABILIZATION,0.15517,0.06103,0.052538,0,0
2,GO RESPONSE TO CHEMOKINE,0.14526,0.060975,0.049648,0,0
2,GO MITOTIC SISTER CHROMATID COHESION,0.18508,0.060872,0.10956,0,0
2,GO FEMALE GAMETE GENERATION,0.10465,0.060855,0.045256,0,0
2,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.27611,0.060831,0.077906,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.14769,0.060777,0.12163,0,0
2,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.70355,0.060566,-0.00091479,0,0
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.13355,0.060353,0.075027,0,0
2,GO MAINTENANCE OF LOCATION IN CELL,0.22235,0.060332,0.04458,0,0
2,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.67776,0.060304,0.0094515,0,0
2,GO CHOLESTEROL EFFLUX,0.18219,0.06026,0.074667,0,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.13814,0.060158,0.085756,0,0
2,GO PROTEIN KINASE A SIGNALING,0.13814,0.059906,0.058759,0,0
2,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.11841,0.0599,0.084224,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.60272,0.059866,0.014885,0,0
2,GO SPINDLE ASSEMBLY,0.21256,0.059852,0.03875,0,0
2,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.75615,0.059804,0.03003,0,0
2,GO CERAMIDE METABOLIC PROCESS,0.17374,0.059721,0.032726,0,0
2,GO PROTEIN K11 LINKED UBIQUITINATION,0.15015,0.059703,0.060585,0,0
2,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.39858,0.059469,0.035602,0,0
2,GO LIPID DIGESTION,0.81668,0.059464,0.02361,0,0
2,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.25729,0.05942,0.14124,0,0
2,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.1028,0.059347,0.041993,0,0
2,GO BIOLOGICAL ADHESION,0.26471,0.059241,0.043815,0,0
2,GO SPERM EGG RECOGNITION,0.1313,0.059211,0.062231,0,0
2,GO REGULATION OF MUSCLE CONTRACTION,0.17099,0.059151,0.055058,0,0
2,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.14769,0.059121,0.047274,0,0
2,GO RESPONSE TO PEPTIDE HORMONE,0.080955,0.059078,0.046692,0,0
2,GO EPITHELIAL CELL DEVELOPMENT,0.51459,0.05905,0.053807,0,0
2,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.72969,0.058997,0.029669,0,0
2,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.54903,0.05892,0.066151,0,0
2,GO ETHANOL CATABOLIC PROCESS,0.10654,0.058886,0.22075,0,0
2,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.38888,0.058769,0.023079,0,0
2,GO PROTEIN POLYMERIZATION,0.22568,0.05864,0.030805,0,0
2,GO THYROID GLAND DEVELOPMENT,0.64605,0.058613,0.01634,0,0
2,GO RESPONSE TO NITRIC OXIDE,0.67137,0.058537,0.011682,0,0
2,GO TELOMERE CAPPING,0.11039,0.058457,0.057419,0,0
2,GO CENTRIOLE ASSEMBLY,0.36991,0.05839,0.050098,0,0
2,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.53742,0.058315,0.12352,0,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.12259,0.058285,0.090305,0,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.79636,0.058264,-0.012582,0,0
2,GO NODAL SIGNALING PATHWAY,0.27999,0.058251,0.052669,0,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.51459,0.05823,0.033042,0,0
2,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.36064,0.058189,0.04263,0,0
2,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.35153,0.058115,0.056884,0,0
2,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.13583,0.057925,0.13194,0,0
2,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.12689,0.057862,0.050336,0,0
2,GO EXTRACELLULAR MATRIX ASSEMBLY,0.60272,0.057685,0.040924,0,0
2,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.44402,0.057612,0.052166,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.91293,0.05738,-0.0030978,0,0
2,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.16559,0.057364,0.078912,0,0
2,GO METHIONINE BIOSYNTHETIC PROCESS,0.66501,0.057312,-0.018015,0,0
2,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.14285,0.057261,0.092605,0,0
2,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.16032,0.057201,0.039392,0,0
2,GO CELLULAR SENESCENCE,0.44924,0.057061,0.032098,0,0
2,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.94769,0.056992,0.011154,0,0
2,GO BLASTOCYST GROWTH,0.12049,0.056992,0.070176,0,0
2,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.063042,0.056932,0.082073,0,0
2,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.57857,0.05693,0.071173,0,0
2,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.26471,0.056924,0.045021,0,0
2,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,0.4545,0.056898,0.092314,0,0
2,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.11235,0.056502,0.084675,0,0
2,GO INTERLEUKIN 5 PRODUCTION,0.22905,0.056353,0.1366,0,0
2,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.16559,0.056087,0.13162,0,0
2,GO RETINA HOMEOSTASIS,0.22905,0.055983,0.073195,0,0
2,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.35607,0.055956,0.12611,0,0
2,GO VITAMIN METABOLIC PROCESS,0.12259,0.055938,0.078718,0,0
2,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.42347,0.05584,0.048543,0,0
2,GO FOAM CELL DIFFERENTIATION,0.32506,0.055815,0.064432,0,0
2,GO FOLIC ACID METABOLIC PROCESS,0.18508,0.055791,0.14098,0,0
2,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.8303,0.055743,0.071818,0,0
2,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.36526,0.05567,0.060907,0,0
2,GO BONE REMODELING,0.67776,0.055495,0.0018481,0,0
2,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.27999,0.055451,0.034104,0,0
2,GO GAMMA DELTA T CELL ACTIVATION,0.33812,0.055397,0.10871,0,0
2,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.36064,0.055328,0.073663,0,0
2,GO DIGESTIVE TRACT MORPHOGENESIS,0.3746,0.055305,0.10122,0,0
2,GO COLLAGEN METABOLIC PROCESS,0.40843,0.055285,0.024037,0,0
2,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.67137,0.055266,0.011387,0,0
2,GO CELL SUBSTRATE ADHESION,0.26098,0.055121,0.074961,0,0
2,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.5726,0.054957,0.0029024,0,0
2,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.35153,0.054829,0.046507,0,0
2,GO STEROL TRANSPORT,0.36064,0.054801,0.057541,0,0
2,GO MEMBRANE DISASSEMBLY,0.56075,0.054697,0.026081,0,0
2,GO ENDOCRINE PANCREAS DEVELOPMENT,0.40349,0.054672,0.069374,0,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.093897,0.054671,0.11261,0,0
2,GO AGING,0.24643,0.054642,0.041461,0,0
2,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.62113,0.054495,0.080096,0,0
2,GO RESPONSE TO VITAMIN,0.40349,0.054491,0.052149,0,0
2,GO REGULATION OF AMYLOID BETA FORMATION,0.44402,0.054363,0.045512,0,0
2,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.42855,0.054257,0.031819,0,0
2,GO NEGATIVE REGULATION OF RNA SPLICING,0.29586,0.054233,0.051363,0,0
2,GO LACTATION,0.061812,0.054089,0.10072,0,0
2,GO ACYLGLYCEROL HOMEOSTASIS,0.23937,0.054042,0.081445,0,0
2,GO AUTOPHAGY OF MITOCHONDRION,0.22905,0.053994,0.03087,0,0
2,GO SEX DIFFERENTIATION,0.49227,0.053991,0.026913,0,0
2,GO UBIQUINONE METABOLIC PROCESS,0.16559,0.053981,0.065246,0,0
2,GO DISTAL TUBULE DEVELOPMENT,0.29586,0.05398,0.15941,0,0
2,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.27611,0.053965,0.040676,0,0
2,GO ARTERY MORPHOGENESIS,0.23589,0.053948,0.08456,0,0
2,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.080955,0.053932,0.089151,0,0
2,GO RESPONSE TO ISCHEMIA,0.16828,0.053809,0.06112,0,0
2,GO SMOOTH MUSCLE CONTRACTION,0.72969,0.053687,-0.015973,0,0
2,GO MAMMARY GLAND DEVELOPMENT,0.16828,0.053519,0.088209,0,0
2,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.27999,0.053497,0.045256,0,0
2,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.99651,0.053398,-0.00069992,0,0
2,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.77618,0.053311,0.039,0,0
2,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.25729,0.053275,0.052918,0,0
2,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.14048,0.053218,0.047171,0,0
2,GO NEUTROPHIL CHEMOTAXIS,0.12049,0.053161,0.033873,0,0
2,GO INNER CELL MASS CELL PROLIFERATION,0.28785,0.052902,0.037388,0,0
2,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.31232,0.052645,0.068914,0,0
2,GO CERAMIDE CATABOLIC PROCESS,0.69707,0.052616,0.017502,0,0
2,GO BONE DEVELOPMENT,0.42347,0.052598,0.052045,0,0
2,GO NEGATIVE REGULATION OF AXONOGENESIS,0.9686,0.052474,-0.022629,0,0
2,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.5726,0.052461,-0.0025141,0,0
2,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.14526,0.052445,0.039609,0,0
2,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.15773,0.052414,0.13329,0,0
2,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.22905,0.052412,0.05365,0,0
2,GO SULFUR COMPOUND CATABOLIC PROCESS,0.17653,0.052285,0.070454,0,0
2,GO CYTOKINE SECRETION,0.2839,0.052253,0.045762,0,0
2,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.26098,0.05217,0.080184,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.60883,0.052093,0.033458,0,0
2,GO CRANIAL NERVE MORPHOGENESIS,0.83713,0.052062,0.00071116,0,0
2,GO CHROMOSOME SEPARATION,0.064293,0.052028,0.066195,0,0
2,GO NCRNA 3 END PROCESSING,0.27999,0.051993,0.049113,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.43367,0.051915,0.027256,0,0
2,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.92682,0.051803,-0.0077261,0,0
2,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.84397,0.051702,-0.0041795,0,0
2,GO SEGMENTATION,0.20309,0.05169,0.056251,0,0
2,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.76281,0.051655,0.013767,0,0
2,GO RESPONSE TO ABIOTIC STIMULUS,0.21579,0.051421,0.034838,0,0
2,GO SENSORY ORGAN MORPHOGENESIS,0.35607,0.051345,0.051473,0,0
2,GO EOSINOPHIL CHEMOTAXIS,0.65866,0.051232,0.01177,0,0
2,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.85768,0.051175,-0.0061845,0,0
2,GO MACROMOLECULE DEACYLATION,0.12473,0.051139,0.044017,0,0
2,GO REGULATION OF PROTEIN BINDING,0.33812,0.051084,0.037003,0,0
2,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.22235,0.050999,0.06295,0,0
2,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.32938,0.050946,0.055806,0,0
2,GO REGULATION OF HEAT GENERATION,0.69707,0.050858,0.018577,0,0
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.25363,0.050834,0.21206,0,0
2,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.96163,0.050764,-0.037167,0,0
2,GO ENDOTHELIAL CELL DEVELOPMENT,0.39371,0.050672,0.051543,0,0
2,GO MUSCLE CELL APOPTOTIC PROCESS,0.39371,0.050646,0.041394,0,0
2,GO REGULATION OF MEMBRANE INVAGINATION,0.84397,0.050566,-0.035629,0,0
2,GO AMEBOIDAL TYPE CELL MIGRATION,0.15264,0.050409,0.080732,0,0
2,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.63978,0.050179,-0.001188,0,0
2,GO RESPONSE TO MINERALOCORTICOID,0.48678,0.049972,0.034318,0,0
2,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.34256,0.049815,0.083913,0,0
2,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.38408,0.049664,0.033353,0,0
2,GO HISTONE H3 K9 MODIFICATION,0.25363,0.049598,0.053925,0,0
2,GO TERPENOID BIOSYNTHETIC PROCESS,0.61497,0.049588,0.1048,0,0
2,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.29586,0.049531,0.039461,0,0
2,GO CHLORIDE ION HOMEOSTASIS,0.85082,0.0494,0.0089154,0,0
2,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.18508,0.049323,0.055498,0,0
2,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.57857,0.04929,0.03603,0,0
2,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.19695,0.049276,0.11657,0,0
2,GO COMPLEMENT ACTIVATION,0.25363,0.049225,0.055402,0,0
2,GO CELLULAR RESPONSE TO MANGANESE ION,0.48678,0.048945,0.050184,0,0
2,GO NEGATIVE REGULATION OF BONE REMODELING,0.86455,0.048812,-0.020336,0,0
2,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.70355,0.04875,-0.003524,0,0
2,GO CARDIAC CELL DEVELOPMENT,0.63354,0.04863,0.011377,0,0
2,GO REGULATORY T CELL DIFFERENTIATION,0.26098,0.048504,0.085795,0,0
2,GO REPLACEMENT OSSIFICATION,0.32506,0.048461,0.12281,0,0
2,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.072231,0.048251,0.097913,0,0
2,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.088862,0.048177,0.049392,0,0
2,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.25729,0.048158,0.11566,0,0
2,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.20309,0.048074,0.045711,0,0
2,GO REGULATION OF MITOTIC CELL CYCLE,0.14526,0.048039,0.050601,0,0
2,GO DNA DEAMINATION,0.3746,0.048018,0.075219,0,0
2,GO POST EMBRYONIC DEVELOPMENT,0.12049,0.047907,0.057357,0,0
2,GO SISTER CHROMATID COHESION,0.37932,0.047877,0.064265,0,0
2,GO CARTILAGE MORPHOGENESIS,0.85768,0.047535,0.0067048,0,0
2,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.78962,0.04753,-0.0015796,0,0
2,GO RENAL SODIUM EXCRETION,0.48131,0.047487,0.072455,0,0
2,GO SKIN EPIDERMIS DEVELOPMENT,0.27611,0.047483,0.11032,0,0
2,GO G0 TO G1 TRANSITION,0.47588,0.047383,0.045866,0,0
2,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.37932,0.047132,0.049471,0,0
2,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.85768,0.047027,0.0034197,0,0
2,GO HORMONE BIOSYNTHETIC PROCESS,0.32938,0.046968,0.057114,0,0
2,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.063042,0.046927,0.057468,0,0
2,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.42855,0.046872,0.12127,0,0
2,GO RECEPTOR INTERNALIZATION,0.29992,0.046865,0.048028,0,0
2,GO MITOTIC CELL CYCLE CHECKPOINT,0.11636,0.046819,0.063289,0,0
2,GO REGULATION OF PHOSPHORYLATION,0.29184,0.046771,0.029323,0,0
2,GO AUTOPHAGIC CELL DEATH,0.82348,0.046658,0.0027666,0,0
2,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.013465,0.046629,0.059808,0,0
2,GO MITOTIC CYTOKINESIS,0.30815,0.046613,0.067228,0,0
2,GO EPITHELIUM DEVELOPMENT,0.42347,0.046485,0.050241,0,0
2,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.21579,0.046463,0.049333,0,0
2,GO MITOCHONDRION MORPHOGENESIS,0.0695,0.046419,0.099192,0,0
2,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.11235,0.046332,0.053318,0,0
2,GO RESPONSE TO AMINE,0.72969,0.046229,0.010764,0,0
2,GO LUNG MORPHOGENESIS,0.1313,0.046194,0.19256,0,0
2,GO GLIAL CELL APOPTOTIC PROCESS,0.72969,0.046183,0.031357,0,0
2,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.33812,0.046154,0.052627,0,0
2,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.043763,0.045971,0.15646,0,0
2,GO CORPUS CALLOSUM DEVELOPMENT,0.89907,0.045845,-0.016325,0,0
2,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.7495,0.045814,0.010805,0,0
2,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.65234,0.045804,0.034302,0,0
2,GO PROTEIN AUTOUBIQUITINATION,0.16828,0.045799,0.03886,0,0
2,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.82348,0.045637,0.020347,0,0
2,GO REGULATION OF PROTEIN ACETYLATION,0.11636,0.045625,0.0581,0,0
2,GO MITOTIC CELL CYCLE,0.11235,0.045536,0.05095,0,0
2,GO PROTEIN TARGETING,0.15517,0.045481,0.064985,0,0
2,GO PROSTATIC BUD FORMATION,0.72969,0.04529,0.032502,0,0
2,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.029068,0.045261,0.11508,0,0
2,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.56075,0.045257,0.018639,0,0
2,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.29184,0.045223,0.072978,0,0
2,GO GLIAL CELL DEVELOPMENT,0.76281,0.04497,0.0047427,0,0
2,GO MITOTIC SPINDLE ORGANIZATION,0.87833,0.044883,0.011785,0,0
2,GO INTERLEUKIN 6 PRODUCTION,0.25001,0.044826,0.055048,0,0
2,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.47588,0.044822,-0.087458,0,0
2,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.47049,0.044746,0.022234,0,0
2,GO DECIDUALIZATION,0.83713,0.044745,-0.010069,0,0
2,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.69707,0.044698,0.0093733,0,0
2,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.24643,0.044696,0.071539,0,0
2,GO QUINONE METABOLIC PROCESS,0.44924,0.044673,0.06904,0,0
2,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.89215,0.044629,-0.0095757,0,0
2,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.83713,0.044178,-0.00079444,0,0
2,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.25729,0.044033,0.053022,0,0
2,GO CARDIAC MUSCLE CONTRACTION,0.27611,0.043973,0.053388,0,0
2,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.36526,0.043854,0.021532,0,0
2,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.56666,0.043746,0.066707,0,0
2,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.1313,0.04351,0.035579,0,0
2,GO ENDOSOME TO LYSOSOME TRANSPORT,0.39371,0.04347,0.030976,0,0
2,GO MICROTUBULE NUCLEATION,0.79636,0.043375,-0.029253,0,0
2,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.60883,0.043335,0.054661,0,0
2,GO REGULATION OF AUTOPHAGY,0.12049,0.043328,0.038046,0,0
2,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.17099,0.043279,0.061053,0,0
2,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,1,0.043253,-0.05713,0,0
2,GO LIPID EXPORT FROM CELL,0.2839,0.043223,0.050833,0,0
2,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.31232,0.043194,0.025754,0,0
2,GO HINDLIMB MORPHOGENESIS,0.17934,0.043168,0.098308,0,0
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.20309,0.043095,0.064295,0,0
2,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.4978,0.043091,0.014743,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.092194,0.042995,0.058439,0,0
2,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.17653,0.042892,0.12975,0,0
2,GO SULFUR COMPOUND TRANSPORT,0.4598,0.042892,0.06622,0,0
2,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.28785,0.042805,0.019618,0,0
2,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.92682,0.042794,0.0022004,0,0
2,GO NON CANONICAL WNT SIGNALING PATHWAY,0.48678,0.042786,0.025058,0,0
2,GO REGULATION OF DNA CATABOLIC PROCESS,0.50337,0.042741,0.022365,0,0
2,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.44924,0.04269,0.02059,0,0
2,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.53167,0.042618,0.029094,0,0
2,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.15264,0.042403,0.11119,0,0
2,GO PRENYLATION,0.33373,0.042256,0.076529,0,0
2,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.59664,0.042106,0.028992,0,0
2,GO ESTABLISHMENT OF CELL POLARITY,0.32077,0.041973,0.037874,0,0
2,GO DNA RECOMBINATION,0.073629,0.041972,0.063612,0,0
2,GO MACROPHAGE CYTOKINE PRODUCTION,0.7495,0.041947,0.0011604,0,0
2,GO REGULATION OF CELL MATRIX ADHESION,0.21905,0.041944,0.085095,0,0
2,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.55487,0.041857,0.02113,0,0
2,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.34702,0.04181,0.032928,0,0
2,GO AMINOGLYCAN METABOLIC PROCESS,0.72313,0.041801,0.014719,0,0
2,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.40843,0.04157,0.020369,0,0
2,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.40843,0.041394,0.033425,0,0
2,GO MULTIVESICULAR BODY ORGANIZATION,0.39371,0.041308,0.059175,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.67137,0.041209,0.020544,0,0
2,GO REGULATION OF FATTY ACID BETA OXIDATION,0.18508,0.041175,0.095371,0,0
2,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.11636,0.041174,0.21743,0,0
2,GO FACE DEVELOPMENT,0.72313,0.040916,0.039901,0,0
2,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.38408,0.040885,0.073523,0,0
2,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.1313,0.040883,0.0633,0,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.65234,0.040842,0.014004,0,0
2,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.85768,0.040832,-0.0087024,0,0
2,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.63978,0.040784,0.026218,0,0
2,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.67776,0.040758,-0.0047225,0,0
2,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.72969,0.040714,0.043791,0,0
2,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.40843,0.040672,0.025004,0,0
2,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.86455,0.040574,-0.023526,0,0
2,GO PIGMENT GRANULE LOCALIZATION,0.52594,0.040529,0.04381,0,0
2,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.85768,0.04052,0.021853,0,0
2,GO RESPONSE TO ZINC ION,0.32938,0.04037,0.10388,0,0
2,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.11434,0.040316,0.070428,0,0
2,GO REGULATION OF CENTROSOME CYCLE,0.80989,0.040132,0.03321,0,0
2,GO REGULATION OF CHROMATIN BINDING,0.54903,0.039991,0.045055,0,0
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.31653,0.039908,0.044427,0,0
2,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.73628,0.039736,-0.005372,0,0
2,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.72969,0.039659,0.021379,0,0
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.30402,0.039517,0.051608,0,0
2,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.23589,0.039502,0.038332,0,0
2,GO CELLULAR RESPONSE TO ATP,0.52025,0.0395,-0.055219,0,0
2,GO REGULATION OF CHLORIDE TRANSPORT,0.54903,0.039445,0.038314,0,0
2,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.58456,0.039428,0.01829,0,0
2,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.61497,0.039356,0.018642,0,0
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.21579,0.039281,0.032189,0,0
2,GO POSITIVE REGULATION OF MAPK CASCADE,0.30815,0.039262,0.033494,0,0
2,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.25363,0.039238,0.037812,0,0
2,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.80989,0.039216,0.028084,0,0
2,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.29992,0.039193,0.026193,0,0
2,GO ATP METABOLIC PROCESS,0.060602,0.039159,0.071659,0,0
2,GO MITOTIC SISTER CHROMATID SEGREGATION,0.090515,0.038997,0.068984,0,0
2,GO ESTROGEN METABOLIC PROCESS,0.35607,0.03892,0.11798,0,0
2,GO SARCOMERE ORGANIZATION,0.59059,0.038797,0.034242,0,0
2,GO REGULATION OF GLIAL CELL MIGRATION,0.93377,0.03867,-0.01905,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.8303,0.038662,0.0060126,0,0
2,GO REGULATION OF MAP KINASE ACTIVITY,0.37932,0.038637,0.029254,0,0
2,GO ENDOTHELIAL CELL MIGRATION,0.21256,0.038631,0.073191,0,0
2,GO PLASMA MEMBRANE TUBULATION,0.98953,0.038607,-0.013592,0,0
2,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.7495,0.038597,-0.016891,0,0
2,GO MITOTIC NUCLEAR DIVISION,0.16294,0.038524,0.052742,0,0
2,GO EPITHELIAL CELL PROLIFERATION,0.48131,0.038449,0.044117,0,0
2,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.36064,0.038378,0.055452,0,0
2,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.74288,0.038324,0.062177,0,0
2,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.24643,0.03826,0.031995,0,0
2,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.4598,0.038212,0.053896,0,0
2,GO PROTEIN HOMOTETRAMERIZATION,0.44402,0.038091,0.025581,0,0
2,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.68418,0.038058,0.056383,0,0
2,GO VAGINA DEVELOPMENT,0.78962,0.037925,-0.047127,0,0
2,GO REGULATION OF MRNA PROCESSING,0.24288,0.037671,0.045098,0,0
2,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.7495,0.037623,-0.02575,0,0
2,GO PROTEIN TARGETING TO MEMBRANE,0.4598,0.037597,0.052169,0,0
2,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.46512,0.037582,0.039643,0,0
2,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.93377,0.037574,-0.010417,0,0
2,GO RECEPTOR RECYCLING,0.70355,0.037371,0.013687,0,0
2,GO CARDIOBLAST DIFFERENTIATION,0.87144,0.037353,0.026408,0,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.60272,0.037353,0.028599,0,0
2,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.38408,0.037328,0.10176,0,0
2,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.42855,0.037287,0.023202,0,0
2,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.71006,0.037185,0.054928,0,0
2,GO SECRETION,0.5726,0.037036,0.0020986,0,0
2,GO REGULATION OF MAPK CASCADE,0.25001,0.036943,0.039906,0,0
2,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.70355,0.036921,0.013616,0,0
2,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.71006,0.03677,0.013583,0,0
2,GO REGULATION OF HISTONE DEACETYLATION,0.29184,0.036694,0.065826,0,0
2,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.80989,0.036635,0.061339,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION,0.56075,0.036622,0.0085201,0,0
2,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.97557,0.036604,-0.042554,0,0
2,GO CHONDROCYTE DIFFERENTIATION,0.59664,0.036566,0.028603,0,0
2,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.32938,0.036552,0.056788,0,0
2,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.5726,0.036531,0.013194,0,0
2,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.69707,0.036392,0.056279,0,0
2,GO AXONAL FASCICULATION,0.82348,0.036389,0.0024468,0,0
2,GO PROTEIN TRIMERIZATION,0.35607,0.036297,0.069392,0,0
2,GO O GLYCAN PROCESSING,0.46512,0.03606,0.0082653,0,0
2,GO INTRACELLULAR TRANSPORT,0.11039,0.036052,0.036249,0,0
2,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.69061,0.035962,0.015121,0,0
2,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.25729,0.03594,0.12133,0,0
2,GO ERROR FREE TRANSLESION SYNTHESIS,0.46512,0.035904,0.025741,0,0
2,GO INTRACELLULAR LIPID TRANSPORT,0.10465,0.035804,0.11171,0,0
2,GO CELLULAR RESPONSE TO PEPTIDE,0.53742,0.035662,0.015703,0,0
2,GO REGULATION OF CELL CYCLE PROCESS,0.075049,0.035549,0.056404,0,0
2,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.61497,0.035503,0.025501,0,0
2,GO REGULATION OF ENDOCYTOSIS,0.91987,0.035488,0.0059609,0,0
2,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.63978,0.035456,0.027149,0,0
2,GO FLUID TRANSPORT,0.73628,0.035326,0.010579,0,0
2,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.42347,0.035276,0.11124,0,0
2,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.53742,0.035207,0.015664,0,0
2,GO P38MAPK CASCADE,0.71006,0.035144,0.006867,0,0
2,GO REGULATION OF RECEPTOR INTERNALIZATION,0.4545,0.035083,0.038645,0,0
2,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.46512,0.035031,0.019268,0,0
2,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.15264,0.035014,0.059982,0,0
2,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.9686,0.034904,-0.02223,0,0
2,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.97557,0.03487,-0.003393,0,0
2,GO REGULATION OF PROTEIN FOLDING,0.46512,0.034825,0.028811,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.29586,0.034589,0.044475,0,0
2,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.18508,0.034566,0.076017,0,0
2,GO PROTEIN INSERTION INTO MEMBRANE,0.72969,0.034552,0.0085737,0,0
2,GO BONE MINERALIZATION,0.76281,0.034529,-0.027994,0,0
2,GO EMBRYONIC ORGAN DEVELOPMENT,0.37932,0.034336,0.046111,0,0
2,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.14526,0.034313,0.054407,0,0
2,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.21905,0.034257,0.039903,0,0
2,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.068167,0.03413,0.046116,0,0
2,GO REGULATION OF NUCLEAR DIVISION,0.32077,0.033934,0.037139,0,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.14048,0.033852,0.10169,0,0
2,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.041967,0.033803,0.069917,0,0
2,GO CIRCULATORY SYSTEM DEVELOPMENT,0.44402,0.033725,0.041712,0,0
2,GO REGULATION OF MUSCLE HYPERTROPHY,0.94073,0.033663,0.0021918,0,0
2,GO REGULATION OF FILOPODIUM ASSEMBLY,0.83713,0.033583,-0.031972,0,0
2,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.29184,0.033551,0.04952,0,0
2,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.43883,0.033417,0.039235,0,0
2,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.40349,0.033339,0.020056,0,0
2,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.76948,0.03327,0.0068478,0,0
2,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.90599,0.033141,-0.021652,0,0
2,GO REGULATION OF MACROAUTOPHAGY,0.1028,0.033129,0.038402,0,0
2,GO CHROMOSOME ORGANIZATION,0.033894,0.03304,0.055595,0,0
2,GO EMBRYO DEVELOPMENT,0.48131,0.032976,0.037728,0,0
2,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.98953,0.032932,0.002905,0,0
2,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.55487,0.03287,0.014214,0,0
2,GO NEGATIVE REGULATION OF GROWTH,0.69061,0.032807,0.006582,0,0
2,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.57857,0.032781,-0.05103,0,0
2,GO REGULATION OF RNA BINDING,0.53742,0.032718,0.041695,0,0
2,GO HEAD MORPHOGENESIS,0.99651,0.032695,-0.0077516,0,0
2,GO BLASTOCYST DEVELOPMENT,0.20309,0.032582,0.039575,0,0
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,1,0.032516,-0.015681,0,0
2,GO GLYCOSIDE METABOLIC PROCESS,0.63978,0.032462,0.10884,0,0
2,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.25363,0.032462,0.030518,0,0
2,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.75615,0.032445,-0.0043502,0,0
2,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.65234,0.03244,0.0039803,0,0
2,GO REGULATION OF CENTRIOLE REPLICATION,0.36991,0.032262,0.052637,0,0
2,GO ATP TRANSPORT,0.91293,0.032258,-0.007011,0,0
2,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.2,0.032057,0.039871,0,0
2,GO APPENDAGE DEVELOPMENT,0.18508,0.03204,0.086136,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.42347,0.032008,0.065739,0,0
2,GO POSITIVE REGULATION OF DNA REPAIR,0.47588,0.031521,0.024743,0,0
2,GO PLATELET DEGRANULATION,0.78962,0.031469,-0.0028543,0,0
2,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.52025,0.031418,0.027699,0,0
2,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.48678,0.031389,0.051235,0,0
2,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.31653,0.03131,0.032266,0,0
2,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.27999,0.031305,0.048618,0,0
2,GO DNA METHYLATION OR DEMETHYLATION,0.19695,0.031297,0.039334,0,0
2,GO REGULATION OF CENTROSOME DUPLICATION,0.73628,0.031236,0.036241,0,0
2,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.48131,0.031182,0.030152,0,0
2,GO REGULATION OF PROTEIN POLYMERIZATION,0.53167,0.031,0.0099123,0,0
2,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.14285,0.030974,0.23046,0,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.90599,0.03097,0.0046589,0,0
2,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.74288,0.030965,-0.012795,0,0
2,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.61497,0.030908,0.0071251,0,0
2,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.82348,0.030891,-0.0083575,0,0
2,GO NEGATIVE REGULATION OF TOR SIGNALING,0.62732,0.030771,0.013266,0,0
2,GO WHITE FAT CELL DIFFERENTIATION,0.90599,0.030763,0.0064894,0,0
2,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.7495,0.030692,0.033281,0,0
2,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.59664,0.030609,0.016718,0,0
2,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.31232,0.030586,0.070966,0,0
2,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.76948,0.03054,0.0027782,0,0
2,GO INTESTINAL LIPID ABSORPTION,0.78289,0.030472,0.02464,0,0
2,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.32506,0.030433,0.047082,0,0
2,GO LYMPH VESSEL MORPHOGENESIS,0.4545,0.03036,0.056778,0,0
2,GO PROTEIN K48 LINKED UBIQUITINATION,0.42347,0.030289,0.03224,0,0
2,GO DISACCHARIDE METABOLIC PROCESS,0.31653,0.030101,0.073736,0,0
2,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.83713,0.029998,0.018595,0,0
2,GO RESPONSE TO STEROL,0.29586,0.029937,0.078741,0,0
2,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.91987,0.029902,-0.01766,0,0
2,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.65866,0.029873,0.03232,0,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.79636,0.029833,0.010621,0,0
2,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.71658,0.029788,0.037452,0,0
2,GO INTRACELLULAR PROTEIN TRANSPORT,0.14285,0.029697,0.039902,0,0
2,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.2839,0.029653,0.040152,0,0
2,GO PROTEIN LOCALIZATION TO ORGANELLE,0.065563,0.029589,0.046567,0,0
2,GO THYROID HORMONE METABOLIC PROCESS,0.36526,0.029547,0.043763,0,0
2,GO TUBE MORPHOGENESIS,0.36526,0.02949,0.059156,0,0
2,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.25001,0.029489,0.064294,0,0
2,GO REGULATION OF KERATINOCYTE MIGRATION,0.56075,0.029395,0.045257,0,0
2,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.21905,0.029375,0.037604,0,0
2,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.80989,0.029323,-0.034324,0,0
2,GO CARDIOCYTE DIFFERENTIATION,0.26847,0.029292,0.065104,0,0
2,GO HETEROCHROMATIN ORGANIZATION,0.4978,0.029202,0.020868,0,0
2,GO MITOCHONDRION ORGANIZATION,0.063042,0.0292,0.055407,0,0
2,GO EPITHELIAL TUBE MORPHOGENESIS,0.20621,0.028946,0.088579,0,0
2,GO LYMPHOCYTE MIGRATION,0.72313,0.028894,0.018142,0,0
2,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.59664,0.028797,0.016951,0,0
2,GO RESPONSE TO INORGANIC SUBSTANCE,0.70355,0.028782,0.0064481,0,0
2,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.54903,0.028766,0.021342,0,0
2,GO CALCINEURIN MEDIATED SIGNALING,0.33373,0.028672,0.050185,0,0
2,GO TRANSITION METAL ION TRANSPORT,0.56666,0.028641,0.0071574,0,0
2,GO HOMOLOGOUS RECOMBINATION,0.22235,0.028598,0.046478,0,0
2,GO COLLAGEN FIBRIL ORGANIZATION,0.29992,0.02859,0.091538,0,0
2,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.47049,0.028517,0.020525,0,0
2,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.42347,0.028448,0.027729,0,0
2,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.188,0.028386,0.10489,0,0
2,GO REGULATION OF T CELL MIGRATION,0.44402,0.028174,0.036356,0,0
2,GO JNK CASCADE,0.29992,0.028047,0.036871,0,0
2,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.35153,0.028027,0.05416,0,0
2,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.42855,0.028019,0.03263,0,0
2,GO REGULATION OF CHROMOSOME SEGREGATION,0.14526,0.028001,0.064574,0,0
2,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.43367,0.027942,0.070998,0,0
2,GO G2 DNA DAMAGE CHECKPOINT,0.21256,0.027936,0.076261,0,0
2,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.47588,0.027911,0.033602,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.36526,0.027829,0.037581,0,0
2,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.58456,0.027781,0.015785,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.43883,0.027726,0.077576,0,0
2,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.42347,0.027708,0.053747,0,0
2,GO HISTONE H2A ACETYLATION,0.75615,0.027704,0.0088158,0,0
2,GO RESPONSE TO PEPTIDE,0.38408,0.027684,0.022862,0,0
2,GO REGULATION OF INTEGRIN ACTIVATION,0.77618,0.027672,0.015587,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.19393,0.027589,0.04921,0,0
2,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.61497,0.027361,0.010952,0,0
2,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.58456,0.027307,0.0058109,0,0
2,GO SUBSTANTIA NIGRA DEVELOPMENT,0.54321,0.027137,-0.044071,0,0
2,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.69061,0.027113,0.022769,0,0
2,GO ENDOCYTOSIS,0.4545,0.027025,0.016522,0,0
2,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.36991,0.026877,0.041981,0,0
2,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.97557,0.026853,0.0075853,0,0
2,GO VACUOLE ORGANIZATION,0.64605,0.026761,0.0044229,0,0
2,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.42347,0.026648,0.0098656,0,0
2,GO CHROMATIN SILENCING,0.31232,0.026638,0.06477,0,0
2,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.78962,0.026614,0.0031865,0,0
2,GO ACTIVATION OF JUN KINASE ACTIVITY,0.72969,0.026485,0.0078607,0,0
2,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.49227,0.026358,0.030857,0,0
2,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.85768,0.026332,-0.0065069,0,0
2,GO RESPONSE TO VITAMIN D,0.90599,0.026294,-0.037903,0,0
2,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.75615,0.026243,-0.021933,0,0
2,GO SEQUESTERING OF TRIGLYCERIDE,0.80312,0.026175,0.0025297,0,0
2,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.60883,0.025945,0.050321,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE,0.66501,0.025811,0.021853,0,0
2,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.25363,0.025784,0.032654,0,0
2,GO PROTEIN O LINKED GLYCOSYLATION,0.52025,0.025618,0.0015567,0,0
2,GO FERTILIZATION,0.7495,0.025285,0.00047148,0,0
2,GO ORGANELLE DISASSEMBLY,0.46512,0.025228,0.017058,0,0
2,GO MACROMOLECULE DEPALMITOYLATION,0.29586,0.025151,0.076327,0,0
2,GO SINGLE FERTILIZATION,0.69061,0.025042,-0.024283,0,0
2,GO TRABECULA FORMATION,0.48131,0.025003,0.050973,0,0
2,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.49227,0.024976,0.056146,0,0
2,GO NEURON REMODELING,0.89907,0.024973,-0.030406,0,0
2,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.47588,0.024924,0.014087,0,0
2,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.4978,0.024857,-0.061763,0,0
2,GO REGULATION OF HISTONE MODIFICATION,0.42855,0.024784,0.025493,0,0
2,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.33373,0.024767,0.02688,0,0
2,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.88523,0.024756,0.014385,0,0
2,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.78962,0.02452,0.034119,0,0
2,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.51459,0.024496,0.026824,0,0
2,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.93377,0.024331,0.010955,0,0
2,GO REGULATION OF CELL CYCLE,0.35607,0.024321,0.030757,0,0
2,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.67776,0.024296,0.0129,0,0
2,GO CELLULAR SODIUM ION HOMEOSTASIS,0.65866,0.024258,0.038721,0,0
2,GO EMBRYONIC ORGAN MORPHOGENESIS,0.53742,0.024154,0.042654,0,0
2,GO MIDGUT DEVELOPMENT,0.80989,0.024043,0.071845,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.54903,0.024034,0.015968,0,0
2,GO METANEPHROS MORPHOGENESIS,0.78289,0.024021,0.0078214,0,0
2,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.39858,0.024006,0.023334,0,0
2,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.63978,0.023907,0.0080017,0,0
2,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.69061,0.023824,0.033469,0,0
2,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.98953,0.023721,0.0029453,0,0
2,GO REGULATION OF PEPTIDE TRANSPORT,0.98953,0.023712,-0.0083586,0,0
2,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.89907,0.023672,-0.0031214,0,0
2,GO RESPONSE TO ENDOGENOUS STIMULUS,0.82348,0.023668,-0.0022776,0,0
2,GO REGULATION OF DNA REPLICATION,0.65234,0.023625,0.03358,0,0
2,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.8303,0.023547,-0.016275,0,0
2,GO CELL PROLIFERATION IN FOREBRAIN,0.80989,0.023451,0.028645,0,0
2,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.87833,0.02345,-0.014675,0,0
2,GO RESPONSE TO ATP,0.9686,0.023282,-0.015126,0,0
2,GO REGULATION OF JUN KINASE ACTIVITY,0.33373,0.022965,0.055703,0,0
2,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.71006,0.022929,0.0014662,0,0
2,GO ANTIMICROBIAL HUMORAL RESPONSE,0.21256,0.02283,0.056155,0,0
2,GO MITOCHONDRIAL GENOME MAINTENANCE,0.77618,0.022795,0.0054464,0,0
2,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.23937,0.02277,0.031305,0,0
2,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.87144,0.02271,0.0025128,0,0
2,GO TUMOR NECROSIS FACTOR SECRETION,0.50337,0.022646,0.04877,0,0
2,GO CELL CYCLE,0.15264,0.022449,0.035142,0,0
2,GO NUCLEOSOME ORGANIZATION,0.80312,0.022427,0.024905,0,0
2,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.41341,0.022287,0.025259,0,0
2,GO VACUOLAR ACIDIFICATION,0.94769,0.022273,-0.015556,0,0
2,GO REGULATION OF HEART GROWTH,0.62113,0.022233,0.024104,0,0
2,GO SISTER CHROMATID SEGREGATION,0.19393,0.0222,0.063441,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.43883,0.022176,0.041355,0,0
2,GO MATING BEHAVIOR,0.99651,0.022062,-0.009965,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.7495,0.02204,0.012448,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.69061,0.021801,0.013839,0,0
2,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.7495,0.021682,-0.0027375,0,0
2,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.15264,0.021488,0.037039,0,0
2,GO DENDRITIC SPINE MAINTENANCE,0.94073,0.021359,-0.013155,0,0
2,GO PEPTIDYL LYSINE ACETYLATION,0.36064,0.021256,0.035434,0,0
2,GO ACTIVATION OF MAPK ACTIVITY,0.85082,0.021009,-0.0070816,0,0
2,GO UTERUS DEVELOPMENT,0.64605,0.020986,-0.059039,0,0
2,GO PROTEIN CONTAINING COMPLEX REMODELING,0.48678,0.020916,0.046324,0,0
2,GO SEX DETERMINATION,0.72313,0.020867,-0.0014263,0,0
2,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.8303,0.020862,0.010301,0,0
2,GO GOLGI ORGANIZATION,0.43883,0.02072,0.027036,0,0
2,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.94769,0.020712,-0.03594,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.67776,0.020673,0.0090346,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION,0.91987,0.02064,-0.014575,0,0
2,GO MITOCHONDRIAL FUSION,0.59059,0.020533,0.017529,0,0
2,GO DRINKING BEHAVIOR,0.85082,0.020339,-0.0051647,0,0
2,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.77618,0.020329,0.030799,0,0
2,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.57857,0.020293,0.0042949,0,0
2,GO DNA PACKAGING,0.73628,0.020284,0.018157,0,0
2,GO KERATAN SULFATE CATABOLIC PROCESS,0.91987,0.020225,-0.025808,0,0
2,GO FAT CELL DIFFERENTIATION,0.8303,0.020208,0.015048,0,0
2,GO CYTOSOLIC TRANSPORT,0.64605,0.020185,0.013705,0,0
2,GO SPECIFICATION OF SYMMETRY,0.4978,0.020146,0.025093,0,0
2,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.80989,0.020108,-0.0063958,0,0
2,GO MULTIVESICULAR BODY SORTING PATHWAY,0.63354,0.020032,0.035783,0,0
2,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.53742,0.020018,0.026049,0,0
2,GO PHOSPHOLIPID EFFLUX,0.5726,0.019895,0.058125,0,0
2,GO LIPID DROPLET ORGANIZATION,0.50896,0.01982,0.05302,0,0
2,GO NEGATIVE CHEMOTAXIS,0.75615,0.019443,-0.059141,0,0
2,GO TUBE DEVELOPMENT,0.71006,0.019328,0.035888,0,0
2,GO BLOOD VESSEL REMODELING,0.48678,0.019247,0.01552,0,0
2,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.60883,0.019238,-0.044648,0,0
2,GO CGMP MEDIATED SIGNALING,0.88523,0.019229,-0.026413,0,0
2,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.48678,0.018993,0.046698,0,0
2,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.73628,0.018971,0.070063,0,0
2,GO PROTEIN TETRAMERIZATION,0.67776,0.018952,0.012088,0,0
2,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.36526,0.018916,-0.059513,0,0
2,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.59059,0.018874,0.039145,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.60272,0.018789,0.010702,0,0
2,GO REGULATION OF MRNA BINDING,0.36526,0.018765,0.067555,0,0
2,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.66501,0.018742,0.075501,0,0
2,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.63354,0.018599,0.013832,0,0
2,GO REGULATION OF REPRODUCTIVE PROCESS,0.60883,0.018535,0.0055299,0,0
2,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.8303,0.018479,0.012257,0,0
2,GO REGULATION OF METAL ION TRANSPORT,1,0.018415,-0.0056358,0,0
2,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.8303,0.018393,-0.0083662,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.50896,0.018105,0.036055,0,0
2,GO REGULATION OF CELL CYCLE ARREST,0.79636,0.018054,0.018746,0,0
2,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.40349,0.01798,0.033161,0,0
2,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.99651,0.017869,-0.00038742,0,0
2,GO SPINDLE MIDZONE ASSEMBLY,0.15015,0.017842,0.10863,0,0
2,GO OOCYTE DIFFERENTIATION,0.7495,0.017722,0.0099445,0,0
2,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.74288,0.017697,0.018622,0,0
2,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.48131,0.017621,0.013141,0,0
2,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.60272,0.017522,0.013426,0,0
2,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.90599,0.017475,-0.025743,0,0
2,GO LIPID TRANSLOCATION,0.85768,0.017406,-0.026045,0,0
2,GO RESPONSE TO FLUID SHEAR STRESS,0.50896,0.017366,0.030647,0,0
2,GO POSITIVE REGULATION OF TRANSPORT,0.98953,0.017365,-0.011546,0,0
2,GO HISTONE H2A MONOUBIQUITINATION,0.86455,0.017239,-0.017393,0,0
2,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.14526,0.017052,0.083043,0,0
2,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.65866,0.016672,-0.034107,0,0
2,GO RESPONSE TO MUSCLE INACTIVITY,0.98255,0.016616,0.0031485,0,0
2,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.42855,0.016576,0.037121,0,0
2,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.20937,0.016546,0.027842,0,0
2,GO PROTEIN REFOLDING,0.89907,0.016486,0.0016649,0,0
2,GO L GLUTAMATE IMPORT,0.87833,0.016469,-0.01442,0,0
2,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.78289,0.016337,0.0038758,0,0
2,GO REGULATION OF PLATELET AGGREGATION,0.41341,0.016285,-0.087819,0,0
2,GO RESPONSE TO ETHER,0.25729,0.016208,0.072016,0,0
2,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.89907,0.016105,0.074946,0,0
2,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.65234,0.016101,0.083137,0,0
2,GO MUSCLE SYSTEM PROCESS,0.97557,0.016034,-0.0089498,0,0
2,GO MODIFIED AMINO ACID TRANSPORT,0.56075,0.015993,0.07165,0,0
2,GO LENS FIBER CELL DIFFERENTIATION,0.36064,0.015979,0.072749,0,0
2,GO MITRAL VALVE DEVELOPMENT,0.29586,0.015937,0.25288,0,0
2,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.89907,0.015922,-0.020164,0,0
2,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.9686,0.015533,-0.027975,0,0
2,GO REGULATION OF MRNA POLYADENYLATION,0.93377,0.015515,0.0033865,0,0
2,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.27999,0.015412,0.14544,0,0
2,GO APPENDAGE MORPHOGENESIS,0.59059,0.015397,0.060253,0,0
2,GO REPLICATION FORK PROCESSING,0.52594,0.015266,0.054076,0,0
2,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.32077,0.01517,0.087686,0,0
2,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.14526,0.0151,0.056854,0,0
2,GO REGULATION OF SISTER CHROMATID COHESION,0.69707,0.015062,0.049906,0,0
2,GO REGULATION OF CELLULAR EXTRAVASATION,0.64605,0.014858,0.013312,0,0
2,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.44402,0.014455,0.053455,0,0
2,GO NEURAL TUBE PATTERNING,0.60883,0.014338,-0.016108,0,0
2,GO EATING BEHAVIOR,0.53167,0.01433,0.024148,0,0
2,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.27999,0.014258,0.051218,0,0
2,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.9686,0.014153,-0.0083412,0,0
2,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.91987,0.014062,0.047162,0,0
2,GO DNA REPLICATION CHECKPOINT,0.31653,0.013991,0.086732,0,0
2,GO BRAIN MORPHOGENESIS,0.78962,0.013964,-0.035771,0,0
2,GO MEMBRANE ORGANIZATION,0.95466,0.013837,-0.0053667,0,0
2,GO ESTABLISHMENT OF TISSUE POLARITY,0.38888,0.013815,0.036363,0,0
2,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.48678,0.013812,0.010328,0,0
2,GO C4 DICARBOXYLATE TRANSPORT,0.75615,0.013802,0.055013,0,0
2,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.73628,0.01373,0.022867,0,0
2,GO CELL MOTILITY,0.74288,0.013634,0.011931,0,0
2,GO MUSCLE CELL DEVELOPMENT,0.72969,0.013625,0.0045963,0,0
2,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.65234,0.013461,-0.04808,0,0
2,GO REGULATION OF CELLULAR COMPONENT SIZE,0.67776,0.013443,0.0065223,0,0
2,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.86455,0.013359,0.0072627,0,0
2,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.46512,0.013255,0.041123,0,0
2,GO RESPONSE TO LEAD ION,0.67137,0.013088,0.039547,0,0
2,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.63354,0.012902,0.016399,0,0
2,GO POSITIVE REGULATION OF SIGNALING,0.94073,0.0129,-0.0099678,0,0
2,GO ARTERY DEVELOPMENT,0.69061,0.012857,0.050188,0,0
2,GO PHOTOTRANSDUCTION,0.59059,0.012838,0.11626,0,0
2,GO SPINDLE ORGANIZATION,0.78289,0.012775,0.012031,0,0
2,GO MITOTIC DNA REPLICATION CHECKPOINT,0.80312,0.012655,0.069119,0,0
2,GO NEGATIVE REGULATION OF CELL GROWTH,0.85082,0.012635,-0.025164,0,0
2,GO PROTEIN ACYLATION,0.60272,0.012622,-0.0069486,0,0
2,GO MYELOID CELL DEVELOPMENT,0.50896,0.012618,0.040322,0,0
2,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.47049,0.012544,0.098085,0,0
2,GO PROTEIN LOCALIZATION TO MEMBRANE,0.78962,0.012481,0.0093054,0,0
2,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.96163,0.012399,0.026879,0,0
2,GO NATURAL KILLER CELL ACTIVATION,0.61497,0.012312,0.029205,0,0
2,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.56075,0.012283,0.027255,0,0
2,GO MITOTIC METAPHASE PLATE CONGRESSION,0.41341,0.012271,0.046036,0,0
2,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.67137,0.012162,0.019518,0,0
2,GO CELLULAR MACROMOLECULE LOCALIZATION,0.68418,0.012041,0.0070634,0,0
2,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.5726,0.012039,0.040014,0,0
2,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.91987,0.012015,-0.013353,0,0
2,GO REGULATION OF ORGANELLE ASSEMBLY,0.72969,0.011852,0.015393,0,0
2,GO CELLULAR RESPONSE TO STARVATION,0.78289,0.011822,-0.022931,0,0
2,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.72969,0.01182,0.057109,0,0
2,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.57857,0.011807,0.023794,0,0
2,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.50337,0.011793,0.043602,0,0
2,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.61497,0.01175,0.027737,0,0
2,GO REGULATION OF DEPHOSPHORYLATION,0.80312,0.01175,0.009354,0,0
2,GO T CELL HOMEOSTASIS,0.53167,0.011627,-0.058445,0,0
2,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.57857,0.011501,0.020879,0,0
2,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.94073,0.01144,-0.0038807,0,0
2,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.4978,0.011111,0.021609,0,0
2,GO ORGANELLE ASSEMBLY,0.80312,0.011049,-0.0078397,0,0
2,GO CHEMICAL HOMEOSTASIS,0.86455,0.011002,-0.004875,0,0
2,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.75615,0.01098,0.024542,0,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.97557,0.010968,0.037476,0,0
2,GO SULFATE TRANSPORT,0.55487,0.010757,0.050956,0,0
2,GO MUSCLE CONTRACTION,0.74288,0.010675,-0.022861,0,0
2,GO RESPONSE TO L GLUTAMATE,0.67776,0.01036,0.045009,0,0
2,GO MISMATCH REPAIR,0.7495,0.010326,0.015596,0,0
2,GO REGULATION OF TOR SIGNALING,0.61497,0.010233,-0.021166,0,0
2,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.71658,0.010171,0.021268,0,0
2,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.32506,0.010076,0.13771,0,0
2,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.89215,0.010036,-0.0097549,0,0
2,GO MORPHOGENESIS OF AN EPITHELIUM,0.44924,0.010004,0.056128,0,0
2,GO MESODERM MORPHOGENESIS,0.41341,0.0098992,0.063608,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.52594,0.0098922,0.064383,0,0
2,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.87833,0.0098736,-0.016701,0,0
2,GO ADAPTATION OF SIGNALING PATHWAY,0.70355,0.0098523,-0.025832,0,0
2,GO MEIOTIC CHROMOSOME SEGREGATION,0.74288,0.0098396,0.009699,0,0
2,GO CELL CYCLE CHECKPOINT,0.22235,0.0098329,0.055913,0,0
2,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.66501,0.0096986,0.050184,0,0
2,GO NEGATIVE REGULATION OF OSSIFICATION,0.40349,0.009694,0.077622,0,0
2,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.82348,0.0096727,-0.012382,0,0
2,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.39858,0.0096105,0.028944,0,0
2,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.77618,0.0095893,0.035763,0,0
2,GO CELL DIVISION,0.36526,0.0095324,0.045682,0,0
2,GO GLAND DEVELOPMENT,0.92682,0.0095112,0.018506,0,0
2,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.85768,0.0094649,0.0017085,0,0
2,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.33812,0.0094588,0.058016,0,0
2,GO RESPONSE TO NITROGEN COMPOUND,0.91987,0.009406,-0.010454,0,0
2,GO CHROMOSOME SEGREGATION,0.39371,0.0092842,0.038284,0,0
2,GO HEAT GENERATION,0.68418,0.0092815,0.022541,0,0
2,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.69707,0.00926,0.07722,0,0
2,GO OSTEOCLAST DEVELOPMENT,0.73628,0.0092581,-0.053737,0,0
2,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.72313,0.0091907,-0.019616,0,0
2,GO POSITIVE REGULATION OF GLIOGENESIS,0.89215,0.0091848,-0.006986,0,0
2,GO MAGNESIUM ION TRANSPORT,0.63978,0.00906,-0.067355,0,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.59059,0.0089028,0.053729,0,0
2,GO POSITIVE REGULATION OF NEURON DEATH,0.91293,0.0088526,0.0067403,0,0
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.75615,0.0088429,-0.0090987,0,0
2,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.4978,0.00876,0.040308,0,0
2,GO REGULATION OF TISSUE REMODELING,0.80989,0.0086779,0.0023625,0,0
2,GO MITOCHONDRIAL FISSION,0.36991,0.008547,-0.059483,0,0
2,GO EXECUTION PHASE OF APOPTOSIS,0.79636,0.0084836,-0.013987,0,0
2,GO MUSCLE TISSUE DEVELOPMENT,0.88523,0.0084633,0.0050016,0,0
2,GO ENDOSOMAL TRANSPORT,0.59059,0.0082531,0.02519,0,0
2,GO PROTEIN OXIDATION,0.69707,0.0082262,0.051567,0,0
2,GO WATER TRANSPORT,0.95466,0.0077279,-0.028291,0,0
2,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.77618,0.0077134,0.023652,0,0
2,GO INOSITOL METABOLIC PROCESS,0.80989,0.0077052,-0.022306,0,0
2,GO CELL CYCLE DNA REPLICATION,0.5726,0.0075946,0.034854,0,0
2,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.53742,0.0075504,0.039163,0,0
2,GO NUCLEUS ORGANIZATION,0.5726,0.0074728,0.011678,0,0
2,GO NUCLEAR CHROMOSOME SEGREGATION,0.4598,0.0074041,0.034769,0,0
2,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.74288,0.0073751,0.021727,0,0
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.75615,0.0072565,0.010879,0,0
2,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.71658,0.0071937,-0.030661,0,0
2,GO REGULATION OF AXON GUIDANCE,0.76948,0.0071827,-0.053506,0,0
2,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.79636,0.0071708,0.015467,0,0
2,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.52594,0.0071061,0.0050166,0,0
2,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.90599,0.0069861,-0.004411,0,0
2,GO MELANOCYTE DIFFERENTIATION,0.85082,0.0069724,0.0062615,0,0
2,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.68418,0.0069102,-0.031353,0,0
2,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.84397,0.0067318,-0.0030574,0,0
2,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.92682,0.0067243,0.0044902,0,0
2,GO CYTOSKELETON ORGANIZATION,0.63978,0.0066741,0.014277,0,0
2,GO PROTEIN ACETYLATION,0.52594,0.006589,0.024734,0,0
2,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.76948,0.0064927,0.034092,0,0
2,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.89215,0.0064517,-0.015807,0,0
2,GO OVULATION CYCLE PROCESS,0.80989,0.0063019,-0.021438,0,0
2,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.56075,0.0061494,0.024294,0,0
2,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.66501,0.006082,0.031611,0,0
2,GO NEGATIVE REGULATION OF ANOIKIS,0.89907,0.006076,-0.032917,0,0
2,GO BONE RESORPTION,0.85768,0.0060643,-0.010131,0,0
2,GO SODIUM ION HOMEOSTASIS,0.94769,0.0057869,-0.015416,0,0
2,GO KETONE CATABOLIC PROCESS,0.84397,0.005628,0.022782,0,0
2,GO PH REDUCTION,0.93377,0.005601,-0.0081931,0,0
2,GO PROTEIN DENEDDYLATION,0.78962,0.0055024,0.0072892,0,0
2,GO WALKING BEHAVIOR,0.4598,0.0054161,-0.054516,0,0
2,GO DEPHOSPHORYLATION,0.87833,0.0053724,-0.0066831,0,0
2,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.71006,0.0053297,-0.030461,0,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.91987,0.0051927,0.010535,0,0
2,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.82348,0.0051331,-0.0021245,0,0
2,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.77618,0.0051145,0.0090304,0,0
2,GO HISTONE EXCHANGE,0.83713,0.0049908,0.012825,0,0
2,GO REGULATION OF CELLULAR PH,0.90599,0.0049615,-0.017841,0,0
2,GO RESPONSE TO CARBOHYDRATE,0.95466,0.0049114,-0.0043188,0,0
2,GO REGULATION OF GOLGI ORGANIZATION,0.76281,0.0049073,0.034467,0,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.84397,0.0048482,-0.028904,0,0
2,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.5726,0.004383,0.017424,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.94073,0.0043415,0.0062301,0,0
2,GO APOPTOTIC DNA FRAGMENTATION,0.8303,0.0042569,-0.024802,0,0
2,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.61497,0.0042378,-0.08825,0,0
2,GO IRON ION TRANSPORT,0.78962,0.0041465,0.0021447,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.91293,0.0041299,0.0027496,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.33373,0.00398,0.10037,0,0
2,GO PEPTIDYL THREONINE MODIFICATION,0.52594,0.0037629,0.028498,0,0
2,GO CELLULAR HOMEOSTASIS,0.74288,0.0037499,0.0051812,0,0
2,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.87833,0.0037383,-0.024991,0,0
2,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.84397,0.0037307,0.052826,0,0
2,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.78289,0.0031905,-0.013152,0,0
2,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.58456,0.003086,0.053702,0,0
2,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.97557,0.0029426,-0.0051277,0,0
2,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.56075,0.0027484,0.036652,0,0
2,GO REGULATION OF MUSCLE ADAPTATION,0.63978,0.0024382,-0.031982,0,0
2,GO REPRODUCTION,0.72313,0.0021527,-0.013962,0,0
2,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.94073,0.0019425,-0.0018992,0,0
2,GO SENSORY PERCEPTION,0.65234,0.0018956,-0.016888,0,0
2,GO MATING,0.36526,0.0018918,-0.054081,0,0
2,GO SKELETAL SYSTEM MORPHOGENESIS,0.82348,0.0018274,0.0095585,0,0
2,GO VIRAL BUDDING,0.97557,0.0016543,0.016957,0,0
2,GO REGULATION OF DNA RECOMBINATION,0.30815,0.0016021,0.062639,0,0
2,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.99651,0.001597,0.0014926,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.87833,0.0015336,0.0040787,0,0
2,GO REGULATION OF PROTEIN DEACETYLATION,0.56075,0.0014938,-0.038684,0,0
2,GO VESICLE ORGANIZATION,0.68418,0.0013084,0.0062369,0,0
2,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.98953,0.0011613,0.0043153,0,0
2,GO PROSTAGLANDIN TRANSPORT,0.82348,0.00116,-0.0097459,0,0
2,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.89215,0.0011231,0.042199,0,0
2,GO EAR DEVELOPMENT,0.77618,0.0010406,0.013661,0,0
2,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.99651,0.00086165,-0.0038053,0,0
2,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.74288,0.00077932,-0.027932,0,0
2,GO GLIAL CELL PROLIFERATION,0.52594,0.00075536,0.036686,0,0
2,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,1,0.00058687,0.001803,0,0
2,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.93377,0.00056386,0.10696,0,0
2,GO REGULATION OF PH,0.76281,0.00039771,-0.030528,0,0
2,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.90599,0.00036424,0.021547,0,0
2,GO T HELPER CELL LINEAGE COMMITMENT,0.52025,0.00033945,0.066979,0,0
2,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.67776,0.0003183,0.045074,0,0
2,GO EMBRYONIC MORPHOGENESIS,0.75615,0.00026735,0.03115,0,0
2,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.82348,0.00025621,-0.0098244,0,0
2,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.49227,0.00018928,0.040537,0,0
2,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.79636,0.00014742,0.017455,0,0
2,GO TAXIS,0.72313,6.2914e-05,-0.024804,0,0
2,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.95466,1.8455e-05,0.0122,0,0
2,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.87833,-0.00012537,0.0068972,0,0
2,GO MUSCLE FIBER DEVELOPMENT,0.70355,-0.00016878,-0.037091,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.37932,-0.00029308,0.052587,0,0
2,GO CARTILAGE DEVELOPMENT,0.9686,-0.00029828,0.0093014,0,0
2,GO CANONICAL WNT SIGNALING PATHWAY,0.98953,-0.00039405,0.021472,0,0
2,GO RESPONSE TO ACID CHEMICAL,0.76281,-0.00056072,0.0034267,0,0
2,GO CENTRIOLE CENTRIOLE COHESION,0.72313,-0.00059637,-0.050412,0,0
2,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.43367,-0.00059704,-0.040982,0,0
2,GO REGULATION OF CHEMOTAXIS,0.88523,-0.00068344,-0.0020245,0,0
2,GO IMMUNOGLOBULIN SECRETION,0.8303,-0.00077609,-0.052762,0,0
2,GO POSITIVE REGULATION OF BINDING,0.91987,-0.00089924,0.0026498,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.72313,-0.00097177,-0.018705,0,0
2,GO UV DAMAGE EXCISION REPAIR,0.56666,-0.0010306,-0.057381,0,0
2,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.87833,-0.0010726,0.0030977,0,0
2,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.8303,-0.0010925,0.00047146,0,0
2,GO FORELIMB MORPHOGENESIS,0.87833,-0.0011968,-0.031024,0,0
2,GO GLAND MORPHOGENESIS,0.36991,-0.0012119,0.11897,0,0
2,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.89907,-0.0013098,-0.0018572,0,0
2,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.38888,-0.0013866,0.022974,0,0
2,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.69707,-0.0014435,0.064384,0,0
2,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.94073,-0.0014555,-0.014599,0,0
2,GO ION HOMEOSTASIS,0.94769,-0.0014913,-0.0059473,0,0
2,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.97557,-0.0015183,-0.0027313,0,0
2,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.88523,-0.001591,0.0283,0,0
2,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.87833,-0.0016381,0.0038563,0,0
2,GO TOR SIGNALING,0.51459,-0.0016716,-0.021523,0,0
2,GO STRIATED MUSCLE CONTRACTION,0.76281,-0.0016826,-0.013681,0,0
2,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.57857,-0.0017304,0.037301,0,0
2,GO BASEMENT MEMBRANE ORGANIZATION,0.98255,-0.0020826,0.0044694,0,0
2,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.91293,-0.0021085,-0.023585,0,0
2,GO ASTRAL MICROTUBULE ORGANIZATION,0.79636,-0.0021736,0.036788,0,0
2,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.54321,-0.0021904,0.033113,0,0
2,GO AMINE METABOLIC PROCESS,0.67137,-0.0022021,0.020501,0,0
2,GO REGULATION OF BIOMINERALIZATION,0.65866,-0.0022196,0.022488,0,0
2,GO CELL CELL SIGNALING BY WNT,0.91293,-0.0022395,0.018842,0,0
2,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.98255,-0.0024613,-0.0048535,0,0
2,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.67137,-0.0024702,0.080555,0,0
2,GO ADAPTIVE THERMOGENESIS,0.54903,-0.0024934,-0.03146,0,0
2,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.25729,-0.0025068,0.04698,0,0
2,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.32506,-0.0026135,-0.035664,0,0
2,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.69707,-0.0027167,0.016843,0,0
2,GO POSITIVE REGULATION OF JNK CASCADE,0.72313,-0.0027333,0.018203,0,0
2,GO MUSCLE STRUCTURE DEVELOPMENT,0.96163,-0.0027628,0.007237,0,0
2,GO RRNA CATABOLIC PROCESS,0.94073,-0.0027738,-0.021793,0,0
2,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.59664,-0.0028348,-0.02644,0,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.94073,-0.0028998,-0.0017574,0,0
2,GO AMYLOID BETA FORMATION,0.51459,-0.0029539,0.035364,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.97557,-0.002971,-0.00084455,0,0
2,GO BIOMINERALIZATION,0.80989,-0.0029999,-0.014685,0,0
2,GO WATER HOMEOSTASIS,0.73628,-0.0031569,-0.029147,0,0
2,GO PEROXISOMAL MEMBRANE TRANSPORT,0.80312,-0.0032039,0.02597,0,0
2,GO PROTEIN LOCALIZATION TO ENDOSOME,0.67137,-0.0032594,-0.028665,0,0
2,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.60272,-0.0033201,0.048687,0,0
2,GO ENSHEATHMENT OF NEURONS,0.73628,-0.0033464,-0.026519,0,0
2,GO PURINE NUCLEOTIDE TRANSPORT,0.33812,-0.0033693,-0.058144,0,0
2,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.53167,-0.0035456,0.052798,0,0
2,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.92682,-0.0037123,0.00080376,0,0
2,GO RESPONSE TO GLUCAGON,0.59664,-0.0037547,-0.027582,0,0
2,GO VASODILATION,0.75615,-0.0038696,-0.062143,0,0
2,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.65866,-0.0039272,-0.041717,0,0
2,GO EMBRYONIC PATTERN SPECIFICATION,0.85768,-0.0039392,-0.014985,0,0
2,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.71006,-0.0039408,0.040754,0,0
2,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.79636,-0.0039936,0.013037,0,0
2,GO MANNOSYLATION,0.88523,-0.0042661,0.0064654,0,0
2,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.8303,-0.0043896,0.0090485,0,0
2,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.96163,-0.0044958,-0.048995,0,0
2,GO CELL CYCLE ARREST,0.44924,-0.0046931,0.029086,0,0
2,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.72313,-0.0048028,-0.033319,0,0
2,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.71658,-0.0048601,0.01158,0,0
2,GO POSITIVE REGULATION OF OSSIFICATION,0.52025,-0.0048895,-0.058711,0,0
2,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.46512,-0.0051292,0.088929,0,0
2,GO OXALATE TRANSPORT,0.76281,-0.0052229,-0.018883,0,0
2,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.83713,-0.0052623,-0.016513,0,0
2,GO ONE CARBON METABOLIC PROCESS,0.89907,-0.0054368,0.0028789,0,0
2,GO REGULATION OF CELL CYCLE CHECKPOINT,0.85082,-0.0054609,0.016751,0,0
2,GO GROWTH,0.5726,-0.0055105,-0.016685,0,0
2,GO SPINDLE LOCALIZATION,0.98255,-0.0055741,-0.0070161,0,0
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.91293,-0.0058966,0.015035,0,0
2,GO SECONDARY METABOLIC PROCESS,0.74288,-0.0059259,-2.0443e-05,0,0
2,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.76948,-0.0059273,-0.0076739,0,0
2,GO NEURAL CREST CELL DIFFERENTIATION,0.71658,-0.0060155,0.046057,0,0
2,GO REGULATION OF MITOCHONDRIAL FISSION,0.33812,-0.0060251,-0.068516,0,0
2,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.88523,-0.0060664,-0.0074116,0,0
2,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.59059,-0.0061222,0.034564,0,0
2,GO OVULATION CYCLE,0.85082,-0.0061384,-0.02061,0,0
2,GO RESPONSE TO PARATHYROID HORMONE,0.58456,-0.0065534,-0.07631,0,0
2,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.44402,-0.0065608,-0.026814,0,0
2,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.38408,-0.0065622,0.087586,0,0
2,GO REGULATION OF LYMPHOCYTE MIGRATION,0.84397,-0.0065923,0.016348,0,0
2,GO LEUKOCYTE TETHERING OR ROLLING,0.87833,-0.0067291,-0.010366,0,0
2,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.88523,-0.0068799,0.010563,0,0
2,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.89907,-0.006896,0.0053878,0,0
2,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.58456,-0.0070655,0.040279,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.89907,-0.0070769,0.0079739,0,0
2,GO RESPONSE TO TEMPERATURE STIMULUS,0.98953,-0.0071707,-0.0013146,0,0
2,GO REGULATION OF MULTI ORGANISM PROCESS,0.81668,-0.0071842,-0.012407,0,0
2,GO LACTATE METABOLIC PROCESS,0.63354,-0.0072825,0.037983,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.63978,-0.0073265,-0.036832,0,0
2,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.5726,-0.007482,-0.029554,0,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.27999,-0.0076264,-0.11404,0,0
2,GO BROWN FAT CELL DIFFERENTIATION,0.92682,-0.0076962,-0.01278,0,0
2,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.87144,-0.0077009,-0.011609,0,0
2,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.53167,-0.0078082,0.051855,0,0
2,GO NOTCH SIGNALING PATHWAY,0.38408,-0.0078258,-0.046534,0,0
2,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.76948,-0.0078298,0.010051,0,0
2,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.96163,-0.0078352,-0.00023404,0,0
2,GO BONE TRABECULA FORMATION,0.57857,-0.0080774,0.09708,0,0
2,GO STRIATED MUSCLE CELL PROLIFERATION,0.98255,-0.0081972,0.028712,0,0
2,GO MEMBRANE FUSION,0.42855,-0.0085795,-0.041218,0,0
2,GO REGULATION OF CELLULAR LOCALIZATION,0.78289,-0.0086888,-0.005884,0,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.91987,-0.008701,0.0071416,0,0
2,GO REGULATION OF VASCULAR PERMEABILITY,0.71658,-0.0088635,-0.026352,0,0
2,GO AXIS SPECIFICATION,0.98953,-0.009185,1.2987e-05,0,0
2,GO CELLULAR RESPONSE TO CAMP,0.77618,-0.0093159,-0.017755,0,0
2,GO DERMATAN SULFATE METABOLIC PROCESS,0.43367,-0.0093751,-0.11005,0,0
2,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.98255,-0.0093771,0.009943,0,0
2,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.84397,-0.0094787,0.0093582,0,0
2,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.42855,-0.0095387,-0.054569,0,0
2,GO POSITIVE REGULATION OF RNA SPLICING,0.69707,-0.0095574,-0.035775,0,0
2,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.42855,-0.0098818,0.054415,0,0
2,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.96163,-0.0099162,-0.0044856,0,0
2,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.79636,-0.010054,-0.019376,0,0
2,GO MOTOR NEURON AXON GUIDANCE,0.89907,-0.010102,-0.03043,0,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.89907,-0.010147,-0.0043319,0,0
2,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.59664,-0.010295,-0.021603,0,0
2,GO CARDIAC SEPTUM DEVELOPMENT,0.84397,-0.010349,0.0039356,0,0
2,GO VACUOLAR TRANSPORT,0.88523,-0.010383,0.0044945,0,0
2,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.81668,-0.010426,0.036238,0,0
2,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.91293,-0.010513,-0.017921,0,0
2,GO RESPONSE TO MONOSACCHARIDE,0.58456,-0.01057,-0.024469,0,0
2,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.97557,-0.010601,0.0074659,0,0
2,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.70355,-0.010632,-0.040248,0,0
2,GO DNA REPLICATION,0.7495,-0.010667,0.040908,0,0
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.91293,-0.010719,-0.0032229,0,0
2,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.27611,-0.010776,-0.048037,0,0
2,GO POSITIVE REGULATION OF CHEMOTAXIS,0.70355,-0.010863,0.017354,0,0
2,GO SOMITOGENESIS,0.98953,-0.010913,0.0086586,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.69061,-0.010932,-0.030905,0,0
2,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.36064,-0.010969,-0.034786,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.80312,-0.011023,-0.015826,0,0
2,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.56666,-0.011113,-0.027263,0,0
2,GO NEGATIVE REGULATION OF SIGNALING,0.87144,-0.011281,-0.0051471,0,0
2,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.60883,-0.011285,-0.031787,0,0
2,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.88523,-0.011296,0.0051333,0,0
2,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.59059,-0.011298,-0.033658,0,0
2,GO CELLULAR ION HOMEOSTASIS,0.89907,-0.011358,-0.0093428,0,0
2,GO CELLULAR COMPONENT MAINTENANCE,0.8303,-0.011383,-0.022394,0,0
2,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.91987,-0.011455,0.015282,0,0
2,GO ENDOTHELIAL CELL PROLIFERATION,0.75615,-0.011487,-0.024704,0,0
2,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.94769,-0.011568,-0.006151,0,0
2,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.65234,-0.011633,0.026623,0,0
2,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.73628,-0.011654,-0.014688,0,0
2,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.47049,-0.011714,-0.036674,0,0
2,GO DNA DEALKYLATION,0.64605,-0.011793,0.032167,0,0
2,GO EXCRETION,0.82348,-0.011851,0.008984,0,0
2,GO PROTEOGLYCAN METABOLIC PROCESS,0.96163,-0.011859,0.00021095,0,0
2,GO REGULATION OF CALCIUM ION TRANSPORT,0.84397,-0.01189,0.008715,0,0
2,GO SYNAPTIC TRANSMISSION GABAERGIC,0.54903,-0.011947,-0.050972,0,0
2,GO MUSCLE CELL DIFFERENTIATION,0.96163,-0.012099,0.010214,0,0
2,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.76948,-0.012111,-0.017649,0,0
2,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.96163,-0.012247,0.020975,0,0
2,GO ATP DEPENDENT CHROMATIN REMODELING,0.77618,-0.012366,0.021347,0,0
2,GO REGULATION OF BONE REMODELING,0.82348,-0.012425,-0.042416,0,0
2,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.78962,-0.012555,-0.023784,0,0
2,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.72313,-0.012921,-0.016024,0,0
2,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.76948,-0.012923,-0.02426,0,0
2,GO HISTONE H3 K9 DEMETHYLATION,0.65234,-0.013032,-0.025508,0,0
2,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.59059,-0.013042,-0.049284,0,0
2,GO REGULATION OF RECEPTOR BINDING,0.87833,-0.013235,0.028008,0,0
2,GO MIDBODY ABSCISSION,0.9686,-0.013379,0.036093,0,0
2,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.89215,-0.01347,0.014831,0,0
2,GO SKELETAL SYSTEM DEVELOPMENT,0.95466,-0.013559,0.0061666,0,0
2,GO CELL JUNCTION ASSEMBLY,0.70355,-0.013663,-0.016974,0,0
2,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.39371,-0.013666,-0.03591,0,0
2,GO NEGATIVE REGULATION OF ION TRANSPORT,0.58456,-0.013689,-0.026542,0,0
2,GO METAL ION HOMEOSTASIS,0.86455,-0.013714,-0.0040677,0,0
2,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.9686,-0.013829,0.028536,0,0
2,GO RESPONSE TO LEUCINE,0.63978,-0.013848,-0.057766,0,0
2,GO REGULATION OF ODONTOGENESIS,0.94769,-0.013859,-0.021025,0,0
2,GO ORGANELLE FISSION,0.80989,-0.013953,0.00059308,0,0
2,GO ASTROCYTE DIFFERENTIATION,0.98255,-0.014185,0.002911,0,0
2,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.78962,-0.014215,0.011186,0,0
2,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.59059,-0.014293,-0.069135,0,0
2,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.98953,-0.014308,0.091397,0,0
2,GO EPIDERMIS MORPHOGENESIS,0.44402,-0.014545,0.16305,0,0
2,GO OOGENESIS,0.63978,-0.01462,-0.036198,0,0
2,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.98953,-0.014844,0.00022346,0,0
2,GO METAPHASE PLATE CONGRESSION,0.7495,-0.0149,0.029571,0,0
2,GO CENTROSOME DUPLICATION,0.52025,-0.015034,-0.0093029,0,0
2,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.78962,-0.015331,-0.030094,0,0
2,GO SPHINGOMYELIN METABOLIC PROCESS,0.87833,-0.015427,-0.043867,0,0
2,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.86455,-0.015443,0.015143,0,0
2,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.67776,-0.015606,0.0016209,0,0
2,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.82348,-0.015717,-0.0019405,0,0
2,GO MULTICELLULAR ORGANISM REPRODUCTION,0.36064,-0.015822,-0.028301,0,0
2,GO RESPONSE TO STARVATION,0.76948,-0.015825,-0.021181,0,0
2,GO FUCOSE METABOLIC PROCESS,0.4978,-0.015903,0.046013,0,0
2,GO PROTEIN TARGETING TO VACUOLE,0.86455,-0.015928,-0.0080455,0,0
2,GO TEMPERATURE HOMEOSTASIS,0.51459,-0.015996,-0.03295,0,0
2,GO VESICLE LOCALIZATION,0.83713,-0.016024,-0.018983,0,0
2,GO MULTI ORGANISM PROCESS,0.43367,-0.016092,-0.027922,0,0
2,GO REGULATION OF MICROTUBULE BASED PROCESS,0.20309,-0.016125,-0.055509,0,0
2,GO AMELOGENESIS,0.17099,-0.016261,0.16302,0,0
2,GO REGULATION OF WNT SIGNALING PATHWAY,0.67137,-0.016512,9.9475e-05,0,0
2,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.5726,-0.016694,-0.015029,0,0
2,GO HORMONE MEDIATED SIGNALING PATHWAY,0.68418,-0.017019,-0.010342,0,0
2,GO INTEGRIN ACTIVATION,0.87833,-0.017089,-0.0030735,0,0
2,GO ORGANELLE FUSION,0.62732,-0.017171,-0.026173,0,0
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.63354,-0.017183,0.03977,0,0
2,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.98953,-0.017205,-0.019084,0,0
2,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.85768,-0.017257,-0.0096711,0,0
2,GO T CELL SELECTION,0.87144,-0.017361,0.0047008,0,0
2,GO GPI ANCHOR METABOLIC PROCESS,0.98953,-0.017592,0.020635,0,0
2,GO CIRCULATORY SYSTEM PROCESS,0.26847,-0.017631,-0.047189,0,0
2,GO APICAL PROTEIN LOCALIZATION,0.4545,-0.017693,-0.12573,0,0
2,GO REGULATION OF PHOSPHATASE ACTIVITY,0.89215,-0.017717,0.0047196,0,0
2,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.72313,-0.017801,-0.051456,0,0
2,GO LYSOSOME LOCALIZATION,0.97557,-0.018245,-0.0037694,0,0
2,GO MUSCLE ORGAN DEVELOPMENT,0.75615,-0.018273,-0.014383,0,0
2,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.36526,-0.018484,-0.047006,0,0
2,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.64605,-0.018594,0.024563,0,0
2,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.76281,-0.01881,-0.098425,0,0
2,GO HEART GROWTH,1,-0.01894,0.01549,0,0
2,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.76281,-0.019128,-0.018297,0,0
2,GO MICROTUBULE ANCHORING,0.47588,-0.019147,-0.035487,0,0
2,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,1,-0.019162,0.032099,0,0
2,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,1,-0.019299,-0.00031802,0,0
2,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.65866,-0.019308,0.056119,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.71658,-0.01932,-0.012586,0,0
2,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.5726,-0.01936,-0.042953,0,0
2,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.17653,-0.019374,-0.084506,0,0
2,GO GOLGI TO ENDOSOME TRANSPORT,0.85082,-0.019467,-0.023315,0,0
2,GO TISSUE MORPHOGENESIS,0.71658,-0.019739,0.03387,0,0
2,GO OSSIFICATION,0.66501,-0.019761,-0.015105,0,0
2,GO SHORT TERM MEMORY,0.77618,-0.019992,0.020355,0,0
2,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.77618,-0.020032,-0.0093307,0,0
2,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.42347,-0.020034,-0.0493,0,0
2,GO REGULATION OF TRANSPORT,0.21579,-0.020034,-0.044335,0,0
2,GO RESPONSE TO FOOD,0.18219,-0.020137,-0.065747,0,0
2,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.60272,-0.020255,0.032877,0,0
2,GO HEART DEVELOPMENT,0.96163,-0.020326,0.011576,0,0
2,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.74288,-0.020533,-0.025706,0,0
2,GO REGULATION OF CELL DIVISION,0.81668,-0.020543,0.0028317,0,0
2,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.88523,-0.020632,0.0080921,0,0
2,GO SOMITE DEVELOPMENT,0.24643,-0.021163,-0.03564,0,0
2,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.63354,-0.021189,-0.044895,0,0
2,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.16294,-0.021193,-0.060615,0,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.39858,-0.021416,-0.070684,0,0
2,GO REGULATION OF VACUOLE ORGANIZATION,0.69707,-0.021563,0.038531,0,0
2,GO HISTONE H3 K36 METHYLATION,0.76281,-0.021667,0.041624,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.50337,-0.021679,0.069387,0,0
2,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.85768,-0.021683,-0.0040034,0,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.85082,-0.021896,0.030312,0,0
2,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.95466,-0.022045,-0.014615,0,0
2,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.89907,-0.0221,0.012742,0,0
2,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.80312,-0.022194,-0.014232,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.26098,-0.022207,-0.071443,0,0
2,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.56666,-0.022296,0.00097749,0,0
2,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.4545,-0.022392,-0.025868,0,0
2,GO NEUROTROPHIN SIGNALING PATHWAY,0.49227,-0.022409,-0.049302,0,0
2,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.71658,-0.022526,-0.061517,0,0
2,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.40843,-0.022631,-0.031686,0,0
2,GO KINETOCHORE ASSEMBLY,0.63354,-0.022648,-0.024484,0,0
2,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.9686,-0.022757,0.012039,0,0
2,GO REGULATION OF BINDING,0.62113,-0.022959,-0.014841,0,0
2,GO DETECTION OF STIMULUS,0.55487,-0.0231,-0.016357,0,0
2,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.80312,-0.023271,-0.016593,0,0
2,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.34702,-0.023286,-0.046481,0,0
2,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.42855,-0.023339,-0.046163,0,0
2,GO MITOPHAGY,0.86455,-0.023514,-0.0090201,0,0
2,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.94073,-0.02364,-0.014966,0,0
2,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.37932,-0.0239,-0.0738,0,0
2,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.66501,-0.023993,-0.085396,0,0
2,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.81668,-0.024007,0.006539,0,0
2,GO GAMETE GENERATION,0.28785,-0.024278,-0.037436,0,0
2,GO SEXUAL REPRODUCTION,0.26847,-0.024443,-0.03858,0,0
2,GO PROTEIN FOLDING,0.94073,-0.024472,0.0025148,0,0
2,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.93377,-0.024573,-0.020054,0,0
2,GO GLIAL CELL MIGRATION,0.76948,-0.024752,-0.025941,0,0
2,GO CARDIAC CHAMBER DEVELOPMENT,0.91987,-0.025332,0.013851,0,0
2,GO CARBOHYDRATE HOMEOSTASIS,0.52594,-0.025364,-0.025083,0,0
2,GO CELL VOLUME HOMEOSTASIS,0.8303,-0.02539,-0.0075711,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.84397,-0.025424,0.016235,0,0
2,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.97557,-0.025741,-0.016785,0,0
2,GO NEUTRAL AMINO ACID TRANSPORT,0.92682,-0.02576,0.01655,0,0
2,GO PEPTIDYL SERINE MODIFICATION,0.41842,-0.025802,-0.020666,0,0
2,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.46512,-0.026013,-0.026384,0,0
2,GO REGULATION OF NEUROBLAST PROLIFERATION,0.59664,-0.026051,-0.048228,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.72969,-0.026141,-0.013437,0,0
2,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.87833,-0.02615,0.0052452,0,0
2,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.74288,-0.026299,-0.0089633,0,0
2,GO CALCIUM MEDIATED SIGNALING,0.33812,-0.026483,-0.037923,0,0
2,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.39371,-0.026505,-0.056251,0,0
2,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.71658,-0.026529,-0.0034536,0,0
2,GO GLUTAMATE METABOLIC PROCESS,0.36526,-0.026618,0.049572,0,0
2,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.62113,-0.026708,0.056237,0,0
2,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.9686,-0.026846,0.0022645,0,0
2,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.38888,-0.026921,-0.033704,0,0
2,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.91987,-0.026986,-0.0020084,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.95466,-0.026993,0.0027768,0,0
2,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.36526,-0.027009,-0.15265,0,0
2,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.91987,-0.027315,0.01477,0,0
2,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.72969,-0.027356,-0.013964,0,0
2,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.58456,-0.027524,-0.00014057,0,0
2,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.95466,-0.027679,0.010391,0,0
2,GO RESPIRATORY SYSTEM DEVELOPMENT,0.31232,-0.027695,-0.045453,0,0
2,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.42855,-0.027783,-0.02595,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.76948,-0.027953,-0.02756,0,0
2,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.53167,-0.028121,-0.089281,0,0
2,GO ORGANIC ANION TRANSPORT,0.87144,-0.028141,-0.0037958,0,0
2,GO MITOTIC CHROMOSOME CONDENSATION,0.85082,-0.028252,0.017435,0,0
2,GO HISTONE H3 K9 METHYLATION,0.85082,-0.028265,0.0062881,0,0
2,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.58456,-0.028513,-0.020902,0,0
2,GO SNORNA METABOLIC PROCESS,0.86455,-0.02859,-0.015164,0,0
2,GO GLUCOSE IMPORT,0.13814,-0.02869,-0.070984,0,0
2,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.32938,-0.0287,0.099575,0,0
2,GO MIDBRAIN DEVELOPMENT,0.92682,-0.028785,0.046084,0,0
2,GO VESICLE CYTOSKELETAL TRAFFICKING,0.36991,-0.028859,-0.038214,0,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.41341,-0.028914,-0.050075,0,0
2,GO REGULATION OF CELL SIZE,0.14048,-0.02905,-0.07173,0,0
2,GO HEART TRABECULA FORMATION,0.56075,-0.029148,-0.070081,0,0
2,GO DETECTION OF LIGHT STIMULUS,0.24643,-0.029197,0.043572,0,0
2,GO OOCYTE MATURATION,0.54321,-0.029201,-0.049253,0,0
2,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.26098,-0.029376,-0.053581,0,0
2,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.58456,-0.029458,-0.020593,0,0
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.50896,-0.029691,-0.07775,0,0
2,GO NEGATIVE REGULATION OF BEHAVIOR,0.4978,-0.029884,0.13171,0,0
2,GO PROTEIN DEPHOSPHORYLATION,0.38408,-0.029942,-0.026644,0,0
2,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.63978,-0.029948,-0.010646,0,0
2,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.53742,-0.030015,-0.0065412,0,0
2,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.65234,-0.030076,-0.024977,0,0
2,GO MALE GAMETE GENERATION,0.26847,-0.030132,-0.039988,0,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.22905,-0.030148,-0.14243,0,0
2,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.64605,-0.03028,-0.011078,0,0
2,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.62113,-0.030451,-0.024901,0,0
2,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.15773,-0.030462,-0.064731,0,0
2,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.74288,-0.030539,-0.0412,0,0
2,GO CELLULAR RESPONSE TO LITHIUM ION,0.87833,-0.030543,-0.0088713,0,0
2,GO HISTONE H4 K16 ACETYLATION,0.61497,-0.030586,-0.013107,0,0
2,GO AORTIC VALVE DEVELOPMENT,0.95466,-0.030716,0.032102,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.23245,-0.030805,-0.027262,0,0
2,GO INORGANIC ANION TRANSPORT,0.35153,-0.030947,-0.031482,0,0
2,GO PLASMA MEMBRANE ORGANIZATION,0.2839,-0.031143,-0.063615,0,0
2,GO MEIOTIC CHROMOSOME SEPARATION,0.95466,-0.031616,-0.01396,0,0
2,GO CARDIAC SEPTUM MORPHOGENESIS,0.46512,-0.031751,-0.047314,0,0
2,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.69707,-0.032064,-0.027486,0,0
2,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.7495,-0.032305,-0.045568,0,0
2,GO ADHERENS JUNCTION ASSEMBLY,0.52594,-0.032955,-0.10194,0,0
2,GO ANION TRANSPORT,0.66501,-0.033115,-0.01571,0,0
2,GO RENAL WATER HOMEOSTASIS,0.4978,-0.03376,-0.038089,0,0
2,GO ACID SECRETION,0.63978,-0.033773,-0.014139,0,0
2,GO AORTA DEVELOPMENT,0.62732,-0.033787,-0.0197,0,0
2,GO RESPONSE TO ORGANOPHOSPHORUS,0.27999,-0.033875,-0.052183,0,0
2,GO DIVALENT INORGANIC CATION TRANSPORT,0.26098,-0.033978,-0.040893,0,0
2,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.61497,-0.03421,-0.028086,0,0
2,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.2839,-0.034363,-0.069568,0,0
2,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.10845,-0.034452,-0.076053,0,0
2,GO ENDOCYTIC RECYCLING,0.53742,-0.034465,-0.025211,0,0
2,GO REGULATION OF PROTEIN TARGETING,0.87144,-0.034617,-0.0012699,0,0
2,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.76281,-0.034838,0.058907,0,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.80989,-0.035077,0.0064644,0,0
2,GO VASCULAR WOUND HEALING,0.68418,-0.03512,-0.047522,0,0
2,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.35607,-0.035191,-0.068666,0,0
2,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.85768,-0.035198,-0.12188,0,0
2,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.86455,-0.035362,-0.011997,0,0
2,GO REGULATION OF GROWTH,0.29184,-0.035374,-0.034842,0,0
2,GO FUCOSYLATION,1,-0.035418,-0.0056255,0,0
2,GO SALIVARY GLAND DEVELOPMENT,0.9686,-0.035452,0.034349,0,0
2,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.23937,-0.035528,-0.055804,0,0
2,GO POSITIVE REGULATION OF MRNA PROCESSING,0.81668,-0.035558,-0.00021331,0,0
2,GO RESPONSE TO PAIN,0.51459,-0.035642,-0.072615,0,0
2,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.69061,-0.035756,0.032522,0,0
2,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.36064,-0.035853,-0.077823,0,0
2,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.38408,-0.035927,-0.11027,0,0
2,GO RESPONSE TO PROSTAGLANDIN E,0.90599,-0.035976,0.013261,0,0
2,GO CYTOKINESIS,0.60883,-0.036034,-0.010199,0,0
2,GO POST ANAL TAIL MORPHOGENESIS,0.41842,-0.03607,-0.041351,0,0
2,GO REGULATION OF FAT CELL DIFFERENTIATION,0.5726,-0.036082,-0.022996,0,0
2,GO CHROMATIN REMODELING AT CENTROMERE,0.46512,-0.036477,-0.026513,0,0
2,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.27227,-0.036518,-0.059104,0,0
2,GO NEPHRIC DUCT DEVELOPMENT,0.79636,-0.036618,0.093057,0,0
2,GO HYALURONAN BIOSYNTHETIC PROCESS,0.33373,-0.036764,-0.08679,0,0
2,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.54321,-0.036963,-0.047315,0,0
2,GO CELL JUNCTION ORGANIZATION,0.17934,-0.037074,-0.062279,0,0
2,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.30402,-0.037264,-0.062774,0,0
2,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.46512,-0.037369,-0.091547,0,0
2,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.98953,-0.037387,0.01358,0,0
2,GO CELL PROJECTION ASSEMBLY,0.33373,-0.037516,-0.022587,0,0
2,GO CONNECTIVE TISSUE DEVELOPMENT,0.62113,-0.037564,-0.014106,0,0
2,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.78289,-0.037755,0.032919,0,0
2,GO ENGULFMENT OF APOPTOTIC CELL,0.61497,-0.037975,-0.032724,0,0
2,GO REGULATION OF PINOCYTOSIS,0.63354,-0.038108,0.044776,0,0
2,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.3746,-0.038253,-0.046474,0,0
2,GO PROTEIN METHYLATION,0.27611,-0.038343,-0.0080718,0,0
2,GO DEVELOPMENTAL GROWTH,0.30402,-0.038458,-0.033293,0,0
2,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.59664,-0.038478,-0.053823,0,0
2,GO REGULATION OF CIRCADIAN RHYTHM,0.13583,-0.038544,-0.04613,0,0
2,GO OSTEOBLAST DIFFERENTIATION,0.8303,-0.038612,0.0083334,0,0
2,GO REGULATION OF CYTOKINESIS,0.53742,-0.038623,-0.020439,0,0
2,GO PHOSPHATE ION TRANSPORT,0.31232,-0.03872,-0.047115,0,0
2,GO POSITIVE T CELL SELECTION,0.7495,-0.038726,-9.7204e-06,0,0
2,GO VASCULAR TRANSPORT,0.92682,-0.038771,-0.010297,0,0
2,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.31653,-0.038901,-0.063993,0,0
2,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.73628,-0.039334,-0.011981,0,0
2,GO POSITIVE REGULATION OF GROWTH,0.052669,-0.039828,-0.060784,0,0
2,GO ORGANELLE MEMBRANE FUSION,0.47049,-0.039905,-0.042693,0,0
2,GO MULTICELLULAR ORGANISM AGING,0.087232,-0.040181,-0.060754,0,0
2,GO REGULATION OF EXCRETION,0.72313,-0.040283,0.06041,0,0
2,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.9686,-0.040353,0.014672,0,0
2,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.22568,-0.040423,-0.084093,0,0
2,GO REGULATION OF DEACETYLASE ACTIVITY,0.93377,-0.040449,-0.0032401,0,0
2,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.71658,-0.040471,-0.013124,0,0
2,GO HISTONE METHYLATION,0.48131,-0.040562,-0.0028625,0,0
2,GO MEIOTIC CELL CYCLE,0.095625,-0.040567,-0.041578,0,0
2,GO ZINC ION TRANSPORT,0.76281,-0.04059,0.019141,0,0
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.40843,-0.040909,-0.064698,0,0
2,GO MEIOSIS I CELL CYCLE PROCESS,0.11235,-0.041019,-0.053328,0,0
2,GO DNA CATABOLIC PROCESS,0.39858,-0.041351,-0.035638,0,0
2,GO LIPOPROTEIN METABOLIC PROCESS,0.47588,-0.041353,-0.040267,0,0
2,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.59059,-0.041376,-0.052631,0,0
2,GO CHROMOSOME LOCALIZATION,0.38408,-0.041405,-0.015596,0,0
2,GO CELLULAR GLUCAN METABOLIC PROCESS,0.44924,-0.041419,-0.044605,0,0
2,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.66501,-0.041442,-0.064975,0,0
2,GO CHONDROCYTE DEVELOPMENT,0.94769,-0.041505,-0.0027582,0,0
2,GO REGULATION OF TUBE SIZE,0.13355,-0.041671,-0.07919,0,0
2,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.8303,-0.041691,-0.0098863,0,0
2,GO PROSTAGLANDIN SECRETION,0.91293,-0.041734,0.0039218,0,0
2,GO REGULATION OF GONAD DEVELOPMENT,0.93377,-0.042096,-0.037719,0,0
2,GO CENTROSOME SEPARATION,0.54903,-0.042115,-0.016338,0,0
2,GO RESPONSE TO INTERLEUKIN 6,0.23245,-0.042278,-0.078595,0,0
2,GO REGULATION OF OSSIFICATION,0.94073,-0.042528,0.024121,0,0
2,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.72969,-0.042759,-0.032082,0,0
2,GO RETINOIC ACID METABOLIC PROCESS,0.43367,-0.042777,-0.065802,0,0
2,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.52594,-0.042794,0.034217,0,0
2,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.48678,-0.042899,-0.041009,0,0
2,GO PROTEIN COMPLEX OLIGOMERIZATION,0.18508,-0.042901,-0.03755,0,0
2,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.23245,-0.043006,-0.074609,0,0
2,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.85768,-0.043017,0.02078,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.44924,-0.043113,-0.039185,0,0
2,GO MULTICELLULAR ORGANISM GROWTH,0.21905,-0.043124,-0.038631,0,0
2,GO POLYSACCHARIDE METABOLIC PROCESS,0.21579,-0.043126,-0.066544,0,0
2,GO REGULATION OF CELL FATE COMMITMENT,0.91293,-0.043553,0.061676,0,0
2,GO MESODERMAL CELL FATE SPECIFICATION,0.44402,-0.04377,-0.062866,0,0
2,GO ASTROCYTE ACTIVATION,0.63978,-0.043899,-0.030368,0,0
2,GO VITAMIN TRANSPORT,0.64605,-0.043911,-0.008399,0,0
2,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.9686,-0.043957,0.037473,0,0
2,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.89215,-0.044064,0.031097,0,0
2,GO MEIOTIC CELL CYCLE PROCESS,0.079444,-0.044238,-0.048435,0,0
2,GO T CELL EXTRAVASATION,0.64605,-0.044242,-0.075127,0,0
2,GO NUCLEOTIDE TRANSPORT,0.21256,-0.044327,-0.076097,0,0
2,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.43883,-0.044329,-0.011793,0,0
2,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.40843,-0.044442,-0.066447,0,0
2,GO ANIMAL ORGAN MORPHOGENESIS,0.36526,-0.044455,-0.019908,0,0
2,GO POSITIVE REGULATION OF ION TRANSPORT,0.22568,-0.044473,-0.043817,0,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.31232,-0.044665,-0.10835,0,0
2,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.51459,-0.044861,-0.073885,0,0
2,GO REGULATION OF CELL DIFFERENTIATION,0.21579,-0.044977,-0.036125,0,0
2,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.69707,-0.045278,0.064034,0,0
2,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.4545,-0.045397,-0.020003,0,0
2,GO MITOTIC CELL CYCLE ARREST,0.48131,-0.045435,-0.095853,0,0
2,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.33373,-0.045543,-0.043934,0,0
2,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.72969,-0.0456,-0.051668,0,0
2,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.25729,-0.045638,-0.049157,0,0
2,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.42855,-0.045924,-0.055066,0,0
2,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.22235,-0.045987,-0.065267,0,0
2,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.80989,-0.046029,0.035084,0,0
2,GO SINGLE STRAND BREAK REPAIR,0.78289,-0.046144,0.015188,0,0
2,GO LAYER FORMATION IN CEREBRAL CORTEX,0.85768,-0.046435,-0.019542,0,0
2,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.35607,-0.046786,-0.038609,0,0
2,GO SULFATION,0.5726,-0.046986,0.018196,0,0
2,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.25363,-0.047016,-0.043905,0,0
2,GO TRABECULA MORPHOGENESIS,0.95466,-0.047126,0.022908,0,0
2,GO DRUG METABOLIC PROCESS,0.78962,-0.047336,0.015121,0,0
2,GO NEUROINFLAMMATORY RESPONSE,0.59664,-0.047347,-0.029478,0,0
2,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.20621,-0.047515,-0.060449,0,0
2,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.31232,-0.047807,-0.14525,0,0
2,GO REGULATION OF NEUTROPHIL MIGRATION,0.31653,-0.04812,-0.093822,0,0
2,GO MEIOTIC SPINDLE ORGANIZATION,0.74288,-0.048221,-0.031974,0,0
2,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.55487,-0.048293,-0.06501,0,0
2,GO ANION TRANSMEMBRANE TRANSPORT,0.38408,-0.048366,-0.019921,0,0
2,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.46512,-0.048599,-0.032635,0,0
2,GO NUCLEAR ENVELOPE ORGANIZATION,0.23937,-0.048606,-0.046691,0,0
2,GO ORGANIC ACID TRANSPORT,0.4598,-0.04865,-0.017585,0,0
2,GO REGULATION OF GLUCOSE IMPORT,0.065563,-0.048836,-0.096684,0,0
2,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.72969,-0.048882,-0.020977,0,0
2,GO REGULATION OF VASCULOGENESIS,0.37932,-0.048933,-0.097995,0,0
2,GO ONE CARBON COMPOUND TRANSPORT,0.72313,-0.049393,0.046123,0,0
2,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.41341,-0.049428,-0.055265,0,0
2,GO EMBRYONIC EYE MORPHOGENESIS,0.98953,-0.049444,0.064661,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.72969,-0.049484,-0.0012847,0,0
2,GO POSITIVE REGULATION OF HEART RATE,0.47588,-0.04952,-0.049253,0,0
2,GO HISTONE H4 ACETYLATION,0.39371,-0.049613,-0.020019,0,0
2,GO GANGLIOSIDE METABOLIC PROCESS,0.26847,-0.049927,-0.069337,0,0
2,GO ORGANELLE LOCALIZATION,0.22568,-0.050186,-0.029873,0,0
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.51459,-0.050322,-0.043136,0,0
2,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.11434,-0.050329,-0.070378,0,0
2,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.014486,-0.050377,-0.07353,0,0
2,GO EYE MORPHOGENESIS,0.71658,-0.050436,-0.010371,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.60272,-0.050598,-0.043531,0,0
2,GO TRANSMEMBRANE TRANSPORT,0.17099,-0.050746,-0.046507,0,0
2,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.39371,-0.050782,-0.088637,0,0
2,GO RHYTHMIC PROCESS,0.26471,-0.050802,-0.032595,0,0
2,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.15015,-0.050831,-0.1095,0,0
2,GO TELENCEPHALON GLIAL CELL MIGRATION,0.2,-0.051029,-0.14215,0,0
2,GO MICROTUBULE BASED PROCESS,0.022165,-0.051252,-0.064916,0,0
2,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.11434,-0.051253,-0.15515,0,0
2,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.99651,-0.051278,-0.0074236,0,0
2,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.22568,-0.051408,-0.03978,0,0
2,GO BONE CELL DEVELOPMENT,0.60883,-0.051431,-0.017881,0,0
2,GO NEURON APOPTOTIC PROCESS,0.090515,-0.051539,-0.054554,0,0
2,GO CARBOHYDRATE PHOSPHORYLATION,0.65234,-0.051598,-0.02741,0,0
2,GO HEART MORPHOGENESIS,0.82348,-0.051725,0.0082847,0,0
2,GO GASTRULATION WITH MOUTH FORMING SECOND,0.86455,-0.052147,-0.012337,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.71006,-0.052262,-0.029372,0,0
2,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.72313,-0.052279,-0.032658,0,0
2,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.25363,-0.052366,-0.068526,0,0
2,GO GENETIC IMPRINTING,0.47588,-0.052394,-0.042353,0,0
2,GO MESENCHYME DEVELOPMENT,0.68418,-0.052527,0.0084847,0,0
2,GO SPERMATID NUCLEUS DIFFERENTIATION,0.26098,-0.052602,-0.07102,0,0
2,GO CIRCADIAN RHYTHM,0.019283,-0.052637,-0.064605,0,0
2,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.063042,-0.052647,-0.18424,0,0
2,GO RESPONSE TO GROWTH FACTOR,0.67776,-0.052956,-0.000308,0,0
2,GO RESPONSE TO GROWTH HORMONE,0.84397,-0.05297,0.017507,0,0
2,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.19393,-0.05302,-0.067996,0,0
2,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.95466,-0.053109,0.064628,0,0
2,GO REGULATION OF MITOPHAGY,0.21256,-0.053177,-0.060991,0,0
2,GO RESPONSE TO REDOX STATE,0.98953,-0.053199,-0.017689,0,0
2,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.85768,-0.053201,0.067541,0,0
2,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.82348,-0.053277,-0.010364,0,0
2,GO ATP BIOSYNTHETIC PROCESS,0.56666,-0.053301,-0.052062,0,0
2,GO REGULATION OF CELL MORPHOGENESIS,0.087232,-0.053536,-0.081352,0,0
2,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.22905,-0.054231,-0.084796,0,0
2,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.47049,-0.054518,-0.013404,0,0
2,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.53742,-0.05466,-0.016985,0,0
2,GO NEUTRAL LIPID CATABOLIC PROCESS,0.49227,-0.054766,-0.045024,0,0
2,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.12473,-0.054853,-0.14175,0,0
2,GO RADIAL GLIAL CELL DIFFERENTIATION,0.30815,-0.054965,-0.13053,0,0
2,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.32506,-0.05523,-0.077225,0,0
2,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.33373,-0.055265,-0.087901,0,0
2,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.82348,-0.055324,0.026021,0,0
2,GO INTERSTRAND CROSS LINK REPAIR,0.18508,-0.05535,-0.031325,0,0
2,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.010773,-0.055575,-0.078245,0,0
2,GO HEART TRABECULA MORPHOGENESIS,0.49227,-0.055629,-0.028897,0,0
2,GO INTRACELLULAR STEROL TRANSPORT,0.85082,-0.055773,0.04983,0,0
2,GO RHYTHMIC BEHAVIOR,0.28785,-0.055791,-0.058893,0,0
2,GO DEFINITIVE HEMOPOIESIS,0.40349,-0.055891,-0.048092,0,0
2,GO PROTEIN HOMOOLIGOMERIZATION,0.095625,-0.05593,-0.050506,0,0
2,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.20937,-0.056098,-0.084387,0,0
2,GO PEPTIDYL LYSINE METHYLATION,0.41341,-0.056256,-0.004091,0,0
2,GO POSITIVE REGULATION OF MITOPHAGY,0.32938,-0.056319,-0.064915,0,0
2,GO CHAPERONE MEDIATED AUTOPHAGY,0.87833,-0.056386,-0.04041,0,0
2,GO THYMIC T CELL SELECTION,0.35153,-0.056415,-0.034688,0,0
2,GO REGULATION OF BEHAVIOR,0.34256,-0.056445,-0.048972,0,0
2,GO PROTEIN TARGETING TO LYSOSOME,0.44924,-0.056445,-0.059471,0,0
2,GO MATERNAL PLACENTA DEVELOPMENT,0.98953,-0.056627,-0.0020032,0,0
2,GO CAMERA TYPE EYE MORPHOGENESIS,0.54903,-0.056738,-0.014405,0,0
2,GO CELL JUNCTION DISASSEMBLY,0.72969,-0.056738,-0.026157,0,0
2,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.77618,-0.056997,0.039936,0,0
2,GO OUTFLOW TRACT MORPHOGENESIS,0.33373,-0.057029,-0.064355,0,0
2,GO AROMATIC AMINO ACID TRANSPORT,0.68418,-0.057132,-0.024346,0,0
2,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.99651,-0.057243,0.0056578,0,0
2,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.093897,-0.057306,-0.063062,0,0
2,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.26847,-0.057378,-0.025327,0,0
2,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.087232,-0.057401,-0.085223,0,0
2,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.11235,-0.057844,-0.058791,0,0
2,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.19095,-0.058063,-0.11712,0,0
2,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.31232,-0.058116,-0.083821,0,0
2,GO CARBOHYDRATE TRANSPORT,0.13583,-0.058121,-0.070379,0,0
2,GO ENDOCARDIUM DEVELOPMENT,0.89215,-0.058394,0.0092809,0,0
2,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.57857,-0.058668,0.00423,0,0
2,GO RESPONSE TO METAL ION,0.26847,-0.058676,-0.049653,0,0
2,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.20937,-0.058759,-0.067843,0,0
2,GO CELL FATE COMMITMENT,0.15773,-0.058795,-0.05904,0,0
2,GO REGULATION OF VASOCONSTRICTION,0.090515,-0.058893,-0.10655,0,0
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.81668,-0.05919,-0.00083678,0,0
2,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.32938,-0.059263,-0.073786,0,0
2,GO POTASSIUM ION HOMEOSTASIS,0.18508,-0.059266,-0.097543,0,0
2,GO MYOTUBE CELL DEVELOPMENT,0.59059,-0.059657,-0.041606,0,0
2,GO RESPONSE TO AMPHETAMINE,0.51459,-0.059932,-0.034617,0,0
2,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.99651,-0.060124,0.0029968,0,0
2,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.15517,-0.060165,-0.075885,0,0
2,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.69707,-0.060185,0.033631,0,0
2,GO RESPIRATORY SYSTEM PROCESS,0.32506,-0.06033,-0.068785,0,0
2,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.4978,-0.060357,-0.024197,0,0
2,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.50896,-0.060604,-0.033191,0,0
2,GO OVARIAN FOLLICLE DEVELOPMENT,0.56075,-0.060615,-0.044859,0,0
2,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.25001,-0.060697,-0.055959,0,0
2,GO GLIOGENESIS,0.20937,-0.060827,-0.058978,0,0
2,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.13583,-0.060883,-0.097349,0,0
2,GO REGULATION OF RESPONSE TO FOOD,0.11235,-0.060924,-0.11574,0,0
2,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.23245,-0.061064,-0.047249,0,0
2,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.073629,-0.06125,-0.013978,0,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.89215,-0.061412,0.055096,0,0
2,GO CHEMOSENSORY BEHAVIOR,0.12908,-0.061435,-0.10799,0,0
2,GO SEGMENT SPECIFICATION,0.36526,-0.061625,-0.091425,0,0
2,GO LYSOSOMAL TRANSPORT,0.7495,-0.061674,-0.014669,0,0
2,GO SENSORY ORGAN DEVELOPMENT,0.29184,-0.061806,-0.036513,0,0
2,GO MITOCHONDRIAL DEPOLARIZATION,0.76281,-0.061857,-0.045413,0,0
2,GO REGULATION OF HORMONE LEVELS,0.188,-0.061874,-0.060799,0,0
2,GO SECOND MESSENGER MEDIATED SIGNALING,0.064293,-0.061962,-0.079133,0,0
2,GO REGULATION OF STEM CELL PROLIFERATION,0.89215,-0.062097,0.014146,0,0
2,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.37932,-0.062197,-0.025281,0,0
2,GO EMBRYONIC BODY MORPHOGENESIS,0.50896,-0.062227,-0.040126,0,0
2,GO ENERGY RESERVE METABOLIC PROCESS,0.16559,-0.062234,-0.059356,0,0
2,GO PROTEIN AUTO ADP RIBOSYLATION,0.53167,-0.062237,-0.032079,0,0
2,GO CELLULAR GLUCOSE HOMEOSTASIS,0.4598,-0.062635,-0.023972,0,0
2,GO MESENCHYMAL CELL PROLIFERATION,0.73628,-0.062895,0.064902,0,0
2,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.69707,-0.062914,-0.012719,0,0
2,GO SPERM MOTILITY,0.0071468,-0.063174,-0.12621,0,0
2,GO HISTONE H3 K27 METHYLATION,0.34256,-0.0632,-0.038491,0,0
2,GO SLEEP,0.69061,-0.063328,0.005272,0,0
2,GO REGULATION OF PEPTIDE SECRETION,0.13355,-0.063335,-0.067574,0,0
2,GO MEMBRANE REPOLARIZATION,0.1313,-0.063438,-0.10407,0,0
2,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.60272,-0.063727,-0.019814,0,0
2,GO REGULATION OF SULFUR METABOLIC PROCESS,0.36991,-0.063827,-0.069585,0,0
2,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.60272,-0.063839,-0.05088,0,0
2,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,1,-0.063886,0.016312,0,0
2,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.29586,-0.063894,-0.040709,0,0
2,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.16294,-0.063912,-0.10677,0,0
2,GO TRIGLYCERIDE CATABOLIC PROCESS,0.75615,-0.063948,-0.02357,0,0
2,GO DEMETHYLATION,0.43367,-0.064005,-0.01497,0,0
2,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.23589,-0.064231,-0.060601,0,0
2,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.2839,-0.064239,-0.10486,0,0
2,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.88523,-0.064419,-0.036031,0,0
2,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.81668,-0.064456,-0.016517,0,0
2,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.11434,-0.064583,-0.11656,0,0
2,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.2839,-0.064641,-0.045622,0,0
2,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.075049,-0.065407,-0.064969,0,0
2,GO CARDIAC MUSCLE CELL PROLIFERATION,0.62732,-0.065427,-0.0078982,0,0
2,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.1028,-0.065429,-0.055874,0,0
2,GO POSITIVE REGULATION OF HEART CONTRACTION,0.21579,-0.065554,-0.070829,0,0
2,GO CELL GROWTH,0.045624,-0.065897,-0.072663,0,0
2,GO NEGATIVE REGULATION OF BINDING,0.29586,-0.066348,-0.040096,0,0
2,GO ION TRANSPORT,0.099158,-0.066432,-0.057574,0,0
2,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.015953,-0.066456,-0.10693,0,0
2,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.50337,-0.066576,-0.023972,0,0
2,GO OLIGODENDROCYTE DEVELOPMENT,0.13814,-0.066579,-0.094896,0,0
2,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.015203,-0.0666,-0.10497,0,0
2,GO SNORNA 3 END PROCESSING,0.48131,-0.0667,-0.061327,0,0
2,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.19095,-0.066803,-0.051865,0,0
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.58456,-0.066982,-0.029499,0,0
2,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.40349,-0.067076,-0.042411,0,0
2,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.11636,-0.067122,-0.059899,0,0
2,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.21579,-0.067209,-0.10196,0,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.25363,-0.067372,-0.086467,0,0
2,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.27227,-0.067376,-0.063143,0,0
2,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.037747,-0.067655,-0.11884,0,0
2,GO RESPONSE TO COLD,0.05824,-0.067722,-0.17604,0,0
2,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.97557,-0.068004,0.0038735,0,0
2,GO MESENCHYMAL CELL DIFFERENTIATION,0.70355,-0.068197,0.0039817,0,0
2,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.33373,-0.068277,-0.032062,0,0
2,GO NEURON PROJECTION ORGANIZATION,0.0695,-0.06839,-0.10995,0,0
2,GO SEMI LUNAR VALVE DEVELOPMENT,0.79636,-0.068403,0.0023372,0,0
2,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.29992,-0.068459,-0.03458,0,0
2,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.80989,-0.069164,-0.012833,0,0
2,GO POSITIVE REGULATION OF CYTOKINESIS,0.24288,-0.069299,-0.046934,0,0
2,GO VENTRICULAR SYSTEM DEVELOPMENT,0.33812,-0.069373,-0.033491,0,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.7495,-0.069818,0.07963,0,0
2,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.55487,-0.070029,-0.039567,0,0
2,GO PROTEIN O LINKED MANNOSYLATION,0.15015,-0.070104,-0.1102,0,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.024846,-0.070236,-0.067997,0,0
2,GO CELLULAR RESPONSE TO ALKALOID,0.13355,-0.070246,-0.098535,0,0
2,GO STEROID HORMONE SECRETION,0.98953,-0.070397,-0.023594,0,0
2,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.19095,-0.070428,-0.071238,0,0
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.20621,-0.070565,-0.079939,0,0
2,GO HEART VALVE DEVELOPMENT,0.58456,-0.070739,-0.029514,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.1313,-0.070935,-0.073739,0,0
2,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.79636,-0.071229,0.02707,0,0
2,GO REGULATION OF MEMBRANE REPOLARIZATION,0.17099,-0.07136,-0.097154,0,0
2,GO REGULATION OF SODIUM ION TRANSPORT,0.32938,-0.071396,-0.055229,0,0
2,GO DIET INDUCED THERMOGENESIS,0.12908,-0.071429,-0.13198,0,0
2,GO RECEPTOR CLUSTERING,0.21579,-0.071505,-0.10225,0,0
2,GO REGULATION OF HISTONE METHYLATION,0.50896,-0.071639,-0.010929,0,0
2,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.99651,-0.071646,0.042389,0,0
2,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.011612,-0.071705,-0.13161,0,0
2,GO DIGESTIVE SYSTEM DEVELOPMENT,0.39371,-0.071749,-0.038725,0,0
2,GO ODONTOGENESIS,0.97557,-0.071949,0.022468,0,0
2,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.24643,-0.072084,-0.11824,0,0
2,GO REGULATION OF ENDOCRINE PROCESS,0.19695,-0.072111,-0.070293,0,0
2,GO PANCREAS DEVELOPMENT,0.47049,-0.072176,-0.0357,0,0
2,GO GLIAL CELL DIFFERENTIATION,0.12689,-0.072244,-0.073364,0,0
2,GO CELL JUNCTION MAINTENANCE,0.40843,-0.072356,-0.042054,0,0
2,GO CENTROMERE COMPLEX ASSEMBLY,0.44924,-0.072378,-0.012235,0,0
2,GO RESPONSE TO FORSKOLIN,0.35153,-0.072381,-0.13813,0,0
2,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.80989,-0.072472,0.041786,0,0
2,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.12908,-0.072766,-0.11958,0,0
2,GO REGULATION OF ANION TRANSPORT,0.11434,-0.072769,-0.088328,0,0
2,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.035393,-0.072864,-0.11203,0,0
2,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.39858,-0.07289,-0.019567,0,0
2,GO REGULATION OF TORC1 SIGNALING,0.0067808,-0.073036,-0.11756,0,0
2,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.26471,-0.073121,-0.09997,0,0
2,GO PROTEIN DEMETHYLATION,0.76281,-0.073123,-0.0082881,0,0
2,GO REGULATION OF MEMBRANE PERMEABILITY,0.9686,-0.073175,0.0022449,0,0
2,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.57857,-0.073347,-0.005607,0,0
2,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.44402,-0.073465,-0.057385,0,0
2,GO CARDIAC CHAMBER MORPHOGENESIS,0.56075,-0.073562,-0.010615,0,0
2,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.001662,-0.073666,-0.13373,0,0
2,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.4545,-0.073666,-0.05009,0,0
2,GO BONE TRABECULA MORPHOGENESIS,0.98255,-0.073864,0.054342,0,0
2,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.72969,-0.073952,0.0042436,0,0
2,GO T CELL LINEAGE COMMITMENT,0.76948,-0.074005,0.015368,0,0
2,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.87144,-0.074126,0.0068299,0,0
2,GO POSITIVE REGULATION OF DNA REPLICATION,0.49227,-0.074484,-0.016629,0,0
2,GO REGULATION OF TRANSPORTER ACTIVITY,0.12049,-0.074542,-0.069182,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.40349,-0.07458,-0.04181,0,0
2,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.54321,-0.07459,-0.024109,0,0
2,GO ECTODERM DEVELOPMENT,0.12259,-0.074657,-0.051655,0,0
2,GO PROTEIN MANNOSYLATION,0.28785,-0.074832,-0.066359,0,0
2,GO RESPONSE TO HYDROXYUREA,0.91293,-0.075051,0.026236,0,0
2,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.31232,-0.075392,-0.055371,0,0
2,GO PROTEIN LOCALIZATION TO VACUOLE,0.27227,-0.075503,-0.054488,0,0
2,GO REGULATION OF NEURON PROJECTION REGENERATION,0.87833,-0.075606,-0.0086654,0,0
2,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.36064,-0.075694,-0.11124,0,0
2,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.080955,-0.076127,-0.087841,0,0
2,GO CELL RECOGNITION,0.068167,-0.076332,-0.079491,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.21256,-0.076383,-0.05364,0,0
2,GO STEM CELL PROLIFERATION,0.71006,-0.076459,-0.010431,0,0
2,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.36991,-0.076593,-0.043299,0,0
2,GO REGULATION OF SPINDLE CHECKPOINT,0.67137,-0.077137,-0.0087186,0,0
2,GO BONE MATURATION,0.23245,-0.077311,-0.080771,0,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.27611,-0.077435,-0.058174,0,0
2,GO NUCLEOSOME ASSEMBLY,0.15264,-0.077522,-0.043279,0,0
2,GO GERM CELL DEVELOPMENT,0.0049174,-0.077626,-0.09572,0,0
2,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.56666,-0.077686,-0.0051062,0,0
2,GO MEGAKARYOCYTE DEVELOPMENT,0.89907,-0.077937,0.022457,0,0
2,GO ATRIAL SEPTUM MORPHOGENESIS,0.29184,-0.078094,-0.1796,0,0
2,GO HISTONE H3 K4 METHYLATION,0.78962,-0.078417,0.019897,0,0
2,GO HINDBRAIN MORPHOGENESIS,0.019283,-0.078538,-0.12392,0,0
2,GO RESPONSE TO BMP,0.25363,-0.078794,-0.033804,0,0
2,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.30402,-0.079454,-0.040451,0,0
2,GO POSITIVE REGULATION OF INSULIN SECRETION,0.05824,-0.079628,-0.098131,0,0
2,GO ENDOTHELIAL CELL CHEMOTAXIS,0.82348,-0.079878,0.028623,0,0
2,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.15773,-0.080014,-0.059344,0,0
2,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.23245,-0.080084,-0.10693,0,0
2,GO MICROTUBULE POLYMERIZATION,0.12049,-0.080307,-0.10055,0,0
2,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.52025,-0.080309,-0.055825,0,0
2,GO REGULATION OF CARTILAGE DEVELOPMENT,0.52594,-0.08032,-0.03684,0,0
2,GO CELLULAR ANION HOMEOSTASIS,0.50337,-0.08037,-0.021891,0,0
2,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.14285,-0.080522,-0.09474,0,0
2,GO MECHANORECEPTOR DIFFERENTIATION,0.097379,-0.080884,-0.11402,0,0
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.4598,-0.08095,-0.04505,0,0
2,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.50896,-0.081153,-0.040243,0,0
2,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.16294,-0.081179,-0.061797,0,0
2,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.58456,-0.081193,-0.03291,0,0
2,GO DENDRITIC SPINE DEVELOPMENT,0.10465,-0.081427,-0.081287,0,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.5726,-0.081803,-0.050244,0,0
2,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.28785,-0.082087,-0.066249,0,0
2,GO AXON EXTENSION,0.01282,-0.08211,-0.15953,0,0
2,GO PROTON TRANSMEMBRANE TRANSPORT,0.17934,-0.082134,-0.057602,0,0
2,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.15773,-0.082405,0.05873,0,0
2,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.35607,-0.082541,-0.06777,0,0
2,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.088862,-0.082657,-0.1399,0,0
2,GO POSITIVE REGULATION OF TOR SIGNALING,0.10845,-0.082762,-0.052332,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.25363,-0.083035,-0.061169,0,0
2,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.8303,-0.083239,-0.012646,0,0
2,GO DENDRITIC SPINE MORPHOGENESIS,0.12689,-0.083294,-0.10674,0,0
2,GO RESPONSE TO ELECTRICAL STIMULUS,0.4598,-0.083486,-0.052829,0,0
2,GO REGULATION OF FIBROBLAST MIGRATION,0.48678,-0.083504,-0.025853,0,0
2,GO REGULATION OF RESPIRATORY BURST,0.50896,-0.08362,-0.059529,0,0
2,GO TRANSFERRIN TRANSPORT,0.063042,-0.083863,-0.11041,0,0
2,GO AMINO ACID IMPORT,0.63354,-0.083922,0.018102,0,0
2,GO CHROMATIN SILENCING AT TELOMERE,0.10465,-0.084116,-0.079904,0,0
2,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.4545,-0.084333,-0.068777,0,0
2,GO DOSAGE COMPENSATION,0.31232,-0.084426,0.0052337,0,0
2,GO CARDIAC MYOFIBRIL ASSEMBLY,0.71658,-0.084473,-0.029654,0,0
2,GO NEGATIVE REGULATION OF NEURON DEATH,0.013465,-0.085073,-0.077396,0,0
2,GO LIMBIC SYSTEM DEVELOPMENT,0.054842,-0.085285,-0.078652,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.56666,-0.085701,-0.0020953,0,0
2,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.0032441,-0.085741,-0.12898,0,0
2,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.16294,-0.085779,-0.049638,0,0
2,GO LOCALIZATION WITHIN MEMBRANE,0.099158,-0.085879,-0.094679,0,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.30815,-0.086002,-0.046272,0,0
2,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.097379,-0.086113,-0.090619,0,0
2,GO HEPARIN METABOLIC PROCESS,0.76281,-0.086115,0.0031747,0,0
2,GO HEART PROCESS,0.046579,-0.086201,-0.089287,0,0
2,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.24288,-0.08625,-0.12657,0,0
2,GO CORTICOSTEROID HORMONE SECRETION,0.78962,-0.08632,-0.04243,0,0
2,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.31653,-0.086833,-0.039914,0,0
2,GO SNARE COMPLEX ASSEMBLY,0.81668,-0.087032,0.036815,0,0
2,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.036948,-0.08713,-0.10318,0,0
2,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.15264,-0.08734,-0.057935,0,0
2,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.4598,-0.087612,-0.041122,0,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.63978,-0.087694,-0.043043,0,0
2,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.090515,-0.088046,-0.13276,0,0
2,GO EXOCRINE SYSTEM DEVELOPMENT,0.75615,-0.088121,0.017645,0,0
2,GO POSITIVE REGULATION OF CELL DIVISION,0.50896,-0.088139,-0.027352,0,0
2,GO AXO DENDRITIC TRANSPORT,0.016734,-0.08822,-0.10836,0,0
2,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.068167,-0.088323,-0.10719,0,0
2,GO HISTONE H3 K9 TRIMETHYLATION,0.099158,-0.08841,-0.072969,0,0
2,GO CELL PROLIFERATION IN HINDBRAIN,0.29992,-0.088442,-0.080892,0,0
2,GO DNA DEMETHYLATION,0.10845,-0.088479,-0.074689,0,0
2,GO VENTRAL SPINAL CORD DEVELOPMENT,0.19095,-0.088728,-0.078426,0,0
2,GO MICROTUBULE BASED MOVEMENT,0.0011549,-0.088785,-0.10941,0,0
2,GO RESPONSE TO CAMP,0.095625,-0.089059,-0.087935,0,0
2,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.60272,-0.089122,-0.074893,0,0
2,GO NEURON PROJECTION GUIDANCE,0.015203,-0.089162,-0.15271,0,0
2,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.61497,-0.089206,-0.01618,0,0
2,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.36526,-0.089357,-0.053387,0,0
2,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.41341,-0.089375,-0.11296,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.4598,-0.089807,-0.090348,0,0
2,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.0060989,-0.08995,-0.10948,0,0
2,GO CAMERA TYPE EYE DEVELOPMENT,0.21256,-0.090005,-0.041903,0,0
2,GO CLATHRIN COAT ASSEMBLY,0.15517,-0.090186,-0.15367,0,0
2,GO AXON DEVELOPMENT,0.0071468,-0.090403,-0.15315,0,0
2,GO REGULATION OF COLLATERAL SPROUTING,0.20309,-0.090673,-0.13826,0,0
2,GO REGULATION OF EXOSOMAL SECRETION,0.51459,-0.090806,-0.045232,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.045624,-0.090954,-0.18368,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.18508,-0.09121,-0.11886,0,0
2,GO ENDOTHELIUM DEVELOPMENT,0.17934,-0.091221,-0.079817,0,0
2,GO MITOCHONDRION LOCALIZATION,0.02843,-0.091259,-0.12136,0,0
2,GO REGULATION OF GLIOGENESIS,0.18508,-0.091735,-0.072454,0,0
2,GO REGIONALIZATION,0.087232,-0.091947,-0.07666,0,0
2,GO HISTONE H4 K5 ACETYLATION,0.25363,-0.09205,-0.065236,0,0
2,GO NUCLEOSIDE SALVAGE,0.78962,-0.09228,-0.019331,0,0
2,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.33373,-0.092517,-0.053062,0,0
2,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.02268,-0.09254,-0.10872,0,0
2,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.43883,-0.092559,-0.10846,0,0
2,GO ANIMAL ORGAN MATURATION,0.23245,-0.092597,-0.054761,0,0
2,GO POLYOL TRANSPORT,0.4598,-0.092676,-0.021326,0,0
2,GO ROOF OF MOUTH DEVELOPMENT,0.30815,-0.09275,-0.040577,0,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.25001,-0.092841,-0.066566,0,0
2,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.76281,-0.092926,-0.016774,0,0
2,GO REGULATION OF HEART RATE,0.17934,-0.093261,-0.073595,0,0
2,GO AXONAL TRANSPORT OF MITOCHONDRION,0.48678,-0.093276,-0.065741,0,0
2,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.72313,-0.093469,0.0021383,0,0
2,GO HYPOTHALAMUS DEVELOPMENT,0.15517,-0.093766,-0.12039,0,0
2,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.21905,-0.093794,-0.083748,0,0
2,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0069616,-0.093862,-0.11782,0,0
2,GO EMBRYONIC AXIS SPECIFICATION,0.22235,-0.093991,-0.060278,0,0
2,GO CILIUM MOVEMENT,0.0041716,-0.094022,-0.12914,0,0
2,GO N GLYCAN PROCESSING,0.066855,-0.094133,-0.19033,0,0
2,GO MUSCLE ORGAN MORPHOGENESIS,0.40843,-0.094189,-0.028715,0,0
2,GO L AMINO ACID TRANSPORT,0.11636,-0.094203,-0.050848,0,0
2,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.084046,-0.094471,-0.10586,0,0
2,GO COMMISSURAL NEURON AXON GUIDANCE,0.30402,-0.094654,-0.15534,0,0
2,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.060602,-0.094911,-0.10163,0,0
2,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.075049,-0.095183,-0.10684,0,0
2,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.51459,-0.095377,-0.035019,0,0
2,GO CELL PROJECTION ORGANIZATION,0.0075304,-0.095528,-0.1012,0,0
2,GO STEROID CATABOLIC PROCESS,0.14769,-0.095932,-0.096242,0,0
2,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.0099891,-0.096128,-0.10281,0,0
2,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.12049,-0.09646,-0.11419,0,0
2,GO ENERGY HOMEOSTASIS,0.041967,-0.096654,-0.15343,0,0
2,GO MITOTIC RECOMBINATION,0.49227,-0.096936,-0.021279,0,0
2,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.030383,-0.097112,-0.078806,0,0
2,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.10465,-0.09724,-0.125,0,0
2,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.31653,-0.097338,-0.18139,0,0
2,GO PROTEIN DEPOLYMERIZATION,0.023205,-0.097567,-0.10192,0,0
2,GO RESPONSE TO NICOTINE,0.30815,-0.097801,-0.073712,0,0
2,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.36064,-0.09829,-0.023491,0,0
2,GO REGULATION OF SYSTEM PROCESS,0.0040578,-0.098446,-0.11473,0,0
2,GO ENDOCRINE HORMONE SECRETION,0.20621,-0.098657,-0.067353,0,0
2,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.5726,-0.098933,0.153,0,0
2,GO ANTEROGRADE AXONAL TRANSPORT,0.012203,-0.099207,-0.1286,0,0
2,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.18219,-0.099341,-0.088766,0,0
2,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.30402,-0.09937,-0.049236,0,0
2,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.12473,-0.099545,-0.10934,0,0
2,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.11636,-0.099561,-0.070567,0,0
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.73628,-0.099578,-0.064133,0,0
2,GO REGULATION OF CYCLASE ACTIVITY,0.16559,-0.099636,-0.098829,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.20937,-0.099731,-0.11087,0,0
2,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.030383,-0.099758,-0.10895,0,0
2,GO REGULATION OF CELL DEVELOPMENT,0.0067808,-0.099974,-0.10964,0,0
2,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.48131,-0.10012,-0.10864,0,0
2,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.41842,-0.10023,-0.12573,0,0
2,GO LYTIC VACUOLE ORGANIZATION,0.14526,-0.10024,-0.081395,0,0
2,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.029068,-0.10046,-0.091212,0,0
2,GO CELL MORPHOGENESIS,0.065563,-0.10053,-0.082466,0,0
2,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.088862,-0.10074,-0.06938,0,0
2,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.41842,-0.10086,-0.065862,0,0
2,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.48131,-0.10099,-0.012107,0,0
2,GO SPERMATID DIFFERENTIATION,0.009256,-0.10126,-0.096652,0,0
2,GO TRANSPORT ALONG MICROTUBULE,0.0025817,-0.10147,-0.1004,0,0
2,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.67137,-0.10154,-0.066936,0,0
2,GO MICROTUBULE BASED TRANSPORT,0.001986,-0.10171,-0.10579,0,0
2,GO VITAMIN TRANSMEMBRANE TRANSPORT,1,-0.10188,0.05218,0,0
2,GO ADULT FEEDING BEHAVIOR,0.11434,-0.10199,-0.096285,0,0
2,GO OSTEOCLAST DIFFERENTIATION,0.53742,-0.10212,-0.01945,0,0
2,GO RESPONSE TO EPINEPHRINE,0.69061,-0.10213,-0.021762,0,0
2,GO TORC1 SIGNALING,0.02068,-0.1023,-0.083363,0,0
2,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.32077,-0.10245,-0.10431,0,0
2,GO LONG TERM SYNAPTIC POTENTIATION,0.02843,-0.10265,-0.16494,0,0
2,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.42855,-0.10284,-0.036568,0,0
2,GO FEMALE SEX DIFFERENTIATION,0.13583,-0.10289,-0.066505,0,0
2,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.53167,-0.10293,-0.055704,0,0
2,GO REGULATION OF BMP SIGNALING PATHWAY,0.30402,-0.10309,-0.039559,0,0
2,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,0.41842,-0.10322,-0.093205,0,0
2,GO REGULATION OF RECEPTOR CLUSTERING,0.23245,-0.10323,-0.1142,0,0
2,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.16032,-0.1034,-0.067653,0,0
2,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.12473,-0.10349,-0.081884,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.14048,-0.10367,-0.086065,0,0
2,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.27227,-0.104,-0.068824,0,0
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.72313,-0.10421,-0.026541,0,0
2,GO REGULATION OF DEVELOPMENTAL GROWTH,0.027188,-0.10437,-0.086604,0,0
2,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.026586,-0.10452,-0.10419,0,0
2,GO ORGANIC CATION TRANSPORT,0.42347,-0.1046,-0.047827,0,0
2,GO PATTERN SPECIFICATION PROCESS,0.031748,-0.10465,-0.09525,0,0
2,GO NUCLEAR BODY ORGANIZATION,0.23937,-0.10473,-0.11168,0,0
2,GO REGULATION OF CILIUM ASSEMBLY,0.024846,-0.10513,-0.099811,0,0
2,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.11841,-0.10537,-0.079774,0,0
2,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.072231,-0.10537,-0.17324,0,0
2,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.087232,-0.10545,-0.094851,0,0
2,GO RESPONSE TO CORTICOSTERONE,0.37932,-0.10547,-0.10631,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.76281,-0.10568,0.038714,0,0
2,GO TOOTH MINERALIZATION,0.90599,-0.10569,0.067913,0,0
2,GO CONVERGENT EXTENSION,0.87833,-0.10573,0.02668,0,0
2,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.20621,-0.10595,-0.044676,0,0
2,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.47049,-0.10597,-0.033148,0,0
2,GO REGULATION OF FATTY ACID TRANSPORT,0.10465,-0.10619,-0.086287,0,0
2,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0020453,-0.10625,-0.16321,0,0
2,GO CELL DIFFERENTIATION IN SPINAL CORD,0.066855,-0.1063,-0.11892,0,0
2,GO RELAXATION OF MUSCLE,0.28785,-0.10667,-0.084047,0,0
2,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.059411,-0.10712,-0.11061,0,0
2,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.011326,-0.10759,-0.12913,0,0
2,GO REGULATION OF LYASE ACTIVITY,0.22235,-0.1076,-0.086417,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.4545,-0.10785,-0.061927,0,0
2,GO ORGAN INDUCTION,0.12049,-0.10798,-0.12241,0,0
2,GO CELL FATE SPECIFICATION,0.22235,-0.10805,-0.083766,0,0
2,GO SENSORY SYSTEM DEVELOPMENT,0.12049,-0.10837,-0.064474,0,0
2,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.1028,-0.10871,-0.19712,0,0
2,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.034637,-0.10884,-0.15788,0,0
2,GO OLIGODENDROCYTE DIFFERENTIATION,0.17099,-0.10893,-0.086647,0,0
2,GO ESTROGEN BIOSYNTHETIC PROCESS,0.54321,-0.10941,0.051535,0,0
2,GO CELLULAR RESPONSE TO VITAMIN D,0.16828,-0.11005,-0.12855,0,0
2,GO BASIC AMINO ACID TRANSPORT,0.29586,-0.11013,-0.036117,0,0
2,GO REGULATION OF LIGASE ACTIVITY,0.10654,-0.11043,-0.12801,0,0
2,GO REGULATION OF ICOSANOID SECRETION,0.1028,-0.11048,-0.10618,0,0
2,GO REGULATION OF DENDRITE MORPHOGENESIS,0.019739,-0.1105,-0.12531,0,0
2,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.51459,-0.11075,-0.042363,0,0
2,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.0017123,-0.1108,-0.1633,0,0
2,GO POSITIVE REGULATION OF AXON EXTENSION,0.018398,-0.11087,-0.17341,0,0
2,GO PHOTORECEPTOR CELL MAINTENANCE,0.024288,-0.11144,-0.088272,0,0
2,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.016734,-0.11176,-0.11239,0,0
2,GO ESCRT COMPLEX DISASSEMBLY,0.41341,-0.11203,-0.035811,0,0
2,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.4978,-0.11204,-0.016094,0,0
2,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.71006,-0.11216,-0.062843,0,0
2,GO SYNAPTIC VESICLE BUDDING,0.20309,-0.1124,-0.082332,0,0
2,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.48678,-0.11288,-0.034736,0,0
2,GO VENTRICULAR SEPTUM DEVELOPMENT,0.18508,-0.11304,-0.076532,0,0
2,GO ACTIVATED T CELL PROLIFERATION,0.5726,-0.11313,-0.0065659,0,0
2,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.05824,-0.11321,-0.15226,0,0
2,GO REGULATION OF PROSTAGLANDIN SECRETION,0.31653,-0.11336,-0.081342,0,0
2,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.0029794,-0.11341,-0.15675,0,0
2,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.038561,-0.11345,-0.10901,0,0
2,GO IMPORT INTO CELL,0.042857,-0.11405,-0.10311,0,0
2,GO REGULATION OF EXTENT OF CELL GROWTH,0.011612,-0.11465,-0.17034,0,0
2,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.19695,-0.11481,-0.087168,0,0
2,GO RESPONSE TO MAGNESIUM ION,0.75615,-0.11493,-0.024123,0,0
2,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.42347,-0.11517,-0.033985,0,0
2,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.17374,-0.11519,-0.065427,0,0
2,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.36991,-0.11536,-0.082397,0,0
2,GO EXTRACELLULAR VESICLE BIOGENESIS,0.15773,-0.11539,-0.064974,0,0
2,GO ACTION POTENTIAL,0.060602,-0.1155,-0.10784,0,0
2,GO CELL CELL SIGNALING,0.0018173,-0.11591,-0.10968,0,0
2,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.25363,-0.11617,-0.056325,0,0
2,GO STRIATED MUSCLE ADAPTATION,0.32506,-0.11617,-0.071486,0,0
2,GO SPERM CAPACITATION,0.054842,-0.11638,-0.12947,0,0
2,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.061812,-0.11674,-0.077513,0,0
2,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.085627,-0.11692,-0.12063,0,0
2,GO REGULATION OF AXONOGENESIS,0.0013054,-0.11737,-0.19695,0,0
2,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.11636,-0.11739,-0.14344,0,0
2,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.44402,-0.11777,-0.047844,0,0
2,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.027188,-0.11827,-0.14011,0,0
2,GO MICROTUBULE ANCHORING AT CENTROSOME,0.0018173,-0.1183,-0.22776,0,0
2,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.12473,-0.11864,-0.077517,0,0
2,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.13814,-0.1191,-0.20047,0,0
2,GO KINETOCHORE ORGANIZATION,0.24288,-0.1196,-0.062911,0,0
2,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.25001,-0.11962,-0.037633,0,0
2,GO ANIMAL ORGAN FORMATION,0.24643,-0.11995,-0.046849,0,0
2,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.063042,-0.11999,-0.13983,0,0
2,GO CILIUM ORGANIZATION,0.0017123,-0.12008,-0.11921,0,0
2,GO DETECTION OF VISIBLE LIGHT,0.017549,-0.12014,-0.0085071,0,0
2,GO REGULATION OF POSITIVE CHEMOTAXIS,0.15517,-0.12043,-0.093358,0,0
2,GO CRANIAL NERVE DEVELOPMENT,0.020205,-0.12068,-0.15033,0,0
2,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.62732,-0.12086,-0.028047,0,0
2,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.18508,-0.12135,-0.09244,0,0
2,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.23245,-0.12154,-0.053399,0,0
2,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.24643,-0.12155,-0.032938,0,0
2,GO MEMBRANE DOCKING,0.001228,-0.12196,-0.10505,0,0
2,GO NEUROGENESIS,0.0014738,-0.12269,-0.12542,0,0
2,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.095625,-0.12338,-0.18995,0,0
2,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.0028141,-0.12363,-0.14604,0,0
2,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.015953,-0.12381,-0.13768,0,0
2,GO FIBROBLAST MIGRATION,0.41842,-0.12387,-0.01757,0,0
2,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.67137,-0.12403,-0.035,0,0
2,GO NEUROBLAST PROLIFERATION,0.03245,-0.12431,-0.14259,0,0
2,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.43367,-0.12442,-0.073922,0,0
2,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.022165,-0.12446,-0.11748,0,0
2,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.036948,-0.12448,-0.12108,0,0
2,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.2839,-0.12475,-0.11974,0,0
2,GO MITOTIC DNA REPLICATION,0.049546,-0.12486,-0.10157,0,0
2,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.1313,-0.12502,-0.11919,0,0
2,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.010773,-0.12562,-0.12681,0,0
2,GO CARDIAC ATRIUM MORPHOGENESIS,0.21905,-0.12567,-0.080485,0,0
2,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.14526,-0.126,-0.13703,0,0
2,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.23937,-0.12607,-0.082686,0,0
2,GO CELLULAR COMPONENT MORPHOGENESIS,0.0036303,-0.12617,-0.13951,0,0
2,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.188,-0.12642,-0.083421,0,0
2,GO VISUAL BEHAVIOR,0.25001,-0.12713,-0.076983,0,0
2,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.046579,-0.12716,-0.12553,0,0
2,GO IMPORT ACROSS PLASMA MEMBRANE,0.05824,-0.12734,-0.090576,0,0
2,GO CELL PART MORPHOGENESIS,0.0007696,-0.12743,-0.16279,0,0
2,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.0025817,-0.12765,-0.12346,0,0
2,GO ERROR PRONE TRANSLESION SYNTHESIS,0.009256,-0.12785,-0.12117,0,0
2,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.047551,-0.12838,-0.095889,0,0
2,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.095625,-0.12863,-0.10272,0,0
2,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.053746,-0.12872,-0.15065,0,0
2,GO HIPPOCAMPUS DEVELOPMENT,0.0695,-0.12889,-0.087897,0,0
2,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0011549,-0.12904,-0.14394,0,0
2,GO POSITIVE REGULATION OF DNA BINDING,0.15264,-0.12904,-0.073056,0,0
2,GO POSITIVE REGULATION OF BONE RESORPTION,0.42855,-0.12924,-0.071783,0,0
2,GO REGULATION OF PROTON TRANSPORT,0.16032,-0.12938,-0.11749,0,0
2,GO EXTRACELLULAR TRANSPORT,0.095625,-0.12951,-0.12535,0,0
2,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.090515,-0.13017,-0.075954,0,0
2,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.0057817,-0.13102,-0.14918,0,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.2,-0.13111,-0.17212,0,0
2,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.37932,-0.13185,-0.081329,0,0
2,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.29184,-0.13263,-0.044778,0,0
2,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.18508,-0.13273,-0.063127,0,0
2,GO DEVELOPMENTAL CELL GROWTH,0.00057693,-0.13303,-0.16903,0,0
2,GO NERVOUS SYSTEM PROCESS,0.0057817,-0.1338,-0.10528,0,0
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.35153,-0.13443,-0.083634,0,0
2,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.50896,-0.13464,-0.066784,0,0
2,GO REGULATION OF CATION CHANNEL ACTIVITY,0.073629,-0.13477,-0.10075,0,0
2,GO REVERSE CHOLESTEROL TRANSPORT,0.32077,-0.13509,-0.060756,0,0
2,GO REGULATION OF FLAGELLATED SPERM MOTILITY,0.055956,-0.13532,-0.10442,0,0
2,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.0016129,-0.13543,-0.16682,0,0
2,GO REGULATION OF NEURON DIFFERENTIATION,0.00050664,-0.13561,-0.16453,0,0
2,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.060602,-0.13562,-0.23041,0,0
2,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.17934,-0.13566,-0.082839,0,0
2,GO ENDOCRINE SYSTEM DEVELOPMENT,0.095625,-0.13572,-0.10661,0,0
2,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.4978,-0.13583,-0.013967,0,0
2,GO MESENCHYME MORPHOGENESIS,0.27227,-0.13621,-0.04142,0,0
2,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.72969,-0.13645,-0.023551,0,0
2,GO REGULATION OF CELL FATE SPECIFICATION,0.71658,-0.13659,0.019399,0,0
2,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.00081984,-0.13677,-0.17393,0,0
2,GO SMOOTHENED SIGNALING PATHWAY,0.19095,-0.13748,-0.058047,0,0
2,GO ANATOMICAL STRUCTURE REGRESSION,0.016734,-0.13783,-0.31307,0,0
2,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.31653,-0.13793,-0.05097,0,0
2,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.0083534,-0.13822,-0.15085,0,0
2,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.12259,-0.13824,-0.11649,0,0
2,GO AXONAL TRANSPORT,0.0085714,-0.13841,-0.13215,0,0
2,GO PHAGOSOME ACIDIFICATION,0.068167,-0.13845,-0.11882,0,0
2,GO DENDRITE MORPHOGENESIS,0.0016129,-0.13885,-0.17899,0,0
2,GO CARDIAC VENTRICLE DEVELOPMENT,0.11039,-0.13891,-0.060742,0,0
2,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.15015,-0.13897,-0.11496,0,0
2,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.0019282,-0.13902,-0.12211,0,0
2,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.088862,-0.13902,-0.13056,0,0
2,GO MRNA SPLICE SITE SELECTION,0.14769,-0.13913,-0.1072,0,0
2,GO CARDIAC VENTRICLE MORPHOGENESIS,0.092194,-0.1393,-0.076793,0,0
2,GO CELLULAR RESPONSE TO NUTRIENT,0.055956,-0.1394,-0.14777,0,0
2,GO LOCOMOTOR RHYTHM,0.22568,-0.13949,-0.085562,0,0
2,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.10654,-0.13965,-0.19386,0,0
2,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.5726,-0.13966,0.012214,0,0
2,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.077957,-0.14051,-0.10708,0,0
2,GO NEURON DEVELOPMENT,0.00052342,-0.14058,-0.15873,0,0
2,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.017549,-0.14079,-0.1273,0,0
2,GO REGULATION OF TRANSPOSITION,0.94073,-0.14101,-0.035037,0,0
2,GO KILLING OF CELLS OF OTHER ORGANISM,0.02843,-0.14133,-0.096811,0,0
2,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.17374,-0.14137,-0.11384,0,0
2,GO COCHLEA DEVELOPMENT,0.024288,-0.14188,-0.13103,0,0
2,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.27999,-0.14221,-0.046313,0,0
2,GO HEAD DEVELOPMENT,0.0028957,-0.1424,-0.11874,0,0
2,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.00098941,-0.14278,-0.11432,0,0
2,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.0097392,-0.14281,-0.25729,0,0
2,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.001872,-0.1432,-0.1353,0,0
2,GO NEURON DIFFERENTIATION,0.00047456,-0.14352,-0.15109,0,0
2,GO REGULATION OF CAMP MEDIATED SIGNALING,0.044685,-0.14359,-0.14032,0,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.4545,-0.14418,-0.048201,0,0
2,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0050528,-0.14442,-0.1548,0,0
2,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.076492,-0.14445,-0.14835,0,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.013798,-0.14468,-0.17854,0,0
2,GO POSITIVE REGULATION OF CELL GROWTH,0.00063551,-0.14502,-0.13949,0,0
2,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.32938,-0.14541,-0.045377,0,0
2,GO MITOCHONDRION DISTRIBUTION,0.085627,-0.14547,-0.15961,0,0
2,GO DEVELOPMENTAL INDUCTION,0.04854,-0.14564,-0.16164,0,0
2,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.11841,-0.14568,-0.14823,0,0
2,GO REGULATION OF PROTEIN GLYCOSYLATION,0.32506,-0.14591,-0.10264,0,0
2,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.48678,-0.14609,-0.0063551,0,0
2,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.1313,-0.14613,-0.16932,0,0
2,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.019739,-0.14668,-0.1028,0,0
2,GO PARTURITION,0.12259,-0.14688,-0.1508,0,0
2,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.59059,-0.14714,-0.068868,0,0
2,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.001228,-0.14715,-0.224,0,0
2,GO RESPONSE TO AXON INJURY,0.034637,-0.1472,-0.12804,0,0
2,GO RELAXATION OF CARDIAC MUSCLE,0.20621,-0.14732,-0.11173,0,0
2,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.079444,-0.14748,-0.12168,0,0
2,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.061812,-0.14797,-0.13079,0,0
2,GO NON MOTILE CILIUM ASSEMBLY,0.30815,-0.14801,-0.041878,0,0
2,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.077957,-0.14865,-0.16494,0,0
2,GO ADULT HEART DEVELOPMENT,0.11039,-0.14922,-0.12612,0,0
2,GO GAMMA DELTA T CELL DIFFERENTIATION,0.93377,-0.15029,0.035227,0,0
2,GO TRANSPOSITION,0.19095,-0.15048,-0.12826,0,0
2,GO NEUROTRANSMITTER REUPTAKE,0.059411,-0.15056,-0.16974,0,0
2,GO NEURAL RETINA DEVELOPMENT,0.0062634,-0.15076,-0.18356,0,0
2,GO CELLULAR RESPONSE TO PH,0.031748,-0.15159,-0.12339,0,0
2,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.11841,-0.15218,-0.09414,0,0
2,GO CIRCADIAN SLEEP WAKE CYCLE,0.29184,-0.15229,-0.053789,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.079444,-0.15233,-0.11913,0,0
2,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.00044439,-0.15257,-0.20677,0,0
2,GO REGULATION OF CARDIAC CONDUCTION,0.0038387,-0.15385,-0.15896,0,0
2,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.11636,-0.15404,-0.1528,0,0
2,GO COLLATERAL SPROUTING,0.027188,-0.15496,-0.18408,0,0
2,GO POSTSYNAPSE ORGANIZATION,0.0038387,-0.15542,-0.17316,0,0
2,GO DETECTION OF ABIOTIC STIMULUS,0.0062634,-0.15569,-0.096481,0,0
2,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.10096,-0.15576,-0.17193,0,0
2,GO ESTROUS CYCLE,0.24643,-0.15718,-0.099037,0,0
2,GO POSITIVE THYMIC T CELL SELECTION,0.023205,-0.15738,-0.13104,0,0
2,GO PHAGOLYSOSOME ASSEMBLY,0.23245,-0.15787,-0.11544,0,0
2,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.025994,-0.1585,-0.12969,0,0
2,GO SENSORY PERCEPTION OF PAIN,0.00353,-0.15857,-0.16196,0,0
2,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.013798,-0.15888,-0.15902,0,0
2,GO REGULATION OF DENDRITE DEVELOPMENT,0.0016129,-0.15933,-0.16154,0,0
2,GO AMYLOID FIBRIL FORMATION,0.082489,-0.16004,-0.15912,0,0
2,GO REGULATION OF SYNAPSE ASSEMBLY,0.034637,-0.16016,-0.13244,0,0
2,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.14285,-0.16033,-0.098759,0,0
2,GO NEURON PROJECTION REGENERATION,0.04854,-0.16035,-0.12272,0,0
2,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.027803,-0.16067,-0.12286,0,0
2,GO CARDIAC CONDUCTION,0.01282,-0.16117,-0.15155,0,0
2,GO RESPONSE TO INTERLEUKIN 2,0.18508,-0.16231,-0.067551,0,0
2,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.060602,-0.16271,-0.1142,0,0
2,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.17374,-0.16292,-0.11459,0,0
2,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.52025,-0.1631,-0.035196,0,0
2,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.11235,-0.1635,-0.17497,0,0
2,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.21256,-0.16382,-0.094304,0,0
2,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.10465,-0.16414,-0.096025,0,0
2,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.66501,-0.16478,-0.02275,0,0
2,GO RESPONSE TO POTASSIUM ION,0.041967,-0.16481,-0.17361,0,0
2,GO RESPONSE TO WATER,0.62113,-0.16512,-0.032047,0,0
2,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.10096,-0.16536,-0.18354,0,0
2,GO HINDBRAIN DEVELOPMENT,0.00012964,-0.16636,-0.19848,0,0
2,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.51459,-0.16756,-0.0099698,0,0
2,GO ALDEHYDE CATABOLIC PROCESS,0.011047,-0.16814,-0.17292,0,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.13814,-0.16831,-0.12968,0,0
2,GO MAINTENANCE OF CELL POLARITY,0.0049174,-0.16946,-0.25552,0,0
2,GO INDOLALKYLAMINE METABOLIC PROCESS,0.25001,-0.17009,-0.091077,0,0
2,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.15264,-0.17013,-0.16543,0,0
2,GO IRON COORDINATION ENTITY TRANSPORT,0.14048,-0.17063,-0.12202,0,0
2,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0045306,-0.17069,-0.18542,0,0
2,GO RESPONSE TO ACIDIC PH,0.23937,-0.17072,-0.068509,0,0
2,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.16559,-0.17136,-0.23761,0,0
2,GO LONG TERM MEMORY,0.015574,-0.17206,-0.15929,0,0
2,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.05824,-0.17249,-0.2604,0,0
2,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.27999,-0.17354,-0.098364,0,0
2,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.29184,-0.17428,-0.037531,0,0
2,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.057089,-0.17434,-0.12944,0,0
2,GO ACROSOME ASSEMBLY,0.0051916,-0.17449,-0.20243,0,0
2,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.092194,-0.17759,-0.24386,0,0
2,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.077957,-0.17792,-0.1111,0,0
2,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0695,-0.17866,-0.18624,0,0
2,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.13355,-0.17884,-0.13873,0,0
2,GO PALLIUM DEVELOPMENT,0.0012662,-0.17991,-0.14982,0,0
2,GO CELLULAR RESPONSE TO VITAMIN,0.099158,-0.18005,-0.1472,0,0
2,GO DENDRITE SELF AVOIDANCE,0.021165,-0.18006,-0.21701,0,0
2,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.13355,-0.18018,-0.18614,0,0
2,GO NEUROMUSCULAR PROCESS,0.0075304,-0.1808,-0.14975,0,0
2,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.20309,-0.18088,-0.10667,0,0
2,GO CARDIAC ATRIUM DEVELOPMENT,0.11636,-0.18103,-0.11612,0,0
2,GO REGULATION OF POTASSIUM ION TRANSPORT,0.0027346,-0.18109,-0.15826,0,0
2,GO FEMALE GENITALIA DEVELOPMENT,0.16828,-0.18178,-0.082065,0,0
2,GO EXPORT ACROSS PLASMA MEMBRANE,0.055956,-0.18189,-0.13368,0,0
2,GO DENDRITE DEVELOPMENT,0.00074557,-0.18222,-0.17873,0,0
2,GO NEGATIVE REGULATION OF DNA BINDING,0.010506,-0.18225,-0.18591,0,0
2,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.13355,-0.18245,-0.12033,0,0
2,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.188,-0.18247,-0.20972,0,0
2,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.047551,-0.18306,-0.18781,0,0
2,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.21256,-0.18364,-0.10485,0,0
2,GO REGULATION OF NEURON MIGRATION,0.014841,-0.18404,-0.19345,0,0
2,GO PROTEIN LOCALIZATION TO CILIUM,0.0099891,-0.18411,-0.16927,0,0
2,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.24288,-0.18434,-0.16383,0,0
2,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.39858,-0.18474,-0.021356,0,0
2,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.0695,-0.18493,-0.25813,0,0
2,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.087232,-0.18582,-0.13971,0,0
2,GO MALE MEIOTIC NUCLEAR DIVISION,0.0025083,-0.18613,-0.1903,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.031059,-0.18633,-0.13876,0,0
2,GO SEROTONIN TRANSPORT,0.052669,-0.18672,-0.15653,0,0
2,GO MONOVALENT INORGANIC CATION TRANSPORT,0.00020448,-0.18717,-0.1579,0,0
2,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.36064,-0.18745,-0.10274,0,0
2,GO GLYCINE TRANSPORT,0.17934,-0.18777,-0.1055,0,0
2,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.1313,-0.18835,-0.10397,0,0
2,GO NEUROTRANSMITTER UPTAKE,0.16828,-0.18843,-0.12204,0,0
2,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.17374,-0.18869,-0.065057,0,0
2,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.035393,-0.18877,-0.13545,0,0
2,GO CARDIAC CELL FATE COMMITMENT,0.25001,-0.18891,-0.1918,0,0
2,GO RESPONSE TO CAFFEINE,0.42347,-0.19098,-0.040653,0,0
2,GO NEURAL PRECURSOR CELL PROLIFERATION,0.00074557,-0.19168,-0.15348,0,0
2,GO DEVELOPMENTAL MATURATION,8.1192e-05,-0.19179,-0.18135,0,0
2,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.03245,-0.19231,-0.17406,0,0
2,GO RESPONSE TO AMINO ACID STARVATION,0.001191,-0.19298,-0.2005,0,0
2,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.066855,-0.19373,-0.1132,0,0
2,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.00045924,-0.19383,-0.18392,0,0
2,GO POSITIVE REGULATION OF CILIUM MOVEMENT,0.041967,-0.19387,-0.14763,0,0
2,GO CARDIAC VENTRICLE FORMATION,0.10845,-0.19469,-0.27994,0,0
2,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.0094949,-0.19529,-0.18911,0,0
2,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.023205,-0.19584,-0.28975,0,0
2,GO AXO DENDRITIC PROTEIN TRANSPORT,0.0022992,-0.19601,-0.26976,0,0
2,GO FAT CELL PROLIFERATION,0.027188,-0.197,-0.18016,0,0
2,GO BEHAVIOR,5.0226e-05,-0.19727,-0.18304,0,0
2,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.0695,-0.19736,-0.13162,0,0
2,GO SKELETAL MUSCLE CONTRACTION,0.018836,-0.1975,-0.14701,0,0
2,GO COGNITION,0.00013917,-0.19805,-0.19697,0,0
2,GO SPINAL CORD DEVELOPMENT,0.001191,-0.1981,-0.18808,0,0
2,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.00087311,-0.19823,-0.26404,0,0
2,GO PEPTIDYL CYSTEINE MODIFICATION,0.0046564,-0.19978,-0.14732,0,0
2,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.21256,-0.19981,-0.081556,0,0
2,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.16032,-0.20007,-0.12623,0,0
2,GO DETECTION OF MECHANICAL STIMULUS,0.0045306,-0.20074,-0.16755,0,0
2,GO CEREBRAL CORTEX CELL MIGRATION,0.0099891,-0.20082,-0.1651,0,0
2,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.0001547,-0.20083,-0.21197,0,0
2,GO INACTIVATION OF MAPK ACTIVITY,0.033894,-0.20092,-0.21033,0,0
2,GO LUNG EPITHELIUM DEVELOPMENT,0.37932,-0.20125,-0.097044,0,0
2,GO MEMORY,5.8301e-05,-0.20125,-0.2259,0,0
2,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.11636,-0.20132,-0.1543,0,0
2,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.20621,-0.20216,-0.090998,0,0
2,GO OUTER DYNEIN ARM ASSEMBLY,0.0021062,-0.20234,-0.25539,0,0
2,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.23937,-0.20318,-0.19951,0,0
2,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.0022992,-0.20403,-0.15169,0,0
2,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0039469,-0.20411,-0.23054,0,0
2,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.043763,-0.20414,-0.23725,0,0
2,GO CEREBRAL CORTEX DEVELOPMENT,0.0018173,-0.2043,-0.15583,0,0
2,GO ATRIAL SEPTUM DEVELOPMENT,0.14769,-0.20464,-0.19872,0,0
2,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.15517,-0.20486,-0.16489,0,0
2,GO SYNAPSE ORGANIZATION,0.001191,-0.20513,-0.19479,0,0
2,GO NEGATIVE REGULATION OF GLIOGENESIS,0.0024367,-0.20554,-0.21439,0,0
2,GO REGULATION OF MICROTUBULE BINDING,0.00019079,-0.20582,-0.27432,0,0
2,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.0046564,-0.20588,-0.29512,0,0
2,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.39371,-0.2063,-0.075492,0,0
2,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,7.547e-05,-0.20693,-0.22894,0,0
2,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.0064317,-0.2075,-0.20056,0,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.029068,-0.20975,-0.26026,0,0
2,GO REGULATION OF CILIUM MOVEMENT,2.6307e-05,-0.2099,-0.20293,0,0
2,GO FOREBRAIN DEVELOPMENT,0.00024286,-0.20996,-0.16718,0,0
2,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.05161,-0.21006,-0.18794,0,0
2,GO REGULATION OF OOGENESIS,0.00081984,-0.21013,-0.1946,0,0
2,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.031059,-0.21246,-0.14597,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.023741,-0.21261,-0.21123,0,0
2,GO CEREBELLAR CORTEX MORPHOGENESIS,0.0001547,-0.21312,-0.25368,0,0
2,GO METENCEPHALON DEVELOPMENT,0.00012074,-0.21327,-0.22203,0,0
2,GO DEFENSE RESPONSE TO FUNGUS,0.00016023,-0.21445,-0.21678,0,0
2,GO PULMONARY VALVE DEVELOPMENT,0.19393,-0.21455,-0.15355,0,0
2,GO NEURON PROJECTION EXTENSION,9.7346e-05,-0.21487,-0.22502,0,0
2,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.0015653,-0.21561,-0.2136,0,0
2,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.26471,-0.21725,-0.091142,0,0
2,GO SECONDARY PALATE DEVELOPMENT,0.0090226,-0.2176,-0.22318,0,0
2,GO POSITIVE REGULATION OF BEHAVIOR,0.0033369,-0.21902,-0.22971,0,0
2,GO COPULATION,0.065563,-0.2195,-0.12403,0,0
2,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.095625,-0.21992,-0.17932,0,0
2,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,3.1888e-05,-0.22034,-0.22296,0,0
2,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.011326,-0.22129,-0.18969,0,0
2,GO MULTICELLULAR ORGANISMAL SIGNALING,0.001191,-0.22222,-0.19739,0,0
2,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.15015,-0.22231,-0.20103,0,0
2,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.10654,-0.22275,-0.1224,0,0
2,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.00037661,-0.22444,-0.22699,0,0
2,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.0046564,-0.22523,-0.29187,0,0
2,GO REGULATION OF HEART MORPHOGENESIS,0.085627,-0.22589,-0.11232,0,0
2,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.033166,-0.22603,-0.20853,0,0
2,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.03939,-0.22788,-0.24771,0,0
2,GO MYELIN MAINTENANCE,0.029068,-0.22874,-0.20169,0,0
2,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.00012074,-0.23028,-0.22111,0,0
2,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.045624,-0.23087,-0.17644,0,0
2,GO EPITHELIAL CELL MATURATION,0.0085714,-0.2347,-0.26325,0,0
2,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.036948,-0.23482,-0.15327,0,0
2,GO ENDOCARDIAL CUSHION FORMATION,0.076492,-0.23486,-0.167,0,0
2,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.00092958,-0.23537,-0.23076,0,0
2,GO MALE MEIOSIS I,0.00047456,-0.23568,-0.30661,0,0
2,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.001662,-0.23585,-0.22547,0,0
2,GO RESPONSE TO NERVE GROWTH FACTOR,0.00023468,-0.23711,-0.21995,0,0
2,GO VESICLE DOCKING,0.00032948,-0.23716,-0.22693,0,0
2,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.23937,-0.23722,-0.099567,0,0
2,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.0025817,-0.23733,-0.32751,0,0
2,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0006154,-0.23832,-0.16553,0,0
2,GO PARAXIAL MESODERM MORPHOGENESIS,0.40349,-0.24025,-0.074586,0,0
2,GO MICROTUBULE SEVERING,0.023205,-0.24075,-0.18688,0,0
2,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.0097392,-0.24089,-0.18148,0,0
2,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.097379,-0.2423,-0.16936,0,0
2,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.2,-0.24277,-0.085125,0,0
2,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.019283,-0.24333,-0.20231,0,0
2,GO NEUROPEPTIDE SIGNALING PATHWAY,0.00023468,-0.2434,-0.2281,0,0
2,GO SEROTONIN SECRETION,0.054842,-0.24417,-0.19844,0,0
2,GO CELL FATE DETERMINATION,0.016339,-0.24432,-0.17805,0,0
2,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.0007696,-0.24627,-0.27139,0,0
2,GO RETINAL GANGLION CELL AXON GUIDANCE,0.011047,-0.24633,-0.32227,0,0
2,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,6.2786e-05,-0.2467,-0.22982,0,0
2,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.00072223,-0.24779,-0.25411,0,0
2,GO RESPONSE TO MUSCLE STRETCH,0.011326,-0.24853,-0.27218,0,0
2,GO SYNAPSE ASSEMBLY,0.00028792,-0.24913,-0.23467,0,0
2,GO REGULATION OF MEMBRANE POTENTIAL,5.6174e-05,-0.24929,-0.23828,0,0
2,GO PHOTORECEPTOR CELL DEVELOPMENT,0.00087311,-0.25066,-0.19984,0,0
2,GO MICROTUBULE DEPOLYMERIZATION,0.00010092,-0.25131,-0.29239,0,0
2,GO CELLULAR RESPONSE TO AMYLOID BETA,0.0040578,-0.25177,-0.18548,0,0
2,GO SECRETORY GRANULE ORGANIZATION,0.00024286,-0.25222,-0.24678,0,0
2,GO INNER DYNEIN ARM ASSEMBLY,0.0050528,-0.25304,-0.33587,0,0
2,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.30402,-0.25338,-0.11827,0,0
2,GO INTRACILIARY RETROGRADE TRANSPORT,0.023741,-0.25381,-0.23691,0,0
2,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.021165,-0.25403,-0.19439,0,0
2,GO PULMONARY VALVE MORPHOGENESIS,0.088862,-0.2547,-0.19483,0,0
2,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.1028,-0.2548,-0.13637,0,0
2,GO RESPONSE TO AMYLOID BETA,0.0049174,-0.25483,-0.17216,0,0
2,GO RESPONSE TO COCAINE,0.00069957,-0.25761,-0.23012,0,0
2,GO FOREBRAIN CELL MIGRATION,0.00042998,-0.25831,-0.22002,0,0
2,GO CARDIAC CHAMBER FORMATION,0.16294,-0.25868,-0.2115,0,0
2,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.00031859,-0.2593,-0.23481,0,0
2,GO MICROTUBULE BUNDLE FORMATION,1.2454e-05,-0.26023,-0.27713,0,0
2,GO PROTEIN LOCALIZATION TO CELL JUNCTION,3.3132e-05,-0.26191,-0.28373,0,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.037747,-0.26323,-0.16705,0,0
2,GO RESPONSE TO CATECHOLAMINE,1.7806e-05,-0.26511,-0.25978,0,0
2,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.009256,-0.26573,-0.3094,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,9.389e-05,-0.2658,-0.28206,0,0
2,GO CELL MIGRATION IN HINDBRAIN,0.0032441,-0.26722,-0.31052,0,0
2,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.00055855,-0.26744,-0.26926,0,0
2,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.0011199,-0.2678,-0.24778,0,0
2,GO ENDOTHELIAL CELL MORPHOGENESIS,0.56666,-0.26881,0.011367,0,0
2,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.004408,-0.26914,-0.23244,0,0
2,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.0099891,-0.27012,-0.21728,0,0
2,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.0039469,-0.27158,-0.26802,0,0
2,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.02068,-0.27243,-0.30108,0,0
2,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.0062634,-0.27246,-0.28057,0,0
2,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.03245,-0.27422,-0.25295,0,0
2,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.099158,-0.27536,-0.094569,0,0
2,GO NERVE DEVELOPMENT,2.8418e-05,-0.27625,-0.28724,0,0
2,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.14526,-0.27672,-0.16164,0,0
2,GO PROTEIN PALMITOYLATION,0.00074557,-0.27874,-0.22261,0,0
2,GO POTASSIUM ION TRANSPORT,9.0551e-05,-0.27874,-0.22649,0,0
2,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.00028792,-0.27923,-0.32231,0,0
2,GO NEURON CELLULAR HOMEOSTASIS,0.0026572,-0.28163,-0.31205,0,0
2,GO RETINA LAYER FORMATION,0.0038387,-0.28213,-0.2967,0,0
2,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.0030654,-0.28232,-0.2738,0,0
2,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0013054,-0.28309,-0.30464,0,0
2,GO SKELETAL MUSCLE ADAPTATION,0.027188,-0.2861,-0.20521,0,0
2,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0036303,-0.28726,-0.22272,0,0
2,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.10465,-0.28726,-0.11925,0,0
2,GO REGULATION OF SYNAPTIC PLASTICITY,6.2786e-05,-0.28806,-0.29603,0,0
2,GO NEURON RECOGNITION,0.00025131,-0.29167,-0.32172,0,0
2,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.0066042,-0.29207,-0.23654,0,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.019283,-0.29231,-0.2116,0,0
2,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.00092958,-0.29337,-0.25233,0,0
2,GO SYNAPTIC SIGNALING,1.349e-05,-0.29393,-0.27318,0,0
2,GO RESPONSE TO DOPAMINE,2.0784e-06,-0.29538,-0.28501,0,0
2,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.00026003,-0.29653,-0.25121,0,0
2,GO DICARBOXYLIC ACID TRANSPORT,0.00047456,-0.29791,-0.22352,0,0
2,GO RESPONSE TO ACETYLCHOLINE,0.0071468,-0.29835,-0.26746,0,0
2,GO POSITIVE REGULATION OF AXONOGENESIS,4.8379e-05,-0.29943,-0.28855,0,0
2,GO NOTCH RECEPTOR PROCESSING,0.0085714,-0.30207,-0.28486,0,0
2,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.14048,-0.30236,-0.18742,0,0
2,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.085627,-0.3027,-0.18191,0,0
2,GO NEURON PROJECTION ARBORIZATION,8.4205e-05,-0.30274,-0.34189,0,0
2,GO SEQUESTERING OF ACTIN MONOMERS,0.17934,-0.30401,-0.32927,0,0
2,GO ADULT LOCOMOTORY BEHAVIOR,1.9263e-05,-0.30462,-0.28124,0,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0016129,-0.3054,-0.3088,0,0
2,GO REGULATION OF TUBULIN DEACETYLATION,0.018836,-0.30616,-0.23974,0,0
2,GO KERATINOCYTE DEVELOPMENT,0.14285,-0.30645,-0.18095,0,0
2,GO REGULATION OF MESODERM DEVELOPMENT,0.0040578,-0.30719,-0.22644,0,0
2,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.004408,-0.30724,-0.21713,0,0
2,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.00016595,-0.30761,-0.33353,0,0
2,GO NEURON MATURATION,0.0013872,-0.30768,-0.23605,0,0
2,GO LONG TERM SYNAPTIC DEPRESSION,0.00014935,-0.30829,-0.303,0,0
2,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.023205,-0.3085,-0.24635,0,0
2,GO LOCOMOTORY BEHAVIOR,7.9801e-06,-0.30916,-0.27576,0,0
2,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.0012662,-0.31016,-0.24519,0,0
2,GO RETROGRADE TRANS SYNAPTIC SIGNALING,0.011047,-0.31029,-0.40552,0,0
2,GO PRESYNAPSE ORGANIZATION,0.00022676,-0.31055,-0.29473,0,0
2,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0041716,-0.31092,-0.29813,0,0
2,GO DIENCEPHALON DEVELOPMENT,5.8301e-05,-0.31156,-0.29536,0,0
2,GO BASEMENT MEMBRANE ASSEMBLY,0.32506,-0.31157,-0.12432,0,0
2,GO NEURAL NUCLEUS DEVELOPMENT,3.1888e-05,-0.31288,-0.33587,0,0
2,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.013139,-0.31491,-0.25885,0,0
2,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,5.7413e-06,-0.31537,-0.29574,0,0
2,GO PROTEIN POLYGLUTAMYLATION,9.0551e-05,-0.31768,-0.27997,0,0
2,GO GROOMING BEHAVIOR,0.0011199,-0.31825,-0.29764,0,0
2,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.031748,-0.31881,-0.22796,0,0
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0028141,-0.31932,-0.273,0,0
2,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,5.2837e-06,-0.32164,-0.34556,0,0
2,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.019739,-0.32165,-0.22635,0,0
2,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.12689,-0.32264,-0.27234,0,0
2,GO MAST CELL MIGRATION,0.25363,-0.32279,-0.11083,0,0
2,GO REGULATION OF CILIUM BEAT FREQUENCY,9.7801e-06,-0.32295,-0.31446,0,0
2,GO NEURON MIGRATION,8.1192e-05,-0.32354,-0.2878,0,0
2,GO NOREPINEPHRINE SECRETION,0.00055855,-0.32373,-0.3068,0,0
2,GO REGULATION OF AMINO ACID TRANSPORT,0.00010462,-0.32373,-0.30426,0,0
2,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.00020448,-0.32505,-0.32347,0,0
2,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.001191,-0.32514,-0.32941,0,0
2,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.0079323,-0.32674,-0.33154,0,0
2,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00016595,-0.32774,-0.3059,0,0
2,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.001228,-0.32889,-0.25414,0,0
2,GO DORSAL VENTRAL PATTERN FORMATION,0.00032948,-0.32902,-0.27937,0,0
2,GO REFLEX,0.0062634,-0.33049,-0.33856,0,0
2,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.00087311,-0.33136,-0.36021,0,0
2,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,3.9418e-06,-0.3328,-0.33353,0,0
2,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.088862,-0.33395,-0.17094,0,0
2,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.00353,-0.334,-0.34468,0,0
2,GO REGULATION OF ANIMAL ORGAN FORMATION,0.0059384,-0.33413,-0.21619,0,0
2,GO TYPE B PANCREATIC CELL PROLIFERATION,0.0064317,-0.33964,-0.32578,0,0
2,GO SYNAPTIC VESICLE TRANSPORT,2.0833e-05,-0.34114,-0.31289,0,0
2,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00011241,-0.34176,-0.32099,0,0
2,GO ACIDIC AMINO ACID TRANSPORT,2.0033e-05,-0.34653,-0.31578,0,0
2,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.073629,-0.34723,-0.18373,0,0
2,GO ADULT BEHAVIOR,5.7413e-06,-0.34936,-0.30585,0,0
2,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,6.2786e-05,-0.34987,-0.3304,0,0
2,GO SYNAPTIC VESICLE RECYCLING,9.7801e-06,-0.35485,-0.3546,0,0
2,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.00079435,-0.35599,-0.32389,0,0
2,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.00069957,-0.35672,-0.33649,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,1.349e-05,-0.35759,-0.39984,0,0
2,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.00019753,-0.36027,-0.33874,0,0
2,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,3.4728e-06,-0.36368,-0.39828,0,0
2,GO REGULATION OF TRANS SYNAPTIC SIGNALING,6.2367e-06,-0.36445,-0.31262,0,0
2,GO PROTEIN LOCALIZATION TO SYNAPSE,1.1493e-05,-0.3655,-0.38361,0,0
2,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.00055855,-0.37017,-0.37113,0,0
2,GO TRANSMISSION OF NERVE IMPULSE,1.4039e-05,-0.37042,-0.36846,0,0
2,GO MOTILE CILIUM ASSEMBLY,0.0022992,-0.37045,-0.25323,0,0
2,GO GAMMA AMINOBUTYRIC ACID SECRETION,6.4994e-06,-0.37119,-0.45625,0,0
2,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.0073363,-0.37229,-0.26976,0,0
2,GO REGULATION OF PROTEIN KINASE C SIGNALING,8.7323e-05,-0.37254,-0.43785,0,0
2,GO LUNG CELL DIFFERENTIATION,0.40843,-0.37364,-0.12833,0,0
2,GO CATECHOLAMINE UPTAKE,0.0017641,-0.3765,-0.29749,0,0
2,GO EXPLORATION BEHAVIOR,1.1493e-05,-0.37666,-0.44339,0,0
2,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.00052342,-0.37804,-0.40865,0,0
2,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.00031859,-0.37851,-0.29406,0,0
2,GO RECEPTOR LOCALIZATION TO SYNAPSE,4.4878e-05,-0.37901,-0.35527,0,0
2,GO NEUROTRANSMITTER TRANSPORT,0.00018427,-0.38009,-0.35303,0,0
2,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00028792,-0.38038,-0.32131,0,0
2,GO REGULATION OF VESICLE FUSION,0.018398,-0.38038,-0.26224,0,0
2,GO AXONEME ASSEMBLY,3.7145e-05,-0.38059,-0.34033,0,0
2,GO HEART INDUCTION,0.0047853,-0.3811,-0.51035,0,0
2,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,9.389e-05,-0.38303,-0.35509,0,0
2,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,3.5759e-05,-0.38486,-0.34848,0,0
2,GO CEREBELLAR CORTEX FORMATION,1.0184e-05,-0.38599,-0.3695,0,0
2,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0015653,-0.38614,-0.46382,0,0
2,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.00044439,-0.38707,-0.29461,0,0
2,GO SPERM AXONEME ASSEMBLY,0.0019282,-0.38751,-0.29654,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0030654,-0.39009,-0.35103,0,0
2,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,2.1663e-05,-0.39358,-0.34316,0,0
2,GO NEURONAL ACTION POTENTIAL,0.00012964,-0.39375,-0.38255,0,0
2,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.066855,-0.39573,-0.23367,0,0
2,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00042998,-0.39646,-0.37475,0,0
2,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.00012512,-0.39729,-0.28993,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,1.906e-06,-0.39738,-0.40355,0,0
2,GO HEART FORMATION,0.00019753,-0.39792,-0.37544,0,0
2,GO PRESYNAPTIC ENDOCYTOSIS,2.7343e-05,-0.40049,-0.35982,0,0
2,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.00032948,-0.40117,-0.39776,0,0
2,GO INCLUSION BODY ASSEMBLY,0.00037661,-0.40517,-0.35682,0,0
2,GO FOREBRAIN NEURON DEVELOPMENT,0.0001165,-0.4078,-0.41052,0,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,3.8583e-05,-0.41092,-0.35373,0,0
2,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00014935,-0.41146,-0.42288,0,0
2,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.00030804,-0.41188,-0.48725,0,0
2,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0075304,-0.41315,-0.32271,0,0
2,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.0032441,-0.41686,-0.37001,0,0
2,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,4.3218e-05,-0.41759,-0.40071,0,0
2,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.00021167,-0.41761,-0.47672,0,0
2,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00016595,-0.42106,-0.37432,0,0
2,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.00032948,-0.42147,-0.34325,0,0
2,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.00029782,-0.42396,-0.32309,0,0
2,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.0041716,-0.42401,-0.41182,0,0
2,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,8.3127e-06,-0.42864,-0.47246,0,0
2,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.0001547,-0.43245,-0.46212,0,0
2,GO SYNAPTIC VESICLE LOCALIZATION,9.7346e-05,-0.4335,-0.3702,0,0
2,GO STARTLE RESPONSE,9.7346e-05,-0.43451,-0.41573,0,0
2,GO TRIGEMINAL NERVE DEVELOPMENT,0.00036427,-0.43471,-0.52049,0,0
2,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,4.3218e-05,-0.4381,-0.36893,0,0
2,GO NEUROTRANSMITTER SECRETION,0.0001165,-0.43911,-0.39431,0,0
2,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.0007696,-0.43936,-0.49714,0,0
2,GO PITUITARY GLAND DEVELOPMENT,2.8418e-05,-0.44241,-0.40207,0,0
2,GO CATECHOLAMINE METABOLIC PROCESS,3.6228e-06,-0.44661,-0.44857,0,0
2,GO BEHAVIORAL RESPONSE TO COCAINE,0.19393,-0.44887,-0.18028,0,0
2,GO SECONDARY HEART FIELD SPECIFICATION,0.00031859,-0.44954,-0.51172,0,0
2,GO NEURON FATE COMMITMENT,9.389e-05,-0.45099,-0.40042,0,0
2,GO SYNAPTIC VESICLE EXOCYTOSIS,0.00019753,-0.45114,-0.39929,0,0
2,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,1.4609e-05,-0.45131,-0.40182,0,0
2,GO SPINAL CORD PATTERNING,0.00014418,-0.45579,-0.43606,0,0
2,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.00072223,-0.45579,-0.44077,0,0
2,GO GLIAL CELL FATE COMMITMENT,0.0069616,-0.45634,-0.38429,0,0
2,GO CARDIOBLAST PROLIFERATION,0.0041716,-0.45976,-0.48552,0,0
2,GO OLFACTORY LOBE DEVELOPMENT,2.0833e-05,-0.46481,-0.42169,0,0
2,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,3.5759e-05,-0.46495,-0.48686,0,0
2,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,5.2837e-06,-0.47011,-0.50826,0,0
2,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.0019282,-0.47184,-0.3142,0,0
2,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,1.4609e-05,-0.47385,-0.48456,0,0
2,GO FOREBRAIN GENERATION OF NEURONS,3.1904e-06,-0.47613,-0.44787,0,0
2,GO NOREPINEPHRINE METABOLIC PROCESS,2.0033e-05,-0.47806,-0.59416,0,0
2,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.0020453,-0.47903,-0.36518,0,0
2,GO DETECTION OF CALCIUM ION,2.1663e-05,-0.47921,-0.4581,0,0
2,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.00027832,-0.48431,-0.38024,0,0
2,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,1.1493e-05,-0.50426,-0.45948,0,0
2,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0056288,-0.50641,-0.4666,0,0
2,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0027346,-0.50924,-0.43193,0,0
2,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,1.3441e-06,-0.50969,-0.55469,0,0
2,GO STABILIZATION OF MEMBRANE POTENTIAL,0.00012964,-0.51217,-0.46023,0,0
2,GO RESPONSE TO AUDITORY STIMULUS,0.00040247,-0.51533,-0.43402,0,0
2,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.0006154,-0.51565,-0.46508,0,0
2,GO PARENTAL BEHAVIOR,2.2658e-06,-0.5173,-0.52335,0,0
2,GO DENSE CORE GRANULE TRANSPORT,2.8418e-05,-0.51826,-0.60454,0,0
2,GO DOPAMINE BIOSYNTHETIC PROCESS,0.00047456,-0.5209,-0.55834,0,0
2,GO GLUTAMATE SECRETION,7.9801e-06,-0.52196,-0.45489,0,0
2,GO ADENOHYPOPHYSIS DEVELOPMENT,0.001191,-0.52376,-0.48236,0,0
2,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.02268,-0.53215,-0.42098,0,0
2,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,4.6623e-06,-0.53818,-0.44798,0,0
2,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.00022676,-0.54078,-0.50822,0,0
2,GO NEURONAL ION CHANNEL CLUSTERING,0.00019079,-0.54665,-0.54081,0,0
2,GO DETECTION OF TEMPERATURE STIMULUS,3.7791e-06,-0.54756,-0.51119,0,0
2,GO NEURON FATE SPECIFICATION,0.00084609,-0.55274,-0.43307,0,0
2,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.00036427,-0.55378,-0.45042,0,0
2,GO AMINE TRANSPORT,1.0604e-05,-0.55393,-0.47415,0,0
2,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,1.2454e-05,-0.55775,-0.47568,0,0
2,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,1.7806e-05,-0.55845,-0.49749,0,0
2,GO FOREBRAIN NEURON DIFFERENTIATION,1.8251e-06,-0.56376,-0.53302,0,0
2,GO SUBPALLIUM DEVELOPMENT,5.508e-06,-0.56698,-0.51447,0,0
2,GO REGULATION OF GLUTAMATE SECRETION,1.4039e-05,-0.5753,-0.49886,0,0
2,GO INHIBITORY POSTSYNAPTIC POTENTIAL,4.4712e-06,-0.57623,-0.63792,0,0
2,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,1.1964e-05,-0.57795,-0.48891,0,0
2,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,8.1192e-05,-0.58511,-0.56837,0,0
2,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,1.4039e-05,-0.58792,-0.49606,0,0
2,GO REGULATION OF SYNAPTIC VESICLE CYCLE,7.013e-05,-0.58816,-0.43887,0,0
2,GO PREPULSE INHIBITION,0.0017641,-0.59001,-0.48413,0,0
2,GO SYNAPTIC MEMBRANE ADHESION,4.6623e-06,-0.59578,-0.60314,0,0
2,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,1.4609e-05,-0.59663,-0.62733,0,0
2,GO HEART FIELD SPECIFICATION,8.4205e-05,-0.60151,-0.54288,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.0010528,-0.61174,-0.5662,0,0
2,GO DENDRITE EXTENSION,2.6902e-06,-0.61273,-0.54732,0,0
2,GO CALCIUM ION IMPORT INTO CYTOSOL,1.349e-05,-0.61804,-0.51355,0,0
2,GO MONOAMINE TRANSPORT,1.1964e-05,-0.61853,-0.48974,0,0
2,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,3.0576e-06,-0.62233,-0.57237,0,0
2,GO POSITIVE REGULATION OF AMINE TRANSPORT,1.2862e-06,-0.63003,-0.58564,0,0
2,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,2.8418e-05,-0.63175,-0.57593,0,0
2,GO GROWTH HORMONE SECRETION,3.17e-07,-0.64066,-0.60111,0,0
2,GO RESPONSE TO INSECTICIDE,1.3441e-06,-0.64942,-0.58409,0,0
2,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,6.2786e-05,-0.64945,-0.57445,0,0
2,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.001986,-0.65138,-0.49689,0,0
2,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,7.889e-07,-0.65177,-0.63147,0,0
2,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,5.9841e-06,-0.67669,-0.59296,0,0
2,GO DORSAL SPINAL CORD DEVELOPMENT,6.5896e-07,-0.67931,-0.65628,0,0
2,GO NEURON CELL CELL ADHESION,7.6603e-06,-0.69428,-0.74771,0,0
2,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,1.7806e-05,-0.70774,-0.61998,0,0
2,GO MECHANOSENSORY BEHAVIOR,0.00065623,-0.71598,-0.62206,0,0
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,2.4692e-06,-0.71759,-0.69427,0,0
2,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.00026903,-0.72004,-0.49951,0,0
2,GO DOPAMINE TRANSPORT,3.5759e-05,-0.72243,-0.57568,0,0
2,GO GANGLION DEVELOPMENT,2.5774e-06,-0.72491,-0.75393,0,0
2,GO SYNAPTIC VESICLE CLUSTERING,0.0007696,-0.73672,-0.60238,0,0
2,GO REGULATION OF GROWTH HORMONE SECRETION,2.9301e-06,-0.76196,-0.67725,0,0
2,GO CATECHOLAMINE SECRETION,5.4121e-05,-0.77421,-0.58309,0,0
2,GO VOCALIZATION BEHAVIOR,1.5816e-05,-0.77548,-0.68249,0,0
2,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,2.0784e-06,-0.80624,-0.81764,0,0
2,GO REGULATION OF DOPAMINE SECRETION,0.00021909,-0.81849,-0.65869,0,0
2,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.0021062,-0.82314,-0.61269,0,0
2,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,6.8936e-07,-0.94969,-0.82317,0,0
2,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,1.7118e-05,-0.9647,-0.8053,0,0
2,GO GABAERGIC NEURON DIFFERENTIATION,5.9841e-06,-1.0785,-0.85681,0,0
2,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,2.8418e-05,-1.2441,-0.96112,0,0
2,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,5.0683e-06,-1.4504,-1.1919,0,0
3,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,3.6228e-06,0.94756,0.94014,1,1
3,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,2.9301e-06,0.91031,0.81499,1,1
3,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,1.071e-07,0.80365,0.80566,1,1
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,1.0311e-06,0.79422,0.73973,1,1
3,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,6.8936e-07,0.7916,0.92578,1,1
3,GO RESPONSE TO HISTAMINE,2.2658e-06,0.74477,0.72042,1,1
3,GO RESPONSE TO L GLUTAMATE,4.2876e-06,0.69465,0.60666,1,1
3,GO SYNAPSE MATURATION,1.4674e-06,0.68545,0.7436,1,1
3,GO SECRETORY GRANULE LOCALIZATION,2.0033e-05,0.65007,0.54422,1,1
3,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,2.8418e-05,0.62605,0.56859,1,1
3,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,1.2454e-05,0.61639,0.52145,1,1
3,GO PYRAMIDAL NEURON DIFFERENTIATION,3.3132e-05,0.60719,0.59391,1,1
3,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,4.0073e-05,0.59411,0.55227,1,1
3,GO REGULATION OF SYNAPSE MATURATION,7.2754e-05,0.57877,0.59374,1,1
3,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,4.1112e-06,0.57691,0.53241,1,1
3,GO BRANCHING MORPHOGENESIS OF A NERVE,4.6623e-06,0.5716,0.67473,1,1
3,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,8.6584e-06,0.5636,0.52821,1,1
3,GO SYNAPTIC VESICLE MATURATION,1.5816e-05,0.56314,0.55209,1,1
3,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,2.2524e-05,0.55993,0.47787,1,1
3,GO OPIOID RECEPTOR SIGNALING PATHWAY,1.906e-06,0.54883,0.56841,1,1
3,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.013465,0.5278,0.27946,1,1
3,GO TELENCEPHALON GLIAL CELL MIGRATION,3.1888e-05,0.52089,0.44522,1,1
3,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.00026003,0.51822,0.43648,1,1
3,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,3.8583e-05,0.51426,0.60361,1,1
3,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.00029782,0.51233,0.39413,1,1
3,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,3.1904e-06,0.50604,0.55189,1,1
3,GO CORPUS CALLOSUM DEVELOPMENT,1.2366e-07,0.50581,0.55815,1,1
3,GO POSTSYNAPSE ASSEMBLY,2.2524e-05,0.50478,0.5522,1,1
3,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.001662,0.49835,0.41138,1,1
3,GO SUCKLING BEHAVIOR,2.6902e-06,0.49306,0.46816,1,1
3,GO PLASMA MEMBRANE REPAIR,6.0198e-07,0.49163,0.5509,1,1
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.00019753,0.4888,0.39291,1,1
3,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,5.2837e-06,0.48509,0.42077,1,1
3,GO UV PROTECTION,3.0576e-06,0.48315,0.47018,1,1
3,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.0026572,0.48243,0.39301,1,1
3,GO OXYGEN TRANSPORT,0.007729,0.48098,0.47859,1,1
3,GO ADULT HEART DEVELOPMENT,2.9532e-05,0.46765,0.43997,1,1
3,GO GLYCINE TRANSPORT,0.010245,0.46638,0.32803,1,1
3,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,1.1964e-05,0.46059,0.47156,1,1
3,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,7.547e-05,0.45958,0.48595,1,1
3,GO PROTEIN LOCALIZATION TO AXON,0.0037331,0.45649,0.45228,1,1
3,GO TELENCEPHALON REGIONALIZATION,0.0066042,0.45498,0.35935,1,1
3,GO MODIFICATION OF SYNAPTIC STRUCTURE,3.3287e-06,0.45296,0.44,1,1
3,GO MATURATION OF LSU RRNA,0.00014935,0.4519,0.37323,1,1
3,GO POSITIVE REGULATION OF NEURON MIGRATION,0.00072223,0.45108,0.37243,1,1
3,GO RIBOSOME ASSEMBLY,0.00032948,0.44701,0.35206,1,1
3,GO EXCITATORY SYNAPSE ASSEMBLY,3.3132e-05,0.44645,0.43335,1,1
3,GO NEGATIVE REGULATION OF LYASE ACTIVITY,2.3418e-05,0.44561,0.41876,1,1
3,GO PEPTIDYL SERINE DEPHOSPHORYLATION,1.5816e-05,0.44531,0.41464,1,1
3,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.00026003,0.44497,0.40363,1,1
3,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.00013433,0.44103,0.35656,1,1
3,GO TRICARBOXYLIC ACID METABOLIC PROCESS,7.8282e-05,0.44058,0.41204,1,1
3,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0019282,0.43622,0.29455,1,1
3,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,3.7145e-05,0.43405,0.49431,1,1
3,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,5.2139e-05,0.43229,0.44291,1,1
3,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.02068,0.42852,0.26809,1,1
3,GO REGULATION OF GONAD DEVELOPMENT,0.00090094,0.42822,0.27321,1,1
3,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,1.4039e-05,0.42626,0.40752,1,1
3,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.00036427,0.41768,0.35519,1,1
3,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.00052342,0.41701,0.41583,1,1
3,GO IMP METABOLIC PROCESS,9.0551e-05,0.41481,0.41783,1,1
3,GO CGMP METABOLIC PROCESS,0.00045924,0.41082,0.36304,1,1
3,GO CARDIAC VENTRICLE FORMATION,0.00040247,0.41063,0.57213,1,1
3,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.00044439,0.40928,0.41246,1,1
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.00034072,0.40609,0.35238,1,1
3,GO RESPONSE TO ELECTRICAL STIMULUS,9.0551e-05,0.40382,0.32816,1,1
3,GO VITAMIN CATABOLIC PROCESS,0.01282,0.40346,0.31243,1,1
3,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,8.3127e-06,0.4005,0.35991,1,1
3,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.0062634,0.3971,0.36548,1,1
3,GO REGULATION OF CGMP MEDIATED SIGNALING,0.013139,0.39707,0.27753,1,1
3,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,2.3418e-05,0.39682,0.38372,1,1
3,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,6.5149e-05,0.39636,0.43113,1,1
3,GO ELASTIC FIBER ASSEMBLY,0.00045924,0.39581,0.47755,1,1
3,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0059384,0.39443,0.26069,1,1
3,GO MYOBLAST PROLIFERATION,4.6623e-06,0.39425,0.4101,1,1
3,GO SIALYLATION,0.0013457,0.39342,0.40768,1,1
3,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,2.2524e-05,0.3916,0.34173,1,1
3,GO CARDIAC CHAMBER FORMATION,0.00041602,0.39111,0.51814,1,1
3,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.0057817,0.38824,0.30976,1,1
3,GO INNERVATION,0.00052342,0.38703,0.39486,1,1
3,GO FACIAL NERVE MORPHOGENESIS,0.0066042,0.38467,0.35033,1,1
3,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00031859,0.38363,0.34614,1,1
3,GO NEGATIVE CHEMOTAXIS,0.00012512,0.38309,0.34246,1,1
3,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.0057817,0.38233,0.2726,1,1
3,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00019753,0.38097,0.35262,1,1
3,GO CYTOPLASMIC TRANSLATION,0.00049035,0.38017,0.35101,1,1
3,GO VESICLE FUSION TO PLASMA MEMBRANE,7.9801e-06,0.37741,0.47846,1,1
3,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.0069616,0.37522,0.29253,1,1
3,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.001228,0.37444,0.36944,1,1
3,GO HEART VALVE FORMATION,0.00037661,0.37386,0.39291,1,1
3,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.00045924,0.36967,0.38396,1,1
3,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00018427,0.36937,0.37404,1,1
3,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00012964,0.36873,0.41623,1,1
3,GO CHEMOSENSORY BEHAVIOR,0.0020453,0.36777,0.26236,1,1
3,GO DENTATE GYRUS DEVELOPMENT,7.8282e-05,0.36694,0.51687,1,1
3,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.009256,0.36495,0.27525,1,1
3,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0036303,0.35922,0.25656,1,1
3,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.033166,0.35692,0.22823,1,1
3,GO L GLUTAMATE IMPORT,0.00045924,0.35529,0.29567,1,1
3,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.00014418,0.3552,0.31646,1,1
3,GO ADAPTATION OF SIGNALING PATHWAY,0.0014299,0.35044,0.24031,1,1
3,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0001547,0.34932,0.33442,1,1
3,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.00065623,0.34881,0.3587,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00090094,0.34876,0.44965,1,1
3,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,2.5774e-06,0.34625,0.39766,1,1
3,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.00022676,0.34618,0.32216,1,1
3,GO ADULT FEEDING BEHAVIOR,0.00065623,0.34356,0.22249,1,1
3,GO DORSAL VENTRAL AXIS SPECIFICATION,0.0022992,0.34218,0.3393,1,1
3,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.00067758,0.34121,0.27606,1,1
3,GO TRANSLATIONAL INITIATION,0.0010528,0.3411,0.3039,1,1
3,GO REGULATION OF CYTOPLASMIC TRANSLATION,1.7806e-05,0.34055,0.31045,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0083534,0.33889,0.32249,1,1
3,GO REGULATION OF TRANSLATIONAL FIDELITY,0.0010859,0.33694,0.25895,1,1
3,GO GAS TRANSPORT,0.0066042,0.33673,0.37192,1,1
3,GO LIMB BUD FORMATION,0.015203,0.33666,0.37697,1,1
3,GO LAYER FORMATION IN CEREBRAL CORTEX,0.0017641,0.33651,0.28969,1,1
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0015189,0.33579,0.29889,1,1
3,GO TELOMERASE RNA LOCALIZATION,0.00013917,0.32701,0.32189,1,1
3,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,1.0604e-05,0.32643,0.36839,1,1
3,GO SYNAPTIC TRANSMISSION GABAERGIC,2.6307e-05,0.32293,0.28974,1,1
3,GO SYNAPTIC VESICLE PRIMING,3.0689e-05,0.32128,0.41314,1,1
3,GO CELL PROLIFERATION IN FOREBRAIN,0.027803,0.32032,0.19312,1,1
3,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.00090094,0.31727,0.30085,1,1
3,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.027803,0.317,0.2786,1,1
3,GO PURINE CONTAINING COMPOUND SALVAGE,0.0023671,0.31699,0.27417,1,1
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,4.1617e-05,0.31621,0.33865,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00016023,0.31598,0.29368,1,1
3,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.00079435,0.31522,0.36813,1,1
3,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00087311,0.31486,0.26049,1,1
3,GO AORTA DEVELOPMENT,0.0016129,0.31397,0.20113,1,1
3,GO MATURATION OF SSU RRNA,0.00045924,0.31375,0.29689,1,1
3,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,1.4609e-05,0.3125,0.37367,1,1
3,GO NEURON PROJECTION ORGANIZATION,3.1904e-06,0.31218,0.30704,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.00059588,0.31056,0.29615,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.0047853,0.31015,0.32372,1,1
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00047456,0.3101,0.30501,1,1
3,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.00081984,0.30788,0.31239,1,1
3,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.041967,0.30776,0.23304,1,1
3,GO RRNA PSEUDOURIDINE SYNTHESIS,0.011904,0.30728,0.28329,1,1
3,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.00042998,0.30492,0.26796,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.0021689,0.30332,0.24321,1,1
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.0037331,0.30275,0.20971,1,1
3,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.00069957,0.30273,0.3116,1,1
3,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.00019753,0.2983,0.34389,1,1
3,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0047853,0.29787,0.27686,1,1
3,GO DIVALENT METAL ION EXPORT,0.00059588,0.29766,0.39797,1,1
3,GO REGULATION OF LYASE ACTIVITY,3.0689e-05,0.29634,0.26996,1,1
3,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.0021062,0.29468,0.22458,1,1
3,GO MATURATION OF 5 8S RRNA,0.0017641,0.29439,0.24399,1,1
3,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.041967,0.29417,0.18102,1,1
3,GO MATING BEHAVIOR,0.0025817,0.29386,0.21672,1,1
3,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.0010206,0.29365,0.4059,1,1
3,GO PENTOSE METABOLIC PROCESS,0.0037331,0.2933,0.23187,1,1
3,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.0079323,0.29304,0.18715,1,1
3,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.00044439,0.29292,0.22038,1,1
3,GO MITOCHONDRIAL TRANSCRIPTION,0.0038387,0.29273,0.25142,1,1
3,GO PEPTIDYL ARGININE N METHYLATION,0.00010462,0.29234,0.31636,1,1
3,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.0075304,0.29187,0.24686,1,1
3,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0026572,0.29084,0.22203,1,1
3,GO EMBRYONIC BRAIN DEVELOPMENT,8.1192e-05,0.29082,0.31637,1,1
3,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.0036303,0.29063,0.33102,1,1
3,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0010528,0.29002,0.23738,1,1
3,GO NAD METABOLIC PROCESS,0.0028957,0.28961,0.2362,1,1
3,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.0025083,0.28931,0.23327,1,1
3,GO L SERINE METABOLIC PROCESS,0.011904,0.28863,0.29792,1,1
3,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.0071468,0.28737,0.21499,1,1
3,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,9.7346e-05,0.28657,0.21378,1,1
3,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00072223,0.28487,0.2813,1,1
3,GO TRNA WOBBLE BASE MODIFICATION,0.0010206,0.28381,0.22364,1,1
3,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.015203,0.2822,0.25272,1,1
3,GO RIBOSOME BIOGENESIS,0.00057693,0.27931,0.25228,1,1
3,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.00025131,0.27665,0.31857,1,1
3,GO REGULATION OF MRNA BINDING,0.00026003,0.27398,0.297,1,1
3,GO PEPTIDYL HISTIDINE MODIFICATION,0.00063551,0.27295,0.21766,1,1
3,GO MESODERMAL CELL FATE SPECIFICATION,0.041093,0.27198,0.18829,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.004408,0.27146,0.1994,1,1
3,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.0015653,0.27089,0.28208,1,1
3,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00054072,0.27016,0.23454,1,1
3,GO STRESS GRANULE ASSEMBLY,1.1493e-05,0.2701,0.24164,1,1
3,GO PROTEIN TARGETING TO MEMBRANE,0.0021689,0.26871,0.22891,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00353,0.26731,0.20427,1,1
3,GO BONE GROWTH,0.009256,0.2629,0.2313,1,1
3,GO NEURON REMODELING,0.0010528,0.2624,0.29998,1,1
3,GO HYPOTONIC RESPONSE,0.025994,0.26188,0.17492,1,1
3,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.013139,0.26177,0.20083,1,1
3,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,4.0073e-05,0.26171,0.23927,1,1
3,GO LEARNING,3.5759e-05,0.26107,0.2771,1,1
3,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.016734,0.26084,0.2363,1,1
3,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0042883,0.26079,0.20316,1,1
3,GO MITOCHONDRION DISTRIBUTION,0.00014935,0.26009,0.25265,1,1
3,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.00014935,0.25989,0.19652,1,1
3,GO TRANSLATIONAL ELONGATION,0.00038934,0.25826,0.22275,1,1
3,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0039469,0.25823,0.2013,1,1
3,GO RRNA MODIFICATION,0.007729,0.2571,0.21839,1,1
3,GO RRNA METABOLIC PROCESS,0.00084609,0.25574,0.22872,1,1
3,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.00087311,0.25477,0.26261,1,1
3,GO REPRODUCTIVE BEHAVIOR,0.0018173,0.25446,0.24261,1,1
3,GO CELL JUNCTION DISASSEMBLY,0.0013054,0.25444,0.25289,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,9.0551e-05,0.25444,0.25267,1,1
3,GO VIRAL TRANSLATION,0.0013054,0.25369,0.28863,1,1
3,GO REGULATION OF NEUROBLAST PROLIFERATION,0.0053338,0.25352,0.22196,1,1
3,GO CELL PROLIFERATION IN HINDBRAIN,0.013798,0.25024,0.23231,1,1
3,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.029068,0.24711,0.20917,1,1
3,GO CELL DIFFERENTIATION IN HINDBRAIN,0.0051916,0.24683,0.26074,1,1
3,GO PSEUDOURIDINE SYNTHESIS,0.015574,0.2463,0.21943,1,1
3,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0022332,0.24555,0.21421,1,1
3,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.0066042,0.24493,0.19261,1,1
3,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.0022332,0.24364,0.23682,1,1
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.0047853,0.24321,0.20474,1,1
3,GO NOREPINEPHRINE TRANSPORT,0.0021689,0.24248,0.20411,1,1
3,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.00079435,0.23776,0.19158,1,1
3,GO INHIBITORY SYNAPSE ASSEMBLY,0.001228,0.23725,0.42057,1,1
3,GO ASSOCIATIVE LEARNING,5.2139e-05,0.23591,0.24356,1,1
3,GO ONE CARBON COMPOUND TRANSPORT,0.020205,0.23556,0.15196,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0060989,0.23513,0.18145,1,1
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00026903,0.23406,0.20807,1,1
3,GO FOREBRAIN REGIONALIZATION,0.016339,0.23337,0.24722,1,1
3,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.00026903,0.23286,0.2258,1,1
3,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.037747,0.23278,0.22524,1,1
3,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.0094949,0.23246,0.20721,1,1
3,GO TRNA WOBBLE URIDINE MODIFICATION,0.0039469,0.2296,0.2025,1,1
3,GO SNORNA 3 END PROCESSING,0.00098941,0.22817,0.34461,1,1
3,GO TRNA MODIFICATION,0.00019079,0.22811,0.22381,1,1
3,GO RRNA TRANSCRIPTION,0.00054072,0.22764,0.21113,1,1
3,GO REGULATION OF CYCLASE ACTIVITY,6.2786e-05,0.22515,0.25885,1,1
3,GO VIRAL GENE EXPRESSION,0.011904,0.22434,0.20572,1,1
3,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.0028141,0.22387,0.20694,1,1
3,GO TRNA METHYLATION,0.0022992,0.22314,0.17565,1,1
3,GO SYNAPTIC VESICLE DOCKING,0.023741,0.22255,0.26474,1,1
3,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.0057817,0.22244,0.24928,1,1
3,GO RESPONSE TO INTERLEUKIN 7,0.00019753,0.22077,0.19118,1,1
3,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0031536,0.22073,0.17238,1,1
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0033369,0.22015,0.19904,1,1
3,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.0026572,0.21849,0.17044,1,1
3,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,8.7323e-05,0.21784,0.23145,1,1
3,GO AROMATIC AMINO ACID TRANSPORT,0.004408,0.21751,0.34059,1,1
3,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.0028141,0.21551,0.28893,1,1
3,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.00087311,0.21531,0.21643,1,1
3,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0073363,0.21512,0.19907,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.00024286,0.21398,0.23165,1,1
3,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.0083534,0.21394,0.15885,1,1
3,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.011612,0.21373,0.23113,1,1
3,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0097392,0.21356,0.18451,1,1
3,GO REGULATION OF RNA BINDING,0.00035231,0.21323,0.24793,1,1
3,GO TUBULIN DEACETYLATION,0.014841,0.2129,0.1902,1,1
3,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.017969,0.21275,0.19516,1,1
3,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.00045924,0.21256,0.19071,1,1
3,GO PROTEIN TARGETING TO MITOCHONDRION,0.0006154,0.21208,0.1453,1,1
3,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.0045306,0.21,0.19261,1,1
3,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0015189,0.20967,0.16934,1,1
3,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0075304,0.20888,0.1496,1,1
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0024367,0.20799,0.17967,1,1
3,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.045624,0.20758,0.15517,1,1
3,GO OXIDATIVE PHOSPHORYLATION,0.0031536,0.20716,0.16271,1,1
3,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.010506,0.20713,0.17369,1,1
3,GO POSITIVE REGULATION OF HEART GROWTH,0.0071468,0.20653,0.178,1,1
3,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.00035231,0.20626,0.23644,1,1
3,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.00059588,0.20539,0.29311,1,1
3,GO URONIC ACID METABOLIC PROCESS,0.00055855,0.20522,0.1716,1,1
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.016734,0.20408,0.20365,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0017641,0.20349,0.19653,1,1
3,GO TELOMERIC LOOP DISASSEMBLY,0.001191,0.20346,0.2066,1,1
3,GO AMINO ACID TRANSMEMBRANE TRANSPORT,6.0504e-05,0.2032,0.21928,1,1
3,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.00012074,0.20188,0.20711,1,1
3,GO CRANIAL NERVE MORPHOGENESIS,0.033894,0.20162,0.20302,1,1
3,GO TRANSLATIONAL TERMINATION,0.0039469,0.20079,0.19092,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0034322,0.20069,0.15221,1,1
3,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.036948,0.19936,0.20169,1,1
3,GO FEAR RESPONSE,0.0097392,0.19857,0.16602,1,1
3,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.00050664,0.19822,0.19569,1,1
3,GO NCRNA PROCESSING,0.0012662,0.19782,0.18397,1,1
3,GO GLUCOSE CATABOLIC PROCESS,0.011612,0.19776,0.2154,1,1
3,GO SNORNA METABOLIC PROCESS,0.0031536,0.1972,0.30796,1,1
3,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.0049174,0.19691,0.19162,1,1
3,GO HISTONE ARGININE METHYLATION,0.00067758,0.1969,0.2115,1,1
3,GO IRON COORDINATION ENTITY TRANSPORT,0.0062634,0.19677,0.19911,1,1
3,GO AMINO ACID IMPORT,0.0041716,0.19661,0.18047,1,1
3,GO POSITIVE REGULATION OF MRNA PROCESSING,2.6902e-06,0.19536,0.20291,1,1
3,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.00028792,0.19524,0.23795,1,1
3,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.014841,0.19511,0.13259,1,1
3,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.0060989,0.19511,0.20831,1,1
3,GO RESPONSE TO PROSTAGLANDIN E,0.052669,0.1941,0.096069,1,1
3,GO AEROBIC RESPIRATION,0.0016129,0.1938,0.17211,1,1
3,GO RNA POLYADENYLATION,0.00042998,0.19367,0.14716,1,1
3,GO CELLULAR ANION HOMEOSTASIS,0.044685,0.19324,0.18555,1,1
3,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.017969,0.1928,0.15027,1,1
3,GO MRNA MODIFICATION,0.0007696,0.19273,0.23559,1,1
3,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.0018173,0.19214,0.17905,1,1
3,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.001191,0.19124,0.22808,1,1
3,GO PLASMA MEMBRANE TUBULATION,0.011326,0.19059,0.15792,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.0060989,0.1887,0.20607,1,1
3,GO MEMBRANE DISASSEMBLY,0.026586,0.1872,0.12351,1,1
3,GO REGULATION OF TRANSLATIONAL ELONGATION,0.0028141,0.18641,0.16102,1,1
3,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.0039469,0.18635,0.20534,1,1
3,GO CRISTAE FORMATION,0.010773,0.18633,0.19498,1,1
3,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.001228,0.18625,0.18231,1,1
3,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0069616,0.18464,0.14181,1,1
3,GO NEGATIVE REGULATION OF BEHAVIOR,0.0056288,0.18358,0.23025,1,1
3,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.05161,0.1833,0.11631,1,1
3,GO PEPTIDYL ARGININE METHYLATION,0.00032948,0.18283,0.21665,1,1
3,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.001191,0.18234,0.20343,1,1
3,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.0049174,0.18212,0.1579,1,1
3,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.007729,0.18164,0.17887,1,1
3,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.0007696,0.17987,0.13438,1,1
3,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.0022992,0.17916,0.17914,1,1
3,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.01282,0.17876,0.14442,1,1
3,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,7.547e-05,0.17796,0.2271,1,1
3,GO PYRUVATE METABOLIC PROCESS,0.0045306,0.17695,0.12067,1,1
3,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0075304,0.17618,0.15109,1,1
3,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.0034322,0.17482,0.21853,1,1
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.0023671,0.17411,0.13803,1,1
3,GO CELLULAR RESPIRATION,0.0041716,0.17387,0.14646,1,1
3,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.0073363,0.17338,0.14406,1,1
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.010245,0.17319,0.13409,1,1
3,GO HISTONE MRNA METABOLIC PROCESS,0.00027832,0.17269,0.15609,1,1
3,GO EXCRETION,0.0056288,0.17257,0.13673,1,1
3,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.0010859,0.17212,0.20056,1,1
3,GO CELLULAR RESPONSE TO HEAT,0.0013457,0.17064,0.12044,1,1
3,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.043763,0.17035,0.16556,1,1
3,GO L AMINO ACID TRANSPORT,0.00063551,0.17017,0.19111,1,1
3,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.0067808,0.17,0.1241,1,1
3,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00023468,0.16976,0.15496,1,1
3,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.0013457,0.16916,0.2218,1,1
3,GO HISTONE H3 K9 DEMETHYLATION,0.0083534,0.16904,0.19259,1,1
3,GO TRNA PROCESSING,0.00090094,0.16875,0.17937,1,1
3,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.036948,0.16846,0.17184,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.010506,0.16785,0.18837,1,1
3,GO HIPPOCAMPUS DEVELOPMENT,0.0054795,0.16721,0.20077,1,1
3,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.0064317,0.16709,0.21801,1,1
3,GO REGULATION OF SPINDLE CHECKPOINT,0.00092958,0.1669,0.14928,1,1
3,GO RRNA METHYLATION,0.0081404,0.16645,0.18496,1,1
3,GO FOLIC ACID METABOLIC PROCESS,0.041967,0.16632,0.17031,1,1
3,GO CARBOHYDRATE PHOSPHORYLATION,0.012203,0.16623,0.14042,1,1
3,GO STRIATUM DEVELOPMENT,0.016339,0.16617,0.18751,1,1
3,GO MITOCHONDRIAL TRANSLATION,0.0042883,0.16381,0.19525,1,1
3,GO MITOCHONDRIAL PROTEIN PROCESSING,0.01282,0.16366,0.17074,1,1
3,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.041093,0.16341,0.1333,1,1
3,GO MITOCHONDRIAL GENE EXPRESSION,0.0046564,0.16254,0.19159,1,1
3,GO REGULATION OF RECEPTOR INTERNALIZATION,0.014486,0.16219,0.099699,1,1
3,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.010506,0.16121,0.17084,1,1
3,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.011047,0.1597,0.20058,1,1
3,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.0029794,0.15835,0.14723,1,1
3,GO NUCLEAR PORE ORGANIZATION,0.041093,0.15717,0.11028,1,1
3,GO MITOTIC DNA REPLICATION CHECKPOINT,0.010506,0.15666,0.14296,1,1
3,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.046579,0.15659,0.12563,1,1
3,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.029068,0.15409,0.1588,1,1
3,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.012203,0.15294,0.16955,1,1
3,GO PROTEIN DEMETHYLATION,0.037747,0.15217,0.11321,1,1
3,GO MRNA METHYLATION,0.01282,0.15177,0.19339,1,1
3,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.011326,0.15121,0.21752,1,1
3,GO RNA SURVEILLANCE,0.033894,0.1503,0.12882,1,1
3,GO REGULATION OF ENDOCYTIC RECYCLING,0.02268,0.14991,0.1987,1,1
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.014486,0.14824,0.12566,1,1
3,GO NCRNA METABOLIC PROCESS,0.0029794,0.14765,0.15371,1,1
3,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.041093,0.1475,0.12282,1,1
3,GO CEREBELLAR CORTEX DEVELOPMENT,0.0046564,0.14683,0.19829,1,1
3,GO REGULATION OF TRANSLATIONAL INITIATION,0.00069957,0.1464,0.12066,1,1
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.015574,0.14537,0.10928,1,1
3,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.035393,0.14524,0.11023,1,1
3,GO PROTEIN TARGETING,0.007729,0.14409,0.10904,1,1
3,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.00026003,0.14301,0.15939,1,1
3,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,7.013e-05,0.14268,0.18832,1,1
3,GO PEPTIDE BIOSYNTHETIC PROCESS,0.0054795,0.14261,0.13749,1,1
3,GO PROTEIN DENEDDYLATION,0.033166,0.14066,0.13452,1,1
3,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.031059,0.1397,0.13311,1,1
3,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.0053338,0.13936,0.16664,1,1
3,GO PROTEIN HETEROOLIGOMERIZATION,0.0020453,0.13918,0.15842,1,1
3,GO RNA CATABOLIC PROCESS,0.012203,0.13892,0.11055,1,1
3,GO DNA REPLICATION INITIATION,0.0018173,0.13857,0.14311,1,1
3,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.00047456,0.13806,0.24592,1,1
3,GO REPLICATION FORK PROCESSING,0.0040578,0.13801,0.13472,1,1
3,GO REGULATION OF MITOCHONDRIAL FISSION,0.03245,0.13664,0.1133,1,1
3,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0042883,0.13658,0.11355,1,1
3,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0011549,0.13652,0.13207,1,1
3,GO REGULATION OF MRNA POLYADENYLATION,0.0014738,0.13645,0.12815,1,1
3,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0026572,0.13383,0.1528,1,1
3,GO ARTERY DEVELOPMENT,0.049546,0.13343,0.062324,1,1
3,GO REGULATION OF CELL CYCLE ARREST,0.011047,0.13304,0.088991,1,1
3,GO RNA METHYLATION,0.0039469,0.1329,0.13947,1,1
3,GO DNA REPLICATION CHECKPOINT,0.0041716,0.13282,0.1289,1,1
3,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.01282,0.13277,0.23479,1,1
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.004408,0.13276,0.139,1,1
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0016129,0.1315,0.11326,1,1
3,GO AMINO ACID TRANSPORT,0.00016595,0.13054,0.1682,1,1
3,GO POSITIVE REGULATION OF TRANSLATION,0.0090226,0.13023,0.11092,1,1
3,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.0010206,0.12938,0.11393,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.019739,0.12764,0.15135,1,1
3,GO RESPONSE TO AMPHETAMINE,0.045624,0.1275,0.13089,1,1
3,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.01282,0.12653,0.14995,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.0056288,0.12485,0.12084,1,1
3,GO TRNA TRANSPORT,0.007729,0.12413,0.1308,1,1
3,GO NUCLEOTIDE PHOSPHORYLATION,0.0047853,0.12371,0.12014,1,1
3,GO ATP METABOLIC PROCESS,0.0024367,0.12365,0.10989,1,1
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.02268,0.12358,0.10602,1,1
3,GO REGULATION OF MRNA PROCESSING,0.001228,0.12321,0.10397,1,1
3,GO BASE EXCISION REPAIR,0.017549,0.12253,0.087776,1,1
3,GO MATING,0.033166,0.12237,0.091484,1,1
3,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.02843,0.12167,0.10248,1,1
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.0039469,0.12166,0.10347,1,1
3,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.029719,0.12095,0.11361,1,1
3,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0075304,0.12071,0.11613,1,1
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.042857,0.11906,0.073813,1,1
3,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.014138,0.11894,0.08456,1,1
3,GO REGULATION OF TELOMERE MAINTENANCE,0.0046564,0.1189,0.11692,1,1
3,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.03939,0.11847,0.11502,1,1
3,GO AMIDE BIOSYNTHETIC PROCESS,0.0087944,0.11847,0.11837,1,1
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0050528,0.11797,0.10938,1,1
3,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.014486,0.11788,0.11892,1,1
3,GO NCRNA EXPORT FROM NUCLEUS,0.033166,0.11753,0.11239,1,1
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.024846,0.11601,0.12444,1,1
3,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.007729,0.11555,0.076652,1,1
3,GO PROTEIN TETRAMERIZATION,0.00059588,0.11506,0.13276,1,1
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0099891,0.11483,0.10236,1,1
3,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.0013054,0.1146,0.172,1,1
3,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.046579,0.1143,0.11196,1,1
3,GO NCRNA 3 END PROCESSING,0.01282,0.11383,0.095253,1,1
3,GO IMPORT ACROSS PLASMA MEMBRANE,0.001986,0.11376,0.13349,1,1
3,GO MUSCLE ORGAN MORPHOGENESIS,0.031059,0.11238,0.095715,1,1
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.029068,0.11227,0.098242,1,1
3,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.022165,0.11169,0.12288,1,1
3,GO CELLULAR RESPONSE TO DRUG,0.0085714,0.11156,0.12578,1,1
3,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.033166,0.1105,0.076747,1,1
3,GO TELENCEPHALON DEVELOPMENT,0.0028141,0.11012,0.13391,1,1
3,GO SPERMATID NUCLEUS DIFFERENTIATION,0.036948,0.10884,0.10272,1,1
3,GO RNA 3 END PROCESSING,0.0064317,0.10664,0.082163,1,1
3,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0050528,0.10659,0.091621,1,1
3,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.023741,0.10627,0.11456,1,1
3,GO MRNA 3 END PROCESSING,0.0075304,0.10424,0.078822,1,1
3,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.018398,0.10337,0.13184,1,1
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.016734,0.1032,0.091181,1,1
3,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.034637,0.10317,0.086476,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.02843,0.10275,0.079815,1,1
3,GO REGULATION OF CELL CYCLE CHECKPOINT,0.0037331,0.10232,0.09644,1,1
3,GO LEUKOCYTE TETHERING OR ROLLING,0.009256,0.1022,0.12556,1,1
3,GO TELOMERE ORGANIZATION,0.0059384,0.1018,0.092471,1,1
3,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.047551,0.10107,0.0937,1,1
3,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.024288,0.099497,0.10904,1,1
3,GO MRNA METABOLIC PROCESS,0.0014299,0.099475,0.10604,1,1
3,GO TRANSCRIPTION BY RNA POLYMERASE I,0.017969,0.098288,0.11512,1,1
3,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.024846,0.097809,0.086502,1,1
3,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.004408,0.096457,0.12148,1,1
3,GO RNA PROCESSING,0.00044439,0.096204,0.11772,1,1
3,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.001986,0.096203,0.10604,1,1
3,GO INTERSTRAND CROSS LINK REPAIR,0.0028141,0.095757,0.09109,1,1
3,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.044685,0.095589,0.080866,1,1
3,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.02268,0.093868,0.12209,1,1
3,GO NCRNA TRANSCRIPTION,0.0025083,0.093842,0.09324,1,1
3,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.024846,0.091317,0.082704,1,1
3,GO TRANSCRIPTION BY RNA POLYMERASE III,0.0094949,0.090542,0.090551,1,1
3,GO PHOSPHATE ION TRANSPORT,0.02166,0.089491,0.090965,1,1
3,GO PROTEIN HOMOOLIGOMERIZATION,0.0022992,0.089404,0.10202,1,1
3,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.037747,0.087362,0.086978,1,1
3,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.0012662,0.08686,0.10335,1,1
3,GO RNA LOCALIZATION,0.0079323,0.084538,0.089299,1,1
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.025994,0.082868,0.082697,1,1
3,GO PROTEIN HETEROTETRAMERIZATION,0.0050528,0.082708,0.13026,1,1
3,GO POSITIVE REGULATION OF RNA SPLICING,0.044685,0.081949,0.065575,1,1
3,GO MRNA PROCESSING,0.0010859,0.07968,0.091229,1,1
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.016339,0.07527,0.067584,1,1
3,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.0056288,0.074586,0.08917,1,1
3,GO RNA SPLICING,0.0023671,0.072933,0.085108,1,1
3,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.037747,0.069404,0.071298,1,1
3,GO REGULATION OF MRNA METABOLIC PROCESS,0.02068,0.061768,0.062723,1,1
3,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.037747,0.053063,0.05135,1,1
3,GO CARDIAC VENTRICLE MORPHOGENESIS,0.036164,0.048604,0.11244,1,1
3,GO METHYLATION,0.033166,0.032322,0.058393,1,1
3,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.00081984,0.49751,0.48283,1,0
3,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.0027346,0.38146,0.25967,1,0
3,GO CHAPERONE MEDIATED AUTOPHAGY,0.0081404,0.35604,0.31425,1,0
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.013798,0.32666,0.44768,1,0
3,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.0073363,0.30895,0.2251,1,0
3,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.01282,0.30544,0.21362,1,0
3,GO REGULATION OF METANEPHROS DEVELOPMENT,0.037747,0.30237,0.18672,1,0
3,GO PHAGOCYTOSIS RECOGNITION,0.052669,0.29655,0.16095,1,0
3,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.013465,0.29312,0.23126,1,0
3,GO BONE TRABECULA FORMATION,0.016339,0.29217,0.28867,1,0
3,GO COLLAGEN BIOSYNTHETIC PROCESS,0.03245,0.26305,0.1703,1,0
3,GO GTP METABOLIC PROCESS,0.0021689,0.26286,0.23585,1,0
3,GO COLLAGEN METABOLIC PROCESS,0.020205,0.24009,0.14035,1,0
3,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.025994,0.23302,0.20211,1,0
3,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.0026572,0.23251,0.2819,1,0
3,GO POLYOL TRANSPORT,0.0079323,0.23114,0.18719,1,0
3,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.03939,0.22828,0.26749,1,0
3,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.0016129,0.22746,0.18799,1,0
3,GO LATERAL VENTRICLE DEVELOPMENT,0.0083534,0.22406,0.22513,1,0
3,GO HISTONE SERINE PHOSPHORYLATION,0.0037331,0.21351,0.17163,1,0
3,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.031059,0.20867,0.18668,1,0
3,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.019283,0.20829,0.13889,1,0
3,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.047551,0.19713,0.17411,1,0
3,GO CELLULAR COPPER ION HOMEOSTASIS,0.014486,0.19694,0.17506,1,0
3,GO CORONARY VASCULATURE MORPHOGENESIS,0.015203,0.19653,0.20902,1,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0016129,0.18413,0.17665,1,0
3,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.013798,0.18278,0.18877,1,0
3,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.0045306,0.18258,0.17858,1,0
3,GO CORONARY VASCULATURE DEVELOPMENT,0.013798,0.18198,0.12879,1,0
3,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.011904,0.18024,0.16927,1,0
3,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.045624,0.17967,0.12845,1,0
3,GO ALDITOL METABOLIC PROCESS,0.0056288,0.17726,0.17885,1,0
3,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0030654,0.17692,0.23384,1,0
3,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.02166,0.1762,0.13534,1,0
3,GO POSITIVE REGULATION OF HEART RATE,0.040234,0.16813,0.18861,1,0
3,GO DENDRITIC TRANSPORT,0.010506,0.16695,0.24093,1,0
3,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.0041716,0.16648,0.13209,1,0
3,GO FATTY ACID HOMEOSTASIS,0.044685,0.16644,0.20355,1,0
3,GO REGULATION OF TRANSLATIONAL TERMINATION,0.010506,0.16562,0.19049,1,0
3,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.0079323,0.16511,0.13868,1,0
3,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.041967,0.16069,0.13783,1,0
3,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.0059384,0.16057,0.19391,1,0
3,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.042857,0.15679,0.097057,1,0
3,GO COPPER ION HOMEOSTASIS,0.024846,0.15663,0.14424,1,0
3,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.02068,0.15485,0.11071,1,0
3,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.015203,0.15295,0.097831,1,0
3,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.042857,0.15178,0.12137,1,0
3,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.0069616,0.14894,0.15764,1,0
3,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.043763,0.14864,0.13656,1,0
3,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0026572,0.14459,0.15038,1,0
3,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.007729,0.14423,0.10342,1,0
3,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.04854,0.13973,0.12553,1,0
3,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.036164,0.13815,0.12703,1,0
3,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.041093,0.13814,0.09988,1,0
3,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0094949,0.13631,0.16419,1,0
3,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.043763,0.13544,0.12947,1,0
3,GO LIVER REGENERATION,0.040234,0.13541,0.077176,1,0
3,GO MODULATION BY HOST OF VIRAL PROCESS,0.0087944,0.13195,0.11512,1,0
3,GO MRNA SPLICE SITE SELECTION,0.042857,0.123,0.13568,1,0
3,GO PROTEOGLYCAN METABOLIC PROCESS,0.041093,0.12291,0.091021,1,0
3,GO GLUTAMINE METABOLIC PROCESS,0.0031536,0.12242,0.15681,1,0
3,GO PEPTIDE METABOLIC PROCESS,0.024846,0.11942,0.091635,1,0
3,GO MAINTENANCE OF PROTEIN LOCATION,0.015574,0.11796,0.081204,1,0
3,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.026586,0.11785,0.1383,1,0
3,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.041967,0.11561,0.11825,1,0
3,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.052669,0.11532,0.078129,1,0
3,GO RNA 5 END PROCESSING,0.035393,0.11506,0.12281,1,0
3,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.043763,0.1138,0.13072,1,0
3,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.015574,0.11325,0.13457,1,0
3,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.03245,0.11289,0.1031,1,0
3,GO CELLULAR GLUCOSE HOMEOSTASIS,0.0047853,0.11257,0.11194,1,0
3,GO NUCLEOBASE METABOLIC PROCESS,0.0037331,0.11212,0.17851,1,0
3,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.036948,0.11156,0.096039,1,0
3,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.016734,0.11143,0.084827,1,0
3,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0069616,0.11107,0.10628,1,0
3,GO TRNA METABOLIC PROCESS,0.0034322,0.10892,0.14407,1,0
3,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0094949,0.10875,0.096243,1,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.009256,0.1067,0.12313,1,0
3,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.029068,0.10605,0.11104,1,0
3,GO CELLULAR IRON ION HOMEOSTASIS,0.015953,0.10552,0.11118,1,0
3,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.031059,0.10453,0.11387,1,0
3,GO MITOTIC RECOMBINATION,0.03939,0.10239,0.12336,1,0
3,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.024846,0.099707,0.083464,1,0
3,GO METAL ION TRANSPORT,0.031059,0.098552,0.068972,1,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.015953,0.09826,0.081023,1,0
3,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.029068,0.097005,0.08091,1,0
3,GO CATION TRANSMEMBRANE TRANSPORT,0.020205,0.095754,0.083423,1,0
3,GO RNA MODIFICATION,0.0075304,0.09438,0.12402,1,0
3,GO SODIUM ION TRANSPORT,0.04854,0.090093,0.07834,1,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.017137,0.089889,0.14576,1,0
3,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.04854,0.089731,0.099952,1,0
3,GO RESPONSE TO CALCIUM ION,0.050569,0.088902,0.089481,1,0
3,GO RESPONSE TO HEAT,0.017969,0.088863,0.079789,1,0
3,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.010245,0.088589,0.06583,1,0
3,GO PIGMENT BIOSYNTHETIC PROCESS,0.033166,0.088546,0.11543,1,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.033894,0.086043,0.089639,1,0
3,GO LACTATION,0.036948,0.081867,0.11724,1,0
3,GO CELL CYCLE DNA REPLICATION,0.044685,0.07298,0.079722,1,0
3,GO NUCLEAR EXPORT,0.024846,0.070434,0.06326,1,0
3,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.047551,0.068477,0.092842,1,0
3,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.024846,0.067091,0.096255,1,0
3,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.016734,0.063443,0.10185,1,0
3,GO RNA EXPORT FROM NUCLEUS,0.041967,0.063385,0.083155,1,0
3,GO DIVALENT INORGANIC CATION TRANSPORT,0.044685,0.060003,0.063979,1,0
3,GO NUCLEOTIDE EXCISION REPAIR,0.05161,0.059969,0.059967,1,0
3,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.045624,0.057252,0.082736,1,0
3,GO NUCLEAR TRANSPORT,0.023741,0.052646,0.053247,1,0
3,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.035393,0.052448,0.055266,1,0
3,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.041093,0.036656,0.074008,1,0
3,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.031748,0.035939,0.067457,1,0
3,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.050569,0.032713,0.064769,1,0
3,GO MITOTIC CELL CYCLE CHECKPOINT,0.049546,-0.031431,-0.054434,1,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.031059,-0.036167,-0.13545,1,0
3,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.047551,-0.037358,-0.049977,1,0
3,GO CYTOKINESIS,0.046579,-0.038365,-0.070188,1,0
3,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.049546,-0.03837,-0.055105,1,0
3,GO PEPTIDYL AMINO ACID MODIFICATION,0.049546,-0.04202,-0.041943,1,0
3,GO TISSUE MORPHOGENESIS,0.047551,-0.042047,-0.080539,1,0
3,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.004408,-0.042958,-0.071349,1,0
3,GO ORGANELLE ASSEMBLY,0.0066042,-0.045259,-0.058024,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION,0.027803,-0.046405,-0.057805,1,0
3,GO PROTEIN O LINKED GLYCOSYLATION,0.025414,-0.046584,-0.13269,1,0
3,GO METAPHASE PLATE CONGRESSION,0.014138,-0.047354,-0.09609,1,0
3,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.025994,-0.047781,-0.15593,1,0
3,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.042857,-0.048096,-0.056265,1,0
3,GO NON RECOMBINATIONAL REPAIR,0.029719,-0.049058,-0.070112,1,0
3,GO ACTIN FILAMENT BASED PROCESS,0.036948,-0.05139,-0.072544,1,0
3,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.047551,-0.052509,-0.059863,1,0
3,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.037747,-0.053669,-0.068959,1,0
3,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.014138,-0.053852,-0.15297,1,0
3,GO PHOSPHOLIPID METABOLIC PROCESS,0.037747,-0.055403,-0.066143,1,0
3,GO CYTOSKELETON ORGANIZATION,0.04854,-0.055548,-0.051262,1,0
3,GO POSITIVE REGULATION OF SIGNALING,0.033166,-0.055813,-0.065149,1,0
3,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.009256,-0.056332,-0.085675,1,0
3,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.03245,-0.056358,-0.056157,1,0
3,GO MACROAUTOPHAGY,0.0054795,-0.057538,-0.080368,1,0
3,GO REGULATION OF CELL POPULATION PROLIFERATION,0.019283,-0.057979,-0.084699,1,0
3,GO ACTIN FILAMENT ORGANIZATION,0.017549,-0.058128,-0.094691,1,0
3,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.038561,-0.058545,-0.10222,1,0
3,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.019739,-0.058587,-0.081149,1,0
3,GO SEXUAL REPRODUCTION,0.0025817,-0.059443,-0.071044,1,0
3,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.024288,-0.059497,-0.077715,1,0
3,GO ORGANELLE FISSION,0.019283,-0.060777,-0.053453,1,0
3,GO HISTONE UBIQUITINATION,0.041093,-0.061309,-0.066636,1,0
3,GO PROTEIN AUTOUBIQUITINATION,0.027188,-0.061491,-0.065572,1,0
3,GO MORPHOGENESIS OF AN EPITHELIUM,0.013139,-0.061745,-0.099152,1,0
3,GO ESTABLISHMENT OF CELL POLARITY,0.05161,-0.061757,-0.075136,1,0
3,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.03939,-0.061936,-0.17826,1,0
3,GO REGULATION OF HYDROLASE ACTIVITY,0.012203,-0.062843,-0.080199,1,0
3,GO HUMORAL IMMUNE RESPONSE,0.0013872,-0.063414,-0.13611,1,0
3,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.042857,-0.06359,-0.11612,1,0
3,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.023741,-0.063699,-0.12651,1,0
3,GO VACUOLE ORGANIZATION,0.049546,-0.063873,-0.080909,1,0
3,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.0067808,-0.064341,-0.1042,1,0
3,GO CELL MOTILITY,0.036948,-0.064481,-0.079393,1,0
3,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.024288,-0.065264,-0.08581,1,0
3,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.042857,-0.065369,-0.13007,1,0
3,GO TUBE MORPHOGENESIS,0.041093,-0.06564,-0.099175,1,0
3,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.033894,-0.065921,-0.067849,1,0
3,GO LEUKOCYTE DIFFERENTIATION,0.011047,-0.066015,-0.10214,1,0
3,GO SECRETION,0.012508,-0.067035,-0.08332,1,0
3,GO REGULATION OF ACTIN FILAMENT LENGTH,0.03245,-0.067433,-0.079096,1,0
3,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.026586,-0.06747,-0.092176,1,0
3,GO GLYCEROLIPID METABOLIC PROCESS,0.024846,-0.067811,-0.070702,1,0
3,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.030383,-0.067849,-0.11162,1,0
3,GO TUBE DEVELOPMENT,0.033894,-0.069626,-0.094207,1,0
3,GO MUSCLE ADAPTATION,0.05161,-0.070042,-0.090495,1,0
3,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0079323,-0.070156,-0.080998,1,0
3,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.04854,-0.07016,-0.070453,1,0
3,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.001872,-0.070793,-0.12646,1,0
3,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.02166,-0.071389,-0.099685,1,0
3,GO REGULATION OF MEIOTIC CELL CYCLE,0.025994,-0.071424,-0.085065,1,0
3,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.014138,-0.071536,-0.11367,1,0
3,GO MULTICELLULAR ORGANISM REPRODUCTION,0.0038387,-0.072065,-0.074907,1,0
3,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.03245,-0.072305,-0.11245,1,0
3,GO LYMPHOCYTE ACTIVATION,0.0075304,-0.072443,-0.11104,1,0
3,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.0085714,-0.072665,-0.087308,1,0
3,GO MULTI ORGANISM PROCESS,0.009256,-0.074202,-0.06881,1,0
3,GO PEPTIDE SECRETION,0.025414,-0.074792,-0.08505,1,0
3,GO NEGATIVE T CELL SELECTION,0.0027346,-0.075183,-0.16075,1,0
3,GO REGULATION OF RESPONSE TO STRESS,0.0064317,-0.075297,-0.092052,1,0
3,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.038561,-0.076032,-0.079738,1,0
3,GO REGULATION OF PEPTIDE TRANSPORT,0.0097392,-0.07785,-0.076389,1,0
3,GO IN UTERO EMBRYONIC DEVELOPMENT,0.011326,-0.077982,-0.078376,1,0
3,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.041967,-0.078097,-0.11692,1,0
3,GO POSITIVE REGULATION OF SECRETION,0.031748,-0.078364,-0.079138,1,0
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.03245,-0.078499,-0.10286,1,0
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0039469,-0.078562,-0.08408,1,0
3,GO EXOCYTOSIS,0.011047,-0.078638,-0.10281,1,0
3,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.018836,-0.078865,-0.058864,1,0
3,GO MACROPHAGE DIFFERENTIATION,0.045624,-0.079261,-0.13395,1,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.017549,-0.079405,-0.10827,1,0
3,GO IMMUNE SYSTEM DEVELOPMENT,0.0015653,-0.079454,-0.10403,1,0
3,GO CHROMOSOME LOCALIZATION,0.0025817,-0.079572,-0.11324,1,0
3,GO DETECTION OF STIMULUS,0.0010859,-0.079666,-0.097326,1,0
3,GO PROTEIN MONOUBIQUITINATION,0.0049174,-0.079687,-0.077954,1,0
3,GO REGULATION OF ENDOCRINE PROCESS,0.049546,-0.08022,-0.12088,1,0
3,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.015574,-0.080753,-0.10773,1,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.037747,-0.080788,-0.11695,1,0
3,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.019739,-0.080956,-0.12703,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.042857,-0.081063,-0.10309,1,0
3,GO TUBE FORMATION,0.023205,-0.081475,-0.096162,1,0
3,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.0021062,-0.081483,-0.10326,1,0
3,GO REGULATION OF HEMOPOIESIS,0.010773,-0.081738,-0.105,1,0
3,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.044685,-0.081822,-0.10828,1,0
3,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.0064317,-0.08192,-0.10728,1,0
3,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.045624,-0.081921,-0.088216,1,0
3,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.016339,-0.081932,-0.096147,1,0
3,GO REGULATION OF IMMUNE RESPONSE,0.010773,-0.082422,-0.11106,1,0
3,GO VACUOLAR TRANSPORT,0.0094949,-0.082562,-0.1011,1,0
3,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.049546,-0.082713,-0.09224,1,0
3,GO FATTY ACID METABOLIC PROCESS,0.031059,-0.082955,-0.10209,1,0
3,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.038561,-0.083001,-0.11834,1,0
3,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.012508,-0.083325,-0.12337,1,0
3,GO FAT CELL DIFFERENTIATION,0.0067808,-0.083727,-0.12377,1,0
3,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.014486,-0.084075,-0.1136,1,0
3,GO MAST CELL MEDIATED IMMUNITY,0.019739,-0.084268,-0.18989,1,0
3,GO GLUCOSE METABOLIC PROCESS,0.044685,-0.084349,-0.067101,1,0
3,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0075304,-0.084664,-0.10493,1,0
3,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.035393,-0.084752,-0.069618,1,0
3,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.010773,-0.085104,-0.11029,1,0
3,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.013139,-0.085154,-0.12442,1,0
3,GO POSITIVE REGULATION OF VIRAL PROCESS,0.0056288,-0.08531,-0.10888,1,0
3,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.011904,-0.08548,-0.080851,1,0
3,GO RESPONSE TO ANTIBIOTIC,0.037747,-0.085625,-0.11302,1,0
3,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.04854,-0.085844,-0.10889,1,0
3,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.011047,-0.085863,-0.17353,1,0
3,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.050569,-0.086101,-0.12924,1,0
3,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.0094949,-0.086271,-0.12897,1,0
3,GO REGULATION OF PROTEOLYSIS,0.0057817,-0.086679,-0.112,1,0
3,GO GOLGI TO VACUOLE TRANSPORT,0.014486,-0.086788,-0.13458,1,0
3,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.041967,-0.08685,-0.069253,1,0
3,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.009256,-0.087266,-0.095113,1,0
3,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.013798,-0.087488,-0.13861,1,0
3,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.036948,-0.08754,-0.090013,1,0
3,GO HOMEOSTASIS OF NUMBER OF CELLS,0.00081984,-0.087676,-0.10881,1,0
3,GO REGULATION OF ERBB SIGNALING PATHWAY,0.033166,-0.087948,-0.13159,1,0
3,GO EMBRYONIC MORPHOGENESIS,0.012203,-0.088139,-0.10272,1,0
3,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.047551,-0.088301,-0.081081,1,0
3,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.014841,-0.088522,-0.1165,1,0
3,GO LYMPHOCYTE DIFFERENTIATION,0.0021062,-0.088558,-0.11587,1,0
3,GO CELLULAR SENESCENCE,0.017549,-0.088653,-0.11054,1,0
3,GO PROTEOLYSIS,0.00044439,-0.089362,-0.10478,1,0
3,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.04854,-0.089702,-0.075698,1,0
3,GO NATURAL KILLER CELL ACTIVATION,0.011904,-0.089745,-0.13561,1,0
3,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.043763,-0.089812,-0.09272,1,0
3,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.02268,-0.089912,-0.090142,1,0
3,GO REGULATION OF T CELL DIFFERENTIATION,0.018398,-0.090064,-0.10809,1,0
3,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.030383,-0.090119,-0.20065,1,0
3,GO ACTIVATION OF GTPASE ACTIVITY,0.0064317,-0.090415,-0.098557,1,0
3,GO REGULATION OF CELLULAR PH,0.0049174,-0.090578,-0.097889,1,0
3,GO CELL CELL ADHESION,0.004408,-0.09071,-0.12249,1,0
3,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0069616,-0.09084,-0.1134,1,0
3,GO CELLULAR PIGMENTATION,0.0036303,-0.09092,-0.13554,1,0
3,GO REGULATION OF NUCLEAR DIVISION,0.0050528,-0.091131,-0.08089,1,0
3,GO CELL MATRIX ADHESION,0.038561,-0.091166,-0.1199,1,0
3,GO REGULATION OF PH,0.0062634,-0.091444,-0.094954,1,0
3,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.02268,-0.091575,-0.10198,1,0
3,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.010245,-0.091642,-0.12579,1,0
3,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.030383,-0.091662,-0.14272,1,0
3,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.016339,-0.092052,-0.097263,1,0
3,GO MALE SEX DIFFERENTIATION,0.0069616,-0.092178,-0.10836,1,0
3,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.012508,-0.092218,-0.10432,1,0
3,GO RESPONSE TO GAMMA RADIATION,0.036948,-0.092257,-0.093986,1,0
3,GO GLAND DEVELOPMENT,0.013139,-0.092267,-0.099714,1,0
3,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0099891,-0.092299,-0.10271,1,0
3,GO ERBB SIGNALING PATHWAY,0.02843,-0.092544,-0.11082,1,0
3,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.012203,-0.092747,-0.12479,1,0
3,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.0028957,-0.092966,-0.091004,1,0
3,GO PROTEIN MATURATION,0.015574,-0.092989,-0.10116,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.017137,-0.093242,-0.1859,1,0
3,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.019739,-0.093259,-0.14598,1,0
3,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.018836,-0.093434,-0.18171,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0024367,-0.093456,-0.1471,1,0
3,GO LIPID LOCALIZATION,0.0079323,-0.09371,-0.11778,1,0
3,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.017969,-0.093974,-0.093809,1,0
3,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.0042883,-0.09409,-0.12622,1,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.013798,-0.094359,-0.11699,1,0
3,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.04854,-0.094558,-0.099281,1,0
3,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.010245,-0.094843,-0.12706,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0025083,-0.094888,-0.15669,1,0
3,GO PEPTIDYL ASPARAGINE MODIFICATION,0.02268,-0.095105,-0.13525,1,0
3,GO RESPONSE TO ALCOHOL,0.044685,-0.095276,-0.077525,1,0
3,GO GOLGI VESICLE BUDDING,0.0081404,-0.095367,-0.11661,1,0
3,GO ACTIVATION OF IMMUNE RESPONSE,0.0097392,-0.095573,-0.10692,1,0
3,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.0013872,-0.095585,-0.121,1,0
3,GO POSTREPLICATION REPAIR,0.011904,-0.096376,-0.08894,1,0
3,GO COPII COATED VESICLE BUDDING,0.0053338,-0.096385,-0.11379,1,0
3,GO RESPONSE TO BMP,0.042857,-0.096422,-0.11419,1,0
3,GO REGULATION OF SPROUTING ANGIOGENESIS,0.052669,-0.096441,-0.12145,1,0
3,GO REGULATION OF BODY FLUID LEVELS,0.0010859,-0.096588,-0.1364,1,0
3,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.038561,-0.09677,-0.13006,1,0
3,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.03939,-0.096774,-0.14335,1,0
3,GO GOLGI ORGANIZATION,0.0025083,-0.097875,-0.11643,1,0
3,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.015574,-0.098282,-0.13644,1,0
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.027803,-0.098302,-0.10269,1,0
3,GO LIPOSACCHARIDE METABOLIC PROCESS,0.050569,-0.098544,-0.10396,1,0
3,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.001986,-0.098769,-0.11462,1,0
3,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.017549,-0.098956,-0.093767,1,0
3,GO ORGANELLE DISASSEMBLY,0.0087944,-0.099028,-0.092583,1,0
3,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.023205,-0.099219,-0.1092,1,0
3,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.0069616,-0.099376,-0.12092,1,0
3,GO COAGULATION,0.0051916,-0.099857,-0.13878,1,0
3,GO REGULATION OF INNATE IMMUNE RESPONSE,0.009256,-0.099859,-0.13181,1,0
3,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00044439,-0.099918,-0.12903,1,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.022165,-0.099988,-0.15007,1,0
3,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.010773,-0.099989,-0.13459,1,0
3,GO APOPTOTIC SIGNALING PATHWAY,0.0041716,-0.10043,-0.1099,1,0
3,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.022165,-0.1009,-0.15697,1,0
3,GO ERAD PATHWAY,0.010506,-0.10131,-0.11486,1,0
3,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.011904,-0.10153,-0.12119,1,0
3,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.00054072,-0.10187,-0.1406,1,0
3,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.0060989,-0.10191,-0.14091,1,0
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.0013054,-0.10192,-0.14426,1,0
3,GO RESPONSE TO XENOBIOTIC STIMULUS,0.014486,-0.10213,-0.14414,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.045624,-0.10218,-0.10611,1,0
3,GO REGULATION OF CELL ADHESION,0.0026572,-0.10247,-0.1538,1,0
3,GO REGULATION OF CELL ACTIVATION,0.0022992,-0.10248,-0.13089,1,0
3,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.0023671,-0.10265,-0.10487,1,0
3,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.015574,-0.10293,-0.1546,1,0
3,GO ENDOCYTIC RECYCLING,0.0020453,-0.10297,-0.1284,1,0
3,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.0053338,-0.10314,-0.1281,1,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0085714,-0.10358,-0.137,1,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00092958,-0.10358,-0.14937,1,0
3,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.0025083,-0.10375,-0.13773,1,0
3,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00092958,-0.10393,-0.11064,1,0
3,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.026586,-0.10435,-0.085846,1,0
3,GO PH REDUCTION,0.0021689,-0.10437,-0.14997,1,0
3,GO CELL ACTIVATION,0.0027346,-0.10443,-0.13744,1,0
3,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.033166,-0.10445,-0.079391,1,0
3,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.015574,-0.10467,-0.13052,1,0
3,GO REGULATION OF CELL SUBSTRATE ADHESION,0.03245,-0.10489,-0.13769,1,0
3,GO ADAPTIVE THERMOGENESIS,0.02268,-0.10497,-0.09286,1,0
3,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.043763,-0.10516,-0.10536,1,0
3,GO REGULATION OF CENTRIOLE REPLICATION,0.0060989,-0.10518,-0.13486,1,0
3,GO HISTONE MONOUBIQUITINATION,0.00026903,-0.10577,-0.13101,1,0
3,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.02166,-0.10578,-0.18634,1,0
3,GO DIGESTIVE SYSTEM PROCESS,0.033894,-0.10582,-0.12398,1,0
3,GO T CELL DIFFERENTIATION,0.0046564,-0.10597,-0.12217,1,0
3,GO PROTEIN POLYUBIQUITINATION,7.547e-05,-0.10635,-0.12601,1,0
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0022992,-0.10682,-0.21834,1,0
3,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.038561,-0.10693,-0.11031,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.011326,-0.10731,-0.18883,1,0
3,GO RESPONSE TO OSMOTIC STRESS,0.023205,-0.10739,-0.11405,1,0
3,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.0069616,-0.10748,-0.13913,1,0
3,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.040234,-0.10761,-0.18224,1,0
3,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.033894,-0.10795,-0.1079,1,0
3,GO IMMUNOGLOBULIN PRODUCTION,0.00049035,-0.10805,-0.13497,1,0
3,GO PROTEIN KINASE B SIGNALING,0.0042883,-0.10819,-0.13353,1,0
3,GO LIPID DIGESTION,0.012508,-0.10865,-0.28191,1,0
3,GO INTERLEUKIN 17 PRODUCTION,0.030383,-0.10907,-0.14524,1,0
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.026586,-0.10914,-0.17042,1,0
3,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.025414,-0.1093,-0.17811,1,0
3,GO PEPTIDYL TYROSINE MODIFICATION,0.0037331,-0.10936,-0.13087,1,0
3,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,8.7323e-05,-0.10953,-0.14344,1,0
3,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.016734,-0.1097,-0.10881,1,0
3,GO REPRODUCTION,0.0007696,-0.10999,-0.092536,1,0
3,GO REGULATION OF PEPTIDE SECRETION,0.0083534,-0.11015,-0.099042,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.031748,-0.11072,-0.18395,1,0
3,GO VESICLE BUDDING FROM MEMBRANE,0.00087311,-0.11132,-0.14441,1,0
3,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.041093,-0.1115,-0.082264,1,0
3,GO REPLACEMENT OSSIFICATION,0.035393,-0.11165,-0.16091,1,0
3,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.00095906,-0.11176,-0.15167,1,0
3,GO RESPONSE TO BIOTIC STIMULUS,0.0023671,-0.11176,-0.13851,1,0
3,GO LYMPHOCYTE CHEMOTAXIS,0.020205,-0.11203,-0.13579,1,0
3,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.00042998,-0.11209,-0.15393,1,0
3,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.041093,-0.1121,-0.089285,1,0
3,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0071468,-0.11215,-0.088894,1,0
3,GO POSITIVE REGULATION OF CELL ACTIVATION,0.00087311,-0.11217,-0.14572,1,0
3,GO EMBRYONIC ORGAN DEVELOPMENT,0.0023671,-0.11228,-0.11441,1,0
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.00090094,-0.11244,-0.15274,1,0
3,GO HEMOGLOBIN METABOLIC PROCESS,0.010506,-0.11274,-0.16972,1,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.014486,-0.11296,-0.11908,1,0
3,GO INNATE IMMUNE RESPONSE,0.00092958,-0.11297,-0.16868,1,0
3,GO LEUKOCYTE CELL CELL ADHESION,0.001662,-0.11298,-0.15534,1,0
3,GO CARBOHYDRATE TRANSPORT,0.0067808,-0.11335,-0.10615,1,0
3,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00052342,-0.11337,-0.19464,1,0
3,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.014138,-0.11384,-0.10532,1,0
3,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.031748,-0.11388,-0.22195,1,0
3,GO REGULATION OF MEMBRANE INVAGINATION,0.044685,-0.11432,-0.19369,1,0
3,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0037331,-0.11433,-0.10729,1,0
3,GO MYELOID CELL DIFFERENTIATION,0.00025131,-0.11435,-0.12563,1,0
3,GO MITOTIC CYTOKINESIS,0.0030654,-0.11455,-0.12727,1,0
3,GO PLATELET MORPHOGENESIS,0.0051916,-0.11539,-0.20988,1,0
3,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.049546,-0.11558,-0.19466,1,0
3,GO REGULATION OF T CELL ACTIVATION,0.00087311,-0.11577,-0.14916,1,0
3,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.0019282,-0.11619,-0.11366,1,0
3,GO ANTIMICROBIAL HUMORAL RESPONSE,0.017969,-0.11697,-0.13148,1,0
3,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.0064317,-0.11699,-0.1915,1,0
3,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.02268,-0.11734,-0.11495,1,0
3,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.0036303,-0.11734,-0.21546,1,0
3,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.02166,-0.11741,-0.21897,1,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.0021689,-0.11744,-0.21493,1,0
3,GO MYOBLAST DIFFERENTIATION,0.00353,-0.1177,-0.18566,1,0
3,GO DENDRITIC CELL MIGRATION,0.03939,-0.11815,-0.17082,1,0
3,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.0042883,-0.11821,-0.15809,1,0
3,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.020205,-0.11829,-0.15136,1,0
3,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.0030654,-0.1183,-0.175,1,0
3,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.0071468,-0.11846,-0.13149,1,0
3,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00079435,-0.11849,-0.1507,1,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0046564,-0.11865,-0.10903,1,0
3,GO REGULATION OF INFLAMMATORY RESPONSE,0.00037661,-0.11881,-0.14684,1,0
3,GO LYMPHOCYTE COSTIMULATION,0.016734,-0.1192,-0.12062,1,0
3,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00012074,-0.11925,-0.16242,1,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.014138,-0.11938,-0.17878,1,0
3,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.00057693,-0.1198,-0.17694,1,0
3,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.0062634,-0.12015,-0.103,1,0
3,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00065623,-0.12034,-0.1434,1,0
3,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.049546,-0.12065,-0.13147,1,0
3,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.036948,-0.12079,-0.19372,1,0
3,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.036948,-0.12122,-0.16682,1,0
3,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.038561,-0.12132,-0.16502,1,0
3,GO DIGESTION,0.0037331,-0.12135,-0.15953,1,0
3,GO NOTCH SIGNALING PATHWAY,0.0041716,-0.12161,-0.12592,1,0
3,GO T CELL ACTIVATION,0.00084609,-0.1218,-0.15324,1,0
3,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.010245,-0.12181,-0.091078,1,0
3,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.027188,-0.12199,-0.11447,1,0
3,GO RESPONSE TO WOUNDING,0.0097392,-0.12206,-0.13851,1,0
3,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.043763,-0.12209,-0.13789,1,0
3,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.052669,-0.12216,-0.15298,1,0
3,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.036164,-0.12218,-0.12394,1,0
3,GO SPINDLE LOCALIZATION,0.001228,-0.12219,-0.14155,1,0
3,GO RESPONSE TO BACTERIUM,0.011612,-0.12235,-0.12854,1,0
3,GO PROTEIN DESTABILIZATION,0.0045306,-0.1224,-0.12012,1,0
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.036164,-0.12245,-0.17099,1,0
3,GO TISSUE MIGRATION,0.052669,-0.12264,-0.10693,1,0
3,GO CYTOKINE PRODUCTION,0.00021167,-0.12282,-0.17499,1,0
3,GO AUTOPHAGY OF MITOCHONDRION,0.0045306,-0.1229,-0.11055,1,0
3,GO TISSUE HOMEOSTASIS,5.508e-06,-0.12321,-0.18363,1,0
3,GO EPITHELIUM DEVELOPMENT,4.6597e-05,-0.12322,-0.15616,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00014418,-0.12327,-0.15893,1,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0045306,-0.12336,-0.10713,1,0
3,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.012508,-0.12338,-0.14282,1,0
3,GO AUTOPHAGOSOME ORGANIZATION,0.00041602,-0.12341,-0.1536,1,0
3,GO BONE CELL DEVELOPMENT,0.021165,-0.12346,-0.13918,1,0
3,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.00010845,-0.12354,-0.12675,1,0
3,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.015203,-0.12356,-0.19931,1,0
3,GO REGULATION OF DEFENSE RESPONSE,0.00049035,-0.12387,-0.14928,1,0
3,GO VIRAL LATENCY,0.024288,-0.12407,-0.12119,1,0
3,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.038561,-0.12409,-0.20943,1,0
3,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.00013433,-0.12422,-0.14223,1,0
3,GO MYELOID LEUKOCYTE ACTIVATION,0.0026572,-0.12426,-0.16489,1,0
3,GO REGULATION OF ISOTYPE SWITCHING,0.0028141,-0.12432,-0.19311,1,0
3,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.0085714,-0.1248,-0.21404,1,0
3,GO TRANSLESION SYNTHESIS,0.004408,-0.12481,-0.11409,1,0
3,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.031748,-0.12484,-0.12044,1,0
3,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.04854,-0.12484,-0.15094,1,0
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0037331,-0.1252,-0.19543,1,0
3,GO ACUTE INFLAMMATORY RESPONSE,0.0064317,-0.12528,-0.19474,1,0
3,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.04854,-0.12536,-0.11375,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.042857,-0.12547,-0.24358,1,0
3,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.0014738,-0.12559,-0.16921,1,0
3,GO VESICLE TARGETING,0.0010859,-0.12596,-0.15258,1,0
3,GO DEFENSE RESPONSE,0.00067758,-0.12607,-0.14936,1,0
3,GO POLYAMINE METABOLIC PROCESS,0.05161,-0.12688,-0.10507,1,0
3,GO RESPIRATORY BURST,0.0030654,-0.12709,-0.24633,1,0
3,GO DNA DEALKYLATION,0.021165,-0.12709,-0.13663,1,0
3,GO REGULATION OF MUSCLE ADAPTATION,0.0073363,-0.12709,-0.13064,1,0
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0050528,-0.12729,-0.17163,1,0
3,GO REGULATION OF PEPTIDASE ACTIVITY,0.00024286,-0.12733,-0.1873,1,0
3,GO REGULATION OF PINOCYTOSIS,0.0049174,-0.12742,-0.21435,1,0
3,GO VIRAL LIFE CYCLE,0.0006154,-0.12754,-0.18525,1,0
3,GO INFLAMMATORY RESPONSE,0.0010528,-0.12767,-0.14813,1,0
3,GO GOLGI TO ENDOSOME TRANSPORT,0.029719,-0.1277,-0.13862,1,0
3,GO RESPONSE TO IRON ION,0.017969,-0.12784,-0.15696,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0014738,-0.12842,-0.14968,1,0
3,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.013465,-0.12854,-0.12884,1,0
3,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.01282,-0.1286,-0.17838,1,0
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00023468,-0.12895,-0.16558,1,0
3,GO WOUND HEALING,0.0054795,-0.1293,-0.15726,1,0
3,GO FIBROBLAST MIGRATION,0.007729,-0.12942,-0.17907,1,0
3,GO REGULATION OF CELL SHAPE,0.007729,-0.12957,-0.13399,1,0
3,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00084609,-0.12995,-0.18643,1,0
3,GO RESPONSE TO INTERLEUKIN 6,0.0012662,-0.13027,-0.18833,1,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00042998,-0.13033,-0.17338,1,0
3,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.024288,-0.13054,-0.14495,1,0
3,GO PHAGOSOME ACIDIFICATION,0.011047,-0.13061,-0.16997,1,0
3,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.004408,-0.13062,-0.18148,1,0
3,GO ACTIN FILAMENT DEPOLYMERIZATION,0.019739,-0.13104,-0.13652,1,0
3,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.042857,-0.13113,-0.13624,1,0
3,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.05161,-0.13174,-0.18714,1,0
3,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.00050664,-0.132,-0.16849,1,0
3,GO REGULATION OF CHEMOTAXIS,0.0025817,-0.13201,-0.13346,1,0
3,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.0083534,-0.13223,-0.22541,1,0
3,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.042857,-0.13227,-0.10183,1,0
3,GO NEURAL TUBE DEVELOPMENT,0.00079435,-0.13232,-0.14758,1,0
3,GO REGULATION OF LEUKOCYTE MIGRATION,0.013465,-0.13233,-0.11869,1,0
3,GO SENSORY PERCEPTION OF BITTER TASTE,0.00067758,-0.13237,-0.17463,1,0
3,GO HISTONE H2A UBIQUITINATION,0.0036303,-0.13238,-0.12349,1,0
3,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.052669,-0.13279,-0.10656,1,0
3,GO PEPTIDE CROSS LINKING,0.031059,-0.1329,-0.19153,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0031536,-0.1334,-0.14323,1,0
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0083534,-0.13365,-0.18128,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION,0.004408,-0.13383,-0.18717,1,0
3,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.00067758,-0.13394,-0.14216,1,0
3,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00079435,-0.13405,-0.18566,1,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.0071468,-0.13466,-0.25989,1,0
3,GO PEPTIDYL THREONINE MODIFICATION,0.0010206,-0.13467,-0.13057,1,0
3,GO LEUKOCYTE MEDIATED IMMUNITY,0.00045924,-0.13472,-0.18616,1,0
3,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.01282,-0.1348,-0.14885,1,0
3,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.03245,-0.13487,-0.15042,1,0
3,GO MYELOID DENDRITIC CELL ACTIVATION,0.0034322,-0.1352,-0.20747,1,0
3,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0010206,-0.13529,-0.18728,1,0
3,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.00012512,-0.13531,-0.11985,1,0
3,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0028957,-0.13533,-0.18301,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.017549,-0.1354,-0.11915,1,0
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.035393,-0.13556,-0.122,1,0
3,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.00040247,-0.13585,-0.15198,1,0
3,GO DIOL BIOSYNTHETIC PROCESS,0.018398,-0.13599,-0.16919,1,0
3,GO B CELL ACTIVATION,1.349e-05,-0.13627,-0.16989,1,0
3,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.00034072,-0.13627,-0.17261,1,0
3,GO REGULATION OF MAST CELL ACTIVATION,0.025994,-0.13635,-0.1584,1,0
3,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0057817,-0.13663,-0.16375,1,0
3,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.044685,-0.13707,-0.10245,1,0
3,GO RESPONSE TO CYTOKINE,0.0015653,-0.13722,-0.15304,1,0
3,GO LEUKOCYTE PROLIFERATION,5.2139e-05,-0.13752,-0.18262,1,0
3,GO CYTOKINE SECRETION,0.00036427,-0.13774,-0.16718,1,0
3,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.00059588,-0.13782,-0.13632,1,0
3,GO REGULATION OF T CELL CHEMOTAXIS,0.017969,-0.13784,-0.13105,1,0
3,GO ATP BIOSYNTHETIC PROCESS,0.017137,-0.13838,-0.12921,1,0
3,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0015653,-0.13838,-0.16625,1,0
3,GO CELLULAR RESPONSE TO ALCOHOL,0.0036303,-0.13851,-0.13108,1,0
3,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0022992,-0.13857,-0.19007,1,0
3,GO B CELL PROLIFERATION,0.0047853,-0.13915,-0.14366,1,0
3,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.025414,-0.13941,-0.14385,1,0
3,GO POSITIVE REGULATION OF CELL ADHESION,0.0013457,-0.13943,-0.17667,1,0
3,GO RESPONSE TO PEPTIDOGLYCAN,0.0011199,-0.13949,-0.21885,1,0
3,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00029782,-0.13965,-0.1945,1,0
3,GO REGULATION OF SPINDLE ORGANIZATION,0.00026003,-0.13967,-0.1549,1,0
3,GO LEUKOCYTE APOPTOTIC PROCESS,0.019283,-0.14022,-0.1494,1,0
3,GO REGULATION OF NEUTROPHIL MIGRATION,0.0085714,-0.14029,-0.15571,1,0
3,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0081404,-0.14034,-0.14479,1,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0011549,-0.14036,-0.19254,1,0
3,GO AMINO SUGAR CATABOLIC PROCESS,0.019739,-0.14046,-0.16668,1,0
3,GO PROTEIN K11 LINKED UBIQUITINATION,0.0028957,-0.14073,-0.1457,1,0
3,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0001547,-0.14116,-0.15776,1,0
3,GO T CELL PROLIFERATION,0.00047456,-0.14122,-0.17393,1,0
3,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.0028141,-0.14125,-0.16001,1,0
3,GO GRANULOCYTE MIGRATION,0.0039469,-0.14139,-0.1513,1,0
3,GO ARACHIDONIC ACID METABOLIC PROCESS,0.030383,-0.14149,-0.14655,1,0
3,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.016734,-0.14167,-0.18334,1,0
3,GO RESPONSE TO ETHER,0.024288,-0.14185,-0.11441,1,0
3,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.0057817,-0.14203,-0.15264,1,0
3,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.00035231,-0.14214,-0.22517,1,0
3,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00012512,-0.14214,-0.20648,1,0
3,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.013465,-0.14252,-0.17536,1,0
3,GO POSITIVE REGULATION OF HEMOPOIESIS,0.00029782,-0.14289,-0.16849,1,0
3,GO VIRAL RNA GENOME REPLICATION,0.0025083,-0.14291,-0.18684,1,0
3,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.0047853,-0.14328,-0.23072,1,0
3,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0024367,-0.14331,-0.18293,1,0
3,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.035393,-0.14355,-0.18871,1,0
3,GO BLOOD VESSEL REMODELING,0.0053338,-0.14366,-0.2213,1,0
3,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.0028957,-0.1439,-0.19045,1,0
3,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0011549,-0.14393,-0.18759,1,0
3,GO PROTEIN K48 LINKED UBIQUITINATION,0.00013917,-0.14424,-0.15291,1,0
3,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.02068,-0.14432,-0.21244,1,0
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.009256,-0.14442,-0.18871,1,0
3,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.042857,-0.14456,-0.15514,1,0
3,GO INTERLEUKIN 4 PRODUCTION,0.0014299,-0.14457,-0.20697,1,0
3,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.0037331,-0.14465,-0.17389,1,0
3,GO EPITHELIAL TUBE FORMATION,0.00022676,-0.14479,-0.15709,1,0
3,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.014841,-0.14516,-0.13223,1,0
3,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.035393,-0.14517,-0.18809,1,0
3,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.017137,-0.14525,-0.11333,1,0
3,GO CHEMOKINE PRODUCTION,0.00035231,-0.14531,-0.21654,1,0
3,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.0018173,-0.14548,-0.14576,1,0
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.0014738,-0.14601,-0.16132,1,0
3,GO MAST CELL ACTIVATION,0.0090226,-0.14638,-0.18771,1,0
3,GO ER NUCLEUS SIGNALING PATHWAY,0.017549,-0.14655,-0.14279,1,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.0010528,-0.14678,-0.18093,1,0
3,GO MYELOID CELL DEVELOPMENT,0.00041602,-0.14679,-0.14912,1,0
3,GO SENSORY PERCEPTION OF TASTE,0.00087311,-0.14694,-0.17863,1,0
3,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00055855,-0.14704,-0.21074,1,0
3,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00019079,-0.14753,-0.18056,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00027832,-0.14789,-0.19066,1,0
3,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.001872,-0.14792,-0.17967,1,0
3,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.033166,-0.14877,-0.19191,1,0
3,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,1.9904e-06,-0.14883,-0.18084,1,0
3,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0015653,-0.14894,-0.18765,1,0
3,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.011904,-0.14926,-0.19602,1,0
3,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.015574,-0.1494,-0.12683,1,0
3,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.009256,-0.14942,-0.17523,1,0
3,GO REGULATION OF VASCULATURE DEVELOPMENT,0.00353,-0.14945,-0.15172,1,0
3,GO ENDOTHELIAL CELL DEVELOPMENT,0.00057693,-0.14947,-0.2105,1,0
3,GO LYMPHOCYTE APOPTOTIC PROCESS,0.013465,-0.14956,-0.1439,1,0
3,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,5.6174e-05,-0.14956,-0.17964,1,0
3,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.00059588,-0.14964,-0.12514,1,0
3,GO RENAL TUBULE DEVELOPMENT,0.001191,-0.14991,-0.17985,1,0
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0025817,-0.14994,-0.20246,1,0
3,GO POSITIVE REGULATION OF NEURON DEATH,0.0075304,-0.14999,-0.11888,1,0
3,GO NUCLEOTIDE TRANSPORT,0.033166,-0.15011,-0.098094,1,0
3,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.00032948,-0.15014,-0.18851,1,0
3,GO SECRETION BY TISSUE,0.013465,-0.15017,-0.16291,1,0
3,GO SECONDARY METABOLIC PROCESS,0.0029794,-0.15038,-0.21197,1,0
3,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.02166,-0.15049,-0.19718,1,0
3,GO REGULATION OF B CELL ACTIVATION,0.00028792,-0.15059,-0.17344,1,0
3,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0038387,-0.15116,-0.14668,1,0
3,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00027832,-0.15117,-0.17891,1,0
3,GO REGULATION OF FIBROBLAST MIGRATION,0.0075304,-0.1512,-0.1891,1,0
3,GO UROGENITAL SYSTEM DEVELOPMENT,0.0015653,-0.15155,-0.14694,1,0
3,GO POSITIVE REGULATION OF HORMONE SECRETION,0.0032441,-0.15164,-0.14705,1,0
3,GO LEUKOCYTE MIGRATION,0.00052342,-0.15167,-0.16869,1,0
3,GO CYTOKINE METABOLIC PROCESS,0.0007696,-0.15171,-0.20216,1,0
3,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00013433,-0.15188,-0.18461,1,0
3,GO PINOCYTOSIS,0.017549,-0.15217,-0.18144,1,0
3,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.00037661,-0.15284,-0.21262,1,0
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00019079,-0.15285,-0.22724,1,0
3,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.007729,-0.15288,-0.25354,1,0
3,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.031748,-0.15312,-0.2892,1,0
3,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.045624,-0.15342,-0.1403,1,0
3,GO DETERMINATION OF ADULT LIFESPAN,0.03939,-0.15348,-0.13741,1,0
3,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.0039469,-0.15351,-0.21867,1,0
3,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.00012074,-0.15356,-0.20431,1,0
3,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0049174,-0.15376,-0.16147,1,0
3,GO REGULATION OF CELL CELL ADHESION,0.00019753,-0.15387,-0.18583,1,0
3,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00036427,-0.15402,-0.19018,1,0
3,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,5.8301e-05,-0.15411,-0.20674,1,0
3,GO INTESTINAL LIPID ABSORPTION,0.0057817,-0.15426,-0.30133,1,0
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0066042,-0.15435,-0.18217,1,0
3,GO GRANULOCYTE CHEMOTAXIS,0.004408,-0.15444,-0.14176,1,0
3,GO DEFENSE RESPONSE TO BACTERIUM,5.0226e-05,-0.15451,-0.18967,1,0
3,GO IMMUNE EFFECTOR PROCESS,0.00027832,-0.15462,-0.18866,1,0
3,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0010528,-0.15478,-0.19313,1,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0032441,-0.15482,-0.23943,1,0
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.01282,-0.15482,-0.17457,1,0
3,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.00027832,-0.15485,-0.20869,1,0
3,GO ACTIN NUCLEATION,9.3916e-06,-0.15517,-0.17974,1,0
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0054795,-0.15535,-0.19323,1,0
3,GO INTRA S DNA DAMAGE CHECKPOINT,0.00084609,-0.15538,-0.14248,1,0
3,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.012508,-0.15608,-0.25662,1,0
3,GO T HELPER 1 CELL DIFFERENTIATION,0.020205,-0.15641,-0.32179,1,0
3,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.001191,-0.15661,-0.24229,1,0
3,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0056288,-0.15663,-0.43877,1,0
3,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.020205,-0.15667,-0.12284,1,0
3,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.00021909,-0.15674,-0.17691,1,0
3,GO RESPONSE TO REDOX STATE,0.042857,-0.15686,-0.15179,1,0
3,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00074557,-0.15704,-0.18448,1,0
3,GO INTERACTION WITH HOST,0.00019079,-0.15709,-0.20914,1,0
3,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.007729,-0.1573,-0.18045,1,0
3,GO NEGATIVE REGULATION OF CELL ADHESION,0.00079435,-0.15766,-0.18699,1,0
3,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0014299,-0.15773,-0.2157,1,0
3,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.014486,-0.15774,-0.12947,1,0
3,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00057693,-0.15783,-0.1292,1,0
3,GO LYMPHOCYTE MEDIATED IMMUNITY,0.00016023,-0.15786,-0.21085,1,0
3,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.00067758,-0.15788,-0.18079,1,0
3,GO PURINE NUCLEOTIDE TRANSPORT,0.035393,-0.15803,-0.10595,1,0
3,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0026572,-0.15807,-0.2037,1,0
3,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.0087944,-0.15853,-0.16251,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0038387,-0.15858,-0.15479,1,0
3,GO LINOLEIC ACID METABOLIC PROCESS,0.041967,-0.15888,-0.19555,1,0
3,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.00034072,-0.1591,-0.19399,1,0
3,GO FOAM CELL DIFFERENTIATION,0.019283,-0.15919,-0.17345,1,0
3,GO RESPONSE TO DSRNA,0.0051916,-0.1593,-0.15298,1,0
3,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00016023,-0.15932,-0.20877,1,0
3,GO HISTAMINE TRANSPORT,0.02843,-0.15977,-0.22185,1,0
3,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.0060989,-0.15995,-0.27992,1,0
3,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00010092,-0.16008,-0.19963,1,0
3,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.00017796,-0.16016,-0.18245,1,0
3,GO REGULATION OF IMMUNE EFFECTOR PROCESS,4.8379e-05,-0.16017,-0.21337,1,0
3,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.020205,-0.16021,-0.17337,1,0
3,GO MALE GENITALIA DEVELOPMENT,0.036164,-0.16024,-0.16504,1,0
3,GO CELL KILLING,0.00074557,-0.16039,-0.18127,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00023468,-0.16045,-0.19554,1,0
3,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,1.5816e-05,-0.16078,-0.24415,1,0
3,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.017549,-0.16089,-0.24785,1,0
3,GO POSITIVE REGULATION OF INSULIN SECRETION,0.0025083,-0.16094,-0.13679,1,0
3,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00026903,-0.16179,-0.2271,1,0
3,GO ENDOTHELIAL CELL MIGRATION,0.017137,-0.16179,-0.13681,1,0
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0036303,-0.16222,-0.20852,1,0
3,GO RESPONSE TO VIRUS,7.2754e-05,-0.16236,-0.22056,1,0
3,GO REPRODUCTIVE SYSTEM DEVELOPMENT,8.7323e-05,-0.16304,-0.15477,1,0
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.023205,-0.16307,-0.22829,1,0
3,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.0037331,-0.16314,-0.18802,1,0
3,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.00024286,-0.16323,-0.17159,1,0
3,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.0039469,-0.16341,-0.16958,1,0
3,GO LEUKOTRIENE METABOLIC PROCESS,0.017549,-0.16375,-0.15881,1,0
3,GO BONE RESORPTION,0.001662,-0.16393,-0.2021,1,0
3,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.0050528,-0.16395,-0.16202,1,0
3,GO EPITHELIAL CELL DEVELOPMENT,4.0073e-05,-0.16412,-0.20926,1,0
3,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,5.4121e-05,-0.16446,-0.21357,1,0
3,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0033369,-0.16459,-0.23974,1,0
3,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.014138,-0.16466,-0.14851,1,0
3,GO PROTEIN K63 LINKED UBIQUITINATION,8.6584e-06,-0.16481,-0.16849,1,0
3,GO PROTEIN PROCESSING,0.00031859,-0.16503,-0.17643,1,0
3,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.016339,-0.16508,-0.20976,1,0
3,GO POSITIVE REGULATION OF BONE RESORPTION,0.030383,-0.16509,-0.17813,1,0
3,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0099891,-0.16521,-0.21723,1,0
3,GO NEGATIVE REGULATION OF JNK CASCADE,0.011904,-0.16609,-0.13149,1,0
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.00035231,-0.16611,-0.20067,1,0
3,GO PROTEIN DEMANNOSYLATION,0.016734,-0.16667,-0.1826,1,0
3,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.00012512,-0.16682,-0.20585,1,0
3,GO REGULATION OF ICOSANOID SECRETION,0.043763,-0.16685,-0.13495,1,0
3,GO REGULATION OF LEUKOCYTE PROLIFERATION,5.4121e-05,-0.16691,-0.21403,1,0
3,GO MEGAKARYOCYTE DIFFERENTIATION,4.4712e-06,-0.1672,-0.18873,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.0090226,-0.16723,-0.18053,1,0
3,GO ALPHA BETA T CELL ACTIVATION,1.5816e-05,-0.16759,-0.22358,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00072223,-0.16822,-0.19688,1,0
3,GO RESPONSE TO ISCHEMIA,0.001986,-0.16838,-0.16397,1,0
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0087944,-0.16857,-0.18176,1,0
3,GO T CELL CYTOKINE PRODUCTION,0.0037331,-0.16864,-0.19095,1,0
3,GO RESPONSE TO PROGESTERONE,0.0049174,-0.1687,-0.22083,1,0
3,GO MESONEPHROS DEVELOPMENT,0.012508,-0.16888,-0.15112,1,0
3,GO MYELOID LEUKOCYTE MIGRATION,0.0014299,-0.16935,-0.16125,1,0
3,GO ORGANOPHOSPHATE ESTER TRANSPORT,1.6455e-05,-0.16944,-0.1757,1,0
3,GO ZYMOGEN ACTIVATION,0.0051916,-0.17036,-0.27421,1,0
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.049546,-0.17037,-0.23522,1,0
3,GO RIG I SIGNALING PATHWAY,0.0025083,-0.17043,-0.18276,1,0
3,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.0010859,-0.17043,-0.23775,1,0
3,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.024846,-0.17045,-0.16178,1,0
3,GO EXECUTION PHASE OF APOPTOSIS,1.0184e-05,-0.17048,-0.1646,1,0
3,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.025414,-0.17053,-0.3756,1,0
3,GO ENTRY INTO HOST,0.00050664,-0.17066,-0.26205,1,0
3,GO ACUTE PHASE RESPONSE,0.0031536,-0.17081,-0.1885,1,0
3,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.013465,-0.17095,-0.14719,1,0
3,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.0022332,-0.17123,-0.19664,1,0
3,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0028141,-0.17125,-0.20777,1,0
3,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,4.1617e-05,-0.17141,-0.24649,1,0
3,GO RESPONSE TO ANGIOTENSIN,0.0024367,-0.17178,-0.21932,1,0
3,GO NEPHRON EPITHELIUM DEVELOPMENT,0.0015653,-0.17192,-0.16732,1,0
3,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00037661,-0.17193,-0.21364,1,0
3,GO DIOL METABOLIC PROCESS,0.019739,-0.17195,-0.17019,1,0
3,GO CENTROSOME DUPLICATION,9.389e-05,-0.17204,-0.17864,1,0
3,GO REGULATION OF CHROMATIN ASSEMBLY,0.00055855,-0.17215,-0.159,1,0
3,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.0025817,-0.17218,-0.21653,1,0
3,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00063551,-0.17254,-0.21976,1,0
3,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.033894,-0.17272,-0.17615,1,0
3,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.0029794,-0.17299,-0.21201,1,0
3,GO REGULATION OF B CELL PROLIFERATION,0.0017123,-0.17333,-0.18159,1,0
3,GO SKELETAL MUSCLE CELL PROLIFERATION,0.036164,-0.17361,-0.19823,1,0
3,GO KIDNEY EPITHELIUM DEVELOPMENT,0.0028957,-0.17377,-0.17369,1,0
3,GO ICOSANOID BIOSYNTHETIC PROCESS,0.012508,-0.17408,-0.20794,1,0
3,GO ERYTHROCYTE DEVELOPMENT,0.0032441,-0.17411,-0.13457,1,0
3,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.0051916,-0.1742,-0.17726,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0014738,-0.17422,-0.17904,1,0
3,GO PROSTANOID BIOSYNTHETIC PROCESS,0.019283,-0.17445,-0.2578,1,0
3,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.0075304,-0.17471,-0.2284,1,0
3,GO CYTOLYSIS,0.0054795,-0.17473,-0.22888,1,0
3,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.0013872,-0.17476,-0.1755,1,0
3,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0045306,-0.17502,-0.19628,1,0
3,GO T HELPER 17 TYPE IMMUNE RESPONSE,6.7596e-05,-0.17559,-0.19025,1,0
3,GO ENDOCRINE HORMONE SECRETION,0.0056288,-0.17573,-0.15316,1,0
3,GO O GLYCAN PROCESSING,0.0031536,-0.17579,-0.2369,1,0
3,GO REGULATION OF RUFFLE ASSEMBLY,0.00079435,-0.17596,-0.1982,1,0
3,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.0025083,-0.17613,-0.17621,1,0
3,GO RETINA HOMEOSTASIS,0.00032948,-0.17619,-0.14676,1,0
3,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.001228,-0.17636,-0.17727,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,5.2139e-05,-0.17658,-0.2252,1,0
3,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.015574,-0.17694,-0.22061,1,0
3,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0047853,-0.17737,-0.19456,1,0
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0001165,-0.17743,-0.194,1,0
3,GO EPOXYGENASE P450 PATHWAY,0.03939,-0.17744,-0.19399,1,0
3,GO PLATELET ACTIVATION,4.1617e-05,-0.17749,-0.21602,1,0
3,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.018836,-0.17791,-0.15795,1,0
3,GO CELL ADHESION MEDIATED BY INTEGRIN,0.013465,-0.17804,-0.23875,1,0
3,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00024286,-0.17827,-0.19891,1,0
3,GO B CELL DIFFERENTIATION,4.1112e-06,-0.17886,-0.20911,1,0
3,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.1663e-05,-0.1789,-0.24823,1,0
3,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0016129,-0.17895,-0.21136,1,0
3,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00036427,-0.17899,-0.16736,1,0
3,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.7806e-05,-0.17912,-0.19717,1,0
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00017186,-0.17933,-0.24299,1,0
3,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.0036303,-0.17976,-0.23816,1,0
3,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00067758,-0.1798,-0.18452,1,0
3,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0034322,-0.17994,-0.15644,1,0
3,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0011549,-0.18011,-0.26679,1,0
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.0018173,-0.18039,-0.20622,1,0
3,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.0031536,-0.18041,-0.17537,1,0
3,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.0067808,-0.18146,-0.20684,1,0
3,GO PHOSPHOLIPID TRANSPORT,9.7346e-05,-0.18173,-0.18523,1,0
3,GO NEPHRON DEVELOPMENT,0.00034072,-0.18181,-0.18869,1,0
3,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.00052342,-0.18189,-0.2359,1,0
3,GO CELLULAR RESPONSE TO VIRUS,3.5759e-05,-0.18208,-0.22268,1,0
3,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0081404,-0.18208,-0.18681,1,0
3,GO DIGESTIVE SYSTEM DEVELOPMENT,0.00081984,-0.18246,-0.19194,1,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,5.8301e-05,-0.18284,-0.21292,1,0
3,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.00019753,-0.18286,-0.20857,1,0
3,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.00017796,-0.18323,-0.26212,1,0
3,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0053338,-0.1835,-0.18746,1,0
3,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00049035,-0.18353,-0.2607,1,0
3,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0046564,-0.18402,-0.23911,1,0
3,GO MYELOID CELL HOMEOSTASIS,1.7806e-05,-0.18416,-0.19416,1,0
3,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.00090094,-0.18552,-0.17905,1,0
3,GO DEFENSE RESPONSE TO VIRUS,3.6228e-06,-0.18591,-0.29096,1,0
3,GO ENDOSOME ORGANIZATION,5.7413e-06,-0.18602,-0.1872,1,0
3,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0027346,-0.18632,-0.20252,1,0
3,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,1.7118e-05,-0.18636,-0.21519,1,0
3,GO INTRACILIARY TRANSPORT,0.0025083,-0.18655,-0.20942,1,0
3,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.0046564,-0.18693,-0.22136,1,0
3,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0028957,-0.18694,-0.3128,1,0
3,GO REGULATION OF TISSUE REMODELING,0.00353,-0.18727,-0.18813,1,0
3,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,6.2786e-05,-0.18748,-0.24241,1,0
3,GO MITOTIC METAPHASE PLATE CONGRESSION,0.00017796,-0.18756,-0.15865,1,0
3,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00010845,-0.18759,-0.23729,1,0
3,GO HYPOTHALAMUS DEVELOPMENT,0.010245,-0.18772,-0.19643,1,0
3,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0039469,-0.18868,-0.22033,1,0
3,GO ACTIN FILAMENT NETWORK FORMATION,0.029068,-0.18875,-0.28838,1,0
3,GO ALPHA BETA T CELL DIFFERENTIATION,3.6228e-06,-0.18876,-0.24018,1,0
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.0087944,-0.18891,-0.22537,1,0
3,GO IMMUNOGLOBULIN SECRETION,5.8301e-05,-0.18902,-0.32871,1,0
3,GO KERATINOCYTE PROLIFERATION,0.023741,-0.18905,-0.1901,1,0
3,GO MATERNAL PLACENTA DEVELOPMENT,0.020205,-0.18916,-0.18951,1,0
3,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.0053338,-0.18936,-0.20841,1,0
3,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00026003,-0.18937,-0.20372,1,0
3,GO MULTIVESICULAR BODY SORTING PATHWAY,4.6597e-05,-0.18985,-0.20809,1,0
3,GO REGULATION OF SYMBIOTIC PROCESS,2.3418e-05,-0.19054,-0.23827,1,0
3,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.042857,-0.19116,-0.1446,1,0
3,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,4.1617e-05,-0.19125,-0.20666,1,0
3,GO MATURE B CELL DIFFERENTIATION,0.0079323,-0.19127,-0.24139,1,0
3,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00042998,-0.19132,-0.18364,1,0
3,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00045924,-0.19145,-0.25472,1,0
3,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.033166,-0.19155,-0.18675,1,0
3,GO MYELOID CELL APOPTOTIC PROCESS,0.0039469,-0.19155,-0.20908,1,0
3,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.009256,-0.1917,-0.21063,1,0
3,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.0014738,-0.19173,-0.19582,1,0
3,GO POSITIVE REGULATION OF TISSUE REMODELING,0.0007696,-0.19186,-0.24411,1,0
3,GO HISTONE H4 DEACETYLATION,0.0083534,-0.19221,-0.18168,1,0
3,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.0040578,-0.19241,-0.17525,1,0
3,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.019283,-0.19244,-0.19172,1,0
3,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.025994,-0.19261,-0.19316,1,0
3,GO MACROPHAGE MIGRATION,0.016734,-0.19285,-0.15018,1,0
3,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.014138,-0.19285,-0.19495,1,0
3,GO REGULATION OF GASTRULATION,0.0036303,-0.19303,-0.19391,1,0
3,GO TYPE I INTERFERON PRODUCTION,0.00012512,-0.19307,-0.22172,1,0
3,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,4.0073e-05,-0.19317,-0.20567,1,0
3,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.0094949,-0.19414,-0.17633,1,0
3,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,8.4205e-05,-0.19418,-0.24207,1,0
3,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0053338,-0.1944,-0.18269,1,0
3,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.030383,-0.19452,-0.19046,1,0
3,GO RESPONSE TO INTERLEUKIN 2,0.0024367,-0.19464,-0.21173,1,0
3,GO LEUKOCYTE CHEMOTAXIS,0.00034072,-0.19467,-0.17473,1,0
3,GO RESPONSE TO INTERFERON GAMMA,0.0022992,-0.19468,-0.25638,1,0
3,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00020448,-0.19474,-0.22513,1,0
3,GO LIPID DROPLET ORGANIZATION,0.00057693,-0.19506,-0.24384,1,0
3,GO INTERMEDIATE FILAMENT BASED PROCESS,0.00072223,-0.19512,-0.22377,1,0
3,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.00052342,-0.19534,-0.26544,1,0
3,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0041716,-0.19545,-0.23709,1,0
3,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.013798,-0.19553,-0.16904,1,0
3,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.0028141,-0.19558,-0.17657,1,0
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0011549,-0.19644,-0.24342,1,0
3,GO B CELL MEDIATED IMMUNITY,4.1617e-05,-0.19658,-0.25168,1,0
3,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.013465,-0.19668,-0.20185,1,0
3,GO ENDODERMAL CELL FATE COMMITMENT,0.0027346,-0.19669,-0.18498,1,0
3,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0053338,-0.19672,-0.37465,1,0
3,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.0001165,-0.19674,-0.23763,1,0
3,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.0090226,-0.19698,-0.16844,1,0
3,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.0025817,-0.19709,-0.1548,1,0
3,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0034322,-0.1971,-0.17857,1,0
3,GO RESPONSE TO OXYGEN RADICAL,0.00031859,-0.19742,-0.19113,1,0
3,GO ADAPTIVE IMMUNE RESPONSE,1.5201e-05,-0.19811,-0.24424,1,0
3,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0024367,-0.19818,-0.25076,1,0
3,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.001228,-0.19822,-0.26604,1,0
3,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.021165,-0.19857,-0.19446,1,0
3,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.0031536,-0.19869,-0.15963,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.0034322,-0.19925,-0.25923,1,0
3,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.050569,-0.19937,-0.14583,1,0
3,GO EMBRYONIC DIGIT MORPHOGENESIS,0.00035231,-0.1996,-0.20529,1,0
3,GO VIRAL GENOME REPLICATION,0.00019079,-0.19966,-0.25058,1,0
3,GO IMMUNE RESPONSE TO TUMOR CELL,0.017549,-0.19969,-0.24726,1,0
3,GO CELL CHEMOTAXIS,0.00014935,-0.19992,-0.19702,1,0
3,GO MICROVILLUS ORGANIZATION,0.0040578,-0.20036,-0.24987,1,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0038387,-0.20094,-0.21145,1,0
3,GO VASCULAR WOUND HEALING,0.047551,-0.20094,-0.1695,1,0
3,GO MOVEMENT IN HOST ENVIRONMENT,4.0073e-05,-0.20127,-0.26159,1,0
3,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.00010092,-0.20136,-0.21635,1,0
3,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,3.0689e-05,-0.20164,-0.24896,1,0
3,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0027346,-0.20192,-0.23749,1,0
3,GO ERYTHROCYTE HOMEOSTASIS,3.1888e-05,-0.20196,-0.18645,1,0
3,GO ETHANOL METABOLIC PROCESS,0.018836,-0.20221,-0.22088,1,0
3,GO ENDOCRINE PROCESS,0.0021689,-0.20277,-0.19742,1,0
3,GO MONONUCLEAR CELL MIGRATION,0.0015189,-0.2029,-0.20107,1,0
3,GO VIRION ASSEMBLY,4.8612e-06,-0.20303,-0.20821,1,0
3,GO T CELL MEDIATED CYTOTOXICITY,0.019739,-0.20305,-0.31241,1,0
3,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.018836,-0.2032,-0.29272,1,0
3,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.0032441,-0.20377,-0.19792,1,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,2.1702e-06,-0.20405,-0.22395,1,0
3,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.00090094,-0.20412,-0.23801,1,0
3,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.035393,-0.20415,-0.19456,1,0
3,GO RESPONSE TO COPPER ION,0.0094949,-0.20454,-0.28372,1,0
3,GO MACROPHAGE CHEMOTAXIS,0.015574,-0.20459,-0.15958,1,0
3,GO POSITIVE REGULATION OF CELL KILLING,0.00027832,-0.20468,-0.24762,1,0
3,GO ACTIN CYTOSKELETON REORGANIZATION,8.3127e-06,-0.20517,-0.19981,1,0
3,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.00090094,-0.20534,-0.19398,1,0
3,GO BONE REMODELING,0.0067808,-0.20576,-0.18857,1,0
3,GO REGULATION OF PROTEIN SUMOYLATION,0.043763,-0.20577,-0.115,1,0
3,GO CELLULAR DEFENSE RESPONSE,3.0576e-06,-0.20588,-0.28847,1,0
3,GO REGULATION OF RESPIRATORY BURST,0.0011549,-0.20635,-0.22913,1,0
3,GO PHOSPHOLIPID DEPHOSPHORYLATION,9.389e-05,-0.2064,-0.21255,1,0
3,GO CYTOKINETIC PROCESS,1.1493e-05,-0.20698,-0.2535,1,0
3,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.001872,-0.20732,-0.23,1,0
3,GO RESPONSE TO MECHANICAL STIMULUS,4.3218e-05,-0.20756,-0.21244,1,0
3,GO LIPID STORAGE,0.0019282,-0.20795,-0.18547,1,0
3,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.0016129,-0.20814,-0.22175,1,0
3,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.0006154,-0.20853,-0.23021,1,0
3,GO SUPEROXIDE METABOLIC PROCESS,0.00031859,-0.2086,-0.20416,1,0
3,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.00030804,-0.2088,-0.23571,1,0
3,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.00014935,-0.2089,-0.20287,1,0
3,GO REPLICATIVE SENESCENCE,0.037747,-0.2091,-0.18202,1,0
3,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.00072223,-0.20911,-0.22309,1,0
3,GO ANTIBACTERIAL HUMORAL RESPONSE,0.0015653,-0.20922,-0.2255,1,0
3,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0034322,-0.20965,-0.15386,1,0
3,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00010092,-0.20979,-0.26298,1,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.00030804,-0.21007,-0.19438,1,0
3,GO REGULATORY T CELL DIFFERENTIATION,0.0024367,-0.21051,-0.25494,1,0
3,GO REGULATION OF ACTIN NUCLEATION,7.013e-05,-0.21059,-0.23706,1,0
3,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00010462,-0.21082,-0.26754,1,0
3,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.026586,-0.21085,-0.2233,1,0
3,GO MONOCYTE CHEMOTAXIS,0.00098941,-0.21086,-0.24741,1,0
3,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.001662,-0.21109,-0.17954,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.00022676,-0.21165,-0.21018,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.017969,-0.21172,-0.29752,1,0
3,GO B CELL APOPTOTIC PROCESS,0.00049035,-0.21179,-0.25333,1,0
3,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00081984,-0.21195,-0.26482,1,0
3,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,5.9841e-06,-0.21209,-0.27498,1,0
3,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.0013054,-0.2125,-0.18284,1,0
3,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.024846,-0.21262,-0.19456,1,0
3,GO POSITIVE T CELL SELECTION,0.0020453,-0.21266,-0.17666,1,0
3,GO HORMONE CATABOLIC PROCESS,0.0040578,-0.21298,-0.268,1,0
3,GO REGULATION OF CENTROSOME CYCLE,7.6603e-06,-0.21304,-0.1946,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00016595,-0.21323,-0.23457,1,0
3,GO ACTIVATED T CELL PROLIFERATION,0.00090094,-0.21349,-0.20102,1,0
3,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.0039469,-0.2135,-0.28308,1,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00030804,-0.21379,-0.2708,1,0
3,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,5.8301e-05,-0.21386,-0.22757,1,0
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,2.0033e-05,-0.21438,-0.24567,1,0
3,GO CELLULAR RESPONSE TO DSRNA,0.0015189,-0.21458,-0.24055,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0027346,-0.21505,-0.19654,1,0
3,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0022332,-0.21511,-0.20742,1,0
3,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.0073363,-0.21563,-0.22312,1,0
3,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00023468,-0.21583,-0.2611,1,0
3,GO NEURAL TUBE FORMATION,5.508e-06,-0.21605,-0.21581,1,0
3,GO ERBB2 SIGNALING PATHWAY,2.0833e-05,-0.21644,-0.26576,1,0
3,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,7.547e-05,-0.21684,-0.28659,1,0
3,GO APICAL PROTEIN LOCALIZATION,0.0049174,-0.21697,-0.17376,1,0
3,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.0028141,-0.21714,-0.20972,1,0
3,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,6.5149e-05,-0.21721,-0.20417,1,0
3,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.036948,-0.21748,-0.15889,1,0
3,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00024286,-0.21769,-0.26093,1,0
3,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.018836,-0.21834,-0.1872,1,0
3,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.0067808,-0.2186,-0.188,1,0
3,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.023741,-0.21892,-0.25559,1,0
3,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.044685,-0.21924,-0.23152,1,0
3,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00024286,-0.21992,-0.23488,1,0
3,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.018836,-0.22005,-0.2922,1,0
3,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.0085714,-0.22029,-0.24136,1,0
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.013139,-0.22034,-0.24011,1,0
3,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.0020453,-0.22041,-0.21338,1,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.00014935,-0.22042,-0.22091,1,0
3,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00074557,-0.22052,-0.23118,1,0
3,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,6.7596e-05,-0.22062,-0.24206,1,0
3,GO RESPONSE TO IMMOBILIZATION STRESS,0.0014738,-0.22117,-0.26106,1,0
3,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0042883,-0.22129,-0.15994,1,0
3,GO REGULATION OF MACROPHAGE MIGRATION,0.0050528,-0.22173,-0.1835,1,0
3,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,2.7343e-05,-0.22194,-0.24205,1,0
3,GO INTERLEUKIN 12 PRODUCTION,3.4728e-06,-0.22211,-0.29373,1,0
3,GO REGULATION OF CELL KILLING,4.8379e-05,-0.22214,-0.25679,1,0
3,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.00063551,-0.22233,-0.19661,1,0
3,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.0083534,-0.22244,-0.24134,1,0
3,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,5.8301e-05,-0.22287,-0.2445,1,0
3,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.011326,-0.22309,-0.29545,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.046579,-0.2238,-0.16822,1,0
3,GO CELLULAR RESPONSE TO LITHIUM ION,0.017137,-0.22444,-0.21637,1,0
3,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,5.508e-06,-0.22459,-0.26358,1,0
3,GO MAMMARY GLAND MORPHOGENESIS,0.016734,-0.22463,-0.21877,1,0
3,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.012203,-0.2247,-0.24322,1,0
3,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.0038387,-0.2247,-0.22273,1,0
3,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.00021167,-0.22558,-0.22814,1,0
3,GO REGULATION OF CENTROSOME DUPLICATION,9.0179e-06,-0.22561,-0.22652,1,0
3,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.00084609,-0.22566,-0.24754,1,0
3,GO MEMBRANE RAFT ORGANIZATION,0.015203,-0.22589,-0.30842,1,0
3,GO AUTOPHAGOSOME MATURATION,8.3127e-06,-0.22632,-0.24604,1,0
3,GO AMYLOID BETA CLEARANCE,0.00098941,-0.22633,-0.22719,1,0
3,GO POSITIVE REGULATION OF CHEMOTAXIS,3.5759e-05,-0.22635,-0.21966,1,0
3,GO UNSATURATED FATTY ACID METABOLIC PROCESS,3.8583e-05,-0.22652,-0.25966,1,0
3,GO PANCREAS DEVELOPMENT,0.00079435,-0.22667,-0.21684,1,0
3,GO ICOSANOID METABOLIC PROCESS,4.8612e-06,-0.22668,-0.29497,1,0
3,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.011326,-0.2269,-0.28724,1,0
3,GO HAIR CELL DIFFERENTIATION,0.00067758,-0.22705,-0.30225,1,0
3,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.00018427,-0.22775,-0.31642,1,0
3,GO CELLULAR RESPONSE TO INTERFERON BETA,0.034637,-0.22817,-0.22697,1,0
3,GO EOSINOPHIL CHEMOTAXIS,0.015574,-0.22819,-0.32833,1,0
3,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.011047,-0.22869,-0.19893,1,0
3,GO EPITHELIAL CELL DIFFERENTIATION,1.349e-05,-0.22914,-0.21975,1,0
3,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.0025083,-0.22917,-0.21106,1,0
3,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.00019079,-0.22951,-0.28921,1,0
3,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.00013433,-0.22958,-0.24524,1,0
3,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.00018427,-0.22973,-0.26764,1,0
3,GO INTERFERON BETA PRODUCTION,7.8282e-05,-0.22975,-0.2223,1,0
3,GO REGULATION OF CELL MATRIX ADHESION,0.0011199,-0.23004,-0.21837,1,0
3,GO NEGATIVE REGULATION OF LIPID STORAGE,0.0014299,-0.23007,-0.22609,1,0
3,GO TISSUE REMODELING,0.00045924,-0.23097,-0.22321,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,7.8282e-05,-0.23157,-0.25202,1,0
3,GO ESTROUS CYCLE,0.0071468,-0.23163,-0.24358,1,0
3,GO T CELL MEDIATED IMMUNITY,0.00022676,-0.23181,-0.28114,1,0
3,GO LIVER MORPHOGENESIS,0.0060989,-0.23202,-0.26133,1,0
3,GO POLYAMINE BIOSYNTHETIC PROCESS,0.001872,-0.23253,-0.22796,1,0
3,GO SMOOTH MUSCLE CELL MIGRATION,6.5149e-05,-0.23294,-0.30385,1,0
3,GO PLACENTA DEVELOPMENT,5.2837e-06,-0.23308,-0.24538,1,0
3,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.011612,-0.23334,-0.22078,1,0
3,GO RADIAL GLIAL CELL DIFFERENTIATION,0.05161,-0.23341,-0.20904,1,0
3,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,2.4346e-05,-0.23393,-0.25058,1,0
3,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.02268,-0.23406,-0.20338,1,0
3,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0013457,-0.23426,-0.22204,1,0
3,GO REGULATION OF COAGULATION,0.00042998,-0.23454,-0.28661,1,0
3,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0018173,-0.23487,-0.22772,1,0
3,GO GLOMERULUS DEVELOPMENT,0.00040247,-0.23508,-0.27223,1,0
3,GO PIGMENT ACCUMULATION,0.00069957,-0.23533,-0.24213,1,0
3,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00011241,-0.23554,-0.26285,1,0
3,GO REGULATION OF RESPONSE TO WOUNDING,0.00016595,-0.2363,-0.24885,1,0
3,GO SPHINGOMYELIN METABOLIC PROCESS,0.0032441,-0.23642,-0.22832,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.011326,-0.23688,-0.29969,1,0
3,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00084609,-0.23692,-0.31663,1,0
3,GO RESPONSE TO LEPTIN,0.014841,-0.23696,-0.21683,1,0
3,GO BILE ACID METABOLIC PROCESS,0.0001547,-0.23739,-0.24479,1,0
3,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0040578,-0.23753,-0.29836,1,0
3,GO GASTRULATION WITH MOUTH FORMING SECOND,0.0099891,-0.23757,-0.19277,1,0
3,GO MULTIVESICULAR BODY ORGANIZATION,1.0311e-06,-0.23775,-0.24534,1,0
3,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.6455e-05,-0.23804,-0.24279,1,0
3,GO REGULATION OF BONE REMODELING,0.0059384,-0.23806,-0.20804,1,0
3,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.013798,-0.23846,-0.24683,1,0
3,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0011549,-0.2385,-0.23034,1,0
3,GO REGULATION OF B CELL DIFFERENTIATION,0.0016129,-0.23864,-0.21939,1,0
3,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.0024367,-0.2387,-0.29907,1,0
3,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,8.6584e-06,-0.23954,-0.27036,1,0
3,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.0014738,-0.24015,-0.29273,1,0
3,GO REGULATION OF VIRAL LIFE CYCLE,9.3916e-06,-0.24069,-0.31282,1,0
3,GO RUFFLE ORGANIZATION,5.753e-07,-0.2416,-0.25942,1,0
3,GO B CELL RECEPTOR SIGNALING PATHWAY,0.00023468,-0.24255,-0.22243,1,0
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.007729,-0.24275,-0.27836,1,0
3,GO REGULATION OF VIRAL GENOME REPLICATION,5.2139e-05,-0.24295,-0.32085,1,0
3,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,3.4421e-05,-0.24328,-0.26399,1,0
3,GO REGULATION OF RECEPTOR BINDING,0.0051916,-0.24406,-0.24122,1,0
3,GO CELL CELL JUNCTION ORGANIZATION,3.4728e-06,-0.24465,-0.27055,1,0
3,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.0047853,-0.24528,-0.28865,1,0
3,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.00049035,-0.24546,-0.21638,1,0
3,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.017549,-0.24561,-0.25071,1,0
3,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.00081984,-0.24588,-0.26629,1,0
3,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.0053338,-0.24622,-0.29305,1,0
3,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.0031536,-0.24657,-0.19922,1,0
3,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.00069957,-0.2476,-0.32612,1,0
3,GO MAGNESIUM ION TRANSPORT,5.7413e-06,-0.24806,-0.30052,1,0
3,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00032948,-0.24865,-0.22503,1,0
3,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.0013457,-0.24887,-0.22264,1,0
3,GO GLYCEROL ETHER METABOLIC PROCESS,0.00092958,-0.24896,-0.26571,1,0
3,GO NEGATIVE REGULATION OF CELL KILLING,0.016734,-0.24956,-0.38989,1,0
3,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.00018427,-0.24982,-0.23766,1,0
3,GO INTERLEUKIN 6 PRODUCTION,1.0311e-06,-0.24986,-0.25164,1,0
3,GO SKIN DEVELOPMENT,3.1888e-05,-0.25008,-0.24267,1,0
3,GO REGULATION OF POSITIVE CHEMOTAXIS,0.014486,-0.25132,-0.20024,1,0
3,GO INTERLEUKIN 8 PRODUCTION,3.4421e-05,-0.25161,-0.26375,1,0
3,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.0067808,-0.25167,-0.24715,1,0
3,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00050664,-0.25182,-0.21858,1,0
3,GO CELLULAR RESPONSE TO CADMIUM ION,0.040234,-0.25236,-0.22468,1,0
3,GO REGULATION OF EXOSOMAL SECRETION,5.7413e-06,-0.25266,-0.30234,1,0
3,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.00016023,-0.25312,-0.30547,1,0
3,GO EOSINOPHIL MIGRATION,0.0039469,-0.25314,-0.33673,1,0
3,GO GLYCOSIDE METABOLIC PROCESS,0.040234,-0.25318,-0.31809,1,0
3,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.031748,-0.2535,-0.21394,1,0
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,8.2505e-07,-0.25363,-0.32642,1,0
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,4.8379e-05,-0.25406,-0.28955,1,0
3,GO EPIDERMIS DEVELOPMENT,2.2524e-05,-0.2541,-0.2431,1,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.00041602,-0.25555,-0.29162,1,0
3,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.0038387,-0.25562,-0.29218,1,0
3,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.0015189,-0.25565,-0.26237,1,0
3,GO BIOLOGICAL PHASE,0.033166,-0.2559,-0.32727,1,0
3,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.00036427,-0.25617,-0.26599,1,0
3,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.0045306,-0.25629,-0.38517,1,0
3,GO GERMINAL CENTER FORMATION,0.017969,-0.25681,-0.28634,1,0
3,GO TRANSCYTOSIS,6.7596e-05,-0.25794,-0.24346,1,0
3,GO VIRAL RELEASE FROM HOST CELL,4.5813e-07,-0.25822,-0.27857,1,0
3,GO T CELL SELECTION,0.0025817,-0.25841,-0.17252,1,0
3,GO BROWN FAT CELL DIFFERENTIATION,5.0226e-05,-0.25842,-0.31036,1,0
3,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0016129,-0.25925,-0.26186,1,0
3,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,1.5331e-06,-0.25932,-0.29812,1,0
3,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.016734,-0.26101,-0.26029,1,0
3,GO NECROTIC CELL DEATH,0.00069957,-0.26175,-0.24807,1,0
3,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.0007696,-0.2618,-0.30188,1,0
3,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.00013917,-0.26277,-0.25581,1,0
3,GO RDNA HETEROCHROMATIN ASSEMBLY,7.013e-05,-0.26277,-0.25226,1,0
3,GO EXTRACELLULAR VESICLE BIOGENESIS,4.4712e-06,-0.26339,-0.28481,1,0
3,GO ER OVERLOAD RESPONSE,0.033166,-0.26405,-0.20384,1,0
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00042998,-0.26408,-0.32444,1,0
3,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.00012074,-0.26412,-0.24638,1,0
3,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.012203,-0.26518,-0.2249,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00029782,-0.26547,-0.32186,1,0
3,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0010528,-0.26567,-0.28976,1,0
3,GO WATER HOMEOSTASIS,0.0010859,-0.2666,-0.24307,1,0
3,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.0030654,-0.26752,-0.26249,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0099891,-0.26796,-0.43197,1,0
3,GO REGULATION OF WOUND HEALING,6.5149e-05,-0.26837,-0.28992,1,0
3,GO INTERLEUKIN 10 PRODUCTION,1.1964e-05,-0.26843,-0.2883,1,0
3,GO LEFT RIGHT AXIS SPECIFICATION,0.0006154,-0.26939,-0.31114,1,0
3,GO INTERLEUKIN 13 PRODUCTION,0.0059384,-0.26991,-0.26897,1,0
3,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,4.3218e-05,-0.27,-0.25704,1,0
3,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.0046564,-0.27219,-0.35907,1,0
3,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.0018173,-0.27289,-0.32491,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,3.0576e-06,-0.27331,-0.32003,1,0
3,GO PROGRAMMED NECROTIC CELL DEATH,0.00036427,-0.27386,-0.27448,1,0
3,GO SIGNAL PEPTIDE PROCESSING,6.2786e-05,-0.27455,-0.35918,1,0
3,GO CELL CELL JUNCTION ASSEMBLY,1.8251e-06,-0.2747,-0.28631,1,0
3,GO GDP METABOLIC PROCESS,0.0099891,-0.27545,-0.23466,1,0
3,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,5.2533e-07,-0.27599,-0.30411,1,0
3,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0060989,-0.27599,-0.27453,1,0
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,4.1112e-06,-0.27697,-0.2946,1,0
3,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.019739,-0.27818,-0.22433,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,2.9532e-05,-0.27823,-0.2547,1,0
3,GO INTERLEUKIN 1 BETA PRODUCTION,6.2367e-06,-0.27843,-0.31747,1,0
3,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.02068,-0.2801,-0.36336,1,0
3,GO REGULATION OF PLATELET ACTIVATION,6.0504e-05,-0.28027,-0.3648,1,0
3,GO REGULATION OF MICROVILLUS ORGANIZATION,0.0010528,-0.28029,-0.33755,1,0
3,GO INTERLEUKIN 5 PRODUCTION,0.011047,-0.28092,-0.21074,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00072223,-0.28173,-0.30843,1,0
3,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,3.7145e-05,-0.2822,-0.29097,1,0
3,GO ACTIN FILAMENT SEVERING,0.0047853,-0.2824,-0.31525,1,0
3,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,1.4674e-06,-0.28415,-0.31777,1,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,6.7596e-05,-0.28487,-0.29067,1,0
3,GO CELLULAR RESPONSE TO ALKALOID,0.00014418,-0.2852,-0.26135,1,0
3,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.00019079,-0.28537,-0.35242,1,0
3,GO DENDRITIC CELL DIFFERENTIATION,2.7343e-05,-0.28633,-0.34976,1,0
3,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.0075304,-0.28692,-0.30594,1,0
3,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.0081404,-0.28721,-0.20979,1,0
3,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00026903,-0.28802,-0.26272,1,0
3,GO INTERLEUKIN 1 PRODUCTION,2.2658e-06,-0.2884,-0.34316,1,0
3,GO PLATELET AGGREGATION,2.6307e-05,-0.28918,-0.28722,1,0
3,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,2.1702e-06,-0.28972,-0.2868,1,0
3,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00019079,-0.28997,-0.36913,1,0
3,GO POSITIVE REGULATION OF CELL SIZE,0.00012512,-0.29019,-0.33138,1,0
3,GO MUSCLE CELL MIGRATION,5.0226e-05,-0.29145,-0.2889,1,0
3,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.00013433,-0.29179,-0.3439,1,0
3,GO INTESTINAL ABSORPTION,0.00014935,-0.29193,-0.32136,1,0
3,GO OLIGOPEPTIDE TRANSPORT,0.0013872,-0.29235,-0.36432,1,0
3,GO HETEROTYPIC CELL CELL ADHESION,3.0576e-06,-0.29252,-0.34378,1,0
3,GO REGULATION OF INTEGRIN ACTIVATION,0.00010462,-0.29321,-0.32558,1,0
3,GO HOMOTYPIC CELL CELL ADHESION,4.1617e-05,-0.29375,-0.31832,1,0
3,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.027803,-0.29423,-0.30208,1,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,7.0571e-06,-0.29463,-0.30316,1,0
3,GO SPLEEN DEVELOPMENT,1.4044e-06,-0.29584,-0.28265,1,0
3,GO OSTEOBLAST PROLIFERATION,0.00010462,-0.29629,-0.3177,1,0
3,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,9.0179e-06,-0.29686,-0.29205,1,0
3,GO DECIDUALIZATION,0.0038387,-0.29723,-0.29606,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,1.9904e-06,-0.29804,-0.33319,1,0
3,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00038934,-0.2983,-0.32016,1,0
3,GO ANOIKIS,1.104e-05,-0.29847,-0.32652,1,0
3,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.020205,-0.29852,-0.27063,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.00054072,-0.29897,-0.33388,1,0
3,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.023205,-0.29949,-0.23421,1,0
3,GO T HELPER CELL LINEAGE COMMITMENT,4.8379e-05,-0.30004,-0.27867,1,0
3,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.0075304,-0.30162,-0.26013,1,0
3,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.0028957,-0.3024,-0.25799,1,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,1.0184e-05,-0.30264,-0.28678,1,0
3,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.0054795,-0.30381,-0.29111,1,0
3,GO ALPHA BETA T CELL PROLIFERATION,1.7806e-05,-0.30409,-0.34839,1,0
3,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.0059384,-0.30429,-0.41633,1,0
3,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.00042998,-0.30511,-0.32144,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,3.9926e-07,-0.3054,-0.31235,1,0
3,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.017137,-0.30542,-0.47191,1,0
3,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00037661,-0.30585,-0.29082,1,0
3,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0079323,-0.30608,-0.25945,1,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,3.7145e-05,-0.30622,-0.36877,1,0
3,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,3.3132e-05,-0.30958,-0.33903,1,0
3,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.0087944,-0.31152,-0.43355,1,0
3,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,6.0504e-05,-0.31164,-0.4274,1,0
3,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,6.2367e-06,-0.31241,-0.29558,1,0
3,GO RESPONSE TO NITROSATIVE STRESS,0.00010092,-0.31387,-0.41922,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,9.7801e-06,-0.316,-0.30444,1,0
3,GO T CELL LINEAGE COMMITMENT,3.7145e-05,-0.31675,-0.28651,1,0
3,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0010528,-0.31782,-0.3985,1,0
3,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.014138,-0.31831,-0.24614,1,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,7.2754e-05,-0.3189,-0.30745,1,0
3,GO NATURAL KILLER CELL PROLIFERATION,0.00022676,-0.31933,-0.35296,1,0
3,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00012512,-0.31948,-0.27264,1,0
3,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,9.7346e-05,-0.32053,-0.26301,1,0
3,GO EMBRYONIC PLACENTA DEVELOPMENT,2.5774e-06,-0.32067,-0.35368,1,0
3,GO BARBED END ACTIN FILAMENT CAPPING,0.00013433,-0.32067,-0.4067,1,0
3,GO ETHER METABOLIC PROCESS,0.00024286,-0.32158,-0.3238,1,0
3,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.0081404,-0.32171,-0.29305,1,0
3,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00010092,-0.32231,-0.41032,1,0
3,GO REGULATION OF NECROTIC CELL DEATH,0.00022676,-0.32293,-0.31857,1,0
3,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00029782,-0.32306,-0.3267,1,0
3,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.0053338,-0.32368,-0.23044,1,0
3,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.00087311,-0.32478,-0.33323,1,0
3,GO NEGATIVE REGULATION OF VIRAL PROCESS,2.4346e-05,-0.32514,-0.37414,1,0
3,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,3.17e-07,-0.32574,-0.36739,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,1.906e-06,-0.32644,-0.35873,1,0
3,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,9.0551e-05,-0.32649,-0.49659,1,0
3,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0062634,-0.32858,-0.25416,1,0
3,GO LEFT RIGHT PATTERN FORMATION,0.00012964,-0.32909,-0.30426,1,0
3,GO KERATINOCYTE DEVELOPMENT,0.025414,-0.33042,-0.28399,1,0
3,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.031059,-0.33255,-0.23364,1,0
3,GO BILE ACID AND BILE SALT TRANSPORT,3.5759e-05,-0.33346,-0.36409,1,0
3,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,9.3916e-06,-0.33422,-0.36738,1,0
3,GO PROGESTERONE METABOLIC PROCESS,0.00044439,-0.3345,-0.46742,1,0
3,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00063551,-0.33785,-0.39231,1,0
3,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,5.8301e-05,-0.33818,-0.3144,1,0
3,GO HEMATOPOIETIC STEM CELL PROLIFERATION,1.4044e-06,-0.33845,-0.33214,1,0
3,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.0010206,-0.33953,-0.36921,1,0
3,GO SUPEROXIDE ANION GENERATION,0.00017186,-0.34021,-0.32774,1,0
3,GO TRANSPOSITION,1.7118e-05,-0.34022,-0.41665,1,0
3,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.0019282,-0.34024,-0.27362,1,0
3,GO ZYMOGEN INHIBITION,0.00018427,-0.34126,-0.40275,1,0
3,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.00054072,-0.3422,-0.34746,1,0
3,GO RESPONSE TO INTERFERON ALPHA,0.0024367,-0.34261,-0.46016,1,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,4.3218e-05,-0.34314,-0.35544,1,0
3,GO PROSTANOID METABOLIC PROCESS,2.3418e-05,-0.34391,-0.43093,1,0
3,GO DETECTION OF OTHER ORGANISM,4.3218e-05,-0.34508,-0.39188,1,0
3,GO IMMUNOLOGICAL MEMORY PROCESS,8.1192e-05,-0.34512,-0.34359,1,0
3,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,0.0069616,-0.34711,-0.41594,1,0
3,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,6.7596e-05,-0.34729,-0.42145,1,0
3,GO LIPID TRANSLOCATION,1.8251e-06,-0.34769,-0.32187,1,0
3,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,8.1192e-05,-0.34789,-0.33195,1,0
3,GO EPIDERMAL CELL DIFFERENTIATION,9.7801e-06,-0.34994,-0.32441,1,0
3,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0031536,-0.3503,-0.31511,1,0
3,GO HISTAMINE SECRETION,0.004408,-0.35224,-0.34449,1,0
3,GO LATE ENDOSOME TO VACUOLE TRANSPORT,5.2533e-07,-0.35314,-0.34367,1,0
3,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.00010462,-0.35389,-0.41795,1,0
3,GO MITOTIC CYTOKINETIC PROCESS,5.1671e-08,-0.35462,-0.38135,1,0
3,GO KERATINOCYTE DIFFERENTIATION,1.104e-05,-0.35542,-0.33714,1,0
3,GO GONADOTROPIN SECRETION,0.00055855,-0.35713,-0.35836,1,0
3,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.0021062,-0.35735,-0.34442,1,0
3,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,2.8891e-07,-0.35749,-0.37725,1,0
3,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.0016129,-0.35752,-0.4848,1,0
3,GO ENDOTHELIAL CELL CHEMOTAXIS,7.2754e-05,-0.35926,-0.38583,1,0
3,GO PROTEIN ADP RIBOSYLATION,1.1493e-05,-0.35936,-0.31088,1,0
3,GO POSITIVE REGULATION OF COAGULATION,2.8077e-06,-0.35968,-0.36426,1,0
3,GO AMINE BIOSYNTHETIC PROCESS,0.0039469,-0.35989,-0.27633,1,0
3,GO VIRAL BUDDING,4.1802e-07,-0.36018,-0.30959,1,0
3,GO REGULATION OF ANOIKIS,3.5759e-05,-0.36079,-0.41494,1,0
3,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.0014299,-0.36235,-0.41913,1,0
3,GO ENDOTHELIAL CELL MORPHOGENESIS,0.0021062,-0.36436,-0.37608,1,0
3,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.00016595,-0.36442,-0.39438,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.0079323,-0.36585,-0.46838,1,0
3,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,5.4977e-07,-0.36655,-0.37184,1,0
3,GO HEPATOCYTE DIFFERENTIATION,0.00072223,-0.36744,-0.33667,1,0
3,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,4.0073e-05,-0.36865,-0.39858,1,0
3,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0021062,-0.36881,-0.41526,1,0
3,GO RESPONSE TO INTERFERON BETA,0.0015189,-0.36925,-0.47942,1,0
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,5.2837e-06,-0.36938,-0.38245,1,0
3,GO ADRENAL GLAND DEVELOPMENT,0.00045924,-0.36996,-0.30908,1,0
3,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.00016595,-0.3702,-0.37092,1,0
3,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,7.3528e-06,-0.37291,-0.4365,1,0
3,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00027832,-0.37409,-0.36678,1,0
3,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,1.6455e-05,-0.37503,-0.39173,1,0
3,GO LUNG EPITHELIUM DEVELOPMENT,0.0010528,-0.37541,-0.29342,1,0
3,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,2.9532e-05,-0.37623,-0.38386,1,0
3,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.035393,-0.37892,-0.28382,1,0
3,GO GAP JUNCTION ASSEMBLY,3.8583e-05,-0.37954,-0.47572,1,0
3,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,1.4039e-05,-0.37995,-0.37162,1,0
3,GO RESPONSE TO MUSCLE INACTIVITY,2.9532e-05,-0.38095,-0.37791,1,0
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,1.9263e-05,-0.3813,-0.36927,1,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,3.3132e-05,-0.38141,-0.47901,1,0
3,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.0014738,-0.38151,-0.48088,1,0
3,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,1.5201e-05,-0.3827,-0.38461,1,0
3,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.0017641,-0.38506,-0.33924,1,0
3,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00017186,-0.38724,-0.38847,1,0
3,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,2.2879e-07,-0.38762,-0.46097,1,0
3,GO POSITIVE REGULATION OF CELL MATURATION,7.8282e-05,-0.38891,-0.42751,1,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,6.0504e-05,-0.38909,-0.49545,1,0
3,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.00092958,-0.39007,-0.34123,1,0
3,GO INTERFERON ALPHA PRODUCTION,9.4334e-07,-0.39028,-0.38184,1,0
3,GO TOXIN METABOLIC PROCESS,0.010506,-0.39189,-0.28136,1,0
3,GO DNA DEAMINATION,0.001191,-0.39408,-0.37956,1,0
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,1.5816e-05,-0.3966,-0.39359,1,0
3,GO RESPONSE TO TYPE I INTERFERON,1.5816e-05,-0.3972,-0.51811,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,5.0194e-07,-0.40082,-0.44143,1,0
3,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,3.0689e-05,-0.40384,-0.38688,1,0
3,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,2.5774e-06,-0.40399,-0.41128,1,0
3,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,3.3287e-06,-0.40454,-0.44126,1,0
3,GO INFLAMMATORY RESPONSE TO WOUNDING,0.038561,-0.40676,-0.32394,1,0
3,GO PARAXIAL MESODERM DEVELOPMENT,0.00040247,-0.4106,-0.35141,1,0
3,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,4.6623e-06,-0.41442,-0.5307,1,0
3,GO REGULATION OF PLATELET AGGREGATION,7.8282e-05,-0.41461,-0.4927,1,0
3,GO REGULATION OF TRANSPOSITION,7.9801e-06,-0.4174,-0.47822,1,0
3,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,3.1888e-05,-0.41765,-0.35528,1,0
3,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,2.2879e-07,-0.41917,-0.37594,1,0
3,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.0025817,-0.41948,-0.3296,1,0
3,GO TOLERANCE INDUCTION,0.00035231,-0.41976,-0.4532,1,0
3,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,6.4994e-06,-0.42159,-0.52534,1,0
3,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,6.2786e-05,-0.42252,-0.46546,1,0
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,1.6015e-06,-0.4252,-0.49017,1,0
3,GO KERATINIZATION,2.7343e-05,-0.42753,-0.36981,1,0
3,GO POSITIVE REGULATION OF WOUND HEALING,5.2533e-07,-0.42842,-0.47284,1,0
3,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,3.7145e-05,-0.4294,-0.39364,1,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,8.1192e-05,-0.4321,-0.41443,1,0
3,GO MAINTENANCE OF BLOOD BRAIN BARRIER,1.2366e-07,-0.43419,-0.49423,1,0
3,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.00013917,-0.43491,-0.44366,1,0
3,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.0019282,-0.43953,-0.34183,1,0
3,GO LEYDIG CELL DIFFERENTIATION,0.001986,-0.44113,-0.40441,1,0
3,GO REGULATION OF TOLERANCE INDUCTION,2.6902e-06,-0.44317,-0.50979,1,0
3,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,1.4268e-07,-0.44578,-0.45789,1,0
3,GO RESPONSE TO INTERLEUKIN 18,0.00017796,-0.44644,-0.5171,1,0
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,9.7801e-06,-0.45496,-0.55607,1,0
3,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.00042998,-0.45839,-0.45926,1,0
3,GO CORNIFICATION,3.5759e-05,-0.45883,-0.41776,1,0
3,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,5.0226e-05,-0.45926,-0.63387,1,0
3,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,7.2754e-05,-0.46042,-0.40321,1,0
3,GO CELLULAR RESPONSE TO NITROGEN STARVATION,5.7413e-06,-0.46129,-0.46877,1,0
3,GO LABYRINTHINE LAYER DEVELOPMENT,1.2962e-05,-0.46211,-0.39934,1,0
3,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.00017186,-0.46555,-0.43602,1,0
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.00065623,-0.46852,-0.37734,1,0
3,GO RESPONSE TO WATER,6.7596e-05,-0.46905,-0.42596,1,0
3,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.0013872,-0.4696,-0.39297,1,0
3,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,5.508e-06,-0.47602,-0.47528,1,0
3,GO CELL CELL JUNCTION MAINTENANCE,0.00036427,-0.48016,-0.39339,1,0
3,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,1.1964e-05,-0.48384,-0.45744,1,0
3,GO MIDBODY ABSCISSION,1.5691e-07,-0.48641,-0.48507,1,0
3,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,3.9418e-06,-0.49691,-0.52259,1,0
3,GO RESPONSE TO LITHIUM ION,3.7145e-05,-0.49709,-0.47986,1,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00095906,-0.50367,-0.36502,1,0
3,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,9.3916e-06,-0.50832,-0.45937,1,0
3,GO SEROTONIN METABOLIC PROCESS,0.011326,-0.50881,-0.31563,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,2.4692e-06,-0.51142,-0.47635,1,0
3,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.00050664,-0.52989,-0.49198,1,0
3,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,4.6597e-05,-0.5309,-0.47422,1,0
3,GO PROTEIN AUTO ADP RIBOSYLATION,5.6174e-05,-0.53712,-0.45348,1,0
3,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0045306,-0.53873,-0.35833,1,0
3,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,5.2837e-06,-0.55036,-0.52776,1,0
3,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,2.2524e-05,-0.55124,-0.4387,1,0
3,GO EPITHELIAL CELL MORPHOGENESIS,4.1112e-06,-0.5572,-0.53601,1,0
3,GO APICAL JUNCTION ASSEMBLY,4.9191e-08,-0.56098,-0.52845,1,0
3,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.00021909,-0.56212,-0.45463,1,0
3,GO REGULATION OF WATER LOSS VIA SKIN,0.00032948,-0.57307,-0.47633,1,0
3,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,4.4712e-06,-0.57605,-0.58621,1,0
3,GO NEGATIVE REGULATION OF ANOIKIS,2.8077e-06,-0.57759,-0.60574,1,0
3,GO ENTRY OF BACTERIUM INTO HOST CELL,2.3418e-05,-0.57882,-0.57934,1,0
3,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,9.389e-05,-0.58673,-0.52029,1,0
3,GO PSEUDOPODIUM ORGANIZATION,0.00020448,-0.5905,-0.44339,1,0
3,GO MUCUS SECRETION,0.00084609,-0.60014,-0.52376,1,0
3,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,2.1702e-06,-0.61866,-0.60316,1,0
3,GO CYTIDINE TO URIDINE EDITING,0.0001165,-0.61921,-0.65655,1,0
3,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,4.3218e-05,-0.64222,-0.63275,1,0
3,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,7.2754e-05,-0.64706,-0.7541,1,0
3,GO LUNG CELL DIFFERENTIATION,0.00012074,-0.65646,-0.51701,1,0
3,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,9.4334e-07,-0.67958,-0.63089,1,0
3,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,2.6322e-07,-0.74931,-0.65572,1,0
3,GO EPITHELIAL CELL CELL ADHESION,1.5691e-07,-0.7504,-0.79986,1,0
3,GO LIPID DROPLET FORMATION,7.3528e-06,-0.767,-0.68572,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,6.0504e-05,-0.8094,-0.88752,1,0
3,GO EMBRYONIC PLACENTA MORPHOGENESIS,2.8891e-07,-0.92382,-0.82664,1,0
3,GO NOSE DEVELOPMENT,0.0001547,-0.96706,-0.65925,1,0
3,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,5.0194e-07,-0.96787,-0.81736,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,7.8282e-05,-0.99536,-1.0952,1,0
3,GO HEPATOCYTE APOPTOTIC PROCESS,1.8084e-07,-0.99605,-1.0676,1,0
3,GO LABYRINTHINE LAYER MORPHOGENESIS,3.0264e-07,-1.0047,-0.89157,1,0
3,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,1.2308e-06,-1.1075,-0.9977,1,0
3,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.14048,0.3332,0.13527,0,1
3,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.079444,0.32819,0.20651,0,1
3,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.060602,0.30348,0.18271,0,1
3,GO GLYCINE METABOLIC PROCESS,0.054842,0.29931,0.20115,0,1
3,GO TOOTH MINERALIZATION,0.075049,0.29597,0.14282,0,1
3,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.054842,0.29297,0.1712,0,1
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.10465,0.27498,0.12566,0,1
3,GO ACTIVATION OF MAPKKK ACTIVITY,0.054842,0.24402,0.13174,0,1
3,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.079444,0.23858,0.17847,0,1
3,GO THALAMUS DEVELOPMENT,0.42347,0.211,0.095315,0,1
3,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.05824,0.2088,0.19463,0,1
3,GO NEUROBLAST DIVISION,0.10465,0.20113,0.16202,0,1
3,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.14285,0.19643,0.11303,0,1
3,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.10654,0.19335,0.18023,0,1
3,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.30402,0.18828,0.071766,0,1
3,GO NEURAL CREST CELL MIGRATION,0.064293,0.18719,0.12956,0,1
3,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.2839,0.18712,0.13208,0,1
3,GO COCHLEA MORPHOGENESIS,0.070855,0.185,0.11256,0,1
3,GO TETRAHYDROFOLATE INTERCONVERSION,0.12908,0.18381,0.11776,0,1
3,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.065563,0.17947,0.11335,0,1
3,GO BASIC AMINO ACID TRANSPORT,0.13583,0.17471,0.16587,0,1
3,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.092194,0.1745,0.11047,0,1
3,GO PROSTATE GLAND GROWTH,0.17099,0.17216,0.068806,0,1
3,GO STABILIZATION OF MEMBRANE POTENTIAL,0.51459,0.17098,0.078423,0,1
3,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.20937,0.16977,0.091043,0,1
3,GO FIBROBLAST APOPTOTIC PROCESS,0.099158,0.1652,0.11653,0,1
3,GO ODONTOGENESIS,0.13814,0.16051,0.075846,0,1
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.061812,0.15431,0.10314,0,1
3,GO NUCLEUS LOCALIZATION,0.082489,0.15271,0.095375,0,1
3,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.072231,0.14838,0.1029,0,1
3,GO BONE MORPHOGENESIS,0.10654,0.1475,0.072442,0,1
3,GO CELLULAR HYPEROSMOTIC RESPONSE,0.26098,0.14593,0.088138,0,1
3,GO MUSCLE CELL FATE COMMITMENT,0.2839,0.14515,0.061047,0,1
3,GO REGULATION OF RIBOSOME BIOGENESIS,0.11235,0.13913,0.10017,0,1
3,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.10096,0.13825,0.077172,0,1
3,GO MESODERMAL CELL FATE COMMITMENT,0.28785,0.13813,0.055579,0,1
3,GO T CELL HOMEOSTASIS,0.12689,0.13464,0.053061,0,1
3,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.064293,0.1315,0.14118,0,1
3,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.075049,0.12975,0.11657,0,1
3,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.27999,0.1293,0.10607,0,1
3,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.20937,0.12905,0.064557,0,1
3,GO AORTIC VALVE DEVELOPMENT,0.18508,0.12903,0.083409,0,1
3,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.52594,0.12846,0.04104,0,1
3,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0695,0.1279,0.11656,0,1
3,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.13583,0.12709,0.104,0,1
3,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.12908,0.1266,0.11207,0,1
3,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.29184,0.12632,0.084081,0,1
3,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.057089,0.12452,0.17914,0,1
3,GO SMOOTH MUSCLE CONTRACTION,0.11636,0.12434,0.063471,0,1
3,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.53167,0.12415,0.026669,0,1
3,GO NEUROBLAST PROLIFERATION,0.14048,0.12256,0.087126,0,1
3,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.093897,0.12094,0.068757,0,1
3,GO MONOSACCHARIDE CATABOLIC PROCESS,0.19695,0.12009,0.063184,0,1
3,GO LYMPH VESSEL DEVELOPMENT,0.14769,0.11937,0.073455,0,1
3,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.16294,0.11889,0.09017,0,1
3,GO MITOCHONDRIAL RNA PROCESSING,0.070855,0.11661,0.15768,0,1
3,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.066855,0.11658,0.080127,0,1
3,GO RESPONSE TO PARATHYROID HORMONE,0.16828,0.11045,0.16887,0,1
3,GO TRIGLYCERIDE CATABOLIC PROCESS,0.25001,0.11002,0.084059,0,1
3,GO SLEEP,0.29184,0.10954,0.05629,0,1
3,GO HEART VALVE DEVELOPMENT,0.27227,0.10804,0.063939,0,1
3,GO ALDEHYDE CATABOLIC PROCESS,0.064293,0.10773,0.10406,0,1
3,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.21905,0.1076,0.065025,0,1
3,GO COENZYME A BIOSYNTHETIC PROCESS,0.26847,0.10608,0.07133,0,1
3,GO SECRETORY GRANULE ORGANIZATION,0.22568,0.10553,0.055856,0,1
3,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.12908,0.10451,0.12432,0,1
3,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.59059,0.10414,0.032692,0,1
3,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.075049,0.10372,0.095769,0,1
3,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.17099,0.10112,0.059583,0,1
3,GO RESPONSE TO LEAD ION,0.2,0.099167,0.066486,0,1
3,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.10654,0.096015,0.079689,0,1
3,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.068167,0.09548,0.080124,0,1
3,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.070855,0.095187,0.082986,0,1
3,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.070855,0.093583,0.11512,0,1
3,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.44402,0.093148,0.037235,0,1
3,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.092194,0.09236,0.080909,0,1
3,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.072231,0.09215,0.069895,0,1
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.095625,0.091975,0.14316,0,1
3,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.12908,0.091841,0.068493,0,1
3,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.073629,0.090744,0.0655,0,1
3,GO AMINO ACID ACTIVATION,0.17099,0.089177,0.096164,0,1
3,GO RNA STABILIZATION,0.13583,0.088143,0.071223,0,1
3,GO CELLULAR RESPONSE TO UV,0.090515,0.086893,0.060283,0,1
3,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.30815,0.085366,0.044127,0,1
3,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.075049,0.084777,0.056319,0,1
3,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.38408,0.084446,0.047501,0,1
3,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.29184,0.083715,0.0484,0,1
3,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.11434,0.082719,0.083548,0,1
3,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.25363,0.081677,0.04365,0,1
3,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.095625,0.080499,0.080015,0,1
3,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.082489,0.076793,0.056017,0,1
3,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.55487,0.076436,0.026264,0,1
3,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.17653,0.075733,0.040967,0,1
3,GO ASTRAL MICROTUBULE ORGANIZATION,0.37932,0.075513,0.046886,0,1
3,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.068167,0.073734,0.06478,0,1
3,GO HISTONE H3 K36 METHYLATION,0.51459,0.07244,0.031562,0,1
3,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.12049,0.071179,0.052823,0,1
3,GO ESTROGEN BIOSYNTHETIC PROCESS,0.60272,0.070872,0.029586,0,1
3,GO REGULATION OF HISTONE PHOSPHORYLATION,0.37932,0.069578,0.054866,0,1
3,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.059411,0.068576,0.062462,0,1
3,GO MITOCHONDRIAL FISSION,0.17934,0.066962,0.067096,0,1
3,GO ATP DEPENDENT CHROMATIN REMODELING,0.060602,0.065935,0.06487,0,1
3,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.063042,0.064006,0.038941,0,1
3,GO EMBRYONIC AXIS SPECIFICATION,0.42855,0.063734,0.056971,0,1
3,GO MISMATCH REPAIR,0.26098,0.061634,0.040266,0,1
3,GO RNA CAPPING,0.087232,0.061067,0.064207,0,1
3,GO HISTONE DEUBIQUITINATION,0.22905,0.058474,0.029267,0,1
3,GO PEPTIDYL LYSINE DIMETHYLATION,0.088862,0.057756,0.05304,0,1
3,GO CHROMOSOME CONDENSATION,0.10465,0.056019,0.064779,0,1
3,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.32506,0.052067,0.043894,0,1
3,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.25363,0.050937,0.02684,0,1
3,GO PROTEIN LOCALIZATION TO MEMBRANE,0.11434,0.050566,0.041946,0,1
3,GO REGULATION OF HISTONE UBIQUITINATION,0.33373,0.048465,0.043883,0,1
3,GO MRNA TRANSPORT,0.095625,0.047191,0.05429,0,1
3,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.14285,0.041947,0.040574,0,1
3,GO MITOCHONDRION ORGANIZATION,0.17653,0.038028,0.029368,0,1
3,GO DNA REPAIR,0.077957,0.037393,0.035463,0,1
3,GO REGULATION OF HISTONE METHYLATION,0.15773,0.036244,0.048961,0,1
3,GO CELL CYCLE G2 M PHASE TRANSITION,0.17099,0.0333,0.029814,0,1
3,GO REGULATION OF CHROMOSOME ORGANIZATION,0.16828,0.022592,0.024635,0,1
3,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,2.3418e-05,0.58202,0.62154,0,0
3,GO DENSE CORE GRANULE TRANSPORT,0.00041602,0.57831,0.51559,0,0
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.00059588,0.56333,0.5821,0,0
3,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,4.1617e-05,0.52422,0.50849,0,0
3,GO NEURON CELLULAR HOMEOSTASIS,1.5331e-06,0.49745,0.49407,0,0
3,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.0047853,0.45378,0.36699,0,0
3,GO SYNAPTIC MEMBRANE ADHESION,0.00038934,0.44341,0.47686,0,0
3,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.020205,0.4197,0.32519,0,0
3,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.010773,0.38101,0.2694,0,0
3,GO ANATOMICAL STRUCTURE REGRESSION,0.0049174,0.37793,0.30971,0,0
3,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,9.0551e-05,0.37466,0.4369,0,0
3,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.00028792,0.37316,0.34224,0,0
3,GO REGULATION OF VESICLE FUSION,4.4878e-05,0.36279,0.4105,0,0
3,GO SYNAPTIC VESICLE CLUSTERING,0.00090094,0.36122,0.49279,0,0
3,GO PROTEIN TRIMERIZATION,0.00022676,0.3573,0.36141,0,0
3,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,7.013e-05,0.3558,0.41317,0,0
3,GO SHORT TERM MEMORY,0.0022332,0.35017,0.32134,0,0
3,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.021165,0.34351,0.2709,0,0
3,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.03939,0.33738,0.25131,0,0
3,GO DENDRITIC SPINE MORPHOGENESIS,2.1663e-05,0.32993,0.32988,0,0
3,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.00031859,0.32762,0.38047,0,0
3,GO REGULATION OF NEURON MIGRATION,0.00036427,0.32467,0.28077,0,0
3,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.0067808,0.32231,0.3593,0,0
3,GO NEUROTRANSMITTER REUPTAKE,0.00029782,0.31881,0.30582,0,0
3,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.053746,0.31706,0.17246,0,0
3,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.027188,0.31677,0.24137,0,0
3,GO PREPULSE INHIBITION,0.011047,0.31329,0.33627,0,0
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0047853,0.3128,0.27844,0,0
3,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00042998,0.30979,0.37234,0,0
3,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.00017186,0.30909,0.303,0,0
3,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.0010528,0.30801,0.47087,0,0
3,GO REGULATION OF HIPPO SIGNALING,0.087232,0.30609,0.1616,0,0
3,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.21256,0.29727,0.11575,0,0
3,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.031748,0.29573,0.37958,0,0
3,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,4.4878e-05,0.2951,0.38378,0,0
3,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,4.2876e-06,0.28722,0.38318,0,0
3,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.0075304,0.28483,0.24571,0,0
3,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.0057817,0.28372,0.27887,0,0
3,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0010859,0.28339,0.25764,0,0
3,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.015953,0.28339,0.195,0,0
3,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.0027346,0.28208,0.29485,0,0
3,GO REGULATION OF POSTSYNAPSE ORGANIZATION,1.9263e-05,0.2812,0.29651,0,0
3,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,9.389e-05,0.27784,0.31439,0,0
3,GO VOCALIZATION BEHAVIOR,0.030383,0.27735,0.35457,0,0
3,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.029068,0.27701,0.172,0,0
3,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.0064317,0.27528,0.21508,0,0
3,GO ARGININE METABOLIC PROCESS,0.0079323,0.27497,0.29089,0,0
3,GO GLUTAMATE SECRETION,0.00029782,0.27482,0.30144,0,0
3,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00016023,0.27422,0.2883,0,0
3,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0010859,0.27257,0.30115,0,0
3,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.077957,0.2721,0.20978,0,0
3,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.018398,0.27165,0.20893,0,0
3,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.012203,0.2705,0.32617,0,0
3,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,9.0551e-05,0.2694,0.31875,0,0
3,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.013465,0.26825,0.30375,0,0
3,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0031536,0.26779,0.27331,0,0
3,GO EXTRACELLULAR MATRIX ASSEMBLY,0.0011199,0.26595,0.24764,0,0
3,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.019739,0.2609,0.27203,0,0
3,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.2,0.25982,0.18244,0,0
3,GO HOMOCYSTEINE METABOLIC PROCESS,0.0038387,0.25753,0.34078,0,0
3,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00019753,0.25151,0.27618,0,0
3,GO MITOCHONDRION LOCALIZATION,3.4421e-05,0.24872,0.21481,0,0
3,GO POSITIVE REGULATION OF VESICLE FUSION,0.11235,0.2487,0.20634,0,0
3,GO REGULATION OF SYNAPTIC PLASTICITY,0.00035231,0.24686,0.23419,0,0
3,GO REGULATION OF DOPAMINE SECRETION,0.025414,0.24193,0.30834,0,0
3,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.0015653,0.2416,0.24139,0,0
3,GO REGULATION OF DENDRITE MORPHOGENESIS,2.0033e-05,0.2415,0.25324,0,0
3,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.0059384,0.24118,0.17636,0,0
3,GO NEUROTRANSMITTER UPTAKE,0.0012662,0.23757,0.23734,0,0
3,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.0056288,0.23754,0.21434,0,0
3,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.037747,0.23697,0.22179,0,0
3,GO RESPONSE TO HYPEROXIA,0.21905,0.23675,0.093777,0,0
3,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.033166,0.2364,0.23571,0,0
3,GO NEGATIVE REGULATION OF AXONOGENESIS,0.034637,0.2307,0.16896,0,0
3,GO EXPLORATION BEHAVIOR,0.0081404,0.22547,0.28578,0,0
3,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,6.7596e-05,0.22515,0.29582,0,0
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00019753,0.22483,0.2524,0,0
3,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.097379,0.22447,0.14673,0,0
3,GO SYNAPTIC VESICLE EXOCYTOSIS,3.1888e-05,0.22368,0.30447,0,0
3,GO SYNAPSE ORGANIZATION,9.0551e-05,0.22201,0.22157,0,0
3,GO POSTSYNAPSE ORGANIZATION,7.8282e-05,0.22101,0.24513,0,0
3,GO LONG TERM SYNAPTIC DEPRESSION,0.0087944,0.2208,0.20689,0,0
3,GO ENAMEL MINERALIZATION,0.19393,0.22049,0.12673,0,0
3,GO CELLULAR RESPONSE TO PH,0.00013433,0.21743,0.2188,0,0
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.05824,0.21712,0.14067,0,0
3,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.0027346,0.2165,0.26938,0,0
3,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.095625,0.21504,0.16926,0,0
3,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.023205,0.21365,0.20936,0,0
3,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.033894,0.21116,0.18694,0,0
3,GO NEURON RECOGNITION,0.014841,0.21085,0.20202,0,0
3,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.097379,0.21014,0.1369,0,0
3,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00021909,0.20953,0.26645,0,0
3,GO REGULATION OF SYNAPSE ASSEMBLY,0.00087311,0.20663,0.2178,0,0
3,GO DENDRITIC SPINE DEVELOPMENT,0.00016023,0.20566,0.23771,0,0
3,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.1028,0.20502,0.1412,0,0
3,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.00044439,0.20471,0.21521,0,0
3,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.0046564,0.20437,0.16281,0,0
3,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.0056288,0.20426,0.24748,0,0
3,GO REGULATION OF TUBULIN DEACETYLATION,0.027188,0.20276,0.20538,0,0
3,GO AXO DENDRITIC PROTEIN TRANSPORT,0.036948,0.20256,0.14063,0,0
3,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0062634,0.20156,0.21024,0,0
3,GO NEPHRIC DUCT MORPHOGENESIS,0.0695,0.20112,0.27288,0,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0079323,0.20082,0.20231,0,0
3,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.29586,0.20077,0.089066,0,0
3,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.3746,0.20026,0.1234,0,0
3,GO SEROTONIN TRANSPORT,0.092194,0.19987,0.13843,0,0
3,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.066855,0.19852,0.15497,0,0
3,GO SALIVARY GLAND DEVELOPMENT,0.12689,0.19843,0.1108,0,0
3,GO AMP METABOLIC PROCESS,0.14769,0.19832,0.097326,0,0
3,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.0022332,0.1974,0.26312,0,0
3,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.064293,0.197,0.15482,0,0
3,GO CGMP MEDIATED SIGNALING,0.022165,0.19695,0.13884,0,0
3,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.014138,0.19562,0.16247,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,0.15773,0.19313,0.1908,0,0
3,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.26471,0.19306,0.087065,0,0
3,GO DENDRITE SELF AVOIDANCE,0.041967,0.19194,0.1856,0,0
3,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00024286,0.19188,0.24956,0,0
3,GO REGULATION OF DENDRITE DEVELOPMENT,0.00012074,0.19017,0.20882,0,0
3,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.0006154,0.18942,0.15551,0,0
3,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.01282,0.18917,0.28102,0,0
3,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.31232,0.18914,0.10494,0,0
3,GO PROTEIN NITROSYLATION,0.020205,0.18795,0.19961,0,0
3,GO AXONAL FASCICULATION,0.066855,0.18785,0.20241,0,0
3,GO RESPONSE TO MANGANESE ION,0.095625,0.18754,0.10711,0,0
3,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.18219,0.18645,0.15957,0,0
3,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.0013054,0.18509,0.20822,0,0
3,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.011047,0.18468,0.17127,0,0
3,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.25001,0.18443,0.067083,0,0
3,GO FOREBRAIN CELL MIGRATION,0.00049035,0.18415,0.23235,0,0
3,GO RESPONSE TO MUSCLE ACTIVITY,0.11434,0.18411,0.11316,0,0
3,GO RESPONSE TO VITAMIN A,0.15015,0.18388,0.10886,0,0
3,GO CALCIUM ION IMPORT INTO CYTOSOL,0.024846,0.18345,0.22184,0,0
3,GO ONE CARBON METABOLIC PROCESS,0.013139,0.18303,0.13074,0,0
3,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.0695,0.18298,0.16604,0,0
3,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.045624,0.18289,0.16825,0,0
3,GO REGULATION OF CATION CHANNEL ACTIVITY,0.00026003,0.18249,0.2041,0,0
3,GO NEURON PROJECTION GUIDANCE,0.0056288,0.18235,0.16389,0,0
3,GO PRESYNAPSE ORGANIZATION,0.007729,0.18186,0.20793,0,0
3,GO MICROTUBULE DEPOLYMERIZATION,0.030383,0.18146,0.16576,0,0
3,GO DETECTION OF TEMPERATURE STIMULUS,0.15264,0.18144,0.16619,0,0
3,GO BEHAVIORAL RESPONSE TO PAIN,0.18508,0.18137,0.13887,0,0
3,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.049546,0.18136,0.15569,0,0
3,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.045624,0.18131,0.1476,0,0
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.0099891,0.18129,0.18737,0,0
3,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.12473,0.18122,0.10465,0,0
3,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.19095,0.1812,0.11729,0,0
3,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.055956,0.17964,0.1357,0,0
3,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.014841,0.17909,0.14522,0,0
3,GO MOTOR NEURON AXON GUIDANCE,0.012203,0.17899,0.17322,0,0
3,GO NEUROTRANSMITTER TRANSPORT,0.00084609,0.17881,0.23235,0,0
3,GO NEURON PROJECTION EXTENSION,0.00065623,0.1778,0.17702,0,0
3,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.1313,0.17674,0.16827,0,0
3,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.00069957,0.17671,0.2571,0,0
3,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.0081404,0.17668,0.20275,0,0
3,GO ACIDIC AMINO ACID TRANSPORT,0.00014935,0.17661,0.21319,0,0
3,GO LONG TERM MEMORY,0.0041716,0.17645,0.19976,0,0
3,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.1313,0.17567,0.12315,0,0
3,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.092194,0.17496,0.12255,0,0
3,GO MIDDLE EAR MORPHOGENESIS,0.41341,0.17478,0.035279,0,0
3,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.0028957,0.17417,0.18703,0,0
3,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.21256,0.17362,0.047425,0,0
3,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.20309,0.17338,0.15988,0,0
3,GO RELAXATION OF MUSCLE,0.082489,0.17281,0.12867,0,0
3,GO LEUKOCYTE AGGREGATION,0.077957,0.17168,0.13519,0,0
3,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.077957,0.17053,0.092339,0,0
3,GO KIDNEY MESENCHYME DEVELOPMENT,0.027803,0.17038,0.1883,0,0
3,GO MINERALOCORTICOID METABOLIC PROCESS,0.22905,0.17035,0.096224,0,0
3,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.0011549,0.17007,0.27365,0,0
3,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.00353,0.16997,0.15308,0,0
3,GO NEUROTRANSMITTER SECRETION,0.0013054,0.16961,0.24314,0,0
3,GO NADH METABOLIC PROCESS,0.0020453,0.16892,0.23118,0,0
3,GO HEME METABOLIC PROCESS,0.13814,0.16832,0.099533,0,0
3,GO NEGATIVE REGULATION OF AXON EXTENSION,0.0073363,0.1681,0.19008,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.059411,0.16806,0.13846,0,0
3,GO TONIC SMOOTH MUSCLE CONTRACTION,0.092194,0.16715,0.09528,0,0
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.0075304,0.16634,0.16894,0,0
3,GO RESPONSE TO ACETYLCHOLINE,0.04854,0.16384,0.18446,0,0
3,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.10654,0.163,0.088909,0,0
3,GO POST ANAL TAIL MORPHOGENESIS,0.13583,0.16295,0.09286,0,0
3,GO DENDRITE MORPHOGENESIS,0.0014738,0.16149,0.18245,0,0
3,GO RESPONSE TO AMINE,0.0094949,0.16148,0.17707,0,0
3,GO CARDIAC CONDUCTION,0.010773,0.16145,0.15299,0,0
3,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.082489,0.16141,0.11853,0,0
3,GO RECEPTOR CLUSTERING,0.065563,0.16141,0.10745,0,0
3,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.12908,0.16023,0.13459,0,0
3,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.18508,0.16014,0.11315,0,0
3,GO RESPONSE TO PROTOZOAN,0.55487,0.15933,0.020455,0,0
3,GO FOREBRAIN NEURON DEVELOPMENT,0.11235,0.1591,0.15054,0,0
3,GO HEPARIN METABOLIC PROCESS,0.045624,0.15858,0.22973,0,0
3,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.00081984,0.15747,0.20098,0,0
3,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.015203,0.15686,0.17096,0,0
3,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.033894,0.15562,0.12154,0,0
3,GO NEURONAL ION CHANNEL CLUSTERING,0.1313,0.15494,0.20744,0,0
3,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.060602,0.15474,0.11877,0,0
3,GO NEPHRIC DUCT DEVELOPMENT,0.20937,0.15455,0.1298,0,0
3,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.30815,0.15376,0.0535,0,0
3,GO THYROID GLAND DEVELOPMENT,0.022165,0.15356,0.18117,0,0
3,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.13814,0.15332,0.096099,0,0
3,GO VASCULOGENESIS,0.32077,0.15279,0.034338,0,0
3,GO IMPORT INTO CELL,0.00031859,0.15268,0.16949,0,0
3,GO RESPONSE TO CAFFEINE,0.10096,0.15263,0.1189,0,0
3,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.029068,0.15185,0.30318,0,0
3,GO NERVE DEVELOPMENT,0.11841,0.15175,0.09633,0,0
3,GO DENDRITE DEVELOPMENT,0.00087311,0.15132,0.17742,0,0
3,GO REGULATION OF CARDIAC CONDUCTION,0.024846,0.15042,0.12439,0,0
3,GO RESPIRATORY SYSTEM PROCESS,0.010506,0.14997,0.14022,0,0
3,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.15517,0.14983,0.13446,0,0
3,GO MEMBRANE REPOLARIZATION,0.014138,0.14965,0.13738,0,0
3,GO XENOBIOTIC TRANSPORT,0.23937,0.14962,0.036327,0,0
3,GO AXON EXTENSION,0.0028957,0.14933,0.15833,0,0
3,GO SYNAPSE ASSEMBLY,0.012203,0.1488,0.16867,0,0
3,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.0087944,0.14827,0.14805,0,0
3,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.044685,0.1478,0.14767,0,0
3,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.12908,0.14773,0.09882,0,0
3,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.017137,0.14759,0.15602,0,0
3,GO BASEMENT MEMBRANE ASSEMBLY,0.054842,0.14706,0.17956,0,0
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.68418,0.14644,0.042439,0,0
3,GO COLLATERAL SPROUTING,0.02843,0.14592,0.15473,0,0
3,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.34702,0.14582,0.067119,0,0
3,GO BONE TRABECULA MORPHOGENESIS,0.12259,0.14555,0.1142,0,0
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.047551,0.14515,0.10055,0,0
3,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.013798,0.14497,0.14402,0,0
3,GO FIBRINOLYSIS,0.27227,0.14489,-0.014555,0,0
3,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.084046,0.14438,0.14979,0,0
3,GO DEVELOPMENTAL CELL GROWTH,0.00074557,0.14342,0.149,0,0
3,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.16294,0.14334,0.094518,0,0
3,GO TRICARBOXYLIC ACID CYCLE,0.0064317,0.14323,0.14307,0,0
3,GO BEHAVIORAL RESPONSE TO COCAINE,0.20621,0.14262,0.15547,0,0
3,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.47588,0.14236,-0.15827,0,0
3,GO PROTEIN ACTIVATION CASCADE,0.68418,0.14226,-0.019158,0,0
3,GO REGULATION OF AXON GUIDANCE,0.059411,0.14205,0.091043,0,0
3,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.18219,0.14187,0.077712,0,0
3,GO LIPID IMPORT INTO CELL,0.27999,0.14127,0.061506,0,0
3,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.24643,0.14089,0.051468,0,0
3,GO REGULATION OF AXONOGENESIS,0.012203,0.13962,0.14762,0,0
3,GO CELL AGGREGATION,0.073629,0.13892,0.10884,0,0
3,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0011549,0.13884,0.15637,0,0
3,GO ALANINE TRANSPORT,0.14048,0.13877,0.13747,0,0
3,GO RESPONSE TO UV B,0.89215,0.13872,-0.044541,0,0
3,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.26471,0.13871,0.055067,0,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.03939,0.13858,0.17548,0,0
3,GO SYNAPTIC VESICLE RECYCLING,0.029719,0.13856,0.14167,0,0
3,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.097379,0.13833,0.14589,0,0
3,GO CELLULAR RESPONSE TO MANGANESE ION,0.060602,0.13743,0.11847,0,0
3,GO REGULATION OF PLASMINOGEN ACTIVATION,0.47049,0.13733,-0.044057,0,0
3,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.033894,0.13709,0.18228,0,0
3,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.0033369,0.13635,0.21006,0,0
3,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.13583,0.13599,0.14502,0,0
3,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.009256,0.13573,0.11999,0,0
3,GO PARENTAL BEHAVIOR,0.27611,0.13494,0.093322,0,0
3,GO PROTEIN LOCALIZATION TO SYNAPSE,0.0090226,0.13417,0.19615,0,0
3,GO STARTLE RESPONSE,0.22235,0.13404,0.12204,0,0
3,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.092194,0.1338,0.0909,0,0
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0026572,0.13362,0.13974,0,0
3,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.18219,0.13362,0.096613,0,0
3,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.0038387,0.13277,0.1505,0,0
3,GO NEUROMUSCULAR PROCESS,0.0060989,0.13239,0.14602,0,0
3,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.15773,0.13179,0.072583,0,0
3,GO LIMBIC SYSTEM DEVELOPMENT,0.04854,0.13163,0.11612,0,0
3,GO REGULATION OF EXTENT OF CELL GROWTH,0.0030654,0.13151,0.15901,0,0
3,GO COLLAGEN FIBRIL ORGANIZATION,0.11841,0.13124,0.05568,0,0
3,GO PROTEIN OXIDATION,0.12049,0.13088,0.072808,0,0
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.17374,0.13022,0.10472,0,0
3,GO PRESYNAPTIC ENDOCYTOSIS,0.034637,0.13006,0.14386,0,0
3,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.20621,0.12996,0.08712,0,0
3,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.085627,0.12959,0.12237,0,0
3,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.054842,0.12954,0.15753,0,0
3,GO REGULATION OF STEROL TRANSPORT,0.49227,0.12951,0.027337,0,0
3,GO REGULATION OF MEMBRANE POTENTIAL,0.02166,0.12912,0.12848,0,0
3,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.54903,0.12856,0.062475,0,0
3,GO COCHLEA DEVELOPMENT,0.0085714,0.12808,0.14509,0,0
3,GO CATECHOLAMINE UPTAKE,0.16828,0.12781,0.13783,0,0
3,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.0010528,0.12762,0.16732,0,0
3,GO SYNAPTIC SIGNALING,0.001986,0.12747,0.172,0,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.27611,0.12734,0.10221,0,0
3,GO REGULATION OF BMP SIGNALING PATHWAY,0.8303,0.1273,0.00708,0,0
3,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.0025083,0.12726,0.12677,0,0
3,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.077957,0.12711,0.08124,0,0
3,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.064293,0.12701,0.11209,0,0
3,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.077957,0.127,0.090624,0,0
3,GO CARDIOLIPIN METABOLIC PROCESS,0.23589,0.12658,0.067219,0,0
3,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.20937,0.1263,0.14382,0,0
3,GO ENDODERM DEVELOPMENT,0.2839,0.12617,0.025249,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.099158,0.12532,0.16393,0,0
3,GO MEMORY,0.0067808,0.12525,0.13818,0,0
3,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.13355,0.12514,0.23131,0,0
3,GO REGULATION OF ODONTOGENESIS,0.40843,0.12506,0.031587,0,0
3,GO METENCEPHALON DEVELOPMENT,0.0054795,0.12488,0.16011,0,0
3,GO REGULATION OF CELLULAR RESPIRATION,0.097379,0.12458,0.11837,0,0
3,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.070855,0.12428,0.11219,0,0
3,GO ACETYL COA BIOSYNTHETIC PROCESS,0.10096,0.12406,0.11849,0,0
3,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.59059,0.12406,0.0070754,0,0
3,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.10654,0.12351,0.24502,0,0
3,GO REGULATION OF HEART RATE,0.10465,0.12348,0.095051,0,0
3,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.39858,0.12348,0.09055,0,0
3,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.11039,0.12311,0.08545,0,0
3,GO REGULATION OF CELLULAR EXTRAVASATION,0.11235,0.12275,0.11146,0,0
3,GO NEURAL CREST FORMATION,0.36991,0.12272,0.07721,0,0
3,GO CAMP METABOLIC PROCESS,0.31232,0.12264,0.054026,0,0
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.17099,0.12222,0.077015,0,0
3,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.34702,0.12148,0.1034,0,0
3,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.20937,0.12099,0.079371,0,0
3,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.070855,0.12077,0.10228,0,0
3,GO RESPONSE TO LIGHT INTENSITY,0.14769,0.12009,0.1245,0,0
3,GO SYNAPTIC VESICLE LOCALIZATION,0.014841,0.11988,0.19226,0,0
3,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.011904,0.11981,0.10207,0,0
3,GO RESPONSE TO NITRIC OXIDE,0.0060989,0.11975,0.1029,0,0
3,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0075304,0.11938,0.12948,0,0
3,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.099158,0.11908,0.091544,0,0
3,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.12689,0.11897,0.11581,0,0
3,GO COMMISSURAL NEURON AXON GUIDANCE,0.20937,0.11875,0.13745,0,0
3,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.188,0.11867,0.089562,0,0
3,GO MECHANOSENSORY BEHAVIOR,0.36526,0.1182,0.17894,0,0
3,GO REGULATION OF POTASSIUM ION TRANSPORT,0.10096,0.11796,0.079862,0,0
3,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.080955,0.1175,0.098141,0,0
3,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.23245,0.11711,0.078572,0,0
3,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.036164,0.11708,0.11111,0,0
3,GO CELLULAR RESPONSE TO RETINOIC ACID,0.11235,0.11693,0.064552,0,0
3,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.014138,0.1168,0.11783,0,0
3,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.14285,0.11668,0.19877,0,0
3,GO STORE OPERATED CALCIUM ENTRY,0.44402,0.11647,0.034577,0,0
3,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.91987,0.11642,0.029245,0,0
3,GO LONG TERM SYNAPTIC POTENTIATION,0.14526,0.11641,0.08259,0,0
3,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.053746,0.11627,0.18126,0,0
3,GO AXON DEVELOPMENT,0.0050528,0.11594,0.15111,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.059411,0.11573,0.1537,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.022165,0.11502,0.13665,0,0
3,GO CELL PART MORPHOGENESIS,0.0024367,0.11485,0.1479,0,0
3,GO REGULATION OF TRANSPORTER ACTIVITY,0.010506,0.11484,0.11228,0,0
3,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.21256,0.11469,0.12975,0,0
3,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.066855,0.11431,0.13884,0,0
3,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.1313,0.11422,0.1157,0,0
3,GO POSITIVE REGULATION OF AXONOGENESIS,0.017137,0.11306,0.15792,0,0
3,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.26098,0.11301,0.14473,0,0
3,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.12908,0.11274,0.14697,0,0
3,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.35607,0.11239,0.068419,0,0
3,GO GLIAL CELL MIGRATION,0.052669,0.11218,0.13199,0,0
3,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.033166,0.1119,0.10784,0,0
3,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.17653,0.11182,0.05138,0,0
3,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.018836,0.11181,0.17577,0,0
3,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.20621,0.11179,0.051553,0,0
3,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.25729,0.1117,0.072017,0,0
3,GO URETER DEVELOPMENT,0.41842,0.11161,0.072538,0,0
3,GO COGNITION,0.0031536,0.11159,0.15657,0,0
3,GO SEQUESTERING OF METAL ION,0.11841,0.11155,0.077539,0,0
3,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.045624,0.11137,0.11873,0,0
3,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.30402,0.11099,0.064195,0,0
3,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.34256,0.11099,0.048058,0,0
3,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.061812,0.11097,0.13005,0,0
3,GO NEURON MIGRATION,0.042857,0.11025,0.14875,0,0
3,GO UBIQUINONE METABOLIC PROCESS,0.2,0.11014,0.02765,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.26471,0.10971,0.089985,0,0
3,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.088862,0.10951,0.10544,0,0
3,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.015203,0.10934,0.19385,0,0
3,GO MYELIN MAINTENANCE,0.46512,0.10871,0.05417,0,0
3,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.10845,0.10842,0.17539,0,0
3,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.013139,0.10831,0.12606,0,0
3,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.066855,0.10823,0.083208,0,0
3,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.047551,0.1078,0.085432,0,0
3,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.30402,0.10773,0.091316,0,0
3,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.004408,0.10765,0.16898,0,0
3,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.079444,0.10761,0.13606,0,0
3,GO DORSAL AORTA DEVELOPMENT,0.24288,0.10736,0.086646,0,0
3,GO ANION HOMEOSTASIS,0.17934,0.10723,0.076362,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.19393,0.10666,0.1672,0,0
3,GO DOPAMINE TRANSPORT,0.33812,0.10662,0.15678,0,0
3,GO ASYMMETRIC CELL DIVISION,0.39371,0.10648,0.0629,0,0
3,GO CEREBELLAR CORTEX MORPHOGENESIS,0.14526,0.10629,0.11146,0,0
3,GO PHOSPHOLIPID HOMEOSTASIS,0.39858,0.10609,0.041172,0,0
3,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.15264,0.10543,0.064202,0,0
3,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.20621,0.10501,0.038164,0,0
3,GO CELLULAR RESPONSE TO ETHANOL,0.11434,0.105,0.12598,0,0
3,GO TOXIN TRANSPORT,0.10096,0.10474,0.067394,0,0
3,GO GROWTH HORMONE SECRETION,0.16294,0.10466,0.10545,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.27227,0.10464,0.079484,0,0
3,GO POSITIVE REGULATION OF ION TRANSPORT,0.076492,0.1043,0.078154,0,0
3,GO SKELETAL SYSTEM MORPHOGENESIS,0.36064,0.10427,0.032545,0,0
3,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.34702,0.10387,0.057386,0,0
3,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.19695,0.10371,0.094687,0,0
3,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.016734,0.1037,0.11503,0,0
3,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.016734,0.10328,0.12458,0,0
3,GO RESPONSE TO AMYLOID BETA,0.0094949,0.10326,0.1324,0,0
3,GO OUTFLOW TRACT MORPHOGENESIS,0.19095,0.10319,0.058589,0,0
3,GO TRNA 5 END PROCESSING,0.12473,0.10284,0.079239,0,0
3,GO POTASSIUM ION TRANSPORT,0.035393,0.10273,0.1169,0,0
3,GO REGULATION OF SYSTEM PROCESS,0.016734,0.10271,0.089714,0,0
3,GO SPINDLE MIDZONE ASSEMBLY,0.60272,0.1027,0.03177,0,0
3,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.084046,0.10254,0.11759,0,0
3,GO CELLULAR RESPONSE TO CALCIUM ION,0.097379,0.10248,0.094569,0,0
3,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.05824,0.10243,0.090781,0,0
3,GO PROTEIN COMPLEX OLIGOMERIZATION,0.0023671,0.10243,0.09872,0,0
3,GO WALKING BEHAVIOR,0.004408,0.10242,0.20944,0,0
3,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.26098,0.10238,0.15396,0,0
3,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.060602,0.10188,0.083724,0,0
3,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.38408,0.10184,0.054856,0,0
3,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.44924,0.1016,0.14169,0,0
3,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.32506,0.10158,0.057278,0,0
3,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.011047,0.10155,0.11642,0,0
3,GO REGULATION OF METAL ION TRANSPORT,0.082489,0.10141,0.067514,0,0
3,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.049546,0.10137,0.11162,0,0
3,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.19393,0.10101,-0.010585,0,0
3,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.22235,0.10099,0.074943,0,0
3,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.14048,0.1007,0.081393,0,0
3,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.23589,0.10064,0.1404,0,0
3,GO AXO DENDRITIC TRANSPORT,0.043763,0.10041,0.10129,0,0
3,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.65866,0.10026,0.046327,0,0
3,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.024846,0.10018,0.11791,0,0
3,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.57857,0.10015,-0.021418,0,0
3,GO PROSTAGLANDIN SECRETION,0.17099,0.10012,0.085141,0,0
3,GO NAD BIOSYNTHETIC PROCESS,0.5726,0.099913,0.02916,0,0
3,GO PHAGOLYSOSOME ASSEMBLY,0.29992,0.099778,0.059685,0,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.63978,0.099585,0.039394,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.41341,0.099415,0.015277,0,0
3,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.17653,0.099388,0.090573,0,0
3,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.22235,0.099251,0.049878,0,0
3,GO ACROSOME ASSEMBLY,0.15773,0.098843,0.14126,0,0
3,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.14285,0.098716,0.046371,0,0
3,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.70355,0.098621,0.01751,0,0
3,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.031059,0.098422,0.099572,0,0
3,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.0060989,0.098297,0.099857,0,0
3,GO REGULATION OF MIRNA METABOLIC PROCESS,0.4545,0.097984,0.073768,0,0
3,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.25363,0.097836,0.044028,0,0
3,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.16032,0.097756,0.10818,0,0
3,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.31653,0.097516,0.041001,0,0
3,GO REGULATION OF ATP METABOLIC PROCESS,0.065563,0.097368,0.064835,0,0
3,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.23245,0.097273,0.072781,0,0
3,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.044685,0.097259,0.12093,0,0
3,GO RENAL VESICLE DEVELOPMENT,0.18219,0.09686,0.12136,0,0
3,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.17374,0.09671,0.085387,0,0
3,GO LATERAL MESODERM DEVELOPMENT,0.99651,0.096493,-0.042264,0,0
3,GO REVERSE CHOLESTEROL TRANSPORT,0.72969,0.096301,-0.0135,0,0
3,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.038561,0.096255,0.11449,0,0
3,GO RENAL SODIUM EXCRETION,0.095625,0.096118,0.077543,0,0
3,GO BICARBONATE TRANSPORT,0.16828,0.095931,0.057661,0,0
3,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.36526,0.095619,0.024502,0,0
3,GO AXONAL TRANSPORT OF MITOCHONDRION,0.18508,0.095579,0.15747,0,0
3,GO ENDODERM FORMATION,0.25363,0.095455,0.025382,0,0
3,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.05824,0.095351,0.080819,0,0
3,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0079323,0.09519,0.12173,0,0
3,GO TRANSEPITHELIAL TRANSPORT,0.060602,0.095126,0.071842,0,0
3,GO PIGMENT METABOLIC PROCESS,0.13355,0.094987,0.079327,0,0
3,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.18219,0.094937,0.063127,0,0
3,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.29586,0.094911,0.033694,0,0
3,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.011326,0.094873,0.17996,0,0
3,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.4978,0.094615,0.011696,0,0
3,GO CELL RECOGNITION,0.057089,0.094592,0.072826,0,0
3,GO MITOCHONDRIAL GENOME MAINTENANCE,0.041967,0.09449,0.13653,0,0
3,GO DENDRITIC SPINE MAINTENANCE,0.14048,0.094365,0.078247,0,0
3,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.54903,0.09376,0.037638,0,0
3,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.2,0.093725,0.074412,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.32938,0.093651,0.17063,0,0
3,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.27227,0.0934,0.11352,0,0
3,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.021165,0.093074,0.086229,0,0
3,GO CELLULAR COMPONENT MORPHOGENESIS,0.010773,0.092962,0.11854,0,0
3,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.0024367,0.092894,0.131,0,0
3,GO NOREPINEPHRINE METABOLIC PROCESS,0.44402,0.092883,0.11071,0,0
3,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.054842,0.092556,0.08351,0,0
3,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.11636,0.092058,0.10672,0,0
3,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.0695,0.091905,0.040213,0,0
3,GO MEMBRANE DEPOLARIZATION,0.14769,0.091862,0.10733,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.27999,0.091737,0.027537,0,0
3,GO SNARE COMPLEX ASSEMBLY,0.63354,0.09169,0.023899,0,0
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.85768,0.091628,-0.035297,0,0
3,GO AMELOGENESIS,0.72313,0.091497,0.017454,0,0
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.29992,0.091025,0.062368,0,0
3,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.079444,0.090943,0.089883,0,0
3,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.12908,0.090858,0.07639,0,0
3,GO REGULATION OF LIPID CATABOLIC PROCESS,0.19393,0.090771,0.067024,0,0
3,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.42855,0.090715,0.051687,0,0
3,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.36526,0.090547,0.066859,0,0
3,GO NUCLEOTIDE SALVAGE,0.16032,0.090474,0.12384,0,0
3,GO EXPORT ACROSS PLASMA MEMBRANE,0.14769,0.090338,0.086928,0,0
3,GO RRNA 3 END PROCESSING,0.1313,0.090271,0.099363,0,0
3,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.15264,0.089392,0.1084,0,0
3,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.02843,0.089345,0.091656,0,0
3,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.045624,0.089295,0.096514,0,0
3,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.036164,0.089277,0.11426,0,0
3,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.079444,0.089231,0.081202,0,0
3,GO DNA DEPENDENT DNA REPLICATION,0.020205,0.089143,0.079149,0,0
3,GO REGULATION OF GLUTAMATE SECRETION,0.17653,0.089087,0.13757,0,0
3,GO REGULATION OF CALCIUM ION TRANSPORT,0.029068,0.08883,0.090382,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.2,0.088542,0.06317,0,0
3,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.064293,0.088449,0.097257,0,0
3,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.43367,0.088351,0.053667,0,0
3,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.15773,0.088278,0.063281,0,0
3,GO CATECHOLAMINE SECRETION,0.070855,0.088274,0.21533,0,0
3,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.94769,0.088241,-0.017123,0,0
3,GO RECEPTOR INTERNALIZATION,0.049546,0.088196,0.094469,0,0
3,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.060602,0.088074,0.064686,0,0
3,GO GROOMING BEHAVIOR,0.20621,0.088031,0.11623,0,0
3,GO COPPER ION TRANSPORT,0.19695,0.087859,0.074573,0,0
3,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.47588,0.087791,0.047237,0,0
3,GO DENDRITIC CELL APOPTOTIC PROCESS,0.39371,0.087635,0.037074,0,0
3,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.25363,0.087382,0.067867,0,0
3,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.72969,0.087255,0.00042408,0,0
3,GO REGULATION OF STEM CELL DIFFERENTIATION,0.32938,0.087207,0.028107,0,0
3,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.39858,0.086961,0.037733,0,0
3,GO PALLIUM DEVELOPMENT,0.011612,0.086703,0.12236,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.047551,0.086679,0.097788,0,0
3,GO SKELETAL MUSCLE CONTRACTION,0.11039,0.086276,0.085481,0,0
3,GO ORGANIC CATION TRANSPORT,0.02268,0.085963,0.1203,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.36526,0.085893,0.021861,0,0
3,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.13814,0.08582,0.079721,0,0
3,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.17099,0.085525,0.043005,0,0
3,GO REGULATION OF ION TRANSPORT,0.14285,0.085163,0.060629,0,0
3,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.0099891,0.085126,0.18506,0,0
3,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.28785,0.085014,0.067548,0,0
3,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.74288,0.084953,-0.011379,0,0
3,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.5726,0.084937,0.0074552,0,0
3,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.25729,0.084792,0.1637,0,0
3,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.14526,0.084508,0.05929,0,0
3,GO HORMONE BIOSYNTHETIC PROCESS,0.10845,0.084391,0.088945,0,0
3,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.38408,0.084332,0.03121,0,0
3,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.34256,0.084212,0.065424,0,0
3,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.088862,0.084073,0.16487,0,0
3,GO BLASTOCYST FORMATION,0.10465,0.083901,0.07186,0,0
3,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.093897,0.083683,0.095142,0,0
3,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.67776,0.083643,-0.0021424,0,0
3,GO POSITIVE REGULATION OF LIPID STORAGE,0.3746,0.083425,0.053785,0,0
3,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.016734,0.083355,0.11394,0,0
3,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.013139,0.083289,0.099556,0,0
3,GO MESODERMAL CELL DIFFERENTIATION,0.31232,0.082899,0.010792,0,0
3,GO NEGATIVE REGULATION OF DNA BINDING,0.044685,0.082305,0.1067,0,0
3,GO PLASMINOGEN ACTIVATION,0.46512,0.082181,-0.039713,0,0
3,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.75615,0.082149,-0.074696,0,0
3,GO PODOSOME ASSEMBLY,0.67137,0.081675,-0.064838,0,0
3,GO ZINC ION TRANSPORT,0.23937,0.081671,0.059316,0,0
3,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.28785,0.081668,0.10687,0,0
3,GO PROSTATE GLAND MORPHOGENESIS,0.25001,0.081626,0.029616,0,0
3,GO ENDOTHELIAL CELL PROLIFERATION,0.74288,0.08162,0.0065297,0,0
3,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.23937,0.081615,0.073582,0,0
3,GO TONGUE MORPHOGENESIS,0.4598,0.081393,0.12758,0,0
3,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.17934,0.081261,0.082883,0,0
3,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.064293,0.081174,0.14722,0,0
3,GO REGULATION OF AMYLOID BETA FORMATION,0.60272,0.080998,0.035328,0,0
3,GO REGULATION OF PROTEIN TARGETING,0.059411,0.080954,0.067854,0,0
3,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.42347,0.080935,0.03634,0,0
3,GO OTIC VESICLE MORPHOGENESIS,0.22235,0.080834,0.17572,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.32077,0.080806,0.049153,0,0
3,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.32077,0.080729,0.029259,0,0
3,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.041093,0.080665,0.085237,0,0
3,GO PULMONARY VALVE MORPHOGENESIS,0.50896,0.080652,0.027984,0,0
3,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.31232,0.08065,0.072418,0,0
3,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.55487,0.080271,0.037342,0,0
3,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.2,0.080203,0.10426,0,0
3,GO GLIAL CELL ACTIVATION,0.69707,0.080002,0.010975,0,0
3,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.14526,0.079913,0.088509,0,0
3,GO ENDOCARDIAL CUSHION FORMATION,0.52594,0.079881,0.033788,0,0
3,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.23245,0.079584,0.11512,0,0
3,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.36991,0.079189,0.044649,0,0
3,GO REGULATION OF DNA METHYLATION,0.55487,0.078676,0.022381,0,0
3,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.18508,0.078595,0.066106,0,0
3,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.12049,0.078554,0.08366,0,0
3,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.31653,0.078538,0.044265,0,0
3,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.5726,0.07847,0.015,0,0
3,GO CELL GROWTH,0.075049,0.078358,0.049189,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.0695,0.078322,0.089378,0,0
3,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.11039,0.078308,0.051503,0,0
3,GO SEQUESTERING OF CALCIUM ION,0.30402,0.078271,0.048713,0,0
3,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.10845,0.078262,0.069084,0,0
3,GO REGULATION OF NEURON PROJECTION REGENERATION,0.60272,0.078197,0.048157,0,0
3,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.3746,0.078174,0.024524,0,0
3,GO MITOTIC CHROMOSOME CONDENSATION,0.084046,0.078058,0.085615,0,0
3,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.21905,0.07805,0.047038,0,0
3,GO NUCLEAR MIGRATION,0.093897,0.077994,0.098162,0,0
3,GO TRABECULA FORMATION,0.22568,0.077658,0.066652,0,0
3,GO DICARBOXYLIC ACID TRANSPORT,0.043763,0.077645,0.10789,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.25729,0.077515,0.06121,0,0
3,GO AMINO SUGAR METABOLIC PROCESS,0.29184,0.077403,0.034278,0,0
3,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.87833,0.077391,-0.031794,0,0
3,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.4598,0.077289,0.012326,0,0
3,GO ADULT BEHAVIOR,0.055956,0.077249,0.14414,0,0
3,GO DRUG CATABOLIC PROCESS,0.085627,0.077231,0.084308,0,0
3,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.070855,0.077169,0.095196,0,0
3,GO AXONAL TRANSPORT,0.070855,0.077143,0.10062,0,0
3,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.26098,0.077094,0.10614,0,0
3,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.56075,0.077027,0.080368,0,0
3,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.4545,0.076803,0.039002,0,0
3,GO PROTEIN CONTAINING COMPLEX REMODELING,0.19095,0.076794,0.038257,0,0
3,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.47049,0.076733,0.087098,0,0
3,GO POSITIVE REGULATION OF HEART CONTRACTION,0.46512,0.076668,0.05701,0,0
3,GO MAINTENANCE OF CELL POLARITY,0.23937,0.076611,0.073465,0,0
3,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.61497,0.076578,0.019408,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.52594,0.076353,0.023953,0,0
3,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.67776,0.076184,0.045548,0,0
3,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.88523,0.076182,-0.051929,0,0
3,GO MONONUCLEAR CELL DIFFERENTIATION,0.31653,0.075882,0.091314,0,0
3,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.32938,0.075861,0.085015,0,0
3,GO REGULATION OF EXCRETION,0.12259,0.075844,0.11051,0,0
3,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.3746,0.075674,0.0491,0,0
3,GO GANGLIOSIDE METABOLIC PROCESS,0.35607,0.075559,0.08742,0,0
3,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.082489,0.07523,0.11739,0,0
3,GO CATION TRANSPORT,0.05824,0.075116,0.060237,0,0
3,GO PLASMA MEMBRANE ORGANIZATION,0.30815,0.07504,0.048406,0,0
3,GO IRON ION HOMEOSTASIS,0.20309,0.074902,0.055373,0,0
3,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.14769,0.074629,0.10781,0,0
3,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.76281,0.074518,0.0086407,0,0
3,GO 3 UTR MEDIATED MRNA STABILIZATION,0.77618,0.074206,-0.012709,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.66501,0.074091,-0.012677,0,0
3,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.085627,0.074082,0.062271,0,0
3,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.11636,0.07407,0.079286,0,0
3,GO REGULATION OF SENSORY PERCEPTION,0.1313,0.073811,0.11994,0,0
3,GO REGULATION OF NEURON DIFFERENTIATION,0.026586,0.073598,0.10531,0,0
3,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.21905,0.073492,0.093333,0,0
3,GO THIOESTER METABOLIC PROCESS,0.25729,0.073276,0.052488,0,0
3,GO PROTEIN KINASE A SIGNALING,0.2839,0.07278,0.047207,0,0
3,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.94073,0.072656,-0.016114,0,0
3,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.33812,0.072441,0.057914,0,0
3,GO LOCOMOTORY BEHAVIOR,0.036164,0.072435,0.13478,0,0
3,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.23245,0.072351,0.14897,0,0
3,GO MITOTIC SISTER CHROMATID COHESION,0.48131,0.072182,0.03863,0,0
3,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.085627,0.07167,0.091229,0,0
3,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.27999,0.071191,0.043413,0,0
3,GO REGULATION OF BLOOD CIRCULATION,0.17099,0.07079,0.06219,0,0
3,GO RESPONSE TO COCAINE,0.47049,0.070694,0.053782,0,0
3,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.32506,0.070677,0.023749,0,0
3,GO CELLULAR AMIDE METABOLIC PROCESS,0.054842,0.070652,0.070367,0,0
3,GO CELL JUNCTION ORGANIZATION,0.188,0.07046,0.04718,0,0
3,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.17934,0.070351,0.051365,0,0
3,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.34702,0.070264,0.030359,0,0
3,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.4545,0.070237,0.023566,0,0
3,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.14526,0.070001,0.11623,0,0
3,GO PROTEIN HOMOTETRAMERIZATION,0.075049,0.069941,0.066948,0,0
3,GO MESENCHYMAL CELL PROLIFERATION,0.090515,0.069754,0.13252,0,0
3,GO TRABECULA MORPHOGENESIS,0.68418,0.069601,0.00042882,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.32506,0.069519,0.047766,0,0
3,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.065563,0.069382,0.070423,0,0
3,GO NEGATIVE REGULATION OF CELL AGING,0.78962,0.069356,-0.046214,0,0
3,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.12908,0.069332,0.057547,0,0
3,GO RESPONSE TO ACIDIC PH,0.61497,0.069269,-0.0041426,0,0
3,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.33812,0.068977,0.040546,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.32506,0.068946,0.054595,0,0
3,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.05824,0.068821,0.071223,0,0
3,GO POSITIVE REGULATION OF FERTILIZATION,0.22905,0.068786,0.12685,0,0
3,GO REGULATION OF DNA BINDING,0.32506,0.068703,0.035944,0,0
3,GO MULTICELLULAR ORGANISMAL SIGNALING,0.092194,0.068576,0.10112,0,0
3,GO RESPONSE TO INTERLEUKIN 12,0.40349,0.068368,0.034789,0,0
3,GO FATTY ACYL COA METABOLIC PROCESS,0.054842,0.06832,0.13079,0,0
3,GO LENS FIBER CELL DEVELOPMENT,0.40349,0.067964,0.057793,0,0
3,GO INTRACELLULAR LIPID TRANSPORT,0.32506,0.067907,0.051331,0,0
3,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.39371,0.067675,0.031582,0,0
3,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.16559,0.067378,0.083294,0,0
3,GO ACTION POTENTIAL,0.31653,0.066927,0.062919,0,0
3,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.03245,0.066848,0.090725,0,0
3,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.092194,0.066661,0.065468,0,0
3,GO NEURON DEVELOPMENT,0.015574,0.066648,0.10551,0,0
3,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.11039,0.066519,0.060207,0,0
3,GO RECOMBINATIONAL REPAIR,0.084046,0.066379,0.049275,0,0
3,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.4545,0.066267,0.05857,0,0
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.22235,0.066172,0.060251,0,0
3,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.63354,0.066041,-0.0040107,0,0
3,GO MULTICELLULAR ORGANISM GROWTH,0.14048,0.065507,0.039674,0,0
3,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.85768,0.065444,-0.0028137,0,0
3,GO HIPPO SIGNALING,0.68418,0.065365,-0.024942,0,0
3,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.024288,0.065336,0.096793,0,0
3,GO HEXOSE CATABOLIC PROCESS,0.4598,0.065182,0.035594,0,0
3,GO RESPONSE TO AMINO ACID STARVATION,0.17653,0.065071,0.077566,0,0
3,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.3746,0.064971,0.040328,0,0
3,GO CELLULAR RESPONSE TO X RAY,0.41842,0.064863,0.016317,0,0
3,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.073629,0.064843,0.15596,0,0
3,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.055956,0.064814,0.067937,0,0
3,GO HISTONE H3 K27 METHYLATION,0.40349,0.064767,0.041694,0,0
3,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.30402,0.064586,0.12124,0,0
3,GO CELLULAR RESPONSE TO AMYLOID BETA,0.12689,0.064443,0.07886,0,0
3,GO POSITIVE REGULATION OF AXON EXTENSION,0.21905,0.064149,0.10092,0,0
3,GO SYNAPTIC VESICLE TRANSPORT,0.11434,0.063924,0.11139,0,0
3,GO DERMATAN SULFATE METABOLIC PROCESS,0.93377,0.063732,-0.0072338,0,0
3,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.72969,0.063652,0.0051246,0,0
3,GO CEREBRAL CORTEX DEVELOPMENT,0.082489,0.063571,0.083382,0,0
3,GO ION TRANSMEMBRANE TRANSPORT,0.05824,0.063493,0.061114,0,0
3,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.39371,0.063293,0.046665,0,0
3,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.54903,0.063118,0.086518,0,0
3,GO METHIONINE BIOSYNTHETIC PROCESS,0.32938,0.062669,0.024869,0,0
3,GO RESPONSE TO SALT,0.92682,0.062643,0.00048644,0,0
3,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.22235,0.06263,0.0745,0,0
3,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.28785,0.062444,0.041102,0,0
3,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.58456,0.062265,0.054427,0,0
3,GO NEURON MATURATION,0.073629,0.062192,0.1618,0,0
3,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.50337,0.062074,0.015222,0,0
3,GO GLUCOCORTICOID METABOLIC PROCESS,0.90599,0.062055,-0.0055476,0,0
3,GO REGULATION OF CAMP MEDIATED SIGNALING,0.31232,0.062028,0.069046,0,0
3,GO COLLAGEN CATABOLIC PROCESS,0.52025,0.062015,0.00011165,0,0
3,GO BEHAVIOR,0.013139,0.062013,0.11244,0,0
3,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.3746,0.06199,0.028828,0,0
3,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.036164,0.061913,0.066182,0,0
3,GO MULTI ORGANISM LOCALIZATION,0.15264,0.061525,0.032862,0,0
3,GO SNRNA PROCESSING,0.15773,0.061408,-0.0063667,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.63978,0.061342,0.018724,0,0
3,GO MEMBRANE HYPERPOLARIZATION,0.44924,0.061284,0.069574,0,0
3,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.58456,0.061271,0.021532,0,0
3,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.76281,0.061217,0.038906,0,0
3,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.13355,0.061175,0.11112,0,0
3,GO NEURON DIFFERENTIATION,0.033166,0.061143,0.09311,0,0
3,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.40349,0.061015,0.054946,0,0
3,GO HEART PROCESS,0.12259,0.06089,0.068836,0,0
3,GO LOCALIZATION WITHIN MEMBRANE,0.2,0.060871,0.062917,0,0
3,GO CERAMIDE TRANSPORT,0.11434,0.060835,0.045107,0,0
3,GO OPTIC NERVE DEVELOPMENT,0.32938,0.060655,0.088409,0,0
3,GO PRENYLATION,0.43883,0.060469,0.026651,0,0
3,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.10654,0.060355,0.045853,0,0
3,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.76281,0.060279,-0.055547,0,0
3,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.049546,0.060199,0.081212,0,0
3,GO POSITIVE REGULATION OF URINE VOLUME,0.5726,0.060194,0.011848,0,0
3,GO REGULATION OF CELL SIZE,0.027803,0.06009,0.078054,0,0
3,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.041093,0.060038,0.10921,0,0
3,GO REGULATION OF MRNA 3 END PROCESSING,0.12049,0.060029,0.062462,0,0
3,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.36526,0.059805,0.094879,0,0
3,GO NUCLEOSIDE METABOLIC PROCESS,0.12908,0.059782,0.047589,0,0
3,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.26098,0.059782,0.039865,0,0
3,GO NEURON PROJECTION ARBORIZATION,0.49227,0.059684,0.069472,0,0
3,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.87144,0.059626,-0.016596,0,0
3,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.12689,0.059588,0.062803,0,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.38888,0.059495,0.059975,0,0
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.96163,0.059474,0.0074326,0,0
3,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.1028,0.059414,0.067347,0,0
3,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.71006,0.059403,-0.061317,0,0
3,GO REGULATION OF EXOCYTOSIS,0.12908,0.059169,0.083328,0,0
3,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.69061,0.059045,0.016918,0,0
3,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.23245,0.058912,0.051956,0,0
3,GO PROTEIN FOLDING,0.19695,0.058895,0.037073,0,0
3,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.21905,0.05883,0.18293,0,0
3,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.39858,0.058732,0.057713,0,0
3,GO REGULATION OF SODIUM ION TRANSPORT,0.36991,0.058589,0.04793,0,0
3,GO NEUTRAL LIPID CATABOLIC PROCESS,0.48678,0.058587,0.043292,0,0
3,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.42855,0.058445,0.01996,0,0
3,GO PROTEIN O LINKED MANNOSYLATION,0.40349,0.058248,0.034762,0,0
3,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.17934,0.057919,0.052955,0,0
3,GO MRNA EXPORT FROM NUCLEUS,0.059411,0.057863,0.069993,0,0
3,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.188,0.057766,0.070135,0,0
3,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.67137,0.057761,-0.0024584,0,0
3,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.32938,0.057662,0.027942,0,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.41341,0.057564,0.03109,0,0
3,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.12908,0.057514,0.096921,0,0
3,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.83713,0.057268,-0.011995,0,0
3,GO REGULATION OF FATTY ACID BETA OXIDATION,0.25001,0.057197,0.081448,0,0
3,GO APOPTOTIC DNA FRAGMENTATION,0.12689,0.056973,0.054069,0,0
3,GO FEEDING BEHAVIOR,0.088862,0.056843,0.084705,0,0
3,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.92682,0.056737,-0.0044084,0,0
3,GO MITOCHONDRIAL DNA REPLICATION,0.44924,0.056697,0.032179,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.56666,0.056407,0.022729,0,0
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.031059,0.056379,0.062983,0,0
3,GO RESPONSE TO MISFOLDED PROTEIN,0.72969,0.05629,-0.0008014,0,0
3,GO MONOVALENT INORGANIC CATION TRANSPORT,0.11636,0.05621,0.064125,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.14526,0.056149,0.057714,0,0
3,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.85768,0.056012,-0.042994,0,0
3,GO ACTIN MEDIATED CELL CONTRACTION,0.47049,0.055942,0.047177,0,0
3,GO REGULATION OF MRNA CATABOLIC PROCESS,0.16032,0.055811,0.040261,0,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.48678,0.055774,-0.077812,0,0
3,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.88523,0.05573,0.0054114,0,0
3,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.23589,0.055727,0.111,0,0
3,GO NEPHRON TUBULE FORMATION,0.79636,0.055653,0.036197,0,0
3,GO ERROR FREE TRANSLESION SYNTHESIS,0.079444,0.055331,0.075593,0,0
3,GO NOREPINEPHRINE SECRETION,0.37932,0.055307,0.052206,0,0
3,GO REGULATION OF HEART GROWTH,0.23589,0.055286,0.066202,0,0
3,GO DNA GEOMETRIC CHANGE,0.054842,0.055228,0.060255,0,0
3,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.25729,0.055025,0.049114,0,0
3,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.065563,0.055002,0.04809,0,0
3,GO ANIMAL ORGAN REGENERATION,0.4978,0.054878,-0.0026538,0,0
3,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.81668,0.054837,-0.034905,0,0
3,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.71006,0.054812,0.0049911,0,0
3,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.68418,0.0548,0.015893,0,0
3,GO G0 TO G1 TRANSITION,0.43367,0.05475,0.036869,0,0
3,GO CYTOCHROME COMPLEX ASSEMBLY,0.24643,0.054744,0.073746,0,0
3,GO PROTEIN DEPOLYMERIZATION,0.40349,0.054687,0.035538,0,0
3,GO TRACHEA DEVELOPMENT,0.4598,0.054649,0.060868,0,0
3,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.34702,0.054639,0.074693,0,0
3,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.29992,0.054492,0.03947,0,0
3,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.56666,0.054206,0.020814,0,0
3,GO PROSTAGLANDIN TRANSPORT,0.58456,0.05399,0.016902,0,0
3,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.26471,0.053979,0.072737,0,0
3,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.71658,0.053975,0.017606,0,0
3,GO OSTEOBLAST DEVELOPMENT,0.71658,0.053807,-0.021909,0,0
3,GO PROTEASOME ASSEMBLY,0.2,0.053773,0.053468,0,0
3,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.76948,0.053703,0.016269,0,0
3,GO ANTEROGRADE AXONAL TRANSPORT,0.11841,0.053664,0.080307,0,0
3,GO STRIATED MUSCLE CONTRACTION,0.14526,0.053577,0.068468,0,0
3,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.42347,0.053419,0.04701,0,0
3,GO NEGATIVE REGULATION OF RNA SPLICING,0.14526,0.053381,0.070599,0,0
3,GO PROTEIN NEDDYLATION,0.12049,0.053309,0.067427,0,0
3,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.26098,0.053132,0.13369,0,0
3,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.14048,0.05306,0.053304,0,0
3,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.33373,0.052918,0.067288,0,0
3,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.1313,0.052863,0.075474,0,0
3,GO MAINTENANCE OF LOCATION IN CELL,0.29184,0.052824,0.043541,0,0
3,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.41842,0.05282,0.050627,0,0
3,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.84397,0.052755,-0.028331,0,0
3,GO NEURON CELL CELL ADHESION,0.61497,0.052642,0.10326,0,0
3,GO PROTEIN POLYGLUTAMYLATION,0.36064,0.052559,0.035699,0,0
3,GO MYELIN ASSEMBLY,0.49227,0.052436,0.042426,0,0
3,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.83713,0.05231,-0.055094,0,0
3,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.63354,0.052278,0.024987,0,0
3,GO NUCLEOSOME ORGANIZATION,0.14526,0.052174,0.050352,0,0
3,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.72969,0.052144,0.013265,0,0
3,GO RESPONSE TO CATECHOLAMINE,0.47588,0.051724,0.0425,0,0
3,GO MUSCLE CONTRACTION,0.13814,0.051623,0.053266,0,0
3,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.63978,0.05139,0.023118,0,0
3,GO IRON SULFUR CLUSTER ASSEMBLY,0.14769,0.05134,0.11065,0,0
3,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.2839,0.051251,0.057719,0,0
3,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.59664,0.051103,-0.044502,0,0
3,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.71658,0.051083,0.0022241,0,0
3,GO MONOAMINE TRANSPORT,0.55487,0.051073,0.10533,0,0
3,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.16294,0.051029,0.064254,0,0
3,GO RESPONSE TO POTASSIUM ION,0.59059,0.050913,0.052922,0,0
3,GO GRANULOCYTE DIFFERENTIATION,0.96163,0.050771,-0.026791,0,0
3,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.24288,0.050528,0.091945,0,0
3,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.38408,0.050521,0.079565,0,0
3,GO ADHESION OF SYMBIONT TO HOST,0.5726,0.050321,0.033531,0,0
3,GO PEPTIDYL METHIONINE MODIFICATION,0.15015,0.050316,0.06293,0,0
3,GO CIRCADIAN SLEEP WAKE CYCLE,0.33812,0.050176,0.083192,0,0
3,GO REGULATION OF CELL PROJECTION SIZE,0.94769,0.050105,-0.0076313,0,0
3,GO CARDIAC CHAMBER DEVELOPMENT,0.53167,0.050087,0.016322,0,0
3,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.40349,0.049989,0.026336,0,0
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.25363,0.049893,0.036914,0,0
3,GO RHYTHMIC BEHAVIOR,0.47049,0.049745,0.042894,0,0
3,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.11434,0.049733,0.11575,0,0
3,GO DEFENSE RESPONSE TO FUNGUS,0.69061,0.049532,0.0085766,0,0
3,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.98953,0.049408,-0.006554,0,0
3,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.15015,0.049344,0.041168,0,0
3,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.70355,0.049297,-0.011863,0,0
3,GO TRANSMEMBRANE TRANSPORT,0.11841,0.049215,0.040787,0,0
3,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.98255,0.049192,-0.017618,0,0
3,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.16294,0.049185,0.099555,0,0
3,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.83713,0.049162,-0.0024512,0,0
3,GO RESPONSE TO CORTICOSTERONE,0.91987,0.049093,-0.019411,0,0
3,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.42347,0.049075,0.01986,0,0
3,GO SCHWANN CELL DEVELOPMENT,0.72313,0.048968,0.017815,0,0
3,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.86455,0.048931,0.016773,0,0
3,GO CHROMATIN DISASSEMBLY,0.22235,0.048408,0.125,0,0
3,GO ACYLGLYCEROL HOMEOSTASIS,0.42347,0.048374,0.038189,0,0
3,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.33812,0.048365,0.058467,0,0
3,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.43883,0.048133,0.06176,0,0
3,GO REGULATION OF CELL MORPHOGENESIS,0.087232,0.048035,0.062806,0,0
3,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.17099,0.048005,0.046503,0,0
3,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.81668,0.047761,0.0094245,0,0
3,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.38888,0.04765,0.031904,0,0
3,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.42855,0.047545,0.038869,0,0
3,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.58456,0.04754,0.013204,0,0
3,GO REGULATION OF ORGAN GROWTH,0.35607,0.04754,0.035379,0,0
3,GO INNER CELL MASS CELL PROLIFERATION,0.25729,0.047341,0.061132,0,0
3,GO CARBOHYDRATE CATABOLIC PROCESS,0.23937,0.047273,0.047214,0,0
3,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.62732,0.047146,0.030781,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.62113,0.047105,0.047123,0,0
3,GO CARDIAC CHAMBER MORPHOGENESIS,0.69061,0.04698,0.0037934,0,0
3,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.86455,0.046963,-0.036538,0,0
3,GO OSTEOCLAST DEVELOPMENT,0.22905,0.046955,0.076249,0,0
3,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.62113,0.046823,0.028654,0,0
3,GO KERATAN SULFATE CATABOLIC PROCESS,0.9686,0.046602,-0.055373,0,0
3,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.43883,0.046447,0.052152,0,0
3,GO ACROSOME REACTION,0.54321,0.046437,0.028279,0,0
3,GO FORMATION OF PRIMARY GERM LAYER,0.65234,0.046422,-0.0089847,0,0
3,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.41842,0.046411,0.052284,0,0
3,GO NEUROGENESIS,0.075049,0.046395,0.071918,0,0
3,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.55487,0.046293,0.032767,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.15773,0.046282,0.068317,0,0
3,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.60883,0.046193,0.036286,0,0
3,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.35153,0.046032,0.060186,0,0
3,GO RESPONSE TO NERVE GROWTH FACTOR,0.082489,0.045935,0.10175,0,0
3,GO MITOTIC CELL CYCLE ARREST,0.60883,0.04592,0.03141,0,0
3,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.25729,0.045851,0.068885,0,0
3,GO MICROTUBULE POLYMERIZATION,0.044685,0.045838,0.11001,0,0
3,GO CEREBELLAR CORTEX FORMATION,0.63978,0.045735,0.048536,0,0
3,GO POSITIVE REGULATION OF DNA BINDING,0.10465,0.045604,0.064125,0,0
3,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.71006,0.045453,-0.0036157,0,0
3,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.33812,0.045402,0.066379,0,0
3,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.21905,0.045383,0.045223,0,0
3,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.95466,0.045349,-0.026062,0,0
3,GO MYOBLAST FUSION,0.89215,0.045198,-0.025843,0,0
3,GO REGULATION OF PROTEIN GLYCOSYLATION,0.69707,0.045174,0.0098476,0,0
3,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.31232,0.044919,0.059493,0,0
3,GO SULFUR COMPOUND CATABOLIC PROCESS,0.093897,0.044885,0.10197,0,0
3,GO RESPONSE TO DOPAMINE,0.61497,0.044837,0.033992,0,0
3,GO CHROMATIN SILENCING,0.46512,0.044804,0.026672,0,0
3,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.71006,0.044783,0.016251,0,0
3,GO ORGAN GROWTH,0.54903,0.044716,0.018631,0,0
3,GO BASEMENT MEMBRANE ORGANIZATION,0.86455,0.044645,-0.072866,0,0
3,GO RRNA CATABOLIC PROCESS,0.62732,0.044437,0.04833,0,0
3,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.78962,0.044324,0.0072863,0,0
3,GO HEART TRABECULA FORMATION,0.95466,0.044239,-0.0041626,0,0
3,GO HISTONE METHYLATION,0.1028,0.044139,0.047003,0,0
3,GO CORTICOSTEROID HORMONE SECRETION,0.81668,0.044039,-0.020328,0,0
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.16828,0.043899,0.12862,0,0
3,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.061812,0.043714,0.131,0,0
3,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.32077,0.043609,0.049395,0,0
3,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.95466,0.043547,-0.012278,0,0
3,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.42347,0.04348,0.037169,0,0
3,GO PHOTORECEPTOR CELL DEVELOPMENT,0.38888,0.043411,0.05894,0,0
3,GO MICROTUBULE NUCLEATION,0.67137,0.043043,0.030211,0,0
3,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.10654,0.042921,0.09844,0,0
3,GO REGULATION OF LIPID KINASE ACTIVITY,0.22905,0.042914,0.041127,0,0
3,GO EXOCRINE SYSTEM DEVELOPMENT,0.48678,0.042716,0.033185,0,0
3,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.88523,0.042581,0.023569,0,0
3,GO REGULATION OF PODOSOME ASSEMBLY,0.50896,0.042552,-0.11406,0,0
3,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.20621,0.042531,0.072654,0,0
3,GO PROTEIN HYDROXYLATION,0.78289,0.042499,0.014227,0,0
3,GO PROTEIN PALMITOYLATION,0.30815,0.042405,0.061275,0,0
3,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.21256,0.04236,0.096539,0,0
3,GO BONE DEVELOPMENT,0.3746,0.042278,0.014209,0,0
3,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.89907,0.042198,-0.021191,0,0
3,GO TRNA 5 LEADER REMOVAL,0.63354,0.041775,0.01211,0,0
3,GO ESTABLISHMENT OF RNA LOCALIZATION,0.092194,0.041691,0.050936,0,0
3,GO PROTEIN STABILIZATION,0.52025,0.041628,0.017604,0,0
3,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.69707,0.041617,0.042231,0,0
3,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,1,0.041609,-0.013308,0,0
3,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.60272,0.04137,-0.015169,0,0
3,GO LYMPHANGIOGENESIS,0.26098,0.041195,0.057051,0,0
3,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.41341,0.041186,0.027773,0,0
3,GO NADP METABOLIC PROCESS,0.70355,0.041152,-0.016033,0,0
3,GO PROTEIN LOCALIZATION TO ORGANELLE,0.05824,0.041143,0.037228,0,0
3,GO ELECTRON TRANSPORT CHAIN,0.37932,0.040798,0.031763,0,0
3,GO REGULATION OF DEVELOPMENTAL GROWTH,0.10654,0.040787,0.053955,0,0
3,GO CARTILAGE MORPHOGENESIS,0.35153,0.04077,0.14204,0,0
3,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.4598,0.040627,0.046269,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.75615,0.040613,-0.040405,0,0
3,GO SNRNA METABOLIC PROCESS,0.25001,0.040524,-0.0053469,0,0
3,GO PROTEIN IMPORT,0.58456,0.040337,0.0071906,0,0
3,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.64605,0.039969,-0.042298,0,0
3,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.91987,0.039865,-0.0085776,0,0
3,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.86455,0.039813,-0.0023915,0,0
3,GO PROTON TRANSMEMBRANE TRANSPORT,0.78962,0.039672,-0.0087641,0,0
3,GO RESPONSE TO UV,0.12259,0.039584,0.042676,0,0
3,GO EMBRYONIC EYE MORPHOGENESIS,0.99651,0.039419,-0.019693,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.80989,0.03933,0.024745,0,0
3,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.84397,0.039168,-0.0045513,0,0
3,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.91293,0.039067,-0.013666,0,0
3,GO CELL MORPHOGENESIS,0.14526,0.038997,0.058199,0,0
3,GO REGULATION OF URINE VOLUME,0.65234,0.038963,0.011216,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.95466,0.038951,-0.010853,0,0
3,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.29184,0.038797,0.040875,0,0
3,GO POLYOL METABOLIC PROCESS,0.24288,0.038771,0.036067,0,0
3,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.96163,0.03877,-0.010743,0,0
3,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.42855,0.038761,0.046427,0,0
3,GO OXIDATIVE DEMETHYLATION,0.15517,0.038625,0.072435,0,0
3,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.038561,0.038589,0.066038,0,0
3,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.20621,0.038547,0.030599,0,0
3,GO ION TRANSPORT,0.23937,0.038322,0.031685,0,0
3,GO CARDIAC MUSCLE CELL CONTRACTION,0.25729,0.038216,0.080229,0,0
3,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.76948,0.038215,0.0055821,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.78962,0.03819,-0.0078515,0,0
3,GO SECOND MESSENGER MEDIATED SIGNALING,0.33373,0.038161,0.031432,0,0
3,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.76948,0.038053,0.035254,0,0
3,GO IMMATURE T CELL PROLIFERATION,0.72969,0.038013,-0.01894,0,0
3,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.30402,0.037981,0.042514,0,0
3,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.9686,0.037969,-0.025374,0,0
3,GO VITAMIN BIOSYNTHETIC PROCESS,0.41842,0.03795,0.046741,0,0
3,GO CELL CELL SIGNALING,0.13355,0.037895,0.047582,0,0
3,GO NEUROPEPTIDE SIGNALING PATHWAY,0.17099,0.037849,0.099701,0,0
3,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.50896,0.037847,0.02657,0,0
3,GO REGULATION OF GENE SILENCING,0.28785,0.037828,0.031926,0,0
3,GO PROTEIN KINASE C SIGNALING,0.98953,0.037794,-0.0076044,0,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.090515,0.037701,0.056622,0,0
3,GO CEREBRAL CORTEX CELL MIGRATION,0.073629,0.037433,0.12602,0,0
3,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.68418,0.037332,0.015243,0,0
3,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.67137,0.037196,0.016443,0,0
3,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.49227,0.037067,0.057624,0,0
3,GO DEVELOPMENTAL GROWTH,0.14285,0.037026,0.047565,0,0
3,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.38888,0.037015,0.016176,0,0
3,GO NEGATIVE REGULATION OF DNA REPAIR,0.78289,0.036885,0.008726,0,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.71658,0.036778,-0.0092596,0,0
3,GO BLASTOCYST GROWTH,0.47049,0.036748,0.016377,0,0
3,GO COENZYME A METABOLIC PROCESS,0.80312,0.03672,0.013962,0,0
3,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.56075,0.036493,0.040761,0,0
3,GO RESPONSE TO RETINOIC ACID,0.76948,0.036452,-0.016635,0,0
3,GO RESPONSE TO LEUCINE,0.4978,0.03628,0.078433,0,0
3,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.52025,0.036273,0.026461,0,0
3,GO GMP METABOLIC PROCESS,0.80989,0.03627,0.042603,0,0
3,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.8303,0.036212,0.032197,0,0
3,GO REGULATION OF DNA REPAIR,0.7495,0.036026,0.0030106,0,0
3,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.67776,0.036019,0.00746,0,0
3,GO REGULATION OF ACROSOME REACTION,0.39371,0.035938,0.070154,0,0
3,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.13814,0.035896,0.10478,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.4598,0.035834,0.062649,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.89907,0.035827,-0.026239,0,0
3,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.21905,0.035753,0.10856,0,0
3,GO SKELETAL MUSCLE TISSUE REGENERATION,0.69707,0.035704,-0.011069,0,0
3,GO CRANIAL NERVE DEVELOPMENT,0.67137,0.035667,-0.061516,0,0
3,GO CHLORIDE TRANSPORT,0.49227,0.035636,0.025545,0,0
3,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.29184,0.035526,0.036014,0,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.47588,0.03537,0.020826,0,0
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.34702,0.035361,0.020919,0,0
3,GO VENTRICULAR SEPTUM DEVELOPMENT,0.47049,0.035198,0.041503,0,0
3,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.98953,0.035074,-0.014027,0,0
3,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.63354,0.035062,0.0040174,0,0
3,GO CHROMATIN REMODELING AT CENTROMERE,0.17099,0.034998,0.078447,0,0
3,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.61497,0.034779,-0.010887,0,0
3,GO RESPONSE TO ESTROGEN,0.48678,0.034711,0.0087973,0,0
3,GO I KAPPAB PHOSPHORYLATION,0.98953,0.034662,-0.030051,0,0
3,GO AMYLOID BETA FORMATION,0.84397,0.034629,0.0047639,0,0
3,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.16828,0.034385,0.030482,0,0
3,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.11434,0.034342,0.062309,0,0
3,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.71006,0.034128,0.023519,0,0
3,GO SULFUR COMPOUND METABOLIC PROCESS,0.36991,0.034056,0.024522,0,0
3,GO AORTA MORPHOGENESIS,0.89215,0.034007,-0.028269,0,0
3,GO GROWTH,0.51459,0.033947,0.014628,0,0
3,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.63978,0.033925,0.0085486,0,0
3,GO REGULATION OF FERTILIZATION,0.39371,0.033886,0.034041,0,0
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.50337,0.033874,-0.070401,0,0
3,GO INACTIVATION OF MAPK ACTIVITY,0.89907,0.033782,0.011946,0,0
3,GO TORC1 SIGNALING,0.088862,0.033763,0.062223,0,0
3,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.26847,0.033624,0.05577,0,0
3,GO NEUROTROPHIN SIGNALING PATHWAY,0.48678,0.03326,0.034975,0,0
3,GO CHOLESTEROL EFFLUX,0.70355,0.033257,-0.045448,0,0
3,GO REGULATION OF CELL DEVELOPMENT,0.12473,0.033246,0.058581,0,0
3,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.43367,0.033047,0.036882,0,0
3,GO CELLULAR HOMEOSTASIS,0.23589,0.033012,0.031681,0,0
3,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.74288,0.032724,-0.042776,0,0
3,GO CARTILAGE DEVELOPMENT,0.73628,0.032683,-0.0058453,0,0
3,GO PORE COMPLEX ASSEMBLY,0.80989,0.032664,-0.034393,0,0
3,GO LYTIC VACUOLE ORGANIZATION,0.85768,0.032642,-0.01039,0,0
3,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.56075,0.032546,0.027683,0,0
3,GO DNA CONFORMATION CHANGE,0.16032,0.032404,0.03942,0,0
3,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.70355,0.032357,-0.046804,0,0
3,GO RNA INTERFERENCE,0.20621,0.03234,0.069483,0,0
3,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.47588,0.032237,0.011778,0,0
3,GO LUNG ALVEOLUS DEVELOPMENT,0.4978,0.032095,0.0372,0,0
3,GO REGULATION OF PROTON TRANSPORT,0.55487,0.03197,0.044068,0,0
3,GO PROTEIN ACETYLATION,0.26847,0.031965,0.017669,0,0
3,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.52594,0.031952,0.059015,0,0
3,GO NEGATIVE REGULATION OF BINDING,0.3746,0.031909,0.033044,0,0
3,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.59664,0.031803,0.021365,0,0
3,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.71658,0.031783,0.0052435,0,0
3,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.24643,0.031667,0.018889,0,0
3,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.85082,0.031627,9.4196e-05,0,0
3,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.75615,0.031621,-0.0013877,0,0
3,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.097379,0.031562,0.062583,0,0
3,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.53167,0.031557,0.022321,0,0
3,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.2,0.031533,0.02891,0,0
3,GO NADPH REGENERATION,0.97557,0.03146,-0.014396,0,0
3,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.68418,0.031428,0.018659,0,0
3,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.86455,0.031386,0.010408,0,0
3,GO FOREBRAIN DEVELOPMENT,0.15773,0.031358,0.064155,0,0
3,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.25001,0.031311,0.038895,0,0
3,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.44402,0.031263,0.018939,0,0
3,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.67137,0.031137,0.014411,0,0
3,GO REGULATION OF TORC1 SIGNALING,0.26847,0.030901,0.038266,0,0
3,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.42855,0.030871,0.025901,0,0
3,GO MEIOTIC SPINDLE ORGANIZATION,0.92682,0.030773,0.0029153,0,0
3,GO SEMI LUNAR VALVE DEVELOPMENT,0.80989,0.030645,-0.0048553,0,0
3,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.78962,0.030489,0.0047626,0,0
3,GO CELLULAR RESPONSE TO VITAMIN,0.51459,0.030433,0.023195,0,0
3,GO MUSCLE SYSTEM PROCESS,0.23937,0.030397,0.038068,0,0
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.78962,0.030362,0.0039012,0,0
3,GO ION HOMEOSTASIS,0.53742,0.030339,0.017595,0,0
3,GO CARDIAC MUSCLE CONTRACTION,0.20937,0.030078,0.067402,0,0
3,GO OVULATION CYCLE PROCESS,0.40349,0.030026,0.040106,0,0
3,GO DNA PACKAGING,0.33373,0.029913,0.028574,0,0
3,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.81668,0.029894,-0.012265,0,0
3,GO ENERGY HOMEOSTASIS,0.55487,0.029863,0.050136,0,0
3,GO QUINONE METABOLIC PROCESS,0.32938,0.029856,-0.15592,0,0
3,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.50896,0.029631,0.028245,0,0
3,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.58456,0.029594,0.057225,0,0
3,GO NEGATIVE REGULATION OF CELL DIVISION,0.94769,0.029519,0.0078431,0,0
3,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.96163,0.029503,-0.013801,0,0
3,GO RESPONSE TO TEMPERATURE STIMULUS,0.14769,0.02944,0.043423,0,0
3,GO RESPONSE TO MAGNESIUM ION,0.9686,0.029394,-0.0081614,0,0
3,GO T CELL DIFFERENTIATION IN THYMUS,0.44924,0.029312,0.026918,0,0
3,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.91987,0.029294,-0.067343,0,0
3,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.71006,0.029261,-0.043304,0,0
3,GO SENSORY PERCEPTION OF PAIN,0.82348,0.029227,0.024267,0,0
3,GO RESPONSE TO GONADOTROPIN,0.92682,0.029167,-0.018143,0,0
3,GO MIRNA METABOLIC PROCESS,0.95466,0.029152,-0.00043178,0,0
3,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.66501,0.029119,0.0058449,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.94073,0.029071,-0.037658,0,0
3,GO DEVELOPMENTAL MATURATION,0.22905,0.028994,0.059102,0,0
3,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.96163,0.028993,0.013514,0,0
3,GO HISTONE EXCHANGE,0.31653,0.028887,0.039289,0,0
3,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.62113,0.028843,-0.063157,0,0
3,GO LYMPH NODE DEVELOPMENT,0.87144,0.028811,-0.013562,0,0
3,GO ACTIVATION OF MAPKK ACTIVITY,0.94769,0.028809,-0.0032546,0,0
3,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.67137,0.028734,0.051423,0,0
3,GO CONVERGENT EXTENSION,0.56666,0.028632,0.041216,0,0
3,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.4978,0.028512,0.02142,0,0
3,GO CHYLOMICRON ASSEMBLY,0.78962,0.028507,-0.019807,0,0
3,GO DNA REPLICATION,0.17653,0.028502,0.033985,0,0
3,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.29184,0.028124,0.017059,0,0
3,GO MIDBRAIN DEVELOPMENT,0.76281,0.028068,-0.035876,0,0
3,GO OXIDATION REDUCTION PROCESS,0.68418,0.028046,0.0095475,0,0
3,GO INORGANIC ANION TRANSPORT,0.42347,0.027832,0.015758,0,0
3,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.42855,0.027774,0.047455,0,0
3,GO METAL ION HOMEOSTASIS,0.84397,0.02774,0.0037628,0,0
3,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.23245,0.027726,0.10127,0,0
3,GO REGULATION OF LIGASE ACTIVITY,0.94073,0.027714,0.004058,0,0
3,GO CELL CYCLE ARREST,0.33373,0.027653,0.025913,0,0
3,GO PEROXISOMAL MEMBRANE TRANSPORT,0.42347,0.027639,0.031295,0,0
3,GO RESPONSE TO MONOSACCHARIDE,0.61497,0.027606,0.0067171,0,0
3,GO STRIATED MUSCLE CELL PROLIFERATION,0.89907,0.027545,-0.023932,0,0
3,GO CELLULAR RESPONSE TO CHOLESTEROL,0.56075,0.027486,0.042877,0,0
3,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.52594,0.027418,0.038913,0,0
3,GO IRON ION TRANSPORT,0.77618,0.027225,-0.0098631,0,0
3,GO CHONDROCYTE DEVELOPMENT,0.47049,0.027036,0.011729,0,0
3,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.46512,0.027007,0.03849,0,0
3,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.36526,0.026823,0.032309,0,0
3,GO NEGATIVE REGULATION OF AUTOPHAGY,0.5726,0.026772,0.026549,0,0
3,GO LAMELLIPODIUM MORPHOGENESIS,0.22568,0.026735,-0.14412,0,0
3,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.42347,0.026586,0.049709,0,0
3,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.25363,0.026583,0.047106,0,0
3,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.42347,0.026536,0.024151,0,0
3,GO PROTEIN ACYLATION,0.13583,0.026497,0.027667,0,0
3,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.80989,0.026417,0.0048714,0,0
3,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.88523,0.026403,-0.0021909,0,0
3,GO MRNA CLEAVAGE,0.22235,0.026381,0.051584,0,0
3,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.72969,0.026187,0.014482,0,0
3,GO CELLULAR RESPONSE TO RADIATION,0.72313,0.026019,-0.0023432,0,0
3,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.56075,0.026014,0.010009,0,0
3,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.12689,0.025895,0.046954,0,0
3,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.55487,0.025797,0.023933,0,0
3,GO NEURAL CREST CELL DIFFERENTIATION,0.55487,0.025671,0.027042,0,0
3,GO SEGMENTATION,0.48678,0.025492,0.021605,0,0
3,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.87833,0.025299,-0.040874,0,0
3,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.92682,0.025244,-0.012407,0,0
3,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.41842,0.025238,0.03403,0,0
3,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.87144,0.025062,-0.039824,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.58456,0.024944,-0.06273,0,0
3,GO NERVOUS SYSTEM PROCESS,0.34702,0.024861,0.038292,0,0
3,GO REGULATION OF GLIOGENESIS,0.78289,0.024815,0.012054,0,0
3,GO MUSCLE ORGAN DEVELOPMENT,0.38408,0.024716,0.01842,0,0
3,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.54321,0.02446,0.042752,0,0
3,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.82348,0.024273,0.004358,0,0
3,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.9686,0.02426,-0.035691,0,0
3,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.70355,0.02423,-0.006168,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.81668,0.024143,-0.031975,0,0
3,GO REGULATION OF FIBRINOLYSIS,0.68418,0.024101,-0.09294,0,0
3,GO FILOPODIUM ASSEMBLY,0.46512,0.023969,0.037676,0,0
3,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.88523,0.023937,-0.016667,0,0
3,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.63978,0.02391,0.020487,0,0
3,GO CHROMOSOME SEPARATION,0.42855,0.02386,0.025272,0,0
3,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.98255,0.023852,-0.025406,0,0
3,GO ALCOHOL BIOSYNTHETIC PROCESS,0.39371,0.023753,0.024745,0,0
3,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.72969,0.023648,0.032474,0,0
3,GO CHROMATIN SILENCING AT TELOMERE,0.34256,0.023635,0.060195,0,0
3,GO HISTONE H3 K4 METHYLATION,0.95466,0.023547,0.0012104,0,0
3,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.65234,0.023542,0.012827,0,0
3,GO REGULATION OF TELOMERASE ACTIVITY,0.83713,0.023357,-0.018905,0,0
3,GO REGULATION OF GROWTH,0.90599,0.023354,-0.00044268,0,0
3,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.96163,0.023258,-0.033939,0,0
3,GO THIOESTER BIOSYNTHETIC PROCESS,0.13814,0.023166,0.084946,0,0
3,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.96163,0.02307,-0.010031,0,0
3,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.86455,0.023017,-0.017188,0,0
3,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.13583,0.022928,0.060352,0,0
3,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.70355,0.022912,0.010331,0,0
3,GO INTERACTION WITH SYMBIONT,0.4545,0.022889,0.0019219,0,0
3,GO LYMPH VESSEL MORPHOGENESIS,0.72313,0.022857,-0.06373,0,0
3,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.62732,0.022769,0.022613,0,0
3,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.98953,0.022752,-0.017444,0,0
3,GO WATER TRANSPORT,0.91293,0.022676,-0.0035743,0,0
3,GO REGULATION OF RECEPTOR RECYCLING,0.61497,0.022614,-0.038741,0,0
3,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.64605,0.022425,0.03981,0,0
3,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.61497,0.022396,0.049255,0,0
3,GO REGULATION OF RNA SPLICING,0.2,0.021959,0.036933,0,0
3,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.61497,0.021905,0.09446,0,0
3,GO INTERMEMBRANE LIPID TRANSFER,0.95466,0.021783,-0.0027989,0,0
3,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.37932,0.02162,0.035968,0,0
3,GO DNA METABOLIC PROCESS,0.39858,0.021597,0.015568,0,0
3,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.60272,0.021583,0.044211,0,0
3,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.72313,0.021456,0.004522,0,0
3,GO RETINAL CONE CELL DIFFERENTIATION,0.60272,0.021411,-0.075543,0,0
3,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.79636,0.021405,-0.0081328,0,0
3,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.71006,0.021397,-0.059285,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.73628,0.021363,-0.015008,0,0
3,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.26471,0.021339,0.07162,0,0
3,GO PROTEIN METHYLATION,0.59059,0.021317,0.020162,0,0
3,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.39371,0.021265,0.10921,0,0
3,GO REGULATION OF BEHAVIOR,0.67137,0.021183,0.017133,0,0
3,GO PROTEIN LOCALIZATION TO CHROMATIN,0.98953,0.021103,0.002342,0,0
3,GO PEPTIDYL ARGININE MODIFICATION,0.13814,0.020855,0.082401,0,0
3,GO CARDIAC SEPTUM DEVELOPMENT,0.53167,0.020774,0.023525,0,0
3,GO PEPTIDYL CYSTEINE MODIFICATION,0.70355,0.020711,0.020402,0,0
3,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.36064,0.020512,0.024503,0,0
3,GO ORGANELLE MEMBRANE FUSION,0.70355,0.020481,0.0053225,0,0
3,GO DNA RECOMBINATION,0.50896,0.020447,0.011395,0,0
3,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.17653,0.020436,0.12032,0,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.32938,0.02037,-0.10796,0,0
3,GO SNRNA TRANSCRIPTION,0.23937,0.020297,0.025213,0,0
3,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.85082,0.02027,0.0037798,0,0
3,GO FOREGUT MORPHOGENESIS,0.8303,0.02027,-0.019063,0,0
3,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.72313,0.020237,-0.00023766,0,0
3,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.39371,0.020216,0.097113,0,0
3,GO CHROMATIN REMODELING,0.23589,0.020082,0.036679,0,0
3,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.36991,0.020018,0.057893,0,0
3,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.57857,0.019838,0.017424,0,0
3,GO HEART TRABECULA MORPHOGENESIS,0.94769,0.019723,-0.004214,0,0
3,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.56666,0.01962,-0.096087,0,0
3,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.68418,0.019617,0.028103,0,0
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.66501,0.019419,0.0024772,0,0
3,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.27999,0.019343,0.048686,0,0
3,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.42347,0.019231,0.069953,0,0
3,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.31653,0.01916,0.034708,0,0
3,GO NEURAL TUBE PATTERNING,0.98953,0.019061,-0.0099716,0,0
3,GO REGULATION OF MYELINATION,0.51459,0.019049,0.051814,0,0
3,GO NEGATIVE REGULATION OF GLIOGENESIS,0.78962,0.018996,-0.01939,0,0
3,GO SECONDARY PALATE DEVELOPMENT,0.53167,0.018966,-0.057617,0,0
3,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.91293,0.018898,0.0007021,0,0
3,GO CALCIUM ION REGULATED EXOCYTOSIS,0.30402,0.018874,0.14205,0,0
3,GO CONNECTIVE TISSUE DEVELOPMENT,0.95466,0.018871,-0.019809,0,0
3,GO BRAIN MORPHOGENESIS,0.67776,0.018857,0.044687,0,0
3,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.67776,0.018855,0.01276,0,0
3,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.48678,0.018828,0.059431,0,0
3,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.50896,0.018781,0.026803,0,0
3,GO TRIGLYCERIDE METABOLIC PROCESS,0.92682,0.0187,0.014684,0,0
3,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.67776,0.018616,-0.066419,0,0
3,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.42855,0.018591,0.029812,0,0
3,GO DENDRITE EXTENSION,0.34702,0.018508,0.14333,0,0
3,GO CARDIAC MUSCLE CELL PROLIFERATION,0.43883,0.018494,0.025655,0,0
3,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.42347,0.018441,0.05027,0,0
3,GO CARBOHYDRATE HOMEOSTASIS,0.4598,0.018052,0.021581,0,0
3,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.94073,0.018001,0.039363,0,0
3,GO HISTONE H3 K4 TRIMETHYLATION,0.87833,0.017889,-0.011816,0,0
3,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.24643,0.017792,0.042424,0,0
3,GO CELLULAR COMPONENT DISASSEMBLY,0.47588,0.017532,0.01762,0,0
3,GO DNA DOUBLE STRAND BREAK PROCESSING,0.86455,0.017507,-0.0079791,0,0
3,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.27611,0.017285,0.039654,0,0
3,GO PROSTATIC BUD FORMATION,0.83713,0.017271,-0.094231,0,0
3,GO ENDODERMAL CELL DIFFERENTIATION,0.63354,0.017071,-0.059135,0,0
3,GO CANONICAL WNT SIGNALING PATHWAY,0.80312,0.017066,-0.0033325,0,0
3,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.85768,0.017032,-0.022861,0,0
3,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.46512,0.016925,0.02599,0,0
3,GO TRANSITION METAL ION HOMEOSTASIS,0.56075,0.016895,0.015071,0,0
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.84397,0.016853,0.0044396,0,0
3,GO REGULATION OF CHROMOSOME SEGREGATION,0.26847,0.016798,0.038712,0,0
3,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.27611,0.016703,0.053101,0,0
3,GO REGULATION OF OOGENESIS,0.44924,0.01662,-0.056119,0,0
3,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.90599,0.01645,0.007407,0,0
3,GO EMBRYONIC PATTERN SPECIFICATION,0.71006,0.016362,0.020384,0,0
3,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.53167,0.016183,0.025218,0,0
3,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.63354,0.016057,0.035845,0,0
3,GO DETECTION OF VISIBLE LIGHT,0.48131,0.0159,0.044241,0,0
3,GO ORGANELLE FUSION,0.80989,0.015796,-0.0066239,0,0
3,GO CHONDROCYTE DIFFERENTIATION,0.89215,0.015664,-0.032996,0,0
3,GO NODAL SIGNALING PATHWAY,0.9686,0.015654,-0.016513,0,0
3,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.42347,0.015603,0.049487,0,0
3,GO VESICLE DOCKING,0.48678,0.015435,0.035588,0,0
3,GO HORMONE MEDIATED SIGNALING PATHWAY,0.85082,0.015429,-0.010858,0,0
3,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.35607,0.015387,0.027589,0,0
3,GO ENSHEATHMENT OF NEURONS,0.75615,0.015249,0.0062892,0,0
3,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.38888,0.015212,0.045411,0,0
3,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.38888,0.015163,0.026909,0,0
3,GO SOMATIC STEM CELL DIVISION,0.87144,0.015116,0.024833,0,0
3,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.95466,0.015107,-0.01713,0,0
3,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.69707,0.015035,-0.00017288,0,0
3,GO RESPONSE TO CAMP,0.29184,0.014955,0.047401,0,0
3,GO CARDIAC VENTRICLE DEVELOPMENT,0.64605,0.014931,0.018597,0,0
3,GO REGULATION OF PROTEIN MATURATION,0.78289,0.014886,-0.048514,0,0
3,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.99651,0.014794,-0.053607,0,0
3,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.82348,0.014788,0.015365,0,0
3,GO COMPLEMENT ACTIVATION,0.8303,0.014705,-0.056068,0,0
3,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.4598,0.014615,0.040127,0,0
3,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.94073,0.014529,-0.013746,0,0
3,GO LYSOSOME LOCALIZATION,0.43883,0.014507,-0.054235,0,0
3,GO RESPONSE TO PROSTAGLANDIN,0.54903,0.014507,0.016201,0,0
3,GO INTRACELLULAR MRNA LOCALIZATION,0.93377,0.014461,-0.018421,0,0
3,GO POSITIVE REGULATION OF ANION TRANSPORT,0.92682,0.014395,-0.020453,0,0
3,GO HISTONE DEACETYLATION,0.86455,0.014311,-0.0095593,0,0
3,GO RETINOIC ACID METABOLIC PROCESS,0.81668,0.014272,-0.058788,0,0
3,GO SYNCYTIUM FORMATION,0.91293,0.014208,-0.00773,0,0
3,GO CELLULAR ION HOMEOSTASIS,0.78962,0.014174,0.0070492,0,0
3,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.98953,0.014172,-0.014974,0,0
3,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.63354,0.014161,0.030027,0,0
3,GO REGULATION OF MICROTUBULE BINDING,0.36064,0.014122,0.06788,0,0
3,GO CELL CYCLE PHASE TRANSITION,0.91987,0.01403,-0.0022613,0,0
3,GO AMINOGLYCAN METABOLIC PROCESS,0.73628,0.014016,-0.00043295,0,0
3,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.78962,0.013994,-0.0028564,0,0
3,GO MEMBRANE BIOGENESIS,0.91293,0.013919,-0.016019,0,0
3,GO ALPHA AMINO ACID METABOLIC PROCESS,0.56075,0.013905,0.031828,0,0
3,GO REGULATION OF ENDOCYTOSIS,0.97557,0.013786,-0.000796,0,0
3,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.98953,0.013741,9.2521e-05,0,0
3,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.99651,0.013716,0.0016867,0,0
3,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.23937,0.013563,0.0867,0,0
3,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.63354,0.013491,0.030871,0,0
3,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.48131,0.013438,0.010475,0,0
3,GO OLIGODENDROCYTE DEVELOPMENT,0.49227,0.013319,-0.052704,0,0
3,GO REGULATION OF CELLULAR LOCALIZATION,0.41341,0.013302,0.020149,0,0
3,GO RESPONSE TO MUSCLE STRETCH,0.65234,0.012963,0.019026,0,0
3,GO TERPENOID METABOLIC PROCESS,0.53167,0.012959,-0.048455,0,0
3,GO CELL CELL SIGNALING BY WNT,0.67776,0.012924,0.0040329,0,0
3,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,1,0.012924,-0.010853,0,0
3,GO SOMITOGENESIS,0.75615,0.012884,-0.013891,0,0
3,GO NCRNA CATABOLIC PROCESS,0.92682,0.012874,-0.00061769,0,0
3,GO POST EMBRYONIC DEVELOPMENT,0.50337,0.012845,-0.03428,0,0
3,GO RESPONSE TO CARBOHYDRATE,0.8303,0.012791,-0.0018795,0,0
3,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.68418,0.012757,0.015022,0,0
3,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.93377,0.012426,-0.011165,0,0
3,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.5726,0.012155,-0.022016,0,0
3,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.22905,0.01208,0.023931,0,0
3,GO HINDBRAIN DEVELOPMENT,0.34702,0.012054,0.056454,0,0
3,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.97557,0.011896,-0.010103,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.85768,0.011887,0.0023157,0,0
3,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.82348,0.01186,0.010332,0,0
3,GO CELL CYCLE G1 S PHASE TRANSITION,0.79636,0.011832,-0.0006604,0,0
3,GO VASODILATION,0.30402,0.011816,0.058037,0,0
3,GO MITOCHONDRIAL TRNA PROCESSING,0.29184,0.011812,0.1047,0,0
3,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.68418,0.011693,0.037641,0,0
3,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.72313,0.011683,0.0096705,0,0
3,GO POSITIVE REGULATION OF T CELL MIGRATION,0.62732,0.011669,-0.044504,0,0
3,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.52025,0.011663,-0.060471,0,0
3,GO MANNOSYLATION,0.72313,0.01166,-0.041711,0,0
3,GO MITOCHONDRIAL TRANSPORT,0.57857,0.011623,0.0083721,0,0
3,GO MESENCHYME DEVELOPMENT,0.92682,0.011533,-0.017653,0,0
3,GO HEAD DEVELOPMENT,0.38888,0.011522,0.035896,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE,0.85768,0.011515,-0.0063422,0,0
3,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.97557,0.011501,-0.0084849,0,0
3,GO DOUBLE STRAND BREAK REPAIR,0.70355,0.011466,0.010564,0,0
3,GO PEPTIDYL PROLINE MODIFICATION,0.76948,0.011348,0.00081077,0,0
3,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.40843,0.011263,-0.051516,0,0
3,GO CIRCULATORY SYSTEM PROCESS,0.95466,0.011262,-0.0044998,0,0
3,GO RESPONSE TO ATP,0.54321,0.011184,0.023555,0,0
3,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.90599,0.011106,-0.077073,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.57857,0.011054,-0.021601,0,0
3,GO VISUAL BEHAVIOR,0.48678,0.011038,0.036199,0,0
3,GO REGULATION OF LIPASE ACTIVITY,0.76948,0.011037,-0.010956,0,0
3,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.9686,0.010961,-0.042987,0,0
3,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.92682,0.010889,-0.0036678,0,0
3,GO DNA LIGATION,0.97557,0.010881,-0.0011536,0,0
3,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.71006,0.010711,0.0058404,0,0
3,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.9686,0.0107,-0.01829,0,0
3,GO SOMITE DEVELOPMENT,0.72969,0.010665,0.01032,0,0
3,GO REGULATION OF FILOPODIUM ASSEMBLY,0.57857,0.010611,0.05109,0,0
3,GO RECEPTOR METABOLIC PROCESS,0.69707,0.010605,0.01992,0,0
3,GO CELL FATE COMMITMENT,0.77618,0.01056,-0.019383,0,0
3,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.56666,0.010495,0.017299,0,0
3,GO REGULATION OF CELL DIFFERENTIATION,0.98953,0.010484,-0.0071665,0,0
3,GO HINDBRAIN MORPHOGENESIS,0.5726,0.010333,0.045606,0,0
3,GO REGULATION OF FEEDING BEHAVIOR,0.19095,0.010159,0.10225,0,0
3,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.87833,0.010127,-0.010742,0,0
3,GO MITOTIC DNA REPLICATION,0.90599,0.010126,-0.013772,0,0
3,GO THYMUS DEVELOPMENT,0.93377,0.010049,-0.0022784,0,0
3,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.78289,0.010027,0.0062207,0,0
3,GO RHYTHMIC PROCESS,0.90599,0.0097994,0.002983,0,0
3,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.76281,0.0097513,0.011355,0,0
3,GO STEM CELL DIFFERENTIATION,0.76281,0.0096906,-0.018138,0,0
3,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.76948,0.0096897,-0.0073922,0,0
3,GO INTRACELLULAR PROTEIN TRANSPORT,0.65866,0.0095956,0.0069814,0,0
3,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.81668,0.0094596,0.0014535,0,0
3,GO GLIAL CELL PROLIFERATION,0.72969,0.0093701,-0.038691,0,0
3,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.59059,0.0093476,0.01958,0,0
3,GO RESPONSE TO DRUG,0.57857,0.0091927,0.020593,0,0
3,GO INTRACELLULAR TRANSPORT,0.9686,0.0091498,-0.0026833,0,0
3,GO LYMPHOCYTE HOMEOSTASIS,0.89907,0.0091333,-0.010242,0,0
3,GO ESTABLISHMENT OF TISSUE POLARITY,0.91987,0.0091104,0.0022079,0,0
3,GO HEAD MORPHOGENESIS,0.73628,0.0090675,-0.054164,0,0
3,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.82348,0.0090306,0.012044,0,0
3,GO INSEMINATION,0.56666,0.0090097,-0.071983,0,0
3,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.83713,0.0088583,-0.029768,0,0
3,GO RESPONSE TO IONIZING RADIATION,0.60272,0.0086388,-0.036803,0,0
3,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.78289,0.0085554,-0.042887,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.86455,0.0083696,-0.047653,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.71006,0.0083209,-0.041158,0,0
3,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.63978,0.0083131,-0.031907,0,0
3,GO NEGATIVE REGULATION OF NEURON DEATH,0.73628,0.0082851,0.011449,0,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.52594,0.0082561,0.044908,0,0
3,GO REGULATION OF ATPASE ACTIVITY,0.9686,0.0081832,-0.010798,0,0
3,GO REGULATION OF MACROAUTOPHAGY,0.87144,0.0081344,-0.0070383,0,0
3,GO FIBROBLAST ACTIVATION,0.80312,0.0081279,-0.041497,0,0
3,GO NUCLEOSOME ASSEMBLY,0.55487,0.0080678,0.024743,0,0
3,GO RESPONSE TO FATTY ACID,0.63354,0.007977,0.014849,0,0
3,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.32077,0.0079634,-0.06499,0,0
3,GO CALCIUM MEDIATED SIGNALING,0.5726,0.0078482,0.013017,0,0
3,GO CELLULAR LIPID CATABOLIC PROCESS,0.39858,0.0078203,-0.050042,0,0
3,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.96163,0.0078085,-0.0010393,0,0
3,GO REGULATION OF DENDRITE EXTENSION,0.5726,0.0077551,0.11384,0,0
3,GO REGULATION OF SULFUR METABOLIC PROCESS,0.62732,0.0077524,0.039512,0,0
3,GO REGULATION OF VACUOLE ORGANIZATION,0.61497,0.0077184,-0.037848,0,0
3,GO POSITIVE REGULATION OF BINDING,0.89215,0.0076239,0.005204,0,0
3,GO ANIMAL ORGAN MORPHOGENESIS,0.76948,0.0075946,-0.023653,0,0
3,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.59059,0.007441,-0.043833,0,0
3,GO ENDOCYTOSIS,0.73628,0.0073062,0.0071156,0,0
3,GO REGULATION OF CHROMOSOME SEPARATION,0.41341,0.0072445,0.032636,0,0
3,GO TETRAPYRROLE METABOLIC PROCESS,0.78289,0.0070853,0.00025501,0,0
3,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.91987,0.0070363,-0.024636,0,0
3,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.43883,0.0069035,0.021505,0,0
3,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.96163,0.0068807,-0.025694,0,0
3,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.91987,0.0068506,-0.020342,0,0
3,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.72969,0.0068365,0.021299,0,0
3,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.90599,0.0067852,-0.0039021,0,0
3,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.73628,0.0067294,-0.0023183,0,0
3,GO DNA STRAND ELONGATION,0.79636,0.0066817,0.033476,0,0
3,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.40349,0.006628,0.032395,0,0
3,GO SPINAL CORD DEVELOPMENT,0.56666,0.0065917,0.036106,0,0
3,GO REGULATION OF DEACETYLASE ACTIVITY,0.8303,0.0064893,-0.02342,0,0
3,GO ISOPRENOID METABOLIC PROCESS,0.41842,0.0064745,-0.050097,0,0
3,GO TRIPARTITE REGIONAL SUBDIVISION,0.39858,0.0064415,-0.082113,0,0
3,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.71006,0.0064107,-0.062065,0,0
3,GO PEPTIDYL LYSINE MODIFICATION,0.81668,0.0064007,-0.0014967,0,0
3,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.3746,0.0063876,0.036079,0,0
3,GO TRANSITION METAL ION TRANSPORT,0.9686,0.0062893,-0.012317,0,0
3,GO GLYCEROLIPID CATABOLIC PROCESS,0.69707,0.0062535,-0.03318,0,0
3,GO PEPTIDYL LYSINE METHYLATION,0.9686,0.0061402,0.0075368,0,0
3,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.85768,0.0060765,-0.0030939,0,0
3,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.71658,0.0059511,-0.039991,0,0
3,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.50337,0.0059337,-0.048614,0,0
3,GO CELLULAR SODIUM ION HOMEOSTASIS,0.96163,0.0058761,-0.011583,0,0
3,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.74288,0.005827,0.038529,0,0
3,GO AMINOGLYCAN CATABOLIC PROCESS,0.74288,0.005808,-0.056682,0,0
3,GO NEURAL PRECURSOR CELL PROLIFERATION,0.98953,0.0056344,0.0085193,0,0
3,GO VESICLE CARGO LOADING,0.96163,0.0055976,-0.034602,0,0
3,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.47049,0.0055959,-0.076542,0,0
3,GO STEROL TRANSPORT,0.5726,0.0055668,-0.042278,0,0
3,GO COVALENT CHROMATIN MODIFICATION,0.84397,0.0055293,0.0032237,0,0
3,GO ASTROCYTE DIFFERENTIATION,0.98953,0.0053946,0.0052026,0,0
3,GO MITOCHONDRION MORPHOGENESIS,0.85768,0.0053581,-0.0010191,0,0
3,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.79636,0.005149,-0.026913,0,0
3,GO MIDGUT DEVELOPMENT,0.96163,0.0051445,-0.015151,0,0
3,GO CHONDROCYTE PROLIFERATION,0.91987,0.0051153,0.0016201,0,0
3,GO CELLULAR RESPONSE TO ATP,0.3746,0.0050817,0.047175,0,0
3,GO ANION TRANSMEMBRANE TRANSPORT,0.41842,0.0050806,0.031823,0,0
3,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.72969,0.0050624,-0.043073,0,0
3,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.94073,0.0050359,-0.0048989,0,0
3,GO HEART GROWTH,0.2839,0.0050315,0.056927,0,0
3,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.30815,0.0050261,0.037477,0,0
3,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.63354,0.0049954,0.013793,0,0
3,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.61497,0.0049698,0.037935,0,0
3,GO REGULATION OF PROTEIN ACETYLATION,0.97557,0.0049425,-0.0017851,0,0
3,GO CHROMATIN ORGANIZATION,0.98255,0.004924,-0.0017387,0,0
3,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.85082,0.0049136,-0.061184,0,0
3,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.48131,0.0048492,0.023663,0,0
3,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.52025,0.0048344,0.01364,0,0
3,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.66501,0.0047222,-0.063692,0,0
3,GO MACROMOLECULE DEACYLATION,0.65866,0.0047171,0.015379,0,0
3,GO CELL CYCLE PROCESS,0.89215,0.0046228,-0.003076,0,0
3,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.74288,0.0046221,-0.027191,0,0
3,GO RECEPTOR RECYCLING,0.91293,0.004562,-0.012386,0,0
3,GO ADULT LOCOMOTORY BEHAVIOR,0.38408,0.0044266,0.080401,0,0
3,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.31653,0.0043766,0.044046,0,0
3,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.69061,0.0042673,-0.0027631,0,0
3,GO REGULATION OF BINDING,0.62732,0.0042594,-0.01871,0,0
3,GO HYPEROSMOTIC RESPONSE,0.78289,0.0042529,-0.031204,0,0
3,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.90599,0.004252,0.011128,0,0
3,GO PEPTIDYL SERINE MODIFICATION,0.33812,0.0041312,-0.028558,0,0
3,GO REGULATION OF PROTEIN STABILITY,0.62732,0.0041212,-0.016858,0,0
3,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.90599,0.0039969,-0.011779,0,0
3,GO VENTRICULAR SYSTEM DEVELOPMENT,0.52594,0.0038315,0.034647,0,0
3,GO ACTIN FILAMENT BASED MOVEMENT,0.85082,0.0037939,-0.0089701,0,0
3,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.7495,0.0037598,0.0014151,0,0
3,GO DRUG METABOLIC PROCESS,0.7495,0.0037539,-0.0068088,0,0
3,GO METHIONINE METABOLIC PROCESS,0.91293,0.0036902,-0.018883,0,0
3,GO ENGULFMENT OF APOPTOTIC CELL,0.73628,0.0036781,-0.043312,0,0
3,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.63978,0.0034803,-0.040616,0,0
3,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.63354,0.0034268,0.01767,0,0
3,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.72313,0.0033832,0.014453,0,0
3,GO REGULATION OF CELL CYCLE PROCESS,0.97557,0.0033497,-0.0034348,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.33812,0.0033183,0.048085,0,0
3,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.77618,0.0032772,-0.0396,0,0
3,GO POSITIVE REGULATION OF MYELINATION,0.53167,0.0032278,0.045445,0,0
3,GO SKELETAL SYSTEM DEVELOPMENT,0.91293,0.0032274,-0.017486,0,0
3,GO MAST CELL MIGRATION,0.79636,0.0030541,-0.057608,0,0
3,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.9686,0.0030387,-0.0057029,0,0
3,GO NEGATIVE REGULATION OF ION TRANSPORT,0.72969,0.0030025,0.01727,0,0
3,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.75615,0.0029931,0.03214,0,0
3,GO MITOTIC CELL CYCLE,0.87144,0.0029303,-0.009113,0,0
3,GO DOPAMINE METABOLIC PROCESS,0.96163,0.0028974,0.028137,0,0
3,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.93377,0.0028891,-0.0074689,0,0
3,GO ACTIVATION OF JNKK ACTIVITY,0.89215,0.0028527,-0.012984,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.59059,0.0027225,-0.033148,0,0
3,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.68418,0.0026018,0.0055043,0,0
3,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.75615,0.0024251,0.011794,0,0
3,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.56666,0.0021858,0.027748,0,0
3,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.66501,0.0021491,-0.012893,0,0
3,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.96163,0.0020983,-0.00019962,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.42855,0.0020975,0.092799,0,0
3,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.65234,0.0019754,0.060867,0,0
3,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.49227,0.0019008,-0.065546,0,0
3,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.76948,0.0018088,-0.0023158,0,0
3,GO ERROR PRONE TRANSLESION SYNTHESIS,0.91987,0.0017719,0.0062413,0,0
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.69061,0.001762,0.016804,0,0
3,GO CELL PROJECTION ORGANIZATION,0.66501,0.0017527,0.018766,0,0
3,GO VESICLE CYTOSKELETAL TRAFFICKING,0.71658,0.0017109,0.023363,0,0
3,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.75615,0.0015939,-0.042717,0,0
3,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.9686,0.0014908,-0.0014358,0,0
3,GO REGULATION OF WNT SIGNALING PATHWAY,0.9686,0.0014733,-0.0091945,0,0
3,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.85082,0.0014074,-0.034616,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.52025,0.0012349,0.026247,0,0
3,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.89907,0.0012121,-0.012278,0,0
3,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.31232,0.0011984,-0.059052,0,0
3,GO RESPONSE TO INTERLEUKIN 4,0.59059,0.0011784,-0.036901,0,0
3,GO IMPORT INTO NUCLEUS,0.93377,0.0011547,-0.0035695,0,0
3,GO HYPEROSMOTIC SALINITY RESPONSE,0.78289,0.0011132,-0.048874,0,0
3,GO LIPID PHOSPHORYLATION,0.50337,0.0010831,0.041144,0,0
3,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.53167,0.0010643,-0.039973,0,0
3,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.65866,0.0010595,0.033711,0,0
3,GO RESPONSE TO ORGANOPHOSPHORUS,0.44402,0.00094454,0.029056,0,0
3,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.78962,0.00092425,-0.029875,0,0
3,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.72969,0.00085306,-0.076354,0,0
3,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.87144,0.00066066,0.0056869,0,0
3,GO HOMOLOGOUS RECOMBINATION,0.97557,0.00061569,-0.001468,0,0
3,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.80312,0.00058415,0.013009,0,0
3,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.83713,0.00054748,-0.013983,0,0
3,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.85768,0.00049936,-0.030225,0,0
3,GO RESPONSE TO NICOTINE,0.69061,0.00045567,0.027831,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.54321,0.00034335,-0.014881,0,0
3,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.41341,0.00014907,0.021634,0,0
3,GO NON CANONICAL WNT SIGNALING PATHWAY,0.91293,0.00013118,0.00040004,0,0
3,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.75615,0.00011039,0.014211,0,0
3,GO IRON ION TRANSMEMBRANE TRANSPORT,0.83713,5.2757e-05,-0.039116,0,0
3,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.5726,-4.8057e-05,-0.016782,0,0
3,GO MAINTENANCE OF LOCATION,0.78289,-6.148e-05,0.0098354,0,0
3,GO PROTEIN AUTOPROCESSING,0.98953,-0.00016379,-0.022545,0,0
3,GO PIRNA METABOLIC PROCESS,0.48131,-0.0002303,-0.10914,0,0
3,GO REGULATION OF MUSCLE CONTRACTION,0.52025,-0.00023226,-0.028183,0,0
3,GO POSITIVE REGULATION OF AUTOPHAGY,0.77618,-0.00036335,0.0048093,0,0
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.63354,-0.000428,-0.044165,0,0
3,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.96163,-0.00048452,0.0017186,0,0
3,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.80312,-0.00049308,-0.05234,0,0
3,GO MUSCLE HYPERTROPHY,0.72969,-0.00058105,-0.028925,0,0
3,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.41842,-0.0007005,-0.034803,0,0
3,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,1,-0.00076563,-0.031239,0,0
3,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.76948,-0.00085104,-0.029858,0,0
3,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.62732,-0.00086836,0.019572,0,0
3,GO FEVER GENERATION,0.53742,-0.0010039,0.030955,0,0
3,GO REGULATION OF RESPONSE TO FOOD,0.69061,-0.001153,-0.019731,0,0
3,GO MITOTIC SISTER CHROMATID SEGREGATION,0.80989,-0.0011931,-0.0028538,0,0
3,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.50896,-0.0012676,-0.044833,0,0
3,GO THYROID HORMONE METABOLIC PROCESS,0.79636,-0.0012742,0.0056948,0,0
3,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.96163,-0.0012755,-0.0061296,0,0
3,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.52594,-0.0013027,0.025534,0,0
3,GO NUCLEAR BODY ORGANIZATION,0.78962,-0.001415,-0.014481,0,0
3,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.89215,-0.0014205,0.011426,0,0
3,GO BODY FLUID SECRETION,0.81668,-0.0014761,0.0029811,0,0
3,GO RESPONSE TO GLUCAGON,0.91987,-0.0015068,-0.014708,0,0
3,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.60883,-0.0015098,-0.030795,0,0
3,GO OVULATION CYCLE,0.4978,-0.0015213,0.032306,0,0
3,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.97557,-0.0016361,0.0037829,0,0
3,GO REGULATION OF REPRODUCTIVE PROCESS,0.63354,-0.0016612,-0.02543,0,0
3,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.85768,-0.0016885,-0.0014084,0,0
3,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.94769,-0.0017264,-0.012812,0,0
3,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.67137,-0.0017465,-0.066126,0,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.59664,-0.0019113,-0.030114,0,0
3,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.39858,-0.0019951,0.039776,0,0
3,GO C21 STEROID HORMONE METABOLIC PROCESS,0.85768,-0.0020953,-0.059625,0,0
3,GO REGULATION OF CARTILAGE DEVELOPMENT,0.78962,-0.0021106,-0.043574,0,0
3,GO REGULATION OF CYTOKINESIS,0.43883,-0.002141,-0.032988,0,0
3,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.78289,-0.0021447,0.0050345,0,0
3,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.97557,-0.0021541,-0.011407,0,0
3,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.7495,-0.0021752,-0.039342,0,0
3,GO NUCLEOSIDE SALVAGE,0.36991,-0.0022156,0.039444,0,0
3,GO EXOCYTIC PROCESS,0.56666,-0.002245,0.062948,0,0
3,GO PIGMENT GRANULE MATURATION,0.85768,-0.0023048,-0.054706,0,0
3,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.97557,-0.0023323,-0.0083782,0,0
3,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.84397,-0.0023651,-0.025005,0,0
3,GO TAXIS,0.7495,-0.0024014,-0.010814,0,0
3,GO NEURON DEATH,0.92682,-0.0025196,-0.0017035,0,0
3,GO POSITIVE REGULATION OF TOR SIGNALING,0.95466,-0.0026231,-0.013383,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.83713,-0.0030017,0.0066233,0,0
3,GO DOSAGE COMPENSATION,0.8303,-0.0030349,-0.013877,0,0
3,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.58456,-0.0030703,-0.15633,0,0
3,GO CHROMOSOME ORGANIZATION,0.87833,-0.0030851,0.0056816,0,0
3,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.37932,-0.0032129,-0.048803,0,0
3,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.40349,-0.003424,0.021385,0,0
3,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.93377,-0.0035655,-0.017228,0,0
3,GO RESPONSE TO LIGHT STIMULUS,0.60883,-0.0037699,0.020089,0,0
3,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.80989,-0.0038033,0.010839,0,0
3,GO PEPTIDYL LYSINE ACETYLATION,0.68418,-0.0038524,-0.013559,0,0
3,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.53742,-0.0038826,0.035653,0,0
3,GO CHEMICAL HOMEOSTASIS,0.95466,-0.003967,-0.0080533,0,0
3,GO HEART MORPHOGENESIS,0.99651,-0.0041449,-0.018148,0,0
3,GO HISTONE H4 K16 ACETYLATION,0.54903,-0.0041466,-0.019115,0,0
3,GO ORGANIC ACID TRANSPORT,0.55487,-0.0042215,0.017458,0,0
3,GO REGULATION OF CATABOLIC PROCESS,0.94073,-0.004325,-0.0048182,0,0
3,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.97557,-0.0043475,-0.013154,0,0
3,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.94769,-0.0043516,-0.016717,0,0
3,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.80312,-0.0043878,-0.024818,0,0
3,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.67776,-0.0045072,0.0046049,0,0
3,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.52025,-0.0047153,-0.030987,0,0
3,GO RESPONSE TO PH,0.76948,-0.004738,-0.027486,0,0
3,GO PROTEIN LOCALIZATION TO NUCLEUS,0.69707,-0.0047639,-0.021699,0,0
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.71658,-0.0048014,-0.013175,0,0
3,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.80312,-0.0048961,-0.015413,0,0
3,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.75615,-0.0049049,-0.025801,0,0
3,GO REGULATION OF DNA CATABOLIC PROCESS,0.97557,-0.005009,0.0067403,0,0
3,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.72313,-0.005061,-0.052126,0,0
3,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.55487,-0.0050735,0.08997,0,0
3,GO MACROMOLECULE CATABOLIC PROCESS,0.90599,-0.0050959,-0.0070516,0,0
3,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.61497,-0.0051145,-0.021377,0,0
3,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.87144,-0.0051889,0.013658,0,0
3,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.72313,-0.0052208,-0.050558,0,0
3,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.82348,-0.0052434,-0.0048747,0,0
3,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.65866,-0.0052449,-0.048825,0,0
3,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.66501,-0.005382,-0.043445,0,0
3,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.20621,-0.0057439,-0.059669,0,0
3,GO CELLULAR OXIDANT DETOXIFICATION,0.87144,-0.0061845,-0.014707,0,0
3,GO LIPID CATABOLIC PROCESS,0.47588,-0.0062484,-0.037588,0,0
3,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.65234,-0.0063962,-0.022471,0,0
3,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.56666,-0.0064213,-0.021922,0,0
3,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.3746,-0.0064736,0.045386,0,0
3,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.91293,-0.0065886,-0.010019,0,0
3,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.95466,-0.0066102,-0.030804,0,0
3,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.85768,-0.0067242,0.0015205,0,0
3,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.48131,-0.0067761,0.044148,0,0
3,GO HEAT GENERATION,0.62113,-0.0067979,-0.041792,0,0
3,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.76281,-0.0068298,-0.040138,0,0
3,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.49227,-0.0068596,-0.061985,0,0
3,GO BLASTODERM SEGMENTATION,0.4978,-0.0069007,0.08959,0,0
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.44402,-0.0069391,-0.061373,0,0
3,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.31232,-0.006964,-0.10786,0,0
3,GO MUSCLE STRUCTURE DEVELOPMENT,0.58456,-0.0069784,-0.030028,0,0
3,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.76948,-0.0071088,-0.0088894,0,0
3,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.86455,-0.0071364,0.018294,0,0
3,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.87833,-0.007325,-0.045401,0,0
3,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.7495,-0.0073674,-0.011251,0,0
3,GO HINDLIMB MORPHOGENESIS,0.66501,-0.0074091,0.010561,0,0
3,GO POLYOL BIOSYNTHETIC PROCESS,0.86455,-0.0074578,-0.016199,0,0
3,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.84397,-0.0076558,-0.01464,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.76281,-0.0076769,-0.0092746,0,0
3,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.92682,-0.0077309,-0.018139,0,0
3,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.80989,-0.008001,-0.01596,0,0
3,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.89907,-0.0080193,-0.0045908,0,0
3,GO MICROTUBULE ANCHORING AT CENTROSOME,0.70355,-0.0080197,-0.011913,0,0
3,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.65234,-0.0080541,-0.025212,0,0
3,GO SERTOLI CELL DEVELOPMENT,0.89215,-0.0080773,0.020725,0,0
3,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.83713,-0.0081249,-0.022048,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.71006,-0.0081736,-0.041355,0,0
3,GO SULFUR AMINO ACID METABOLIC PROCESS,0.61497,-0.008546,0.029044,0,0
3,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.80989,-0.0085715,-0.015401,0,0
3,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.54321,-0.0086583,-0.029287,0,0
3,GO APOPTOTIC CELL CLEARANCE,0.82348,-0.0088617,-0.082832,0,0
3,GO ERK1 AND ERK2 CASCADE,0.51459,-0.0089105,-0.046951,0,0
3,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.85768,-0.0089968,-0.012245,0,0
3,GO TRACHEA MORPHOGENESIS,0.89907,-0.0091072,-0.018687,0,0
3,GO DRINKING BEHAVIOR,0.7495,-0.0093318,-0.0030326,0,0
3,GO PIGMENT GRANULE ORGANIZATION,0.97557,-0.0093498,0.0090277,0,0
3,GO REGULATION OF MICROTUBULE BASED PROCESS,0.69707,-0.009508,-0.004935,0,0
3,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.87144,-0.00953,-0.011361,0,0
3,GO RESPONSE TO X RAY,0.60272,-0.0096007,-0.065705,0,0
3,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.50896,-0.0096237,-0.068419,0,0
3,GO FIBROBLAST PROLIFERATION,0.54903,-0.0097005,0.024163,0,0
3,GO MITRAL VALVE DEVELOPMENT,0.59664,-0.00975,-0.0624,0,0
3,GO PERICARDIUM DEVELOPMENT,0.94073,-0.0097832,-0.011658,0,0
3,GO RESPONSE TO ETHANOL,0.99651,-0.0098929,-0.00047781,0,0
3,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.60883,-0.010035,-0.049841,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.65866,-0.01009,-0.037508,0,0
3,GO POSITIVE REGULATION OF GLIOGENESIS,0.62732,-0.010112,-0.030351,0,0
3,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.53167,-0.010163,-0.041355,0,0
3,GO PROSTATE GLAND DEVELOPMENT,0.69707,-0.010221,-0.027857,0,0
3,GO CENTROMERE COMPLEX ASSEMBLY,0.49227,-0.010278,0.037499,0,0
3,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.8303,-0.010279,-0.010079,0,0
3,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.73628,-0.010351,-0.018502,0,0
3,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.81668,-0.010369,0.0030049,0,0
3,GO REGULATION OF PROTEIN FOLDING,0.65234,-0.010619,-0.0232,0,0
3,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.97557,-0.010684,-0.013915,0,0
3,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.60272,-0.010713,-0.10836,0,0
3,GO HEART DEVELOPMENT,0.48678,-0.010727,-0.037599,0,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.36064,-0.010749,-0.084745,0,0
3,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.99651,-0.010795,-0.023231,0,0
3,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.31653,-0.010802,-0.029142,0,0
3,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.80989,-0.010999,-0.0041155,0,0
3,GO BASE EXCISION REPAIR AP SITE FORMATION,0.95466,-0.011084,0.01409,0,0
3,GO GENE SILENCING,0.40843,-0.011122,-0.021814,0,0
3,GO SENSORY PERCEPTION OF SMELL,0.44924,-0.011182,-0.034949,0,0
3,GO CELLULAR RESPONSE TO ZINC ION,0.67776,-0.011203,-0.1668,0,0
3,GO COLLECTING DUCT DEVELOPMENT,0.68418,-0.011264,-0.036411,0,0
3,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.64605,-0.011307,0.058723,0,0
3,GO BLOOD VESSEL MORPHOGENESIS,0.19095,-0.011431,-0.080238,0,0
3,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.4545,-0.011468,-0.032258,0,0
3,GO RESPONSE TO AXON INJURY,0.91293,-0.011778,-0.0012456,0,0
3,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.62113,-0.011837,-0.034786,0,0
3,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.44402,-0.011893,0.12852,0,0
3,GO VESICLE LOCALIZATION,0.26847,-0.012029,-0.033037,0,0
3,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.47049,-0.012085,-0.032097,0,0
3,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.69061,-0.012213,-0.018482,0,0
3,GO CELLULAR RESPONSE TO STARVATION,0.40843,-0.012282,-0.041562,0,0
3,GO MUSCLE TISSUE DEVELOPMENT,0.44924,-0.012391,-0.031789,0,0
3,GO MESODERM DEVELOPMENT,0.44924,-0.012459,-0.050142,0,0
3,GO FEMALE SEX DIFFERENTIATION,0.56075,-0.012515,-0.022809,0,0
3,GO NEUTRAL AMINO ACID TRANSPORT,0.62732,-0.012588,0.025694,0,0
3,GO PROTEIN SUMOYLATION,0.77618,-0.012736,-0.0075734,0,0
3,GO NEGATIVE REGULATION OF SIGNALING,0.50337,-0.012781,-0.022183,0,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.87833,-0.012867,-0.0079675,0,0
3,GO BIOMINERALIZATION,0.89215,-0.012871,-0.020201,0,0
3,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.34256,-0.012913,-0.031051,0,0
3,GO CELLULAR RESPONSE TO VITAMIN D,0.55487,-0.012973,0.085402,0,0
3,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.17934,-0.013086,-0.058279,0,0
3,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.21579,-0.013223,-0.045768,0,0
3,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.33812,-0.01325,-0.059833,0,0
3,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.93377,-0.013264,0.0035065,0,0
3,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.57857,-0.013331,-0.027579,0,0
3,GO DNA BIOSYNTHETIC PROCESS,0.65866,-0.013388,-0.013358,0,0
3,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.76948,-0.013403,0.024341,0,0
3,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.20309,-0.013471,-0.05008,0,0
3,GO PROTEIN TARGETING TO LYSOSOME,0.56666,-0.013499,-0.066469,0,0
3,GO POLYOL CATABOLIC PROCESS,0.78962,-0.013535,-0.024826,0,0
3,GO GASTRULATION,0.65866,-0.013544,-0.044904,0,0
3,GO MICROTUBULE ANCHORING,0.63978,-0.013549,-0.024947,0,0
3,GO GLYCOPROTEIN METABOLIC PROCESS,0.56666,-0.013641,-0.035936,0,0
3,GO PHOTOPERIODISM,0.88523,-0.013648,-0.015083,0,0
3,GO BLASTOCYST DEVELOPMENT,0.60272,-0.013652,-0.018421,0,0
3,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.98255,-0.013772,-0.0020253,0,0
3,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.36064,-0.013815,-0.055739,0,0
3,GO REGULATION OF GLIAL CELL PROLIFERATION,0.7495,-0.013861,-0.027981,0,0
3,GO SERTOLI CELL DIFFERENTIATION,0.96163,-0.013871,-5.346e-05,0,0
3,GO RETROGRADE AXONAL TRANSPORT,0.93377,-0.013925,0.012308,0,0
3,GO REGULATION OF FATTY ACID OXIDATION,0.65866,-0.013971,0.046057,0,0
3,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.8303,-0.013999,0.0024329,0,0
3,GO HISTONE H3 K9 MODIFICATION,0.36526,-0.014096,-0.039662,0,0
3,GO NEUROINFLAMMATORY RESPONSE,0.72969,-0.014098,-0.032344,0,0
3,GO REGULATION OF BIOMINERALIZATION,0.59664,-0.014158,-0.038722,0,0
3,GO MITOPHAGY,0.33812,-0.014368,-0.059769,0,0
3,GO VITAMIN TRANSPORT,0.78289,-0.01444,0.035671,0,0
3,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.96163,-0.014539,-0.053293,0,0
3,GO HISTONE PHOSPHORYLATION,0.5726,-0.014694,-0.040065,0,0
3,GO HISTONE H3 K9 METHYLATION,0.59664,-0.01473,-0.027067,0,0
3,GO CELL DIVISION,0.48131,-0.014868,-0.022416,0,0
3,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.80312,-0.015031,-0.031949,0,0
3,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.60272,-0.015053,-0.043052,0,0
3,GO CELLULAR MACROMOLECULE LOCALIZATION,0.60272,-0.015136,-0.0088106,0,0
3,GO REGULATION OF HISTONE MODIFICATION,0.89215,-0.015318,-0.0092663,0,0
3,GO REGULATION OF T CELL MIGRATION,0.42347,-0.015403,-0.054232,0,0
3,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.40843,-0.015546,-0.019983,0,0
3,GO G2 DNA DAMAGE CHECKPOINT,0.87144,-0.015547,-0.015575,0,0
3,GO OSTEOBLAST DIFFERENTIATION,0.81668,-0.015593,-0.0057824,0,0
3,GO POSITIVE REGULATION OF CELL GROWTH,0.15517,-0.015865,-0.045594,0,0
3,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.98255,-0.015901,-0.023011,0,0
3,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.39371,-0.015977,-0.05669,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.4545,-0.016055,-0.03357,0,0
3,GO SPINDLE ORGANIZATION,0.39858,-0.016137,-0.028088,0,0
3,GO GLIOGENESIS,0.74288,-0.016142,-0.017504,0,0
3,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.59664,-0.016208,-0.068997,0,0
3,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.61497,-0.016301,0.028317,0,0
3,GO RESPONSE TO STEROL,0.77618,-0.016342,-0.017548,0,0
3,GO POSITIVE REGULATION OF DNA REPAIR,0.56666,-0.016354,-0.024477,0,0
3,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.39371,-0.016433,-0.052615,0,0
3,GO ORGAN INDUCTION,0.4978,-0.016484,-0.074804,0,0
3,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.15264,-0.016519,-0.058883,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.24288,-0.016529,-0.032371,0,0
3,GO REGULATION OF ORGANELLE ORGANIZATION,0.50337,-0.016546,-0.015016,0,0
3,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.50896,-0.016593,-0.053644,0,0
3,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.20937,-0.016604,-0.065645,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.44924,-0.016703,-0.027995,0,0
3,GO SISTER CHROMATID COHESION,0.92682,-0.016719,0.0106,0,0
3,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.68418,-0.016808,-0.052488,0,0
3,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.72313,-0.016871,-0.073009,0,0
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.46512,-0.016947,-0.030799,0,0
3,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.80312,-0.01708,-0.062657,0,0
3,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.4545,-0.017094,-0.030825,0,0
3,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.83713,-0.017231,-0.034079,0,0
3,GO SMOOTHENED SIGNALING PATHWAY,0.33373,-0.017298,-0.048122,0,0
3,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.72969,-0.017307,-0.013092,0,0
3,GO AUTOPHAGIC CELL DEATH,0.52594,-0.017344,-0.05563,0,0
3,GO REGULATION OF VASCULAR PERMEABILITY,0.70355,-0.017345,-0.030833,0,0
3,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.76281,-0.017359,-0.012146,0,0
3,GO REGULATION OF TRANSPORT,0.61497,-0.017377,-0.014246,0,0
3,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.53742,-0.017379,-0.029342,0,0
3,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.5726,-0.01739,-0.0339,0,0
3,GO GLAND MORPHOGENESIS,0.46512,-0.017413,-0.092293,0,0
3,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.27611,-0.017446,-0.045449,0,0
3,GO CALCIUM ION IMPORT,0.65866,-0.017459,0.027533,0,0
3,GO TRANSPORT ALONG MICROTUBULE,0.89907,-0.01748,0.01167,0,0
3,GO REGULATION OF CHROMATIN ORGANIZATION,0.53167,-0.017485,-0.019121,0,0
3,GO KERATAN SULFATE METABOLIC PROCESS,0.77618,-0.017605,-0.041129,0,0
3,GO CARDIAC SEPTUM MORPHOGENESIS,0.86455,-0.017617,-0.029001,0,0
3,GO ACETYL COA METABOLIC PROCESS,0.74288,-0.017803,0.024424,0,0
3,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.58456,-0.017903,-0.012086,0,0
3,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.72313,-0.017932,-0.0043403,0,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.47049,-0.017987,-0.049102,0,0
3,GO AMMONIUM ION METABOLIC PROCESS,0.36991,-0.01823,-0.09678,0,0
3,GO SISTER CHROMATID SEGREGATION,0.60272,-0.018329,-0.011517,0,0
3,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.91293,-0.01838,-0.080202,0,0
3,GO ANION TRANSPORT,0.7495,-0.018423,-0.010151,0,0
3,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.94769,-0.018629,0.018076,0,0
3,GO SKIN EPIDERMIS DEVELOPMENT,0.88523,-0.018726,-0.024389,0,0
3,GO RESPONSE TO ZINC ION,0.62113,-0.018737,-0.069647,0,0
3,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.58456,-0.018831,0.020753,0,0
3,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.53742,-0.018839,-0.060528,0,0
3,GO REGULATION OF DNA METABOLIC PROCESS,0.71006,-0.018859,-0.010004,0,0
3,GO PROTEIN N LINKED GLYCOSYLATION,0.34702,-0.018873,-0.071356,0,0
3,GO DIACYLGLYCEROL METABOLIC PROCESS,0.32506,-0.018886,-0.078006,0,0
3,GO REGULATION OF STEM CELL PROLIFERATION,0.53167,-0.01915,-0.046456,0,0
3,GO REGULATION OF CELL CYCLE,0.30815,-0.019229,-0.020215,0,0
3,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.41341,-0.019283,-0.022807,0,0
3,GO ORGANELLE INHERITANCE,0.49227,-0.019439,-0.037226,0,0
3,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.48131,-0.019447,-0.032394,0,0
3,GO EPITHELIAL STRUCTURE MAINTENANCE,0.49227,-0.019517,-0.042666,0,0
3,GO VASCULATURE DEVELOPMENT,0.25363,-0.019522,-0.066452,0,0
3,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.48678,-0.019665,-0.050587,0,0
3,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.58456,-0.019705,0.028858,0,0
3,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.23589,-0.019711,-0.054555,0,0
3,GO REGULATION OF LYMPHOCYTE MIGRATION,0.39858,-0.019807,-0.060449,0,0
3,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.56666,-0.019892,-0.028081,0,0
3,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.2,-0.019967,-0.071375,0,0
3,GO REGULATION OF AUTOPHAGY,0.4978,-0.019997,-0.022612,0,0
3,GO REGULATION OF CELLULAR COMPONENT SIZE,0.68418,-0.020077,-0.014108,0,0
3,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.50896,-0.020125,0.067618,0,0
3,GO POSITIVE REGULATION OF GROWTH,0.67776,-0.020305,-0.012599,0,0
3,GO REGULATION OF PHOSPHORYLATION,0.20937,-0.020325,-0.042632,0,0
3,GO CELL VOLUME HOMEOSTASIS,0.15264,-0.020357,-0.080097,0,0
3,GO LAMELLIPODIUM ORGANIZATION,0.23245,-0.020431,-0.059592,0,0
3,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.77618,-0.02049,-0.033878,0,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.65234,-0.020664,-0.02965,0,0
3,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.24643,-0.020679,-0.10669,0,0
3,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.65866,-0.021099,-0.030584,0,0
3,GO MEMBRANE FUSION,0.27999,-0.021176,-0.048341,0,0
3,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.89907,-0.021317,0.071593,0,0
3,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.25363,-0.02133,-0.028237,0,0
3,GO MICROTUBULE BASED MOVEMENT,0.27227,-0.021344,-0.033256,0,0
3,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.89907,-0.021446,-0.0045247,0,0
3,GO MUSCLE FILAMENT SLIDING,0.91987,-0.021468,-0.016047,0,0
3,GO ORGANIC ACID METABOLIC PROCESS,0.81668,-0.021567,-0.016558,0,0
3,GO NUCLEAR ENVELOPE REASSEMBLY,0.4598,-0.021573,-0.051162,0,0
3,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.67776,-0.021645,-0.032571,0,0
3,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.51459,-0.021663,-0.03962,0,0
3,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.4545,-0.021732,-0.015393,0,0
3,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.53167,-0.021734,-0.026713,0,0
3,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.67776,-0.021846,-0.0047164,0,0
3,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.70355,-0.021862,-0.021587,0,0
3,GO REGULATION OF VASCULOGENESIS,0.33373,-0.021997,-0.093101,0,0
3,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.50337,-0.022015,-0.027923,0,0
3,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.78289,-0.022044,-0.03604,0,0
3,GO VITAMIN D BIOSYNTHETIC PROCESS,0.67137,-0.022119,-0.031084,0,0
3,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.72313,-0.02213,-0.051099,0,0
3,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.59664,-0.022203,-0.017086,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.21905,-0.022287,-0.090021,0,0
3,GO PEPTIDYL LYSINE TRIMETHYLATION,0.47588,-0.022386,-0.021315,0,0
3,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.80312,-0.022407,-0.038593,0,0
3,GO RESPONSE TO OXYGEN LEVELS,0.93377,-0.022455,-0.013078,0,0
3,GO FERTILIZATION,0.26098,-0.022487,-0.028927,0,0
3,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.188,-0.022569,-0.04408,0,0
3,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.29586,-0.022607,-0.034894,0,0
3,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.18219,-0.02268,-0.13403,0,0
3,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.50337,-0.022701,-0.035619,0,0
3,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.89907,-0.022744,-0.020357,0,0
3,GO POLYSACCHARIDE CATABOLIC PROCESS,0.92682,-0.022747,-0.0033542,0,0
3,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.77618,-0.02277,-0.02659,0,0
3,GO GLIAL CELL DIFFERENTIATION,0.61497,-0.02287,-0.023392,0,0
3,GO CELLULAR RESPONSE TO KETONE,0.32938,-0.022926,-0.066363,0,0
3,GO BODY MORPHOGENESIS,0.31653,-0.022946,-0.081159,0,0
3,GO INTERLEUKIN 2 PRODUCTION,0.72313,-0.023015,-0.049528,0,0
3,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.59664,-0.023039,-0.081571,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.21579,-0.023048,-0.1047,0,0
3,GO P BODY ASSEMBLY,0.61497,-0.023064,-0.018746,0,0
3,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.95466,-0.023077,0.00022288,0,0
3,GO PROTEIN TARGETING TO VACUOLE,0.36991,-0.023133,-0.057583,0,0
3,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.32506,-0.023137,-0.056151,0,0
3,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.78962,-0.023186,-0.082528,0,0
3,GO DNA INTEGRITY CHECKPOINT,0.29586,-0.023214,-0.038719,0,0
3,GO RECEPTOR BIOSYNTHETIC PROCESS,0.36064,-0.02324,-0.063778,0,0
3,GO ORGANIC ACID CATABOLIC PROCESS,0.40349,-0.023243,-0.049346,0,0
3,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.17374,-0.023355,-0.046619,0,0
3,GO FATTY ACID TRANSPORT,0.72969,-0.023384,-0.024542,0,0
3,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.49227,-0.023425,-0.050692,0,0
3,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.49227,-0.023635,-0.021057,0,0
3,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.38408,-0.023652,-0.068116,0,0
3,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.15773,-0.024099,-0.049024,0,0
3,GO AMINE CATABOLIC PROCESS,0.44924,-0.024209,-0.093456,0,0
3,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.30402,-0.024269,-0.1025,0,0
3,GO POLYSACCHARIDE METABOLIC PROCESS,0.27611,-0.024315,-0.054826,0,0
3,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.32938,-0.024508,-0.030476,0,0
3,GO RESPONSE TO ABIOTIC STIMULUS,0.52025,-0.024594,-0.023625,0,0
3,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.35607,-0.024607,-0.033533,0,0
3,GO CARBOHYDRATE METABOLIC PROCESS,0.80989,-0.024674,-0.0090311,0,0
3,GO REGULATION OF DNA REPLICATION,0.92682,-0.02468,-0.0045385,0,0
3,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.65866,-0.024829,-0.01931,0,0
3,GO NEGATIVE REGULATION OF OSSIFICATION,0.36064,-0.024879,-0.07039,0,0
3,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.41341,-0.024891,-0.055045,0,0
3,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.67137,-0.024914,-0.030866,0,0
3,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.019739,-0.024923,-0.086715,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.30815,-0.024951,-0.031347,0,0
3,GO C4 DICARBOXYLATE TRANSPORT,0.98255,-0.024992,0.01505,0,0
3,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.35153,-0.025158,-0.071753,0,0
3,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.38888,-0.025203,-0.024403,0,0
3,GO REGULATION OF DEPHOSPHORYLATION,0.41842,-0.025215,-0.021795,0,0
3,GO MELANOCYTE DIFFERENTIATION,0.43367,-0.025222,-0.056351,0,0
3,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.78962,-0.025276,-0.01593,0,0
3,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.2839,-0.025285,-0.029132,0,0
3,GO PATTERN SPECIFICATION PROCESS,0.44924,-0.025338,-0.030402,0,0
3,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.60272,-0.025653,-0.045093,0,0
3,GO AMINE TRANSPORT,0.99651,-0.025839,0.064469,0,0
3,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.98953,-0.025852,0.045742,0,0
3,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.53742,-0.025889,-0.011043,0,0
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.99651,-0.025897,0.0025506,0,0
3,GO CELLULAR KETONE METABOLIC PROCESS,0.5726,-0.02593,-0.053479,0,0
3,GO REGULATION OF ORGANELLE ASSEMBLY,0.11841,-0.025953,-0.040729,0,0
3,GO CELL CYCLE,0.25001,-0.025977,-0.022523,0,0
3,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.27227,-0.026075,-0.049069,0,0
3,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.24288,-0.026102,-0.018355,0,0
3,GO POSITIVE REGULATION OF EXOCYTOSIS,0.72313,-0.02615,0.0020184,0,0
3,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.87144,-0.026156,-0.015939,0,0
3,GO MEMBRANE DOCKING,0.20309,-0.026247,-0.029645,0,0
3,GO MAMMARY GLAND DEVELOPMENT,0.20621,-0.026289,-0.071253,0,0
3,GO RESPONSE TO RADIATION,0.65866,-0.02629,-0.0067871,0,0
3,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.24643,-0.026311,-0.028875,0,0
3,GO MUSCLE CELL DIFFERENTIATION,0.40349,-0.026345,-0.042672,0,0
3,GO MACROPHAGE ACTIVATION,0.84397,-0.026365,-0.024553,0,0
3,GO MESENCHYMAL CELL DIFFERENTIATION,0.56075,-0.026375,-0.047339,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,1,-0.026387,-0.012159,0,0
3,GO T CELL MIGRATION,0.43367,-0.026446,-0.06959,0,0
3,GO TRANSMISSION OF NERVE IMPULSE,0.9686,-0.026471,0.027409,0,0
3,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.25363,-0.026567,-0.076366,0,0
3,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.36064,-0.026647,-0.055413,0,0
3,GO BLEB ASSEMBLY,0.33373,-0.026684,-0.25347,0,0
3,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.15773,-0.026729,-0.097364,0,0
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.43367,-0.026904,-0.028678,0,0
3,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.50337,-0.026967,-0.044751,0,0
3,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.36064,-0.027007,-0.033968,0,0
3,GO AXIS SPECIFICATION,0.69707,-0.027023,-0.00131,0,0
3,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.46512,-0.027051,-0.040504,0,0
3,GO COPII COATED VESICLE CARGO LOADING,0.62732,-0.027099,-0.023682,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.87144,-0.027157,-0.0027098,0,0
3,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.85082,-0.02721,-0.0089129,0,0
3,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.17934,-0.027252,-0.048935,0,0
3,GO HOMEOSTATIC PROCESS,0.26847,-0.02729,-0.030685,0,0
3,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.15264,-0.027331,-0.13456,0,0
3,GO MUSCLE ATROPHY,0.51459,-0.027353,-0.093716,0,0
3,GO FACE DEVELOPMENT,0.2,-0.027398,-0.098459,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.81668,-0.02754,-0.022786,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.34256,-0.027581,-0.03578,0,0
3,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.33373,-0.027635,-0.03034,0,0
3,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.67776,-0.027651,-0.017569,0,0
3,GO REGULATION OF ACTION POTENTIAL,0.78289,-0.027837,-0.022079,0,0
3,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.56075,-0.027854,-0.10173,0,0
3,GO RESPONSE TO INSULIN,0.23937,-0.027872,-0.040946,0,0
3,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.95466,-0.027884,0.0057815,0,0
3,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.7495,-0.027931,-0.0022154,0,0
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.96163,-0.028046,-0.020998,0,0
3,GO REGULATION OF INTRACELLULAR TRANSPORT,0.34256,-0.028056,-0.028641,0,0
3,GO SMOOTH MUSCLE CELL PROLIFERATION,0.61497,-0.028077,-0.044532,0,0
3,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.68418,-0.028218,-0.021905,0,0
3,GO RESPONSE TO STARVATION,0.69707,-0.028266,-0.019755,0,0
3,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.32077,-0.028559,-0.044567,0,0
3,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.32938,-0.028631,-0.061288,0,0
3,GO CHROMOSOME SEGREGATION,0.4598,-0.028657,-0.022158,0,0
3,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.12473,-0.028662,-0.054169,0,0
3,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.83713,-0.028844,-0.0091235,0,0
3,GO REGULATION OF MEMBRANE REPOLARIZATION,0.67776,-0.028846,0.028935,0,0
3,GO ORGANIC ANION TRANSPORT,0.52594,-0.028995,-0.022643,0,0
3,GO EPIDERMIS MORPHOGENESIS,0.87144,-0.029194,-0.039638,0,0
3,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.69707,-0.0292,-0.0099276,0,0
3,GO CELL SUBSTRATE ADHESION,0.56666,-0.029225,-0.050192,0,0
3,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.88523,-0.029295,-0.023462,0,0
3,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.5726,-0.029314,-0.027981,0,0
3,GO OSSIFICATION,0.33373,-0.029494,-0.057957,0,0
3,GO REGULATION OF CELL DIVISION,0.25729,-0.029523,-0.04194,0,0
3,GO MUSCLE CELL PROLIFERATION,0.61497,-0.029577,-0.039756,0,0
3,GO FOCAL ADHESION ASSEMBLY,0.43883,-0.029639,-0.064164,0,0
3,GO LEUKOCYTE HOMEOSTASIS,0.28785,-0.02964,-0.067543,0,0
3,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.20937,-0.029771,-0.10267,0,0
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.27227,-0.029816,-0.030102,0,0
3,GO CIRCULATORY SYSTEM DEVELOPMENT,0.25729,-0.029835,-0.058054,0,0
3,GO NUCLEAR ENVELOPE ORGANIZATION,0.25729,-0.029843,-0.056505,0,0
3,GO NIK NF KAPPAB SIGNALING,0.27227,-0.029898,-0.085049,0,0
3,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.059411,-0.02991,-0.065,0,0
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.070855,-0.030125,-0.036356,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.25001,-0.030207,-0.042938,0,0
3,GO MOLTING CYCLE,0.63354,-0.030221,-0.044955,0,0
3,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.31653,-0.03029,-0.057567,0,0
3,GO LONG CHAIN FATTY ACID TRANSPORT,0.62113,-0.030407,-0.03705,0,0
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.21256,-0.030434,-0.071756,0,0
3,GO CELL JUNCTION ASSEMBLY,0.31232,-0.030441,-0.050339,0,0
3,GO STEM CELL DIVISION,0.94769,-0.03047,-0.0068845,0,0
3,GO ALCOHOL CATABOLIC PROCESS,0.4978,-0.030495,-0.053634,0,0
3,GO ACID SECRETION,0.90599,-0.030511,-0.0013233,0,0
3,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.77618,-0.030557,-0.010788,0,0
3,GO CELLULAR EXTRAVASATION,0.56075,-0.030612,-0.031455,0,0
3,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.50896,-0.030648,-0.056695,0,0
3,GO GLUTATHIONE METABOLIC PROCESS,0.91987,-0.030648,-0.02002,0,0
3,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.40349,-0.030654,-0.052955,0,0
3,GO REGULATION OF CHOLESTEROL EFFLUX,0.30402,-0.030756,-0.068411,0,0
3,GO T CELL RECEPTOR SIGNALING PATHWAY,0.080955,-0.030783,-0.083591,0,0
3,GO REGULATION OF GLUCONEOGENESIS,0.76948,-0.030822,-0.021881,0,0
3,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.69707,-0.030851,-0.027205,0,0
3,GO RESPIRATORY SYSTEM DEVELOPMENT,0.14526,-0.03092,-0.079507,0,0
3,GO REGULATION OF CELL AGING,0.32506,-0.030984,-0.064828,0,0
3,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.14526,-0.031013,-0.041615,0,0
3,GO INOSITOL LIPID MEDIATED SIGNALING,0.20621,-0.031033,-0.058887,0,0
3,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.22568,-0.031154,-0.053133,0,0
3,GO AGING,0.1028,-0.031162,-0.074528,0,0
3,GO REGULATION OF CALCIUM ION IMPORT,0.54321,-0.031173,-0.040351,0,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.23589,-0.031365,-0.062076,0,0
3,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.69707,-0.031397,-0.026546,0,0
3,GO HAIR FOLLICLE MATURATION,0.27611,-0.031505,-0.10466,0,0
3,GO PROTEIN CATABOLIC PROCESS,0.095625,-0.031539,-0.052693,0,0
3,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.47588,-0.031565,-0.039208,0,0
3,GO SKIN MORPHOGENESIS,0.39371,-0.031647,-0.14764,0,0
3,GO SULFATE TRANSPORT,0.073629,-0.031684,-0.062673,0,0
3,GO POSITIVE REGULATION OF HEAT GENERATION,0.69061,-0.03171,-0.032563,0,0
3,GO CORTICAL CYTOSKELETON ORGANIZATION,0.38888,-0.031726,-0.06098,0,0
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.068167,-0.031776,-0.037793,0,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.4545,-0.031787,-0.045034,0,0
3,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.0695,-0.031794,-0.043171,0,0
3,GO LAMELLIPODIUM ASSEMBLY,0.44402,-0.031798,-0.036458,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.65234,-0.031911,-0.028526,0,0
3,GO DNA CATABOLIC PROCESS,0.15773,-0.032259,-0.067355,0,0
3,GO SMALL MOLECULE CATABOLIC PROCESS,0.23245,-0.032418,-0.05419,0,0
3,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.78962,-0.032572,-0.052148,0,0
3,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.15264,-0.03268,-0.16772,0,0
3,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.51459,-0.032754,-0.026166,0,0
3,GO REGULATION OF PHAGOCYTOSIS,0.22235,-0.032766,-0.090831,0,0
3,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.24643,-0.032795,-0.071503,0,0
3,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.90599,-0.032901,-0.019411,0,0
3,GO SODIUM ION HOMEOSTASIS,0.27999,-0.032947,-0.046438,0,0
3,GO REGULATION OF PROTEIN BINDING,0.36064,-0.03295,-0.037602,0,0
3,GO REGULATION OF GROWTH HORMONE SECRETION,0.89907,-0.033011,0.01014,0,0
3,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.22568,-0.033062,-0.068204,0,0
3,GO NEUTRAL LIPID METABOLIC PROCESS,0.61497,-0.033134,-0.010585,0,0
3,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.23245,-0.033202,-0.07845,0,0
3,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.11039,-0.033212,-0.03158,0,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.60272,-0.033233,-0.022539,0,0
3,GO HISTONE H2B UBIQUITINATION,0.19095,-0.033276,-0.077911,0,0
3,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.36064,-0.033339,-0.15957,0,0
3,GO REGULATION OF TRANSFERASE ACTIVITY,0.15517,-0.033368,-0.037576,0,0
3,GO DNA METHYLATION,0.59664,-0.033528,-0.014798,0,0
3,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.60883,-0.033558,-0.077682,0,0
3,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.85768,-0.03357,0.0008337,0,0
3,GO LYSOSOMAL TRANSPORT,0.32506,-0.033694,-0.053499,0,0
3,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.46512,-0.033767,-0.044268,0,0
3,GO HISTONE H3 K9 ACETYLATION,0.32938,-0.033798,-0.055461,0,0
3,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.5726,-0.033834,-0.029344,0,0
3,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.22905,-0.033836,-0.080209,0,0
3,GO RESPONSE TO METAL ION,0.29184,-0.033855,-0.042174,0,0
3,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.17099,-0.033886,-0.03698,0,0
3,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.89907,-0.033909,0.016014,0,0
3,GO ALCOHOL METABOLIC PROCESS,0.69707,-0.033941,-0.029167,0,0
3,GO DETOXIFICATION,0.53167,-0.033965,-0.044965,0,0
3,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.48678,-0.033968,-0.067663,0,0
3,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.35607,-0.034059,-0.10266,0,0
3,GO FLUID TRANSPORT,0.25363,-0.034061,-0.074638,0,0
3,GO SIGNAL RELEASE,0.65866,-0.034071,-0.0010474,0,0
3,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.20309,-0.034174,-0.10134,0,0
3,GO INTRACELLULAR STEROL TRANSPORT,0.57857,-0.034258,-0.055949,0,0
3,GO MICROTUBULE BASED PROCESS,0.38408,-0.034271,-0.014227,0,0
3,GO NUCLEAR CHROMOSOME SEGREGATION,0.12259,-0.034518,-0.043649,0,0
3,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.81668,-0.034534,0.0091153,0,0
3,GO SUBSTANTIA NIGRA DEVELOPMENT,0.62113,-0.03477,-0.047274,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.38408,-0.034804,-0.028389,0,0
3,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.99651,-0.034977,-0.0036248,0,0
3,GO CYTOSOLIC TRANSPORT,0.36526,-0.03502,-0.030797,0,0
3,GO ENERGY RESERVE METABOLIC PROCESS,0.51459,-0.035137,-0.030078,0,0
3,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.2,-0.035363,-0.031391,0,0
3,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.79636,-0.03559,-0.02196,0,0
3,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.39371,-0.035609,-0.026577,0,0
3,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.67776,-0.035659,-0.014561,0,0
3,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.43367,-0.035699,-0.042587,0,0
3,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.21256,-0.035736,-0.040174,0,0
3,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.093897,-0.035767,-0.054094,0,0
3,GO RESPONSE TO PEPTIDE,0.25729,-0.035808,-0.036664,0,0
3,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.22235,-0.035875,-0.065438,0,0
3,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.89215,-0.035892,0.015056,0,0
3,GO CIRCADIAN RHYTHM,0.24643,-0.035946,-0.029111,0,0
3,GO RESPONSE TO HYDROXYUREA,0.27999,-0.035971,-0.074191,0,0
3,GO REGULATION OF HEAT GENERATION,0.54903,-0.036122,-0.056632,0,0
3,GO NEGATIVE REGULATION OF CELL GROWTH,0.58456,-0.036219,-0.018153,0,0
3,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.31653,-0.036249,-0.052113,0,0
3,GO CERAMIDE CATABOLIC PROCESS,0.55487,-0.03626,-0.098518,0,0
3,GO CELL REDOX HOMEOSTASIS,0.92682,-0.036266,-0.024957,0,0
3,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.54321,-0.03635,-0.019318,0,0
3,GO PIGMENT CELL DIFFERENTIATION,0.38408,-0.036384,-0.055867,0,0
3,GO RESPONSE TO HYDROPEROXIDE,0.95466,-0.03645,-0.0058813,0,0
3,GO NEURON APOPTOTIC PROCESS,0.63978,-0.036481,-0.0072482,0,0
3,GO RESPONSE TO THYROID HORMONE,0.82348,-0.036511,-0.029967,0,0
3,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.38408,-0.036559,-0.050379,0,0
3,GO SEQUESTERING OF TRIGLYCERIDE,0.72313,-0.036686,0.025592,0,0
3,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.13583,-0.036791,-0.10331,0,0
3,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.38408,-0.036805,-0.071526,0,0
3,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.26471,-0.036864,-0.060497,0,0
3,GO PEPTIDE CATABOLIC PROCESS,0.36991,-0.036872,-0.066441,0,0
3,GO RESPONSE TO ACID CHEMICAL,0.80989,-0.036963,-0.013388,0,0
3,GO CELLULAR RESPONSE TO PEPTIDE,0.14769,-0.037064,-0.045112,0,0
3,GO DENDRITIC CELL CHEMOTAXIS,0.27999,-0.037255,-0.097812,0,0
3,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.93377,-0.03729,-0.0008696,0,0
3,GO VESICLE ORGANIZATION,0.053746,-0.037366,-0.070643,0,0
3,GO NEPHRON MORPHOGENESIS,0.20309,-0.037413,-0.073062,0,0
3,GO LIPID MODIFICATION,0.061812,-0.037429,-0.071872,0,0
3,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.28785,-0.037451,-0.044029,0,0
3,GO GLIAL CELL DEVELOPMENT,0.40349,-0.037506,-0.044883,0,0
3,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.73628,-0.037519,-0.033958,0,0
3,GO LOCOMOTOR RHYTHM,0.94073,-0.037552,0.010264,0,0
3,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.51459,-0.037629,-0.069764,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE,0.12049,-0.037645,-0.032588,0,0
3,GO MACROMOLECULE DEPALMITOYLATION,0.29992,-0.03767,-0.062206,0,0
3,GO RENAL SYSTEM PROCESS,0.084046,-0.037818,-0.092098,0,0
3,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.84397,-0.038001,-0.039616,0,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.2,-0.038061,-0.10665,0,0
3,GO DE NOVO PROTEIN FOLDING,0.31653,-0.038069,-0.038373,0,0
3,GO REGULATION OF AMINO ACID TRANSPORT,0.59664,-0.038191,-0.018397,0,0
3,GO REGULATION OF MULTI ORGANISM PROCESS,0.53167,-0.038201,-0.051807,0,0
3,GO RESPONSE TO ACTIVITY,0.23937,-0.03821,-0.067827,0,0
3,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.54903,-0.038384,-0.041155,0,0
3,GO RESPONSE TO GROWTH FACTOR,0.20309,-0.03839,-0.059884,0,0
3,GO PROTEIN DEPHOSPHORYLATION,0.51459,-0.038394,-0.014103,0,0
3,GO N GLYCAN PROCESSING,0.39858,-0.038396,-0.10408,0,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.11841,-0.038424,-0.059097,0,0
3,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.49227,-0.038452,-0.11563,0,0
3,GO APPENDAGE DEVELOPMENT,0.12689,-0.038465,-0.09591,0,0
3,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.3746,-0.038467,-0.10747,0,0
3,GO CARNITINE SHUTTLE,0.91293,-0.038579,0.013771,0,0
3,GO ORGANELLE LOCALIZATION,0.05824,-0.038687,-0.039002,0,0
3,GO TRANSFERRIN TRANSPORT,0.2839,-0.038787,-0.062721,0,0
3,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.084046,-0.038791,-0.06953,0,0
3,GO REGULATION OF MITOTIC CELL CYCLE,0.073629,-0.038847,-0.04078,0,0
3,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.48678,-0.038902,-0.067253,0,0
3,GO DIET INDUCED THERMOGENESIS,0.73628,-0.038937,0.06081,0,0
3,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.29586,-0.039185,-0.04237,0,0
3,GO DNA MODIFICATION,0.17653,-0.039344,-0.043046,0,0
3,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.057089,-0.039424,-0.10535,0,0
3,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.12473,-0.039426,-0.062679,0,0
3,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.099158,-0.03947,-0.056999,0,0
3,GO CENTRIOLE CENTRIOLE COHESION,0.84397,-0.039504,0.013789,0,0
3,GO REGENERATION,0.44924,-0.039542,-0.050252,0,0
3,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.061812,-0.039547,-0.085658,0,0
3,GO PEROXISOMAL TRANSPORT,0.33812,-0.039597,-0.047467,0,0
3,GO REGULATION OF INSULIN SECRETION,0.91987,-0.039604,-0.00057665,0,0
3,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.22905,-0.039639,-0.047706,0,0
3,GO NEGATIVE REGULATION OF DNA REPLICATION,0.59664,-0.039711,-0.031453,0,0
3,GO ADIPOSE TISSUE DEVELOPMENT,0.86455,-0.03972,-0.00070276,0,0
3,GO NEURON PROJECTION REGENERATION,0.89215,-0.039762,0.010796,0,0
3,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.84397,-0.039803,-0.0012998,0,0
3,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.71658,-0.039815,-0.06205,0,0
3,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.11039,-0.0399,-0.060889,0,0
3,GO AXIS ELONGATION,0.43883,-0.039958,-0.092542,0,0
3,GO REGULATION OF BLOOD PRESSURE,0.27611,-0.039994,-0.057518,0,0
3,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.80312,-0.039999,-0.020449,0,0
3,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.26847,-0.04001,-0.029269,0,0
3,GO LIPID OXIDATION,0.39371,-0.040258,-0.057369,0,0
3,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.51459,-0.040537,-0.031294,0,0
3,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.20309,-0.040573,-0.078009,0,0
3,GO METANEPHROS DEVELOPMENT,0.18219,-0.040599,-0.08717,0,0
3,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.59664,-0.040689,-0.083843,0,0
3,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.9686,-0.040872,-0.0072722,0,0
3,GO VAGINA DEVELOPMENT,0.66501,-0.040942,-0.065526,0,0
3,GO NEGATIVE REGULATION OF TRANSPORT,0.30402,-0.040996,-0.030411,0,0
3,GO REGULATION OF GASTRIC ACID SECRETION,0.74288,-0.041092,-0.053444,0,0
3,GO ANIMAL ORGAN FORMATION,0.64605,-0.041307,-0.04753,0,0
3,GO REGULATION OF PROTEIN POLYMERIZATION,0.62113,-0.041312,-0.014243,0,0
3,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.070855,-0.041433,-0.062038,0,0
3,GO CHOLESTEROL STORAGE,0.55487,-0.041642,-0.043475,0,0
3,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.43367,-0.041695,-0.070172,0,0
3,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.31232,-0.041744,-0.037809,0,0
3,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.11841,-0.041768,-0.1354,0,0
3,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.41341,-0.041783,-0.041813,0,0
3,GO STEROID BIOSYNTHETIC PROCESS,0.5726,-0.041792,-0.0294,0,0
3,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.13355,-0.041859,-0.046722,0,0
3,GO PROTEIN AUTOPHOSPHORYLATION,0.47588,-0.04197,-0.025186,0,0
3,GO CHRONIC INFLAMMATORY RESPONSE,0.65234,-0.041986,-0.10079,0,0
3,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.98953,-0.042116,0.020262,0,0
3,GO CERAMIDE METABOLIC PROCESS,0.12049,-0.042272,-0.079071,0,0
3,GO PEROXISOME ORGANIZATION,0.22905,-0.04234,-0.053457,0,0
3,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.75615,-0.042351,-0.032161,0,0
3,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.26847,-0.042466,-0.059192,0,0
3,GO NEGATIVE REGULATION OF GENE SILENCING,0.71658,-0.042635,0.017626,0,0
3,GO ENDOSOME TO LYSOSOME TRANSPORT,0.19695,-0.042642,-0.054506,0,0
3,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.96163,-0.042652,-0.013778,0,0
3,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.21256,-0.042748,-0.068053,0,0
3,GO OOGENESIS,0.093897,-0.042759,-0.089788,0,0
3,GO VITAMIN D METABOLIC PROCESS,0.53167,-0.042766,-0.062195,0,0
3,GO REGULATION OF SISTER CHROMATID COHESION,0.53742,-0.042845,-0.027221,0,0
3,GO CD40 SIGNALING PATHWAY,0.34702,-0.042873,-0.12019,0,0
3,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.1313,-0.04288,-0.061497,0,0
3,GO REGULATION OF CILIUM MOVEMENT,0.061812,-0.042892,-0.10529,0,0
3,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.61497,-0.04295,-0.0063505,0,0
3,GO REGULATION OF APPETITE,0.31232,-0.042951,-0.063649,0,0
3,GO ZINC ION HOMEOSTASIS,0.52594,-0.042958,-0.094631,0,0
3,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.72969,-0.043058,-0.013679,0,0
3,GO ASTROCYTE ACTIVATION,0.30402,-0.043064,-0.078155,0,0
3,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.38408,-0.043199,-0.024521,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.29184,-0.043241,-0.051012,0,0
3,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.19095,-0.043286,-0.058209,0,0
3,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.064293,-0.04336,-0.054893,0,0
3,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.53167,-0.043416,-0.034598,0,0
3,GO MAINTENANCE OF CELL NUMBER,0.1028,-0.043477,-0.074725,0,0
3,GO MEMBRANE ORGANIZATION,0.33812,-0.043611,-0.030583,0,0
3,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.082489,-0.043676,-0.056599,0,0
3,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.79636,-0.043696,-0.0084209,0,0
3,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.78289,-0.043801,-0.027243,0,0
3,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.36991,-0.043886,-0.054294,0,0
3,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.16294,-0.044033,-0.045415,0,0
3,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.46512,-0.044044,-0.047773,0,0
3,GO REGULATION OF MITOPHAGY,0.25729,-0.044058,-0.068177,0,0
3,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.55487,-0.044097,-0.048412,0,0
3,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.56666,-0.04418,-0.033172,0,0
3,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.21256,-0.044222,-0.038824,0,0
3,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.14526,-0.044224,-0.094239,0,0
3,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.44924,-0.044239,-0.077296,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.05824,-0.044253,-0.04826,0,0
3,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.14769,-0.044285,-0.058075,0,0
3,GO PROTEIN POLYMERIZATION,0.42855,-0.044392,-0.022277,0,0
3,GO TOR SIGNALING,0.15517,-0.044434,-0.034649,0,0
3,GO RESPONSE TO HORMONE,0.29184,-0.044482,-0.03894,0,0
3,GO REGULATION OF SECRETION,0.17099,-0.044584,-0.046648,0,0
3,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.31232,-0.044735,-0.068603,0,0
3,GO HETEROCHROMATIN ORGANIZATION,0.04854,-0.044763,-0.052471,0,0
3,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.52025,-0.044783,-0.023919,0,0
3,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.29586,-0.044801,-0.12579,0,0
3,GO POSITIVE REGULATION OF CILIUM MOVEMENT,0.78962,-0.044913,0.036864,0,0
3,GO SPINDLE ASSEMBLY,0.05824,-0.044964,-0.053659,0,0
3,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.41842,-0.04497,-0.073289,0,0
3,GO RESPONSE TO INTERLEUKIN 1,0.088862,-0.044973,-0.10864,0,0
3,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.85082,-0.045019,-0.013569,0,0
3,GO POSITIVE REGULATION OF CELL DEATH,0.21905,-0.045074,-0.044078,0,0
3,GO PHOSPHOLIPID CATABOLIC PROCESS,0.054842,-0.045134,-0.14388,0,0
3,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.8303,-0.045257,-0.051683,0,0
3,GO CALCINEURIN MEDIATED SIGNALING,0.42347,-0.045265,-0.037511,0,0
3,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.72969,-0.04527,-0.037436,0,0
3,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.17099,-0.045311,-0.073217,0,0
3,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.1313,-0.045372,-0.06962,0,0
3,GO POSITIVE REGULATION OF TRANSPORT,0.14769,-0.045383,-0.037579,0,0
3,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.83713,-0.045384,-0.031136,0,0
3,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.94769,-0.045392,-0.018674,0,0
3,GO RECEPTOR CATABOLIC PROCESS,0.44402,-0.045482,-0.055209,0,0
3,GO RESPONSE TO KETONE,0.17099,-0.045567,-0.077068,0,0
3,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.69061,-0.045643,-0.045265,0,0
3,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.079444,-0.045653,-0.065112,0,0
3,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.0695,-0.045681,-0.090317,0,0
3,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.20309,-0.045849,-0.066294,0,0
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.22568,-0.045864,-0.093317,0,0
3,GO NEGATIVE REGULATION OF CELL DEATH,0.055956,-0.046016,-0.073182,0,0
3,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.62113,-0.046024,0.076036,0,0
3,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.48678,-0.046026,-0.060973,0,0
3,GO ASTROCYTE DEVELOPMENT,0.43883,-0.046047,-0.057739,0,0
3,GO CHLORIDE ION HOMEOSTASIS,0.73628,-0.046056,-0.023494,0,0
3,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.17653,-0.04608,-0.052696,0,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.23937,-0.046175,-0.13623,0,0
3,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.18219,-0.046193,-0.029822,0,0
3,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.24643,-0.046277,-0.050009,0,0
3,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.12259,-0.0464,-0.055246,0,0
3,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.60272,-0.046604,-0.025664,0,0
3,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.27999,-0.046728,-0.2537,0,0
3,GO BONE MINERALIZATION,0.59664,-0.046734,-0.031952,0,0
3,GO RESPONSE TO NUTRIENT,0.32938,-0.046753,-0.060608,0,0
3,GO REGULATION OF GLUCOSE IMPORT,0.29586,-0.046767,-0.05418,0,0
3,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.44402,-0.046786,-0.032654,0,0
3,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.24643,-0.046825,-0.039587,0,0
3,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.22235,-0.046875,-0.044578,0,0
3,GO RESPONSE TO PAIN,0.65866,-0.047002,-0.062546,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.077957,-0.047005,-0.087691,0,0
3,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.13814,-0.047021,-0.037595,0,0
3,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.13583,-0.047041,-0.062751,0,0
3,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.25363,-0.047043,-0.053979,0,0
3,GO RESPONSE TO INORGANIC SUBSTANCE,0.085627,-0.047119,-0.056345,0,0
3,GO STEROL BIOSYNTHETIC PROCESS,0.7495,-0.047182,0.022279,0,0
3,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.11039,-0.047234,-0.072339,0,0
3,GO LIPID HOMEOSTASIS,0.18508,-0.047324,-0.072075,0,0
3,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.54903,-0.047375,-0.017306,0,0
3,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.030383,-0.047395,-0.0479,0,0
3,GO JNK CASCADE,0.17653,-0.047471,-0.046982,0,0
3,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.9686,-0.047642,0.0054404,0,0
3,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.092194,-0.047734,-0.074036,0,0
3,GO NUCLEUS ORGANIZATION,0.066855,-0.047765,-0.048761,0,0
3,GO REGULATION OF DNA RECOMBINATION,0.43367,-0.047786,-0.033608,0,0
3,GO OSTEOCLAST DIFFERENTIATION,0.59664,-0.047815,-0.013753,0,0
3,GO MEMBRANE LIPID METABOLIC PROCESS,0.077957,-0.048062,-0.084675,0,0
3,GO REGULATION OF LIPID LOCALIZATION,0.25729,-0.048159,-0.055455,0,0
3,GO CELLULAR RESPONSE TO STEROL,0.98255,-0.048185,0.0053542,0,0
3,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.29992,-0.048244,-0.041564,0,0
3,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.8303,-0.048266,-0.017858,0,0
3,GO MECHANORECEPTOR DIFFERENTIATION,0.15015,-0.048332,-0.12801,0,0
3,GO GLUCOSE IMPORT,0.25363,-0.048497,-0.047554,0,0
3,GO PENILE ERECTION,0.74288,-0.048522,-0.028242,0,0
3,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.12049,-0.048531,-0.082053,0,0
3,GO VACUOLAR ACIDIFICATION,0.16294,-0.048637,-0.11439,0,0
3,GO REGULATION OF PHOSPHATASE ACTIVITY,0.18219,-0.048821,-0.045107,0,0
3,GO MANGANESE ION TRANSPORT,0.72313,-0.048862,-0.010146,0,0
3,GO REGULATION OF MUSCLE HYPERTROPHY,0.21905,-0.048885,-0.066053,0,0
3,GO HISTONE H3 ACETYLATION,0.13583,-0.048885,-0.042872,0,0
3,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.092194,-0.049001,-0.069983,0,0
3,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.3746,-0.049032,-0.15971,0,0
3,GO RESPONSE TO TUMOR CELL,0.26098,-0.049036,-0.1034,0,0
3,GO KETONE BIOSYNTHETIC PROCESS,0.64605,-0.049193,-0.053361,0,0
3,GO RESPONSE TO ENDOGENOUS STIMULUS,0.11039,-0.049196,-0.049893,0,0
3,GO PEPTIDYL PROLINE HYDROXYLATION,0.82348,-0.049413,-0.061782,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.26847,-0.049473,-0.043069,0,0
3,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.060602,-0.049595,-0.054655,0,0
3,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.22905,-0.049611,-0.14107,0,0
3,GO INTEGRIN ACTIVATION,0.35153,-0.049632,-0.079514,0,0
3,GO REGULATION OF FLAGELLATED SPERM MOTILITY,0.83713,-0.049665,0.00089528,0,0
3,GO MEMBRANE INVAGINATION,0.20937,-0.049668,-0.072821,0,0
3,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.15517,-0.049676,-0.13311,0,0
3,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.10096,-0.049693,-0.16087,0,0
3,GO SCHWANN CELL DIFFERENTIATION,0.43883,-0.04979,-0.039119,0,0
3,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.22568,-0.049796,-0.044982,0,0
3,GO SINGLE FERTILIZATION,0.090515,-0.049836,-0.05013,0,0
3,GO MITOTIC SPINDLE ORGANIZATION,0.1313,-0.04992,-0.059113,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.77618,-0.049942,-0.013333,0,0
3,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.075049,-0.049967,-0.085534,0,0
3,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.44402,-0.049996,-0.022489,0,0
3,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.7495,-0.050075,-0.022681,0,0
3,GO BIOLOGICAL ADHESION,0.13355,-0.050117,-0.073472,0,0
3,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.23589,-0.050222,-0.094412,0,0
3,GO LYMPHOCYTE MIGRATION,0.24288,-0.050246,-0.078135,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.21905,-0.050306,-0.091423,0,0
3,GO ARACHIDONIC ACID SECRETION,0.26847,-0.050416,-0.084436,0,0
3,GO REGIONALIZATION,0.29992,-0.050447,-0.039031,0,0
3,GO KINETOCHORE ORGANIZATION,0.41341,-0.050601,-0.055677,0,0
3,GO EPITHELIAL CELL PROLIFERATION,0.053746,-0.050618,-0.10607,0,0
3,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.20937,-0.050746,-0.1183,0,0
3,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.70355,-0.050754,-0.029724,0,0
3,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.93377,-0.050779,0.004387,0,0
3,GO RESPONSE TO ALKALOID,0.33373,-0.050782,-0.045193,0,0
3,GO CERAMIDE BIOSYNTHETIC PROCESS,0.17653,-0.050807,-0.069296,0,0
3,GO CAMERA TYPE EYE DEVELOPMENT,0.26471,-0.05083,-0.039678,0,0
3,GO MITOTIC NUCLEAR DIVISION,0.12689,-0.050997,-0.040191,0,0
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.99651,-0.051017,-0.015055,0,0
3,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.11434,-0.051027,-0.046379,0,0
3,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.91987,-0.051057,-0.0029276,0,0
3,GO STRESS FIBER ASSEMBLY,0.40349,-0.051068,-0.051594,0,0
3,GO REGULATION OF LIPID TRANSPORT,0.32077,-0.051105,-0.056605,0,0
3,GO REGULATION OF TUBE SIZE,0.19393,-0.051248,-0.067098,0,0
3,GO CELL CYCLE CHECKPOINT,0.082489,-0.05134,-0.045361,0,0
3,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.19393,-0.051372,-0.079947,0,0
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.28785,-0.051375,-0.076763,0,0
3,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.50337,-0.051386,-0.034784,0,0
3,GO SPHINGOLIPID METABOLIC PROCESS,0.14526,-0.051479,-0.072734,0,0
3,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.48678,-0.05157,-0.073262,0,0
3,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.25729,-0.051725,-0.090823,0,0
3,GO PIGMENTATION,0.12908,-0.051755,-0.068555,0,0
3,GO OVULATION,0.44402,-0.051842,-0.081234,0,0
3,GO LIPOPROTEIN CATABOLIC PROCESS,0.20309,-0.05186,-0.10054,0,0
3,GO RESPONSE TO CHEMOKINE,0.54903,-0.051865,-0.045098,0,0
3,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.093897,-0.051995,-0.11452,0,0
3,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.24643,-0.052098,-0.041733,0,0
3,GO REGULATION OF CELL DEATH,0.079444,-0.052102,-0.059277,0,0
3,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.15517,-0.052159,-0.046643,0,0
3,GO REGULATION OF ORGANIC ACID TRANSPORT,0.33373,-0.052205,-0.060209,0,0
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.35153,-0.052596,-0.088513,0,0
3,GO RESPONSE TO VITAMIN,0.55487,-0.052661,-0.045344,0,0
3,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.54321,-0.052702,-0.047104,0,0
3,GO REGULATION OF LIPID METABOLIC PROCESS,0.3746,-0.052811,-0.037548,0,0
3,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.71006,-0.052823,-0.083316,0,0
3,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.036948,-0.052873,-0.041961,0,0
3,GO RESPONSE TO PEPTIDE HORMONE,0.17374,-0.052919,-0.042604,0,0
3,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.75615,-0.053214,-0.024949,0,0
3,GO RESPONSE TO TOXIC SUBSTANCE,0.13583,-0.053266,-0.066299,0,0
3,GO REGULATION OF GTPASE ACTIVITY,0.38888,-0.0533,-0.023923,0,0
3,GO PHAGOCYTOSIS,0.2839,-0.053521,-0.068683,0,0
3,GO NEGATIVE REGULATION OF SECRETION,0.12473,-0.053615,-0.055788,0,0
3,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.46512,-0.053724,-0.024273,0,0
3,GO ATP TRANSPORT,0.89907,-0.053776,0.0065594,0,0
3,GO PROTEIN LOCALIZATION TO LYSOSOME,0.52594,-0.053879,-0.040107,0,0
3,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.10096,-0.053887,-0.04293,0,0
3,GO EMBRYO DEVELOPMENT,0.1028,-0.053924,-0.053059,0,0
3,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.22235,-0.053968,-0.061382,0,0
3,GO ESTROGEN METABOLIC PROCESS,0.27227,-0.054029,-0.073494,0,0
3,GO THYMIC T CELL SELECTION,0.20309,-0.054055,-0.050215,0,0
3,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.27999,-0.054061,-0.15296,0,0
3,GO AMINO ACID BETAINE METABOLIC PROCESS,0.5726,-0.05411,-0.066397,0,0
3,GO SYMBIOTIC PROCESS,0.087232,-0.054117,-0.079782,0,0
3,GO RESPONSE TO NITROGEN COMPOUND,0.20309,-0.054237,-0.035746,0,0
3,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.093897,-0.054293,-0.060521,0,0
3,GO STRIATED MUSCLE ADAPTATION,0.63354,-0.054364,-0.021443,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.43367,-0.054601,-0.011595,0,0
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.11039,-0.054657,-0.054942,0,0
3,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.25729,-0.054699,-0.077944,0,0
3,GO MESENCHYME MORPHOGENESIS,0.092194,-0.054741,-0.13341,0,0
3,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.48131,-0.054777,-0.025516,0,0
3,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.43367,-0.054815,-0.060493,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.32938,-0.054824,-0.034578,0,0
3,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.2,-0.05483,-0.098465,0,0
3,GO REGULATION OF PROTEIN DEACETYLATION,0.69061,-0.055013,-0.013454,0,0
3,GO ACTIVATION OF MAPK ACTIVITY,0.2,-0.055256,-0.055429,0,0
3,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.076492,-0.055397,-0.065251,0,0
3,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.39858,-0.055449,-0.042461,0,0
3,GO PRE MIRNA PROCESSING,0.51459,-0.055494,-0.034901,0,0
3,GO SELECTIVE AUTOPHAGY,0.19695,-0.055543,-0.07192,0,0
3,GO APOPTOTIC PROCESS,0.1028,-0.055601,-0.054798,0,0
3,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.41842,-0.055681,-0.052568,0,0
3,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.25001,-0.055796,-0.043774,0,0
3,GO DEVELOPMENTAL PIGMENTATION,0.14769,-0.055822,-0.076351,0,0
3,GO DEMETHYLATION,0.088862,-0.055835,-0.051845,0,0
3,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.47588,-0.05587,-0.023843,0,0
3,GO PROTEIN LOCALIZATION TO VACUOLE,0.2839,-0.056102,-0.05852,0,0
3,GO REGULATION OF CILIUM ASSEMBLY,0.10654,-0.056109,-0.057024,0,0
3,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.13355,-0.056217,-0.044563,0,0
3,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.53742,-0.056224,0.12115,0,0
3,GO MALE GAMETE GENERATION,0.0045306,-0.056225,-0.08556,0,0
3,GO CELL CELL RECOGNITION,0.11841,-0.056289,-0.073026,0,0
3,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.93377,-0.056476,-0.015392,0,0
3,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.34702,-0.05653,-0.031693,0,0
3,GO MAINTENANCE OF ORGANELLE LOCATION,0.43367,-0.056572,-0.024253,0,0
3,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.14048,-0.056629,-0.12413,0,0
3,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.74288,-0.056701,-0.022079,0,0
3,GO SINGLE STRAND BREAK REPAIR,0.38408,-0.056713,-0.047228,0,0
3,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.22235,-0.056787,-0.051562,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.60272,-0.057025,-0.0053905,0,0
3,GO REGULATION OF FAT CELL DIFFERENTIATION,0.16032,-0.05722,-0.075605,0,0
3,GO POSITIVE REGULATION OF JNK CASCADE,0.12259,-0.057266,-0.061562,0,0
3,GO REGULATION OF BONE MINERALIZATION,0.32506,-0.057299,-0.06991,0,0
3,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.065563,-0.05744,-0.13976,0,0
3,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.43367,-0.057444,-0.057828,0,0
3,GO RESPONSE TO TESTOSTERONE,0.4598,-0.057452,-0.053363,0,0
3,GO REGULATION OF KIDNEY DEVELOPMENT,0.33812,-0.057477,-0.081057,0,0
3,GO MEMBRANE PROTEIN PROTEOLYSIS,0.11039,-0.057543,-0.13967,0,0
3,GO PROTEIN MANNOSYLATION,0.69707,-0.057564,-0.020375,0,0
3,GO MICROTUBULE BASED TRANSPORT,0.16828,-0.05759,-0.040918,0,0
3,GO HISTONE H4 ACETYLATION,0.087232,-0.057684,-0.047474,0,0
3,GO SENSORY PERCEPTION,0.11841,-0.057936,-0.04304,0,0
3,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.32077,-0.058163,-0.063558,0,0
3,GO POSITIVE REGULATION OF PROTEOLYSIS,0.12908,-0.058167,-0.06074,0,0
3,GO AMYLOID BETA METABOLIC PROCESS,0.30402,-0.058198,-0.055448,0,0
3,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.38408,-0.058241,-0.092118,0,0
3,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.042857,-0.058243,-0.13615,0,0
3,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.077957,-0.058284,-0.05069,0,0
3,GO RESPONSE TO DEXAMETHASONE,0.49227,-0.058314,-0.050802,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.18219,-0.058361,-0.082675,0,0
3,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.91987,-0.058464,0.0099453,0,0
3,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.15517,-0.058631,-0.077146,0,0
3,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.31653,-0.05865,-0.095502,0,0
3,GO EMBRYONIC ORGAN MORPHOGENESIS,0.059411,-0.058702,-0.086829,0,0
3,GO REGULATION OF NUCLEASE ACTIVITY,0.11434,-0.058703,-0.11516,0,0
3,GO GLYCOSYLATION,0.15517,-0.058708,-0.07068,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.32077,-0.058723,-0.035755,0,0
3,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.16828,-0.058764,-0.069985,0,0
3,GO FATTY ACID BETA OXIDATION,0.32077,-0.058862,-0.064597,0,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.085627,-0.059026,-0.091971,0,0
3,GO CAMP BIOSYNTHETIC PROCESS,0.36064,-0.059118,-0.096058,0,0
3,GO NEURONAL ACTION POTENTIAL,0.25001,-0.059138,-0.076407,0,0
3,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.76948,-0.059148,-0.0038809,0,0
3,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.19095,-0.05917,-0.1236,0,0
3,GO POSITIVE REGULATION OF MAPK CASCADE,0.35607,-0.059229,-0.048949,0,0
3,GO TONGUE DEVELOPMENT,0.41341,-0.059263,-0.085089,0,0
3,GO GOLGI RIBBON FORMATION,0.38888,-0.059418,-0.062741,0,0
3,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.48678,-0.059444,-0.068701,0,0
3,GO GLYCOLIPID CATABOLIC PROCESS,0.24643,-0.059615,-0.15713,0,0
3,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.12049,-0.059713,-0.082747,0,0
3,GO RESPONSE TO FUNGUS,0.30815,-0.059877,-0.047315,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.18219,-0.05992,-0.097341,0,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.095625,-0.059945,-0.069165,0,0
3,GO T CELL CHEMOTAXIS,0.12049,-0.059949,-0.082357,0,0
3,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.98953,-0.059995,0.029895,0,0
3,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.23937,-0.060031,-0.081232,0,0
3,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.059411,-0.060173,-0.10032,0,0
3,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.26098,-0.06027,-0.040523,0,0
3,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.12473,-0.060364,-0.082909,0,0
3,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.13583,-0.06039,-0.067139,0,0
3,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.20309,-0.0604,-0.10067,0,0
3,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.12259,-0.060446,-0.085593,0,0
3,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.36991,-0.060454,-0.041694,0,0
3,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.92682,-0.060632,0.0018042,0,0
3,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.12908,-0.060711,-0.11151,0,0
3,GO NEGATIVE REGULATION OF GROWTH,0.14048,-0.060887,-0.052195,0,0
3,GO RESPONSE TO INTERLEUKIN 15,0.17653,-0.060934,-0.11468,0,0
3,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.44402,-0.061,-0.041059,0,0
3,GO APPENDAGE MORPHOGENESIS,0.15773,-0.061007,-0.10467,0,0
3,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.53742,-0.061014,-0.037754,0,0
3,GO SEX DIFFERENTIATION,0.11636,-0.061016,-0.050249,0,0
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.19095,-0.061072,-0.057507,0,0
3,GO CELLULAR HORMONE METABOLIC PROCESS,0.36991,-0.061221,-0.056979,0,0
3,GO FC RECEPTOR SIGNALING PATHWAY,0.082489,-0.061364,-0.077825,0,0
3,GO REGULATION OF HORMONE METABOLIC PROCESS,0.2,-0.061378,-0.1525,0,0
3,GO CELL DIFFERENTIATION IN SPINAL CORD,0.25729,-0.061488,-0.067297,0,0
3,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.63978,-0.061547,-0.025898,0,0
3,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.15517,-0.061581,-0.11519,0,0
3,GO REGULATION OF TOR SIGNALING,0.15015,-0.061624,-0.047396,0,0
3,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.11841,-0.0617,-0.068346,0,0
3,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.25001,-0.061778,-0.080982,0,0
3,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.24288,-0.061829,-0.1638,0,0
3,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.059411,-0.061852,-0.081493,0,0
3,GO RENAL FILTRATION,0.55487,-0.061867,-0.041388,0,0
3,GO HISTONE H3 K14 ACETYLATION,0.33812,-0.06193,-0.0471,0,0
3,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.51459,-0.062005,-0.030543,0,0
3,GO MODIFIED AMINO ACID TRANSPORT,0.16294,-0.062178,-0.10012,0,0
3,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.22235,-0.062194,-0.090051,0,0
3,GO ANATOMICAL STRUCTURE MATURATION,0.16559,-0.062198,-0.044743,0,0
3,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.80312,-0.062241,-0.021675,0,0
3,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.045624,-0.0624,-0.12938,0,0
3,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.44402,-0.062587,-0.02347,0,0
3,GO CELLULAR LIPID METABOLIC PROCESS,0.053746,-0.062759,-0.071512,0,0
3,GO PULMONARY VALVE DEVELOPMENT,0.33373,-0.062824,-0.10819,0,0
3,GO REGULATION OF VASOCONSTRICTION,0.19695,-0.062861,-0.070382,0,0
3,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.019739,-0.062998,-0.085776,0,0
3,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.32077,-0.063034,-0.033723,0,0
3,GO HYALURONAN METABOLIC PROCESS,0.35153,-0.063039,-0.069863,0,0
3,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.15015,-0.063307,-0.057595,0,0
3,GO POSITIVE REGULATION OF CELL AGING,0.1028,-0.063568,-0.11919,0,0
3,GO OOCYTE MATURATION,0.66501,-0.063675,-0.020409,0,0
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.065563,-0.063757,-0.063544,0,0
3,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.13583,-0.0638,-0.086583,0,0
3,GO POSITIVE THYMIC T CELL SELECTION,0.25001,-0.063803,-0.094649,0,0
3,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.85768,-0.063809,0.0040887,0,0
3,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.36064,-0.063845,-0.049305,0,0
3,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.23589,-0.063872,-0.10514,0,0
3,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.70355,-0.064012,-0.031214,0,0
3,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.14048,-0.06404,-0.070882,0,0
3,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.13583,-0.064134,-0.12509,0,0
3,GO REGULATION OF STEROID METABOLIC PROCESS,0.27611,-0.064153,-0.061548,0,0
3,GO REGULATION OF CELL MATURATION,0.087232,-0.064441,-0.072833,0,0
3,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.55487,-0.064485,0.094908,0,0
3,GO PROTEIN LOCALIZATION TO CILIUM,0.066855,-0.06483,-0.10504,0,0
3,GO GPI ANCHOR METABOLIC PROCESS,0.18219,-0.064888,-0.10029,0,0
3,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.053746,-0.064966,-0.079914,0,0
3,GO MONOCARBOXYLIC ACID TRANSPORT,0.43367,-0.065007,-0.031353,0,0
3,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.18219,-0.065068,-0.11325,0,0
3,GO LIPID BIOSYNTHETIC PROCESS,0.060602,-0.065325,-0.070494,0,0
3,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.16294,-0.065333,-0.050958,0,0
3,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.21579,-0.065418,-0.049418,0,0
3,GO PRIMARY MIRNA PROCESSING,0.48131,-0.065474,-0.048068,0,0
3,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.52594,-0.065615,-0.050706,0,0
3,GO POSITIVE REGULATION OF PROTEIN BINDING,0.49227,-0.065623,-0.042442,0,0
3,GO REGULATION OF EXIT FROM MITOSIS,0.14048,-0.065695,-0.089292,0,0
3,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.76948,-0.065715,0.0055686,0,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.18219,-0.065767,-0.079642,0,0
3,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.11434,-0.065784,-0.15275,0,0
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.068167,-0.065843,-0.055671,0,0
3,GO FATTY ACID CATABOLIC PROCESS,0.088862,-0.066178,-0.098585,0,0
3,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.059411,-0.066245,-0.086528,0,0
3,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.12259,-0.066303,-0.10011,0,0
3,GO REGULATION OF ANION TRANSPORT,0.092194,-0.066316,-0.072435,0,0
3,GO RESPONSE TO MINERALOCORTICOID,0.24643,-0.066361,-0.08214,0,0
3,GO HYALURONAN BIOSYNTHETIC PROCESS,0.22568,-0.06646,-0.10443,0,0
3,GO MULTICELLULAR ORGANISM AGING,0.017549,-0.066565,-0.12547,0,0
3,GO EPIBOLY,0.29184,-0.066593,-0.129,0,0
3,GO EATING BEHAVIOR,0.21905,-0.066676,-0.069817,0,0
3,GO CELLULAR RESPONSE TO CAMP,0.69061,-0.06671,0.0053828,0,0
3,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.061812,-0.066742,-0.086157,0,0
3,GO DETECTION OF ABIOTIC STIMULUS,0.05824,-0.066789,-0.083841,0,0
3,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.65866,-0.066992,-0.020116,0,0
3,GO TUMOR NECROSIS FACTOR SECRETION,0.05161,-0.067007,-0.10693,0,0
3,GO INTERFERON GAMMA PRODUCTION,0.12049,-0.06706,-0.076101,0,0
3,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.59664,-0.067076,-0.059338,0,0
3,GO VITAMIN METABOLIC PROCESS,0.98255,-0.067183,0.0024998,0,0
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.74288,-0.067271,-0.035863,0,0
3,GO NEURAL RETINA DEVELOPMENT,0.78289,-0.067299,-0.0081928,0,0
3,GO AMEBOIDAL TYPE CELL MIGRATION,0.082489,-0.067305,-0.089652,0,0
3,GO CELLULAR RESPONSE TO SALT STRESS,0.4598,-0.067345,-0.088499,0,0
3,GO RESPONSE TO OXIDATIVE STRESS,0.095625,-0.067411,-0.069622,0,0
3,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.095625,-0.067649,-0.063693,0,0
3,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.10845,-0.067715,-0.05579,0,0
3,GO REGULATION OF PROSTAGLANDIN SECRETION,0.4545,-0.06773,-0.059121,0,0
3,GO REGULATION OF JUN KINASE ACTIVITY,0.064293,-0.067756,-0.080653,0,0
3,GO HISTONE H2A ACETYLATION,0.22235,-0.067757,-0.061376,0,0
3,GO REGULATION OF BONE DEVELOPMENT,0.16559,-0.067791,-0.08264,0,0
3,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.81668,-0.067959,0.006514,0,0
3,GO REGULATION OF MAPK CASCADE,0.21256,-0.068029,-0.055321,0,0
3,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.097379,-0.068033,-0.14833,0,0
3,GO MEMBRANE RAFT ASSEMBLY,0.4598,-0.068115,-0.19913,0,0
3,GO STEROID HORMONE SECRETION,0.25001,-0.068121,-0.099478,0,0
3,GO NATURAL KILLER CELL DIFFERENTIATION,0.39858,-0.068122,-0.048999,0,0
3,GO FOREBRAIN NEURON DIFFERENTIATION,0.25363,-0.068167,-0.091611,0,0
3,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.27611,-0.068202,-0.070329,0,0
3,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.94769,-0.06822,0.063735,0,0
3,GO STEROID CATABOLIC PROCESS,0.4545,-0.068223,-0.067968,0,0
3,GO LIPID METABOLIC PROCESS,0.082489,-0.06838,-0.061218,0,0
3,GO BONE MATURATION,0.39371,-0.068413,-0.070685,0,0
3,GO FATTY ACID BIOSYNTHETIC PROCESS,0.10465,-0.068465,-0.090477,0,0
3,GO CELLULAR RESPONSE TO LIPID,0.17653,-0.068646,-0.067613,0,0
3,GO GLYCOPROTEIN CATABOLIC PROCESS,0.38888,-0.068737,-0.15186,0,0
3,GO TROPHOBLAST CELL MIGRATION,0.24643,-0.068763,-0.17683,0,0
3,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.11636,-0.068841,-0.13751,0,0
3,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.11039,-0.068864,-0.084924,0,0
3,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.15773,-0.068878,-0.087709,0,0
3,GO DETECTION OF BIOTIC STIMULUS,0.49227,-0.069196,-0.09461,0,0
3,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.25729,-0.069239,-0.044835,0,0
3,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.44924,-0.069307,-0.059768,0,0
3,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.32938,-0.069376,-0.083875,0,0
3,GO REGULATION OF PROTEIN IMPORT,0.14048,-0.069387,-0.10439,0,0
3,GO RESPONSE TO CORTICOSTEROID,0.10845,-0.069552,-0.097558,0,0
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.063042,-0.069572,-0.07148,0,0
3,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.055956,-0.069583,-0.079324,0,0
3,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.14285,-0.06961,-0.12077,0,0
3,GO MAGNESIUM ION HOMEOSTASIS,0.52025,-0.069614,-0.072431,0,0
3,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.65866,-0.069665,-0.029161,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.42347,-0.069711,-0.12189,0,0
3,GO STEM CELL PROLIFERATION,0.085627,-0.069873,-0.088511,0,0
3,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.49227,-0.069902,-0.047194,0,0
3,GO MUSCLE CELL DEVELOPMENT,0.14048,-0.069984,-0.069522,0,0
3,GO RESPONSE TO EPINEPHRINE,1,-0.070059,0.0084342,0,0
3,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.36526,-0.070127,-0.11902,0,0
3,GO L PHENYLALANINE METABOLIC PROCESS,0.34256,-0.070147,-0.16427,0,0
3,GO RESPONSE TO SALT STRESS,0.17099,-0.070179,-0.097227,0,0
3,GO CELLULAR RESPONSE TO FATTY ACID,0.55487,-0.07019,-0.051358,0,0
3,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.32077,-0.070281,-0.075533,0,0
3,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.21579,-0.070396,-0.15765,0,0
3,GO OOCYTE DIFFERENTIATION,0.088862,-0.070457,-0.11075,0,0
3,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.23589,-0.070469,-0.048612,0,0
3,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.077957,-0.070546,-0.10172,0,0
3,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.076492,-0.070944,-0.075557,0,0
3,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.52025,-0.071008,-0.14249,0,0
3,GO POSITIVE REGULATION OF ERAD PATHWAY,0.18508,-0.071112,-0.073072,0,0
3,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.12473,-0.071121,-0.13684,0,0
3,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.088862,-0.07116,-0.081142,0,0
3,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.26471,-0.071183,-0.050459,0,0
3,GO UV DAMAGE EXCISION REPAIR,0.41842,-0.07124,-0.038872,0,0
3,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.34702,-0.071327,-0.081445,0,0
3,GO HISTONE H4 K5 ACETYLATION,0.66501,-0.071361,-0.014335,0,0
3,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.19393,-0.071443,-0.10888,0,0
3,GO POSITIVE REGULATION OF DNA REPLICATION,0.12908,-0.071506,-0.057411,0,0
3,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.16032,-0.071682,-0.19393,0,0
3,GO BRANCH ELONGATION OF AN EPITHELIUM,0.20309,-0.071726,-0.19148,0,0
3,GO RESPONSE TO STEROID HORMONE,0.090515,-0.071862,-0.082773,0,0
3,GO REGULATION OF ERAD PATHWAY,0.11039,-0.072218,-0.056497,0,0
3,GO NEUTROPHIL CHEMOTAXIS,0.088862,-0.072555,-0.076916,0,0
3,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.079444,-0.072652,-0.096508,0,0
3,GO CELL MATURATION,0.095625,-0.072739,-0.059033,0,0
3,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.26098,-0.072774,-0.040754,0,0
3,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.22905,-0.072841,-0.10171,0,0
3,GO FEMALE GAMETE GENERATION,0.05824,-0.072977,-0.071017,0,0
3,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.14526,-0.073112,-0.063294,0,0
3,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.11636,-0.073163,-0.12615,0,0
3,GO RESPONSE TO GROWTH HORMONE,0.38888,-0.073195,-0.069182,0,0
3,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.42855,-0.073636,-0.063622,0,0
3,GO LENS FIBER CELL DIFFERENTIATION,0.31232,-0.073693,-0.086789,0,0
3,GO REGULATION OF AMYLOID BETA CLEARANCE,0.19695,-0.073724,-0.14012,0,0
3,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.084046,-0.073751,-0.072273,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.059411,-0.073851,-0.076544,0,0
3,GO REGULATION OF HORMONE SECRETION,0.17653,-0.074032,-0.05161,0,0
3,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.013139,-0.074079,-0.11156,0,0
3,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.13583,-0.074207,-0.10346,0,0
3,GO POTASSIUM ION HOMEOSTASIS,0.19695,-0.074241,-0.085051,0,0
3,GO SPERM EGG RECOGNITION,0.14526,-0.07425,-0.060326,0,0
3,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.015203,-0.074726,-0.069842,0,0
3,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.25729,-0.074747,-0.10372,0,0
3,GO FUCOSE METABOLIC PROCESS,0.33812,-0.074971,-0.086857,0,0
3,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.082489,-0.075002,-0.073294,0,0
3,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.27999,-0.075064,-0.074805,0,0
3,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.29586,-0.075212,-0.11366,0,0
3,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.10654,-0.075306,-0.11015,0,0
3,GO SPERM MOTILITY,0.012203,-0.075329,-0.091459,0,0
3,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.16559,-0.075576,-0.098151,0,0
3,GO REGULATION OF MAP KINASE ACTIVITY,0.077957,-0.075608,-0.077803,0,0
3,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.42347,-0.075615,-0.030029,0,0
3,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.095625,-0.075639,-0.089565,0,0
3,GO CELLULAR RESPONSE TO IRON ION,0.076492,-0.075751,-0.2086,0,0
3,GO MODULATION BY VIRUS OF HOST PROCESS,0.10096,-0.075787,-0.081429,0,0
3,GO DIGESTIVE TRACT MORPHOGENESIS,0.34256,-0.075824,-0.063825,0,0
3,GO NEGATIVE REGULATION OF TOR SIGNALING,0.66501,-0.075893,-0.013919,0,0
3,GO HISTONE H3 DEACETYLATION,0.16294,-0.076023,-0.060796,0,0
3,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.017969,-0.07604,-0.099561,0,0
3,GO REGULATION OF VIRAL TRANSCRIPTION,0.068167,-0.07605,-0.079694,0,0
3,GO POSITIVE REGULATION OF HAIR CYCLE,0.27227,-0.076241,-0.12255,0,0
3,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.188,-0.076252,-0.099063,0,0
3,GO EAR DEVELOPMENT,0.035393,-0.0763,-0.099769,0,0
3,GO OXALATE TRANSPORT,0.18508,-0.076339,-0.070137,0,0
3,GO STEROL METABOLIC PROCESS,0.36991,-0.076559,-0.044179,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.28785,-0.076608,-0.048475,0,0
3,GO GOLGI VESICLE TRANSPORT,0.064293,-0.076635,-0.067156,0,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.12259,-0.076699,-0.13211,0,0
3,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.14285,-0.076791,-0.075534,0,0
3,GO DNA METHYLATION OR DEMETHYLATION,0.023205,-0.076905,-0.071375,0,0
3,GO PEPTIDE HORMONE SECRETION,0.53167,-0.077103,-0.0186,0,0
3,GO OLIGODENDROCYTE DIFFERENTIATION,0.25363,-0.077124,-0.059487,0,0
3,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.16032,-0.077268,-0.064251,0,0
3,GO SENSORY SYSTEM DEVELOPMENT,0.12049,-0.077274,-0.06012,0,0
3,GO KIDNEY MORPHOGENESIS,0.054842,-0.077294,-0.10155,0,0
3,GO RESPONSE TO LIPID,0.13355,-0.077308,-0.066226,0,0
3,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.070855,-0.077435,-0.099518,0,0
3,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.031059,-0.07751,-0.091504,0,0
3,GO RESPONSE TO VITAMIN D,0.80989,-0.077594,0.039877,0,0
3,GO CARDIAC ATRIUM MORPHOGENESIS,0.53167,-0.077645,-0.031668,0,0
3,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.40349,-0.077647,-0.11588,0,0
3,GO DEPHOSPHORYLATION,0.021165,-0.077657,-0.058171,0,0
3,GO NEUROTRANSMITTER METABOLIC PROCESS,0.19095,-0.077662,-0.098862,0,0
3,GO SENSORY ORGAN DEVELOPMENT,0.084046,-0.077666,-0.067344,0,0
3,GO REGULATION OF MACROPHAGE ACTIVATION,0.16294,-0.077716,-0.099133,0,0
3,GO REGULATION OF LYSOSOMAL LUMEN PH,0.21905,-0.077791,-0.1154,0,0
3,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.63354,-0.07786,0.021852,0,0
3,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.16559,-0.077919,-0.073781,0,0
3,GO NEUTROPHIL MIGRATION,0.082489,-0.078095,-0.096768,0,0
3,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.041967,-0.078222,-0.095114,0,0
3,GO CELL AGING,0.061812,-0.078269,-0.080006,0,0
3,GO ARTERY MORPHOGENESIS,0.11039,-0.078324,-0.10161,0,0
3,GO MONOSACCHARIDE METABOLIC PROCESS,0.1313,-0.078506,-0.057484,0,0
3,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.093897,-0.078605,-0.17566,0,0
3,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.21579,-0.078614,-0.08538,0,0
3,GO REGULATION OF HORMONE LEVELS,0.095625,-0.078628,-0.068587,0,0
3,GO DEVELOPMENTAL INDUCTION,0.17099,-0.078658,-0.1118,0,0
3,GO REGULATION OF OSSIFICATION,0.12049,-0.078785,-0.0924,0,0
3,GO RESPONSE TO FLUID SHEAR STRESS,0.10845,-0.07879,-0.13168,0,0
3,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.15517,-0.078833,-0.093369,0,0
3,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.077957,-0.078852,-0.08791,0,0
3,GO FOREBRAIN MORPHOGENESIS,0.82348,-0.078887,-0.0056324,0,0
3,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.17653,-0.078912,-0.081512,0,0
3,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.087232,-0.079113,-0.065285,0,0
3,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.13814,-0.079144,-0.091213,0,0
3,GO SULFUR COMPOUND TRANSPORT,0.072231,-0.079169,-0.082162,0,0
3,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.39858,-0.079174,-0.063072,0,0
3,GO INCLUSION BODY ASSEMBLY,0.89907,-0.079179,0.033338,0,0
3,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.082489,-0.079539,-0.095341,0,0
3,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.62732,-0.079689,-0.12377,0,0
3,GO POSITIVE REGULATION OF CYTOKINESIS,0.17653,-0.079723,-0.071325,0,0
3,GO STEROID ESTERIFICATION,0.11434,-0.079851,-0.19435,0,0
3,GO EMBRYO IMPLANTATION,0.24643,-0.079902,-0.10811,0,0
3,GO CENTRIOLE ASSEMBLY,0.13814,-0.079905,-0.068935,0,0
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.10096,-0.079933,-0.089764,0,0
3,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.15517,-0.079957,-0.097999,0,0
3,GO HEMIDESMOSOME ASSEMBLY,0.66501,-0.079977,-0.12878,0,0
3,GO PHOSPHOLIPID EFFLUX,0.21905,-0.080125,-0.1366,0,0
3,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.088862,-0.080256,-0.13641,0,0
3,GO HORMONE TRANSPORT,0.19695,-0.080339,-0.05185,0,0
3,GO REGULATION OF CIRCADIAN RHYTHM,0.027188,-0.080418,-0.06057,0,0
3,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.32938,-0.080418,-0.079,0,0
3,GO COBALAMIN METABOLIC PROCESS,0.21256,-0.08045,-0.092696,0,0
3,GO KERATINOCYTE MIGRATION,0.61497,-0.08049,-0.039674,0,0
3,GO AMINE METABOLIC PROCESS,0.12049,-0.080577,-0.079885,0,0
3,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.60883,-0.080587,-0.0053089,0,0
3,GO NEGATIVE REGULATION OF MAPK CASCADE,0.11434,-0.08078,-0.068347,0,0
3,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.14285,-0.08084,-0.24794,0,0
3,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.17934,-0.080883,-0.082861,0,0
3,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.38888,-0.081216,-0.039415,0,0
3,GO GAMETE GENERATION,0.0010206,-0.081244,-0.088169,0,0
3,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.89907,-0.08135,0.012913,0,0
3,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.79636,-0.081497,-0.014733,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.36064,-0.081499,-0.088131,0,0
3,GO REGULATION OF GLIAL CELL MIGRATION,0.46512,-0.081511,-0.043248,0,0
3,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.21905,-0.081737,-0.10744,0,0
3,GO MALE MEIOSIS I,0.14526,-0.081746,-0.16335,0,0
3,GO MEIOTIC CELL CYCLE PROCESS,0.0018173,-0.081769,-0.08676,0,0
3,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.27999,-0.081823,-0.079765,0,0
3,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.36991,-0.081949,-0.11858,0,0
3,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.11039,-0.081967,-0.073009,0,0
3,GO DETECTION OF LIGHT STIMULUS,0.17934,-0.082008,-0.068604,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.98953,-0.082031,0.0090464,0,0
3,GO ENDOSOMAL TRANSPORT,0.00028792,-0.082157,-0.10138,0,0
3,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.057089,-0.082351,-0.1822,0,0
3,GO FOREBRAIN GENERATION OF NEURONS,0.12908,-0.082473,-0.10733,0,0
3,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.11636,-0.082782,-0.07921,0,0
3,GO REGULATION OF LIPID STORAGE,0.087232,-0.082949,-0.091851,0,0
3,GO REGULATION OF KERATINOCYTE MIGRATION,0.14526,-0.082951,-0.092192,0,0
3,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.21579,-0.082956,-0.10327,0,0
3,GO ERYTHROCYTE MATURATION,0.12049,-0.08344,-0.088107,0,0
3,GO PROTEIN DEGLYCOSYLATION,0.11039,-0.08417,-0.14361,0,0
3,GO REGULATION OF HAIR CYCLE,0.20937,-0.084269,-0.10289,0,0
3,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.027803,-0.08431,-0.14589,0,0
3,GO POSITIVE REGULATION OF CELL DIVISION,0.20937,-0.084536,-0.056248,0,0
3,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.39858,-0.084864,-0.049769,0,0
3,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.12473,-0.0849,-0.10945,0,0
3,GO EXIT FROM MITOSIS,0.022165,-0.084988,-0.10847,0,0
3,GO GASTRIC ACID SECRETION,0.60883,-0.08499,-0.037888,0,0
3,GO CARDIAC CELL DEVELOPMENT,0.20309,-0.085085,-0.06729,0,0
3,GO CELLULAR RESPONSE TO NUTRIENT,0.55487,-0.085163,-0.041185,0,0
3,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.10654,-0.085236,-0.081822,0,0
3,GO B CELL HOMEOSTASIS,0.32506,-0.085482,-0.0654,0,0
3,GO P38MAPK CASCADE,0.095625,-0.085628,-0.11232,0,0
3,GO INNER EAR MORPHOGENESIS,0.055956,-0.085652,-0.10908,0,0
3,GO CILIUM MOVEMENT,0.0020453,-0.085741,-0.127,0,0
3,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.18508,-0.085753,-0.10198,0,0
3,GO LIPOPROTEIN METABOLIC PROCESS,0.076492,-0.086105,-0.076304,0,0
3,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.36064,-0.086299,-0.092187,0,0
3,GO SPHINGOID METABOLIC PROCESS,0.29586,-0.086473,-0.083811,0,0
3,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.082489,-0.086596,-0.067863,0,0
3,GO TEMPERATURE HOMEOSTASIS,0.087232,-0.086657,-0.064314,0,0
3,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.25363,-0.086693,-0.11179,0,0
3,GO INOSITOL METABOLIC PROCESS,0.060602,-0.086994,-0.11438,0,0
3,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.13814,-0.087059,-0.083389,0,0
3,GO CARDIAC MYOFIBRIL ASSEMBLY,0.059411,-0.0872,-0.13205,0,0
3,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.67776,-0.087223,-0.074606,0,0
3,GO MULTI ORGANISM CELLULAR PROCESS,0.092194,-0.087339,-0.18318,0,0
3,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.13814,-0.087407,-0.19943,0,0
3,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.057089,-0.087547,-0.16547,0,0
3,GO OTIC VESICLE DEVELOPMENT,0.68418,-0.087736,-0.044953,0,0
3,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.080955,-0.087739,-0.094854,0,0
3,GO ACTIN CROSSLINK FORMATION,0.87144,-0.087869,0.077755,0,0
3,GO STEROL HOMEOSTASIS,0.20621,-0.088167,-0.089323,0,0
3,GO TISSUE REGENERATION,0.1028,-0.088299,-0.11001,0,0
3,GO CELLULAR GLUCAN METABOLIC PROCESS,0.13814,-0.088552,-0.066869,0,0
3,GO POSITIVE REGULATION OF MITOPHAGY,0.13583,-0.088655,-0.096032,0,0
3,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.10096,-0.088765,-0.076278,0,0
3,GO WHITE FAT CELL DIFFERENTIATION,0.095625,-0.088786,-0.10801,0,0
3,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.13355,-0.088807,-0.1344,0,0
3,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.072231,-0.089101,-0.11879,0,0
3,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.16559,-0.089316,-0.093759,0,0
3,GO RESPONSE TO HYDROGEN PEROXIDE,0.053746,-0.089326,-0.087658,0,0
3,GO POSITIVE CHEMOTAXIS,0.068167,-0.089478,-0.12492,0,0
3,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.15015,-0.089579,-0.11969,0,0
3,GO DISTAL TUBULE DEVELOPMENT,0.28785,-0.089763,-0.11846,0,0
3,GO RNA DESTABILIZATION,0.087232,-0.090047,-0.076442,0,0
3,GO REGULATION OF COLLATERAL SPROUTING,0.91987,-0.090175,-0.0011283,0,0
3,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.87144,-0.090279,-0.050626,0,0
3,GO FUCOSYLATION,0.42347,-0.090311,-0.05878,0,0
3,GO MUSCLE FIBER DEVELOPMENT,0.12473,-0.090507,-0.078158,0,0
3,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.31653,-0.090544,-0.089967,0,0
3,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.26098,-0.09056,-0.093363,0,0
3,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.084046,-0.09068,-0.10219,0,0
3,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.21256,-0.090789,-0.040896,0,0
3,GO CYCLOOXYGENASE PATHWAY,0.89907,-0.090943,-0.0083277,0,0
3,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.087232,-0.091064,-0.091989,0,0
3,GO MEIOSIS I CELL CYCLE PROCESS,0.0087944,-0.091301,-0.11058,0,0
3,GO GERM CELL DEVELOPMENT,0.0056288,-0.091316,-0.088962,0,0
3,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.054842,-0.091353,-0.054921,0,0
3,GO INSULIN SECRETION,0.41842,-0.091501,-0.034162,0,0
3,GO MEIOTIC CELL CYCLE,0.00037661,-0.091734,-0.09741,0,0
3,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.015953,-0.091744,-0.12223,0,0
3,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.072231,-0.091962,-0.18076,0,0
3,GO MACROPHAGE PROLIFERATION,0.43883,-0.091977,-0.11518,0,0
3,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.073629,-0.092056,-0.086216,0,0
3,GO LUNG MORPHOGENESIS,0.072231,-0.092227,-0.14341,0,0
3,GO CELLULAR COMPONENT MAINTENANCE,0.015203,-0.092248,-0.10601,0,0
3,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.21256,-0.092277,-0.063994,0,0
3,GO PROTEIN INSERTION INTO MEMBRANE,0.095625,-0.092371,-0.060268,0,0
3,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.042857,-0.092571,-0.14696,0,0
3,GO VENTRAL SPINAL CORD DEVELOPMENT,0.12908,-0.092676,-0.074987,0,0
3,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.063042,-0.0929,-0.13949,0,0
3,GO RNA DECAPPING,0.063042,-0.093165,-0.084048,0,0
3,GO RESPONSE TO FOOD,0.064293,-0.093167,-0.092211,0,0
3,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.12689,-0.093304,-0.11504,0,0
3,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.38408,-0.093305,-0.080008,0,0
3,GO PHAGOSOME MATURATION,0.14526,-0.093437,-0.085654,0,0
3,GO GLUTAMATE METABOLIC PROCESS,0.14285,-0.093568,-0.094321,0,0
3,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.10096,-0.093605,-0.091261,0,0
3,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.48678,-0.093985,-0.065317,0,0
3,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.12049,-0.094103,-0.18566,0,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.75615,-0.09437,-0.026685,0,0
3,GO MEIOTIC CHROMOSOME SEPARATION,0.080955,-0.094409,-0.083872,0,0
3,GO SUBPALLIUM DEVELOPMENT,0.21905,-0.094589,-0.086714,0,0
3,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.063042,-0.094642,-0.11428,0,0
3,GO KINETOCHORE ASSEMBLY,0.57857,-0.094721,-0.053244,0,0
3,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.15264,-0.095036,-0.13654,0,0
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.090515,-0.095162,-0.13351,0,0
3,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.44402,-0.095188,-0.03795,0,0
3,GO STEROID METABOLIC PROCESS,0.079444,-0.095191,-0.083801,0,0
3,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.099158,-0.095222,-0.11135,0,0
3,GO PROTEIN REFOLDING,0.29586,-0.09544,-0.053965,0,0
3,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.99651,-0.095512,-0.06923,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.18508,-0.095779,-0.12623,0,0
3,GO MITOCHONDRIAL FUSION,0.031748,-0.0959,-0.098395,0,0
3,GO DETOXIFICATION OF INORGANIC COMPOUND,0.30402,-0.096014,-0.34622,0,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.16294,-0.096559,-0.099548,0,0
3,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.44402,-0.09674,-0.097956,0,0
3,GO REGULATION OF HISTONE H4 ACETYLATION,0.23937,-0.097144,-0.072208,0,0
3,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.20309,-0.097336,-0.073089,0,0
3,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.041967,-0.097474,-0.17357,0,0
3,GO HISTONE H2A MONOUBIQUITINATION,0.070855,-0.097522,-0.078017,0,0
3,GO CYTOPLASM ORGANIZATION,0.084046,-0.097634,-0.12684,0,0
3,GO MITOTIC SPINDLE ASSEMBLY,0.0032441,-0.097681,-0.12134,0,0
3,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.64605,-0.097792,-0.053434,0,0
3,GO GENITALIA DEVELOPMENT,0.031748,-0.097801,-0.11878,0,0
3,GO RENAL WATER HOMEOSTASIS,0.13355,-0.097948,-0.091902,0,0
3,GO ECTODERM DEVELOPMENT,0.015574,-0.09795,-0.11081,0,0
3,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.15264,-0.09813,-0.10051,0,0
3,GO CATECHOLAMINE METABOLIC PROCESS,0.81668,-0.098187,0.018086,0,0
3,GO SPROUTING ANGIOGENESIS,0.073629,-0.098418,-0.10615,0,0
3,GO AUTOPHAGY OF NUCLEUS,0.054842,-0.098654,-0.13863,0,0
3,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.19695,-0.098759,-0.10064,0,0
3,GO RETROGRADE TRANS SYNAPTIC SIGNALING,0.5726,-0.098813,-0.040628,0,0
3,GO PROTEIN LOCALIZATION TO ENDOSOME,0.12473,-0.098825,-0.1131,0,0
3,GO MESODERM MORPHOGENESIS,0.077957,-0.098903,-0.11643,0,0
3,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.060602,-0.099032,-0.18398,0,0
3,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.080955,-0.099088,-0.11472,0,0
3,GO ANDROGEN METABOLIC PROCESS,0.47588,-0.09924,-0.057015,0,0
3,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.23937,-0.099259,-0.062738,0,0
3,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.26098,-0.099356,-0.063304,0,0
3,GO RESPONSE TO STEROL DEPLETION,0.25363,-0.099511,-0.10718,0,0
3,GO T CELL APOPTOTIC PROCESS,0.084046,-0.099884,-0.11709,0,0
3,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.12259,-0.099893,-0.08762,0,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.62732,-0.10003,-0.082911,0,0
3,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.085627,-0.10012,-0.096106,0,0
3,GO HEART INDUCTION,0.36064,-0.10018,-0.082211,0,0
3,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.0023671,-0.1002,-0.15959,0,0
3,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.4978,-0.10032,-0.068885,0,0
3,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.33812,-0.10033,-0.061251,0,0
3,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.072231,-0.10036,-0.1479,0,0
3,GO NEGATIVE REGULATION OF COAGULATION,0.32938,-0.10056,-0.14047,0,0
3,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.097379,-0.10059,-0.072517,0,0
3,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.64605,-0.10088,-0.066347,0,0
3,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.20309,-0.10109,-0.14733,0,0
3,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.092194,-0.10111,-0.078679,0,0
3,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.60883,-0.10114,-0.049575,0,0
3,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.34256,-0.10131,-0.11721,0,0
3,GO RELAXATION OF CARDIAC MUSCLE,0.46512,-0.10141,-0.083864,0,0
3,GO NOTOCHORD DEVELOPMENT,0.39371,-0.10143,-0.12899,0,0
3,GO MACROPHAGE APOPTOTIC PROCESS,0.11434,-0.10143,-0.12999,0,0
3,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.00050664,-0.1016,-0.097924,0,0
3,GO MALE MEIOTIC NUCLEAR DIVISION,0.11636,-0.1018,-0.11731,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.03939,-0.10185,-0.078305,0,0
3,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.0054795,-0.10192,-0.097993,0,0
3,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.034637,-0.10216,-0.10785,0,0
3,GO POSITIVE REGULATION OF OSSIFICATION,0.047551,-0.10217,-0.13505,0,0
3,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.15773,-0.10298,-0.10393,0,0
3,GO GOLGI LOCALIZATION,0.095625,-0.10299,-0.088866,0,0
3,GO EPITHELIAL CELL FATE COMMITMENT,0.35607,-0.10336,-0.057254,0,0
3,GO RESPONSE TO COLD,0.090515,-0.10342,-0.13864,0,0
3,GO EAR MORPHOGENESIS,0.012203,-0.1035,-0.12465,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.20621,-0.10359,-0.083018,0,0
3,GO DEFINITIVE HEMOPOIESIS,0.34256,-0.10408,-0.054531,0,0
3,GO SULFATION,0.11235,-0.10413,-0.13199,0,0
3,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.16828,-0.10432,-0.20675,0,0
3,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.23937,-0.10438,-0.14381,0,0
3,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.023741,-0.10443,-0.11891,0,0
3,GO MUSCLE CELL APOPTOTIC PROCESS,0.10845,-0.10455,-0.077879,0,0
3,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.041093,-0.10467,-0.12192,0,0
3,GO CARDIAC ATRIUM DEVELOPMENT,0.85768,-0.10474,-0.010847,0,0
3,GO XENOBIOTIC CATABOLIC PROCESS,0.7495,-0.10487,-0.049168,0,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.05824,-0.10505,-0.15867,0,0
3,GO KETONE BODY METABOLIC PROCESS,0.47049,-0.10567,-0.069096,0,0
3,GO PANCREATIC JUICE SECRETION,0.24288,-0.10591,-0.073648,0,0
3,GO RESPONSE TO ESTRADIOL,0.093897,-0.10593,-0.083027,0,0
3,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.55487,-0.10596,-0.081441,0,0
3,GO OLFACTORY LOBE DEVELOPMENT,0.40843,-0.10605,-0.070457,0,0
3,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.22235,-0.10614,-0.084726,0,0
3,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.12049,-0.1064,-0.078279,0,0
3,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.1313,-0.1066,-0.088014,0,0
3,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.7495,-0.10672,-0.023395,0,0
3,GO SPERMATID DIFFERENTIATION,0.0087944,-0.1071,-0.10775,0,0
3,GO SEX DETERMINATION,0.033894,-0.10741,-0.13898,0,0
3,GO DETECTION OF MECHANICAL STIMULUS,0.012508,-0.10772,-0.16527,0,0
3,GO DIENCEPHALON DEVELOPMENT,0.092194,-0.10818,-0.10951,0,0
3,GO FATTY ACID DERIVATIVE TRANSPORT,0.25363,-0.10856,-0.05197,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0049174,-0.10864,-0.10882,0,0
3,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.38408,-0.10867,-0.090366,0,0
3,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.27227,-0.10892,-0.076187,0,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.097379,-0.10894,-0.1109,0,0
3,GO REGULATION OF FATTY ACID TRANSPORT,0.24643,-0.1092,-0.076207,0,0
3,GO MRNA TRANSCRIPTION,0.25363,-0.10935,-0.072209,0,0
3,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.41341,-0.10941,-0.042975,0,0
3,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.042857,-0.10946,-0.09126,0,0
3,GO NUCLEOSIDE CATABOLIC PROCESS,0.053746,-0.10949,-0.15808,0,0
3,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.63978,-0.10983,-0.14513,0,0
3,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.016734,-0.11011,-0.10868,0,0
3,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.082489,-0.11013,-0.081344,0,0
3,GO FAT CELL PROLIFERATION,0.26098,-0.11081,-0.081584,0,0
3,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.16828,-0.11097,-0.14394,0,0
3,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.072231,-0.11222,-0.16981,0,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.75615,-0.11251,-0.048589,0,0
3,GO KETONE CATABOLIC PROCESS,0.070855,-0.11282,-0.1894,0,0
3,GO RESPONSE TO INSECTICIDE,0.80989,-0.11311,-0.013078,0,0
3,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.079444,-0.11333,-0.084827,0,0
3,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.12049,-0.1136,-0.28901,0,0
3,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.068167,-0.11386,-0.18963,0,0
3,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.47588,-0.11402,-0.045653,0,0
3,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.21579,-0.1141,-0.11565,0,0
3,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.099158,-0.11447,-0.17675,0,0
3,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.91293,-0.11454,0.022408,0,0
3,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.12259,-0.11456,-0.16197,0,0
3,GO MEIOTIC CHROMOSOME SEGREGATION,0.0085714,-0.1146,-0.11829,0,0
3,GO MEMBRANE LIPID CATABOLIC PROCESS,0.060602,-0.11507,-0.16772,0,0
3,GO LIPOPROTEIN LOCALIZATION,0.14285,-0.11514,-0.10287,0,0
3,GO RESPONSE TO UV C,0.030383,-0.11551,-0.1629,0,0
3,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.072231,-0.11557,-0.12803,0,0
3,GO MYOTUBE DIFFERENTIATION,0.10096,-0.11618,-0.088465,0,0
3,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.12049,-0.11621,-0.17828,0,0
3,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.23937,-0.11666,-0.12927,0,0
3,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.042857,-0.11675,-0.12906,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.088862,-0.11691,-0.12826,0,0
3,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.25001,-0.11722,-0.16384,0,0
3,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.2,-0.11725,-0.11246,0,0
3,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.092194,-0.11832,-0.1604,0,0
3,GO NEURON FATE COMMITMENT,0.41341,-0.11835,-0.040205,0,0
3,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.15015,-0.11851,-0.15717,0,0
3,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.095625,-0.11896,-0.12616,0,0
3,GO CARDIOCYTE DIFFERENTIATION,0.17934,-0.11901,-0.068565,0,0
3,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.090515,-0.11902,-0.13531,0,0
3,GO HORMONE METABOLIC PROCESS,0.11434,-0.1193,-0.098397,0,0
3,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.72313,-0.11935,-0.041044,0,0
3,GO STEROL IMPORT,0.34702,-0.11938,-0.055777,0,0
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.030383,-0.1196,-0.11207,0,0
3,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.085627,-0.11962,-0.18799,0,0
3,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.25729,-0.11971,-0.079686,0,0
3,GO REGULATION OF HISTONE DEACETYLATION,0.054842,-0.11977,-0.10854,0,0
3,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.27611,-0.12024,-0.076403,0,0
3,GO ROOF OF MOUTH DEVELOPMENT,0.016339,-0.12098,-0.13489,0,0
3,GO RESPONSE TO MURAMYL DIPEPTIDE,0.087232,-0.12111,-0.15455,0,0
3,GO HISTONE H3 K9 TRIMETHYLATION,0.11434,-0.12172,-0.08329,0,0
3,GO HEART FORMATION,0.25001,-0.12187,-0.08206,0,0
3,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.41842,-0.12194,-0.056898,0,0
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0073363,-0.1225,-0.12381,0,0
3,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.085627,-0.12254,-0.10509,0,0
3,GO T HELPER 2 CELL DIFFERENTIATION,0.33373,-0.12264,-0.19267,0,0
3,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.36064,-0.12265,-0.09638,0,0
3,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.16828,-0.12326,-0.14239,0,0
3,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.25001,-0.12327,-0.12467,0,0
3,GO NEGATIVE REGULATION OF CELL SIZE,0.082489,-0.12343,-0.094469,0,0
3,GO SYNAPTIC VESICLE BUDDING,0.15015,-0.12357,-0.10189,0,0
3,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.63354,-0.12361,-0.079345,0,0
3,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.22568,-0.12369,-0.10727,0,0
3,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.35153,-0.12382,-0.085274,0,0
3,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.084046,-0.12411,-0.18517,0,0
3,GO REGULATION OF MESODERM DEVELOPMENT,0.14285,-0.12419,-0.11158,0,0
3,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.0036303,-0.12448,-0.13972,0,0
3,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.13583,-0.12451,-0.12157,0,0
3,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.21579,-0.12457,-0.073951,0,0
3,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.12908,-0.125,-0.10917,0,0
3,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.10096,-0.12573,-0.1186,0,0
3,GO EPITHELIAL TUBE MORPHOGENESIS,0.00017186,-0.12589,-0.15114,0,0
3,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.18219,-0.126,-0.11398,0,0
3,GO POSITIVE REGULATION OF BEHAVIOR,0.036948,-0.12609,-0.18719,0,0
3,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.05161,-0.12619,-0.18499,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.054842,-0.12653,-0.11945,0,0
3,GO CYSTEINE METABOLIC PROCESS,0.56666,-0.12668,-0.065246,0,0
3,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.054842,-0.12674,-0.11463,0,0
3,GO RESPONSE TO DIETARY EXCESS,0.46512,-0.12681,-0.073083,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.15264,-0.12731,-0.085475,0,0
3,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.076492,-0.1274,-0.17121,0,0
3,GO RESPONSE TO CADMIUM ION,0.11039,-0.12778,-0.12653,0,0
3,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.075049,-0.12815,-0.11737,0,0
3,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.060602,-0.12853,-0.15283,0,0
3,GO KILLING OF CELLS OF OTHER ORGANISM,0.0046564,-0.12856,-0.12382,0,0
3,GO NEUTROPHIL HOMEOSTASIS,0.29992,-0.12898,-0.14992,0,0
3,GO CILIUM ORGANIZATION,0.00052342,-0.12901,-0.13345,0,0
3,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.042857,-0.12913,-0.2315,0,0
3,GO REGULATION OF GTP BINDING,0.40843,-0.12916,-0.069615,0,0
3,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.090515,-0.12965,-0.19235,0,0
3,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.014138,-0.12982,-0.14473,0,0
3,GO ETHER BIOSYNTHETIC PROCESS,0.12689,-0.12983,-0.19409,0,0
3,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.076492,-0.1303,-0.10402,0,0
3,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.095625,-0.13039,-0.10267,0,0
3,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.017549,-0.13045,-0.11113,0,0
3,GO AMMONIUM TRANSPORT,0.10845,-0.13054,-0.19741,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.072231,-0.1308,-0.1429,0,0
3,GO LIPID EXPORT FROM CELL,0.076492,-0.1312,-0.11281,0,0
3,GO SPECIFICATION OF SYMMETRY,0.001986,-0.13171,-0.11453,0,0
3,GO BILE ACID BIOSYNTHETIC PROCESS,0.057089,-0.13195,-0.10423,0,0
3,GO REGULATION OF RESPONSE TO TUMOR CELL,0.077957,-0.13235,-0.13666,0,0
3,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0032441,-0.13243,-0.12134,0,0
3,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.12908,-0.13297,-0.23336,0,0
3,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.12689,-0.13369,-0.12255,0,0
3,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.13355,-0.13395,-0.18851,0,0
3,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.099158,-0.13406,-0.087686,0,0
3,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.00037661,-0.1343,-0.18074,0,0
3,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.32938,-0.13435,-0.081308,0,0
3,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.010245,-0.13504,-0.138,0,0
3,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0073363,-0.13507,-0.13492,0,0
3,GO NEGATIVE REGULATION OF WOUND HEALING,0.066855,-0.1352,-0.15909,0,0
3,GO ADHERENS JUNCTION ORGANIZATION,0.072231,-0.13536,-0.10553,0,0
3,GO SENSORY ORGAN MORPHOGENESIS,0.00044439,-0.13553,-0.14304,0,0
3,GO METANEPHRIC NEPHRON DEVELOPMENT,0.1313,-0.13603,-0.097823,0,0
3,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.29992,-0.13626,-0.13545,0,0
3,GO PIGMENT GRANULE LOCALIZATION,0.01282,-0.13658,-0.1564,0,0
3,GO REGULATION OF NEURON MATURATION,0.4598,-0.13662,-0.043819,0,0
3,GO RETINOL METABOLIC PROCESS,0.057089,-0.13684,-0.17424,0,0
3,GO PLASMA MEMBRANE FUSION,0.13814,-0.13697,-0.13578,0,0
3,GO FORELIMB MORPHOGENESIS,0.15264,-0.137,-0.11631,0,0
3,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.19695,-0.13708,-0.070767,0,0
3,GO ENDOCRINE PANCREAS DEVELOPMENT,0.2839,-0.13874,-0.069496,0,0
3,GO UTERUS DEVELOPMENT,0.27999,-0.14048,-0.068691,0,0
3,GO REGULATION OF RENAL SYSTEM PROCESS,0.12473,-0.14058,-0.11492,0,0
3,GO MEMBRANE FISSION,0.055956,-0.14069,-0.11701,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.24288,-0.14184,-0.10259,0,0
3,GO L ASCORBIC ACID METABOLIC PROCESS,0.37932,-0.1419,-0.095205,0,0
3,GO REGULATION OF MITOCHONDRIAL FUSION,0.05824,-0.14226,-0.10691,0,0
3,GO PHOTORECEPTOR CELL MAINTENANCE,0.052669,-0.14262,-0.11501,0,0
3,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.097379,-0.14286,-0.1077,0,0
3,GO PHOTOTRANSDUCTION,0.0073363,-0.14296,-0.14348,0,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0057817,-0.14298,-0.17715,0,0
3,GO V D J RECOMBINATION,0.011904,-0.14309,-0.19634,0,0
3,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.21905,-0.14358,-0.11073,0,0
3,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.16294,-0.14358,-0.17508,0,0
3,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.082489,-0.14419,-0.11358,0,0
3,GO OVARIAN FOLLICLE DEVELOPMENT,0.014486,-0.14453,-0.12149,0,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.013465,-0.14492,-0.17924,0,0
3,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.00022676,-0.14503,-0.1583,0,0
3,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.24288,-0.14552,-0.19843,0,0
3,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.15264,-0.14566,-0.16436,0,0
3,GO ANIMAL ORGAN MATURATION,0.13355,-0.14576,-0.10707,0,0
3,GO CARNITINE METABOLIC PROCESS,0.38888,-0.14588,-0.064017,0,0
3,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.26847,-0.14619,-0.090231,0,0
3,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.53742,-0.14649,-0.16679,0,0
3,GO NEGATIVE REGULATION OF BONE REMODELING,0.10845,-0.14707,-0.17964,0,0
3,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.35607,-0.1471,-0.082958,0,0
3,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.066855,-0.14727,-0.1549,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.19393,-0.14817,-0.10305,0,0
3,GO PLATELET DEGRANULATION,0.20621,-0.1483,-0.1132,0,0
3,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.21256,-0.14852,-0.17387,0,0
3,GO DISACCHARIDE METABOLIC PROCESS,0.05161,-0.1488,-0.1726,0,0
3,GO ENDOTHELIUM DEVELOPMENT,0.0013872,-0.14899,-0.16446,0,0
3,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.48131,-0.14951,-0.075744,0,0
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.32506,-0.14965,-0.11279,0,0
3,GO MICROTUBULE BUNDLE FORMATION,0.00087311,-0.14969,-0.16357,0,0
3,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.093897,-0.14977,-0.11086,0,0
3,GO COPULATION,0.068167,-0.1504,-0.11843,0,0
3,GO REGULATION OF MYOBLAST FUSION,0.12049,-0.15075,-0.17769,0,0
3,GO MACROPHAGE CYTOKINE PRODUCTION,0.20309,-0.15141,-0.14563,0,0
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.26098,-0.15142,-0.14635,0,0
3,GO CELL PROJECTION ASSEMBLY,5.4121e-05,-0.15189,-0.12875,0,0
3,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.21579,-0.15203,-0.12687,0,0
3,GO DETECTION OF CALCIUM ION,0.2,-0.15249,-0.13043,0,0
3,GO REGULATION OF HEART MORPHOGENESIS,0.22568,-0.15254,-0.10321,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.023205,-0.15258,-0.1816,0,0
3,GO MICROTUBULE SEVERING,0.024846,-0.15297,-0.14641,0,0
3,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.20309,-0.15304,-0.15205,0,0
3,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.12689,-0.15324,-0.15939,0,0
3,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.0028957,-0.15332,-0.18154,0,0
3,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.070855,-0.15402,-0.13608,0,0
3,GO MYOFIBRIL ASSEMBLY,0.0013054,-0.15403,-0.1654,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.15015,-0.15425,-0.13189,0,0
3,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.0049174,-0.1545,-0.18074,0,0
3,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.17099,-0.1547,-0.067165,0,0
3,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.29586,-0.15483,-0.054061,0,0
3,GO AMYLOID FIBRIL FORMATION,0.33373,-0.15512,-0.11336,0,0
3,GO SEROTONIN SECRETION,0.14526,-0.15553,-0.095884,0,0
3,GO EYE MORPHOGENESIS,0.0007696,-0.15573,-0.15378,0,0
3,GO GENETIC IMPRINTING,0.001662,-0.1559,-0.18531,0,0
3,GO GANGLION DEVELOPMENT,0.1313,-0.15648,-0.18093,0,0
3,GO HYALURONAN CATABOLIC PROCESS,0.20309,-0.15652,-0.16605,0,0
3,GO EPITHELIAL CELL MATURATION,0.070855,-0.1566,-0.13123,0,0
3,GO T CELL EXTRAVASATION,0.13583,-0.15669,-0.23466,0,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.073629,-0.15673,-0.15122,0,0
3,GO TELOMERE CAPPING,0.0041716,-0.15682,-0.11467,0,0
3,GO ADHERENS JUNCTION ASSEMBLY,0.23589,-0.15705,-0.067929,0,0
3,GO NEURAL NUCLEUS DEVELOPMENT,0.019739,-0.1571,-0.15153,0,0
3,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.0037331,-0.15743,-0.14227,0,0
3,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.18508,-0.15763,-0.13072,0,0
3,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.0017641,-0.15846,-0.16745,0,0
3,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.12259,-0.15903,-0.20717,0,0
3,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.25363,-0.15953,-0.13287,0,0
3,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.054842,-0.1597,-0.22913,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.070855,-0.16018,-0.14161,0,0
3,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.033894,-0.16114,-0.19282,0,0
3,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.25001,-0.16144,-0.11423,0,0
3,GO TYPE 2 IMMUNE RESPONSE,0.065563,-0.16191,-0.19482,0,0
3,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.42347,-0.1623,-0.10631,0,0
3,GO CELL FATE DETERMINATION,0.0094949,-0.16255,-0.18638,0,0
3,GO REGULATION OF HELICASE ACTIVITY,0.21256,-0.16348,-0.1121,0,0
3,GO LACTATE METABOLIC PROCESS,0.077957,-0.16484,-0.14518,0,0
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.019739,-0.16498,-0.16212,0,0
3,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.74288,-0.16555,-0.03071,0,0
3,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.0053338,-0.16686,-0.18038,0,0
3,GO LYSINE METABOLIC PROCESS,0.082489,-0.16717,-0.21034,0,0
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.20621,-0.16786,-0.12081,0,0
3,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.080955,-0.16839,-0.11155,0,0
3,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.0042883,-0.1685,-0.20823,0,0
3,GO TRNA CATABOLIC PROCESS,0.24643,-0.16872,-0.13514,0,0
3,GO REGULATION OF CHROMATIN BINDING,0.00095906,-0.16935,-0.21586,0,0
3,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.0033369,-0.16957,-0.33203,0,0
3,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.10465,-0.16995,-0.22625,0,0
3,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.038561,-0.17029,-0.16591,0,0
3,GO ACTIVATION OF JUN KINASE ACTIVITY,0.00035231,-0.17079,-0.15974,0,0
3,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.18219,-0.17115,-0.077585,0,0
3,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.004408,-0.17196,-0.17018,0,0
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.53167,-0.17269,-0.038424,0,0
3,GO INTERMEDIATE FILAMENT ORGANIZATION,0.23245,-0.17407,-0.10281,0,0
3,GO REGULATION OF GOLGI ORGANIZATION,0.044685,-0.17453,-0.14119,0,0
3,GO DORSAL VENTRAL PATTERN FORMATION,0.0037331,-0.17487,-0.14148,0,0
3,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.0022992,-0.17542,-0.16577,0,0
3,GO MYOTUBE CELL DEVELOPMENT,0.016339,-0.17563,-0.15797,0,0
3,GO METANEPHROS MORPHOGENESIS,0.25001,-0.17581,-0.075415,0,0
3,GO DNA DEMETHYLATION,0.00029782,-0.17626,-0.19988,0,0
3,GO CAMERA TYPE EYE MORPHOGENESIS,0.00052342,-0.17744,-0.15958,0,0
3,GO SPERM AXONEME ASSEMBLY,0.018398,-0.17897,-0.14658,0,0
3,GO MITOCHONDRIAL DEPOLARIZATION,0.11039,-0.17905,-0.12555,0,0
3,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.14769,-0.17951,-0.12749,0,0
3,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.21256,-0.17955,-0.1377,0,0
3,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.036164,-0.17974,-0.1366,0,0
3,GO BRONCHUS DEVELOPMENT,0.20309,-0.18006,-0.13595,0,0
3,GO REGULATION OF CILIUM BEAT FREQUENCY,0.013139,-0.18018,-0.17527,0,0
3,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.0056288,-0.1806,-0.16351,0,0
3,GO ETHANOL CATABOLIC PROCESS,0.27999,-0.18063,-0.10727,0,0
3,GO CELL FATE SPECIFICATION,0.013798,-0.18077,-0.14292,0,0
3,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.12689,-0.18205,-0.097632,0,0
3,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.10654,-0.18215,-0.1864,0,0
3,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.080955,-0.18238,-0.2116,0,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00036427,-0.18249,-0.21438,0,0
3,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.0029794,-0.18274,-0.23216,0,0
3,GO RESPONSE TO INACTIVITY,0.02166,-0.18324,-0.15967,0,0
3,GO REGULATION OF TELOMERE CAPPING,0.0025083,-0.18534,-0.14784,0,0
3,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.0011549,-0.18602,-0.16315,0,0
3,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.12689,-0.18625,-0.15532,0,0
3,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.00032948,-0.18658,-0.16686,0,0
3,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.16032,-0.1866,-0.18686,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0056288,-0.18666,-0.16861,0,0
3,GO GENITALIA MORPHOGENESIS,0.1028,-0.18737,-0.14642,0,0
3,GO PRO B CELL DIFFERENTIATION,0.03939,-0.18773,-0.17599,0,0
3,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.0069616,-0.18822,-0.15997,0,0
3,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.072231,-0.18966,-0.20207,0,0
3,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.22235,-0.18976,-0.20246,0,0
3,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.080955,-0.18988,-0.14246,0,0
3,GO POSITIVE REGULATION OF VASCULOGENESIS,0.32938,-0.18998,-0.11467,0,0
3,GO RESPONSE TO AUDITORY STIMULUS,0.11235,-0.19042,-0.13911,0,0
3,GO RENAL ABSORPTION,0.082489,-0.19141,-0.23081,0,0
3,GO ETHANOL OXIDATION,0.15773,-0.19142,-0.23688,0,0
3,GO CELL MIGRATION IN HINDBRAIN,0.041093,-0.19215,-0.19747,0,0
3,GO REGULATION OF CHLORIDE TRANSPORT,0.05824,-0.19226,-0.1733,0,0
3,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0011549,-0.19228,-0.17259,0,0
3,GO GALACTOSE METABOLIC PROCESS,0.10465,-0.19284,-0.15601,0,0
3,GO SEGMENT SPECIFICATION,0.016734,-0.1934,-0.22752,0,0
3,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.17934,-0.19379,-0.14419,0,0
3,GO NON MOTILE CILIUM ASSEMBLY,0.0062634,-0.19384,-0.15592,0,0
3,GO FEMALE GENITALIA DEVELOPMENT,0.0030654,-0.19429,-0.21205,0,0
3,GO ENDOCRINE SYSTEM DEVELOPMENT,0.0083534,-0.19517,-0.14355,0,0
3,GO PROXIMAL DISTAL PATTERN FORMATION,0.18508,-0.19669,-0.13112,0,0
3,GO REGULATION OF MEMBRANE PERMEABILITY,2.8418e-05,-0.19715,-0.20872,0,0
3,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.17934,-0.19725,-0.1207,0,0
3,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.12473,-0.1974,-0.18682,0,0
3,GO MICROVILLUS ASSEMBLY,0.053746,-0.19753,-0.20991,0,0
3,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.073629,-0.19844,-0.1825,0,0
3,GO SARCOMERE ORGANIZATION,0.0040578,-0.19847,-0.18119,0,0
3,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.0047853,-0.20082,-0.23713,0,0
3,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.075049,-0.20108,-0.12896,0,0
3,GO CARDIOBLAST DIFFERENTIATION,0.10654,-0.20179,-0.12994,0,0
3,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.11636,-0.20224,-0.095155,0,0
3,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.1313,-0.20253,-0.1455,0,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.014486,-0.20301,-0.21454,0,0
3,GO PARTURITION,0.082489,-0.2036,-0.1589,0,0
3,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.0016129,-0.20414,-0.21579,0,0
3,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.070855,-0.20441,-0.18912,0,0
3,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.17374,-0.20468,-0.1526,0,0
3,GO SECONDARY HEART FIELD SPECIFICATION,0.017549,-0.20492,-0.26988,0,0
3,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.049546,-0.20493,-0.15013,0,0
3,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.036948,-0.2058,-0.3584,0,0
3,GO CLATHRIN COAT ASSEMBLY,0.11039,-0.20747,-0.10216,0,0
3,GO SEQUESTERING OF ACTIN MONOMERS,0.25729,-0.20766,-0.15062,0,0
3,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.033166,-0.20879,-0.1891,0,0
3,GO CENTROSOME SEPARATION,0.0067808,-0.20902,-0.19563,0,0
3,GO REGULATION OF STEM CELL DIVISION,0.12259,-0.20926,-0.10614,0,0
3,GO FOREBRAIN NEURON FATE COMMITMENT,0.13583,-0.20935,-0.15585,0,0
3,GO DORSAL SPINAL CORD DEVELOPMENT,0.40349,-0.21308,-0.034826,0,0
3,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.12473,-0.2133,-0.15283,0,0
3,GO REGULATION OF ANIMAL ORGAN FORMATION,0.16828,-0.21457,-0.11528,0,0
3,GO ATRIAL SEPTUM DEVELOPMENT,0.05161,-0.21646,-0.16836,0,0
3,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.076492,-0.21747,-0.23213,0,0
3,GO EMBRYONIC BODY MORPHOGENESIS,0.00026903,-0.21769,-0.26574,0,0
3,GO TERPENOID BIOSYNTHETIC PROCESS,0.059411,-0.21796,-0.28744,0,0
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.040234,-0.21923,-0.20719,0,0
3,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.21579,-0.22055,-0.073047,0,0
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.0032441,-0.22215,-0.3142,0,0
3,GO MALE SEX DETERMINATION,0.0038387,-0.22247,-0.24751,0,0
3,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.00011241,-0.22664,-0.19871,0,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.10845,-0.22751,-0.16087,0,0
3,GO TRIGEMINAL NERVE DEVELOPMENT,0.060602,-0.22914,-0.31862,0,0
3,GO INTRACILIARY RETROGRADE TRANSPORT,0.063042,-0.22994,-0.19183,0,0
3,GO SPERM CAPACITATION,0.00035231,-0.23005,-0.20641,0,0
3,GO CELL JUNCTION MAINTENANCE,0.0011549,-0.23176,-0.2268,0,0
3,GO THYMOCYTE APOPTOTIC PROCESS,0.079444,-0.23252,-0.16641,0,0
3,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.12689,-0.23289,-0.19345,0,0
3,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.21905,-0.23403,-0.11081,0,0
3,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.084046,-0.23463,-0.20178,0,0
3,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0020453,-0.23597,-0.2163,0,0
3,GO REGULATION OF GLOMERULAR FILTRATION,0.076492,-0.23651,-0.24512,0,0
3,GO SKELETAL MUSCLE ADAPTATION,0.04854,-0.23652,-0.1312,0,0
3,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.17934,-0.23766,-0.081558,0,0
3,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.029068,-0.23779,-0.17505,0,0
3,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.23937,-0.23921,-0.13675,0,0
3,GO RETINAL ROD CELL DIFFERENTIATION,0.15264,-0.23973,-0.14753,0,0
3,GO ATRIAL SEPTUM MORPHOGENESIS,0.03245,-0.23999,-0.22587,0,0
3,GO OUTER DYNEIN ARM ASSEMBLY,0.001191,-0.24059,-0.28135,0,0
3,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.0066042,-0.24254,-0.23492,0,0
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,1.8521e-05,-0.24306,-0.24897,0,0
3,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00044439,-0.24388,-0.23842,0,0
3,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.011904,-0.2446,-0.21774,0,0
3,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.027188,-0.24568,-0.13963,0,0
3,GO RUFFLE ASSEMBLY,7.889e-07,-0.24772,-0.25036,0,0
3,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.00011241,-0.24842,-0.29403,0,0
3,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.00084609,-0.24956,-0.22203,0,0
3,GO RETINAL METABOLIC PROCESS,0.077957,-0.25064,-0.21635,0,0
3,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.03245,-0.25371,-0.31817,0,0
3,GO REGULATION OF SPINDLE ASSEMBLY,7.3528e-06,-0.25391,-0.26491,0,0
3,GO SPINAL CORD PATTERNING,0.0087944,-0.25563,-0.24283,0,0
3,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0001165,-0.25592,-0.26039,0,0
3,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.054842,-0.25594,-0.24168,0,0
3,GO EMBRYONIC HEMOPOIESIS,0.001228,-0.2566,-0.21903,0,0
3,GO PITUITARY GLAND DEVELOPMENT,0.001986,-0.25694,-0.27516,0,0
3,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.19393,-0.25813,-0.1016,0,0
3,GO MYOBLAST MIGRATION,0.082489,-0.2586,-0.2141,0,0
3,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.015574,-0.26558,-0.25503,0,0
3,GO ACTIN FILAMENT BASED TRANSPORT,0.00087311,-0.26765,-0.27725,0,0
3,GO HEART FIELD SPECIFICATION,0.060602,-0.26833,-0.17541,0,0
3,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.029719,-0.26862,-0.19443,0,0
3,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.061812,-0.26905,-0.21526,0,0
3,GO ENDOCARDIUM DEVELOPMENT,0.018398,-0.2693,-0.2307,0,0
3,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0017123,-0.26948,-0.25984,0,0
3,GO FRUCTOSE METABOLIC PROCESS,0.079444,-0.2717,-0.24901,0,0
3,GO REGULATION OF CELL FATE COMMITMENT,0.00050664,-0.2724,-0.26348,0,0
3,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.00055855,-0.27266,-0.22664,0,0
3,GO ECTODERMAL PLACODE DEVELOPMENT,0.036164,-0.2733,-0.22995,0,0
3,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.068167,-0.27576,-0.22095,0,0
3,GO TYPE B PANCREATIC CELL PROLIFERATION,0.043763,-0.2761,-0.25581,0,0
3,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.041967,-0.28645,-0.22356,0,0
3,GO EXTRACELLULAR TRANSPORT,1.104e-05,-0.28703,-0.35817,0,0
3,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.0024367,-0.28859,-0.21119,0,0
3,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.070855,-0.29173,-0.17678,0,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.018836,-0.29395,-0.20767,0,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.00067758,-0.29434,-0.31884,0,0
3,GO CARDIOBLAST PROLIFERATION,0.43883,-0.2964,-0.11467,0,0
3,GO CELLULAR RESPONSE TO COPPER ION,0.019283,-0.29926,-0.345,0,0
3,GO INDOLALKYLAMINE METABOLIC PROCESS,0.02843,-0.30537,-0.18731,0,0
3,GO AXONEME ASSEMBLY,3.1888e-05,-0.30878,-0.31671,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.00052342,-0.31439,-0.28122,0,0
3,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.011612,-0.3153,-0.23936,0,0
3,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.057089,-0.31534,-0.16377,0,0
3,GO IMMATURE B CELL DIFFERENTIATION,0.0019282,-0.31535,-0.23545,0,0
3,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.00081984,-0.31857,-0.24577,0,0
3,GO ESCRT COMPLEX DISASSEMBLY,0.00013433,-0.32177,-0.30842,0,0
3,GO GABAERGIC NEURON DIFFERENTIATION,0.095625,-0.32207,-0.1348,0,0
3,GO DOPAMINE BIOSYNTHETIC PROCESS,0.097379,-0.32331,-0.24581,0,0
3,GO LIPOXYGENASE PATHWAY,0.0015653,-0.32839,-0.35137,0,0
3,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,7.3528e-06,-0.33772,-0.40042,0,0
3,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.017969,-0.34458,-0.29141,0,0
3,GO REFLEX,0.00087311,-0.34684,-0.36676,0,0
3,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,7.0571e-06,-0.35948,-0.3418,0,0
3,GO MOTILE CILIUM ASSEMBLY,0.00059588,-0.36813,-0.30731,0,0
3,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.0025083,-0.36907,-0.34298,0,0
3,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.0099891,-0.37217,-0.32764,0,0
3,GO MEGAKARYOCYTE DEVELOPMENT,0.00028792,-0.38116,-0.38153,0,0
3,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.12689,-0.38618,-0.17745,0,0
3,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.0059384,-0.3883,-0.31908,0,0
3,GO GLIAL CELL FATE COMMITMENT,0.0079323,-0.41107,-0.33351,0,0
3,GO VASCULAR TRANSPORT,0.00032948,-0.41351,-0.43145,0,0
3,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.0085714,-0.42279,-0.3354,0,0
3,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00012512,-0.43125,-0.3942,0,0
3,GO NEURON FATE SPECIFICATION,0.0081404,-0.43561,-0.28917,0,0
3,GO ADENOHYPOPHYSIS DEVELOPMENT,0.04854,-0.43791,-0.27687,0,0
3,GO GLIAL CELL APOPTOTIC PROCESS,0.00017796,-0.43898,-0.42635,0,0
3,GO RETINAL GANGLION CELL AXON GUIDANCE,0.00016595,-0.44235,-0.4661,0,0
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00074557,-0.44239,-0.4068,0,0
3,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,6.7728e-06,-0.44842,-0.39402,0,0
3,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0012662,-0.45043,-0.52504,0,0
3,GO REGULATION OF CELL FATE SPECIFICATION,9.0551e-05,-0.45104,-0.41235,0,0
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,2.0833e-05,-0.47305,-0.4793,0,0
3,GO RETINA LAYER FORMATION,0.00010845,-0.48066,-0.42623,0,0
3,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.0050528,-0.48127,-0.48072,0,0
3,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.038561,-0.49499,-0.24544,0,0
3,GO RESPONSE TO FORSKOLIN,4.2876e-06,-0.50527,-0.46257,0,0
3,GO CARDIAC CELL FATE COMMITMENT,0.0027346,-0.52433,-0.42865,0,0
3,GO NOTCH RECEPTOR PROCESSING,8.6584e-06,-0.52724,-0.48523,0,0
3,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.00020448,-0.53073,-0.48748,0,0
3,GO INNER DYNEIN ARM ASSEMBLY,5.7413e-06,-0.53986,-0.59671,0,0
3,GO REGULATION OF RECEPTOR CLUSTERING,0.00024286,-0.54336,-0.47666,0,0
3,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00016595,-0.56502,-0.52614,0,0
3,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.00049035,-0.5793,-0.43966,0,0
3,GO GAMMA DELTA T CELL ACTIVATION,1.4044e-06,-0.59862,-0.56138,0,0
3,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.0025817,-0.63422,-0.53362,0,0
3,GO PARAXIAL MESODERM MORPHOGENESIS,6.4994e-06,-0.63775,-0.59594,0,0
3,GO GAMMA DELTA T CELL DIFFERENTIATION,8.3127e-06,-0.66246,-0.65678,0,0
3,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,7.6603e-06,-0.72682,-0.57253,0,0
3,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,3.1904e-06,-0.77652,-0.71411,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,4.4878e-05,1.6643,1.332,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,4.8379e-05,1.3282,1.0595,1,1
4,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,1.1267e-06,1.2926,1.2044,1,1
4,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,8.3127e-06,0.90295,0.78564,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.00034072,0.88801,0.71686,1,1
4,GO CYTIDINE TO URIDINE EDITING,4.8379e-05,0.87532,0.73085,1,1
4,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,1.5201e-05,0.84588,0.64061,1,1
4,GO TOLERANCE INDUCTION,7.9801e-06,0.79848,0.74312,1,1
4,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,1.104e-05,0.77816,0.76592,1,1
4,GO MUCUS SECRETION,9.7346e-05,0.76818,0.64826,1,1
4,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00023468,0.76582,0.57149,1,1
4,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,7.6603e-06,0.73848,0.63264,1,1
4,GO HISTAMINE SECRETION,1.4268e-07,0.73013,0.79058,1,1
4,GO LIPID DROPLET FORMATION,5.753e-07,0.7282,0.75666,1,1
4,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,1.9263e-05,0.70915,0.63959,1,1
4,GO EOSINOPHIL CHEMOTAXIS,2.6307e-05,0.70833,0.53276,1,1
4,GO REGULATION OF PLASMINOGEN ACTIVATION,0.0071468,0.67171,0.41655,1,1
4,GO RESPONSE TO TYPE I INTERFERON,3.6228e-06,0.66205,0.65334,1,1
4,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,9.7346e-05,0.66063,0.54153,1,1
4,GO HISTAMINE TRANSPORT,2.0829e-07,0.65361,0.73368,1,1
4,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,3.1888e-05,0.65203,0.53229,1,1
4,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,6.5149e-05,0.65046,0.55737,1,1
4,GO ACTIN FILAMENT NETWORK FORMATION,0.00031859,0.64318,0.4998,1,1
4,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,1.1237e-07,0.64091,0.62291,1,1
4,GO PROGESTERONE METABOLIC PROCESS,0.00010462,0.63721,0.76857,1,1
4,GO RESPONSE TO IMMOBILIZATION STRESS,1.0184e-05,0.63619,0.50321,1,1
4,GO EOSINOPHIL MIGRATION,3.7145e-05,0.635,0.50896,1,1
4,GO DENDRITIC CELL DIFFERENTIATION,7.0571e-06,0.62672,0.53568,1,1
4,GO T CELL MEDIATED CYTOTOXICITY,0.00016595,0.6267,0.48896,1,1
4,GO REGULATION OF VITAMIN METABOLIC PROCESS,2.2524e-05,0.62499,0.60278,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.00017186,0.62185,0.65265,1,1
4,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,2.7343e-05,0.61712,0.59127,1,1
4,GO GERMINAL CENTER FORMATION,0.00027832,0.616,0.46725,1,1
4,GO MATURE B CELL DIFFERENTIATION,3.3132e-05,0.61012,0.44719,1,1
4,GO RENAL ABSORPTION,3.1888e-05,0.60893,0.64507,1,1
4,GO INTESTINAL ABSORPTION,1.1788e-07,0.60799,0.67836,1,1
4,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.00069957,0.6077,0.50629,1,1
4,GO SEROTONIN METABOLIC PROCESS,2.9532e-05,0.60488,0.5984,1,1
4,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.00022676,0.6045,0.43797,1,1
4,GO REGULATION OF TOLERANCE INDUCTION,5.6174e-05,0.60097,0.58407,1,1
4,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,5.7413e-06,0.60091,0.58009,1,1
4,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,4.4712e-06,0.60002,0.57652,1,1
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,8.7323e-05,0.59818,0.53808,1,1
4,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,3.6228e-06,0.5977,0.59854,1,1
4,GO SPHINGOMYELIN METABOLIC PROCESS,8.2505e-07,0.59359,0.53704,1,1
4,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,8.628e-07,0.58873,0.50778,1,1
4,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,1.8251e-06,0.58576,0.60975,1,1
4,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,9.7346e-05,0.58478,0.6094,1,1
4,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,4.4878e-05,0.58169,0.49069,1,1
4,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,2.2658e-06,0.5764,0.57014,1,1
4,GO DETECTION OF OTHER ORGANISM,1.3441e-06,0.57504,0.63087,1,1
4,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,1.2308e-06,0.57367,0.56723,1,1
4,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.00017796,0.57125,0.54992,1,1
4,GO GLYCOSIDE METABOLIC PROCESS,0.0021062,0.56936,0.71037,1,1
4,GO FRUCTOSE METABOLIC PROCESS,0.0006154,0.56841,0.54981,1,1
4,GO ADHESION OF SYMBIONT TO HOST,0.00011241,0.56592,0.4787,1,1
4,GO RESPONSE TO NITROSATIVE STRESS,0.00028792,0.5566,0.46402,1,1
4,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.0069616,0.55442,0.47978,1,1
4,GO POSITIVE REGULATION OF CELL MATURATION,6.7596e-05,0.5529,0.4816,1,1
4,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,9.389e-05,0.54781,0.41477,1,1
4,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.00027832,0.54408,0.51357,1,1
4,GO O GLYCAN PROCESSING,5.2533e-07,0.54305,0.53197,1,1
4,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,2.5308e-05,0.5404,0.52384,1,1
4,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,9.389e-05,0.53894,0.43567,1,1
4,GO TOXIN METABOLIC PROCESS,2.6902e-06,0.53844,0.52177,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,9.0551e-05,0.53727,0.55072,1,1
4,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,5.0683e-06,0.53547,0.53702,1,1
4,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.00059588,0.53497,0.46489,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,8.1192e-05,0.53324,0.4905,1,1
4,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,8.2505e-07,0.53172,0.56869,1,1
4,GO KETONE CATABOLIC PROCESS,0.00010845,0.53151,0.47726,1,1
4,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,4.6597e-05,0.53059,0.59294,1,1
4,GO REGULATION OF PLATELET AGGREGATION,2.6307e-05,0.52876,0.48719,1,1
4,GO NEGATIVE REGULATION OF ANOIKIS,2.5308e-05,0.52772,0.65785,1,1
4,GO AMMONIUM ION METABOLIC PROCESS,2.4346e-05,0.52345,0.50699,1,1
4,GO CERAMIDE CATABOLIC PROCESS,0.0010528,0.522,0.41546,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00012074,0.52109,0.4012,1,1
4,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.00021909,0.52039,0.53155,1,1
4,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,1.4609e-05,0.51654,0.50493,1,1
4,GO RESPONSE TO EPINEPHRINE,0.001872,0.51035,0.36955,1,1
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,3.3132e-05,0.50847,0.47338,1,1
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,7.9801e-06,0.50785,0.51149,1,1
4,GO NEGATIVE REGULATION OF TISSUE REMODELING,2.1702e-06,0.50771,0.50508,1,1
4,GO LEYDIG CELL DIFFERENTIATION,0.0006154,0.50765,0.48962,1,1
4,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,3.8583e-05,0.50746,0.48154,1,1
4,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.0071468,0.50743,0.34224,1,1
4,GO RESPONSE TO COLD,7.2111e-07,0.49689,0.45466,1,1
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0017641,0.49544,0.37839,1,1
4,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.00035231,0.4949,0.52959,1,1
4,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,3.6414e-07,0.49426,0.4666,1,1
4,GO REGULATION OF WATER LOSS VIA SKIN,4.0073e-05,0.49381,0.4622,1,1
4,GO ACTIN FILAMENT SEVERING,0.00037661,0.49226,0.41909,1,1
4,GO LIPID DIGESTION,7.2754e-05,0.49113,0.56795,1,1
4,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.0099891,0.48947,0.49794,1,1
4,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.00025131,0.48639,0.48821,1,1
4,GO RESPONSE TO INTERLEUKIN 18,0.0042883,0.48491,0.43396,1,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.00010845,0.48408,0.39343,1,1
4,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.0001547,0.48394,0.43593,1,1
4,GO REGULATION OF B CELL APOPTOTIC PROCESS,3.7791e-06,0.48333,0.4757,1,1
4,GO EPITHELIAL CELL MORPHOGENESIS,0.00054072,0.47659,0.38235,1,1
4,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.00010462,0.4749,0.36314,1,1
4,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.00092958,0.47287,0.44188,1,1
4,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00026903,0.4726,0.38044,1,1
4,GO REGULATION OF PROTEIN COMPLEX STABILITY,3.3287e-06,0.47244,0.43617,1,1
4,GO MEMBRANE LIPID CATABOLIC PROCESS,1.2962e-05,0.4714,0.47278,1,1
4,GO INTESTINAL LIPID ABSORPTION,1.4609e-05,0.47058,0.63648,1,1
4,GO REGULATION OF PLATELET ACTIVATION,2.3654e-06,0.47025,0.45004,1,1
4,GO LABYRINTHINE LAYER MORPHOGENESIS,0.0010528,0.47018,0.45749,1,1
4,GO RESPONSE TO DIETARY EXCESS,2.0033e-05,0.46774,0.46041,1,1
4,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.00092958,0.46637,0.38416,1,1
4,GO NEGATIVE REGULATION OF BONE REMODELING,6.4994e-06,0.46518,0.51347,1,1
4,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,9.0551e-05,0.46206,0.51686,1,1
4,GO REGULATION OF ANOIKIS,3.7145e-05,0.46161,0.51446,1,1
4,GO AMINE BIOSYNTHETIC PROCESS,2.2879e-07,0.46157,0.47008,1,1
4,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,3.8583e-05,0.46138,0.41166,1,1
4,GO REGULATORY T CELL DIFFERENTIATION,2.5308e-05,0.46117,0.41346,1,1
4,GO RESPONSE TO REDOX STATE,2.7343e-05,0.4565,0.3938,1,1
4,GO REGULATION OF BONE REMODELING,2.4692e-06,0.4563,0.44936,1,1
4,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,8.3127e-06,0.45616,0.41357,1,1
4,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,6.7596e-05,0.45412,0.52354,1,1
4,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,2.9532e-05,0.45388,0.49085,1,1
4,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.00027832,0.45333,0.36988,1,1
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,3.1888e-05,0.45244,0.4227,1,1
4,GO REGULATION OF ACROSOME REACTION,0.00017186,0.45083,0.44396,1,1
4,GO ZYMOGEN ACTIVATION,0.00011241,0.45031,0.40312,1,1
4,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.00049035,0.44912,0.38427,1,1
4,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00028792,0.44804,0.3903,1,1
4,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.00012512,0.44732,0.47018,1,1
4,GO BASE CONVERSION OR SUBSTITUTION EDITING,7.2754e-05,0.4452,0.41305,1,1
4,GO PHAGOLYSOSOME ASSEMBLY,3.7791e-06,0.44519,0.45953,1,1
4,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,5.7413e-06,0.4441,0.44202,1,1
4,GO BONE RESORPTION,1.0779e-06,0.44246,0.446,1,1
4,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00017186,0.4421,0.39286,1,1
4,GO QUINONE METABOLIC PROCESS,0.00013917,0.44188,0.57815,1,1
4,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,6.5149e-05,0.44017,0.35063,1,1
4,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.024288,0.43999,0.29724,1,1
4,GO MICROVILLUS ORGANIZATION,0.00079435,0.43977,0.36368,1,1
4,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,6.2786e-05,0.43938,0.45411,1,1
4,GO RESPONSE TO STEROL DEPLETION,9.3916e-06,0.43925,0.48569,1,1
4,GO INSEMINATION,0.00017796,0.43903,0.41333,1,1
4,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.001662,0.43885,0.34849,1,1
4,GO REGULATION OF TISSUE REMODELING,4.1112e-06,0.43875,0.39577,1,1
4,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,2.6307e-05,0.43866,0.45893,1,1
4,GO SIGNAL PEPTIDE PROCESSING,1.104e-05,0.43827,0.4406,1,1
4,GO LIVER MORPHOGENESIS,5.4121e-05,0.43779,0.40583,1,1
4,GO POSITIVE REGULATION OF FERTILIZATION,0.00014935,0.43775,0.38817,1,1
4,GO GALACTOSE METABOLIC PROCESS,0.0021689,0.4369,0.4482,1,1
4,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,4.6597e-05,0.43678,0.3998,1,1
4,GO ALPHA BETA T CELL PROLIFERATION,9.0179e-06,0.43613,0.41297,1,1
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.00027832,0.43498,0.47586,1,1
4,GO HEPATOCYTE APOPTOTIC PROCESS,0.0018173,0.43323,0.45409,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.00017796,0.43283,0.35134,1,1
4,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00026003,0.43277,0.3777,1,1
4,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,7.547e-05,0.43262,0.41844,1,1
4,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.0010528,0.43096,0.38488,1,1
4,GO IMMUNOGLOBULIN SECRETION,3.0689e-05,0.4306,0.3953,1,1
4,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,2.2524e-05,0.43023,0.40444,1,1
4,GO REGULATION OF NEURON MATURATION,0.00020448,0.4297,0.35391,1,1
4,GO CELL ADHESION MEDIATED BY INTEGRIN,9.0551e-05,0.4289,0.37972,1,1
4,GO NEUROTRANSMITTER METABOLIC PROCESS,2.3654e-06,0.42794,0.42583,1,1
4,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,1.2454e-05,0.42576,0.36945,1,1
4,GO PARTURITION,0.010506,0.42557,0.28295,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00098941,0.42506,0.40545,1,1
4,GO REGULATION OF MICROVILLUS ORGANIZATION,0.014841,0.42466,0.34184,1,1
4,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,1.0604e-05,0.42452,0.33737,1,1
4,GO INTRACELLULAR STEROL TRANSPORT,2.2524e-05,0.42364,0.3802,1,1
4,GO REGULATION OF VIRAL GENOME REPLICATION,7.8282e-05,0.42207,0.3327,1,1
4,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.0024367,0.42138,0.38398,1,1
4,GO PLASMINOGEN ACTIVATION,0.0026572,0.42061,0.3948,1,1
4,GO REGULATION OF INTEGRIN ACTIVATION,2.4692e-06,0.42049,0.47411,1,1
4,GO IMMUNOLOGICAL MEMORY PROCESS,2.5308e-05,0.41947,0.40552,1,1
4,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,2.8077e-06,0.41896,0.46553,1,1
4,GO B CELL APOPTOTIC PROCESS,5.0194e-07,0.41876,0.46959,1,1
4,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.012508,0.41843,0.33148,1,1
4,GO L PHENYLALANINE METABOLIC PROCESS,0.00047456,0.41786,0.58192,1,1
4,GO CELLULAR DEFENSE RESPONSE,8.6584e-06,0.41768,0.4027,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,1.9263e-05,0.41707,0.35887,1,1
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0010859,0.41676,0.32843,1,1
4,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,1.1267e-06,0.4166,0.36804,1,1
4,GO T CELL MEDIATED IMMUNITY,0.00013433,0.41651,0.32212,1,1
4,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.0031536,0.41607,0.42588,1,1
4,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.00055855,0.413,0.32944,1,1
4,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.001191,0.41176,0.29286,1,1
4,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.023205,0.41161,0.25807,1,1
4,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,3.4421e-05,0.4112,0.38532,1,1
4,GO PROTEIN DEMANNOSYLATION,2.6307e-05,0.41112,0.41011,1,1
4,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,8.1192e-05,0.41045,0.40464,1,1
4,GO ACTIVATION OF JANUS KINASE ACTIVITY,2.8418e-05,0.41013,0.41948,1,1
4,GO VITAMIN D METABOLIC PROCESS,1.1493e-05,0.41001,0.40106,1,1
4,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.00044439,0.4099,0.38547,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.0013872,0.40875,0.37207,1,1
4,GO FOAM CELL DIFFERENTIATION,1.7118e-05,0.40809,0.33499,1,1
4,GO POSITIVE REGULATION OF WOUND HEALING,1.349e-05,0.40634,0.38473,1,1
4,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00063551,0.40634,0.33381,1,1
4,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.0011199,0.40573,0.37036,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00012964,0.40505,0.40491,1,1
4,GO RESPONSE TO INTERFERON GAMMA,6.5149e-05,0.4038,0.34964,1,1
4,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,4.8379e-05,0.40314,0.34282,1,1
4,GO BARBED END ACTIN FILAMENT CAPPING,0.0018173,0.40298,0.38489,1,1
4,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,4.4712e-06,0.40206,0.36733,1,1
4,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.0015653,0.40188,0.37773,1,1
4,GO NATURAL KILLER CELL MEDIATED IMMUNITY,1.5201e-05,0.40164,0.35429,1,1
4,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,5.9841e-06,0.4014,0.37898,1,1
4,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,3.1904e-06,0.40127,0.40675,1,1
4,GO MITOCHONDRIAL DEPOLARIZATION,1.0184e-05,0.39919,0.37903,1,1
4,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.00018427,0.39914,0.48966,1,1
4,GO VITAMIN D BIOSYNTHETIC PROCESS,6.0504e-05,0.39883,0.39568,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0001547,0.39877,0.27787,1,1
4,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.001662,0.39844,0.41622,1,1
4,GO MUSCLE ATROPHY,0.0050528,0.39736,0.27454,1,1
4,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.00034072,0.39693,0.29728,1,1
4,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,1.8251e-06,0.39654,0.34069,1,1
4,GO LUNG CELL DIFFERENTIATION,0.00054072,0.39634,0.44046,1,1
4,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.0094949,0.39619,0.35561,1,1
4,GO REGULATION OF VIRAL LIFE CYCLE,7.8282e-05,0.39616,0.31521,1,1
4,GO STEROID ESTERIFICATION,0.00092958,0.39615,0.42252,1,1
4,GO RESPONSE TO THYROID HORMONE,0.00069957,0.39571,0.28531,1,1
4,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.0010528,0.39436,0.31581,1,1
4,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.00084609,0.39378,0.47931,1,1
4,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00012074,0.39346,0.32037,1,1
4,GO RESPONSE TO LITHIUM ION,1.9904e-06,0.39243,0.50975,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,3.3287e-06,0.39231,0.42557,1,1
4,GO DIGESTION,8.3127e-06,0.39193,0.34562,1,1
4,GO REGULATION OF NEUTROPHIL MIGRATION,8.628e-07,0.39147,0.39109,1,1
4,GO DIGESTIVE SYSTEM PROCESS,4.2876e-06,0.39141,0.33044,1,1
4,GO REGULATION OF PROTEIN GLYCOSYLATION,0.00037661,0.39117,0.4559,1,1
4,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00040247,0.39085,0.33217,1,1
4,GO RETINAL METABOLIC PROCESS,0.0010206,0.38968,0.51808,1,1
4,GO CELLULAR RESPONSE TO INTERFERON BETA,0.00029782,0.38964,0.37405,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.00029782,0.38794,0.4518,1,1
4,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,2.1831e-07,0.38702,0.3945,1,1
4,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.0047853,0.3867,0.43582,1,1
4,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,4.3218e-05,0.38613,0.35081,1,1
4,GO DEFENSE RESPONSE TO VIRUS,5.0226e-05,0.38613,0.29726,1,1
4,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,1.0604e-05,0.38574,0.35787,1,1
4,GO BILE ACID AND BILE SALT TRANSPORT,0.00084609,0.38562,0.5548,1,1
4,GO SECONDARY METABOLIC PROCESS,0.00036427,0.38505,0.38459,1,1
4,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,2.3654e-06,0.38489,0.47187,1,1
4,GO NEGATIVE REGULATION OF EXOCYTOSIS,6.5149e-05,0.38464,0.33803,1,1
4,GO REGULATION OF VASCULOGENESIS,0.00038934,0.38453,0.3895,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,9.3916e-06,0.38441,0.31077,1,1
4,GO ANOIKIS,1.2454e-05,0.38393,0.39835,1,1
4,GO VASODILATION,0.00023468,0.38393,0.39145,1,1
4,GO POSITIVE REGULATION OF B CELL PROLIFERATION,1.0311e-06,0.38176,0.38607,1,1
4,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.0013054,0.38156,0.39683,1,1
4,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.00014935,0.38134,0.36415,1,1
4,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.00026003,0.38092,0.34107,1,1
4,GO DORSAL AORTA DEVELOPMENT,0.00069957,0.38088,0.30301,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0024367,0.38065,0.33265,1,1
4,GO POSITIVE REGULATION OF CELL KILLING,8.3127e-06,0.37869,0.37577,1,1
4,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.00059588,0.3757,0.31565,1,1
4,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.00098941,0.3757,0.3139,1,1
4,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,8.7323e-05,0.37561,0.30787,1,1
4,GO ACUTE PHASE RESPONSE,9.7346e-05,0.37529,0.33656,1,1
4,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0036303,0.37501,0.25518,1,1
4,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,7.2754e-05,0.37436,0.35723,1,1
4,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,7.3528e-06,0.37397,0.34107,1,1
4,GO REGULATION OF LEUKOCYTE DEGRANULATION,3.3132e-05,0.37312,0.32776,1,1
4,GO PROTEIN O LINKED GLYCOSYLATION,9.4334e-07,0.37261,0.36223,1,1
4,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.0036303,0.37254,0.45187,1,1
4,GO CORTICOSTEROID HORMONE SECRETION,0.0025817,0.37233,0.34201,1,1
4,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,7.8282e-05,0.37224,0.41592,1,1
4,GO SUPEROXIDE ANION GENERATION,0.00037661,0.3717,0.37257,1,1
4,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,1.7806e-05,0.37151,0.3237,1,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,7.3528e-06,0.37091,0.32279,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,2.2524e-05,0.37071,0.42794,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,5.6174e-05,0.37061,0.30989,1,1
4,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00019753,0.37054,0.30709,1,1
4,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.001662,0.37044,0.3639,1,1
4,GO NATURAL KILLER CELL PROLIFERATION,0.00037661,0.37032,0.36506,1,1
4,GO NEGATIVE REGULATION OF B CELL ACTIVATION,1.1493e-05,0.36967,0.34149,1,1
4,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,3.0689e-05,0.36938,0.37483,1,1
4,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.00019079,0.36893,0.38156,1,1
4,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0015189,0.36886,0.3108,1,1
4,GO LEUKOCYTE MEDIATED CYTOTOXICITY,3.0689e-05,0.36822,0.30423,1,1
4,GO LIPID TRANSLOCATION,1.104e-05,0.36796,0.31382,1,1
4,GO TISSUE REMODELING,1.349e-05,0.36757,0.32001,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,9.7801e-06,0.36748,0.35447,1,1
4,GO MOVEMENT IN HOST ENVIRONMENT,0.00036427,0.36725,0.24584,1,1
4,GO REGULATION OF HORMONE METABOLIC PROCESS,0.0042883,0.36696,0.29366,1,1
4,GO CARBOHYDRATE DERIVATIVE TRANSPORT,9.8628e-07,0.36681,0.37114,1,1
4,GO REGULATION OF LIGASE ACTIVITY,0.00081984,0.36499,0.2548,1,1
4,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.00013917,0.3645,0.35283,1,1
4,GO REGULATION OF ICOSANOID SECRETION,2.1831e-07,0.36362,0.43501,1,1
4,GO REGULATION OF COAGULATION,0.00029782,0.36332,0.31394,1,1
4,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0017641,0.36307,0.28233,1,1
4,GO RESPONSE TO COPPER ION,0.00050664,0.36221,0.44339,1,1
4,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00095906,0.36177,0.36331,1,1
4,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,3.7791e-06,0.36075,0.36888,1,1
4,GO RESPONSE TO MAGNESIUM ION,0.00036427,0.36047,0.41654,1,1
4,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.00041602,0.36002,0.34203,1,1
4,GO RESPONSE TO INTERLEUKIN 2,5.0226e-05,0.35966,0.30468,1,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.0013054,0.35917,0.26425,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00017796,0.35869,0.32287,1,1
4,GO VIRAL GENOME REPLICATION,8.7323e-05,0.35831,0.2824,1,1
4,GO ENDOTHELIAL CELL CHEMOTAXIS,0.00042998,0.35821,0.3309,1,1
4,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0028141,0.35807,0.29904,1,1
4,GO LEUKOTRIENE METABOLIC PROCESS,0.00010462,0.3575,0.33007,1,1
4,GO B CELL MEDIATED IMMUNITY,0.00021167,0.35743,0.25433,1,1
4,GO RESPONSE TO WATER,0.0025083,0.35662,0.3051,1,1
4,GO ETHER METABOLIC PROCESS,0.00034072,0.35661,0.26781,1,1
4,GO REGULATION OF RESPIRATORY BURST,3.3132e-05,0.356,0.38076,1,1
4,GO EPITHELIAL CELL FATE COMMITMENT,0.0027346,0.3554,0.31398,1,1
4,GO LYMPHOCYTE MEDIATED IMMUNITY,6.0504e-05,0.35533,0.26571,1,1
4,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,3.1888e-05,0.3553,0.35632,1,1
4,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0011549,0.35463,0.30443,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00010845,0.35445,0.31047,1,1
4,GO BONE REMODELING,7.9801e-06,0.35442,0.36566,1,1
4,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.0031536,0.35346,0.27811,1,1
4,GO STEROL HOMEOSTASIS,6.0504e-05,0.35303,0.34343,1,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.00018427,0.35276,0.26052,1,1
4,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,3.0689e-05,0.35265,0.30819,1,1
4,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00049035,0.35203,0.28942,1,1
4,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.2962e-05,0.35143,0.29013,1,1
4,GO ANTIBACTERIAL HUMORAL RESPONSE,8.6584e-06,0.35128,0.37601,1,1
4,GO ACUTE INFLAMMATORY RESPONSE,2.6307e-05,0.35102,0.35317,1,1
4,GO MAGNESIUM ION TRANSPORT,2.5308e-05,0.34988,0.32443,1,1
4,GO REGULATION OF STEROID METABOLIC PROCESS,3.3132e-05,0.34972,0.30194,1,1
4,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.00026003,0.34961,0.32044,1,1
4,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,1.104e-05,0.3495,0.26845,1,1
4,GO ETHANOL OXIDATION,0.004408,0.34893,0.46405,1,1
4,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00010462,0.34805,0.24813,1,1
4,GO N GLYCAN PROCESSING,0.001872,0.34777,0.29003,1,1
4,GO FUCOSE METABOLIC PROCESS,0.007729,0.34715,0.30927,1,1
4,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00044439,0.34708,0.25882,1,1
4,GO PHAGOSOME ACIDIFICATION,2.4692e-06,0.34703,0.36089,1,1
4,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.0097392,0.34685,0.26685,1,1
4,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.00017186,0.34617,0.27905,1,1
4,GO REGULATION OF FERTILIZATION,1.4609e-05,0.34615,0.36835,1,1
4,GO MYOBLAST FUSION,0.0001547,0.34615,0.28378,1,1
4,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.031748,0.34606,0.26756,1,1
4,GO AMINO SUGAR CATABOLIC PROCESS,4.1617e-05,0.34592,0.36154,1,1
4,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.0015189,0.3452,0.31425,1,1
4,GO LYTIC VACUOLE ORGANIZATION,3.4772e-07,0.34517,0.35757,1,1
4,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.0019282,0.34508,0.29177,1,1
4,GO DIET INDUCED THERMOGENESIS,8.7323e-05,0.34457,0.30979,1,1
4,GO LIPID DROPLET ORGANIZATION,1.0604e-05,0.34421,0.31514,1,1
4,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,5.2837e-06,0.34392,0.31161,1,1
4,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.0006154,0.34369,0.23249,1,1
4,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.00016595,0.34296,0.30869,1,1
4,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,4.0073e-05,0.34261,0.38845,1,1
4,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.019739,0.34213,0.26183,1,1
4,GO REGULATION OF B CELL PROLIFERATION,1.2862e-06,0.34144,0.36412,1,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.011326,0.34143,0.30452,1,1
4,GO SMOOTH MUSCLE CELL MIGRATION,0.0033369,0.3414,0.25962,1,1
4,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00054072,0.34124,0.40601,1,1
4,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.00010092,0.34116,0.35083,1,1
4,GO ICOSANOID METABOLIC PROCESS,3.3132e-05,0.34061,0.35228,1,1
4,GO STEROL METABOLIC PROCESS,3.7791e-06,0.34058,0.30283,1,1
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00017796,0.34043,0.29595,1,1
4,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,4.3218e-05,0.33995,0.35442,1,1
4,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,7.2754e-05,0.33942,0.25357,1,1
4,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.0015189,0.33912,0.36024,1,1
4,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,4.3218e-05,0.33857,0.33162,1,1
4,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,3.3132e-05,0.33837,0.30263,1,1
4,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,5.7413e-06,0.33803,0.30051,1,1
4,GO CELLULAR RESPONSE TO STEROL DEPLETION,4.4878e-05,0.33768,0.38789,1,1
4,GO REGULATION OF GLIAL CELL PROLIFERATION,0.0031536,0.33756,0.23112,1,1
4,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,1.6455e-05,0.3371,0.32653,1,1
4,GO CELLULAR RESPONSE TO FATTY ACID,0.00012512,0.33626,0.3243,1,1
4,GO ARACHIDONIC ACID METABOLIC PROCESS,4.8612e-06,0.33605,0.35182,1,1
4,GO STEROID BIOSYNTHETIC PROCESS,3.3287e-06,0.33602,0.3031,1,1
4,GO KERATINIZATION,5.508e-06,0.33601,0.3082,1,1
4,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.0012662,0.33575,0.37527,1,1
4,GO REGULATION OF CELL KILLING,1.349e-05,0.33559,0.33695,1,1
4,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,4.8379e-05,0.33538,0.3513,1,1
4,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.0014299,0.33504,0.29755,1,1
4,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,6.2367e-06,0.33476,0.30339,1,1
4,GO RESPONSE TO MINERALOCORTICOID,0.00028792,0.33443,0.28797,1,1
4,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,1.9263e-05,0.33402,0.28048,1,1
4,GO SNARE COMPLEX ASSEMBLY,0.00019753,0.33363,0.28501,1,1
4,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,6.0504e-05,0.33252,0.25599,1,1
4,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.00052342,0.33184,0.27697,1,1
4,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,3.7145e-05,0.33182,0.32765,1,1
4,GO HYPOTHALAMUS DEVELOPMENT,0.00021909,0.3317,0.31222,1,1
4,GO CORNIFICATION,9.7801e-06,0.33161,0.34567,1,1
4,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00074557,0.33124,0.33284,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0001547,0.33118,0.24925,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.001986,0.33058,0.24474,1,1
4,GO INNATE IMMUNE RESPONSE,1.1964e-05,0.3304,0.26438,1,1
4,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,1.6455e-05,0.33039,0.28847,1,1
4,GO PEPTIDYL PROLINE HYDROXYLATION,0.01282,0.33015,0.26193,1,1
4,GO CELL KILLING,2.2658e-06,0.33,0.28553,1,1
4,GO CELLULAR RESPONSE TO CADMIUM ION,0.0050528,0.32937,0.2871,1,1
4,GO EPOXYGENASE P450 PATHWAY,0.025414,0.32925,0.2509,1,1
4,GO IMMUNE EFFECTOR PROCESS,2.1663e-05,0.3288,0.25556,1,1
4,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,5.2139e-05,0.32867,0.29293,1,1
4,GO TYPE I INTERFERON PRODUCTION,3.0689e-05,0.32848,0.26986,1,1
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0011199,0.32792,0.25151,1,1
4,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00012964,0.32754,0.41498,1,1
4,GO RESPONSE TO INTERLEUKIN 15,0.00074557,0.32713,0.29328,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,7.547e-05,0.32679,0.27114,1,1
4,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,1.349e-05,0.32667,0.31663,1,1
4,GO REGULATION OF WOUND HEALING,0.00014935,0.32558,0.2849,1,1
4,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,6.7596e-05,0.32528,0.26453,1,1
4,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00017796,0.32418,0.24075,1,1
4,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.0014299,0.32376,0.25077,1,1
4,GO STEROID HORMONE SECRETION,0.0019282,0.32371,0.27158,1,1
4,GO REGULATION OF PROSTAGLANDIN SECRETION,3.8583e-05,0.32356,0.36298,1,1
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00036427,0.32348,0.30104,1,1
4,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.00014935,0.32342,0.37151,1,1
4,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.00040247,0.32336,0.25047,1,1
4,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.00026903,0.3227,0.27687,1,1
4,GO POSITIVE REGULATION OF TISSUE REMODELING,0.00024286,0.32219,0.34264,1,1
4,GO DEFENSE RESPONSE TO OTHER ORGANISM,1.0184e-05,0.32218,0.25484,1,1
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0018173,0.32214,0.24781,1,1
4,GO APICAL JUNCTION ASSEMBLY,1.5201e-05,0.32178,0.37267,1,1
4,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,6.0504e-05,0.32177,0.36997,1,1
4,GO STEROID METABOLIC PROCESS,5.0683e-06,0.32163,0.31648,1,1
4,GO KETONE BIOSYNTHETIC PROCESS,0.0032441,0.32057,0.26254,1,1
4,GO RESPONSE TO CORTICOSTERONE,0.0024367,0.31983,0.28751,1,1
4,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0001165,0.3198,0.36535,1,1
4,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,6.4994e-06,0.3197,0.29425,1,1
4,GO PLATELET DEGRANULATION,0.0015653,0.31951,0.22844,1,1
4,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,2.3418e-05,0.31941,0.33943,1,1
4,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.00019079,0.31933,0.26434,1,1
4,GO MAST CELL ACTIVATION,2.2524e-05,0.31927,0.29247,1,1
4,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.0001547,0.31916,0.22506,1,1
4,GO GLYCEROL ETHER METABOLIC PROCESS,0.001872,0.31905,0.21453,1,1
4,GO RESPONSE TO VIRUS,4.8379e-05,0.31871,0.2558,1,1
4,GO OLIGOPEPTIDE TRANSPORT,0.00063551,0.31817,0.37455,1,1
4,GO MAST CELL MEDIATED IMMUNITY,4.3218e-05,0.31812,0.28813,1,1
4,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,9.389e-05,0.31794,0.39664,1,1
4,GO PROTEIN DEGLYCOSYLATION,7.547e-05,0.31783,0.37401,1,1
4,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.00095906,0.31774,0.27721,1,1
4,GO RETINOL METABOLIC PROCESS,0.00014935,0.31713,0.40854,1,1
4,GO REGULATION OF SULFUR METABOLIC PROCESS,0.0085714,0.31679,0.22933,1,1
4,GO MAINTENANCE OF BLOOD BRAIN BARRIER,7.3528e-06,0.3166,0.37149,1,1
4,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.0081404,0.31656,0.33268,1,1
4,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.00054072,0.31651,0.32022,1,1
4,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,9.389e-05,0.31628,0.2762,1,1
4,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.00016595,0.31617,0.28566,1,1
4,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,9.0179e-06,0.3159,0.2673,1,1
4,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.0046564,0.31579,0.19076,1,1
4,GO ADRENAL GLAND DEVELOPMENT,0.00027832,0.31537,0.40509,1,1
4,GO B CELL PROLIFERATION,2.5774e-06,0.31511,0.29009,1,1
4,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0079323,0.31484,0.28989,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00031859,0.31456,0.22675,1,1
4,GO UBIQUINONE METABOLIC PROCESS,4.4878e-05,0.31423,0.30601,1,1
4,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,1.2962e-05,0.3137,0.33101,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,5.2139e-05,0.31355,0.25821,1,1
4,GO CYTOKINE MEDIATED SIGNALING PATHWAY,1.5816e-05,0.31267,0.26687,1,1
4,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.018398,0.31252,0.24132,1,1
4,GO LEUKOCYTE MEDIATED IMMUNITY,2.4346e-05,0.31236,0.26496,1,1
4,GO LABYRINTHINE LAYER DEVELOPMENT,0.00055855,0.31161,0.28225,1,1
4,GO REGULATION OF B CELL ACTIVATION,8.6584e-06,0.31129,0.26655,1,1
4,GO REGULATION OF ACTIN NUCLEATION,4.1617e-05,0.31106,0.33338,1,1
4,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,7.3528e-06,0.31085,0.3118,1,1
4,GO REGULATION OF FIBRINOLYSIS,0.001872,0.31084,0.35213,1,1
4,GO TRNA CATABOLIC PROCESS,0.010245,0.31084,0.31856,1,1
4,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00019753,0.3103,0.22926,1,1
4,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.00026003,0.31025,0.32115,1,1
4,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.00024286,0.30929,0.39586,1,1
4,GO METHIONINE METABOLIC PROCESS,4.0073e-05,0.30855,0.31125,1,1
4,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.007729,0.30809,0.23987,1,1
4,GO GLYCOSYLATION,2.4692e-06,0.30808,0.31008,1,1
4,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.027188,0.3078,0.16338,1,1
4,GO RESPONSE TO XENOBIOTIC STIMULUS,0.00063551,0.30776,0.28866,1,1
4,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,2.9301e-06,0.30749,0.27251,1,1
4,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,3.4772e-07,0.30715,0.31772,1,1
4,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.0056288,0.30709,0.23926,1,1
4,GO INTERLEUKIN 12 PRODUCTION,1.906e-06,0.30703,0.32707,1,1
4,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.00055855,0.3069,0.3066,1,1
4,GO RESPONSE TO GROWTH HORMONE,3.4421e-05,0.3068,0.3439,1,1
4,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0025083,0.30662,0.21929,1,1
4,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,2.5308e-05,0.30658,0.27727,1,1
4,GO REGULATION OF LEUKOCYTE PROLIFERATION,9.7346e-05,0.3065,0.25455,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,4.0073e-05,0.3064,0.25828,1,1
4,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.0038387,0.30573,0.29832,1,1
4,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,1.7118e-05,0.30526,0.26739,1,1
4,GO LIPID LOCALIZATION,2.6902e-06,0.30521,0.27855,1,1
4,GO ACETYL COA BIOSYNTHETIC PROCESS,0.001872,0.30503,0.26916,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00013917,0.30487,0.24859,1,1
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.00054072,0.30467,0.41358,1,1
4,GO T CELL CYTOKINE PRODUCTION,0.0022332,0.3045,0.22485,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,8.3127e-06,0.3044,0.34218,1,1
4,GO I KAPPAB KINASE NF KAPPAB SIGNALING,2.7343e-05,0.30427,0.24282,1,1
4,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00036427,0.30423,0.35831,1,1
4,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.015203,0.30417,0.2241,1,1
4,GO VACUOLAR ACIDIFICATION,4.2876e-06,0.30365,0.35869,1,1
4,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,9.0221e-07,0.30322,0.31866,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,6.5149e-05,0.30303,0.32751,1,1
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00081984,0.30301,0.26229,1,1
4,GO HETEROTYPIC CELL CELL ADHESION,0.0037331,0.30299,0.20849,1,1
4,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,3.7145e-05,0.30295,0.34086,1,1
4,GO KERATAN SULFATE METABOLIC PROCESS,0.00030804,0.3027,0.25975,1,1
4,GO B CELL HOMEOSTASIS,5.2139e-05,0.3019,0.28619,1,1
4,GO OPTIC NERVE DEVELOPMENT,0.00012512,0.30189,0.3765,1,1
4,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.00055855,0.30165,0.25984,1,1
4,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0029794,0.30127,0.29574,1,1
4,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.019739,0.30123,0.1664,1,1
4,GO POSITIVE REGULATION OF BONE RESORPTION,0.0010528,0.30108,0.37335,1,1
4,GO REGULATION OF SYMBIOTIC PROCESS,0.00025131,0.30104,0.21992,1,1
4,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.018836,0.30072,0.31608,1,1
4,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,3.3132e-05,0.30069,0.2587,1,1
4,GO INTERLEUKIN 1 PRODUCTION,0.0010528,0.30043,0.22486,1,1
4,GO WATER HOMEOSTASIS,2.3418e-05,0.30025,0.29538,1,1
4,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00019079,0.29997,0.26578,1,1
4,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00026903,0.29977,0.35713,1,1
4,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.00042998,0.29966,0.33611,1,1
4,GO RESPONSE TO TUMOR NECROSIS FACTOR,3.3132e-05,0.29962,0.25253,1,1
4,GO BILE ACID METABOLIC PROCESS,1.4039e-05,0.29912,0.36592,1,1
4,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,4.3218e-05,0.29856,0.26855,1,1
4,GO REGULATION OF EXOSOMAL SECRETION,0.00021909,0.29816,0.27126,1,1
4,GO RESPIRATORY BURST,0.00018427,0.29796,0.27325,1,1
4,GO FUCOSYLATION,0.001228,0.29784,0.30757,1,1
4,GO REGULATION OF IMMUNE EFFECTOR PROCESS,7.8282e-05,0.29751,0.23322,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,5.2139e-05,0.29721,0.25951,1,1
4,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00038934,0.29671,0.21257,1,1
4,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.0028141,0.29662,0.19925,1,1
4,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.0099891,0.29632,0.24962,1,1
4,GO NEGATIVE REGULATION OF LIPID STORAGE,8.1192e-05,0.29631,0.29408,1,1
4,GO LUNG ALVEOLUS DEVELOPMENT,7.013e-05,0.29623,0.30572,1,1
4,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.00016595,0.29608,0.28192,1,1
4,GO REGULATION OF RECEPTOR BINDING,0.017549,0.29593,0.24531,1,1
4,GO INTERLEUKIN 8 PRODUCTION,0.00012512,0.29592,0.27583,1,1
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE,3.9418e-06,0.29563,0.26017,1,1
4,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.00010092,0.29548,0.34286,1,1
4,GO LIPOPROTEIN CATABOLIC PROCESS,0.00052342,0.29529,0.2621,1,1
4,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.0037331,0.29524,0.2379,1,1
4,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,4.0073e-05,0.29522,0.32287,1,1
4,GO MYELOID LEUKOCYTE ACTIVATION,3.0689e-05,0.29516,0.25621,1,1
4,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.9263e-05,0.29439,0.2494,1,1
4,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.00035231,0.29433,0.4784,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.0015653,0.29414,0.30551,1,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.001191,0.2941,0.205,1,1
4,GO REVERSE CHOLESTEROL TRANSPORT,0.0010859,0.29326,0.41698,1,1
4,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.010245,0.29307,0.29476,1,1
4,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.0028957,0.29286,0.27368,1,1
4,GO POLYOL TRANSPORT,0.00021909,0.29263,0.35115,1,1
4,GO GASTRULATION WITH MOUTH FORMING SECOND,0.00054072,0.29231,0.26968,1,1
4,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.00090094,0.29231,0.35256,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,8.6584e-06,0.29225,0.34003,1,1
4,GO CELLULAR RESPONSE TO LITHIUM ION,0.00026003,0.29207,0.31375,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.00047456,0.29205,0.22044,1,1
4,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00063551,0.2919,0.27052,1,1
4,GO INTERLEUKIN 6 PRODUCTION,1.8521e-05,0.29186,0.2442,1,1
4,GO DEFENSE RESPONSE TO BACTERIUM,9.0221e-07,0.29159,0.2816,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.00028792,0.29157,0.21663,1,1
4,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.00069957,0.2909,0.33681,1,1
4,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0015189,0.29082,0.20586,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00012964,0.29042,0.27546,1,1
4,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.033894,0.29027,0.26063,1,1
4,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,1.349e-05,0.29024,0.29436,1,1
4,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,1.7806e-05,0.28973,0.32206,1,1
4,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.0011549,0.28949,0.35101,1,1
4,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00036427,0.28946,0.32826,1,1
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00016595,0.28939,0.32586,1,1
4,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.011047,0.28938,0.20778,1,1
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0037331,0.28853,0.19109,1,1
4,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00035231,0.2885,0.23464,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.001191,0.2885,0.26887,1,1
4,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00037661,0.28833,0.2303,1,1
4,GO GOLGI TO ENDOSOME TRANSPORT,0.0013054,0.28833,0.26493,1,1
4,GO REGULATION OF NECROTIC CELL DEATH,0.0006154,0.28827,0.27805,1,1
4,GO BILE ACID BIOSYNTHETIC PROCESS,5.2139e-05,0.28812,0.31145,1,1
4,GO INTEGRIN ACTIVATION,3.4421e-05,0.28796,0.30828,1,1
4,GO REGULATION OF INNATE IMMUNE RESPONSE,2.9301e-06,0.28746,0.2742,1,1
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.0021689,0.2874,0.30855,1,1
4,GO DEFENSE RESPONSE,1.2962e-05,0.28718,0.23778,1,1
4,GO INTERLEUKIN 10 PRODUCTION,4.1617e-05,0.28714,0.27088,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.00034072,0.28707,0.354,1,1
4,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.0019282,0.28704,0.2878,1,1
4,GO OLIGODENDROCYTE DEVELOPMENT,0.00025131,0.2869,0.25205,1,1
4,GO PROSTAGLANDIN TRANSPORT,0.00026903,0.28661,0.34518,1,1
4,GO ADAPTIVE IMMUNE RESPONSE,0.00011241,0.28652,0.2542,1,1
4,GO PROSTANOID METABOLIC PROCESS,0.0046564,0.28647,0.34279,1,1
4,GO PROTEIN N LINKED GLYCOSYLATION,2.7343e-05,0.28613,0.26675,1,1
4,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0025083,0.28607,0.24302,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0024367,0.28599,0.24969,1,1
4,GO TRANSPOSITION,0.0036303,0.28564,0.28204,1,1
4,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00055855,0.28559,0.23739,1,1
4,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.00081984,0.2854,0.24341,1,1
4,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,2.9532e-05,0.28522,0.2433,1,1
4,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00035231,0.28508,0.23429,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00045924,0.28467,0.23168,1,1
4,GO INTERLEUKIN 13 PRODUCTION,0.022165,0.28458,0.21645,1,1
4,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.00017796,0.28375,0.23379,1,1
4,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.0034322,0.28358,0.19502,1,1
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00014418,0.28335,0.29875,1,1
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00087311,0.28297,0.27898,1,1
4,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0085714,0.28252,0.27975,1,1
4,GO LEUKOCYTE PROLIFERATION,5.0226e-05,0.28242,0.22742,1,1
4,GO STEROL BIOSYNTHETIC PROCESS,4.1112e-06,0.28231,0.29704,1,1
4,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0017641,0.28216,0.29268,1,1
4,GO LUNG EPITHELIUM DEVELOPMENT,0.0097392,0.28193,0.24231,1,1
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.01282,0.28187,0.21448,1,1
4,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.0023671,0.28153,0.23777,1,1
4,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.001228,0.28136,0.28771,1,1
4,GO PHOSPHOLIPID TRANSPORT,4.1112e-06,0.2811,0.25307,1,1
4,GO LIPOSACCHARIDE METABOLIC PROCESS,0.00011241,0.28096,0.26843,1,1
4,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,2.3418e-05,0.28051,0.29963,1,1
4,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00050664,0.28048,0.25915,1,1
4,GO PEPTIDYL ASPARAGINE MODIFICATION,0.00057693,0.28038,0.25409,1,1
4,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00090094,0.28036,0.18661,1,1
4,GO PROGRAMMED NECROTIC CELL DEATH,8.7323e-05,0.28,0.302,1,1
4,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.00013917,0.27943,0.21233,1,1
4,GO CELLULAR RESPONSE TO STARVATION,3.1904e-06,0.27942,0.26212,1,1
4,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,1.1964e-05,0.27919,0.3123,1,1
4,GO CELL CELL JUNCTION ASSEMBLY,3.4421e-05,0.27914,0.26247,1,1
4,GO REGULATION OF ORGANIC ACID TRANSPORT,7.2754e-05,0.27909,0.29487,1,1
4,GO HAIR CELL DIFFERENTIATION,0.00017186,0.27896,0.24362,1,1
4,GO EXTRACELLULAR VESICLE BIOGENESIS,6.7596e-05,0.2788,0.24827,1,1
4,GO VITAMIN CATABOLIC PROCESS,0.02268,0.27866,0.27482,1,1
4,GO CERAMIDE BIOSYNTHETIC PROCESS,5.9841e-06,0.27847,0.25704,1,1
4,GO ORGANIC HYDROXY COMPOUND TRANSPORT,1.5816e-05,0.27786,0.24752,1,1
4,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.0011549,0.27785,0.35404,1,1
4,GO AMELOGENESIS,0.0046564,0.27758,0.23773,1,1
4,GO ENDOCRINE PROCESS,8.7323e-05,0.27722,0.26944,1,1
4,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,1.0604e-05,0.27721,0.27457,1,1
4,GO RESPONSE TO INTERLEUKIN 6,0.00052342,0.27702,0.26938,1,1
4,GO GDP METABOLIC PROCESS,0.012508,0.277,0.23624,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,3.1888e-05,0.27678,0.24348,1,1
4,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,2.9301e-06,0.27672,0.26106,1,1
4,GO C21 STEROID HORMONE METABOLIC PROCESS,0.013139,0.27629,0.31538,1,1
4,GO RESPONSE TO BIOTIC STIMULUS,2.7343e-05,0.27626,0.21543,1,1
4,GO CELLULAR RESPONSE TO ALCOHOL,0.001986,0.27608,0.18042,1,1
4,GO ER NUCLEUS SIGNALING PATHWAY,0.0007696,0.27607,0.26912,1,1
4,GO RESPONSE TO TUMOR CELL,0.00098941,0.27601,0.31161,1,1
4,GO CELLULAR METABOLIC COMPOUND SALVAGE,4.6597e-05,0.27584,0.27707,1,1
4,GO RESPONSE TO ACIDIC PH,0.0099891,0.27562,0.24756,1,1
4,GO CELL CELL JUNCTION ORGANIZATION,0.00021167,0.27537,0.23241,1,1
4,GO PHOSPHOLIPID EFFLUX,0.0019282,0.27536,0.33416,1,1
4,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00090094,0.27525,0.26344,1,1
4,GO AMINE METABOLIC PROCESS,1.3441e-06,0.27516,0.29274,1,1
4,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,1.4039e-05,0.27508,0.28113,1,1
4,GO REGULATION OF MYOTUBE DIFFERENTIATION,4.4878e-05,0.27503,0.25818,1,1
4,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.0033369,0.27499,0.2246,1,1
4,GO LIPID STORAGE,0.00012964,0.27492,0.26646,1,1
4,GO POLYAMINE BIOSYNTHETIC PROCESS,0.00041602,0.2749,0.29293,1,1
4,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00040247,0.27478,0.20427,1,1
4,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.00010845,0.27476,0.23944,1,1
4,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.0025083,0.27475,0.21567,1,1
4,GO OSTEOBLAST PROLIFERATION,0.0026572,0.2746,0.24783,1,1
4,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.0059384,0.27447,0.30823,1,1
4,GO PHOSPHOLIPID HOMEOSTASIS,0.014486,0.2744,0.23082,1,1
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00026003,0.27416,0.22771,1,1
4,GO STEROL TRANSPORT,0.00012964,0.27395,0.2626,1,1
4,GO BONE CELL DEVELOPMENT,0.0036303,0.27388,0.19749,1,1
4,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.020205,0.27382,0.22038,1,1
4,GO DIOL METABOLIC PROCESS,4.8379e-05,0.2736,0.34422,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.011612,0.27353,0.2757,1,1
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00090094,0.27341,0.20629,1,1
4,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.017969,0.27305,0.20722,1,1
4,GO EMBRYONIC PLACENTA DEVELOPMENT,0.00095906,0.27246,0.2379,1,1
4,GO RESPONSE TO FATTY ACID,0.0006154,0.27234,0.22108,1,1
4,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.0013457,0.27219,0.24854,1,1
4,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.009256,0.27183,0.23134,1,1
4,GO ORGANOPHOSPHATE ESTER TRANSPORT,5.0194e-07,0.27153,0.26761,1,1
4,GO DETERMINATION OF ADULT LIFESPAN,0.00029782,0.27149,0.28674,1,1
4,GO REGULATION OF B CELL DIFFERENTIATION,0.00022676,0.2711,0.27008,1,1
4,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,2.0033e-05,0.27076,0.3063,1,1
4,GO ALANINE TRANSPORT,0.0029794,0.27024,0.28417,1,1
4,GO CHEMOKINE PRODUCTION,0.0012662,0.26967,0.20004,1,1
4,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.0069616,0.2696,0.23345,1,1
4,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,1.906e-06,0.26941,0.32128,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0021062,0.26887,0.19688,1,1
4,GO TISSUE HOMEOSTASIS,2.7343e-05,0.26871,0.22388,1,1
4,GO POSITIVE REGULATION OF B CELL ACTIVATION,1.7806e-05,0.26853,0.24922,1,1
4,GO RADIAL GLIAL CELL DIFFERENTIATION,0.036948,0.26832,0.23232,1,1
4,GO HORMONE CATABOLIC PROCESS,0.0049174,0.26823,0.35057,1,1
4,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00079435,0.26765,0.28558,1,1
4,GO ANTIMICROBIAL HUMORAL RESPONSE,9.0179e-06,0.26765,0.26092,1,1
4,GO RESPONSE TO PEPTIDOGLYCAN,0.0030654,0.26757,0.21576,1,1
4,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.00038934,0.26749,0.23776,1,1
4,GO RESPONSE TO NUTRIENT,0.0050528,0.26733,0.15964,1,1
4,GO INTERLEUKIN 4 PRODUCTION,0.007729,0.26702,0.19915,1,1
4,GO DRUG METABOLIC PROCESS,0.00042998,0.26696,0.32471,1,1
4,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,9.7801e-06,0.26685,0.26793,1,1
4,GO B CELL RECEPTOR SIGNALING PATHWAY,1.8521e-05,0.26674,0.34369,1,1
4,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.0010859,0.26671,0.2481,1,1
4,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.00036427,0.26636,0.23651,1,1
4,GO CYTOPLASM ORGANIZATION,0.00081984,0.26633,0.2819,1,1
4,GO INTRACELLULAR LIPID TRANSPORT,9.389e-05,0.26624,0.26178,1,1
4,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,5.6174e-05,0.26612,0.29637,1,1
4,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,2.5308e-05,0.26603,0.24304,1,1
4,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.0028141,0.26602,0.22801,1,1
4,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,4.1617e-05,0.26598,0.24522,1,1
4,GO REGULATION OF FATTY ACID TRANSPORT,1.6729e-06,0.26531,0.40306,1,1
4,GO EPIDERMAL CELL DIFFERENTIATION,2.4346e-05,0.26522,0.25772,1,1
4,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0079323,0.26484,0.25034,1,1
4,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.022165,0.26469,0.20987,1,1
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0090226,0.26432,0.23843,1,1
4,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.00045924,0.26431,0.24221,1,1
4,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.00013917,0.26415,0.248,1,1
4,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,3.6228e-06,0.2638,0.21733,1,1
4,GO MEMBRANE LIPID METABOLIC PROCESS,2.8077e-06,0.2638,0.2774,1,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00069957,0.26376,0.20245,1,1
4,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,2.4346e-05,0.26335,0.23453,1,1
4,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.0071468,0.26328,0.19235,1,1
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0022332,0.26327,0.19286,1,1
4,GO KERATINOCYTE DIFFERENTIATION,4.1617e-05,0.26325,0.25818,1,1
4,GO HORMONE METABOLIC PROCESS,0.00036427,0.26322,0.26822,1,1
4,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.00092958,0.26286,0.3066,1,1
4,GO TRANSFERRIN TRANSPORT,2.8077e-06,0.26283,0.33209,1,1
4,GO UNSATURATED FATTY ACID METABOLIC PROCESS,9.389e-05,0.26277,0.30283,1,1
4,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00063551,0.26271,0.24005,1,1
4,GO RESPONSE TO CAFFEINE,0.0057817,0.26265,0.22279,1,1
4,GO MYELOID LEUKOCYTE MIGRATION,2.2524e-05,0.26247,0.22718,1,1
4,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.00042998,0.26238,0.24248,1,1
4,GO AMYLOID BETA METABOLIC PROCESS,0.00050664,0.26197,0.22905,1,1
4,GO CELLULAR RESPONSE TO STEROL,0.00035231,0.26162,0.29265,1,1
4,GO INFLAMMATORY RESPONSE,4.8379e-05,0.26145,0.21426,1,1
4,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00010462,0.26144,0.19679,1,1
4,GO DENDRITIC CELL MIGRATION,0.0050528,0.26118,0.18549,1,1
4,GO SECRETION BY TISSUE,0.00081984,0.26114,0.23218,1,1
4,GO ANDROGEN METABOLIC PROCESS,9.7346e-05,0.26105,0.39053,1,1
4,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.012508,0.26105,0.20901,1,1
4,GO HYALURONAN BIOSYNTHETIC PROCESS,0.0014299,0.26101,0.23368,1,1
4,GO HOMOTYPIC CELL CELL ADHESION,0.00010092,0.26086,0.28115,1,1
4,GO POSITIVE REGULATION OF HORMONE SECRETION,1.7806e-05,0.26066,0.2493,1,1
4,GO ORGANELLE MEMBRANE FUSION,9.0551e-05,0.25928,0.22533,1,1
4,GO REGULATION OF MUSCLE ADAPTATION,0.0022992,0.25923,0.16875,1,1
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.00030804,0.25919,0.25422,1,1
4,GO RESPONSE TO PROTOZOAN,0.001872,0.25893,0.18604,1,1
4,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.023205,0.25891,0.18398,1,1
4,GO LYMPHOCYTE MIGRATION,0.00026903,0.25889,0.2021,1,1
4,GO FATTY ACID CATABOLIC PROCESS,8.1192e-05,0.25881,0.25558,1,1
4,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.00029782,0.25881,0.21296,1,1
4,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0007696,0.25864,0.1869,1,1
4,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00014935,0.25859,0.19844,1,1
4,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,3.7145e-05,0.25855,0.25349,1,1
4,GO LEUKOCYTE MIGRATION,4.1617e-05,0.25848,0.23181,1,1
4,GO POSITIVE REGULATION OF ANION TRANSPORT,0.00036427,0.25826,0.29566,1,1
4,GO SPHINGOLIPID METABOLIC PROCESS,1.7474e-06,0.25752,0.28605,1,1
4,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.00087311,0.25711,0.23071,1,1
4,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.00029782,0.25693,0.2766,1,1
4,GO REGULATION OF CELL CELL ADHESION,0.00017186,0.25681,0.21205,1,1
4,GO CELLULAR RESPONSE TO CHOLESTEROL,0.0041716,0.25657,0.26391,1,1
4,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.00054072,0.25654,0.2507,1,1
4,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0001547,0.25642,0.26558,1,1
4,GO RESPONSE TO GONADOTROPIN,0.00092958,0.25639,0.23103,1,1
4,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.00063551,0.25623,0.21185,1,1
4,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00026003,0.25593,0.20409,1,1
4,GO RESPONSE TO CADMIUM ION,0.0039469,0.25583,0.21678,1,1
4,GO VASCULAR WOUND HEALING,0.0047853,0.25579,0.34509,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,4.1112e-06,0.25558,0.27044,1,1
4,GO EXOCYTOSIS,3.1888e-05,0.2547,0.20379,1,1
4,GO PIRNA METABOLIC PROCESS,0.0017123,0.25452,0.2943,1,1
4,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.0016129,0.25408,0.18433,1,1
4,GO OXALATE TRANSPORT,0.0051916,0.25365,0.17519,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.00019079,0.25351,0.26406,1,1
4,GO NOTCH SIGNALING PATHWAY,0.00016023,0.25332,0.202,1,1
4,GO RESPONSE TO CYTOKINE,6.7596e-05,0.25328,0.20643,1,1
4,GO MONOCYTE CHEMOTAXIS,0.0028957,0.25294,0.20085,1,1
4,GO RESPONSE TO BACTERIUM,8.4205e-05,0.25283,0.20618,1,1
4,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.00016595,0.25267,0.23089,1,1
4,GO CELLULAR KETONE METABOLIC PROCESS,0.00019753,0.25262,0.23189,1,1
4,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.00092958,0.25253,0.30543,1,1
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,4.6597e-05,0.25239,0.23901,1,1
4,GO FATTY ACID DERIVATIVE TRANSPORT,4.6597e-05,0.25212,0.28025,1,1
4,GO CERAMIDE METABOLIC PROCESS,3.3287e-06,0.25149,0.27659,1,1
4,GO CELLULAR RESPONSE TO ALKALOID,6.0504e-05,0.25134,0.24545,1,1
4,GO REGULATION OF LYSOSOMAL LUMEN PH,9.0551e-05,0.25107,0.33524,1,1
4,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.001228,0.25102,0.24654,1,1
4,GO MUSCLE HYPERTROPHY,0.00021167,0.25089,0.21239,1,1
4,GO SPHINGOID METABOLIC PROCESS,0.0010206,0.25071,0.27105,1,1
4,GO T CELL PROLIFERATION,0.0001547,0.25037,0.21971,1,1
4,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0020453,0.25033,0.19401,1,1
4,GO REGULATION OF DEFENSE RESPONSE,1.7118e-05,0.24999,0.21797,1,1
4,GO REGULATION OF RESPONSE TO WOUNDING,0.00087311,0.24996,0.21792,1,1
4,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,1.8251e-06,0.24994,0.25414,1,1
4,GO VESICLE BUDDING FROM MEMBRANE,0.0013457,0.24972,0.19693,1,1
4,GO CARBOHYDRATE TRANSPORT,8.3127e-06,0.24963,0.25733,1,1
4,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.010245,0.24943,0.23047,1,1
4,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,9.0179e-06,0.24917,0.23693,1,1
4,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0083534,0.24892,0.18916,1,1
4,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00025131,0.24889,0.26208,1,1
4,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.015203,0.24868,0.21873,1,1
4,GO REGULATION OF GLUCOSE METABOLIC PROCESS,2.9301e-06,0.24856,0.26048,1,1
4,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00037661,0.24843,0.24076,1,1
4,GO CYTOKINE PRODUCTION,4.8379e-05,0.24837,0.22345,1,1
4,GO MEMBRANE FISSION,0.024288,0.2483,0.19537,1,1
4,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0006154,0.24822,0.19389,1,1
4,GO EPITHELIAL STRUCTURE MAINTENANCE,0.00026003,0.24803,0.23774,1,1
4,GO MEMBRANE FUSION,6.0504e-05,0.248,0.2102,1,1
4,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,6.2367e-06,0.24765,0.24306,1,1
4,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,9.0551e-05,0.24763,0.2257,1,1
4,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00022676,0.24742,0.19772,1,1
4,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,9.7346e-05,0.24719,0.21491,1,1
4,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.01282,0.2471,0.18961,1,1
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00069957,0.24708,0.25241,1,1
4,GO REGULATION OF T CELL MIGRATION,0.0073363,0.247,0.19739,1,1
4,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.00026903,0.24687,0.23509,1,1
4,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,2.6307e-05,0.24686,0.24396,1,1
4,GO REGULATION OF RESPONSE TO TUMOR CELL,0.007729,0.24682,0.20868,1,1
4,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.6455e-05,0.2468,0.24456,1,1
4,GO LIPOPROTEIN METABOLIC PROCESS,5.4121e-05,0.24646,0.21725,1,1
4,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0050528,0.24639,0.2685,1,1
4,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,1.4039e-05,0.24634,0.26636,1,1
4,GO PANCREAS DEVELOPMENT,0.0023671,0.24608,0.1957,1,1
4,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,9.3916e-06,0.24575,0.24375,1,1
4,GO T CELL MIGRATION,0.0054795,0.2457,0.18398,1,1
4,GO SYNCYTIUM FORMATION,0.00087311,0.2457,0.19563,1,1
4,GO COAGULATION,0.001191,0.2457,0.16588,1,1
4,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.034637,0.24559,0.18283,1,1
4,GO HEART TRABECULA FORMATION,0.02166,0.24558,0.25232,1,1
4,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,4.6623e-06,0.24557,0.26643,1,1
4,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.050569,0.24551,0.18113,1,1
4,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,7.0571e-06,0.24505,0.26982,1,1
4,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.001872,0.24492,0.28237,1,1
4,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.019283,0.24488,0.15774,1,1
4,GO DIOL BIOSYNTHETIC PROCESS,0.00012074,0.24479,0.36015,1,1
4,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.004408,0.24465,0.25035,1,1
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0025083,0.24459,0.34244,1,1
4,GO PHOSPHOLIPID CATABOLIC PROCESS,6.2786e-05,0.24428,0.32674,1,1
4,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,5.8301e-05,0.24409,0.21722,1,1
4,GO POSITIVE REGULATION OF CELL ADHESION,0.00059588,0.24407,0.19209,1,1
4,GO ER OVERLOAD RESPONSE,0.0028957,0.24407,0.25128,1,1
4,GO NEUTROPHIL MIGRATION,1.104e-05,0.24393,0.22387,1,1
4,GO KERATINOCYTE DEVELOPMENT,0.024288,0.2438,0.26342,1,1
4,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,3.1904e-06,0.24374,0.22295,1,1
4,GO CAMP BIOSYNTHETIC PROCESS,0.014138,0.24342,0.22746,1,1
4,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.036164,0.24331,0.2085,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,4.2876e-06,0.24307,0.23679,1,1
4,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,5.8301e-05,0.24302,0.21548,1,1
4,GO PH REDUCTION,2.0033e-05,0.24288,0.24787,1,1
4,GO REGULATION OF ACTION POTENTIAL,0.0041716,0.24255,0.20241,1,1
4,GO GRANULOCYTE MIGRATION,5.6174e-05,0.24249,0.21929,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.00042998,0.24249,0.20857,1,1
4,GO RENAL SYSTEM PROCESS,0.00026003,0.2419,0.20784,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00072223,0.24151,0.18863,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.019283,0.24149,0.22718,1,1
4,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.034637,0.24127,0.2497,1,1
4,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.004408,0.2409,0.36918,1,1
4,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.00072223,0.2409,0.206,1,1
4,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0029794,0.24087,0.22417,1,1
4,GO REGULATION OF MUSCLE HYPERTROPHY,0.0059384,0.24079,0.1728,1,1
4,GO POSITIVE CHEMOTAXIS,0.0014299,0.24075,0.17976,1,1
4,GO METHIONINE BIOSYNTHETIC PROCESS,0.00032948,0.24068,0.33699,1,1
4,GO POSITIVE REGULATION OF HEART RATE,0.00054072,0.23984,0.31418,1,1
4,GO INTERLEUKIN 1 BETA PRODUCTION,0.00092958,0.23977,0.22424,1,1
4,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,2.1663e-05,0.23969,0.23882,1,1
4,GO LEUKOCYTE CELL CELL ADHESION,0.00026003,0.23941,0.20224,1,1
4,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.0071468,0.23909,0.21961,1,1
4,GO REGULATION OF BODY FLUID LEVELS,0.00027832,0.239,0.1801,1,1
4,GO POSITIVE REGULATION OF IMMUNE RESPONSE,7.013e-05,0.23888,0.19569,1,1
4,GO PROTEIN PROCESSING,1.1493e-05,0.23882,0.26246,1,1
4,GO GLIAL CELL PROLIFERATION,0.0083534,0.23849,0.18914,1,1
4,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0015653,0.23843,0.24345,1,1
4,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00031859,0.23842,0.18585,1,1
4,GO CELLULAR RESPONSE TO CALCIUM ION,0.0007696,0.23833,0.22619,1,1
4,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00092958,0.23809,0.2135,1,1
4,GO HEXOSE CATABOLIC PROCESS,0.027188,0.23788,0.18506,1,1
4,GO AUTOPHAGY OF NUCLEUS,0.0060989,0.23755,0.21503,1,1
4,GO MUSCLE ADAPTATION,0.00052342,0.23754,0.18452,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.00016595,0.23751,0.24717,1,1
4,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,2.2524e-05,0.23741,0.23551,1,1
4,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.049546,0.23701,0.16342,1,1
4,GO AMMONIUM TRANSPORT,0.011904,0.23701,0.17111,1,1
4,GO ALCOHOL BIOSYNTHETIC PROCESS,4.6597e-05,0.2369,0.22969,1,1
4,GO ALCOHOL METABOLIC PROCESS,2.0033e-05,0.23674,0.24663,1,1
4,GO REGULATION OF POSITIVE CHEMOTAXIS,0.001662,0.23667,0.22097,1,1
4,GO RESPONSE TO STARVATION,1.104e-05,0.23661,0.23933,1,1
4,GO POLYSACCHARIDE METABOLIC PROCESS,8.4205e-05,0.23647,0.21784,1,1
4,GO PROTEIN KINASE C SIGNALING,0.031748,0.23646,0.18767,1,1
4,GO VITAMIN BIOSYNTHETIC PROCESS,0.0028957,0.23645,0.2264,1,1
4,GO LEUKOCYTE CHEMOTAXIS,2.0833e-05,0.23632,0.22311,1,1
4,GO PIGMENTATION,0.00063551,0.23614,0.15838,1,1
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,9.0551e-05,0.2356,0.21506,1,1
4,GO REGULATION OF BLOOD PRESSURE,2.1663e-05,0.23545,0.20475,1,1
4,GO REGULATION OF IMMUNE RESPONSE,0.0001165,0.23535,0.18316,1,1
4,GO GRANULOCYTE CHEMOTAXIS,0.00010092,0.23526,0.18519,1,1
4,GO NADP METABOLIC PROCESS,0.0067808,0.23526,0.25391,1,1
4,GO INTERFERON ALPHA PRODUCTION,0.00019753,0.23524,0.23374,1,1
4,GO PROTEIN CONTAINING COMPLEX REMODELING,0.0047853,0.23523,0.23395,1,1
4,GO B CELL ACTIVATION,3.1888e-05,0.23521,0.20739,1,1
4,GO ALPHA BETA T CELL ACTIVATION,7.013e-05,0.23513,0.23178,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0011549,0.23511,0.23453,1,1
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0017123,0.23508,0.1841,1,1
4,GO CELL CHEMOTAXIS,3.7145e-05,0.23498,0.21897,1,1
4,GO CELL ACTIVATION,0.00010462,0.23495,0.19091,1,1
4,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.0015189,0.2344,0.1941,1,1
4,GO NEUTRAL AMINO ACID TRANSPORT,0.0045306,0.23438,0.25851,1,1
4,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.00092958,0.2343,0.18281,1,1
4,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.0045306,0.23425,0.17132,1,1
4,GO ACTIVATION OF IMMUNE RESPONSE,5.4121e-05,0.23406,0.19656,1,1
4,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.0039469,0.23362,0.2509,1,1
4,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.00063551,0.23359,0.14791,1,1
4,GO MACROMOLECULE DEPALMITOYLATION,0.00026903,0.23314,0.26301,1,1
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00069957,0.2331,0.23352,1,1
4,GO RESPONSE TO PROGESTERONE,0.0079323,0.2329,0.19459,1,1
4,GO SODIUM ION HOMEOSTASIS,0.00012512,0.23288,0.21413,1,1
4,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.00010092,0.23282,0.19325,1,1
4,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,7.2754e-05,0.23254,0.2572,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00040247,0.23243,0.1786,1,1
4,GO EPIDERMIS DEVELOPMENT,0.00016023,0.23201,0.20037,1,1
4,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,9.389e-05,0.23199,0.23756,1,1
4,GO REGULATION OF HORMONE SECRETION,3.0689e-05,0.23197,0.20782,1,1
4,GO AMYLOID FIBRIL FORMATION,0.0069616,0.23181,0.21461,1,1
4,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0097392,0.23181,0.19832,1,1
4,GO PROTEIN AUTOPROCESSING,0.00041602,0.23172,0.31979,1,1
4,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.00047456,0.23167,0.18836,1,1
4,GO MONOSACCHARIDE CATABOLIC PROCESS,0.024846,0.23166,0.16515,1,1
4,GO RESPONSE TO METAL ION,4.3218e-05,0.23158,0.21271,1,1
4,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.021165,0.2315,0.21665,1,1
4,GO PEPTIDE SECRETION,5.2837e-06,0.23147,0.21372,1,1
4,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.00027832,0.23145,0.225,1,1
4,GO HORMONE TRANSPORT,8.6584e-06,0.23142,0.22906,1,1
4,GO PURINE NUCLEOTIDE TRANSPORT,5.6174e-05,0.23133,0.23777,1,1
4,GO VESICLE TARGETING,0.0014299,0.23129,0.2082,1,1
4,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,9.0551e-05,0.23117,0.195,1,1
4,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,5.6174e-05,0.23115,0.24072,1,1
4,GO RESPONSE TO PH,0.0040578,0.23109,0.17704,1,1
4,GO VITAMIN METABOLIC PROCESS,0.0033369,0.2309,0.20812,1,1
4,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.0006154,0.2309,0.25084,1,1
4,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.0017641,0.23074,0.24299,1,1
4,GO REGULATION OF INFLAMMATORY RESPONSE,8.7323e-05,0.23047,0.2031,1,1
4,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.040234,0.23045,0.14057,1,1
4,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.00052342,0.23034,0.17204,1,1
4,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00013433,0.23005,0.25135,1,1
4,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00013917,0.23002,0.21461,1,1
4,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00016023,0.23001,0.17676,1,1
4,GO REGULATION OF PEPTIDE SECRETION,2.4692e-06,0.22957,0.21601,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.0050528,0.22947,0.24744,1,1
4,GO GOLGI VESICLE BUDDING,8.7323e-05,0.22943,0.22031,1,1
4,GO MANNOSYLATION,1.7118e-05,0.22889,0.26719,1,1
4,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.011326,0.22856,0.1518,1,1
4,GO POSITIVE REGULATION OF T CELL MIGRATION,0.0085714,0.22847,0.16298,1,1
4,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.0069616,0.22817,0.2495,1,1
4,GO CELLULAR RESPONSE TO KETONE,0.0022992,0.22814,0.20019,1,1
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,2.2524e-05,0.22785,0.21256,1,1
4,GO CYTOKINE SECRETION,5.0226e-05,0.22741,0.22891,1,1
4,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.015953,0.22729,0.17336,1,1
4,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.023741,0.22705,0.22103,1,1
4,GO LIPID HOMEOSTASIS,0.00035231,0.22697,0.23198,1,1
4,GO POSITIVE REGULATION OF HEART CONTRACTION,0.00019079,0.22695,0.26868,1,1
4,GO LINOLEIC ACID METABOLIC PROCESS,0.049546,0.22686,0.20247,1,1
4,GO REGULATION OF PEPTIDASE ACTIVITY,0.00013433,0.22676,0.22319,1,1
4,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0017641,0.22674,0.20301,1,1
4,GO LYMPHOCYTE COSTIMULATION,0.00054072,0.22641,0.19783,1,1
4,GO REGULATION OF CELLULAR PH,5.7413e-06,0.22619,0.22284,1,1
4,GO SKIN DEVELOPMENT,0.00022676,0.22608,0.19576,1,1
4,GO CHLORIDE ION HOMEOSTASIS,0.013798,0.22601,0.16407,1,1
4,GO ARACHIDONIC ACID SECRETION,5.6174e-05,0.22593,0.26084,1,1
4,GO REGULATION OF RUFFLE ASSEMBLY,0.0020453,0.2258,0.21079,1,1
4,GO REGULATION OF PEPTIDE HORMONE SECRETION,2.4346e-05,0.22545,0.21655,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.036948,0.22532,0.19231,1,1
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,7.3528e-06,0.22502,0.214,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,1.1964e-05,0.22495,0.20309,1,1
4,GO ISOPRENOID METABOLIC PROCESS,0.0020453,0.22467,0.21534,1,1
4,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.0030654,0.22465,0.1641,1,1
4,GO INSULIN SECRETION,2.3418e-05,0.22428,0.21678,1,1
4,GO LYMPHOCYTE HOMEOSTASIS,0.00013917,0.22424,0.21169,1,1
4,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.0042883,0.22423,0.22443,1,1
4,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,3.1888e-05,0.22369,0.34264,1,1
4,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00038934,0.22365,0.18022,1,1
4,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.0041716,0.22352,0.22487,1,1
4,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,4.6623e-06,0.22315,0.24846,1,1
4,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,2.8418e-05,0.22312,0.19361,1,1
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.013798,0.22304,0.16688,1,1
4,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.0010528,0.22304,0.1834,1,1
4,GO RESPONSE TO CORTICOSTEROID,0.0056288,0.22299,0.16033,1,1
4,GO RESPONSE TO CALCIUM ION,0.00052342,0.22276,0.19483,1,1
4,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00353,0.22274,0.15926,1,1
4,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.001872,0.22266,0.17672,1,1
4,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00018427,0.2226,0.24747,1,1
4,GO MUSCLE CELL MIGRATION,0.017137,0.22236,0.16004,1,1
4,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.031059,0.22234,0.13936,1,1
4,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,2.5308e-05,0.22231,0.2089,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00098941,0.22227,0.16291,1,1
4,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.0025083,0.22209,0.20616,1,1
4,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.017549,0.22207,0.18257,1,1
4,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0016129,0.22181,0.17838,1,1
4,GO POSITIVE REGULATION OF BLOOD CIRCULATION,5.4121e-05,0.22157,0.22173,1,1
4,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0016129,0.22148,0.18156,1,1
4,GO RESPONSE TO ALCOHOL,0.00041602,0.22136,0.16428,1,1
4,GO PHAGOSOME MATURATION,0.00026003,0.22091,0.2666,1,1
4,GO NUCLEOTIDE TRANSPORT,3.7145e-05,0.22082,0.22928,1,1
4,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,6.2786e-05,0.22077,0.18926,1,1
4,GO REGULATION OF NUCLEASE ACTIVITY,0.0014299,0.22077,0.1906,1,1
4,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,2.6307e-05,0.22031,0.19281,1,1
4,GO RESPONSE TO KETONE,0.0017641,0.22018,0.16167,1,1
4,GO KERATINOCYTE PROLIFERATION,0.010245,0.21999,0.17005,1,1
4,GO REGULATION OF GLUCONEOGENESIS,6.5149e-05,0.21997,0.26122,1,1
4,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,2.0033e-05,0.21988,0.2412,1,1
4,GO PROTEIN HYDROXYLATION,0.025414,0.2198,0.18668,1,1
4,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.001228,0.21963,0.16898,1,1
4,GO APOPTOTIC SIGNALING PATHWAY,0.00019753,0.21958,0.17307,1,1
4,GO ACTIN NUCLEATION,1.6455e-05,0.21947,0.23567,1,1
4,GO WOUND HEALING,0.004408,0.21933,0.14776,1,1
4,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0046564,0.21913,0.21081,1,1
4,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.02268,0.21911,0.22024,1,1
4,GO REGULATION OF MAST CELL ACTIVATION,0.0021062,0.21908,0.20592,1,1
4,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.03245,0.21847,0.22899,1,1
4,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.0011549,0.21847,0.16929,1,1
4,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00029782,0.21839,0.17395,1,1
4,GO FATTY ACID BIOSYNTHETIC PROCESS,0.00042998,0.21835,0.21266,1,1
4,GO LYMPHOCYTE APOPTOTIC PROCESS,0.00034072,0.2182,0.23178,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,5.8301e-05,0.21806,0.19086,1,1
4,GO CELLULAR LIPID CATABOLIC PROCESS,2.0833e-05,0.21799,0.25942,1,1
4,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.00042998,0.2178,0.1928,1,1
4,GO PROTEIN LOCALIZATION TO ENDOSOME,0.0040578,0.21775,0.21193,1,1
4,GO REGULATION OF HORMONE LEVELS,7.9801e-06,0.21767,0.23473,1,1
4,GO COPULATION,0.013465,0.21722,0.17864,1,1
4,GO REGULATION OF LIPID TRANSPORT,0.00034072,0.21705,0.23333,1,1
4,GO DOPAMINE METABOLIC PROCESS,0.0024367,0.21649,0.25856,1,1
4,GO CELLULAR HORMONE METABOLIC PROCESS,0.0037331,0.21597,0.23462,1,1
4,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.0037331,0.21585,0.17541,1,1
4,GO ADIPOSE TISSUE DEVELOPMENT,0.00021909,0.21573,0.207,1,1
4,GO CELLULAR GLUCAN METABOLIC PROCESS,0.00072223,0.21569,0.18009,1,1
4,GO POSITIVE REGULATION OF COAGULATION,0.0012662,0.21541,0.23593,1,1
4,GO T CELL ACTIVATION,0.00016595,0.21531,0.18867,1,1
4,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.0030654,0.21521,0.29284,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00087311,0.21506,0.15627,1,1
4,GO ORGANELLE FUSION,7.8282e-05,0.21503,0.18665,1,1
4,GO RESPONSE TO INORGANIC SUBSTANCE,2.1663e-05,0.21503,0.17629,1,1
4,GO LIPID EXPORT FROM CELL,0.00353,0.21499,0.25144,1,1
4,GO LIPID OXIDATION,0.00065623,0.21492,0.1905,1,1
4,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.00044439,0.21488,0.18329,1,1
4,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.0006154,0.21486,0.26505,1,1
4,GO RESPONSE TO DSRNA,0.00026903,0.21471,0.1807,1,1
4,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.00016595,0.21469,0.19916,1,1
4,GO PROSTAGLANDIN SECRETION,0.0022332,0.2146,0.25205,1,1
4,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0041716,0.21429,0.26271,1,1
4,GO B CELL DIFFERENTIATION,2.2524e-05,0.21419,0.2133,1,1
4,GO EPITHELIAL CELL DIFFERENTIATION,0.00019753,0.2139,0.18999,1,1
4,GO REGULATION OF CELL ACTIVATION,0.00067758,0.21375,0.15826,1,1
4,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.0018173,0.21364,0.21534,1,1
4,GO REGULATION OF ENDOCRINE PROCESS,0.00020448,0.21357,0.24599,1,1
4,GO PROTEIN ADP RIBOSYLATION,0.0050528,0.21353,0.17749,1,1
4,GO PLASMA MEMBRANE FUSION,0.014841,0.21266,0.20074,1,1
4,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.00021909,0.21253,0.20842,1,1
4,GO LIPID BIOSYNTHETIC PROCESS,1.349e-05,0.21241,0.20508,1,1
4,GO LAMELLIPODIUM MORPHOGENESIS,0.024288,0.21221,0.20442,1,1
4,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0094949,0.2122,0.12408,1,1
4,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,1.1493e-05,0.21204,0.25673,1,1
4,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.0007696,0.21177,0.20039,1,1
4,GO POSITIVE REGULATION OF CELL ACTIVATION,0.00057693,0.21153,0.16461,1,1
4,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00044439,0.21102,0.17195,1,1
4,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.0010859,0.21072,0.15919,1,1
4,GO RESPONSE TO MECHANICAL STIMULUS,0.00010462,0.21065,0.1965,1,1
4,GO NEUTRAL LIPID CATABOLIC PROCESS,0.0018173,0.21054,0.22764,1,1
4,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.015953,0.21043,0.16146,1,1
4,GO PEPTIDE HORMONE SECRETION,1.6455e-05,0.21025,0.21802,1,1
4,GO TERPENOID METABOLIC PROCESS,0.0059384,0.21002,0.19434,1,1
4,GO GOLGI RIBBON FORMATION,0.0040578,0.20998,0.19847,1,1
4,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.02268,0.2099,0.13692,1,1
4,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,6.0504e-05,0.20973,0.17375,1,1
4,GO CARBOHYDRATE HOMEOSTASIS,2.2524e-05,0.2095,0.20628,1,1
4,GO LEUKOCYTE DIFFERENTIATION,7.2754e-05,0.20935,0.17176,1,1
4,GO WHITE FAT CELL DIFFERENTIATION,0.0010528,0.20931,0.21935,1,1
4,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.0013872,0.20918,0.16184,1,1
4,GO NECROTIC CELL DEATH,0.00012074,0.20918,0.27978,1,1
4,GO GLYCEROLIPID CATABOLIC PROCESS,0.00026903,0.20914,0.24484,1,1
4,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0012662,0.20909,0.19454,1,1
4,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0097392,0.20903,0.14963,1,1
4,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.00063551,0.20898,0.23208,1,1
4,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,7.013e-05,0.20893,0.18126,1,1
4,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.041093,0.20888,0.14863,1,1
4,GO CHOLESTEROL STORAGE,0.00036427,0.2086,0.27375,1,1
4,GO ADAPTIVE THERMOGENESIS,3.4728e-06,0.20858,0.22271,1,1
4,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.011047,0.20829,0.20863,1,1
4,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.043763,0.20829,0.10276,1,1
4,GO RESPONSE TO STEROL,0.0027346,0.20799,0.20739,1,1
4,GO REGULATION OF APPETITE,0.0013872,0.20791,0.15694,1,1
4,GO VACUOLE ORGANIZATION,7.6603e-06,0.20791,0.22962,1,1
4,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.01282,0.20779,0.39279,1,1
4,GO GLUTAMATE METABOLIC PROCESS,0.0017123,0.20778,0.18892,1,1
4,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.00032948,0.20773,0.18823,1,1
4,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.023205,0.20754,0.16854,1,1
4,GO T HELPER CELL LINEAGE COMMITMENT,0.0027346,0.20748,0.18469,1,1
4,GO REGULATION OF CELL ADHESION,0.0013054,0.20709,0.16506,1,1
4,GO REGULATION OF FATTY ACID OXIDATION,0.0075304,0.20706,0.18527,1,1
4,GO REGULATION OF T CELL ACTIVATION,0.00054072,0.2063,0.17602,1,1
4,GO PROTEIN MATURATION,3.7145e-05,0.2062,0.20794,1,1
4,GO FC RECEPTOR SIGNALING PATHWAY,0.00017186,0.20603,0.16297,1,1
4,GO LONG CHAIN FATTY ACID TRANSPORT,4.8379e-05,0.206,0.21744,1,1
4,GO ACTIVATION OF INNATE IMMUNE RESPONSE,6.7728e-06,0.20567,0.24944,1,1
4,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.010506,0.20564,0.19299,1,1
4,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.00049035,0.20545,0.16888,1,1
4,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,6.0504e-05,0.20542,0.19135,1,1
4,GO EATING BEHAVIOR,0.001872,0.20514,0.19322,1,1
4,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,8.4205e-05,0.2049,0.20353,1,1
4,GO PROTEIN AUTO ADP RIBOSYLATION,0.0053338,0.20454,0.28873,1,1
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.0033369,0.20415,0.191,1,1
4,GO REGULATION OF HISTONE H4 ACETYLATION,0.004408,0.20405,0.16646,1,1
4,GO PLATELET ACTIVATION,0.00045924,0.20404,0.18562,1,1
4,GO CELL CELL ADHESION,0.0022992,0.20398,0.14603,1,1
4,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.0011549,0.20395,0.20142,1,1
4,GO LYMPHOCYTE ACTIVATION,0.00032948,0.20383,0.15803,1,1
4,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.037747,0.20346,0.12504,1,1
4,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,1.2962e-05,0.20343,0.21494,1,1
4,GO REGULATION OF LIPID STORAGE,0.00067758,0.20338,0.20178,1,1
4,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.011612,0.20326,0.224,1,1
4,GO REGULATION OF INSULIN SECRETION,6.5149e-05,0.20308,0.19335,1,1
4,GO GLYCOPROTEIN METABOLIC PROCESS,0.00014418,0.20271,0.20387,1,1
4,GO SECRETION,3.1888e-05,0.20263,0.18064,1,1
4,GO MEMBRANE DEPOLARIZATION,0.0031536,0.20259,0.19853,1,1
4,GO XENOBIOTIC TRANSPORT,0.004408,0.20258,0.26879,1,1
4,GO BROWN FAT CELL DIFFERENTIATION,0.00050664,0.20257,0.24787,1,1
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0042883,0.20222,0.18775,1,1
4,GO ACTIN FILAMENT DEPOLYMERIZATION,0.00040247,0.20211,0.19489,1,1
4,GO NEUTROPHIL CHEMOTAXIS,2.4346e-05,0.20199,0.18075,1,1
4,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.010506,0.20188,0.17054,1,1
4,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0069616,0.20182,0.1501,1,1
4,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0010528,0.20163,0.14405,1,1
4,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0021689,0.20158,0.16911,1,1
4,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.00055855,0.20157,0.19451,1,1
4,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.025994,0.20154,0.18566,1,1
4,GO RESPONSE TO OSMOTIC STRESS,0.0066042,0.20098,0.17288,1,1
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.022165,0.20098,0.19439,1,1
4,GO GPI ANCHOR METABOLIC PROCESS,0.00040247,0.20089,0.22709,1,1
4,GO REGULATION OF PH,7.6603e-06,0.20089,0.21831,1,1
4,GO COPII COATED VESICLE BUDDING,0.00021167,0.20059,0.20399,1,1
4,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.0031536,0.20059,0.16249,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.00095906,0.20035,0.15896,1,1
4,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.00049035,0.20017,0.17495,1,1
4,GO AMYLOID BETA FORMATION,0.0064317,0.19963,0.18261,1,1
4,GO REGULATION OF AMYLOID BETA FORMATION,0.014841,0.19958,0.18838,1,1
4,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,7.013e-05,0.19939,0.18164,1,1
4,GO REGULATION OF CHROMATIN ASSEMBLY,0.0006154,0.19853,0.16543,1,1
4,GO DIGESTIVE SYSTEM DEVELOPMENT,0.0028957,0.19851,0.15235,1,1
4,GO POSITIVE REGULATION OF INSULIN SECRETION,0.00010845,0.19806,0.2066,1,1
4,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.0025817,0.19757,0.17673,1,1
4,GO ENDOCYTIC RECYCLING,0.0015653,0.19748,0.14843,1,1
4,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.014486,0.19711,0.17067,1,1
4,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.00035231,0.19699,0.25261,1,1
4,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0016129,0.19697,0.23274,1,1
4,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00047456,0.19687,0.18214,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.00098941,0.19686,0.17308,1,1
4,GO TRANSCYTOSIS,0.009256,0.19667,0.21487,1,1
4,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.0017641,0.19656,0.19454,1,1
4,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.011047,0.19654,0.29132,1,1
4,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.042857,0.19651,0.11462,1,1
4,GO REPLICATIVE SENESCENCE,0.0067808,0.19644,0.23158,1,1
4,GO RESPONSE TO MUSCLE INACTIVITY,0.02268,0.19634,0.22059,1,1
4,GO RESPONSE TO INSULIN,0.00016023,0.19606,0.17273,1,1
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,4.6597e-05,0.19601,0.19943,1,1
4,GO LIPID METABOLIC PROCESS,3.7145e-05,0.196,0.19635,1,1
4,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0041716,0.19581,0.15059,1,1
4,GO REGULATION OF LIPID LOCALIZATION,0.00052342,0.19577,0.20578,1,1
4,GO T CELL DIFFERENTIATION,0.00016595,0.19552,0.16296,1,1
4,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.033166,0.19543,0.14354,1,1
4,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0064317,0.1954,0.1926,1,1
4,GO FATTY ACID METABOLIC PROCESS,0.00014418,0.19533,0.22228,1,1
4,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.01282,0.19515,0.16797,1,1
4,GO ENGULFMENT OF APOPTOTIC CELL,0.0066042,0.19491,0.15879,1,1
4,GO DENDRITIC CELL CHEMOTAXIS,0.014841,0.19486,0.15564,1,1
4,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00040247,0.19479,0.21735,1,1
4,GO EPITHELIUM DEVELOPMENT,0.00052342,0.19478,0.13875,1,1
4,GO VESICLE ORGANIZATION,0.00031859,0.1947,0.1696,1,1
4,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.00090094,0.19459,0.18147,1,1
4,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,7.013e-05,0.1941,0.18923,1,1
4,GO RESPONSE TO OXYGEN RADICAL,0.00024286,0.19404,0.21549,1,1
4,GO REGULATION OF RENAL SYSTEM PROCESS,0.014486,0.19404,0.19533,1,1
4,GO REGULATION OF TUBE SIZE,0.001662,0.19401,0.1669,1,1
4,GO REGULATION OF ERBB SIGNALING PATHWAY,0.0034322,0.19398,0.16842,1,1
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.0026572,0.19374,0.22287,1,1
4,GO CARNITINE METABOLIC PROCESS,0.036948,0.19344,0.19421,1,1
4,GO T CELL RECEPTOR SIGNALING PATHWAY,0.00054072,0.19337,0.15967,1,1
4,GO HUMORAL IMMUNE RESPONSE,7.0571e-06,0.19299,0.22613,1,1
4,GO REGULATION OF DENDRITE EXTENSION,0.0054795,0.19293,0.32579,1,1
4,GO POSITIVE REGULATION OF SECRETION,1.4609e-05,0.19256,0.206,1,1
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00081984,0.19254,0.17065,1,1
4,GO SEQUESTERING OF CALCIUM ION,0.001191,0.19223,0.16471,1,1
4,GO REGULATION OF T CELL DIFFERENTIATION,0.0007696,0.19218,0.14359,1,1
4,GO REGULATION OF HEMOPOIESIS,0.00022676,0.19211,0.15158,1,1
4,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.017549,0.19168,0.16754,1,1
4,GO MUSCLE CELL APOPTOTIC PROCESS,0.00032948,0.19151,0.18783,1,1
4,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.00021909,0.19138,0.15842,1,1
4,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0014299,0.19117,0.1624,1,1
4,GO PROTEIN O LINKED MANNOSYLATION,0.0045306,0.19116,0.202,1,1
4,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.0010528,0.19109,0.20778,1,1
4,GO ALPHA BETA T CELL DIFFERENTIATION,0.00055855,0.19049,0.19549,1,1
4,GO CELLULAR LIPID METABOLIC PROCESS,3.3132e-05,0.19022,0.19784,1,1
4,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.00050664,0.19018,0.15896,1,1
4,GO POSITIVE REGULATION OF CHEMOTAXIS,0.0017123,0.18998,0.15807,1,1
4,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00063551,0.18974,0.17256,1,1
4,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.0022992,0.18966,0.16337,1,1
4,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0073363,0.18945,0.18835,1,1
4,GO RESPONSE TO IRON ION,0.011904,0.18932,0.17299,1,1
4,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.014138,0.18925,0.18699,1,1
4,GO RESPONSE TO DEXAMETHASONE,0.0056288,0.18895,0.20412,1,1
4,GO PROTEIN KINASE B SIGNALING,0.011047,0.18885,0.11878,1,1
4,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.00032948,0.18858,0.32325,1,1
4,GO POSITIVE REGULATION OF HEMOPOIESIS,0.00049035,0.18847,0.16682,1,1
4,GO MYOTUBE DIFFERENTIATION,0.00041602,0.1883,0.18474,1,1
4,GO REGULATION OF LIPID METABOLIC PROCESS,0.00016023,0.18795,0.17366,1,1
4,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0025083,0.18771,0.18168,1,1
4,GO LEUKOCYTE HOMEOSTASIS,0.0038387,0.18766,0.14734,1,1
4,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.0039469,0.18759,0.17789,1,1
4,GO EPITHELIAL CELL DEVELOPMENT,0.0075304,0.18754,0.13209,1,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.011904,0.18741,0.18279,1,1
4,GO RDNA HETEROCHROMATIN ASSEMBLY,0.00042998,0.18737,0.20213,1,1
4,GO AMINOGLYCAN METABOLIC PROCESS,0.004408,0.18728,0.15764,1,1
4,GO PHOSPHOLIPID METABOLIC PROCESS,1.1493e-05,0.18726,0.17791,1,1
4,GO LYMPHOCYTE DIFFERENTIATION,0.00026903,0.18722,0.14618,1,1
4,GO GLUCOSE METABOLIC PROCESS,7.0571e-06,0.18714,0.22853,1,1
4,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.00017186,0.18706,0.17353,1,1
4,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.00017186,0.1869,0.16832,1,1
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,9.389e-05,0.18666,0.17149,1,1
4,GO THIOESTER BIOSYNTHETIC PROCESS,0.0021062,0.18663,0.19564,1,1
4,GO SENSORY PERCEPTION OF TASTE,0.0024367,0.18652,0.1498,1,1
4,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.0021689,0.18632,0.14144,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0097392,0.18623,0.19386,1,1
4,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.0049174,0.18606,0.13804,1,1
4,GO RENAL TUBULE DEVELOPMENT,0.015203,0.18606,0.1179,1,1
4,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,2.8418e-05,0.18602,0.23329,1,1
4,GO IRON ION TRANSPORT,7.8282e-05,0.18597,0.23853,1,1
4,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.040234,0.18593,0.11377,1,1
4,GO OXIDATION REDUCTION PROCESS,0.00010462,0.18558,0.19524,1,1
4,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.00052342,0.18551,0.22367,1,1
4,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00095906,0.18503,0.27503,1,1
4,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.00049035,0.18439,0.22314,1,1
4,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,5.4121e-05,0.18429,0.17888,1,1
4,GO DEVELOPMENTAL PIGMENTATION,0.0064317,0.18413,0.13226,1,1
4,GO SUPEROXIDE METABOLIC PROCESS,0.0012662,0.18413,0.21111,1,1
4,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.0056288,0.18395,0.23512,1,1
4,GO ACID SECRETION,0.0067808,0.18391,0.14584,1,1
4,GO MYELOID DENDRITIC CELL ACTIVATION,0.01282,0.18384,0.17251,1,1
4,GO CHLORIDE TRANSPORT,0.00023468,0.18369,0.16092,1,1
4,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.0012662,0.18367,0.1592,1,1
4,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.010506,0.18354,0.14514,1,1
4,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.00019753,0.18306,0.14259,1,1
4,GO FIBROBLAST PROLIFERATION,0.046579,0.18291,0.10955,1,1
4,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.0010528,0.1829,0.18697,1,1
4,GO POSITIVE REGULATION OF EXOCYTOSIS,0.00037661,0.18277,0.20048,1,1
4,GO RESPONSE TO WOUNDING,0.0067808,0.18272,0.12906,1,1
4,GO CARBOHYDRATE METABOLIC PROCESS,0.0001547,0.18254,0.18744,1,1
4,GO ENDOTHELIAL CELL MIGRATION,0.0036303,0.18232,0.16213,1,1
4,GO RESPONSE TO EXTRACELLULAR STIMULUS,6.0504e-05,0.1823,0.17779,1,1
4,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.046579,0.18217,0.1559,1,1
4,GO POSITIVE REGULATION OF PEPTIDE SECRETION,3.6228e-06,0.18209,0.2187,1,1
4,GO PROTON TRANSMEMBRANE TRANSPORT,4.8379e-05,0.18201,0.20383,1,1
4,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.001872,0.18165,0.24104,1,1
4,GO TEMPERATURE HOMEOSTASIS,5.6174e-05,0.18151,0.18218,1,1
4,GO CALCIUM ION REGULATED EXOCYTOSIS,0.00087311,0.18149,0.27856,1,1
4,GO POLYOL BIOSYNTHETIC PROCESS,0.00027832,0.18111,0.22319,1,1
4,GO RESPONSE TO LIPID,0.0017641,0.18072,0.13667,1,1
4,GO ENDOCRINE PANCREAS DEVELOPMENT,0.0036303,0.17996,0.18947,1,1
4,GO RESPONSE TO CHEMOKINE,0.00040247,0.17992,0.15619,1,1
4,GO POSITIVE REGULATION OF PROTEIN BINDING,0.0056288,0.17979,0.15963,1,1
4,GO LIPID CATABOLIC PROCESS,3.0689e-05,0.17976,0.22057,1,1
4,GO CHEMICAL HOMEOSTASIS,4.8379e-05,0.17955,0.16693,1,1
4,GO TRANSITION METAL ION HOMEOSTASIS,0.0073363,0.17947,0.14551,1,1
4,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.041967,0.17939,0.18135,1,1
4,GO MECHANORECEPTOR DIFFERENTIATION,0.00087311,0.17938,0.17232,1,1
4,GO TRIGLYCERIDE METABOLIC PROCESS,0.0016129,0.17866,0.16172,1,1
4,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.00019079,0.1786,0.19514,1,1
4,GO PROTEIN DESTABILIZATION,0.00034072,0.17843,0.17308,1,1
4,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.0038387,0.17829,0.2436,1,1
4,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.041093,0.17809,0.13412,1,1
4,GO ORGANELLE INHERITANCE,0.0030654,0.17796,0.146,1,1
4,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.00047456,0.17788,0.15531,1,1
4,GO MYELOID CELL DIFFERENTIATION,0.00041602,0.17776,0.14455,1,1
4,GO MANGANESE ION TRANSPORT,0.0040578,0.17775,0.17988,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0031536,0.17742,0.14841,1,1
4,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0099891,0.17736,0.19481,1,1
4,GO RESPONSE TO STEROID HORMONE,0.0031536,0.17733,0.14137,1,1
4,GO REGULATION OF SODIUM ION TRANSPORT,0.0099891,0.17722,0.15489,1,1
4,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,3.8583e-05,0.1772,0.15986,1,1
4,GO GLOMERULUS DEVELOPMENT,0.0057817,0.17713,0.18073,1,1
4,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00019079,0.17712,0.16738,1,1
4,GO MONOSACCHARIDE METABOLIC PROCESS,4.3218e-05,0.17709,0.2356,1,1
4,GO ORGANIC ANION TRANSPORT,1.9263e-05,0.17705,0.19793,1,1
4,GO INTERFERON GAMMA PRODUCTION,0.0051916,0.17698,0.13927,1,1
4,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,8.1192e-05,0.17687,0.15729,1,1
4,GO REGULATION OF LEUKOCYTE MIGRATION,0.001191,0.17687,0.15558,1,1
4,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0075304,0.17668,0.26872,1,1
4,GO NEUTRAL LIPID METABOLIC PROCESS,0.001191,0.17647,0.16741,1,1
4,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.00098941,0.1759,0.12912,1,1
4,GO NEGATIVE REGULATION OF CELL ADHESION,0.0036303,0.17574,0.15296,1,1
4,GO EXECUTION PHASE OF APOPTOSIS,3.1904e-06,0.17553,0.20256,1,1
4,GO SPLEEN DEVELOPMENT,0.0049174,0.17525,0.17676,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0081404,0.17523,0.17215,1,1
4,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.00017796,0.17522,0.15392,1,1
4,GO FATTY ACID TRANSPORT,0.00011241,0.17513,0.21913,1,1
4,GO PLATELET MORPHOGENESIS,0.011326,0.17486,0.16778,1,1
4,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.00019079,0.17477,0.18368,1,1
4,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.00052342,0.17468,0.15887,1,1
4,GO NEGATIVE REGULATION OF OSSIFICATION,0.015203,0.1746,0.13731,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00021167,0.1744,0.18697,1,1
4,GO RESPONSE TO PROSTAGLANDIN,0.046579,0.17408,0.17283,1,1
4,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.0062634,0.17389,0.1673,1,1
4,GO METAL ION HOMEOSTASIS,0.00036427,0.17349,0.13935,1,1
4,GO REGULATION OF ANION TRANSPORT,0.00045924,0.17344,0.22462,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.030383,0.17331,0.15711,1,1
4,GO ANION TRANSMEMBRANE TRANSPORT,0.0001547,0.17297,0.1685,1,1
4,GO RESPONSE TO MONOSACCHARIDE,0.00067758,0.17273,0.15077,1,1
4,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0028957,0.17236,0.17553,1,1
4,GO IMMUNE SYSTEM DEVELOPMENT,0.00016595,0.17198,0.13618,1,1
4,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.0056288,0.17189,0.24792,1,1
4,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.052669,0.17177,0.16694,1,1
4,GO RESPONSE TO ETHER,0.0030654,0.17168,0.17725,1,1
4,GO ACTIVATED T CELL PROLIFERATION,0.0023671,0.17164,0.18333,1,1
4,GO OOCYTE DIFFERENTIATION,0.00063551,0.1715,0.16157,1,1
4,GO SENSORY PERCEPTION OF SMELL,0.00012964,0.17099,0.16362,1,1
4,GO T CELL HOMEOSTASIS,0.0036303,0.17089,0.14953,1,1
4,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.026586,0.17087,0.16879,1,1
4,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.01282,0.17083,0.13359,1,1
4,GO DETECTION OF STIMULUS,7.013e-05,0.17072,0.13871,1,1
4,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.04854,0.17046,0.18725,1,1
4,GO REGULATION OF SECRETION,7.2754e-05,0.17039,0.16527,1,1
4,GO REGULATION OF BONE DEVELOPMENT,0.025994,0.17017,0.12796,1,1
4,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.0047853,0.16955,0.12166,1,1
4,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0073363,0.16952,0.14784,1,1
4,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.0073363,0.16944,0.24566,1,1
4,GO CELLULAR PIGMENTATION,0.001662,0.16927,0.16752,1,1
4,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.033894,0.16925,0.13648,1,1
4,GO MONOCARBOXYLIC ACID TRANSPORT,7.8282e-05,0.16914,0.22127,1,1
4,GO RESPONSE TO FUNGUS,0.00035231,0.16914,0.16824,1,1
4,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.00087311,0.16913,0.18577,1,1
4,GO GLYCEROLIPID METABOLIC PROCESS,2.4346e-05,0.16865,0.16967,1,1
4,GO RESPONSE TO CARBOHYDRATE,0.0014299,0.16858,0.14295,1,1
4,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00032948,0.16835,0.14251,1,1
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.0022332,0.16804,0.17417,1,1
4,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.00081984,0.16743,0.23594,1,1
4,GO REGULATION OF LYMPHOCYTE MIGRATION,0.011326,0.16725,0.15329,1,1
4,GO MONONUCLEAR CELL MIGRATION,0.010506,0.16722,0.13184,1,1
4,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,2.4346e-05,0.16716,0.18801,1,1
4,GO INORGANIC ANION TRANSPORT,0.00016595,0.16693,0.15229,1,1
4,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0059384,0.16693,0.13752,1,1
4,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.001872,0.16666,0.16397,1,1
4,GO RESPONSE TO OXIDATIVE STRESS,0.00074557,0.16658,0.14345,1,1
4,GO REGULATION OF PROTEOLYSIS,0.00045924,0.16654,0.15361,1,1
4,GO ANION TRANSPORT,2.7343e-05,0.16632,0.18053,1,1
4,GO BIOLOGICAL ADHESION,0.011326,0.16627,0.11225,1,1
4,GO PROTEOLYSIS,0.00012964,0.16613,0.14203,1,1
4,GO AGING,0.00072223,0.16607,0.13025,1,1
4,GO REGULATION OF RESPONSE TO STRESS,0.00047456,0.166,0.13031,1,1
4,GO PEROXISOME ORGANIZATION,0.0021062,0.16595,0.18033,1,1
4,GO HEPATOCYTE DIFFERENTIATION,0.015203,0.16589,0.21894,1,1
4,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.021165,0.16557,0.10723,1,1
4,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.018398,0.16554,0.14435,1,1
4,GO RESPONSE TO DRUG,0.0022992,0.16528,0.1457,1,1
4,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.0059384,0.16519,0.1656,1,1
4,GO FATTY ACID BETA OXIDATION,0.0049174,0.16475,0.18015,1,1
4,GO CIRCULATORY SYSTEM PROCESS,0.00057693,0.16462,0.13518,1,1
4,GO REGULATION OF LIPID CATABOLIC PROCESS,0.0011199,0.16439,0.15122,1,1
4,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.0013872,0.16412,0.14421,1,1
4,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.017969,0.16403,0.13882,1,1
4,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.016339,0.16373,0.13518,1,1
4,GO ION HOMEOSTASIS,0.00027832,0.16357,0.14329,1,1
4,GO NEGATIVE REGULATION OF TOR SIGNALING,0.0079323,0.16357,0.11845,1,1
4,GO ORGANELLE DISASSEMBLY,0.00014935,0.1634,0.16815,1,1
4,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00074557,0.16291,0.17709,1,1
4,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.00098941,0.16257,0.13383,1,1
4,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.012203,0.16251,0.15827,1,1
4,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0087944,0.16244,0.12027,1,1
4,GO ENDOCRINE HORMONE SECRETION,0.001662,0.16243,0.15881,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0028957,0.16241,0.12757,1,1
4,GO PROTEIN K48 LINKED UBIQUITINATION,0.00087311,0.16228,0.1319,1,1
4,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.033894,0.16169,0.1344,1,1
4,GO REGULATION OF GLUCOSE IMPORT,0.0019282,0.16163,0.16874,1,1
4,GO CELLULAR RESPONSE TO LIPID,0.0046564,0.16152,0.12294,1,1
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0007696,0.16143,0.1752,1,1
4,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0071468,0.16089,0.17689,1,1
4,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.00047456,0.16057,0.17416,1,1
4,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.00098941,0.16009,0.13218,1,1
4,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.012203,0.1598,0.203,1,1
4,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.00036427,0.15968,0.18488,1,1
4,GO NEGATIVE REGULATION OF MAPK CASCADE,0.01282,0.15963,0.13141,1,1
4,GO EPITHELIAL CELL PROLIFERATION,0.0075304,0.15958,0.1206,1,1
4,GO MULTIVESICULAR BODY ORGANIZATION,0.0025083,0.15957,0.1394,1,1
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.010245,0.15935,0.22533,1,1
4,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.0028957,0.15931,0.12724,1,1
4,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.00034072,0.15916,0.1691,1,1
4,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.00098941,0.15914,0.13549,1,1
4,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,4.1617e-05,0.15911,0.17371,1,1
4,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.0016129,0.15898,0.18467,1,1
4,GO TRANSLESION SYNTHESIS,0.0037331,0.15881,0.12379,1,1
4,GO RUFFLE ORGANIZATION,0.0022992,0.15837,0.17999,1,1
4,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.030383,0.15792,0.13009,1,1
4,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.038561,0.15789,0.19461,1,1
4,GO PEROXISOMAL TRANSPORT,0.0021689,0.1578,0.18827,1,1
4,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.027803,0.15779,0.1235,1,1
4,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.011326,0.15748,0.16793,1,1
4,GO REGULATION OF PEPTIDE TRANSPORT,1.2454e-05,0.15728,0.15572,1,1
4,GO RRNA CATABOLIC PROCESS,0.0066042,0.1569,0.17175,1,1
4,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.033894,0.1565,0.20335,1,1
4,GO BIOMINERALIZATION,0.0050528,0.15626,0.13833,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.0064317,0.15607,0.12711,1,1
4,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.00034072,0.15591,0.1335,1,1
4,GO INTERMEDIATE FILAMENT BASED PROCESS,0.022165,0.15589,0.14861,1,1
4,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0050528,0.15571,0.11877,1,1
4,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.00011241,0.15567,0.21073,1,1
4,GO RESPONSE TO ACID CHEMICAL,0.0013054,0.15556,0.13198,1,1
4,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.0033369,0.15555,0.18605,1,1
4,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.015574,0.15551,0.12864,1,1
4,GO LYSOSOME LOCALIZATION,0.00057693,0.1555,0.16348,1,1
4,GO REGULATION OF CELL MATRIX ADHESION,0.0079323,0.15536,0.17033,1,1
4,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.0029794,0.15522,0.15349,1,1
4,GO REGULATION OF BLOOD CIRCULATION,0.0090226,0.15503,0.11856,1,1
4,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.022165,0.15459,0.1312,1,1
4,GO MULTIVESICULAR BODY SORTING PATHWAY,0.0015189,0.15452,0.15531,1,1
4,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00017186,0.1544,0.17394,1,1
4,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0021062,0.15419,0.11602,1,1
4,GO RESPONSE TO HYDROGEN PEROXIDE,0.00067758,0.15403,0.159,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.001662,0.15368,0.14149,1,1
4,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.031059,0.15358,0.16064,1,1
4,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.00030804,0.15324,0.16604,1,1
4,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.0010859,0.15295,0.13813,1,1
4,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.00012512,0.15287,0.16437,1,1
4,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.012508,0.15252,0.14565,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.014486,0.15249,0.13522,1,1
4,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.0027346,0.15248,0.20895,1,1
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,7.8282e-05,0.15195,0.19485,1,1
4,GO SENSORY PERCEPTION OF BITTER TASTE,0.001662,0.15177,0.13779,1,1
4,GO REGULATION OF DEACETYLASE ACTIVITY,0.040234,0.15173,0.1496,1,1
4,GO REGULATION OF MAP KINASE ACTIVITY,0.0011199,0.15156,0.1475,1,1
4,GO GLAND DEVELOPMENT,0.001228,0.15138,0.12976,1,1
4,GO MYELOID CELL DEVELOPMENT,0.0046564,0.15135,0.1259,1,1
4,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0020453,0.15123,0.1505,1,1
4,GO CALCIUM ION IMPORT,0.0094949,0.15116,0.12242,1,1
4,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.027188,0.1511,0.1437,1,1
4,GO HOMEOSTATIC PROCESS,5.6174e-05,0.15108,0.13752,1,1
4,GO SIGNAL RELEASE,0.00055855,0.15085,0.14969,1,1
4,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.041093,0.15082,0.26953,1,1
4,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.0037331,0.15068,0.13823,1,1
4,GO CARDIAC CELL DEVELOPMENT,0.013465,0.15054,0.11914,1,1
4,GO NCRNA CATABOLIC PROCESS,0.015574,0.1505,0.12696,1,1
4,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.027188,0.15047,0.13135,1,1
4,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0010206,0.15039,0.16637,1,1
4,GO SODIUM ION TRANSPORT,0.0015189,0.15033,0.14993,1,1
4,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,2.9532e-05,0.15032,0.17114,1,1
4,GO ORGANIC ACID CATABOLIC PROCESS,0.0030654,0.15028,0.17705,1,1
4,GO ZINC ION TRANSPORT,0.019283,0.15,0.16104,1,1
4,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.040234,0.14991,0.088987,1,1
4,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.0015189,0.14964,0.12721,1,1
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.02166,0.14955,0.13525,1,1
4,GO ENDOSOME ORGANIZATION,0.0010859,0.14931,0.16385,1,1
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.00098941,0.14924,0.1416,1,1
4,GO ACROSOME REACTION,0.02068,0.14917,0.18018,1,1
4,GO RESPONSE TO ALKALOID,0.0081404,0.14861,0.13472,1,1
4,GO CELL MOTILITY,0.014486,0.1486,0.095819,1,1
4,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.001986,0.14831,0.11549,1,1
4,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0018173,0.14815,0.11821,1,1
4,GO REGULATION OF CELL POPULATION PROLIFERATION,0.0022332,0.1481,0.11734,1,1
4,GO RESPONSE TO ANTIBIOTIC,0.0046564,0.14808,0.15306,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.0017641,0.14803,0.16847,1,1
4,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0047853,0.14802,0.1146,1,1
4,GO REGULATION OF MEIOTIC CELL CYCLE,0.0097392,0.14791,0.10796,1,1
4,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.02268,0.14777,0.10983,1,1
4,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.011326,0.14763,0.10271,1,1
4,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.0017123,0.14747,0.12176,1,1
4,GO POSITIVE REGULATION OF GLIOGENESIS,0.023205,0.14696,0.11916,1,1
4,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0073363,0.14657,0.11211,1,1
4,GO RESPONSE TO HORMONE,0.00084609,0.14653,0.13942,1,1
4,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.0011549,0.14623,0.17739,1,1
4,GO PROTEIN MANNOSYLATION,0.012203,0.1462,0.16025,1,1
4,GO REGULATION OF ION TRANSPORT,0.0049174,0.14615,0.11345,1,1
4,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.0013054,0.14599,0.12646,1,1
4,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.012508,0.14566,0.077985,1,1
4,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.00090094,0.14559,0.12816,1,1
4,GO AUTOPHAGY OF MITOCHONDRION,0.0014299,0.14545,0.16352,1,1
4,GO GLUCOSE IMPORT,0.0046564,0.14521,0.16207,1,1
4,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.001191,0.145,0.18409,1,1
4,GO ORGANIC ACID TRANSPORT,8.4205e-05,0.14499,0.19492,1,1
4,GO CELLULAR RESPONSE TO PEPTIDE,0.0010206,0.14489,0.12635,1,1
4,GO MEMBRANE ORGANIZATION,0.0028957,0.14444,0.10388,1,1
4,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.049546,0.14435,0.13914,1,1
4,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.011904,0.14413,0.36147,1,1
4,GO REGULATION OF PROTEIN BINDING,0.0050528,0.1438,0.12555,1,1
4,GO POLYOL CATABOLIC PROCESS,0.0050528,0.14372,0.14923,1,1
4,GO CELL MATURATION,0.00038934,0.14327,0.14324,1,1
4,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00095906,0.14306,0.15968,1,1
4,GO ORGANIC ACID METABOLIC PROCESS,0.00092958,0.14263,0.1652,1,1
4,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0053338,0.14239,0.11726,1,1
4,GO RESPONSE TO ISCHEMIA,0.0029794,0.14219,0.19935,1,1
4,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.00044439,0.14183,0.15848,1,1
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0097392,0.14179,0.18579,1,1
4,GO RESPONSE TO PEPTIDE HORMONE,0.00052342,0.14169,0.134,1,1
4,GO ACTIVATION OF MAPK ACTIVITY,0.0011549,0.14155,0.12857,1,1
4,GO POSITIVE REGULATION OF CELL AGING,0.050569,0.14145,0.16262,1,1
4,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0051916,0.14132,0.1368,1,1
4,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00023468,0.14125,0.13609,1,1
4,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.00029782,0.14119,0.18242,1,1
4,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.045624,0.1411,0.074441,1,1
4,GO REGULATION OF MAPK CASCADE,0.0060989,0.14108,0.11356,1,1
4,GO REGULATION OF TOR SIGNALING,4.6597e-05,0.141,0.14146,1,1
4,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.00090094,0.14078,0.20088,1,1
4,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0010206,0.14075,0.12733,1,1
4,GO RETINA HOMEOSTASIS,0.02166,0.14015,0.07609,1,1
4,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.049546,0.13974,0.15827,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00054072,0.13962,0.12852,1,1
4,GO CELLULAR ION HOMEOSTASIS,0.0010859,0.13958,0.12403,1,1
4,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0011199,0.13952,0.118,1,1
4,GO RESPONSE TO ETHANOL,0.015203,0.13943,0.11012,1,1
4,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0036303,0.13934,0.11473,1,1
4,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.045624,0.13919,0.10344,1,1
4,GO TISSUE MIGRATION,0.0051916,0.13913,0.14639,1,1
4,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0015653,0.13887,0.15455,1,1
4,GO RESPONSE TO TOXIC SUBSTANCE,0.0057817,0.13886,0.1686,1,1
4,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.0015653,0.13879,0.12562,1,1
4,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.00016023,0.13835,0.16499,1,1
4,GO TRANSMEMBRANE TRANSPORT,0.00014418,0.13819,0.14607,1,1
4,GO REGULATION OF CHEMOTAXIS,0.0056288,0.13767,0.11095,1,1
4,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.012203,0.13767,0.1072,1,1
4,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00098941,0.13766,0.13584,1,1
4,GO MAMMARY GLAND DEVELOPMENT,0.012203,0.13759,0.116,1,1
4,GO FEEDING BEHAVIOR,0.019283,0.13754,0.11937,1,1
4,GO PROTEIN AUTOUBIQUITINATION,0.00014418,0.13753,0.12872,1,1
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.022165,0.13684,0.22154,1,1
4,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0020453,0.13658,0.13859,1,1
4,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.016734,0.13627,0.1037,1,1
4,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.00018427,0.13624,0.14761,1,1
4,GO ENDOCYTOSIS,0.044685,0.13586,0.080089,1,1
4,GO RESPONSE TO NITROGEN COMPOUND,0.0006154,0.13562,0.11485,1,1
4,GO ION TRANSPORT,0.00017796,0.13539,0.14793,1,1
4,GO EXOCYTIC PROCESS,0.0085714,0.13513,0.16195,1,1
4,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.014486,0.13422,0.14971,1,1
4,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.001662,0.13415,0.15018,1,1
4,GO ALCOHOL CATABOLIC PROCESS,0.011612,0.13404,0.14548,1,1
4,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.023741,0.13399,0.089883,1,1
4,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.045624,0.13394,0.10398,1,1
4,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.023741,0.13372,0.15911,1,1
4,GO REGULATION OF HYDROLASE ACTIVITY,0.0027346,0.1336,0.10804,1,1
4,GO LIPID MODIFICATION,0.00065623,0.13355,0.15319,1,1
4,GO EXCRETION,0.0090226,0.13355,0.13096,1,1
4,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.02268,0.13343,0.12479,1,1
4,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.0064317,0.13332,0.10869,1,1
4,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.0034322,0.13197,0.11975,1,1
4,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.050569,0.13174,0.11412,1,1
4,GO RESPONSE TO ESTRADIOL,0.052669,0.13157,0.073558,1,1
4,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.0071468,0.13131,0.11434,1,1
4,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.0018173,0.13121,0.10968,1,1
4,GO ERYTHROCYTE HOMEOSTASIS,0.0014738,0.13104,0.13329,1,1
4,GO SECOND MESSENGER MEDIATED SIGNALING,0.00074557,0.13079,0.12514,1,1
4,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.009256,0.13064,0.15908,1,1
4,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.0029794,0.13062,0.11694,1,1
4,GO RESPONSE TO OXYGEN LEVELS,0.0031536,0.13023,0.12284,1,1
4,GO IMPORT ACROSS PLASMA MEMBRANE,0.011612,0.13017,0.13795,1,1
4,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.0014299,0.13014,0.14924,1,1
4,GO T CELL SELECTION,0.001662,0.13011,0.13446,1,1
4,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0062634,0.13004,0.13106,1,1
4,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.015203,0.12975,0.1582,1,1
4,GO NEPHRON DEVELOPMENT,0.030383,0.12958,0.092296,1,1
4,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0059384,0.12957,0.13673,1,1
4,GO POSITIVE REGULATION OF MAPK CASCADE,0.0039469,0.12942,0.11991,1,1
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.019283,0.12917,0.10106,1,1
4,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.018836,0.12908,0.090674,1,1
4,GO SOMITOGENESIS,0.0033369,0.12902,0.11899,1,1
4,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.012203,0.12883,0.097762,1,1
4,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.03245,0.12878,0.13428,1,1
4,GO RESPONSE TO PEPTIDE,0.00095906,0.12876,0.12127,1,1
4,GO TRANSITION METAL ION TRANSPORT,0.00018427,0.12873,0.20866,1,1
4,GO REGULATION OF TRANSPORT,0.001228,0.12863,0.10351,1,1
4,GO RESPONSE TO ACTIVITY,0.0050528,0.12851,0.15561,1,1
4,GO ION TRANSMEMBRANE TRANSPORT,0.0011199,0.1285,0.12545,1,1
4,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.00069957,0.12839,0.15977,1,1
4,GO ESTROGEN METABOLIC PROCESS,0.045624,0.12837,0.16554,1,1
4,GO METAL ION TRANSPORT,0.0024367,0.12836,0.11686,1,1
4,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.0050528,0.12836,0.15598,1,1
4,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.017969,0.12827,0.11286,1,1
4,GO ENERGY RESERVE METABOLIC PROCESS,0.0057817,0.12816,0.14797,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION,0.00054072,0.12745,0.11098,1,1
4,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.0099891,0.12725,0.15469,1,1
4,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0075304,0.12725,0.16769,1,1
4,GO CALCIUM MEDIATED SIGNALING,0.00067758,0.12719,0.10153,1,1
4,GO DRUG CATABOLIC PROCESS,0.02843,0.127,0.20738,1,1
4,GO REGULATION OF CELL DEATH,0.0013872,0.12694,0.10994,1,1
4,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.017137,0.12688,0.13586,1,1
4,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.012203,0.12678,0.17486,1,1
4,GO GOLGI ORGANIZATION,0.00018427,0.12648,0.16125,1,1
4,GO SINGLE FERTILIZATION,0.0083534,0.12646,0.094825,1,1
4,GO HOMEOSTASIS OF NUMBER OF CELLS,0.0049174,0.12641,0.10353,1,1
4,GO POSITIVE REGULATION OF SIGNALING,0.00029782,0.12628,0.12366,1,1
4,GO POLYOL METABOLIC PROCESS,0.0025817,0.12612,0.13641,1,1
4,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0064317,0.126,0.13128,1,1
4,GO REGULATION OF ATP METABOLIC PROCESS,0.012203,0.12599,0.10701,1,1
4,GO UROGENITAL SYSTEM DEVELOPMENT,0.03939,0.12597,0.081892,1,1
4,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.0025817,0.12596,0.10325,1,1
4,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.0051916,0.12552,0.11694,1,1
4,GO THYMIC T CELL SELECTION,0.05161,0.12519,0.075973,1,1
4,GO TOR SIGNALING,1.349e-05,0.12502,0.12472,1,1
4,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.0028957,0.12491,0.11274,1,1
4,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.024846,0.12464,0.10816,1,1
4,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.026586,0.12459,0.10972,1,1
4,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.017549,0.12395,0.10335,1,1
4,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0020453,0.12391,0.10467,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.023741,0.12388,0.16086,1,1
4,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.0097392,0.12341,0.12799,1,1
4,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.024288,0.12285,0.088271,1,1
4,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0054795,0.12226,0.12197,1,1
4,GO RESPONSE TO ENDOGENOUS STIMULUS,0.0013872,0.12195,0.11338,1,1
4,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.00084609,0.12185,0.11681,1,1
4,GO CELLULAR GLUCOSE HOMEOSTASIS,0.0015653,0.12145,0.13928,1,1
4,GO SMALL MOLECULE CATABOLIC PROCESS,0.00090094,0.12096,0.1779,1,1
4,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.00095906,0.12069,0.11158,1,1
4,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.033166,0.11995,0.07992,1,1
4,GO PEPTIDYL TYROSINE MODIFICATION,0.01282,0.11954,0.10757,1,1
4,GO MESONEPHROS DEVELOPMENT,0.023741,0.11934,0.10811,1,1
4,GO POSITIVE REGULATION OF CELL DEATH,0.0081404,0.11934,0.099329,1,1
4,GO ACTIVATION OF GTPASE ACTIVITY,0.0054795,0.11927,0.099949,1,1
4,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.011047,0.11859,0.12227,1,1
4,GO OOGENESIS,0.043763,0.11829,0.076635,1,1
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.00012512,0.11756,0.13384,1,1
4,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0028141,0.1171,0.10186,1,1
4,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0051916,0.11709,0.13999,1,1
4,GO NEGATIVE REGULATION OF SECRETION,0.0073363,0.11689,0.10029,1,1
4,GO FAT CELL DIFFERENTIATION,0.0049174,0.11682,0.13891,1,1
4,GO HORMONE MEDIATED SIGNALING PATHWAY,0.0073363,0.11678,0.092905,1,1
4,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0060989,0.11669,0.10921,1,1
4,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.0014299,0.11647,0.12311,1,1
4,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0050528,0.11614,0.12265,1,1
4,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.0020453,0.11591,0.11772,1,1
4,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0022992,0.11581,0.1319,1,1
4,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.031748,0.11556,0.16145,1,1
4,GO LYMPH NODE DEVELOPMENT,0.019739,0.11534,0.16031,1,1
4,GO VIRAL BUDDING,0.0073363,0.11466,0.14008,1,1
4,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.033894,0.11429,0.075888,1,1
4,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.00018427,0.11425,0.13908,1,1
4,GO ANATOMICAL STRUCTURE MATURATION,0.0081404,0.11408,0.095618,1,1
4,GO APOPTOTIC PROCESS,0.00098941,0.11407,0.11337,1,1
4,GO DNA CATABOLIC PROCESS,0.0010859,0.11396,0.12276,1,1
4,GO CATION TRANSPORT,0.0018173,0.11393,0.12239,1,1
4,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.0060989,0.11383,0.17934,1,1
4,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.049546,0.11373,0.078177,1,1
4,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.031748,0.11371,0.091483,1,1
4,GO REGULATION OF REPRODUCTIVE PROCESS,0.0066042,0.11341,0.10107,1,1
4,GO INTRA S DNA DAMAGE CHECKPOINT,0.030383,0.1133,0.090855,1,1
4,GO CATION TRANSMEMBRANE TRANSPORT,0.0075304,0.11326,0.10481,1,1
4,GO RESPONSE TO ABIOTIC STIMULUS,0.0028957,0.11296,0.097182,1,1
4,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.035393,0.11268,0.12838,1,1
4,GO POSITIVE REGULATION OF CYTOKINESIS,0.031059,0.11236,0.09876,1,1
4,GO NEGATIVE REGULATION OF CELL DEATH,0.0034322,0.11234,0.10583,1,1
4,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0025817,0.1121,0.10091,1,1
4,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.014138,0.11186,0.10184,1,1
4,GO ALPHA AMINO ACID METABOLIC PROCESS,0.03245,0.11169,0.14992,1,1
4,GO KIDNEY EPITHELIUM DEVELOPMENT,0.033894,0.11142,0.096887,1,1
4,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0081404,0.11117,0.096041,1,1
4,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.007729,0.10983,0.093005,1,1
4,GO POSITIVE REGULATION OF TRANSPORT,0.0013872,0.10978,0.11056,1,1
4,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.013465,0.10952,0.15356,1,1
4,GO T CELL LINEAGE COMMITMENT,0.0045306,0.10749,0.15195,1,1
4,GO REGULATION OF DNA CATABOLIC PROCESS,0.019739,0.10748,0.11539,1,1
4,GO CELLULAR HOMEOSTASIS,0.0013457,0.10737,0.11462,1,1
4,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.029068,0.10723,0.080471,1,1
4,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.00012512,0.10672,0.13638,1,1
4,GO BODY FLUID SECRETION,0.018836,0.10641,0.093733,1,1
4,GO DIVALENT INORGANIC CATION TRANSPORT,0.013139,0.10609,0.09621,1,1
4,GO CARBOHYDRATE CATABOLIC PROCESS,0.01282,0.10525,0.13106,1,1
4,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.02068,0.105,0.07846,1,1
4,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.00025131,0.10491,0.15378,1,1
4,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.0054795,0.10449,0.091499,1,1
4,GO LEUKOCYTE TETHERING OR ROLLING,0.045624,0.10447,0.07899,1,1
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.018398,0.10425,0.082554,1,1
4,GO MEGAKARYOCYTE DIFFERENTIATION,0.011326,0.10391,0.10017,1,1
4,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.0010859,0.10374,0.11856,1,1
4,GO MULTI ORGANISM PROCESS,0.026586,0.10252,0.067993,1,1
4,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.043763,0.10223,0.065161,1,1
4,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.004408,0.10176,0.10161,1,1
4,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.014486,0.1013,0.084424,1,1
4,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.02166,0.10115,0.095596,1,1
4,GO PROTEIN K11 LINKED UBIQUITINATION,0.03245,0.10039,0.12949,1,1
4,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.049546,0.10027,0.11035,1,1
4,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.0071468,0.09916,0.10434,1,1
4,GO POSITIVE REGULATION OF NEURON DEATH,0.016339,0.099057,0.1158,1,1
4,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.018836,0.09896,0.089565,1,1
4,GO JNK CASCADE,0.0075304,0.098803,0.10945,1,1
4,GO POSITIVE T CELL SELECTION,0.012203,0.097813,0.10902,1,1
4,GO REGULATION OF PROTEIN STABILITY,0.0036303,0.097367,0.10347,1,1
4,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.050569,0.09721,0.1312,1,1
4,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.009256,0.097043,0.11938,1,1
4,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.014486,0.097021,0.083444,1,1
4,GO FERTILIZATION,0.012203,0.096811,0.081027,1,1
4,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0067808,0.09659,0.094272,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.019739,0.096461,0.091748,1,1
4,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.014486,0.094521,0.12501,1,1
4,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.013465,0.094026,0.091287,1,1
4,GO REGULATION OF PHOSPHORYLATION,0.0036303,0.093668,0.09398,1,1
4,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.03245,0.092942,0.072541,1,1
4,GO BONE MINERALIZATION,0.036164,0.092232,0.104,1,1
4,GO CYTOSOLIC TRANSPORT,0.0059384,0.091387,0.093335,1,1
4,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0087944,0.091238,0.083,1,1
4,GO REPRODUCTION,0.014486,0.091163,0.076131,1,1
4,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.013465,0.090848,0.096384,1,1
4,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.009256,0.090784,0.097367,1,1
4,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.013465,0.090584,0.12861,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0038387,0.089947,0.11037,1,1
4,GO REGULATION OF AUTOPHAGY,0.00063551,0.08954,0.12164,1,1
4,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.012508,0.089413,0.07812,1,1
4,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.01282,0.088373,0.082007,1,1
4,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.0017123,0.088291,0.096355,1,1
4,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.021165,0.088254,0.073995,1,1
4,GO REGULATION OF OSSIFICATION,0.024288,0.088222,0.097624,1,1
4,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.022165,0.087474,0.072842,1,1
4,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.0057817,0.08744,0.15075,1,1
4,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.0054795,0.087366,0.085868,1,1
4,GO COBALAMIN METABOLIC PROCESS,0.050569,0.087316,0.20758,1,1
4,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.042857,0.087265,0.077405,1,1
4,GO REGULATION OF EXOCYTOSIS,0.011326,0.086981,0.12042,1,1
4,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.041967,0.086767,0.058141,1,1
4,GO SENSORY PERCEPTION,0.01282,0.086766,0.073341,1,1
4,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.0097392,0.086719,0.10177,1,1
4,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.0054795,0.086554,0.092326,1,1
4,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.011612,0.085515,0.10152,1,1
4,GO BLASTOCYST DEVELOPMENT,0.0059384,0.085403,0.094573,1,1
4,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.01282,0.08523,0.072842,1,1
4,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0066042,0.085158,0.10615,1,1
4,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.009256,0.084985,0.088634,1,1
4,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.019283,0.084624,0.078478,1,1
4,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.015574,0.084275,0.080821,1,1
4,GO MALE SEX DIFFERENTIATION,0.025414,0.083363,0.09639,1,1
4,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.025994,0.083273,0.1489,1,1
4,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.031748,0.08318,0.091249,1,1
4,GO TUBE DEVELOPMENT,0.045624,0.082063,0.072007,1,1
4,GO NEGATIVE REGULATION OF TRANSPORT,0.030383,0.079597,0.076876,1,1
4,GO REGULATION OF TRANSFERASE ACTIVITY,0.011612,0.079462,0.07978,1,1
4,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.0025817,0.078131,0.096229,1,1
4,GO VESICLE LOCALIZATION,0.024846,0.077178,0.090455,1,1
4,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.024846,0.076268,0.13779,1,1
4,GO DNA MODIFICATION,0.041967,0.075823,0.054613,1,1
4,GO MITOCHONDRIAL TRANSPORT,0.0057817,0.075283,0.083422,1,1
4,GO REGULATION OF CELLULAR LOCALIZATION,0.049546,0.075227,0.050553,1,1
4,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.0062634,0.073097,0.089844,1,1
4,GO NEURON DEATH,0.041967,0.072877,0.057891,1,1
4,GO RESPONSE TO TEMPERATURE STIMULUS,0.0030654,0.072863,0.11058,1,1
4,GO RHYTHMIC PROCESS,0.031059,0.071908,0.065535,1,1
4,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.014486,0.071852,0.064571,1,1
4,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.037747,0.071651,0.078548,1,1
4,GO MULTICELLULAR ORGANISM REPRODUCTION,0.046579,0.071169,0.056288,1,1
4,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.0097392,0.070833,0.086487,1,1
4,GO INTRACELLULAR TRANSPORT,0.0045306,0.069899,0.068765,1,1
4,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.020205,0.0685,0.07448,1,1
4,GO POSITIVE REGULATION OF CELL CYCLE,0.049546,0.065903,0.052451,1,1
4,GO REGULATION OF BINDING,0.042857,0.063386,0.071169,1,1
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.0028141,0.062937,0.068006,1,1
4,GO CELLULAR MACROMOLECULE LOCALIZATION,0.022165,0.062551,0.053457,1,1
4,GO SEXUAL REPRODUCTION,0.033894,0.061944,0.058399,1,1
4,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.033166,0.058467,0.070369,1,1
4,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.031059,0.056636,0.048113,1,1
4,GO REGULATION OF GTPASE ACTIVITY,0.036164,0.056291,0.07071,1,1
4,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.036164,0.052483,0.070694,1,1
4,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.0064317,0.051948,0.083208,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.049546,0.050642,0.052383,1,1
4,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.031748,0.05034,0.050652,1,1
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.010773,0.049143,0.056701,1,1
4,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.037747,0.036413,0.07211,1,1
4,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0011199,0.82556,0.65147,1,0
4,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,3.3132e-05,0.78029,0.80443,1,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0020453,0.66173,0.54088,1,0
4,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.00029782,0.64438,0.44544,1,0
4,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.0007696,0.6157,0.47998,1,0
4,GO RESPONSE TO INTERFERON BETA,0.0006154,0.60465,0.46084,1,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,5.0226e-05,0.5861,0.5079,1,0
4,GO RESPONSE TO INTERFERON ALPHA,0.0029794,0.58109,0.34946,1,0
4,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.00059588,0.5729,0.40039,1,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,7.013e-05,0.56985,0.51854,1,0
4,GO NEGATIVE REGULATION OF CELL KILLING,0.0031536,0.56804,0.45664,1,0
4,GO GLYCOLIPID CATABOLIC PROCESS,0.00014935,0.52577,0.50213,1,0
4,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.00014935,0.49291,0.41283,1,0
4,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.011047,0.49069,0.35235,1,0
4,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.00090094,0.47261,0.29828,1,0
4,GO DENDRITIC CELL APOPTOTIC PROCESS,9.0551e-05,0.4681,0.46903,1,0
4,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.025994,0.46512,0.2911,1,0
4,GO MEMBRANE RAFT ASSEMBLY,0.044685,0.45338,0.27791,1,0
4,GO GAP JUNCTION ASSEMBLY,0.0081404,0.43059,0.29959,1,0
4,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.0099891,0.41337,0.30295,1,0
4,GO T CELL EXTRAVASATION,0.0024367,0.41089,0.47233,1,0
4,GO ENTRY INTO HOST,0.00042998,0.40711,0.26508,1,0
4,GO MEMBRANE RAFT ORGANIZATION,0.0033369,0.38837,0.30999,1,0
4,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.00020448,0.38802,0.3455,1,0
4,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.00023468,0.38504,0.35074,1,0
4,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.00014418,0.38261,0.3088,1,0
4,GO BLOOD VESSEL REMODELING,0.00022676,0.37935,0.28591,1,0
4,GO RESPONSE TO HISTAMINE,0.0094949,0.37834,0.39127,1,0
4,GO NEGATIVE REGULATION OF COAGULATION,0.0033369,0.37812,0.31014,1,0
4,GO REGULATION OF MYOBLAST FUSION,4.8379e-05,0.36713,0.37717,1,0
4,GO NUCLEOSIDE CATABOLIC PROCESS,0.00054072,0.36267,0.25244,1,0
4,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.00028792,0.3606,0.35421,1,0
4,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.00044439,0.34975,0.32782,1,0
4,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.0032441,0.34599,0.32005,1,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.00012074,0.3454,0.29923,1,0
4,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.00074557,0.34257,0.25913,1,0
4,GO BASEMENT MEMBRANE ORGANIZATION,0.029719,0.33877,0.2073,1,0
4,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.00050664,0.33455,0.22938,1,0
4,GO ANTIGEN PROCESSING AND PRESENTATION,0.00012074,0.33393,0.28089,1,0
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0023671,0.3313,0.2158,1,0
4,GO KERATAN SULFATE CATABOLIC PROCESS,0.0013872,0.33014,0.31513,1,0
4,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00017796,0.32781,0.22772,1,0
4,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0013054,0.32659,0.2478,1,0
4,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00031859,0.32392,0.25422,1,0
4,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.00098941,0.32263,0.26248,1,0
4,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0017123,0.32198,0.23264,1,0
4,GO CYCLOOXYGENASE PATHWAY,0.0041716,0.32082,0.41753,1,0
4,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00020448,0.31691,0.24656,1,0
4,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.017969,0.31623,0.26915,1,0
4,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.037747,0.3154,0.14316,1,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.00021167,0.31437,0.23062,1,0
4,GO L ASCORBIC ACID METABOLIC PROCESS,0.0062634,0.31388,0.3412,1,0
4,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.0014738,0.31329,0.22402,1,0
4,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.0050528,0.31195,0.2668,1,0
4,GO IMMUNE RESPONSE TO TUMOR CELL,0.0039469,0.31075,0.32433,1,0
4,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,0.015574,0.31044,0.31558,1,0
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00063551,0.31002,0.29136,1,0
4,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.0039469,0.30974,0.27834,1,0
4,GO ENTRY OF BACTERIUM INTO HOST CELL,0.015203,0.30744,0.29857,1,0
4,GO ZYMOGEN INHIBITION,0.0013054,0.30662,0.25854,1,0
4,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0045306,0.30485,0.26331,1,0
4,GO REGULATION OF TRANSPOSITION,0.0090226,0.3021,0.273,1,0
4,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.023205,0.29748,0.15034,1,0
4,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00063551,0.29628,0.24215,1,0
4,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.00353,0.29401,0.21834,1,0
4,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00016023,0.29358,0.21075,1,0
4,GO ICOSANOID BIOSYNTHETIC PROCESS,0.00013917,0.28982,0.28131,1,0
4,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.0047853,0.28756,0.30356,1,0
4,GO POSITIVE REGULATION OF CELL SIZE,0.00047456,0.28451,0.29557,1,0
4,GO DETECTION OF BIOTIC STIMULUS,0.00034072,0.28159,0.30937,1,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.0011199,0.28099,0.29287,1,0
4,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.033894,0.28091,0.29575,1,0
4,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.0062634,0.28075,0.16059,1,0
4,GO DNA DEAMINATION,0.0047853,0.27893,0.32362,1,0
4,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.0090226,0.27892,0.19442,1,0
4,GO INTERACTION WITH HOST,0.00049035,0.27766,0.19896,1,0
4,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.015203,0.27567,0.32777,1,0
4,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00081984,0.26983,0.20611,1,0
4,GO NEGATIVE REGULATION OF WOUND HEALING,0.0032441,0.26719,0.24816,1,0
4,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.0064317,0.26602,0.18371,1,0
4,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00087311,0.26567,0.21947,1,0
4,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.011326,0.26399,0.20074,1,0
4,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.024288,0.26346,0.18249,1,0
4,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.022165,0.26339,0.20979,1,0
4,GO CYTOKINE METABOLIC PROCESS,0.0010859,0.26064,0.16756,1,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.016339,0.25959,0.17375,1,0
4,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.044685,0.25914,0.23118,1,0
4,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.00055855,0.25885,0.20048,1,0
4,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.007729,0.25736,0.14791,1,0
4,GO ETHER BIOSYNTHETIC PROCESS,0.033166,0.25261,0.13551,1,0
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0028957,0.25141,0.20757,1,0
4,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,5.0226e-05,0.25037,0.24007,1,0
4,GO PURINE CONTAINING COMPOUND SALVAGE,0.011904,0.25009,0.21583,1,0
4,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.013798,0.24869,0.14809,1,0
4,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.010773,0.24818,0.23367,1,0
4,GO TYPE 2 IMMUNE RESPONSE,0.011612,0.24761,0.18319,1,0
4,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,0.04854,0.24663,0.25141,1,0
4,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.0021062,0.246,0.2378,1,0
4,GO INTERFERON BETA PRODUCTION,0.0013457,0.24591,0.19123,1,0
4,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.01282,0.24297,0.15647,1,0
4,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.0019282,0.24289,0.21926,1,0
4,GO VIRAL LIFE CYCLE,0.00028792,0.24259,0.18658,1,0
4,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.013139,0.24028,0.14126,1,0
4,GO CELLULAR RESPONSE TO DSRNA,0.001228,0.24009,0.21195,1,0
4,GO MEMBRANE PROTEIN PROTEOLYSIS,0.0050528,0.24007,0.16626,1,0
4,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0011199,0.23657,0.27812,1,0
4,GO PROTEIN TARGETING TO LYSOSOME,0.0090226,0.23438,0.22767,1,0
4,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.019739,0.23433,0.15993,1,0
4,GO HYALURONAN METABOLIC PROCESS,0.0027346,0.23288,0.15745,1,0
4,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.0059384,0.23281,0.20952,1,0
4,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0040578,0.23116,0.17027,1,0
4,GO MACROPHAGE CYTOKINE PRODUCTION,0.015953,0.22969,0.17717,1,0
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.030383,0.22871,0.16913,1,0
4,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.0059384,0.22822,0.20003,1,0
4,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.007729,0.22805,0.23629,1,0
4,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.026586,0.22734,0.17997,1,0
4,GO RESPONSE TO INTERLEUKIN 1,0.00010462,0.22566,0.19368,1,0
4,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.01282,0.22563,0.24423,1,0
4,GO CYTOLYSIS,0.02843,0.22463,0.15603,1,0
4,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.031059,0.22362,0.11013,1,0
4,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.025414,0.22338,0.13691,1,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.023205,0.22205,0.18059,1,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.0085714,0.22183,0.17407,1,0
4,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.0013872,0.22136,0.26255,1,0
4,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.0029794,0.2204,0.2493,1,0
4,GO EPITHELIAL CELL CELL ADHESION,0.0062634,0.22022,0.35004,1,0
4,GO AUTOPHAGOSOME MATURATION,0.00054072,0.21939,0.22667,1,0
4,GO CELLULAR RESPONSE TO VIRUS,0.00019753,0.21899,0.21643,1,0
4,GO ANIMAL ORGAN REGENERATION,0.0034322,0.21886,0.15788,1,0
4,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.016339,0.21788,0.18599,1,0
4,GO PLATELET AGGREGATION,0.0031536,0.21775,0.17869,1,0
4,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.0026572,0.21747,0.15206,1,0
4,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.010245,0.21619,0.1688,1,0
4,GO REGULATION OF ISOTYPE SWITCHING,0.0090226,0.21546,0.11294,1,0
4,GO THYMOCYTE APOPTOTIC PROCESS,0.031748,0.21504,0.18266,1,0
4,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.0015653,0.21474,0.17218,1,0
4,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.042857,0.21425,0.13594,1,0
4,GO AMINOGLYCAN CATABOLIC PROCESS,0.018398,0.21266,0.16169,1,0
4,GO NIK NF KAPPAB SIGNALING,0.00031859,0.21246,0.17428,1,0
4,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.025994,0.21141,0.26255,1,0
4,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.031748,0.21027,0.19641,1,0
4,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.00037661,0.21008,0.21494,1,0
4,GO RECEPTOR CATABOLIC PROCESS,0.038561,0.20794,0.10613,1,0
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.00014418,0.20761,0.20756,1,0
4,GO CELL CELL RECOGNITION,0.0038387,0.20658,0.17384,1,0
4,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0023671,0.20617,0.18446,1,0
4,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0010206,0.20591,0.20586,1,0
4,GO RESPONSE TO LEPTIN,0.0067808,0.20582,0.20606,1,0
4,GO AMYLOID BETA CLEARANCE,0.0049174,0.2054,0.18396,1,0
4,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.018836,0.20521,0.18171,1,0
4,GO VIRAL RELEASE FROM HOST CELL,0.0013457,0.20427,0.18673,1,0
4,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.0057817,0.20359,0.15283,1,0
4,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0037331,0.20268,0.22193,1,0
4,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.017549,0.20232,0.11326,1,0
4,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.00079435,0.20121,0.19104,1,0
4,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.023205,0.20062,0.14079,1,0
4,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.016339,0.19989,0.14637,1,0
4,GO NATURAL KILLER CELL ACTIVATION,0.00022676,0.19952,0.19039,1,0
4,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.0029794,0.19939,0.20138,1,0
4,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.015203,0.19904,0.16946,1,0
4,GO CD40 SIGNALING PATHWAY,0.009256,0.19852,0.15039,1,0
4,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.044685,0.19785,0.32245,1,0
4,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.0069616,0.19774,0.1699,1,0
4,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.036164,0.19762,0.16322,1,0
4,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.03245,0.19739,0.15559,1,0
4,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.0087944,0.19727,0.32911,1,0
4,GO CARDIOLIPIN METABOLIC PROCESS,0.045624,0.19647,0.09816,1,0
4,GO RECEPTOR BIOSYNTHETIC PROCESS,0.0075304,0.19644,0.14425,1,0
4,GO PHAGOCYTOSIS,0.0027346,0.19478,0.14515,1,0
4,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.0051916,0.1943,0.18594,1,0
4,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0001165,0.19418,0.20999,1,0
4,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.02068,0.19407,0.12138,1,0
4,GO POLYAMINE METABOLIC PROCESS,0.015574,0.19336,0.16856,1,0
4,GO LYMPHOCYTE CHEMOTAXIS,0.018398,0.19331,0.10086,1,0
4,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.0024367,0.19187,0.17649,1,0
4,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.001228,0.1898,0.18226,1,0
4,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.00034072,0.18911,0.22234,1,0
4,GO CELL REDOX HOMEOSTASIS,0.0016129,0.18843,0.22982,1,0
4,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.047551,0.18769,0.11631,1,0
4,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.017549,0.18654,0.17181,1,0
4,GO AMINO ACID BETAINE METABOLIC PROCESS,0.0029794,0.1859,0.27848,1,0
4,GO RIG I SIGNALING PATHWAY,0.015574,0.18579,0.12788,1,0
4,GO SELECTIVE AUTOPHAGY,0.00069957,0.18574,0.19537,1,0
4,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.026586,0.18546,0.10621,1,0
4,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.043763,0.18536,0.15027,1,0
4,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00084609,0.18409,0.2021,1,0
4,GO IMMUNOGLOBULIN PRODUCTION,0.00014418,0.18381,0.16704,1,0
4,GO REGULATION OF STEROL TRANSPORT,0.0073363,0.18362,0.16452,1,0
4,GO RESPONSE TO TESTOSTERONE,0.029719,0.18072,0.12918,1,0
4,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.010245,0.17996,0.2155,1,0
4,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.037747,0.17868,0.15709,1,0
4,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.022165,0.1778,0.17353,1,0
4,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.02268,0.17716,0.13182,1,0
4,GO MIDBODY ABSCISSION,0.0012662,0.17682,0.22826,1,0
4,GO FLUID TRANSPORT,0.0010528,0.17674,0.18515,1,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0079323,0.17478,0.15218,1,0
4,GO VIRION ASSEMBLY,0.00353,0.17411,0.13157,1,0
4,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.052669,0.17392,0.12527,1,0
4,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.01282,0.1733,0.13696,1,0
4,GO SMOOTH MUSCLE CELL PROLIFERATION,0.020205,0.17294,0.13828,1,0
4,GO LEUKOCYTE APOPTOTIC PROCESS,0.0025083,0.17238,0.17448,1,0
4,GO SYMBIOTIC PROCESS,0.0010528,0.17154,0.12638,1,0
4,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.021165,0.17127,0.1349,1,0
4,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.00038934,0.16976,0.24978,1,0
4,GO CYTOKINETIC PROCESS,0.010245,0.16959,0.12575,1,0
4,GO GLAND MORPHOGENESIS,0.045624,0.16939,0.11901,1,0
4,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.0025083,0.16934,0.14665,1,0
4,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0028957,0.16915,0.19815,1,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0018173,0.16865,0.17714,1,0
4,GO PROTEIN TARGETING TO VACUOLE,0.0075304,0.16686,0.15613,1,0
4,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.0013457,0.16622,0.18448,1,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.031748,0.16608,0.12127,1,0
4,GO MACROPHAGE CHEMOTAXIS,0.012508,0.16557,0.11142,1,0
4,GO VIRAL RNA GENOME REPLICATION,0.01282,0.16469,0.13554,1,0
4,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0046564,0.16373,0.1288,1,0
4,GO MACROPHAGE MIGRATION,0.026586,0.16304,0.11147,1,0
4,GO PROSTANOID BIOSYNTHETIC PROCESS,0.0039469,0.1626,0.26009,1,0
4,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.013465,0.16219,0.13995,1,0
4,GO T CELL APOPTOTIC PROCESS,0.024288,0.1619,0.14416,1,0
4,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.0049174,0.1609,0.11727,1,0
4,GO TETRAPYRROLE METABOLIC PROCESS,0.0097392,0.16082,0.21107,1,0
4,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.0012662,0.15922,0.16537,1,0
4,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.0062634,0.15919,0.19926,1,0
4,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.038561,0.15908,0.21775,1,0
4,GO TRNA 5 LEADER REMOVAL,0.037747,0.15794,0.13447,1,0
4,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.041093,0.15791,0.18309,1,0
4,GO POSITIVE REGULATION OF LIPID STORAGE,0.030383,0.15739,0.16039,1,0
4,GO ERK1 AND ERK2 CASCADE,0.042857,0.15714,0.10515,1,0
4,GO MACROPHAGE DIFFERENTIATION,0.0090226,0.15694,0.14816,1,0
4,GO IRON ION TRANSMEMBRANE TRANSPORT,0.027803,0.15668,0.19022,1,0
4,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.0073363,0.15604,0.14034,1,0
4,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.05161,0.15557,0.11192,1,0
4,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0060989,0.15414,0.17652,1,0
4,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.015203,0.1525,0.09349,1,0
4,GO CELL MATRIX ADHESION,0.013465,0.15204,0.12014,1,0
4,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.013139,0.1516,0.12993,1,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.04854,0.1507,0.19651,1,0
4,GO POSITIVE REGULATION OF AUTOPHAGY,0.00081984,0.15018,0.15977,1,0
4,GO CHOLESTEROL EFFLUX,0.012203,0.14909,0.17126,1,0
4,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.0012662,0.14883,0.14177,1,0
4,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.0026572,0.14838,0.16532,1,0
4,GO PEPTIDE CATABOLIC PROCESS,0.018398,0.14828,0.19061,1,0
4,GO SULFUR COMPOUND TRANSPORT,0.00032948,0.14724,0.19872,1,0
4,GO REGULATION OF VASCULATURE DEVELOPMENT,0.0099891,0.14705,0.11813,1,0
4,GO RESPONSE TO ANGIOTENSIN,0.049546,0.14699,0.16941,1,0
4,GO MITOPHAGY,0.0060989,0.1456,0.14815,1,0
4,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.024846,0.14529,0.21287,1,0
4,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.0046564,0.14464,0.15169,1,0
4,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.015953,0.14459,0.14002,1,0
4,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.0028141,0.14435,0.17185,1,0
4,GO PLASMA MEMBRANE ORGANIZATION,0.0064317,0.14399,0.14783,1,0
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.013798,0.14363,0.14712,1,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.023205,0.14343,0.12985,1,0
4,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.019283,0.14313,0.14133,1,0
4,GO REGULATION OF MACROPHAGE ACTIVATION,0.05161,0.14291,0.11821,1,0
4,GO REGULATION OF MACROPHAGE MIGRATION,0.0066042,0.14284,0.13699,1,0
4,GO AMEBOIDAL TYPE CELL MIGRATION,0.033166,0.14249,0.089981,1,0
4,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0083534,0.1404,0.10923,1,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.013465,0.1382,0.1301,1,0
4,GO ERBB SIGNALING PATHWAY,0.04854,0.13749,0.09968,1,0
4,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.00092958,0.13738,0.22633,1,0
4,GO MAINTENANCE OF LOCATION,0.0030654,0.13737,0.11564,1,0
4,GO ERAD PATHWAY,0.0094949,0.13733,0.12201,1,0
4,GO SPERM EGG RECOGNITION,0.015203,0.13723,0.11837,1,0
4,GO LIPID IMPORT INTO CELL,0.044685,0.13702,0.17806,1,0
4,GO MAMMARY GLAND MORPHOGENESIS,0.044685,0.13685,0.13985,1,0
4,GO MYELOID CELL HOMEOSTASIS,0.0041716,0.13679,0.12134,1,0
4,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.024288,0.13629,0.12807,1,0
4,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.027803,0.13597,0.15792,1,0
4,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.026586,0.13566,0.11272,1,0
4,GO RESPONSE TO FLUID SHEAR STRESS,0.02843,0.13542,0.15236,1,0
4,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.01282,0.13469,0.16107,1,0
4,GO CELLULAR RESPIRATION,0.0090226,0.13255,0.15276,1,0
4,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.016734,0.13103,0.14158,1,0
4,GO SULFUR AMINO ACID METABOLIC PROCESS,0.012203,0.13076,0.16909,1,0
4,GO REGULATION OF MULTI ORGANISM PROCESS,0.012203,0.12997,0.12423,1,0
4,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0067808,0.12964,0.1989,1,0
4,GO PROTEIN LOCALIZATION TO VACUOLE,0.02268,0.12911,0.12272,1,0
4,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.031059,0.12857,0.13448,1,0
4,GO AMINE CATABOLIC PROCESS,0.02268,0.12852,0.23536,1,0
4,GO CELLULAR RESPONSE TO IRON ION,0.05161,0.12782,0.17904,1,0
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.042857,0.12748,0.09922,1,0
4,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0040578,0.12733,0.27083,1,0
4,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.027803,0.12728,0.14386,1,0
4,GO MUSCLE CELL PROLIFERATION,0.038561,0.12713,0.084525,1,0
4,GO OXIDATIVE PHOSPHORYLATION,0.021165,0.12637,0.1452,1,0
4,GO NEGATIVE T CELL SELECTION,0.043763,0.12577,0.070516,1,0
4,GO AUTOPHAGOSOME ORGANIZATION,0.00081984,0.12486,0.18433,1,0
4,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.00353,0.12458,0.15622,1,0
4,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.025414,0.1243,0.10322,1,0
4,GO REGULATION OF VASOCONSTRICTION,0.0067808,0.12399,0.15341,1,0
4,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.033894,0.12371,0.11438,1,0
4,GO CARNITINE SHUTTLE,0.012508,0.12244,0.20189,1,0
4,GO MAINTENANCE OF LOCATION IN CELL,0.0041716,0.12203,0.1062,1,0
4,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.00081984,0.12181,0.11855,1,0
4,GO TISSUE REGENERATION,0.040234,0.12171,0.13048,1,0
4,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.042857,0.12152,0.13412,1,0
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.036948,0.12127,0.088062,1,0
4,GO POSITIVE REGULATION OF MITOPHAGY,0.05161,0.1202,0.14846,1,0
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.014486,0.11963,0.086167,1,0
4,GO INTERLEUKIN 17 PRODUCTION,0.049546,0.11924,0.13781,1,0
4,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.0087944,0.11869,0.11726,1,0
4,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.0099891,0.11678,0.088703,1,0
4,GO IRON ION HOMEOSTASIS,0.030383,0.1162,0.12612,1,0
4,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.045624,0.11587,0.075864,1,0
4,GO PROTEIN CATABOLIC PROCESS,0.0010859,0.11568,0.10378,1,0
4,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.0067808,0.11508,0.17182,1,0
4,GO ATP BIOSYNTHETIC PROCESS,0.037747,0.11452,0.14449,1,0
4,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.033166,0.11322,0.12268,1,0
4,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.035393,0.11306,0.15031,1,0
4,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.013798,0.11167,0.14359,1,0
4,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.049546,0.11166,0.087206,1,0
4,GO MEMBRANE INVAGINATION,0.025414,0.11115,0.1107,1,0
4,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.020205,0.11092,0.10298,1,0
4,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.027803,0.10985,0.12536,1,0
4,GO POSTREPLICATION REPAIR,0.018398,0.10978,0.077482,1,0
4,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.033166,0.1091,0.14382,1,0
4,GO RESPONSE TO MISFOLDED PROTEIN,0.031748,0.10714,0.14085,1,0
4,GO MORPHOGENESIS OF AN EPITHELIUM,0.047551,0.10617,0.059455,1,0
4,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.029719,0.1061,0.088462,1,0
4,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0015189,0.10511,0.11777,1,0
4,GO ATP METABOLIC PROCESS,0.015953,0.10359,0.10389,1,0
4,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.035393,0.10308,0.14253,1,0
4,GO PROTEIN POLYUBIQUITINATION,0.00012074,0.10233,0.12142,1,0
4,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.049546,0.10017,0.056535,1,0
4,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.012508,0.099731,0.093032,1,0
4,GO URONIC ACID METABOLIC PROCESS,0.046579,0.098422,0.12981,1,0
4,GO DE NOVO PROTEIN FOLDING,0.052669,0.097916,0.11538,1,0
4,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.036164,0.09777,0.11283,1,0
4,GO SULFUR COMPOUND METABOLIC PROCESS,0.015203,0.097256,0.12995,1,0
4,GO POSITIVE REGULATION OF VIRAL PROCESS,0.0056288,0.096918,0.10375,1,0
4,GO VACUOLAR TRANSPORT,0.0046564,0.096403,0.13377,1,0
4,GO REGULATION OF PROTEIN MATURATION,0.03939,0.096157,0.099528,1,0
4,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.00092958,0.096057,0.10315,1,0
4,GO PROTEIN AUTOPHOSPHORYLATION,0.027188,0.093621,0.075436,1,0
4,GO AEROBIC RESPIRATION,0.0099891,0.093312,0.16292,1,0
4,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.011612,0.091927,0.10631,1,0
4,GO POSITIVE REGULATION OF PROTEOLYSIS,0.0038387,0.090768,0.12675,1,0
4,GO PROTEIN K63 LINKED UBIQUITINATION,0.0069616,0.08666,0.11696,1,0
4,GO CELL AGING,0.05161,0.086541,0.064095,1,0
4,GO MACROMOLECULE CATABOLIC PROCESS,0.010773,0.085533,0.070021,1,0
4,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.02068,0.08551,0.073822,1,0
4,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.040234,0.084863,0.090145,1,0
4,GO CELLULAR COMPONENT DISASSEMBLY,0.021165,0.084021,0.072073,1,0
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.047551,0.083598,0.060336,1,0
4,GO RESPONSE TO INTERLEUKIN 7,0.024846,0.081432,0.11316,1,0
4,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.013798,0.077873,0.06444,1,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.038561,0.077436,0.0865,1,0
4,GO REGULATION OF VACUOLE ORGANIZATION,0.014841,0.076522,0.12561,1,0
4,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.02843,0.076364,0.11159,1,0
4,GO GOLGI VESICLE TRANSPORT,0.0069616,0.076169,0.10426,1,0
4,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.031059,0.075783,0.052421,1,0
4,GO NEGATIVE REGULATION OF SIGNALING,0.04854,0.073609,0.063428,1,0
4,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.036164,0.072005,0.07328,1,0
4,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.027188,0.070986,0.1346,1,0
4,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0090226,0.070548,0.065721,1,0
4,GO REGULATION OF CATABOLIC PROCESS,0.017969,0.070039,0.069483,1,0
4,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.019739,0.070029,0.084301,1,0
4,GO MACROAUTOPHAGY,0.00079435,0.069962,0.12498,1,0
4,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.019283,0.065112,0.12264,1,0
4,GO LYSOSOMAL TRANSPORT,0.047551,0.064501,0.11502,1,0
4,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.038561,0.063635,0.086904,1,0
4,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.0028957,0.062414,0.081791,1,0
4,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.05161,0.061138,0.060483,1,0
4,GO INTRACELLULAR PROTEIN TRANSPORT,0.019739,0.060241,0.052258,1,0
4,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.019283,0.059241,0.072415,1,0
4,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.045624,0.058988,0.042766,1,0
4,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.014486,0.053496,0.073776,1,0
4,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.040234,0.048232,0.046778,1,0
4,GO MATING,0.041093,0.047726,0.10605,1,0
4,GO MITOCHONDRION ORGANIZATION,0.009256,0.046949,0.089795,1,0
4,GO REGULATION OF MACROAUTOPHAGY,0.042857,0.028468,0.085404,1,0
4,GO PEPTIDYL LYSINE TRIMETHYLATION,0.052669,-0.036943,-0.075482,1,0
4,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.015574,-0.043957,-0.081262,1,0
4,GO DNA PACKAGING,0.027803,-0.044336,-0.062395,1,0
4,GO HISTONE UBIQUITINATION,0.029719,-0.050386,-0.072608,1,0
4,GO DOUBLE STRAND BREAK REPAIR,0.026586,-0.051762,-0.071928,1,0
4,GO DNA CONFORMATION CHANGE,0.043763,-0.052683,-0.059371,1,0
4,GO TRNA WOBBLE BASE MODIFICATION,0.047551,-0.055618,-0.1367,1,0
4,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.049546,-0.056316,-0.084363,1,0
4,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.045624,-0.058345,-0.060019,1,0
4,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.014841,-0.058652,-0.094198,1,0
4,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.047551,-0.060327,-0.071546,1,0
4,GO DNA GEOMETRIC CHANGE,0.029719,-0.06364,-0.087262,1,0
4,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.022165,-0.063644,-0.075586,1,0
4,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.02166,-0.064071,-0.095134,1,0
4,GO MRNA PROCESSING,0.013465,-0.066946,-0.069146,1,0
4,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.023205,-0.068353,-0.094855,1,0
4,GO DNA RECOMBINATION,0.041967,-0.070969,-0.05476,1,0
4,GO RNA SPLICING,0.0047853,-0.071689,-0.080921,1,0
4,GO BASE EXCISION REPAIR,0.024288,-0.074039,-0.091047,1,0
4,GO SPINDLE ORGANIZATION,0.023205,-0.076132,-0.064936,1,0
4,GO CHROMOSOME CONDENSATION,0.025994,-0.076574,-0.10429,1,0
4,GO RECOMBINATIONAL REPAIR,0.0075304,-0.076864,-0.092513,1,0
4,GO HISTONE MRNA METABOLIC PROCESS,0.046579,-0.077135,-0.097117,1,0
4,GO REGULATION OF DNA METABOLIC PROCESS,0.0064317,-0.077235,-0.069538,1,0
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.0079323,-0.077746,-0.096537,1,0
4,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.038561,-0.077857,-0.077777,1,0
4,GO NUCLEOSOME ORGANIZATION,0.020205,-0.078249,-0.08664,1,0
4,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.0079323,-0.079053,-0.13549,1,0
4,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.019739,-0.079203,-0.10483,1,0
4,GO MRNA TRANSPORT,0.041967,-0.081547,-0.079487,1,0
4,GO MUSCLE FILAMENT SLIDING,0.018398,-0.083711,-0.20408,1,0
4,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.021165,-0.083808,-0.080795,1,0
4,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.043763,-0.085049,-0.12906,1,0
4,GO MITOTIC SPINDLE ORGANIZATION,0.030383,-0.085532,-0.07431,1,0
4,GO REGULATION OF DNA RECOMBINATION,0.023205,-0.085542,-0.092481,1,0
4,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.01282,-0.086904,-0.095247,1,0
4,GO STRIATED MUSCLE CELL PROLIFERATION,0.038561,-0.086935,-0.13279,1,0
4,GO POSITIVE REGULATION OF DNA REPAIR,0.00065623,-0.087858,-0.11772,1,0
4,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.019283,-0.090892,-0.087425,1,0
4,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.0014299,-0.091142,-0.10606,1,0
4,GO CHROMATIN REMODELING,0.010506,-0.091718,-0.074417,1,0
4,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.034637,-0.091865,-0.15304,1,0
4,GO REGULATION OF MYELINATION,0.010773,-0.09426,-0.12585,1,0
4,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.043763,-0.094294,-0.11666,1,0
4,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.0075304,-0.095234,-0.087593,1,0
4,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.0029794,-0.09675,-0.099318,1,0
4,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.00032948,-0.096796,-0.10814,1,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.034637,-0.097187,-0.13483,1,0
4,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.031059,-0.09744,-0.10766,1,0
4,GO CELLULAR RESPONSE TO X RAY,0.007729,-0.098706,-0.20987,1,0
4,GO REGULATION OF TELOMERE MAINTENANCE,0.0032441,-0.09894,-0.11578,1,0
4,GO NEURAL CREST CELL DIFFERENTIATION,0.044685,-0.099704,-0.13463,1,0
4,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.05161,-0.10006,-0.11037,1,0
4,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.041093,-0.1004,-0.09384,1,0
4,GO MITOTIC CHROMOSOME CONDENSATION,0.038561,-0.10044,-0.14687,1,0
4,GO COLLAGEN FIBRIL ORGANIZATION,0.016734,-0.10188,-0.23623,1,0
4,GO TRNA WOBBLE URIDINE MODIFICATION,0.021165,-0.10194,-0.14621,1,0
4,GO NEGATIVE REGULATION OF DNA REPAIR,0.0054795,-0.10386,-0.12859,1,0
4,GO STRESS GRANULE ASSEMBLY,0.025994,-0.10832,-0.12261,1,0
4,GO CHROMOSOME SEPARATION,0.021165,-0.10979,-0.092138,1,0
4,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.031059,-0.11098,-0.21521,1,0
4,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0025817,-0.11137,-0.10169,1,0
4,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.042857,-0.11241,-0.15893,1,0
4,GO HISTONE DEUBIQUITINATION,0.013139,-0.1133,-0.090877,1,0
4,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.041967,-0.11624,-0.084836,1,0
4,GO G0 TO G1 TRANSITION,0.036948,-0.11651,-0.096279,1,0
4,GO NEGATIVE REGULATION OF RNA SPLICING,0.014841,-0.11703,-0.10694,1,0
4,GO CARDIAC MUSCLE CELL PROLIFERATION,0.0097392,-0.11705,-0.17759,1,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.0067808,-0.11775,-0.12782,1,0
4,GO REGULATION OF MRNA PROCESSING,0.0024367,-0.11779,-0.10471,1,0
4,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.0064317,-0.118,-0.17479,1,0
4,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.03245,-0.11822,-0.19193,1,0
4,GO REGULATION OF CELL CYCLE CHECKPOINT,0.024846,-0.11863,-0.079003,1,0
4,GO REGULATION OF DNA REPAIR,7.2754e-05,-0.1194,-0.12597,1,0
4,GO CORONARY VASCULATURE MORPHOGENESIS,0.046579,-0.1198,-0.15839,1,0
4,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00026003,-0.1199,-0.13272,1,0
4,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.022165,-0.12054,-0.15121,1,0
4,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00092958,-0.12056,-0.13601,1,0
4,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.030383,-0.12154,-0.12938,1,0
4,GO DNA REPLICATION INITIATION,0.00050664,-0.12315,-0.16931,1,0
4,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.0066042,-0.12316,-0.10806,1,0
4,GO REPLICATION FORK PROCESSING,0.0013872,-0.12585,-0.17531,1,0
4,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.036164,-0.12668,-0.12308,1,0
4,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0047853,-0.12676,-0.12822,1,0
4,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.0016129,-0.12689,-0.24729,1,0
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,3.5759e-05,-0.1271,-0.14809,1,0
4,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.012508,-0.12932,-0.14386,1,0
4,GO HISTONE H3 K9 ACETYLATION,0.031748,-0.12991,-0.10035,1,0
4,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.046579,-0.13025,-0.12736,1,0
4,GO CENTRIOLE ASSEMBLY,0.024846,-0.13039,-0.093113,1,0
4,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.043763,-0.13175,-0.1261,1,0
4,GO SNORNA 3 END PROCESSING,0.026586,-0.13228,-0.17028,1,0
4,GO REGULATION OF STEM CELL PROLIFERATION,0.023205,-0.13316,-0.13104,1,0
4,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.00081984,-0.13725,-0.12562,1,0
4,GO BONE MORPHOGENESIS,0.011047,-0.1374,-0.16423,1,0
4,GO MITOCHONDRION DISTRIBUTION,0.013465,-0.13747,-0.14312,1,0
4,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.0054795,-0.14052,-0.18213,1,0
4,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.013465,-0.14106,-0.14929,1,0
4,GO POSITIVE REGULATION OF ORGAN GROWTH,0.019283,-0.14212,-0.15272,1,0
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00036427,-0.14263,-0.13886,1,0
4,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.0066042,-0.14345,-0.18926,1,0
4,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.033894,-0.14425,-0.12894,1,0
4,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.011047,-0.14473,-0.29537,1,0
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.00038934,-0.14544,-0.16091,1,0
4,GO MESODERMAL CELL FATE SPECIFICATION,0.040234,-0.14696,-0.17324,1,0
4,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.03245,-0.1495,-0.1612,1,0
4,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0087944,-0.14961,-0.16483,1,0
4,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.0030654,-0.14974,-0.24185,1,0
4,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.0073363,-0.14979,-0.13228,1,0
4,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.034637,-0.15015,-0.15407,1,0
4,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.033166,-0.15067,-0.21746,1,0
4,GO TELENCEPHALON DEVELOPMENT,0.023205,-0.15167,-0.10635,1,0
4,GO REGULATION OF LYASE ACTIVITY,0.0085714,-0.1521,-0.15816,1,0
4,GO REGULATION OF SPINDLE CHECKPOINT,0.010506,-0.1525,-0.14539,1,0
4,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.030383,-0.15341,-0.10435,1,0
4,GO REGULATION OF CYCLASE ACTIVITY,0.0010206,-0.15482,-0.2114,1,0
4,GO REPLACEMENT OSSIFICATION,0.021165,-0.15509,-0.17684,1,0
4,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.001228,-0.15555,-0.13566,1,0
4,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0054795,-0.15685,-0.23903,1,0
4,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.018398,-0.15696,-0.14004,1,0
4,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.022165,-0.15818,-0.22694,1,0
4,GO HIPPOCAMPUS DEVELOPMENT,0.024846,-0.1584,-0.13892,1,0
4,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,6.2985e-07,-0.16177,-0.16856,1,0
4,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.042857,-0.16314,-0.16988,1,0
4,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.0026572,-0.16344,-0.22336,1,0
4,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.0025083,-0.16398,-0.15315,1,0
4,GO LYMPHANGIOGENESIS,0.014486,-0.16436,-0.20836,1,0
4,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.00016595,-0.16457,-0.14979,1,0
4,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.041093,-0.16468,-0.17974,1,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.047551,-0.16499,-0.18895,1,0
4,GO NEURAL TUBE PATTERNING,0.0014299,-0.16582,-0.19983,1,0
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.042857,-0.1662,-0.12545,1,0
4,GO HINDLIMB MORPHOGENESIS,0.027188,-0.16639,-0.17427,1,0
4,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.014486,-0.16728,-0.10655,1,0
4,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.021165,-0.17172,-0.15827,1,0
4,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.041967,-0.17288,-0.16572,1,0
4,GO INTRACILIARY TRANSPORT,0.041093,-0.17341,-0.12616,1,0
4,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.007729,-0.1747,-0.13868,1,0
4,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.017969,-0.17483,-0.11757,1,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0059384,-0.17597,-0.18104,1,0
4,GO MITRAL VALVE DEVELOPMENT,0.03245,-0.17598,-0.22668,1,0
4,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.019739,-0.17642,-0.26254,1,0
4,GO CELLULAR RESPONSE TO SALT STRESS,0.014841,-0.17672,-0.28449,1,0
4,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.044685,-0.17763,-0.10866,1,0
4,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.013139,-0.17849,-0.15949,1,0
4,GO CELL DIFFERENTIATION IN HINDBRAIN,0.029719,-0.18065,-0.18473,1,0
4,GO TELENCEPHALON GLIAL CELL MIGRATION,0.0079323,-0.18076,-0.20996,1,0
4,GO FOREBRAIN REGIONALIZATION,0.017969,-0.18302,-0.21708,1,0
4,GO BONE TRABECULA MORPHOGENESIS,0.040234,-0.18366,-0.25489,1,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.0019282,-0.18422,-0.18667,1,0
4,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.042857,-0.18468,-0.13198,1,0
4,GO HIPPO SIGNALING,0.0051916,-0.18537,-0.2481,1,0
4,GO TRACHEA DEVELOPMENT,0.041093,-0.18558,-0.17559,1,0
4,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.029068,-0.18652,-0.18005,1,0
4,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.0060989,-0.18796,-0.15832,1,0
4,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.025994,-0.18814,-0.27192,1,0
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,4.1112e-06,-0.1884,-0.17223,1,0
4,GO HISTONE H3 K9 DEMETHYLATION,0.0028141,-0.18855,-0.21484,1,0
4,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.024288,-0.18968,-0.22343,1,0
4,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.047551,-0.18986,-0.17629,1,0
4,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.02268,-0.19049,-0.19063,1,0
4,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.021165,-0.1936,-0.17526,1,0
4,GO ADULT HEART DEVELOPMENT,0.015203,-0.19388,-0.21064,1,0
4,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.042857,-0.19566,-0.21153,1,0
4,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.00098941,-0.19575,-0.17386,1,0
4,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.041093,-0.20133,-0.22298,1,0
4,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.0019282,-0.20257,-0.23873,1,0
4,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.00034072,-0.20432,-0.26367,1,0
4,GO TELOMERASE RNA LOCALIZATION,0.020205,-0.20904,-0.21127,1,0
4,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00038934,-0.21034,-0.19536,1,0
4,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.00010845,-0.21158,-0.24342,1,0
4,GO NEGATIVE CHEMOTAXIS,0.031748,-0.21172,-0.20206,1,0
4,GO CELL PROLIFERATION IN HINDBRAIN,0.023205,-0.21326,-0.19822,1,0
4,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.014841,-0.21401,-0.15813,1,0
4,GO LAYER FORMATION IN CEREBRAL CORTEX,0.0017123,-0.21569,-0.28761,1,0
4,GO TELOMERIC LOOP DISASSEMBLY,0.00013917,-0.22009,-0.22307,1,0
4,GO NEURAL CREST CELL MIGRATION,0.0015653,-0.2222,-0.24906,1,0
4,GO SPERMATID NUCLEUS DIFFERENTIATION,0.00012074,-0.22309,-0.25958,1,0
4,GO DNA LIGATION,0.033894,-0.22326,-0.15495,1,0
4,GO NEURON PROJECTION ORGANIZATION,0.0013457,-0.22715,-0.21047,1,0
4,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,1.9263e-05,-0.22815,-0.27946,1,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0071468,-0.22887,-0.25494,1,0
4,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.0041716,-0.23204,-0.20209,1,0
4,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.00041602,-0.2321,-0.24524,1,0
4,GO PROTEIN DEMETHYLATION,0.00016595,-0.23219,-0.21368,1,0
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.05161,-0.23525,-0.13919,1,0
4,GO HYPEROSMOTIC SALINITY RESPONSE,0.0056288,-0.23776,-0.26643,1,0
4,GO LATERAL MESODERM DEVELOPMENT,0.0045306,-0.23842,-0.31854,1,0
4,GO MRNA SPLICE SITE SELECTION,0.0007696,-0.23871,-0.20896,1,0
4,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.0041716,-0.24078,-0.1796,1,0
4,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.00081984,-0.24299,-0.31573,1,0
4,GO MUSCLE CELL FATE COMMITMENT,0.0013054,-0.24321,-0.29061,1,0
4,GO RESPONSE TO ELECTRICAL STIMULUS,0.00081984,-0.24355,-0.23536,1,0
4,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.00049035,-0.24379,-0.2746,1,0
4,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.037747,-0.24456,-0.24149,1,0
4,GO BONE GROWTH,0.00041602,-0.24498,-0.30482,1,0
4,GO TONGUE DEVELOPMENT,0.031748,-0.24545,-0.23346,1,0
4,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.0038387,-0.24602,-0.3179,1,0
4,GO CARDIOBLAST DIFFERENTIATION,0.0026572,-0.24757,-0.28079,1,0
4,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.011047,-0.24806,-0.33279,1,0
4,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.025994,-0.25172,-0.25392,1,0
4,GO DERMATAN SULFATE METABOLIC PROCESS,0.019739,-0.2537,-0.27362,1,0
4,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.00013433,-0.25409,-0.21255,1,0
4,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.0097392,-0.25526,-0.31182,1,0
4,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.00090094,-0.25822,-0.34966,1,0
4,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.00090094,-0.25958,-0.29886,1,0
4,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.0014738,-0.26067,-0.26572,1,0
4,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,1.0604e-05,-0.26123,-0.26197,1,0
4,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,5.7413e-06,-0.26146,-0.32526,1,0
4,GO CELL PROLIFERATION IN FOREBRAIN,6.7596e-05,-0.26301,-0.28974,1,0
4,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.00079435,-0.26428,-0.29543,1,0
4,GO UV PROTECTION,0.0085714,-0.27124,-0.24475,1,0
4,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,1.2862e-06,-0.27256,-0.27448,1,0
4,GO SECRETORY GRANULE LOCALIZATION,0.02268,-0.27317,-0.22852,1,0
4,GO EMBRYONIC BRAIN DEVELOPMENT,0.00013917,-0.27499,-0.28311,1,0
4,GO ELASTIC FIBER ASSEMBLY,0.015574,-0.27721,-0.32748,1,0
4,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.0075304,-0.27976,-0.20373,1,0
4,GO REGULATION OF NEURON PROJECTION REGENERATION,0.0019282,-0.27977,-0.24992,1,0
4,GO FOREBRAIN MORPHOGENESIS,0.00023468,-0.28077,-0.2837,1,0
4,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.0024367,-0.28173,-0.22941,1,0
4,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.0040578,-0.28291,-0.26811,1,0
4,GO RESPONSE TO L GLUTAMATE,0.01282,-0.28978,-0.25744,1,0
4,GO BONE TRABECULA FORMATION,0.0057817,-0.29379,-0.41215,1,0
4,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.0064317,-0.30147,-0.34081,1,0
4,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.016339,-0.30185,-0.29811,1,0
4,GO MYOBLAST MIGRATION,0.013465,-0.30213,-0.33786,1,0
4,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0025817,-0.3041,-0.24762,1,0
4,GO REGULATION OF NEUROBLAST PROLIFERATION,0.00026903,-0.3046,-0.30486,1,0
4,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.016734,-0.30493,-0.24849,1,0
4,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.00037661,-0.30873,-0.32359,1,0
4,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.014138,-0.31109,-0.27044,1,0
4,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.00050664,-0.31121,-0.32246,1,0
4,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,5.8301e-05,-0.31142,-0.29355,1,0
4,GO GTP METABOLIC PROCESS,0.0033369,-0.31728,-0.24262,1,0
4,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.00054072,-0.32888,-0.26133,1,0
4,GO CHROMATIN DISASSEMBLY,1.1493e-05,-0.32947,-0.31795,1,0
4,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,4.6597e-05,-0.34194,-0.383,1,0
4,GO EMBRYONIC EYE MORPHOGENESIS,8.7323e-05,-0.34238,-0.30078,1,0
4,GO DENDRITIC TRANSPORT,0.00084609,-0.34787,-0.30757,1,0
4,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0014299,-0.3479,-0.26284,1,0
4,GO LATERAL VENTRICLE DEVELOPMENT,0.001872,-0.35123,-0.35308,1,0
4,GO GROWTH PLATE CARTILAGE DEVELOPMENT,2.7343e-05,-0.36696,-0.39373,1,0
4,GO LIMB BUD FORMATION,0.017549,-0.36817,-0.31264,1,0
4,GO CENTRIOLE CENTRIOLE COHESION,5.508e-06,-0.37242,-0.36558,1,0
4,GO NEGATIVE REGULATION OF LYASE ACTIVITY,6.7596e-05,-0.37628,-0.39234,1,0
4,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0022992,-0.37911,-0.34982,1,0
4,GO PHAGOCYTOSIS RECOGNITION,0.00014418,-0.38047,-0.37621,1,0
4,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.0071468,-0.3814,-0.28449,1,0
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.024288,-0.3897,-0.25278,1,0
4,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00021167,-0.39287,-0.42992,1,0
4,GO DORSAL VENTRAL AXIS SPECIFICATION,0.00026903,-0.39552,-0.40028,1,0
4,GO POSITIVE REGULATION OF NEURON MIGRATION,0.00031859,-0.39693,-0.3339,1,0
4,GO MODIFICATION OF SYNAPTIC STRUCTURE,9.3916e-06,-0.40753,-0.41702,1,0
4,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,1.4609e-05,-0.40814,-0.3792,1,0
4,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0010528,-0.42044,-0.31803,1,0
4,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.00014418,-0.43212,-0.38858,1,0
4,GO SYNAPTIC VESICLE MATURATION,0.0017123,-0.43645,-0.31763,1,0
4,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.00034072,-0.44841,-0.44614,1,0
4,GO EXCITATORY SYNAPSE ASSEMBLY,1.5201e-05,-0.4801,-0.5302,1,0
4,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.00081984,-0.48322,-0.44409,1,0
4,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,4.6623e-06,-0.48476,-0.54326,1,0
4,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,3.4421e-05,-0.48506,-0.50366,1,0
4,GO TELENCEPHALON REGIONALIZATION,0.0097392,-0.48622,-0.36422,1,0
4,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,4.3218e-05,-0.49671,-0.57224,1,0
4,GO CORPUS CALLOSUM DEVELOPMENT,4.0073e-05,-0.49918,-0.41905,1,0
4,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.00014418,-0.50419,-0.47033,1,0
4,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.00035231,-0.52234,-0.43631,1,0
4,GO CARDIAC CHAMBER FORMATION,7.013e-05,-0.56084,-0.56197,1,0
4,GO CARDIAC VENTRICLE FORMATION,0.00012074,-0.60332,-0.58187,1,0
4,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.00014935,-0.60876,-0.72461,1,0
4,GO POSTSYNAPSE ASSEMBLY,0.00024286,-0.6104,-0.53509,1,0
4,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,5.6174e-05,-0.61647,-0.58269,1,0
4,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,3.1888e-05,-0.75088,-0.75945,1,0
4,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.077957,0.46831,0.22175,0,1
4,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.063042,0.30281,0.25581,0,1
4,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.05824,0.27741,0.1563,0,1
4,GO BEHAVIORAL RESPONSE TO PAIN,0.060602,0.26124,0.18054,0,1
4,GO POSITIVE REGULATION OF HAIR CYCLE,0.073629,0.24634,0.18485,0,1
4,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.059411,0.23419,0.12297,0,1
4,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.082489,0.22897,0.1329,0,1
4,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.066855,0.22829,0.12062,0,1
4,GO MITOCHONDRIAL RNA PROCESSING,0.064293,0.22721,0.15411,0,1
4,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.10096,0.22644,0.23371,0,1
4,GO REGULATION OF CHLORIDE TRANSPORT,0.085627,0.22338,0.2481,0,1
4,GO RESPONSE TO UV B,0.17374,0.21592,0.080917,0,1
4,GO ETHANOL METABOLIC PROCESS,0.061812,0.21326,0.17851,0,1
4,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.064293,0.21104,0.17211,0,1
4,GO DETOXIFICATION,0.093897,0.20227,0.14704,0,1
4,GO MAINTENANCE OF CELL POLARITY,0.080955,0.20096,0.13312,0,1
4,GO SYNAPTIC VESICLE BUDDING,0.14769,0.20076,0.12012,0,1
4,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.097379,0.19368,0.13139,0,1
4,GO REGULATION OF RESPONSE TO FOOD,0.14285,0.19231,0.070409,0,1
4,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.10845,0.19099,0.14039,0,1
4,GO PODOSOME ASSEMBLY,0.31653,0.19081,0.045147,0,1
4,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.05824,0.18705,0.12941,0,1
4,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.057089,0.18698,0.14085,0,1
4,GO HEART TRABECULA MORPHOGENESIS,0.084046,0.18695,0.10578,0,1
4,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.23245,0.18679,0.086028,0,1
4,GO ALDEHYDE CATABOLIC PROCESS,0.093897,0.18468,0.094064,0,1
4,GO PARAXIAL MESODERM DEVELOPMENT,0.21579,0.18313,0.11153,0,1
4,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.22235,0.18308,0.075019,0,1
4,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.13814,0.18182,0.10779,0,1
4,GO FAT CELL PROLIFERATION,0.23245,0.18072,0.13389,0,1
4,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.097379,0.18055,0.13212,0,1
4,GO PANCREATIC JUICE SECRETION,0.059411,0.17827,0.14914,0,1
4,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.065563,0.17818,0.13825,0,1
4,GO REGULATION OF MITOCHONDRIAL FUSION,0.13355,0.178,0.11262,0,1
4,GO RNA INTERFERENCE,0.064293,0.17546,0.11587,0,1
4,GO GANGLIOSIDE METABOLIC PROCESS,0.080955,0.17461,0.1372,0,1
4,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.38888,0.17347,0.096914,0,1
4,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.059411,0.1732,0.14897,0,1
4,GO PLACENTA DEVELOPMENT,0.054842,0.17203,0.10354,0,1
4,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.15264,0.17191,0.057823,0,1
4,GO RENAL WATER HOMEOSTASIS,0.11235,0.17079,0.074713,0,1
4,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.099158,0.17055,0.13454,0,1
4,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.061812,0.17025,0.12354,0,1
4,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.19695,0.17024,0.1335,0,1
4,GO METANEPHROS MORPHOGENESIS,0.068167,0.16277,0.13451,0,1
4,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.15773,0.15999,0.1127,0,1
4,GO LUNG MORPHOGENESIS,0.10845,0.15909,0.092691,0,1
4,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.064293,0.1588,0.083816,0,1
4,GO RESPONSE TO VITAMIN,0.25363,0.15855,0.054932,0,1
4,GO PROTEIN LOCALIZATION TO AXON,0.066855,0.15694,0.24855,0,1
4,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.072231,0.15619,0.10888,0,1
4,GO AORTA MORPHOGENESIS,0.26471,0.15551,0.061525,0,1
4,GO DRINKING BEHAVIOR,0.24643,0.15481,0.072851,0,1
4,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.17653,0.15415,0.055464,0,1
4,GO GLIAL CELL DEVELOPMENT,0.065563,0.15178,0.091359,0,1
4,GO GLIAL CELL APOPTOTIC PROCESS,0.065563,0.15143,0.1668,0,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.18508,0.15027,0.1517,0,1
4,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.087232,0.15007,0.10672,0,1
4,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.1313,0.14878,0.11673,0,1
4,GO RESPONSE TO MUSCLE ACTIVITY,0.65866,0.14547,0.045925,0,1
4,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.070855,0.14416,0.082532,0,1
4,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.097379,0.14398,0.14269,0,1
4,GO ENDOTHELIAL CELL DEVELOPMENT,0.13814,0.14132,0.080628,0,1
4,GO DEFINITIVE HEMOPOIESIS,0.13814,0.14071,0.065153,0,1
4,GO RESPONSE TO LIGHT INTENSITY,0.14526,0.14031,0.10033,0,1
4,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.059411,0.14021,0.096938,0,1
4,GO CELLULAR EXTRAVASATION,0.060602,0.1396,0.094106,0,1
4,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.2839,0.13853,0.047889,0,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.26471,0.13647,0.084543,0,1
4,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.44402,0.13593,0.06506,0,1
4,GO CRANIAL NERVE DEVELOPMENT,0.1313,0.13504,0.10348,0,1
4,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.1028,0.1345,0.11539,0,1
4,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.19095,0.13274,0.05921,0,1
4,GO DEVELOPMENTAL INDUCTION,0.080955,0.13252,0.094125,0,1
4,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.077957,0.1314,0.073715,0,1
4,GO AROMATIC AMINO ACID TRANSPORT,0.27227,0.12979,0.10705,0,1
4,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.14285,0.12715,0.11566,0,1
4,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.13355,0.12592,0.065257,0,1
4,GO PIGMENT CELL DIFFERENTIATION,0.085627,0.12435,0.072639,0,1
4,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.057089,0.12357,0.1191,0,1
4,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.13355,0.12337,0.10291,0,1
4,GO HYPEROSMOTIC RESPONSE,0.34256,0.12325,0.063744,0,1
4,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.075049,0.12274,0.10336,0,1
4,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.15517,0.12236,0.10371,0,1
4,GO SERTOLI CELL DIFFERENTIATION,0.17099,0.12208,0.080634,0,1
4,GO ACYLGLYCEROL HOMEOSTASIS,0.097379,0.1215,0.13788,0,1
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.073629,0.11916,0.087248,0,1
4,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.082489,0.11904,0.093604,0,1
4,GO REGULATION OF FATTY ACID BETA OXIDATION,0.097379,0.11859,0.12282,0,1
4,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.097379,0.11852,0.090615,0,1
4,GO EPIDERMIS MORPHOGENESIS,0.16828,0.11732,0.057385,0,1
4,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.11636,0.11731,0.073219,0,1
4,GO KERATINOCYTE MIGRATION,0.15517,0.11659,0.076549,0,1
4,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.15773,0.1165,0.084865,0,1
4,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.10845,0.11648,0.067908,0,1
4,GO PEPTIDYL METHIONINE MODIFICATION,0.52594,0.11234,0.10874,0,1
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.060602,0.11134,0.14579,0,1
4,GO CERAMIDE TRANSPORT,0.12259,0.11118,0.16579,0,1
4,GO PHOTOTRANSDUCTION,0.090515,0.11097,0.047551,0,1
4,GO STRESS FIBER ASSEMBLY,0.22235,0.11055,0.051019,0,1
4,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.0695,0.11038,0.12884,0,1
4,GO RESPONSE TO NITRIC OXIDE,0.22568,0.1093,0.046285,0,1
4,GO RESPIRATORY SYSTEM DEVELOPMENT,0.082489,0.10888,0.07594,0,1
4,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.073629,0.10878,0.10737,0,1
4,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.29586,0.10847,0.047911,0,1
4,GO SULFATE TRANSPORT,0.11636,0.10824,0.074861,0,1
4,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.10465,0.10743,0.13468,0,1
4,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.064293,0.1074,0.11175,0,1
4,GO MUSCLE CELL DIFFERENTIATION,0.10096,0.10737,0.058028,0,1
4,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.22905,0.1072,0.097695,0,1
4,GO MODULATION BY VIRUS OF HOST PROCESS,0.13583,0.10718,0.079424,0,1
4,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.061812,0.10686,0.06914,0,1
4,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.59059,0.10638,0.019776,0,1
4,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.082489,0.10539,0.13,0,1
4,GO REGULATION OF CELL FATE SPECIFICATION,0.2,0.10469,0.063001,0,1
4,GO EPITHELIAL TUBE MORPHOGENESIS,0.077957,0.10328,0.055958,0,1
4,GO BICARBONATE TRANSPORT,0.0695,0.10256,0.096485,0,1
4,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.087232,0.10246,0.18367,0,1
4,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.23589,0.10204,0.06438,0,1
4,GO PEPTIDYL CYSTEINE MODIFICATION,0.087232,0.10191,0.076283,0,1
4,GO MODIFIED AMINO ACID TRANSPORT,0.053746,0.10158,0.11625,0,1
4,GO PRESYNAPTIC ENDOCYTOSIS,0.2839,0.10139,0.062209,0,1
4,GO RESPONSE TO UV C,0.16828,0.10124,0.078135,0,1
4,GO DETECTION OF MECHANICAL STIMULUS,0.25001,0.10087,0.059435,0,1
4,GO REGULATION OF METAL ION TRANSPORT,0.055956,0.10082,0.067392,0,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.1028,0.10033,0.068624,0,1
4,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.064293,0.099334,0.068498,0,1
4,GO RESPONSE TO ORGANOPHOSPHORUS,0.14526,0.099212,0.058223,0,1
4,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.090515,0.098952,0.081554,0,1
4,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.22568,0.098253,0.15784,0,1
4,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.085627,0.097265,0.076524,0,1
4,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.059411,0.097222,0.071418,0,1
4,GO ACTIN FILAMENT ORGANIZATION,0.053746,0.096972,0.068051,0,1
4,GO POSITIVE THYMIC T CELL SELECTION,0.16032,0.094785,0.067137,0,1
4,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.11636,0.093695,0.071315,0,1
4,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.1028,0.093634,0.068991,0,1
4,GO HEAD MORPHOGENESIS,0.76948,0.092914,-0.017903,0,1
4,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.26847,0.092585,0.059639,0,1
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.088862,0.092086,0.090433,0,1
4,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.54903,0.091225,0.04659,0,1
4,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.188,0.091212,0.06098,0,1
4,GO IN UTERO EMBRYONIC DEVELOPMENT,0.092194,0.091197,0.051634,0,1
4,GO MITOCHONDRIAL FUSION,0.17934,0.091041,0.077352,0,1
4,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.093897,0.090963,0.060496,0,1
4,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.53742,0.09092,0.011047,0,1
4,GO REGULATION OF PROTEIN DEACETYLATION,0.1028,0.090889,0.10538,0,1
4,GO REGULATION OF CALCIUM ION TRANSPORT,0.057089,0.090714,0.078615,0,1
4,GO REGULATION OF FAT CELL DIFFERENTIATION,0.057089,0.0906,0.10985,0,1
4,GO ARTERY MORPHOGENESIS,0.059411,0.08941,0.056822,0,1
4,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.064293,0.089363,0.055517,0,1
4,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.58456,0.088261,0.0025891,0,1
4,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.16828,0.088153,0.058509,0,1
4,GO KIDNEY MORPHOGENESIS,0.12908,0.087337,0.06971,0,1
4,GO POSITIVE REGULATION OF BINDING,0.070855,0.087128,0.062289,0,1
4,GO NEGATIVE REGULATION OF ION TRANSPORT,0.12908,0.086365,0.046852,0,1
4,GO NEPHRON EPITHELIUM DEVELOPMENT,0.073629,0.086231,0.074967,0,1
4,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.05824,0.085264,0.11228,0,1
4,GO ACTIN FILAMENT BASED PROCESS,0.12259,0.085084,0.049335,0,1
4,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.087232,0.084931,0.067262,0,1
4,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.23589,0.084823,0.059507,0,1
4,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.15015,0.082769,0.090712,0,1
4,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.34256,0.077747,0.017145,0,1
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.054842,0.077168,0.053701,0,1
4,GO REGULATION OF GTP BINDING,0.71658,0.076457,0.012884,0,1
4,GO ENSHEATHMENT OF NEURONS,0.23589,0.075624,0.050273,0,1
4,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.10654,0.075215,0.057017,0,1
4,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.1313,0.073092,0.06868,0,1
4,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.11235,0.072744,0.071084,0,1
4,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.23245,0.072176,0.071063,0,1
4,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.13583,0.071805,0.039798,0,1
4,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.099158,0.069758,0.048952,0,1
4,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.20621,0.069525,0.089293,0,1
4,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.18219,0.068442,0.048195,0,1
4,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.13583,0.067821,0.056361,0,1
4,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.15015,0.067656,0.058073,0,1
4,GO PIGMENT GRANULE ORGANIZATION,0.1313,0.065229,0.071405,0,1
4,GO REGULATION OF ACTIN FILAMENT LENGTH,0.075049,0.064592,0.058267,0,1
4,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.44924,0.061171,0.030529,0,1
4,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.54321,0.059366,0.014765,0,1
4,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.24288,0.059329,0.044838,0,1
4,GO REGULATION OF CIRCADIAN RHYTHM,0.14048,0.058692,0.065557,0,1
4,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.16559,0.05798,0.040316,0,1
4,GO TAXIS,0.79636,0.057722,0.003322,0,1
4,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.17374,0.05765,0.051136,0,1
4,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.088862,0.057066,0.037185,0,1
4,GO DEVELOPMENTAL MATURATION,0.17934,0.05696,0.061403,0,1
4,GO GAMETE GENERATION,0.073629,0.05554,0.050229,0,1
4,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.27227,0.055464,0.040581,0,1
4,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.49227,0.0536,0.021361,0,1
4,GO GLIOGENESIS,0.32506,0.050917,0.046044,0,1
4,GO MALE GAMETE GENERATION,0.070855,0.050912,0.054414,0,1
4,GO SEX DIFFERENTIATION,0.14526,0.049381,0.056429,0,1
4,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.16828,0.047561,0.054417,0,1
4,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.17099,0.047217,0.044267,0,1
4,GO RESPONSE TO LIGHT STIMULUS,0.52025,0.046867,0.0047713,0,1
4,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.43883,0.045777,0.027543,0,1
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.4598,0.04562,0.031601,0,1
4,GO MUSCLE STRUCTURE DEVELOPMENT,0.17934,0.044896,0.035551,0,1
4,GO MITOCHONDRION MORPHOGENESIS,0.67776,0.044023,3.3762e-05,0,1
4,GO REGULATION OF ORGANELLE ORGANIZATION,0.30402,0.043794,0.022506,0,1
4,GO REGULATION OF CELL CYCLE,0.27227,0.043426,0.021729,0,1
4,GO OVULATION CYCLE,0.60272,0.042181,0.018012,0,1
4,GO ANIMAL ORGAN MORPHOGENESIS,0.43883,0.041918,0.021304,0,1
4,GO POSITIVE REGULATION OF CELL DIVISION,0.16559,0.041333,0.046313,0,1
4,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.40349,0.039813,0.02187,0,1
4,GO REGULATION OF CELL DIFFERENTIATION,0.38888,0.038972,0.028131,0,1
4,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.49227,0.038946,0.018372,0,1
4,GO METHYLATION,0.19695,0.038536,0.015673,0,1
4,GO CARDIOCYTE DIFFERENTIATION,0.69707,0.037808,0.0066989,0,1
4,GO CELL CYCLE ARREST,0.23937,0.037153,0.034162,0,1
4,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.060602,0.037076,0.045166,0,1
4,GO ORGANELLE LOCALIZATION,0.23245,0.033485,0.028929,0,1
4,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.095625,0.032585,0.036346,0,1
4,GO MACROMOLECULE DEACYLATION,0.32506,0.025786,0.027322,0,1
4,GO DETOXIFICATION OF INORGANIC COMPOUND,0.087232,0.52689,0.36987,0,0
4,GO DOPAMINE BIOSYNTHETIC PROCESS,0.00035231,0.50128,0.59027,0,0
4,GO RESPONSE TO PAIN,2.5308e-05,0.43688,0.41315,0,0
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00081984,0.43535,0.352,0,0
4,GO RETROGRADE TRANS SYNAPTIC SIGNALING,0.022165,0.42582,0.30092,0,0
4,GO TYPE B PANCREATIC CELL PROLIFERATION,0.0028141,0.41069,0.37682,0,0
4,GO CELLULAR RESPONSE TO COPPER ION,0.0099891,0.37731,0.42431,0,0
4,GO CELLULAR RESPONSE TO ZINC ION,0.099158,0.37664,0.27838,0,0
4,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.090515,0.37331,0.20281,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.054842,0.36727,0.19905,0,0
4,GO REFLEX,0.0081404,0.36322,0.30952,0,0
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0013054,0.36162,0.50417,0,0
4,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.0059384,0.36121,0.3147,0,0
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.0047853,0.35804,0.34605,0,0
4,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.0038387,0.35664,0.2821,0,0
4,GO HEMIDESMOSOME ASSEMBLY,0.15773,0.35328,0.18202,0,0
4,GO RESPONSE TO MUSCLE STRETCH,0.00084609,0.34631,0.36372,0,0
4,GO LIPOXYGENASE PATHWAY,0.033166,0.34335,0.25896,0,0
4,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.0028957,0.32945,0.36222,0,0
4,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.084046,0.32774,0.22894,0,0
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.0075304,0.32521,0.27153,0,0
4,GO NEURONAL ACTION POTENTIAL,0.00052342,0.32443,0.4034,0,0
4,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.00095906,0.3193,0.41756,0,0
4,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.0010206,0.31655,0.41734,0,0
4,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.017969,0.30555,0.25899,0,0
4,GO RELAXATION OF CARDIAC MUSCLE,0.0026572,0.30359,0.2886,0,0
4,GO DETECTION OF CALCIUM ION,0.0046564,0.29858,0.32456,0,0
4,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.11235,0.29772,0.19269,0,0
4,GO RESPONSE TO FORSKOLIN,0.012508,0.29453,0.26666,0,0
4,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.079444,0.28415,0.20645,0,0
4,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.0056288,0.28354,0.30415,0,0
4,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,2.5308e-05,0.28012,0.26683,0,0
4,GO PARENTAL BEHAVIOR,0.072231,0.27695,0.18869,0,0
4,GO GAMMA DELTA T CELL DIFFERENTIATION,0.029719,0.27287,0.29749,0,0
4,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.011612,0.27212,0.24246,0,0
4,GO SEGMENT SPECIFICATION,0.20309,0.27064,0.1448,0,0
4,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0037331,0.26589,0.29518,0,0
4,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.0075304,0.2647,0.21026,0,0
4,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.031748,0.25319,0.19326,0,0
4,GO PARAXIAL MESODERM MORPHOGENESIS,0.027188,0.25115,0.27218,0,0
4,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0036303,0.25081,0.26217,0,0
4,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.064293,0.24869,0.15092,0,0
4,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.0032441,0.24805,0.20196,0,0
4,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.046579,0.24708,0.2268,0,0
4,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.29992,0.24637,0.10612,0,0
4,GO STABILIZATION OF MEMBRANE POTENTIAL,0.047551,0.24582,0.21531,0,0
4,GO INDOLALKYLAMINE METABOLIC PROCESS,0.00041602,0.24554,0.33872,0,0
4,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.12473,0.24436,0.20149,0,0
4,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.033166,0.24358,0.25991,0,0
4,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.0038387,0.24142,0.30925,0,0
4,GO ZINC ION HOMEOSTASIS,0.017549,0.2401,0.22372,0,0
4,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.10096,0.23725,0.1262,0,0
4,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.22235,0.2371,0.11196,0,0
4,GO XENOBIOTIC CATABOLIC PROCESS,0.4545,0.23663,0.13901,0,0
4,GO MEGAKARYOCYTE DEVELOPMENT,0.0032441,0.23508,0.29192,0,0
4,GO HYALURONAN CATABOLIC PROCESS,0.075049,0.23469,0.085726,0,0
4,GO REGULATION OF CGMP MEDIATED SIGNALING,0.13583,0.2318,0.13101,0,0
4,GO NUCLEOTIDE SALVAGE,0.019283,0.2274,0.2287,0,0
4,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.57857,0.22708,0.087914,0,0
4,GO DISACCHARIDE METABOLIC PROCESS,0.0094949,0.22609,0.29442,0,0
4,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.13583,0.22566,0.098328,0,0
4,GO INTERLEUKIN 5 PRODUCTION,0.12473,0.22251,0.14944,0,0
4,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.10845,0.22243,0.17772,0,0
4,GO ENDOCARDIUM DEVELOPMENT,0.034637,0.21983,0.21195,0,0
4,GO INOSITOL METABOLIC PROCESS,0.0025083,0.21897,0.23007,0,0
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.072231,0.21864,0.12402,0,0
4,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.40843,0.21822,0.11375,0,0
4,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.16032,0.21789,0.22942,0,0
4,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.095625,0.21648,0.1552,0,0
4,GO CYSTEINE METABOLIC PROCESS,0.25729,0.21628,0.15504,0,0
4,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.23937,0.21585,0.13782,0,0
4,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.060602,0.21574,0.16732,0,0
4,GO ENAMEL MINERALIZATION,0.065563,0.21513,0.17943,0,0
4,GO VASCULAR TRANSPORT,0.063042,0.2141,0.21283,0,0
4,GO REGULATION OF AMYLOID BETA CLEARANCE,0.10654,0.21174,0.15493,0,0
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.088862,0.21124,0.076124,0,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.02268,0.21079,0.1759,0,0
4,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.0051916,0.21007,0.15533,0,0
4,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.14285,0.20984,0.083232,0,0
4,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.14048,0.20982,0.14003,0,0
4,GO DOPAMINE TRANSPORT,0.0073363,0.20969,0.2895,0,0
4,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.22905,0.2095,0.079248,0,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.17374,0.20911,0.084622,0,0
4,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.11434,0.20875,0.2086,0,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.054842,0.20832,0.15469,0,0
4,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.18219,0.20726,0.13725,0,0
4,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.16032,0.20546,0.1734,0,0
4,GO MALE SEX DETERMINATION,0.066855,0.20436,0.16302,0,0
4,GO MYELIN MAINTENANCE,0.046579,0.2039,0.20621,0,0
4,GO REGULATION OF CELLULAR EXTRAVASATION,0.054842,0.20294,0.17287,0,0
4,GO INCLUSION BODY ASSEMBLY,0.035393,0.20266,0.20965,0,0
4,GO REGULATION OF AMINO ACID TRANSPORT,0.029719,0.20166,0.16322,0,0
4,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.0071468,0.20108,0.17623,0,0
4,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.23245,0.20005,0.036058,0,0
4,GO REGULATION OF DOPAMINE SECRETION,0.10096,0.19984,0.26383,0,0
4,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.031748,0.19984,0.20335,0,0
4,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.12049,0.19874,0.10741,0,0
4,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.010506,0.19858,0.16416,0,0
4,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00092958,0.19359,0.23315,0,0
4,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.0023671,0.19329,0.16309,0,0
4,GO REGULATION OF HEART RATE,0.0030654,0.19327,0.18196,0,0
4,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.11636,0.19306,0.15923,0,0
4,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.18219,0.19287,0.082249,0,0
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.01282,0.19281,0.18588,0,0
4,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.029719,0.19249,0.15483,0,0
4,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.075049,0.19163,0.16164,0,0
4,GO CATECHOLAMINE METABOLIC PROCESS,0.0066042,0.19138,0.22429,0,0
4,GO T HELPER 2 CELL DIFFERENTIATION,0.38888,0.19138,-0.011359,0,0
4,GO GLIAL CELL FATE COMMITMENT,0.10465,0.18946,0.22723,0,0
4,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.040234,0.18926,0.15865,0,0
4,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.2,0.18903,0.033767,0,0
4,GO REGULATION OF CELL PROJECTION SIZE,0.017549,0.18895,0.24811,0,0
4,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.14048,0.18842,0.099879,0,0
4,GO ENERGY HOMEOSTASIS,0.0067808,0.18778,0.18786,0,0
4,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.10654,0.18679,0.21018,0,0
4,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.17374,0.1858,0.08517,0,0
4,GO REGULATION OF CARDIAC CONDUCTION,0.0030654,0.18356,0.15212,0,0
4,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.0037331,0.18273,0.26605,0,0
4,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.12908,0.18236,0.10752,0,0
4,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.25363,0.18233,0.056518,0,0
4,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0083534,0.18053,0.19416,0,0
4,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.5726,0.18017,0.068247,0,0
4,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.00021909,0.17986,0.22071,0,0
4,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.099158,0.17982,0.1837,0,0
4,GO POSITIVE REGULATION OF VASCULOGENESIS,0.17934,0.17894,0.18148,0,0
4,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.0041716,0.17887,0.24217,0,0
4,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.0059384,0.17875,0.22589,0,0
4,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.047551,0.17866,0.25995,0,0
4,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.43367,0.17846,0.053616,0,0
4,GO CAMP METABOLIC PROCESS,0.10845,0.17805,0.1194,0,0
4,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.2839,0.17776,0.1684,0,0
4,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.0054795,0.17694,0.34319,0,0
4,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.39858,0.1769,0.21301,0,0
4,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.0062634,0.17665,0.15381,0,0
4,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.076492,0.17555,0.16753,0,0
4,GO REGULATION OF METANEPHROS DEVELOPMENT,0.16828,0.17486,0.090319,0,0
4,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.32506,0.17463,0.092644,0,0
4,GO KETONE BODY METABOLIC PROCESS,0.034637,0.17421,0.24111,0,0
4,GO TRANSMISSION OF NERVE IMPULSE,0.0097392,0.17357,0.20508,0,0
4,GO TERPENOID BIOSYNTHETIC PROCESS,0.017137,0.17354,0.30268,0,0
4,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.21579,0.17352,0.25669,0,0
4,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.16828,0.17339,0.12518,0,0
4,GO RESPONSE TO HYPEROXIA,0.22905,0.17301,0.057251,0,0
4,GO MITOCHONDRIAL TRNA PROCESSING,0.10465,0.17224,0.14612,0,0
4,GO NEPHRIC DUCT DEVELOPMENT,0.12908,0.17153,0.13839,0,0
4,GO NEGATIVE REGULATION OF DNA REPLICATION,0.13355,0.17148,0.095887,0,0
4,GO REGULATION OF VASCULAR PERMEABILITY,0.0054795,0.17137,0.20483,0,0
4,GO CYTOCHROME COMPLEX ASSEMBLY,0.012203,0.17122,0.16867,0,0
4,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.26847,0.1711,0.12649,0,0
4,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.036164,0.17032,0.14036,0,0
4,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.053746,0.17017,0.2102,0,0
4,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.017137,0.16978,0.23445,0,0
4,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.11636,0.16923,0.099231,0,0
4,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.095625,0.16875,0.21746,0,0
4,GO MICROVILLUS ASSEMBLY,0.16828,0.16763,0.13747,0,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.51459,0.16705,0.027477,0,0
4,GO OSTEOCLAST DEVELOPMENT,0.084046,0.16656,0.11356,0,0
4,GO GAMMA DELTA T CELL ACTIVATION,0.021165,0.16633,0.2276,0,0
4,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.31232,0.16609,0.11349,0,0
4,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.85082,0.16508,-0.060188,0,0
4,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.055956,0.165,0.19646,0,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.088862,0.16398,0.15108,0,0
4,GO SKIN MORPHOGENESIS,0.71006,0.16342,-0.044206,0,0
4,GO BASIC AMINO ACID TRANSPORT,0.095625,0.16286,0.2573,0,0
4,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.11235,0.16179,0.065238,0,0
4,GO RESPONSE TO INSECTICIDE,0.019283,0.16109,0.24931,0,0
4,GO MULTICELLULAR ORGANISMAL SIGNALING,0.014486,0.15978,0.13735,0,0
4,GO PEROXISOMAL MEMBRANE TRANSPORT,0.0019282,0.15967,0.17519,0,0
4,GO REGULATION OF KERATINOCYTE MIGRATION,0.099158,0.15928,0.10173,0,0
4,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.33812,0.15921,0.073156,0,0
4,GO MITOTIC DNA REPLICATION,0.049546,0.15843,0.12337,0,0
4,GO RESPONSE TO AMINE,0.39371,0.15816,0.054342,0,0
4,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.20937,0.1571,0.059734,0,0
4,GO HEART INDUCTION,0.21256,0.15632,0.16835,0,0
4,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.021165,0.15593,0.25078,0,0
4,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.0033369,0.15593,0.19233,0,0
4,GO MACROPHAGE PROLIFERATION,0.093897,0.15565,0.17693,0,0
4,GO INACTIVATION OF MAPK ACTIVITY,0.088862,0.15554,0.13601,0,0
4,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.084046,0.15551,0.094348,0,0
4,GO ARGININE METABOLIC PROCESS,0.055956,0.15507,0.27901,0,0
4,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.19095,0.15477,0.14409,0,0
4,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.087232,0.15453,0.076751,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.053746,0.15431,0.19668,0,0
4,GO NERVE DEVELOPMENT,0.092194,0.15401,0.11454,0,0
4,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.16559,0.15392,0.075911,0,0
4,GO REGULATION OF CELL SUBSTRATE ADHESION,0.065563,0.15369,0.078958,0,0
4,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.0695,0.15368,0.13151,0,0
4,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.34256,0.15343,0.070327,0,0
4,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.30402,0.15309,0.060276,0,0
4,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.46512,0.15284,0.052594,0,0
4,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.32938,0.15168,-0.024173,0,0
4,GO LOCOMOTOR RHYTHM,0.14285,0.15156,0.092421,0,0
4,GO MALE MEIOSIS I,0.17934,0.1514,0.1437,0,0
4,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.25729,0.15138,0.095333,0,0
4,GO RESPONSE TO LEUCINE,0.12473,0.15121,0.13886,0,0
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.087232,0.15085,0.13171,0,0
4,GO NEUROPEPTIDE SIGNALING PATHWAY,0.0069616,0.15042,0.16896,0,0
4,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.25001,0.15031,0.065896,0,0
4,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.11039,0.15027,0.10814,0,0
4,GO I KAPPAB PHOSPHORYLATION,0.077957,0.14957,0.11675,0,0
4,GO AMINO ACID IMPORT,0.059411,0.14954,0.13235,0,0
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.095625,0.14919,0.087518,0,0
4,GO DEFENSE RESPONSE TO FUNGUS,0.0060989,0.14912,0.13996,0,0
4,GO GLYCINE TRANSPORT,0.25001,0.14837,0.11725,0,0
4,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.14285,0.14801,0.13881,0,0
4,GO ENDOTHELIUM DEVELOPMENT,0.013139,0.14791,0.13327,0,0
4,GO REPRODUCTIVE BEHAVIOR,0.070855,0.14752,0.11543,0,0
4,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.011047,0.14706,0.22622,0,0
4,GO HORMONE BIOSYNTHETIC PROCESS,0.090515,0.14676,0.13214,0,0
4,GO MITOTIC CYTOKINETIC PROCESS,0.087232,0.14671,0.097922,0,0
4,GO GLYCOPROTEIN CATABOLIC PROCESS,0.3746,0.14594,0.012206,0,0
4,GO PSEUDOPODIUM ORGANIZATION,0.076492,0.14424,0.20672,0,0
4,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.029719,0.14398,0.23435,0,0
4,GO AMINE TRANSPORT,0.015953,0.14384,0.20114,0,0
4,GO PROTEIN LOCALIZATION TO LYSOSOME,0.079444,0.14364,0.11916,0,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.047551,0.1434,0.11429,0,0
4,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.27999,0.14251,0.071323,0,0
4,GO MYELOID CELL APOPTOTIC PROCESS,0.20937,0.14243,0.072001,0,0
4,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.02068,0.14238,0.12832,0,0
4,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.2,0.14238,0.1042,0,0
4,GO PRO B CELL DIFFERENTIATION,0.063042,0.14234,0.1543,0,0
4,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.011904,0.14232,0.14223,0,0
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.02268,0.14212,0.16131,0,0
4,GO NEUROINFLAMMATORY RESPONSE,0.0695,0.14206,0.08653,0,0
4,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.065563,0.14203,0.11036,0,0
4,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.34702,0.1419,0.0024496,0,0
4,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.0032441,0.14155,0.15947,0,0
4,GO ALDITOL METABOLIC PROCESS,0.11039,0.1414,0.096736,0,0
4,GO AMINO ACID ACTIVATION,0.17934,0.14113,0.099453,0,0
4,GO ESTROGEN BIOSYNTHETIC PROCESS,0.041967,0.14103,0.21556,0,0
4,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.0094949,0.14077,0.1829,0,0
4,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.011612,0.14075,0.12428,0,0
4,GO ACTION POTENTIAL,0.013139,0.14005,0.14849,0,0
4,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.1028,0.13976,0.11657,0,0
4,GO OVARIAN FOLLICLE DEVELOPMENT,0.016734,0.13966,0.11862,0,0
4,GO STRIATED MUSCLE ADAPTATION,0.04854,0.13962,0.13706,0,0
4,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.14769,0.13947,0.068838,0,0
4,GO OSTEOCLAST DIFFERENTIATION,0.087232,0.13928,0.079839,0,0
4,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.0695,0.13887,0.1412,0,0
4,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.31653,0.13885,0.12666,0,0
4,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.027803,0.13865,0.15349,0,0
4,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.16032,0.13865,0.19157,0,0
4,GO HEPARIN METABOLIC PROCESS,0.25363,0.1384,0.10753,0,0
4,GO RETINOIC ACID METABOLIC PROCESS,0.26471,0.13836,0.073635,0,0
4,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.10654,0.13799,0.094237,0,0
4,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.047551,0.13786,0.20533,0,0
4,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.54321,0.13783,-0.0054577,0,0
4,GO REGULATION OF CELL MATURATION,0.040234,0.13751,0.109,0,0
4,GO PITUITARY GLAND DEVELOPMENT,0.19393,0.13736,0.1275,0,0
4,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.11235,0.13702,0.12991,0,0
4,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.05824,0.13693,0.10809,0,0
4,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.1028,0.1367,0.093563,0,0
4,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.34702,0.1364,0.051116,0,0
4,GO FIBRINOLYSIS,0.22568,0.13607,0.13284,0,0
4,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.087232,0.13565,0.097694,0,0
4,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.34256,0.13502,0.060817,0,0
4,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.0046564,0.13487,0.24073,0,0
4,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.11636,0.1347,0.10003,0,0
4,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.56075,0.13402,-0.010195,0,0
4,GO MYELIN ASSEMBLY,0.1313,0.13386,0.10951,0,0
4,GO CELLULAR ANION HOMEOSTASIS,0.37932,0.1337,0.024593,0,0
4,GO MONOAMINE TRANSPORT,0.04854,0.13346,0.19722,0,0
4,GO ANION HOMEOSTASIS,0.090515,0.13344,0.11732,0,0
4,GO REGULATION OF VESICLE FUSION,0.14769,0.13339,0.14598,0,0
4,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.16828,0.13334,0.14788,0,0
4,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.14048,0.13282,0.057609,0,0
4,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.36064,0.13268,0.096553,0,0
4,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.21905,0.13247,0.12419,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.15264,0.13229,0.10063,0,0
4,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.19695,0.13184,0.056409,0,0
4,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.097379,0.13179,0.16368,0,0
4,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.23245,0.13159,0.10109,0,0
4,GO MEMBRANE HYPERPOLARIZATION,0.14048,0.13137,0.10242,0,0
4,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.014486,0.13114,0.12606,0,0
4,GO REGULATION OF PODOSOME ASSEMBLY,0.34702,0.13108,0.05196,0,0
4,GO DNA DEALKYLATION,0.22235,0.13089,0.07665,0,0
4,GO HEMOGLOBIN METABOLIC PROCESS,0.12689,0.13089,0.065516,0,0
4,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.38408,0.13072,0.040256,0,0
4,GO NOREPINEPHRINE METABOLIC PROCESS,0.33373,0.12999,0.12203,0,0
4,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.63978,0.12995,0.034175,0,0
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.023205,0.1299,0.11218,0,0
4,GO CHYLOMICRON ASSEMBLY,0.17653,0.12974,0.18441,0,0
4,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.32506,0.1294,0.109,0,0
4,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.16828,0.12929,0.14333,0,0
4,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.1028,0.12922,0.090487,0,0
4,GO HEART PROCESS,0.033894,0.12917,0.089965,0,0
4,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.020205,0.12856,0.22466,0,0
4,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.19393,0.12822,0.035396,0,0
4,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.72313,0.12805,-0.035183,0,0
4,GO REGENERATION,0.090515,0.12759,0.06315,0,0
4,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.02843,0.12753,0.14405,0,0
4,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.42347,0.12743,0.058446,0,0
4,GO RESPONSE TO INACTIVITY,0.030383,0.12677,0.18839,0,0
4,GO CELL FATE DETERMINATION,0.15773,0.1267,0.1026,0,0
4,GO REGULATION OF MEMBRANE PERMEABILITY,0.0075304,0.12662,0.13172,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.29184,0.1265,0.043362,0,0
4,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.017137,0.12617,0.13635,0,0
4,GO NEURON MATURATION,0.061812,0.12601,0.14143,0,0
4,GO POTASSIUM ION HOMEOSTASIS,0.068167,0.12598,0.10057,0,0
4,GO SEX DETERMINATION,0.22235,0.12568,0.061451,0,0
4,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.19393,0.12546,0.10699,0,0
4,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.40349,0.12543,0.046642,0,0
4,GO RESPONSE TO ESTROGEN,0.33812,0.12516,0.052862,0,0
4,GO MACROPHAGE ACTIVATION,0.0023671,0.12492,0.14849,0,0
4,GO PENILE ERECTION,0.76281,0.12476,0.019864,0,0
4,GO MULTICELLULAR ORGANISM AGING,0.00353,0.12473,0.14289,0,0
4,GO ENDOTHELIAL CELL PROLIFERATION,0.026586,0.12429,0.098407,0,0
4,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.001986,0.1242,0.1822,0,0
4,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.12049,0.1239,0.076161,0,0
4,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.029719,0.12386,0.092403,0,0
4,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.64605,0.12352,0.030603,0,0
4,GO KILLING OF CELLS OF OTHER ORGANISM,0.00017796,0.12317,0.18972,0,0
4,GO POSITIVE REGULATION OF MYELINATION,0.05161,0.12308,0.099284,0,0
4,GO PINOCYTOSIS,0.17653,0.12296,0.0493,0,0
4,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.33373,0.1223,0.051927,0,0
4,GO SPERM CAPACITATION,0.012203,0.12224,0.18724,0,0
4,GO VITAMIN TRANSPORT,0.03939,0.12217,0.17486,0,0
4,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.17099,0.12146,0.13363,0,0
4,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.023741,0.12133,0.095176,0,0
4,GO BRANCH ELONGATION OF AN EPITHELIUM,0.64605,0.1212,0.0067255,0,0
4,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.25729,0.12115,0.11008,0,0
4,GO IMMATURE B CELL DIFFERENTIATION,0.15773,0.12111,0.10676,0,0
4,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.0071468,0.1211,0.20117,0,0
4,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.66501,0.12083,0.030677,0,0
4,GO MONOVALENT INORGANIC CATION TRANSPORT,0.0010528,0.12072,0.14722,0,0
4,GO COPPER ION HOMEOSTASIS,0.080955,0.12067,0.12478,0,0
4,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.05824,0.12056,0.15123,0,0
4,GO PIGMENT GRANULE LOCALIZATION,0.010506,0.12028,0.13706,0,0
4,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.13814,0.12023,0.06826,0,0
4,GO REGULATION OF CELLULAR RESPIRATION,0.050569,0.12005,0.18493,0,0
4,GO NEPHRIC DUCT MORPHOGENESIS,0.60272,0.12004,0.02875,0,0
4,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.066855,0.11963,0.10192,0,0
4,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.30402,0.11902,0.17852,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.099158,0.1187,0.087001,0,0
4,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.78289,0.11854,0.053373,0,0
4,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.0097392,0.11848,0.14324,0,0
4,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.99651,0.11837,-0.036149,0,0
4,GO NUCLEOSIDE SALVAGE,0.2839,0.11816,0.042141,0,0
4,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.56075,0.11775,0.02582,0,0
4,GO METANEPHRIC NEPHRON DEVELOPMENT,0.087232,0.11771,0.11809,0,0
4,GO REGULATION OF CAMP MEDIATED SIGNALING,0.084046,0.11738,0.096041,0,0
4,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.12259,0.11714,0.18995,0,0
4,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.13583,0.11705,0.058482,0,0
4,GO REGULATION OF FLAGELLATED SPERM MOTILITY,0.23245,0.117,0.063305,0,0
4,GO CATECHOLAMINE UPTAKE,0.073629,0.11629,0.18959,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.24643,0.11616,0.049685,0,0
4,GO REGULATION OF CALCIUM ION IMPORT,0.11841,0.11603,0.10837,0,0
4,GO SEQUESTERING OF TRIGLYCERIDE,0.092194,0.11587,0.16457,0,0
4,GO ACETYL COA METABOLIC PROCESS,0.054842,0.11558,0.12571,0,0
4,GO FATTY ACYL COA METABOLIC PROCESS,0.011612,0.11528,0.17495,0,0
4,GO REGULATION OF MITOPHAGY,0.059411,0.11523,0.10633,0,0
4,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.054842,0.11517,0.14736,0,0
4,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.23589,0.11499,0.038349,0,0
4,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.016734,0.11479,0.074521,0,0
4,GO REGULATION OF CHROMATIN BINDING,0.099158,0.11439,0.090143,0,0
4,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.37932,0.1143,0.062006,0,0
4,GO CIRCADIAN RHYTHM,0.0015653,0.11423,0.10963,0,0
4,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.16294,0.11422,0.066187,0,0
4,GO REGULATION OF MEMBRANE REPOLARIZATION,0.043763,0.11405,0.11121,0,0
4,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.30402,0.11402,0.1237,0,0
4,GO REGULATION OF PHAGOCYTOSIS,0.080955,0.1134,0.085236,0,0
4,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.02068,0.11324,0.10968,0,0
4,GO ORGANIC CATION TRANSPORT,0.02166,0.11297,0.15194,0,0
4,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.71006,0.11284,0.064216,0,0
4,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.23245,0.11272,0.059491,0,0
4,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.87833,0.11229,0.027627,0,0
4,GO REGULATION OF HISTONE DEACETYLATION,0.0099891,0.11208,0.1699,0,0
4,GO ELECTRON TRANSPORT CHAIN,0.0024367,0.11206,0.19546,0,0
4,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.60272,0.11178,0.014837,0,0
4,GO RUFFLE ASSEMBLY,0.066855,0.11175,0.10429,0,0
4,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.34702,0.11168,0.11799,0,0
4,GO T HELPER 1 CELL DIFFERENTIATION,0.98953,0.11166,-0.035217,0,0
4,GO RESPONSE TO INTERLEUKIN 12,0.10465,0.11155,0.093364,0,0
4,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.050569,0.11151,0.15972,0,0
4,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.20309,0.11147,0.019028,0,0
4,GO DNA DEMETHYLATION,0.099158,0.11146,0.11665,0,0
4,GO OUTER DYNEIN ARM ASSEMBLY,0.28785,0.11143,0.043085,0,0
4,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.69707,0.11141,0.015278,0,0
4,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.0054795,0.11063,0.12953,0,0
4,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.014486,0.1106,0.13154,0,0
4,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.042857,0.11057,0.10146,0,0
4,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.082489,0.11045,0.08369,0,0
4,GO AMINO SUGAR METABOLIC PROCESS,0.12259,0.11032,0.096123,0,0
4,GO ENDOSOME TO LYSOSOME TRANSPORT,0.0040578,0.11005,0.15125,0,0
4,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.05824,0.11002,0.072302,0,0
4,GO BLOOD VESSEL MORPHOGENESIS,0.088862,0.10995,0.06166,0,0
4,GO MEMBRANE REPOLARIZATION,0.1313,0.10991,0.087647,0,0
4,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.097379,0.10966,0.074888,0,0
4,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.10654,0.10955,0.095026,0,0
4,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.14526,0.10938,0.080853,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.049546,0.10926,0.12138,0,0
4,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.27611,0.10904,0.087972,0,0
4,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.1028,0.10899,0.12311,0,0
4,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.0099891,0.10896,0.13431,0,0
4,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.21256,0.10869,0.11474,0,0
4,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.001872,0.1086,0.11231,0,0
4,GO ACTIVATION OF MAPKKK ACTIVITY,0.4545,0.10846,0.0824,0,0
4,GO FIBROBLAST ACTIVATION,0.38408,0.10844,0.043036,0,0
4,GO RESPONSE TO PROSTAGLANDIN E,0.2839,0.10841,0.062713,0,0
4,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.72313,0.10827,-0.0089046,0,0
4,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.27999,0.1081,0.027852,0,0
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.21579,0.10799,0.1984,0,0
4,GO COMPLEMENT ACTIVATION,0.035393,0.10783,0.13045,0,0
4,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.066855,0.10754,0.12069,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.10465,0.10744,0.091208,0,0
4,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.02166,0.10739,0.16112,0,0
4,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.43883,0.10738,0.080855,0,0
4,GO TUMOR NECROSIS FACTOR SECRETION,0.05161,0.10736,0.085752,0,0
4,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.89215,0.10726,-0.035018,0,0
4,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.12259,0.10719,0.091421,0,0
4,GO ACTIN FILAMENT BASED TRANSPORT,0.033166,0.10695,0.19016,0,0
4,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.12689,0.10686,0.17856,0,0
4,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.076492,0.10638,0.12379,0,0
4,GO PROTEIN REFOLDING,0.076492,0.10624,0.14588,0,0
4,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.10096,0.106,0.10419,0,0
4,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.21579,0.10583,0.062779,0,0
4,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.13583,0.1058,0.11411,0,0
4,GO MIDGUT DEVELOPMENT,0.32077,0.10566,0.099342,0,0
4,GO POSITIVE REGULATION OF TOR SIGNALING,0.0050528,0.10553,0.1039,0,0
4,GO REGULATION OF SYNAPSE MATURATION,0.84397,0.10552,-0.025462,0,0
4,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.017969,0.10537,0.13118,0,0
4,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.16828,0.10531,0.10413,0,0
4,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.4598,0.10518,0.041373,0,0
4,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.18219,0.1051,0.082224,0,0
4,GO GLUTATHIONE METABOLIC PROCESS,0.095625,0.10497,0.1873,0,0
4,GO EPITHELIAL CELL MATURATION,0.26098,0.10479,0.11661,0,0
4,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.076492,0.10457,0.10041,0,0
4,GO EXPORT ACROSS PLASMA MEMBRANE,0.023741,0.10446,0.15814,0,0
4,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.1313,0.10439,0.043321,0,0
4,GO DIENCEPHALON DEVELOPMENT,0.25363,0.10415,0.079625,0,0
4,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.17099,0.10396,0.057121,0,0
4,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.11039,0.10376,0.070663,0,0
4,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.043763,0.10367,0.18292,0,0
4,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0031536,0.1036,0.14972,0,0
4,GO ENDOSOMAL TRANSPORT,0.00084609,0.10357,0.094593,0,0
4,GO COLLAGEN CATABOLIC PROCESS,0.15773,0.1032,0.061993,0,0
4,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.19393,0.10286,0.094107,0,0
4,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.085627,0.10284,0.069839,0,0
4,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.20309,0.10262,0.091448,0,0
4,GO STORE OPERATED CALCIUM ENTRY,0.38888,0.1025,0.086288,0,0
4,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.10465,0.10246,0.053766,0,0
4,GO ENDODERMAL CELL FATE COMMITMENT,0.23937,0.10237,0.059955,0,0
4,GO ACTIN CYTOSKELETON REORGANIZATION,0.070855,0.10209,0.059006,0,0
4,GO MATING BEHAVIOR,0.26098,0.10181,0.069622,0,0
4,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.082489,0.10163,0.090355,0,0
4,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.2839,0.10159,0.12778,0,0
4,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.061812,0.10156,0.11172,0,0
4,GO ESTROUS CYCLE,0.38408,0.10147,0.079742,0,0
4,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.041967,0.10134,0.16838,0,0
4,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.21256,0.10088,0.14193,0,0
4,GO RESPONSE TO AMPHETAMINE,0.31232,0.10082,0.10043,0,0
4,GO BEHAVIORAL RESPONSE TO COCAINE,0.67137,0.10008,-0.054841,0,0
4,GO GLUCOCORTICOID METABOLIC PROCESS,0.81668,0.10001,0.014489,0,0
4,GO RESPONSE TO RETINOIC ACID,0.26471,0.099901,0.04982,0,0
4,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.30815,0.099676,0.055018,0,0
4,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.88523,0.099536,-0.032826,0,0
4,GO L AMINO ACID TRANSPORT,0.10845,0.099398,0.10701,0,0
4,GO AUTOPHAGIC CELL DEATH,0.061812,0.099367,0.11971,0,0
4,GO COENZYME A BIOSYNTHETIC PROCESS,0.025994,0.099346,0.16281,0,0
4,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.070855,0.099333,0.11928,0,0
4,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.14285,0.099227,0.097566,0,0
4,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.57857,0.099133,0.015984,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.061812,0.099054,0.088451,0,0
4,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.087232,0.099006,0.071086,0,0
4,GO CELL JUNCTION DISASSEMBLY,0.5726,0.098954,0.026696,0,0
4,GO ASTROCYTE ACTIVATION,0.61497,0.098928,-0.0035062,0,0
4,GO GLIAL CELL MIGRATION,0.34256,0.098874,0.026323,0,0
4,GO PRE MIRNA PROCESSING,0.77618,0.098802,-0.031214,0,0
4,GO POSITIVE REGULATION OF ION TRANSPORT,0.013139,0.098705,0.096186,0,0
4,GO CARDIAC CONDUCTION,0.14769,0.098621,0.074992,0,0
4,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.25001,0.098615,0.080463,0,0
4,GO ORGAN INDUCTION,0.23245,0.098569,0.044287,0,0
4,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.16294,0.098502,0.079314,0,0
4,GO THIOESTER METABOLIC PROCESS,0.0037331,0.09835,0.1645,0,0
4,GO SULFUR COMPOUND CATABOLIC PROCESS,0.29586,0.098323,0.037325,0,0
4,GO MITOCHONDRIAL TRANSCRIPTION,0.20621,0.098224,0.10315,0,0
4,GO POSITIVE REGULATION OF JNK CASCADE,0.0014299,0.097975,0.13907,0,0
4,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.23245,0.097821,0.10312,0,0
4,GO GROOMING BEHAVIOR,0.2,0.097677,0.12631,0,0
4,GO IMMATURE T CELL PROLIFERATION,0.60272,0.097653,0.075542,0,0
4,GO REGULATION OF GLOMERULAR FILTRATION,0.49227,0.097462,0.1063,0,0
4,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.15517,0.097344,0.085369,0,0
4,GO MUSCLE SYSTEM PROCESS,0.040234,0.097302,0.068933,0,0
4,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.12908,0.09697,0.04182,0,0
4,GO PROTEIN PALMITOYLATION,0.14048,0.096921,0.075588,0,0
4,GO TRIGLYCERIDE CATABOLIC PROCESS,0.093897,0.096905,0.11039,0,0
4,GO REGULATION OF HAIR CYCLE,0.15773,0.096901,0.07847,0,0
4,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.35607,0.096779,0.10492,0,0
4,GO CELLULAR COPPER ION HOMEOSTASIS,0.16032,0.096573,0.10329,0,0
4,GO INFLAMMATORY RESPONSE TO WOUNDING,0.80989,0.096302,0.010545,0,0
4,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.10845,0.096116,0.068884,0,0
4,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.24288,0.096063,0.15358,0,0
4,GO CELLULAR SODIUM ION HOMEOSTASIS,0.12049,0.095969,0.11519,0,0
4,GO REGULATION OF MEMBRANE INVAGINATION,0.55487,0.095648,0.08162,0,0
4,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.087232,0.095538,0.073489,0,0
4,GO COPPER ION TRANSPORT,0.035393,0.09551,0.15867,0,0
4,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.42347,0.095414,0.089879,0,0
4,GO CELL SUBSTRATE ADHESION,0.16828,0.095328,0.043601,0,0
4,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.16828,0.095321,0.047926,0,0
4,GO LACTATE METABOLIC PROCESS,0.23245,0.09489,0.071485,0,0
4,GO TUBE MORPHOGENESIS,0.084046,0.094824,0.060127,0,0
4,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.39371,0.094745,0.048077,0,0
4,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.02268,0.094647,0.11382,0,0
4,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.0053338,0.094521,0.13823,0,0
4,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.48678,0.094457,0.057761,0,0
4,GO MYOBLAST DIFFERENTIATION,0.31232,0.094179,0.023005,0,0
4,GO METANEPHROS DEVELOPMENT,0.26471,0.093988,0.05857,0,0
4,GO AMP METABOLIC PROCESS,0.23937,0.093513,0.12488,0,0
4,GO PYRUVATE METABOLIC PROCESS,0.073629,0.093462,0.083376,0,0
4,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.16032,0.093345,0.091757,0,0
4,GO P38MAPK CASCADE,0.12049,0.093295,0.091608,0,0
4,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.053746,0.093238,0.090204,0,0
4,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.2839,0.093163,0.016412,0,0
4,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.092194,0.093115,0.1554,0,0
4,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.14285,0.093036,0.12535,0,0
4,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.064293,0.09302,0.090478,0,0
4,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.33812,0.092842,0.032533,0,0
4,GO MELANOCYTE DIFFERENTIATION,0.038561,0.09279,0.12334,0,0
4,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.2839,0.092756,0.028192,0,0
4,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.35607,0.092674,0.065005,0,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.10465,0.092636,0.10243,0,0
4,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.97557,0.092632,0.007885,0,0
4,GO ADULT FEEDING BEHAVIOR,0.89215,0.09263,-0.040153,0,0
4,GO MUSCLE CELL DEVELOPMENT,0.033894,0.092581,0.087585,0,0
4,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.2839,0.092528,0.051979,0,0
4,GO VASCULATURE DEVELOPMENT,0.19393,0.092478,0.04094,0,0
4,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.031059,0.092465,0.090484,0,0
4,GO BRONCHUS DEVELOPMENT,0.56075,0.092317,0.072735,0,0
4,GO NEURON CELL CELL ADHESION,0.70355,0.092022,0.088381,0,0
4,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.14769,0.092006,0.10905,0,0
4,GO FATTY ACID HOMEOSTASIS,0.33373,0.091868,0.094703,0,0
4,GO NEGATIVE REGULATION OF AUTOPHAGY,0.080955,0.09178,0.071732,0,0
4,GO BLEB ASSEMBLY,0.73628,0.091735,-0.10133,0,0
4,GO LAMELLIPODIUM ORGANIZATION,0.23937,0.091328,0.044936,0,0
4,GO T CELL DIFFERENTIATION IN THYMUS,0.16294,0.091266,0.060416,0,0
4,GO SEGMENTATION,0.17099,0.091238,0.062059,0,0
4,GO RESPONSE TO SALT,0.10465,0.090922,0.082656,0,0
4,GO MONONUCLEAR CELL DIFFERENTIATION,0.17934,0.090805,0.10516,0,0
4,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.088862,0.090749,0.10515,0,0
4,GO FORMATION OF PRIMARY GERM LAYER,0.31232,0.090431,0.043949,0,0
4,GO POSITIVE REGULATION OF CELL GROWTH,0.043763,0.090309,0.069459,0,0
4,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.060602,0.09021,0.11291,0,0
4,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.031059,0.090164,0.099898,0,0
4,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.088862,0.090144,0.10268,0,0
4,GO NOTOCHORD DEVELOPMENT,0.60883,0.089854,-0.022511,0,0
4,GO STEROL IMPORT,0.085627,0.089519,0.18024,0,0
4,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.63354,0.08949,-0.0019199,0,0
4,GO DIACYLGLYCEROL METABOLIC PROCESS,0.11039,0.089313,0.16783,0,0
4,GO EMBRYONIC AXIS SPECIFICATION,0.21579,0.089179,0.090403,0,0
4,GO MALE MEIOTIC NUCLEAR DIVISION,0.20621,0.089167,0.083712,0,0
4,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.14285,0.089078,0.058037,0,0
4,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.090515,0.088945,0.073192,0,0
4,GO REGULATION OF KIDNEY DEVELOPMENT,0.1028,0.088817,0.094022,0,0
4,GO THYROID HORMONE METABOLIC PROCESS,0.10654,0.088763,0.086864,0,0
4,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.21905,0.088637,0.099377,0,0
4,GO PULMONARY VALVE MORPHOGENESIS,0.29586,0.088574,0.077585,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.22905,0.088419,0.015001,0,0
4,GO TISSUE MORPHOGENESIS,0.079444,0.088288,0.048877,0,0
4,GO NEGATIVE REGULATION OF GENE SILENCING,0.32938,0.088132,0.038095,0,0
4,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.21579,0.087946,0.054686,0,0
4,GO EXOCRINE SYSTEM DEVELOPMENT,0.23245,0.087848,0.08135,0,0
4,GO TRNA 5 END PROCESSING,0.2839,0.087807,0.065116,0,0
4,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.18219,0.087792,0.052894,0,0
4,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.068167,0.08771,0.075115,0,0
4,GO OSSIFICATION,0.057089,0.087689,0.070347,0,0
4,GO CELLULAR IRON ION HOMEOSTASIS,0.076492,0.087476,0.11617,0,0
4,GO REGULATION OF MIRNA METABOLIC PROCESS,0.72313,0.087347,-0.015595,0,0
4,GO CELLULAR SENESCENCE,0.10845,0.087024,0.05731,0,0
4,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.8303,0.087016,-0.055879,0,0
4,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.042857,0.086958,0.20346,0,0
4,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.10465,0.086522,0.076773,0,0
4,GO PROTEIN OXIDATION,0.72969,0.086462,-0.033159,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.30815,0.086438,0.068058,0,0
4,GO SEMI LUNAR VALVE DEVELOPMENT,0.57857,0.086371,-0.0057585,0,0
4,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.18219,0.086016,0.054078,0,0
4,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.088862,0.085844,0.24918,0,0
4,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.29992,0.085822,0.069439,0,0
4,GO MULTI ORGANISM CELLULAR PROCESS,0.2,0.084977,0.053599,0,0
4,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.17099,0.084761,0.055201,0,0
4,GO OOCYTE MATURATION,0.26847,0.084707,0.052128,0,0
4,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.063042,0.08464,0.1283,0,0
4,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.31653,0.084455,0.11722,0,0
4,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.36991,0.084416,0.054407,0,0
4,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.188,0.084237,0.042633,0,0
4,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.12473,0.084101,0.19795,0,0
4,GO GLIAL CELL ACTIVATION,0.20621,0.083833,0.057612,0,0
4,GO CARBOHYDRATE PHOSPHORYLATION,0.61497,0.083731,0.034796,0,0
4,GO REGULATION OF SYSTEM PROCESS,0.054842,0.083507,0.071428,0,0
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.18508,0.08328,0.086653,0,0
4,GO REGULATION OF BIOMINERALIZATION,0.12908,0.082911,0.066409,0,0
4,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.099158,0.082905,0.090536,0,0
4,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.14526,0.082902,0.05297,0,0
4,GO CELL JUNCTION ASSEMBLY,0.073629,0.082805,0.079978,0,0
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.13814,0.082695,0.056586,0,0
4,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.13583,0.082627,0.061814,0,0
4,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.4545,0.082533,0.10805,0,0
4,GO CELLULAR AMIDE METABOLIC PROCESS,0.053746,0.082494,0.078649,0,0
4,GO REGULATION OF SPROUTING ANGIOGENESIS,0.15773,0.082492,0.063242,0,0
4,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.44402,0.082442,0.041182,0,0
4,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.32077,0.082416,0.12827,0,0
4,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.075049,0.081841,0.16013,0,0
4,GO REGULATION OF ENDOCYTOSIS,0.19695,0.081835,0.048809,0,0
4,GO LYSINE METABOLIC PROCESS,0.22905,0.081499,0.12819,0,0
4,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.001986,0.081426,0.14104,0,0
4,GO REGULATION OF RECEPTOR CLUSTERING,0.33812,0.081415,0.1221,0,0
4,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.48678,0.08103,0.066105,0,0
4,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.097379,0.080979,0.10503,0,0
4,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.15015,0.080648,0.082797,0,0
4,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.076492,0.08064,0.053793,0,0
4,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.19095,0.080434,0.094155,0,0
4,GO REGULATION OF CARTILAGE DEVELOPMENT,0.079444,0.080362,0.088651,0,0
4,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.5726,0.080311,0.03094,0,0
4,GO REGULATION OF MUSCLE CONTRACTION,0.063042,0.080143,0.075175,0,0
4,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.46512,0.080078,0.035587,0,0
4,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.25363,0.079933,0.055004,0,0
4,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.084046,0.07993,0.058511,0,0
4,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.084046,0.079619,0.078239,0,0
4,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.65866,0.079613,-0.040381,0,0
4,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.23589,0.079219,0.047702,0,0
4,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.188,0.079043,0.045397,0,0
4,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.040234,0.078852,0.14965,0,0
4,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.44924,0.078823,0.016679,0,0
4,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.10096,0.078629,0.13614,0,0
4,GO REGULATION OF CHOLESTEROL EFFLUX,0.085627,0.078626,0.087778,0,0
4,GO RESPONSE TO ZINC ION,0.24643,0.078497,0.090455,0,0
4,GO FACE DEVELOPMENT,0.85082,0.078409,-0.0039074,0,0
4,GO FEMALE GAMETE GENERATION,0.17934,0.078395,0.047493,0,0
4,GO CELLULAR RESPONSE TO AMYLOID BETA,0.064293,0.078354,0.11364,0,0
4,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.24288,0.078353,0.15564,0,0
4,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.21256,0.078347,0.097048,0,0
4,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.26847,0.078226,0.043525,0,0
4,GO OLIGODENDROCYTE DIFFERENTIATION,0.18508,0.078168,0.085569,0,0
4,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.0695,0.078067,0.092509,0,0
4,GO GMP METABOLIC PROCESS,0.21579,0.077815,0.075899,0,0
4,GO VESICLE DOCKING,0.22905,0.077284,0.065222,0,0
4,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.21579,0.077249,0.060218,0,0
4,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.23589,0.077242,0.054686,0,0
4,GO RESPONSE TO INTERLEUKIN 4,0.057089,0.077219,0.086547,0,0
4,GO PROTEIN HOMOTETRAMERIZATION,0.14048,0.077192,0.052847,0,0
4,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.24288,0.077148,0.038478,0,0
4,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.20621,0.077106,0.079018,0,0
4,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.28785,0.077032,0.027622,0,0
4,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.10465,0.076857,0.079536,0,0
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.14048,0.076815,0.059488,0,0
4,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.2839,0.076499,0.043993,0,0
4,GO SPROUTING ANGIOGENESIS,0.41341,0.076419,0.020645,0,0
4,GO ACTIN FILAMENT BASED MOVEMENT,0.33373,0.076188,0.036607,0,0
4,GO NUCLEAR ENVELOPE ORGANIZATION,0.082489,0.075857,0.047153,0,0
4,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.42347,0.075752,0.031752,0,0
4,GO REGULATION OF GASTRIC ACID SECRETION,0.2,0.07566,0.11907,0,0
4,GO IMPORT INTO CELL,0.095625,0.075636,0.086032,0,0
4,GO SOMITE DEVELOPMENT,0.052669,0.075568,0.065929,0,0
4,GO SECRETORY GRANULE ORGANIZATION,0.14285,0.075518,0.084534,0,0
4,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.11434,0.075459,0.073801,0,0
4,GO REGULATION OF ERAD PATHWAY,0.47588,0.07538,0.025717,0,0
4,GO PIGMENT METABOLIC PROCESS,0.12259,0.075371,0.099749,0,0
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.017549,0.075349,0.10263,0,0
4,GO RENAL SODIUM EXCRETION,0.046579,0.075117,0.14672,0,0
4,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.064293,0.075103,0.0873,0,0
4,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.27999,0.075074,0.094639,0,0
4,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.48131,0.075069,-0.045102,0,0
4,GO MALE GENITALIA DEVELOPMENT,0.084046,0.074746,0.12815,0,0
4,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.78962,0.074671,0.0022601,0,0
4,GO SENSORY PERCEPTION OF PAIN,0.099158,0.074409,0.088784,0,0
4,GO INTERMEMBRANE LIPID TRANSFER,0.060602,0.073839,0.080549,0,0
4,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.63354,0.073832,-0.062628,0,0
4,GO BLASTODERM SEGMENTATION,0.65234,0.073814,0.028204,0,0
4,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.25001,0.073525,0.065507,0,0
4,GO PERICARDIUM DEVELOPMENT,0.89215,0.073507,-0.026152,0,0
4,GO POTASSIUM ION TRANSPORT,0.11235,0.073402,0.094843,0,0
4,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.22568,0.073086,0.053948,0,0
4,GO VISUAL BEHAVIOR,0.17099,0.072972,0.087807,0,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.05824,0.072904,0.092436,0,0
4,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.80312,0.072755,-0.029159,0,0
4,GO MITOCHONDRIAL GENE EXPRESSION,0.23937,0.07246,0.066333,0,0
4,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.43883,0.072367,0.033973,0,0
4,GO TOXIN TRANSPORT,0.095625,0.072312,0.10912,0,0
4,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.25001,0.072218,0.094068,0,0
4,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.17099,0.072213,0.099252,0,0
4,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.082489,0.072068,0.070722,0,0
4,GO ADHERENS JUNCTION ORGANIZATION,0.19695,0.071856,0.07916,0,0
4,GO REGULATION OF PROTON TRANSPORT,0.50896,0.071793,0.064233,0,0
4,GO CHEMOSENSORY BEHAVIOR,0.39858,0.07178,0.0316,0,0
4,GO DEPHOSPHORYLATION,0.027188,0.071715,0.059031,0,0
4,GO INTERMEDIATE FILAMENT ORGANIZATION,0.25729,0.071686,0.060848,0,0
4,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.17374,0.071682,0.086551,0,0
4,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.2839,0.071667,0.075745,0,0
4,GO REGULATION OF RECEPTOR RECYCLING,0.29992,0.071545,0.047653,0,0
4,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.2,0.071438,0.059745,0,0
4,GO FEMALE SEX DIFFERENTIATION,0.24643,0.071405,0.040981,0,0
4,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.0695,0.071388,0.055079,0,0
4,GO PEPTIDYL PROLINE MODIFICATION,0.1313,0.071239,0.075447,0,0
4,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.53742,0.071145,0.034835,0,0
4,GO STRIATED MUSCLE CONTRACTION,0.18219,0.070997,0.059849,0,0
4,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.62113,0.07088,0.026536,0,0
4,GO REGULATION OF INTRACELLULAR TRANSPORT,0.16559,0.070769,0.032365,0,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.84397,0.070737,-0.00043298,0,0
4,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.04854,0.070718,0.13238,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.22568,0.070672,0.078083,0,0
4,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.18219,0.070644,0.11574,0,0
4,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.35153,0.070317,0.038237,0,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.013798,0.070315,0.12253,0,0
4,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.17374,0.070288,0.091378,0,0
4,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.14769,0.070241,0.070284,0,0
4,GO REGULATION OF PROTEIN SUMOYLATION,0.26471,0.070088,0.057722,0,0
4,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.8303,0.070045,-0.062878,0,0
4,GO NEURONAL ION CHANNEL CLUSTERING,0.25363,0.07,0.13257,0,0
4,GO INNER DYNEIN ARM ASSEMBLY,0.72969,0.069933,0.012195,0,0
4,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.12473,0.069754,0.17996,0,0
4,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.38888,0.069679,0.075171,0,0
4,GO GRANULOCYTE DIFFERENTIATION,0.40843,0.069572,0.070066,0,0
4,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.37932,0.069531,0.047712,0,0
4,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.27227,0.069449,0.059133,0,0
4,GO ASTROCYTE DEVELOPMENT,0.91293,0.0691,-0.00095255,0,0
4,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.44924,0.06904,0.014552,0,0
4,GO DETECTION OF TEMPERATURE STIMULUS,0.35153,0.068888,0.1104,0,0
4,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.059411,0.068801,0.080256,0,0
4,GO POSITIVE REGULATION OF OSSIFICATION,0.19695,0.068784,0.075908,0,0
4,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.22905,0.068283,0.051241,0,0
4,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.53742,0.068223,0.047945,0,0
4,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.82348,0.068201,0.0062786,0,0
4,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.49227,0.068129,0.056981,0,0
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.9686,0.068013,-0.022928,0,0
4,GO STEROID CATABOLIC PROCESS,0.042857,0.067905,0.22206,0,0
4,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.7495,0.067801,-0.06856,0,0
4,GO GERM CELL DEVELOPMENT,0.097379,0.067583,0.051381,0,0
4,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.066855,0.067534,0.051461,0,0
4,GO REGULATION OF DNA METHYLATION,0.29992,0.067283,0.056739,0,0
4,GO UV DAMAGE EXCISION REPAIR,0.36526,0.067261,0.037814,0,0
4,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.26471,0.067011,0.063763,0,0
4,GO TRABECULA MORPHOGENESIS,0.65234,0.066977,-0.0005858,0,0
4,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.30402,0.066945,0.10761,0,0
4,GO MACROPHAGE APOPTOTIC PROCESS,0.30815,0.066924,0.0903,0,0
4,GO PHOTOPERIODISM,0.21256,0.066771,0.088864,0,0
4,GO REGULATION OF CELL SHAPE,0.1028,0.066738,0.055856,0,0
4,GO PEPTIDE METABOLIC PROCESS,0.29586,0.066379,0.043711,0,0
4,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.10096,0.066341,0.060474,0,0
4,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.082489,0.066246,0.15757,0,0
4,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.25363,0.066152,0.027951,0,0
4,GO MOLTING CYCLE,0.13355,0.066076,0.056212,0,0
4,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.46512,0.065893,0.042282,0,0
4,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.26098,0.065716,0.10637,0,0
4,GO PROTEIN FOLDING,0.070855,0.065715,0.085004,0,0
4,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.18508,0.06569,0.039216,0,0
4,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.20621,0.06561,0.063209,0,0
4,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.19095,0.065474,0.063132,0,0
4,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.20937,0.065418,0.042414,0,0
4,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.52025,0.065409,0.021947,0,0
4,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.21579,0.064991,0.10922,0,0
4,GO RENAL FILTRATION,0.65866,0.064921,0.063475,0,0
4,GO REGULATION OF ODONTOGENESIS,0.82348,0.064855,-0.039933,0,0
4,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.27611,0.064775,0.030388,0,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.21579,0.064756,0.056279,0,0
4,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.4978,0.064641,0.0065185,0,0
4,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.12259,0.064405,0.071516,0,0
4,GO THYMUS DEVELOPMENT,0.58456,0.064391,0.023101,0,0
4,GO ASSOCIATIVE LEARNING,0.38888,0.064371,0.046273,0,0
4,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.84397,0.064311,0.015376,0,0
4,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.87144,0.064218,0.0021017,0,0
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.14285,0.063947,0.13067,0,0
4,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.71658,0.063929,-0.025211,0,0
4,GO REGULATION OF JUN KINASE ACTIVITY,0.035393,0.063888,0.09115,0,0
4,GO REGULATION OF CELL FATE COMMITMENT,0.25729,0.063874,0.053031,0,0
4,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.14048,0.063696,0.059098,0,0
4,GO COENZYME A METABOLIC PROCESS,0.12473,0.063669,0.10871,0,0
4,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.44924,0.063659,0.013104,0,0
4,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.49227,0.063299,0.045086,0,0
4,GO OSTEOBLAST DEVELOPMENT,0.40843,0.062936,0.011491,0,0
4,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.12049,0.062931,0.084871,0,0
4,GO EPITHELIAL TUBE FORMATION,0.54903,0.062915,0.00076328,0,0
4,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.076492,0.062886,0.12093,0,0
4,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.20621,0.062781,0.12404,0,0
4,GO REGULATION OF CELL AGING,0.95466,0.062553,-0.0080438,0,0
4,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.054842,0.062501,0.034336,0,0
4,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.10096,0.062264,0.14335,0,0
4,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.43883,0.062128,0.13996,0,0
4,GO RELAXATION OF MUSCLE,0.49227,0.062038,0.043538,0,0
4,GO PORE COMPLEX ASSEMBLY,0.37932,0.061954,0.054286,0,0
4,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.63978,0.061948,0.01457,0,0
4,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.31232,0.061896,0.029311,0,0
4,GO NUCLEOTIDE PHOSPHORYLATION,0.15773,0.061895,0.058982,0,0
4,GO REGULATION OF URINE VOLUME,0.97557,0.061881,-0.0052108,0,0
4,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.097379,0.061786,0.13393,0,0
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.94769,0.061553,-0.029997,0,0
4,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.42855,0.061418,0.067518,0,0
4,GO RECEPTOR RECYCLING,0.17653,0.061313,0.071489,0,0
4,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.15773,0.06131,0.055996,0,0
4,GO ENDODERM DEVELOPMENT,0.42855,0.06129,0.022586,0,0
4,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.14769,0.061282,0.055985,0,0
4,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.092194,0.061106,0.076467,0,0
4,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.59664,0.061049,0.038331,0,0
4,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.080955,0.061045,0.067368,0,0
4,GO WATER TRANSPORT,0.13355,0.060958,0.055903,0,0
4,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.40843,0.060794,0.015614,0,0
4,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.72969,0.060627,-0.0023925,0,0
4,GO REGULATION OF MRNA CATABOLIC PROCESS,0.49227,0.060626,0.010742,0,0
4,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.53167,0.060548,0.018378,0,0
4,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.20309,0.060538,0.052061,0,0
4,GO REGULATION OF STEM CELL DIFFERENTIATION,0.54903,0.060468,0.012354,0,0
4,GO CIRCULATORY SYSTEM DEVELOPMENT,0.28785,0.060347,0.031497,0,0
4,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.83713,0.060262,-0.054779,0,0
4,GO CENTROSOME SEPARATION,0.48131,0.059989,0.054745,0,0
4,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.34256,0.059957,0.07638,0,0
4,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.8303,0.059884,0.021241,0,0
4,GO PRIMARY MIRNA PROCESSING,0.4598,0.059736,0.018194,0,0
4,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.17653,0.059674,0.076107,0,0
4,GO NEGATIVE REGULATION OF GLIOGENESIS,0.27611,0.059412,0.10656,0,0
4,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.29586,0.059384,0.0537,0,0
4,GO CARDIAC MUSCLE CONTRACTION,0.20621,0.059315,0.058491,0,0
4,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.24643,0.059131,0.057131,0,0
4,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.47049,0.059105,0.026959,0,0
4,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.71658,0.0591,0.010638,0,0
4,GO REGULATION OF EXIT FROM MITOSIS,0.14526,0.05907,0.072586,0,0
4,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.60883,0.05879,0.017137,0,0
4,GO AXIS SPECIFICATION,0.24643,0.058602,0.055143,0,0
4,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.26098,0.058547,0.090923,0,0
4,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.53167,0.058517,0.051527,0,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.40843,0.058498,0.038193,0,0
4,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.54903,0.058477,0.018357,0,0
4,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.88523,0.058231,0.0018374,0,0
4,GO PROTEIN COMPLEX OLIGOMERIZATION,0.077957,0.058077,0.061362,0,0
4,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.27227,0.057925,0.033359,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.16559,0.057825,0.045662,0,0
4,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.87144,0.057783,-0.0053465,0,0
4,GO ADENOHYPOPHYSIS DEVELOPMENT,0.59664,0.057776,0.07692,0,0
4,GO PROTEASOME ASSEMBLY,0.33812,0.057724,0.075472,0,0
4,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.10096,0.05757,0.068341,0,0
4,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.53742,0.057371,0.018713,0,0
4,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.44924,0.057226,0.044211,0,0
4,GO RESPONSE TO NICOTINE,0.58456,0.057102,0.040499,0,0
4,GO MESODERM MORPHOGENESIS,0.42855,0.057064,0.022713,0,0
4,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.22235,0.057031,0.044217,0,0
4,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.65234,0.057023,0.0060259,0,0
4,GO RESPONSE TO RADIATION,0.15773,0.056869,0.028604,0,0
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.12259,0.056821,0.049928,0,0
4,GO NOSE DEVELOPMENT,0.5726,0.056814,0.14655,0,0
4,GO SKELETAL MUSCLE TISSUE REGENERATION,0.55487,0.056811,0.012382,0,0
4,GO RESPONSE TO GROWTH FACTOR,0.15517,0.056544,0.044744,0,0
4,GO NADPH REGENERATION,0.41341,0.056535,0.094847,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.94073,0.056522,-0.021169,0,0
4,GO OXYGEN TRANSPORT,0.56666,0.056476,-0.14133,0,0
4,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.32938,0.056354,0.062432,0,0
4,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.10465,0.056234,0.042768,0,0
4,GO MODULATION BY HOST OF VIRAL PROCESS,0.41842,0.056037,0.0051075,0,0
4,GO MUSCLE CONTRACTION,0.12689,0.055996,0.045959,0,0
4,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.36064,0.055812,0.061328,0,0
4,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.046579,0.055781,0.075359,0,0
4,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.80312,0.055761,-0.033344,0,0
4,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.74288,0.055673,0.0079242,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.19393,0.055651,0.077071,0,0
4,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.38408,0.05563,0.025876,0,0
4,GO INNERVATION,0.78289,0.055579,0.077785,0,0
4,GO SECONDARY PALATE DEVELOPMENT,0.48678,0.055538,0.045568,0,0
4,GO ECTODERMAL PLACODE DEVELOPMENT,0.65866,0.055412,0.025671,0,0
4,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.22568,0.055248,0.030371,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.36064,0.055233,0.028898,0,0
4,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.28785,0.055208,0.078201,0,0
4,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.49227,0.055123,0.064639,0,0
4,GO APOPTOTIC CELL CLEARANCE,0.62113,0.055112,-0.043285,0,0
4,GO NEPHRON MORPHOGENESIS,0.35153,0.055068,0.035728,0,0
4,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.63354,0.055046,0.0038974,0,0
4,GO NAD BIOSYNTHETIC PROCESS,0.28785,0.054995,0.080987,0,0
4,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.20937,0.054942,0.10046,0,0
4,GO CELL AGGREGATION,0.69061,0.054765,-0.048468,0,0
4,GO ESTABLISHMENT OF CELL POLARITY,0.63978,0.054663,0.029127,0,0
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.099158,0.054546,0.054818,0,0
4,GO AXONEME ASSEMBLY,0.40349,0.054544,0.050568,0,0
4,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.17099,0.054409,0.039136,0,0
4,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.41341,0.054245,0.068581,0,0
4,GO LIPID PHOSPHORYLATION,0.26471,0.054209,0.060471,0,0
4,GO ATP TRANSPORT,0.27611,0.054153,0.055065,0,0
4,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.15264,0.054033,0.058801,0,0
4,GO CATECHOLAMINE SECRETION,0.11636,0.05396,0.20746,0,0
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.095625,0.053937,0.051462,0,0
4,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.29586,0.053825,0.047989,0,0
4,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.26471,0.053696,0.061155,0,0
4,GO ANIMAL ORGAN MATURATION,0.4545,0.053611,0.036465,0,0
4,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.27611,0.0535,0.097053,0,0
4,GO TRICARBOXYLIC ACID CYCLE,0.10654,0.05328,0.15448,0,0
4,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.36526,0.053269,0.018774,0,0
4,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.4545,0.053247,0.014691,0,0
4,GO NEURON REMODELING,0.77618,0.053239,-0.0041255,0,0
4,GO PHOSPHATE ION TRANSPORT,0.1313,0.053182,0.081908,0,0
4,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.72313,0.053001,0.023008,0,0
4,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.066855,0.052847,0.074692,0,0
4,GO DENDRITE EXTENSION,0.14526,0.052779,0.16362,0,0
4,GO CELLULAR RESPONSE TO DRUG,0.85768,0.052742,0.012798,0,0
4,GO OSTEOBLAST DIFFERENTIATION,0.56666,0.052716,0.015903,0,0
4,GO VAGINA DEVELOPMENT,0.74288,0.052697,-0.0056884,0,0
4,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.85768,0.052687,0.0058528,0,0
4,GO REGULATION OF GLIOGENESIS,0.19393,0.052586,0.073885,0,0
4,GO TORC1 SIGNALING,0.079444,0.052521,0.063049,0,0
4,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.12049,0.052512,0.11682,0,0
4,GO APICAL PROTEIN LOCALIZATION,0.48678,0.052157,0.042621,0,0
4,GO DECIDUALIZATION,0.69061,0.052145,-0.062949,0,0
4,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.28785,0.052109,0.046203,0,0
4,GO POSITIVE REGULATION OF GROWTH,0.18219,0.052107,0.043998,0,0
4,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.42855,0.051952,0.071398,0,0
4,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.27999,0.051793,0.090748,0,0
4,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.50337,0.051694,0.062482,0,0
4,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.23589,0.051415,0.04494,0,0
4,GO HEME METABOLIC PROCESS,0.16294,0.051332,0.14285,0,0
4,GO RECEPTOR METABOLIC PROCESS,0.52025,0.05117,0.023007,0,0
4,GO PROTEIN TARGETING TO MEMBRANE,0.97557,0.051107,-0.018909,0,0
4,GO IRON SULFUR CLUSTER ASSEMBLY,0.15264,0.051098,0.10385,0,0
4,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.099158,0.050906,0.085557,0,0
4,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.7495,0.050805,0.013855,0,0
4,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.54321,0.050765,0.073919,0,0
4,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.82348,0.050371,-0.014027,0,0
4,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.31232,0.050318,0.038815,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.15773,0.050264,0.035207,0,0
4,GO REGULATION OF GLUTAMATE SECRETION,0.64605,0.05016,0.049476,0,0
4,GO REGULATION OF PROTEIN FOLDING,0.22235,0.050102,0.055188,0,0
4,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.92682,0.05007,-0.0073095,0,0
4,GO RNA DECAPPING,0.83713,0.050027,-0.008397,0,0
4,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.19393,0.050004,0.037865,0,0
4,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.78962,0.049995,-0.027436,0,0
4,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.78962,0.049989,0.025325,0,0
4,GO SEQUESTERING OF ACTIN MONOMERS,0.98953,0.049784,-0.10574,0,0
4,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.073629,0.049726,0.080043,0,0
4,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.22568,0.049717,0.03389,0,0
4,GO PIGMENT ACCUMULATION,0.72969,0.04968,0.019098,0,0
4,GO AMIDE BIOSYNTHETIC PROCESS,0.38408,0.049523,0.031597,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.7495,0.049416,0.0093638,0,0
4,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.14048,0.0494,0.097995,0,0
4,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.7495,0.049238,-0.0094947,0,0
4,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.36991,0.049161,0.041043,0,0
4,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.60272,0.049053,0.052626,0,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.030383,0.048706,0.089456,0,0
4,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.32938,0.048691,0.021028,0,0
4,GO GASTRULATION,0.30402,0.048609,0.042581,0,0
4,GO MYOFIBRIL ASSEMBLY,0.16032,0.048427,0.055064,0,0
4,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.21579,0.048343,0.044372,0,0
4,GO VASCULOGENESIS,0.98953,0.048259,-0.028345,0,0
4,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.17934,0.048171,0.037172,0,0
4,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.47049,0.048109,0.054022,0,0
4,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.20937,0.048051,0.10377,0,0
4,GO NON CANONICAL WNT SIGNALING PATHWAY,0.075049,0.04781,0.076846,0,0
4,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.33373,0.047628,0.030102,0,0
4,GO REGULATION OF PHOSPHATASE ACTIVITY,0.17099,0.047607,0.044136,0,0
4,GO PROTEIN TARGETING,0.32077,0.047565,0.035027,0,0
4,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.36526,0.047559,0.026398,0,0
4,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.83713,0.04753,-0.0029587,0,0
4,GO PROTEIN NITROSYLATION,0.84397,0.047446,-0.035243,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE,0.15773,0.047411,0.031289,0,0
4,GO ERYTHROCYTE DEVELOPMENT,0.54903,0.047225,0.018268,0,0
4,GO PROTEIN TETRAMERIZATION,0.35153,0.047152,0.028416,0,0
4,GO REGULATION OF GROWTH,0.18219,0.047085,0.04373,0,0
4,GO RESPONSE TO IONIZING RADIATION,0.16032,0.046872,0.033383,0,0
4,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.72313,0.046828,0.024238,0,0
4,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.97557,0.046638,-0.062706,0,0
4,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.69707,0.046507,0.02728,0,0
4,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.37932,0.046487,0.019051,0,0
4,GO CALCIUM ION IMPORT INTO CYTOSOL,0.83713,0.046463,-0.048776,0,0
4,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.36526,0.046352,0.092406,0,0
4,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.41842,0.046104,0.033289,0,0
4,GO REGULATION OF VIRAL TRANSCRIPTION,0.19393,0.046009,0.029046,0,0
4,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.11235,0.045849,0.061347,0,0
4,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.32506,0.045843,0.074058,0,0
4,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.72969,0.04581,-0.011034,0,0
4,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.47588,0.045743,0.066119,0,0
4,GO REGULATION OF GLIAL CELL MIGRATION,0.12473,0.045568,0.080296,0,0
4,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.76948,0.045509,0.0080287,0,0
4,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.17099,0.045483,0.024075,0,0
4,GO PROTEIN HOMOOLIGOMERIZATION,0.075049,0.045441,0.053771,0,0
4,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.43883,0.045184,0.046184,0,0
4,GO DETECTION OF LIGHT STIMULUS,0.48131,0.04506,-0.00095752,0,0
4,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.13355,0.044917,0.059311,0,0
4,GO EMBRYO IMPLANTATION,0.74288,0.044889,-0.0059151,0,0
4,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.05161,0.044855,0.1409,0,0
4,GO NUCLEOSIDE METABOLIC PROCESS,0.41341,0.044855,0.023359,0,0
4,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.91293,0.044796,0.003469,0,0
4,GO RNA CATABOLIC PROCESS,0.8303,0.044677,0.00033924,0,0
4,GO BASE EXCISION REPAIR AP SITE FORMATION,0.11636,0.044468,0.10563,0,0
4,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.80989,0.044454,-0.12947,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.30815,0.044331,0.053383,0,0
4,GO REGULATION OF MITOTIC CELL CYCLE,0.15773,0.044209,0.031811,0,0
4,GO ESCRT COMPLEX DISASSEMBLY,0.94073,0.044111,0.011629,0,0
4,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.26098,0.04368,0.049278,0,0
4,GO PROTEIN ACTIVATION CASCADE,0.23937,0.043619,0.13759,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.22905,0.043489,0.046927,0,0
4,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.34256,0.043317,0.049083,0,0
4,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.33373,0.04325,0.0795,0,0
4,GO NATURAL KILLER CELL DIFFERENTIATION,0.54321,0.043021,0.031659,0,0
4,GO AORTA DEVELOPMENT,0.39858,0.042993,-0.093146,0,0
4,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.27611,0.042919,0.061622,0,0
4,GO C4 DICARBOXYLATE TRANSPORT,0.26098,0.042909,0.045528,0,0
4,GO REGIONALIZATION,0.58456,0.042823,0.028666,0,0
4,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.15015,0.042784,0.087633,0,0
4,GO RESPONSE TO GAMMA RADIATION,0.21905,0.04268,0.053869,0,0
4,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.86455,0.042552,-0.043241,0,0
4,GO SKIN EPIDERMIS DEVELOPMENT,0.37932,0.042477,0.033394,0,0
4,GO TUBE FORMATION,0.69061,0.042444,-0.0058347,0,0
4,GO REGULATION OF EXCRETION,0.54903,0.042441,0.037196,0,0
4,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.072231,0.042387,0.068199,0,0
4,GO REGULATION OF TORC1 SIGNALING,0.23937,0.042384,0.061647,0,0
4,GO REGULATION OF HEAT GENERATION,0.82348,0.042335,0.033445,0,0
4,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.23937,0.042167,0.03528,0,0
4,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.61497,0.042107,0.035465,0,0
4,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.71658,0.042018,0.015805,0,0
4,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.39371,0.041935,0.018336,0,0
4,GO NUCLEAR ENVELOPE REASSEMBLY,0.89907,0.041806,-0.035627,0,0
4,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.68418,0.041732,0.032129,0,0
4,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.34702,0.041596,0.048457,0,0
4,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.77618,0.041373,0.0049477,0,0
4,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.16559,0.041208,0.15815,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.89907,0.041133,-0.0087721,0,0
4,GO REGULATION OF BONE MINERALIZATION,0.4598,0.041004,0.031425,0,0
4,GO ASTROCYTE DIFFERENTIATION,0.52025,0.04098,0.054707,0,0
4,GO ADULT LOCOMOTORY BEHAVIOR,0.18219,0.040901,0.10458,0,0
4,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.52025,0.040838,0.07711,0,0
4,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.12473,0.040818,0.062302,0,0
4,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.41842,0.040792,0.034676,0,0
4,GO ENDOCRINE SYSTEM DEVELOPMENT,0.088862,0.04077,0.10893,0,0
4,GO PENTOSE METABOLIC PROCESS,0.87833,0.040763,0.035763,0,0
4,GO EMBRYO DEVELOPMENT,0.61497,0.040699,0.0090394,0,0
4,GO DNA METHYLATION OR DEMETHYLATION,0.10096,0.040656,0.058884,0,0
4,GO GONADOTROPIN SECRETION,0.50337,0.040608,0.041575,0,0
4,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.10096,0.040595,0.18776,0,0
4,GO CELL GROWTH,0.62113,0.040454,0.016616,0,0
4,GO DETECTION OF ABIOTIC STIMULUS,0.26847,0.040434,0.045691,0,0
4,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.36064,0.040354,0.021395,0,0
4,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.60883,0.040161,-0.090446,0,0
4,GO REGULATION OF GOLGI ORGANIZATION,0.35607,0.040153,0.063947,0,0
4,GO OVULATION,0.62732,0.040041,0.040888,0,0
4,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.045624,0.039986,0.084103,0,0
4,GO FEVER GENERATION,0.87144,0.03996,0.0045483,0,0
4,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.30815,0.039866,0.049547,0,0
4,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.91987,0.03976,0.0075932,0,0
4,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.89215,0.039756,-0.027399,0,0
4,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.22905,0.039753,0.052728,0,0
4,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.74288,0.039729,-0.037983,0,0
4,GO RESPONSE TO AMINO ACID STARVATION,0.22568,0.039567,0.068401,0,0
4,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.71658,0.039541,0.00094501,0,0
4,GO GLIAL CELL DIFFERENTIATION,0.54903,0.039524,0.032736,0,0
4,GO PROTEIN INSERTION INTO MEMBRANE,0.17374,0.039499,0.051952,0,0
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.54903,0.03947,0.017263,0,0
4,GO REGULATION OF NUCLEAR DIVISION,0.32506,0.039432,0.029132,0,0
4,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.65866,0.039418,0.035913,0,0
4,GO ACTIVATION OF JUN KINASE ACTIVITY,0.19095,0.039287,0.067216,0,0
4,GO NCRNA 3 END PROCESSING,0.72313,0.0389,-0.019801,0,0
4,GO EAR DEVELOPMENT,0.36991,0.038825,0.035047,0,0
4,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.36526,0.03875,0.016358,0,0
4,GO GOLGI LOCALIZATION,0.44924,0.038606,0.047704,0,0
4,GO PIGMENT BIOSYNTHETIC PROCESS,0.53742,0.038535,0.018578,0,0
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.1313,0.038308,0.073951,0,0
4,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.62113,0.038296,0.051062,0,0
4,GO INOSITOL LIPID MEDIATED SIGNALING,0.22568,0.037732,0.047551,0,0
4,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.90599,0.037653,-0.0095587,0,0
4,GO NEGATIVE REGULATION OF NEURON DEATH,0.24288,0.037649,0.033886,0,0
4,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.26098,0.037599,0.025651,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.63354,0.037568,0.028112,0,0
4,GO RESPONSE TO HYDROXYUREA,0.21905,0.037323,0.0822,0,0
4,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.4545,0.037296,0.030172,0,0
4,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.11434,0.037278,0.035308,0,0
4,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.56666,0.037271,0.0137,0,0
4,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.10465,0.037163,0.076894,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEUS,0.12049,0.037117,0.043422,0,0
4,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.38888,0.036969,0.062765,0,0
4,GO ACTIN CROSSLINK FORMATION,0.91987,0.036921,-0.026527,0,0
4,GO REGULATION OF SPINDLE ASSEMBLY,0.25729,0.036798,0.055396,0,0
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.10465,0.036763,0.045844,0,0
4,GO LAMELLIPODIUM ASSEMBLY,0.78962,0.03673,0.0089528,0,0
4,GO PROTEIN DEPHOSPHORYLATION,0.4598,0.036681,0.015126,0,0
4,GO ENDODERM FORMATION,0.74288,0.036617,-0.026955,0,0
4,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.68418,0.036548,-0.006497,0,0
4,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.40843,0.036541,0.11862,0,0
4,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.27999,0.03642,0.024439,0,0
4,GO NOTCH RECEPTOR PROCESSING,0.15773,0.036393,0.21647,0,0
4,GO REGULATION OF PINOCYTOSIS,0.84397,0.036386,-0.049839,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.85082,0.036301,-0.00029284,0,0
4,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.12049,0.036297,0.08369,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.4978,0.036295,0.057863,0,0
4,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.73628,0.036203,0.0085787,0,0
4,GO PROTEIN LOCALIZATION TO ORGANELLE,0.25001,0.036152,0.025481,0,0
4,GO EMBRYONIC PATTERN SPECIFICATION,0.36526,0.03611,0.049935,0,0
4,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.26847,0.035987,0.045551,0,0
4,GO HEART FIELD SPECIFICATION,0.62732,0.035949,-0.04369,0,0
4,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.60272,0.035787,0.019563,0,0
4,GO EMBRYONIC DIGIT MORPHOGENESIS,0.67137,0.035784,0.022895,0,0
4,GO DORSAL SPINAL CORD DEVELOPMENT,0.66501,0.035754,0.091468,0,0
4,GO REGULATION OF T CELL CHEMOTAXIS,0.33812,0.035681,0.045549,0,0
4,GO GROWTH,0.63978,0.035521,0.012395,0,0
4,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.27999,0.035446,0.036741,0,0
4,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.24288,0.03527,0.035781,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.60272,0.035257,0.015301,0,0
4,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.11636,0.035256,0.041669,0,0
4,GO STARTLE RESPONSE,0.74288,0.034676,0.01643,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.94073,0.034672,-0.0047138,0,0
4,GO REGULATION OF CHROMATIN ORGANIZATION,0.19095,0.034637,0.027941,0,0
4,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.76948,0.034476,-0.024417,0,0
4,GO CARDIAC SEPTUM MORPHOGENESIS,0.73628,0.034459,-0.057216,0,0
4,GO HEAT GENERATION,0.64605,0.034394,0.033956,0,0
4,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.54903,0.034394,0.019779,0,0
4,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.63354,0.034231,0.030928,0,0
4,GO CLATHRIN COAT ASSEMBLY,0.85082,0.034107,0.018428,0,0
4,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.40843,0.034025,0.068838,0,0
4,GO FEMALE GENITALIA DEVELOPMENT,0.98255,0.033974,-0.0091094,0,0
4,GO VESICLE CARGO LOADING,0.7495,0.033922,0.047274,0,0
4,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.98953,0.033891,-0.022236,0,0
4,GO POLYSACCHARIDE CATABOLIC PROCESS,0.60272,0.033871,0.029162,0,0
4,GO SMOOTH MUSCLE CONTRACTION,0.42347,0.033857,0.01593,0,0
4,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.79636,0.033853,0.015178,0,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.57857,0.033828,0.022286,0,0
4,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.14769,0.033813,0.11281,0,0
4,GO SYNAPTIC VESICLE RECYCLING,0.77618,0.03362,0.024893,0,0
4,GO NOREPINEPHRINE SECRETION,0.62113,0.033582,0.060812,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.51459,0.033569,0.031171,0,0
4,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.64605,0.033545,-0.066717,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.28785,0.033411,0.036989,0,0
4,GO HETEROCHROMATIN ORGANIZATION,0.60272,0.033398,0.0013154,0,0
4,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.98255,0.033301,-0.012046,0,0
4,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.19393,0.033297,0.031647,0,0
4,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.98255,0.033286,-0.022096,0,0
4,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.49227,0.033093,0.026667,0,0
4,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.71658,0.032781,0.015326,0,0
4,GO PROTEIN POLYMERIZATION,0.59664,0.03277,0.0085814,0,0
4,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.56075,0.032703,0.043681,0,0
4,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.73628,0.032396,-0.024457,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.27611,0.032368,0.055892,0,0
4,GO CELLULAR RESPONSE TO MANGANESE ION,0.65866,0.031841,0.034042,0,0
4,GO NEGATIVE REGULATION OF JNK CASCADE,0.64605,0.031786,0.025176,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.19695,0.031534,0.067949,0,0
4,GO MITOCHONDRIAL TRANSLATION,0.36526,0.031347,0.053555,0,0
4,GO TRANSLATIONAL TERMINATION,0.46512,0.031068,0.035541,0,0
4,GO REGULATION OF WNT SIGNALING PATHWAY,0.78962,0.030963,-0.018507,0,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.68418,0.03088,0.021256,0,0
4,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.67776,0.030676,0.0031485,0,0
4,GO NEURON APOPTOTIC PROCESS,0.54903,0.030602,0.018055,0,0
4,GO SEROTONIN SECRETION,0.9686,0.030268,0.022714,0,0
4,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.72313,0.030211,-0.0017294,0,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.51459,0.030137,0.012295,0,0
4,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.9686,0.029943,-0.028316,0,0
4,GO AMINO ACID TRANSPORT,0.15015,0.029925,0.10217,0,0
4,GO NEGATIVE REGULATION OF GROWTH,0.19695,0.029836,0.058364,0,0
4,GO MEIOTIC CELL CYCLE,0.16032,0.029775,0.044717,0,0
4,GO CELL CYCLE,0.56075,0.029761,0.0092284,0,0
4,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.7495,0.029686,0.012449,0,0
4,GO CYTOSKELETON ORGANIZATION,0.74288,0.029653,0.0067089,0,0
4,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.065563,0.029607,0.076441,0,0
4,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.86455,0.029509,-0.024897,0,0
4,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.71658,0.029433,-0.048511,0,0
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.21256,0.029226,0.10708,0,0
4,GO HISTONE DEACETYLATION,0.54321,0.029172,0.013699,0,0
4,GO FEAR RESPONSE,0.39858,0.029044,0.047926,0,0
4,GO HISTONE H2B UBIQUITINATION,0.27999,0.028447,0.044684,0,0
4,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.29184,0.028394,0.026097,0,0
4,GO REGULATION OF DEPHOSPHORYLATION,0.39371,0.028289,0.019614,0,0
4,GO INTERACTION WITH SYMBIONT,0.40349,0.028251,0.014007,0,0
4,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.46512,0.028191,0.014738,0,0
4,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.49227,0.028145,0.051238,0,0
4,GO LACTATION,0.7495,0.027991,0.02777,0,0
4,GO PULMONARY VALVE DEVELOPMENT,0.32506,0.027978,0.081015,0,0
4,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.94769,0.027977,-0.016665,0,0
4,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.11841,0.027865,0.060473,0,0
4,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.30815,0.02776,0.15591,0,0
4,GO PROTEIN LOCALIZATION TO MEMBRANE,0.38888,0.02747,0.019741,0,0
4,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.51459,0.027319,0.021822,0,0
4,GO BODY MORPHOGENESIS,0.90599,0.027249,-0.007867,0,0
4,GO ESTABLISHMENT OF TISSUE POLARITY,0.22568,0.027243,0.047697,0,0
4,GO SPERM AXONEME ASSEMBLY,0.81668,0.027162,-0.0089325,0,0
4,GO CELLULAR RESPONSE TO NUTRIENT,0.47049,0.027079,0.039859,0,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.80312,0.027022,-0.0075062,0,0
4,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.36064,0.026928,0.067921,0,0
4,GO PROTEIN DEPOLYMERIZATION,0.42855,0.026869,0.038818,0,0
4,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.93377,0.02672,0.014806,0,0
4,GO SARCOMERE ORGANIZATION,0.30402,0.026711,0.055225,0,0
4,GO MEIOTIC CELL CYCLE PROCESS,0.43367,0.026606,0.029692,0,0
4,GO RESPONSE TO BMP,0.12908,0.026526,0.048332,0,0
4,GO NEURAL TUBE DEVELOPMENT,0.85768,0.026508,-0.026876,0,0
4,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.86455,0.026376,-0.018947,0,0
4,GO RESPONSE TO CAMP,0.36064,0.026299,0.041076,0,0
4,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.21905,0.025959,0.040599,0,0
4,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.21256,0.025914,0.08027,0,0
4,GO ARTERY DEVELOPMENT,0.61497,0.025851,-0.05647,0,0
4,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.39371,0.025715,0.009711,0,0
4,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.80989,0.025704,0.0048946,0,0
4,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.94769,0.025657,-0.025377,0,0
4,GO GLUCOSE CATABOLIC PROCESS,0.54903,0.025578,0.054745,0,0
4,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.27999,0.025528,0.13465,0,0
4,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.85768,0.025463,-0.063402,0,0
4,GO RECEPTOR INTERNALIZATION,0.91293,0.025416,-0.021401,0,0
4,GO CANONICAL WNT SIGNALING PATHWAY,0.86455,0.025361,-0.020221,0,0
4,GO PROTEIN STABILIZATION,0.10465,0.025263,0.058578,0,0
4,GO BLASTOCYST FORMATION,0.37932,0.025225,0.06672,0,0
4,GO REGULATION OF HISTONE MODIFICATION,0.19695,0.025196,0.032334,0,0
4,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.69707,0.025084,0.013772,0,0
4,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.080955,0.025045,0.046625,0,0
4,GO GASTRIC ACID SECRETION,0.36526,0.025026,0.068433,0,0
4,GO MITOTIC CELL CYCLE ARREST,0.57857,0.024918,0.051433,0,0
4,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.5726,0.024827,0.017058,0,0
4,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.80989,0.024752,0.0042192,0,0
4,GO ACTIN MEDIATED CELL CONTRACTION,0.62732,0.024723,0.020003,0,0
4,GO SPERMATID DIFFERENTIATION,0.34702,0.024681,0.032934,0,0
4,GO NEGATIVE REGULATION OF BEHAVIOR,0.60272,0.02446,-0.055832,0,0
4,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.96163,0.024415,-0.0092672,0,0
4,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.78289,0.024408,-0.014605,0,0
4,GO RESPONSE TO COCAINE,0.62732,0.024279,0.035741,0,0
4,GO IRON COORDINATION ENTITY TRANSPORT,0.72969,0.024127,0.067428,0,0
4,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.50337,0.024066,0.071092,0,0
4,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.98255,0.02399,-0.012794,0,0
4,GO REGULATION OF PROTEIN IMPORT,0.3746,0.023987,0.028697,0,0
4,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.48131,0.02394,0.014682,0,0
4,GO CARDIAC ATRIUM DEVELOPMENT,0.57857,0.023598,0.038808,0,0
4,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.4598,0.023562,0.015489,0,0
4,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.40349,0.023484,0.01388,0,0
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.85768,0.023472,-0.0024978,0,0
4,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.85768,0.023372,-0.014654,0,0
4,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.21256,0.02328,0.081132,0,0
4,GO REGULATION OF PROTEIN POLYMERIZATION,0.99651,0.023235,-0.0064817,0,0
4,GO POSITIVE REGULATION OF ERAD PATHWAY,0.67776,0.023184,0.024136,0,0
4,GO RESPONSE TO HEAT,0.53742,0.022972,0.041786,0,0
4,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.87833,0.02292,-0.011889,0,0
4,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.68418,0.022895,0.0091408,0,0
4,GO FIBROBLAST MIGRATION,0.4598,0.022815,0.021502,0,0
4,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.31653,0.022807,0.030024,0,0
4,GO REGULATION OF CELL CYCLE ARREST,0.57857,0.022795,0.020719,0,0
4,GO RESPONSE TO ATP,0.60272,0.022728,0.040557,0,0
4,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.30815,0.022727,0.040941,0,0
4,GO TRIPARTITE REGIONAL SUBDIVISION,0.54321,0.022592,0.067825,0,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.7495,0.02247,-0.003041,0,0
4,GO POSITIVE REGULATION OF DNA REPLICATION,0.71006,0.022466,0.016467,0,0
4,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.59664,0.022392,0.0056353,0,0
4,GO REGULATION OF PROTEIN TARGETING,0.65866,0.02236,0.025122,0,0
4,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.36991,0.022345,0.024549,0,0
4,GO HISTONE H3 DEACETYLATION,0.76281,0.022323,-0.026726,0,0
4,GO DENDRITIC SPINE MAINTENANCE,0.82348,0.0222,-0.022143,0,0
4,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.61497,0.022114,0.016718,0,0
4,GO ORGANELLE FISSION,0.73628,0.021968,0.010895,0,0
4,GO PEPTIDYL THREONINE MODIFICATION,0.22905,0.021563,0.052398,0,0
4,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.19095,0.021561,0.072008,0,0
4,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.68418,0.021555,0.0070544,0,0
4,GO POST EMBRYONIC DEVELOPMENT,0.71006,0.021335,-0.014976,0,0
4,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.69707,0.02132,0.0040316,0,0
4,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.21256,0.021299,0.051835,0,0
4,GO CELL CYCLE G1 S PHASE TRANSITION,0.43883,0.021288,0.012963,0,0
4,GO 3 UTR MEDIATED MRNA STABILIZATION,0.98255,0.021127,-0.027626,0,0
4,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.78289,0.021082,-0.0060365,0,0
4,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.81668,0.021022,0.063704,0,0
4,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.29992,0.020951,0.041501,0,0
4,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.89215,0.02093,-0.0038213,0,0
4,GO PROTEIN HETEROOLIGOMERIZATION,0.59664,0.020798,0.01556,0,0
4,GO EMBRYONIC MORPHOGENESIS,0.61497,0.02071,0.0080771,0,0
4,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.89907,0.020589,0.016894,0,0
4,GO CARDIAC MUSCLE CELL CONTRACTION,0.5726,0.020433,0.035007,0,0
4,GO NEUTROPHIL HOMEOSTASIS,0.99651,0.020346,-0.061243,0,0
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.85082,0.020271,0.0068078,0,0
4,GO PLASMA MEMBRANE TUBULATION,0.9686,0.020267,-0.0069926,0,0
4,GO NEGATIVE REGULATION OF BINDING,0.20309,0.020025,0.058006,0,0
4,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.65866,0.020025,-0.037009,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.50896,0.020023,0.016548,0,0
4,GO PROTEIN HETEROTETRAMERIZATION,0.53742,0.020006,0.024175,0,0
4,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.80989,0.01965,0.013161,0,0
4,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.76281,0.01963,-0.04097,0,0
4,GO RESPONSE TO GLUCAGON,0.70355,0.019594,0.046704,0,0
4,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.72969,0.019507,0.005606,0,0
4,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.52025,0.019394,0.0027306,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.43883,0.019361,-0.072391,0,0
4,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.67137,0.019168,0.014087,0,0
4,GO FOLIC ACID METABOLIC PROCESS,0.91987,0.018833,-0.045453,0,0
4,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.92682,0.018779,-0.0081784,0,0
4,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.67137,0.018754,0.0053423,0,0
4,GO REGULATION OF MRNA METABOLIC PROCESS,0.64605,0.018726,-0.023184,0,0
4,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.10654,0.018625,0.069959,0,0
4,GO FOCAL ADHESION ASSEMBLY,0.46512,0.018624,0.0188,0,0
4,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.60272,0.018616,0.023319,0,0
4,GO MITOCHONDRIAL FISSION,0.42855,0.018536,0.073016,0,0
4,GO TRANSEPITHELIAL TRANSPORT,0.41341,0.018452,0.07753,0,0
4,GO RESPONSE TO HYDROPEROXIDE,0.85768,0.01833,0.015904,0,0
4,GO CYTOKINESIS,1,0.018106,-0.00252,0,0
4,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.76281,0.018,0.017196,0,0
4,GO FOREBRAIN GENERATION OF NEURONS,0.9686,0.017984,0.02166,0,0
4,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.82348,0.017844,-0.018779,0,0
4,GO REGULATION OF TRANSLATIONAL TERMINATION,0.90599,0.017689,-0.031301,0,0
4,GO PEPTIDYL AMINO ACID MODIFICATION,0.2,0.017537,0.033406,0,0
4,GO NUCLEOBASE METABOLIC PROCESS,0.52025,0.01745,0.030626,0,0
4,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.65234,0.017435,-0.030195,0,0
4,GO COPII COATED VESICLE CARGO LOADING,0.88523,0.017321,0.016233,0,0
4,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.67137,0.017312,0.0027012,0,0
4,GO CARDIAC VENTRICLE MORPHOGENESIS,0.79636,0.017271,0.0036324,0,0
4,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.60883,0.017241,0.018765,0,0
4,GO GENITALIA DEVELOPMENT,0.40349,0.016948,0.041441,0,0
4,GO CONNECTIVE TISSUE DEVELOPMENT,0.36526,0.016863,0.02112,0,0
4,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.7495,0.016801,0.034733,0,0
4,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.61497,0.016553,0.047721,0,0
4,GO ADAPTATION OF SIGNALING PATHWAY,0.92682,0.016355,-0.021886,0,0
4,GO SLEEP,0.74288,0.016162,0.03088,0,0
4,GO MIRNA METABOLIC PROCESS,0.67776,0.0161,-0.029952,0,0
4,GO FOREBRAIN NEURON DIFFERENTIATION,0.93377,0.01597,0.024792,0,0
4,GO REGULATION OF GASTRULATION,0.93377,0.015912,-0.028721,0,0
4,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.62113,0.015886,-0.036342,0,0
4,GO REGULATION OF TRANSLATIONAL INITIATION,0.72313,0.015796,-0.031236,0,0
4,GO REGULATION OF LIPASE ACTIVITY,0.71658,0.015739,-0.0011213,0,0
4,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.74288,0.015722,-0.11609,0,0
4,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.43883,0.015645,0.036018,0,0
4,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.67137,0.015514,0.016146,0,0
4,GO NUCLEUS ORGANIZATION,0.49227,0.015495,0.030881,0,0
4,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.66501,0.015397,0.038242,0,0
4,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.72969,0.015301,-0.055274,0,0
4,GO PEPTIDE BIOSYNTHETIC PROCESS,0.77618,0.015279,-0.003459,0,0
4,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.21256,0.014969,0.071233,0,0
4,GO MESENCHYME DEVELOPMENT,0.44402,0.01495,-0.064425,0,0
4,GO RESPONSE TO VITAMIN D,0.61497,0.014876,-0.069271,0,0
4,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.62732,0.014833,-0.055301,0,0
4,GO PROSTATE GLAND DEVELOPMENT,0.85082,0.014729,-0.072981,0,0
4,GO CELLULAR RESPONSE TO ATP,0.40349,0.014721,0.06423,0,0
4,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.74288,0.014709,-0.038248,0,0
4,GO SKELETAL MUSCLE CONTRACTION,0.65866,0.014412,-0.032267,0,0
4,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.58456,0.014126,0.0085342,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.88523,0.014057,0.0083877,0,0
4,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.95466,0.014035,-0.01943,0,0
4,GO MEIOSIS I CELL CYCLE PROCESS,0.54321,0.013975,0.023617,0,0
4,GO CELLULAR OXIDANT DETOXIFICATION,0.24643,0.013911,0.089597,0,0
4,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.36064,0.01391,0.039982,0,0
4,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.88523,0.013835,-0.0044525,0,0
4,GO BONE DEVELOPMENT,0.2839,0.013781,-0.070097,0,0
4,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.97557,0.013714,-0.0014291,0,0
4,GO PROTEIN IMPORT,0.59059,0.013686,0.028667,0,0
4,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.36526,0.013592,-0.2007,0,0
4,GO FACIAL NERVE MORPHOGENESIS,0.87144,0.013445,-0.061585,0,0
4,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.71006,0.013429,-0.046462,0,0
4,GO CELLULAR RESPONSE TO CAMP,0.64605,0.013243,0.024166,0,0
4,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.47588,0.013161,0.055632,0,0
4,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.98953,0.012888,-0.0034478,0,0
4,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.63978,0.012773,0.028106,0,0
4,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.99651,0.012616,-0.010512,0,0
4,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.77618,0.012509,0.017858,0,0
4,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.67776,0.0125,0.027692,0,0
4,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.50896,0.012357,0.074856,0,0
4,GO MITOTIC CELL CYCLE,0.99651,0.012239,-0.001724,0,0
4,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.78962,0.012222,-0.034387,0,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.90599,0.012153,-0.033031,0,0
4,GO ASYMMETRIC CELL DIVISION,0.53167,0.012129,0.046547,0,0
4,GO IMPORT INTO NUCLEUS,0.8303,0.012081,0.011579,0,0
4,GO NEURAL TUBE FORMATION,0.7495,0.012027,0.0015569,0,0
4,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.17374,0.012006,0.1116,0,0
4,GO MAINTENANCE OF PROTEIN LOCATION,0.83713,0.011578,-0.019974,0,0
4,GO ENDODERMAL CELL DIFFERENTIATION,0.80989,0.011473,-0.043277,0,0
4,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.86455,0.011325,-0.0019131,0,0
4,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.56666,0.011299,0.018072,0,0
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.91987,0.01124,0.012432,0,0
4,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.87833,0.011211,-0.034995,0,0
4,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.7495,0.011071,0.024607,0,0
4,GO NAD METABOLIC PROCESS,0.63354,0.011044,0.041608,0,0
4,GO VENTRICULAR SEPTUM DEVELOPMENT,0.77618,0.010976,-0.029499,0,0
4,GO EAR MORPHOGENESIS,0.76948,0.010971,-0.027386,0,0
4,GO NEGATIVE REGULATION OF CELL GROWTH,0.53167,0.010752,0.020686,0,0
4,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.99651,0.010706,-0.015609,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.37932,0.010452,0.049554,0,0
4,GO MULTICELLULAR ORGANISM GROWTH,0.86455,0.010202,-0.0078583,0,0
4,GO RESPONSE TO CATECHOLAMINE,0.26847,0.010136,0.063678,0,0
4,GO ONE CARBON METABOLIC PROCESS,0.86455,0.0098374,-0.006815,0,0
4,GO THALAMUS DEVELOPMENT,0.98953,0.009564,0.023707,0,0
4,GO CELL CELL SIGNALING BY WNT,0.96163,0.0095261,-0.0051686,0,0
4,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.7495,0.0093923,0.0034327,0,0
4,GO RESPONSE TO FOOD,0.79636,0.0093511,0.0057218,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.91987,0.0092621,-0.062728,0,0
4,GO REGULATION OF CELLULAR COMPONENT SIZE,0.98953,0.009184,-0.0045336,0,0
4,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.91293,0.0090643,-0.012581,0,0
4,GO REGULATION OF TRANSPORTER ACTIVITY,0.85768,0.0090588,0.0056162,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.53167,0.008992,0.0081526,0,0
4,GO EMBRYONIC ORGAN DEVELOPMENT,0.78289,0.0088368,0.0037362,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.50896,0.0087639,-0.053985,0,0
4,GO REGULATION OF CENTROSOME DUPLICATION,0.41341,0.0087602,0.043775,0,0
4,GO CHRONIC INFLAMMATORY RESPONSE,0.75615,0.0087357,-0.07866,0,0
4,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.86455,0.0085754,-0.011894,0,0
4,GO CHONDROCYTE DIFFERENTIATION,0.88523,0.0085682,0.0051446,0,0
4,GO NERVOUS SYSTEM PROCESS,0.39858,0.0084899,0.027288,0,0
4,GO CRANIAL NERVE MORPHOGENESIS,0.59664,0.0084174,-0.060355,0,0
4,GO DOSAGE COMPENSATION,0.65866,0.0084009,0.024228,0,0
4,GO LEFT RIGHT PATTERN FORMATION,0.83713,0.008256,0.013151,0,0
4,GO CARTILAGE DEVELOPMENT,0.85082,0.0082319,-0.028904,0,0
4,GO CELL DIVISION,0.34256,0.0080844,-0.029709,0,0
4,GO CHROMATIN SILENCING AT TELOMERE,0.59059,0.0080232,0.035078,0,0
4,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.7495,0.0079425,0.04101,0,0
4,GO REGULATION OF CELL DIVISION,0.77618,0.0079281,0.0061567,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.44402,0.0078262,0.01724,0,0
4,GO CARDIAC VENTRICLE DEVELOPMENT,0.82348,0.0077126,-0.01381,0,0
4,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.60272,0.0076186,0.011994,0,0
4,GO CAMERA TYPE EYE MORPHOGENESIS,0.58456,0.0075801,0.028896,0,0
4,GO NADH METABOLIC PROCESS,0.91987,0.0075794,0.02324,0,0
4,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.85082,0.0074049,0.00242,0,0
4,GO POSITIVE REGULATION OF RNA SPLICING,0.64605,0.0073018,0.045179,0,0
4,GO MULTI ORGANISM LOCALIZATION,0.7495,0.0072834,-0.042251,0,0
4,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.35607,0.0072392,0.062438,0,0
4,GO DNA INTEGRITY CHECKPOINT,0.91987,0.0072285,-0.0074102,0,0
4,GO CELL CYCLE PROCESS,0.64605,0.0071615,-0.0083401,0,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.54321,0.0069923,-0.056275,0,0
4,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.91293,0.0068331,-0.034942,0,0
4,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.4598,0.0067455,-0.04229,0,0
4,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.87144,0.0065842,-0.030378,0,0
4,GO MUSCLE TISSUE DEVELOPMENT,0.50896,0.0064815,0.015275,0,0
4,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.8303,0.0063649,0.010707,0,0
4,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.62113,0.006228,-0.036594,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.97557,0.0061817,-0.0068501,0,0
4,GO APOPTOTIC DNA FRAGMENTATION,0.83713,0.0061784,0.004128,0,0
4,GO CHAPERONE MEDIATED AUTOPHAGY,0.9686,0.0061475,-0.025178,0,0
4,GO EPIBOLY,0.99651,0.0061151,-0.066786,0,0
4,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.47588,0.0060114,-0.083241,0,0
4,GO NEURON FATE SPECIFICATION,0.93377,0.0059555,0.062876,0,0
4,GO NON RECOMBINATIONAL REPAIR,0.7495,0.0059439,-0.020816,0,0
4,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.41842,0.0059039,0.019675,0,0
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.60883,0.0058446,-0.04559,0,0
4,GO SKELETAL SYSTEM DEVELOPMENT,0.87833,0.0054552,-0.0086784,0,0
4,GO HISTONE MONOUBIQUITINATION,0.68418,0.005439,-0.023381,0,0
4,GO VIRAL LATENCY,0.38888,0.0052867,-0.088751,0,0
4,GO GOLGI TO VACUOLE TRANSPORT,0.188,0.0052018,0.097224,0,0
4,GO HEART DEVELOPMENT,0.96163,0.0051669,-0.0062728,0,0
4,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.98953,0.0050162,-0.003716,0,0
4,GO TRANSLATIONAL ELONGATION,0.83713,0.0049845,-0.0025486,0,0
4,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.93377,0.0048443,0.0098893,0,0
4,GO SUBPALLIUM DEVELOPMENT,0.56075,0.0047076,0.082058,0,0
4,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.84397,0.0046339,-0.0030253,0,0
4,GO MUSCLE ORGAN MORPHOGENESIS,0.89215,0.0044609,-0.027453,0,0
4,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.87144,0.0042436,-0.0039149,0,0
4,GO LIVER REGENERATION,0.50896,0.004151,0.024956,0,0
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.85768,0.0040068,-0.024046,0,0
4,GO MAINTENANCE OF CELL NUMBER,0.26847,0.0039167,-0.066902,0,0
4,GO GENE SILENCING,0.53167,0.0038318,0.004412,0,0
4,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.79636,0.0036372,-0.0089723,0,0
4,GO TRNA METABOLIC PROCESS,0.78962,0.0036155,0.013987,0,0
4,GO PSEUDOURIDINE SYNTHESIS,0.69061,0.003608,-0.031195,0,0
4,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.86455,0.0035413,0.0043555,0,0
4,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.78289,0.0033742,0.038545,0,0
4,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.63978,0.0032926,-0.019507,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.53742,0.0032827,0.0275,0,0
4,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.52025,0.003237,-0.091736,0,0
4,GO ACTIVATION OF MAPKK ACTIVITY,0.83713,0.0031347,0.0054716,0,0
4,GO REGULATION OF MITOCHONDRIAL FISSION,0.95466,0.0031326,0.042448,0,0
4,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.95466,0.0029572,-0.0050094,0,0
4,GO PROTEIN TARGETING TO MITOCHONDRION,0.58456,0.0026885,0.0090567,0,0
4,GO ERROR FREE TRANSLESION SYNTHESIS,0.92682,0.0025922,0.0049366,0,0
4,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.85082,0.0025254,0.0053532,0,0
4,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.95466,0.0025241,-0.0054642,0,0
4,GO INNER EAR MORPHOGENESIS,0.72969,0.0022967,-0.022799,0,0
4,GO TOOTH MINERALIZATION,0.87833,0.0022929,0.0053009,0,0
4,GO MAST CELL MIGRATION,0.73628,0.002289,-0.054832,0,0
4,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.87833,0.0021269,-0.0069405,0,0
4,GO MITOTIC CYTOKINESIS,0.83713,0.0020523,-0.011985,0,0
4,GO PEPTIDYL SERINE MODIFICATION,0.15015,0.0020493,0.041182,0,0
4,GO RESPONSE TO VITAMIN A,0.94073,0.001889,-0.018876,0,0
4,GO AXONAL FASCICULATION,0.19393,0.0018092,-0.17299,0,0
4,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.80312,0.0017938,-0.038192,0,0
4,GO GENETIC IMPRINTING,0.51459,0.0016781,-0.045021,0,0
4,GO GLUTAMINE METABOLIC PROCESS,0.66501,0.0015229,-0.049732,0,0
4,GO P BODY ASSEMBLY,0.56666,0.0015014,0.0181,0,0
4,GO RNA MODIFICATION,0.63978,0.0014311,0.020798,0,0
4,GO NEURAL PRECURSOR CELL PROLIFERATION,0.89907,0.001376,0.0024663,0,0
4,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.71006,0.0013082,-0.025504,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.59664,0.001291,0.025879,0,0
4,GO T CELL CHEMOTAXIS,0.73628,0.0012771,-0.0342,0,0
4,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.48131,0.0011253,0.094472,0,0
4,GO DNA BIOSYNTHETIC PROCESS,0.80312,0.0010809,-0.014467,0,0
4,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.77618,0.0010417,0.0042059,0,0
4,GO SPERM MOTILITY,0.90599,0.00093353,-0.00036611,0,0
4,GO MATERNAL PLACENTA DEVELOPMENT,0.33373,0.00091134,-0.11201,0,0
4,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.95466,0.00088492,0.011125,0,0
4,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.83713,0.0007506,-0.0039565,0,0
4,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.80312,0.00064911,-0.020315,0,0
4,GO CELL FATE COMMITMENT,0.89907,0.00062146,0.0014892,0,0
4,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.91987,0.00054712,0.0061279,0,0
4,GO DICARBOXYLIC ACID TRANSPORT,0.85768,0.00032438,0.022672,0,0
4,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.78962,0.00026315,0.020435,0,0
4,GO CELL CELL SIGNALING,0.47588,0.00020379,0.028281,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.56075,0.00013203,0.041299,0,0
4,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.81668,1.8642e-05,-0.021092,0,0
4,GO RESPONSE TO AMYLOID BETA,0.68418,-1.7363e-06,0.031397,0,0
4,GO MESENCHYMAL CELL PROLIFERATION,0.72313,-0.00026364,-0.021105,0,0
4,GO CELL CYCLE PHASE TRANSITION,0.8303,-0.00041192,-0.0057125,0,0
4,GO POSITIVE REGULATION OF HEAT GENERATION,0.82348,-0.00041905,0.01652,0,0
4,GO RNA METHYLATION,0.95466,-0.00060742,-0.00175,0,0
4,GO DEMETHYLATION,0.77618,-0.00070662,0.0059301,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.96163,-0.00071358,-0.01833,0,0
4,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.30402,-0.00072061,0.091162,0,0
4,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.56666,-0.00076126,-0.01889,0,0
4,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,1,-0.00088807,-0.012561,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.87144,-0.00097339,-0.0053213,0,0
4,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.88523,-0.0010159,-0.0088152,0,0
4,GO LOCOMOTORY BEHAVIOR,0.89215,-0.0011554,0.027532,0,0
4,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.85768,-0.001202,-0.010492,0,0
4,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.97557,-0.0012966,-0.00376,0,0
4,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.8303,-0.0013502,-0.0022709,0,0
4,GO HYPOTONIC RESPONSE,0.56666,-0.0013745,-0.072721,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.84397,-0.0014335,-0.0049576,0,0
4,GO SENSORY ORGAN MORPHOGENESIS,0.95466,-0.0014466,-0.012922,0,0
4,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.87833,-0.0015731,0.03793,0,0
4,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.90599,-0.0015778,0.026321,0,0
4,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.95466,-0.0017996,0.0056189,0,0
4,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.73628,-0.0018591,0.012074,0,0
4,GO REGULATION OF CILIUM MOVEMENT,0.75615,-0.0018792,0.0095962,0,0
4,GO MRNA CLEAVAGE,0.39371,-0.0020954,-0.032919,0,0
4,GO FOREGUT MORPHOGENESIS,0.89907,-0.0021372,-0.036323,0,0
4,GO MRNA TRANSCRIPTION,0.80989,-0.0021928,-0.024075,0,0
4,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.59059,-0.0022843,0.04289,0,0
4,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.52025,-0.0024589,0.039618,0,0
4,GO STRIATUM DEVELOPMENT,0.71006,-0.0027939,0.029992,0,0
4,GO SCHWANN CELL DEVELOPMENT,0.7495,-0.0029019,-0.018832,0,0
4,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.88523,-0.0029953,-0.016244,0,0
4,GO INTERLEUKIN 2 PRODUCTION,0.93377,-0.0031357,-0.042058,0,0
4,GO NEURAL NUCLEUS DEVELOPMENT,0.53167,-0.0031778,0.07428,0,0
4,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.90599,-0.0031984,-0.004744,0,0
4,GO CRISTAE FORMATION,0.70355,-0.003271,0.040294,0,0
4,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.7495,-0.0035256,-0.033924,0,0
4,GO MESENCHYMAL CELL DIFFERENTIATION,0.89907,-0.0036472,-0.022556,0,0
4,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.64605,-0.0037807,-0.024142,0,0
4,GO SYNAPTIC TRANSMISSION GABAERGIC,0.14285,-0.0037935,-0.10636,0,0
4,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.72969,-0.0038133,-0.024881,0,0
4,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.94073,-0.0038262,-0.011081,0,0
4,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.55487,-0.0040149,0.047576,0,0
4,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.47588,-0.0040772,0.045649,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.59664,-0.0042473,0.030853,0,0
4,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.22568,-0.0042751,0.07765,0,0
4,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.71658,-0.0043377,-0.049216,0,0
4,GO CELL RECOGNITION,0.80989,-0.0044357,-0.02988,0,0
4,GO EMBRYONIC BODY MORPHOGENESIS,0.78289,-0.0045963,-0.013912,0,0
4,GO MITOTIC NUCLEAR DIVISION,0.65866,-0.0046769,-0.012675,0,0
4,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.85768,-0.0049655,-0.024198,0,0
4,GO RESPONSE TO MANGANESE ION,0.59059,-0.0050432,0.061447,0,0
4,GO DNA METHYLATION,0.56666,-0.0052058,0.027178,0,0
4,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.90599,-0.0053533,-0.011388,0,0
4,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.8303,-0.0054491,-0.016901,0,0
4,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.63978,-0.0054556,-0.052292,0,0
4,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.64605,-0.0054865,-0.037594,0,0
4,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.85082,-0.0055118,0.0036645,0,0
4,GO MESENCHYME MORPHOGENESIS,0.86455,-0.0055283,-0.042945,0,0
4,GO TRANSLATIONAL INITIATION,0.55487,-0.0056924,-0.063515,0,0
4,GO TRABECULA FORMATION,0.94769,-0.0058384,-0.015976,0,0
4,GO ANATOMICAL STRUCTURE REGRESSION,0.62113,-0.0059258,-0.089405,0,0
4,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.50337,-0.0060261,-0.1025,0,0
4,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.90599,-0.0060513,0.14597,0,0
4,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.87833,-0.0061566,-0.0023722,0,0
4,GO MIDDLE EAR MORPHOGENESIS,0.62732,-0.0061732,-0.062574,0,0
4,GO REGULATION OF HISTONE METHYLATION,0.79636,-0.0063446,-0.0067458,0,0
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.92682,-0.0063955,-0.018839,0,0
4,GO CELL JUNCTION ORGANIZATION,0.69061,-0.0064762,0.012524,0,0
4,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.80989,-0.0064787,-0.0010799,0,0
4,GO CHROMATIN ORGANIZATION,0.16828,-0.006861,-0.037384,0,0
4,GO HISTONE SERINE PHOSPHORYLATION,0.98255,-0.0069366,0.02927,0,0
4,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.69061,-0.0070545,0.038548,0,0
4,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.97557,-0.0072395,-0.00059674,0,0
4,GO CARDIAC CHAMBER MORPHOGENESIS,0.89215,-0.0072405,-0.0084893,0,0
4,GO CILIUM MOVEMENT,0.49227,-0.0073267,0.0063061,0,0
4,GO RNA 5 END PROCESSING,0.60883,-0.0073268,0.031633,0,0
4,GO EXIT FROM MITOSIS,0.85082,-0.0074765,0.0066297,0,0
4,GO POSITIVE REGULATION OF TRANSLATION,0.72313,-0.007746,-0.041081,0,0
4,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.52594,-0.0078619,-0.050343,0,0
4,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.68418,-0.0079476,0.067441,0,0
4,GO REGULATION OF ATPASE ACTIVITY,0.33373,-0.0082084,-0.03524,0,0
4,GO RESPONSE TO POTASSIUM ION,0.55487,-0.0082432,-0.047279,0,0
4,GO DNA METABOLIC PROCESS,0.4545,-0.0082761,-0.019554,0,0
4,GO LIPOPROTEIN LOCALIZATION,0.41842,-0.0086436,-0.079111,0,0
4,GO RNA DESTABILIZATION,0.65234,-0.0087892,-0.041428,0,0
4,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.85082,-0.0087918,-0.0058397,0,0
4,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.54903,-0.0088006,-0.048757,0,0
4,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.67776,-0.0089108,-0.066087,0,0
4,GO REGULATION OF HELICASE ACTIVITY,0.69061,-0.0090775,-0.028102,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.80312,-0.0091513,0.097881,0,0
4,GO NOREPINEPHRINE TRANSPORT,0.48678,-0.0094869,0.059567,0,0
4,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.63978,-0.0096903,-0.10175,0,0
4,GO PATTERN SPECIFICATION PROCESS,0.87144,-0.0097097,-0.0052332,0,0
4,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.79636,-0.0097649,0.061459,0,0
4,GO VESICLE CYTOSKELETAL TRAFFICKING,0.98953,-0.0099182,0.017762,0,0
4,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.72313,-0.010115,-0.021877,0,0
4,GO REGULATION OF CELL CYCLE PROCESS,0.69061,-0.01019,-0.0094793,0,0
4,GO MITOCHONDRIAL DNA REPLICATION,0.82348,-0.010331,-0.026951,0,0
4,GO PROTEIN SUMOYLATION,0.60883,-0.010357,-0.017408,0,0
4,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.95466,-0.010403,-0.0013535,0,0
4,GO NCRNA METABOLIC PROCESS,0.98255,-0.010454,-0.011878,0,0
4,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.32938,-0.010478,0.058159,0,0
4,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.39371,-0.010916,-0.04676,0,0
4,GO CELL CYCLE CHECKPOINT,0.83713,-0.011022,-0.0057731,0,0
4,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.69707,-0.011058,-0.049382,0,0
4,GO LENS FIBER CELL DEVELOPMENT,0.66501,-0.011307,-0.055379,0,0
4,GO NUCLEAR TRANSPORT,0.74288,-0.01131,-0.016729,0,0
4,GO MITOTIC SPINDLE ASSEMBLY,0.97557,-0.011503,-0.0010205,0,0
4,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.75615,-0.011626,-0.021072,0,0
4,GO MRNA MODIFICATION,0.60272,-0.011817,-0.045178,0,0
4,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.69061,-0.011873,0.038501,0,0
4,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.75615,-0.011938,-0.013279,0,0
4,GO PROTEIN TRIMERIZATION,0.79636,-0.012208,0.0017082,0,0
4,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.26847,-0.012265,-0.16182,0,0
4,GO AXIS ELONGATION,0.64605,-0.01228,-0.056007,0,0
4,GO CELLULAR COMPONENT MAINTENANCE,0.71658,-0.012366,-0.018614,0,0
4,GO AORTIC VALVE DEVELOPMENT,0.68418,-0.012396,-0.065155,0,0
4,GO SENSORY ORGAN DEVELOPMENT,0.80989,-0.012413,-0.014275,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.59664,-0.012416,-0.040293,0,0
4,GO ENDOTHELIAL CELL MORPHOGENESIS,0.50337,-0.012495,-0.10831,0,0
4,GO EMBRYONIC ORGAN MORPHOGENESIS,0.60272,-0.012616,-0.030517,0,0
4,GO REGULATION OF LIPID KINASE ACTIVITY,0.67137,-0.012638,-0.014252,0,0
4,GO REGULATION OF ORGANELLE ASSEMBLY,0.2839,-0.01274,-0.029442,0,0
4,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.60883,-0.012793,-0.018313,0,0
4,GO EXPLORATION BEHAVIOR,0.28785,-0.012843,-0.14192,0,0
4,GO HISTONE H3 K36 METHYLATION,0.29586,-0.012872,-0.081285,0,0
4,GO METAPHASE PLATE CONGRESSION,0.79636,-0.012878,0.0001524,0,0
4,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.67137,-0.012951,-0.045553,0,0
4,GO REGULATION OF POTASSIUM ION TRANSPORT,0.91293,-0.013051,-0.0046925,0,0
4,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.92682,-0.013059,-0.022872,0,0
4,GO STEM CELL DIFFERENTIATION,0.4978,-0.013299,-0.027096,0,0
4,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.68418,-0.013471,-0.0051582,0,0
4,GO REGULATION OF MRNA 3 END PROCESSING,0.28785,-0.013751,-0.06204,0,0
4,GO GABAERGIC NEURON DIFFERENTIATION,0.82348,-0.0138,0.080985,0,0
4,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.74288,-0.013833,0.0030985,0,0
4,GO EYE MORPHOGENESIS,0.87833,-0.014016,-0.015785,0,0
4,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.75615,-0.014269,-0.032306,0,0
4,GO CELLULAR RESPONSE TO RETINOIC ACID,0.78962,-0.014311,-0.036353,0,0
4,GO LYMPH VESSEL MORPHOGENESIS,0.44402,-0.014357,-0.0796,0,0
4,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.56075,-0.014393,-0.032676,0,0
4,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.35153,-0.014412,-0.062813,0,0
4,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.83713,-0.014529,-0.0073575,0,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.50896,-0.014792,-0.038994,0,0
4,GO REGULATION OF DEVELOPMENTAL GROWTH,0.5726,-0.015067,-0.032464,0,0
4,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.58456,-0.015098,-0.034728,0,0
4,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.71658,-0.015177,0.092564,0,0
4,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.97557,-0.01523,0.028289,0,0
4,GO PIGMENT GRANULE MATURATION,0.7495,-0.015324,-0.049036,0,0
4,GO PROTEIN MONOUBIQUITINATION,0.76281,-0.015415,-0.013052,0,0
4,GO GROWTH HORMONE SECRETION,0.99651,-0.015544,0.034628,0,0
4,GO PHOTORECEPTOR CELL MAINTENANCE,0.67137,-0.015651,-0.038797,0,0
4,GO PROSTATE GLAND MORPHOGENESIS,0.73628,-0.015845,-0.093905,0,0
4,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.52025,-0.015867,0.048113,0,0
4,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.82348,-0.015887,-0.0045531,0,0
4,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.87833,-0.015938,0.0042824,0,0
4,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.98255,-0.015969,0.036212,0,0
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.84397,-0.016074,-0.031198,0,0
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.71658,-0.016129,-0.014133,0,0
4,GO PROTEIN ACYLATION,0.37932,-0.016175,-0.015907,0,0
4,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.49227,-0.016205,0.057158,0,0
4,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.42855,-0.016214,0.05878,0,0
4,GO BEHAVIOR,0.87144,-0.016252,0.0089212,0,0
4,GO MISMATCH REPAIR,0.49227,-0.016267,-0.027254,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.4978,-0.0163,-0.030093,0,0
4,GO EXTRACELLULAR TRANSPORT,0.68418,-0.016396,0.020084,0,0
4,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.51459,-0.016486,-0.10275,0,0
4,GO NUCLEUS LOCALIZATION,0.43883,-0.016545,-0.058564,0,0
4,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.47588,-0.016685,-0.081532,0,0
4,GO TROPHOBLAST CELL MIGRATION,0.88523,-0.017106,-0.068798,0,0
4,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.62113,-0.017118,-0.079376,0,0
4,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.39858,-0.017132,0.09516,0,0
4,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.95466,-0.017203,-0.011296,0,0
4,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.92682,-0.017284,-0.026081,0,0
4,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.9686,-0.017425,0.044257,0,0
4,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.61497,-0.017457,0.012615,0,0
4,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.34702,-0.017496,-0.087675,0,0
4,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.96163,-0.017852,0.014239,0,0
4,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.48131,-0.017937,-0.02737,0,0
4,GO HINDBRAIN MORPHOGENESIS,0.66501,-0.01799,-0.023513,0,0
4,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.59059,-0.018022,-0.072095,0,0
4,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.59664,-0.018023,-0.045189,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.54903,-0.018063,-0.051911,0,0
4,GO SKELETAL MUSCLE ADAPTATION,0.53742,-0.018164,0.063687,0,0
4,GO MAGNESIUM ION HOMEOSTASIS,0.8303,-0.01843,-0.0094834,0,0
4,GO COVALENT CHROMATIN MODIFICATION,0.12908,-0.018604,-0.04306,0,0
4,GO HOMOLOGOUS RECOMBINATION,0.65866,-0.018759,-0.021525,0,0
4,GO DEVELOPMENTAL GROWTH,0.48678,-0.01876,-0.031603,0,0
4,GO MEMORY,0.98953,-0.018769,0.0035399,0,0
4,GO MICROTUBULE BUNDLE FORMATION,0.9686,-0.018776,-0.0011117,0,0
4,GO MITOTIC METAPHASE PLATE CONGRESSION,0.55487,-0.018888,0.034458,0,0
4,GO MITOTIC CELL CYCLE CHECKPOINT,0.71658,-0.01901,-0.0086567,0,0
4,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.63354,-0.019383,-0.027178,0,0
4,GO MIDBRAIN DEVELOPMENT,0.59059,-0.01944,-0.026373,0,0
4,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.81668,-0.01965,0.0050782,0,0
4,GO REGULATION OF TUBULIN DEACETYLATION,0.89215,-0.01978,0.014183,0,0
4,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.79636,-0.019902,-0.0039366,0,0
4,GO CELLULAR RESPONSE TO RADIATION,0.61497,-0.020082,-0.021032,0,0
4,GO OVULATION CYCLE PROCESS,0.83713,-0.020104,0.0241,0,0
4,GO PROTEIN METHYLATION,0.8303,-0.020137,-0.0030958,0,0
4,GO RHYTHMIC BEHAVIOR,0.99651,-0.020152,0.015785,0,0
4,GO CELL PROJECTION ASSEMBLY,0.67776,-0.020157,-0.0067512,0,0
4,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.13355,-0.020334,-0.060014,0,0
4,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.54321,-0.020374,-0.036342,0,0
4,GO NEGATIVE REGULATION OF CELL SIZE,0.75615,-0.020518,-0.046373,0,0
4,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.93377,-0.020659,0.0032135,0,0
4,GO REGULATION OF PROTEIN ACETYLATION,0.98255,-0.020789,0.014273,0,0
4,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.32938,-0.020929,-0.067011,0,0
4,GO SKELETAL MUSCLE CELL PROLIFERATION,0.59059,-0.020975,-0.058325,0,0
4,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.41842,-0.020985,-0.054177,0,0
4,GO CARDIAC ATRIUM MORPHOGENESIS,0.60272,-0.021133,-0.040525,0,0
4,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.94073,-0.021325,0.049947,0,0
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.16294,-0.02154,-0.056976,0,0
4,GO ORGANELLE ASSEMBLY,0.71658,-0.021554,-0.00522,0,0
4,GO PEPTIDYL LYSINE MODIFICATION,0.088862,-0.021854,-0.033758,0,0
4,GO MESODERM DEVELOPMENT,0.51459,-0.021905,-0.042909,0,0
4,GO SNRNA PROCESSING,0.89215,-0.021917,-0.023094,0,0
4,GO NUCLEOSOME ASSEMBLY,0.2839,-0.02201,-0.055974,0,0
4,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.78962,-0.022055,-0.0018552,0,0
4,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.73628,-0.022109,-0.031395,0,0
4,GO REGULATION OF MEMBRANE POTENTIAL,0.73628,-0.022192,0.028751,0,0
4,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.44402,-0.022233,-0.061174,0,0
4,GO TONIC SMOOTH MUSCLE CONTRACTION,1,-0.022412,-0.002632,0,0
4,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.54903,-0.022415,0.058088,0,0
4,GO HISTONE ARGININE METHYLATION,0.65866,-0.022489,-0.021734,0,0
4,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.93377,-0.022882,-0.0076938,0,0
4,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.76281,-0.022942,-0.022975,0,0
4,GO NUCLEOTIDE EXCISION REPAIR,0.21579,-0.023054,-0.039943,0,0
4,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.84397,-0.023164,-0.0075827,0,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.95466,-0.02331,-0.0089187,0,0
4,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.48678,-0.023314,-0.03801,0,0
4,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.77618,-0.023319,-0.0016157,0,0
4,GO RETINA LAYER FORMATION,0.68418,-0.023466,0.083558,0,0
4,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.4598,-0.02349,-0.064171,0,0
4,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.34702,-0.023494,-0.077932,0,0
4,GO VIRAL GENE EXPRESSION,0.76948,-0.023586,-0.037174,0,0
4,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.75615,-0.02364,0.095345,0,0
4,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.4598,-0.023731,-0.061154,0,0
4,GO SPECIFICATION OF SYMMETRY,0.49227,-0.023899,-0.042209,0,0
4,GO THYROID GLAND DEVELOPMENT,0.32938,-0.023935,-0.11243,0,0
4,GO REGULATION OF MRNA BINDING,0.50896,-0.02397,-0.078367,0,0
4,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.74288,-0.02402,-0.034545,0,0
4,GO CORTICAL CYTOSKELETON ORGANIZATION,0.84397,-0.02417,-0.0085009,0,0
4,GO REGULATION OF FEEDING BEHAVIOR,0.39858,-0.024511,-0.07344,0,0
4,GO CHROMOSOME LOCALIZATION,0.67776,-0.024795,-0.0040375,0,0
4,GO ONE CARBON COMPOUND TRANSPORT,0.67137,-0.024889,0.039737,0,0
4,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.78962,-0.024906,-0.0095353,0,0
4,GO NUCLEAR EXPORT,0.38888,-0.025363,-0.045258,0,0
4,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.71658,-0.025411,-0.024184,0,0
4,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.83713,-0.025641,-0.038001,0,0
4,GO CEREBELLAR CORTEX FORMATION,0.64605,-0.025747,-0.017744,0,0
4,GO SNRNA TRANSCRIPTION,0.188,-0.025777,-0.048523,0,0
4,GO CARDIAC MYOFIBRIL ASSEMBLY,0.30402,-0.025789,-0.080011,0,0
4,GO RESPONSE TO MURAMYL DIPEPTIDE,0.55487,-0.026073,-0.07367,0,0
4,GO SKELETAL SYSTEM MORPHOGENESIS,0.20621,-0.026116,-0.068305,0,0
4,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.65866,-0.026352,-0.022096,0,0
4,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.19695,-0.026379,-0.053968,0,0
4,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.90599,-0.026397,-0.11327,0,0
4,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.89907,-0.026436,0.072313,0,0
4,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.55487,-0.026609,0.044287,0,0
4,GO MRNA METHYLATION,0.24288,-0.026689,-0.087626,0,0
4,GO ECTODERM DEVELOPMENT,0.85082,-0.026739,0.017155,0,0
4,GO HISTONE H3 ACETYLATION,0.33373,-0.026875,-0.035997,0,0
4,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.11039,-0.027091,-0.10294,0,0
4,GO REGULATION OF GROWTH HORMONE SECRETION,0.97557,-0.027189,0.04115,0,0
4,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.28785,-0.027206,-0.064163,0,0
4,GO ODONTOGENESIS,0.3746,-0.027247,-0.076953,0,0
4,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.4598,-0.027412,0.057335,0,0
4,GO PROTEIN NEDDYLATION,0.33373,-0.027543,-0.055527,0,0
4,GO REGULATION OF BMP SIGNALING PATHWAY,0.35607,-0.02772,-0.07231,0,0
4,GO NEGATIVE REGULATION OF CELL DIVISION,0.85768,-0.027815,-0.007067,0,0
4,GO HISTONE H3 K4 METHYLATION,0.56666,-0.027842,-0.012959,0,0
4,GO REGULATION OF DNA REPLICATION,0.80312,-0.027854,-0.012587,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.83713,-0.027891,0.016329,0,0
4,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.59664,-0.027998,-0.046935,0,0
4,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.32077,-0.028214,-0.057983,0,0
4,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.98255,-0.028342,0.032198,0,0
4,GO HISTONE H3 K9 METHYLATION,0.51459,-0.028463,-0.035363,0,0
4,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.58456,-0.028463,-0.077109,0,0
4,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.23245,-0.028486,-0.092283,0,0
4,GO DNA REPAIR,0.11039,-0.028518,-0.039684,0,0
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.96163,-0.028562,-0.0074024,0,0
4,GO CAMERA TYPE EYE DEVELOPMENT,0.54321,-0.028568,-0.031681,0,0
4,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.50337,-0.028615,-0.042539,0,0
4,GO SPINDLE ASSEMBLY,0.30402,-0.028632,-0.030308,0,0
4,GO REGULATION OF HISTONE UBIQUITINATION,0.13583,-0.02869,-0.061748,0,0
4,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.89215,-0.028796,-7.3825e-05,0,0
4,GO GANGLION DEVELOPMENT,0.83713,-0.028822,0.091454,0,0
4,GO ESTABLISHMENT OF RNA LOCALIZATION,0.30402,-0.028908,-0.05013,0,0
4,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.31653,-0.028968,-0.095802,0,0
4,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.86455,-0.028998,-0.030996,0,0
4,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.94073,-0.029035,-0.0071438,0,0
4,GO SNRNA METABOLIC PROCESS,0.91293,-0.029081,-0.0058496,0,0
4,GO SINGLE STRAND BREAK REPAIR,0.42347,-0.029197,-0.051508,0,0
4,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.32506,-0.029304,-0.065319,0,0
4,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.47588,-0.029448,-0.065406,0,0
4,GO PROTEIN KINASE A SIGNALING,0.37932,-0.029519,-0.051938,0,0
4,GO LIMBIC SYSTEM DEVELOPMENT,0.41341,-0.029565,-0.040245,0,0
4,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.2839,-0.029854,-0.057625,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.74288,-0.030181,-0.038513,0,0
4,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.64605,-0.030206,-0.078548,0,0
4,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.20621,-0.030215,-0.1051,0,0
4,GO CELL VOLUME HOMEOSTASIS,0.72313,-0.030257,0.005856,0,0
4,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.22905,-0.030354,-0.029102,0,0
4,GO LYMPH VESSEL DEVELOPMENT,0.19393,-0.030371,-0.11534,0,0
4,GO REGULATION OF SPINDLE ORGANIZATION,0.31232,-0.030564,-0.041587,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.50896,-0.030603,-0.086331,0,0
4,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.58456,-0.030846,-0.05237,0,0
4,GO SCHWANN CELL DIFFERENTIATION,0.61497,-0.03086,-0.037675,0,0
4,GO CELL CYCLE G2 M PHASE TRANSITION,0.2839,-0.03097,-0.034279,0,0
4,GO REGULATION OF CENTROSOME CYCLE,0.42855,-0.030972,-0.01349,0,0
4,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.50896,-0.031067,-0.014075,0,0
4,GO STEM CELL DIVISION,0.37932,-0.031119,-0.059188,0,0
4,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.30815,-0.031207,-0.095126,0,0
4,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.65234,-0.031499,-0.052795,0,0
4,GO REGULATION OF CYTOKINESIS,0.68418,-0.031639,-0.0051998,0,0
4,GO LENS FIBER CELL DIFFERENTIATION,0.98255,-0.031647,0.001021,0,0
4,GO REGULATION OF TRANSLATIONAL FIDELITY,0.90599,-0.031665,0.019965,0,0
4,GO REGULATION OF CHROMOSOME ORGANIZATION,0.25363,-0.031872,-0.027812,0,0
4,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.88523,-0.031911,0.02148,0,0
4,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.25001,-0.031982,-0.044192,0,0
4,GO REGULATION OF GENE SILENCING,0.54321,-0.031997,-0.035744,0,0
4,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.26847,-0.032115,-0.075688,0,0
4,GO MRNA 3 END PROCESSING,0.054842,-0.032138,-0.077331,0,0
4,GO HISTONE PHOSPHORYLATION,0.71658,-0.032292,-0.014278,0,0
4,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.47049,-0.03233,-0.037552,0,0
4,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.89215,-0.032356,-0.0055825,0,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.53742,-0.032397,-0.036217,0,0
4,GO PEPTIDE CROSS LINKING,0.83713,-0.032454,-0.0076122,0,0
4,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.80989,-0.032576,0.012983,0,0
4,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.72969,-0.032744,0.006417,0,0
4,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.59059,-0.032815,-0.019547,0,0
4,GO TETRAHYDROFOLATE INTERCONVERSION,0.48678,-0.032988,-0.08318,0,0
4,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.4978,-0.033064,-0.040731,0,0
4,GO MINERALOCORTICOID METABOLIC PROCESS,0.5726,-0.033254,-0.074276,0,0
4,GO HISTONE EXCHANGE,0.33812,-0.033256,-0.044509,0,0
4,GO TELOMERE ORGANIZATION,0.13355,-0.033281,-0.060141,0,0
4,GO NEUROTRANSMITTER REUPTAKE,0.63978,-0.033621,0.047714,0,0
4,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.099158,-0.033621,-0.06944,0,0
4,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.31232,-0.033634,-0.084767,0,0
4,GO SECONDARY HEART FIELD SPECIFICATION,0.85082,-0.033806,-0.011016,0,0
4,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.35153,-0.033808,-0.062018,0,0
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.41842,-0.033897,-0.066059,0,0
4,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.47588,-0.034009,-0.047479,0,0
4,GO RNA LOCALIZATION,0.087232,-0.034184,-0.075798,0,0
4,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.8303,-0.03424,-0.020346,0,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.78962,-0.034319,-0.01626,0,0
4,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.78962,-0.034584,-0.027189,0,0
4,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.8303,-0.0346,-0.017791,0,0
4,GO CELLULAR RESPONSE TO HEAT,0.42347,-0.034837,-0.033125,0,0
4,GO NCRNA PROCESSING,0.51459,-0.034856,-0.0489,0,0
4,GO GAS TRANSPORT,0.37932,-0.03486,-0.15108,0,0
4,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.21256,-0.035305,-0.067509,0,0
4,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.9686,-0.03534,-0.012271,0,0
4,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.75615,-0.035517,0.020912,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.78962,-0.035978,-0.04885,0,0
4,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.082489,-0.03614,-0.049179,0,0
4,GO PROTEOGLYCAN METABOLIC PROCESS,0.80989,-0.036347,-0.027606,0,0
4,GO HISTONE H4 ACETYLATION,0.24643,-0.036449,-0.028291,0,0
4,GO HEART MORPHOGENESIS,0.50896,-0.036533,-0.041117,0,0
4,GO RNA PROCESSING,0.19393,-0.036695,-0.051795,0,0
4,GO SENSORY SYSTEM DEVELOPMENT,0.44924,-0.036718,-0.032589,0,0
4,GO PEPTIDYL HISTIDINE MODIFICATION,0.82348,-0.03678,-0.014862,0,0
4,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.97557,-0.036928,0.059909,0,0
4,GO CGMP MEDIATED SIGNALING,0.48131,-0.037154,-0.044244,0,0
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.72969,-0.037278,-0.033801,0,0
4,GO HEART VALVE DEVELOPMENT,0.48678,-0.037674,-0.065311,0,0
4,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.62113,-0.037785,-0.041216,0,0
4,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.87144,-0.037822,-0.019216,0,0
4,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.31653,-0.037862,-0.12289,0,0
4,GO CARDIAC CHAMBER DEVELOPMENT,0.53742,-0.038226,-0.035119,0,0
4,GO RNA POLYADENYLATION,0.084046,-0.038296,-0.07526,0,0
4,GO REGULATION OF BEHAVIOR,0.22568,-0.038367,-0.081816,0,0
4,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.40349,-0.038456,-0.024245,0,0
4,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.72969,-0.038624,-0.0034819,0,0
4,GO REGULATION OF ENDOCYTIC RECYCLING,0.26471,-0.038627,-0.09775,0,0
4,GO PEPTIDYL LYSINE METHYLATION,0.30402,-0.038649,-0.0275,0,0
4,GO CHROMOSOME ORGANIZATION,0.12689,-0.038659,-0.033811,0,0
4,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.085627,-0.038703,-0.086616,0,0
4,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.46512,-0.03879,-0.048021,0,0
4,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.39371,-0.038993,-0.038005,0,0
4,GO URETER DEVELOPMENT,0.80312,-0.039276,-0.050067,0,0
4,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.92682,-0.039406,0.0099948,0,0
4,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.072231,-0.03945,-0.072297,0,0
4,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.32077,-0.039499,-0.025201,0,0
4,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.13355,-0.039835,-0.055075,0,0
4,GO MEIOTIC CHROMOSOME SEGREGATION,0.73628,-0.039835,-0.0138,0,0
4,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.78289,-0.039873,-0.032677,0,0
4,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.85082,-0.039961,-0.028352,0,0
4,GO RRNA METABOLIC PROCESS,0.55487,-0.040395,-0.043788,0,0
4,GO RENAL VESICLE DEVELOPMENT,0.69707,-0.040499,-0.051551,0,0
4,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.35607,-0.040665,-0.13624,0,0
4,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.87144,-0.040732,-0.0025289,0,0
4,GO CARDIAC SEPTUM DEVELOPMENT,0.25363,-0.0408,-0.081414,0,0
4,GO RNA EXPORT FROM NUCLEUS,0.0695,-0.040887,-0.076516,0,0
4,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.52025,-0.041129,-0.076637,0,0
4,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.33812,-0.041148,-0.075715,0,0
4,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.55487,-0.041197,-0.044702,0,0
4,GO SERTOLI CELL DEVELOPMENT,0.65866,-0.041392,-0.087521,0,0
4,GO SALIVARY GLAND DEVELOPMENT,0.65866,-0.04148,0.014739,0,0
4,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.8303,-0.041528,0.048961,0,0
4,GO ERBB2 SIGNALING PATHWAY,0.90599,-0.041641,0.011351,0,0
4,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.44924,-0.041856,-0.029064,0,0
4,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.11039,-0.041872,-0.083598,0,0
4,GO SISTER CHROMATID SEGREGATION,0.14769,-0.042011,-0.044291,0,0
4,GO DNA DOUBLE STRAND BREAK PROCESSING,0.17934,-0.042036,-0.072483,0,0
4,GO DIGESTIVE TRACT MORPHOGENESIS,0.72969,-0.042044,-0.029389,0,0
4,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.88523,-0.042063,-0.0028136,0,0
4,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.4598,-0.042346,0.15075,0,0
4,GO STEM CELL PROLIFERATION,0.58456,-0.042426,-0.022347,0,0
4,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.60272,-0.042543,-0.024935,0,0
4,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.41842,-0.042633,-0.028042,0,0
4,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.31653,-0.042647,-0.055984,0,0
4,GO SPINAL CORD PATTERNING,0.87144,-0.042729,0.036385,0,0
4,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.33812,-0.042738,-0.064129,0,0
4,GO SHORT TERM MEMORY,0.74288,-0.04285,-0.046723,0,0
4,GO CALCINEURIN MEDIATED SIGNALING,0.82348,-0.042894,-0.011095,0,0
4,GO MYOTUBE CELL DEVELOPMENT,0.65234,-0.042974,-0.017908,0,0
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.76948,-0.043133,0.0003999,0,0
4,GO MEMBRANE DOCKING,0.43883,-0.043243,-0.018024,0,0
4,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.33373,-0.043256,-0.12497,0,0
4,GO REGULATION OF DNA BINDING,0.66501,-0.04339,-0.0068916,0,0
4,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.33373,-0.043544,-0.077512,0,0
4,GO MRNA METABOLIC PROCESS,0.19695,-0.043565,-0.046064,0,0
4,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.57857,-0.043681,-0.043353,0,0
4,GO HISTONE H2A UBIQUITINATION,0.16294,-0.043699,-0.066029,0,0
4,GO NCRNA TRANSCRIPTION,0.084046,-0.044168,-0.066482,0,0
4,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.29992,-0.045101,-0.063158,0,0
4,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.99651,-0.045172,0.025491,0,0
4,GO NEUROTROPHIN SIGNALING PATHWAY,0.70355,-0.045223,-0.023642,0,0
4,GO RESPONSE TO DOPAMINE,0.84397,-0.045287,0.015512,0,0
4,GO ORGAN GROWTH,0.31653,-0.045302,-0.052202,0,0
4,GO CELL CYCLE DNA REPLICATION,0.15517,-0.045349,-0.061572,0,0
4,GO VESICLE FUSION TO PLASMA MEMBRANE,0.81668,-0.045384,0.061421,0,0
4,GO PEPTIDYL LYSINE ACETYLATION,0.0695,-0.045406,-0.047735,0,0
4,GO HISTONE METHYLATION,0.27999,-0.045577,-0.028541,0,0
4,GO MITOTIC SISTER CHROMATID SEGREGATION,0.12049,-0.045595,-0.048573,0,0
4,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.74288,-0.045892,0.10302,0,0
4,GO TRANSCRIPTION BY RNA POLYMERASE III,0.15015,-0.045899,-0.046972,0,0
4,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.76948,-0.046057,-0.011893,0,0
4,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.83713,-0.046097,-0.015381,0,0
4,GO PROTEIN ACETYLATION,0.084046,-0.046141,-0.033258,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.67137,-0.04623,-0.01313,0,0
4,GO NEUROMUSCULAR PROCESS,0.22235,-0.04627,-0.056822,0,0
4,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.22235,-0.046354,-0.080431,0,0
4,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.30815,-0.046548,-0.030821,0,0
4,GO CELL CELL JUNCTION MAINTENANCE,0.36526,-0.046672,-0.11029,0,0
4,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.92682,-0.046888,-0.0074455,0,0
4,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.77618,-0.046901,-0.012152,0,0
4,GO REGULATION OF CENTRIOLE REPLICATION,0.36064,-0.04709,-0.038112,0,0
4,GO NEUROTRANSMITTER UPTAKE,0.84397,-0.047696,0.02924,0,0
4,GO RNA 3 END PROCESSING,0.17099,-0.047849,-0.063391,0,0
4,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.39371,-0.047953,-0.060324,0,0
4,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.87144,-0.04797,0.018086,0,0
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.34256,-0.048078,-0.077623,0,0
4,GO REGULATION OF RNA SPLICING,0.041967,-0.048226,-0.050315,0,0
4,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.34702,-0.048771,-0.031401,0,0
4,GO CENTROSOME DUPLICATION,0.46512,-0.049221,-0.026845,0,0
4,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.48678,-0.049393,-0.12772,0,0
4,GO CHROMATIN SILENCING,0.188,-0.049442,-0.045891,0,0
4,GO PEPTIDYL ARGININE MODIFICATION,0.25001,-0.049465,-0.049321,0,0
4,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.36526,-0.049981,-0.042984,0,0
4,GO CELL MORPHOGENESIS,0.2,-0.0501,-0.060138,0,0
4,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.2839,-0.050164,-0.09285,0,0
4,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.17099,-0.050396,-0.082677,0,0
4,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.89215,-0.050552,-0.032206,0,0
4,GO REGULATION OF ORGAN GROWTH,0.16294,-0.050707,-0.07961,0,0
4,GO REGULATION OF CILIUM BEAT FREQUENCY,0.59059,-0.050713,-0.041269,0,0
4,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.32938,-0.051036,-0.059164,0,0
4,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.15015,-0.051084,-0.078292,0,0
4,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.26471,-0.051167,-0.041929,0,0
4,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.31232,-0.051518,-0.062241,0,0
4,GO GENITALIA MORPHOGENESIS,0.78962,-0.051611,-0.030044,0,0
4,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.76281,-0.051821,-0.033922,0,0
4,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.55487,-0.051873,-0.057337,0,0
4,GO REGULATION OF RECEPTOR INTERNALIZATION,0.14285,-0.052043,-0.073228,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.55487,-0.052094,-0.049973,0,0
4,GO DNA REPLICATION,0.079444,-0.052403,-0.055237,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.62113,-0.05242,-0.030113,0,0
4,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.23245,-0.052468,-0.11004,0,0
4,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.16828,-0.052481,-0.15338,0,0
4,GO REGULATION OF CELL MORPHOGENESIS,0.13814,-0.052487,-0.063545,0,0
4,GO TRNA PROCESSING,0.47588,-0.052738,-0.040187,0,0
4,GO CYTOPLASMIC TRANSLATION,0.41842,-0.052755,-0.091624,0,0
4,GO COLLAGEN METABOLIC PROCESS,0.94769,-0.0528,-0.044073,0,0
4,GO HISTONE H3 K14 ACETYLATION,0.22905,-0.052906,-0.057486,0,0
4,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.27999,-0.053316,-0.08182,0,0
4,GO REGULATION OF FILOPODIUM ASSEMBLY,0.44402,-0.05332,-0.053898,0,0
4,GO REGULATION OF OOGENESIS,0.43883,-0.05334,-0.026827,0,0
4,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.41842,-0.053371,-0.026649,0,0
4,GO HISTONE H4 K5 ACETYLATION,0.4545,-0.053565,-0.02906,0,0
4,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.092194,-0.053578,-0.08779,0,0
4,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.35153,-0.053895,-0.096322,0,0
4,GO MEIOTIC SPINDLE ORGANIZATION,0.10654,-0.054058,-0.10391,0,0
4,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.93377,-0.054264,-0.004321,0,0
4,GO REGULATION OF FIBROBLAST MIGRATION,0.43367,-0.054297,-0.070152,0,0
4,GO RNA CAPPING,0.14769,-0.054466,-0.060092,0,0
4,GO MESODERMAL CELL FATE COMMITMENT,0.55487,-0.054562,-0.052695,0,0
4,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.36064,-0.054748,-0.051533,0,0
4,GO ANIMAL ORGAN FORMATION,0.17934,-0.054773,-0.090124,0,0
4,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.24288,-0.054951,-0.058482,0,0
4,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.26098,-0.055416,-0.10726,0,0
4,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.25001,-0.055492,-0.055296,0,0
4,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.082489,-0.055504,-0.11217,0,0
4,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.14285,-0.05551,-0.050605,0,0
4,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.89215,-0.055533,-0.071948,0,0
4,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.48678,-0.055816,-0.046216,0,0
4,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.69707,-0.055997,0.1745,0,0
4,GO POSITIVE REGULATION OF DNA BINDING,0.3746,-0.056749,-0.035195,0,0
4,GO REGULATION OF ANIMAL ORGAN FORMATION,0.72313,-0.056899,-0.054922,0,0
4,GO MEIOTIC CHROMOSOME SEPARATION,0.070855,-0.0569,-0.10901,0,0
4,GO ERYTHROCYTE MATURATION,0.27999,-0.057178,-0.099531,0,0
4,GO REGULATION OF CHROMOSOME SEGREGATION,0.12259,-0.0572,-0.067344,0,0
4,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.36991,-0.05722,-0.040686,0,0
4,GO MITOCHONDRIAL GENOME MAINTENANCE,0.56075,-0.057504,-0.029165,0,0
4,GO ACTIVATION OF JNKK ACTIVITY,0.69061,-0.057612,-0.016758,0,0
4,GO SUCKLING BEHAVIOR,0.52025,-0.057801,-0.068391,0,0
4,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.21579,-0.057951,-0.045288,0,0
4,GO TRNA TRANSPORT,0.30815,-0.058005,-0.070285,0,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.50337,-0.058016,-0.031533,0,0
4,GO NCRNA EXPORT FROM NUCLEUS,0.35153,-0.058251,-0.063805,0,0
4,GO POSITIVE REGULATION OF URINE VOLUME,0.36526,-0.058257,-0.073569,0,0
4,GO HEART GROWTH,0.50896,-0.058298,-0.032574,0,0
4,GO LEFT RIGHT AXIS SPECIFICATION,0.91987,-0.058709,-0.00566,0,0
4,GO DETECTION OF VISIBLE LIGHT,0.12049,-0.059051,-0.092925,0,0
4,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.32938,-0.059178,-0.04438,0,0
4,GO G2 DNA DAMAGE CHECKPOINT,0.16032,-0.059207,-0.075328,0,0
4,GO PEPTIDYL ARGININE METHYLATION,0.41341,-0.059276,-0.039659,0,0
4,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.17099,-0.059309,-0.13207,0,0
4,GO ERROR PRONE TRANSLESION SYNTHESIS,0.75615,-0.059725,-0.0044855,0,0
4,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.085627,-0.060026,-0.092329,0,0
4,GO TRNA METHYLATION,0.61497,-0.060059,-0.026529,0,0
4,GO HISTONE H3 K9 MODIFICATION,0.39858,-0.060325,-0.03868,0,0
4,GO NUCLEAR CHROMOSOME SEGREGATION,0.12473,-0.060444,-0.039952,0,0
4,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.68418,-0.060447,-0.062416,0,0
4,GO RESPONSE TO UV,0.14526,-0.061089,-0.051301,0,0
4,GO RIBOSOME BIOGENESIS,0.43883,-0.061202,-0.06373,0,0
4,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.72969,-0.06132,-0.061098,0,0
4,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.097379,-0.061425,-0.078638,0,0
4,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.24288,-0.061464,-0.071184,0,0
4,GO SPINDLE LOCALIZATION,0.188,-0.061732,-0.052559,0,0
4,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.22905,-0.061949,-0.052634,0,0
4,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.16294,-0.062127,-0.078827,0,0
4,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.48131,-0.062175,-0.10654,0,0
4,GO ADULT BEHAVIOR,0.93377,-0.062203,0.037536,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.19695,-0.062243,-0.088453,0,0
4,GO HINDBRAIN DEVELOPMENT,0.7495,-0.062292,0.033508,0,0
4,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.36991,-0.062412,-0.061347,0,0
4,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.32506,-0.062519,-0.043372,0,0
4,GO RESPONSE TO AUDITORY STIMULUS,0.87144,-0.062636,-0.0012014,0,0
4,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.10845,-0.062732,-0.074047,0,0
4,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.12473,-0.062908,-0.096466,0,0
4,GO METENCEPHALON DEVELOPMENT,0.71658,-0.063307,0.011403,0,0
4,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.055956,-0.063508,-0.20578,0,0
4,GO EMBRYONIC HEMOPOIESIS,0.51459,-0.063552,-0.04418,0,0
4,GO DNA REPLICATION CHECKPOINT,0.10465,-0.063818,-0.10736,0,0
4,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.3746,-0.063873,-0.066238,0,0
4,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.0695,-0.064005,-0.076137,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.40843,-0.064016,-0.051902,0,0
4,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.29184,-0.064016,-0.040185,0,0
4,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.23937,-0.064462,-0.092963,0,0
4,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.28785,-0.06461,-0.048587,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.70355,-0.064611,0.012605,0,0
4,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.79636,-0.06467,0.096055,0,0
4,GO RESPONSE TO NERVE GROWTH FACTOR,0.4978,-0.064883,-0.020384,0,0
4,GO REGULATION OF TELOMERASE ACTIVITY,0.30815,-0.064901,-0.062818,0,0
4,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.22905,-0.064928,-0.069947,0,0
4,GO RESPONSE TO AXON INJURY,0.51459,-0.064964,-0.031423,0,0
4,GO SYNAPTIC VESICLE EXOCYTOSIS,0.18219,-0.064979,-0.017372,0,0
4,GO CELL PROJECTION ORGANIZATION,0.22905,-0.065123,-0.041732,0,0
4,GO REGULATION OF MRNA POLYADENYLATION,0.054842,-0.065299,-0.090786,0,0
4,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.73628,-0.065332,-0.0047794,0,0
4,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.25363,-0.065728,-0.092841,0,0
4,GO HISTONE H3 K4 TRIMETHYLATION,0.16559,-0.065761,-0.062454,0,0
4,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.041093,-0.066259,-0.11353,0,0
4,GO HOMOCYSTEINE METABOLIC PROCESS,0.87833,-0.066348,0.040024,0,0
4,GO POSITIVE REGULATION OF MRNA PROCESSING,0.18508,-0.066355,-0.06213,0,0
4,GO SULFATION,0.088862,-0.066407,-0.11088,0,0
4,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.74288,-0.066425,-0.011767,0,0
4,GO CELLULAR RESPONSE TO ETHANOL,0.61497,-0.066561,-0.035623,0,0
4,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.29184,-0.06669,-0.043173,0,0
4,GO DEVELOPMENTAL CELL GROWTH,0.10845,-0.067142,-0.083956,0,0
4,GO REGULATION OF TRANSLATIONAL ELONGATION,0.89215,-0.06717,-0.011723,0,0
4,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.66501,-0.067311,-0.048915,0,0
4,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.82348,-0.067688,0.062742,0,0
4,GO MRNA EXPORT FROM NUCLEUS,0.024846,-0.067734,-0.086972,0,0
4,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.80989,-0.06774,-0.065864,0,0
4,GO MUSCLE ORGAN DEVELOPMENT,0.29992,-0.067759,-0.03346,0,0
4,GO REGULATION OF MICROTUBULE BASED PROCESS,0.0045306,-0.068087,-0.083537,0,0
4,GO CELLULAR RESPONSE TO VITAMIN D,0.53742,-0.068374,-0.057171,0,0
4,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.69707,-0.068406,-0.0050364,0,0
4,GO SEQUESTERING OF METAL ION,0.23245,-0.068442,-0.11036,0,0
4,GO PEPTIDYL LYSINE DIMETHYLATION,0.093897,-0.068785,-0.065777,0,0
4,GO REGULATION OF HISTONE PHOSPHORYLATION,0.11636,-0.068824,-0.1026,0,0
4,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.63978,-0.069003,-0.085165,0,0
4,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.32938,-0.069173,-0.063187,0,0
4,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.68418,-0.069174,0.028057,0,0
4,GO MAINTENANCE OF ORGANELLE LOCATION,0.44924,-0.069215,-0.056416,0,0
4,GO REGULATION OF CELL DEVELOPMENT,0.32938,-0.0696,-0.041187,0,0
4,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.22235,-0.069612,-0.073647,0,0
4,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.53167,-0.06989,-0.062793,0,0
4,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.072231,-0.070014,-0.064562,0,0
4,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.24288,-0.070034,-0.089764,0,0
4,GO OTIC VESICLE DEVELOPMENT,0.31653,-0.070222,-0.12727,0,0
4,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.16032,-0.070487,-0.079229,0,0
4,GO MUSCLE FIBER DEVELOPMENT,0.25729,-0.070501,-0.054505,0,0
4,GO HISTONE H2A ACETYLATION,0.16828,-0.070527,-0.076221,0,0
4,GO FOREBRAIN NEURON FATE COMMITMENT,0.67776,-0.070654,-0.022671,0,0
4,GO PREPULSE INHIBITION,0.68418,-0.070919,-0.046934,0,0
4,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.012203,-0.07092,-0.065725,0,0
4,GO NEUROGENESIS,0.22568,-0.070965,-0.050171,0,0
4,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.4545,-0.071,-0.052381,0,0
4,GO TRANSCRIPTION BY RNA POLYMERASE I,0.57857,-0.071062,-0.02072,0,0
4,GO REGULATION OF GONAD DEVELOPMENT,0.55487,-0.071365,-0.04727,0,0
4,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.72313,-0.071376,-0.025214,0,0
4,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.29184,-0.071485,-0.11818,0,0
4,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.99651,-0.071551,-0.0095614,0,0
4,GO REGULATION OF RNA BINDING,0.17099,-0.071756,-0.097238,0,0
4,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.093897,-0.071958,-0.23714,0,0
4,GO SNORNA METABOLIC PROCESS,0.11841,-0.072186,-0.12647,0,0
4,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.68418,-0.072749,-0.027821,0,0
4,GO PROSTATE GLAND GROWTH,0.17374,-0.072775,-0.14895,0,0
4,GO APPENDAGE DEVELOPMENT,0.16828,-0.072793,-0.067453,0,0
4,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.080955,-0.07307,-0.057087,0,0
4,GO REGULATION OF CELL SIZE,0.075049,-0.073223,-0.095749,0,0
4,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.2839,-0.073293,-0.06993,0,0
4,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.59059,-0.073314,-0.030122,0,0
4,GO RNA SURVEILLANCE,0.18508,-0.07346,-0.06576,0,0
4,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.26847,-0.07372,-0.10906,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.18508,-0.073823,-0.07446,0,0
4,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.10465,-0.074162,-0.085805,0,0
4,GO POST ANAL TAIL MORPHOGENESIS,0.084046,-0.074199,-0.11361,0,0
4,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.10465,-0.074357,-0.070667,0,0
4,GO POSITIVE REGULATION OF HEART GROWTH,0.16559,-0.074422,-0.10611,0,0
4,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.41842,-0.074529,-0.063187,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.26471,-0.07454,-0.053534,0,0
4,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.23589,-0.074547,-0.063688,0,0
4,GO TRNA MODIFICATION,0.3746,-0.074577,-0.052926,0,0
4,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.27999,-0.074677,-0.11412,0,0
4,GO RIBOSOME ASSEMBLY,0.61497,-0.07512,-0.05591,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.26847,-0.075164,-0.10332,0,0
4,GO CELL FATE SPECIFICATION,0.44924,-0.075194,-0.037989,0,0
4,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.35607,-0.075299,-0.15114,0,0
4,GO REGULATION OF SISTER CHROMATID COHESION,0.079444,-0.075326,-0.10232,0,0
4,GO ATP DEPENDENT CHROMATIN REMODELING,0.064293,-0.075401,-0.09241,0,0
4,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.67137,-0.075602,-0.024511,0,0
4,GO CHROMOSOME SEGREGATION,0.064293,-0.075627,-0.050817,0,0
4,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.188,-0.075643,-0.055674,0,0
4,GO MICROTUBULE ANCHORING,0.035393,-0.075993,-0.084049,0,0
4,GO HEAD DEVELOPMENT,0.29992,-0.076016,-0.034602,0,0
4,GO PROXIMAL DISTAL PATTERN FORMATION,0.25729,-0.076144,-0.13732,0,0
4,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.017137,-0.076199,-0.11994,0,0
4,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.39858,-0.076216,-0.077797,0,0
4,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.27611,-0.076243,-0.038426,0,0
4,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.79636,-0.07636,-0.011227,0,0
4,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.26471,-0.076801,-0.10779,0,0
4,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.188,-0.076809,-0.048424,0,0
4,GO DISTAL TUBULE DEVELOPMENT,0.83713,-0.07687,0.0046189,0,0
4,GO ENDOCARDIAL CUSHION FORMATION,0.22568,-0.077071,-0.094468,0,0
4,GO COGNITION,0.31653,-0.077142,-0.0497,0,0
4,GO NUCLEAR BODY ORGANIZATION,0.87144,-0.077373,0.060372,0,0
4,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.49227,-0.077398,-0.046317,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.36064,-0.077909,-0.067758,0,0
4,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.188,-0.078136,-0.10088,0,0
4,GO MICROTUBULE NUCLEATION,0.053746,-0.078206,-0.083312,0,0
4,GO CELLULAR RESPONSE TO PH,0.19095,-0.078242,-0.081271,0,0
4,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.38408,-0.07826,-0.042333,0,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.16032,-0.078457,-0.13832,0,0
4,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.050569,-0.078624,-0.059919,0,0
4,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.26098,-0.078657,-0.066741,0,0
4,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.4598,-0.078778,-0.061548,0,0
4,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.099158,-0.078783,-0.14307,0,0
4,GO CORONARY VASCULATURE DEVELOPMENT,0.084046,-0.078922,-0.12253,0,0
4,GO POSITIVE REGULATION OF BEHAVIOR,0.11039,-0.078998,-0.16868,0,0
4,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.092194,-0.079093,-0.079124,0,0
4,GO MATURATION OF 5 8S RRNA,0.25729,-0.079107,-0.098137,0,0
4,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.18508,-0.079271,-0.093771,0,0
4,GO MESODERMAL CELL DIFFERENTIATION,0.19393,-0.07939,-0.10835,0,0
4,GO FIBROBLAST APOPTOTIC PROCESS,0.90599,-0.079879,-0.029626,0,0
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.61497,-0.079962,-0.05555,0,0
4,GO MEMBRANE DISASSEMBLY,0.19393,-0.080071,-0.092041,0,0
4,GO CELL JUNCTION MAINTENANCE,0.31232,-0.080135,-0.075574,0,0
4,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.30402,-0.080163,-0.079995,0,0
4,GO SYNAPTIC VESICLE DOCKING,0.89907,-0.080277,0.064629,0,0
4,GO NUCLEAR MIGRATION,0.16559,-0.080513,-0.10063,0,0
4,GO OXIDATIVE DEMETHYLATION,0.24643,-0.080529,-0.041932,0,0
4,GO PHOTORECEPTOR CELL DEVELOPMENT,0.35607,-0.080535,-0.050538,0,0
4,GO SEROTONIN TRANSPORT,0.58456,-0.080675,-0.026249,0,0
4,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.46512,-0.080695,-0.029633,0,0
4,GO MEMBRANE BIOGENESIS,0.36991,-0.081007,-0.086902,0,0
4,GO REGULATION OF TELOMERE CAPPING,0.060602,-0.081028,-0.078387,0,0
4,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.18219,-0.081106,-0.064391,0,0
4,GO VIRAL TRANSLATION,0.20621,-0.081189,-0.11769,0,0
4,GO MICROTUBULE BASED PROCESS,0.01282,-0.081194,-0.062364,0,0
4,GO MITOTIC RECOMBINATION,0.10465,-0.081629,-0.10097,0,0
4,GO CEREBELLAR CORTEX MORPHOGENESIS,0.14285,-0.081692,-0.10627,0,0
4,GO DNA STRAND ELONGATION,0.2,-0.081694,-0.055154,0,0
4,GO ETHANOL CATABOLIC PROCESS,0.31232,-0.081717,-0.095805,0,0
4,GO HISTONE H4 DEACETYLATION,0.18219,-0.081751,-0.12002,0,0
4,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.22568,-0.082092,-0.08802,0,0
4,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.16559,-0.082275,-0.066353,0,0
4,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.076492,-0.082409,-0.13011,0,0
4,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.63978,-0.082563,-0.027108,0,0
4,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.76281,-0.082572,-0.047432,0,0
4,GO CIRCADIAN SLEEP WAKE CYCLE,0.52594,-0.082595,-0.021324,0,0
4,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.011612,-0.082675,-0.134,0,0
4,GO PROTEIN DENEDDYLATION,0.53167,-0.082765,-0.041235,0,0
4,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.2839,-0.082833,-0.071148,0,0
4,GO OTIC VESICLE MORPHOGENESIS,0.25729,-0.082943,-0.12302,0,0
4,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.19393,-0.083132,-0.11862,0,0
4,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.93377,-0.083142,-0.02455,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.14526,-0.083244,-0.064659,0,0
4,GO CILIUM ORGANIZATION,0.11039,-0.083263,-0.050735,0,0
4,GO REGULATION OF CHROMOSOME SEPARATION,0.080955,-0.083301,-0.078124,0,0
4,GO MICROTUBULE BASED MOVEMENT,0.03939,-0.083386,-0.061482,0,0
4,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.12908,-0.08349,-0.069971,0,0
4,GO NODAL SIGNALING PATHWAY,0.31232,-0.083677,-0.056253,0,0
4,GO MICROTUBULE POLYMERIZATION,0.013139,-0.083829,-0.1251,0,0
4,GO CONVERGENT EXTENSION,0.28785,-0.084125,-0.10197,0,0
4,GO MITOTIC DNA REPLICATION CHECKPOINT,0.084046,-0.08424,-0.14063,0,0
4,GO NEUROTRANSMITTER TRANSPORT,0.36064,-0.084693,-0.013503,0,0
4,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.054842,-0.085014,-0.20375,0,0
4,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.16559,-0.085041,-0.11874,0,0
4,GO TELOMERE CAPPING,0.10845,-0.08522,-0.047869,0,0
4,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.27611,-0.085469,-0.096773,0,0
4,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.50337,-0.085614,-0.031263,0,0
4,GO HISTONE H2A MONOUBIQUITINATION,0.021165,-0.085767,-0.11983,0,0
4,GO ADHERENS JUNCTION ASSEMBLY,0.90599,-0.085879,-0.0015256,0,0
4,GO CELLULAR RESPONSE TO UV,0.11636,-0.08603,-0.065404,0,0
4,GO MITOCHONDRIAL PROTEIN PROCESSING,0.43367,-0.086324,-0.030728,0,0
4,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.19695,-0.086452,-0.081997,0,0
4,GO HAIR FOLLICLE MATURATION,0.13355,-0.086466,-0.14403,0,0
4,GO ASTRAL MICROTUBULE ORGANIZATION,0.61497,-0.086622,-0.03175,0,0
4,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.18508,-0.086923,-0.082021,0,0
4,GO LONG TERM MEMORY,0.21256,-0.087014,-0.099454,0,0
4,GO DORSAL VENTRAL PATTERN FORMATION,0.4978,-0.087105,-0.0061311,0,0
4,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.15517,-0.087125,-0.066432,0,0
4,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.061812,-0.087184,-0.062611,0,0
4,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.62732,-0.087526,-0.078366,0,0
4,GO RNA STABILIZATION,0.072231,-0.087536,-0.093616,0,0
4,GO CHONDROCYTE DEVELOPMENT,0.40843,-0.087618,-0.086248,0,0
4,GO PRENYLATION,0.40843,-0.087823,-0.063171,0,0
4,GO NEURAL RETINA DEVELOPMENT,0.38888,-0.087843,-0.036162,0,0
4,GO MOTOR NEURON AXON GUIDANCE,0.041093,-0.087995,-0.15413,0,0
4,GO NEGATIVE REGULATION OF CELL AGING,0.23245,-0.088223,-0.12033,0,0
4,GO NEURON FATE COMMITMENT,0.62732,-0.088881,-0.017442,0,0
4,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.32938,-0.088994,-0.11448,0,0
4,GO NEURON DEVELOPMENT,0.14285,-0.089175,-0.068797,0,0
4,GO ACIDIC AMINO ACID TRANSPORT,0.27227,-0.089488,-0.042752,0,0
4,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.24288,-0.089504,-0.088286,0,0
4,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.036164,-0.089649,-0.12376,0,0
4,GO L GLUTAMATE IMPORT,0.19695,-0.08988,-0.098868,0,0
4,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.40843,-0.089892,-0.13426,0,0
4,GO LONG TERM SYNAPTIC POTENTIATION,0.41842,-0.089924,-0.047633,0,0
4,GO WALKING BEHAVIOR,0.031059,-0.08996,-0.13651,0,0
4,GO CELLULAR RESPONSE TO VITAMIN,0.44402,-0.089976,-0.066413,0,0
4,GO INTERSTRAND CROSS LINK REPAIR,0.060602,-0.089985,-0.058973,0,0
4,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.070855,-0.089998,-0.11367,0,0
4,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.48131,-0.090026,-0.065418,0,0
4,GO COLLATERAL SPROUTING,0.15773,-0.090299,-0.12454,0,0
4,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.084046,-0.091008,-0.14447,0,0
4,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.076492,-0.091041,-0.093052,0,0
4,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.24288,-0.091492,-0.062736,0,0
4,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.93377,-0.091704,0.0082232,0,0
4,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.41341,-0.091728,-0.069438,0,0
4,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.31232,-0.092227,-0.081968,0,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.073629,-0.092248,-0.12852,0,0
4,GO TUBULIN DEACETYLATION,0.38408,-0.092279,-0.045868,0,0
4,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.001872,-0.092326,-0.10074,0,0
4,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.51459,-0.092618,-0.03198,0,0
4,GO RETINAL CONE CELL DIFFERENTIATION,0.52594,-0.092777,-0.077305,0,0
4,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.47049,-0.092846,-0.049743,0,0
4,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.43883,-0.093038,-0.071022,0,0
4,GO HEART FORMATION,0.2839,-0.093138,-0.083688,0,0
4,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.11841,-0.093249,-0.088251,0,0
4,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.070855,-0.093385,-0.12958,0,0
4,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.62113,-0.093466,-0.049761,0,0
4,GO NEGATIVE REGULATION OF DNA BINDING,0.052669,-0.093972,-0.099746,0,0
4,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.188,-0.094206,-0.12321,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.17934,-0.094411,-0.12552,0,0
4,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.51459,-0.094599,-0.11853,0,0
4,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.16294,-0.094727,-0.08488,0,0
4,GO POSITIVE REGULATION OF CILIUM MOVEMENT,0.63354,-0.095356,-0.037473,0,0
4,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.12689,-0.095426,-0.07816,0,0
4,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.0081404,-0.095492,-0.15231,0,0
4,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.33373,-0.095573,-0.1286,0,0
4,GO REGULATION OF MICROTUBULE BINDING,0.11235,-0.095788,-0.11115,0,0
4,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.4598,-0.096246,-0.082979,0,0
4,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.05824,-0.096461,-0.14627,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.12259,-0.096715,-0.083798,0,0
4,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.19393,-0.096893,-0.10978,0,0
4,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.29992,-0.097116,-0.12814,0,0
4,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.55487,-0.097936,-0.058063,0,0
4,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.02843,-0.097982,-0.093518,0,0
4,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.041093,-0.097991,-0.13401,0,0
4,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.029719,-0.098764,-0.11382,0,0
4,GO SOMATIC STEM CELL DIVISION,0.24288,-0.099067,-0.16282,0,0
4,GO REGULATION OF RIBOSOME BIOGENESIS,0.14769,-0.099179,-0.12494,0,0
4,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.11434,-0.099222,-0.14757,0,0
4,GO REGULATION OF HEART MORPHOGENESIS,0.17653,-0.099741,-0.12431,0,0
4,GO LEARNING,0.12908,-0.099909,-0.097697,0,0
4,GO FILOPODIUM ASSEMBLY,0.34702,-0.099964,-0.063245,0,0
4,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.44402,-0.10033,-0.064064,0,0
4,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.11434,-0.1005,-0.16027,0,0
4,GO SYNAPTIC VESICLE TRANSPORT,0.22905,-0.10051,-0.068517,0,0
4,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.57857,-0.10104,-0.03781,0,0
4,GO CELL MIGRATION IN HINDBRAIN,0.53167,-0.10155,-0.038788,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.25729,-0.10172,-0.10098,0,0
4,GO PROSTATIC BUD FORMATION,0.17934,-0.10203,-0.19587,0,0
4,GO CELLULAR COMPONENT MORPHOGENESIS,0.033166,-0.103,-0.10896,0,0
4,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.045624,-0.10314,-0.1256,0,0
4,GO RESPONSE TO SALT STRESS,0.25363,-0.10401,-0.098891,0,0
4,GO BONE MATURATION,0.085627,-0.1044,-0.14063,0,0
4,GO RRNA 3 END PROCESSING,0.40349,-0.10453,-0.044776,0,0
4,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.21579,-0.10497,-0.10925,0,0
4,GO ATRIAL SEPTUM DEVELOPMENT,0.58456,-0.10508,-0.041687,0,0
4,GO NEURON DIFFERENTIATION,0.14285,-0.1052,-0.067613,0,0
4,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.17934,-0.10543,-0.10428,0,0
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.29992,-0.10553,-0.05814,0,0
4,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.5726,-0.10566,-0.031594,0,0
4,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.077957,-0.1057,-0.097136,0,0
4,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.12473,-0.10599,-0.081379,0,0
4,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.21905,-0.10616,-0.17129,0,0
4,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.32506,-0.10623,-0.095453,0,0
4,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.0097392,-0.10679,-0.12211,0,0
4,GO DNA DEPENDENT DNA REPLICATION,0.007729,-0.10717,-0.096697,0,0
4,GO NEUROBLAST PROLIFERATION,0.075049,-0.10722,-0.11641,0,0
4,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.32506,-0.10782,-0.063013,0,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.40349,-0.108,-0.06895,0,0
4,GO SISTER CHROMATID COHESION,0.12473,-0.10812,-0.055661,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.4978,-0.10824,-0.08391,0,0
4,GO NEURON PROJECTION ARBORIZATION,0.10465,-0.10843,-0.13024,0,0
4,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.082489,-0.10861,-0.12578,0,0
4,GO ANTEROGRADE AXONAL TRANSPORT,0.0057817,-0.10863,-0.12518,0,0
4,GO SMOOTHENED SIGNALING PATHWAY,0.066855,-0.10954,-0.082284,0,0
4,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.59664,-0.10972,-0.050275,0,0
4,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.061812,-0.10975,-0.15357,0,0
4,GO REGULATION OF STEM CELL DIVISION,0.17099,-0.1106,-0.089965,0,0
4,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.23937,-0.11072,-0.10435,0,0
4,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0073363,-0.11174,-0.15643,0,0
4,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.58456,-0.11183,-0.030948,0,0
4,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.064293,-0.11267,-0.11132,0,0
4,GO RRNA MODIFICATION,0.3746,-0.11302,-0.067536,0,0
4,GO RRNA TRANSCRIPTION,0.077957,-0.11313,-0.1198,0,0
4,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.50337,-0.11327,-0.15326,0,0
4,GO COLLAGEN BIOSYNTHETIC PROCESS,0.47588,-0.11345,-0.12199,0,0
4,GO PEPTIDYL ARGININE N METHYLATION,0.32938,-0.11379,-0.071678,0,0
4,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.35607,-0.11413,-0.093668,0,0
4,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.30815,-0.11423,-0.05244,0,0
4,GO EXTRACELLULAR MATRIX ASSEMBLY,0.37932,-0.11526,-0.10922,0,0
4,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.020205,-0.1155,-0.1437,0,0
4,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.10654,-0.11552,-0.096677,0,0
4,GO NEPHRON TUBULE FORMATION,0.11434,-0.11623,-0.18858,0,0
4,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.97557,-0.11635,0.039485,0,0
4,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.40843,-0.11656,-0.11971,0,0
4,GO REGULATION OF NEURON DIFFERENTIATION,0.13814,-0.11714,-0.071499,0,0
4,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.14769,-0.11736,-0.050612,0,0
4,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.23245,-0.11753,-0.10408,0,0
4,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.082489,-0.11764,-0.11919,0,0
4,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.43367,-0.11769,-0.030564,0,0
4,GO TRACHEA MORPHOGENESIS,0.37932,-0.11773,-0.059873,0,0
4,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.0018173,-0.11808,-0.13594,0,0
4,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.5726,-0.11829,-0.06146,0,0
4,GO SYNAPTIC VESICLE PRIMING,0.50337,-0.11842,0.014201,0,0
4,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.057089,-0.11875,-0.082608,0,0
4,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.10845,-0.11891,-0.13296,0,0
4,GO MYOBLAST PROLIFERATION,0.10096,-0.11914,-0.13136,0,0
4,GO COLLECTING DUCT DEVELOPMENT,0.19695,-0.11919,-0.12082,0,0
4,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.10096,-0.11934,-0.06631,0,0
4,GO HISTONE H3 K9 TRIMETHYLATION,0.061812,-0.11968,-0.086976,0,0
4,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.54903,-0.1202,-0.076594,0,0
4,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.093897,-0.12052,-0.15933,0,0
4,GO RESPONSE TO X RAY,0.085627,-0.12069,-0.13644,0,0
4,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.0097392,-0.12107,-0.11783,0,0
4,GO IMP METABOLIC PROCESS,0.35153,-0.12125,-0.12072,0,0
4,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.13814,-0.12154,-0.093364,0,0
4,GO SUBSTANTIA NIGRA DEVELOPMENT,0.060602,-0.12166,-0.080572,0,0
4,GO ACROSOME ASSEMBLY,0.055956,-0.12183,-0.12931,0,0
4,GO MITOTIC SISTER CHROMATID COHESION,0.059411,-0.12194,-0.10684,0,0
4,GO REGULATION OF SENSORY PERCEPTION,0.066855,-0.12199,-0.11071,0,0
4,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.05824,-0.12208,-0.10843,0,0
4,GO CELL PART MORPHOGENESIS,0.017549,-0.12214,-0.13236,0,0
4,GO UTERUS DEVELOPMENT,0.30815,-0.12215,-0.10666,0,0
4,GO PROTEIN LOCALIZATION TO CHROMATIN,0.00059588,-0.12231,-0.14557,0,0
4,GO SPINAL CORD DEVELOPMENT,0.11235,-0.12246,-0.11273,0,0
4,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.037747,-0.12255,-0.11993,0,0
4,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.073629,-0.12295,-0.14638,0,0
4,GO TRANSPORT ALONG MICROTUBULE,0.0010859,-0.12333,-0.12253,0,0
4,GO INTRACELLULAR MRNA LOCALIZATION,0.4545,-0.12337,-0.079811,0,0
4,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.52594,-0.1234,-0.058378,0,0
4,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.047551,-0.12378,-0.11808,0,0
4,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.02843,-0.12395,-0.15898,0,0
4,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.12473,-0.12396,-0.088727,0,0
4,GO MITOCHONDRION LOCALIZATION,0.00087311,-0.12403,-0.13411,0,0
4,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.19393,-0.12411,-0.10421,0,0
4,GO REGULATION OF CATION CHANNEL ACTIVITY,0.27999,-0.12438,-0.066485,0,0
4,GO CEREBRAL CORTEX DEVELOPMENT,0.088862,-0.12455,-0.060994,0,0
4,GO RESPONSE TO PARATHYROID HORMONE,0.068167,-0.12485,-0.16449,0,0
4,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.05824,-0.12503,-0.078117,0,0
4,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.080955,-0.12609,-0.14487,0,0
4,GO MOTILE CILIUM ASSEMBLY,0.49227,-0.12652,-0.057746,0,0
4,GO OLFACTORY LOBE DEVELOPMENT,0.063042,-0.12658,-0.19412,0,0
4,GO OUTFLOW TRACT MORPHOGENESIS,0.14285,-0.1268,-0.115,0,0
4,GO RRNA METHYLATION,0.49227,-0.12684,-0.036345,0,0
4,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.035393,-0.12723,-0.086426,0,0
4,GO FOREBRAIN DEVELOPMENT,0.065563,-0.12741,-0.07565,0,0
4,GO L SERINE METABOLIC PROCESS,0.44402,-0.12759,-0.084637,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.023741,-0.1278,-0.15708,0,0
4,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.057089,-0.12822,-0.14547,0,0
4,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.12689,-0.12855,-0.12594,0,0
4,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.38408,-0.12898,-0.052194,0,0
4,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.15015,-0.12913,-0.11173,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.4978,-0.12976,-0.046945,0,0
4,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.077957,-0.13029,-0.095726,0,0
4,GO BRANCHING MORPHOGENESIS OF A NERVE,0.16828,-0.13033,-0.16811,0,0
4,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.037747,-0.13115,-0.12971,0,0
4,GO REGULATION OF HEART GROWTH,0.075049,-0.13149,-0.10016,0,0
4,GO CHROMATIN REMODELING AT CENTROMERE,0.080955,-0.13152,-0.11317,0,0
4,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.099158,-0.13338,-0.090692,0,0
4,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.11841,-0.13362,-0.078183,0,0
4,GO BLASTOCYST GROWTH,0.16294,-0.13388,-0.056182,0,0
4,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.064293,-0.13438,-0.098769,0,0
4,GO MICROTUBULE BASED TRANSPORT,0.0059384,-0.13446,-0.10964,0,0
4,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.53167,-0.13446,-0.027561,0,0
4,GO SYNAPSE MATURATION,0.35153,-0.13512,-0.12949,0,0
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.17374,-0.13518,-0.097913,0,0
4,GO HISTONE H4 K16 ACETYLATION,0.20937,-0.13519,-0.067854,0,0
4,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.29586,-0.13548,-0.085623,0,0
4,GO NEUROTRANSMITTER SECRETION,0.12049,-0.13553,-0.041523,0,0
4,GO CEREBELLAR CORTEX DEVELOPMENT,0.21579,-0.13596,-0.066158,0,0
4,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.087232,-0.13644,-0.19452,0,0
4,GO BIOLOGICAL PHASE,0.4545,-0.13665,-0.079606,0,0
4,GO NEURON PROJECTION EXTENSION,0.023205,-0.13724,-0.13738,0,0
4,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.22235,-0.13731,-0.11082,0,0
4,GO APPENDAGE MORPHOGENESIS,0.085627,-0.13735,-0.095507,0,0
4,GO CHONDROCYTE PROLIFERATION,0.14769,-0.13745,-0.15562,0,0
4,GO SPINDLE MIDZONE ASSEMBLY,0.1028,-0.13757,-0.10511,0,0
4,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.4545,-0.13808,0.0042745,0,0
4,GO GLUTAMATE SECRETION,0.14526,-0.13833,-0.086385,0,0
4,GO REGULATION OF CILIUM ASSEMBLY,0.0006154,-0.13904,-0.14032,0,0
4,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.02068,-0.13906,-0.12945,0,0
4,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.15264,-0.13912,-0.11667,0,0
4,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.097379,-0.13996,-0.14802,0,0
4,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.23589,-0.14034,-0.10776,0,0
4,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.11235,-0.14056,-0.087167,0,0
4,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.15015,-0.14057,-0.12324,0,0
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.00067758,-0.14112,-0.14917,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.03939,-0.14119,-0.14872,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.22905,-0.14121,-0.089518,0,0
4,GO PYRAMIDAL NEURON DIFFERENTIATION,0.087232,-0.14127,-0.18802,0,0
4,GO MATURATION OF SSU RRNA,0.14526,-0.14179,-0.12648,0,0
4,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.19393,-0.14225,-0.10246,0,0
4,GO DIVALENT METAL ION EXPORT,0.073629,-0.14256,-0.19176,0,0
4,GO NUCLEAR PORE ORGANIZATION,0.15264,-0.14263,-0.10893,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.079444,-0.14314,-0.1675,0,0
4,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.17934,-0.1433,-0.13548,0,0
4,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.34256,-0.14368,-0.050069,0,0
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.80989,-0.14382,-0.004935,0,0
4,GO PALLIUM DEVELOPMENT,0.033166,-0.14437,-0.092015,0,0
4,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.16559,-0.14444,-0.09009,0,0
4,GO NEURON PROJECTION REGENERATION,0.047551,-0.14564,-0.12984,0,0
4,GO REGULATION OF COLLATERAL SPROUTING,0.095625,-0.146,-0.18377,0,0
4,GO PROTEIN POLYGLUTAMYLATION,0.040234,-0.14692,-0.11312,0,0
4,GO VENTRAL SPINAL CORD DEVELOPMENT,0.14285,-0.14751,-0.11377,0,0
4,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.2,-0.14752,-0.11814,0,0
4,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.0053338,-0.14767,-0.17167,0,0
4,GO NEURON PROJECTION GUIDANCE,0.0028957,-0.14769,-0.20951,0,0
4,GO VENTRICULAR SYSTEM DEVELOPMENT,0.0090226,-0.14775,-0.14533,0,0
4,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.0022992,-0.14802,-0.10524,0,0
4,GO AXON DEVELOPMENT,0.004408,-0.14808,-0.18431,0,0
4,GO NEURAL CREST FORMATION,0.059411,-0.14809,-0.1793,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,0.47049,-0.14906,-0.078859,0,0
4,GO CENTROMERE COMPLEX ASSEMBLY,0.079444,-0.14906,-0.1133,0,0
4,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.12473,-0.14941,-0.1869,0,0
4,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.030383,-0.15011,-0.18696,0,0
4,GO ROOF OF MOUTH DEVELOPMENT,0.24288,-0.15062,-0.084251,0,0
4,GO RESPONSE TO LEAD ION,0.017549,-0.15156,-0.12802,0,0
4,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.21256,-0.15232,-0.15946,0,0
4,GO REGULATION OF EXTENT OF CELL GROWTH,0.0042883,-0.15241,-0.206,0,0
4,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.11636,-0.15341,-0.17251,0,0
4,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.010773,-0.15344,-0.12193,0,0
4,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.63978,-0.15362,0.0025793,0,0
4,GO PROTEIN LOCALIZATION TO CILIUM,0.00040247,-0.15503,-0.19805,0,0
4,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.12049,-0.15521,-0.16656,0,0
4,GO TONGUE MORPHOGENESIS,0.10845,-0.15528,-0.21463,0,0
4,GO REGULATION OF SYNAPSE ASSEMBLY,0.16559,-0.15543,-0.10687,0,0
4,GO REGULATION OF SYNAPTIC PLASTICITY,0.072231,-0.15579,-0.10704,0,0
4,GO CARDIOBLAST PROLIFERATION,0.17374,-0.15652,-0.23257,0,0
4,GO REGULATION OF AXONOGENESIS,0.013139,-0.15653,-0.19272,0,0
4,GO BASEMENT MEMBRANE ASSEMBLY,0.20621,-0.15663,-0.14533,0,0
4,GO REGULATION OF DENDRITE DEVELOPMENT,0.03939,-0.15709,-0.10628,0,0
4,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.093897,-0.15745,-0.16049,0,0
4,GO CELL DIFFERENTIATION IN SPINAL CORD,0.13583,-0.15815,-0.10202,0,0
4,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.0099891,-0.15826,-0.14874,0,0
4,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.047551,-0.15832,-0.2069,0,0
4,GO KINETOCHORE ASSEMBLY,0.40843,-0.15833,-0.069058,0,0
4,GO FOREBRAIN CELL MIGRATION,0.073629,-0.16048,-0.13104,0,0
4,GO KIDNEY MESENCHYME DEVELOPMENT,0.18219,-0.16091,-0.11139,0,0
4,GO KINETOCHORE ORGANIZATION,0.23245,-0.16095,-0.08117,0,0
4,GO POSITIVE REGULATION OF VESICLE FUSION,0.41842,-0.16175,-0.078029,0,0
4,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.17934,-0.16192,-0.16608,0,0
4,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.076492,-0.16228,-0.18055,0,0
4,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.013465,-0.16268,-0.15828,0,0
4,GO REGULATION OF HIPPO SIGNALING,0.057089,-0.16309,-0.17837,0,0
4,GO SYNAPTIC SIGNALING,0.188,-0.16311,-0.069405,0,0
4,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.018398,-0.16347,-0.10032,0,0
4,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.057089,-0.16359,-0.16024,0,0
4,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.188,-0.16507,-0.12606,0,0
4,GO GLYCINE METABOLIC PROCESS,0.15773,-0.16561,-0.082631,0,0
4,GO SYNAPSE ORGANIZATION,0.034637,-0.16707,-0.1241,0,0
4,GO V D J RECOMBINATION,0.036948,-0.16769,-0.17076,0,0
4,GO REGULATION OF AXON GUIDANCE,0.0056288,-0.16775,-0.19131,0,0
4,GO MATURATION OF LSU RRNA,0.2,-0.16791,-0.13558,0,0
4,GO HISTONE H3 K27 METHYLATION,0.001986,-0.16835,-0.16444,0,0
4,GO FORELIMB MORPHOGENESIS,0.013798,-0.16858,-0.21601,0,0
4,GO REGULATION OF MESODERM DEVELOPMENT,0.027188,-0.16941,-0.17936,0,0
4,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.42347,-0.16967,-0.054754,0,0
4,GO FOREBRAIN NEURON DEVELOPMENT,0.15015,-0.17053,-0.12369,0,0
4,GO DENDRITE SELF AVOIDANCE,0.065563,-0.17056,-0.18161,0,0
4,GO RETINAL ROD CELL DIFFERENTIATION,0.27611,-0.1707,-0.12766,0,0
4,GO POSITIVE REGULATION OF AXON EXTENSION,0.0032441,-0.17089,-0.19958,0,0
4,GO AXONAL TRANSPORT OF MITOCHONDRION,0.010245,-0.17461,-0.21345,0,0
4,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.054842,-0.17522,-0.14047,0,0
4,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.13814,-0.17568,-0.19842,0,0
4,GO RETINAL GANGLION CELL AXON GUIDANCE,0.36064,-0.1764,-0.084759,0,0
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.097379,-0.17655,-0.17847,0,0
4,GO SYNAPSE ASSEMBLY,0.33812,-0.17704,-0.06257,0,0
4,GO MICROTUBULE ANCHORING AT CENTROSOME,0.014138,-0.17784,-0.15531,0,0
4,GO NEURON RECOGNITION,0.087232,-0.17936,-0.18185,0,0
4,GO INHIBITORY SYNAPSE ASSEMBLY,0.16559,-0.17966,-0.13152,0,0
4,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.041967,-0.18028,-0.16448,0,0
4,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.042857,-0.18051,-0.19042,0,0
4,GO RRNA PSEUDOURIDINE SYNTHESIS,0.25729,-0.18083,-0.11842,0,0
4,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.56666,-0.18187,-0.055974,0,0
4,GO LEUKOCYTE AGGREGATION,0.11636,-0.18248,-0.24842,0,0
4,GO AXO DENDRITIC TRANSPORT,0.00047456,-0.18289,-0.16502,0,0
4,GO SYNAPTIC VESICLE LOCALIZATION,0.0024367,-0.18312,-0.19354,0,0
4,GO INNER CELL MASS CELL PROLIFERATION,0.088862,-0.18393,-0.1035,0,0
4,GO COCHLEA MORPHOGENESIS,0.0032441,-0.18406,-0.22655,0,0
4,GO POSITIVE REGULATION OF AXONOGENESIS,0.009256,-0.18564,-0.19563,0,0
4,GO AXONAL TRANSPORT,0.00057693,-0.18595,-0.17125,0,0
4,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.25001,-0.18598,-0.10477,0,0
4,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.019739,-0.18625,-0.12621,0,0
4,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0069616,-0.18682,-0.1471,0,0
4,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.026586,-0.18735,-0.18295,0,0
4,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.00022676,-0.18755,-0.22343,0,0
4,GO DENDRITE DEVELOPMENT,0.025994,-0.18792,-0.11522,0,0
4,GO HEART VALVE FORMATION,0.17653,-0.18873,-0.16311,0,0
4,GO SIALYLATION,0.50337,-0.19032,-0.071535,0,0
4,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.014841,-0.19048,-0.15204,0,0
4,GO NEURON CELLULAR HOMEOSTASIS,0.04854,-0.19205,-0.19957,0,0
4,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.090515,-0.19207,-0.13906,0,0
4,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.12689,-0.19391,-0.26443,0,0
4,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.30402,-0.19413,-0.10701,0,0
4,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.025414,-0.19643,-0.25916,0,0
4,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.27611,-0.19677,-0.077477,0,0
4,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.20621,-0.19727,-0.10939,0,0
4,GO CELLULAR HYPEROSMOTIC RESPONSE,0.11039,-0.19753,-0.18719,0,0
4,GO INTRACILIARY RETROGRADE TRANSPORT,0.026586,-0.19772,-0.2021,0,0
4,GO AXON EXTENSION,0.00029782,-0.19879,-0.23226,0,0
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.10845,-0.19889,-0.1114,0,0
4,GO NEUROBLAST DIVISION,0.23937,-0.19906,-0.12173,0,0
4,GO MECHANOSENSORY BEHAVIOR,0.65866,-0.19951,-0.074367,0,0
4,GO CEREBRAL CORTEX CELL MIGRATION,0.055956,-0.19983,-0.1211,0,0
4,GO POSTSYNAPSE ORGANIZATION,0.001662,-0.2001,-0.20978,0,0
4,GO REGULATION OF DENDRITE MORPHOGENESIS,0.0038387,-0.20195,-0.16463,0,0
4,GO NON MOTILE CILIUM ASSEMBLY,0.0054795,-0.20507,-0.15534,0,0
4,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.075049,-0.20536,-0.10524,0,0
4,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.034637,-0.20551,-0.16706,0,0
4,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.036948,-0.20552,-0.25039,0,0
4,GO LOCALIZATION WITHIN MEMBRANE,0.001986,-0.20721,-0.18217,0,0
4,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.0030654,-0.20768,-0.17251,0,0
4,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.12908,-0.2082,-0.097939,0,0
4,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00069957,-0.20981,-0.22976,0,0
4,GO RECEPTOR CLUSTERING,0.0024367,-0.21358,-0.2097,0,0
4,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.11235,-0.21385,-0.20838,0,0
4,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.00067758,-0.21482,-0.22089,0,0
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.018398,-0.21631,-0.19352,0,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.063042,-0.21669,-0.1817,0,0
4,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.00050664,-0.21685,-0.22173,0,0
4,GO CARDIAC CELL FATE COMMITMENT,0.036948,-0.21686,-0.25884,0,0
4,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.084046,-0.21688,-0.20257,0,0
4,GO NEURON MIGRATION,0.021165,-0.21904,-0.16205,0,0
4,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.052669,-0.21978,-0.18208,0,0
4,GO COCHLEA DEVELOPMENT,0.043763,-0.22034,-0.17504,0,0
4,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.024288,-0.22034,-0.23086,0,0
4,GO RESPONSE TO ACETYLCHOLINE,0.026586,-0.22125,-0.22477,0,0
4,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.017969,-0.22153,-0.18405,0,0
4,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.085627,-0.22404,-0.15919,0,0
4,GO RETROGRADE AXONAL TRANSPORT,0.00032948,-0.22488,-0.27795,0,0
4,GO DENDRITIC SPINE DEVELOPMENT,0.0022992,-0.22514,-0.19911,0,0
4,GO CGMP METABOLIC PROCESS,0.27611,-0.22529,-0.097119,0,0
4,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.018836,-0.23208,-0.12282,0,0
4,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.076492,-0.23249,-0.21558,0,0
4,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.0013457,-0.23274,-0.2923,0,0
4,GO REGULATION OF NEURON MIGRATION,0.00040247,-0.23512,-0.28459,0,0
4,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0016129,-0.23606,-0.20918,0,0
4,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.39858,-0.23693,-0.071981,0,0
4,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.082489,-0.23884,-0.14016,0,0
4,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.0099891,-0.24119,-0.20433,0,0
4,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.059411,-0.24435,-0.15229,0,0
4,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.001872,-0.24687,-0.22712,0,0
4,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,8.4205e-05,-0.24834,-0.28267,0,0
4,GO DENDRITE MORPHOGENESIS,0.012203,-0.25078,-0.15765,0,0
4,GO DENSE CORE GRANULE TRANSPORT,0.19393,-0.2513,-0.13076,0,0
4,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.009256,-0.25282,-0.20393,0,0
4,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.0695,-0.25364,-0.26631,0,0
4,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.0017123,-0.25401,-0.31283,0,0
4,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0010528,-0.25418,-0.23969,0,0
4,GO RESPIRATORY SYSTEM PROCESS,5.2139e-05,-0.2548,-0.25498,0,0
4,GO ATRIAL SEPTUM MORPHOGENESIS,0.017137,-0.25545,-0.24902,0,0
4,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.0036303,-0.25606,-0.29687,0,0
4,GO BRAIN MORPHOGENESIS,6.0504e-05,-0.2569,-0.22419,0,0
4,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.019739,-0.25806,-0.31399,0,0
4,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.00044439,-0.25957,-0.22223,0,0
4,GO COMMISSURAL NEURON AXON GUIDANCE,0.0015189,-0.25982,-0.40507,0,0
4,GO AXO DENDRITIC PROTEIN TRANSPORT,0.001986,-0.26045,-0.26065,0,0
4,GO PLASMA MEMBRANE REPAIR,0.11841,-0.26061,-0.15492,0,0
4,GO PROTEIN LOCALIZATION TO SYNAPSE,0.0066042,-0.26142,-0.20329,0,0
4,GO PRESYNAPSE ORGANIZATION,0.15264,-0.26619,-0.13112,0,0
4,GO NEGATIVE REGULATION OF AXON EXTENSION,0.0021062,-0.26733,-0.25263,0,0
4,GO MICROTUBULE DEPOLYMERIZATION,0.0079323,-0.2698,-0.20156,0,0
4,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.017549,-0.27025,-0.24561,0,0
4,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.19095,-0.27512,-0.1194,0,0
4,GO NEGATIVE REGULATION OF AXONOGENESIS,0.0012662,-0.27689,-0.29052,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.11841,-0.27923,-0.12694,0,0
4,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.0014299,-0.2803,-0.222,0,0
4,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.097379,-0.28331,-0.17124,0,0
4,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.033894,-0.28436,-0.15434,0,0
4,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.00050664,-0.28757,-0.26556,0,0
4,GO DENTATE GYRUS DEVELOPMENT,0.060602,-0.28767,-0.18795,0,0
4,GO MICROTUBULE SEVERING,0.02268,-0.28877,-0.16943,0,0
4,GO TRIGEMINAL NERVE DEVELOPMENT,0.038561,-0.29587,-0.32698,0,0
4,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.0033369,-0.30127,-0.30472,0,0
4,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.0022332,-0.30138,-0.35339,0,0
4,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.0038387,-0.30153,-0.26251,0,0
4,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.001191,-0.30607,-0.24149,0,0
4,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.011904,-0.31056,-0.28321,0,0
4,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.00020448,-0.31432,-0.27896,0,0
4,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.015574,-0.31907,-0.25132,0,0
4,GO SYNAPTIC MEMBRANE ADHESION,0.043763,-0.31929,-0.25739,0,0
4,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.0085714,-0.32152,-0.32898,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,1.5201e-05,-0.32392,-0.37012,0,0
4,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0017641,-0.32783,-0.27006,0,0
4,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.010245,-0.3279,-0.22129,0,0
4,GO DENDRITIC SPINE MORPHOGENESIS,0.00029782,-0.33244,-0.28956,0,0
4,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0036303,-0.33275,-0.26812,0,0
4,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.0018173,-0.33451,-0.25811,0,0
4,GO CARTILAGE MORPHOGENESIS,0.0036303,-0.33826,-0.35935,0,0
4,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.0075304,-0.34183,-0.35601,0,0
4,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.00018427,-0.34446,-0.37244,0,0
4,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.018836,-0.34682,-0.32602,0,0
4,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.014486,-0.35836,-0.24784,0,0
4,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.00059588,-0.36312,-0.33069,0,0
4,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.036948,-0.36512,-0.30992,0,0
4,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0066042,-0.38005,-0.34011,0,0
4,GO LONG TERM SYNAPTIC DEPRESSION,0.00074557,-0.39018,-0.30167,0,0
4,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.010506,-0.39144,-0.34235,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,4.4878e-05,-0.41276,-0.43606,0,0
4,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.00052342,-0.43089,-0.5061,0,0
4,GO VOCALIZATION BEHAVIOR,0.031059,-0.44779,-0.33209,0,0
4,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.010245,-0.45242,-0.37414,0,0
4,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00072223,-0.48161,-0.52442,0,0
4,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.00041602,-0.49511,-0.42976,0,0
4,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.0017641,-0.51041,-0.38427,0,0
4,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0028141,-0.53656,-0.40658,0,0
4,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.00010092,-0.57796,-0.57755,0,0
4,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.00029782,-0.59052,-0.55874,0,0
4,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.015953,-0.62037,-0.40464,0,0
4,GO SYNAPTIC VESICLE CLUSTERING,0.00020448,-0.73562,-0.60829,0,0
5,GO FOREBRAIN NEURON FATE COMMITMENT,9.389e-05,0.71711,0.80186,1,1
5,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,4.6623e-06,0.55173,0.51129,1,1
5,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.0064317,0.52017,0.4028,1,1
5,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,5.7413e-06,0.42961,0.43401,1,1
5,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.001662,0.40189,0.43636,1,1
5,GO THALAMUS DEVELOPMENT,0.0030654,0.34803,0.3007,1,1
5,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0056288,0.34268,0.38809,1,1
5,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.00069957,0.33994,0.32635,1,1
5,GO NOSE DEVELOPMENT,0.00069957,0.31685,0.49465,1,1
5,GO ESTROUS CYCLE,0.052669,0.28315,0.1734,1,1
5,GO KINETOCHORE ORGANIZATION,0.0011199,0.25095,0.21623,1,1
5,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.02843,0.24932,0.2353,1,1
5,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.00057693,0.24842,0.22834,1,1
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.0056288,0.24639,0.32097,1,1
5,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.0045306,0.23628,0.22267,1,1
5,GO MRNA SPLICE SITE SELECTION,9.7346e-05,0.23498,0.25837,1,1
5,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.021165,0.22443,0.16205,1,1
5,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.004408,0.22431,0.18055,1,1
5,GO REGULATION OF SISTER CHROMATID COHESION,0.001662,0.21515,0.17146,1,1
5,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.03245,0.21131,0.16347,1,1
5,GO KINETOCHORE ASSEMBLY,0.0037331,0.20983,0.18191,1,1
5,GO HISTONE H4 K16 ACETYLATION,6.7596e-05,0.20893,0.21464,1,1
5,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.019283,0.20669,0.16686,1,1
5,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.02268,0.20268,0.14706,1,1
5,GO APICAL PROTEIN LOCALIZATION,0.0014738,0.20132,0.19976,1,1
5,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.0023671,0.1997,0.16584,1,1
5,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.02268,0.19484,0.16869,1,1
5,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.011612,0.1918,0.157,1,1
5,GO HISTONE H3 K9 TRIMETHYLATION,0.0013457,0.19125,0.16551,1,1
5,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.014841,0.18427,0.13251,1,1
5,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0087944,0.18181,0.14668,1,1
5,GO DENDRITIC TRANSPORT,0.036164,0.1809,0.16379,1,1
5,GO INTRACILIARY TRANSPORT,0.004408,0.17781,0.20037,1,1
5,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.00017796,0.17735,0.19303,1,1
5,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.0062634,0.17377,0.18316,1,1
5,GO HISTONE H4 K5 ACETYLATION,7.8282e-05,0.17219,0.23057,1,1
5,GO CHROMATIN REMODELING AT CENTROMERE,0.0023671,0.1689,0.18077,1,1
5,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.009256,0.16873,0.14068,1,1
5,GO POST ANAL TAIL MORPHOGENESIS,0.020205,0.168,0.12913,1,1
5,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00016595,0.16518,0.17921,1,1
5,GO HISTONE H3 K9 METHYLATION,0.001662,0.16495,0.15188,1,1
5,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.0030654,0.16183,0.15187,1,1
5,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.0018173,0.1616,0.19978,1,1
5,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.001228,0.15959,0.14229,1,1
5,GO MITOTIC SISTER CHROMATID COHESION,0.00074557,0.15708,0.2021,1,1
5,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.014841,0.15605,0.14197,1,1
5,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.0053338,0.15466,0.13805,1,1
5,GO VIRAL LATENCY,0.018398,0.15335,0.15821,1,1
5,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.0075304,0.15066,0.16181,1,1
5,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.017969,0.14957,0.16419,1,1
5,GO MITOTIC CHROMOSOME CONDENSATION,0.00049035,0.14904,0.19246,1,1
5,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.0099891,0.14669,0.13357,1,1
5,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.0090226,0.14631,0.18841,1,1
5,GO MAINTENANCE OF ORGANELLE LOCATION,0.027803,0.14457,0.086262,1,1
5,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.011047,0.14377,0.15009,1,1
5,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.0060989,0.14327,0.12321,1,1
5,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.00098941,0.14262,0.14932,1,1
5,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0049174,0.14194,0.114,1,1
5,GO CENTROSOME DUPLICATION,0.0014738,0.14193,0.13551,1,1
5,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.014138,0.14171,0.13144,1,1
5,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.024288,0.14085,0.08773,1,1
5,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.018836,0.13876,0.15832,1,1
5,GO POSITIVE REGULATION OF DNA REPAIR,0.0028957,0.13856,0.11061,1,1
5,GO DOSAGE COMPENSATION,0.0036303,0.13802,0.11567,1,1
5,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.035393,0.13456,0.13946,1,1
5,GO HISTONE H2A ACETYLATION,0.0029794,0.1334,0.15648,1,1
5,GO ATP DEPENDENT CHROMATIN REMODELING,0.00055855,0.13302,0.13964,1,1
5,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.0010859,0.12899,0.12425,1,1
5,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.00025131,0.12819,0.14341,1,1
5,GO CENTRIOLE ASSEMBLY,0.0067808,0.12724,0.10893,1,1
5,GO NATURAL KILLER CELL DIFFERENTIATION,0.024846,0.12086,0.12242,1,1
5,GO HISTONE H4 ACETYLATION,0.0010528,0.11655,0.11425,1,1
5,GO DNA STRAND ELONGATION,0.012203,0.11409,0.11334,1,1
5,GO PEPTIDYL LYSINE TRIMETHYLATION,0.0059384,0.11377,0.098808,1,1
5,GO HISTONE H2A UBIQUITINATION,0.0051916,0.11361,0.12739,1,1
5,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.0031536,0.11323,0.1096,1,1
5,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.010773,0.11285,0.12603,1,1
5,GO HISTONE MONOUBIQUITINATION,0.00081984,0.11174,0.11912,1,1
5,GO NEGATIVE REGULATION OF RNA SPLICING,0.0029794,0.11102,0.12406,1,1
5,GO G0 TO G1 TRANSITION,0.0021689,0.11076,0.13728,1,1
5,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.0062634,0.10927,0.12693,1,1
5,GO PEPTIDYL LYSINE ACETYLATION,0.00063551,0.10704,0.0901,1,1
5,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.024846,0.10679,0.13066,1,1
5,GO REGULATION OF CELL CYCLE CHECKPOINT,0.001228,0.10592,0.10112,1,1
5,GO NUCLEOSOME ASSEMBLY,0.010245,0.10483,0.12713,1,1
5,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.030383,0.10204,0.12581,1,1
5,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.00047456,0.10158,0.12537,1,1
5,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.01282,0.10152,0.14671,1,1
5,GO HISTONE H3 K4 METHYLATION,0.0042883,0.097565,0.13621,1,1
5,GO SISTER CHROMATID COHESION,0.0046564,0.095238,0.12185,1,1
5,GO CELL CYCLE DNA REPLICATION,0.036164,0.094995,0.077081,1,1
5,GO CHROMOSOME LOCALIZATION,0.012508,0.092369,0.075688,1,1
5,GO PROTEIN ACETYLATION,0.0034322,0.091896,0.065752,1,1
5,GO NUCLEOSOME ORGANIZATION,0.0081404,0.09049,0.09764,1,1
5,GO HISTONE UBIQUITINATION,0.016734,0.087846,0.075099,1,1
5,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.0062634,0.086238,0.12136,1,1
5,GO REGULATION OF PROTEIN ACETYLATION,0.049546,0.080845,0.059045,1,1
5,GO RECOMBINATIONAL REPAIR,0.035393,0.077267,0.058113,1,1
5,GO HISTONE EXCHANGE,0.019739,0.076629,0.10184,1,1
5,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.018398,0.076167,0.12658,1,1
5,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0045306,0.07494,0.09936,1,1
5,GO CHROMOSOME SEGREGATION,0.022165,0.073868,0.056315,1,1
5,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.050569,0.073369,0.091951,1,1
5,GO CHROMATIN REMODELING,0.0071468,0.072561,0.081955,1,1
5,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.0034322,0.071547,0.095989,1,1
5,GO MITOTIC SISTER CHROMATID SEGREGATION,0.02843,0.067949,0.072722,1,1
5,GO CHROMOSOME CONDENSATION,0.038561,0.067571,0.085457,1,1
5,GO SISTER CHROMATID SEGREGATION,0.01282,0.066281,0.073421,1,1
5,GO CELL CYCLE CHECKPOINT,0.0097392,0.066261,0.0593,1,1
5,GO PEPTIDYL LYSINE MODIFICATION,0.040234,0.066025,0.042966,1,1
5,GO DNA INTEGRITY CHECKPOINT,0.024288,0.064855,0.051358,1,1
5,GO REGULATION OF DNA REPAIR,0.050569,0.063867,0.053422,1,1
5,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.052669,0.060045,0.073759,1,1
5,GO DEMETHYLATION,0.019739,0.058928,0.067902,1,1
5,GO DNA PACKAGING,0.0066042,0.057153,0.089103,1,1
5,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.037747,0.054907,0.049116,1,1
5,GO NUCLEAR CHROMOSOME SEGREGATION,0.027803,0.053652,0.051478,1,1
5,GO DNA CONFORMATION CHANGE,0.044685,0.053238,0.053727,1,1
5,GO CHROMATIN ORGANIZATION,0.0094949,0.052844,0.053259,1,1
5,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.015953,0.30182,0.25199,1,0
5,GO MYOBLAST MIGRATION,0.052669,0.27438,0.17545,1,0
5,GO CARDIAC VENTRICLE FORMATION,0.031059,0.20414,0.32357,1,0
5,GO CARDIOBLAST DIFFERENTIATION,0.02166,0.19928,0.18101,1,0
5,GO FOREBRAIN REGIONALIZATION,0.0064317,0.19132,0.22103,1,0
5,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.0041716,0.18139,0.18608,1,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.0046564,0.16246,0.16274,1,0
5,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.011904,0.15874,0.14473,1,0
5,GO NEURAL TUBE PATTERNING,0.025994,0.15051,0.11483,1,0
5,GO RDNA HETEROCHROMATIN ASSEMBLY,0.0050528,0.12948,0.1631,1,0
5,GO SPERMATID NUCLEUS DIFFERENTIATION,0.018398,0.11623,0.12315,1,0
5,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.026586,0.10711,0.14126,1,0
5,GO HISTONE H3 K4 TRIMETHYLATION,0.05161,0.10704,0.10645,1,0
5,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.04854,0.10375,0.12271,1,0
5,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.045624,0.096449,0.07978,1,0
5,GO REGULATION OF STEM CELL PROLIFERATION,0.041967,0.090087,0.083708,1,0
5,GO REGULATION OF MRNA PROCESSING,0.050569,0.077168,0.065605,1,0
5,GO METAPHASE PLATE CONGRESSION,0.049546,0.076649,0.060018,1,0
5,GO REGULATION OF CENTROSOME CYCLE,0.040234,0.069246,0.084908,1,0
5,GO MITOTIC CELL CYCLE CHECKPOINT,0.025994,0.056015,0.050783,1,0
5,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.044685,0.055706,0.093762,1,0
5,GO INTERSTRAND CROSS LINK REPAIR,0.052669,0.039709,0.066139,1,0
5,GO RESPONSE TO RADIATION,0.050569,-0.034911,-0.045321,1,0
5,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.036948,-0.040025,-0.06527,1,0
5,GO PROTEIN K63 LINKED UBIQUITINATION,0.043763,-0.042327,-0.068833,1,0
5,GO REGULATION OF ORGANELLE ORGANIZATION,0.0039469,-0.045773,-0.05924,1,0
5,GO REGULATION OF ATPASE ACTIVITY,0.050569,-0.047561,-0.06749,1,0
5,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.010773,-0.048521,-0.05446,1,0
5,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.027188,-0.049938,-0.065968,1,0
5,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.0042883,-0.050253,-0.08435,1,0
5,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.05161,-0.050831,-0.056923,1,0
5,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.045624,-0.051112,-0.045935,1,0
5,GO SULFATE TRANSPORT,0.029719,-0.051374,-0.13741,1,0
5,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.0075304,-0.052258,-0.056055,1,0
5,GO MULTI ORGANISM PROCESS,0.013798,-0.05313,-0.061706,1,0
5,GO MESODERM DEVELOPMENT,0.035393,-0.053694,-0.10011,1,0
5,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.0028957,-0.053954,-0.07023,1,0
5,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.031748,-0.054178,-0.091972,1,0
5,GO REGULATION OF PH,0.020205,-0.056029,-0.078192,1,0
5,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.031059,-0.056219,-0.10265,1,0
5,GO HOMEOSTASIS OF NUMBER OF CELLS,0.0097392,-0.056509,-0.084735,1,0
5,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.035393,-0.056841,-0.082517,1,0
5,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.0033369,-0.058042,-0.060061,1,0
5,GO GPI ANCHOR METABOLIC PROCESS,0.038561,-0.058739,-0.11992,1,0
5,GO LYMPHOCYTE DIFFERENTIATION,0.026586,-0.058843,-0.088333,1,0
5,GO IMPORT INTO NUCLEUS,0.014841,-0.059684,-0.078264,1,0
5,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.025994,-0.060572,-0.073529,1,0
5,GO MITOCHONDRIAL PROTEIN PROCESSING,0.02843,-0.061449,-0.16983,1,0
5,GO UBIQUINONE METABOLIC PROCESS,0.050569,-0.061824,-0.11231,1,0
5,GO REPRODUCTION,0.02843,-0.062979,-0.060368,1,0
5,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.023741,-0.063649,-0.13746,1,0
5,GO CELL CELL SIGNALING BY WNT,0.027803,-0.064063,-0.075925,1,0
5,GO REGULATION OF VIRAL TRANSCRIPTION,0.018398,-0.064113,-0.10791,1,0
5,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.001872,-0.06472,-0.08694,1,0
5,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.0027346,-0.064797,-0.074367,1,0
5,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.035393,-0.06538,-0.067675,1,0
5,GO ANIMAL ORGAN FORMATION,0.03245,-0.066142,-0.12514,1,0
5,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.043763,-0.066419,-0.064823,1,0
5,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.05161,-0.066486,-0.13231,1,0
5,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.04854,-0.066567,-0.10884,1,0
5,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.04854,-0.06684,-0.11838,1,0
5,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.029068,-0.067928,-0.1521,1,0
5,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.0038387,-0.068215,-0.066256,1,0
5,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00052342,-0.068558,-0.070069,1,0
5,GO DETECTION OF STIMULUS,0.0014299,-0.068634,-0.083192,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.041967,-0.068635,-0.084282,1,0
5,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.025414,-0.069556,-0.11704,1,0
5,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.035393,-0.069678,-0.077268,1,0
5,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.050569,-0.069799,-0.18897,1,0
5,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.010773,-0.06998,-0.090428,1,0
5,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.037747,-0.070324,-0.10745,1,0
5,GO PEPTIDYL AMINO ACID MODIFICATION,0.00069957,-0.070558,-0.076986,1,0
5,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.012508,-0.070811,-0.097925,1,0
5,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.05161,-0.071275,-0.093258,1,0
5,GO NEURON DEATH,0.036948,-0.071548,-0.057931,1,0
5,GO DNA BIOSYNTHETIC PROCESS,0.0050528,-0.071953,-0.074594,1,0
5,GO METHIONINE METABOLIC PROCESS,0.017137,-0.072164,-0.13274,1,0
5,GO PROTEIN O LINKED GLYCOSYLATION,0.016339,-0.072213,-0.14407,1,0
5,GO POSITIVE REGULATION OF SECRETION,0.025414,-0.072427,-0.081678,1,0
5,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.010245,-0.072535,-0.074538,1,0
5,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.031748,-0.073009,-0.063026,1,0
5,GO COPII COATED VESICLE CARGO LOADING,0.038561,-0.073354,-0.11934,1,0
5,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0027346,-0.073609,-0.081007,1,0
5,GO REGULATION OF INTRACELLULAR TRANSPORT,0.016339,-0.074196,-0.064965,1,0
5,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.004408,-0.074344,-0.098503,1,0
5,GO REGULATION OF SECRETION,0.015203,-0.074443,-0.084273,1,0
5,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.00092958,-0.074482,-0.0864,1,0
5,GO TRANSCRIPTION BY RNA POLYMERASE III,0.025994,-0.074876,-0.077561,1,0
5,GO CELL AGING,0.013139,-0.075339,-0.092346,1,0
5,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.0051916,-0.075599,-0.12359,1,0
5,GO CELLULAR RESPONSE TO ALCOHOL,0.023205,-0.075925,-0.10266,1,0
5,GO RESPONSE TO IONIZING RADIATION,0.013798,-0.076217,-0.087732,1,0
5,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.02068,-0.076461,-0.10772,1,0
5,GO ALPHA BETA T CELL ACTIVATION,0.041967,-0.076883,-0.11077,1,0
5,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.0014738,-0.076984,-0.077668,1,0
5,GO PROTEIN KINASE A SIGNALING,0.026586,-0.076988,-0.10207,1,0
5,GO CANONICAL WNT SIGNALING PATHWAY,0.017549,-0.077196,-0.091977,1,0
5,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.031059,-0.078428,-0.11463,1,0
5,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.0062634,-0.078668,-0.093702,1,0
5,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0056288,-0.078702,-0.094097,1,0
5,GO NUCLEAR ENVELOPE ORGANIZATION,0.02268,-0.078932,-0.079299,1,0
5,GO BLASTOCYST DEVELOPMENT,0.011612,-0.078993,-0.075752,1,0
5,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.018398,-0.079202,-0.068024,1,0
5,GO PROTON TRANSMEMBRANE TRANSPORT,0.0054795,-0.079251,-0.10491,1,0
5,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.02166,-0.080151,-0.1145,1,0
5,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.00032948,-0.080767,-0.11593,1,0
5,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.016734,-0.080923,-0.071233,1,0
5,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.0027346,-0.081175,-0.1011,1,0
5,GO REGULATION OF PROTEIN LOCALIZATION,0.0021689,-0.081225,-0.084282,1,0
5,GO IMMUNOGLOBULIN PRODUCTION,0.0069616,-0.081255,-0.11673,1,0
5,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.019739,-0.081541,-0.090697,1,0
5,GO LIPID DROPLET ORGANIZATION,0.034637,-0.081755,-0.13046,1,0
5,GO MORPHOGENESIS OF AN EPITHELIUM,0.0054795,-0.082088,-0.11459,1,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.049546,-0.082297,-0.10993,1,0
5,GO CELLULAR PIGMENTATION,0.024846,-0.082299,-0.10026,1,0
5,GO POSITIVE REGULATION OF CELL ACTIVATION,0.013798,-0.082591,-0.11743,1,0
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.015203,-0.082603,-0.069477,1,0
5,GO EPITHELIUM DEVELOPMENT,0.020205,-0.08262,-0.094415,1,0
5,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.0046564,-0.082757,-0.13372,1,0
5,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.0013054,-0.082813,-0.10214,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.025994,-0.083267,-0.10717,1,0
5,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.019283,-0.083532,-0.13733,1,0
5,GO REGULATION OF CELLULAR LOCALIZATION,0.0013457,-0.08367,-0.082594,1,0
5,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.0064317,-0.083791,-0.10867,1,0
5,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.00017796,-0.083819,-0.11295,1,0
5,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.010245,-0.083938,-0.096161,1,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.037747,-0.084409,-0.07976,1,0
5,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0027346,-0.08481,-0.091693,1,0
5,GO TISSUE MORPHOGENESIS,0.0026572,-0.084861,-0.12181,1,0
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.011904,-0.085007,-0.095667,1,0
5,GO SKELETAL SYSTEM DEVELOPMENT,0.0047853,-0.085185,-0.10649,1,0
5,GO HISTONE PHOSPHORYLATION,0.013798,-0.085357,-0.12155,1,0
5,GO REGULATION OF MRNA CATABOLIC PROCESS,0.0036303,-0.085453,-0.12346,1,0
5,GO ORGAN GROWTH,0.02068,-0.085592,-0.096908,1,0
5,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.050569,-0.085863,-0.2181,1,0
5,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.0020453,-0.086137,-0.086928,1,0
5,GO CELLULAR MACROMOLECULE LOCALIZATION,3.8583e-05,-0.086212,-0.086393,1,0
5,GO POSITIVE REGULATION OF URINE VOLUME,0.052669,-0.086368,-0.12769,1,0
5,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.038561,-0.086528,-0.072259,1,0
5,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.00084609,-0.086652,-0.11403,1,0
5,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.0079323,-0.086748,-0.09648,1,0
5,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.050569,-0.08699,-0.12197,1,0
5,GO MUSCLE ORGAN DEVELOPMENT,0.0018173,-0.087233,-0.10723,1,0
5,GO RESPONSE TO ALKALOID,0.025994,-0.087235,-0.098085,1,0
5,GO IMMUNE SYSTEM DEVELOPMENT,0.0028141,-0.087463,-0.097701,1,0
5,GO REGULATION OF CELL POPULATION PROLIFERATION,0.00072223,-0.087937,-0.11666,1,0
5,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.011326,-0.087958,-0.067739,1,0
5,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.00057693,-0.088307,-0.088125,1,0
5,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.010773,-0.088397,-0.15413,1,0
5,GO REGULATION OF PROTEIN FOLDING,0.016339,-0.08841,-0.11878,1,0
5,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0060989,-0.088559,-0.073741,1,0
5,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.041093,-0.088622,-0.11904,1,0
5,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.02268,-0.088738,-0.11838,1,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00353,-0.089153,-0.1078,1,0
5,GO UROGENITAL SYSTEM DEVELOPMENT,0.024846,-0.089325,-0.1135,1,0
5,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.021165,-0.089934,-0.10566,1,0
5,GO ENDOSOME ORGANIZATION,0.033894,-0.090244,-0.089964,1,0
5,GO REGULATION OF PEPTIDE TRANSPORT,0.0025083,-0.090331,-0.08835,1,0
5,GO MRNA METABOLIC PROCESS,0.02843,-0.090674,-0.070577,1,0
5,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,2.1702e-06,-0.090923,-0.1023,1,0
5,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0013054,-0.091052,-0.11848,1,0
5,GO ORGANELLE DISASSEMBLY,0.0025083,-0.09109,-0.10837,1,0
5,GO CELL CELL ADHESION,0.00065623,-0.091147,-0.14679,1,0
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.00090094,-0.091431,-0.18246,1,0
5,GO HEART TRABECULA MORPHOGENESIS,0.025414,-0.091516,-0.14711,1,0
5,GO PROTEIN KINASE B SIGNALING,0.0097392,-0.091596,-0.11524,1,0
5,GO SENSORY PERCEPTION,0.0030654,-0.091788,-0.08896,1,0
5,GO MUSCLE CELL DIFFERENTIATION,0.0024367,-0.091824,-0.11216,1,0
5,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.011612,-0.091878,-0.14069,1,0
5,GO TRNA WOBBLE URIDINE MODIFICATION,0.038561,-0.092034,-0.132,1,0
5,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.049546,-0.092098,-0.11067,1,0
5,GO SYNAPTIC TRANSMISSION GABAERGIC,0.035393,-0.092237,-0.12101,1,0
5,GO PROTEIN IMPORT,0.00098941,-0.092637,-0.11416,1,0
5,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.00063551,-0.092729,-0.11437,1,0
5,GO REGULATION OF PROTEIN MATURATION,0.0094949,-0.092872,-0.15497,1,0
5,GO B CELL DIFFERENTIATION,0.018836,-0.092999,-0.10907,1,0
5,GO MODULATION BY VIRUS OF HOST PROCESS,0.05161,-0.093211,-0.10517,1,0
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0079323,-0.093262,-0.10312,1,0
5,GO MESENCHYME DEVELOPMENT,0.0032441,-0.093538,-0.13315,1,0
5,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.034637,-0.093663,-0.1481,1,0
5,GO PROTEOLYSIS,5.6174e-05,-0.093768,-0.11639,1,0
5,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.023205,-0.093887,-0.13631,1,0
5,GO TOR SIGNALING,0.0031536,-0.09412,-0.07884,1,0
5,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.0060989,-0.09431,-0.11207,1,0
5,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.001228,-0.094346,-0.088416,1,0
5,GO GOLGI ORGANIZATION,0.00087311,-0.094428,-0.11631,1,0
5,GO POSITIVE REGULATION OF SIGNALING,0.00042998,-0.094437,-0.10866,1,0
5,GO CARTILAGE DEVELOPMENT,0.019283,-0.094645,-0.12195,1,0
5,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.00020448,-0.094677,-0.13846,1,0
5,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.0085714,-0.09478,-0.14369,1,0
5,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.023741,-0.094836,-0.082731,1,0
5,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,9.389e-05,-0.094938,-0.11346,1,0
5,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.036164,-0.094944,-0.09179,1,0
5,GO POSITIVE REGULATION OF TRANSPORT,0.00026003,-0.094965,-0.11417,1,0
5,GO POSITIVE REGULATION OF HEMOPOIESIS,0.021165,-0.094988,-0.11368,1,0
5,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.00016023,-0.095141,-0.10027,1,0
5,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.034637,-0.095168,-0.083464,1,0
5,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.012508,-0.095372,-0.13612,1,0
5,GO RESPONSE TO ACTIVITY,0.012203,-0.095531,-0.10106,1,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0099891,-0.095846,-0.124,1,0
5,GO TRABECULA MORPHOGENESIS,0.015953,-0.095915,-0.15346,1,0
5,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.04854,-0.095955,-0.099008,1,0
5,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0099891,-0.096014,-0.092126,1,0
5,GO LEUKOCYTE TETHERING OR ROLLING,0.014138,-0.096018,-0.098015,1,0
5,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.00020448,-0.09612,-0.119,1,0
5,GO AMINO ACID TRANSPORT,0.01282,-0.096417,-0.096706,1,0
5,GO HORMONE MEDIATED SIGNALING PATHWAY,0.00054072,-0.096523,-0.10292,1,0
5,GO MACROPHAGE DIFFERENTIATION,0.009256,-0.096553,-0.16649,1,0
5,GO TRANSFERRIN TRANSPORT,0.0067808,-0.096633,-0.15005,1,0
5,GO INTERLEUKIN 2 PRODUCTION,0.025994,-0.096751,-0.1291,1,0
5,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.016734,-0.096997,-0.12615,1,0
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.029068,-0.097036,-0.13756,1,0
5,GO BILE ACID BIOSYNTHETIC PROCESS,0.022165,-0.097357,-0.15089,1,0
5,GO SMOOTH MUSCLE CELL MIGRATION,0.020205,-0.097436,-0.17857,1,0
5,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.02166,-0.097606,-0.12881,1,0
5,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0010528,-0.09761,-0.11803,1,0
5,GO PROTEIN CATABOLIC PROCESS,8.4205e-05,-0.097677,-0.098736,1,0
5,GO MACROMOLECULE DEACYLATION,0.0057817,-0.097898,-0.077012,1,0
5,GO LEUKOCYTE DIFFERENTIATION,0.00038934,-0.097919,-0.13538,1,0
5,GO NEUTROPHIL MIGRATION,0.007729,-0.098032,-0.13222,1,0
5,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.023205,-0.098089,-0.12564,1,0
5,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.0062634,-0.098163,-0.12634,1,0
5,GO LIPOPROTEIN METABOLIC PROCESS,0.0032441,-0.098306,-0.125,1,0
5,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.0090226,-0.098375,-0.13284,1,0
5,GO PINOCYTOSIS,0.029719,-0.098491,-0.16478,1,0
5,GO AORTA DEVELOPMENT,0.011326,-0.098612,-0.16712,1,0
5,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.0029794,-0.098742,-0.12535,1,0
5,GO CALCIUM MEDIATED SIGNALING,0.0034322,-0.098806,-0.0952,1,0
5,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0085714,-0.098837,-0.14134,1,0
5,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.00019753,-0.099023,-0.1185,1,0
5,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.024846,-0.099071,-0.14345,1,0
5,GO CHEMOKINE PRODUCTION,0.042857,-0.099097,-0.14782,1,0
5,GO RESPONSE TO ESTRADIOL,0.001986,-0.099389,-0.12541,1,0
5,GO AUTOPHAGY OF MITOCHONDRION,0.0015653,-0.0994,-0.12632,1,0
5,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.036948,-0.099496,-0.20262,1,0
5,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.023741,-0.099523,-0.1871,1,0
5,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0057817,-0.099604,-0.11341,1,0
5,GO MACROAUTOPHAGY,0.00034072,-0.099609,-0.11098,1,0
5,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.043763,-0.099632,-0.12653,1,0
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0053338,-0.099703,-0.10613,1,0
5,GO ARACHIDONIC ACID SECRETION,0.011612,-0.099771,-0.13526,1,0
5,GO AMINE METABOLIC PROCESS,0.001662,-0.099826,-0.14094,1,0
5,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.001872,-0.099859,-0.1125,1,0
5,GO REGULATION OF HYDROLASE ACTIVITY,5.2139e-05,-0.099907,-0.13275,1,0
5,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.0030654,-0.099926,-0.13114,1,0
5,GO ACTIN FILAMENT BASED PROCESS,0.00067758,-0.099942,-0.12477,1,0
5,GO REGULATION OF TELOMERASE ACTIVITY,0.010506,-0.10007,-0.12523,1,0
5,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.04854,-0.10016,-0.13649,1,0
5,GO CALCIUM ION IMPORT,0.0085714,-0.10016,-0.11274,1,0
5,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.03939,-0.10017,-0.1344,1,0
5,GO REGULATION OF HORMONE LEVELS,0.0045306,-0.10019,-0.11475,1,0
5,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0039469,-0.10044,-0.17537,1,0
5,GO ERAD PATHWAY,0.001191,-0.10055,-0.14205,1,0
5,GO REGULATION OF TRANSPORT,0.00017796,-0.10061,-0.11252,1,0
5,GO DEVELOPMENTAL PIGMENTATION,0.019283,-0.10078,-0.11045,1,0
5,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.034637,-0.10085,-0.12169,1,0
5,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.014138,-0.10086,-0.15187,1,0
5,GO VIRAL RELEASE FROM HOST CELL,0.04854,-0.10092,-0.10677,1,0
5,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.042857,-0.10104,-0.076452,1,0
5,GO LEUKOCYTE HOMEOSTASIS,0.0021062,-0.10106,-0.13145,1,0
5,GO FEVER GENERATION,0.047551,-0.10123,-0.15469,1,0
5,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.014841,-0.10128,-0.1286,1,0
5,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.0030654,-0.10132,-0.15835,1,0
5,GO BONE DEVELOPMENT,0.0090226,-0.10143,-0.11247,1,0
5,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.05161,-0.10151,-0.089108,1,0
5,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.010506,-0.10186,-0.10462,1,0
5,GO SENSORY PERCEPTION OF BITTER TASTE,0.02268,-0.10192,-0.12638,1,0
5,GO LYMPHOCYTE HOMEOSTASIS,0.0067808,-0.10196,-0.10683,1,0
5,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.029719,-0.10245,-0.14788,1,0
5,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.015574,-0.10255,-0.11277,1,0
5,GO REGULATION OF PROTEIN MODIFICATION PROCESS,9.0551e-05,-0.10256,-0.11295,1,0
5,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.05161,-0.10284,-0.11686,1,0
5,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.02843,-0.10296,-0.10255,1,0
5,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.00063551,-0.10299,-0.12283,1,0
5,GO REGULATION OF ACTIN FILAMENT LENGTH,0.0010528,-0.10301,-0.11365,1,0
5,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.038561,-0.10306,-0.10239,1,0
5,GO APOPTOTIC PROCESS,3.5759e-05,-0.10309,-0.12197,1,0
5,GO LIVER REGENERATION,0.0033369,-0.1035,-0.21527,1,0
5,GO REGULATION OF TOR SIGNALING,0.011326,-0.10355,-0.080302,1,0
5,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.02268,-0.10358,-0.13184,1,0
5,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.0013457,-0.10372,-0.11005,1,0
5,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.0059384,-0.1039,-0.11227,1,0
5,GO ANIMAL ORGAN MORPHOGENESIS,0.0022992,-0.10408,-0.11172,1,0
5,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0020453,-0.10423,-0.11592,1,0
5,GO REGULATION OF T CELL ACTIVATION,0.0036303,-0.10426,-0.13402,1,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.029719,-0.10426,-0.10977,1,0
5,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.00013433,-0.10466,-0.11279,1,0
5,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00042998,-0.10468,-0.094905,1,0
5,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.0094949,-0.10482,-0.13107,1,0
5,GO ENDOCYTIC RECYCLING,0.021165,-0.10496,-0.098074,1,0
5,GO MULTI ORGANISM LOCALIZATION,0.0039469,-0.1051,-0.13757,1,0
5,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.033894,-0.10512,-0.060245,1,0
5,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.00036427,-0.10512,-0.11731,1,0
5,GO METHIONINE BIOSYNTHETIC PROCESS,0.010245,-0.10533,-0.18173,1,0
5,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.025994,-0.10544,-0.12249,1,0
5,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.0041716,-0.10545,-0.14307,1,0
5,GO GOLGI VESICLE TRANSPORT,0.0010859,-0.10549,-0.10364,1,0
5,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.041967,-0.1055,-0.15056,1,0
5,GO CONNECTIVE TISSUE DEVELOPMENT,0.0075304,-0.10568,-0.12236,1,0
5,GO MYELOID CELL DIFFERENTIATION,0.00041602,-0.10584,-0.12937,1,0
5,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.010245,-0.10584,-0.17604,1,0
5,GO REGULATION OF TRANSLATIONAL INITIATION,0.00041602,-0.10598,-0.13692,1,0
5,GO REGULATION OF B CELL ACTIVATION,0.0059384,-0.10602,-0.13756,1,0
5,GO REGULATION OF CELL DEATH,4.4878e-05,-0.10613,-0.12155,1,0
5,GO POSITIVE REGULATION OF CELL DEATH,0.00010845,-0.10614,-0.12727,1,0
5,GO POSITIVE REGULATION OF VIRAL PROCESS,0.00021167,-0.10615,-0.13277,1,0
5,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.022165,-0.10621,-0.11908,1,0
5,GO CELL MOTILITY,0.00079435,-0.10628,-0.12988,1,0
5,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.021165,-0.10638,-0.12685,1,0
5,GO CELLULAR RESPONSE TO KETONE,0.0013054,-0.10639,-0.15629,1,0
5,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.0066042,-0.10647,-0.11697,1,0
5,GO CYTOKINE SECRETION,0.046579,-0.1066,-0.096938,1,0
5,GO NEGATIVE REGULATION OF BINDING,0.0013054,-0.10667,-0.11127,1,0
5,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0022992,-0.10673,-0.17387,1,0
5,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.0057817,-0.10675,-0.10535,1,0
5,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.016339,-0.10682,-0.14466,1,0
5,GO CELLULAR PROTEIN CATABOLIC PROCESS,6.5149e-05,-0.10683,-0.097999,1,0
5,GO REGULATION OF CELL AGING,0.021165,-0.10703,-0.1168,1,0
5,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.0018173,-0.10708,-0.15398,1,0
5,GO AGING,0.0001547,-0.10708,-0.14418,1,0
5,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.0094949,-0.10729,-0.11534,1,0
5,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.00055855,-0.10732,-0.12669,1,0
5,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,5.2139e-05,-0.10736,-0.12699,1,0
5,GO RESPONSE TO ABIOTIC STIMULUS,9.7801e-06,-0.10736,-0.13077,1,0
5,GO GOLGI TO VACUOLE TRANSPORT,0.017969,-0.10778,-0.14337,1,0
5,GO REGULATION OF BINDING,0.00065623,-0.10778,-0.10986,1,0
5,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0069616,-0.1078,-0.11196,1,0
5,GO COAGULATION,0.00031859,-0.10795,-0.17492,1,0
5,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.009256,-0.10806,-0.15576,1,0
5,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.0057817,-0.10809,-0.14867,1,0
5,GO INTRACELLULAR TRANSPORT,8.6584e-06,-0.10811,-0.10047,1,0
5,GO POSITIVE REGULATION OF CELL AGING,0.010245,-0.10815,-0.15133,1,0
5,GO VACUOLAR TRANSPORT,0.0057817,-0.10815,-0.10978,1,0
5,GO EPITHELIAL CELL DEVELOPMENT,0.037747,-0.10815,-0.11384,1,0
5,GO AUTOPHAGOSOME MATURATION,0.017969,-0.10841,-0.13473,1,0
5,GO REGULATION OF MACROAUTOPHAGY,0.00044439,-0.10848,-0.11562,1,0
5,GO PEPTIDE SECRETION,0.0028957,-0.10851,-0.11438,1,0
5,GO REGULATION OF CHOLESTEROL EFFLUX,0.029068,-0.10866,-0.12427,1,0
5,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.00020448,-0.10867,-0.13382,1,0
5,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.011047,-0.10877,-0.10615,1,0
5,GO RESPONSE TO GROWTH FACTOR,0.00052342,-0.10908,-0.12742,1,0
5,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.00057693,-0.10918,-0.10207,1,0
5,GO NEGATIVE REGULATION OF CELL DEATH,0.0001165,-0.10924,-0.1251,1,0
5,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.0045306,-0.10928,-0.095589,1,0
5,GO T CELL ACTIVATION,0.0037331,-0.1093,-0.13808,1,0
5,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.037747,-0.10933,-0.17394,1,0
5,GO TUBE DEVELOPMENT,0.001662,-0.10942,-0.1325,1,0
5,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.00014935,-0.10946,-0.11825,1,0
5,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.017137,-0.10964,-0.13879,1,0
5,GO MESENCHYME MORPHOGENESIS,0.019739,-0.10969,-0.16787,1,0
5,GO CYTOSOLIC TRANSPORT,0.0054795,-0.10972,-0.093645,1,0
5,GO MACROMOLECULE DEPALMITOYLATION,0.018836,-0.10975,-0.17123,1,0
5,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.007729,-0.10979,-0.1293,1,0
5,GO RESPONSE TO PROSTAGLANDIN E,0.020205,-0.11008,-0.12814,1,0
5,GO INOSITOL LIPID MEDIATED SIGNALING,0.0028141,-0.11025,-0.11739,1,0
5,GO REGULATION OF LIPID KINASE ACTIVITY,0.0023671,-0.11064,-0.13746,1,0
5,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.026586,-0.11074,-0.092112,1,0
5,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,7.013e-05,-0.11077,-0.11823,1,0
5,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.022165,-0.11079,-0.16742,1,0
5,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.033894,-0.11104,-0.17065,1,0
5,GO FATTY ACID DERIVATIVE TRANSPORT,0.015203,-0.11107,-0.12326,1,0
5,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0045306,-0.1112,-0.11195,1,0
5,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0073363,-0.11133,-0.13937,1,0
5,GO APOPTOTIC SIGNALING PATHWAY,0.00020448,-0.11139,-0.13459,1,0
5,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0059384,-0.11143,-0.13688,1,0
5,GO MITOCHONDRIAL DNA REPLICATION,0.035393,-0.11148,-0.11223,1,0
5,GO T CELL RECEPTOR SIGNALING PATHWAY,0.00021909,-0.11164,-0.16445,1,0
5,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.023205,-0.11169,-0.1295,1,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0067808,-0.11176,-0.12945,1,0
5,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.0094949,-0.11184,-0.089506,1,0
5,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00057693,-0.11185,-0.14056,1,0
5,GO PROTEIN N LINKED GLYCOSYLATION,0.00069957,-0.11194,-0.16462,1,0
5,GO REGULATION OF CELL ACTIVATION,0.0015189,-0.11204,-0.13939,1,0
5,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.027803,-0.11206,-0.13973,1,0
5,GO PROTEIN LOCALIZATION TO LYSOSOME,0.004408,-0.11222,-0.1665,1,0
5,GO OSTEOCLAST DIFFERENTIATION,0.019283,-0.11232,-0.10417,1,0
5,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.00047456,-0.11232,-0.1229,1,0
5,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.027803,-0.11237,-0.19654,1,0
5,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,4.2876e-06,-0.11237,-0.12055,1,0
5,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.0015653,-0.11244,-0.1311,1,0
5,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.013798,-0.11248,-0.11236,1,0
5,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,9.389e-05,-0.11255,-0.1393,1,0
5,GO GLYCOSYLATION,0.0006154,-0.11272,-0.14871,1,0
5,GO NEGATIVE REGULATION OF CELL ADHESION,0.011326,-0.1128,-0.14204,1,0
5,GO ACTIN FILAMENT ORGANIZATION,0.0012662,-0.11282,-0.12379,1,0
5,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.026586,-0.11287,-0.11113,1,0
5,GO LENS FIBER CELL DEVELOPMENT,0.015953,-0.11293,-0.22945,1,0
5,GO PIGMENTATION,0.00031859,-0.11295,-0.1459,1,0
5,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,8.1192e-05,-0.11296,-0.12819,1,0
5,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,2.3418e-05,-0.11296,-0.13444,1,0
5,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.023205,-0.11299,-0.10872,1,0
5,GO LYMPH VESSEL MORPHOGENESIS,0.034637,-0.11309,-0.15732,1,0
5,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.038561,-0.11352,-0.1543,1,0
5,GO LIPOSACCHARIDE METABOLIC PROCESS,0.011612,-0.11359,-0.13116,1,0
5,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00026003,-0.1136,-0.13588,1,0
5,GO CELLULAR RESPONSE TO INSULIN STIMULUS,3.5759e-05,-0.11366,-0.1385,1,0
5,GO PLATELET ACTIVATION,0.0015189,-0.11374,-0.15934,1,0
5,GO RECEPTOR RECYCLING,0.0017123,-0.11379,-0.14403,1,0
5,GO NEURAL CREST CELL DIFFERENTIATION,0.037747,-0.11383,-0.1246,1,0
5,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.01282,-0.11385,-0.10301,1,0
5,GO INTERLEUKIN 4 PRODUCTION,0.0049174,-0.11385,-0.16467,1,0
5,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.016339,-0.11397,-0.1362,1,0
5,GO REGULATION OF MUSCLE ADAPTATION,0.0079323,-0.11399,-0.13349,1,0
5,GO MAINTENANCE OF PROTEIN LOCATION,0.0057817,-0.11399,-0.11628,1,0
5,GO PHOSPHATE ION TRANSPORT,0.016734,-0.11411,-0.10803,1,0
5,GO POST TRANSLATIONAL PROTEIN MODIFICATION,8.1192e-05,-0.11419,-0.15073,1,0
5,GO ACTIN FILAMENT DEPOLYMERIZATION,0.030383,-0.11426,-0.11272,1,0
5,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.0014738,-0.11448,-0.12906,1,0
5,GO POSITIVE REGULATION OF HEART GROWTH,0.0064317,-0.11468,-0.17512,1,0
5,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.00014418,-0.11496,-0.16563,1,0
5,GO REGULATION OF CARTILAGE DEVELOPMENT,0.0049174,-0.11507,-0.15394,1,0
5,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,3.3132e-05,-0.11528,-0.12796,1,0
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.0067808,-0.11529,-0.15062,1,0
5,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0007696,-0.11531,-0.12589,1,0
5,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.045624,-0.11537,-0.14375,1,0
5,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.0007696,-0.11547,-0.15269,1,0
5,GO EPITHELIAL CELL DIFFERENTIATION,0.052669,-0.11566,-0.088535,1,0
5,GO NUCLEOTIDE TRANSPORT,0.033166,-0.11571,-0.10461,1,0
5,GO VESICLE CARGO LOADING,0.0021689,-0.11574,-0.17791,1,0
5,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.0047853,-0.11576,-0.14265,1,0
5,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.014138,-0.11583,-0.099474,1,0
5,GO LYMPHOCYTE ACTIVATION,0.0006154,-0.11589,-0.13532,1,0
5,GO REGULATION OF TRANSFERASE ACTIVITY,9.7346e-05,-0.1159,-0.12203,1,0
5,GO PURINE NUCLEOTIDE TRANSPORT,0.036164,-0.11594,-0.11167,1,0
5,GO AMELOGENESIS,0.041093,-0.11595,-0.16811,1,0
5,GO ACID SECRETION,0.0030654,-0.11595,-0.15695,1,0
5,GO PROTEIN LOCALIZATION TO ORGANELLE,1.9263e-05,-0.11596,-0.10101,1,0
5,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.0057817,-0.11598,-0.14266,1,0
5,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.010506,-0.11599,-0.11051,1,0
5,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.010245,-0.11619,-0.17947,1,0
5,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.00079435,-0.11639,-0.12566,1,0
5,GO RNA METHYLATION,0.001872,-0.11641,-0.14087,1,0
5,GO REGULATION OF HEMOPOIESIS,0.0013872,-0.11641,-0.12558,1,0
5,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.00087311,-0.11647,-0.11747,1,0
5,GO PRIMARY MIRNA PROCESSING,0.009256,-0.11657,-0.16886,1,0
5,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.033894,-0.11665,-0.14512,1,0
5,GO GLAND DEVELOPMENT,0.0025817,-0.1167,-0.11786,1,0
5,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0041716,-0.11672,-0.11576,1,0
5,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0042883,-0.11674,-0.13604,1,0
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.023205,-0.1168,-0.12856,1,0
5,GO RESPONSE TO RETINOIC ACID,0.00098941,-0.11681,-0.17443,1,0
5,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.0023671,-0.11697,-0.12107,1,0
5,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.00049035,-0.11708,-0.13114,1,0
5,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,9.0551e-05,-0.11712,-0.13127,1,0
5,GO REGULATION OF MIRNA METABOLIC PROCESS,0.015574,-0.11723,-0.15489,1,0
5,GO INTRACELLULAR PROTEIN TRANSPORT,9.3916e-06,-0.11723,-0.10676,1,0
5,GO CELLULAR RESPONSE TO DSRNA,0.052669,-0.11723,-0.15318,1,0
5,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.018398,-0.11724,-0.15127,1,0
5,GO MESENCHYMAL CELL DIFFERENTIATION,0.0029794,-0.11726,-0.1538,1,0
5,GO REGULATION OF BODY FLUID LEVELS,0.00022676,-0.11726,-0.15996,1,0
5,GO MACROMOLECULE CATABOLIC PROCESS,2.2658e-06,-0.1175,-0.12709,1,0
5,GO REGULATION OF CGMP MEDIATED SIGNALING,0.042857,-0.11764,-0.23318,1,0
5,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.016734,-0.11765,-0.1353,1,0
5,GO NEGATIVE REGULATION OF SIGNALING,0.00019753,-0.11772,-0.11424,1,0
5,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.00052342,-0.11779,-0.14261,1,0
5,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00028792,-0.11781,-0.13411,1,0
5,GO REGULATION OF PROTEIN IMPORT,0.024846,-0.11784,-0.14393,1,0
5,GO HEART DEVELOPMENT,0.0017641,-0.11788,-0.1164,1,0
5,GO PROTEIN LOCALIZATION TO VACUOLE,0.0013457,-0.11792,-0.1485,1,0
5,GO SINGLE FERTILIZATION,0.0029794,-0.11794,-0.11276,1,0
5,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0026572,-0.11814,-0.13743,1,0
5,GO PHOSPHOLIPID TRANSPORT,0.00029782,-0.11834,-0.17012,1,0
5,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.0031536,-0.11836,-0.12008,1,0
5,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.017969,-0.11844,-0.18238,1,0
5,GO PEPTIDYL ASPARAGINE MODIFICATION,0.0081404,-0.1185,-0.1482,1,0
5,GO MUSCLE STRUCTURE DEVELOPMENT,0.00079435,-0.11858,-0.12291,1,0
5,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0010528,-0.11878,-0.10915,1,0
5,GO REGULATION OF CALCIUM ION IMPORT,0.013139,-0.11887,-0.14187,1,0
5,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0010859,-0.11899,-0.1875,1,0
5,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.019739,-0.11901,-0.12361,1,0
5,GO CYTOLYSIS,0.034637,-0.11923,-0.18997,1,0
5,GO FC RECEPTOR SIGNALING PATHWAY,0.0026572,-0.11927,-0.12082,1,0
5,GO HUMORAL IMMUNE RESPONSE,0.00031859,-0.11942,-0.16131,1,0
5,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.00012074,-0.11948,-0.13324,1,0
5,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.0037331,-0.11963,-0.13032,1,0
5,GO RESPONSE TO MECHANICAL STIMULUS,0.019739,-0.11965,-0.11388,1,0
5,GO MEMBRANE ORGANIZATION,3.0689e-05,-0.11977,-0.13593,1,0
5,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.014138,-0.12021,-0.22372,1,0
5,GO LIPID BIOSYNTHETIC PROCESS,8.6584e-06,-0.12024,-0.16034,1,0
5,GO REGULATION OF RESPONSE TO STRESS,8.4205e-05,-0.12026,-0.12631,1,0
5,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0020453,-0.12041,-0.15481,1,0
5,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.015203,-0.12056,-0.089235,1,0
5,GO PEPTIDYL ARGININE MODIFICATION,0.0010528,-0.12056,-0.14712,1,0
5,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,3.1888e-05,-0.12061,-0.1281,1,0
5,GO REGULATION OF PHOSPHORYLATION,3.1888e-05,-0.12062,-0.13443,1,0
5,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.00025131,-0.12109,-0.13088,1,0
5,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.001662,-0.12115,-0.1352,1,0
5,GO I KAPPAB PHOSPHORYLATION,0.0085714,-0.12127,-0.17238,1,0
5,GO AUTOPHAGOSOME ORGANIZATION,0.0033369,-0.12132,-0.148,1,0
5,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.017137,-0.12139,-0.20703,1,0
5,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0067808,-0.12146,-0.12406,1,0
5,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00034072,-0.12152,-0.15271,1,0
5,GO CARBOHYDRATE TRANSPORT,0.0011199,-0.12156,-0.12404,1,0
5,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.00023468,-0.1216,-0.15426,1,0
5,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0051916,-0.12161,-0.1384,1,0
5,GO POSITIVE REGULATION OF CHEMOTAXIS,0.0081404,-0.12163,-0.14052,1,0
5,GO REGULATION OF PROTEIN STABILITY,1.0604e-05,-0.12173,-0.12983,1,0
5,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.0071468,-0.12184,-0.10297,1,0
5,GO INSULIN SECRETION,0.03939,-0.12188,-0.092157,1,0
5,GO REGULATION OF PEPTIDE SECRETION,0.0046564,-0.12194,-0.10594,1,0
5,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.0006154,-0.1221,-0.13866,1,0
5,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,6.5149e-05,-0.1221,-0.12829,1,0
5,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.00054072,-0.12219,-0.13824,1,0
5,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.02843,-0.12227,-0.13165,1,0
5,GO HOMEOSTATIC PROCESS,3.4728e-06,-0.12228,-0.12621,1,0
5,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.00069957,-0.12235,-0.19844,1,0
5,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.01282,-0.1225,-0.1603,1,0
5,GO CELL CELL JUNCTION ASSEMBLY,0.049546,-0.12265,-0.10535,1,0
5,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,2.3418e-05,-0.12278,-0.13014,1,0
5,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.0017641,-0.12279,-0.13803,1,0
5,GO REGULATION OF ORGAN GROWTH,0.027188,-0.12287,-0.11305,1,0
5,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0064317,-0.12288,-0.13102,1,0
5,GO REGULATION OF MITOCHONDRIAL FISSION,0.009256,-0.12292,-0.12639,1,0
5,GO ARTERY DEVELOPMENT,0.0069616,-0.12295,-0.1462,1,0
5,GO HISTONE ARGININE METHYLATION,0.023741,-0.12309,-0.10717,1,0
5,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0067808,-0.12317,-0.13758,1,0
5,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.019739,-0.12332,-0.15767,1,0
5,GO REGULATION OF FERTILIZATION,0.010506,-0.12339,-0.18192,1,0
5,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0031536,-0.12356,-0.10982,1,0
5,GO RESPONSE TO MONOSACCHARIDE,7.2754e-05,-0.12357,-0.13731,1,0
5,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0087944,-0.12368,-0.15504,1,0
5,GO SECRETION,1.8521e-05,-0.12384,-0.15314,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,8.4205e-05,-0.12384,-0.13141,1,0
5,GO TUBE MORPHOGENESIS,0.00067758,-0.12395,-0.15147,1,0
5,GO LEUKOTRIENE METABOLIC PROCESS,0.013139,-0.12398,-0.1792,1,0
5,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.013798,-0.12403,-0.23233,1,0
5,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.0037331,-0.12412,-0.13197,1,0
5,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0032441,-0.1243,-0.14514,1,0
5,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.0032441,-0.12431,-0.14294,1,0
5,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.00072223,-0.12434,-0.10846,1,0
5,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.044685,-0.12436,-0.1196,1,0
5,GO OSSIFICATION,0.00032948,-0.1244,-0.15929,1,0
5,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,9.389e-05,-0.1244,-0.13711,1,0
5,GO CARDIAC SEPTUM DEVELOPMENT,0.0097392,-0.12469,-0.15679,1,0
5,GO MYELOID CELL HOMEOSTASIS,0.0031536,-0.12469,-0.12689,1,0
5,GO RENAL TUBULE DEVELOPMENT,0.02166,-0.12471,-0.1266,1,0
5,GO RESPONSE TO INTERLEUKIN 7,0.0040578,-0.1249,-0.1599,1,0
5,GO WHITE FAT CELL DIFFERENTIATION,0.013798,-0.12492,-0.16322,1,0
5,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.020205,-0.12532,-0.28914,1,0
5,GO ICOSANOID BIOSYNTHETIC PROCESS,0.0097392,-0.12533,-0.17939,1,0
5,GO RESPONSE TO ENDOGENOUS STIMULUS,6.0504e-05,-0.12534,-0.1259,1,0
5,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.029719,-0.12554,-0.13286,1,0
5,GO LUNG ALVEOLUS DEVELOPMENT,0.046579,-0.12566,-0.12035,1,0
5,GO MANGANESE ION TRANSPORT,0.0056288,-0.12584,-0.15906,1,0
5,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.014486,-0.12596,-0.14327,1,0
5,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.034637,-0.12599,-0.19173,1,0
5,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.013798,-0.12616,-0.16978,1,0
5,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.017969,-0.12622,-0.15815,1,0
5,GO RESPONSE TO IRON ION,0.0083534,-0.12623,-0.13642,1,0
5,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0062634,-0.12632,-0.20454,1,0
5,GO CRISTAE FORMATION,0.0031536,-0.12647,-0.20949,1,0
5,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.03245,-0.12655,-0.29726,1,0
5,GO RIG I SIGNALING PATHWAY,0.019739,-0.12661,-0.14656,1,0
5,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.017969,-0.12662,-0.13652,1,0
5,GO CATION TRANSPORT,0.00012964,-0.12665,-0.13775,1,0
5,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.0022992,-0.12669,-0.13059,1,0
5,GO NUCLEOBASE METABOLIC PROCESS,0.0066042,-0.12675,-0.18627,1,0
5,GO RRNA TRANSCRIPTION,0.047551,-0.12684,-0.1203,1,0
5,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0081404,-0.12695,-0.16359,1,0
5,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00026003,-0.12701,-0.11875,1,0
5,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0075304,-0.12708,-0.13052,1,0
5,GO HEART MORPHOGENESIS,0.018398,-0.12716,-0.11039,1,0
5,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.0079323,-0.12735,-0.13512,1,0
5,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,3.7791e-06,-0.12736,-0.13291,1,0
5,GO DENDRITIC CELL MIGRATION,0.020205,-0.12749,-0.1882,1,0
5,GO TYPE I INTERFERON PRODUCTION,0.0094949,-0.12768,-0.15709,1,0
5,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.00095906,-0.12773,-0.138,1,0
5,GO NEGATIVE REGULATION OF GROWTH,0.00019079,-0.12781,-0.15687,1,0
5,GO HEART VALVE DEVELOPMENT,0.024846,-0.12781,-0.16796,1,0
5,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.0010206,-0.12787,-0.17984,1,0
5,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.03245,-0.12788,-0.17514,1,0
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.00017796,-0.12789,-0.11659,1,0
5,GO NIK NF KAPPAB SIGNALING,0.0022992,-0.12796,-0.1682,1,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.00049035,-0.128,-0.14849,1,0
5,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.010245,-0.12807,-0.15137,1,0
5,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0085714,-0.12812,-0.15059,1,0
5,GO JNK CASCADE,0.00016595,-0.12812,-0.13424,1,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.015203,-0.12819,-0.099758,1,0
5,GO REGULATION OF INSULIN SECRETION,0.015574,-0.12826,-0.099286,1,0
5,GO RESPONSE TO NITROGEN COMPOUND,1.2454e-05,-0.12852,-0.13289,1,0
5,GO RESPONSE TO OSMOTIC STRESS,0.0040578,-0.12876,-0.14693,1,0
5,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,2.9301e-06,-0.12877,-0.149,1,0
5,GO NEGATIVE REGULATION OF SECRETION,0.00028792,-0.12877,-0.12818,1,0
5,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.0010859,-0.12884,-0.1222,1,0
5,GO REGULATION OF REPRODUCTIVE PROCESS,0.00065623,-0.12885,-0.10912,1,0
5,GO NEPHRON EPITHELIUM DEVELOPMENT,0.027803,-0.12887,-0.11884,1,0
5,GO REGULATION OF INNATE IMMUNE RESPONSE,0.0021689,-0.12888,-0.14587,1,0
5,GO GOLGI TO ENDOSOME TRANSPORT,0.019283,-0.12888,-0.14811,1,0
5,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.00021909,-0.12889,-0.15172,1,0
5,GO RESPONSE TO PEPTIDE,2.4346e-05,-0.12903,-0.14109,1,0
5,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.049546,-0.12912,-0.14984,1,0
5,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.0046564,-0.12915,-0.15555,1,0
5,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.0001547,-0.12932,-0.10595,1,0
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.018398,-0.12934,-0.13811,1,0
5,GO TEMPERATURE HOMEOSTASIS,0.0010859,-0.12958,-0.13269,1,0
5,GO MITOCHONDRION ORGANIZATION,1.1964e-05,-0.12962,-0.12819,1,0
5,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.01282,-0.12962,-0.16476,1,0
5,GO CELLULAR RESPONSE TO HEAT,0.00098941,-0.12971,-0.12784,1,0
5,GO B CELL RECEPTOR SIGNALING PATHWAY,0.015574,-0.12978,-0.14381,1,0
5,GO REGULATION OF CELL CELL ADHESION,0.00044439,-0.12979,-0.17833,1,0
5,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0025817,-0.1299,-0.14929,1,0
5,GO REGULATION OF GTPASE ACTIVITY,0.00035231,-0.12993,-0.12396,1,0
5,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.018836,-0.12995,-0.18611,1,0
5,GO URONIC ACID METABOLIC PROCESS,0.011326,-0.13006,-0.13823,1,0
5,GO NEGATIVE REGULATION OF TRANSPORT,6.7596e-05,-0.13018,-0.129,1,0
5,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0020453,-0.13019,-0.12765,1,0
5,GO STRESS FIBER ASSEMBLY,0.0041716,-0.13035,-0.1609,1,0
5,GO PHOSPHOLIPID METABOLIC PROCESS,6.4994e-06,-0.13047,-0.14661,1,0
5,GO TRNA WOBBLE BASE MODIFICATION,0.0067808,-0.13058,-0.17006,1,0
5,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.00038934,-0.13059,-0.12562,1,0
5,GO LIPOPROTEIN LOCALIZATION,0.001872,-0.13062,-0.18697,1,0
5,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00057693,-0.13068,-0.1886,1,0
5,GO REGULATION OF CATABOLIC PROCESS,8.3127e-06,-0.13077,-0.12926,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.022165,-0.13094,-0.14281,1,0
5,GO BIOLOGICAL ADHESION,6.7596e-05,-0.13099,-0.16931,1,0
5,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.00055855,-0.13103,-0.18065,1,0
5,GO RESPONSE TO CARBOHYDRATE,1.8521e-05,-0.1311,-0.14494,1,0
5,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,3.3132e-05,-0.13121,-0.13446,1,0
5,GO VESICLE ORGANIZATION,0.0001547,-0.13127,-0.13216,1,0
5,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.0064317,-0.13132,-0.13212,1,0
5,GO GLUTAMATE METABOLIC PROCESS,0.021165,-0.13136,-0.1143,1,0
5,GO PROTEIN HETEROOLIGOMERIZATION,0.0039469,-0.1314,-0.13822,1,0
5,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0017123,-0.13146,-0.1686,1,0
5,GO LIPID DIGESTION,0.036948,-0.13146,-0.20322,1,0
5,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.015203,-0.13148,-0.17611,1,0
5,GO NEGATIVE REGULATION OF OSSIFICATION,0.0047853,-0.13167,-0.16401,1,0
5,GO AMYLOID FIBRIL FORMATION,0.030383,-0.1317,-0.18121,1,0
5,GO RNA MODIFICATION,0.00059588,-0.13171,-0.14539,1,0
5,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.00065623,-0.13175,-0.20298,1,0
5,GO ERBB SIGNALING PATHWAY,0.0014738,-0.13176,-0.14859,1,0
5,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0067808,-0.13185,-0.18253,1,0
5,GO METAL ION TRANSPORT,5.4121e-05,-0.13186,-0.14327,1,0
5,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.045624,-0.13195,-0.15753,1,0
5,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.017969,-0.13197,-0.13153,1,0
5,GO VIRAL LIFE CYCLE,0.0020453,-0.13199,-0.17,1,0
5,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,4.8379e-05,-0.13223,-0.14213,1,0
5,GO REGULATION OF CELL KILLING,0.0090226,-0.13249,-0.16666,1,0
5,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.00028792,-0.13266,-0.13109,1,0
5,GO CELLULAR ION HOMEOSTASIS,1.1267e-06,-0.13278,-0.15799,1,0
5,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.015203,-0.13279,-0.29643,1,0
5,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00019753,-0.13283,-0.1573,1,0
5,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.010506,-0.13292,-0.10241,1,0
5,GO ANTIBACTERIAL HUMORAL RESPONSE,0.0079323,-0.13296,-0.1954,1,0
5,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.010245,-0.13305,-0.16184,1,0
5,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.023205,-0.13318,-0.14367,1,0
5,GO CELLULAR RESPONSE TO HORMONE STIMULUS,1.9263e-05,-0.1332,-0.13917,1,0
5,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0010859,-0.13322,-0.16172,1,0
5,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00059588,-0.13325,-0.17153,1,0
5,GO MEMBRANE LIPID METABOLIC PROCESS,0.0010206,-0.13333,-0.15919,1,0
5,GO RESPONSE TO VIRUS,0.013139,-0.13339,-0.15277,1,0
5,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0087944,-0.13342,-0.13539,1,0
5,GO FERTILIZATION,0.00087311,-0.13355,-0.11767,1,0
5,GO CELLULAR DEFENSE RESPONSE,0.0037331,-0.13356,-0.20304,1,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0073363,-0.13366,-0.15988,1,0
5,GO REGULATION OF PROTEOLYSIS,2.8418e-05,-0.13367,-0.15702,1,0
5,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.00017186,-0.13378,-0.13015,1,0
5,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0013457,-0.13382,-0.15537,1,0
5,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.025994,-0.13393,-0.15543,1,0
5,GO IRON ION TRANSPORT,0.00010092,-0.13416,-0.15393,1,0
5,GO CERAMIDE METABOLIC PROCESS,0.00023468,-0.13434,-0.16315,1,0
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.024288,-0.13435,-0.15609,1,0
5,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.0069616,-0.13437,-0.13754,1,0
5,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.00035231,-0.13442,-0.1206,1,0
5,GO SEQUESTERING OF METAL ION,0.045624,-0.13445,-0.1455,1,0
5,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.027803,-0.1345,-0.22655,1,0
5,GO LEUKOCYTE CELL CELL ADHESION,0.00038934,-0.13457,-0.17376,1,0
5,GO SENSORY PERCEPTION OF SMELL,0.00029782,-0.1347,-0.15035,1,0
5,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.027803,-0.13483,-0.1264,1,0
5,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.035393,-0.13488,-0.16206,1,0
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.00040247,-0.13508,-0.15232,1,0
5,GO L GLUTAMATE IMPORT,0.037747,-0.13509,-0.15496,1,0
5,GO VACUOLAR ACIDIFICATION,0.0032441,-0.13513,-0.17581,1,0
5,GO BONE GROWTH,0.030383,-0.13534,-0.21467,1,0
5,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.00011241,-0.13535,-0.23064,1,0
5,GO ION TRANSMEMBRANE TRANSPORT,4.3218e-05,-0.13535,-0.14336,1,0
5,GO PROTEIN HETEROTETRAMERIZATION,0.0060989,-0.13538,-0.13683,1,0
5,GO RESPONSE TO IMMOBILIZATION STRESS,0.02166,-0.13541,-0.20068,1,0
5,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,6.0504e-05,-0.13545,-0.16764,1,0
5,GO REGULATION OF RUFFLE ASSEMBLY,0.027188,-0.13546,-0.13008,1,0
5,GO ENDOTHELIAL CELL DEVELOPMENT,0.0039469,-0.13556,-0.18076,1,0
5,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0056288,-0.13556,-0.12699,1,0
5,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00024286,-0.13571,-0.14442,1,0
5,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.0016129,-0.13576,-0.1327,1,0
5,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.00012074,-0.13588,-0.1388,1,0
5,GO POSITIVE REGULATION OF TRANSLATION,5.0226e-05,-0.13606,-0.19045,1,0
5,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.00012074,-0.13627,-0.13635,1,0
5,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0094949,-0.13629,-0.13523,1,0
5,GO PROTEIN HOMOOLIGOMERIZATION,2.2524e-05,-0.13633,-0.14312,1,0
5,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0020453,-0.13634,-0.15687,1,0
5,GO REGULATION OF ION TRANSPORT,0.00059588,-0.13637,-0.14524,1,0
5,GO FEEDING BEHAVIOR,0.010506,-0.13642,-0.10849,1,0
5,GO RESPONSE TO ALCOHOL,0.00019753,-0.13643,-0.15143,1,0
5,GO CIRCULATORY SYSTEM DEVELOPMENT,0.00040247,-0.13645,-0.14798,1,0
5,GO TRANSMEMBRANE TRANSPORT,6.2367e-06,-0.13654,-0.14785,1,0
5,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0010528,-0.13664,-0.16797,1,0
5,GO GRANULOCYTE CHEMOTAXIS,0.0031536,-0.13668,-0.16017,1,0
5,GO SYMBIOTIC PROCESS,1.8521e-05,-0.13696,-0.16093,1,0
5,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,1.9263e-05,-0.13699,-0.14309,1,0
5,GO REGULATION OF MULTI ORGANISM PROCESS,0.00027832,-0.1371,-0.17162,1,0
5,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.001191,-0.13713,-0.14891,1,0
5,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.014486,-0.13715,-0.1753,1,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.013139,-0.13723,-0.16839,1,0
5,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.0059384,-0.1375,-0.17573,1,0
5,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0018173,-0.13755,-0.16737,1,0
5,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.0028957,-0.13758,-0.14903,1,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.0018173,-0.1376,-0.1547,1,0
5,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.0075304,-0.1376,-0.18235,1,0
5,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.007729,-0.13767,-0.15764,1,0
5,GO MYOTUBE DIFFERENTIATION,0.00353,-0.13767,-0.14453,1,0
5,GO ALANINE TRANSPORT,0.02166,-0.13771,-0.17664,1,0
5,GO IMMUNOGLOBULIN SECRETION,0.0021062,-0.13772,-0.2313,1,0
5,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.035393,-0.13782,-0.12377,1,0
5,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.0039469,-0.13789,-0.11916,1,0
5,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.023205,-0.13813,-0.14262,1,0
5,GO CELLULAR RESPONSE TO PEPTIDE,7.547e-05,-0.13817,-0.13107,1,0
5,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.014138,-0.13824,-0.26053,1,0
5,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.05161,-0.13829,-0.14413,1,0
5,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.019283,-0.13831,-0.17692,1,0
5,GO MUSCLE CELL PROLIFERATION,0.001986,-0.13835,-0.1572,1,0
5,GO CATION TRANSMEMBRANE TRANSPORT,0.00017186,-0.13843,-0.1399,1,0
5,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00079435,-0.13843,-0.17277,1,0
5,GO PROTEIN TARGETING TO VACUOLE,0.0016129,-0.13843,-0.16305,1,0
5,GO REGULATION OF TRANSLATIONAL TERMINATION,0.026586,-0.13858,-0.1688,1,0
5,GO METAL ION HOMEOSTASIS,1.1776e-06,-0.13874,-0.16463,1,0
5,GO CARDIOCYTE DIFFERENTIATION,0.0054795,-0.13883,-0.13435,1,0
5,GO GRANULOCYTE MIGRATION,0.00052342,-0.13885,-0.18309,1,0
5,GO RECEPTOR METABOLIC PROCESS,0.00054072,-0.13893,-0.13399,1,0
5,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.00019753,-0.13895,-0.15968,1,0
5,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,5.4121e-05,-0.13895,-0.136,1,0
5,GO INTRACELLULAR STEROL TRANSPORT,0.04854,-0.13898,-0.14382,1,0
5,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.00059588,-0.13906,-0.16236,1,0
5,GO REGULATION OF LYASE ACTIVITY,0.020205,-0.13909,-0.13878,1,0
5,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0032441,-0.13913,-0.13045,1,0
5,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.0010528,-0.13916,-0.17773,1,0
5,GO REGULATION OF GLUCONEOGENESIS,0.0025083,-0.13925,-0.12839,1,0
5,GO RESPONSE TO INTERLEUKIN 1,1.0604e-05,-0.13931,-0.19898,1,0
5,GO SECOND MESSENGER MEDIATED SIGNALING,0.0010206,-0.13931,-0.11549,1,0
5,GO MITOCHONDRIAL TRANSPORT,9.7801e-06,-0.13938,-0.13304,1,0
5,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.001872,-0.1395,-0.14574,1,0
5,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00014935,-0.13952,-0.14784,1,0
5,GO HEART GROWTH,0.014138,-0.13955,-0.11415,1,0
5,GO CELL ACTIVATION,6.2786e-05,-0.13957,-0.17315,1,0
5,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.0030654,-0.13957,-0.15241,1,0
5,GO OSTEOBLAST DIFFERENTIATION,0.00029782,-0.13985,-0.1783,1,0
5,GO CORTICAL CYTOSKELETON ORGANIZATION,0.014138,-0.13995,-0.14457,1,0
5,GO CHEMICAL HOMEOSTASIS,1.8251e-06,-0.14003,-0.15346,1,0
5,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,2.2658e-06,-0.14008,-0.15959,1,0
5,GO VITAMIN D METABOLIC PROCESS,0.02068,-0.14016,-0.19071,1,0
5,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.00021167,-0.1402,-0.16074,1,0
5,GO CIRCULATORY SYSTEM PROCESS,4.6597e-05,-0.14023,-0.15824,1,0
5,GO B CELL ACTIVATION,0.00040247,-0.14031,-0.14781,1,0
5,GO TOXIN TRANSPORT,0.026586,-0.14037,-0.11232,1,0
5,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00049035,-0.14043,-0.14675,1,0
5,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.00087311,-0.14048,-0.16445,1,0
5,GO ORGANIC ACID TRANSPORT,7.0571e-06,-0.1405,-0.15698,1,0
5,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.0073363,-0.14055,-0.12771,1,0
5,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00010092,-0.14061,-0.15568,1,0
5,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.00012074,-0.14069,-0.1767,1,0
5,GO RESPONSE TO OXYGEN RADICAL,0.014138,-0.14069,-0.12802,1,0
5,GO NEGATIVE REGULATION OF LIPID STORAGE,0.011612,-0.14071,-0.18603,1,0
5,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.0016129,-0.14088,-0.13692,1,0
5,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.01282,-0.14093,-0.23483,1,0
5,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.00010845,-0.14107,-0.15859,1,0
5,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,1.5201e-05,-0.14109,-0.14319,1,0
5,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0015653,-0.14109,-0.1409,1,0
5,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,9.389e-05,-0.14122,-0.14309,1,0
5,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.00095906,-0.14133,-0.16877,1,0
5,GO REGULATION OF CELL ADHESION,0.00029782,-0.14142,-0.17988,1,0
5,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.0066042,-0.14154,-0.1849,1,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.015203,-0.14154,-0.13899,1,0
5,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.011612,-0.14157,-0.15418,1,0
5,GO REGULATION OF SYMBIOTIC PROCESS,0.015203,-0.14165,-0.15457,1,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.023205,-0.14172,-0.17167,1,0
5,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00090094,-0.14173,-0.14345,1,0
5,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.013798,-0.14173,-0.18669,1,0
5,GO LINOLEIC ACID METABOLIC PROCESS,0.033894,-0.14176,-0.21101,1,0
5,GO INORGANIC ANION TRANSPORT,1.5816e-05,-0.1418,-0.15582,1,0
5,GO ION TRANSPORT,2.1663e-05,-0.14193,-0.14831,1,0
5,GO LIPID MODIFICATION,2.6307e-05,-0.14201,-0.1594,1,0
5,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00012512,-0.14202,-0.16182,1,0
5,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00012512,-0.14212,-0.13922,1,0
5,GO POSITIVE REGULATION OF CELL KILLING,0.02166,-0.14229,-0.16194,1,0
5,GO VASCULATURE DEVELOPMENT,0.00019753,-0.14236,-0.18073,1,0
5,GO REGULATION OF DEFENSE RESPONSE,0.00014935,-0.14237,-0.15109,1,0
5,GO LYSOSOMAL TRANSPORT,0.001662,-0.1425,-0.13474,1,0
5,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.0062634,-0.14262,-0.16074,1,0
5,GO SPHINGOLIPID METABOLIC PROCESS,0.00035231,-0.14264,-0.17605,1,0
5,GO RESPONSE TO PEPTIDE HORMONE,1.9263e-05,-0.14283,-0.14394,1,0
5,GO MUSCLE ADAPTATION,0.00065623,-0.14292,-0.17662,1,0
5,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.043763,-0.14299,-0.16599,1,0
5,GO ERYTHROCYTE HOMEOSTASIS,0.0032441,-0.14307,-0.1256,1,0
5,GO RESPONSE TO NUTRIENT,0.001872,-0.14307,-0.16097,1,0
5,GO REGULATION OF T CELL MIGRATION,0.0037331,-0.14311,-0.15984,1,0
5,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.02068,-0.14313,-0.15472,1,0
5,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.023741,-0.14313,-0.14576,1,0
5,GO REGULATION OF RECEPTOR RECYCLING,0.017549,-0.14315,-0.13253,1,0
5,GO CELLULAR COMPONENT DISASSEMBLY,1.1267e-06,-0.14324,-0.15529,1,0
5,GO REGULATION OF INFLAMMATORY RESPONSE,7.8282e-05,-0.14327,-0.18103,1,0
5,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.00016595,-0.14335,-0.13695,1,0
5,GO REGULATION OF ENDOCRINE PROCESS,0.0021062,-0.14339,-0.16762,1,0
5,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.0069616,-0.14343,-0.14554,1,0
5,GO CELLULAR RESPONSE TO SALT STRESS,0.04854,-0.14349,-0.19083,1,0
5,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.013139,-0.14351,-0.13888,1,0
5,GO EPITHELIAL CELL PROLIFERATION,0.0011549,-0.14369,-0.15757,1,0
5,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.00016595,-0.14372,-0.15083,1,0
5,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0001547,-0.14376,-0.16151,1,0
5,GO DIGESTION,0.0051916,-0.14392,-0.14133,1,0
5,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00012512,-0.144,-0.1394,1,0
5,GO RESPONSE TO FATTY ACID,0.00042998,-0.14411,-0.19114,1,0
5,GO FAT CELL DIFFERENTIATION,0.0025083,-0.14415,-0.14851,1,0
5,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,1.104e-05,-0.14416,-0.1531,1,0
5,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,4.1617e-05,-0.14425,-0.18391,1,0
5,GO REGULATION OF NUCLEASE ACTIVITY,0.0073363,-0.14452,-0.16126,1,0
5,GO POSITIVE REGULATION OF CATABOLIC PROCESS,5.0226e-05,-0.14461,-0.14087,1,0
5,GO DIGESTIVE SYSTEM PROCESS,0.0079323,-0.14469,-0.13036,1,0
5,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.00018427,-0.14471,-0.18698,1,0
5,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00012964,-0.14482,-0.15359,1,0
5,GO RECEPTOR BIOSYNTHETIC PROCESS,0.0028957,-0.14486,-0.1769,1,0
5,GO ASTROCYTE DEVELOPMENT,0.033166,-0.14486,-0.1648,1,0
5,GO REGULATION OF TUBE SIZE,0.0014299,-0.14486,-0.14475,1,0
5,GO METANEPHROS DEVELOPMENT,0.014486,-0.14488,-0.13106,1,0
5,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.001986,-0.14488,-0.22302,1,0
5,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.011047,-0.14504,-0.15242,1,0
5,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.027188,-0.14511,-0.13177,1,0
5,GO ER NUCLEUS SIGNALING PATHWAY,0.0083534,-0.1452,-0.14499,1,0
5,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0019282,-0.14522,-0.18081,1,0
5,GO CARDIAC CHAMBER DEVELOPMENT,0.0023671,-0.14522,-0.151,1,0
5,GO RESPONSE TO KETONE,7.547e-05,-0.1453,-0.17426,1,0
5,GO LIPID EXPORT FROM CELL,0.012508,-0.1453,-0.13629,1,0
5,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.0017641,-0.14534,-0.15053,1,0
5,GO ANION TRANSPORT,3.4728e-06,-0.14548,-0.15544,1,0
5,GO MAMMARY GLAND DEVELOPMENT,0.00074557,-0.14554,-0.16069,1,0
5,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.0029794,-0.14556,-0.163,1,0
5,GO PEPTIDYL ARGININE METHYLATION,0.0066042,-0.14564,-0.14626,1,0
5,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,1.4609e-05,-0.14578,-0.12876,1,0
5,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.025994,-0.14582,-0.16612,1,0
5,GO VESICLE BUDDING FROM MEMBRANE,7.013e-05,-0.14585,-0.16802,1,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.031059,-0.14589,-0.13141,1,0
5,GO ENDOCYTOSIS,7.2754e-05,-0.14593,-0.15017,1,0
5,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.00031859,-0.14594,-0.13798,1,0
5,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.0033369,-0.14626,-0.19051,1,0
5,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,3.4728e-06,-0.14632,-0.15724,1,0
5,GO EXOCYTOSIS,2.4346e-05,-0.14638,-0.18191,1,0
5,GO URETER DEVELOPMENT,0.016734,-0.14641,-0.20403,1,0
5,GO REGULATION OF ERBB SIGNALING PATHWAY,0.00057693,-0.14645,-0.18056,1,0
5,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,7.8282e-05,-0.14649,-0.13319,1,0
5,GO ORGANIC ANION TRANSPORT,3.3287e-06,-0.1465,-0.16267,1,0
5,GO MESODERM MORPHOGENESIS,0.011612,-0.14666,-0.16886,1,0
5,GO WOUND HEALING,0.00079435,-0.14672,-0.19116,1,0
5,GO ACROSOME REACTION,0.022165,-0.14685,-0.15301,1,0
5,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00014935,-0.14698,-0.14641,1,0
5,GO PROTEIN TARGETING TO MITOCHONDRION,3.1888e-05,-0.14699,-0.17051,1,0
5,GO INTEGRIN ACTIVATION,0.0097392,-0.14711,-0.18621,1,0
5,GO ALCOHOL CATABOLIC PROCESS,0.0021062,-0.14711,-0.14554,1,0
5,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.010773,-0.14722,-0.11183,1,0
5,GO HYALURONAN BIOSYNTHETIC PROCESS,0.0037331,-0.14735,-0.19407,1,0
5,GO T CELL CHEMOTAXIS,0.024288,-0.14756,-0.12654,1,0
5,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.035393,-0.14758,-0.19157,1,0
5,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.0075304,-0.14762,-0.14188,1,0
5,GO RESPONSE TO INSULIN,4.6623e-06,-0.1477,-0.15685,1,0
5,GO PROTEIN DEMANNOSYLATION,0.0034322,-0.1479,-0.2378,1,0
5,GO GLYCOPROTEIN METABOLIC PROCESS,0.00010845,-0.14798,-0.16013,1,0
5,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,4.2876e-06,-0.14798,-0.16705,1,0
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00028792,-0.14802,-0.17489,1,0
5,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.00029782,-0.14804,-0.1867,1,0
5,GO BLOOD VESSEL MORPHOGENESIS,0.00017796,-0.14806,-0.19486,1,0
5,GO REGULATION OF B CELL PROLIFERATION,0.0012662,-0.14814,-0.19098,1,0
5,GO CORONARY VASCULATURE DEVELOPMENT,0.0028141,-0.14817,-0.17703,1,0
5,GO CARBOHYDRATE HOMEOSTASIS,4.3218e-05,-0.14821,-0.16431,1,0
5,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.021165,-0.14826,-0.15786,1,0
5,GO RRNA METHYLATION,0.0039469,-0.14837,-0.18841,1,0
5,GO REGULATION OF CELLULAR CATABOLIC PROCESS,1.8251e-06,-0.1485,-0.14949,1,0
5,GO RESPONSE TO WOUNDING,0.00090094,-0.1486,-0.17847,1,0
5,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.00069957,-0.14871,-0.16329,1,0
5,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.031748,-0.14884,-0.1419,1,0
5,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.0001547,-0.14888,-0.16355,1,0
5,GO REGULATION OF URINE VOLUME,0.0069616,-0.149,-0.14221,1,0
5,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0013872,-0.14922,-0.1486,1,0
5,GO ADIPOSE TISSUE DEVELOPMENT,0.023205,-0.14934,-0.11408,1,0
5,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.013139,-0.14936,-0.20903,1,0
5,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,1.4609e-05,-0.14954,-0.17699,1,0
5,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.0097392,-0.1496,-0.18339,1,0
5,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.00074557,-0.14976,-0.18023,1,0
5,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.00013433,-0.14998,-0.18941,1,0
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.00038934,-0.15002,-0.2355,1,0
5,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.00024286,-0.15012,-0.15136,1,0
5,GO TRANSEPITHELIAL TRANSPORT,0.0006154,-0.15019,-0.17938,1,0
5,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0020453,-0.15023,-0.2211,1,0
5,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.00032948,-0.15036,-0.15431,1,0
5,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0018173,-0.15036,-0.15267,1,0
5,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0013457,-0.15041,-0.16511,1,0
5,GO SCHWANN CELL DIFFERENTIATION,0.0049174,-0.15043,-0.13942,1,0
5,GO TRANSITION METAL ION TRANSPORT,2.9532e-05,-0.15045,-0.14108,1,0
5,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.029068,-0.15046,-0.19493,1,0
5,GO ESTABLISHMENT OF TISSUE POLARITY,0.0017641,-0.15056,-0.13055,1,0
5,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.0081404,-0.15064,-0.16653,1,0
5,GO SODIUM ION TRANSPORT,0.00065623,-0.15067,-0.14792,1,0
5,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.0051916,-0.15071,-0.19785,1,0
5,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.0067808,-0.15073,-0.15596,1,0
5,GO LIPID HOMEOSTASIS,7.8282e-05,-0.15074,-0.16987,1,0
5,GO ALCOHOL BIOSYNTHETIC PROCESS,0.00019753,-0.1508,-0.16111,1,0
5,GO RESPONSE TO TEMPERATURE STIMULUS,5.7413e-06,-0.151,-0.15978,1,0
5,GO FACE DEVELOPMENT,0.024846,-0.15105,-0.12851,1,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.001228,-0.15106,-0.14761,1,0
5,GO FATTY ACID TRANSPORT,0.00013433,-0.15108,-0.16577,1,0
5,GO GLIAL CELL PROLIFERATION,0.022165,-0.15112,-0.14041,1,0
5,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00065623,-0.15116,-0.1646,1,0
5,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.00090094,-0.15117,-0.18525,1,0
5,GO RESPONSE TO ISCHEMIA,0.004408,-0.15118,-0.15274,1,0
5,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,9.0551e-05,-0.15123,-0.14106,1,0
5,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00010092,-0.15124,-0.14693,1,0
5,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.0050528,-0.15149,-0.17065,1,0
5,GO PROTEIN LOCALIZATION TO MEMBRANE,2.3418e-05,-0.15174,-0.12995,1,0
5,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.0099891,-0.15182,-0.12341,1,0
5,GO ORGANELLE FUSION,0.00047456,-0.15184,-0.13873,1,0
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00052342,-0.15206,-0.16581,1,0
5,GO FLUID TRANSPORT,0.012508,-0.1521,-0.1313,1,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.00027832,-0.15212,-0.18701,1,0
5,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0025817,-0.15213,-0.16597,1,0
5,GO HYALURONAN METABOLIC PROCESS,0.00038934,-0.15223,-0.22018,1,0
5,GO DRUG CATABOLIC PROCESS,3.7145e-05,-0.15225,-0.22621,1,0
5,GO PLATELET MORPHOGENESIS,0.0013457,-0.15247,-0.176,1,0
5,GO RESPONSE TO EXTRACELLULAR STIMULUS,1.8521e-05,-0.15248,-0.1562,1,0
5,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.018398,-0.15274,-0.23221,1,0
5,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.0056288,-0.15278,-0.14879,1,0
5,GO CELLULAR HOMEOSTASIS,9.4334e-07,-0.15301,-0.15794,1,0
5,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00010462,-0.15318,-0.13113,1,0
5,GO PHOSPHATIDIC ACID METABOLIC PROCESS,2.8418e-05,-0.15319,-0.18516,1,0
5,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.00059588,-0.1532,-0.17222,1,0
5,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.015574,-0.15328,-0.19347,1,0
5,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.00069957,-0.15331,-0.18057,1,0
5,GO NEPHRON DEVELOPMENT,0.0073363,-0.15333,-0.1396,1,0
5,GO CELL KILLING,0.00090094,-0.15333,-0.16772,1,0
5,GO CELLULAR EXTRAVASATION,0.0013457,-0.15334,-0.16011,1,0
5,GO REGULATION OF AUTOPHAGY,6.4994e-06,-0.15343,-0.161,1,0
5,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.00072223,-0.15348,-0.21806,1,0
5,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00020448,-0.15352,-0.15832,1,0
5,GO ACTIVATION OF IMMUNE RESPONSE,0.00011241,-0.15386,-0.15874,1,0
5,GO ORGANELLE MEMBRANE FUSION,0.00095906,-0.1539,-0.15904,1,0
5,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.02268,-0.15393,-0.13134,1,0
5,GO RESPIRATORY BURST,0.0087944,-0.15397,-0.20948,1,0
5,GO CELLULAR RESPONSE TO RETINOIC ACID,0.0022992,-0.15408,-0.20207,1,0
5,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.00081984,-0.1541,-0.20766,1,0
5,GO LENS FIBER CELL DIFFERENTIATION,0.046579,-0.15412,-0.14888,1,0
5,GO PEPTIDYL TYROSINE MODIFICATION,0.00045924,-0.15416,-0.15653,1,0
5,GO ACUTE PHASE RESPONSE,0.0033369,-0.1542,-0.18963,1,0
5,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.0028957,-0.15431,-0.1551,1,0
5,GO NEUTRAL AMINO ACID TRANSPORT,0.0018173,-0.15443,-0.19766,1,0
5,GO VESICLE TARGETING,8.1192e-05,-0.15472,-0.18917,1,0
5,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.0026572,-0.15477,-0.13192,1,0
5,GO ADAPTIVE THERMOGENESIS,0.001191,-0.15479,-0.13867,1,0
5,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.00013917,-0.15487,-0.19236,1,0
5,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.007729,-0.15492,-0.15715,1,0
5,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0033369,-0.15492,-0.16664,1,0
5,GO RESPONSE TO HEAT,3.7145e-05,-0.15498,-0.16306,1,0
5,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.0099891,-0.15514,-0.19833,1,0
5,GO MEMBRANE FUSION,0.0010206,-0.15519,-0.14239,1,0
5,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.0040578,-0.15524,-0.12882,1,0
5,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,8.1192e-05,-0.15525,-0.16724,1,0
5,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.012203,-0.15534,-0.18338,1,0
5,GO REGULATION OF LIPASE ACTIVITY,7.0571e-06,-0.15537,-0.19932,1,0
5,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.00098941,-0.15545,-0.16448,1,0
5,GO CERAMIDE BIOSYNTHETIC PROCESS,0.0021689,-0.15552,-0.1588,1,0
5,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00040247,-0.15554,-0.15434,1,0
5,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.0051916,-0.15564,-0.15164,1,0
5,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.0064317,-0.15575,-0.15486,1,0
5,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00012964,-0.15577,-0.21144,1,0
5,GO ANTIMICROBIAL HUMORAL RESPONSE,0.00027832,-0.15582,-0.18082,1,0
5,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,1.1964e-05,-0.15584,-0.17715,1,0
5,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,8.4205e-05,-0.15609,-0.14562,1,0
5,GO RESPONSE TO INTERLEUKIN 15,0.00074557,-0.15616,-0.28846,1,0
5,GO CELLULAR LIPID METABOLIC PROCESS,2.1702e-06,-0.15625,-0.17911,1,0
5,GO STEROID BIOSYNTHETIC PROCESS,2.8418e-05,-0.15634,-0.19498,1,0
5,GO ANION TRANSMEMBRANE TRANSPORT,6.4994e-06,-0.1564,-0.16532,1,0
5,GO ACTIVATION OF MAPK ACTIVITY,0.00041602,-0.1564,-0.14145,1,0
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0041716,-0.15641,-0.15672,1,0
5,GO REGULATION OF LIPID TRANSPORT,0.00036427,-0.15647,-0.172,1,0
5,GO ION HOMEOSTASIS,8.2505e-07,-0.15649,-0.16868,1,0
5,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,1.7806e-05,-0.15658,-0.14244,1,0
5,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.035393,-0.15659,-0.24489,1,0
5,GO POLYSACCHARIDE METABOLIC PROCESS,0.00011241,-0.15665,-0.17089,1,0
5,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.023205,-0.15677,-0.22692,1,0
5,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.0038387,-0.15682,-0.16171,1,0
5,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.015203,-0.15686,-0.23243,1,0
5,GO RESPONSE TO INORGANIC SUBSTANCE,2.4692e-06,-0.15696,-0.18272,1,0
5,GO NOTCH SIGNALING PATHWAY,0.0049174,-0.15699,-0.13109,1,0
5,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.00044439,-0.157,-0.14094,1,0
5,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.036948,-0.15703,-0.11148,1,0
5,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.036948,-0.15726,-0.20256,1,0
5,GO LONG CHAIN FATTY ACID TRANSPORT,5.4121e-05,-0.15733,-0.1746,1,0
5,GO REGULATION OF STEROL TRANSPORT,0.0013872,-0.15744,-0.20538,1,0
5,GO GLYCEROLIPID METABOLIC PROCESS,1.4609e-05,-0.15749,-0.15175,1,0
5,GO P38MAPK CASCADE,0.0019282,-0.15753,-0.19186,1,0
5,GO CELLULAR RESPONSE TO OXYGEN LEVELS,1.1493e-05,-0.15753,-0.17299,1,0
5,GO DIACYLGLYCEROL METABOLIC PROCESS,0.015574,-0.15757,-0.14237,1,0
5,GO LEUKOCYTE CHEMOTAXIS,0.00057693,-0.1576,-0.17374,1,0
5,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.014841,-0.15781,-0.15124,1,0
5,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,1.8521e-05,-0.15786,-0.16159,1,0
5,GO RESPONSE TO ACID CHEMICAL,0.00026903,-0.15802,-0.15659,1,0
5,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00023468,-0.15815,-0.18411,1,0
5,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.035393,-0.15822,-0.12954,1,0
5,GO NON CANONICAL WNT SIGNALING PATHWAY,7.547e-05,-0.15824,-0.15895,1,0
5,GO INNATE IMMUNE RESPONSE,0.00031859,-0.15826,-0.18292,1,0
5,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,2.4346e-05,-0.15833,-0.15931,1,0
5,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,2.3418e-05,-0.15836,-0.15211,1,0
5,GO OUTFLOW TRACT MORPHOGENESIS,0.0083534,-0.15838,-0.17821,1,0
5,GO TRIGLYCERIDE METABOLIC PROCESS,5.2139e-05,-0.1584,-0.20404,1,0
5,GO LYMPHOCYTE MEDIATED IMMUNITY,0.00081984,-0.15843,-0.19707,1,0
5,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.020205,-0.15846,-0.12683,1,0
5,GO GLIAL CELL ACTIVATION,0.00037661,-0.15846,-0.21349,1,0
5,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0069616,-0.15849,-0.11701,1,0
5,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.00042998,-0.15853,-0.18246,1,0
5,GO NEUTRAL LIPID METABOLIC PROCESS,1.9263e-05,-0.15856,-0.19527,1,0
5,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.04854,-0.15865,-0.14309,1,0
5,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.043763,-0.15868,-0.12002,1,0
5,GO POSITIVE REGULATION OF IMMUNE RESPONSE,6.7596e-05,-0.15879,-0.16265,1,0
5,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,2.3418e-05,-0.15896,-0.16128,1,0
5,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.020205,-0.15896,-0.1668,1,0
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00031859,-0.15901,-0.219,1,0
5,GO ISOPRENOID METABOLIC PROCESS,0.0030654,-0.15913,-0.16795,1,0
5,GO SECONDARY METABOLIC PROCESS,0.0057817,-0.15914,-0.20854,1,0
5,GO CHLORIDE TRANSPORT,0.00050664,-0.15921,-0.14962,1,0
5,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.0012662,-0.15922,-0.17814,1,0
5,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.02843,-0.15925,-0.18341,1,0
5,GO RNA CATABOLIC PROCESS,0.00012512,-0.1593,-0.18387,1,0
5,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0066042,-0.15932,-0.22835,1,0
5,GO RESPONSE TO HORMONE,6.7728e-06,-0.15934,-0.16196,1,0
5,GO INTERACTION WITH SYMBIONT,5.0226e-05,-0.15935,-0.18147,1,0
5,GO TERPENOID METABOLIC PROCESS,0.0046564,-0.15941,-0.16821,1,0
5,GO NUCLEAR ENVELOPE REASSEMBLY,0.047551,-0.15957,-0.099279,1,0
5,GO T CELL PROLIFERATION,0.00026903,-0.15971,-0.18968,1,0
5,GO NEGATIVE REGULATION OF PHOSPHORYLATION,7.8282e-05,-0.15978,-0.15878,1,0
5,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.031059,-0.15995,-0.20564,1,0
5,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.00042998,-0.16012,-0.20605,1,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.00084609,-0.16017,-0.22039,1,0
5,GO RESPONSE TO ETHANOL,0.00023468,-0.16018,-0.16409,1,0
5,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.0046564,-0.16021,-0.16057,1,0
5,GO COPII COATED VESICLE BUDDING,1.6455e-05,-0.16023,-0.18167,1,0
5,GO RESPONSE TO REACTIVE OXYGEN SPECIES,2.3418e-05,-0.16051,-0.18008,1,0
5,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,1.6455e-05,-0.16063,-0.15721,1,0
5,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.001191,-0.16064,-0.19467,1,0
5,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.0054795,-0.16065,-0.22965,1,0
5,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00038934,-0.16072,-0.14622,1,0
5,GO AMINO SUGAR METABOLIC PROCESS,0.00090094,-0.16078,-0.18827,1,0
5,GO DIVALENT INORGANIC CATION HOMEOSTASIS,2.4692e-06,-0.16093,-0.17029,1,0
5,GO LIPID METABOLIC PROCESS,2.2658e-06,-0.16101,-0.17361,1,0
5,GO RIBONUCLEOSIDE METABOLIC PROCESS,8.7323e-05,-0.16101,-0.17852,1,0
5,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.00018427,-0.16104,-0.17329,1,0
5,GO KIDNEY EPITHELIUM DEVELOPMENT,0.014486,-0.1611,-0.14196,1,0
5,GO CORPUS CALLOSUM DEVELOPMENT,0.044685,-0.16114,-0.16999,1,0
5,GO AMYLOID BETA CLEARANCE,0.0029794,-0.16123,-0.22197,1,0
5,GO DEFENSE RESPONSE TO BACTERIUM,0.0012662,-0.16135,-0.15671,1,0
5,GO MULTI ORGANISM CELLULAR PROCESS,0.013465,-0.16137,-0.2523,1,0
5,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00019753,-0.16142,-0.20401,1,0
5,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.025414,-0.16154,-0.1961,1,0
5,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00012074,-0.16162,-0.16903,1,0
5,GO REGULATION OF VIRAL LIFE CYCLE,0.033894,-0.1617,-0.18293,1,0
5,GO TRNA PROCESSING,0.0014738,-0.16177,-0.15191,1,0
5,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0007696,-0.16181,-0.18966,1,0
5,GO DIVALENT INORGANIC CATION TRANSPORT,1.0184e-05,-0.16184,-0.16347,1,0
5,GO TRNA MODIFICATION,0.00092958,-0.16201,-0.17513,1,0
5,GO RESPONSE TO STEROID HORMONE,4.1617e-05,-0.16204,-0.17993,1,0
5,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.0079323,-0.16241,-0.1916,1,0
5,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.00037661,-0.16248,-0.15725,1,0
5,GO REGULATION OF PEPTIDASE ACTIVITY,0.00042998,-0.16251,-0.17296,1,0
5,GO HYPOTONIC RESPONSE,0.0059384,-0.16264,-0.23026,1,0
5,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,6.0504e-05,-0.16277,-0.1518,1,0
5,GO MONOCARBOXYLIC ACID TRANSPORT,7.9801e-06,-0.16281,-0.17391,1,0
5,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.0014738,-0.16284,-0.17928,1,0
5,GO CELLULAR RESPONSE TO STARVATION,0.00042998,-0.16301,-0.14886,1,0
5,GO GLAND MORPHOGENESIS,0.012203,-0.16305,-0.20086,1,0
5,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.00021909,-0.16316,-0.20068,1,0
5,GO IMMATURE T CELL PROLIFERATION,0.014138,-0.16318,-0.19115,1,0
5,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00054072,-0.1632,-0.19423,1,0
5,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,6.2786e-05,-0.16321,-0.16805,1,0
5,GO L AMINO ACID TRANSPORT,0.00022676,-0.16322,-0.18843,1,0
5,GO CELLULAR RESPONSE TO ATP,0.007729,-0.16332,-0.14794,1,0
5,GO REGULATION OF MACROPHAGE MIGRATION,0.00098941,-0.16333,-0.1808,1,0
5,GO NEURAL CREST CELL MIGRATION,0.024288,-0.16334,-0.16351,1,0
5,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.018836,-0.16336,-0.18212,1,0
5,GO RESPONSE TO LEPTIN,0.0032441,-0.16337,-0.19159,1,0
5,GO LYMPHOCYTE CHEMOTAXIS,0.0016129,-0.16346,-0.16498,1,0
5,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.00069957,-0.16351,-0.19108,1,0
5,GO PROTEIN AUTOPHOSPHORYLATION,3.4421e-05,-0.16354,-0.15372,1,0
5,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.007729,-0.16356,-0.25385,1,0
5,GO REGULATION OF FATTY ACID OXIDATION,0.0042883,-0.16361,-0.18253,1,0
5,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,1.0604e-05,-0.16366,-0.17704,1,0
5,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.029719,-0.16368,-0.24914,1,0
5,GO REGULATION OF SODIUM ION TRANSPORT,0.0022332,-0.16387,-0.17287,1,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.023741,-0.16388,-0.15928,1,0
5,GO INTRACELLULAR LIPID TRANSPORT,0.0062634,-0.16401,-0.15994,1,0
5,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,6.5149e-05,-0.16403,-0.16636,1,0
5,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0038387,-0.16406,-0.21248,1,0
5,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.0060989,-0.1642,-0.1405,1,0
5,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.00041602,-0.16426,-0.15603,1,0
5,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.00019079,-0.16429,-0.21359,1,0
5,GO REGULATION OF BLOOD PRESSURE,7.2754e-05,-0.16429,-0.16963,1,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.009256,-0.16433,-0.1343,1,0
5,GO RESPONSE TO PROSTAGLANDIN,0.015953,-0.16446,-0.17302,1,0
5,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.00050664,-0.16447,-0.14224,1,0
5,GO GOLGI VESICLE BUDDING,9.0179e-06,-0.16456,-0.18602,1,0
5,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.0017123,-0.16459,-0.19227,1,0
5,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.00079435,-0.16475,-0.17713,1,0
5,GO B CELL PROLIFERATION,0.00010845,-0.16476,-0.19716,1,0
5,GO SUPEROXIDE METABOLIC PROCESS,0.011326,-0.16483,-0.14816,1,0
5,GO REGULATION OF CHEMOTAXIS,0.00055855,-0.16486,-0.16337,1,0
5,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.0045306,-0.16487,-0.16926,1,0
5,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.0001165,-0.16496,-0.19813,1,0
5,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.00019753,-0.1651,-0.19335,1,0
5,GO RESPONSE TO OXIDATIVE STRESS,3.9418e-06,-0.16512,-0.18727,1,0
5,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.010245,-0.16523,-0.27582,1,0
5,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,7.0571e-06,-0.16539,-0.18501,1,0
5,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.024846,-0.1654,-0.2279,1,0
5,GO CYTOKINE METABOLIC PROCESS,0.00026003,-0.16544,-0.2193,1,0
5,GO COLLAGEN FIBRIL ORGANIZATION,0.0056288,-0.16547,-0.25407,1,0
5,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,3.4421e-05,-0.16578,-0.21325,1,0
5,GO CELLULAR KETONE METABOLIC PROCESS,8.1192e-05,-0.1658,-0.18653,1,0
5,GO PROTEOGLYCAN METABOLIC PROCESS,0.011904,-0.16595,-0.14116,1,0
5,GO REGULATION OF VASCULATURE DEVELOPMENT,0.0001547,-0.16612,-0.19953,1,0
5,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00021909,-0.16615,-0.21462,1,0
5,GO CHOLESTEROL EFFLUX,0.00052342,-0.16627,-0.18991,1,0
5,GO GLYCINE METABOLIC PROCESS,0.014841,-0.16633,-0.25105,1,0
5,GO CELLULAR RESPONSE TO LIPID,1.5816e-05,-0.16638,-0.17083,1,0
5,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.013798,-0.16645,-0.26053,1,0
5,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0059384,-0.1665,-0.16319,1,0
5,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.00022676,-0.16656,-0.17677,1,0
5,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.03245,-0.16662,-0.15506,1,0
5,GO RESPONSE TO METAL ION,1.5816e-05,-0.16662,-0.18397,1,0
5,GO REGULATION OF MUSCLE HYPERTROPHY,0.00353,-0.16673,-0.1649,1,0
5,GO GASTRULATION,0.0015189,-0.16674,-0.18236,1,0
5,GO AMMONIUM ION METABOLIC PROCESS,0.021165,-0.16689,-0.19128,1,0
5,GO PROTEIN MATURATION,2.4346e-05,-0.16716,-0.17068,1,0
5,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,1.2308e-06,-0.16734,-0.17956,1,0
5,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0027346,-0.16737,-0.16518,1,0
5,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.0020453,-0.16739,-0.1701,1,0
5,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,2.0784e-06,-0.16741,-0.18015,1,0
5,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.044685,-0.16748,-0.2036,1,0
5,GO PROTEIN CONTAINING COMPLEX REMODELING,0.0049174,-0.16749,-0.16806,1,0
5,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.0006154,-0.16753,-0.18464,1,0
5,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0021062,-0.1676,-0.20778,1,0
5,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,4.6623e-06,-0.16774,-0.175,1,0
5,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.036948,-0.16793,-0.16613,1,0
5,GO BONE REMODELING,0.0013872,-0.16794,-0.21285,1,0
5,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.043763,-0.16796,-0.17732,1,0
5,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.014841,-0.16813,-0.15558,1,0
5,GO NEUTRAL LIPID CATABOLIC PROCESS,0.034637,-0.1682,-0.12783,1,0
5,GO ICOSANOID METABOLIC PROCESS,0.00042998,-0.16834,-0.21285,1,0
5,GO PIGMENT GRANULE MATURATION,0.010773,-0.16838,-0.21774,1,0
5,GO POSITIVE REGULATION OF BINDING,0.00022676,-0.1684,-0.13741,1,0
5,GO LIPID LOCALIZATION,9.7801e-06,-0.16845,-0.19197,1,0
5,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.00013433,-0.16846,-0.18127,1,0
5,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.017137,-0.16857,-0.14491,1,0
5,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.00092958,-0.16867,-0.15808,1,0
5,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0023671,-0.16869,-0.15993,1,0
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00041602,-0.16884,-0.18113,1,0
5,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.00011241,-0.16898,-0.17546,1,0
5,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.00038934,-0.16905,-0.18991,1,0
5,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,1.2962e-05,-0.16917,-0.16986,1,0
5,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,1.0604e-05,-0.1692,-0.16871,1,0
5,GO LYMPHOCYTE MIGRATION,0.00014418,-0.16926,-0.18652,1,0
5,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.015203,-0.16933,-0.20316,1,0
5,GO RESPONSE TO OXYGEN LEVELS,9.0221e-07,-0.16939,-0.2075,1,0
5,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.00044439,-0.16942,-0.20427,1,0
5,GO OXALATE TRANSPORT,0.001191,-0.16945,-0.23145,1,0
5,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.00084609,-0.1695,-0.21055,1,0
5,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.036164,-0.1697,-0.2563,1,0
5,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.00052342,-0.16973,-0.18343,1,0
5,GO REGULATION OF IMMUNE RESPONSE,6.7596e-05,-0.16976,-0.16714,1,0
5,GO CYTOKINE PRODUCTION,0.00010845,-0.16982,-0.17782,1,0
5,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.001986,-0.16982,-0.14549,1,0
5,GO FEAR RESPONSE,0.00074557,-0.16983,-0.17573,1,0
5,GO REGULATION OF MUSCLE SYSTEM PROCESS,9.0179e-06,-0.16984,-0.17997,1,0
5,GO REGULATION OF ATP METABOLIC PROCESS,2.9532e-05,-0.16985,-0.16059,1,0
5,GO B CELL MEDIATED IMMUNITY,0.0040578,-0.17015,-0.182,1,0
5,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.013465,-0.17034,-0.19612,1,0
5,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0013457,-0.17035,-0.17736,1,0
5,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.0057817,-0.17035,-0.19727,1,0
5,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00045924,-0.17053,-0.2257,1,0
5,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.00072223,-0.17071,-0.14839,1,0
5,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.010773,-0.17112,-0.13563,1,0
5,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,9.7801e-06,-0.17116,-0.18493,1,0
5,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.004408,-0.17117,-0.16653,1,0
5,GO CELLULAR RESPONSE TO CALCIUM ION,0.00092958,-0.17117,-0.22232,1,0
5,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,2.5308e-05,-0.17118,-0.22028,1,0
5,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,4.8379e-05,-0.17123,-0.19738,1,0
5,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.00018427,-0.17128,-0.1619,1,0
5,GO ENERGY RESERVE METABOLIC PROCESS,4.1617e-05,-0.1713,-0.18877,1,0
5,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.013465,-0.17135,-0.14543,1,0
5,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.00055855,-0.17142,-0.16819,1,0
5,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.00013433,-0.17147,-0.22175,1,0
5,GO POSITIVE REGULATION OF PROTEOLYSIS,3.8583e-05,-0.17156,-0.16283,1,0
5,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.0097392,-0.17187,-0.27062,1,0
5,GO LEUKOCYTE PROLIFERATION,7.8282e-05,-0.17195,-0.19401,1,0
5,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.0030654,-0.17198,-0.23391,1,0
5,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.0018173,-0.17205,-0.19927,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION,0.00095906,-0.17208,-0.20318,1,0
5,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,1.5816e-05,-0.17226,-0.16289,1,0
5,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,2.2524e-05,-0.17228,-0.16981,1,0
5,GO MEMBRANE BIOGENESIS,0.036948,-0.17229,-0.15444,1,0
5,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.007729,-0.17236,-0.16565,1,0
5,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.0028141,-0.17255,-0.19404,1,0
5,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.0059384,-0.1726,-0.17136,1,0
5,GO LIPOPROTEIN CATABOLIC PROCESS,0.009256,-0.17261,-0.21366,1,0
5,GO PEPTIDYL METHIONINE MODIFICATION,0.0064317,-0.17263,-0.17914,1,0
5,GO PROTEIN LOCALIZATION TO CELL SURFACE,9.0551e-05,-0.17273,-0.18215,1,0
5,GO MACROPHAGE MIGRATION,0.00072223,-0.17288,-0.20305,1,0
5,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.023741,-0.17296,-0.17478,1,0
5,GO DENDRITIC CELL CHEMOTAXIS,0.0087944,-0.17298,-0.18781,1,0
5,GO MESONEPHROS DEVELOPMENT,0.014841,-0.17306,-0.15187,1,0
5,GO RESPONSE TO STEROL,0.00074557,-0.17314,-0.21663,1,0
5,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,6.7596e-05,-0.17328,-0.15345,1,0
5,GO LIVER MORPHOGENESIS,0.047551,-0.17334,-0.19782,1,0
5,GO VITAMIN BIOSYNTHETIC PROCESS,0.02843,-0.17346,-0.15872,1,0
5,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0050528,-0.17348,-0.18728,1,0
5,GO REGULATION OF BLOOD CIRCULATION,0.00032948,-0.17385,-0.17077,1,0
5,GO CELLULAR RESPIRATION,0.00016595,-0.17401,-0.20997,1,0
5,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00034072,-0.17402,-0.1778,1,0
5,GO NUCLEOSIDE METABOLIC PROCESS,9.0551e-05,-0.17409,-0.15753,1,0
5,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.0064317,-0.17422,-0.15137,1,0
5,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.052669,-0.1743,-0.2077,1,0
5,GO RESPONSE TO INTERLEUKIN 4,0.00026003,-0.17432,-0.18275,1,0
5,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,1.0184e-05,-0.17444,-0.22788,1,0
5,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.00018427,-0.17452,-0.20354,1,0
5,GO OXIDATIVE PHOSPHORYLATION,0.00026903,-0.17454,-0.21437,1,0
5,GO CARDIAC CHAMBER MORPHOGENESIS,0.011904,-0.17464,-0.1507,1,0
5,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.0014738,-0.17474,-0.18973,1,0
5,GO REGULATION OF LIPID METABOLIC PROCESS,8.6584e-06,-0.17474,-0.18053,1,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00040247,-0.17477,-0.19625,1,0
5,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0034322,-0.17486,-0.16561,1,0
5,GO PROTEIN FOLDING,1.0311e-06,-0.17505,-0.19663,1,0
5,GO INFLAMMATORY RESPONSE,6.0504e-05,-0.17513,-0.18794,1,0
5,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00037661,-0.17517,-0.17695,1,0
5,GO MUSCLE ORGAN MORPHOGENESIS,0.0051916,-0.17519,-0.14253,1,0
5,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.0011549,-0.1752,-0.19104,1,0
5,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.00018427,-0.17525,-0.22111,1,0
5,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0047853,-0.17551,-0.16644,1,0
5,GO FATTY ACID BETA OXIDATION,0.00044439,-0.17558,-0.1882,1,0
5,GO BONE RESORPTION,0.0016129,-0.17558,-0.1944,1,0
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0028957,-0.17564,-0.19358,1,0
5,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.00098941,-0.17571,-0.16136,1,0
5,GO PURINE NUCLEOSIDE METABOLIC PROCESS,9.3916e-06,-0.17581,-0.18715,1,0
5,GO LEUKOCYTE MEDIATED IMMUNITY,4.8379e-05,-0.17585,-0.20905,1,0
5,GO LAMELLIPODIUM ORGANIZATION,0.00014935,-0.1759,-0.18764,1,0
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.00025131,-0.17595,-0.20746,1,0
5,GO PROTEIN PROCESSING,0.00022676,-0.17604,-0.17575,1,0
5,GO REGULATION OF MAPK CASCADE,2.3418e-05,-0.17608,-0.17794,1,0
5,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,2.1663e-05,-0.17621,-0.17767,1,0
5,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.00031859,-0.17621,-0.19921,1,0
5,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.0010859,-0.17627,-0.1991,1,0
5,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.0013872,-0.17628,-0.18449,1,0
5,GO PROTEIN HOMOTETRAMERIZATION,7.547e-05,-0.1763,-0.15239,1,0
5,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0013872,-0.17667,-0.21927,1,0
5,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,1.7806e-05,-0.1767,-0.19074,1,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.00067758,-0.17679,-0.21389,1,0
5,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,9.7346e-05,-0.17681,-0.18999,1,0
5,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.00081984,-0.17691,-0.16179,1,0
5,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.013139,-0.17696,-0.18938,1,0
5,GO RESPONSE TO CADMIUM ION,0.011904,-0.17705,-0.20038,1,0
5,GO REGULATION OF PHAGOCYTOSIS,0.00069957,-0.17715,-0.1971,1,0
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.0014738,-0.17719,-0.21836,1,0
5,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.0010859,-0.1772,-0.26418,1,0
5,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.00072223,-0.17736,-0.2283,1,0
5,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0029794,-0.17741,-0.20766,1,0
5,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.00042998,-0.1775,-0.19222,1,0
5,GO RESPONSE TO PEPTIDOGLYCAN,0.0014738,-0.17783,-0.20724,1,0
5,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,3.0689e-05,-0.17784,-0.20056,1,0
5,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.0010206,-0.17786,-0.16007,1,0
5,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,3.9418e-06,-0.17801,-0.19912,1,0
5,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.00040247,-0.17806,-0.18818,1,0
5,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.0042883,-0.17808,-0.20188,1,0
5,GO MYELOID LEUKOCYTE MIGRATION,3.3132e-05,-0.17809,-0.20991,1,0
5,GO PEPTIDYL ARGININE N METHYLATION,0.007729,-0.1782,-0.18803,1,0
5,GO INTERLEUKIN 1 BETA PRODUCTION,0.0034322,-0.17829,-0.211,1,0
5,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.00026003,-0.1783,-0.19005,1,0
5,GO DEFENSE RESPONSE,4.3218e-05,-0.17832,-0.17788,1,0
5,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.00021909,-0.17842,-0.22171,1,0
5,GO RESPONSE TO BIOTIC STIMULUS,4.1617e-05,-0.17853,-0.17908,1,0
5,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.0075304,-0.17856,-0.17779,1,0
5,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0026572,-0.17857,-0.17072,1,0
5,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.00065623,-0.17876,-0.23399,1,0
5,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.0031536,-0.17878,-0.20007,1,0
5,GO PROTEIN TARGETING TO LYSOSOME,0.0047853,-0.17879,-0.21742,1,0
5,GO ENDODERMAL CELL DIFFERENTIATION,0.00030804,-0.17885,-0.33631,1,0
5,GO RESPONSE TO DSRNA,0.00072223,-0.1789,-0.18219,1,0
5,GO PROTEIN TARGETING,1.8251e-06,-0.17898,-0.21031,1,0
5,GO RHO PROTEIN SIGNAL TRANSDUCTION,4.0073e-05,-0.179,-0.21,1,0
5,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.0094949,-0.17901,-0.17867,1,0
5,GO LIPID OXIDATION,4.8379e-05,-0.17915,-0.20554,1,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,1.906e-06,-0.17915,-0.17524,1,0
5,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.05161,-0.17919,-0.13435,1,0
5,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.0039469,-0.17923,-0.19369,1,0
5,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0028957,-0.17932,-0.21128,1,0
5,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.026586,-0.17934,-0.14688,1,0
5,GO PIGMENT GRANULE ORGANIZATION,0.0081404,-0.17942,-0.15055,1,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.001872,-0.17943,-0.18783,1,0
5,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.00010845,-0.17943,-0.19877,1,0
5,GO SENSORY PERCEPTION OF TASTE,0.0019282,-0.17961,-0.15128,1,0
5,GO RESPONSE TO LIPID,7.6603e-06,-0.17964,-0.18015,1,0
5,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.012203,-0.1799,-0.19041,1,0
5,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.010245,-0.18007,-0.18121,1,0
5,GO REGULATION OF LEUKOCYTE MIGRATION,3.3132e-05,-0.1803,-0.20446,1,0
5,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,1.349e-05,-0.18033,-0.19826,1,0
5,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,7.5427e-07,-0.18059,-0.1941,1,0
5,GO IMMUNE EFFECTOR PROCESS,6.5149e-05,-0.18061,-0.19534,1,0
5,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.019283,-0.18063,-0.19404,1,0
5,GO CELLULAR GLUCAN METABOLIC PROCESS,0.00016023,-0.18065,-0.1913,1,0
5,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.00045924,-0.18085,-0.16778,1,0
5,GO VACUOLE ORGANIZATION,1.5201e-05,-0.18091,-0.17377,1,0
5,GO NEGATIVE REGULATION OF GENE SILENCING,0.00030804,-0.18092,-0.21951,1,0
5,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.0083534,-0.18102,-0.1752,1,0
5,GO FOCAL ADHESION ASSEMBLY,0.00074557,-0.18113,-0.21238,1,0
5,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.026586,-0.18115,-0.19484,1,0
5,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.00016023,-0.18132,-0.15969,1,0
5,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.043763,-0.18135,-0.25562,1,0
5,GO POSITIVE REGULATION OF T CELL MIGRATION,0.0001165,-0.18137,-0.21916,1,0
5,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00057693,-0.1814,-0.20506,1,0
5,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,8.4205e-05,-0.1816,-0.21772,1,0
5,GO LAMELLIPODIUM ASSEMBLY,0.00065623,-0.18161,-0.16453,1,0
5,GO MUSCLE HYPERTROPHY,0.00035231,-0.18163,-0.18849,1,0
5,GO REGULATION OF ENDOCYTOSIS,4.1617e-05,-0.18163,-0.16846,1,0
5,GO MYOBLAST PROLIFERATION,0.012203,-0.18163,-0.16856,1,0
5,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.0013872,-0.1818,-0.2215,1,0
5,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.0064317,-0.18191,-0.20979,1,0
5,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.0028957,-0.18195,-0.22966,1,0
5,GO RESPONSE TO ANGIOTENSIN,0.0056288,-0.18213,-0.20812,1,0
5,GO SMOOTH MUSCLE CELL PROLIFERATION,0.00049035,-0.18213,-0.20658,1,0
5,GO REGENERATION,9.7346e-05,-0.18215,-0.19543,1,0
5,GO CARBOHYDRATE METABOLIC PROCESS,3.0264e-07,-0.18218,-0.19763,1,0
5,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.020205,-0.1822,-0.24155,1,0
5,GO ESTROGEN METABOLIC PROCESS,8.1192e-05,-0.18222,-0.23095,1,0
5,GO ASYMMETRIC CELL DIVISION,0.0075304,-0.18231,-0.20121,1,0
5,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,1.906e-06,-0.18236,-0.16685,1,0
5,GO BLOOD VESSEL REMODELING,0.00031859,-0.18243,-0.26522,1,0
5,GO GLUCOSE METABOLIC PROCESS,2.4692e-06,-0.18245,-0.17794,1,0
5,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0032441,-0.18245,-0.18306,1,0
5,GO ATP METABOLIC PROCESS,2.0784e-06,-0.18248,-0.18734,1,0
5,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,2.6307e-05,-0.18251,-0.20446,1,0
5,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.04854,-0.18259,-0.20773,1,0
5,GO ALPHA AMINO ACID METABOLIC PROCESS,7.3528e-06,-0.1828,-0.21147,1,0
5,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,1.9263e-05,-0.18313,-0.2112,1,0
5,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.00042998,-0.18323,-0.19701,1,0
5,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,9.0221e-07,-0.18323,-0.20385,1,0
5,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00035231,-0.18339,-0.18274,1,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0079323,-0.1834,-0.26846,1,0
5,GO ORGANIC ACID BIOSYNTHETIC PROCESS,2.3654e-06,-0.18341,-0.19467,1,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.047551,-0.18359,-0.19013,1,0
5,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,1.4609e-05,-0.1837,-0.2077,1,0
5,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.00019079,-0.1839,-0.2221,1,0
5,GO RESPONSE TO TOXIC SUBSTANCE,9.3916e-06,-0.18393,-0.1968,1,0
5,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.0026572,-0.18393,-0.22565,1,0
5,GO REGULATION OF OSSIFICATION,0.00026003,-0.18398,-0.18629,1,0
5,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00018427,-0.18412,-0.27467,1,0
5,GO TRNA METABOLIC PROCESS,0.00030804,-0.18416,-0.17427,1,0
5,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.00079435,-0.18445,-0.17555,1,0
5,GO ENDODERM DEVELOPMENT,0.0013054,-0.1845,-0.26058,1,0
5,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.00020448,-0.18451,-0.22421,1,0
5,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00045924,-0.18464,-0.25475,1,0
5,GO POSITIVE REGULATION OF CELL ADHESION,0.00011241,-0.18472,-0.21051,1,0
5,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.00030804,-0.18491,-0.21334,1,0
5,GO AMINE CATABOLIC PROCESS,0.015203,-0.18505,-0.20909,1,0
5,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.00018427,-0.18516,-0.26376,1,0
5,GO STEROID METABOLIC PROCESS,6.4994e-06,-0.18518,-0.20742,1,0
5,GO REGULATION OF PROTEIN BINDING,1.1493e-05,-0.18519,-0.18304,1,0
5,GO MYELOID LEUKOCYTE ACTIVATION,1.1493e-05,-0.18527,-0.22685,1,0
5,GO RESPONSE TO STARVATION,5.6174e-05,-0.18528,-0.17561,1,0
5,GO PLATELET AGGREGATION,0.0013457,-0.18529,-0.2319,1,0
5,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.00353,-0.18541,-0.1674,1,0
5,GO SELECTIVE AUTOPHAGY,0.00026003,-0.18546,-0.18089,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.0014299,-0.18551,-0.20893,1,0
5,GO PROTEIN AUTOPROCESSING,0.00045924,-0.18553,-0.23779,1,0
5,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.025994,-0.18558,-0.19502,1,0
5,GO RESPONSE TO CYTOKINE,2.6307e-05,-0.18564,-0.196,1,0
5,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,1.725e-07,-0.18565,-0.18866,1,0
5,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.00035231,-0.18568,-0.17865,1,0
5,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00031859,-0.18569,-0.19027,1,0
5,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.00045924,-0.18582,-0.22761,1,0
5,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.00036427,-0.18587,-0.25546,1,0
5,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.013139,-0.18593,-0.14698,1,0
5,GO CELLULAR RESPONSE TO FATTY ACID,0.0051916,-0.18616,-0.19316,1,0
5,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.049546,-0.18623,-0.19591,1,0
5,GO PROSTAGLANDIN SECRETION,0.011047,-0.1863,-0.16735,1,0
5,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.0033369,-0.18638,-0.19181,1,0
5,GO NEGATIVE REGULATION OF PROTEIN BINDING,4.1617e-05,-0.18642,-0.19373,1,0
5,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,2.5308e-05,-0.18643,-0.1977,1,0
5,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00018427,-0.18645,-0.208,1,0
5,GO MOVEMENT IN HOST ENVIRONMENT,0.00040247,-0.18677,-0.22989,1,0
5,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.00037661,-0.18683,-0.1755,1,0
5,GO LEUKOCYTE MIGRATION,0.00011241,-0.18692,-0.1908,1,0
5,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.00031859,-0.18693,-0.26456,1,0
5,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00057693,-0.187,-0.24911,1,0
5,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,6.2786e-05,-0.18705,-0.20404,1,0
5,GO OSTEOCLAST DEVELOPMENT,0.0081404,-0.18709,-0.18497,1,0
5,GO SULFUR COMPOUND TRANSPORT,0.00022676,-0.18711,-0.17536,1,0
5,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.036948,-0.18712,-0.22646,1,0
5,GO TISSUE REMODELING,0.0013872,-0.18713,-0.20168,1,0
5,GO TRNA METHYLATION,0.0017123,-0.18721,-0.1751,1,0
5,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.026586,-0.18735,-0.21321,1,0
5,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00052342,-0.18736,-0.23139,1,0
5,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.0094949,-0.18741,-0.18362,1,0
5,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,3.0689e-05,-0.18744,-0.24839,1,0
5,GO ACETYL COA METABOLIC PROCESS,0.0014299,-0.18752,-0.18349,1,0
5,GO CELL CHEMOTAXIS,0.00016595,-0.18762,-0.19854,1,0
5,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.0013872,-0.18769,-0.22603,1,0
5,GO SPERM EGG RECOGNITION,2.5308e-05,-0.18772,-0.21067,1,0
5,GO ORGANOPHOSPHATE METABOLIC PROCESS,3.8131e-07,-0.18774,-0.17132,1,0
5,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.00013917,-0.18776,-0.20675,1,0
5,GO BROWN FAT CELL DIFFERENTIATION,0.0073363,-0.18792,-0.16931,1,0
5,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,6.2985e-07,-0.18796,-0.19112,1,0
5,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.0083534,-0.18797,-0.19068,1,0
5,GO EXCRETION,0.00038934,-0.18799,-0.17383,1,0
5,GO REGULATION OF RIBOSOME BIOGENESIS,0.00067758,-0.18809,-0.27475,1,0
5,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.0011199,-0.18825,-0.1924,1,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.0011549,-0.18826,-0.2042,1,0
5,GO NEGATIVE REGULATION OF MAPK CASCADE,7.8282e-05,-0.18828,-0.18378,1,0
5,GO COENZYME A METABOLIC PROCESS,0.0011199,-0.18832,-0.19981,1,0
5,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.00023468,-0.18833,-0.16927,1,0
5,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.001228,-0.18834,-0.25482,1,0
5,GO BONE MINERALIZATION,2.3418e-05,-0.18835,-0.23646,1,0
5,GO NUCLEOSIDE SALVAGE,0.0099891,-0.18845,-0.19665,1,0
5,GO CELLULAR RESPONSE TO STEROL,0.0047853,-0.1885,-0.20662,1,0
5,GO PROTEASOME ASSEMBLY,0.0067808,-0.1885,-0.17325,1,0
5,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0017123,-0.18865,-0.21938,1,0
5,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.0087944,-0.18892,-0.32368,1,0
5,GO GLUTAMINE METABOLIC PROCESS,0.0038387,-0.189,-0.16529,1,0
5,GO CELLULAR RESPONSE TO CHEMICAL STRESS,6.7728e-06,-0.189,-0.2046,1,0
5,GO FORMATION OF PRIMARY GERM LAYER,0.00040247,-0.189,-0.24217,1,0
5,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,9.389e-05,-0.18922,-0.18041,1,0
5,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.0017123,-0.18926,-0.20715,1,0
5,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.00063551,-0.1893,-0.25852,1,0
5,GO STEROL TRANSPORT,5.0226e-05,-0.18943,-0.22753,1,0
5,GO PROTEIN TETRAMERIZATION,1.0604e-05,-0.18973,-0.17338,1,0
5,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.02068,-0.18977,-0.18059,1,0
5,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.019283,-0.18984,-0.1984,1,0
5,GO CELLULAR IRON ION HOMEOSTASIS,3.5759e-05,-0.18988,-0.18743,1,0
5,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.00087311,-0.19012,-0.23059,1,0
5,GO INTERLEUKIN 8 PRODUCTION,0.0023671,-0.19016,-0.20246,1,0
5,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.0017641,-0.1902,-0.19244,1,0
5,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0012662,-0.19033,-0.24025,1,0
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00018427,-0.1905,-0.24342,1,0
5,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.037747,-0.19066,-0.14086,1,0
5,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,8.6584e-06,-0.19081,-0.22833,1,0
5,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.00034072,-0.19087,-0.21901,1,0
5,GO POSITIVE REGULATION OF MAPK CASCADE,1.9263e-05,-0.19088,-0.18582,1,0
5,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.00353,-0.19102,-0.21321,1,0
5,GO PROSTANOID METABOLIC PROCESS,0.0081404,-0.19114,-0.26019,1,0
5,GO REGULATION OF TISSUE REMODELING,0.00014935,-0.19117,-0.22821,1,0
5,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,7.9801e-06,-0.19122,-0.22099,1,0
5,GO CARDIOLIPIN METABOLIC PROCESS,0.00010845,-0.19123,-0.24104,1,0
5,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.001228,-0.19124,-0.21958,1,0
5,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00040247,-0.19125,-0.23824,1,0
5,GO DIET INDUCED THERMOGENESIS,0.00353,-0.19126,-0.2081,1,0
5,GO REGULATION OF RESPONSE TO WOUNDING,0.0069616,-0.19136,-0.17976,1,0
5,GO CELLULAR RESPONSE TO CHOLESTEROL,0.0047853,-0.19147,-0.23207,1,0
5,GO INTERACTION WITH HOST,0.00045924,-0.19149,-0.19805,1,0
5,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.02843,-0.1915,-0.19152,1,0
5,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,2.4346e-05,-0.19155,-0.1868,1,0
5,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,2.9532e-05,-0.19163,-0.16615,1,0
5,GO INTERLEUKIN 17 PRODUCTION,0.00016595,-0.19183,-0.23356,1,0
5,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,8.6584e-06,-0.19198,-0.16944,1,0
5,GO METANEPHRIC NEPHRON DEVELOPMENT,0.0033369,-0.19198,-0.18857,1,0
5,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,2.9532e-05,-0.192,-0.22993,1,0
5,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.0031536,-0.19206,-0.16768,1,0
5,GO ADAPTIVE IMMUNE RESPONSE,0.00017796,-0.19221,-0.21167,1,0
5,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0051916,-0.19234,-0.26862,1,0
5,GO ADAPTATION OF SIGNALING PATHWAY,0.015953,-0.19249,-0.18043,1,0
5,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,2.2524e-05,-0.19267,-0.21505,1,0
5,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.00069957,-0.19267,-0.22378,1,0
5,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.0016129,-0.19277,-0.21124,1,0
5,GO ENGULFMENT OF APOPTOTIC CELL,0.00084609,-0.19285,-0.2232,1,0
5,GO CELLULAR GLUCOSE HOMEOSTASIS,7.2754e-05,-0.19294,-0.16642,1,0
5,GO T CELL MIGRATION,0.00018427,-0.19297,-0.22853,1,0
5,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.012203,-0.19302,-0.17181,1,0
5,GO CD40 SIGNALING PATHWAY,0.0006154,-0.19312,-0.27562,1,0
5,GO ENDOCRINE PROCESS,0.0010206,-0.19324,-0.19017,1,0
5,GO REGULATION OF T CELL CHEMOTAXIS,0.0066042,-0.19335,-0.16923,1,0
5,GO MONOSACCHARIDE METABOLIC PROCESS,2.2879e-07,-0.19363,-0.22265,1,0
5,GO BIOMINERALIZATION,2.2524e-05,-0.19391,-0.21847,1,0
5,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,5.753e-07,-0.19392,-0.19777,1,0
5,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0017641,-0.19395,-0.25569,1,0
5,GO MACROPHAGE CHEMOTAXIS,0.00036427,-0.19414,-0.22917,1,0
5,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.041093,-0.19426,-0.19683,1,0
5,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.0083534,-0.19427,-0.18405,1,0
5,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.0064317,-0.1944,-0.21077,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,5.6174e-05,-0.19459,-0.19266,1,0
5,GO RESPONSE TO CHEMOKINE,7.0571e-06,-0.19466,-0.20231,1,0
5,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.01282,-0.19471,-0.23051,1,0
5,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0014738,-0.19475,-0.20099,1,0
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,1.1964e-05,-0.19481,-0.20605,1,0
5,GO RESPONSE TO COLD,0.00057693,-0.19483,-0.27574,1,0
5,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.031059,-0.19496,-0.14282,1,0
5,GO REGULATION OF PROSTAGLANDIN SECRETION,0.031748,-0.19522,-0.16461,1,0
5,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.0073363,-0.19527,-0.166,1,0
5,GO VITAMIN METABOLIC PROCESS,1.5816e-05,-0.19532,-0.20519,1,0
5,GO REGULATION OF SULFUR METABOLIC PROCESS,0.018398,-0.19533,-0.1913,1,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.019739,-0.19541,-0.28079,1,0
5,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.009256,-0.19542,-0.21339,1,0
5,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.01282,-0.19547,-0.20163,1,0
5,GO MAINTENANCE OF LOCATION,9.4334e-07,-0.19558,-0.19905,1,0
5,GO PEPTIDYL PROLINE MODIFICATION,4.8379e-05,-0.19558,-0.27821,1,0
5,GO RESPONSE TO DRUG,1.3441e-06,-0.19559,-0.22355,1,0
5,GO INTERLEUKIN 1 PRODUCTION,0.0046564,-0.1956,-0.20947,1,0
5,GO REGULATION OF LIPID LOCALIZATION,4.3218e-05,-0.19576,-0.19524,1,0
5,GO RESPONSE TO ESTROGEN,5.0226e-05,-0.19578,-0.23696,1,0
5,GO STEROL HOMEOSTASIS,9.389e-05,-0.19585,-0.21927,1,0
5,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,5.9841e-06,-0.19595,-0.20077,1,0
5,GO PYRUVATE METABOLIC PROCESS,2.5774e-06,-0.19602,-0.21143,1,0
5,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,8.2505e-07,-0.19612,-0.22245,1,0
5,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.00035231,-0.19629,-0.26836,1,0
5,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0025817,-0.19632,-0.23128,1,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.010506,-0.19636,-0.1534,1,0
5,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.012508,-0.19652,-0.30557,1,0
5,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.0051916,-0.19682,-0.19006,1,0
5,GO T CELL CYTOKINE PRODUCTION,0.00035231,-0.19683,-0.22495,1,0
5,GO AEROBIC RESPIRATION,1.5201e-05,-0.1969,-0.24815,1,0
5,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,5.0226e-05,-0.19695,-0.1862,1,0
5,GO POSITIVE REGULATION OF LIPID LOCALIZATION,8.1192e-05,-0.19702,-0.20791,1,0
5,GO REGULATION OF MACROPHAGE CHEMOTAXIS,9.0551e-05,-0.19721,-0.23907,1,0
5,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.001986,-0.19729,-0.18367,1,0
5,GO REGULATION OF LYMPHOCYTE MIGRATION,0.00029782,-0.19744,-0.20121,1,0
5,GO REGULATION OF BONE REMODELING,0.0059384,-0.19747,-0.20068,1,0
5,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,2.6902e-06,-0.19749,-0.24211,1,0
5,GO MYELOID CELL APOPTOTIC PROCESS,0.013465,-0.19754,-0.19412,1,0
5,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.0030654,-0.19763,-0.20722,1,0
5,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.0013872,-0.19763,-0.22504,1,0
5,GO CELLULAR RESPONSE TO IRON ION,0.024846,-0.19783,-0.17769,1,0
5,GO REGULATION OF PLATELET ACTIVATION,0.0032441,-0.1979,-0.26432,1,0
5,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.001872,-0.19795,-0.32195,1,0
5,GO SCHWANN CELL DEVELOPMENT,6.0504e-05,-0.19804,-0.20174,1,0
5,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,6.7728e-06,-0.19833,-0.20829,1,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.0049174,-0.19835,-0.29511,1,0
5,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00013917,-0.19837,-0.21991,1,0
5,GO LAMELLIPODIUM MORPHOGENESIS,0.013798,-0.19876,-0.20242,1,0
5,GO ORGANIC ACID METABOLIC PROCESS,1.8958e-07,-0.1991,-0.20421,1,0
5,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.0057817,-0.19917,-0.20529,1,0
5,GO RESPONSE TO MINERALOCORTICOID,0.00079435,-0.19919,-0.23084,1,0
5,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.0037331,-0.1996,-0.19764,1,0
5,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.02268,-0.19973,-0.17805,1,0
5,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,6.0198e-07,-0.19974,-0.19708,1,0
5,GO ERK1 AND ERK2 CASCADE,9.7346e-05,-0.2001,-0.20306,1,0
5,GO POLYOL BIOSYNTHETIC PROCESS,1.2862e-06,-0.20017,-0.21972,1,0
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.00017796,-0.20024,-0.20953,1,0
5,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.01282,-0.20041,-0.21598,1,0
5,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0090226,-0.20053,-0.21047,1,0
5,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.0013872,-0.20053,-0.27305,1,0
5,GO REGULATION OF LIPID STORAGE,0.0001165,-0.20068,-0.23342,1,0
5,GO FATTY ACID CATABOLIC PROCESS,2.6307e-05,-0.20072,-0.21556,1,0
5,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.0006154,-0.20073,-0.23499,1,0
5,GO MEMBRANE INVAGINATION,9.0551e-05,-0.20098,-0.22654,1,0
5,GO ANDROGEN METABOLIC PROCESS,0.0037331,-0.20113,-0.21284,1,0
5,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,5.6174e-05,-0.20124,-0.19829,1,0
5,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,1.2962e-05,-0.20127,-0.19922,1,0
5,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.042857,-0.20142,-0.12693,1,0
5,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00074557,-0.20149,-0.2633,1,0
5,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,3.3132e-05,-0.20154,-0.22404,1,0
5,GO PRIMARY ALCOHOL METABOLIC PROCESS,5.8301e-05,-0.20157,-0.25989,1,0
5,GO MUSCLE FILAMENT SLIDING,0.0006154,-0.20162,-0.24915,1,0
5,GO RESPONSE TO AMPHETAMINE,0.0026572,-0.20164,-0.25293,1,0
5,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.0033369,-0.20181,-0.21322,1,0
5,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0023671,-0.20186,-0.25076,1,0
5,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.0022992,-0.20186,-0.28688,1,0
5,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,1.1493e-05,-0.20192,-0.22981,1,0
5,GO REGULATION OF LIPID CATABOLIC PROCESS,0.00041602,-0.20192,-0.1754,1,0
5,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.00035231,-0.20194,-0.24951,1,0
5,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.004408,-0.20194,-0.17427,1,0
5,GO NUCLEOTIDE PHOSPHORYLATION,9.0179e-06,-0.20198,-0.20473,1,0
5,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0013457,-0.20208,-0.20118,1,0
5,GO STEROL METABOLIC PROCESS,8.7323e-05,-0.20218,-0.19264,1,0
5,GO TRNA 5 LEADER REMOVAL,0.0013457,-0.20231,-0.22124,1,0
5,GO NCRNA PROCESSING,0.00098941,-0.20232,-0.19208,1,0
5,GO REGULATION OF MAP KINASE ACTIVITY,5.0226e-05,-0.20239,-0.17267,1,0
5,GO CYTOSOLIC CALCIUM ION TRANSPORT,5.9841e-06,-0.20241,-0.20069,1,0
5,GO INTERFERON GAMMA PRODUCTION,4.1617e-05,-0.20241,-0.20003,1,0
5,GO TRANSLATIONAL TERMINATION,0.00017186,-0.20242,-0.24152,1,0
5,GO INOSITOL PHOSPHATE METABOLIC PROCESS,2.6902e-06,-0.20246,-0.20127,1,0
5,GO LIPID CATABOLIC PROCESS,1.8251e-06,-0.20252,-0.21191,1,0
5,GO RRNA MODIFICATION,0.001872,-0.20258,-0.21572,1,0
5,GO PEPTIDE BIOSYNTHETIC PROCESS,2.5308e-05,-0.20259,-0.20778,1,0
5,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,2.7343e-05,-0.20265,-0.28167,1,0
5,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.00012512,-0.2027,-0.25855,1,0
5,GO REGULATION OF ACTION POTENTIAL,0.0013872,-0.20298,-0.20136,1,0
5,GO NCRNA METABOLIC PROCESS,0.00026003,-0.20307,-0.18874,1,0
5,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.0045306,-0.20313,-0.24821,1,0
5,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.00087311,-0.20322,-0.19004,1,0
5,GO RESPONSE TO PURINE CONTAINING COMPOUND,2.9301e-06,-0.20332,-0.20575,1,0
5,GO STEROID HORMONE SECRETION,0.0090226,-0.20342,-0.21013,1,0
5,GO T CELL EXTRAVASATION,0.0075304,-0.20366,-0.34489,1,0
5,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.00032948,-0.20385,-0.21757,1,0
5,GO MEMBRANE PROTEIN PROTEOLYSIS,0.00087311,-0.2039,-0.22365,1,0
5,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.00095906,-0.2039,-0.25797,1,0
5,GO POSITIVE REGULATION OF COAGULATION,0.0028141,-0.20453,-0.20808,1,0
5,GO TRANSITION METAL ION HOMEOSTASIS,8.3127e-06,-0.20477,-0.21654,1,0
5,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,4.2876e-06,-0.20495,-0.20276,1,0
5,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.025414,-0.20511,-0.27802,1,0
5,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,1.8521e-05,-0.20526,-0.2495,1,0
5,GO ORGANIC ACID CATABOLIC PROCESS,2.6902e-06,-0.2053,-0.22515,1,0
5,GO HEPATOCYTE DIFFERENTIATION,0.02843,-0.20531,-0.22485,1,0
5,GO REGULATION OF MACROPHAGE ACTIVATION,1.104e-05,-0.20533,-0.24544,1,0
5,GO RESPONSE TO CALCIUM ION,5.8301e-05,-0.20537,-0.2161,1,0
5,GO OSTEOBLAST PROLIFERATION,0.0046564,-0.20546,-0.25245,1,0
5,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.00040247,-0.20562,-0.23617,1,0
5,GO RESPONSE TO DEXAMETHASONE,0.00026003,-0.20563,-0.25229,1,0
5,GO REGULATION OF SPROUTING ANGIOGENESIS,0.00032948,-0.20576,-0.20954,1,0
5,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.00067758,-0.20578,-0.22731,1,0
5,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,1.7806e-05,-0.20583,-0.20779,1,0
5,GO HAIR FOLLICLE MATURATION,0.001662,-0.20585,-0.28647,1,0
5,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.00067758,-0.20601,-0.18931,1,0
5,GO PROSTANOID BIOSYNTHETIC PROCESS,0.0099891,-0.20602,-0.254,1,0
5,GO VASCULOGENESIS,0.0041716,-0.20615,-0.25974,1,0
5,GO RESPONSE TO BACTERIUM,1.2962e-05,-0.20621,-0.20722,1,0
5,GO SPROUTING ANGIOGENESIS,2.4346e-05,-0.20635,-0.23117,1,0
5,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.00044439,-0.20648,-0.19382,1,0
5,GO MEMBRANE DEPOLARIZATION,0.0087944,-0.2071,-0.17616,1,0
5,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.007729,-0.2071,-0.27686,1,0
5,GO IRON ION HOMEOSTASIS,8.6584e-06,-0.20714,-0.22003,1,0
5,GO TISSUE REGENERATION,0.00029782,-0.20717,-0.2393,1,0
5,GO PROTEIN KINASE C SIGNALING,0.015953,-0.20717,-0.15807,1,0
5,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,7.0571e-06,-0.20733,-0.18902,1,0
5,GO REGULATION OF LYSOSOMAL LUMEN PH,0.0054795,-0.2074,-0.19211,1,0
5,GO PHOSPHOLIPID CATABOLIC PROCESS,9.389e-05,-0.20745,-0.2397,1,0
5,GO REGULATION OF WATER LOSS VIA SKIN,0.047551,-0.20749,-0.20813,1,0
5,GO PEPTIDE CATABOLIC PROCESS,0.0010528,-0.20752,-0.20533,1,0
5,GO BLASTODERM SEGMENTATION,0.013798,-0.20756,-0.26782,1,0
5,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0050528,-0.20761,-0.21215,1,0
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00029782,-0.20817,-0.24266,1,0
5,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.0033369,-0.20836,-0.17861,1,0
5,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.00010462,-0.20838,-0.26055,1,0
5,GO PEPTIDE CROSS LINKING,0.00063551,-0.20845,-0.31363,1,0
5,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.0030654,-0.20848,-0.26226,1,0
5,GO ALCOHOL METABOLIC PROCESS,1.6015e-06,-0.20877,-0.21186,1,0
5,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0049174,-0.2089,-0.2787,1,0
5,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0039469,-0.2089,-0.22417,1,0
5,GO FATTY ACID BIOSYNTHETIC PROCESS,3.7791e-06,-0.20891,-0.23466,1,0
5,GO HORMONE METABOLIC PROCESS,5.0226e-05,-0.20894,-0.20556,1,0
5,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.041967,-0.209,-0.14879,1,0
5,GO REGULATION OF RECEPTOR BINDING,0.011904,-0.20902,-0.2434,1,0
5,GO ENDOCARDIAL CUSHION FORMATION,0.027803,-0.20906,-0.20506,1,0
5,GO MUSCLE CELL APOPTOTIC PROCESS,3.4421e-05,-0.20906,-0.21973,1,0
5,GO AMINO SUGAR CATABOLIC PROCESS,0.00036427,-0.20916,-0.24689,1,0
5,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.0094949,-0.20918,-0.16362,1,0
5,GO STORE OPERATED CALCIUM ENTRY,0.0022992,-0.20922,-0.23019,1,0
5,GO AUTOPHAGY OF NUCLEUS,0.00095906,-0.20924,-0.21711,1,0
5,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0022332,-0.2093,-0.21344,1,0
5,GO CELLULAR AMIDE METABOLIC PROCESS,1.2971e-07,-0.20942,-0.21341,1,0
5,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.0031536,-0.20959,-0.21679,1,0
5,GO SMALL MOLECULE CATABOLIC PROCESS,9.4334e-07,-0.20961,-0.20854,1,0
5,GO AMINO ACID IMPORT,0.00022676,-0.20963,-0.23655,1,0
5,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.023205,-0.20968,-0.20957,1,0
5,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.013465,-0.20978,-0.2463,1,0
5,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.0057817,-0.20983,-0.2506,1,0
5,GO CARBOHYDRATE CATABOLIC PROCESS,3.0264e-07,-0.20989,-0.22738,1,0
5,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.00028792,-0.21,-0.21939,1,0
5,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.012203,-0.21016,-0.2092,1,0
5,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.0036303,-0.2102,-0.35083,1,0
5,GO T HELPER 1 CELL DIFFERENTIATION,0.014841,-0.21045,-0.28616,1,0
5,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.00079435,-0.2106,-0.20854,1,0
5,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.009256,-0.21076,-0.16252,1,0
5,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.022165,-0.211,-0.21061,1,0
5,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.023741,-0.21104,-0.30481,1,0
5,GO OXIDATION REDUCTION PROCESS,2.2879e-07,-0.21128,-0.2188,1,0
5,GO CELL MATRIX ADHESION,0.00012964,-0.21158,-0.23055,1,0
5,GO CARDIAC VENTRICLE MORPHOGENESIS,0.023741,-0.21181,-0.13095,1,0
5,GO SPHINGOID METABOLIC PROCESS,9.7346e-05,-0.21186,-0.27301,1,0
5,GO PEPTIDE METABOLIC PROCESS,5.4977e-07,-0.21195,-0.21809,1,0
5,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.0053338,-0.21197,-0.20048,1,0
5,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.00021167,-0.21201,-0.23791,1,0
5,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.00037661,-0.21217,-0.26375,1,0
5,GO ETHER BIOSYNTHETIC PROCESS,0.0020453,-0.21223,-0.34288,1,0
5,GO AMINO ACID BETAINE METABOLIC PROCESS,0.0029794,-0.21254,-0.23706,1,0
5,GO GASTRIC ACID SECRETION,0.026586,-0.21256,-0.1646,1,0
5,GO AMEBOIDAL TYPE CELL MIGRATION,5.6174e-05,-0.2126,-0.21077,1,0
5,GO ORGANOPHOSPHATE CATABOLIC PROCESS,1.2308e-06,-0.21263,-0.19682,1,0
5,GO AMYLOID BETA FORMATION,0.00024286,-0.21271,-0.24902,1,0
5,GO REGULATION OF GONAD DEVELOPMENT,0.027803,-0.21277,-0.16806,1,0
5,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,1.9263e-05,-0.21294,-0.26732,1,0
5,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.0029794,-0.21306,-0.21791,1,0
5,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.00021909,-0.2131,-0.25982,1,0
5,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.024288,-0.2132,-0.18678,1,0
5,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.001872,-0.21332,-0.27561,1,0
5,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0013457,-0.21338,-0.2042,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,7.3528e-06,-0.21338,-0.24935,1,0
5,GO CELLULAR AMINO ACID METABOLIC PROCESS,5.9841e-06,-0.2134,-0.20827,1,0
5,GO PSEUDOURIDINE SYNTHESIS,0.00098941,-0.2136,-0.27759,1,0
5,GO DIOL BIOSYNTHETIC PROCESS,0.00067758,-0.21375,-0.22128,1,0
5,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0001547,-0.21377,-0.28371,1,0
5,GO DIOL METABOLIC PROCESS,0.00023468,-0.21379,-0.25118,1,0
5,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.0040578,-0.21385,-0.21611,1,0
5,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.00021167,-0.21389,-0.28212,1,0
5,GO CELL CELL RECOGNITION,2.6902e-06,-0.21391,-0.2541,1,0
5,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00041602,-0.21405,-0.2198,1,0
5,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.0028141,-0.21425,-0.26745,1,0
5,GO T CELL APOPTOTIC PROCESS,0.00018427,-0.21431,-0.22277,1,0
5,GO GLYCEROL ETHER METABOLIC PROCESS,0.00084609,-0.21438,-0.23859,1,0
5,GO B CELL HOMEOSTASIS,0.00090094,-0.21448,-0.19344,1,0
5,GO RESPONSE TO CORTICOSTERONE,0.0049174,-0.21449,-0.24513,1,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,3.4421e-05,-0.21459,-0.24265,1,0
5,GO GLYCEROLIPID CATABOLIC PROCESS,0.00041602,-0.21467,-0.19153,1,0
5,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.014841,-0.21489,-0.216,1,0
5,GO FATTY ACID METABOLIC PROCESS,1.1267e-06,-0.21492,-0.22318,1,0
5,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.00030804,-0.21506,-0.19275,1,0
5,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0020453,-0.21509,-0.28228,1,0
5,GO CARNITINE METABOLIC PROCESS,0.04854,-0.21535,-0.13847,1,0
5,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.049546,-0.21541,-0.22302,1,0
5,GO REGULATION OF CELL SUBSTRATE ADHESION,0.00012512,-0.21544,-0.23839,1,0
5,GO IMPORT ACROSS PLASMA MEMBRANE,2.1663e-05,-0.21558,-0.19839,1,0
5,GO CELL SUBSTRATE ADHESION,6.2786e-05,-0.21561,-0.23475,1,0
5,GO RESPONSE TO MUSCLE ACTIVITY,0.0054795,-0.21574,-0.22156,1,0
5,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.0046564,-0.2159,-0.16758,1,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00067758,-0.21601,-0.20789,1,0
5,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,9.7346e-05,-0.21627,-0.21319,1,0
5,GO TRANSLATIONAL ELONGATION,7.8282e-05,-0.21635,-0.23847,1,0
5,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.00037661,-0.21637,-0.24273,1,0
5,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.00029782,-0.21667,-0.22838,1,0
5,GO ENTRY INTO HOST,0.00012964,-0.21668,-0.27588,1,0
5,GO POLYOL METABOLIC PROCESS,1.725e-07,-0.21669,-0.22407,1,0
5,GO MAINTENANCE OF LOCATION IN CELL,1.6729e-06,-0.21674,-0.20748,1,0
5,GO HISTONE SERINE PHOSPHORYLATION,0.00028792,-0.21675,-0.25826,1,0
5,GO SEQUESTERING OF TRIGLYCERIDE,0.0038387,-0.21696,-0.2902,1,0
5,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,2.3654e-06,-0.21697,-0.26117,1,0
5,GO SIGNAL PEPTIDE PROCESSING,0.027188,-0.217,-0.1814,1,0
5,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,1.8521e-05,-0.21708,-0.24269,1,0
5,GO CELLULAR HORMONE METABOLIC PROCESS,6.2786e-05,-0.21711,-0.24235,1,0
5,GO IRON SULFUR CLUSTER ASSEMBLY,0.00010092,-0.21724,-0.27613,1,0
5,GO FIBROBLAST PROLIFERATION,0.00050664,-0.21727,-0.24187,1,0
5,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.00028792,-0.21741,-0.21437,1,0
5,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,2.3418e-05,-0.21772,-0.23632,1,0
5,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.00025131,-0.21774,-0.22223,1,0
5,GO CARNITINE SHUTTLE,0.019283,-0.2178,-0.18486,1,0
5,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.0021062,-0.21791,-0.24265,1,0
5,GO B CELL APOPTOTIC PROCESS,0.0083534,-0.21826,-0.19242,1,0
5,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.017549,-0.21827,-0.24681,1,0
5,GO CELLULAR RESPONSE TO DRUG,5.9841e-06,-0.21827,-0.21165,1,0
5,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.0049174,-0.21832,-0.28891,1,0
5,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.00084609,-0.21832,-0.23304,1,0
5,GO GERMINAL CENTER FORMATION,0.0056288,-0.21833,-0.33386,1,0
5,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0011199,-0.21834,-0.22224,1,0
5,GO AMIDE BIOSYNTHETIC PROCESS,2.3654e-06,-0.21834,-0.20941,1,0
5,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,2.7343e-05,-0.21868,-0.20376,1,0
5,GO RECEPTOR MEDIATED ENDOCYTOSIS,7.8282e-05,-0.21872,-0.16624,1,0
5,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,2.2658e-06,-0.21884,-0.22182,1,0
5,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0057817,-0.21953,-0.21547,1,0
5,GO BLASTOCYST FORMATION,5.4121e-05,-0.21964,-0.21018,1,0
5,GO LYTIC VACUOLE ORGANIZATION,8.4205e-05,-0.2199,-0.21287,1,0
5,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00012074,-0.21998,-0.23612,1,0
5,GO T CELL MEDIATED IMMUNITY,5.6174e-05,-0.22003,-0.29917,1,0
5,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.00074557,-0.22016,-0.2341,1,0
5,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0021062,-0.2203,-0.20632,1,0
5,GO I KAPPAB KINASE NF KAPPAB SIGNALING,6.7596e-05,-0.22065,-0.21834,1,0
5,GO FOLIC ACID METABOLIC PROCESS,0.00036427,-0.22074,-0.22593,1,0
5,GO PHAGOCYTOSIS,2.0033e-05,-0.22093,-0.22511,1,0
5,GO REGULATION OF TRANSLATIONAL FIDELITY,0.00020448,-0.22104,-0.25875,1,0
5,GO FIBROBLAST APOPTOTIC PROCESS,0.0094949,-0.2211,-0.19857,1,0
5,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.00019753,-0.22121,-0.27747,1,0
5,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0041716,-0.22133,-0.23283,1,0
5,GO NEGATIVE CHEMOTAXIS,0.00037661,-0.22168,-0.27809,1,0
5,GO SULFUR COMPOUND METABOLIC PROCESS,1.2971e-07,-0.22176,-0.24402,1,0
5,GO ACTIN FILAMENT BASED MOVEMENT,2.9532e-05,-0.22179,-0.2199,1,0
5,GO MITOCHONDRIAL TRANSLATION,6.7596e-05,-0.22219,-0.25256,1,0
5,GO INTERMEDIATE FILAMENT BASED PROCESS,0.0032441,-0.22222,-0.20028,1,0
5,GO SYNCYTIUM FORMATION,0.00016595,-0.22227,-0.24865,1,0
5,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.0056288,-0.22229,-0.23253,1,0
5,GO REGULATION OF KERATINOCYTE MIGRATION,0.0028141,-0.2224,-0.19517,1,0
5,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,2.5308e-05,-0.22243,-0.29196,1,0
5,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00026003,-0.22267,-0.19426,1,0
5,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.0031536,-0.22271,-0.20713,1,0
5,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,3.4421e-05,-0.22301,-0.26136,1,0
5,GO DENDRITIC CELL DIFFERENTIATION,0.0023671,-0.22312,-0.27027,1,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.0026572,-0.22333,-0.21268,1,0
5,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.00029782,-0.22333,-0.28822,1,0
5,GO FUCOSYLATION,0.00012074,-0.22339,-0.27084,1,0
5,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,7.547e-05,-0.2234,-0.25655,1,0
5,GO MALE GENITALIA DEVELOPMENT,0.0028957,-0.22354,-0.21593,1,0
5,GO REGULATION OF COAGULATION,0.00044439,-0.2236,-0.28008,1,0
5,GO REGULATION OF WOUND HEALING,0.0013872,-0.22363,-0.22904,1,0
5,GO AMYLOID BETA METABOLIC PROCESS,0.00047456,-0.22366,-0.22261,1,0
5,GO AMINOGLYCAN METABOLIC PROCESS,0.00013433,-0.22384,-0.22036,1,0
5,GO FOAM CELL DIFFERENTIATION,0.001191,-0.22396,-0.23317,1,0
5,GO DE NOVO PROTEIN FOLDING,8.4205e-05,-0.22406,-0.21779,1,0
5,GO RNA 5 END PROCESSING,0.00044439,-0.2241,-0.22171,1,0
5,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.029719,-0.22417,-0.20182,1,0
5,GO PLASMA MEMBRANE ORGANIZATION,7.8282e-05,-0.22442,-0.21605,1,0
5,GO IRON ION TRANSMEMBRANE TRANSPORT,8.4205e-05,-0.22452,-0.24786,1,0
5,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.0017641,-0.22452,-0.25958,1,0
5,GO PROTEIN TARGETING TO MEMBRANE,0.00029782,-0.2248,-0.24352,1,0
5,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00010845,-0.22502,-0.26807,1,0
5,GO REGULATION OF ACROSOME REACTION,0.033894,-0.22534,-0.21853,1,0
5,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00054072,-0.2254,-0.22881,1,0
5,GO RESPONSE TO FLUID SHEAR STRESS,0.00049035,-0.22575,-0.25068,1,0
5,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.00023468,-0.22576,-0.24334,1,0
5,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00026003,-0.22576,-0.22665,1,0
5,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.00044439,-0.22581,-0.26578,1,0
5,GO POSITIVE REGULATION OF WOUND HEALING,0.010245,-0.22593,-0.19506,1,0
5,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.0007696,-0.22599,-0.23037,1,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.00090094,-0.22615,-0.20885,1,0
5,GO PEPTIDYL HISTIDINE MODIFICATION,0.00026903,-0.22627,-0.23963,1,0
5,GO REGULATION OF TRANSLATIONAL ELONGATION,0.00012512,-0.22633,-0.22861,1,0
5,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,5.6174e-05,-0.22656,-0.22113,1,0
5,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.0040578,-0.2269,-0.20248,1,0
5,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.02068,-0.22707,-0.30182,1,0
5,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,5.508e-06,-0.2272,-0.22504,1,0
5,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,1.5816e-05,-0.2273,-0.22048,1,0
5,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.00057693,-0.22758,-0.26055,1,0
5,GO VITAMIN CATABOLIC PROCESS,0.0081404,-0.22761,-0.25403,1,0
5,GO EXTRACELLULAR STRUCTURE ORGANIZATION,1.1493e-05,-0.22773,-0.27992,1,0
5,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.00063551,-0.2278,-0.2282,1,0
5,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.015203,-0.22782,-0.24237,1,0
5,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.0045306,-0.22787,-0.37198,1,0
5,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0020453,-0.22789,-0.20809,1,0
5,GO ETHER METABOLIC PROCESS,0.00024286,-0.22813,-0.27456,1,0
5,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.0062634,-0.22824,-0.2097,1,0
5,GO COLLAGEN CATABOLIC PROCESS,6.0504e-05,-0.22836,-0.29765,1,0
5,GO OPTIC NERVE DEVELOPMENT,0.052669,-0.22855,-0.18401,1,0
5,GO ACUTE INFLAMMATORY RESPONSE,3.1888e-05,-0.22859,-0.29056,1,0
5,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,3.5759e-05,-0.22891,-0.32001,1,0
5,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0034322,-0.22898,-0.24193,1,0
5,GO POSITIVE CHEMOTAXIS,3.5759e-05,-0.22902,-0.25042,1,0
5,GO PENTOSE METABOLIC PROCESS,0.00026003,-0.22937,-0.29728,1,0
5,GO REVERSE CHOLESTEROL TRANSPORT,0.0019282,-0.22943,-0.28763,1,0
5,GO SUPEROXIDE ANION GENERATION,0.020205,-0.22974,-0.22805,1,0
5,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.00020448,-0.22978,-0.3157,1,0
5,GO ELASTIC FIBER ASSEMBLY,0.013798,-0.22978,-0.3421,1,0
5,GO RESPONSE TO HYPEROXIA,0.001872,-0.22991,-0.28963,1,0
5,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.00044439,-0.23003,-0.29566,1,0
5,GO REGULATION OF FIBRINOLYSIS,2.0784e-06,-0.23011,-0.40254,1,0
5,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.00074557,-0.23034,-0.24852,1,0
5,GO GENITALIA MORPHOGENESIS,0.025414,-0.23037,-0.21898,1,0
5,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.0053338,-0.23043,-0.25467,1,0
5,GO POSITIVE REGULATION OF AUTOPHAGY,1.7118e-05,-0.23056,-0.20445,1,0
5,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.00017796,-0.2307,-0.26628,1,0
5,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.00010092,-0.23078,-0.25992,1,0
5,GO CELLULAR RESPONSE TO CADMIUM ION,0.02843,-0.23089,-0.25183,1,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,3.5759e-05,-0.23109,-0.23299,1,0
5,GO MODULATION BY HOST OF VIRAL PROCESS,1.6455e-05,-0.23111,-0.27478,1,0
5,GO LIPID STORAGE,0.00012074,-0.23157,-0.23628,1,0
5,GO CARBOHYDRATE DERIVATIVE TRANSPORT,1.5816e-05,-0.23176,-0.2369,1,0
5,GO REGULATION OF MICROVILLUS ORGANIZATION,0.0040578,-0.23193,-0.31812,1,0
5,GO BODY FLUID SECRETION,2.6902e-06,-0.23208,-0.2408,1,0
5,GO CELLULAR OXIDANT DETOXIFICATION,0.00011241,-0.23239,-0.20944,1,0
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,1.5331e-06,-0.2324,-0.23415,1,0
5,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.00025131,-0.23265,-0.28952,1,0
5,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.001986,-0.23268,-0.25225,1,0
5,GO CHEMOSENSORY BEHAVIOR,1.8521e-05,-0.23283,-0.26254,1,0
5,GO RESPONSE TO HYDROGEN PEROXIDE,2.4346e-05,-0.23286,-0.24242,1,0
5,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.00069957,-0.23319,-0.2523,1,0
5,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.0023671,-0.23329,-0.23253,1,0
5,GO SEMI LUNAR VALVE DEVELOPMENT,0.0012662,-0.2334,-0.30666,1,0
5,GO RESPONSE TO CORTICOSTEROID,4.1617e-05,-0.23363,-0.23813,1,0
5,GO MITOCHONDRIAL GENE EXPRESSION,6.0504e-05,-0.23373,-0.25433,1,0
5,GO MATURATION OF 5 8S RRNA,0.0022992,-0.23377,-0.23771,1,0
5,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.050569,-0.23379,-0.18707,1,0
5,GO ETHANOL METABOLIC PROCESS,0.021165,-0.23387,-0.20332,1,0
5,GO CAMP METABOLIC PROCESS,0.0017641,-0.23389,-0.23041,1,0
5,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0001547,-0.23409,-0.26753,1,0
5,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00036427,-0.23442,-0.24846,1,0
5,GO FIBRINOLYSIS,0.00021909,-0.23477,-0.36315,1,0
5,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.0020453,-0.23479,-0.34723,1,0
5,GO RRNA METABOLIC PROCESS,0.00059588,-0.23481,-0.22755,1,0
5,GO REGULATION OF CELL MATRIX ADHESION,0.00029782,-0.23518,-0.25367,1,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0033369,-0.23519,-0.30217,1,0
5,GO REGULATION OF STEROID METABOLIC PROCESS,1.4039e-05,-0.2352,-0.25665,1,0
5,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.00021167,-0.23522,-0.28716,1,0
5,GO RESPONSE TO REDOX STATE,0.00092958,-0.23552,-0.25469,1,0
5,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.0017641,-0.23619,-0.22364,1,0
5,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,3.4728e-06,-0.23655,-0.28255,1,0
5,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,9.4334e-07,-0.23657,-0.2566,1,0
5,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.00092958,-0.23665,-0.22523,1,0
5,GO CELLULAR LIPID CATABOLIC PROCESS,1.0779e-06,-0.23675,-0.23226,1,0
5,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,1.2862e-06,-0.23678,-0.26383,1,0
5,GO CARDIAC CELL DEVELOPMENT,7.547e-05,-0.23712,-0.20839,1,0
5,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.00057693,-0.23712,-0.27815,1,0
5,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,5.6174e-05,-0.23715,-0.28409,1,0
5,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,3.0689e-05,-0.2378,-0.22946,1,0
5,GO REGULATION OF STRIATED MUSCLE CONTRACTION,1.7118e-05,-0.23796,-0.24405,1,0
5,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0028957,-0.23809,-0.24385,1,0
5,GO PLATELET DEGRANULATION,7.013e-05,-0.23821,-0.28767,1,0
5,GO TROPHOBLAST CELL MIGRATION,0.0021062,-0.23861,-0.31665,1,0
5,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.0031536,-0.23894,-0.21774,1,0
5,GO RESPONSE TO PROTOZOAN,0.00047456,-0.23894,-0.23527,1,0
5,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.025414,-0.23917,-0.20621,1,0
5,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.016339,-0.23918,-0.26473,1,0
5,GO RIBOSOME BIOGENESIS,0.00084609,-0.23936,-0.23349,1,0
5,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.0032441,-0.23943,-0.21001,1,0
5,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.0071468,-0.23945,-0.19594,1,0
5,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,5.2139e-05,-0.23954,-0.26525,1,0
5,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,2.1663e-05,-0.2399,-0.30358,1,0
5,GO RESPONSE TO INTERLEUKIN 12,5.6174e-05,-0.23992,-0.26494,1,0
5,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,3.1888e-05,-0.24001,-0.29755,1,0
5,GO ENTRY OF BACTERIUM INTO HOST CELL,0.041967,-0.24045,-0.24876,1,0
5,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.0026572,-0.24051,-0.25865,1,0
5,GO CELLULAR HYPEROSMOTIC RESPONSE,0.015574,-0.24099,-0.24322,1,0
5,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,1.4039e-05,-0.24117,-0.30583,1,0
5,GO MAMMARY GLAND MORPHOGENESIS,0.010773,-0.24129,-0.21257,1,0
5,GO RESPONSE TO DIETARY EXCESS,0.029068,-0.24136,-0.20042,1,0
5,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00021167,-0.24147,-0.25291,1,0
5,GO RESPONSE TO XENOBIOTIC STIMULUS,1.8521e-05,-0.24175,-0.25171,1,0
5,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,6.5149e-05,-0.24186,-0.27085,1,0
5,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.017549,-0.24191,-0.17282,1,0
5,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.015953,-0.24201,-0.20418,1,0
5,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0010859,-0.24223,-0.32745,1,0
5,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,9.389e-05,-0.24239,-0.32371,1,0
5,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.0006154,-0.24249,-0.22374,1,0
5,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,3.7145e-05,-0.24268,-0.25387,1,0
5,GO DRUG METABOLIC PROCESS,2.3418e-05,-0.2428,-0.28338,1,0
5,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0064317,-0.24283,-0.20272,1,0
5,GO CHOLESTEROL STORAGE,0.0014299,-0.24291,-0.2325,1,0
5,GO SULFUR AMINO ACID METABOLIC PROCESS,4.8379e-05,-0.24303,-0.25524,1,0
5,GO ZINC ION TRANSPORT,0.00037661,-0.24309,-0.2062,1,0
5,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,1.2454e-05,-0.24341,-0.24974,1,0
5,GO PIGMENT BIOSYNTHETIC PROCESS,1.8521e-05,-0.24356,-0.25018,1,0
5,GO REGULATION OF VACUOLE ORGANIZATION,2.0833e-05,-0.24357,-0.23678,1,0
5,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.025994,-0.24396,-0.23759,1,0
5,GO SPHINGOMYELIN METABOLIC PROCESS,0.00016023,-0.24399,-0.29962,1,0
5,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.0030654,-0.24405,-0.23333,1,0
5,GO LYMPHOCYTE APOPTOTIC PROCESS,0.00011241,-0.24414,-0.21153,1,0
5,GO VIRAL TRANSLATION,0.0024367,-0.24416,-0.26498,1,0
5,GO LEUKOCYTE APOPTOTIC PROCESS,0.00041602,-0.24448,-0.20942,1,0
5,GO RECEPTOR CATABOLIC PROCESS,0.001872,-0.24477,-0.205,1,0
5,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.0049174,-0.24483,-0.20305,1,0
5,GO PEROXISOME ORGANIZATION,8.2505e-07,-0.24494,-0.26927,1,0
5,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.00042998,-0.24496,-0.29786,1,0
5,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.013465,-0.24603,-0.44557,1,0
5,GO TRNA 5 END PROCESSING,0.001662,-0.24611,-0.20014,1,0
5,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0039469,-0.24676,-0.27621,1,0
5,GO SKIN MORPHOGENESIS,0.019283,-0.24677,-0.32003,1,0
5,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.0038387,-0.24721,-0.33836,1,0
5,GO ANIMAL ORGAN REGENERATION,1.6455e-05,-0.24725,-0.27599,1,0
5,GO TETRAPYRROLE METABOLIC PROCESS,2.5774e-06,-0.24759,-0.28197,1,0
5,GO CELL JUNCTION DISASSEMBLY,0.00024286,-0.24771,-0.27193,1,0
5,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,6.7596e-05,-0.24772,-0.30221,1,0
5,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0001547,-0.24782,-0.24916,1,0
5,GO NCRNA CATABOLIC PROCESS,0.0015653,-0.24786,-0.18347,1,0
5,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.015953,-0.24787,-0.263,1,0
5,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.00067758,-0.2482,-0.33016,1,0
5,GO AMINOGLYCAN CATABOLIC PROCESS,0.00047456,-0.24871,-0.29573,1,0
5,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,3.7145e-05,-0.24924,-0.25717,1,0
5,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,1.2962e-05,-0.24938,-0.28857,1,0
5,GO OVULATION,0.0050528,-0.24945,-0.23651,1,0
5,GO PROGRAMMED NECROTIC CELL DEATH,0.00031859,-0.24959,-0.27747,1,0
5,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.00030804,-0.24964,-0.23129,1,0
5,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.00012512,-0.24975,-0.33623,1,0
5,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.00044439,-0.24983,-0.31049,1,0
5,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.017969,-0.24993,-0.21322,1,0
5,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,2.2658e-06,-0.25002,-0.27645,1,0
5,GO REGULATION OF PROTEIN GLYCOSYLATION,0.001872,-0.25007,-0.24956,1,0
5,GO REGULATION OF AMYLOID BETA CLEARANCE,0.0011549,-0.25009,-0.29991,1,0
5,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.00019079,-0.25055,-0.24319,1,0
5,GO LACTATION,8.7323e-05,-0.25071,-0.23694,1,0
5,GO CARBOHYDRATE PHOSPHORYLATION,0.0024367,-0.25077,-0.20321,1,0
5,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0071468,-0.25087,-0.25241,1,0
5,GO HYALURONAN CATABOLIC PROCESS,0.001191,-0.25098,-0.35875,1,0
5,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.00026003,-0.25103,-0.30715,1,0
5,GO FUCOSE METABOLIC PROCESS,0.0022992,-0.25151,-0.25644,1,0
5,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.029719,-0.25158,-0.26468,1,0
5,GO MYOBLAST FUSION,5.0226e-05,-0.25161,-0.29969,1,0
5,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.0011199,-0.25202,-0.27826,1,0
5,GO RESPONSE TO TYPE I INTERFERON,0.018836,-0.25216,-0.30489,1,0
5,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.0024367,-0.25219,-0.22568,1,0
5,GO EPIBOLY,0.0021689,-0.25225,-0.30818,1,0
5,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.00028792,-0.25256,-0.27638,1,0
5,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,8.628e-07,-0.2527,-0.2855,1,0
5,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,4.3218e-05,-0.25284,-0.25494,1,0
5,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,2.1702e-06,-0.25288,-0.26456,1,0
5,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.0024367,-0.25319,-0.24848,1,0
5,GO CYTOPLASMIC TRANSLATION,0.0010528,-0.25343,-0.30242,1,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.0012662,-0.25356,-0.32242,1,0
5,GO PULMONARY VALVE DEVELOPMENT,0.00057693,-0.2536,-0.40012,1,0
5,GO BONE TRABECULA FORMATION,0.014486,-0.25372,-0.40608,1,0
5,GO REGULATION OF RESPONSE TO TUMOR CELL,8.4205e-05,-0.25377,-0.28253,1,0
5,GO EMBRYO IMPLANTATION,0.0019282,-0.2539,-0.21994,1,0
5,GO EXOCRINE SYSTEM DEVELOPMENT,0.0015653,-0.25421,-0.2641,1,0
5,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.0081404,-0.25469,-0.27355,1,0
5,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,1.4609e-05,-0.25485,-0.23244,1,0
5,GO PROTEIN DEGLYCOSYLATION,0.0001165,-0.25487,-0.31339,1,0
5,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,5.0683e-06,-0.25492,-0.26899,1,0
5,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.00049035,-0.25532,-0.27569,1,0
5,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00012512,-0.2556,-0.28672,1,0
5,GO ENDODERM FORMATION,0.00021167,-0.25606,-0.32917,1,0
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.001662,-0.25667,-0.21087,1,0
5,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0079323,-0.25695,-0.25569,1,0
5,GO ACETYL COA BIOSYNTHETIC PROCESS,8.7323e-05,-0.25698,-0.29282,1,0
5,GO XENOBIOTIC TRANSPORT,2.7343e-05,-0.25766,-0.27124,1,0
5,GO NECROTIC CELL DEATH,7.8282e-05,-0.2578,-0.29659,1,0
5,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0060989,-0.25833,-0.27014,1,0
5,GO GLUTATHIONE METABOLIC PROCESS,8.6584e-06,-0.25852,-0.35117,1,0
5,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.00010845,-0.25879,-0.27722,1,0
5,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,1.1493e-05,-0.25893,-0.36565,1,0
5,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00098941,-0.25895,-0.277,1,0
5,GO RRNA PSEUDOURIDINE SYNTHESIS,0.00353,-0.25943,-0.28353,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.0014738,-0.25964,-0.2326,1,0
5,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.0010206,-0.25986,-0.25993,1,0
5,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.00010845,-0.25988,-0.28392,1,0
5,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,1.0184e-05,-0.25988,-0.31689,1,0
5,GO REGULATION OF MYOBLAST FUSION,0.00063551,-0.25992,-0.32256,1,0
5,GO PLASMA MEMBRANE FUSION,0.0034322,-0.26,-0.27144,1,0
5,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,2.0033e-05,-0.2602,-0.28945,1,0
5,GO MITOCHONDRIAL DEPOLARIZATION,0.001986,-0.26022,-0.24743,1,0
5,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.00050664,-0.26024,-0.23807,1,0
5,GO MICROVILLUS ASSEMBLY,0.0053338,-0.2604,-0.26284,1,0
5,GO GLOMERULUS DEVELOPMENT,0.00049035,-0.26061,-0.26725,1,0
5,GO REGULATION OF KIDNEY DEVELOPMENT,4.8379e-05,-0.26067,-0.25582,1,0
5,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.00050664,-0.26095,-0.2457,1,0
5,GO POSITIVE REGULATION OF PROTEIN BINDING,2.4346e-05,-0.261,-0.21188,1,0
5,GO CELLULAR ALDEHYDE METABOLIC PROCESS,5.0683e-06,-0.26162,-0.29852,1,0
5,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0037331,-0.26175,-0.27194,1,0
5,GO HEART TRABECULA FORMATION,0.0097392,-0.26176,-0.24827,1,0
5,GO BILE ACID AND BILE SALT TRANSPORT,0.0028957,-0.26187,-0.28244,1,0
5,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.00098941,-0.26196,-0.24108,1,0
5,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.00012512,-0.26207,-0.27425,1,0
5,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.023205,-0.26212,-0.27854,1,0
5,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.00010092,-0.26224,-0.27333,1,0
5,GO SKELETAL MUSCLE TISSUE REGENERATION,9.7801e-06,-0.26252,-0.32249,1,0
5,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.0075304,-0.2626,-0.29916,1,0
5,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.02268,-0.26265,-0.31091,1,0
5,GO MEMBRANE LIPID CATABOLIC PROCESS,2.0833e-05,-0.26277,-0.3222,1,0
5,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,2.0033e-05,-0.26287,-0.28814,1,0
5,GO RESPONSE TO PH,9.7346e-05,-0.26295,-0.25993,1,0
5,GO ACTIN FILAMENT SEVERING,0.0097392,-0.26303,-0.29128,1,0
5,GO REGULATION OF ANOIKIS,0.0049174,-0.26311,-0.28798,1,0
5,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.012508,-0.26331,-0.2334,1,0
5,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,1.7806e-05,-0.26354,-0.26621,1,0
5,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,1.4609e-05,-0.26384,-0.30874,1,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,3.8583e-05,-0.26384,-0.30415,1,0
5,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.014841,-0.2639,-0.26215,1,0
5,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0001547,-0.26392,-0.29835,1,0
5,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,1.3605e-07,-0.26393,-0.28673,1,0
5,GO CORTICOSTEROID HORMONE SECRETION,0.0025817,-0.26401,-0.27566,1,0
5,GO RESPONSE TO TESTOSTERONE,0.0011199,-0.26405,-0.21368,1,0
5,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,4.4712e-06,-0.26412,-0.25523,1,0
5,GO BLOOD COAGULATION INTRINSIC PATHWAY,2.1702e-06,-0.2646,-0.28904,1,0
5,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.0013054,-0.26494,-0.22218,1,0
5,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,1.6455e-05,-0.26506,-0.3108,1,0
5,GO RETINAL METABOLIC PROCESS,0.0097392,-0.26523,-0.32379,1,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00084609,-0.26527,-0.26855,1,0
5,GO KERATINOCYTE MIGRATION,0.00014935,-0.2654,-0.24559,1,0
5,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,5.0226e-05,-0.26542,-0.28096,1,0
5,GO ALDITOL METABOLIC PROCESS,1.7806e-05,-0.26579,-0.29325,1,0
5,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.00038934,-0.26581,-0.36621,1,0
5,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00025131,-0.26584,-0.36638,1,0
5,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,8.6584e-06,-0.26655,-0.26324,1,0
5,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0015189,-0.26664,-0.26247,1,0
5,GO SERTOLI CELL DIFFERENTIATION,0.0033369,-0.26675,-0.22324,1,0
5,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.0025083,-0.26684,-0.33417,1,0
5,GO AORTIC VALVE DEVELOPMENT,0.0010859,-0.26685,-0.31163,1,0
5,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.00037661,-0.26696,-0.25356,1,0
5,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,4.3218e-05,-0.26727,-0.25566,1,0
5,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,2.8418e-05,-0.2673,-0.28064,1,0
5,GO VIRAL GENE EXPRESSION,0.00052342,-0.26745,-0.27615,1,0
5,GO RESPONSE TO ACIDIC PH,0.00045924,-0.26773,-0.31502,1,0
5,GO NEUROBLAST DIVISION,0.00049035,-0.26822,-0.32184,1,0
5,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.0038387,-0.2684,-0.25791,1,0
5,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.0014299,-0.26849,-0.37761,1,0
5,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00063551,-0.26888,-0.2561,1,0
5,GO ENDOTHELIAL CELL MIGRATION,1.2962e-05,-0.26895,-0.27734,1,0
5,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.02166,-0.2694,-0.29089,1,0
5,GO REGULATION OF TOLERANCE INDUCTION,0.001986,-0.26976,-0.34748,1,0
5,GO ETHANOL OXIDATION,0.013465,-0.26986,-0.34143,1,0
5,GO SULFUR COMPOUND CATABOLIC PROCESS,5.753e-07,-0.26996,-0.30539,1,0
5,GO NEGATIVE REGULATION OF CHEMOTAXIS,8.1192e-05,-0.27015,-0.27725,1,0
5,GO RESPONSE TO MISFOLDED PROTEIN,3.4421e-05,-0.27043,-0.25966,1,0
5,GO NADP METABOLIC PROCESS,7.013e-05,-0.27059,-0.27439,1,0
5,GO APOPTOTIC CELL CLEARANCE,3.3132e-05,-0.27075,-0.32861,1,0
5,GO TRANSLATIONAL INITIATION,0.00025131,-0.27079,-0.31491,1,0
5,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0069616,-0.27274,-0.21536,1,0
5,GO TISSUE MIGRATION,1.4609e-05,-0.27285,-0.25868,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,1.5201e-05,-0.27304,-0.31261,1,0
5,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.024846,-0.27329,-0.34001,1,0
5,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.0028141,-0.27335,-0.37271,1,0
5,GO PEROXISOMAL TRANSPORT,9.0221e-07,-0.27336,-0.2873,1,0
5,GO TRABECULA FORMATION,0.0010859,-0.27337,-0.29288,1,0
5,GO POSITIVE REGULATION OF HAIR CYCLE,0.015574,-0.27371,-0.24992,1,0
5,GO REGULATION OF MONONUCLEAR CELL MIGRATION,1.6455e-05,-0.27371,-0.27811,1,0
5,GO TYPE 2 IMMUNE RESPONSE,9.0551e-05,-0.27391,-0.3252,1,0
5,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,1.0604e-05,-0.27397,-0.30654,1,0
5,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00065623,-0.27408,-0.27961,1,0
5,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,9.3916e-06,-0.27408,-0.29585,1,0
5,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.00035231,-0.27409,-0.33897,1,0
5,GO CELL REDOX HOMEOSTASIS,5.8301e-05,-0.27414,-0.26456,1,0
5,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,3.7145e-05,-0.27415,-0.36982,1,0
5,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.001872,-0.27421,-0.34463,1,0
5,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.0029794,-0.27436,-0.2397,1,0
5,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.0015653,-0.27459,-0.42138,1,0
5,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0001547,-0.27479,-0.30427,1,0
5,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,2.9532e-05,-0.27505,-0.30754,1,0
5,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,3.4421e-05,-0.27509,-0.28611,1,0
5,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.0087944,-0.27515,-0.28524,1,0
5,GO RETINOL METABOLIC PROCESS,0.00018427,-0.27521,-0.29929,1,0
5,GO OLIGOPEPTIDE TRANSPORT,0.0060989,-0.27535,-0.30209,1,0
5,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00017186,-0.27565,-0.29772,1,0
5,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.00021167,-0.2759,-0.2748,1,0
5,GO ARACHIDONIC ACID METABOLIC PROCESS,2.5774e-06,-0.27594,-0.31681,1,0
5,GO REGULATION OF AMYLOID BETA FORMATION,2.8418e-05,-0.27678,-0.31844,1,0
5,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,3.4421e-05,-0.27716,-0.297,1,0
5,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.0040578,-0.27722,-0.25049,1,0
5,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,5.2139e-05,-0.2776,-0.28893,1,0
5,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.00030804,-0.27767,-0.28796,1,0
5,GO COLLAGEN METABOLIC PROCESS,0.00029782,-0.27813,-0.29217,1,0
5,GO PODOSOME ASSEMBLY,0.0025083,-0.27831,-0.24545,1,0
5,GO PHOSPHOLIPID EFFLUX,0.00042998,-0.27868,-0.30918,1,0
5,GO ENDOTHELIAL CELL CHEMOTAXIS,0.0041716,-0.27924,-0.25336,1,0
5,GO MACROPHAGE CYTOKINE PRODUCTION,0.0018173,-0.27947,-0.29233,1,0
5,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.00353,-0.2804,-0.27517,1,0
5,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,8.6584e-06,-0.2809,-0.32655,1,0
5,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,4.4878e-05,-0.28106,-0.2889,1,0
5,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.0011549,-0.28112,-0.32882,1,0
5,GO MONOSACCHARIDE CATABOLIC PROCESS,1.906e-06,-0.28174,-0.30121,1,0
5,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0051916,-0.28209,-0.26935,1,0
5,GO GLUCOCORTICOID METABOLIC PROCESS,3.4421e-05,-0.28229,-0.30189,1,0
5,GO RADIAL GLIAL CELL DIFFERENTIATION,0.011047,-0.2824,-0.2699,1,0
5,GO RESPONSE TO GROWTH HORMONE,0.00025131,-0.28258,-0.27279,1,0
5,GO RESPONSE TO MANGANESE ION,3.4421e-05,-0.28273,-0.28746,1,0
5,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,9.0551e-05,-0.28282,-0.28381,1,0
5,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0066042,-0.28324,-0.36384,1,0
5,GO HEXOSE CATABOLIC PROCESS,3.4728e-06,-0.28341,-0.32552,1,0
5,GO THIOESTER BIOSYNTHETIC PROCESS,1.4039e-05,-0.28362,-0.27303,1,0
5,GO NEGATIVE REGULATION OF WOUND HEALING,0.00026003,-0.28369,-0.28721,1,0
5,GO SEQUESTERING OF CALCIUM ION,1.0311e-06,-0.2843,-0.26362,1,0
5,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.00092958,-0.28475,-0.33708,1,0
5,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,9.7346e-05,-0.28496,-0.28456,1,0
5,GO MACROPHAGE PROLIFERATION,0.0017641,-0.28528,-0.34734,1,0
5,GO NEUTROPHIL HOMEOSTASIS,0.0012662,-0.28529,-0.35566,1,0
5,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,4.6597e-05,-0.2855,-0.33935,1,0
5,GO PIGMENT METABOLIC PROCESS,5.0683e-06,-0.28559,-0.28181,1,0
5,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,2.3418e-05,-0.28586,-0.32119,1,0
5,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.0083534,-0.2861,-0.26639,1,0
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.012203,-0.28617,-0.29995,1,0
5,GO REGULATION OF BONE DEVELOPMENT,2.9532e-05,-0.2862,-0.25645,1,0
5,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.00069957,-0.28625,-0.26918,1,0
5,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.00065623,-0.28628,-0.30371,1,0
5,GO CHAPERONE MEDIATED PROTEIN FOLDING,1.4609e-05,-0.28632,-0.26392,1,0
5,GO MONONUCLEAR CELL MIGRATION,1.6015e-06,-0.2864,-0.30837,1,0
5,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.0051916,-0.28649,-0.23904,1,0
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.00014935,-0.28667,-0.29272,1,0
5,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00045924,-0.28712,-0.33762,1,0
5,GO REGULATION OF NECROTIC CELL DEATH,0.00038934,-0.28721,-0.31313,1,0
5,GO KERATAN SULFATE METABOLIC PROCESS,3.0576e-06,-0.28724,-0.339,1,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.00026903,-0.28773,-0.30594,1,0
5,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00025131,-0.28802,-0.33624,1,0
5,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.0010859,-0.28839,-0.31349,1,0
5,GO T HELPER 2 CELL DIFFERENTIATION,0.004408,-0.28891,-0.37511,1,0
5,GO POSITIVE REGULATION OF LIPID STORAGE,8.6584e-06,-0.28899,-0.34807,1,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,5.2139e-05,-0.28904,-0.3676,1,0
5,GO COPPER ION HOMEOSTASIS,0.00057693,-0.28931,-0.25362,1,0
5,GO RESPONSE TO INTERFERON GAMMA,2.0033e-05,-0.28941,-0.35633,1,0
5,GO DETECTION OF BIOTIC STIMULUS,7.547e-05,-0.28975,-0.33919,1,0
5,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,1.9263e-05,-0.29021,-0.30066,1,0
5,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,2.3418e-05,-0.29084,-0.28278,1,0
5,GO HISTAMINE SECRETION,0.020205,-0.29091,-0.2825,1,0
5,GO KETONE BIOSYNTHETIC PROCESS,9.7801e-06,-0.29097,-0.30446,1,0
5,GO CHRONIC INFLAMMATORY RESPONSE,0.00031859,-0.2914,-0.32259,1,0
5,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.00019079,-0.29143,-0.31966,1,0
5,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,7.6603e-06,-0.29171,-0.35041,1,0
5,GO RIBOSOME ASSEMBLY,0.00047456,-0.29219,-0.32062,1,0
5,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.015203,-0.29331,-0.22502,1,0
5,GO REGULATION OF EPITHELIAL CELL MIGRATION,2.1663e-05,-0.2943,-0.2639,1,0
5,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,2.8418e-05,-0.29443,-0.25899,1,0
5,GO PROTEIN OXIDATION,3.3132e-05,-0.29468,-0.3624,1,0
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,2.3418e-05,-0.295,-0.3369,1,0
5,GO RESPONSE TO GONADOTROPIN,3.7145e-05,-0.2955,-0.30582,1,0
5,GO ZYMOGEN INHIBITION,0.0027346,-0.29594,-0.30048,1,0
5,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.0020453,-0.29608,-0.23301,1,0
5,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00029782,-0.2962,-0.31878,1,0
5,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.0042883,-0.29678,-0.26322,1,0
5,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.00035231,-0.29688,-0.35679,1,0
5,GO NEGATIVE REGULATION OF COAGULATION,0.00012964,-0.2969,-0.35956,1,0
5,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,7.013e-05,-0.29703,-0.33167,1,0
5,GO REGULATION OF T CELL APOPTOTIC PROCESS,3.5759e-05,-0.29704,-0.30411,1,0
5,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,3.1888e-05,-0.29717,-0.36986,1,0
5,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,2.2524e-05,-0.29773,-0.28693,1,0
5,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.0059384,-0.29784,-0.28661,1,0
5,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00012074,-0.29805,-0.2945,1,0
5,GO KERATAN SULFATE CATABOLIC PROCESS,9.0179e-06,-0.29807,-0.36279,1,0
5,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.017549,-0.29845,-0.30294,1,0
5,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.023741,-0.29881,-0.20715,1,0
5,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0021062,-0.29923,-0.27128,1,0
5,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.00057693,-0.30011,-0.29226,1,0
5,GO SECRETION BY TISSUE,0.00044439,-0.30044,-0.2561,1,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.001872,-0.30076,-0.33346,1,0
5,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.00074557,-0.3008,-0.31727,1,0
5,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,2.0833e-05,-0.30104,-0.32786,1,0
5,GO LIPID IMPORT INTO CELL,6.5149e-05,-0.30114,-0.29172,1,0
5,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.0083534,-0.30137,-0.31766,1,0
5,GO NADPH REGENERATION,0.0013872,-0.30147,-0.25737,1,0
5,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.0087944,-0.30199,-0.27367,1,0
5,GO POSITIVE REGULATION OF HEART CONTRACTION,0.00047456,-0.30267,-0.25162,1,0
5,GO NEGATIVE REGULATION OF ANOIKIS,0.011612,-0.30268,-0.3168,1,0
5,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.00017186,-0.30299,-0.31538,1,0
5,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,1.1964e-05,-0.30335,-0.30568,1,0
5,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,4.8612e-06,-0.30355,-0.32016,1,0
5,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.00054072,-0.30404,-0.31514,1,0
5,GO CELLULAR COPPER ION HOMEOSTASIS,0.00087311,-0.30404,-0.26698,1,0
5,GO L SERINE METABOLIC PROCESS,0.037747,-0.30418,-0.21136,1,0
5,GO C21 STEROID HORMONE METABOLIC PROCESS,3.0689e-05,-0.30468,-0.38649,1,0
5,GO GLYCOSIDE METABOLIC PROCESS,0.025994,-0.30521,-0.30058,1,0
5,GO MICROVILLUS ORGANIZATION,0.00079435,-0.30566,-0.29587,1,0
5,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.00090094,-0.30602,-0.36406,1,0
5,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,6.5149e-05,-0.30604,-0.46113,1,0
5,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00031859,-0.30628,-0.40449,1,0
5,GO PHAGOCYTOSIS RECOGNITION,0.0022332,-0.30645,-0.29726,1,0
5,GO MATURATION OF LSU RRNA,0.0025083,-0.30713,-0.28148,1,0
5,GO HISTAMINE TRANSPORT,0.0075304,-0.30804,-0.30223,1,0
5,GO STEROID ESTERIFICATION,7.2754e-05,-0.30831,-0.39012,1,0
5,GO RESPONSE TO STEROL DEPLETION,0.00034072,-0.30836,-0.27667,1,0
5,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,3.5759e-05,-0.30959,-0.28463,1,0
5,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00016023,-0.30995,-0.30674,1,0
5,GO REGULATION OF MEMBRANE INVAGINATION,0.0059384,-0.31021,-0.25518,1,0
5,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,3.7145e-05,-0.3103,-0.32617,1,0
5,GO HORMONE BIOSYNTHETIC PROCESS,1.7474e-06,-0.31108,-0.30756,1,0
5,GO MATURATION OF SSU RRNA,0.00025131,-0.31186,-0.29467,1,0
5,GO CELL ADHESION MEDIATED BY INTEGRIN,7.0571e-06,-0.31187,-0.39144,1,0
5,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.0033369,-0.31197,-0.35524,1,0
5,GO SNARE COMPLEX ASSEMBLY,0.0014738,-0.31232,-0.24881,1,0
5,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.00020448,-0.31341,-0.2739,1,0
5,GO RESPONSE TO TUMOR CELL,7.0571e-06,-0.31395,-0.3722,1,0
5,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00047456,-0.31409,-0.38296,1,0
5,GO POLYOL TRANSPORT,0.00057693,-0.3143,-0.28455,1,0
5,GO RESPONSE TO MAGNESIUM ION,0.0010206,-0.31456,-0.33596,1,0
5,GO DETECTION OF OTHER ORGANISM,0.00092958,-0.31458,-0.32531,1,0
5,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,6.7728e-06,-0.31515,-0.34666,1,0
5,GO GLUCOSE CATABOLIC PROCESS,1.7806e-05,-0.31527,-0.34892,1,0
5,GO T CELL MEDIATED CYTOTOXICITY,0.00021167,-0.31557,-0.42035,1,0
5,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.00090094,-0.31564,-0.3626,1,0
5,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.001872,-0.31585,-0.27069,1,0
5,GO HOMOTYPIC CELL CELL ADHESION,0.0001547,-0.31638,-0.28191,1,0
5,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,3.9418e-06,-0.31744,-0.34289,1,0
5,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.0051916,-0.31761,-0.32437,1,0
5,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0030654,-0.31869,-0.28615,1,0
5,GO REGULATION OF MEMBRANE DEPOLARIZATION,3.6228e-06,-0.31917,-0.32183,1,0
5,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00016595,-0.31981,-0.36428,1,0
5,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.00034072,-0.32045,-0.35292,1,0
5,GO REGULATION OF CELLULAR EXTRAVASATION,8.7323e-05,-0.32076,-0.31136,1,0
5,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,3.4421e-05,-0.32085,-0.33647,1,0
5,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.00047456,-0.32104,-0.34583,1,0
5,GO PURINE CONTAINING COMPOUND SALVAGE,8.7323e-05,-0.32129,-0.34817,1,0
5,GO PROTEIN HYDROXYLATION,0.00010462,-0.32225,-0.38752,1,0
5,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.00052342,-0.32247,-0.3692,1,0
5,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.0011549,-0.32279,-0.3576,1,0
5,GO MATURE B CELL DIFFERENTIATION,7.8282e-05,-0.32317,-0.34957,1,0
5,GO ZYMOGEN ACTIVATION,4.6597e-05,-0.32364,-0.3918,1,0
5,GO VAGINA DEVELOPMENT,0.00095906,-0.32389,-0.28532,1,0
5,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.00079435,-0.32455,-0.34126,1,0
5,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.020205,-0.32486,-0.49122,1,0
5,GO MONOCYTE CHEMOTAXIS,2.8077e-06,-0.32504,-0.34345,1,0
5,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.00022676,-0.32772,-0.35241,1,0
5,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,6.0504e-05,-0.32775,-0.33233,1,0
5,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.00010462,-0.32816,-0.33318,1,0
5,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00092958,-0.32867,-0.3308,1,0
5,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00027832,-0.32927,-0.31597,1,0
5,GO PULMONARY VALVE MORPHOGENESIS,0.00022676,-0.33043,-0.50551,1,0
5,GO EXTRACELLULAR MATRIX DISASSEMBLY,3.1904e-06,-0.33074,-0.36195,1,0
5,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.0064317,-0.33172,-0.38398,1,0
5,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.0016129,-0.33198,-0.31279,1,0
5,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0013872,-0.33202,-0.34658,1,0
5,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0012662,-0.33215,-0.31467,1,0
5,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,2.4346e-05,-0.33271,-0.38305,1,0
5,GO MITOCHONDRIAL RNA METABOLIC PROCESS,4.3218e-05,-0.33298,-0.30123,1,0
5,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.0001165,-0.33418,-0.29301,1,0
5,GO GTP METABOLIC PROCESS,8.4205e-05,-0.33452,-0.32387,1,0
5,GO COLLAGEN BIOSYNTHETIC PROCESS,0.0014299,-0.33518,-0.35463,1,0
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0066042,-0.33542,-0.30196,1,0
5,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,4.6597e-05,-0.33582,-0.36965,1,0
5,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00041602,-0.33598,-0.34318,1,0
5,GO REGULATION OF COLLAGEN METABOLIC PROCESS,7.547e-05,-0.33598,-0.36311,1,0
5,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0034322,-0.33717,-0.30812,1,0
5,GO RESPONSE TO THYROID HORMONE,9.0551e-05,-0.33768,-0.32757,1,0
5,GO AMP METABOLIC PROCESS,1.7118e-05,-0.33777,-0.38675,1,0
5,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.0034322,-0.33783,-0.31266,1,0
5,GO POSITIVE REGULATION OF HEART RATE,0.00029782,-0.33801,-0.33513,1,0
5,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,2.4346e-05,-0.33848,-0.33442,1,0
5,GO RESPONSE TO CAFFEINE,2.6307e-05,-0.33882,-0.3212,1,0
5,GO SALIVARY GLAND DEVELOPMENT,0.00036427,-0.33917,-0.31957,1,0
5,GO NAD METABOLIC PROCESS,4.8612e-06,-0.3395,-0.36342,1,0
5,GO THYMOCYTE APOPTOTIC PROCESS,0.00045924,-0.33989,-0.31171,1,0
5,GO BLEB ASSEMBLY,0.00074557,-0.34015,-0.57866,1,0
5,GO RESPONSE TO COPPER ION,0.00026003,-0.34102,-0.39116,1,0
5,GO REGULATION OF PODOSOME ASSEMBLY,0.0066042,-0.34224,-0.2645,1,0
5,GO CELLULAR METABOLIC COMPOUND SALVAGE,1.5201e-05,-0.34328,-0.3045,1,0
5,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.0021062,-0.34434,-0.28272,1,0
5,GO REGULATION OF THE FORCE OF HEART CONTRACTION,8.1192e-05,-0.34449,-0.32041,1,0
5,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0013457,-0.34455,-0.30901,1,0
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,4.8612e-06,-0.34513,-0.33818,1,0
5,GO CELLULAR RESPONSE TO INTERFERON BETA,0.00057693,-0.34551,-0.34614,1,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00035231,-0.34624,-0.40177,1,0
5,GO CERAMIDE CATABOLIC PROCESS,1.9263e-05,-0.34629,-0.4011,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.00090094,-0.34651,-0.38172,1,0
5,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.00011241,-0.3469,-0.3965,1,0
5,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,3.5759e-05,-0.34724,-0.38788,1,0
5,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,4.4712e-06,-0.34749,-0.37833,1,0
5,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.00063551,-0.34752,-0.30051,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.00087311,-0.34774,-0.35575,1,0
5,GO NOTOCHORD DEVELOPMENT,0.0026572,-0.34893,-0.31171,1,0
5,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00035231,-0.34981,-0.34919,1,0
5,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,5.2837e-06,-0.35144,-0.30487,1,0
5,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.018398,-0.35169,-0.33651,1,0
5,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,9.0179e-06,-0.35211,-0.40274,1,0
5,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00092958,-0.35327,-0.33045,1,0
5,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00098941,-0.35375,-0.36075,1,0
5,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,9.0179e-06,-0.35566,-0.32263,1,0
5,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00014418,-0.35577,-0.35298,1,0
5,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.0030654,-0.35609,-0.30272,1,0
5,GO VASODILATION,1.5816e-05,-0.35633,-0.36543,1,0
5,GO GLYCOPROTEIN CATABOLIC PROCESS,1.6455e-05,-0.35742,-0.51097,1,0
5,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,2.0033e-05,-0.35761,-0.34668,1,0
5,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.0026572,-0.35872,-0.29469,1,0
5,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.00032948,-0.35915,-0.30545,1,0
5,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.007729,-0.35932,-0.27617,1,0
5,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,0.001662,-0.35936,-0.4101,1,0
5,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.00022676,-0.36046,-0.40222,1,0
5,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.0047853,-0.36102,-0.31215,1,0
5,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.00026003,-0.36102,-0.37393,1,0
5,GO DENDRITIC CELL APOPTOTIC PROCESS,3.4421e-05,-0.36144,-0.41126,1,0
5,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.00095906,-0.36181,-0.4211,1,0
5,GO INFLAMMATORY RESPONSE TO WOUNDING,0.016339,-0.3625,-0.34819,1,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.0013872,-0.36259,-0.38583,1,0
5,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,5.4121e-05,-0.36279,-0.38406,1,0
5,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,1.4609e-05,-0.3634,-0.30793,1,0
5,GO FATTY ACID HOMEOSTASIS,6.5149e-05,-0.36386,-0.35872,1,0
5,GO RESPONSE TO INTERFERON BETA,0.0023671,-0.36555,-0.4404,1,0
5,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0028141,-0.3667,-0.36952,1,0
5,GO EPOXYGENASE P450 PATHWAY,0.00012964,-0.36741,-0.35602,1,0
5,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.031059,-0.36775,-0.23254,1,0
5,GO CYSTEINE METABOLIC PROCESS,0.00012964,-0.36804,-0.45755,1,0
5,GO NEGATIVE REGULATION OF TISSUE REMODELING,4.6623e-06,-0.36837,-0.4215,1,0
5,GO ADHESION OF SYMBIONT TO HOST,0.00014935,-0.36876,-0.38339,1,0
5,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.00090094,-0.369,-0.37655,1,0
5,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.00050664,-0.36926,-0.35358,1,0
5,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,7.013e-05,-0.36939,-0.47523,1,0
5,GO NEURON REMODELING,0.0001547,-0.36951,-0.37866,1,0
5,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,5.0683e-06,-0.37081,-0.45652,1,0
5,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0021062,-0.37109,-0.36418,1,0
5,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,4.0073e-05,-0.37172,-0.373,1,0
5,GO NEGATIVE REGULATION OF BONE REMODELING,3.4421e-05,-0.37177,-0.39336,1,0
5,GO HEME METABOLIC PROCESS,5.7413e-06,-0.37226,-0.40896,1,0
5,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.0015189,-0.37232,-0.33474,1,0
5,GO MONOACYLGLYCEROL METABOLIC PROCESS,1.7806e-05,-0.37275,-0.41966,1,0
5,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,7.2754e-05,-0.37309,-0.39339,1,0
5,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.00022676,-0.37376,-0.39162,1,0
5,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,2.5308e-05,-0.3741,-0.37881,1,0
5,GO STEROL IMPORT,5.6174e-05,-0.37426,-0.34854,1,0
5,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,2.0033e-05,-0.37478,-0.41974,1,0
5,GO GAS TRANSPORT,0.0010528,-0.37506,-0.36395,1,0
5,GO REGULATION OF HORMONE METABOLIC PROCESS,4.4712e-06,-0.37836,-0.42581,1,0
5,GO EOSINOPHIL MIGRATION,7.547e-05,-0.37848,-0.42583,1,0
5,GO BASEMENT MEMBRANE ORGANIZATION,3.4421e-05,-0.37894,-0.41456,1,0
5,GO MEMBRANE RAFT ORGANIZATION,0.00025131,-0.37924,-0.45552,1,0
5,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.0011549,-0.38216,-0.43859,1,0
5,GO FRUCTOSE METABOLIC PROCESS,0.0042883,-0.38455,-0.37512,1,0
5,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,7.547e-05,-0.38526,-0.45665,1,0
5,GO PLASMINOGEN ACTIVATION,2.4692e-06,-0.387,-0.45645,1,0
5,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.00079435,-0.38859,-0.42662,1,0
5,GO POSITIVE REGULATION OF VASCULOGENESIS,0.00029782,-0.38876,-0.43928,1,0
5,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0012662,-0.38933,-0.408,1,0
5,GO HEMIDESMOSOME ASSEMBLY,0.00069957,-0.39013,-0.51421,1,0
5,GO MITOCHONDRIAL TRANSCRIPTION,2.8077e-06,-0.39117,-0.39856,1,0
5,GO INTERLEUKIN 5 PRODUCTION,5.2139e-05,-0.3915,-0.38461,1,0
5,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.00011241,-0.39241,-0.36615,1,0
5,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.0006154,-0.39274,-0.38299,1,0
5,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.00047456,-0.39437,-0.37209,1,0
5,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00027832,-0.395,-0.38141,1,0
5,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,2.0033e-05,-0.39772,-0.38255,1,0
5,GO RESPONSE TO INTERLEUKIN 18,0.0036303,-0.3978,-0.41759,1,0
5,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,8.628e-07,-0.3984,-0.38935,1,0
5,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,1.7118e-05,-0.40016,-0.39576,1,0
5,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.0006154,-0.40209,-0.35899,1,0
5,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.00074557,-0.40361,-0.30993,1,0
5,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.0050528,-0.40374,-0.27655,1,0
5,GO IMP METABOLIC PROCESS,0.0012662,-0.40428,-0.33221,1,0
5,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.0059384,-0.4047,-0.28671,1,0
5,GO TRNA CATABOLIC PROCESS,0.044685,-0.40505,-0.23104,1,0
5,GO L ASCORBIC ACID METABOLIC PROCESS,0.00028792,-0.4058,-0.40161,1,0
5,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,1.7118e-05,-0.41254,-0.38943,1,0
5,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.0017641,-0.41266,-0.32194,1,0
5,GO GLYCOLIPID CATABOLIC PROCESS,1.2454e-05,-0.41282,-0.45322,1,0
5,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00025131,-0.4129,-0.43875,1,0
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,4.6623e-06,-0.41397,-0.44008,1,0
5,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.0017123,-0.41491,-0.40152,1,0
5,GO GLYCINE TRANSPORT,0.00038934,-0.41694,-0.40567,1,0
5,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.00057693,-0.41707,-0.38125,1,0
5,GO TOLERANCE INDUCTION,4.4878e-05,-0.4171,-0.51207,1,0
5,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,9.7801e-06,-0.41809,-0.50923,1,0
5,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,3.5759e-05,-0.41886,-0.3424,1,0
5,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.0001165,-0.41989,-0.40574,1,0
5,GO EOSINOPHIL CHEMOTAXIS,0.0001547,-0.42169,-0.45413,1,0
5,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,9.0179e-06,-0.42274,-0.44373,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.0021689,-0.42438,-0.50379,1,0
5,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.0007696,-0.42499,-0.49894,1,0
5,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,3.1888e-05,-0.42558,-0.47761,1,0
5,GO IMMUNE RESPONSE TO TUMOR CELL,4.8612e-06,-0.42667,-0.47047,1,0
5,GO L PHENYLALANINE METABOLIC PROCESS,2.7343e-05,-0.42668,-0.40132,1,0
5,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.001872,-0.42755,-0.32151,1,0
5,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00012074,-0.42951,-0.34918,1,0
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,8.6584e-06,-0.43053,-0.49959,1,0
5,GO BIOLOGICAL PHASE,0.0014738,-0.4318,-0.43736,1,0
5,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,8.1192e-05,-0.43296,-0.61941,1,0
5,GO MUSCLE CELL CELLULAR HOMEOSTASIS,4.5813e-07,-0.43406,-0.48815,1,0
5,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.00018427,-0.43467,-0.41343,1,0
5,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,4.1112e-06,-0.43856,-0.51814,1,0
5,GO INTERLEUKIN 13 PRODUCTION,5.2139e-05,-0.43931,-0.38042,1,0
5,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.0001165,-0.44032,-0.44324,1,0
5,GO POSITIVE REGULATION OF ACTION POTENTIAL,1.6455e-05,-0.44124,-0.43499,1,0
5,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00049035,-0.44325,-0.43538,1,0
5,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,1.7806e-05,-0.44338,-0.53106,1,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00044439,-0.44562,-0.52313,1,0
5,GO REGULATION OF METANEPHROS DEVELOPMENT,8.3127e-06,-0.44689,-0.5346,1,0
5,GO ACTIN FILAMENT NETWORK FORMATION,0.0001547,-0.45243,-0.42331,1,0
5,GO NEGATIVE REGULATION OF CELL KILLING,0.00021167,-0.45409,-0.51054,1,0
5,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,3.6228e-06,-0.45794,-0.46378,1,0
5,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,4.8612e-06,-0.46281,-0.48572,1,0
5,GO CHAPERONE MEDIATED AUTOPHAGY,1.2962e-05,-0.46548,-0.52901,1,0
5,GO MONONUCLEAR CELL DIFFERENTIATION,3.0264e-07,-0.46939,-0.48692,1,0
5,GO GALACTOSE METABOLIC PROCESS,2.0033e-05,-0.47797,-0.46729,1,0
5,GO ALDEHYDE BIOSYNTHETIC PROCESS,1.0779e-06,-0.4787,-0.53485,1,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,1.7806e-05,-0.4807,-0.49394,1,0
5,GO CYCLOOXYGENASE PATHWAY,2.8077e-06,-0.48337,-0.61458,1,0
5,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0013872,-0.48603,-0.49143,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,2.3654e-06,-0.48787,-0.44849,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.007729,-0.48978,-0.61582,1,0
5,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,3.1888e-05,-0.49518,-0.53452,1,0
5,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00026903,-0.49775,-0.59213,1,0
5,GO XENOBIOTIC CATABOLIC PROCESS,0.0015189,-0.49785,-0.48485,1,0
5,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,7.9801e-06,-0.49791,-0.56322,1,0
5,GO PEPTIDYL PROLINE HYDROXYLATION,0.00014418,-0.49813,-0.4636,1,0
5,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.00014935,-0.50509,-0.41143,1,0
5,GO REGULATION OF GLOMERULUS DEVELOPMENT,8.1192e-05,-0.51717,-0.50251,1,0
5,GO REGULATION OF VASCULOGENESIS,0.0017123,-0.5175,-0.42793,1,0
5,GO OXYGEN TRANSPORT,0.0025817,-0.52104,-0.4527,1,0
5,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,0.00072223,-0.52213,-0.4459,1,0
5,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,6.2367e-06,-0.52902,-0.48112,1,0
5,GO REGULATION OF PLASMINOGEN ACTIVATION,3.7791e-06,-0.53743,-0.6377,1,0
5,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,5.2139e-05,-0.54096,-0.50493,1,0
5,GO MUCUS SECRETION,0.001662,-0.54961,-0.51736,1,0
5,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,9.7346e-05,-0.55077,-0.52975,1,0
5,GO RESPONSE TO EPINEPHRINE,0.00045924,-0.55953,-0.45211,1,0
5,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.0001165,-0.56395,-0.59615,1,0
5,GO OLIGOSACCHARIDE CATABOLIC PROCESS,2.5774e-06,-0.57026,-0.55587,1,0
5,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.0007696,-0.57773,-0.42223,1,0
5,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,3.4728e-06,-0.57845,-0.48128,1,0
5,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,1.4609e-05,-0.65131,-0.6615,1,0
5,GO MEMBRANE RAFT ASSEMBLY,0.00034072,-0.66245,-0.69588,1,0
5,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,5.7413e-06,-0.67697,-0.61919,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.0059384,-0.70253,-0.79131,1,0
5,GO RESPONSE TO FORSKOLIN,0.12049,0.28264,0.16844,0,1
5,GO GDP METABOLIC PROCESS,0.11039,0.20235,0.14242,0,1
5,GO THYROID GLAND DEVELOPMENT,0.34702,0.17619,0.063111,0,1
5,GO MITOTIC DNA REPLICATION CHECKPOINT,0.0695,0.16388,0.10044,0,1
5,GO REGULATION OF RECEPTOR CLUSTERING,0.46512,0.15638,0.090594,0,1
5,GO TONGUE DEVELOPMENT,0.42347,0.13693,0.041071,0,1
5,GO PROTEIN DEMETHYLATION,0.054842,0.13459,0.09604,0,1
5,GO DNA DEMETHYLATION,0.053746,0.12979,0.096663,0,1
5,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.42855,0.12377,0.060018,0,1
5,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.070855,0.1204,0.094494,0,1
5,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.16294,0.11843,0.077888,0,1
5,GO RESPONSE TO FOOD,0.12259,0.11771,0.068088,0,1
5,GO HISTONE H3 K9 ACETYLATION,0.073629,0.11545,0.07204,0,1
5,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.084046,0.11232,0.114,0,1
5,GO CENTRIOLE CENTRIOLE COHESION,0.070855,0.11126,0.11461,0,1
5,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.14048,0.10952,0.049704,0,1
5,GO DNA REPLICATION CHECKPOINT,0.11636,0.10768,0.083792,0,1
5,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.054842,0.099741,0.10317,0,1
5,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.14526,0.099623,0.11894,0,1
5,GO MITOTIC DNA REPLICATION,0.22568,0.095759,0.068184,0,1
5,GO POSITIVE T CELL SELECTION,0.082489,0.093465,0.067208,0,1
5,GO DNA REPLICATION INITIATION,0.10096,0.091722,0.070534,0,1
5,GO T CELL SELECTION,0.080955,0.088852,0.066285,0,1
5,GO DNA DOUBLE STRAND BREAK PROCESSING,0.17099,0.087602,0.062577,0,1
5,GO REGULATION OF HELICASE ACTIVITY,0.17374,0.084145,0.10837,0,1
5,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.27227,0.082387,0.043179,0,1
5,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.12908,0.080005,0.060314,0,1
5,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.12908,0.078513,0.057524,0,1
5,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.27999,0.07116,0.055528,0,1
5,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.32077,0.070344,0.071136,0,1
5,GO MRNA EXPORT FROM NUCLEUS,0.14285,0.070127,0.048599,0,1
5,GO MICROTUBULE ANCHORING AT CENTROSOME,0.10465,0.066607,0.10143,0,1
5,GO DNA DEPENDENT DNA REPLICATION,0.2,0.065954,0.044791,0,1
5,GO MICROTUBULE NUCLEATION,0.67776,0.065722,0.0082311,0,1
5,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.19393,0.061228,0.062416,0,1
5,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.17099,0.058996,0.081338,0,1
5,GO SPINDLE ORGANIZATION,0.16032,0.058772,0.028984,0,1
5,GO UV DAMAGE EXCISION REPAIR,0.57857,0.055616,0.021402,0,1
5,GO PROTEIN MONOUBIQUITINATION,0.090515,0.055036,0.037937,0,1
5,GO REGULATION OF CIRCADIAN RHYTHM,0.088862,0.05493,0.046645,0,1
5,GO POSITIVE REGULATION OF MRNA PROCESSING,0.38408,0.054414,0.036222,0,1
5,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.72969,0.051473,0.022748,0,1
5,GO VENTRICULAR SYSTEM DEVELOPMENT,0.44402,0.05109,0.034732,0,1
5,GO SPLEEN DEVELOPMENT,0.83713,0.049499,0.0092873,0,1
5,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.11636,0.04586,0.069748,0,1
5,GO PROTEIN ACYLATION,0.064293,0.04313,0.039342,0,1
5,GO REGULATION OF SPINDLE ASSEMBLY,0.43367,0.041741,0.036698,0,1
5,GO DOUBLE STRAND BREAK REPAIR,0.17934,0.037909,0.030994,0,1
5,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.22905,0.036987,0.045786,0,1
5,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.8303,0.035347,0.0075086,0,1
5,GO DNA REPLICATION,0.24643,0.032593,0.028663,0,1
5,GO TRIGEMINAL NERVE DEVELOPMENT,0.001191,0.54552,0.40782,0,0
5,GO CARDIOBLAST PROLIFERATION,0.0013054,0.50011,0.48581,0,0
5,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.0071468,0.47662,0.35148,0,0
5,GO NEURON FATE SPECIFICATION,0.00065623,0.44934,0.45148,0,0
5,GO NEURON FATE COMMITMENT,5.0226e-05,0.37594,0.40696,0,0
5,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.00021167,0.36995,0.49417,0,0
5,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.033894,0.36834,0.26404,0,0
5,GO GANGLION DEVELOPMENT,0.0069616,0.35613,0.35143,0,0
5,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.007729,0.35612,0.45648,0,0
5,GO ATRIAL SEPTUM MORPHOGENESIS,0.0064317,0.35169,0.29661,0,0
5,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0011199,0.34553,0.33017,0,0
5,GO CARDIAC CELL FATE COMMITMENT,0.0021062,0.33536,0.38518,0,0
5,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0021689,0.32398,0.41485,0,0
5,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.0037331,0.31537,0.32085,0,0
5,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.0033369,0.29852,0.31807,0,0
5,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.1313,0.2966,0.19018,0,0
5,GO SPINAL CORD PATTERNING,0.00084609,0.27147,0.3498,0,0
5,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.00014935,0.26719,0.36733,0,0
5,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.00027832,0.26176,0.40976,0,0
5,GO DENDRITE SELF AVOIDANCE,0.013139,0.25662,0.19146,0,0
5,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.0056288,0.25445,0.21479,0,0
5,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.025414,0.25208,0.28074,0,0
5,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.092194,0.2497,0.20522,0,0
5,GO ECTODERMAL PLACODE DEVELOPMENT,0.027803,0.24788,0.24972,0,0
5,GO CELL DIFFERENTIATION IN SPINAL CORD,6.2786e-05,0.247,0.24228,0,0
5,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.00057693,0.24166,0.23197,0,0
5,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0056288,0.23116,0.21496,0,0
5,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.085627,0.22924,0.23311,0,0
5,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.017969,0.21531,0.20878,0,0
5,GO LATERAL MESODERM DEVELOPMENT,0.18508,0.21285,0.078038,0,0
5,GO CELL FATE SPECIFICATION,0.0036303,0.21076,0.17565,0,0
5,GO VOCALIZATION BEHAVIOR,0.25363,0.20997,0.17722,0,0
5,GO EMBRYONIC BRAIN DEVELOPMENT,0.068167,0.20121,0.11899,0,0
5,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.0695,0.20055,0.1732,0,0
5,GO MICROTUBULE DEPOLYMERIZATION,0.040234,0.19877,0.15054,0,0
5,GO PARENTAL BEHAVIOR,0.03939,0.19777,0.28395,0,0
5,GO SYNAPTIC VESICLE CLUSTERING,0.050569,0.19594,0.32317,0,0
5,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.56666,0.19302,0.057978,0,0
5,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.041967,0.19146,0.24323,0,0
5,GO CARDIAC CHAMBER FORMATION,0.059411,0.19076,0.27078,0,0
5,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.46512,0.18846,0.031844,0,0
5,GO VENTRAL SPINAL CORD DEVELOPMENT,0.010245,0.18748,0.16349,0,0
5,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.088862,0.18652,0.19348,0,0
5,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.41842,0.18447,0.098049,0,0
5,GO SINGLE STRAND BREAK REPAIR,0.011326,0.18404,0.14482,0,0
5,GO REGULATION OF GROWTH HORMONE SECRETION,0.023741,0.18392,0.27568,0,0
5,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.02166,0.18221,0.20367,0,0
5,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.097379,0.18145,0.2857,0,0
5,GO POSITIVE REGULATION OF BEHAVIOR,0.1028,0.18125,0.13085,0,0
5,GO COMMISSURAL NEURON AXON GUIDANCE,0.064293,0.1811,0.19304,0,0
5,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.25363,0.17453,0.083571,0,0
5,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.084046,0.17207,0.17698,0,0
5,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.00049035,0.16926,0.16482,0,0
5,GO ADENOHYPOPHYSIS DEVELOPMENT,0.59059,0.16916,0.060973,0,0
5,GO HISTONE H2A MONOUBIQUITINATION,9.389e-05,0.16798,0.2078,0,0
5,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.15264,0.16686,0.10471,0,0
5,GO FOREBRAIN MORPHOGENESIS,0.39858,0.16646,0.053931,0,0
5,GO PENILE ERECTION,0.10845,0.16614,0.16999,0,0
5,GO SECONDARY HEART FIELD SPECIFICATION,0.14769,0.16432,0.16444,0,0
5,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.02268,0.16333,0.19067,0,0
5,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.12689,0.15827,0.15241,0,0
5,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.029068,0.15604,0.20768,0,0
5,GO FORELIMB MORPHOGENESIS,0.016339,0.15555,0.16974,0,0
5,GO RETINAL ROD CELL DIFFERENTIATION,0.025994,0.15547,0.23136,0,0
5,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.054842,0.15282,0.13392,0,0
5,GO LIMB BUD FORMATION,0.12473,0.15271,0.13979,0,0
5,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.40843,0.15244,0.076042,0,0
5,GO FOREBRAIN NEURON DIFFERENTIATION,0.17374,0.15235,0.15013,0,0
5,GO ESCRT COMPLEX DISASSEMBLY,0.066855,0.15078,0.1147,0,0
5,GO GAMMA DELTA T CELL DIFFERENTIATION,0.15015,0.1507,0.23919,0,0
5,GO SPINAL CORD DEVELOPMENT,0.0049174,0.15034,0.13978,0,0
5,GO CELL PROLIFERATION IN HINDBRAIN,0.38888,0.15031,0.072876,0,0
5,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.19095,0.14998,0.13833,0,0
5,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.073629,0.14967,0.16937,0,0
5,GO GENETIC IMPRINTING,0.0064317,0.14937,0.17501,0,0
5,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.12908,0.14793,0.15788,0,0
5,GO CELL MIGRATION IN HINDBRAIN,0.21579,0.14724,0.1004,0,0
5,GO V D J RECOMBINATION,0.019739,0.14637,0.19057,0,0
5,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.20937,0.14586,0.11061,0,0
5,GO REGULATION OF TRANSPOSITION,0.48678,0.14137,0.03879,0,0
5,GO MIDDLE EAR MORPHOGENESIS,0.50896,0.14103,0.011346,0,0
5,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.52025,0.14028,0.10259,0,0
5,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.27227,0.13913,0.17297,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.038561,0.13882,0.16536,0,0
5,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.0094949,0.13846,0.24372,0,0
5,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.11636,0.13827,0.11215,0,0
5,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.030383,0.1382,0.13265,0,0
5,GO EMBRYONIC HEMOPOIESIS,0.15264,0.13588,0.10582,0,0
5,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.10465,0.13473,0.13795,0,0
5,GO REGULATION OF CILIUM ASSEMBLY,0.0025083,0.13463,0.12352,0,0
5,GO CEREBELLAR CORTEX MORPHOGENESIS,0.033894,0.13371,0.13115,0,0
5,GO CENTROMERE COMPLEX ASSEMBLY,0.0022992,0.13267,0.17334,0,0
5,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.24288,0.13213,0.089247,0,0
5,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.025994,0.13198,0.11092,0,0
5,GO TRANSPOSITION,0.35607,0.13139,0.072486,0,0
5,GO REGULATION OF STEM CELL DIVISION,0.092194,0.131,0.11728,0,0
5,GO NATURAL KILLER CELL PROLIFERATION,0.16032,0.13056,0.099839,0,0
5,GO CARDIAC ATRIUM MORPHOGENESIS,0.068167,0.12984,0.12284,0,0
5,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.12908,0.12846,0.079727,0,0
5,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.16559,0.12828,0.12399,0,0
5,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.10465,0.12768,0.14908,0,0
5,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.017549,0.12766,0.10716,0,0
5,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.0097392,0.12632,0.22087,0,0
5,GO NON MOTILE CILIUM ASSEMBLY,0.0071468,0.12574,0.14765,0,0
5,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.23589,0.12559,0.11609,0,0
5,GO LONG TERM SYNAPTIC DEPRESSION,0.093897,0.12415,0.12736,0,0
5,GO NEPHRON TUBULE FORMATION,0.39371,0.12348,0.076601,0,0
5,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.22905,0.12322,0.058183,0,0
5,GO DNA DEAMINATION,0.48678,0.12293,0.029735,0,0
5,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.26847,0.12284,0.054631,0,0
5,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.61497,0.12256,0.034219,0,0
5,GO HISTONE H3 K9 MODIFICATION,0.0013872,0.12246,0.13143,0,0
5,GO MALE SEX DETERMINATION,0.16294,0.12234,0.13612,0,0
5,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.15015,0.12045,0.091862,0,0
5,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.16559,0.12032,0.10239,0,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.21256,0.11988,0.081417,0,0
5,GO SEGMENT SPECIFICATION,0.18219,0.11849,0.14272,0,0
5,GO NEURON PROJECTION ARBORIZATION,0.15773,0.11809,0.11516,0,0
5,GO KERATINOCYTE DEVELOPMENT,0.32077,0.11798,0.12193,0,0
5,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.036948,0.11706,0.10566,0,0
5,GO CELL FATE DETERMINATION,0.36526,0.11583,0.058087,0,0
5,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.24288,0.11553,0.10414,0,0
5,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.20309,0.11534,0.11814,0,0
5,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.16828,0.11467,0.14933,0,0
5,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.015203,0.11435,0.14566,0,0
5,GO CEREBELLAR CORTEX DEVELOPMENT,0.092194,0.11365,0.10885,0,0
5,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.98953,0.11351,0.0059237,0,0
5,GO ACROSOME ASSEMBLY,0.10654,0.11305,0.094677,0,0
5,GO INSEMINATION,0.11636,0.11246,0.11538,0,0
5,GO CELLULAR RESPONSE TO LITHIUM ION,0.25001,0.11215,0.1103,0,0
5,GO ATRIAL SEPTUM DEVELOPMENT,0.19095,0.11151,0.12808,0,0
5,GO RESPONSE TO UV B,0.58456,0.11096,0.04512,0,0
5,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.69707,0.11061,-0.085316,0,0
5,GO PROTEIN LOCALIZATION TO CHROMATIN,0.050569,0.10927,0.07314,0,0
5,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.099158,0.10919,0.095756,0,0
5,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.36064,0.10853,0.080187,0,0
5,GO INTRACILIARY RETROGRADE TRANSPORT,0.62113,0.10821,0.084949,0,0
5,GO RETINA LAYER FORMATION,0.18219,0.10808,0.13735,0,0
5,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.15264,0.10806,0.17762,0,0
5,GO MEGAKARYOCYTE DEVELOPMENT,0.17099,0.10731,0.1375,0,0
5,GO REGULATION OF HISTONE H4 ACETYLATION,0.084046,0.10726,0.11195,0,0
5,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.070855,0.10665,0.12384,0,0
5,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.23245,0.10661,0.095957,0,0
5,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.27999,0.10618,0.16782,0,0
5,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.097379,0.10609,0.13471,0,0
5,GO DORSAL VENTRAL PATTERN FORMATION,0.0060989,0.10569,0.14183,0,0
5,GO REGULATION OF NEURON PROJECTION REGENERATION,0.73628,0.10553,0.021819,0,0
5,GO COLLECTING DUCT DEVELOPMENT,0.1313,0.10459,0.10391,0,0
5,GO SYNAPTIC VESICLE LOCALIZATION,0.02268,0.10303,0.18334,0,0
5,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.65866,0.10293,0.018553,0,0
5,GO NOREPINEPHRINE SECRETION,0.17653,0.10216,0.095997,0,0
5,GO OTIC VESICLE DEVELOPMENT,0.19095,0.10191,0.13252,0,0
5,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.36064,0.10114,0.054158,0,0
5,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.14769,0.10053,0.10392,0,0
5,GO TELENCEPHALON REGIONALIZATION,0.29992,0.099644,0.14019,0,0
5,GO RESPONSE TO HYDROXYUREA,0.017137,0.098928,0.16914,0,0
5,GO NEURON CELL CELL ADHESION,0.19695,0.098451,0.22352,0,0
5,GO RESPONSE TO DOPAMINE,0.49227,0.096731,0.032803,0,0
5,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.20937,0.096543,0.092212,0,0
5,GO HISTONE H3 K27 METHYLATION,0.036164,0.09634,0.094944,0,0
5,GO TONGUE MORPHOGENESIS,0.41842,0.096008,0.11807,0,0
5,GO REGULATION OF CENTRIOLE REPLICATION,0.070855,0.095996,0.067691,0,0
5,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.23589,0.095701,0.10588,0,0
5,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.25363,0.095574,0.054122,0,0
5,GO FOREBRAIN GENERATION OF NEURONS,0.22905,0.09434,0.10457,0,0
5,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.021165,0.092933,0.13075,0,0
5,GO REGULATION OF CHROMATIN BINDING,0.11434,0.091874,0.083705,0,0
5,GO PROTEIN AUTO ADP RIBOSYLATION,0.32506,0.091804,0.10673,0,0
5,GO OLFACTORY LOBE DEVELOPMENT,0.13814,0.090999,0.13258,0,0
5,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.98255,0.090508,-0.061942,0,0
5,GO MEIOTIC CHROMOSOME SEPARATION,0.47049,0.088759,0.022795,0,0
5,GO SEQUESTERING OF ACTIN MONOMERS,0.38408,0.088747,0.16944,0,0
5,GO SEROTONIN SECRETION,0.16294,0.087775,0.13329,0,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.29586,0.087573,0.044047,0,0
5,GO SIALYLATION,0.58456,0.086864,0.052293,0,0
5,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.4978,0.086667,0.042114,0,0
5,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.25729,0.086289,0.062168,0,0
5,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.25729,0.085858,0.10552,0,0
5,GO MICROTUBULE SEVERING,0.188,0.085813,0.096232,0,0
5,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.16294,0.085742,0.084353,0,0
5,GO COPULATION,0.079444,0.085702,0.12096,0,0
5,GO ERYTHROCYTE MATURATION,0.47049,0.085692,0.032013,0,0
5,GO PITUITARY GLAND DEVELOPMENT,0.35607,0.085494,0.085397,0,0
5,GO PEPTIDYL LYSINE METHYLATION,0.0060989,0.085453,0.090425,0,0
5,GO CENTROSOME SEPARATION,0.025414,0.084959,0.14625,0,0
5,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.16828,0.084887,0.10454,0,0
5,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.099158,0.084774,0.097851,0,0
5,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.56075,0.084472,0.11838,0,0
5,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.11434,0.084406,0.21037,0,0
5,GO REGULATION OF PROTON TRANSPORT,0.65866,0.08427,0.034629,0,0
5,GO ERYTHROCYTE DEVELOPMENT,0.11434,0.083885,0.053642,0,0
5,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.19095,0.083273,0.10823,0,0
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.68418,0.082971,0.030436,0,0
5,GO CELLULAR RESPONSE TO VITAMIN D,0.87144,0.081911,-0.019948,0,0
5,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.072231,0.081871,0.11783,0,0
5,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.19095,0.081725,0.045158,0,0
5,GO IMMUNOLOGICAL MEMORY PROCESS,0.24288,0.081533,0.096969,0,0
5,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.28785,0.08125,0.041605,0,0
5,GO MITOTIC SPINDLE ASSEMBLY,0.047551,0.081179,0.060676,0,0
5,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.68418,0.081041,0.061498,0,0
5,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.27999,0.080007,0.12771,0,0
5,GO ERROR PRONE TRANSLESION SYNTHESIS,0.064293,0.079962,0.080851,0,0
5,GO CILIUM ORGANIZATION,0.038561,0.079761,0.084264,0,0
5,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.95466,0.079545,0.0033481,0,0
5,GO DNA DEALKYLATION,0.21579,0.079103,0.048957,0,0
5,GO DNA LIGATION,0.40843,0.07865,0.056827,0,0
5,GO REGULATION OF MICROTUBULE BINDING,0.05824,0.078527,0.13352,0,0
5,GO REGULATION OF NEUROBLAST PROLIFERATION,0.11235,0.078,0.11097,0,0
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.81668,0.077515,-0.015593,0,0
5,GO CEREBELLAR CORTEX FORMATION,0.084046,0.077046,0.14771,0,0
5,GO T HELPER CELL LINEAGE COMMITMENT,0.29586,0.076901,0.047884,0,0
5,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.0069616,0.076468,0.10949,0,0
5,GO NEURAL RETINA DEVELOPMENT,0.19695,0.076373,0.076543,0,0
5,GO NEURAL PRECURSOR CELL PROLIFERATION,0.060602,0.076257,0.074643,0,0
5,GO GABAERGIC NEURON DIFFERENTIATION,0.52025,0.075887,0.18542,0,0
5,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.26098,0.075588,0.072901,0,0
5,GO MAGNESIUM ION HOMEOSTASIS,0.8303,0.075417,-0.030265,0,0
5,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.39858,0.074874,0.22261,0,0
5,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.12259,0.074141,0.13747,0,0
5,GO MESODERMAL CELL FATE SPECIFICATION,0.61497,0.073818,0.04464,0,0
5,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.64605,0.073648,-0.11644,0,0
5,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.64605,0.073217,-0.12186,0,0
5,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.20937,0.073155,0.059185,0,0
5,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.23937,0.072954,0.06171,0,0
5,GO MITRAL VALVE DEVELOPMENT,0.43883,0.072875,0.029592,0,0
5,GO PHOTORECEPTOR CELL DEVELOPMENT,0.35607,0.072744,0.047599,0,0
5,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.10465,0.072556,0.084882,0,0
5,GO MITOTIC SPINDLE ORGANIZATION,0.16559,0.072265,0.034055,0,0
5,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.11434,0.071962,0.082473,0,0
5,GO CHROMATIN SILENCING,0.024288,0.071656,0.086782,0,0
5,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.31653,0.07102,0.06023,0,0
5,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.55487,0.070947,0.010116,0,0
5,GO GLIAL CELL FATE COMMITMENT,0.188,0.070765,0.19251,0,0
5,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.012508,0.07068,0.089298,0,0
5,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.065563,0.069073,0.094253,0,0
5,GO NEGATIVE REGULATION OF DNA BINDING,0.24643,0.068986,0.055977,0,0
5,GO FAT CELL PROLIFERATION,0.21905,0.068828,0.106,0,0
5,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.33812,0.068244,0.059261,0,0
5,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.55487,0.067979,0.0063392,0,0
5,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.26098,0.067203,0.10906,0,0
5,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.23589,0.067183,0.13476,0,0
5,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.38888,0.067167,0.050912,0,0
5,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.40349,0.066163,0.048087,0,0
5,GO DECIDUALIZATION,0.63354,0.066155,0.021705,0,0
5,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.024846,0.066075,0.09136,0,0
5,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.070855,0.065691,0.27076,0,0
5,GO ENDOCARDIUM DEVELOPMENT,0.20621,0.065682,0.13861,0,0
5,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.33373,0.065434,0.049613,0,0
5,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.56075,0.065378,0.066775,0,0
5,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.60272,0.065346,0.033789,0,0
5,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.90599,0.065168,0.012533,0,0
5,GO TRACHEA MORPHOGENESIS,0.74288,0.064706,0.029167,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.0097392,0.064359,0.09305,0,0
5,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.26471,0.064317,0.046132,0,0
5,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.26847,0.063924,0.099812,0,0
5,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.27611,0.063911,0.1495,0,0
5,GO NEURAL NUCLEUS DEVELOPMENT,0.21256,0.063706,0.11219,0,0
5,GO POSITIVE REGULATION OF CILIUM MOVEMENT,0.41842,0.063608,0.050139,0,0
5,GO NOREPINEPHRINE METABOLIC PROCESS,0.20309,0.063447,0.14362,0,0
5,GO MITOTIC METAPHASE PLATE CONGRESSION,0.0695,0.063263,0.0731,0,0
5,GO REGULATION OF HISTONE METHYLATION,0.023741,0.063262,0.084361,0,0
5,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.19393,0.06283,0.048663,0,0
5,GO REGULATION OF FLAGELLATED SPERM MOTILITY,0.69061,0.062823,0.01356,0,0
5,GO RESPONSE TO LITHIUM ION,0.30815,0.062811,0.15475,0,0
5,GO SYNAPTIC VESICLE TRANSPORT,0.12689,0.062598,0.11857,0,0
5,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.10465,0.062586,0.047533,0,0
5,GO RENAL WATER HOMEOSTASIS,0.23245,0.062524,0.069591,0,0
5,GO REGULATION OF CHROMATIN ASSEMBLY,0.46512,0.062475,0.035351,0,0
5,GO NON RECOMBINATIONAL REPAIR,0.33373,0.062471,0.031822,0,0
5,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.16828,0.062352,0.033866,0,0
5,GO CAMP BIOSYNTHETIC PROCESS,0.48678,0.061846,0.066991,0,0
5,GO CARDIAC ATRIUM DEVELOPMENT,0.32506,0.061738,0.071392,0,0
5,GO NOTCH RECEPTOR PROCESSING,0.42855,0.061661,0.062508,0,0
5,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.87144,0.061499,-0.0069523,0,0
5,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.47588,0.061394,0.028734,0,0
5,GO CHROMATIN DISASSEMBLY,0.41341,0.061367,0.046794,0,0
5,GO REPLICATION FORK PROCESSING,0.12689,0.061159,0.060314,0,0
5,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.35607,0.06016,0.026005,0,0
5,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.11235,0.05978,0.078503,0,0
5,GO 3 UTR MEDIATED MRNA STABILIZATION,0.40843,0.059708,0.01362,0,0
5,GO HETEROCHROMATIN ORGANIZATION,0.011612,0.059165,0.090138,0,0
5,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.20309,0.058896,0.062031,0,0
5,GO CELLULAR RESPONSE TO X RAY,0.52594,0.058859,-0.016991,0,0
5,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.57857,0.058388,0.073039,0,0
5,GO REGULATION OF EXIT FROM MITOSIS,0.90599,0.057933,-0.0066758,0,0
5,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.34702,0.057577,0.11954,0,0
5,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.42855,0.057386,0.035117,0,0
5,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.188,0.057144,0.044547,0,0
5,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.33373,0.056636,0.021049,0,0
5,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.93377,0.056571,-0.02882,0,0
5,GO MATERNAL PLACENTA DEVELOPMENT,0.50337,0.056537,0.024622,0,0
5,GO CELL DIFFERENTIATION IN HINDBRAIN,0.30815,0.055588,0.080635,0,0
5,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.65866,0.055373,0.024447,0,0
5,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.48678,0.055348,0.093275,0,0
5,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.43883,0.055134,0.026945,0,0
5,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.80312,0.055124,-0.031544,0,0
5,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.072231,0.054897,0.060732,0,0
5,GO PYRAMIDAL NEURON DIFFERENTIATION,0.43367,0.054875,0.071333,0,0
5,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.19393,0.054666,0.15347,0,0
5,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.70355,0.054565,0.023433,0,0
5,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.60883,0.05456,-0.0046219,0,0
5,GO TRANSCYTOSIS,0.71658,0.054432,0.0015103,0,0
5,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.019283,0.054112,0.063509,0,0
5,GO LUNG CELL DIFFERENTIATION,0.63978,0.053863,0.11053,0,0
5,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.21905,0.053778,0.061678,0,0
5,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.65866,0.053772,0.02434,0,0
5,GO SULFATION,0.5726,0.052843,0.018156,0,0
5,GO SMOOTHENED SIGNALING PATHWAY,0.14526,0.052532,0.050316,0,0
5,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.17934,0.051951,0.077355,0,0
5,GO MESODERMAL CELL FATE COMMITMENT,0.98953,0.051912,-0.004827,0,0
5,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.13583,0.051825,0.034058,0,0
5,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.94769,0.051505,0.029536,0,0
5,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.69061,0.051497,0.01373,0,0
5,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.98255,0.050997,-0.010746,0,0
5,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.51459,0.050946,0.034649,0,0
5,GO PROTEIN LOCALIZATION TO CILIUM,0.17653,0.050128,0.084732,0,0
5,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.39371,0.050011,0.046152,0,0
5,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.36526,0.049837,0.046104,0,0
5,GO SUBPALLIUM DEVELOPMENT,0.41842,0.049443,0.10145,0,0
5,GO CHROMATIN SILENCING AT TELOMERE,0.3746,0.049236,0.040294,0,0
5,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.29184,0.049144,0.031149,0,0
5,GO HISTONE H3 K36 METHYLATION,0.26847,0.049137,0.061578,0,0
5,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.86455,0.04842,-0.031816,0,0
5,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.79636,0.048216,-0.028518,0,0
5,GO SKELETAL MUSCLE CELL PROLIFERATION,0.85082,0.04809,-0.00064233,0,0
5,GO REGULATION OF CELL FATE COMMITMENT,0.30402,0.047933,0.053777,0,0
5,GO DIENCEPHALON DEVELOPMENT,0.34256,0.047926,0.072456,0,0
5,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.12049,0.047912,0.099285,0,0
5,GO REGULATION OF MICROTUBULE BASED PROCESS,0.26471,0.047856,0.030834,0,0
5,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.32077,0.047784,0.30925,0,0
5,GO IMMATURE B CELL DIFFERENTIATION,0.56075,0.047515,0.042233,0,0
5,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.56075,0.047459,0.067268,0,0
5,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.44402,0.047455,0.027488,0,0
5,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.060602,0.047414,0.058961,0,0
5,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.18219,0.04736,0.22711,0,0
5,GO HISTONE METHYLATION,0.065563,0.047251,0.058799,0,0
5,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.50337,0.046846,0.095531,0,0
5,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.88523,0.046844,0.0069555,0,0
5,GO REGULATION OF RNA SPLICING,0.054842,0.04662,0.050026,0,0
5,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.76948,0.046527,0.028475,0,0
5,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.30815,0.046337,0.063958,0,0
5,GO DIGESTIVE TRACT MORPHOGENESIS,0.40843,0.046112,0.02484,0,0
5,GO SPINDLE ASSEMBLY,0.21905,0.046098,0.02834,0,0
5,GO CELLULAR RESPONSE TO VITAMIN,0.76281,0.04609,-0.028813,0,0
5,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.94073,0.045864,-0.046187,0,0
5,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.19393,0.045772,0.038869,0,0
5,GO DORSAL AORTA DEVELOPMENT,0.83713,0.045291,0.0097871,0,0
5,GO REGULATION OF CILIUM BEAT FREQUENCY,0.51459,0.045242,0.039124,0,0
5,GO CELLULAR SODIUM ION HOMEOSTASIS,0.87144,0.045201,-0.0030577,0,0
5,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.39858,0.045185,0.0207,0,0
5,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.68418,0.045002,0.03315,0,0
5,GO CELL FATE COMMITMENT,0.28785,0.0447,0.025282,0,0
5,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.85082,0.044567,0.0036065,0,0
5,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.48131,0.044483,0.023749,0,0
5,GO ASTRAL MICROTUBULE ORGANIZATION,0.060602,0.04428,0.12432,0,0
5,GO MICROTUBULE BASED PROCESS,0.25001,0.044096,0.029213,0,0
5,GO SPERM CAPACITATION,0.44402,0.044015,0.031695,0,0
5,GO RESPONSE TO ETHER,0.25729,0.043776,0.051651,0,0
5,GO PROTEIN METHYLATION,0.095625,0.043661,0.046079,0,0
5,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.7495,0.043317,-0.054956,0,0
5,GO RETINAL GANGLION CELL AXON GUIDANCE,0.43367,0.043247,0.13056,0,0
5,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.50337,0.043235,0.026604,0,0
5,GO RESPONSE TO ACETYLCHOLINE,0.53742,0.043129,0.056495,0,0
5,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.066855,0.043119,0.044905,0,0
5,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.17653,0.043054,0.043282,0,0
5,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.47049,0.042964,0.058991,0,0
5,GO BRAIN MORPHOGENESIS,0.40349,0.04292,0.032291,0,0
5,GO SPERM AXONEME ASSEMBLY,0.46512,0.042865,0.07228,0,0
5,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.4598,0.042644,0.071869,0,0
5,GO ACTIN FILAMENT BASED TRANSPORT,0.38888,0.041975,0.073001,0,0
5,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.98953,0.040995,-0.061029,0,0
5,GO ER OVERLOAD RESPONSE,0.93377,0.040911,6.4835e-06,0,0
5,GO PHOTORECEPTOR CELL MAINTENANCE,0.25729,0.040584,0.047533,0,0
5,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.59664,0.040374,0.0072174,0,0
5,GO REGULATION OF SPINDLE CHECKPOINT,0.19095,0.04029,0.070679,0,0
5,GO COVALENT CHROMATIN MODIFICATION,0.063042,0.040161,0.037837,0,0
5,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.17653,0.039928,0.082889,0,0
5,GO REGULATION OF SPINDLE ORGANIZATION,0.39858,0.039891,0.024916,0,0
5,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.31232,0.03982,0.055628,0,0
5,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.91293,0.039628,-0.034997,0,0
5,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.47049,0.03942,0.062829,0,0
5,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.96163,0.03888,-0.056412,0,0
5,GO STEM CELL PROLIFERATION,0.15773,0.038483,0.055062,0,0
5,GO POSITIVE REGULATION OF DNA REPLICATION,0.70355,0.03844,0.013274,0,0
5,GO METENCEPHALON DEVELOPMENT,0.38888,0.038354,0.055914,0,0
5,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.063042,0.038094,0.061822,0,0
5,GO DENSE CORE GRANULE TRANSPORT,0.77618,0.03809,0.090493,0,0
5,GO REGULATION OF COLLATERAL SPROUTING,0.94073,0.03778,-0.0081191,0,0
5,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.63978,0.037779,0.006132,0,0
5,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.2,0.037753,0.046799,0,0
5,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.76281,0.037127,-0.060044,0,0
5,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.7495,0.037111,-0.0020562,0,0
5,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.56666,0.036854,0.022113,0,0
5,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.31232,0.036752,0.036615,0,0
5,GO POSITIVE REGULATION OF BONE RESORPTION,0.87833,0.036721,-0.022262,0,0
5,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.80312,0.036662,-0.013403,0,0
5,GO REGULATION OF PROTEIN SUMOYLATION,0.77618,0.036595,0.019569,0,0
5,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.35607,0.036195,0.083891,0,0
5,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.50896,0.036095,0.092547,0,0
5,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.98255,0.035876,-0.01112,0,0
5,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.91987,0.03563,-0.014097,0,0
5,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.44924,0.034428,0.056293,0,0
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.64605,0.034345,-0.051008,0,0
5,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.80312,0.034129,-0.023601,0,0
5,GO REGULATION OF ODONTOGENESIS,0.58456,0.034106,-0.077051,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.38888,0.033942,0.039115,0,0
5,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.83713,0.033897,-0.062615,0,0
5,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.36526,0.033788,0.052537,0,0
5,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.56666,0.033567,0.011324,0,0
5,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.95466,0.033375,-0.035697,0,0
5,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.67137,0.033071,0.029085,0,0
5,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.39858,0.03303,0.026751,0,0
5,GO ANTEROGRADE AXONAL TRANSPORT,0.62113,0.032968,0.021353,0,0
5,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.70355,0.032939,0.021087,0,0
5,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.0695,0.032664,0.063382,0,0
5,GO P BODY ASSEMBLY,0.19695,0.03255,0.047742,0,0
5,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.96163,0.03238,-0.014072,0,0
5,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.9686,0.032214,0.0075134,0,0
5,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.21579,0.031792,0.11548,0,0
5,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.71658,0.031655,-0.01207,0,0
5,GO SUBSTANTIA NIGRA DEVELOPMENT,0.56666,0.031616,0.032295,0,0
5,GO T CELL LINEAGE COMMITMENT,0.36064,0.031597,0.044063,0,0
5,GO HISTONE H3 K9 DEMETHYLATION,0.38408,0.031457,0.063169,0,0
5,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.67137,0.031424,0.033881,0,0
5,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.74288,0.031093,0.0048326,0,0
5,GO CHROMOSOME ORGANIZATION,0.084046,0.030765,0.028931,0,0
5,GO ROOF OF MOUTH DEVELOPMENT,0.54903,0.030381,0.020667,0,0
5,GO DENDRITE MORPHOGENESIS,0.47588,0.030349,0.05802,0,0
5,GO DENDRITIC SPINE MAINTENANCE,0.73628,0.030291,-0.032374,0,0
5,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.58456,0.030273,0.029982,0,0
5,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.67776,0.030199,0.028042,0,0
5,GO LEFT RIGHT PATTERN FORMATION,0.93377,0.030164,0.0045095,0,0
5,GO NEGATIVE REGULATION OF GLIOGENESIS,0.39858,0.030148,0.052514,0,0
5,GO REGULATION OF MESODERM DEVELOPMENT,0.73628,0.030057,0.032637,0,0
5,GO EPITHELIAL CELL MORPHOGENESIS,0.85082,0.030008,-0.01364,0,0
5,GO TRANSPORT ALONG MICROTUBULE,0.14048,0.029955,0.050473,0,0
5,GO REGULATION OF CENTROSOME DUPLICATION,0.28785,0.02995,0.04868,0,0
5,GO MAINTENANCE OF CELL NUMBER,0.90599,0.029558,-0.021019,0,0
5,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.73628,0.029403,0.019994,0,0
5,GO EPITHELIAL CELL MATURATION,0.60272,0.029378,0.054367,0,0
5,GO SPINDLE LOCALIZATION,0.50896,0.029315,0.031977,0,0
5,GO MEIOTIC SPINDLE ORGANIZATION,0.4598,0.029189,0.028156,0,0
5,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.39858,0.029155,0.044829,0,0
5,GO OLIGODENDROCYTE DIFFERENTIATION,0.94769,0.029046,0.0081625,0,0
5,GO PROTEIN K11 LINKED UBIQUITINATION,0.82348,0.028831,-0.0021414,0,0
5,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.3746,0.028685,0.016574,0,0
5,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.72969,0.028615,-0.019325,0,0
5,GO OOGENESIS,0.63978,0.02843,0.018013,0,0
5,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.22235,0.028264,0.047637,0,0
5,GO REGULATION OF CHROMOSOME SEGREGATION,0.25729,0.028154,0.045725,0,0
5,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.67776,0.028074,0.013767,0,0
5,GO RETINAL CONE CELL DIFFERENTIATION,0.67776,0.028039,0.016993,0,0
5,GO RNA SPLICING,0.17099,0.027982,0.040319,0,0
5,GO VIRAL RNA GENOME REPLICATION,0.91293,0.027894,-0.026383,0,0
5,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.93377,0.027465,-0.0092419,0,0
5,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.42347,0.027173,0.032948,0,0
5,GO HISTONE H3 ACETYLATION,0.85768,0.026879,0.0010716,0,0
5,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.22568,0.026826,0.087152,0,0
5,GO PROTEIN SUMOYLATION,0.54321,0.026822,0.01625,0,0
5,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.50896,0.026724,0.02068,0,0
5,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.72969,0.026445,0.022156,0,0
5,GO CELLULAR RESPONSE TO NUTRIENT,0.63978,0.02639,-0.057759,0,0
5,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.84397,0.026081,-0.038373,0,0
5,GO GROWTH HORMONE SECRETION,0.36991,0.02591,0.10608,0,0
5,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.5726,0.025443,0.024498,0,0
5,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.39371,0.025437,0.077407,0,0
5,GO MICROTUBULE BASED TRANSPORT,0.32506,0.025017,0.033895,0,0
5,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.73628,0.025008,0.0032188,0,0
5,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.48678,0.024786,0.011978,0,0
5,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.52594,0.024664,0.030609,0,0
5,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.91987,0.024443,-0.012168,0,0
5,GO FOREBRAIN DEVELOPMENT,0.35607,0.023591,0.035573,0,0
5,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.070855,0.023504,0.05474,0,0
5,GO CELL PROJECTION ASSEMBLY,0.70355,0.023332,-0.010667,0,0
5,GO MEIOTIC CHROMOSOME SEGREGATION,0.4545,0.023314,0.016427,0,0
5,GO MICROTUBULE BASED MOVEMENT,0.38888,0.022888,0.029688,0,0
5,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.48678,0.022874,0.036184,0,0
5,GO PROTEIN INSERTION INTO MEMBRANE,0.34256,0.02281,0.036299,0,0
5,GO MRNA TRANSPORT,0.94769,0.022601,-0.0037796,0,0
5,GO APPENDAGE MORPHOGENESIS,0.37932,0.022437,0.021689,0,0
5,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.36991,0.022372,0.02419,0,0
5,GO CYTOKINESIS,0.94769,0.022359,-0.0046435,0,0
5,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.38888,0.02233,0.027263,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.67137,0.0221,0.0074559,0,0
5,GO DNA METHYLATION OR DEMETHYLATION,0.41842,0.021946,0.021753,0,0
5,GO RETROGRADE AXONAL TRANSPORT,0.37932,0.021894,0.075609,0,0
5,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.42347,0.02172,-0.084819,0,0
5,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.59059,0.021715,0.0198,0,0
5,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.85082,0.021711,-0.010759,0,0
5,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.71006,0.021683,0.05726,0,0
5,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.43367,0.02153,0.045127,0,0
5,GO AMINE BIOSYNTHETIC PROCESS,0.80989,0.021508,0.02147,0,0
5,GO PANCREAS DEVELOPMENT,0.84397,0.021355,0.008403,0,0
5,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.98255,0.021257,-0.0050673,0,0
5,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.72313,0.020995,0.012785,0,0
5,GO PHAGOSOME ACIDIFICATION,0.76948,0.020982,-0.039556,0,0
5,GO DORSAL SPINAL CORD DEVELOPMENT,0.50337,0.020961,0.11848,0,0
5,GO POSITIVE REGULATION OF RNA SPLICING,0.60883,0.020955,0.017384,0,0
5,GO REGULATION OF CYTOKINESIS,0.64605,0.020645,0.0036717,0,0
5,GO EXIT FROM MITOSIS,0.9686,0.020559,-0.0041997,0,0
5,GO SECRETORY GRANULE LOCALIZATION,0.96163,0.020559,-0.0035141,0,0
5,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.34702,0.020519,0.049276,0,0
5,GO MITOTIC NUCLEAR DIVISION,0.23589,0.020453,0.034456,0,0
5,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.59664,0.020271,0.014658,0,0
5,GO ECTODERM DEVELOPMENT,0.29184,0.020182,0.045674,0,0
5,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.95466,0.020157,0.0086039,0,0
5,GO REGULATION OF APPETITE,0.90599,0.020126,-0.0075825,0,0
5,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.78962,0.020077,0.038625,0,0
5,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.41341,0.02,0.083812,0,0
5,GO MRNA PROCESSING,0.22568,0.01958,0.031668,0,0
5,GO NEURON PROJECTION REGENERATION,0.60883,0.019567,-0.037102,0,0
5,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.78289,0.019557,0.046074,0,0
5,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.79636,0.019107,0.019527,0,0
5,GO PROTEIN K48 LINKED UBIQUITINATION,0.51459,0.018964,0.017293,0,0
5,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.98953,0.018671,-0.016778,0,0
5,GO SEX DETERMINATION,0.71658,0.018443,0.040687,0,0
5,GO DETECTION OF TEMPERATURE STIMULUS,0.96163,0.018342,0.0078806,0,0
5,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.83713,0.01833,-0.033244,0,0
5,GO ADRENAL GLAND DEVELOPMENT,0.80989,0.018036,-0.044912,0,0
5,GO MRNA 3 END PROCESSING,0.35607,0.01789,0.028299,0,0
5,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.65234,0.017844,-0.045397,0,0
5,GO SOMITE DEVELOPMENT,0.74288,0.017763,-0.011427,0,0
5,GO REGULATION OF TORC1 SIGNALING,0.91987,0.017717,-0.021662,0,0
5,GO REGULATION OF FIBROBLAST MIGRATION,0.97557,0.017676,-0.027381,0,0
5,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.48131,0.017643,0.024204,0,0
5,GO TELOMERE CAPPING,0.43883,0.017522,0.024982,0,0
5,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.7495,0.017437,0.0098323,0,0
5,GO AMMONIUM TRANSPORT,0.94769,0.01741,0.0084347,0,0
5,GO DNA RECOMBINATION,0.35153,0.017134,0.018776,0,0
5,GO REGULATION OF NEURON MIGRATION,0.74288,0.017133,0.01548,0,0
5,GO SPERMATID DIFFERENTIATION,0.60272,0.016978,0.026963,0,0
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.78962,0.01695,-0.015536,0,0
5,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.68418,0.016843,0.0084317,0,0
5,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.52025,0.016788,0.0053252,0,0
5,GO MITOCHONDRIAL GENOME MAINTENANCE,0.62732,0.016678,0.028117,0,0
5,GO NEGATIVE REGULATION OF DNA REPAIR,0.85082,0.016663,-0.028279,0,0
5,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.60883,0.016447,0.03059,0,0
5,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.77618,0.01641,-0.0041003,0,0
5,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.38408,0.016381,0.011546,0,0
5,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.92682,0.016372,-0.0050292,0,0
5,GO CARTILAGE MORPHOGENESIS,0.53167,0.016352,0.057036,0,0
5,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.83713,0.016343,-0.009681,0,0
5,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.52594,0.016256,0.019644,0,0
5,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.44924,0.016216,0.066163,0,0
5,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.66501,0.016215,-0.027114,0,0
5,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.93377,0.016193,0.0066453,0,0
5,GO MRNA METHYLATION,0.86455,0.016013,-0.013238,0,0
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.99651,0.015939,-0.052544,0,0
5,GO GAMETE GENERATION,0.99651,0.015845,-0.0043193,0,0
5,GO CLATHRIN COAT ASSEMBLY,0.93377,0.01581,0.0085499,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.63354,0.015788,-0.048451,0,0
5,GO HINDBRAIN DEVELOPMENT,0.65866,0.015767,0.033184,0,0
5,GO DNA REPAIR,0.36064,0.015607,0.015163,0,0
5,GO POSITIVE REGULATION OF AXONOGENESIS,0.88523,0.015528,0.013366,0,0
5,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.64605,0.015446,-0.033844,0,0
5,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.99651,0.015442,0.0093,0,0
5,GO MYELOID CELL DEVELOPMENT,0.67137,0.015188,0.014633,0,0
5,GO REGULATION OF CHROMOSOME SEPARATION,0.72969,0.015097,0.015075,0,0
5,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.82348,0.015036,-0.078198,0,0
5,GO REGULATION OF HISTONE MODIFICATION,0.60883,0.014848,0.0087366,0,0
5,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.68418,0.014655,-0.030299,0,0
5,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.50337,0.014618,0.0071159,0,0
5,GO DENDRITE DEVELOPMENT,0.81668,0.014533,0.021022,0,0
5,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.96163,0.014464,-0.0099476,0,0
5,GO EPITHELIAL STRUCTURE MAINTENANCE,0.42855,0.013904,-0.050825,0,0
5,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.20309,0.013895,0.051115,0,0
5,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.87833,0.013528,0.015786,0,0
5,GO RESPONSE TO UV,0.81668,0.013462,2.8717e-06,0,0
5,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.80989,0.013422,0.0028691,0,0
5,GO NEURAL CREST FORMATION,0.52025,0.013406,0.049915,0,0
5,GO MEGAKARYOCYTE DIFFERENTIATION,0.28785,0.013332,0.035488,0,0
5,GO GERM CELL DEVELOPMENT,0.48131,0.013289,0.02117,0,0
5,GO CELL DIVISION,0.52594,0.013214,0.012295,0,0
5,GO REGULATION OF HISTONE PHOSPHORYLATION,0.57857,0.01294,-0.063527,0,0
5,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.72313,0.012851,-0.084193,0,0
5,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.70355,0.012685,-0.039387,0,0
5,GO MITOCHONDRION LOCALIZATION,0.9686,0.012644,0.0055974,0,0
5,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.8303,0.012625,0.011987,0,0
5,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.33812,0.012496,-0.12105,0,0
5,GO RESPONSE TO NERVE GROWTH FACTOR,0.27611,0.012493,0.062971,0,0
5,GO MICROTUBULE BUNDLE FORMATION,0.42855,0.012401,0.061631,0,0
5,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.94769,0.012252,-0.0094631,0,0
5,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.65866,0.012172,0.033884,0,0
5,GO MALE GAMETE GENERATION,0.79636,0.012057,-0.011529,0,0
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.57857,0.011875,0.025971,0,0
5,GO INTRACELLULAR MRNA LOCALIZATION,0.87833,0.011824,-9.756e-05,0,0
5,GO CYTIDINE TO URIDINE EDITING,0.57857,0.011816,-0.12103,0,0
5,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.87144,0.011763,0.0083288,0,0
5,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.90599,0.011724,-0.036173,0,0
5,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.39858,0.011708,-0.14853,0,0
5,GO CGMP METABOLIC PROCESS,0.89215,0.011575,-0.025657,0,0
5,GO CELLULAR COMPONENT MAINTENANCE,0.63354,0.011326,0.033594,0,0
5,GO DETECTION OF ABIOTIC STIMULUS,0.84397,0.011151,-0.0089043,0,0
5,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.81668,0.011124,0.023161,0,0
5,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.90599,0.011014,0.001709,0,0
5,GO RNA EXPORT FROM NUCLEUS,0.77618,0.010823,0.0047707,0,0
5,GO HINDBRAIN MORPHOGENESIS,0.23245,0.01069,0.044695,0,0
5,GO MEMBRANE DOCKING,0.94769,0.010537,0.0052531,0,0
5,GO POSITIVE REGULATION OF TISSUE REMODELING,0.84397,0.01049,-0.021842,0,0
5,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.87833,0.010475,0.0089867,0,0
5,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.89215,0.01043,-0.01161,0,0
5,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.83713,0.010418,-0.011837,0,0
5,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.73628,0.010411,0.030898,0,0
5,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.64605,0.010073,-0.0070948,0,0
5,GO REGULATION OF DNA RECOMBINATION,0.80312,0.010039,-0.0034388,0,0
5,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.76281,0.010025,-0.026259,0,0
5,GO CAMERA TYPE EYE MORPHOGENESIS,0.60272,0.0098931,0.017654,0,0
5,GO HISTONE DEUBIQUITINATION,0.86455,0.009799,-0.017151,0,0
5,GO REGULATORY T CELL DIFFERENTIATION,0.89907,0.0097463,-0.016405,0,0
5,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.47588,0.009633,0.029269,0,0
5,GO RESPONSE TO CATECHOLAMINE,0.39371,0.0096222,-0.045232,0,0
5,GO REGULATION OF MITOTIC CELL CYCLE,0.76281,0.0095393,-0.015362,0,0
5,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.63978,0.0095074,-0.028101,0,0
5,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.35607,0.0093865,0.088894,0,0
5,GO REGULATION OF CELL FATE SPECIFICATION,0.75615,0.0092142,0.027349,0,0
5,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.96163,0.0090325,-0.018421,0,0
5,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.80989,0.0089945,0.025496,0,0
5,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.32938,0.0088129,-0.17469,0,0
5,GO DNA GEOMETRIC CHANGE,0.4598,0.0087768,0.02147,0,0
5,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.98953,0.0087371,0.0023396,0,0
5,GO MICROTUBULE ANCHORING,0.78289,0.0086105,0.0084613,0,0
5,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.71658,0.0086095,-0.036367,0,0
5,GO APOPTOTIC DNA FRAGMENTATION,0.8303,0.008385,0.0069306,0,0
5,GO AXONAL TRANSPORT,0.56666,0.0082362,0.035763,0,0
5,GO MICROTUBULE POLYMERIZATION,0.95466,0.0081383,-0.0080756,0,0
5,GO RESPONSE TO NITROSATIVE STRESS,0.67137,0.0081328,-0.10853,0,0
5,GO NEURON MIGRATION,0.47049,0.0080618,0.079898,0,0
5,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.87144,0.0079747,-0.013945,0,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.68418,0.0079009,-0.032213,0,0
5,GO AXO DENDRITIC TRANSPORT,0.75615,0.0078359,0.029289,0,0
5,GO ERROR FREE TRANSLESION SYNTHESIS,0.98953,0.0075882,-0.0035513,0,0
5,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.35607,0.0075825,-0.084644,0,0
5,GO GENE SILENCING,0.60272,0.0074361,-0.016065,0,0
5,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,1,0.0074305,-0.0077515,0,0
5,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.32938,0.0074163,0.025184,0,0
5,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.94073,0.0074109,-0.042807,0,0
5,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.62732,0.0072829,0.045937,0,0
5,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.85082,0.0072076,-0.01792,0,0
5,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.74288,0.0070768,0.072699,0,0
5,GO PROTEIN LOCALIZATION TO SYNAPSE,0.78962,0.0069535,0.034826,0,0
5,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.83713,0.006948,-0.044709,0,0
5,GO REGULATION OF CILIUM MOVEMENT,0.73628,0.0069048,0.016766,0,0
5,GO ORGANELLE LOCALIZATION,0.81668,0.0069022,-0.0035309,0,0
5,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.91987,0.0068318,-0.013329,0,0
5,GO HIPPOCAMPUS DEVELOPMENT,0.93377,0.0064656,0.0041135,0,0
5,GO POSITIVE REGULATION OF MITOPHAGY,0.77618,0.0064393,-0.021168,0,0
5,GO REGULATION OF CHROMATIN ORGANIZATION,0.59059,0.0063978,0.011171,0,0
5,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.89215,0.0063509,-0.0020789,0,0
5,GO VESICLE CYTOSKELETAL TRAFFICKING,0.34702,0.0061658,0.038333,0,0
5,GO NEUROTROPHIN SIGNALING PATHWAY,0.69061,0.00607,-0.023693,0,0
5,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.52025,0.006052,0.031631,0,0
5,GO REGULATION OF GOLGI ORGANIZATION,0.97557,0.0059992,0.0024992,0,0
5,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.8303,0.0059327,-0.013953,0,0
5,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.99651,0.0059208,-0.041178,0,0
5,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.67776,0.0058918,0.019952,0,0
5,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.4598,0.0058706,0.064916,0,0
5,GO CELLULAR RESPONSE TO UV,0.98255,0.0058525,-0.0070744,0,0
5,GO PHOTOPERIODISM,0.72969,0.0057481,-0.023356,0,0
5,GO RNA CAPPING,0.64605,0.005672,-0.025561,0,0
5,GO SNRNA TRANSCRIPTION,0.93377,0.0055566,-0.0010267,0,0
5,GO REGULATION OF RECEPTOR INTERNALIZATION,0.54321,0.0055042,-0.040424,0,0
5,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.55487,0.0054382,0.031312,0,0
5,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.90599,0.0053719,0.010693,0,0
5,GO CELL PROLIFERATION IN FOREBRAIN,0.94073,0.0052748,-0.02043,0,0
5,GO REGULATION OF CELL CYCLE ARREST,0.96163,0.0051429,-0.001963,0,0
5,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.50337,0.0050901,0.033001,0,0
5,GO PALLIUM DEVELOPMENT,0.99651,0.0050815,0.0073556,0,0
5,GO REGULATION OF AXONOGENESIS,0.89907,0.0048146,-0.0087536,0,0
5,GO NUCLEAR BODY ORGANIZATION,0.9686,0.004624,2.6853e-05,0,0
5,GO REGULATION OF PINOCYTOSIS,0.29586,0.004561,-0.1302,0,0
5,GO INNER CELL MASS CELL PROLIFERATION,0.80312,0.0045335,-0.015493,0,0
5,GO REGULATION OF GLIAL CELL MIGRATION,0.86455,0.0044526,0.0031494,0,0
5,GO LYMPHANGIOGENESIS,0.59664,0.0043268,-0.078861,0,0
5,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.87833,0.00414,0.00095155,0,0
5,GO REGULATION OF DNA REPLICATION,0.94073,0.0041086,-0.0083969,0,0
5,GO RRNA 3 END PROCESSING,0.29184,0.0040998,-0.075758,0,0
5,GO FOREGUT MORPHOGENESIS,0.94769,0.0040717,-0.015439,0,0
5,GO POSITIVE REGULATION OF GLIOGENESIS,0.81668,0.0038707,0.013693,0,0
5,GO POST EMBRYONIC DEVELOPMENT,0.78289,0.0037792,-0.010724,0,0
5,GO CELL JUNCTION MAINTENANCE,0.40843,0.0036498,0.070464,0,0
5,GO REGULATION OF DNA BINDING,0.60272,0.0036292,0.017011,0,0
5,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.62732,0.0036014,-0.032289,0,0
5,GO SYNAPTIC MEMBRANE ADHESION,0.85768,0.0035647,-0.032541,0,0
5,GO DETERMINATION OF ADULT LIFESPAN,0.67776,0.0033718,-0.033668,0,0
5,GO REGULATION OF ORGANIC ACID TRANSPORT,0.69707,0.0032236,-0.043041,0,0
5,GO HISTONE H4 DEACETYLATION,0.94769,0.0031445,-0.017654,0,0
5,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.73628,0.0030072,0.0011723,0,0
5,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.79636,0.0025757,-0.022829,0,0
5,GO TELENCEPHALON DEVELOPMENT,0.98255,0.0025339,0.0013904,0,0
5,GO DNA CATABOLIC PROCESS,0.7495,0.0024619,0.014554,0,0
5,GO NEUROBLAST PROLIFERATION,0.37932,0.002288,0.051821,0,0
5,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.76281,0.0020487,-0.003959,0,0
5,GO REGULATION OF GLUCOSE IMPORT,0.63978,0.0020164,-0.022669,0,0
5,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.94073,0.0019687,-0.00061305,0,0
5,GO SPINDLE MIDZONE ASSEMBLY,0.89215,0.0019383,-0.017175,0,0
5,GO NODAL SIGNALING PATHWAY,0.73628,0.0016259,-0.021114,0,0
5,GO REGULATION OF EXTENT OF CELL GROWTH,0.60883,0.0013691,-0.031536,0,0
5,GO REGULATION OF GLUTAMATE SECRETION,0.21256,0.0012079,0.18885,0,0
5,GO SPERM MOTILITY,0.8303,0.0011182,0.0099871,0,0
5,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.87144,0.0011127,-0.011639,0,0
5,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.91293,0.001104,-0.0081178,0,0
5,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.7495,0.0010997,-0.032078,0,0
5,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.55487,0.00080925,-0.064497,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE,0.39371,0.00052982,-0.017491,0,0
5,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.41341,0.00045416,0.021067,0,0
5,GO REGULATION OF CELL DIVISION,0.86455,0.00040656,-0.011688,0,0
5,GO THYMUS DEVELOPMENT,0.39858,0.00038251,0.049581,0,0
5,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.93377,0.0003753,0.015933,0,0
5,GO RUFFLE ASSEMBLY,0.59059,0.00036327,-0.033148,0,0
5,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.86455,0.00026442,0.021645,0,0
5,GO NEURON PROJECTION GUIDANCE,0.81668,0.00026261,0.0085431,0,0
5,GO POSITIVE REGULATION OF DNA BINDING,0.94769,0.00018966,0.0024308,0,0
5,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.79636,-0.00010702,-0.0015626,0,0
5,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.69707,-0.000205,-0.018002,0,0
5,GO THYMIC T CELL SELECTION,0.8303,-0.00032982,0.009016,0,0
5,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.59059,-0.00036798,0.025066,0,0
5,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.67137,-0.00046375,-0.023769,0,0
5,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.62113,-0.00048821,0.027313,0,0
5,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.91987,-0.00052924,0.015121,0,0
5,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.87833,-0.00054054,0.0035329,0,0
5,GO BLASTOCYST GROWTH,0.72313,-0.00065843,-0.036338,0,0
5,GO MALE SEX DIFFERENTIATION,0.15264,-0.00087771,-0.074837,0,0
5,GO NATURAL KILLER CELL ACTIVATION,0.78289,-0.0009779,-0.037558,0,0
5,GO COCHLEA DEVELOPMENT,0.92682,-0.00099627,0.012934,0,0
5,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.71006,-0.0010223,0.020345,0,0
5,GO RNA DECAPPING,0.56666,-0.0010231,-0.04878,0,0
5,GO MEMBRANE HYPERPOLARIZATION,0.61497,-0.0011084,-0.054964,0,0
5,GO REGULATION OF MRNA POLYADENYLATION,0.5726,-0.0013866,-0.031918,0,0
5,GO HEPATOCYTE APOPTOTIC PROCESS,0.60883,-0.0014446,0.14431,0,0
5,GO LEFT RIGHT AXIS SPECIFICATION,0.85082,-0.00151,-0.039554,0,0
5,GO EYE MORPHOGENESIS,0.96163,-0.0015743,-0.0034951,0,0
5,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.36064,-0.001644,-0.12294,0,0
5,GO ENDOCRINE SYSTEM DEVELOPMENT,0.67137,-0.0016996,0.0228,0,0
5,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.49227,-0.0019108,0.051597,0,0
5,GO AXONEME ASSEMBLY,0.48678,-0.0020976,0.075677,0,0
5,GO G2 DNA DAMAGE CHECKPOINT,0.72313,-0.0025613,0.024605,0,0
5,GO REGULATION OF CHROMOSOME ORGANIZATION,0.65866,-0.0025674,0.010854,0,0
5,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.91293,-0.0026681,-0.0076551,0,0
5,GO MITOTIC CELL CYCLE,0.88523,-0.0028162,-0.012446,0,0
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.69061,-0.0028213,-0.032442,0,0
5,GO RESPONSE TO ELECTRICAL STIMULUS,0.91987,-0.0028549,-0.00036881,0,0
5,GO REGULATION OF DNA METABOLIC PROCESS,0.99651,-0.0028574,-0.0035645,0,0
5,GO CEREBRAL CORTEX DEVELOPMENT,0.78289,-0.0028579,0.019415,0,0
5,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.77618,-0.0030598,-0.061994,0,0
5,GO CHROMOSOME SEPARATION,0.72969,-0.0031588,0.01748,0,0
5,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.66501,-0.003275,-0.08373,0,0
5,GO REGULATION OF SENSORY PERCEPTION,0.50896,-0.0033416,-0.056024,0,0
5,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.65234,-0.0033467,0.12421,0,0
5,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.80312,-0.0034468,-0.024885,0,0
5,GO SECRETORY GRANULE ORGANIZATION,0.95466,-0.0036986,-0.0036566,0,0
5,GO CELL CYCLE G2 M PHASE TRANSITION,0.83713,-0.0038862,0.0025527,0,0
5,GO REGULATION OF CELL CYCLE PROCESS,0.91293,-0.0039861,-0.0076272,0,0
5,GO REGULATION OF CELL CYCLE,0.53742,-0.004061,-0.020096,0,0
5,GO UTERUS DEVELOPMENT,0.90599,-0.0042212,0.0090734,0,0
5,GO GRANULOCYTE DIFFERENTIATION,0.24643,-0.0044369,-0.093262,0,0
5,GO MOTILE CILIUM ASSEMBLY,0.78289,-0.0045878,0.046324,0,0
5,GO OXIDATIVE DEMETHYLATION,0.74288,-0.0047559,0.019864,0,0
5,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,1,-0.0048081,-0.0032642,0,0
5,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.61497,-0.0048515,0.054973,0,0
5,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.60883,-0.004909,0.026335,0,0
5,GO MITOTIC RECOMBINATION,0.80989,-0.0050048,0.017309,0,0
5,GO DNA METABOLIC PROCESS,0.74288,-0.0050077,-0.0091054,0,0
5,GO MULTICELLULAR ORGANISM AGING,0.63978,-0.0050831,-0.029271,0,0
5,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.89907,-0.0052616,0.037476,0,0
5,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.65234,-0.0054142,-0.029557,0,0
5,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.41341,-0.00562,-0.029426,0,0
5,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.38408,-0.0056215,-0.042962,0,0
5,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.34256,-0.0056804,0.065844,0,0
5,GO RESPONSE TO AUDITORY STIMULUS,0.4598,-0.0057075,0.11942,0,0
5,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.63978,-0.0057451,0.025662,0,0
5,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.78962,-0.0059026,-0.034935,0,0
5,GO REGULATION OF DENDRITE MORPHOGENESIS,0.94769,-0.005929,0.013324,0,0
5,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.85082,-0.0059332,-0.008256,0,0
5,GO PHOTOTRANSDUCTION,0.67137,-0.0060551,-0.035463,0,0
5,GO CELLULAR RESPONSE TO RADIATION,0.3746,-0.0061338,-0.037087,0,0
5,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.92682,-0.0062595,-0.0091489,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.93377,-0.0063165,0.00038883,0,0
5,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.60883,-0.0063246,-0.016907,0,0
5,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.50337,-0.0063535,0.037675,0,0
5,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.69707,-0.0064124,-0.0151,0,0
5,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.96163,-0.006481,0.0012935,0,0
5,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.3746,-0.0065623,-0.11351,0,0
5,GO CELL CYCLE PHASE TRANSITION,0.83713,-0.0066149,-0.014103,0,0
5,GO PROTEIN DEPOLYMERIZATION,0.94769,-0.0066302,0.0029375,0,0
5,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.91293,-0.006706,-0.0098897,0,0
5,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.50337,-0.006744,-0.10281,0,0
5,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.59059,-0.0067538,0.049924,0,0
5,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.43367,-0.0067781,-0.030676,0,0
5,GO REGULATION OF NEURON DIFFERENTIATION,0.60883,-0.0067838,-0.016945,0,0
5,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.84397,-0.0068222,-0.022238,0,0
5,GO HEAD DEVELOPMENT,0.88523,-0.0068585,0.0010817,0,0
5,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.93377,-0.0068813,0.011513,0,0
5,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.69707,-0.0069424,0.024368,0,0
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.84397,-0.0071062,-0.0048934,0,0
5,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.62732,-0.0073956,-0.045292,0,0
5,GO INNER DYNEIN ARM ASSEMBLY,0.78289,-0.0074931,0.056665,0,0
5,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.99651,-0.007513,0.0070331,0,0
5,GO EMBRYONIC DIGIT MORPHOGENESIS,0.78962,-0.0075736,-0.028224,0,0
5,GO SOMATIC STEM CELL DIVISION,0.17934,-0.0076638,0.21439,0,0
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.86455,-0.0077453,-0.0034407,0,0
5,GO CELL CYCLE,0.60272,-0.0079831,-0.015392,0,0
5,GO MYOTUBE CELL DEVELOPMENT,0.71658,-0.0081481,0.014727,0,0
5,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.50337,-0.0081655,-0.026573,0,0
5,GO LYMPHOCYTE COSTIMULATION,0.2839,-0.0084207,-0.064075,0,0
5,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.98255,-0.0084273,-0.020614,0,0
5,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.4978,-0.0084318,-0.026103,0,0
5,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.99651,-0.0085476,-0.000507,0,0
5,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.39858,-0.008576,-0.075064,0,0
5,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.22235,-0.0087399,-0.1105,0,0
5,GO DETECTION OF LIGHT STIMULUS,0.70355,-0.0088382,-0.031828,0,0
5,GO DETECTION OF MECHANICAL STIMULUS,0.87833,-0.0088652,0.021748,0,0
5,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.98953,-0.0089548,0.0045962,0,0
5,GO FEMALE GAMETE GENERATION,0.39371,-0.0090663,-0.030954,0,0
5,GO PROTEIN MANNOSYLATION,0.69707,-0.0091695,-0.018998,0,0
5,GO DNA MODIFICATION,0.62732,-0.0092481,-0.011754,0,0
5,GO MEIOTIC CELL CYCLE,0.9686,-0.0093658,-0.0066663,0,0
5,GO BONE CELL DEVELOPMENT,0.67776,-0.0093698,-0.03322,0,0
5,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.35607,-0.0093817,-0.028016,0,0
5,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.36991,-0.0094165,-0.034723,0,0
5,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.81668,-0.0095142,-0.037617,0,0
5,GO SEXUAL REPRODUCTION,0.34702,-0.0096613,-0.027494,0,0
5,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.88523,-0.009832,0.0051146,0,0
5,GO RESPIRATORY SYSTEM PROCESS,0.89215,-0.0098352,0.021369,0,0
5,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.41842,-0.010064,-0.06232,0,0
5,GO NUCLEOTIDE EXCISION REPAIR,0.47588,-0.010201,-0.021805,0,0
5,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.37932,-0.010275,-0.065896,0,0
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.91987,-0.010279,-0.010695,0,0
5,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.36064,-0.010422,-0.076035,0,0
5,GO ORGANELLE FISSION,0.92682,-0.010533,-0.0031575,0,0
5,GO AXON DEVELOPMENT,0.76948,-0.010602,-0.0060866,0,0
5,GO MISMATCH REPAIR,0.53167,-0.010919,-0.02625,0,0
5,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.36064,-0.010969,-0.045293,0,0
5,GO TUMOR NECROSIS FACTOR SECRETION,0.74288,-0.010992,-0.024153,0,0
5,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.72313,-0.011026,0.089501,0,0
5,GO REGULATION OF AMINO ACID TRANSPORT,0.88523,-0.011052,0.015722,0,0
5,GO POSITIVE THYMIC T CELL SELECTION,0.73628,-0.01106,0.037237,0,0
5,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.84397,-0.011063,-0.011165,0,0
5,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.68418,-0.011117,-0.038222,0,0
5,GO MEIOTIC CELL CYCLE PROCESS,0.55487,-0.011126,-0.018812,0,0
5,GO DETECTION OF VISIBLE LIGHT,0.80989,-0.011298,-0.011923,0,0
5,GO TELENCEPHALON GLIAL CELL MIGRATION,0.67776,-0.011317,-0.052369,0,0
5,GO CHONDROCYTE DEVELOPMENT,0.71658,-0.011332,-0.0018132,0,0
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.89215,-0.011375,-0.033536,0,0
5,GO POLYAMINE BIOSYNTHETIC PROCESS,0.78962,-0.011644,0.017183,0,0
5,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.93377,-0.011891,-0.00011116,0,0
5,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.91293,-0.01204,0.0084714,0,0
5,GO WATER TRANSPORT,0.96163,-0.012122,0.020271,0,0
5,GO COLLATERAL SPROUTING,0.35607,-0.012153,-0.056849,0,0
5,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.69061,-0.01217,-0.033207,0,0
5,GO CELL PART MORPHOGENESIS,0.89215,-0.012319,-0.00032983,0,0
5,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.87833,-0.012359,0.0050342,0,0
5,GO BASE EXCISION REPAIR,0.57857,-0.012554,-0.045645,0,0
5,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.59059,-0.012678,-0.017347,0,0
5,GO SODIUM ION HOMEOSTASIS,0.80989,-0.012698,0.016483,0,0
5,GO REGULATION OF TELOMERE CAPPING,0.89215,-0.012736,-0.010559,0,0
5,GO SNORNA 3 END PROCESSING,0.76948,-0.012858,0.034578,0,0
5,GO MITOTIC CYTOKINESIS,0.98953,-0.012934,-0.003348,0,0
5,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.91987,-0.013098,-0.0025953,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.62113,-0.013138,-0.017407,0,0
5,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.82348,-0.01334,0.015048,0,0
5,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.55487,-0.013371,-0.02062,0,0
5,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.76948,-0.013396,0.0091249,0,0
5,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.54321,-0.013396,-0.02824,0,0
5,GO POSITIVE REGULATION OF CELL DIVISION,0.98255,-0.01343,-0.017842,0,0
5,GO REGULATION OF DENDRITE DEVELOPMENT,0.81668,-0.013761,-0.0055153,0,0
5,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.54903,-0.013929,-0.076945,0,0
5,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.7495,-0.014087,-0.026902,0,0
5,GO LIPID DROPLET FORMATION,0.42347,-0.014298,-0.11274,0,0
5,GO STRIATUM DEVELOPMENT,0.47049,-0.014649,-0.067137,0,0
5,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.17934,-0.014867,-0.031443,0,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.7495,-0.014922,-0.022824,0,0
5,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.63354,-0.015025,-0.032191,0,0
5,GO NUCLEAR EXPORT,0.32506,-0.015394,-0.039001,0,0
5,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.26098,-0.015457,-0.079289,0,0
5,GO MITOCHONDRIAL FUSION,0.32506,-0.015479,-0.045725,0,0
5,GO MITOTIC CYTOKINETIC PROCESS,0.83713,-0.015542,0.022732,0,0
5,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.86455,-0.015622,-0.018141,0,0
5,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.51459,-0.015791,-0.013336,0,0
5,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.83713,-0.01583,0.029505,0,0
5,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.32938,-0.016085,-0.13972,0,0
5,GO NEURAL TUBE DEVELOPMENT,0.85768,-0.016194,-0.027324,0,0
5,GO CELL CYCLE G1 S PHASE TRANSITION,0.35153,-0.016434,-0.03224,0,0
5,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.76948,-0.016438,-0.08243,0,0
5,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.53742,-0.016466,-0.020303,0,0
5,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.50337,-0.016605,-0.080551,0,0
5,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.40349,-0.016612,-0.054034,0,0
5,GO REGULATION OF B CELL DIFFERENTIATION,0.69707,-0.01676,-0.03496,0,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.54321,-0.016832,-0.05837,0,0
5,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.43883,-0.01689,-0.035923,0,0
5,GO CELL CYCLE PROCESS,0.50337,-0.01697,-0.021198,0,0
5,GO SYNAPTIC VESICLE BUDDING,0.44924,-0.017135,-0.071271,0,0
5,GO REGULATION OF BEHAVIOR,0.62732,-0.017139,-0.036502,0,0
5,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.80989,-0.017198,-0.022002,0,0
5,GO NEGATIVE REGULATION OF CELL DIVISION,0.76281,-0.01725,-0.03124,0,0
5,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.76948,-0.017472,0.042101,0,0
5,GO SKELETAL MUSCLE ADAPTATION,0.41341,-0.017549,-0.061183,0,0
5,GO STRIATED MUSCLE CELL PROLIFERATION,0.51459,-0.017651,-0.042173,0,0
5,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.44924,-0.017779,-0.062576,0,0
5,GO EMBRYONIC EYE MORPHOGENESIS,0.79636,-0.01779,0.016045,0,0
5,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.33812,-0.017908,-0.042756,0,0
5,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.56075,-0.017925,-0.076521,0,0
5,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.4598,-0.018027,-0.016648,0,0
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.94073,-0.018156,-0.025906,0,0
5,GO CYTOPLASM ORGANIZATION,0.97557,-0.018234,-0.005859,0,0
5,GO EXTRACELLULAR VESICLE BIOGENESIS,0.55487,-0.018291,-0.044516,0,0
5,GO SYNAPTIC VESICLE RECYCLING,0.63354,-0.018446,-0.014101,0,0
5,GO SENSORY ORGAN MORPHOGENESIS,0.60883,-0.018456,-0.0271,0,0
5,GO CIRCADIAN RHYTHM,0.34702,-0.01848,-0.033707,0,0
5,GO NEUROGENESIS,0.46512,-0.018515,-0.018246,0,0
5,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.50337,-0.018689,0.13206,0,0
5,GO REGULATION OF ERAD PATHWAY,0.29184,-0.018819,-0.049449,0,0
5,GO SPECIFICATION OF SYMMETRY,0.80312,-0.018821,-0.0022426,0,0
5,GO NCRNA TRANSCRIPTION,0.43883,-0.018993,-0.023687,0,0
5,GO CELL CELL JUNCTION MAINTENANCE,0.74288,-0.019026,0.051093,0,0
5,GO POSITIVE REGULATION OF CELL GROWTH,0.32938,-0.01907,-0.038034,0,0
5,GO CELL PROJECTION ORGANIZATION,0.42855,-0.019301,-0.02319,0,0
5,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.42855,-0.019336,-0.11699,0,0
5,GO MEIOSIS I CELL CYCLE PROCESS,0.56075,-0.019385,-0.023179,0,0
5,GO POSTREPLICATION REPAIR,0.43883,-0.019645,-0.029915,0,0
5,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.40349,-0.019774,-0.055836,0,0
5,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.52025,-0.019929,-0.04241,0,0
5,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.59664,-0.020007,-0.068558,0,0
5,GO POSITIVE REGULATION OF HORMONE SECRETION,0.52025,-0.020084,-0.023952,0,0
5,GO LUNG EPITHELIUM DEVELOPMENT,0.91987,-0.020107,0.030549,0,0
5,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.98953,-0.020139,-0.0073348,0,0
5,GO PH REDUCTION,0.8303,-0.020183,-0.016003,0,0
5,GO AROMATIC AMINO ACID TRANSPORT,0.50337,-0.020196,-0.10611,0,0
5,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.23245,-0.020204,-0.052695,0,0
5,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.61497,-0.020519,-0.01423,0,0
5,GO AXIS SPECIFICATION,0.26098,-0.020676,-0.062965,0,0
5,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.26098,-0.020765,-0.12596,0,0
5,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.17653,-0.020819,-0.03218,0,0
5,GO NEGATIVE REGULATION OF CELL CYCLE,0.15015,-0.020879,-0.037527,0,0
5,GO DNA METHYLATION,0.76948,-0.020911,-0.0040747,0,0
5,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.5726,-0.021064,-0.034696,0,0
5,GO NEURON DIFFERENTIATION,0.73628,-0.021237,-0.0037087,0,0
5,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.48131,-0.021367,-0.055381,0,0
5,GO VASCULAR WOUND HEALING,0.24643,-0.021446,-0.1088,0,0
5,GO AXON EXTENSION,0.4598,-0.021469,-0.042037,0,0
5,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.41341,-0.021531,-0.021464,0,0
5,GO RENAL ABSORPTION,0.27227,-0.021649,-0.17625,0,0
5,GO REGULATION OF SYNAPTIC PLASTICITY,0.74288,-0.021654,-0.0099479,0,0
5,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.43883,-0.021783,-0.076265,0,0
5,GO MULTIVESICULAR BODY ORGANIZATION,0.76281,-0.02183,-0.009642,0,0
5,GO RESPONSE TO LIGHT STIMULUS,0.26098,-0.021856,-0.030585,0,0
5,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.61497,-0.022021,-0.0071042,0,0
5,GO EAR DEVELOPMENT,0.38888,-0.022034,-0.043922,0,0
5,GO REGULATION OF STEM CELL DIFFERENTIATION,0.20309,-0.022086,-0.088371,0,0
5,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.44402,-0.02219,-0.043895,0,0
5,GO REGULATION OF CELL DEVELOPMENT,0.27999,-0.022195,-0.03681,0,0
5,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.43883,-0.022304,-0.03844,0,0
5,GO MEMBRANE FISSION,0.31232,-0.022511,0.089667,0,0
5,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.98255,-0.022548,-0.0063342,0,0
5,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.53167,-0.022554,-0.024582,0,0
5,GO MULTICELLULAR ORGANISM REPRODUCTION,0.31653,-0.022592,-0.026966,0,0
5,GO STRESS GRANULE ASSEMBLY,0.28785,-0.022699,-0.06421,0,0
5,GO APPENDAGE DEVELOPMENT,0.61497,-0.022707,-0.036618,0,0
5,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.7495,-0.022721,-0.019621,0,0
5,GO PATTERN SPECIFICATION PROCESS,0.72313,-0.022824,-0.021064,0,0
5,GO CALCINEURIN MEDIATED SIGNALING,0.37932,-0.022829,-0.049407,0,0
5,GO NEURON APOPTOTIC PROCESS,0.67137,-0.022866,-0.0066899,0,0
5,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.81668,-0.022988,-0.011957,0,0
5,GO HIPPO SIGNALING,0.50896,-0.023011,-0.10249,0,0
5,GO N GLYCAN PROCESSING,0.67137,-0.023022,-0.033875,0,0
5,GO DISTAL TUBULE DEVELOPMENT,0.95466,-0.023046,-0.052431,0,0
5,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.35153,-0.023071,-0.039126,0,0
5,GO WATER HOMEOSTASIS,0.60883,-0.023081,-0.03158,0,0
5,GO CARDIAC MUSCLE CELL PROLIFERATION,0.53167,-0.023086,-0.052046,0,0
5,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.81668,-0.023129,-0.015448,0,0
5,GO CRANIAL NERVE DEVELOPMENT,0.36991,-0.023212,-0.067045,0,0
5,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.67776,-0.023214,-0.015688,0,0
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.66501,-0.02341,0.030296,0,0
5,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.43367,-0.023523,-0.084836,0,0
5,GO LIPID PHOSPHORYLATION,0.22568,-0.023546,-0.045078,0,0
5,GO REGULATION OF ANIMAL ORGAN FORMATION,0.89215,-0.023793,-0.037558,0,0
5,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.79636,-0.023805,0.04173,0,0
5,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.27227,-0.023888,-0.025037,0,0
5,GO PRO B CELL DIFFERENTIATION,0.78289,-0.02395,0.020827,0,0
5,GO SYNAPSE MATURATION,0.65866,-0.024006,-0.057189,0,0
5,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.88523,-0.02405,-0.033262,0,0
5,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.17374,-0.024184,-0.030456,0,0
5,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.85082,-0.024238,0.0102,0,0
5,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.40349,-0.024401,-0.014544,0,0
5,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.60883,-0.024436,-0.035903,0,0
5,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.11636,-0.02463,-0.068989,0,0
5,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.74288,-0.024716,-0.015294,0,0
5,GO PEPTIDYL LYSINE DIMETHYLATION,0.93377,-0.024843,0.012488,0,0
5,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.77618,-0.024976,-0.031617,0,0
5,GO OOCYTE MATURATION,0.41842,-0.02498,-0.03103,0,0
5,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.41341,-0.024991,-0.05251,0,0
5,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.29184,-0.025109,-0.0089488,0,0
5,GO REGULATION OF NUCLEAR DIVISION,0.72313,-0.025338,-0.01145,0,0
5,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.98255,-0.025344,0.00455,0,0
5,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,1,-0.025633,-0.0067667,0,0
5,GO MALE MEIOSIS I,0.21256,-0.025643,-0.12418,0,0
5,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.80989,-0.025667,-0.016302,0,0
5,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.80989,-0.02574,0.0050909,0,0
5,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.4545,-0.025784,-0.065862,0,0
5,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.94073,-0.025933,-0.0040084,0,0
5,GO NEURON DEVELOPMENT,0.57857,-0.026006,-0.017359,0,0
5,GO NUCLEAR MIGRATION,0.76948,-0.026036,-0.027583,0,0
5,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.59059,-0.026042,-0.01965,0,0
5,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.86455,-0.026094,-0.013499,0,0
5,GO ORGANELLE ASSEMBLY,0.17099,-0.026101,-0.032575,0,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.55487,-0.026137,-0.059076,0,0
5,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.88523,-0.026214,0.012449,0,0
5,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.49227,-0.026307,-0.049555,0,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.56666,-0.026534,-0.016754,0,0
5,GO RESPONSE TO COCAINE,0.66501,-0.026617,-0.0084415,0,0
5,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.30815,-0.026636,-0.060054,0,0
5,GO REGULATION OF TELOMERE MAINTENANCE,0.33373,-0.02668,-0.043495,0,0
5,GO POSITIVE REGULATION OF NEURON MIGRATION,0.33812,-0.026778,-0.1058,0,0
5,GO POSITIVE REGULATION OF CYTOKINESIS,0.52025,-0.026904,-0.018628,0,0
5,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.47049,-0.027035,0.063502,0,0
5,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.25729,-0.027046,-0.049904,0,0
5,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.8303,-0.02714,0.056734,0,0
5,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.61497,-0.027241,-0.11571,0,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.38408,-0.027358,-0.054809,0,0
5,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.65234,-0.027372,0.042094,0,0
5,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.48131,-0.027447,-0.033463,0,0
5,GO ASTROCYTE ACTIVATION,0.65234,-0.027489,-0.039566,0,0
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.41341,-0.027493,-0.073142,0,0
5,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.36526,-0.027572,-0.034386,0,0
5,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.93377,-0.027649,0.013008,0,0
5,GO VESICLE LOCALIZATION,0.10465,-0.027779,-0.047995,0,0
5,GO NEGATIVE T CELL SELECTION,0.35607,-0.027922,-0.074662,0,0
5,GO LONG TERM SYNAPTIC POTENTIATION,0.67137,-0.027976,-0.0353,0,0
5,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.59664,-0.028374,-0.034249,0,0
5,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.29992,-0.028521,-0.041723,0,0
5,GO NUCLEUS ORGANIZATION,0.23937,-0.028732,-0.037932,0,0
5,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.7495,-0.02882,-0.00075488,0,0
5,GO HAIR CELL DIFFERENTIATION,0.73628,-0.028848,-0.036165,0,0
5,GO HISTONE H3 K14 ACETYLATION,0.95466,-0.028955,0.0079094,0,0
5,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.69061,-0.028981,-0.027133,0,0
5,GO ALDEHYDE CATABOLIC PROCESS,0.59059,-0.029128,-0.050802,0,0
5,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.3746,-0.029179,-0.025945,0,0
5,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.91293,-0.029283,-0.031183,0,0
5,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.89215,-0.029358,-0.0024768,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.12049,-0.029409,-0.040232,0,0
5,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.32077,-0.029423,-0.065977,0,0
5,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.36064,-0.029573,-0.04422,0,0
5,GO GAMMA DELTA T CELL ACTIVATION,0.39371,-0.029614,0.09806,0,0
5,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.20621,-0.029641,-0.076345,0,0
5,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.55487,-0.029749,-0.030738,0,0
5,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.37932,-0.02982,-0.040406,0,0
5,GO HINDLIMB MORPHOGENESIS,0.93377,-0.029854,-0.0028301,0,0
5,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.71658,-0.029859,-0.048033,0,0
5,GO CELLULAR COMPONENT MORPHOGENESIS,0.50896,-0.029951,-0.015822,0,0
5,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.20937,-0.030082,-0.048219,0,0
5,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.19695,-0.030177,-0.082663,0,0
5,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.31653,-0.030336,-0.067646,0,0
5,GO NUCLEAR TRANSPORT,0.059411,-0.030356,-0.05576,0,0
5,GO NEURON RECOGNITION,0.78289,-0.030365,0.02732,0,0
5,GO T CELL HOMEOSTASIS,0.57857,-0.030473,-0.02237,0,0
5,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.63354,-0.030497,-0.018489,0,0
5,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.26098,-0.030593,-0.09502,0,0
5,GO REGULATION OF GLIOGENESIS,0.72313,-0.030609,0.0083032,0,0
5,GO VESICLE FUSION TO PLASMA MEMBRANE,0.4598,-0.030624,0.005668,0,0
5,GO ACTIVATION OF MAPKK ACTIVITY,0.51459,-0.030671,-0.048712,0,0
5,GO NEURON PROJECTION ORGANIZATION,0.60272,-0.030729,-0.043325,0,0
5,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.96163,-0.030833,0.00063951,0,0
5,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.44402,-0.030859,-0.029893,0,0
5,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.50337,-0.030865,-0.036705,0,0
5,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.98953,-0.030953,0.030169,0,0
5,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.49227,-0.031235,-0.042939,0,0
5,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.64605,-0.031237,-0.063717,0,0
5,GO POSITIVE REGULATION OF CELL MATURATION,0.53742,-0.031303,-0.11776,0,0
5,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.63978,-0.031318,-0.02525,0,0
5,GO CEREBRAL CORTEX CELL MIGRATION,0.5726,-0.031339,-0.032676,0,0
5,GO PROTEIN LOCALIZATION TO NUCLEUS,0.070855,-0.031387,-0.056119,0,0
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.42855,-0.031491,-0.049532,0,0
5,GO METHYLATION,0.057089,-0.031857,-0.040341,0,0
5,GO MIDBODY ABSCISSION,0.89215,-0.03195,0.039192,0,0
5,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.75615,-0.03207,-0.029682,0,0
5,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.2839,-0.032173,-0.078524,0,0
5,GO REGULATION OF MRNA METABOLIC PROCESS,0.15015,-0.032174,-0.047116,0,0
5,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.65234,-0.032419,-0.054976,0,0
5,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.80312,-0.032451,-0.016179,0,0
5,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.60883,-0.032579,-0.010035,0,0
5,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.74288,-0.032631,0.00087537,0,0
5,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.14285,-0.03264,-0.10415,0,0
5,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.44924,-0.032668,-0.033421,0,0
5,GO SNORNA METABOLIC PROCESS,0.69707,-0.032691,-0.023134,0,0
5,GO RESPONSE TO VITAMIN D,0.72969,-0.032727,-0.05141,0,0
5,GO HISTONE H2B UBIQUITINATION,0.91293,-0.032775,-0.0085243,0,0
5,GO COBALAMIN METABOLIC PROCESS,0.29992,-0.033012,-0.094602,0,0
5,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.12259,-0.033034,-0.051695,0,0
5,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.097379,-0.033152,-0.063276,0,0
5,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.8303,-0.033161,0.078211,0,0
5,GO RNA LOCALIZATION,0.15015,-0.033194,-0.058152,0,0
5,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.57857,-0.033256,-0.02174,0,0
5,GO REGULATION OF GENE SILENCING,0.063042,-0.033335,-0.076712,0,0
5,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.38888,-0.033447,-0.047062,0,0
5,GO MRNA CLEAVAGE,0.26098,-0.033464,-0.039648,0,0
5,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.10096,-0.033504,-0.04843,0,0
5,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.51459,-0.033522,-0.039391,0,0
5,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.26098,-0.033587,-0.052559,0,0
5,GO REPRODUCTIVE BEHAVIOR,0.56666,-0.033631,-0.044329,0,0
5,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.31232,-0.033673,-0.082631,0,0
5,GO POTASSIUM ION HOMEOSTASIS,0.73628,-0.033702,-0.017617,0,0
5,GO SLEEP,0.29992,-0.033736,-0.064797,0,0
5,GO MIDBRAIN DEVELOPMENT,0.4545,-0.03381,-0.028751,0,0
5,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.51459,-0.033822,-0.019102,0,0
5,GO SENSORY ORGAN DEVELOPMENT,0.34256,-0.033824,-0.037252,0,0
5,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.26847,-0.033854,-0.060662,0,0
5,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.62113,-0.033865,-0.0079919,0,0
5,GO REGULATION OF CELL MATURATION,0.46512,-0.033933,-0.032311,0,0
5,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.98255,-0.033934,0.016786,0,0
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.59059,-0.033942,-0.048284,0,0
5,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.48678,-0.033962,-0.087823,0,0
5,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.85082,-0.034032,-0.0046472,0,0
5,GO HISTONE MRNA METABOLIC PROCESS,0.32506,-0.034243,-0.046667,0,0
5,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.41341,-0.034599,-0.079966,0,0
5,GO MULTICELLULAR ORGANISM GROWTH,0.23589,-0.034748,-0.036105,0,0
5,GO REGULATION OF INTEGRIN ACTIVATION,0.34256,-0.034768,-0.097004,0,0
5,GO HEART FORMATION,0.91987,-0.034826,0.0071559,0,0
5,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.48131,-0.034852,-0.042293,0,0
5,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.4978,-0.034881,-0.032604,0,0
5,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.42347,-0.034959,-0.056422,0,0
5,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.67137,-0.035457,-0.050445,0,0
5,GO CELLULAR SENESCENCE,0.13814,-0.035491,-0.05516,0,0
5,GO CYTOSKELETON ORGANIZATION,0.054842,-0.035532,-0.058207,0,0
5,GO AXO DENDRITIC PROTEIN TRANSPORT,0.88523,-0.035536,-0.0084278,0,0
5,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.26471,-0.035563,-0.041378,0,0
5,GO REGULATION OF MITOPHAGY,0.62113,-0.035579,-0.021042,0,0
5,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.11434,-0.035684,-0.095012,0,0
5,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.68418,-0.035864,-0.026114,0,0
5,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.8303,-0.03589,0.0073254,0,0
5,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.58456,-0.036057,-0.054125,0,0
5,GO RESPONSE TO GLUCAGON,0.55487,-0.036217,-0.031535,0,0
5,GO RNA POLYADENYLATION,0.099158,-0.036394,-0.074677,0,0
5,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.87833,-0.036653,0.002457,0,0
5,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.19095,-0.036825,-0.099701,0,0
5,GO MIDGUT DEVELOPMENT,0.32506,-0.036834,-0.10514,0,0
5,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.011612,-0.037054,-0.053987,0,0
5,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.28785,-0.03713,-0.041607,0,0
5,GO COGNITION,0.52594,-0.03714,-0.026257,0,0
5,GO ACTIN NUCLEATION,0.15517,-0.037227,-0.069169,0,0
5,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.20937,-0.037255,-0.087951,0,0
5,GO SYNAPTIC VESICLE MATURATION,0.88523,-0.037294,0.035884,0,0
5,GO TORC1 SIGNALING,0.27611,-0.037373,-0.056403,0,0
5,GO ERBB2 SIGNALING PATHWAY,0.31232,-0.037405,-0.073469,0,0
5,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.34256,-0.037546,-0.047706,0,0
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.72969,-0.03761,0.01066,0,0
5,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.085627,-0.037622,-0.062759,0,0
5,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.22568,-0.037625,-0.073689,0,0
5,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.32938,-0.03763,-0.092671,0,0
5,GO EMBRYONIC AXIS SPECIFICATION,0.35607,-0.037845,-0.058105,0,0
5,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.32077,-0.037922,-0.062939,0,0
5,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.58456,-0.03796,-0.043204,0,0
5,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.097379,-0.038056,-0.0638,0,0
5,GO POLYAMINE METABOLIC PROCESS,0.92682,-0.038127,0.0068499,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.38408,-0.038285,-0.059056,0,0
5,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.2839,-0.038455,-0.096756,0,0
5,GO INHIBITORY SYNAPSE ASSEMBLY,0.90599,-0.038481,0.045413,0,0
5,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.60883,-0.038578,-0.023324,0,0
5,GO PROTEIN ADP RIBOSYLATION,0.67137,-0.038605,-0.0073519,0,0
5,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.14285,-0.038711,-0.057201,0,0
5,GO LIMBIC SYSTEM DEVELOPMENT,0.42347,-0.038909,-0.035662,0,0
5,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.44402,-0.038961,-0.085002,0,0
5,GO ACTIVATION OF GTPASE ACTIVITY,0.079444,-0.038971,-0.075588,0,0
5,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.33373,-0.039301,-0.092221,0,0
5,GO REGULATION OF MYELINATION,0.38888,-0.039445,-0.037529,0,0
5,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.79636,-0.039532,-0.069757,0,0
5,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.27227,-0.039569,-0.052484,0,0
5,GO ACTIN CYTOSKELETON REORGANIZATION,0.25001,-0.039698,-0.064596,0,0
5,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.54903,-0.039935,-0.033326,0,0
5,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.30815,-0.03994,-0.041623,0,0
5,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.83713,-0.040137,-0.010501,0,0
5,GO ESTABLISHMENT OF RNA LOCALIZATION,0.15517,-0.040169,-0.054154,0,0
5,GO ENDOCRINE PANCREAS DEVELOPMENT,0.43367,-0.040205,-0.0482,0,0
5,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.26098,-0.040273,-0.035178,0,0
5,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.78962,-0.040321,-0.019825,0,0
5,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.62732,-0.040432,-0.016728,0,0
5,GO HOMOLOGOUS RECOMBINATION,0.29586,-0.040471,-0.050234,0,0
5,GO RETINOIC ACID METABOLIC PROCESS,0.4978,-0.040485,-0.055218,0,0
5,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.30815,-0.040497,-0.066222,0,0
5,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.68418,-0.040575,-0.054096,0,0
5,GO AORTA MORPHOGENESIS,0.78289,-0.040621,-0.030632,0,0
5,GO SENSORY SYSTEM DEVELOPMENT,0.36064,-0.040706,-0.033957,0,0
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.35607,-0.040709,-0.040786,0,0
5,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.51459,-0.040951,-0.084723,0,0
5,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.29586,-0.040995,-0.051324,0,0
5,GO SYNAPTIC VESICLE PRIMING,0.77618,-0.041045,0.047387,0,0
5,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.78289,-0.041125,-0.013819,0,0
5,GO ADHERENS JUNCTION ORGANIZATION,0.24643,-0.041233,-0.058574,0,0
5,GO MYELOID DENDRITIC CELL ACTIVATION,0.2839,-0.041337,-0.076406,0,0
5,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.30815,-0.041499,-0.059229,0,0
5,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.46512,-0.041515,-0.03518,0,0
5,GO REGULATION OF MEIOTIC CELL CYCLE,0.4978,-0.041551,-0.023618,0,0
5,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.20937,-0.041575,-0.069188,0,0
5,GO NUCLEUS LOCALIZATION,0.52594,-0.041771,-0.033561,0,0
5,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.51459,-0.041841,-0.047789,0,0
5,GO CAMERA TYPE EYE DEVELOPMENT,0.34702,-0.041885,-0.034865,0,0
5,GO REGULATION OF MRNA 3 END PROCESSING,0.41842,-0.041886,-0.04302,0,0
5,GO HYPOTHALAMUS DEVELOPMENT,0.27999,-0.041917,-0.081219,0,0
5,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.21579,-0.042012,-0.051619,0,0
5,GO SKIN EPIDERMIS DEVELOPMENT,0.24643,-0.042182,-0.090592,0,0
5,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.17374,-0.042208,-0.051388,0,0
5,GO NEURON PROJECTION EXTENSION,0.33812,-0.042398,-0.042369,0,0
5,GO REGULATION OF CELLULAR PH,0.059411,-0.042585,-0.071217,0,0
5,GO REGULATION OF RNA BINDING,0.34256,-0.042615,-0.0725,0,0
5,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.79636,-0.042669,-0.03441,0,0
5,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.93377,-0.042956,0.0028466,0,0
5,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.32077,-0.04301,-0.057888,0,0
5,GO PROSTATE GLAND MORPHOGENESIS,0.87144,-0.043021,-0.071266,0,0
5,GO ETHANOL CATABOLIC PROCESS,0.36064,-0.043026,-0.083685,0,0
5,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.16294,-0.043079,-0.070889,0,0
5,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.75615,-0.04316,-0.039928,0,0
5,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.32506,-0.043238,-0.049258,0,0
5,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.43367,-0.043242,-0.019871,0,0
5,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0695,-0.043386,-0.054656,0,0
5,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.31653,-0.04344,-0.054397,0,0
5,GO REGULATION OF LIGASE ACTIVITY,0.25729,-0.043453,-0.093372,0,0
5,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.36526,-0.043642,-0.057319,0,0
5,GO ARTERY MORPHOGENESIS,0.30402,-0.043674,-0.074375,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.24288,-0.043884,-0.080945,0,0
5,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.41341,-0.043944,-0.03342,0,0
5,GO NEGATIVE REGULATION OF NEURON DEATH,0.095625,-0.043964,-0.046006,0,0
5,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.15517,-0.043971,-0.063611,0,0
5,GO CELL MATURATION,0.20621,-0.044071,-0.044226,0,0
5,GO EMBRYONIC BODY MORPHOGENESIS,0.54321,-0.044143,-0.043876,0,0
5,GO EPITHELIAL TUBE FORMATION,0.41341,-0.04415,-0.048695,0,0
5,GO POSITIVE REGULATION OF INSULIN SECRETION,0.30815,-0.044186,-0.044702,0,0
5,GO EXCITATORY SYNAPSE ASSEMBLY,0.74288,-0.04421,-0.029808,0,0
5,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.38888,-0.044354,-0.03836,0,0
5,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.47049,-0.044401,-0.049781,0,0
5,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.15773,-0.044463,-0.083932,0,0
5,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.13814,-0.044464,-0.17537,0,0
5,GO PIGMENT GRANULE LOCALIZATION,0.5726,-0.044534,-0.03159,0,0
5,GO RNA DESTABILIZATION,0.62113,-0.044623,-0.036263,0,0
5,GO DENDRITIC SPINE DEVELOPMENT,0.43367,-0.044762,-0.053526,0,0
5,GO REGULATION OF CELL DIFFERENTIATION,0.012508,-0.044949,-0.073069,0,0
5,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.46512,-0.044997,-0.030054,0,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.97557,-0.045017,0.0006929,0,0
5,GO RNA 3 END PROCESSING,0.70355,-0.045115,-0.024948,0,0
5,GO NEGATIVE REGULATION OF BEHAVIOR,0.36991,-0.045319,-0.060283,0,0
5,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.10096,-0.045412,-0.075887,0,0
5,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.26847,-0.045435,-0.035956,0,0
5,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.41842,-0.045501,-0.041285,0,0
5,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.47049,-0.045815,-0.061991,0,0
5,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.084046,-0.045824,-0.13267,0,0
5,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.32077,-0.045857,-0.10776,0,0
5,GO REGULATION OF ENDOCYTIC RECYCLING,0.44402,-0.045862,-0.058783,0,0
5,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.76281,-0.045864,-0.049741,0,0
5,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.39371,-0.045965,-0.03366,0,0
5,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.85082,-0.046016,0.0030344,0,0
5,GO PROTEIN POLYUBIQUITINATION,0.13355,-0.046034,-0.04647,0,0
5,GO AXONAL FASCICULATION,0.43367,-0.046072,-0.069956,0,0
5,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.60883,-0.046082,-0.048643,0,0
5,GO RESPONSE TO ANTIBIOTIC,0.21256,-0.046212,-0.06221,0,0
5,GO CYTOKINETIC PROCESS,0.42855,-0.046225,-0.049813,0,0
5,GO REGULATION OF WNT SIGNALING PATHWAY,0.075049,-0.046339,-0.068046,0,0
5,GO NEURAL TUBE FORMATION,0.44402,-0.046367,-0.043523,0,0
5,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.41341,-0.046392,-0.044818,0,0
5,GO DEVELOPMENTAL CELL GROWTH,0.087232,-0.046439,-0.068449,0,0
5,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.50337,-0.046466,-0.095925,0,0
5,GO LAYER FORMATION IN CEREBRAL CORTEX,0.39858,-0.046495,-0.062556,0,0
5,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.020205,-0.046738,-0.081151,0,0
5,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.40349,-0.046775,-0.056522,0,0
5,GO REGULATION OF VASOCONSTRICTION,0.22235,-0.046904,-0.078293,0,0
5,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.83713,-0.046917,0.018461,0,0
5,GO SYNAPTIC VESICLE EXOCYTOSIS,0.3746,-0.046967,0.011593,0,0
5,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.97557,-0.046975,-0.0029792,0,0
5,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.60883,-0.047078,-0.015564,0,0
5,GO RESPIRATORY SYSTEM DEVELOPMENT,0.20621,-0.047172,-0.063978,0,0
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.25729,-0.047327,-0.097207,0,0
5,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.26471,-0.047378,-0.08531,0,0
5,GO VIRAL BUDDING,0.83713,-0.047408,0.0074334,0,0
5,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.5726,-0.047427,-0.074618,0,0
5,GO PHAGOLYSOSOME ASSEMBLY,0.27999,-0.047506,-0.11811,0,0
5,GO MEMORY,0.25001,-0.047513,-0.055161,0,0
5,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.14769,-0.0476,-0.069107,0,0
5,GO REGULATION OF ANION TRANSPORT,0.14526,-0.04762,-0.073603,0,0
5,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.22568,-0.047645,-0.063565,0,0
5,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.41341,-0.047719,-0.08365,0,0
5,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.084046,-0.047981,-0.08692,0,0
5,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.25729,-0.04803,-0.050982,0,0
5,GO REGULATION OF EXOCYTOSIS,0.099158,-0.048188,-0.050869,0,0
5,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.12908,-0.048255,-0.056911,0,0
5,GO RESPONSE TO POTASSIUM ION,0.76281,-0.048336,-0.0056634,0,0
5,GO HISTONE H3 DEACETYLATION,0.52025,-0.048388,-0.027064,0,0
5,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.11235,-0.048506,-0.055169,0,0
5,GO PROTEIN AUTOUBIQUITINATION,0.092194,-0.048508,-0.049086,0,0
5,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.69707,-0.048541,-0.025343,0,0
5,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.33812,-0.048559,-0.019001,0,0
5,GO REGULATION OF ACTIN NUCLEATION,0.20937,-0.048593,-0.082058,0,0
5,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.63978,-0.048668,-0.021726,0,0
5,GO ACTIVATED T CELL PROLIFERATION,0.54321,-0.048772,-0.041481,0,0
5,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.38888,-0.048823,-0.046396,0,0
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.28785,-0.049037,-0.10881,0,0
5,GO INTRA S DNA DAMAGE CHECKPOINT,0.28785,-0.049175,-0.04752,0,0
5,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.42347,-0.049387,-0.041197,0,0
5,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.71658,-0.049492,-0.0042801,0,0
5,GO CILIUM MOVEMENT,0.87833,-0.04957,0.0012142,0,0
5,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.31232,-0.049618,-0.10111,0,0
5,GO PROTEIN O LINKED MANNOSYLATION,0.46512,-0.049856,-0.04094,0,0
5,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.16828,-0.049948,-0.089976,0,0
5,GO REGULATION OF CELL MORPHOGENESIS,0.14048,-0.050133,-0.059542,0,0
5,GO EATING BEHAVIOR,0.23589,-0.050168,-0.057355,0,0
5,GO SYNAPTIC VESICLE DOCKING,0.4598,-0.05026,0.0071232,0,0
5,GO SOMITOGENESIS,0.080955,-0.050309,-0.078712,0,0
5,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.59664,-0.050477,-0.016909,0,0
5,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.19393,-0.050737,-0.050725,0,0
5,GO PEPTIDYL THREONINE MODIFICATION,0.082489,-0.050833,-0.059545,0,0
5,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.62732,-0.051112,-0.06381,0,0
5,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.17934,-0.051316,-0.079516,0,0
5,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.061812,-0.051326,-0.066899,0,0
5,GO RUFFLE ORGANIZATION,0.31653,-0.051657,-0.04678,0,0
5,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.54903,-0.051863,-0.036008,0,0
5,GO EPIDERMIS MORPHOGENESIS,0.91293,-0.051867,-0.013463,0,0
5,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.32506,-0.05196,-0.09291,0,0
5,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.26471,-0.052186,-0.032265,0,0
5,GO CIRCADIAN SLEEP WAKE CYCLE,0.38888,-0.052248,-0.058333,0,0
5,GO NEGATIVE REGULATION OF AXON EXTENSION,0.43883,-0.052397,-0.059547,0,0
5,GO REGULATION OF HEART MORPHOGENESIS,0.57857,-0.05242,-0.075702,0,0
5,GO PARTURITION,0.87833,-0.052528,-0.013812,0,0
5,GO NUCLEAR PORE ORGANIZATION,0.62732,-0.052539,-0.047107,0,0
5,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.16828,-0.052553,-0.053607,0,0
5,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.1313,-0.052571,-0.053123,0,0
5,GO POSITIVE REGULATION OF ERAD PATHWAY,0.19095,-0.052575,-0.10706,0,0
5,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.090515,-0.052687,-0.057877,0,0
5,GO TRANSLESION SYNTHESIS,0.17934,-0.052704,-0.055838,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.21905,-0.052841,-0.04996,0,0
5,GO RESPONSE TO LEAD ION,0.33812,-0.052939,-0.063094,0,0
5,GO PROTEIN DESTABILIZATION,0.16559,-0.052953,-0.056082,0,0
5,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.14769,-0.053003,-0.067707,0,0
5,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.35153,-0.053205,-0.034101,0,0
5,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.37932,-0.053432,-0.05963,0,0
5,GO SEGMENTATION,0.065563,-0.053457,-0.089991,0,0
5,GO REGULATION OF ORGANELLE ASSEMBLY,0.082489,-0.053505,-0.045905,0,0
5,GO SNRNA METABOLIC PROCESS,0.15264,-0.053583,-0.10139,0,0
5,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.092194,-0.053759,-0.092776,0,0
5,GO REGULATION OF OOGENESIS,0.67776,-0.053799,-0.0060459,0,0
5,GO REGULATION OF RENAL SYSTEM PROCESS,0.35607,-0.053859,-0.078787,0,0
5,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.49227,-0.053897,-0.015693,0,0
5,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.055956,-0.05408,-0.063144,0,0
5,GO POSITIVE REGULATION OF AXON EXTENSION,0.43367,-0.054136,-0.042707,0,0
5,GO REGULATION OF RESPONSE TO FOOD,0.37932,-0.054208,-0.057225,0,0
5,GO INOSITOL METABOLIC PROCESS,0.58456,-0.054385,-0.035045,0,0
5,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.65866,-0.054474,-0.0039713,0,0
5,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.36064,-0.054503,-0.12201,0,0
5,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.15015,-0.054542,-0.10284,0,0
5,GO EAR MORPHOGENESIS,0.29184,-0.054565,-0.056037,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.32938,-0.054584,-0.06904,0,0
5,GO STEM CELL DIFFERENTIATION,0.072231,-0.054589,-0.064709,0,0
5,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.2839,-0.054883,-0.070919,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.24643,-0.055477,-0.053394,0,0
5,GO RESPONSE TO UV C,0.68418,-0.055518,-0.024969,0,0
5,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.15015,-0.055575,-0.047475,0,0
5,GO C4 DICARBOXYLATE TRANSPORT,0.23937,-0.055697,-0.065832,0,0
5,GO MIRNA METABOLIC PROCESS,0.080955,-0.055792,-0.079534,0,0
5,GO TISSUE HOMEOSTASIS,0.085627,-0.055792,-0.077946,0,0
5,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.60272,-0.055924,-0.02575,0,0
5,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.27611,-0.056118,-0.12826,0,0
5,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.52594,-0.056183,-0.030177,0,0
5,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.19695,-0.056189,-0.10943,0,0
5,GO SYNAPTIC SIGNALING,0.50337,-0.056219,-0.010069,0,0
5,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.12259,-0.056309,-0.055822,0,0
5,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.059411,-0.056353,-0.12189,0,0
5,GO ADULT FEEDING BEHAVIOR,0.64605,-0.05637,-0.050924,0,0
5,GO PRESYNAPTIC ENDOCYTOSIS,0.49227,-0.056454,-0.026071,0,0
5,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.18219,-0.05646,-0.07579,0,0
5,GO REGULATION OF GTP BINDING,0.17653,-0.056546,-0.12085,0,0
5,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.61497,-0.056616,-0.039324,0,0
5,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.44402,-0.056658,-0.053228,0,0
5,GO NEGATIVE REGULATION OF CELL SIZE,0.090515,-0.056924,-0.11115,0,0
5,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.22905,-0.056927,-0.07492,0,0
5,GO LEARNING,0.59059,-0.056928,-0.021715,0,0
5,GO KERATINIZATION,0.55487,-0.056947,-0.022468,0,0
5,GO CELL MORPHOGENESIS,0.17934,-0.056969,-0.047084,0,0
5,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.24643,-0.057062,-0.050648,0,0
5,GO NEGATIVE REGULATION OF JNK CASCADE,0.12259,-0.057076,-0.072662,0,0
5,GO VIRION ASSEMBLY,0.14048,-0.057083,-0.063703,0,0
5,GO CONVERGENT EXTENSION,0.62113,-0.057086,-0.032408,0,0
5,GO REGIONALIZATION,0.54903,-0.057086,-0.031747,0,0
5,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.31653,-0.057182,-0.12746,0,0
5,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.35153,-0.057191,-0.041034,0,0
5,GO CELL VOLUME HOMEOSTASIS,0.087232,-0.057435,-0.07305,0,0
5,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.36991,-0.057508,-0.071666,0,0
5,GO FOREBRAIN CELL MIGRATION,0.35607,-0.057569,-0.040507,0,0
5,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.17374,-0.057577,-0.04471,0,0
5,GO IN UTERO EMBRYONIC DEVELOPMENT,0.084046,-0.057608,-0.056977,0,0
5,GO PROTEIN PALMITOYLATION,0.38408,-0.057637,-0.031696,0,0
5,GO MAST CELL MEDIATED IMMUNITY,0.36064,-0.057811,-0.050694,0,0
5,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.20621,-0.057826,-0.12645,0,0
5,GO SKELETAL SYSTEM MORPHOGENESIS,0.075049,-0.057889,-0.094254,0,0
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.26471,-0.058001,-0.093459,0,0
5,GO ADULT BEHAVIOR,0.4598,-0.058046,-0.011037,0,0
5,GO LACTATE METABOLIC PROCESS,0.54321,-0.058058,-0.024513,0,0
5,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.53742,-0.058112,-0.13505,0,0
5,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.188,-0.058162,-0.062856,0,0
5,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.33812,-0.058256,-0.061067,0,0
5,GO POSITIVE REGULATION OF NEURON DEATH,0.099158,-0.058289,-0.062218,0,0
5,GO ALPHA BETA T CELL DIFFERENTIATION,0.26847,-0.058319,-0.075739,0,0
5,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.36526,-0.058523,-0.037411,0,0
5,GO RHYTHMIC PROCESS,0.066855,-0.058602,-0.053447,0,0
5,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.48678,-0.05863,-0.044364,0,0
5,GO RNA STABILIZATION,0.29992,-0.058718,-0.055389,0,0
5,GO CELLULAR RESPONSE TO ALKALOID,0.11841,-0.058895,-0.075949,0,0
5,GO INTERFERON ALPHA PRODUCTION,0.46512,-0.05892,-0.059891,0,0
5,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.16294,-0.059173,-0.10448,0,0
5,GO RESPONSE TO BMP,0.085627,-0.059469,-0.089375,0,0
5,GO REGULATION OF HISTONE UBIQUITINATION,0.1028,-0.059505,-0.060821,0,0
5,GO RESPONSE TO INSECTICIDE,0.35607,-0.059649,-0.064307,0,0
5,GO TERPENOID BIOSYNTHETIC PROCESS,0.59059,-0.059651,-0.053766,0,0
5,GO PROTEIN POLYMERIZATION,0.016734,-0.059654,-0.072695,0,0
5,GO RESPONSE TO INTERLEUKIN 6,0.25001,-0.059723,-0.071762,0,0
5,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.91293,-0.059755,-0.039683,0,0
5,GO GMP METABOLIC PROCESS,0.52594,-0.059799,-0.035738,0,0
5,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.62732,-0.059844,-0.038611,0,0
5,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.73628,-0.059909,-0.040124,0,0
5,GO REGULATION OF DNA CATABOLIC PROCESS,0.27611,-0.059975,-0.040264,0,0
5,GO CALCIUM ION IMPORT INTO CYTOSOL,0.49227,-0.059977,-0.044518,0,0
5,GO RNA SURVEILLANCE,0.60272,-0.060132,-0.02014,0,0
5,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.43883,-0.060195,-0.03576,0,0
5,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.188,-0.060246,-0.10299,0,0
5,GO BRONCHUS DEVELOPMENT,0.92682,-0.060328,-0.030046,0,0
5,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.88523,-0.060334,-0.0030877,0,0
5,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.39858,-0.060366,-0.033989,0,0
5,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.43883,-0.060461,-0.062346,0,0
5,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.25363,-0.060623,-0.053281,0,0
5,GO CELL CELL SIGNALING,0.044685,-0.060635,-0.060153,0,0
5,GO HYPEROSMOTIC SALINITY RESPONSE,0.63978,-0.060752,0.0013189,0,0
5,GO SEX DIFFERENTIATION,0.015953,-0.060867,-0.081873,0,0
5,GO DENTATE GYRUS DEVELOPMENT,0.44924,-0.060903,-0.07795,0,0
5,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.50896,-0.061303,-0.071217,0,0
5,GO OLIGODENDROCYTE DEVELOPMENT,0.14048,-0.061305,-0.089104,0,0
5,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.88523,-0.061398,-0.010498,0,0
5,GO PREPULSE INHIBITION,0.75615,-0.06143,-0.012286,0,0
5,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.15264,-0.06154,-0.0809,0,0
5,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.85082,-0.061601,-0.0050898,0,0
5,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.12689,-0.061832,-0.15152,0,0
5,GO AXONAL TRANSPORT OF MITOCHONDRION,0.53742,-0.062007,-0.072834,0,0
5,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.11636,-0.062053,-0.094422,0,0
5,GO ACIDIC AMINO ACID TRANSPORT,0.48131,-0.062146,-0.021578,0,0
5,GO PROTEIN NEDDYLATION,0.22905,-0.062207,-0.073422,0,0
5,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.22905,-0.062306,-0.10862,0,0
5,GO PROTEIN POLYGLUTAMYLATION,0.62113,-0.062358,-0.020507,0,0
5,GO NEGATIVE REGULATION OF DNA REPLICATION,0.43367,-0.062378,-0.066601,0,0
5,GO ORGANELLE INHERITANCE,0.099158,-0.062437,-0.068114,0,0
5,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.33373,-0.062483,-0.068491,0,0
5,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.079444,-0.062612,-0.075591,0,0
5,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.23937,-0.062632,-0.065477,0,0
5,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.62113,-0.062647,-0.049643,0,0
5,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.40843,-0.062652,-0.05119,0,0
5,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.40349,-0.06286,-0.041881,0,0
5,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.25729,-0.063065,-0.12891,0,0
5,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.32077,-0.063085,-0.056405,0,0
5,GO HORMONE CATABOLIC PROCESS,0.94769,-0.063114,0.015037,0,0
5,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.23245,-0.063229,-0.066402,0,0
5,GO PROXIMAL DISTAL PATTERN FORMATION,0.78289,-0.063313,-0.02175,0,0
5,GO MULTIVESICULAR BODY SORTING PATHWAY,0.34256,-0.063603,-0.036723,0,0
5,GO INTERLEUKIN 10 PRODUCTION,0.12908,-0.063644,-0.088833,0,0
5,GO TELOMERE ORGANIZATION,0.092194,-0.063663,-0.057677,0,0
5,GO BONE MORPHOGENESIS,0.10845,-0.063948,-0.111,0,0
5,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.10465,-0.063951,-0.070104,0,0
5,GO TELOMERASE RNA LOCALIZATION,0.090515,-0.064076,-0.15499,0,0
5,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.061812,-0.064241,-0.10894,0,0
5,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.15264,-0.064256,-0.079397,0,0
5,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.019739,-0.064298,-0.088401,0,0
5,GO RECEPTOR CLUSTERING,0.53167,-0.064371,-0.037515,0,0
5,GO POSITIVE REGULATION OF EXOCYTOSIS,0.19695,-0.064514,-0.065514,0,0
5,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.11039,-0.064596,-0.076436,0,0
5,GO FIBROBLAST MIGRATION,0.34702,-0.064611,-0.047833,0,0
5,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.19095,-0.064988,-0.073144,0,0
5,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.50337,-0.064996,-0.038151,0,0
5,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.15517,-0.065109,-0.10357,0,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.12689,-0.065118,-0.076958,0,0
5,GO WALKING BEHAVIOR,0.31232,-0.065265,-0.053035,0,0
5,GO TUBE FORMATION,0.29586,-0.06538,-0.055959,0,0
5,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.059411,-0.065491,-0.067454,0,0
5,GO REGULATION OF PROTEIN POLYMERIZATION,0.068167,-0.065554,-0.060762,0,0
5,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.91293,-0.065592,0.046455,0,0
5,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.070855,-0.065632,-0.07768,0,0
5,GO CELL GROWTH,0.0028141,-0.06567,-0.099764,0,0
5,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.37932,-0.065706,-0.049359,0,0
5,GO MAGNESIUM ION TRANSPORT,0.42347,-0.065816,-0.050558,0,0
5,GO LOCALIZATION WITHIN MEMBRANE,0.38888,-0.065866,-0.042875,0,0
5,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0695,-0.065933,-0.073941,0,0
5,GO REGULATION OF T CELL DIFFERENTIATION,0.092194,-0.065967,-0.084076,0,0
5,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.10465,-0.066012,-0.059644,0,0
5,GO GLUCOSE IMPORT,0.11636,-0.06604,-0.060317,0,0
5,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.082489,-0.066052,-0.072016,0,0
5,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.3746,-0.066073,-0.082427,0,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.39858,-0.066087,-0.095994,0,0
5,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.32506,-0.066123,-0.090794,0,0
5,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.095625,-0.066153,-0.075663,0,0
5,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.17934,-0.06617,-0.073852,0,0
5,GO PROSTATIC BUD FORMATION,0.21905,-0.0663,-0.20417,0,0
5,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.11434,-0.066369,-0.1662,0,0
5,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.084046,-0.066422,-0.0546,0,0
5,GO EPITHELIAL TUBE MORPHOGENESIS,0.04854,-0.066439,-0.088729,0,0
5,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.32938,-0.066873,-0.064428,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.22905,-0.066931,-0.11034,0,0
5,GO RESPONSE TO FUNGUS,0.17374,-0.066953,-0.057653,0,0
5,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.13355,-0.067105,-0.081241,0,0
5,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.19695,-0.067165,-0.069287,0,0
5,GO EMBRYO DEVELOPMENT,0.064293,-0.067212,-0.063027,0,0
5,GO T CELL DIFFERENTIATION,0.1313,-0.067239,-0.076343,0,0
5,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.71658,-0.067275,-0.029172,0,0
5,GO HISTONE DEACETYLATION,0.066855,-0.067321,-0.062424,0,0
5,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.17374,-0.067341,-0.089676,0,0
5,GO RENAL SYSTEM PROCESS,0.093897,-0.067457,-0.098499,0,0
5,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.21579,-0.067503,-0.11041,0,0
5,GO NEGATIVE REGULATION OF TOR SIGNALING,0.26847,-0.067506,-0.049885,0,0
5,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.097379,-0.067615,-0.099453,0,0
5,GO REGULATION OF DNA METHYLATION,0.12259,-0.067639,-0.092806,0,0
5,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.66501,-0.067707,-0.059362,0,0
5,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.11434,-0.067785,-0.063515,0,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.36064,-0.067827,-0.096596,0,0
5,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.16294,-0.067885,-0.053587,0,0
5,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.3746,-0.067945,-0.072367,0,0
5,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.41842,-0.067957,-0.051895,0,0
5,GO TELOMERIC LOOP DISASSEMBLY,0.62113,-0.067962,-0.034105,0,0
5,GO NEUROTRANSMITTER SECRETION,0.38408,-0.068063,0.0026009,0,0
5,GO REGULATION OF DEVELOPMENTAL GROWTH,0.060602,-0.068202,-0.068044,0,0
5,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.12473,-0.068244,-0.12516,0,0
5,GO PROGESTERONE METABOLIC PROCESS,0.17653,-0.068284,-0.27186,0,0
5,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.075049,-0.068395,-0.16505,0,0
5,GO INNER EAR MORPHOGENESIS,0.39858,-0.068488,-0.048646,0,0
5,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.13355,-0.068661,-0.0843,0,0
5,GO EMBRYONIC ORGAN DEVELOPMENT,0.10465,-0.068753,-0.064946,0,0
5,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.94073,-0.06879,0.0015407,0,0
5,GO LYMPH VESSEL DEVELOPMENT,0.15015,-0.068848,-0.12587,0,0
5,GO PIRNA METABOLIC PROCESS,0.095625,-0.068872,-0.14625,0,0
5,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.76281,-0.068872,0.042836,0,0
5,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.10465,-0.069004,-0.082504,0,0
5,GO POSTSYNAPSE ORGANIZATION,0.53167,-0.069009,-0.031705,0,0
5,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.34702,-0.069064,-0.10308,0,0
5,GO FOREBRAIN NEURON DEVELOPMENT,0.62113,-0.069333,-0.014747,0,0
5,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.19393,-0.069353,-0.06215,0,0
5,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.29184,-0.069353,-0.074783,0,0
5,GO ACTIN CROSSLINK FORMATION,0.56666,-0.069605,-0.052751,0,0
5,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.20937,-0.06964,-0.085143,0,0
5,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.5726,-0.069783,-0.026537,0,0
5,GO HEART VALVE FORMATION,0.35607,-0.069809,-0.11656,0,0
5,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.073629,-0.069855,-0.083155,0,0
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.0010859,-0.069951,-0.090862,0,0
5,GO RESPONSE TO PROGESTERONE,0.13355,-0.070111,-0.12031,0,0
5,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.34702,-0.070245,-0.090267,0,0
5,GO EPIDERMIS DEVELOPMENT,0.17374,-0.070423,-0.077667,0,0
5,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.063042,-0.070522,-0.086488,0,0
5,GO REGULATION OF ISOTYPE SWITCHING,0.62113,-0.070528,-0.081778,0,0
5,GO ADHERENS JUNCTION ASSEMBLY,0.38888,-0.070569,-0.050892,0,0
5,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.093897,-0.070619,-0.098159,0,0
5,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.054842,-0.070652,-0.072985,0,0
5,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.04854,-0.070723,-0.061338,0,0
5,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.17099,-0.070733,-0.081506,0,0
5,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.21905,-0.070734,-0.079252,0,0
5,GO PROTEIN LOCALIZATION TO ENDOSOME,0.26471,-0.070796,-0.081623,0,0
5,GO ENDOSOMAL TRANSPORT,0.017137,-0.071172,-0.062457,0,0
5,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.36064,-0.071309,-0.027967,0,0
5,GO ONE CARBON COMPOUND TRANSPORT,0.17934,-0.071386,-0.11699,0,0
5,GO REGULATION OF FEEDING BEHAVIOR,0.31653,-0.071768,-0.081702,0,0
5,GO DENDRITIC SPINE MORPHOGENESIS,0.77618,-0.07183,-0.024692,0,0
5,GO REGULATION OF FATTY ACID TRANSPORT,0.13583,-0.071839,-0.10042,0,0
5,GO REGULATION OF MEMBRANE PERMEABILITY,0.22568,-0.071848,-0.048838,0,0
5,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.090515,-0.071923,-0.10383,0,0
5,GO TAXIS,0.00353,-0.072031,-0.10401,0,0
5,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.24288,-0.072035,-0.19135,0,0
5,GO KILLING OF CELLS OF OTHER ORGANISM,0.34702,-0.072203,-0.028034,0,0
5,GO SHORT TERM MEMORY,0.67137,-0.072223,-0.064792,0,0
5,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.024288,-0.072234,-0.1177,0,0
5,GO MANNOSYLATION,0.1313,-0.07224,-0.084324,0,0
5,GO NERVOUS SYSTEM PROCESS,0.04854,-0.072247,-0.062777,0,0
5,GO LYSOSOME LOCALIZATION,0.30402,-0.072288,-0.030776,0,0
5,GO EPITHELIAL CELL CELL ADHESION,0.68418,-0.072381,-0.027076,0,0
5,GO OOCYTE DIFFERENTIATION,0.099158,-0.072458,-0.07949,0,0
5,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.4978,-0.072645,-0.049742,0,0
5,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.40843,-0.072681,-0.051383,0,0
5,GO REGULATION OF MRNA BINDING,0.070855,-0.072773,-0.15272,0,0
5,GO GOLGI RIBBON FORMATION,0.11039,-0.072834,-0.094219,0,0
5,GO BRANCHING MORPHOGENESIS OF A NERVE,0.46512,-0.072839,-0.08396,0,0
5,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.59059,-0.07286,-0.009806,0,0
5,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.079444,-0.072886,-0.050911,0,0
5,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.23589,-0.072933,-0.055048,0,0
5,GO SECONDARY PALATE DEVELOPMENT,0.20937,-0.07295,-0.094901,0,0
5,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.12049,-0.073309,-0.11282,0,0
5,GO MITOCHONDRION DISTRIBUTION,0.42347,-0.073366,-0.02664,0,0
5,GO EMBRYONIC ORGAN MORPHOGENESIS,0.17653,-0.073421,-0.066044,0,0
5,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.060602,-0.07347,-0.06961,0,0
5,GO RNA PROCESSING,0.057089,-0.073534,-0.06752,0,0
5,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.14769,-0.073548,-0.088333,0,0
5,GO POSITIVE REGULATION OF TOR SIGNALING,0.0037331,-0.073597,-0.11255,0,0
5,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.033894,-0.073609,-0.056438,0,0
5,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.29586,-0.073676,-0.074796,0,0
5,GO DORSAL VENTRAL AXIS SPECIFICATION,0.58456,-0.07371,-0.05598,0,0
5,GO NEUTROPHIL CHEMOTAXIS,0.082489,-0.073742,-0.094195,0,0
5,GO GLUTAMATE SECRETION,0.91293,-0.073783,0.015326,0,0
5,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.43367,-0.073893,-0.053603,0,0
5,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.075049,-0.07402,-0.11456,0,0
5,GO ENDOTHELIUM DEVELOPMENT,0.12473,-0.074111,-0.089248,0,0
5,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.087232,-0.074216,-0.12866,0,0
5,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.2839,-0.074497,-0.11404,0,0
5,GO RESPONSE TO WATER,0.40843,-0.074536,-0.076963,0,0
5,GO NCRNA EXPORT FROM NUCLEUS,0.21256,-0.074586,-0.067344,0,0
5,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.39858,-0.074589,-0.068713,0,0
5,GO BEHAVIOR,0.14048,-0.074602,-0.056315,0,0
5,GO THYROID HORMONE METABOLIC PROCESS,0.20937,-0.074731,-0.064779,0,0
5,GO GLIAL CELL DIFFERENTIATION,0.080955,-0.074906,-0.079609,0,0
5,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.52594,-0.07497,0.0077437,0,0
5,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.59059,-0.07498,-0.025341,0,0
5,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.70355,-0.075184,0.012167,0,0
5,GO PHOSPHOLIPID HOMEOSTASIS,0.19393,-0.075334,-0.1132,0,0
5,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.30815,-0.075374,-0.065789,0,0
5,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.085627,-0.075384,-0.077955,0,0
5,GO REGULATION OF CYCLASE ACTIVITY,0.10096,-0.075401,-0.096102,0,0
5,GO EXECUTION PHASE OF APOPTOSIS,0.085627,-0.075416,-0.056705,0,0
5,GO REGULATION OF CELL PROJECTION SIZE,0.38408,-0.07553,-0.097372,0,0
5,GO DEPHOSPHORYLATION,0.0032441,-0.075574,-0.081032,0,0
5,GO SYNAPSE ASSEMBLY,0.29184,-0.075693,-0.03283,0,0
5,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.19695,-0.075699,-0.058963,0,0
5,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.22235,-0.075731,-0.062273,0,0
5,GO RETINA HOMEOSTASIS,0.13583,-0.075927,-0.059083,0,0
5,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.35153,-0.075935,-0.040355,0,0
5,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.17374,-0.076248,-0.12504,0,0
5,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.31653,-0.076263,-0.099249,0,0
5,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.13355,-0.076474,-0.09222,0,0
5,GO MESENCHYMAL CELL PROLIFERATION,0.69061,-0.076594,-0.071152,0,0
5,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.56666,-0.076607,-0.0083299,0,0
5,GO REGULATION OF HEAT GENERATION,0.7495,-0.076608,0.016422,0,0
5,GO RESPONSE TO LEUCINE,0.44924,-0.076647,-0.035087,0,0
5,GO DIGESTIVE SYSTEM DEVELOPMENT,0.33812,-0.076668,-0.051492,0,0
5,GO EPIDERMAL CELL DIFFERENTIATION,0.22235,-0.076685,-0.058541,0,0
5,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.085627,-0.076766,-0.18714,0,0
5,GO ENDODERMAL CELL FATE COMMITMENT,0.25001,-0.07679,-0.071797,0,0
5,GO SIGNAL RELEASE,0.082489,-0.076835,-0.05065,0,0
5,GO PROSTATE GLAND GROWTH,0.21905,-0.076974,-0.14931,0,0
5,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.02166,-0.077198,-0.15558,0,0
5,GO INTERLEUKIN 6 PRODUCTION,0.084046,-0.0772,-0.083412,0,0
5,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.22235,-0.077246,-0.067699,0,0
5,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.74288,-0.07732,-0.0032063,0,0
5,GO REGULATION OF HAIR CYCLE,0.064293,-0.077333,-0.1343,0,0
5,GO T CELL DIFFERENTIATION IN THYMUS,0.16559,-0.077366,-0.070255,0,0
5,GO MUSCLE CELL FATE COMMITMENT,0.090515,-0.077602,-0.16509,0,0
5,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.33373,-0.07763,-0.078673,0,0
5,GO MAST CELL ACTIVATION,0.15015,-0.077717,-0.084097,0,0
5,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.12908,-0.077767,-0.088096,0,0
5,GO DEVELOPMENTAL MATURATION,0.092194,-0.077772,-0.064244,0,0
5,GO MESODERMAL CELL DIFFERENTIATION,0.14285,-0.078029,-0.13015,0,0
5,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.27227,-0.078118,-0.049857,0,0
5,GO TUBULIN DEACETYLATION,0.32506,-0.078382,-0.055699,0,0
5,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.21579,-0.078383,-0.079207,0,0
5,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.16032,-0.078582,-0.11348,0,0
5,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.076492,-0.0786,-0.14054,0,0
5,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.0057817,-0.078608,-0.088652,0,0
5,GO EMBRYONIC MORPHOGENESIS,0.075049,-0.078628,-0.080775,0,0
5,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.079444,-0.078701,-0.069547,0,0
5,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.025994,-0.078773,-0.106,0,0
5,GO PORE COMPLEX ASSEMBLY,0.087232,-0.079008,-0.098749,0,0
5,GO CELL CYCLE ARREST,0.0071468,-0.079149,-0.076343,0,0
5,GO EMBRYONIC PLACENTA DEVELOPMENT,0.28785,-0.079298,-0.075073,0,0
5,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.097379,-0.079602,-0.10131,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.34702,-0.079654,-0.054964,0,0
5,GO RESPONSE TO GAMMA RADIATION,0.070855,-0.079755,-0.077426,0,0
5,GO AXIS ELONGATION,0.36064,-0.079865,-0.086494,0,0
5,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.060602,-0.079952,-0.16783,0,0
5,GO REGULATION OF CELLULAR COMPONENT SIZE,0.0057817,-0.079995,-0.088383,0,0
5,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.29992,-0.080131,-0.095942,0,0
5,GO DEVELOPMENTAL GROWTH,0.01282,-0.080167,-0.0791,0,0
5,GO MITOCHONDRION MORPHOGENESIS,0.19393,-0.080185,-0.058634,0,0
5,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.17653,-0.080288,-0.098125,0,0
5,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.4545,-0.080291,-0.075936,0,0
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0014738,-0.080374,-0.094322,0,0
5,GO TONIC SMOOTH MUSCLE CONTRACTION,0.30402,-0.080431,-0.11457,0,0
5,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.064293,-0.080432,-0.13579,0,0
5,GO TRNA TRANSPORT,0.21579,-0.080529,-0.055163,0,0
5,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.063042,-0.080556,-0.055001,0,0
5,GO COENZYME A BIOSYNTHETIC PROCESS,0.016339,-0.080578,-0.1598,0,0
5,GO REGULATION OF ICOSANOID SECRETION,0.52594,-0.080757,-0.039716,0,0
5,GO ASTROCYTE DIFFERENTIATION,0.097379,-0.080822,-0.1052,0,0
5,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.0069616,-0.080842,-0.099279,0,0
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.072231,-0.080849,-0.08318,0,0
5,GO REGULATION OF GASTRULATION,0.12259,-0.080965,-0.10229,0,0
5,GO MOTOR NEURON AXON GUIDANCE,0.14048,-0.081025,-0.08019,0,0
5,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.21579,-0.08127,-0.11606,0,0
5,GO SEROTONIN TRANSPORT,0.27227,-0.08142,-0.11378,0,0
5,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.22905,-0.08148,-0.094725,0,0
5,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.12049,-0.081486,-0.10538,0,0
5,GO MAST CELL MIGRATION,0.66501,-0.081724,-0.044811,0,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.12908,-0.081814,-0.079085,0,0
5,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.29184,-0.082051,-0.16889,0,0
5,GO LYMPH NODE DEVELOPMENT,0.32506,-0.082081,-0.067157,0,0
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.42347,-0.082389,-0.06289,0,0
5,GO ATP BIOSYNTHETIC PROCESS,0.1313,-0.082466,-0.096876,0,0
5,GO REGULATION OF MITOCHONDRIAL FUSION,0.055956,-0.08271,-0.13116,0,0
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.31232,-0.082802,-0.11186,0,0
5,GO REGULATION OF HORMONE SECRETION,0.10465,-0.083071,-0.066914,0,0
5,GO TRACHEA DEVELOPMENT,0.20309,-0.083145,-0.1296,0,0
5,GO VESICLE DOCKING,0.036164,-0.083156,-0.09772,0,0
5,GO GROWTH,0.0017123,-0.08319,-0.091609,0,0
5,GO PLACENTA DEVELOPMENT,0.16559,-0.083251,-0.083662,0,0
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.50337,-0.083283,-0.07243,0,0
5,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.2839,-0.0833,-0.089401,0,0
5,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.25363,-0.083367,-0.10353,0,0
5,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.54321,-0.083394,-0.066078,0,0
5,GO NEUROTRANSMITTER METABOLIC PROCESS,0.30402,-0.083407,-0.082347,0,0
5,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.073629,-0.083419,-0.096303,0,0
5,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.082489,-0.08358,-0.097898,0,0
5,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.20309,-0.08374,-0.14461,0,0
5,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.12473,-0.083773,-0.10069,0,0
5,GO HORMONE TRANSPORT,0.085627,-0.083839,-0.071565,0,0
5,GO POSITIVE REGULATION OF GROWTH,0.036948,-0.083977,-0.067677,0,0
5,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.47588,-0.084117,-0.14097,0,0
5,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.031748,-0.084188,-0.13465,0,0
5,GO BILE ACID METABOLIC PROCESS,0.061812,-0.084272,-0.13419,0,0
5,GO MOLTING CYCLE,0.046579,-0.084341,-0.10454,0,0
5,GO DEVELOPMENTAL INDUCTION,0.090515,-0.084794,-0.097438,0,0
5,GO ESTABLISHMENT OF CELL POLARITY,0.065563,-0.084855,-0.062763,0,0
5,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.13814,-0.08489,-0.064278,0,0
5,GO BODY MORPHOGENESIS,0.095625,-0.084966,-0.095374,0,0
5,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.17374,-0.084969,-0.097531,0,0
5,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0020453,-0.08497,-0.077626,0,0
5,GO CELLULAR RESPONSE TO MANGANESE ION,0.29586,-0.085117,-0.062715,0,0
5,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.10845,-0.085124,-0.098596,0,0
5,GO REGULATION OF AXON GUIDANCE,0.21905,-0.085231,-0.070825,0,0
5,GO FIBROBLAST ACTIVATION,0.15773,-0.085244,-0.11654,0,0
5,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.12049,-0.085245,-0.086139,0,0
5,GO DENDRITE EXTENSION,0.58456,-0.085253,0.064197,0,0
5,GO LOCOMOTORY BEHAVIOR,0.21256,-0.085329,-0.048945,0,0
5,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.087232,-0.085923,-0.082121,0,0
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.061812,-0.086087,-0.12411,0,0
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.13355,-0.086374,-0.16332,0,0
5,GO LUNG MORPHOGENESIS,0.20621,-0.086432,-0.097647,0,0
5,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.51459,-0.086446,-0.056174,0,0
5,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.2,-0.086477,-0.10962,0,0
5,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.33373,-0.086585,-0.078605,0,0
5,GO REGULATION OF POTASSIUM ION TRANSPORT,0.11636,-0.086618,-0.084833,0,0
5,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.62113,-0.086691,-0.053641,0,0
5,GO SENSORY PERCEPTION OF PAIN,0.066855,-0.086695,-0.073232,0,0
5,GO BONE TRABECULA MORPHOGENESIS,0.16294,-0.08673,-0.20253,0,0
5,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.29184,-0.086791,-0.0056822,0,0
5,GO NAD BIOSYNTHETIC PROCESS,0.059411,-0.087328,-0.13633,0,0
5,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.090515,-0.087473,-0.10966,0,0
5,GO ENDOTHELIAL CELL MORPHOGENESIS,0.38888,-0.087534,-0.1237,0,0
5,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.075049,-0.087592,-0.15795,0,0
5,GO REGULATION OF CELL SIZE,0.022165,-0.087742,-0.080932,0,0
5,GO REGULATION OF DEPHOSPHORYLATION,0.019739,-0.087743,-0.060404,0,0
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.14526,-0.087782,-0.078362,0,0
5,GO CHLORIDE ION HOMEOSTASIS,0.16828,-0.088004,-0.092402,0,0
5,GO PRESYNAPSE ORGANIZATION,0.29586,-0.088078,-0.053803,0,0
5,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.12049,-0.08808,-0.10781,0,0
5,GO MECHANORECEPTOR DIFFERENTIATION,0.14526,-0.088167,-0.097869,0,0
5,GO RESPONSE TO VITAMIN,0.076492,-0.088181,-0.1159,0,0
5,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.097379,-0.088242,-0.074509,0,0
5,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.62113,-0.088438,-0.027153,0,0
5,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.075049,-0.088596,-0.05961,0,0
5,GO REGULATION OF PHOSPHATASE ACTIVITY,0.03245,-0.088739,-0.059727,0,0
5,GO REGULATION OF GROWTH,0.0013457,-0.088786,-0.10189,0,0
5,GO ENDOCRINE HORMONE SECRETION,0.053746,-0.088858,-0.12221,0,0
5,GO MUSCLE TISSUE DEVELOPMENT,0.0054795,-0.088957,-0.095756,0,0
5,GO RESPONSE TO L GLUTAMATE,0.85768,-0.08901,0.021011,0,0
5,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.17374,-0.089018,-0.10071,0,0
5,GO BRANCH ELONGATION OF AN EPITHELIUM,0.10654,-0.089137,-0.2079,0,0
5,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.2839,-0.089356,-0.067801,0,0
5,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.36991,-0.089379,-0.073843,0,0
5,GO MUSCLE CELL MIGRATION,0.12908,-0.089421,-0.11957,0,0
5,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.16294,-0.089452,-0.064937,0,0
5,GO PROTEIN DEPHOSPHORYLATION,0.0056288,-0.08949,-0.074461,0,0
5,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.090515,-0.089619,-0.07811,0,0
5,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.34702,-0.089806,-0.088827,0,0
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.054842,-0.089861,-0.11189,0,0
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.48678,-0.089906,-0.043743,0,0
5,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.13814,-0.090099,-0.10112,0,0
5,GO RHYTHMIC BEHAVIOR,0.0060989,-0.09013,-0.11158,0,0
5,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.12473,-0.09029,-0.052071,0,0
5,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.0025083,-0.090326,-0.099656,0,0
5,GO POLYOL CATABOLIC PROCESS,0.077957,-0.090329,-0.065223,0,0
5,GO PRENYLATION,0.19393,-0.090418,-0.075743,0,0
5,GO RESPONSE TO MURAMYL DIPEPTIDE,0.22235,-0.090604,-0.12443,0,0
5,GO OVARIAN FOLLICLE DEVELOPMENT,0.2,-0.09061,-0.056682,0,0
5,GO VISUAL BEHAVIOR,0.14048,-0.090659,-0.059987,0,0
5,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.11841,-0.09076,-0.090994,0,0
5,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.17934,-0.090861,-0.091322,0,0
5,GO SARCOMERE ORGANIZATION,0.066855,-0.09104,-0.097496,0,0
5,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.024288,-0.091085,-0.11193,0,0
5,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.11434,-0.09115,-0.17972,0,0
5,GO MYOBLAST DIFFERENTIATION,0.15015,-0.091288,-0.092835,0,0
5,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.11434,-0.091882,-0.12182,0,0
5,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.11039,-0.091919,-0.12844,0,0
5,GO ACTIVATION OF JNKK ACTIVITY,0.21256,-0.091928,-0.074557,0,0
5,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.064293,-0.091947,-0.10077,0,0
5,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.63354,-0.0921,-0.018428,0,0
5,GO MITOPHAGY,0.072231,-0.092135,-0.081115,0,0
5,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.00090094,-0.092485,-0.092177,0,0
5,GO SKIN DEVELOPMENT,0.11039,-0.092572,-0.098626,0,0
5,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.061812,-0.092642,-0.13166,0,0
5,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.17934,-0.092739,-0.095308,0,0
5,GO REGULATION OF PLATELET AGGREGATION,0.19393,-0.092984,-0.15485,0,0
5,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.080955,-0.093022,-0.11597,0,0
5,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.17374,-0.093149,-0.083955,0,0
5,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.23937,-0.093192,-0.05763,0,0
5,GO STRIATED MUSCLE ADAPTATION,0.027803,-0.093262,-0.14545,0,0
5,GO ANATOMICAL STRUCTURE MATURATION,0.063042,-0.093272,-0.068476,0,0
5,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.16294,-0.093279,-0.10143,0,0
5,GO EMBRYONIC PATTERN SPECIFICATION,0.10096,-0.093279,-0.088009,0,0
5,GO NEGATIVE REGULATION OF ION TRANSPORT,0.0037331,-0.093335,-0.097756,0,0
5,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.15015,-0.093351,-0.11149,0,0
5,GO SNRNA PROCESSING,0.10465,-0.093487,-0.13436,0,0
5,GO QUINONE METABOLIC PROCESS,0.10465,-0.093576,-0.18432,0,0
5,GO ADULT HEART DEVELOPMENT,0.62732,-0.093579,-0.055927,0,0
5,GO INTERLEUKIN 12 PRODUCTION,0.084046,-0.093639,-0.086438,0,0
5,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.17374,-0.093683,-0.090285,0,0
5,GO KETONE CATABOLIC PROCESS,0.19393,-0.093864,-0.14831,0,0
5,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.036164,-0.093893,-0.085186,0,0
5,GO DEFINITIVE HEMOPOIESIS,0.37932,-0.093946,-0.075556,0,0
5,GO HEAD MORPHOGENESIS,0.14048,-0.093978,-0.086886,0,0
5,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.16294,-0.094008,-0.080697,0,0
5,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.95466,-0.094059,0.014893,0,0
5,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.33373,-0.094151,-0.0867,0,0
5,GO PHAGOSOME MATURATION,0.064293,-0.094446,-0.10334,0,0
5,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.02268,-0.094474,-0.073675,0,0
5,GO GOLGI LOCALIZATION,0.21905,-0.09456,-0.071965,0,0
5,GO OUTER DYNEIN ARM ASSEMBLY,0.53742,-0.094731,-0.025069,0,0
5,GO GANGLIOSIDE METABOLIC PROCESS,0.29992,-0.094906,-0.082885,0,0
5,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.30815,-0.095127,-0.11498,0,0
5,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.21905,-0.095273,-0.093328,0,0
5,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.037747,-0.09532,-0.092537,0,0
5,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.068167,-0.095324,-0.18536,0,0
5,GO DEFENSE RESPONSE TO FUNGUS,0.027188,-0.095553,-0.11554,0,0
5,GO LATERAL VENTRICLE DEVELOPMENT,0.41341,-0.096074,-0.06521,0,0
5,GO CRANIAL NERVE MORPHOGENESIS,0.12689,-0.096158,-0.15453,0,0
5,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.11841,-0.096198,-0.085088,0,0
5,GO GLIOGENESIS,0.02166,-0.096219,-0.097348,0,0
5,GO RESPONSE TO AMINO ACID STARVATION,0.10465,-0.096506,-0.085504,0,0
5,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.4545,-0.096509,-0.062652,0,0
5,GO STEROL BIOSYNTHETIC PROCESS,0.082489,-0.096513,-0.10641,0,0
5,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.33812,-0.096556,-0.053546,0,0
5,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.72313,-0.096655,-0.023044,0,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.036164,-0.096667,-0.07909,0,0
5,GO NCRNA 3 END PROCESSING,0.097379,-0.097004,-0.11212,0,0
5,GO OTIC VESICLE MORPHOGENESIS,0.69061,-0.097058,-0.03171,0,0
5,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.031059,-0.097189,-0.14401,0,0
5,GO REGULATION OF PROTEIN TARGETING,0.0022992,-0.097191,-0.10906,0,0
5,GO CARDIAC SEPTUM MORPHOGENESIS,0.17374,-0.097295,-0.12227,0,0
5,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.080955,-0.097441,-0.10474,0,0
5,GO CELL CELL JUNCTION ORGANIZATION,0.097379,-0.097495,-0.09558,0,0
5,GO DIVALENT METAL ION EXPORT,0.32938,-0.097524,-0.091056,0,0
5,GO PRE MIRNA PROCESSING,0.16828,-0.097548,-0.099583,0,0
5,GO RNA INTERFERENCE,0.059411,-0.097587,-0.11448,0,0
5,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.28785,-0.09764,-0.078653,0,0
5,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.066855,-0.097751,-0.085159,0,0
5,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.5726,-0.09782,-0.035175,0,0
5,GO CELLULAR RESPONSE TO VIRUS,0.054842,-0.097974,-0.1104,0,0
5,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.0073363,-0.098119,-0.10136,0,0
5,GO REGULATION OF HEART GROWTH,0.065563,-0.098228,-0.097152,0,0
5,GO SYNAPSE ORGANIZATION,0.14285,-0.09826,-0.065955,0,0
5,GO PEPTIDYL SERINE MODIFICATION,0.0090226,-0.098289,-0.073941,0,0
5,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.087232,-0.09834,-0.091829,0,0
5,GO REGULATION OF MEMBRANE REPOLARIZATION,0.018398,-0.098411,-0.15171,0,0
5,GO NEGATIVE REGULATION OF CELL GROWTH,0.004408,-0.098445,-0.1129,0,0
5,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.16294,-0.098555,-0.094611,0,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.0050528,-0.098656,-0.11716,0,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.088862,-0.098705,-0.14571,0,0
5,GO HEMOGLOBIN METABOLIC PROCESS,0.087232,-0.09883,-0.11849,0,0
5,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.63978,-0.098852,-0.0069094,0,0
5,GO AUTOPHAGIC CELL DEATH,0.27999,-0.099068,-0.069729,0,0
5,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.2,-0.099275,-0.14451,0,0
5,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.084046,-0.099439,-0.089438,0,0
5,GO CHONDROCYTE DIFFERENTIATION,0.063042,-0.099478,-0.11216,0,0
5,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.11235,-0.099526,-0.092079,0,0
5,GO MATING,0.064293,-0.09953,-0.078139,0,0
5,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.49227,-0.099604,-0.14007,0,0
5,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.076492,-0.099622,-0.15288,0,0
5,GO CALCIUM ION REGULATED EXOCYTOSIS,0.19095,-0.09974,-0.051845,0,0
5,GO MUSCLE FIBER DEVELOPMENT,0.014138,-0.099743,-0.11015,0,0
5,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.10654,-0.099878,-0.11194,0,0
5,GO NEURON MATURATION,0.085627,-0.09997,-0.1026,0,0
5,GO RESPONSE TO PARATHYROID HORMONE,0.17374,-0.099992,-0.11852,0,0
5,GO POSITIVE REGULATION OF ANION TRANSPORT,0.080955,-0.10024,-0.10861,0,0
5,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.052669,-0.10054,-0.13347,0,0
5,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.11434,-0.10064,-0.16049,0,0
5,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.13355,-0.10073,-0.08759,0,0
5,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.18219,-0.10082,-0.12772,0,0
5,GO OVULATION CYCLE,0.049546,-0.10086,-0.10453,0,0
5,GO POSTSYNAPSE ASSEMBLY,0.91293,-0.10101,-0.0034289,0,0
5,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.59664,-0.10122,-0.039703,0,0
5,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.010506,-0.10137,-0.12099,0,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.22905,-0.10156,-0.090384,0,0
5,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.0025817,-0.1016,-0.13055,0,0
5,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.17653,-0.10175,-0.10991,0,0
5,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.045624,-0.10188,-0.12145,0,0
5,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.12473,-0.10191,-0.042168,0,0
5,GO PEPTIDE HORMONE SECRETION,0.087232,-0.10193,-0.067217,0,0
5,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.0021062,-0.10218,-0.11641,0,0
5,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.080955,-0.10225,-0.11343,0,0
5,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.095625,-0.10234,-0.12583,0,0
5,GO MRNA MODIFICATION,0.15264,-0.10241,-0.091565,0,0
5,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.097379,-0.10252,-0.13696,0,0
5,GO CELL AGGREGATION,0.26847,-0.10276,-0.075732,0,0
5,GO DICARBOXYLIC ACID TRANSPORT,0.093897,-0.10286,-0.060829,0,0
5,GO FILOPODIUM ASSEMBLY,0.22235,-0.10315,-0.066714,0,0
5,GO INTERFERON BETA PRODUCTION,0.079444,-0.10316,-0.11088,0,0
5,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.0025817,-0.10333,-0.10866,0,0
5,GO CGMP MEDIATED SIGNALING,0.0090226,-0.10345,-0.17362,0,0
5,GO KERATINOCYTE DIFFERENTIATION,0.13814,-0.10351,-0.084485,0,0
5,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.080955,-0.10353,-0.17258,0,0
5,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.22568,-0.1042,-0.064325,0,0
5,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.066855,-0.10433,-0.1838,0,0
5,GO ADULT LOCOMOTORY BEHAVIOR,0.16559,-0.10451,-0.066104,0,0
5,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.30402,-0.10453,-0.040273,0,0
5,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.065563,-0.10462,-0.16099,0,0
5,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.060602,-0.10494,-0.12838,0,0
5,GO REGULATION OF JUN KINASE ACTIVITY,0.024288,-0.10508,-0.10414,0,0
5,GO HEAT GENERATION,0.33812,-0.10571,-0.038431,0,0
5,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.1313,-0.10586,-0.11277,0,0
5,GO ENDOSOME TO LYSOSOME TRANSPORT,0.02268,-0.10611,-0.09813,0,0
5,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.4545,-0.10635,-0.087655,0,0
5,GO IRON COORDINATION ENTITY TRANSPORT,0.21256,-0.10644,-0.085999,0,0
5,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.044685,-0.10655,-0.11915,0,0
5,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.48678,-0.10657,0.033622,0,0
5,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.36064,-0.10661,-0.033048,0,0
5,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.2,-0.10672,-0.092144,0,0
5,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.21905,-0.10679,-0.087268,0,0
5,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.23245,-0.10687,-0.13185,0,0
5,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.32506,-0.10688,-0.077323,0,0
5,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.068167,-0.10697,-0.16984,0,0
5,GO REGULATION OF BMP SIGNALING PATHWAY,0.082489,-0.107,-0.11018,0,0
5,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.1028,-0.10708,-0.077812,0,0
5,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.22235,-0.10719,-0.14974,0,0
5,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.054842,-0.10727,-0.10734,0,0
5,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.011326,-0.10756,-0.081493,0,0
5,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.86455,-0.10761,0.029192,0,0
5,GO EXOCYTIC PROCESS,0.20937,-0.10761,-0.045857,0,0
5,GO BASE EXCISION REPAIR AP SITE FORMATION,0.12049,-0.10761,-0.11974,0,0
5,GO REGULATION OF HISTONE DEACETYLATION,0.13355,-0.10811,-0.085956,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.076492,-0.10811,-0.14055,0,0
5,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.18219,-0.10822,-0.12403,0,0
5,GO TRANSCRIPTION BY RNA POLYMERASE I,0.080955,-0.10824,-0.080962,0,0
5,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.71006,-0.10865,-0.0062311,0,0
5,GO REGULATION OF POSITIVE CHEMOTAXIS,0.11636,-0.10868,-0.11502,0,0
5,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0024367,-0.10871,-0.11212,0,0
5,GO REGULATION OF PROTEIN DEACETYLATION,0.0695,-0.10935,-0.07682,0,0
5,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.4545,-0.10937,-0.075409,0,0
5,GO VIRAL GENOME REPLICATION,0.059411,-0.10948,-0.15402,0,0
5,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.44402,-0.10953,-0.071459,0,0
5,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.070855,-0.10972,-0.12942,0,0
5,GO REGULATION OF EXCRETION,0.4978,-0.11002,-0.038955,0,0
5,GO FEMALE SEX DIFFERENTIATION,0.0064317,-0.11016,-0.12147,0,0
5,GO TOXIN METABOLIC PROCESS,0.14048,-0.11024,-0.14893,0,0
5,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.055956,-0.11074,-0.14988,0,0
5,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.087232,-0.11086,-0.093735,0,0
5,GO RESPONSE TO SALT STRESS,0.11235,-0.11119,-0.11171,0,0
5,GO TOOTH MINERALIZATION,0.085627,-0.11132,-0.14965,0,0
5,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.18219,-0.11148,-0.069793,0,0
5,GO REGULATION OF GLIAL CELL PROLIFERATION,0.32938,-0.11148,-0.061298,0,0
5,GO NEUROTRANSMITTER TRANSPORT,0.16828,-0.11159,-0.036102,0,0
5,GO PROSTATE GLAND DEVELOPMENT,0.084046,-0.11172,-0.15756,0,0
5,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.079444,-0.11179,-0.086694,0,0
5,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.00049035,-0.11205,-0.12982,0,0
5,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.16032,-0.11214,-0.074159,0,0
5,GO MEMBRANE DISASSEMBLY,0.05824,-0.11245,-0.12491,0,0
5,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.11434,-0.11263,-0.16448,0,0
5,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.063042,-0.11319,-0.24284,0,0
5,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.088862,-0.1132,-0.11502,0,0
5,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.011326,-0.11323,-0.16889,0,0
5,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.13814,-0.11334,-0.12082,0,0
5,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.029068,-0.11348,-0.12765,0,0
5,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.12473,-0.1137,-0.13373,0,0
5,GO LYSINE METABOLIC PROCESS,0.15773,-0.11377,-0.15984,0,0
5,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.22568,-0.11385,-0.08471,0,0
5,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.11039,-0.11393,-0.15342,0,0
5,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.070855,-0.11399,-0.10936,0,0
5,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.35153,-0.11403,-0.15676,0,0
5,GO NUCLEOSIDE CATABOLIC PROCESS,0.076492,-0.1141,-0.14561,0,0
5,GO MELANOCYTE DIFFERENTIATION,0.082489,-0.11418,-0.10921,0,0
5,GO PEPTIDYL CYSTEINE MODIFICATION,0.037747,-0.11425,-0.083364,0,0
5,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.42347,-0.11449,-0.063546,0,0
5,GO PROTEIN DENEDDYLATION,0.12049,-0.11478,-0.08884,0,0
5,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.11235,-0.11498,-0.12985,0,0
5,GO OSTEOBLAST DEVELOPMENT,0.16294,-0.11549,-0.12011,0,0
5,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.11039,-0.11556,-0.10753,0,0
5,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.29992,-0.11557,-0.067896,0,0
5,GO REGULATION OF GASTRIC ACID SECRETION,0.2,-0.11564,-0.12556,0,0
5,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.11235,-0.11565,-0.12612,0,0
5,GO DEFENSE RESPONSE TO VIRUS,0.068167,-0.11581,-0.14319,0,0
5,GO LABYRINTHINE LAYER DEVELOPMENT,0.2839,-0.11582,-0.074643,0,0
5,GO O GLYCAN PROCESSING,0.064293,-0.11617,-0.16383,0,0
5,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0695,-0.11643,-0.16341,0,0
5,GO REGULATION OF EXOSOMAL SECRETION,0.065563,-0.11655,-0.14471,0,0
5,GO STABILIZATION OF MEMBRANE POTENTIAL,0.19095,-0.11656,-0.15251,0,0
5,GO RENAL SODIUM EXCRETION,0.16559,-0.11662,-0.084701,0,0
5,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.0695,-0.11667,-0.11857,0,0
5,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.080955,-0.11674,-0.15759,0,0
5,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.033166,-0.11691,-0.11418,0,0
5,GO ENERGY HOMEOSTASIS,0.075049,-0.11697,-0.11524,0,0
5,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.063042,-0.1171,-0.088126,0,0
5,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.068167,-0.11719,-0.1497,0,0
5,GO RESPONSE TO INTERLEUKIN 2,0.27227,-0.11721,-0.075497,0,0
5,GO POSITIVE REGULATION OF HEAT GENERATION,0.38408,-0.11733,-0.030899,0,0
5,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.079444,-0.11744,-0.073543,0,0
5,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.0031536,-0.11753,-0.10808,0,0
5,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.055956,-0.11755,-0.1374,0,0
5,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.0094949,-0.11778,-0.11493,0,0
5,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.69061,-0.11795,-0.01893,0,0
5,GO MAINTENANCE OF CELL POLARITY,0.14526,-0.1183,-0.092406,0,0
5,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.17099,-0.11837,-0.085,0,0
5,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.079444,-0.11851,-0.12992,0,0
5,GO RESPONSE TO NITRIC OXIDE,0.044685,-0.11868,-0.076481,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.12908,-0.11875,-0.13006,0,0
5,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.1028,-0.11876,-0.22616,0,0
5,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.070855,-0.11887,-0.14495,0,0
5,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.22568,-0.11892,-0.045928,0,0
5,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.063042,-0.11904,-0.11377,0,0
5,GO EPITHELIAL CELL FATE COMMITMENT,0.20309,-0.11934,-0.10527,0,0
5,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.090515,-0.11935,-0.0877,0,0
5,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.063042,-0.11954,-0.15277,0,0
5,GO REGULATION OF FILOPODIUM ASSEMBLY,0.088862,-0.11999,-0.10577,0,0
5,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.27227,-0.12005,-0.066006,0,0
5,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.17374,-0.12023,-0.16521,0,0
5,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.0025083,-0.12031,-0.090627,0,0
5,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.17934,-0.12033,-0.083707,0,0
5,GO NOREPINEPHRINE TRANSPORT,0.38888,-0.12033,-0.052476,0,0
5,GO BARBED END ACTIN FILAMENT CAPPING,0.22568,-0.12038,-0.13341,0,0
5,GO RESPONSE TO INTERFERON ALPHA,0.35607,-0.12046,-0.24571,0,0
5,GO REGULATION OF NEUTROPHIL MIGRATION,0.053746,-0.12059,-0.11908,0,0
5,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.050569,-0.12065,-0.095964,0,0
5,GO NEPHRON MORPHOGENESIS,0.02268,-0.1208,-0.11039,0,0
5,GO PROSTAGLANDIN TRANSPORT,0.070855,-0.12082,-0.11119,0,0
5,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.95466,-0.12089,0.025795,0,0
5,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.016339,-0.12106,-0.12553,0,0
5,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.13355,-0.12111,-0.16888,0,0
5,GO REGULATION OF VIRAL GENOME REPLICATION,0.10096,-0.12131,-0.16183,0,0
5,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.00353,-0.12133,-0.15987,0,0
5,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.090515,-0.1214,-0.21762,0,0
5,GO NEGATIVE REGULATION OF AXONOGENESIS,0.19393,-0.1214,-0.082098,0,0
5,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.070855,-0.12162,-0.11705,0,0
5,GO NERVE DEVELOPMENT,0.10096,-0.12184,-0.10566,0,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.05824,-0.122,-0.1332,0,0
5,GO INTESTINAL LIPID ABSORPTION,0.055956,-0.12202,-0.20978,0,0
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.024288,-0.12215,-0.19471,0,0
5,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.29586,-0.1223,-0.1043,0,0
5,GO MATING BEHAVIOR,0.093897,-0.12242,-0.11193,0,0
5,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.059411,-0.12247,-0.16449,0,0
5,GO REGULATION OF SYNAPSE MATURATION,0.50337,-0.12286,-0.093656,0,0
5,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.23937,-0.12325,-0.1176,0,0
5,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.12259,-0.12336,-0.11922,0,0
5,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.10465,-0.12371,-0.12057,0,0
5,GO HETEROTYPIC CELL CELL ADHESION,0.055956,-0.12379,-0.12562,0,0
5,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.43883,-0.12414,-0.067823,0,0
5,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.093897,-0.12429,-0.19947,0,0
5,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.14048,-0.12444,-0.10002,0,0
5,GO GASTRULATION WITH MOUTH FORMING SECOND,0.23937,-0.12447,-0.081937,0,0
5,GO CHONDROCYTE PROLIFERATION,0.40843,-0.12459,-0.10996,0,0
5,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.48131,-0.1247,-0.073082,0,0
5,GO ASSOCIATIVE LEARNING,0.063042,-0.12474,-0.09359,0,0
5,GO MITOCHONDRIAL FISSION,0.0069616,-0.12478,-0.12405,0,0
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.14526,-0.12481,-0.096777,0,0
5,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.015574,-0.12515,-0.1152,0,0
5,GO NEUROINFLAMMATORY RESPONSE,0.0040578,-0.1252,-0.16004,0,0
5,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.079444,-0.12567,-0.17262,0,0
5,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.090515,-0.12574,-0.13771,0,0
5,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.00092958,-0.1259,-0.19283,0,0
5,GO CELL RECOGNITION,0.0013457,-0.12613,-0.14067,0,0
5,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.21256,-0.12633,-0.12606,0,0
5,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.031059,-0.12646,-0.1442,0,0
5,GO CELL JUNCTION ORGANIZATION,0.0081404,-0.12668,-0.11325,0,0
5,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.11039,-0.12696,-0.10406,0,0
5,GO RESPONSE TO X RAY,0.11039,-0.12702,-0.12783,0,0
5,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.14769,-0.12726,-0.12485,0,0
5,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.11636,-0.12739,-0.12724,0,0
5,GO BONE MATURATION,0.043763,-0.12756,-0.12949,0,0
5,GO ENSHEATHMENT OF NEURONS,0.0025817,-0.12779,-0.12455,0,0
5,GO PROTEIN STABILIZATION,5.0226e-05,-0.12781,-0.13309,0,0
5,GO REGULATION OF MEMBRANE POTENTIAL,0.024846,-0.12785,-0.10076,0,0
5,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.50896,-0.12794,-0.071263,0,0
5,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.014138,-0.12795,-0.16598,0,0
5,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.02166,-0.12816,-0.11154,0,0
5,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.14048,-0.12827,-0.16762,0,0
5,GO REGULATION OF SYSTEM PROCESS,0.0013872,-0.12833,-0.12859,0,0
5,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.029068,-0.12836,-0.13686,0,0
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.17099,-0.12846,-0.079681,0,0
5,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.54321,-0.12855,-0.029919,0,0
5,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.00031859,-0.12858,-0.14772,0,0
5,GO TRIPARTITE REGIONAL SUBDIVISION,0.11841,-0.12869,-0.19336,0,0
5,GO RESPONSE TO AMYLOID BETA,0.0073363,-0.12876,-0.15306,0,0
5,GO LABYRINTHINE LAYER MORPHOGENESIS,0.38888,-0.12883,-0.078849,0,0
5,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,9.0551e-05,-0.12895,-0.10162,0,0
5,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.024846,-0.12911,-0.10948,0,0
5,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.21905,-0.12913,-0.21504,0,0
5,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.065563,-0.12919,-0.18208,0,0
5,GO ATP TRANSPORT,0.046579,-0.12929,-0.10164,0,0
5,GO NEURON CELLULAR HOMEOSTASIS,0.26098,-0.1293,-0.10515,0,0
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.0062634,-0.12944,-0.15431,0,0
5,GO STEM CELL DIVISION,0.072231,-0.12954,-0.11186,0,0
5,GO BEHAVIORAL RESPONSE TO COCAINE,0.26847,-0.12978,-0.089083,0,0
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.065563,-0.1298,-0.14163,0,0
5,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.088862,-0.13015,-0.22245,0,0
5,GO BASIC AMINO ACID TRANSPORT,0.033166,-0.13031,-0.19655,0,0
5,GO INTESTINAL ABSORPTION,0.10096,-0.13048,-0.14786,0,0
5,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.097379,-0.13052,-0.14248,0,0
5,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.0037331,-0.13098,-0.17273,0,0
5,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.66501,-0.13108,0.11551,0,0
5,GO ALPHA BETA T CELL PROLIFERATION,0.053746,-0.13142,-0.1485,0,0
5,GO RESPONSE TO INACTIVITY,0.11434,-0.13165,-0.15288,0,0
5,GO OVULATION CYCLE PROCESS,0.0050528,-0.1328,-0.16228,0,0
5,GO CELL JUNCTION ASSEMBLY,0.0075304,-0.13303,-0.11416,0,0
5,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.10845,-0.13351,-0.09269,0,0
5,GO CARDIAC MYOFIBRIL ASSEMBLY,0.21256,-0.13358,-0.089804,0,0
5,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.082489,-0.13361,-0.10285,0,0
5,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.043763,-0.13362,-0.10524,0,0
5,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.33812,-0.13364,-0.059672,0,0
5,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.013798,-0.13365,-0.12812,0,0
5,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.05824,-0.13366,-0.11409,0,0
5,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.00084609,-0.13367,-0.12882,0,0
5,GO APICAL JUNCTION ASSEMBLY,0.11636,-0.13368,-0.088277,0,0
5,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.2839,-0.13389,-0.057273,0,0
5,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.14526,-0.13391,-0.13035,0,0
5,GO REPLICATIVE SENESCENCE,0.076492,-0.13397,-0.1708,0,0
5,GO REGULATION OF HIPPO SIGNALING,0.063042,-0.13425,-0.19746,0,0
5,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.11235,-0.1345,-0.16083,0,0
5,GO RESPONSE TO NICOTINE,0.20309,-0.13463,-0.049711,0,0
5,GO LEUKOCYTE AGGREGATION,0.14285,-0.1349,-0.19313,0,0
5,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.057089,-0.13501,-0.15182,0,0
5,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.35153,-0.13507,-0.096669,0,0
5,GO PERICARDIUM DEVELOPMENT,0.25729,-0.13538,-0.087962,0,0
5,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.054842,-0.13561,-0.12672,0,0
5,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.19695,-0.13564,-0.12875,0,0
5,GO REGULATION OF CELL SHAPE,0.061812,-0.13568,-0.093721,0,0
5,GO UV PROTECTION,0.10465,-0.13568,-0.14197,0,0
5,GO REGULATION OF FATTY ACID BETA OXIDATION,0.13814,-0.13578,-0.08954,0,0
5,GO DOPAMINE METABOLIC PROCESS,0.29992,-0.13603,-0.045653,0,0
5,GO PANCREATIC JUICE SECRETION,0.029719,-0.13614,-0.13485,0,0
5,GO RESPONSE TO AXON INJURY,0.026586,-0.13649,-0.11631,0,0
5,GO KIDNEY MORPHOGENESIS,0.17653,-0.13668,-0.067757,0,0
5,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.17374,-0.13676,-0.13518,0,0
5,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0040578,-0.13724,-0.13027,0,0
5,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.23937,-0.13749,-0.07999,0,0
5,GO KERATINOCYTE PROLIFERATION,0.11636,-0.13767,-0.13082,0,0
5,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.097379,-0.1378,-0.1345,0,0
5,GO EXTRACELLULAR TRANSPORT,0.32938,-0.13805,-0.058321,0,0
5,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.070855,-0.13884,-0.14395,0,0
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.29586,-0.13921,-0.078497,0,0
5,GO DRINKING BEHAVIOR,0.12259,-0.13926,-0.16533,0,0
5,GO INTERMEMBRANE LIPID TRANSFER,0.0014299,-0.13968,-0.14461,0,0
5,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.17099,-0.13971,-0.10473,0,0
5,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.025414,-0.13974,-0.15333,0,0
5,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.20309,-0.13978,-0.2051,0,0
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.12049,-0.1402,-0.15823,0,0
5,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.36526,-0.14028,-0.082596,0,0
5,GO MYOFIBRIL ASSEMBLY,0.0099891,-0.1412,-0.12828,0,0
5,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.070855,-0.14174,-0.11913,0,0
5,GO POSITIVE REGULATION OF FERTILIZATION,0.080955,-0.14187,-0.18436,0,0
5,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.50896,-0.1419,-0.084016,0,0
5,GO PROTEIN TRANSMEMBRANE TRANSPORT,3.7791e-06,-0.14225,-0.17559,0,0
5,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.18508,-0.14225,-0.068177,0,0
5,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.16294,-0.14249,-0.13188,0,0
5,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.1313,-0.14249,-0.13098,0,0
5,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.065563,-0.14284,-0.31667,0,0
5,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.057089,-0.14291,-0.11474,0,0
5,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.15773,-0.1431,-0.097128,0,0
5,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.00057693,-0.14348,-0.16023,0,0
5,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.057089,-0.14365,-0.13981,0,0
5,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.077957,-0.14396,-0.15758,0,0
5,GO HEART FIELD SPECIFICATION,0.52025,-0.14468,-0.04469,0,0
5,GO REFLEX,0.31232,-0.14475,-0.11523,0,0
5,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.02068,-0.14495,-0.21959,0,0
5,GO REPLACEMENT OSSIFICATION,0.16828,-0.14513,-0.12602,0,0
5,GO RECEPTOR INTERNALIZATION,0.0011199,-0.14529,-0.13482,0,0
5,GO CELLULAR RESPONSE TO AMYLOID BETA,0.0053338,-0.14559,-0.16851,0,0
5,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.00014418,-0.14569,-0.15928,0,0
5,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.10096,-0.14572,-0.12018,0,0
5,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.044685,-0.14572,-0.12481,0,0
5,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.11039,-0.14574,-0.17984,0,0
5,GO DETECTION OF CALCIUM ION,0.24643,-0.1459,-0.11827,0,0
5,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.0087944,-0.14609,-0.11475,0,0
5,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.26471,-0.1463,-0.050921,0,0
5,GO CORONARY VASCULATURE MORPHOGENESIS,0.099158,-0.14636,-0.13671,0,0
5,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.72969,-0.14649,-3.1083e-05,0,0
5,GO PIGMENT CELL DIFFERENTIATION,0.009256,-0.14672,-0.14113,0,0
5,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.21579,-0.14707,-0.066886,0,0
5,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.011047,-0.14737,-0.13217,0,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.076492,-0.14744,-0.13673,0,0
5,GO CATECHOLAMINE METABOLIC PROCESS,0.33373,-0.1477,-0.044683,0,0
5,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.12689,-0.14795,-0.11795,0,0
5,GO RETROGRADE TRANS SYNAPTIC SIGNALING,0.18508,-0.1481,-0.15705,0,0
5,GO REGULATION OF DEACETYLASE ACTIVITY,0.082489,-0.14815,-0.099092,0,0
5,GO POSITIVE REGULATION OF CELL SIZE,0.085627,-0.14841,-0.13189,0,0
5,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.67776,-0.14862,-0.071413,0,0
5,GO MITOCHONDRIAL TRNA PROCESSING,0.057089,-0.14866,-0.15719,0,0
5,GO PROTEIN NITROSYLATION,0.026586,-0.14897,-0.15767,0,0
5,GO NEURONAL ION CHANNEL CLUSTERING,0.075049,-0.14916,-0.22522,0,0
5,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.17374,-0.1492,-0.089454,0,0
5,GO MRNA TRANSCRIPTION,0.090515,-0.1493,-0.11109,0,0
5,GO STEROID CATABOLIC PROCESS,0.010506,-0.14987,-0.16657,0,0
5,GO LIPID TRANSLOCATION,0.0695,-0.14997,-0.12629,0,0
5,GO CORNIFICATION,0.28785,-0.15005,-0.07828,0,0
5,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.0060989,-0.15024,-0.14002,0,0
5,GO ALPHA AMINO ACID CATABOLIC PROCESS,3.4421e-05,-0.15045,-0.2065,0,0
5,GO ODONTOGENESIS,0.012508,-0.15057,-0.15223,0,0
5,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,0.33373,-0.15078,-0.12142,0,0
5,GO PROTEIN COMPLEX OLIGOMERIZATION,3.3287e-06,-0.15087,-0.16577,0,0
5,GO CELLULAR RESPONSE TO CAMP,0.009256,-0.15129,-0.14034,0,0
5,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0028141,-0.15174,-0.12752,0,0
5,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.044685,-0.15217,-0.16271,0,0
5,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.25363,-0.15217,-0.13063,0,0
5,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.073629,-0.15219,-0.10861,0,0
5,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.35153,-0.15229,-0.051495,0,0
5,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.00031859,-0.15247,-0.1864,0,0
5,GO SKELETAL MUSCLE CONTRACTION,0.0075304,-0.1525,-0.183,0,0
5,GO TRIGLYCERIDE CATABOLIC PROCESS,0.16559,-0.15295,-0.086899,0,0
5,GO REGULATION OF DENDRITE EXTENSION,0.13814,-0.153,-0.044463,0,0
5,GO GROOMING BEHAVIOR,0.68418,-0.15313,-0.0017132,0,0
5,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.027803,-0.15324,-0.12177,0,0
5,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,1.5816e-05,-0.15352,-0.13137,0,0
5,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.082489,-0.1536,-0.11642,0,0
5,GO NEURONAL ACTION POTENTIAL,0.17374,-0.1539,-0.1034,0,0
5,GO FACIAL NERVE MORPHOGENESIS,0.29586,-0.15436,-0.1018,0,0
5,GO POSITIVE REGULATION OF ION TRANSPORT,5.4121e-05,-0.15463,-0.16822,0,0
5,GO PIGMENT ACCUMULATION,0.064293,-0.15479,-0.12869,0,0
5,GO MALE MEIOTIC NUCLEAR DIVISION,0.054842,-0.15481,-0.1252,0,0
5,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.063042,-0.15498,-0.17015,0,0
5,GO GLIAL CELL DEVELOPMENT,0.0081404,-0.15506,-0.13073,0,0
5,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.00040247,-0.15506,-0.23354,0,0
5,GO LIPOXYGENASE PATHWAY,0.084046,-0.15509,-0.2016,0,0
5,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.14048,-0.15522,-0.14824,0,0
5,GO SUCKLING BEHAVIOR,0.13583,-0.15587,-0.1157,0,0
5,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.10096,-0.15613,-0.10348,0,0
5,GO LONG TERM MEMORY,0.064293,-0.15621,-0.12751,0,0
5,GO POTASSIUM ION TRANSPORT,0.020205,-0.15628,-0.1059,0,0
5,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.001191,-0.15635,-0.16703,0,0
5,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.15517,-0.15642,-0.087164,0,0
5,GO MITOCHONDRIAL RNA PROCESSING,0.016734,-0.15663,-0.19277,0,0
5,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.023205,-0.15681,-0.14325,0,0
5,GO SMOOTH MUSCLE CONTRACTION,3.5759e-05,-0.15684,-0.18612,0,0
5,GO REGULATION OF CAMP MEDIATED SIGNALING,0.010773,-0.15711,-0.14426,0,0
5,GO METANEPHROS MORPHOGENESIS,0.11636,-0.15713,-0.10267,0,0
5,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.11434,-0.1573,-0.14833,0,0
5,GO AMINE TRANSPORT,0.188,-0.15731,-0.056039,0,0
5,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.060602,-0.15735,-0.19461,0,0
5,GO MONOVALENT INORGANIC CATION TRANSPORT,0.0031536,-0.15747,-0.12136,0,0
5,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.092194,-0.15764,-0.18472,0,0
5,GO NEUROMUSCULAR PROCESS,0.010245,-0.15782,-0.12171,0,0
5,GO REGULATION OF MAST CELL ACTIVATION,0.072231,-0.15789,-0.10828,0,0
5,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.097379,-0.15856,-0.14389,0,0
5,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.090515,-0.15879,-0.1714,0,0
5,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.17374,-0.15912,-0.19846,0,0
5,GO PARAXIAL MESODERM DEVELOPMENT,0.11235,-0.15916,-0.14552,0,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.23245,-0.15934,-0.088497,0,0
5,GO RESPONSE TO ATP,0.00042998,-0.15939,-0.16354,0,0
5,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.011047,-0.15952,-0.188,0,0
5,GO PEROXISOMAL MEMBRANE TRANSPORT,0.0060989,-0.15989,-0.13405,0,0
5,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.13583,-0.15992,-0.15286,0,0
5,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.068167,-0.16014,-0.15245,0,0
5,GO RESPONSE TO HISTAMINE,0.063042,-0.1604,-0.23698,0,0
5,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.10096,-0.16063,-0.14162,0,0
5,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.12473,-0.16068,-0.10315,0,0
5,GO CELLULAR ANION HOMEOSTASIS,0.11841,-0.16077,-0.10933,0,0
5,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.024846,-0.16081,-0.16714,0,0
5,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.00025131,-0.16098,-0.14479,0,0
5,GO PLASMA MEMBRANE TUBULATION,0.080955,-0.16154,-0.1278,0,0
5,GO ONE CARBON METABOLIC PROCESS,0.0015653,-0.16185,-0.18147,0,0
5,GO CHYLOMICRON ASSEMBLY,0.00026903,-0.16204,-0.21735,0,0
5,GO RESPONSE TO MUSCLE INACTIVITY,0.32506,-0.16222,-0.055515,0,0
5,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.00079435,-0.16293,-0.14576,0,0
5,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.03939,-0.163,-0.17198,0,0
5,GO REGULATION OF SYNAPSE ASSEMBLY,0.023205,-0.1631,-0.14138,0,0
5,GO LOCOMOTOR RHYTHM,0.072231,-0.16322,-0.13109,0,0
5,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.031748,-0.16322,-0.13833,0,0
5,GO TRANSMISSION OF NERVE IMPULSE,0.073629,-0.16333,-0.11518,0,0
5,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.097379,-0.16351,-0.13501,0,0
5,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.070855,-0.1636,-0.11513,0,0
5,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.11039,-0.16365,-0.14756,0,0
5,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.036948,-0.16409,-0.21791,0,0
5,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.0051916,-0.16425,-0.17399,0,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.02166,-0.16429,-0.16334,0,0
5,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.052669,-0.16439,-0.1411,0,0
5,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.17653,-0.16442,-0.10906,0,0
5,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.057089,-0.1648,-0.18453,0,0
5,GO RESPONSE TO VITAMIN A,0.092194,-0.16494,-0.12224,0,0
5,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.05824,-0.16498,-0.12654,0,0
5,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.16828,-0.16547,-0.11501,0,0
5,GO NEPHRIC DUCT MORPHOGENESIS,0.021165,-0.16572,-0.27228,0,0
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,1.4044e-06,-0.16594,-0.17128,0,0
5,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.068167,-0.16625,-0.15843,0,0
5,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.075049,-0.16671,-0.20944,0,0
5,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.16828,-0.16679,-0.12329,0,0
5,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.0087944,-0.16689,-0.15856,0,0
5,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.20621,-0.1669,-0.16535,0,0
5,GO MUSCLE CELL DEVELOPMENT,0.0006154,-0.16705,-0.1572,0,0
5,GO NEUROPEPTIDE SIGNALING PATHWAY,0.011326,-0.16732,-0.1546,0,0
5,GO ACTIVATION OF JUN KINASE ACTIVITY,0.19095,-0.1674,-0.066091,0,0
5,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.073629,-0.16753,-0.19211,0,0
5,GO MUSCLE ATROPHY,0.15015,-0.16802,-0.12974,0,0
5,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.19695,-0.16867,-0.19807,0,0
5,GO COCHLEA MORPHOGENESIS,0.070855,-0.169,-0.16039,0,0
5,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.036948,-0.16925,-0.16671,0,0
5,GO RENAL FILTRATION,0.67776,-0.16927,-0.048957,0,0
5,GO RENAL VESICLE DEVELOPMENT,0.017549,-0.16937,-0.19777,0,0
5,GO REGULATION OF TUBULIN DEACETYLATION,0.17653,-0.16941,-0.099946,0,0
5,GO REGULATION OF VASCULAR PERMEABILITY,0.0028957,-0.17028,-0.17993,0,0
5,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0060989,-0.17031,-0.18954,0,0
5,GO HYPEROSMOTIC RESPONSE,0.066855,-0.17037,-0.1315,0,0
5,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.016339,-0.17051,-0.14234,0,0
5,GO GLIAL CELL MIGRATION,0.0064317,-0.17068,-0.1813,0,0
5,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.0027346,-0.1711,-0.17768,0,0
5,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.00052342,-0.17172,-0.20999,0,0
5,GO RESPONSE TO ORGANOPHOSPHORUS,1.6455e-05,-0.17179,-0.19402,0,0
5,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.14526,-0.17217,-0.17817,0,0
5,GO GAP JUNCTION ASSEMBLY,0.084046,-0.17241,-0.18289,0,0
5,GO REGULATION OF NEURON MATURATION,0.095625,-0.17262,-0.12466,0,0
5,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.0057817,-0.17305,-0.16474,0,0
5,GO ELECTRON TRANSPORT CHAIN,0.00010462,-0.17315,-0.19386,0,0
5,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.14048,-0.17316,-0.083795,0,0
5,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.33373,-0.17317,-0.093404,0,0
5,GO REGULATION OF FAT CELL DIFFERENTIATION,0.0049174,-0.17334,-0.15093,0,0
5,GO MODIFIED AMINO ACID TRANSPORT,0.0012662,-0.17337,-0.19934,0,0
5,GO ORGANIC CATION TRANSPORT,0.0019282,-0.17338,-0.18026,0,0
5,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.1028,-0.17357,-0.15983,0,0
5,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0069616,-0.1738,-0.1861,0,0
5,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.047551,-0.17385,-0.12563,0,0
5,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.13583,-0.17402,-0.1658,0,0
5,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,7.2111e-07,-0.17455,-0.18446,0,0
5,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.055956,-0.17471,-0.14397,0,0
5,GO RESPONSE TO CAMP,6.5149e-05,-0.17474,-0.20177,0,0
5,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.16032,-0.17501,-0.15651,0,0
5,GO ANOIKIS,0.060602,-0.17503,-0.14795,0,0
5,GO NEGATIVE REGULATION OF CELL AGING,0.19695,-0.17514,-0.12569,0,0
5,GO REGULATION OF RESPIRATORY BURST,0.082489,-0.17515,-0.16072,0,0
5,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.0010528,-0.17527,-0.17278,0,0
5,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.082489,-0.17556,-0.1124,0,0
5,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.00019753,-0.17614,-0.18313,0,0
5,GO GONADOTROPIN SECRETION,0.28785,-0.17654,-0.063664,0,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.0023671,-0.1766,-0.25663,0,0
5,GO REGULATION OF CHLORIDE TRANSPORT,0.05824,-0.1769,-0.15611,0,0
5,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.057089,-0.17715,-0.18217,0,0
5,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.082489,-0.17826,-0.1883,0,0
5,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.029719,-0.17854,-0.28761,0,0
5,GO MUSCLE SYSTEM PROCESS,9.4334e-07,-0.17901,-0.19434,0,0
5,GO REGULATION OF METAL ION TRANSPORT,7.3528e-06,-0.17902,-0.17448,0,0
5,GO REGULATION OF TRANSPORTER ACTIVITY,0.00026003,-0.1792,-0.17194,0,0
5,GO ACYLGLYCEROL HOMEOSTASIS,0.0001547,-0.17961,-0.21269,0,0
5,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.13583,-0.17969,-0.1809,0,0
5,GO HEART PROCESS,0.00017796,-0.18012,-0.18416,0,0
5,GO POSITIVE REGULATION OF OSSIFICATION,0.0016129,-0.18052,-0.20482,0,0
5,GO ORGAN INDUCTION,0.0034322,-0.18092,-0.19231,0,0
5,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.0010206,-0.18103,-0.23299,0,0
5,GO MEMBRANE REPOLARIZATION,0.0017641,-0.1812,-0.19639,0,0
5,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.11434,-0.18152,-0.1205,0,0
5,GO CELLULAR AMINO ACID CATABOLIC PROCESS,2.7343e-05,-0.18183,-0.21483,0,0
5,GO RIBOSE PHOSPHATE METABOLIC PROCESS,5.0194e-07,-0.18207,-0.19346,0,0
5,GO PROTEIN ACTIVATION CASCADE,0.00063551,-0.18209,-0.2495,0,0
5,GO CARDIAC VENTRICLE DEVELOPMENT,0.0094949,-0.18214,-0.14727,0,0
5,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,1.104e-05,-0.18231,-0.17836,0,0
5,GO SEROTONIN METABOLIC PROCESS,0.28785,-0.18242,-0.10344,0,0
5,GO TYPE B PANCREATIC CELL PROLIFERATION,0.065563,-0.18267,-0.23492,0,0
5,GO MUSCLE CONTRACTION,9.8628e-07,-0.18273,-0.2016,0,0
5,GO ANATOMICAL STRUCTURE REGRESSION,0.007729,-0.183,-0.24519,0,0
5,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.072231,-0.18325,-0.19736,0,0
5,GO VENTRICULAR SEPTUM DEVELOPMENT,0.025414,-0.18397,-0.1576,0,0
5,GO MITOTIC CELL CYCLE ARREST,0.23937,-0.18411,-0.077164,0,0
5,GO DERMATAN SULFATE METABOLIC PROCESS,0.11039,-0.1845,-0.21025,0,0
5,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.00019753,-0.18455,-0.15821,0,0
5,GO VITAMIN D BIOSYNTHETIC PROCESS,0.15517,-0.18466,-0.13912,0,0
5,GO POSITIVE REGULATION OF MYELINATION,0.00059588,-0.18474,-0.20163,0,0
5,GO REGULATION OF MUSCLE CONTRACTION,5.2837e-06,-0.18506,-0.20734,0,0
5,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.082489,-0.18576,-0.14869,0,0
5,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.0071468,-0.18673,-0.20238,0,0
5,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.090515,-0.18704,-0.20282,0,0
5,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.031748,-0.18709,-0.1905,0,0
5,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.0010528,-0.18734,-0.26275,0,0
5,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.0695,-0.18795,-0.24925,0,0
5,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.020205,-0.1882,-0.14754,0,0
5,GO TETRAHYDROFOLATE INTERCONVERSION,0.0051916,-0.18833,-0.21195,0,0
5,GO COMPLEMENT ACTIVATION,0.00013917,-0.18856,-0.23424,0,0
5,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.065563,-0.18868,-0.090667,0,0
5,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.061812,-0.18895,-0.24185,0,0
5,GO TRICARBOXYLIC ACID CYCLE,0.00047456,-0.18913,-0.21692,0,0
5,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0097392,-0.18914,-0.14005,0,0
5,GO REGULATION OF CALCIUM ION TRANSPORT,1.906e-06,-0.18945,-0.21004,0,0
5,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.0053338,-0.18951,-0.14349,0,0
5,GO SERTOLI CELL DEVELOPMENT,0.055956,-0.18965,-0.1681,0,0
5,GO MYELIN ASSEMBLY,0.0042883,-0.18995,-0.20408,0,0
5,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0094949,-0.19012,-0.19521,0,0
5,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.033894,-0.19026,-0.16924,0,0
5,GO REGULATION OF BIOMINERALIZATION,5.0226e-05,-0.19086,-0.22659,0,0
5,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00074557,-0.19096,-0.20624,0,0
5,GO MECHANOSENSORY BEHAVIOR,0.41842,-0.19107,-0.057516,0,0
5,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.099158,-0.19157,-0.13702,0,0
5,GO POSITIVE REGULATION OF JNK CASCADE,0.00012512,-0.19214,-0.16283,0,0
5,GO LEYDIG CELL DIFFERENTIATION,0.19095,-0.19243,-0.14418,0,0
5,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0038387,-0.19301,-0.22559,0,0
5,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.0032441,-0.19343,-0.20033,0,0
5,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.25729,-0.19359,-0.088262,0,0
5,GO PLASMA MEMBRANE REPAIR,0.14526,-0.19376,-0.12202,0,0
5,GO PARAXIAL MESODERM MORPHOGENESIS,0.10845,-0.19386,-0.17257,0,0
5,GO CELLULAR RESPONSE TO PH,0.0025083,-0.19405,-0.18166,0,0
5,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.00023468,-0.19435,-0.17589,0,0
5,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.00031859,-0.19478,-0.26106,0,0
5,GO GENITALIA DEVELOPMENT,0.00018427,-0.19482,-0.18227,0,0
5,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,3.4421e-05,-0.19488,-0.17843,0,0
5,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.00037661,-0.19537,-0.16214,0,0
5,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.42347,-0.19557,-0.075129,0,0
5,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.073629,-0.19591,-0.20948,0,0
5,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.10465,-0.19611,-0.15267,0,0
5,GO EXTRACELLULAR MATRIX ASSEMBLY,0.0046564,-0.19632,-0.25546,0,0
5,GO PSEUDOPODIUM ORGANIZATION,0.15264,-0.19641,-0.16278,0,0
5,GO MYELIN MAINTENANCE,0.0097392,-0.19738,-0.25954,0,0
5,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00038934,-0.1975,-0.18888,0,0
5,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.0042883,-0.19784,-0.18553,0,0
5,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,7.8282e-05,-0.19787,-0.2329,0,0
5,GO KIDNEY MESENCHYME DEVELOPMENT,0.054842,-0.19797,-0.17046,0,0
5,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.00026903,-0.19818,-0.20537,0,0
5,GO POSITIVE REGULATION OF ENDOCYTOSIS,3.8583e-05,-0.19824,-0.2206,0,0
5,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.055956,-0.19859,-0.22992,0,0
5,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.00038934,-0.19888,-0.26138,0,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.084046,-0.19959,-0.12716,0,0
5,GO VASCULAR TRANSPORT,0.059411,-0.20023,-0.24442,0,0
5,GO REGULATION OF CELL JUNCTION ASSEMBLY,9.389e-05,-0.20024,-0.18688,0,0
5,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.22568,-0.20035,-0.097701,0,0
5,GO ANIMAL ORGAN MATURATION,0.0062634,-0.20041,-0.17195,0,0
5,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.092194,-0.20041,-0.091375,0,0
5,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.036164,-0.2009,-0.17064,0,0
5,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.007729,-0.20195,-0.16362,0,0
5,GO ENDOTHELIAL CELL PROLIFERATION,4.8379e-05,-0.20203,-0.22345,0,0
5,GO RESPONSE TO SALT,0.00079435,-0.2025,-0.16118,0,0
5,GO NEGATIVE REGULATION OF AUTOPHAGY,1.8521e-05,-0.20295,-0.20963,0,0
5,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,2.5122e-07,-0.20394,-0.20644,0,0
5,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.0079323,-0.20436,-0.17123,0,0
5,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.0046564,-0.20614,-0.20865,0,0
5,GO INDOLALKYLAMINE METABOLIC PROCESS,0.093897,-0.20635,-0.14345,0,0
5,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,1.0604e-05,-0.20752,-0.20772,0,0
5,GO IMPORT INTO CELL,6.5149e-05,-0.20869,-0.19233,0,0
5,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.0094949,-0.20893,-0.18058,0,0
5,GO EXPLORATION BEHAVIOR,0.015953,-0.20908,-0.1913,0,0
5,GO REGULATION OF GLOMERULAR FILTRATION,0.57857,-0.20936,-0.057499,0,0
5,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,3.7791e-06,-0.20962,-0.21359,0,0
5,GO RESPONSE TO LIGHT INTENSITY,0.007729,-0.20966,-0.20859,0,0
5,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,5.7413e-06,-0.21009,-0.21297,0,0
5,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.088862,-0.21055,-0.14857,0,0
5,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.041093,-0.2108,-0.17209,0,0
5,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.010773,-0.2114,-0.30444,0,0
5,GO RRNA CATABOLIC PROCESS,0.17653,-0.21188,-0.077463,0,0
5,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.00031859,-0.21258,-0.21542,0,0
5,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.079444,-0.21271,-0.15013,0,0
5,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.00025131,-0.21278,-0.17136,0,0
5,GO CERAMIDE TRANSPORT,0.0021689,-0.21321,-0.23131,0,0
5,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.065563,-0.21345,-0.11854,0,0
5,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.024846,-0.21393,-0.19799,0,0
5,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.022165,-0.21455,-0.16647,0,0
5,GO REGULATION OF BONE MINERALIZATION,2.0833e-05,-0.2146,-0.25424,0,0
5,GO MACROPHAGE ACTIVATION,1.9263e-05,-0.21468,-0.22347,0,0
5,GO MONOAMINE TRANSPORT,0.061812,-0.21557,-0.081465,0,0
5,GO DICARBOXYLIC ACID METABOLIC PROCESS,8.3127e-06,-0.21643,-0.22201,0,0
5,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,3.9418e-06,-0.21684,-0.22271,0,0
5,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,7.8282e-05,-0.2175,-0.21578,0,0
5,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0038387,-0.21752,-0.20803,0,0
5,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.093897,-0.21815,-0.16207,0,0
5,GO ANION HOMEOSTASIS,0.00067758,-0.21841,-0.20465,0,0
5,GO REGULATION OF CATION CHANNEL ACTIVITY,0.00081984,-0.21847,-0.184,0,0
5,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.05824,-0.21872,-0.15295,0,0
5,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.075049,-0.21905,-0.12913,0,0
5,GO DISACCHARIDE METABOLIC PROCESS,0.0097392,-0.21939,-0.22914,0,0
5,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.0069616,-0.21941,-0.16951,0,0
5,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.038561,-0.21945,-0.24328,0,0
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,7.013e-05,-0.22041,-0.20419,0,0
5,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.073629,-0.22287,-0.1659,0,0
5,GO FEMALE GENITALIA DEVELOPMENT,0.014138,-0.22328,-0.17503,0,0
5,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.38888,-0.22377,-0.11017,0,0
5,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,2.4346e-05,-0.22567,-0.20396,0,0
5,GO MULTICELLULAR ORGANISMAL SIGNALING,0.0041716,-0.22675,-0.16376,0,0
5,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.12049,-0.22719,-0.1276,0,0
5,GO INACTIVATION OF MAPK ACTIVITY,0.013465,-0.2275,-0.21131,0,0
5,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,1.5201e-05,-0.22777,-0.25504,0,0
5,GO STRIATED MUSCLE CONTRACTION,5.4121e-05,-0.22942,-0.2147,0,0
5,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.001986,-0.23063,-0.19097,0,0
5,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.068167,-0.23128,-0.14516,0,0
5,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.04854,-0.23143,-0.22941,0,0
5,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.00014935,-0.23153,-0.31756,0,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.001872,-0.23172,-0.2041,0,0
5,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.00079435,-0.23337,-0.18695,0,0
5,GO DETOXIFICATION,8.3127e-06,-0.23381,-0.25247,0,0
5,GO CATECHOLAMINE UPTAKE,0.0066042,-0.23463,-0.24439,0,0
5,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,9.3916e-06,-0.23561,-0.2124,0,0
5,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,3.7791e-06,-0.23637,-0.22819,0,0
5,GO EXPORT ACROSS PLASMA MEMBRANE,0.0013872,-0.23653,-0.2052,0,0
5,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.066855,-0.23695,-0.21619,0,0
5,GO MACROPHAGE APOPTOTIC PROCESS,0.01282,-0.23822,-0.2119,0,0
5,GO CARDIAC CONDUCTION,0.0013457,-0.23853,-0.19286,0,0
5,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.25001,-0.23998,-0.08153,0,0
5,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.00081984,-0.24124,-0.21283,0,0
5,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.14048,-0.24216,-0.21668,0,0
5,GO POLYSACCHARIDE CATABOLIC PROCESS,2.9532e-05,-0.24258,-0.25066,0,0
5,GO STARTLE RESPONSE,0.22568,-0.24296,-0.10611,0,0
5,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.56075,-0.24337,-0.04952,0,0
5,GO PROTEIN LOCALIZATION TO AXON,0.23937,-0.24371,-0.11649,0,0
5,GO REGULATION OF CARDIAC CONDUCTION,5.4121e-05,-0.24442,-0.232,0,0
5,GO VITAMIN TRANSPORT,2.0833e-05,-0.24464,-0.26271,0,0
5,GO ACTIVATION OF MAPKKK ACTIVITY,0.02166,-0.24505,-0.19841,0,0
5,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.11039,-0.24537,-0.19067,0,0
5,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.11636,-0.24596,-0.14249,0,0
5,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.013465,-0.24623,-0.21227,0,0
5,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.010245,-0.24666,-0.21656,0,0
5,GO THIOESTER METABOLIC PROCESS,6.7728e-06,-0.24734,-0.23751,0,0
5,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.065563,-0.24832,-0.18096,0,0
5,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0017641,-0.24946,-0.25391,0,0
5,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.011047,-0.24957,-0.2344,0,0
5,GO REGULATION OF VESICLE FUSION,0.0090226,-0.24961,-0.26153,0,0
5,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0045306,-0.25017,-0.2406,0,0
5,GO ACTION POTENTIAL,0.001191,-0.25044,-0.18594,0,0
5,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,4.3218e-05,-0.25098,-0.3309,0,0
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,4.6597e-05,-0.25156,-0.24907,0,0
5,GO INNERVATION,0.22235,-0.2521,-0.077151,0,0
5,GO ENAMEL MINERALIZATION,0.068167,-0.2521,-0.20024,0,0
5,GO CATECHOLAMINE SECRETION,0.061812,-0.25259,-0.083799,0,0
5,GO BICARBONATE TRANSPORT,0.00035231,-0.25414,-0.20943,0,0
5,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.014138,-0.25485,-0.19733,0,0
5,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.00010092,-0.25579,-0.27595,0,0
5,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.053746,-0.25795,-0.25986,0,0
5,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.057089,-0.25827,-0.14327,0,0
5,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,2.3654e-06,-0.25831,-0.25675,0,0
5,GO CARDIAC MUSCLE CONTRACTION,4.1617e-05,-0.25847,-0.22845,0,0
5,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00084609,-0.25895,-0.24932,0,0
5,GO GLIAL CELL APOPTOTIC PROCESS,0.47049,-0.25915,-0.084307,0,0
5,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.0033369,-0.26051,-0.26205,0,0
5,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.00034072,-0.26107,-0.26509,0,0
5,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,5.0683e-06,-0.26158,-0.24242,0,0
5,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.00072223,-0.2618,-0.32391,0,0
5,GO HOMOCYSTEINE METABOLIC PROCESS,0.00059588,-0.26197,-0.35718,0,0
5,GO RESPONSE TO AMINE,3.5759e-05,-0.2625,-0.28748,0,0
5,GO KETONE BODY METABOLIC PROCESS,0.0031536,-0.26269,-0.26093,0,0
5,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,3.0576e-06,-0.26384,-0.29973,0,0
5,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,2.3418e-05,-0.26416,-0.25489,0,0
5,GO CELLULAR RESPONSE TO ZINC ION,0.0049174,-0.26447,-0.41901,0,0
5,GO COPPER ION TRANSPORT,0.00019079,-0.26524,-0.27507,0,0
5,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,9.0179e-06,-0.26594,-0.29158,0,0
5,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,2.2524e-05,-0.26596,-0.27588,0,0
5,GO ZINC ION HOMEOSTASIS,0.0087944,-0.26673,-0.2532,0,0
5,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.20621,-0.26757,-0.18345,0,0
5,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.03939,-0.26768,-0.19645,0,0
5,GO RESPONSE TO HYDROPEROXIDE,0.0050528,-0.27121,-0.27581,0,0
5,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,3.8583e-05,-0.27168,-0.26911,0,0
5,GO RESPONSE TO ZINC ION,0.0017123,-0.27599,-0.26421,0,0
5,GO REGULATION OF DOPAMINE SECRETION,0.041967,-0.2767,-0.17574,0,0
5,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00038934,-0.27732,-0.25749,0,0
5,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.053746,-0.27756,-0.20431,0,0
5,GO PROTEIN REFOLDING,0.00018427,-0.27847,-0.27488,0,0
5,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.064293,-0.27985,-0.24689,0,0
5,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.0030654,-0.28012,-0.23682,0,0
5,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.0021062,-0.28342,-0.32316,0,0
5,GO NEPHRIC DUCT DEVELOPMENT,0.0014738,-0.28432,-0.30614,0,0
5,GO REGULATION OF HEART RATE,7.547e-05,-0.28525,-0.24992,0,0
5,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,2.1702e-06,-0.2856,-0.29594,0,0
5,GO CELLULAR RESPONSE TO COPPER ION,0.0050528,-0.28574,-0.37856,0,0
5,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.0014299,-0.28588,-0.27021,0,0
5,GO RIBONUCLEOTIDE CATABOLIC PROCESS,6.7596e-05,-0.28741,-0.2799,0,0
5,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.059411,-0.28761,-0.17559,0,0
5,GO RESPONSE TO PAIN,0.00018427,-0.28811,-0.33119,0,0
5,GO NEUROTRANSMITTER UPTAKE,0.0028141,-0.28828,-0.22422,0,0
5,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.0039469,-0.2883,-0.19898,0,0
5,GO BEHAVIORAL RESPONSE TO PAIN,0.00020448,-0.28847,-0.42688,0,0
5,GO RESPONSE TO MUSCLE STRETCH,0.0025083,-0.29116,-0.30942,0,0
5,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.00012074,-0.29274,-0.32054,0,0
5,GO CYTOCHROME COMPLEX ASSEMBLY,0.00069957,-0.29275,-0.23396,0,0
5,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.063042,-0.29399,-0.2084,0,0
5,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.00024286,-0.29416,-0.25615,0,0
5,GO INTERMEDIATE FILAMENT ORGANIZATION,0.00092958,-0.29421,-0.26395,0,0
5,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.0062634,-0.29423,-0.2331,0,0
5,GO FATTY ACYL COA METABOLIC PROCESS,0.00026003,-0.29468,-0.2479,0,0
5,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,3.5759e-05,-0.29584,-0.32042,0,0
5,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0037331,-0.29594,-0.29088,0,0
5,GO CELLULAR RESPONSE TO ETHANOL,0.0033369,-0.30212,-0.22876,0,0
5,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.00027832,-0.30418,-0.28559,0,0
5,GO PROTEIN TRIMERIZATION,5.4121e-05,-0.30884,-0.36965,0,0
5,GO DETOXIFICATION OF INORGANIC COMPOUND,0.052669,-0.30947,-0.48334,0,0
5,GO CARDIAC MUSCLE CELL CONTRACTION,0.00010845,-0.31008,-0.26424,0,0
5,GO ACTIN MEDIATED CELL CONTRACTION,3.6228e-06,-0.31117,-0.28996,0,0
5,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.0079323,-0.31146,-0.31192,0,0
5,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.00014418,-0.3131,-0.30359,0,0
5,GO REGULATION OF CELLULAR RESPIRATION,1.1493e-05,-0.31389,-0.32741,0,0
5,GO DOPAMINE BIOSYNTHETIC PROCESS,0.27611,-0.31661,-0.15441,0,0
5,GO RELAXATION OF MUSCLE,3.4421e-05,-0.31822,-0.32155,0,0
5,GO NEUROTRANSMITTER REUPTAKE,0.001191,-0.32135,-0.28389,0,0
5,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.001228,-0.32292,-0.29679,0,0
5,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.012508,-0.32569,-0.26711,0,0
5,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.00042998,-0.32771,-0.3161,0,0
5,GO AMINO ACID ACTIVATION,9.389e-05,-0.3282,-0.27381,0,0
5,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.00035231,-0.33124,-0.33316,0,0
5,GO DOPAMINE TRANSPORT,0.015203,-0.33295,-0.18134,0,0
5,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.00029782,-0.33964,-0.38791,0,0
5,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.0018173,-0.34028,-0.31167,0,0
5,GO INCLUSION BODY ASSEMBLY,0.00013917,-0.34739,-0.31934,0,0
5,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.02268,-0.34827,-0.25171,0,0
5,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.059411,-0.35195,-0.26032,0,0
5,GO STEROID HORMONE BIOSYNTHETIC PROCESS,5.4977e-07,-0.3522,-0.38936,0,0
5,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.0012662,-0.35284,-0.25051,0,0
5,GO RELAXATION OF CARDIAC MUSCLE,0.00025131,-0.35407,-0.35967,0,0
5,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,5.9841e-06,-0.35415,-0.30354,0,0
5,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.02068,-0.36053,-0.2837,0,0
5,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.0022332,-0.3639,-0.28188,0,0
5,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.010506,-0.37784,-0.2663,0,0
5,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.0081404,-0.37865,-0.28814,0,0
5,GO POSITIVE REGULATION OF VESICLE FUSION,0.0028141,-0.37865,-0.41576,0,0
5,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,2.3418e-05,-0.3791,-0.3505,0,0
5,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,3.7791e-06,-0.3821,-0.33707,0,0
5,GO NUCLEOTIDE SALVAGE,5.2837e-06,-0.38253,-0.47451,0,0
5,GO MINERALOCORTICOID METABOLIC PROCESS,2.8418e-05,-0.38366,-0.45049,0,0
5,GO BASEMENT MEMBRANE ASSEMBLY,0.0025817,-0.38372,-0.35484,0,0
5,GO VITAMIN TRANSMEMBRANE TRANSPORT,6.7596e-05,-0.38538,-0.36746,0,0
5,GO ESTROGEN BIOSYNTHETIC PROCESS,4.2876e-06,-0.38728,-0.39161,0,0
5,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.0045306,-0.38744,-0.34707,0,0
5,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00014418,-0.38804,-0.48107,0,0
5,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.00017186,-0.39434,-0.35197,0,0
5,GO ARGININE METABOLIC PROCESS,0.00037661,-0.39643,-0.37605,0,0
5,GO NADH METABOLIC PROCESS,6.4994e-06,-0.40048,-0.3627,0,0
5,GO HEPARIN METABOLIC PROCESS,4.8379e-05,-0.42313,-0.43483,0,0
5,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00026003,-0.44146,-0.35095,0,0
5,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.00027832,-0.44936,-0.42252,0,0
5,GO HEART INDUCTION,0.00095906,-0.46333,-0.38167,0,0
5,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.00013917,-0.47155,-0.42526,0,0
5,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.00010092,-0.48708,-0.4881,0,0
5,GO REGULATION OF MONOCYTE DIFFERENTIATION,3.5759e-05,-0.49783,-0.46999,0,0
5,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,1.1267e-06,-0.5331,-0.60074,0,0
5,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,1.104e-05,-0.56083,-0.5082,0,0
5,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,6.5896e-07,-0.56341,-0.58498,0,0
